data_2rnm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rnm _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.842 0.354 . . . . 73.13 110.899 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -83.94 114.16 21.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 62.22 110.858 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 2.6 m -133.97 144.42 48.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 64.34 110.853 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.05 127.27 41.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 74.55 111.076 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -42.96 37.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 73.43 110.952 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -164.99 138.34 4.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 75.31 110.906 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 3.1 mp -138.43 117.14 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 75.35 111.113 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -113.59 123.31 49.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 75.33 110.874 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.8 p -135.4 141.74 45.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 74.13 111.175 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.6 pm0 -149.2 167.69 25.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.4 110.886 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 68.56 68.85 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 75.21 110.89 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 47.43 55.68 7.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 65.24 110.844 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.4 156.78 17.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 60.31 111.064 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -125.79 142.77 51.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 73.15 110.896 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 5.4 p -142.99 131.28 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 74.04 111.127 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -138.02 137.26 37.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 73.13 110.89 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.69 118.23 33.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.454 . . . . 75.13 110.876 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 146.67 -176.74 25.41 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.701 -0.761 . . . . 74.42 112.481 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -85.92 140.38 30.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.903 0.382 . . . . 64.0 110.882 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 30.1 t -111.82 115.33 49.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 75.33 111.146 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 64.7 t -103.96 128.84 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.41 111.136 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 74.32 111.121 -179.924 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.877 0.37 . . . . 72.31 111.115 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 84.7 m -92.03 120.36 32.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 71.04 111.157 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -101.75 119.52 38.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 74.34 110.931 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 17.6 t -142.06 123.98 15.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.43 110.806 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.9 p -110.75 137.77 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 73.34 111.107 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.44 -76.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 73.04 110.857 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 17.5 p -129.41 129.5 44.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 72.45 111.136 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 19.3 t -118.39 120.75 65.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 74.13 111.11 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 26.0 t -111.32 126.49 68.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 63.02 111.1 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.75 132.94 8.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.743 -0.741 . . . . 71.54 112.466 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.73 147.41 52.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.832 0.348 . . . . 73.25 110.87 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 59.66 71.76 0.72 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.713 -0.756 . . . . 75.24 112.451 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 50.06 61.05 3.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.886 0.374 . . . . 72.31 110.868 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 15.9 t -85.99 147.99 25.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 73.15 110.841 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -110.57 128.67 55.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 75.35 110.854 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 92.2 t -115.59 123.03 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 60.34 111.125 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.53 111.74 13.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 71.44 110.888 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 18.1 mm -106.35 104.35 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 63.13 111.115 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.3 179.76 17.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.731 . . . . 75.32 112.48 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -89.84 156.04 18.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 73.41 110.879 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -130.31 140.29 50.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 71.12 110.868 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -119.24 126.01 50.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 73.42 110.9 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 161.08 142.55 3.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.731 . . . . 75.51 112.494 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.27 -18.83 10.62 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.733 -0.746 . . . . 64.34 112.491 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.4 79.33 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 74.13 110.888 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 67.22 112.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.768 -0.73 . . . . 64.52 112.483 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -52.32 111.52 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 74.24 110.877 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 3.1 t90 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.486 . . . . 74.31 110.931 -179.933 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.817 0.341 . . . . 74.34 110.919 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -105.09 114.23 28.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 72.21 110.927 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.68 143.68 48.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 73.04 110.86 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.09 136.73 53.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 71.24 111.116 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.13 -36.28 16.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 65.13 110.927 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -165.12 137.74 4.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 75.52 110.848 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 7.7 mt -138.43 117.88 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 62.45 111.134 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -111.53 125.14 53.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 72.11 110.891 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 4.8 p -135.26 134.83 40.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.476 . . . . 72.05 111.148 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -150.94 167.4 27.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 75.14 110.92 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 66.98 64.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.864 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 77.9 mtm-85 50.46 55.34 9.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 71.33 110.869 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.04 156.57 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 74.04 111.126 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.27 140.79 52.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.87 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 3.0 p -132.62 130.43 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 75.12 111.139 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -136.6 130.85 32.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 74.3 110.956 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.54 117.9 30.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 72.44 110.973 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.56 175.85 23.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 42.24 112.508 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.88 128.87 34.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.836 0.35 . . . . 73.12 110.925 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -97.15 126.17 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 71.45 111.154 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 93.4 t -122.11 112.89 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 61.04 111.111 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 78.1 p -76.84 170.28 16.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 74.42 111.115 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.75 81.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 75.41 111.13 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.67 77.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 62.44 111.131 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 72.34 111.101 179.923 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.905 0.383 . . . . 73.15 110.908 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 15.1 t -100.77 137.27 39.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 71.13 111.119 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 23.7 m -98.45 110.76 23.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 71.11 111.172 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -93.21 119.56 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 71.23 110.886 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 24.8 p -142.17 123.68 14.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 71.3 110.857 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.35 137.45 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 61.45 111.128 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.05 -76.78 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 74.02 110.849 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -133.71 130.69 38.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 74.04 111.127 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.52 120.53 64.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 73.3 111.148 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 30.4 t -105.04 121.41 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 71.05 111.11 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.47 132.94 10.61 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 64.34 112.449 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.95 147.3 52.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.351 . . . . 75.25 110.895 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.02 78.66 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 73.51 112.461 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 49.68 73.48 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.845 0.355 . . . . 73.35 110.907 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 14.8 t -96.66 147.84 23.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 74.34 110.881 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 24.2 mtm-85 -113.8 128.27 56.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 65.14 110.893 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 84.6 t -115.75 122.96 70.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 74.4 111.171 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.59 112.61 13.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 74.23 110.917 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 27.1 mm -109.44 103.98 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 70.24 111.145 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.16 -178.39 19.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 71.14 112.479 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -89.85 156.09 18.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.78 0.324 . . . . 71.2 110.858 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -126.8 139.1 53.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.22 110.862 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -120.9 125.87 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 74.24 110.913 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 161.76 149.91 5.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.734 -0.746 . . . . 61.04 112.517 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -105.25 -29.84 4.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 75.12 112.505 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -69.68 86.22 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 75.54 110.902 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 69.65 133.13 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.764 -0.731 . . . . 64.14 112.494 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -77.37 89.54 3.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.379 . . . . 72.24 110.858 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 4.9 t90 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 75.44 110.956 -179.953 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.836 0.351 . . . . 74.33 110.88 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.85 116.78 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 75.12 110.872 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.93 146.36 51.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 43.54 110.866 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.22 134.87 48.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 74.01 111.093 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.73 -34.66 21.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 74.53 110.887 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -165.52 137.57 4.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 64.02 110.885 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 8.7 mt -138.36 121.19 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 71.44 111.14 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 21.9 ttm-85 -111.57 125.5 54.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 75.1 110.814 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 3.8 p -135.1 131.74 37.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 74.34 111.157 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -147.82 167.77 23.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 74.23 110.836 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 63.36 72.71 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 75.43 110.898 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? 47.29 40.32 10.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 75.44 110.882 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.28 156.1 18.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 70.1 111.091 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -134.57 144.09 47.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 73.11 110.87 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 3.5 p -130.66 121.88 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 74.52 111.15 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -124.81 126.68 45.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 74.31 110.938 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.35 117.43 29.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 74.53 110.911 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 153.35 176.23 25.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.771 -0.728 . . . . 74.45 112.519 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -85.89 128.75 34.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 70.2 110.911 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.91 128.18 46.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 75.22 111.088 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.44 113.43 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 75.21 111.129 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 23.3 p -69.67 169.03 13.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 75.31 111.115 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.17 93.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 72.24 111.043 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.06 82.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 63.34 111.075 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 63.12 111.08 179.955 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.84 0.352 . . . . 70.24 110.922 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 8.6 t -70.87 131.45 43.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 71.24 111.15 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.41 139.66 36.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 74.41 111.166 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -124.5 128.65 49.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 73.12 110.836 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 5.5 p -141.56 123.77 15.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 75.24 110.887 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.27 137.65 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 74.25 111.132 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.58 -76.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.167 -0.469 . . . . 73.45 110.908 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.72 130.53 43.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 70.45 111.144 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 19.5 t -118.64 129.6 74.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 75.15 111.146 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.68 119.06 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 65.44 111.149 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.39 132.47 10.34 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.767 -0.73 . . . . 74.1 112.488 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -134.05 147.58 50.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.361 . . . . 71.54 110.871 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.39 87.2 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.717 -0.754 . . . . 54.21 112.482 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 45.66 64.4 1.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 74.51 110.915 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 4.1 t -88.27 145.78 25.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 63.22 110.871 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 4.0 mtm-85 -117.45 127.8 54.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.505 . . . . 75.33 110.851 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 83.9 t -116.13 123.5 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.42 111.108 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.5 113.65 15.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.861 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 24.7 mm -112.14 104.41 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 73.04 111.132 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.36 -175.08 22.19 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.753 . . . . 72.53 112.512 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.47 156.22 16.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.846 0.355 . . . . 72.14 110.861 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -126.8 138.04 53.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 72.24 110.887 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -120.63 125.11 46.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.472 . . . . 75.12 110.923 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 164.84 147.7 5.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.752 -0.737 . . . . 73.23 112.503 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -80.77 -48.99 5.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.749 -0.739 . . . . 73.41 112.509 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -51.67 103.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.357 . . . . 65.44 110.868 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 53.69 -147.36 19.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 53.43 112.473 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -122.35 -35.31 3.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 74.33 110.859 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 13.2 t90 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 72.51 110.891 -179.951 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.808 0.337 . . . . 74.25 110.856 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -84.31 114.52 21.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 72.25 110.911 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 3.8 t -134.5 142.71 47.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.41 110.809 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.29 119.99 24.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.505 . . . . 53.41 111.1 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -34.42 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 73.35 110.892 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -166.12 137.51 3.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 63.33 110.865 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 6.3 mt -138.58 121.69 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 71.43 111.151 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -111.45 126.15 54.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 75.42 110.843 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 5.8 p -135.16 130.57 35.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 61.24 111.141 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -146.44 166.84 25.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 73.32 110.9 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 64.99 71.05 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 74.23 110.925 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.33 34.88 4.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 75.34 110.893 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.89 154.21 23.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 71.44 111.13 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.49 144.43 51.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 74.41 110.899 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 6.0 p -131.51 121.91 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 74.21 111.11 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -125.58 125.78 43.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 74.11 110.915 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.51 118.01 31.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 74.02 110.872 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.01 179.48 26.78 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.752 . . . . 33.23 112.454 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -86.02 133.54 33.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.902 0.382 . . . . 74.34 110.88 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 19.9 t -103.67 114.95 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 72.11 111.137 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 21.8 t -110.76 120.7 62.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 73.33 111.168 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 9.6 p -76.56 167.17 22.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.14 111.125 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.26 79.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 72.43 111.109 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.38 -38.25 73.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 63.43 111.046 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 75.14 111.101 179.956 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 14.3 t . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.89 0.376 . . . . 74.44 111.121 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 26.8 m -106.68 108.85 20.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 63.3 111.166 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.02 130.53 46.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 72.35 110.885 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 5.5 t -140.95 123.76 16.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 74.44 110.867 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -108.26 141.34 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 73.34 111.126 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -81.07 -76.65 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 75.23 110.9 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.49 128.26 46.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 72.12 111.192 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 17.8 t -118.5 135.05 60.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 73.2 111.126 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 50.7 t -126.41 126.32 68.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.145 -0.479 . . . . 75.11 111.109 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.07 132.42 8.08 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.729 -0.748 . . . . 70.03 112.504 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -133.51 147.3 51.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.828 0.346 . . . . 73.3 110.931 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.19 89.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 75.15 112.469 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 44.06 59.73 3.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 75.35 110.895 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 17.1 t -83.84 145.41 28.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 74.04 110.861 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -118.1 128.09 54.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 75.55 110.883 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 92.0 t -119.44 122.02 67.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 71.24 111.135 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.77 112.11 13.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 75.44 110.949 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 28.3 mm -112.68 104.34 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 71.23 111.106 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.6 -174.24 26.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.678 -0.772 . . . . 75.05 112.509 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -100.37 156.11 17.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.332 . . . . 74.44 110.889 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -121.72 118.9 30.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.905 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -112.42 136.66 51.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 75.23 110.918 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 135.67 175.71 13.98 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 51.32 112.475 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -107.89 107.69 2.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 62.33 112.463 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -166.07 28.05 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 73.13 110.889 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 76.39 -66.48 2.63 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.76 -0.733 . . . . 72.43 112.479 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -174.98 156.74 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 62.32 110.866 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 33.8 t90 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 75.03 110.903 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.458 -0.048 0 CA-C-O 120.844 0.354 . . . . 70.45 110.884 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -83.78 113.72 21.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 72.12 110.9 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 73.3 m -131.05 144.74 51.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 72.21 110.864 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.78 134.63 51.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 74.34 111.086 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.13 -37.1 16.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 64.15 110.881 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -164.98 136.98 4.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 71.21 110.876 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 9.8 mt -138.78 119.65 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 64.31 111.171 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -111.23 124.88 53.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 74.54 110.884 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 8.4 p -135.07 132.9 38.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 75.33 111.127 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -152.8 166.6 31.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.21 110.927 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 65.14 69.42 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 74.4 110.907 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.47 53.67 12.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 75.03 110.888 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.66 155.91 18.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 52.23 111.119 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 -131.3 135.94 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 73.32 110.847 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 4.0 p -125.99 129.71 72.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 74.22 111.175 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -137.62 135.66 36.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 72.12 110.912 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 2.0 mp -129.99 118.54 21.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.35 110.918 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 155.25 176.64 27.68 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 54.4 112.505 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -88.95 128.66 35.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 73.44 110.914 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 93.1 t -98.75 123.1 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 60.12 111.14 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.17 117.14 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 65.52 111.134 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.9 t -68.11 174.98 3.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 63.3 111.117 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.05 -32.3 71.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.453 . . . . 74.41 111.081 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.12 -35.25 61.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 63.32 111.137 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.11 111.088 179.902 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 90.6 m . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.789 0.328 . . . . 73.54 111.151 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -126.16 134.41 51.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 74.22 110.866 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.86 123.93 15.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 61.41 110.871 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 11.4 p -108.2 140.72 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 62.35 111.129 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -81.16 -76.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 72.13 110.903 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.6 m -138.03 129.49 27.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 75.41 111.139 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 23.7 t -118.14 120.5 64.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 74.41 111.108 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 52.0 t -104.64 115.82 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 74.41 111.157 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.93 132.58 11.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.743 . . . . 64.34 112.462 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.25 144.25 49.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 74.42 110.943 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.42 87.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.73 . . . . 75.41 112.481 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 48.86 74.84 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 72.4 110.865 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 36.7 t -100.79 145.8 28.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 72.33 110.826 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.66 128.66 54.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 74.23 110.847 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.7 122.68 70.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 75.2 111.144 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.05 111.72 13.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.942 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 37.2 mm -113.39 104.31 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 74.55 111.091 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 138.89 -172.72 22.98 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.713 -0.756 . . . . 73.43 112.484 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -89.02 154.12 20.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.802 0.334 . . . . 65.11 110.843 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -128.29 130.14 47.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 65.33 110.93 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -132.41 121.76 23.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 64.24 110.946 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.68 -0.771 . . . . 72.11 112.447 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.836 0.35 . . . . 75.5 110.863 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -98.31 124.31 42.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 75.23 110.888 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.23 137.85 54.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 75.54 110.82 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.29 123.32 15.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 72.41 111.066 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -84.92 -36.79 21.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.446 . . . . 75.11 110.865 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -164.18 139.29 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 72.45 110.871 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 13.0 mt -137.01 117.68 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 73.21 111.182 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -120.19 115.76 24.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 64.33 110.86 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.23 132.93 47.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 74.55 111.206 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -138.27 157.08 46.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 73.34 110.883 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.468 ' O ' ' C ' ' A' ' 236' ' ' ARG . 6.3 tt0 65.13 88.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 75.03 110.883 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.468 ' C ' ' O ' ' A' ' 235' ' ' GLU . 0.0 OUTLIER 31.68 52.55 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 74.52 110.903 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.79 145.59 24.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 75.35 111.113 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -125.76 136.71 53.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 75.13 110.908 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.9 m -142.5 121.75 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 71.12 111.089 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.26 137.25 54.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 71.4 110.849 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.68 122.05 26.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.196 -0.456 . . . . 71.4 110.968 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.85 -115.83 0.88 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 73.1 112.523 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -145.44 128.96 17.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 74.5 110.879 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 20.9 m -111.79 127.68 68.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 74.1 111.083 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.1 t -122.24 129.08 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 71.51 111.124 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 73.22 111.125 -179.945 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 30.8 p . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.883 0.373 . . . . 74.53 111.145 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -107.75 108.98 20.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.44 111.126 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -94.18 124.97 38.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 73.21 110.907 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.99 123.82 15.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 70.23 110.904 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.4 p -118.66 135.78 57.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 72.42 111.103 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 -75.29 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.469 . . . . 71.21 110.847 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.4 m -123.46 130.29 52.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 73.34 111.108 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 33.7 t -118.12 129.83 73.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 72.53 111.112 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 36.7 t -127.68 124.83 64.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 74.45 111.114 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.01 134.02 8.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 73.5 112.47 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -132.8 141.68 48.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.78 0.324 . . . . 73.31 110.92 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 57.29 85.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 50.35 112.485 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 44.0 60.56 2.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.827 0.346 . . . . 75.3 110.902 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 11.0 t -83.92 145.36 28.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 70.21 110.93 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 3.3 mpp_? -129.49 127.25 40.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.887 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 17.6 t -137.06 124.01 30.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 72.04 111.13 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.0 111.16 17.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 73.23 110.901 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 30.5 mm -103.3 104.63 16.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 73.53 111.11 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.24 -163.61 28.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 64.43 112.467 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -103.43 155.92 18.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 73.41 110.844 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -129.93 147.32 51.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.12 -0.491 . . . . 72.34 110.922 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -129.69 125.84 36.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 73.23 110.927 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 165.69 -86.14 0.1 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.705 -0.76 . . . . 70.13 112.506 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 127.75 -97.79 0.47 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.76 -0.733 . . . . 63.34 112.51 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -51.73 127.85 21.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.794 0.33 . . . . 74.11 110.895 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 93.72 -33.22 5.31 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.753 -0.737 . . . . 74.42 112.474 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.39 -174.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.373 . . . . 74.02 110.865 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 19.3 t90 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 75.33 110.91 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.714 0.292 . . . . 73.44 110.913 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -106.61 115.63 30.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.42 110.897 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.91 137.93 54.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 63.44 110.779 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.16 129.38 29.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 74.22 111.118 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 4.8 tttm -88.88 -36.32 16.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 71.05 110.869 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.4 139.16 5.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 72.14 110.869 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 13.6 mt -137.31 117.84 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 75.41 111.075 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -127.03 119.65 27.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 72.21 110.84 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.52 140.36 48.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 65.42 111.149 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -140.35 164.38 30.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 72.52 110.874 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' B' ' 236' ' ' ARG . 2.2 tt0 64.07 72.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 74.53 110.809 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' B' ' 235' ' ' GLU . 19.5 ptt-85 37.19 63.43 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 75.23 110.854 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.56 155.06 19.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 60.3 111.107 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.96 135.32 48.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 71.31 110.854 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 21.0 m -143.11 121.9 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 74.43 111.147 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -118.37 137.26 53.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.33 110.845 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 5.2 mp -125.02 118.54 26.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 74.32 110.897 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 143.02 -177.64 21.81 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.739 -0.743 . . . . 63.12 112.473 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.93 139.0 31.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 73.42 110.905 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.82 127.49 74.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 64.32 111.139 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 54.2 t -117.5 129.28 74.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 72.01 111.088 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.18 162.81 24.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 64.32 111.191 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.14 79.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 73.51 111.075 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -62.55 -41.71 99.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.306 -0.407 . . . . 75.05 111.104 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 70.11 111.128 179.87 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.854 0.359 . . . . 74.41 110.881 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 86.3 m -95.4 122.92 38.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 71.12 111.131 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 5.4 m -94.6 108.84 20.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 74.41 111.149 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -96.59 127.72 42.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 62.31 110.927 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 63.9 p -142.03 123.99 15.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 74.53 110.898 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 8.8 p -115.18 136.83 50.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 65.33 111.062 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.26 -75.71 0.22 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.117 -0.492 . . . . 74.54 110.862 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -127.4 130.8 50.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 71.1 111.147 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 28.6 t -118.32 128.29 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 73.34 111.129 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.56 120.43 54.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 74.24 111.1 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.88 133.69 8.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 74.4 112.46 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -133.09 148.02 52.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 75.23 110.893 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.63 76.58 0.19 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.708 -0.758 . . . . 53.12 112.476 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 48.35 62.19 2.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.342 . . . . 73.24 110.924 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 32.6 t -87.43 145.67 26.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 75.55 110.879 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.74 127.38 43.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 73.34 110.937 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 10.0 t -135.59 124.07 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 74.43 111.148 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.46 116.53 26.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.471 . . . . 71.33 110.872 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 29.0 mm -107.72 135.09 47.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 70.24 111.089 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 118.39 -168.75 13.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 64.32 112.392 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -112.38 155.38 24.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.791 0.329 . . . . 65.4 110.908 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -120.13 137.45 54.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 74.41 110.935 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.94 125.96 50.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 74.35 110.874 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 127.12 159.84 10.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 75.22 112.452 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -101.53 -19.03 16.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.82 -0.705 . . . . 71.23 112.477 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -66.97 89.31 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 72.03 110.948 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 66.86 113.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 71.14 112.506 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -52.85 -66.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.812 0.339 . . . . 75.32 110.865 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 15.4 t90 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 73.24 110.916 -179.947 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.777 0.322 . . . . 65.22 110.839 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -94.64 134.93 36.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 73.51 110.882 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 8.1 t -132.46 137.84 47.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 64.55 110.894 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.95 138.83 44.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 74.21 111.12 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.86 -33.47 11.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.41 . . . . 74.51 110.897 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.71 138.54 5.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 73.51 110.822 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 11.0 mt -137.59 117.89 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 75.22 111.135 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -127.74 121.9 31.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 74.04 110.918 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 141.67 45.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 65.1 111.167 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.18 166.31 25.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 73.51 110.863 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 65.0 57.68 0.96 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.156 -0.475 . . . . 74.22 110.874 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 50.87 61.2 3.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 73.42 110.887 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 151.97 22.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 72.34 111.168 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -125.92 135.38 51.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 73.01 110.886 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 4.4 m -140.66 121.9 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 75.24 111.155 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -115.68 129.71 56.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.34 110.986 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.91 118.72 34.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.938 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.1 174.28 13.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.759 -0.734 . . . . 71.32 112.471 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.54 147.92 22.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.869 0.366 . . . . 70.12 110.856 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.09 130.42 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 74.44 111.122 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.07 128.97 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 75.23 111.096 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 7.8 p -74.41 162.97 28.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 74.35 111.158 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.08 -33.97 76.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 73.42 111.06 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.81 -41.85 78.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 74.11 111.064 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 73.44 111.097 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.917 0.389 . . . . 74.2 110.93 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 26.4 m -76.3 121.98 23.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 75.31 111.175 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.7 m -92.33 125.5 37.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 73.23 111.123 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -113.83 119.99 39.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 75.52 110.878 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 8.3 t -129.9 123.66 31.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 45.53 110.843 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.3 p -117.06 135.97 55.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 72.51 111.128 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -79.12 -76.09 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 72.34 110.884 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 2.1 m -124.53 130.71 52.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 65.53 111.197 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.09 125.27 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 75.44 111.209 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 57.8 t -127.24 118.73 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.24 111.119 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.1 133.78 8.9 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 60.21 112.522 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -132.53 147.66 52.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.337 . . . . 74.22 110.885 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.14 75.46 0.26 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.686 -0.769 . . . . 61.42 112.499 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 48.64 60.43 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 73.42 110.846 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 21.3 t -85.55 145.85 27.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.34 110.846 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -128.32 127.86 43.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 74.14 110.823 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.18 123.89 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 72.42 111.126 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.89 112.29 18.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 72.24 110.865 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 24.7 mm -106.17 123.51 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 72.12 111.105 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 129.17 167.11 12.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 63.34 112.55 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -89.97 145.3 25.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.774 0.321 . . . . 74.34 110.91 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.05 134.62 54.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 74.23 110.913 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -119.68 125.95 49.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 73.52 110.986 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 153.55 168.78 17.77 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 74.5 112.523 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -111.68 -18.32 8.03 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.715 -0.755 . . . . 65.4 112.499 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -76.37 67.11 2.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 71.42 110.929 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 78.31 159.63 13.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 71.23 112.518 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -81.27 -74.67 0.32 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.865 0.364 . . . . 73.33 110.859 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 3.7 t90 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 72.04 110.927 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.81 0.338 . . . . 72.33 110.891 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.75 113.1 20.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 73.32 110.861 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 2.6 m -128.3 139.76 52.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 72.43 110.84 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.33 157.63 42.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 72.21 111.158 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -112.6 -34.41 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 73.02 110.895 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -164.53 138.86 5.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 73.53 110.869 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 8.9 mt -137.64 117.74 16.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 72.43 111.196 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -130.54 123.53 29.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 70.13 110.932 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.2 146.64 48.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 74.12 111.118 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -146.51 166.61 25.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 74.51 110.901 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 64.93 55.88 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 75.51 110.877 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.85 62.79 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.477 . . . . 73.13 110.862 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.49 156.06 18.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 71.43 111.123 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -128.05 135.71 50.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 73.11 110.817 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 20.5 m -138.27 122.85 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 75.32 111.148 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.37 136.43 53.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 72.35 110.938 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.96 118.98 32.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 74.42 110.89 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.14 171.61 13.0 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.75 . . . . 63.51 112.495 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -93.28 153.95 18.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 74.42 110.888 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 18.5 m -120.67 136.85 56.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 75.34 111.093 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 97.9 t -122.24 130.09 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 74.34 111.098 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 1.7 p -68.35 168.54 12.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 75.31 111.097 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.57 -34.49 72.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 72.22 111.136 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.44 -37.53 72.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 74.31 111.162 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 72.5 111.146 179.919 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.851 0.358 . . . . 63.45 111.141 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 98.0 m -102.61 139.17 38.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 75.24 111.148 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.14 130.98 52.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 74.04 110.807 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 5.8 t -142.07 123.9 15.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 70.32 110.81 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.76 138.34 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 64.21 111.131 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.73 -76.4 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 74.05 110.847 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 6.2 m -128.3 130.46 47.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 71.24 111.081 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.4 120.93 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.144 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 18.1 t -121.68 118.45 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 72.51 111.169 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.52 136.49 12.23 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.715 -0.755 . . . . 62.22 112.456 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.44 147.51 52.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.879 0.371 . . . . 75.11 110.894 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.43 76.22 0.2 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.723 -0.751 . . . . 63.53 112.468 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 47.93 61.95 2.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 72.12 110.866 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 30.5 t -87.15 145.99 26.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 75.0 110.871 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -127.49 127.67 44.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 73.44 110.903 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 14.2 t -132.66 124.15 50.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 74.34 111.071 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.44 112.38 17.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.22 110.889 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 28.0 mm -105.0 129.06 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 74.44 111.111 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 120.03 170.46 14.36 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 63.43 112.561 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -89.68 154.01 20.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.327 . . . . 73.43 110.867 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -127.95 133.17 49.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 74.34 110.858 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -116.22 124.18 49.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 73.14 110.925 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 174.42 -58.32 0.13 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 75.34 112.443 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 91.47 -66.83 2.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.795 -0.717 . . . . 42.12 112.476 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -51.43 -30.32 19.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 75.54 110.917 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -140.34 97.57 0.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.677 -0.773 . . . . 75.23 112.478 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -51.3 -75.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 72.44 110.883 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 15.4 t90 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 64.5 110.932 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? . . . . . 0 CA--C 1.526 0.045 0 CA-C-O 120.78 0.324 . . . . 64.24 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -97.29 111.66 23.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 75.33 110.868 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 14.8 m -121.94 138.96 54.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 72.41 110.839 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.79 132.82 35.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 74.34 111.073 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.06 -29.24 15.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.878 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -164.52 139.33 5.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 63.2 110.896 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 10.5 mt -136.87 117.57 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 70.12 111.162 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.61 121.11 23.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 74.1 110.869 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.51 145.36 48.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 74.52 111.096 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -148.17 167.09 25.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 63.33 110.881 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 65.74 54.41 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 64.43 110.916 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 51.2 62.07 2.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.477 . . . . 74.54 110.852 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.76 156.15 18.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 73.31 111.12 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -128.32 135.83 50.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.33 110.855 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 4.2 m -131.99 121.98 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 60.0 111.109 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.48 137.07 52.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 74.51 110.9 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -126.74 121.17 31.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 74.23 110.958 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.19 163.3 11.5 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 64.03 112.456 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -85.7 156.98 20.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.906 0.384 . . . . 74.4 110.854 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 31.6 m -119.42 134.08 64.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 75.52 111.121 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.53 129.54 75.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 65.22 111.085 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t -69.49 175.54 4.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 74.01 111.112 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.34 86.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 73.42 111.104 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.4 -53.03 62.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 62.4 111.1 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 73.02 111.085 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.851 0.358 . . . . 74.45 111.107 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -105.09 119.93 40.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 71.21 110.932 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 29.2 t -127.27 123.83 37.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 62.34 110.822 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 10.0 p -122.62 137.82 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 75.33 111.152 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.86 -75.07 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 71.44 110.904 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 60.5 m -125.23 133.58 52.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 72.32 111.123 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.23 126.5 75.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 75.24 111.142 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.2 122.89 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 61.41 111.125 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.65 134.43 9.96 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 73.4 112.5 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -133.01 147.75 52.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 70.02 110.884 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.48 78.9 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.843 -0.694 . . . . 71.44 112.444 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 47.18 64.16 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 74.25 110.936 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 41.2 t -86.76 145.88 26.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 75.02 110.852 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -130.73 127.87 39.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 60.41 110.853 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 18.7 t -130.4 123.72 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 72.44 111.189 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.79 111.94 17.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 72.12 110.914 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 50.5 mm -108.55 132.64 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 71.42 111.18 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 124.42 -177.68 16.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.744 . . . . 73.23 112.483 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -103.18 153.67 20.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.787 0.327 . . . . 64.11 110.839 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.91 132.07 55.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 62.33 110.83 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -130.09 123.74 31.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 74.31 110.908 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 64.45 112.485 179.909 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.797 0.332 . . . . 74.3 110.843 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.99 129.65 30.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.885 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 2.1 p -134.5 140.25 46.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 70.23 110.897 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.82 149.53 51.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 65.45 111.059 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -106.25 -35.63 7.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 72.23 110.874 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -164.86 137.86 4.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 75.43 110.907 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 17.4 mt -138.91 118.72 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 74.32 111.131 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -134.12 117.74 16.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 72.23 110.847 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.7 p -135.55 142.09 45.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 74.44 111.127 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.0 pm0 -147.01 167.9 22.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 72.31 110.93 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 68.94 57.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 75.55 110.909 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 50.37 57.43 6.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.804 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.2 151.75 22.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 75.41 111.101 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -126.11 135.92 52.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 75.42 110.797 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.1 p -138.38 121.88 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.02 111.096 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.01 136.0 53.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 72.31 110.948 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 tp -130.16 118.88 22.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.199 -0.455 . . . . 75.51 110.888 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 139.57 173.22 13.04 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.699 -0.762 . . . . 74.52 112.478 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -85.67 160.45 19.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 74.54 110.903 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 97.9 t -133.07 121.02 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.475 . . . . 72.44 111.16 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.19 129.04 75.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 70.35 111.131 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 74.3 111.108 -179.945 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 95.1 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.805 0.336 . . . . 72.42 111.108 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 26.0 m -116.48 122.41 44.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 73.15 111.147 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -107.41 139.34 42.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 73.14 110.875 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.91 123.25 15.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.509 . . . . 64.22 110.812 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.0 p -119.87 137.59 53.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 74.52 111.127 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.91 -77.39 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 72.11 110.857 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 35.3 p -127.21 130.18 49.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 73.44 111.146 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 20.5 t -118.04 120.69 65.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 74.11 111.125 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.77 118.12 53.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 64.3 111.109 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.17 134.37 10.09 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 71.44 112.49 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.63 147.76 52.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.347 . . . . 75.31 110.895 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.78 78.97 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.79 -0.719 . . . . 54.13 112.45 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 47.9 66.3 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.842 0.353 . . . . 73.41 110.825 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 32.7 t -92.76 145.9 24.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 70.53 110.756 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -125.42 128.29 47.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 74.45 110.9 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 20.6 t -134.1 123.76 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 75.34 111.139 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.42 111.86 17.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.14 110.858 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 3.4 mp -109.78 106.25 20.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.251 -0.431 . . . . 75.45 111.146 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.5 175.56 19.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 63.12 112.488 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -107.14 147.72 29.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.817 0.342 . . . . 75.41 110.879 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -118.97 126.37 51.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 65.05 110.905 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -118.55 125.76 50.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.13 110.921 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 151.33 -39.66 0.8 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.684 -0.769 . . . . 75.23 112.5 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 123.99 -119.8 3.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 75.41 112.442 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 63.34 25.92 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 74.02 110.857 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 77.3 -63.63 3.28 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.705 -0.76 . . . . 72.43 112.49 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -174.49 -167.96 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 73.34 110.893 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 15.6 t90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 74.11 110.947 -179.949 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.771 0.32 . . . . 75.33 110.93 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.8 137.51 45.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 75.15 110.852 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.59 137.9 38.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 73.25 110.897 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.17 147.85 52.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 74.32 111.104 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.87 -31.46 9.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 75.21 110.917 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.51 137.79 4.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 74.24 110.89 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 15.6 mt -138.19 117.18 14.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 74.23 111.139 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -134.57 115.26 13.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 71.24 110.883 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.3 p -135.86 137.19 41.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 61.14 111.096 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -141.93 167.28 22.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 71.14 110.912 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 66.95 69.51 0.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 73.14 110.792 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 46.06 40.52 7.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 70.34 110.82 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.81 148.79 23.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 72.51 111.096 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.8 140.82 50.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 74.53 110.829 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 6.1 p -138.96 121.99 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.113 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.61 131.76 56.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 74.03 110.865 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 1.2 tp -130.23 118.94 22.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 71.31 110.921 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 154.92 -138.27 6.05 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 64.41 112.42 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -144.54 143.69 30.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.852 0.358 . . . . 75.34 110.863 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 58.2 t -119.11 115.63 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 73.4 111.134 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 63.9 t -122.21 122.73 67.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 74.31 111.117 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 81.2 p -69.85 163.02 26.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.183 -0.462 . . . . 65.24 111.147 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.76 -34.07 76.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 75.14 111.093 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.06 -41.48 78.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 72.01 111.04 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 75.02 111.107 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.939 0.4 . . . . 75.11 110.884 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 76.3 m -100.95 121.95 42.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 73.21 111.119 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 91.3 m -124.06 131.86 53.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.28 -0.418 . . . . 75.33 111.138 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -115.57 132.51 56.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 75.23 110.885 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 36.7 m -132.74 123.32 26.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 60.34 110.867 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.89 137.09 54.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 73.14 111.132 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -78.99 -77.5 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 75.21 110.857 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 39.1 m -129.9 130.48 45.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.166 -0.47 . . . . 63.41 111.141 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.9 120.68 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 73.13 111.168 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.04 121.61 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 73.3 111.17 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.27 133.8 8.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 71.43 112.543 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -132.55 147.52 52.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.824 0.345 . . . . 75.0 110.893 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.92 84.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.688 -0.768 . . . . 72.1 112.525 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 45.15 63.52 1.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 74.24 110.888 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 26.5 t -93.06 145.68 24.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 63.31 110.884 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -128.57 127.7 42.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.919 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.6 123.91 53.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.414 . . . . 72.51 111.144 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.76 111.44 15.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.086 -0.506 . . . . 74.02 110.921 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 2.1 mp -111.66 104.83 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 72.2 111.142 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.28 -168.53 32.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 72.22 112.514 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -123.44 153.59 40.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 74.42 110.939 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.07 121.19 32.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 73.22 110.845 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -109.45 125.71 52.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 73.3 110.928 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 106.21 171.32 23.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.799 -0.715 . . . . 71.51 112.516 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 51.96 -171.68 0.34 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.779 -0.724 . . . . 71.2 112.476 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 131.09 47.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.806 0.336 . . . . 74.22 110.879 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -72.54 78.95 0.7 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.718 . . . . 65.34 112.455 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -178.44 131.22 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 64.34 110.856 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 15.1 t90 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 74.12 110.921 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.852 0.358 . . . . 71.25 110.813 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -122.78 136.43 54.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 75.51 110.95 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 75.6 m -137.7 145.16 42.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 63.02 110.878 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.05 154.35 49.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 74.14 111.061 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.87 -28.48 10.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 72.23 110.922 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.45 137.59 4.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 74.33 110.867 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 18.1 mt -138.43 116.93 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.142 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.12 115.61 13.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 73.25 110.949 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.8 p -135.81 139.27 43.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 74.25 111.15 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -145.62 166.99 24.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 71.21 110.922 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 66.56 66.97 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 74.4 110.9 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 46.84 51.99 11.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.499 . . . . 74.42 110.897 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.08 151.45 23.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 73.34 111.179 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.24 137.17 47.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 75.25 110.836 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 6.2 p -133.59 121.95 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 73.21 111.126 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -114.15 135.66 53.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 73.1 110.837 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.16 118.86 22.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.13 110.91 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.9 -173.47 22.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.752 -0.737 . . . . 51.42 112.51 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.02 150.4 23.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 70.32 110.931 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 92.7 t -128.87 121.48 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 75.53 111.125 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.06 129.04 75.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 74.31 111.133 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.9 t -77.03 163.66 26.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 73.43 111.248 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.16 -33.65 75.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 74.31 111.106 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.53 -35.98 68.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 74.53 111.056 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 72.32 111.118 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.91 0.385 . . . . 74.32 110.918 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 20.2 p -99.4 130.51 45.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.199 -0.455 . . . . 75.14 111.097 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 30.2 m -134.06 132.15 39.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 65.42 111.178 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -125.38 135.47 52.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 72.23 110.844 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.06 123.78 26.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 71.51 110.829 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.67 136.84 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 74.35 111.192 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -79.21 -77.0 0.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 74.45 110.907 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 5.0 m -129.82 130.52 45.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 75.33 111.145 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.0 t -117.87 120.64 65.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 71.12 111.114 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 26.2 t -123.84 120.77 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 73.23 111.111 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.02 133.3 8.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.741 . . . . 64.45 112.436 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -133.27 147.47 51.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.82 0.343 . . . . 72.52 110.89 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.2 87.86 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.793 -0.717 . . . . 65.2 112.474 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 44.38 61.04 2.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.889 0.376 . . . . 74.51 110.863 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 35.2 t -92.15 145.33 24.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 74.01 110.909 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.7 127.69 39.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 74.3 110.93 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.03 123.76 51.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 73.14 111.135 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.05 111.8 13.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 73.55 110.9 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.77 119.9 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 74.31 111.109 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.31 -158.34 25.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.735 -0.745 . . . . 73.11 112.467 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -127.98 132.95 49.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.823 0.344 . . . . 74.24 110.851 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.92 137.78 49.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 74.23 110.88 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -129.52 125.46 36.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 74.34 110.899 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 126.56 165.68 12.03 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.768 -0.73 . . . . 65.13 112.497 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 64.7 155.1 0.15 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.717 -0.754 . . . . 60.51 112.432 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -93.26 65.14 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 75.14 110.961 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -160.28 -113.44 0.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.726 -0.75 . . . . 75.24 112.516 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -174.58 -35.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 72.35 110.833 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 7.2 t90 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 72.0 110.93 -179.905 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.04 0 CA-C-O 120.836 0.35 . . . . 73.24 110.851 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -110.77 127.44 55.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 64.43 110.937 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.3 137.96 49.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 71.12 110.885 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.2 155.25 42.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 63.12 111.126 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.46 -24.69 10.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 71.34 110.91 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.29 137.09 4.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.858 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 16.6 mt -138.66 117.16 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 63.32 111.136 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 -134.6 115.9 14.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 74.53 110.844 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.7 p -135.75 136.63 40.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 74.35 111.094 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -144.44 167.19 23.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 73.33 110.895 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 64.93 68.07 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 71.33 110.831 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 46.35 52.09 10.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 73.3 110.87 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.08 149.98 24.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 74.43 111.126 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -131.47 139.27 49.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 74.14 110.883 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.94 124.24 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 74.05 111.098 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -113.06 132.89 55.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 75.42 110.911 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -122.34 134.69 54.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.941 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 109.0 -174.66 18.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 70.33 112.431 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -99.36 145.57 27.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.897 0.379 . . . . 74.44 110.911 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 88.1 t -122.19 131.54 72.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 74.23 111.132 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 66.7 t -122.16 129.15 75.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 64.35 111.101 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t -69.85 167.68 16.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 74.34 111.147 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.95 -33.91 76.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 73.4 111.129 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.97 -52.06 66.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.4 111.044 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 74.32 111.073 179.913 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 96.1 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.879 0.371 . . . . 74.44 111.144 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 7.7 m -114.14 123.1 48.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 73.55 111.111 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -126.37 146.7 49.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.894 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 12.8 m -136.99 123.44 20.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 72.32 110.817 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.47 133.9 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 74.04 111.127 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.64 -69.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 73.35 110.831 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 92.9 m -143.85 133.39 23.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.13 111.169 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.16 125.88 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 73.53 111.181 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 59.9 t -127.11 125.67 66.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 64.12 111.124 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.63 133.74 8.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.769 -0.729 . . . . 71.24 112.532 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.63 138.34 48.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.831 0.348 . . . . 75.04 110.925 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.5 86.28 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.72 -0.752 . . . . 71.04 112.499 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 51.08 81.66 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 74.32 110.871 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 44.8 t -113.54 145.23 41.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 74.0 110.909 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.61 127.5 39.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 64.42 110.833 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.05 123.72 48.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 62.23 111.104 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.37 111.5 13.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 73.15 110.94 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.74 130.17 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 71.54 111.124 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.05 172.47 16.2 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.791 -0.719 . . . . 75.42 112.549 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -89.94 141.97 28.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.329 . . . . 75.02 110.888 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.17 136.74 54.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 70.13 110.884 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -117.26 125.75 51.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 74.25 110.953 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.38 -118.53 6.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 50.12 112.528 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 72.74 157.62 3.9 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.776 -0.726 . . . . 71.3 112.443 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -56.02 -25.33 44.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.803 0.335 . . . . 74.44 110.873 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -171.58 -35.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 74.52 112.513 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -152.93 -72.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.314 . . . . 73.1 110.917 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 14.7 t90 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 74.43 110.831 -179.949 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.899 0.38 . . . . 75.44 110.939 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -89.19 137.31 32.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.911 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.9 147.21 44.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 73.44 110.839 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.83 162.08 29.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 61.53 111.095 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' E' ' 265' ' ' GLU . 3.5 mttm -116.34 -27.32 6.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 75.32 110.884 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -165.85 137.26 3.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 65.35 110.807 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 15.2 mt -138.07 117.54 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 75.11 111.083 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 15.5 ttt-85 -134.46 118.08 16.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.43 110.825 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 2.3 p -135.52 147.4 48.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 72.44 111.133 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -156.32 166.87 32.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 74.03 110.886 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 64.08 68.91 0.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 75.14 110.901 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 50.42 31.43 5.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 74.24 110.873 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.64 140.65 30.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 71.4 111.064 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.49 137.67 50.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 72.22 110.89 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 6.2 p -130.38 121.95 52.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 64.4 111.084 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.94 136.85 52.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 74.41 110.877 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -124.21 134.16 53.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 75.32 110.869 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 109.18 177.56 21.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.693 -0.765 . . . . 74.3 112.441 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -90.05 148.95 22.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.833 0.349 . . . . 75.3 110.895 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 95.8 t -122.08 131.09 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 63.32 111.145 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 95.4 t -120.8 127.56 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 73.02 111.116 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.6 t -76.84 171.29 14.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 63.53 111.211 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.56 -33.98 76.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 65.42 111.066 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -51.56 68.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 73.55 111.071 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 72.22 111.076 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 85.9 m . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.855 0.36 . . . . 65.14 111.153 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -126.12 138.19 53.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.484 . . . . 70.44 110.903 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.42 128.81 53.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 70.24 110.847 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -125.55 137.73 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 73.2 111.188 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . 0.418 ' HA ' ' HB2' ' E' ' 229' ' ' LYS . 17.5 mt-10 -82.97 -74.72 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 75.2 110.928 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 38.9 p -142.54 128.06 19.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.54 111.132 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.76 120.84 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 74.31 111.162 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 81.9 t -115.72 121.57 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 74.15 111.176 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.45 132.54 10.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.758 -0.734 . . . . 74.43 112.521 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.84 139.45 46.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 72.51 110.85 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.84 88.47 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 41.42 112.512 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 49.59 75.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.872 0.368 . . . . 73.41 110.917 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.23 145.38 30.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 55.1 110.863 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -132.83 127.63 34.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 74.02 110.839 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 74.9 t -133.69 122.97 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 71.25 111.135 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.19 111.34 12.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 61.1 110.88 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 9.7 mt -112.59 105.84 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 71.03 111.106 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.9 -158.57 28.19 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.787 -0.721 . . . . 63.23 112.448 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -127.96 145.73 50.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.758 0.314 . . . . 75.52 110.871 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -111.89 122.27 47.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 73.11 110.86 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.25 125.94 51.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 73.22 110.985 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.725 -0.75 . . . . 72.32 112.418 179.91 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.862 0.363 . . . . 74.31 110.845 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.57 109.83 10.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 74.04 110.879 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 1.5 t -125.43 141.81 51.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 62.32 110.896 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.83 119.68 12.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 73.34 111.053 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -74.65 -33.39 62.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 74.34 110.92 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -164.92 138.93 4.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 71.22 110.872 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 10.3 pt -137.35 119.01 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 73.51 111.116 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.85 120.64 37.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.931 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.1 p -129.44 139.18 51.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.216 -0.447 . . . . 74.25 111.108 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -146.53 167.5 23.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 74.33 110.899 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 66.61 65.87 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 75.21 110.944 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 48.85 36.5 8.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.886 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.24 155.83 21.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 74.5 111.121 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -131.71 145.6 51.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 74.24 110.897 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.05 121.83 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 74.43 111.2 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -114.54 129.74 56.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 74.44 110.927 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 118.53 33.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 62.4 110.891 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.72 174.87 13.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 71.12 112.54 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -90.92 154.79 19.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 71.42 110.897 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.02 123.99 57.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 74.54 111.11 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.07 125.73 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 63.53 111.104 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 74.43 111.189 -179.971 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 24.4 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.914 0.388 . . . . 73.2 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 98.0 m -134.02 124.71 26.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.212 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.53 121.04 42.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 74.0 110.857 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.11 123.81 16.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 72.41 110.842 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.9 p -119.21 139.58 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 72.23 111.177 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.09 -71.28 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 72.11 110.875 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.6 m -124.19 136.09 53.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 74.23 111.081 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 19.4 t -120.27 133.5 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 74.42 111.175 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.49 127.13 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.33 111.165 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.38 133.39 8.38 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.747 . . . . 52.41 112.42 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.61 147.94 51.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 74.33 110.886 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.18 81.6 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 64.23 112.503 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 46.45 65.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 74.51 110.907 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 42.2 t -89.63 145.68 25.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 72.3 110.783 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -119.53 127.9 53.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.088 -0.506 . . . . 74.41 110.88 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 98.8 t -124.38 123.03 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 73.55 111.111 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 27.6 tp -128.71 111.7 13.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.964 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 26.3 mm -110.86 104.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.24 111.131 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.73 170.92 18.4 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 75.51 112.455 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -90.45 137.81 32.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.774 0.321 . . . . 74.22 110.927 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -111.95 120.27 41.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 74.14 110.923 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.6 125.91 51.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 74.21 110.967 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 118.5 169.95 14.71 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.661 -0.781 . . . . 60.23 112.427 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -67.42 -119.81 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.737 -0.744 . . . . 65.41 112.488 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.53 27.07 7.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.336 . . . . 74.41 110.913 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.02 -103.04 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.762 -0.732 . . . . 74.11 112.458 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -132.08 146.02 51.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.361 . . . . 75.21 110.869 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 75.05 110.904 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.752 0.31 . . . . 75.21 110.865 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.06 109.43 6.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 63.51 110.915 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 22.1 t -126.83 145.96 50.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 61.33 110.87 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -139.89 119.76 13.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 73.34 111.076 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -35.76 77.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 65.04 110.968 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -165.4 138.28 4.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 73.33 110.899 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 31.5 pt -132.86 131.25 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 73.44 111.071 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -134.5 125.16 26.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 73.52 110.856 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.75 128.73 37.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 72.44 111.136 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -134.97 167.4 20.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 73.53 110.883 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 63.06 68.99 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.12 110.918 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 2.6 mtm-85 47.65 40.76 12.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 71.52 110.905 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.74 156.14 17.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 73.13 111.086 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.64 148.41 50.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 73.34 110.905 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 4.1 p -138.28 121.53 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 70.12 111.172 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -111.2 129.2 56.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 73.51 110.859 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.79 118.55 34.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.483 . . . . 75.31 110.973 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.24 179.75 16.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.721 . . . . 73.45 112.514 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -87.42 144.51 26.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 73.2 110.918 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 4.7 p -118.88 119.86 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 73.22 111.141 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.35 128.32 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 74.35 111.237 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 48.9 p -80.19 173.92 12.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 72.13 111.172 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.04 96.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 73.23 111.087 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.54 -51.58 68.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 72.4 111.125 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 73.34 111.151 179.884 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.863 0.363 . . . . 71.44 110.901 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 35.5 p -100.86 121.99 42.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 71.51 111.104 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 2.1 t -126.69 127.27 44.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.429 . . . . 65.11 111.192 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.59 129.03 56.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 75.42 110.887 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.9 t -140.95 122.9 15.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 73.11 110.879 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 4.8 p -112.93 141.97 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.484 . . . . 64.24 111.092 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -80.7 -77.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 74.32 110.886 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 18.9 m -120.87 133.71 55.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 65.21 111.099 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . 0.405 ' HA ' HG13 ' C' ' 231' ' ' ILE . 3.2 t -117.69 124.5 73.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.14 -0.482 . . . . 75.01 111.088 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 59.7 t -123.66 116.02 46.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.495 . . . . 65.25 111.12 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.58 133.33 10.83 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.723 -0.751 . . . . 61.54 112.511 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.35 147.58 51.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.323 . . . . 65.03 110.965 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.94 84.1 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.713 -0.756 . . . . 73.03 112.496 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 46.1 64.98 1.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.808 0.337 . . . . 75.32 110.865 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 27.9 t -93.94 145.61 24.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 74.24 110.838 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.46 128.02 50.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 72.42 110.833 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 78.5 t -122.95 123.7 68.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 75.41 111.133 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.55 111.64 14.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 75.13 110.924 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 27.0 mm -109.59 104.64 17.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 74.31 111.104 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.76 175.87 18.28 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.691 -0.766 . . . . 50.3 112.453 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -89.9 154.99 19.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 72.25 110.834 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -128.72 146.87 50.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 73.12 110.868 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.44 125.85 42.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.932 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 128.97 -147.88 17.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.669 -0.777 . . . . 75.54 112.474 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -128.62 -145.09 5.92 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.837 -0.697 . . . . 61.12 112.508 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 63.27 78.82 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.874 0.368 . . . . 73.35 110.867 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.12 -108.61 0.68 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.761 -0.733 . . . . 70.44 112.458 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.06 -60.06 1.79 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 75.33 110.922 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 5.9 p90 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.02 110.872 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.868 0.366 . . . . 71.11 110.883 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.58 110.49 6.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.43 110.953 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.4 t -130.86 141.09 50.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 75.52 110.863 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.16 135.16 46.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 74.33 111.127 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -29.92 21.01 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.218 -0.447 . . . . 72.42 110.909 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.81 136.61 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 64.14 110.883 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . 0.405 HG13 ' HA ' ' B' ' 267' ' ' VAL . 3.7 pt -138.4 117.52 14.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 73.41 111.113 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -122.12 116.46 24.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 74.11 110.866 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 2.6 p -124.11 128.76 49.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 72.54 111.143 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.48 167.5 21.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 74.44 110.904 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 64.33 74.72 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 74.53 110.906 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 44.38 38.65 2.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 73.31 110.829 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -93.16 156.17 17.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 74.44 111.1 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.24 156.17 49.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 74.11 110.901 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 7.8 p -138.19 146.92 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 72.54 111.117 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -134.75 137.49 43.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 75.04 110.901 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.88 124.89 40.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 75.01 110.92 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.52 178.09 16.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.676 -0.773 . . . . 72.41 112.489 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -86.47 157.02 19.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 64.45 110.864 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 5.4 p -128.69 135.4 62.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 74.34 111.176 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.09 127.96 75.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 74.23 111.132 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 27.9 p -83.8 162.89 20.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 74.41 111.136 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.23 -34.27 76.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 63.32 111.161 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.95 -51.16 70.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.141 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 74.21 111.118 179.944 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.87 0.367 . . . . 75.54 110.913 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 27.1 p -90.1 126.08 35.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 64.14 111.124 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.8 m -107.46 108.68 20.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 74.5 111.155 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.15 130.6 46.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 72.12 110.886 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 29.3 t -142.05 123.26 14.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 75.44 110.798 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.04 148.06 18.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 54.15 111.154 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.94 -72.77 0.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 71.32 110.858 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 27.7 m -129.08 137.54 51.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 75.01 111.066 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 4.2 t -118.79 129.54 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 71.25 111.108 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 73.1 t -127.13 115.96 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 74.34 111.183 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.8 133.04 9.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.727 . . . . 75.41 112.475 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -133.74 147.68 51.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.351 . . . . 74.53 110.941 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.56 89.13 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.769 -0.729 . . . . 64.44 112.499 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 44.8 60.59 2.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.804 0.335 . . . . 75.13 110.873 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.28 144.98 25.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 73.33 110.874 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.59 128.07 48.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.487 . . . . 74.04 110.951 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 94.2 t -123.44 123.56 67.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 64.14 111.159 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.58 111.69 14.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 74.3 110.925 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 27.4 mm -108.32 104.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 73.45 111.134 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.42 -164.65 29.04 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.814 -0.708 . . . . 72.55 112.606 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -122.01 156.01 34.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.314 . . . . 72.13 110.91 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -119.51 146.7 45.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 74.53 110.903 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -129.94 134.89 47.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 72.24 110.902 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.49 148.4 20.46 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 64.42 112.549 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 51.77 -161.55 1.89 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 74.43 112.462 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -131.99 -169.47 2.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 74.45 110.934 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 81.2 139.02 2.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.784 -0.722 . . . . 52.3 112.427 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -45.74 -39.64 8.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.782 0.325 . . . . 72.3 110.91 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 4.0 p90 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.156 -0.475 . . . . 72.41 110.899 -179.997 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.853 0.359 . . . . 72.31 110.863 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.3 115.63 22.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 64.32 110.859 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.16 138.43 48.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 75.34 110.823 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.19 119.81 15.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 63.34 111.09 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.41 -27.46 56.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 63.14 110.933 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.24 136.76 2.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 74.3 110.867 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 4.3 pt -139.35 117.17 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 72.21 111.067 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -126.54 128.98 47.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 73.14 110.882 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.14 128.83 32.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 75.42 111.164 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -133.16 167.34 20.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 75.45 110.943 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 63.88 72.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.469 . . . . 71.24 110.886 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 44.63 47.25 8.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 74.2 110.867 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.98 155.62 17.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 73.02 111.102 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.37 144.4 46.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 73.41 110.866 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 5.6 p -129.11 140.21 49.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 71.33 111.114 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -133.39 121.72 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 74.21 110.927 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.78 118.88 36.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 75.53 110.904 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.77 172.35 13.11 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.754 -0.736 . . . . 74.04 112.451 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -86.0 143.23 28.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.373 . . . . 73.1 110.938 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 4.4 p -110.23 128.76 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 75.1 111.158 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 23.1 t -122.02 128.94 75.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 71.03 111.198 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 30.5 p -86.14 174.17 9.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 73.04 111.154 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.37 -44.58 92.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 51.42 111.069 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.3 -51.23 70.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 73.33 111.121 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 72.42 111.089 179.878 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.861 0.363 . . . . 73.0 111.098 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 76.9 m -134.13 125.54 28.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 73.42 111.165 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.71 122.16 43.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 74.11 110.925 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.1 123.54 14.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 73.11 110.786 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 8.0 p -122.76 138.56 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 72.01 111.149 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -72.09 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 74.41 110.898 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 72.9 p -124.48 135.65 53.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 71.34 111.108 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 7.7 t -119.08 130.51 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 71.23 111.1 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.38 120.79 55.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 73.2 111.108 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.46 132.64 9.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.766 -0.73 . . . . 74.42 112.542 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -134.35 149.15 50.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.79 0.329 . . . . 73.15 110.976 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.45 87.53 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 72.01 112.467 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 43.29 56.87 4.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 65.44 110.814 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 30.5 t -86.71 145.08 26.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 74.41 110.88 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.72 128.28 49.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 75.35 110.861 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 98.6 t -119.97 123.21 70.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.469 . . . . 75.34 111.116 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.46 113.33 15.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 74.24 110.955 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 29.9 mm -112.41 104.73 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 73.31 111.118 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.99 175.89 17.52 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.764 -0.732 . . . . 44.34 112.473 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -89.92 156.12 18.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 74.44 110.909 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -124.7 134.06 52.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 72.21 110.88 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -124.76 125.78 44.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.91 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 168.81 -152.2 19.67 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 72.41 112.51 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -78.83 57.95 4.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.687 -0.768 . . . . 75.11 112.516 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.13 -174.12 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.757 0.313 . . . . 74.44 110.901 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 66.87 144.46 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 71.13 112.534 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -59.73 -172.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 63.12 110.833 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 8.8 p90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.079 -0.51 . . . . 74.55 110.945 -179.954 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.824 0.345 . . . . 72.54 110.872 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.83 109.94 22.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 73.01 110.859 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 1.8 m -134.28 137.51 44.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 75.24 110.892 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -139.32 124.88 19.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 74.14 111.091 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.41 -25.88 60.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 74.52 110.922 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -167.15 137.26 2.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 75.55 110.91 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 23.5 pt -138.18 128.94 36.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 63.41 111.182 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -133.87 131.41 39.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 74.34 110.906 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.43 128.57 31.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 64.54 111.146 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -132.29 166.47 21.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.419 . . . . 74.51 110.896 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 64.53 69.71 0.5 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.474 . . . . 73.3 110.943 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 47.15 35.18 3.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 71.2 110.941 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.38 156.35 18.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.138 -0.483 . . . . 65.03 111.119 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -140.94 158.89 43.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 72.25 110.856 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 4.8 p -138.08 143.12 33.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 63.11 111.114 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -132.39 125.99 32.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.085 -0.507 . . . . 71.12 110.852 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -111.9 118.74 36.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 75.32 110.943 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.22 -173.83 20.21 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.758 -0.734 . . . . 73.1 112.524 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -104.97 154.76 19.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.925 0.393 . . . . 74.53 110.803 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 4.6 p -115.86 125.02 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 73.1 111.092 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 91.0 t -112.84 129.14 68.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 75.32 111.168 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 1.4 m -85.58 163.47 18.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 72.23 111.165 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.83 -34.85 68.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 71.43 111.132 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.07 -52.0 67.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 74.31 111.085 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.23 111.113 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.745 0.307 . . . . 63.44 111.11 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.69 119.91 39.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 64.54 110.944 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 48.0 t -133.3 125.15 28.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 63.05 110.882 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 5.1 p -128.22 146.68 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 72.0 111.101 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.64 -64.94 1.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.873 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 2.5 m -135.85 138.13 42.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 71.12 111.17 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 7.9 t -126.48 130.84 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 64.23 111.136 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 5.7 p -128.37 124.01 61.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 71.11 111.101 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.77 138.99 15.04 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.718 -0.753 . . . . 60.31 112.475 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -132.93 148.84 52.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.779 0.323 . . . . 70.25 110.963 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.08 88.91 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.726 -0.75 . . . . 62.32 112.494 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 41.84 56.96 3.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.855 0.36 . . . . 53.11 110.925 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 30.2 t -83.92 145.01 28.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 62.15 110.815 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -126.29 127.88 46.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 74.02 110.898 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 99.6 t -116.93 123.52 71.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 73.11 111.155 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.77 111.83 13.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.885 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 29.4 mm -112.14 104.95 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 75.31 111.09 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.73 -165.06 28.82 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.791 -0.719 . . . . 62.42 112.505 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -116.48 156.01 27.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.343 . . . . 73.44 110.893 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -118.01 118.92 33.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 72.04 110.973 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -106.86 126.08 51.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 75.02 110.915 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 C-N-CA 120.724 -0.75 . . . . 75.35 112.466 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.058 0 CA-C-O 120.837 0.351 . . . . 75.03 110.895 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -142.42 135.72 28.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 75.25 110.821 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.99 137.48 54.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 74.55 110.818 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -127.65 119.64 26.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 71.32 111.096 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.19 -34.04 37.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 75.14 110.915 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.77 132.21 1.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.469 . . . . 72.21 110.907 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 9.9 pt -141.05 134.35 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 71.54 111.149 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -134.08 128.2 33.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 74.54 110.834 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.21 141.34 45.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 74.21 111.192 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -148.87 151.14 34.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 72.54 110.894 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 64.16 91.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 62.32 110.886 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 39.27 41.12 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 75.53 110.817 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -102.49 139.69 37.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 72.43 111.097 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.31 158.62 44.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 72.22 110.874 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 16.3 m -142.72 134.94 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 71.0 111.058 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.45 134.16 52.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 74.31 110.863 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.79 118.78 21.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.948 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.34 -121.16 3.07 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.692 -0.766 . . . . 72.21 112.465 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -144.39 129.15 18.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.931 0.396 . . . . 75.03 110.834 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.44 123.01 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.483 . . . . 71.43 111.169 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.0 m -121.97 129.05 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 75.14 111.154 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 72.54 111.108 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.857 0.36 . . . . 52.41 111.137 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 86.2 m -132.01 125.47 31.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 74.15 111.111 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -105.84 143.51 33.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 74.22 110.933 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.6 p -135.72 123.82 22.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 74.4 110.882 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -111.19 146.46 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 74.2 111.197 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.63 -64.73 1.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 74.32 110.852 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.3 m -138.8 127.94 24.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 74.4 111.207 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 13.8 t -118.4 132.12 69.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 74.14 111.133 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.31 115.16 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 74.34 111.13 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.07 133.37 10.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 53.44 112.482 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.72 141.99 48.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.818 0.342 . . . . 63.51 110.896 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.28 86.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 63.34 112.546 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 51.57 81.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 71.23 110.859 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 13.2 t -113.88 144.66 42.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 74.31 110.857 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 49.6 mtt85 -127.79 127.63 43.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 73.42 110.933 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 13.3 t -124.06 123.97 67.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 73.13 111.11 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 1.5 mt -115.15 111.75 21.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 74.33 110.927 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 47.2 mm -112.1 104.92 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 74.45 111.123 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.39 -146.58 18.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.683 -0.77 . . . . 75.43 112.479 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -117.45 150.59 38.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 72.21 110.908 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -129.54 133.76 47.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 71.42 110.821 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -114.42 126.06 54.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.864 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 132.57 150.95 6.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.69 -0.767 . . . . 72.35 112.454 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -116.37 -144.36 8.01 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 61.34 112.499 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.02 -75.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 74.22 110.899 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -117.8 92.63 0.55 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.762 -0.732 . . . . 72.32 112.494 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -52.36 114.05 1.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.35 . . . . 74.01 110.896 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 3.0 t90 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.197 -0.456 . . . . 72.31 110.88 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 5.2 mtt85 . . . . . 0 CA--C 1.526 0.047 0 CA-C-O 120.856 0.36 . . . . 74.4 110.825 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -103.51 137.01 42.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 73.32 110.911 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.83 137.65 54.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 73.52 110.91 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.35 139.51 49.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 75.52 111.107 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.32 -36.37 9.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 75.44 110.854 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -164.52 138.77 5.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 73.44 110.785 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -137.43 117.77 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 74.43 111.16 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.36 119.51 30.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 70.42 110.919 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.62 135.39 42.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 71.03 111.136 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -144.94 161.88 38.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 71.2 110.865 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 62.37 74.14 0.44 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.148 -0.478 . . . . 64.31 110.844 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 46.96 51.75 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 74.23 110.905 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.25 148.43 26.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 74.32 111.039 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.28 136.31 43.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 75.42 110.872 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.34 123.53 66.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.4 111.071 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -105.74 129.21 53.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 73.52 110.906 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 4.5 mp -125.62 118.65 26.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 74.55 110.892 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.9 -168.93 13.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.716 -0.754 . . . . 74.21 112.488 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -87.73 135.06 33.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.875 0.369 . . . . 74.25 110.842 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 6.8 p -119.0 123.95 72.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 72.43 111.147 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.1 129.14 75.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 72.13 111.126 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.1 t -76.74 168.89 19.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 64.33 111.159 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.07 -33.9 76.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 74.23 111.064 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.91 -35.89 69.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 74.43 111.066 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 72.3 111.113 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.838 0.352 . . . . 75.43 110.909 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 27.8 p -98.64 124.86 43.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 74.52 111.122 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 3.9 t -119.99 139.95 51.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 74.03 111.136 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.3 145.51 48.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.2 110.918 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.3 t -142.11 123.51 14.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 63.0 110.853 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 9.0 p -118.16 139.15 46.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 74.51 111.08 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -83.24 -77.37 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.93 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 23.0 m -122.25 127.9 50.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 74.34 111.133 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 11.9 t -118.53 124.19 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 75.54 111.095 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.7 128.14 69.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 70.24 111.144 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -136.4 133.23 6.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.761 -0.733 . . . . 72.0 112.546 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -133.43 147.93 51.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.843 0.354 . . . . 74.51 110.891 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.24 90.55 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.714 -0.755 . . . . 71.0 112.498 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 43.73 56.3 4.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 75.15 110.888 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 2.3 t -86.85 145.05 26.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 71.4 110.872 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -132.47 127.5 35.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 74.14 110.861 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 5.9 t -125.66 130.15 72.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 75.14 111.149 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.17 112.07 17.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 75.12 110.991 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.81 115.18 49.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 71.43 111.181 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 122.87 -174.31 16.33 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.698 -0.763 . . . . 72.3 112.46 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -89.87 141.55 28.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 70.31 110.825 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -117.49 142.18 47.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 74.43 110.842 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -126.6 126.05 42.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 73.33 110.871 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 158.75 -55.74 0.36 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.782 -0.723 . . . . 71.41 112.504 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 83.93 -60.44 4.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.751 -0.738 . . . . 74.44 112.495 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -51.81 108.7 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.851 0.358 . . . . 74.51 110.903 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.08 95.38 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 32.24 112.503 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -51.72 132.6 31.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.808 0.337 . . . . 61.4 110.918 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.876 179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.06 0 CA-C-O 120.802 0.334 . . . . 72.11 110.871 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.91 124.99 21.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 64.01 110.879 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 3.6 t -131.71 137.88 48.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 71.34 110.861 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.7 150.8 51.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 73.44 111.114 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.84 -30.41 9.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 73.34 110.849 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -165.89 137.95 3.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 71.32 110.848 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 5.4 mt -138.8 117.44 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 73.4 111.162 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -132.19 121.5 23.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.13 110.888 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.6 144.1 47.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.106 -0.497 . . . . 73.02 111.046 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -146.75 166.74 25.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 71.34 110.89 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.49 67.58 0.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 72.2 110.881 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 46.73 56.96 5.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 75.22 110.863 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.66 149.72 25.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 75.44 111.05 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -130.54 135.82 48.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 74.15 110.871 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.02 123.19 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 74.45 111.156 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -105.58 129.73 53.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.923 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -125.78 118.86 26.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.902 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 121.31 -178.5 16.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.665 -0.778 . . . . 75.34 112.474 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -85.61 147.08 26.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 71.54 110.857 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.39 123.98 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 70.0 111.116 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.11 129.22 75.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 73.33 111.152 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 44.0 p -69.83 172.08 8.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 72.12 111.123 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.82 76.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 74.53 111.093 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.84 -35.84 69.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.418 . . . . 64.34 111.107 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 70.54 111.126 179.95 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.862 0.363 . . . . 72.03 110.925 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 45.9 p -101.09 138.04 38.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 70.13 111.111 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 75.9 m -120.45 139.27 53.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 70.34 111.106 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.18 132.13 51.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 72.54 110.901 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.56 123.56 28.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 61.4 110.883 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.09 142.82 40.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 70.32 111.197 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -87.21 -74.62 0.43 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.2 -0.455 . . . . 70.52 110.914 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 87.0 m -128.57 129.17 45.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 74.31 111.171 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.67 120.68 64.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 70.22 111.054 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.89 126.32 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 73.21 111.076 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.63 133.4 7.85 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.744 -0.741 . . . . 74.31 112.496 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -133.02 148.27 52.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.784 0.326 . . . . 72.04 110.925 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.74 84.73 0.02 OUTLIER Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.68 -0.771 . . . . 64.52 112.499 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 45.39 63.19 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 62.14 110.855 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 27.5 t -91.91 145.23 24.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 74.52 110.853 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -131.66 127.61 37.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 74.41 110.882 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 15.1 t -126.74 131.11 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 62.41 111.151 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.47 111.62 17.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 74.0 110.841 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 51.7 mm -112.22 107.72 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 75.53 111.169 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.05 172.73 12.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 71.3 112.459 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -89.9 147.42 23.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.352 . . . . 73.43 110.869 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.13 131.58 56.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 73.21 110.887 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -121.85 133.8 54.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 72.44 110.935 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 134.94 155.76 7.5 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.763 -0.732 . . . . 54.0 112.436 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -93.75 -15.61 48.78 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.818 -0.706 . . . . 54.22 112.445 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -72.42 79.17 1.03 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 74.31 110.898 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 65.52 151.85 0.11 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 64.12 112.488 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -78.91 -32.38 45.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 75.44 110.869 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 6.5 t90 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 62.43 110.913 -179.995 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.807 0.337 . . . . 73.24 110.86 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.66 110.66 18.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.907 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 12.7 p -126.06 143.12 51.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 75.42 110.832 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.09 156.89 48.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 63.23 111.17 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.47 -31.21 6.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 74.2 110.895 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.43 138.58 5.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 74.44 110.898 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 9.9 mt -137.66 117.81 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 75.22 111.143 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -132.9 120.49 21.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.22 110.826 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.97 139.27 44.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 63.42 111.137 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -144.8 166.45 25.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 74.24 110.895 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 61.17 68.15 0.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 74.3 110.848 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 47.44 55.61 8.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 70.15 110.916 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.07 149.01 25.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 71.43 111.054 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.77 135.98 47.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 74.53 110.898 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 5.3 m -127.07 121.99 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 74.05 111.129 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -105.94 132.83 51.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 75.32 110.844 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -129.94 118.64 21.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 71.45 110.964 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.27 176.59 14.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.737 -0.744 . . . . 53.23 112.508 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -85.99 149.56 25.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 75.32 110.894 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 3.4 t -120.54 115.05 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 75.31 111.159 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 6.1 m -122.16 129.39 75.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 75.14 111.108 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 11.5 t -69.16 175.2 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 75.35 111.133 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.76 -33.72 49.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 74.04 111.097 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.67 -51.94 66.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 71.24 111.062 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.43 . . . . 72.53 111.123 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.888 0.375 . . . . 73.15 111.134 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 81.2 m -105.49 133.18 50.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.448 . . . . 64.12 111.109 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.11 137.17 53.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 71.53 110.868 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 10.0 t -142.05 123.74 15.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 70.24 110.889 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -126.06 145.07 34.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 74.42 111.138 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -88.83 -76.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 74.01 110.927 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 48.0 m -127.05 128.1 45.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 72.51 111.117 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.02 120.86 65.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 73.45 111.195 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.42 125.88 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.251 -0.431 . . . . 73.2 111.125 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.62 133.67 8.18 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.75 -0.738 . . . . 61.15 112.524 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.38 147.82 51.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 74.2 110.878 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.79 86.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 73.02 112.507 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 47.62 69.39 0.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.374 . . . . 70.3 110.899 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 19.3 t -100.19 145.35 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 73.32 110.82 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -135.35 128.02 30.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 74.51 110.855 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 14.2 t -128.87 124.22 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 71.34 111.101 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.54 114.37 25.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 73.54 110.917 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 38.1 mm -112.03 104.95 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 72.44 111.095 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.55 -174.54 22.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.738 . . . . 74.41 112.521 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -106.78 148.35 28.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 73.4 110.833 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.75 133.86 54.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 75.44 110.893 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -129.37 125.27 36.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.524 . . . . 74.2 110.95 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.23 -139.92 11.1 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.65 -0.786 . . . . 64.24 112.448 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -118.57 -120.52 2.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.76 -0.733 . . . . 75.13 112.444 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt 56.95 24.25 9.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 75.13 110.931 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 76.07 -68.26 2.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.753 . . . . 73.53 112.478 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -161.26 -75.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 71.35 110.886 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 6.4 t90 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.502 . . . . 73.11 110.848 -179.938 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.857 0.361 . . . . 73.24 110.873 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.45 118.5 13.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 45.42 110.867 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.44 146.31 48.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 73.13 110.801 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.57 155.54 49.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 74.32 111.129 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.05 -27.82 10.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 75.23 110.962 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.36 139.03 5.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 73.35 110.911 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 10.5 mt -137.32 117.49 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 72.04 111.13 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -131.92 116.75 17.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 75.2 110.93 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.13 134.29 42.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 74.34 111.172 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.96 160.66 40.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 71.22 110.867 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 65.13 74.9 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 73.14 110.919 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 45.52 52.99 8.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 72.11 110.892 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.48 141.22 36.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.274 -0.421 . . . . 72.24 111.106 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -132.37 137.84 47.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 75.52 110.875 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.16 137.78 51.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 70.14 111.156 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -124.14 134.26 53.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 64.41 110.921 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.28 126.68 44.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 71.24 110.896 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 127.43 179.97 16.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 55.31 112.478 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -88.05 161.56 17.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 55.14 110.882 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 98.9 t -132.68 121.98 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 54.22 111.175 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.24 128.91 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 71.23 111.144 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.8 t -69.77 174.02 5.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 74.43 111.167 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.03 78.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 72.31 111.066 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.83 -35.82 69.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 63.22 111.142 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 75.24 111.049 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.82 0.343 . . . . 72.3 111.163 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -126.14 122.9 37.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 65.1 110.851 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 3.4 m -127.48 124.06 37.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 61.44 110.866 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.8 125.34 72.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 74.44 111.116 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -61.07 -77.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 72.34 110.888 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.81 135.76 28.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 63.42 111.179 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 39.8 t -118.35 129.35 74.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 74.43 111.053 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 79.4 t -127.32 124.69 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 73.52 111.109 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.02 132.66 8.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 64.14 112.518 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -133.42 116.96 16.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 74.22 110.944 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 71.8 84.46 0.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.739 . . . . 74.34 112.487 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 56.22 86.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 74.14 110.913 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 11.7 t -119.96 145.56 46.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 74.44 110.844 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -137.03 128.22 27.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 71.31 110.878 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 57.4 t -128.93 132.22 67.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 74.04 111.099 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -128.39 111.71 13.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.886 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 24.9 mm -108.74 138.58 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 75.21 111.183 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 110.85 -155.84 15.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 52.51 112.52 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -128.12 149.65 50.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 73.52 110.908 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.91 133.28 54.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 74.04 110.887 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -126.38 125.56 42.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 75.11 110.884 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 63.03 112.528 179.927 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.769 0.318 . . . . 72.03 110.888 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -112.71 130.98 55.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.269 -0.423 . . . . 63.12 110.9 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 2.3 t -121.8 137.66 54.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 72.43 110.841 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.93 129.63 21.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 75.44 111.027 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.3 -36.1 21.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 70.51 110.904 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -165.6 138.59 4.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 64.14 110.914 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.419 ' HA ' HG21 ' A' ' 267' ' ' VAL . 10.3 pt -138.33 134.49 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.21 111.101 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -134.34 129.26 35.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 74.54 110.923 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.68 148.14 51.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 75.15 111.14 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -150.47 167.45 27.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.453 . . . . 74.34 110.884 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.59 65.48 0.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 74.24 110.906 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 50.3 42.21 25.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 75.32 110.948 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.36 156.82 17.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.13 111.104 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.27 143.71 40.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.3 110.896 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.12 121.16 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.23 111.165 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -117.12 128.34 55.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.462 . . . . 75.32 110.923 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 5.8 mp -124.69 118.2 25.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.907 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.05 165.33 10.4 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 64.14 112.45 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -85.95 135.7 33.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.933 0.397 . . . . 71.54 110.812 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 6.4 p -116.12 122.21 69.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 75.34 111.115 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.08 128.93 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 74.32 111.21 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 70.23 111.13 -179.908 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.857 0.361 . . . . 73.21 111.093 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 2.6 t -134.11 120.71 20.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 75.04 111.169 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -99.3 132.65 44.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 75.21 110.915 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.9 p -142.25 123.39 14.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 71.14 110.828 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.8 p -119.68 133.85 65.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 70.44 111.118 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -65.29 -69.84 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.12 110.823 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.2 m -131.64 135.78 47.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.52 111.186 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.419 HG21 ' HA ' ' A' ' 231' ' ' ILE . 15.5 m -127.33 136.04 61.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 72.33 111.17 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 36.6 t -127.19 137.32 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 73.13 111.156 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.43 133.61 7.18 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.676 -0.773 . . . . 74.54 112.489 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.63 148.54 52.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.748 0.308 . . . . 73.44 110.906 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.77 84.33 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 71.42 112.445 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 43.52 55.81 4.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 72.35 110.954 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 45.5 t -83.62 144.83 29.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.095 -0.502 . . . . 71.14 110.821 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.02 128.41 49.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 72.12 110.838 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 25.0 t -115.03 126.69 72.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 73.05 111.173 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.41 109.85 11.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.457 . . . . 75.41 111.008 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 19.6 mm -112.97 104.49 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 74.21 111.107 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.8 -147.01 17.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.815 -0.707 . . . . 61.12 112.518 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -128.07 155.66 44.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 72.4 110.929 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -122.31 118.94 29.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 63.51 110.926 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -109.45 125.89 52.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 74.12 110.866 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 62.3 176.07 2.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 75.23 112.509 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 120.7 16.12 4.66 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.772 -0.728 . . . . 73.55 112.492 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.1 mttm 59.9 69.41 0.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 74.31 110.891 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.51 174.26 23.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.795 -0.717 . . . . 53.03 112.55 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -60.4 -167.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 75.42 110.851 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 9.4 t90 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 71.34 110.887 179.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.76 0.314 . . . . 73.44 110.907 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -125.68 128.06 47.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 72.35 110.857 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.86 141.57 51.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 65.2 110.858 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.17 128.12 25.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 75.33 111.149 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -40.11 39.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 74.33 110.871 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -166.51 138.1 3.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 71.15 110.854 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 5.3 pt -138.71 133.13 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 72.02 111.144 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -135.35 128.55 31.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 75.35 110.944 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.55 137.31 41.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 74.33 111.155 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 13.1 pm0 -141.59 166.65 24.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 72.41 110.903 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 65.96 67.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 75.23 110.79 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 18.9 mtt180 48.65 49.93 17.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.886 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.49 156.72 17.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 73.52 111.114 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 9.5 mtt-85 -134.29 142.9 47.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 73.01 110.872 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.21 124.76 69.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.485 . . . . 74.55 111.092 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.49 128.32 54.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 72.43 110.902 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.87 118.62 31.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 75.45 110.933 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.13 -177.91 16.48 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.748 . . . . 64.32 112.482 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -85.98 148.95 25.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 74.53 110.937 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 6.7 p -131.08 127.87 61.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 70.33 111.1 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 30.8 m -121.93 129.05 75.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 71.32 111.11 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 20.9 p -80.28 175.0 11.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 63.15 111.129 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.01 -45.29 93.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 71.02 111.082 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.55 -36.02 77.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 70.23 111.126 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 73.25 111.127 179.928 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.803 0.335 . . . . 75.42 110.875 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 7.3 t -74.17 130.89 40.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 75.32 111.167 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 90.6 m -133.04 108.89 9.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 75.04 111.115 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.82 136.12 33.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 73.24 110.878 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 19.5 t -142.51 123.15 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 73.34 110.859 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 4.0 p -119.34 140.09 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 70.33 111.116 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -78.1 -73.87 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 65.42 110.869 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.9 m -131.5 127.68 37.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 74.41 111.138 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 19.4 m -122.61 135.33 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 75.54 111.181 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 57.8 t -127.85 133.33 67.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 75.51 111.147 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.82 133.25 7.54 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.757 . . . . 75.01 112.464 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -132.4 148.56 52.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.332 . . . . 71.35 110.937 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.42 91.65 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.749 . . . . 71.01 112.484 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 40.44 51.14 2.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 64.11 110.866 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.05 144.55 29.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 71.53 110.88 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.47 128.19 45.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 72.42 110.907 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 26.2 t -118.79 124.61 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 74.42 111.105 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.52 111.49 14.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 71.24 110.917 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 35.6 mm -110.98 104.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 74.43 111.095 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.91 -142.81 10.68 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.711 -0.757 . . . . 63.13 112.431 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -123.26 147.37 47.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 75.41 110.809 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -111.99 129.77 56.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 73.22 110.895 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.11 130.36 52.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 75.05 110.92 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 81.95 159.25 24.32 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.765 -0.731 . . . . 70.14 112.499 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 126.1 -87.89 0.35 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.818 -0.706 . . . . 74.23 112.539 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.47 -51.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 71.11 110.858 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -130.2 -89.23 0.52 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.744 -0.741 . . . . 62.34 112.488 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -122.19 -34.03 3.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 71.0 110.864 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.113 -0.494 . . . . 73.45 110.939 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 14.4 mmt-85 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.811 0.339 . . . . 72.21 110.848 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -141.98 112.75 7.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 75.11 110.892 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 4.5 t -123.17 137.73 54.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 63.33 110.826 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.06 119.65 20.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 74.25 111.094 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -43.51 74.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 74.23 110.873 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -167.24 136.71 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.247 -0.433 . . . . 72.34 110.887 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 3.8 pt -138.13 131.79 41.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 74.53 111.129 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.09 128.37 30.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 74.12 110.891 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -135.46 144.97 46.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 74.5 111.138 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.88 166.73 25.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 74.21 110.907 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 66.96 68.27 0.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 74.22 110.864 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 46.66 53.92 9.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 74.21 110.871 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.23 156.89 17.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.051 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -132.23 141.3 48.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.34 110.885 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.06 121.01 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.41 111.132 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.78 117.27 30.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 74.3 110.905 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.82 118.94 36.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 64.34 110.943 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 122.75 -177.43 16.52 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.76 . . . . 63.31 112.481 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -85.95 131.94 34.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 61.44 110.834 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 3.1 p -116.34 122.52 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 73.04 111.068 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.88 129.27 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 71.24 111.148 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 59.3 p -69.8 175.2 4.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 75.4 111.093 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.12 -46.1 86.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 73.45 111.078 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -67.96 -36.74 80.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.21 111.114 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 73.45 111.162 179.865 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.898 0.38 . . . . 74.31 110.951 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 7.6 t -64.97 124.56 22.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 75.13 111.128 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 6.5 t -134.16 141.4 47.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 73.31 111.118 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -113.88 143.04 45.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 73.43 110.86 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 8.5 t -140.16 123.94 17.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 75.31 110.903 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.7 p -120.81 135.78 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 73.32 111.102 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.72 -75.58 0.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 75.14 110.894 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 2.2 m -127.19 127.76 45.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 73.4 111.162 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.78 128.28 75.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 74.42 111.151 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 41.7 t -127.92 115.93 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 75.51 111.144 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.67 133.98 11.04 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.794 -0.717 . . . . 64.22 112.472 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -132.08 148.2 52.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.897 0.38 . . . . 75.15 110.888 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 53.55 90.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.683 -0.77 . . . . 60.04 112.513 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 40.87 51.41 3.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.878 0.37 . . . . 74.54 110.859 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 39.1 t -84.87 144.98 28.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.04 110.843 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -127.74 127.85 44.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 74.2 110.884 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 23.4 t -122.89 123.63 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 72.2 111.129 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.93 114.35 19.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 70.44 110.949 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 31.5 mm -112.57 104.56 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 74.55 111.133 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.04 -164.05 27.61 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.676 -0.774 . . . . 41.35 112.483 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -89.84 155.99 18.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 75.35 110.87 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -129.84 134.87 47.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 74.54 110.911 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.15 125.38 34.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 73.33 110.967 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -122.54 -166.86 12.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.727 -0.749 . . . . 75.5 112.487 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -101.27 -23.37 9.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 73.12 112.525 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -172.34 32.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 74.45 110.866 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -173.82 -174.01 40.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.796 -0.716 . . . . 74.03 112.531 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -100.84 -173.54 2.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.804 0.335 . . . . 74.14 110.948 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 11.6 t90 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 74.55 110.906 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.816 0.341 . . . . 72.35 110.928 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -81.43 109.43 15.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 74.55 110.902 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.01 149.62 51.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 75.31 110.816 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.02 160.93 35.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 73.23 111.08 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.42 -37.05 5.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.907 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -164.6 139.08 5.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.211 -0.45 . . . . 71.35 110.949 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -136.66 117.51 17.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 75.5 111.155 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -130.38 115.59 17.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 73.22 110.865 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 2.7 p -135.65 147.42 48.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 74.34 111.151 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.74 167.52 24.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 74.11 110.866 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 68.34 67.57 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 73.41 110.855 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 46.46 60.35 3.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 73.32 110.824 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.18 155.78 18.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 64.13 111.12 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -133.35 135.94 45.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.884 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.48 121.85 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 64.45 111.153 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -118.06 120.37 37.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.33 110.949 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.37 119.8 40.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 74.21 110.948 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.99 -175.5 19.11 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.723 -0.751 . . . . 71.35 112.498 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -96.29 128.45 43.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 75.42 110.867 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 3.7 p -111.28 115.81 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 73.33 111.121 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.75 124.78 71.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 74.13 111.118 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 6.4 t -70.58 175.23 5.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.181 -0.463 . . . . 63.21 111.197 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.38 90.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 65.25 111.14 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.71 -35.96 69.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 63.24 111.109 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 74.31 111.103 179.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.812 0.339 . . . . 75.12 111.151 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.05 141.4 47.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 74.01 111.22 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -122.27 144.54 48.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 72.23 110.889 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.22 123.68 14.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.902 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 14.4 p -120.54 131.53 72.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 75.54 111.101 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.2 -76.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 73.01 110.925 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 3.8 m -128.09 132.05 49.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 74.52 111.165 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.59 123.63 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 75.3 111.12 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 23.6 t -122.15 115.88 47.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 74.14 111.187 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.05 133.63 10.75 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.767 -0.73 . . . . 63.24 112.529 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -132.11 148.01 52.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.813 0.34 . . . . 75.25 110.878 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.29 76.38 0.17 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.748 . . . . 73.0 112.478 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 48.44 71.68 0.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.362 . . . . 72.23 110.93 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 20.5 t -102.27 145.41 29.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 63.11 110.893 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -123.03 128.33 50.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 73.52 110.814 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 18.8 t -129.47 123.43 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 74.13 111.103 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 15.5 mt -127.85 116.8 20.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 72.32 110.871 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 34.2 mm -112.18 104.68 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 74.44 111.188 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.84 -159.25 28.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.783 -0.722 . . . . 53.53 112.48 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -96.61 156.1 16.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 74.04 110.892 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -129.18 118.99 23.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 74.2 110.806 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.75 124.17 44.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 71.02 110.905 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.81 -76.55 2.22 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 61.54 112.421 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 51.98 -156.11 4.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.749 -0.739 . . . . 32.5 112.516 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -179.42 -34.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.848 0.356 . . . . 75.43 110.964 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -84.27 -126.0 1.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.762 -0.732 . . . . 64.32 112.459 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -22.4 50.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 74.22 110.91 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 75.35 110.933 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 29.5 mtt-85 . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.833 0.349 . . . . 72.04 110.908 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.03 109.92 22.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 72.34 110.942 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.89 137.84 54.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.482 . . . . 54.1 110.886 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.13 128.14 37.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.32 111.133 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.52 -30.43 25.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 72.23 110.918 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -165.0 138.16 4.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 75.52 110.813 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 8.4 mt -137.98 116.71 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 74.22 111.116 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -134.76 115.68 14.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 74.43 110.836 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 1.3 p -135.88 145.11 46.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 63.03 111.124 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -143.99 167.72 21.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.147 -0.479 . . . . 74.32 110.886 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 68.07 68.2 0.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 74.44 110.821 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 46.86 61.69 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 71.52 110.937 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.88 156.05 18.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 74.1 111.025 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -136.35 136.25 39.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 72.53 110.868 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.72 138.65 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 71.43 111.149 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -136.98 129.52 30.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 65.23 110.904 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 5.6 mp -114.48 118.71 34.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 74.24 110.839 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.92 179.71 16.21 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.733 -0.746 . . . . 74.31 112.473 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -93.07 143.2 26.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 72.11 110.85 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 5.5 p -118.59 122.36 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 74.44 111.099 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 5.7 m -122.35 122.09 65.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 75.22 111.138 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.0 t -70.09 173.78 6.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 71.15 111.139 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.0 92.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 74.52 111.174 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.19 72.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 75.3 111.078 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 73.12 111.025 -179.994 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 94.3 m . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.747 0.308 . . . . 71.12 111.12 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -108.63 124.4 50.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 73.43 110.907 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 3.8 m -125.83 123.72 39.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 64.54 110.909 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 12.9 p -123.21 131.73 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 73.13 111.142 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.67 -77.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 73.13 110.913 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 75.4 p -133.52 131.19 39.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 72.21 111.131 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 4.9 m -118.34 120.95 65.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 74.32 111.135 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.63 120.04 63.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 74.21 111.13 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.51 133.76 11.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.776 -0.726 . . . . 75.44 112.477 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -131.87 148.13 52.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 74.42 110.895 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.48 78.74 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.735 -0.745 . . . . 73.24 112.457 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 47.51 68.38 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.372 . . . . 60.43 110.848 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 40.4 t -99.69 145.41 27.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 73.13 110.872 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.96 128.54 43.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 74.14 110.836 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 30.1 t -129.96 123.43 56.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.21 111.115 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 54.8 mt -126.01 111.87 15.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 71.34 110.904 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 27.1 mm -104.21 106.35 20.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 65.52 111.131 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.85 -171.8 29.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.753 -0.737 . . . . 71.43 112.463 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -89.87 154.94 19.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 74.31 110.907 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -127.15 120.58 29.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 71.02 110.902 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.27 125.77 45.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 74.54 110.876 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.74 -0.743 . . . . 54.21 112.501 179.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.842 0.354 . . . . 71.0 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -107.28 132.79 52.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.884 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 46.8 m -140.51 148.06 40.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 75.45 110.932 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.11 119.35 10.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 62.33 111.06 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -36.68 78.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 74.1 110.89 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -165.29 137.76 4.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 72.0 110.909 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 6.3 pt -138.5 116.9 13.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 62.13 111.14 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -126.33 129.75 49.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 75.34 110.838 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 5.4 p -136.05 148.97 48.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 73.0 111.169 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.99 168.41 21.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.272 -0.422 . . . . 61.11 110.894 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 69.69 60.41 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.87 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 48.31 58.93 4.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 74.21 110.883 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.09 156.53 17.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 74.23 111.078 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.55 147.67 49.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 75.32 110.865 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.68 121.69 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 74.0 111.099 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -125.1 125.1 43.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 74.33 110.914 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.77 117.98 29.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 65.04 110.906 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 161.58 162.7 13.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 52.21 112.485 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -85.74 140.66 30.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.875 0.369 . . . . 74.43 110.883 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 97.9 t -114.25 118.56 58.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.48 . . . . 63.42 111.161 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.61 129.07 75.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 72.4 111.121 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 74.2 111.162 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.829 0.347 . . . . 74.15 111.125 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.5 t -108.49 120.72 43.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 63.5 111.101 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -102.68 119.79 39.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 71.03 110.903 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.6 t -132.05 123.79 27.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 70.33 110.891 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 4.2 p -116.9 141.38 35.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.143 -0.481 . . . . 75.51 111.082 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.51 -74.8 0.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 71.31 110.869 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.5 m -124.11 136.53 54.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 74.03 111.143 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.84 132.57 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 74.11 111.195 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.23 119.87 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 70.23 111.111 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.11 133.66 11.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.717 -0.754 . . . . 73.43 112.52 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -132.36 148.22 52.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 74.33 110.843 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 53.22 74.24 0.32 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.742 . . . . 73.42 112.489 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 47.57 59.52 4.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.898 0.38 . . . . 73.5 110.945 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.61 145.81 28.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 63.55 110.782 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 57.9 mtt85 -118.03 128.31 54.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 72.55 110.902 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 13.6 t -117.4 123.61 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 75.25 111.215 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.87 112.63 16.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 75.21 110.991 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.11 104.4 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 71.23 111.068 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.23 166.18 14.68 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.718 -0.753 . . . . 63.02 112.489 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -100.1 156.21 17.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.817 0.341 . . . . 75.24 110.889 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -115.71 119.75 37.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.898 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.52 125.97 51.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 63.11 110.933 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 69.37 142.56 0.14 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.775 -0.726 . . . . 65.21 112.471 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 129.36 -28.94 3.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.735 -0.745 . . . . 71.31 112.465 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 62.91 56.95 1.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 73.33 110.954 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -154.07 -119.58 0.73 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.765 -0.731 . . . . 42.42 112.499 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -176.24 -38.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 74.11 110.844 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 73.44 110.954 -179.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.798 0.332 . . . . 75.05 110.941 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -83.99 130.88 34.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 73.44 110.909 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.0 m -140.39 146.02 37.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 73.13 110.853 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.45 119.93 12.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 52.5 111.074 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -32.2 69.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 74.03 110.918 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -166.69 137.41 3.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.275 -0.42 . . . . 72.11 110.912 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . 0.405 ' HA ' HG23 ' B' ' 267' ' ' VAL . 12.8 pt -138.54 117.61 13.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 75.03 111.149 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -131.07 129.18 41.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.846 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 2.3 p -135.59 148.77 49.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 63.14 111.116 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 15.6 pm0 -144.46 168.29 20.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 72.35 110.898 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 69.6 64.85 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 63.44 110.856 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.33 48.38 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 74.11 110.888 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.69 156.63 16.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 73.41 111.126 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.9 154.91 51.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 74.31 110.897 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.92 138.55 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.22 111.175 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -138.42 123.18 18.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.87 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.65 118.67 33.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 72.24 110.952 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 159.18 161.88 11.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.7 -0.762 . . . . 53.14 112.422 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -86.06 131.12 34.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 64.44 110.935 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 85.9 t -96.97 115.05 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 73.54 111.146 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 91.2 t -109.78 128.99 65.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 73.53 111.099 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -70.25 167.52 17.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 65.11 111.134 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.09 76.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 75.25 111.063 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.51 -50.44 73.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 72.31 111.159 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 72.24 111.05 179.89 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.931 0.396 . . . . 74.41 110.891 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 2.5 m -100.62 129.32 46.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 72.13 111.182 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 4.8 t -110.53 134.58 52.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 73.43 111.076 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.49 133.38 56.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 72.31 110.854 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.3 m -142.81 123.13 13.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 74.23 110.894 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 8.0 p -119.0 134.43 62.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 73.23 111.161 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -66.51 -75.2 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 75.23 110.885 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 68.8 m -133.32 133.33 42.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 63.33 111.142 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' B' ' 231' ' ' ILE . 0.7 OUTLIER -120.55 138.0 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 74.42 111.148 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.06 124.45 66.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 74.53 111.082 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.31 133.62 11.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.638 -0.792 . . . . 74.42 112.477 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -132.02 148.04 52.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 74.11 110.892 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.3 80.78 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 61.41 112.421 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 44.19 57.79 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.958 0.409 . . . . 72.43 110.923 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.71 145.55 28.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 75.55 110.844 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -119.3 128.77 54.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 74.44 110.901 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 18.0 t -115.16 125.05 72.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 75.34 111.107 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.11 110.9 12.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.145 -0.48 . . . . 73.33 110.96 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 4.7 mp -112.61 104.44 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 73.51 111.14 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.31 170.97 21.44 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.754 -0.736 . . . . 64.13 112.486 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -103.89 156.0 18.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.813 0.34 . . . . 73.54 110.909 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -115.92 119.41 35.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.885 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.94 127.74 51.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 72.4 110.951 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 63.19 160.31 0.24 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.696 -0.764 . . . . 63.33 112.539 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 98.4 104.62 2.44 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.806 -0.711 . . . . 51.41 112.473 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.76 103.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.777 0.322 . . . . 75.12 110.98 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 157.99 -127.87 1.98 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.71 -0.757 . . . . 75.13 112.457 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -178.11 -38.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.801 0.334 . . . . 75.11 110.87 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 18.0 t90 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.155 -0.475 . . . . 74.42 110.916 -179.929 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.797 0.332 . . . . 72.54 110.837 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -100.49 119.6 38.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 75.24 110.897 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.3 m -140.22 142.73 35.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 72.1 110.857 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -142.29 130.13 21.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 73.02 111.132 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -31.62 39.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 73.25 110.905 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -167.46 135.16 2.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.408 . . . . 65.44 110.851 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . 0.465 ' HA ' HG23 ' C' ' 267' ' ' VAL . 6.3 pt -142.02 117.23 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 74.44 111.13 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.16 133.51 46.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 74.1 110.807 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 5.0 p -136.22 152.43 50.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 75.1 111.169 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -145.88 168.25 21.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 75.44 110.816 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 69.67 63.81 0.26 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 74.24 110.892 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.32 58.47 4.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.872 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.62 156.22 18.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 74.04 111.148 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -131.28 137.33 48.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 74.23 110.848 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 6.5 m -123.68 121.77 63.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 72.35 111.161 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -119.83 115.82 24.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 75.41 110.929 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.51 118.69 36.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 72.11 110.934 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.1 166.05 13.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.673 -0.775 . . . . 72.11 112.471 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -85.8 146.63 26.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.924 0.392 . . . . 65.11 110.874 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 46.2 t -116.37 122.88 70.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 75.24 111.145 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 74.6 t -122.05 128.53 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 65.45 111.117 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.8 t -69.83 173.23 6.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 74.12 111.164 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.54 76.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 54.44 111.059 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.93 -51.87 67.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 73.31 111.107 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 43.41 111.047 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.854 0.359 . . . . 74.15 110.857 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.37 137.69 35.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 71.51 111.146 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 87.2 m -128.8 119.83 25.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 65.34 111.094 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -104.86 119.96 40.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 65.21 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 29.2 t -134.32 123.64 24.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.827 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.3 p -119.49 153.32 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 74.45 111.144 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.02 -60.45 1.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 72.02 110.905 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 31.6 p -145.63 127.68 15.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 74.44 111.136 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' C' ' 231' ' ' ILE . 1.0 OUTLIER -122.82 137.38 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 73.11 111.14 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 49.1 t -124.9 125.56 69.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 73.32 111.124 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.77 134.06 11.74 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 73.04 112.52 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -132.36 148.52 52.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.841 0.353 . . . . 74.22 110.864 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.72 85.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.682 -0.77 . . . . 73.13 112.548 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 42.72 59.26 2.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 72.45 110.871 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.8 145.13 28.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 73.32 110.825 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -121.32 128.2 52.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 73.15 110.874 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 31.0 t -116.04 125.19 73.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 72.22 111.14 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.2 111.59 13.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 75.01 110.918 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 57.2 mt -111.14 104.2 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 71.44 111.14 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.39 178.22 24.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.725 -0.75 . . . . 42.42 112.465 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -108.69 150.96 26.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.779 0.323 . . . . 74.42 110.905 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -112.0 127.9 56.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.44 110.894 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -113.63 125.87 54.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 72.1 110.919 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 51.56 -170.45 0.36 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.767 -0.73 . . . . 63.55 112.489 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 84.94 -133.01 11.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.818 -0.705 . . . . 51.13 112.457 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -45.38 66.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.83 0.348 . . . . 74.43 110.876 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 128.02 -9.17 6.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.713 -0.756 . . . . 71.52 112.443 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -171.51 -75.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 73.21 110.87 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 14.6 t90 . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 74.44 110.908 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.856 0.36 . . . . 72.21 110.837 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -83.66 115.31 22.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 71.53 110.85 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.35 147.33 49.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.912 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.06 119.91 11.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 71.02 111.092 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.49 -39.33 70.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 73.42 110.913 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -165.81 138.89 4.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 74.25 110.844 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.38 116.25 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 74.04 111.149 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -125.59 125.6 43.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 75.14 110.826 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.5 p -135.51 149.0 49.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 64.02 111.096 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 14.9 pm0 -145.65 167.95 21.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 65.1 110.861 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 64.79 76.03 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 73.11 110.899 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 10.5 mtm-85 41.42 56.74 3.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.857 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.54 156.29 18.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 74.11 111.049 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -136.83 151.96 49.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 70.34 110.915 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.23 139.53 43.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 71.24 111.078 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -137.66 121.28 17.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 74.55 110.912 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.21 118.37 35.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 72.14 110.899 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 146.23 169.48 14.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.741 . . . . 75.2 112.534 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -85.95 152.1 23.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 72.42 110.909 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 18.2 t -117.57 114.81 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.33 111.139 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 67.8 t -107.47 124.06 63.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 73.11 111.181 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t -69.73 168.21 15.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 74.3 111.178 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.19 -34.1 73.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 75.34 111.078 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.74 -36.45 72.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 54.41 111.115 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 73.11 111.126 179.939 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 85.8 m . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.843 0.354 . . . . 70.24 111.162 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 99.8 m -105.33 125.08 50.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.424 . . . . 64.13 111.127 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.98 129.47 49.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 63.3 110.857 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.23 123.56 14.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 70.32 110.882 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 14.2 p -109.89 128.77 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 74.01 111.122 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.55 -79.55 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 74.32 110.793 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -121.68 129.93 53.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 75.11 111.085 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.75 120.33 64.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 65.42 111.103 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 22.4 t -118.74 115.97 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 73.4 111.154 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.14 133.76 10.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.707 -0.759 . . . . 73.43 112.527 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -131.53 147.81 52.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.766 0.317 . . . . 74.25 110.888 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.16 90.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.761 . . . . 73.22 112.521 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 44.28 61.27 2.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 75.33 110.914 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.56 145.81 24.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 75.14 110.937 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 10.7 mtm-85 -124.04 131.23 53.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 65.44 110.865 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.27 124.9 72.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 72.43 111.106 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -128.4 111.46 13.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 72.43 110.911 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 18.2 mt -114.16 103.99 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 64.41 111.165 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.6 -164.68 30.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 72.33 112.42 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -128.26 150.07 50.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.786 0.327 . . . . 74.44 110.904 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -113.39 145.36 41.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 61.44 110.889 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -129.86 125.93 36.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 74.13 110.927 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 62.28 168.46 0.76 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.76 -0.733 . . . . 75.21 112.449 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 107.63 -124.52 7.6 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 72.23 112.477 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -137.84 91.53 2.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 74.22 110.881 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 71.19 167.29 7.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.748 -0.739 . . . . 33.13 112.518 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -51.92 -31.95 30.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.834 0.349 . . . . 74.12 110.874 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 3.0 t90 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 75.0 110.873 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.834 0.349 . . . . 74.04 110.86 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -96.75 109.75 22.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 75.41 110.881 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 31.9 t -134.06 137.85 44.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 71.04 110.802 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.45 136.61 54.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 74.22 111.158 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.44 -35.14 13.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 74.03 110.861 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.39 137.32 3.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 72.23 110.824 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 1.3 mt -138.06 116.55 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 64.31 111.166 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -123.16 121.68 36.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.03 110.861 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 9.6 p -136.74 149.14 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.42 111.227 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.98 166.44 24.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 73.44 110.862 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . 0.466 ' O ' ' C ' ' E' ' 236' ' ' ARG . 2.4 mt-10 62.23 90.46 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 71.33 110.904 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' E' ' 235' ' ' GLU . 0.9 OUTLIER 31.94 63.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 72.34 110.935 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.03 156.28 18.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 71.14 111.087 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -137.4 137.2 38.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 75.24 110.903 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 16.6 m -126.08 137.76 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 70.43 111.092 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -134.78 126.51 29.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 72.15 110.931 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 1.3 mp -116.98 118.64 32.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 73.5 110.859 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.61 172.38 12.55 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.786 -0.721 . . . . 75.12 112.535 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.57 163.39 18.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 73.12 110.914 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.64 135.54 61.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 73.35 111.132 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 70.3 t -122.86 124.11 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 75.53 111.226 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.7 t -68.47 167.03 15.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 73.51 111.172 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.17 75.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 63.21 111.127 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.89 -36.94 70.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 52.32 111.087 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 71.3 111.053 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.794 0.33 . . . . 72.44 111.125 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -123.0 119.75 31.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 70.02 110.903 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 4.2 p -133.12 123.29 25.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.883 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.3 136.64 47.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 72.14 111.168 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -81.36 -75.53 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 74.41 110.904 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.2 m -125.21 129.62 50.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 64.33 111.142 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 17.6 t -117.32 123.9 72.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 75.43 111.142 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 87.4 t -127.07 115.82 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 74.35 111.133 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.58 133.87 8.81 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 73.4 112.516 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.84 147.54 46.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.359 . . . . 74.54 110.897 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.27 84.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.777 -0.725 . . . . 44.43 112.46 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 49.1 88.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.853 0.359 . . . . 73.4 110.905 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 67.2 m -116.25 145.19 43.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.13 110.85 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.82 128.78 55.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 74.42 110.925 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 16.4 t -115.12 122.86 70.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 72.01 111.11 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.25 111.56 13.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 75.54 110.874 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 61.5 mt -113.71 104.09 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 73.02 111.087 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.3 176.88 15.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 73.44 112.445 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -89.35 156.43 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.826 0.345 . . . . 64.33 110.899 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -128.53 137.52 51.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 64.1 110.94 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -120.2 123.75 44.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 74.22 110.923 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 C-N-CA 120.686 -0.769 . . . . 75.14 112.536 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.861 0.363 . . . . 60.01 110.831 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -83.19 145.15 29.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 71.21 110.899 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.57 150.26 47.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 75.02 110.85 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.8 119.13 17.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.497 . . . . 61.12 111.092 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -70.76 -49.98 40.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 74.51 110.927 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -165.25 136.37 3.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 72.34 110.862 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 8.0 pt -138.84 134.39 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 74.44 111.1 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -134.49 128.2 32.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 73.25 110.837 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 11.8 p -136.41 149.79 48.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 71.53 111.107 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -120.54 166.24 13.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 75.43 110.869 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 65.39 -159.27 0.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 72.32 110.914 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -74.33 61.41 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 73.33 110.835 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.23 156.43 16.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 74.25 111.108 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.64 143.49 47.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 75.41 110.869 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.83 120.83 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 74.14 111.161 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.44 137.7 52.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.889 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.41 118.37 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.92 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 149.78 -126.73 2.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 74.21 112.516 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -145.51 143.11 29.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.808 0.337 . . . . 75.0 110.944 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.65 119.9 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 75.35 111.121 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 36.7 t -109.19 116.15 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 72.14 111.12 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 71.21 111.166 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.823 0.344 . . . . 75.32 111.077 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 54.0 m -132.5 133.64 44.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 74.15 111.167 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.88 144.45 44.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 71.02 110.862 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.7 m -141.69 127.97 19.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 71.42 110.824 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.7 p -113.57 137.41 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.508 . . . . 74.3 111.088 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -85.61 -78.82 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 75.31 110.829 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 4.0 m -115.71 127.04 54.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 75.33 111.101 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 40.9 t -118.42 124.12 72.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 74.2 111.076 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 78.9 t -124.76 115.21 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.116 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.42 133.08 9.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 53.2 112.499 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -109.03 129.3 55.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.35 . . . . 75.33 110.884 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.92 178.74 10.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.743 . . . . 54.15 112.465 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -47.53 101.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.835 0.35 . . . . 74.32 110.923 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 44.9 t -129.63 154.14 47.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.096 -0.502 . . . . 74.33 110.837 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -112.16 128.05 56.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 75.2 110.827 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.0 123.58 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 73.03 111.137 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.16 111.01 14.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 64.21 110.913 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 31.0 mm -109.96 104.3 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 62.52 111.119 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.74 -163.48 29.67 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.765 -0.731 . . . . 74.14 112.508 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -114.36 156.36 24.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 72.04 110.843 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -129.23 129.24 44.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.114 -0.494 . . . . 64.43 110.88 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.8 128.97 50.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 73.34 110.907 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 151.34 -169.19 30.94 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.808 -0.71 . . . . 74.14 112.494 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -78.72 -173.84 43.66 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.681 -0.771 . . . . 75.12 112.513 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.477 ' N ' ' HZ2' ' A' ' 284' ' ' LYS . 0.0 OUTLIER 69.3 -75.55 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 61.44 110.927 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 286' ' ' PHE . . . 100.58 175.81 29.77 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.689 -0.767 . . . . 74.42 112.489 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.402 ' HB3' ' O ' ' A' ' 285' ' ' GLY . 9.9 t80 64.01 -81.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 75.42 110.883 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.084 -0.507 . . . . 75.12 110.976 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.827 0.346 . . . . 73.32 110.849 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.57 140.17 30.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 75.11 110.942 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 41.4 m -134.05 140.49 46.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 72.12 110.911 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -122.71 119.33 30.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 64.11 111.07 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.93 -44.99 75.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 75.42 110.872 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -156.7 137.53 13.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.53 110.806 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.34 117.34 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 72.13 111.16 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -120.1 123.82 44.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 74.01 110.921 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 17.1 p -136.17 140.8 43.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 75.1 111.135 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -121.7 166.93 13.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.167 -0.469 . . . . 63.33 110.809 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.58 -165.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 74.53 110.894 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -73.5 69.84 1.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 75.13 110.892 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 156.4 17.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 42.33 111.077 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.83 135.48 50.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 70.4 110.844 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 19.0 m -126.45 136.08 61.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.41 111.099 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -134.78 126.4 28.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 73.32 110.867 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 mp -118.46 119.01 33.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 72.52 110.863 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.83 -174.95 21.82 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.727 -0.749 . . . . 75.14 112.471 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -93.53 141.13 28.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 74.31 110.87 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 18.0 m -118.33 122.44 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 73.31 111.125 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 21.3 t -116.54 127.59 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 75.4 111.142 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 57.6 p -87.2 172.79 9.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 74.34 111.131 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.07 -43.1 99.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 72.54 111.129 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -42.68 80.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 71.54 111.16 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 71.14 111.091 179.925 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.862 0.363 . . . . 74.13 110.947 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 6.0 m -99.88 121.78 41.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 74.43 111.128 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 96.9 m -105.02 130.4 53.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 64.25 111.213 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.43 147.29 48.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 70.32 110.847 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 28.2 t -142.08 123.45 14.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.44 110.909 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 p -109.36 143.53 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 72.23 111.128 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -84.58 -75.32 0.35 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 75.14 110.865 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 18.5 p -125.12 127.87 47.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 73.1 111.166 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.27 120.99 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 74.22 111.088 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.8 123.68 70.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 62.42 111.14 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -131.38 133.47 7.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.699 -0.762 . . . . 73.01 112.454 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.28 147.21 31.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 72.11 110.809 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.26 -162.43 32.52 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.751 -0.737 . . . . 65.03 112.565 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -69.56 83.17 0.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 74.55 110.899 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 32.1 t -104.63 164.58 11.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 72.21 110.836 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -124.14 128.72 49.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 75.12 110.839 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 56.6 t -117.94 123.86 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 75.42 111.127 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.0 111.32 13.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 74.42 110.952 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 12.7 mm -112.76 103.8 16.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 65.54 111.087 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.26 -154.03 25.24 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.777 -0.725 . . . . 63.34 112.514 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -125.31 149.63 47.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.734 0.302 . . . . 72.24 110.899 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -113.95 136.32 53.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 64.42 110.824 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -130.04 127.31 39.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 74.44 110.955 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.36 172.55 43.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 72.22 112.484 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 80.11 125.99 0.6 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.808 -0.71 . . . . 71.05 112.521 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -75.88 68.2 2.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.861 0.363 . . . . 75.22 110.954 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -174.96 -153.12 9.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.705 -0.76 . . . . 53.51 112.49 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -122.0 -33.8 3.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.834 0.35 . . . . 63.41 110.86 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 1.4 t90 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 73.24 110.906 -179.966 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.718 0.295 . . . . 72.43 110.906 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.43 144.15 30.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 62.34 110.889 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.14 137.99 44.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 65.22 110.832 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . 0.406 ' HA ' HG11 ' C' ' 264' ' ' VAL . . . -116.86 119.91 36.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.055 -0.521 . . . . 74.4 111.124 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -72.72 -42.92 63.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 71.32 110.926 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -158.23 136.58 10.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 72.3 110.805 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 1.7 mt -140.01 116.39 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 75.04 111.077 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 16.0 ttp85 -125.63 125.63 43.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 73.11 110.879 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 21.2 p -136.32 146.3 46.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 62.14 111.099 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -121.21 166.1 14.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 63.22 110.88 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.46 -162.5 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 73.02 110.858 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -72.85 70.83 1.01 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.838 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.25 157.22 17.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 72.32 111.058 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -125.59 149.16 48.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 75.21 110.901 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 12.9 m -141.58 137.84 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 74.02 111.138 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -136.65 132.16 34.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 75.35 110.922 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -117.89 117.91 30.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 72.51 110.957 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.44 -177.5 17.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.727 -0.749 . . . . 71.12 112.473 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -85.76 140.89 30.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 74.24 110.817 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.29 115.85 50.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 73.24 111.139 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.66 123.07 68.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 72.41 111.137 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 13.2 t -79.95 175.1 10.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 74.11 111.202 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.91 97.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 74.52 111.12 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.68 -52.03 66.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 71.41 111.094 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 75.31 111.072 179.953 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.871 0.367 . . . . 74.21 110.945 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 38.1 p -99.09 137.88 36.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 74.44 111.205 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.7 t -134.13 133.75 41.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 75.24 111.135 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.13 147.7 49.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 64.41 110.898 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.17 123.21 13.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 74.3 110.878 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' C' ' 228' ' ' ALA . 9.0 p -105.52 153.56 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 73.2 111.156 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -97.45 -49.34 4.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 74.42 110.857 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.74 127.96 14.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 73.44 111.157 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 29.1 t -125.0 120.95 59.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 73.43 111.184 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 52.1 t -126.51 134.86 65.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 75.11 111.156 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.65 133.41 6.39 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.789 -0.719 . . . . 71.23 112.489 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.17 147.38 28.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 73.2 110.863 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 61.93 -152.64 42.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.728 -0.749 . . . . 74.02 112.507 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -73.64 73.78 1.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.359 . . . . 73.23 110.865 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 58.8 m -97.68 157.8 15.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 72.12 110.847 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -119.56 132.72 55.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 64.34 110.82 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 78.7 t -115.32 122.26 68.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 74.42 111.172 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.14 111.66 15.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 74.42 110.899 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 20.1 mm -112.63 104.15 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 75.44 111.12 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.58 -159.16 26.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.741 . . . . 70.13 112.459 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.48 156.22 24.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 74.11 110.901 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -113.94 144.61 42.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 74.01 110.848 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -130.14 125.61 35.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 75.43 110.907 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 67.06 150.69 0.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 62.01 112.499 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 138.33 150.67 5.67 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.792 -0.718 . . . . 70.32 112.486 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -64.74 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 74.32 110.896 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -100.81 174.9 25.98 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.748 . . . . 72.52 112.515 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -52.02 -30.37 25.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.868 0.366 . . . . 75.41 110.852 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 2.0 t90 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 74.33 110.836 -179.91 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.849 0.356 . . . . 73.21 110.843 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -83.03 110.01 17.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 71.43 110.907 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 60.5 p -133.22 156.9 46.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 63.41 110.844 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.72 146.79 51.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 75.03 111.029 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.56 -39.91 12.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 74.31 110.847 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -165.3 137.26 4.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 74.03 110.854 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 5.2 mt -139.35 117.19 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 72.42 111.135 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -119.8 130.26 54.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 75.44 110.859 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 18.6 p -135.9 142.63 44.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 74.02 111.152 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -121.52 163.68 18.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 74.4 110.948 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 63.86 -164.34 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 71.11 110.891 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 38.6 mtt85 -73.77 69.41 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 74.21 110.84 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.15 156.98 17.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 73.14 111.088 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.57 135.69 52.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 75.24 110.851 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.53 136.0 61.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 75.12 111.063 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -136.8 127.53 27.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 75.21 110.862 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 1.2 mt -111.86 118.2 34.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.959 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.74 174.35 13.65 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 61.5 112.479 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.54 149.45 25.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 74.42 110.867 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.49 134.42 62.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 73.35 111.166 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 19.5 t -122.55 123.19 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.24 111.117 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 5.0 t -73.37 165.0 25.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 74.42 111.159 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.81 92.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 74.41 111.043 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.63 -35.72 68.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.14 111.043 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 64.3 111.054 -179.94 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.904 0.383 . . . . 74.03 111.181 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 23.9 m -92.0 113.77 26.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 71.01 111.18 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -122.08 151.12 41.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 64.33 110.88 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.72 121.98 13.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 74.14 110.848 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 10.6 p -106.48 142.47 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.072 -0.513 . . . . 75.24 111.132 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -84.06 -79.78 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 72.33 110.831 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 48.9 m -127.44 131.97 50.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 74.32 111.099 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 20.1 t -124.06 120.12 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 62.45 111.16 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 26.6 t -118.25 122.99 70.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 63.52 111.116 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.62 133.19 8.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.655 -0.784 . . . . 60.3 112.476 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.0 147.29 31.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 74.42 110.836 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 60.51 -142.62 48.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 73.21 112.468 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.38 60.28 2.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.827 0.346 . . . . 72.23 110.88 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 12.7 m -83.83 152.83 24.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.901 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.78 132.41 54.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 74.44 110.866 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 92.5 t -115.71 122.75 70.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 75.3 111.129 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.05 115.91 18.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 73.05 110.913 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 30.7 mm -113.15 103.52 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 70.13 111.109 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.96 -163.15 26.68 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 64.52 112.483 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.97 156.83 25.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.72 0.295 . . . . 63.44 110.876 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.9 118.85 34.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 72.34 110.884 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -103.83 128.64 51.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 72.13 110.93 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 88.94 145.65 11.88 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 71.42 112.515 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 95.16 84.19 1.65 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 63.2 112.478 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -58.02 98.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.798 0.332 . . . . 75.12 110.873 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -174.73 -102.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.723 -0.751 . . . . 63.52 112.491 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -173.71 -37.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.863 0.363 . . . . 74.22 110.854 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 73.55 110.906 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.806 0.336 . . . . 74.24 110.854 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.45 138.01 52.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 75.12 110.897 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 73.9 p -140.65 160.88 39.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 71.02 110.843 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.52 127.95 46.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.501 . . . . 72.41 111.116 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -35.44 65.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 61.35 110.922 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.53 137.18 3.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 64.42 110.888 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 9.8 mt -139.67 116.4 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 73.32 111.04 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.6 126.29 48.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 72.43 110.904 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 32.6 p -135.82 139.57 43.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 74.1 111.205 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -120.96 167.08 12.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 73.24 110.851 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 65.17 -162.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 75.21 110.877 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -75.23 61.16 1.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.52 110.85 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.32 156.76 17.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 63.44 111.151 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -129.88 135.65 48.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 71.34 110.884 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 20.2 m -122.92 134.89 64.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 74.41 111.189 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -135.81 128.99 31.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 75.31 110.868 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 9.9 tp -111.38 118.0 34.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 75.3 110.949 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.31 171.91 12.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 65.13 112.446 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.91 163.05 18.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 74.33 110.881 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.99 134.06 60.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 75.43 111.142 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 7.2 t -122.08 121.18 63.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 74.33 111.105 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 12.9 t -69.47 173.45 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 62.44 111.171 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.91 89.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 73.52 111.087 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.72 -36.38 69.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 65.34 111.063 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 53.42 111.098 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.764 0.316 . . . . 73.4 111.165 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.01 119.93 28.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 63.44 110.908 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.73 122.86 40.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 75.13 110.807 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -105.19 145.5 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.21 111.099 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -80.59 -76.61 0.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.885 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.38 126.67 17.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 75.21 111.165 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.32 120.59 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 72.13 111.132 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 23.4 t -119.69 115.07 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 74.33 111.155 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.02 133.97 11.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.782 -0.723 . . . . 52.44 112.442 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.73 131.45 52.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 65.31 110.871 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.44 -149.65 30.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 73.33 112.484 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -74.97 68.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 72.55 110.894 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 10.3 t -94.01 162.39 13.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 72.24 110.918 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.53 136.0 47.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 71.31 110.852 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 90.8 t -115.57 124.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 74.15 111.135 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.66 117.99 21.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 73.43 110.96 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 24.7 mm -113.47 102.19 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 73.33 111.15 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 131.85 178.89 15.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.789 -0.719 . . . . 51.42 112.509 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -95.69 156.9 16.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 72.24 110.872 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.57 138.68 54.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 74.34 110.869 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -124.8 124.52 42.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.492 . . . . 72.13 110.88 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 C-N-CA 120.796 -0.716 . . . . 72.54 112.563 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.816 0.341 . . . . 74.33 110.911 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -142.07 120.94 12.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 72.43 110.911 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 76.7 p -121.96 151.65 40.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 73.21 110.876 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.63 119.38 16.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 74.35 111.116 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -67.51 -51.64 48.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 73.3 110.875 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.78 135.47 4.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.276 -0.42 . . . . 73.22 110.834 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 6.4 pt -140.12 134.05 35.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 74.14 111.145 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.19 141.64 48.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 72.54 110.926 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.41 152.84 50.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 74.4 111.133 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -138.35 168.62 19.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 65.01 110.887 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.5 -70.7 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 73.44 110.886 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.8 ptt-85 177.88 63.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 75.02 110.857 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.0 157.21 16.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 75.21 111.145 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -126.41 135.32 51.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 74.42 110.913 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 31.2 m -124.43 124.74 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 72.21 111.13 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -114.12 137.49 51.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.877 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 6.0 mp -127.88 118.88 24.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.878 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.07 178.38 15.39 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.794 -0.717 . . . . 74.03 112.557 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -87.97 142.95 27.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 75.42 110.882 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.3 m -122.2 123.63 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 74.15 111.118 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.91 129.19 75.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 74.45 111.156 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 74.14 111.16 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.845 0.355 . . . . 72.21 111.143 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.59 109.75 16.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 75.34 111.154 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -106.21 137.89 43.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 75.03 110.874 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 14.7 m -135.71 123.26 22.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 74.32 110.871 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 50.8 t -115.54 115.87 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 72.44 111.118 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -75.17 -75.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.021 0.439 . . . . 73.53 110.903 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.41 126.78 45.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 73.42 111.166 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 1.6 t -117.47 132.56 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 73.22 111.154 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 72.1 t -127.08 114.97 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 74.31 111.126 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.04 131.71 10.69 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.81 -0.71 . . . . 53.01 112.448 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.81 139.94 47.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.866 0.365 . . . . 73.41 110.924 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 47.71 79.5 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.669 -0.777 . . . . 75.34 112.554 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 49.3 77.66 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 75.12 110.86 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.08 145.26 26.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 74.35 110.853 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -111.06 127.41 55.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 75.12 110.906 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 73.0 t -131.06 122.58 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 74.43 111.133 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.92 111.84 17.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 75.24 110.853 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 25.9 mm -110.24 103.94 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 74.23 111.144 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 142.61 -169.53 25.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.725 -0.75 . . . . 45.44 112.481 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -112.59 155.95 23.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.78 0.324 . . . . 71.53 110.851 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.04 141.3 50.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.43 110.842 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -125.61 133.35 52.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 74.31 110.92 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 109.3 149.89 13.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.69 -0.767 . . . . 72.3 112.475 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -68.15 -127.83 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 61.31 112.468 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.28 25.67 14.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.801 0.334 . . . . 62.41 110.875 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.4 133.41 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.685 -0.769 . . . . 61.15 112.523 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -52.44 131.48 33.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.783 0.325 . . . . 71.43 110.853 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 2.0 t90 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.88 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 16.3 ttt-85 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.856 0.36 . . . . 73.34 110.842 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -121.68 129.67 52.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.24 110.886 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.2 p -124.04 145.19 49.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 63.45 110.868 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.19 119.71 23.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 74.22 111.073 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.73 -46.11 76.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 74.25 110.867 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -166.1 137.1 3.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 75.04 110.849 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 6.4 pt -140.08 132.88 34.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 75.34 111.16 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -135.33 138.43 43.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 74.31 110.883 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.47 151.92 50.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.236 -0.438 . . . . 71.32 111.153 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -141.96 167.59 21.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.423 . . . . 71.33 110.908 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 72.81 -71.2 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.882 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -178.68 67.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 75.3 110.867 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.45 156.42 18.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 73.31 111.084 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -130.38 135.19 47.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.885 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 25.3 m -126.68 130.2 71.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 73.53 111.112 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -119.07 119.89 35.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 75.52 110.942 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.82 118.57 35.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 73.32 110.945 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.07 175.09 13.81 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 75.05 112.462 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -85.99 136.2 33.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.894 0.378 . . . . 71.21 110.847 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 18.2 m -118.51 121.63 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 71.05 111.11 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 41.0 t -119.52 129.06 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 62.43 111.124 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 12.3 t -83.32 175.19 10.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 74.43 111.164 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.09 99.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 74.5 111.047 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.85 77.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 71.12 111.126 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 73.32 111.052 179.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.827 0.346 . . . . 74.52 110.851 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 8.7 t -66.17 126.18 27.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 73.2 111.13 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 94.2 m -131.84 108.98 9.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 74.03 111.144 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -108.96 136.56 48.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.85 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.84 123.76 21.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.483 . . . . 71.13 110.87 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 70.5 t -110.34 118.53 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 73.4 111.108 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -67.8 -75.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 73.44 110.884 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 24.7 p -129.56 133.69 47.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 74.14 111.229 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.37 129.37 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 73.11 111.164 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.36 114.79 37.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 73.24 111.099 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.78 132.42 10.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.678 -0.772 . . . . 51.54 112.45 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -132.09 143.25 49.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 74.42 110.934 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 42.98 69.11 0.67 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 33.32 112.429 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 63.57 101.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.836 0.35 . . . . 71.31 110.911 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 3.6 t -130.33 145.77 51.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 60.24 110.898 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -117.28 127.85 54.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 75.23 110.858 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 85.8 t -130.48 123.65 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 75.24 111.165 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.49 112.13 22.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 73.43 110.936 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 14.4 mm -108.47 104.94 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 75.32 111.108 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 135.7 -157.89 23.51 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.774 -0.727 . . . . 51.25 112.527 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.5 156.04 27.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 74.43 110.878 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -129.39 141.8 50.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 74.11 110.881 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -129.98 125.73 36.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 74.34 110.888 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 152.35 156.14 7.37 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.685 -0.769 . . . . 64.4 112.474 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -96.11 -53.19 1.52 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 73.55 112.521 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -52.08 103.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 73.53 110.833 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.52 116.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.751 -0.737 . . . . 74.33 112.457 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -52.1 -33.44 39.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.347 . . . . 75.21 110.903 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 15.9 t90 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 75.01 110.962 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.039 0 CA-C-O 120.884 0.373 . . . . 74.24 110.85 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.05 120.63 41.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 75.14 110.864 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 3.3 t -129.67 138.69 51.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 71.02 110.894 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -119.04 131.98 56.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 73.21 111.133 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -33.05 34.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 71.13 110.901 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -166.01 138.0 3.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 73.31 110.864 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -138.69 117.31 13.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 73.54 111.143 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -131.82 130.23 41.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 70.24 110.898 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.25 155.44 50.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 74.51 111.144 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -144.35 168.06 20.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 72.22 110.885 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.78 -72.23 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 73.31 110.856 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -177.99 64.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 75.55 110.85 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.69 156.46 18.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 52.13 111.087 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -128.79 135.25 48.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 73.31 110.892 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 20.9 m -126.14 121.6 59.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.469 . . . . 70.32 111.117 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -115.63 120.65 40.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 73.24 110.913 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.96 118.72 34.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 72.44 110.935 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.48 178.23 15.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 74.34 112.503 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -85.65 128.52 34.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.857 0.36 . . . . 72.02 110.891 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.07 128.4 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 75.21 111.136 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 46.8 t -122.17 129.02 75.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 73.21 111.086 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -77.5 174.27 11.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 75.23 111.126 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.04 -41.03 77.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 74.33 111.045 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.1 -51.91 67.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 65.03 111.044 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 64.3 111.088 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.973 0.416 . . . . 75.04 110.925 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 4.9 t -100.94 130.01 46.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 71.22 111.125 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 18.7 m -126.58 118.96 25.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.261 -0.427 . . . . 75.32 111.121 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -120.63 144.63 48.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 62.11 110.866 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 9.4 t -141.62 123.85 15.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 71.53 110.905 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 46.2 t -108.07 145.86 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 64.34 111.205 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.92 -55.69 3.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 74.32 110.84 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.46 128.51 11.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 73.35 111.165 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 54.4 t -118.75 120.42 64.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 73.01 111.106 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.14 118.06 47.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 74.33 111.16 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.9 133.23 10.1 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.715 -0.755 . . . . 62.11 112.502 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -125.44 147.75 49.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 74.23 110.869 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 47.2 67.85 1.35 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.812 -0.709 . . . . 63.42 112.474 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 64.14 107.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.883 0.373 . . . . 73.4 110.899 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 3.3 m -139.8 150.16 44.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 73.2 110.865 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -124.72 128.24 48.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.831 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 89.8 t -132.28 123.34 50.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 75.25 111.134 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.98 117.14 28.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 75.12 110.921 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 24.9 mm -110.63 104.24 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 74.41 111.134 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.03 -162.74 25.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.743 . . . . 55.43 112.491 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -106.66 155.97 19.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.787 0.327 . . . . 72.33 110.897 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -131.22 150.15 52.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 73.41 110.852 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -130.05 126.03 36.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 72.14 110.905 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 145.75 141.97 3.73 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.745 -0.741 . . . . 73.21 112.499 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -112.2 -169.5 18.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.732 . . . . 64.22 112.463 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 7.8 tttt 53.89 29.44 9.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 73.25 110.879 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -179.11 -35.26 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.683 -0.77 . . . . 72.34 112.415 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 5.4 t80 71.9 -69.25 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.898 0.38 . . . . 75.22 110.912 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 15.9 t90 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 74.53 110.87 179.993 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.882 0.372 . . . . 73.11 110.879 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.44 111.98 23.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 73.32 110.887 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.77 137.58 54.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 64.33 110.786 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.09 155.94 37.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.114 -0.493 . . . . 75.21 111.094 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.88 -29.8 8.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 75.01 110.895 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.49 138.31 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 73.31 110.884 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 2.4 mt -138.91 117.28 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.144 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -131.64 131.23 43.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 75.2 110.936 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.28 155.9 49.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 72.53 111.086 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -148.28 166.91 26.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 72.44 110.876 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.9 -71.99 0.12 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.104 -0.498 . . . . 73.02 110.861 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -177.0 63.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 74.44 110.845 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.76 154.51 19.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 65.55 111.158 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -130.01 134.98 47.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 73.34 110.93 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 21.6 m -127.89 121.19 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 70.31 111.154 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -121.31 128.58 52.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 74.32 110.964 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 mp -120.66 118.79 31.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 73.23 110.917 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 143.14 179.0 19.48 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.752 -0.737 . . . . 73.52 112.474 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -85.83 129.11 34.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.919 0.39 . . . . 74.2 110.864 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 35.1 m -111.39 129.52 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 74.4 111.138 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.31 129.03 75.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 71.25 111.138 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 21.5 p -77.6 174.84 10.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 63.34 111.138 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.1 85.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 74.33 111.144 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.03 -52.01 66.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 74.34 111.136 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 74.11 111.105 179.897 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.869 0.366 . . . . 72.22 111.151 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 3.1 m -134.53 126.77 30.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 73.43 111.192 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -126.08 139.61 53.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.295 -0.411 . . . . 75.34 110.955 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 7.9 t -142.09 123.81 15.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 74.43 110.844 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.34 149.61 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 75.44 111.172 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.84 -77.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 72.44 110.939 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 1.5 m -127.71 127.83 44.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 63.3 111.108 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 98.2 t -118.69 120.41 64.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 75.02 111.122 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 4.7 p -126.53 117.81 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 74.44 111.102 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.72 132.65 10.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 63.03 112.427 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -126.02 147.13 49.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 73.12 110.84 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 44.86 76.75 0.11 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.769 -0.729 . . . . 74.54 112.475 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.74 98.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.802 0.334 . . . . 70.23 110.899 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 4.1 t -130.18 145.33 51.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 61.41 110.908 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -123.97 127.97 48.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 72.23 110.849 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 94.3 t -135.56 123.38 37.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 73.32 111.106 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -121.72 119.57 32.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 75.41 110.893 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 27.5 mm -112.29 104.24 16.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 75.32 111.165 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.3 -159.07 27.44 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.75 -0.738 . . . . 71.14 112.52 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -115.92 156.12 26.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.77 0.319 . . . . 71.44 110.917 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -126.03 134.92 51.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 74.13 110.803 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -120.32 125.94 49.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 74.33 110.958 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.01 158.36 7.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.79 -0.719 . . . . 60.13 112.544 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -104.57 63.93 0.34 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 62.1 112.416 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.94 32.91 1.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.8 0.333 . . . . 74.12 110.876 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 78.98 -67.82 3.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 52.34 112.459 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -178.81 108.75 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 71.05 110.852 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 74.0 110.921 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.824 0.345 . . . . 75.2 110.874 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -83.8 109.92 17.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 74.25 110.857 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.43 139.85 45.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.2 110.824 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.38 162.06 26.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 75.44 111.151 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.05 -26.87 7.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 73.24 110.887 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.82 138.62 4.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.43 . . . . 75.12 110.841 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 5.0 mt -138.55 117.35 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 73.43 111.127 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.32 131.23 39.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 73.2 110.791 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.29 157.81 45.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 63.03 111.128 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -150.29 167.55 26.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 62.51 110.933 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 72.09 -73.35 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 74.51 110.846 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -178.29 62.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 74.53 110.85 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.34 156.45 17.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 63.0 111.196 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.19 135.15 47.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 74.02 110.856 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 18.0 m -122.74 121.84 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 72.32 111.143 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -119.59 114.41 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.23 110.921 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.84 135.09 54.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 71.43 110.976 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.06 -120.18 2.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.718 -0.754 . . . . 62.21 112.508 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -144.0 128.85 18.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.884 0.373 . . . . 71.43 110.851 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.86 119.6 51.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 74.35 111.16 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.05 123.52 69.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 72.2 111.138 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.1 t -74.43 174.88 8.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 71.02 111.133 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.22 -45.64 68.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 75.44 111.099 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.92 -49.8 74.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 71.53 111.132 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 44.4 111.073 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 34.9 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.821 0.343 . . . . 73.14 111.129 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.12 123.45 38.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 72.34 110.858 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 43.2 t -127.18 123.81 37.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 64.12 110.878 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.32 150.34 28.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 75.03 111.102 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.01 -77.5 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 74.02 110.865 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 9.4 m -126.37 127.83 46.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 75.14 111.162 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.08 120.16 63.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 65.11 111.156 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 4.1 p -123.78 118.18 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 74.53 111.154 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.28 136.18 13.39 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.756 -0.735 . . . . 74.55 112.399 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -132.58 133.54 43.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.756 0.313 . . . . 74.24 110.897 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.81 93.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 53.25 112.522 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 44.1 69.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 70.22 110.826 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.34 145.25 26.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 64.15 110.817 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -127.24 128.19 45.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 74.22 110.872 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 84.2 t -136.85 123.92 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 74.32 111.134 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.64 122.55 36.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 74.31 110.899 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 30.4 mm -112.0 104.53 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 74.41 111.169 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 135.07 -169.84 23.14 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.755 . . . . 74.53 112.518 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -99.82 155.96 17.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 71.52 110.897 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -130.6 132.03 45.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.491 . . . . 73.43 110.856 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -113.8 125.9 54.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 73.42 110.874 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.742 -0.742 . . . . 73.32 112.485 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.867 0.365 . . . . 74.42 110.879 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.27 130.35 26.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 72.32 110.876 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 48.4 t -121.81 137.69 54.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.478 . . . . 74.1 110.843 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.62 128.18 34.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 74.34 111.111 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.67 -37.14 13.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 75.21 110.938 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.38 138.9 5.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 75.45 110.878 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 7.7 mt -137.25 117.53 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 74.02 111.116 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -124.98 117.04 23.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 75.42 110.839 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.31 131.2 36.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 74.32 111.123 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -132.95 164.9 25.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 74.1 110.906 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 236' ' ' ARG . 2.7 tt0 65.0 79.53 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 72.43 110.897 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 235' ' ' GLU . 16.9 ptt180 35.29 60.46 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 74.52 110.918 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.29 152.75 21.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 75.54 111.136 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -129.28 142.52 50.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 74.35 110.831 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.1 p -143.02 121.65 7.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 64.41 111.124 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -108.84 137.46 46.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 72.5 110.98 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.58 118.65 22.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 72.22 110.891 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.37 -172.61 20.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.708 -0.758 . . . . 75.12 112.504 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -92.24 139.19 30.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.909 0.385 . . . . 74.54 110.909 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.02 129.7 65.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 75.54 111.21 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 89.5 t -122.07 127.28 75.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 72.41 111.127 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 53.6 p . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 75.44 111.155 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 99.6 m . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.819 0.342 . . . . 72.31 111.132 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 98.4 m -112.91 111.74 22.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 73.5 111.159 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -111.48 150.3 30.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 71.54 110.805 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.4 t -138.31 123.97 19.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 72.55 110.951 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.81 135.77 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 75.43 111.135 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.32 -75.96 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 71.24 110.952 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 1.6 m -130.14 131.98 45.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 73.42 111.153 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 96.7 t -117.89 131.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 55.24 111.147 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 58.6 t -127.55 128.03 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 72.54 111.117 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.98 133.62 7.87 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.735 -0.745 . . . . 70.25 112.515 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -132.8 147.77 52.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.793 0.33 . . . . 71.11 110.877 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.28 78.17 0.11 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.761 -0.733 . . . . 71.25 112.459 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 47.59 64.58 1.55 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.882 0.372 . . . . 71.23 110.941 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 26.3 t -92.93 145.65 24.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 62.43 110.873 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -126.39 128.31 46.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 74.52 110.929 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 20.6 t -128.92 123.59 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 73.54 111.137 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.07 117.24 32.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 71.21 110.917 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.15 112.41 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 71.05 111.152 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 133.01 -164.91 24.11 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 70.15 112.443 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -103.8 152.61 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 62.42 110.84 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -131.49 134.51 46.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 74.11 110.968 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.4 125.94 54.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 73.45 110.915 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.84 135.8 3.17 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.717 -0.754 . . . . 72.3 112.521 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -111.22 177.11 18.94 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.691 -0.766 . . . . 73.53 112.441 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt 52.0 53.4 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 70.31 110.871 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 177.56 -69.02 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.822 -0.704 . . . . 74.11 112.521 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 2.1 t80 64.34 109.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 75.32 110.823 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 74.03 110.875 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.806 0.336 . . . . 74.14 110.922 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.34 123.44 14.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 75.21 110.93 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 1.4 t -121.51 137.71 54.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 64.3 110.86 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -127.7 129.16 46.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 72.15 111.082 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.26 -35.28 23.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 74.02 110.953 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.56 138.42 5.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.31 110.869 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 11.2 mt -137.64 117.6 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 74.33 111.059 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -130.64 119.3 22.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 73.24 110.846 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.02 131.41 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 74.31 111.148 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -132.04 167.3 19.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 73.55 110.837 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' B' ' 236' ' ' ARG . 0.1 OUTLIER 64.24 78.43 0.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 71.24 110.868 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' B' ' 235' ' ' GLU . 11.0 ptt180 36.34 54.84 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 73.34 110.931 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -100.61 156.15 17.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 71.03 111.137 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -132.59 136.3 46.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 73.54 110.877 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 6.2 p -137.24 121.71 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 70.42 111.177 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.22 137.48 51.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.891 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.71 118.6 23.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 75.05 110.897 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.7 176.45 14.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.718 -0.753 . . . . 65.44 112.536 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -85.95 133.48 33.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.882 0.372 . . . . 75.02 110.841 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 33.7 m -116.51 132.18 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 74.33 111.105 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 60.1 t -122.04 120.26 60.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 74.15 111.123 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 33.6 p -84.68 163.21 19.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 73.14 111.126 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.47 -36.95 84.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 64.23 111.13 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -62.06 -36.51 81.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 65.53 111.138 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 51.41 111.017 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.895 0.378 . . . . 74.24 110.933 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 49.2 p -101.09 122.55 43.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.438 . . . . 75.14 111.147 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 1.1 t -134.14 108.95 8.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 75.54 111.172 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -95.94 149.52 21.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 65.14 110.897 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 44.6 m -140.22 124.08 17.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 74.34 110.852 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 13.4 p -109.58 131.62 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.48 . . . . 71.41 111.125 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -73.63 -76.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 74.42 110.835 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -131.52 135.38 47.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 71.34 111.118 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 85.5 t -117.67 128.4 74.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 74.22 111.151 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 68.8 t -127.23 119.47 52.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 73.54 111.104 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.3 132.98 9.05 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.743 -0.742 . . . . 74.22 112.461 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.65 147.93 51.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 72.52 110.902 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.44 82.66 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.753 . . . . 55.23 112.478 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 46.3 63.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 75.14 110.849 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 25.7 t -96.78 145.66 25.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 72.42 110.867 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.12 127.99 46.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 74.13 110.859 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.85 123.77 55.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 75.53 111.135 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.86 116.76 29.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 72.2 110.887 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 25.4 mm -110.79 104.18 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.24 111.146 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.49 -176.91 21.54 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.781 -0.723 . . . . 72.43 112.463 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -92.17 147.12 23.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.727 0.299 . . . . 71.41 110.91 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.45 141.7 51.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 74.22 110.858 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -127.1 125.99 42.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.181 -0.463 . . . . 75.11 110.952 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 168.26 151.22 6.98 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.769 -0.729 . . . . 72.13 112.496 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -53.82 176.23 0.31 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.781 -0.723 . . . . 72.31 112.497 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.88 104.76 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 75.41 110.883 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -159.05 -38.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 73.44 112.541 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 10.6 t80 64.43 111.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.858 0.361 . . . . 73.42 110.881 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 75.3 110.885 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.824 0.345 . . . . 73.23 110.844 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -83.91 139.69 32.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 70.22 110.917 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.88 144.64 50.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.35 110.82 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.94 143.09 51.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 73.35 111.134 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.35 -32.61 12.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 75.32 110.898 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.04 137.85 4.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 74.53 110.924 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 16.7 mt -137.34 117.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 74.22 111.078 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -132.71 115.87 15.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 74.44 110.861 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -135.41 135.48 40.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.461 . . . . 74.31 111.123 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.48 166.99 23.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 72.2 110.88 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 66.87 72.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 74.43 110.93 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 44.32 53.26 6.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 72.15 110.84 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.2 147.9 26.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 72.41 111.047 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.0 135.75 52.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.868 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 6.0 p -133.78 121.86 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.54 111.098 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -108.77 136.55 48.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 73.21 110.946 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.17 119.21 22.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 74.54 110.888 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.15 173.66 13.46 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.758 -0.734 . . . . 73.01 112.439 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -85.81 134.22 33.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 73.34 110.865 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 30.9 m -113.45 131.95 63.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.082 -0.508 . . . . 60.33 111.156 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.18 129.24 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 74.35 111.145 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 12.9 p -86.71 169.33 12.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 73.44 111.185 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.03 76.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 73.34 111.174 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.37 76.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 71.41 111.106 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 63.53 111.126 179.939 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.838 0.352 . . . . 74.52 110.951 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 29.3 m -100.85 137.89 38.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 75.5 111.127 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.5 t -125.01 133.17 53.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 74.43 111.149 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.8 145.73 50.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 71.14 110.893 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.69 123.39 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 63.21 110.885 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -110.48 127.77 67.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 71.1 111.081 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.91 -71.83 0.26 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.107 -0.497 . . . . 74.44 110.847 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 5.7 p -140.48 137.18 33.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 72.02 111.081 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 19.2 t -116.8 128.36 74.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 71.05 111.18 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 2.0 t -127.24 117.91 48.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 73.43 111.137 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.1 132.74 9.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.736 -0.745 . . . . 62.45 112.452 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.81 140.94 48.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 72.44 110.931 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 46.58 84.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.701 -0.761 . . . . 71.44 112.49 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 51.1 82.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.885 0.374 . . . . 70.0 110.87 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 29.2 t -116.44 145.61 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 72.31 110.881 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -128.97 127.62 42.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.488 . . . . 72.44 110.825 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 48.2 t -132.07 123.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 74.33 111.125 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.54 111.58 22.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.221 -0.445 . . . . 74.53 110.952 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 23.4 mm -111.0 104.71 17.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 74.3 111.134 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.5 -154.58 25.6 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 72.41 112.48 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -128.14 145.25 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.347 . . . . 74.44 110.92 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -113.06 129.72 56.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 72.02 110.946 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -119.8 126.02 49.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 65.13 110.846 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 103.28 101.68 2.66 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.692 -0.765 . . . . 74.55 112.415 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 95.16 -167.45 26.44 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.712 -0.756 . . . . 61.31 112.478 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -172.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 74.12 110.893 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -86.01 -18.62 59.16 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.754 -0.736 . . . . 71.22 112.45 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.96 124.0 22.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 73.05 110.925 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 16.1 p90 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.926 -179.948 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.792 0.33 . . . . 72.31 110.908 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.78 132.17 38.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 62.43 110.847 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.09 150.76 44.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 71.4 110.842 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.1 158.86 36.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 73.05 111.154 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -109.15 -32.94 7.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.29 -0.414 . . . . 72.1 110.938 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -164.63 138.18 5.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 72.25 110.834 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 13.8 mt -138.85 117.82 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 70.53 111.141 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -133.22 121.39 22.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 72.12 110.859 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.7 p -136.39 148.41 47.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.177 -0.465 . . . . 73.22 111.135 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.79 166.52 33.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 74.31 110.915 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 64.09 72.76 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 72.04 110.959 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 47.8 33.86 3.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 74.24 110.853 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.8 142.57 27.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 74.35 111.155 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -126.88 135.87 51.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 74.35 110.902 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 5.3 p -128.54 137.51 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 73.23 111.114 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -117.32 135.91 53.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 63.34 110.935 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.19 129.75 43.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 74.02 110.898 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 121.74 -131.3 8.44 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.699 -0.762 . . . . 72.32 112.464 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -144.99 150.8 37.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 72.5 110.815 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 13.7 m -122.73 124.36 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 74.44 111.133 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 28.4 t -121.23 129.05 76.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 72.11 111.194 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 68.4 p -72.26 174.57 7.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 65.34 111.17 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.48 -45.9 73.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.277 -0.419 . . . . 71.53 111.103 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.27 -50.38 73.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 61.43 111.071 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 64.42 111.091 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 75.8 m . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.878 0.371 . . . . 72.35 111.142 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 261' ' ' THR . . . . . 0.588 ' H ' ' NE ' ' E' ' 225' ' ' ARG . 95.1 m -100.33 108.95 21.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 74.2 111.17 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -116.31 150.32 37.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 73.41 110.892 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.37 123.79 16.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 73.52 110.859 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 11.4 p -107.55 134.23 49.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 65.22 111.094 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.45 -75.44 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 75.31 110.855 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 44.8 p -148.74 135.38 19.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 73.11 111.153 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 14.5 t -117.67 128.24 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 62.53 111.07 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.19 122.87 60.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 73.1 111.204 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.57 133.84 10.54 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.698 -0.763 . . . . 63.42 112.473 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -132.48 136.48 46.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.808 0.337 . . . . 75.44 110.849 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.68 87.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 64.42 112.506 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 51.95 80.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 75.4 110.883 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 40.7 t -114.61 145.29 42.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 75.25 110.828 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -130.62 127.12 38.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 72.25 110.873 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 85.1 t -136.17 126.74 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 75.04 111.163 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.2 111.22 15.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 72.15 110.917 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 31.1 mm -109.68 104.85 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 63.53 111.167 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 159.25 -165.36 34.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.795 -0.717 . . . . 75.5 112.522 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -123.66 156.19 36.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.774 0.321 . . . . 70.55 110.92 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -111.77 119.24 37.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 70.31 110.959 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -103.68 125.82 50.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 64.13 110.89 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 62.88 31.63 81.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.718 -0.753 . . . . 72.04 112.471 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -95.75 -116.46 3.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 74.31 112.546 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -179.41 34.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 71.24 110.868 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.25 -113.18 3.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 73.23 112.455 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.85 -179.35 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.853 0.358 . . . . 71.23 110.844 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 12.0 p90 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 74.15 110.911 -179.933 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . 0.588 ' NE ' ' H ' ' D' ' 261' ' ' THR . 1.5 ptp180 . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.844 0.354 . . . . 72.51 110.934 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -105.42 108.83 20.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 63.44 110.895 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.59 152.41 45.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 61.41 110.873 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.8 163.01 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 63.5 111.123 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.49 -33.31 6.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 75.43 110.942 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.27 140.44 3.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 74.45 110.804 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 17.3 mt -136.98 114.9 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 72.34 111.118 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -132.27 119.93 21.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 75.55 110.917 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.69 144.35 45.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 72.44 111.129 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -156.4 166.13 34.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 73.23 110.883 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 59.42 72.3 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 70.33 110.88 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 50.0 43.57 25.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 73.15 110.923 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.09 144.93 29.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 74.44 111.071 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -128.92 141.66 51.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.53 110.881 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.77 134.48 53.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 75.23 111.158 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? -119.42 137.22 53.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.428 . . . . 73.11 110.864 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.31 118.72 21.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 75.41 110.935 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 123.73 177.88 15.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.696 -0.764 . . . . 73.25 112.481 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -89.65 145.38 25.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.787 0.327 . . . . 73.42 110.941 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 9.6 m -120.16 139.16 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 74.12 111.114 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.5 128.32 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 74.14 111.177 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.5 t -69.77 175.2 4.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 71.32 111.17 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.43 76.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 62.04 111.124 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.13 -51.72 68.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 63.45 111.116 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 75.45 111.088 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.765 0.317 . . . . 72.51 111.177 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.3 136.18 52.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 75.5 110.936 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 1.3 t -126.8 121.88 33.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.841 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.41 123.0 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 75.13 111.134 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . 0.432 ' CD ' ' N ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -65.23 -142.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 73.52 110.907 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 266' ' ' THR . . . . . 0.401 ' N ' ' CG ' ' E' ' 265' ' ' GLU . 3.2 p -92.14 128.79 38.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 71.22 111.122 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 8.9 t -115.35 133.34 61.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 75.24 111.119 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.45 121.53 60.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 75.44 111.188 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.44 132.87 11.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.785 -0.721 . . . . 75.04 112.493 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -132.82 116.05 16.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 74.43 110.897 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 64.49 88.14 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 75.44 112.455 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 56.99 86.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 65.41 110.857 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 16.9 t -124.35 145.49 49.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 54.0 110.851 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -136.7 127.13 26.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 75.4 110.892 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 57.9 t -132.73 134.67 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 74.42 111.094 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.39 114.85 17.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 63.33 110.926 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 28.4 mm -111.13 141.16 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 75.3 111.1 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 113.1 -171.86 14.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.694 -0.765 . . . . 72.32 112.442 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -106.82 153.52 22.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.797 0.332 . . . . 71.51 110.868 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -111.85 144.47 41.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 72.33 110.826 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.12 125.35 43.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 75.42 110.902 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.756 -0.735 . . . . 62.01 112.484 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 . . . . . 0 N--CA 1.458 -0.056 0 CA-C-O 120.808 0.337 . . . . 74.41 110.885 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -142.41 143.63 32.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 70.32 110.852 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 34.5 p -121.72 137.5 54.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 63.44 110.859 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.94 139.92 48.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.486 . . . . 74.23 111.088 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.15 -28.18 13.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 75.22 110.879 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -166.17 137.93 3.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 73.31 110.879 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.39 117.29 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 73.45 111.157 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -129.55 122.48 29.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 75.23 110.861 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.8 152.12 50.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 75.23 111.163 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.98 158.94 37.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 70.11 110.948 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 236' ' ' ARG . 1.6 tt0 64.11 83.35 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 71.25 110.892 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 235' ' ' GLU . 0.0 OUTLIER 36.15 59.89 0.89 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 75.01 110.883 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.21 144.02 32.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 73.23 111.087 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -125.79 135.81 52.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 75.03 110.923 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 19.7 m -143.01 121.29 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 64.42 111.137 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -124.88 137.64 54.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 74.13 110.895 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 mp -129.4 118.26 21.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 75.34 110.909 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 148.23 -161.87 28.69 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 61.44 112.51 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -91.11 137.86 32.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 74.35 110.992 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -120.54 131.77 71.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 72.4 111.092 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 61.7 t -122.17 128.97 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 65.32 111.133 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 72.22 111.189 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.854 0.359 . . . . 74.43 111.151 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.7 t -131.07 140.59 50.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 71.4 111.144 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -99.31 126.2 45.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.87 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 87.4 p -134.56 123.65 24.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 62.24 110.849 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.67 125.68 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.084 -0.507 . . . . 74.41 111.136 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -74.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.839 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 25.8 m -136.45 135.06 38.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 71.52 111.193 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.48 126.52 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 73.13 111.124 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 23.2 t -127.48 118.14 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.14 111.162 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.68 133.06 8.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.747 . . . . 62.04 112.489 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 147.6 52.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.906 0.384 . . . . 71.32 110.892 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.52 84.21 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 70.13 112.444 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 51.35 80.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 75.03 110.865 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 31.6 t -113.34 145.69 40.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 65.41 110.842 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -132.77 127.59 34.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 73.24 110.88 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 19.0 t -137.7 123.62 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 73.41 111.156 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.4 112.36 18.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 74.35 110.906 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 35.6 mm -103.93 104.51 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 74.41 111.158 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.2 -169.43 28.88 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.67 -0.776 . . . . 72.4 112.486 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -111.12 149.89 30.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.784 0.326 . . . . 71.24 110.88 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.6 119.1 30.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 75.4 110.923 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -108.14 154.01 22.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 72.31 110.903 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 122.88 -120.16 4.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.72 -0.752 . . . . 62.1 112.496 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -171.3 -143.8 4.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 45.04 112.565 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 69.03 -75.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 71.33 110.888 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -144.48 143.53 12.18 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.728 . . . . 65.14 112.481 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -61.1 -20.71 62.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 64.41 110.881 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 5.0 t90 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.129 -0.487 . . . . 73.22 110.982 -179.966 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.783 0.325 . . . . 75.23 110.818 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -115.25 120.66 40.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 71.32 110.938 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.33 137.93 51.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 74.31 110.825 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.95 152.34 45.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 73.44 111.108 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -28.02 10.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 74.32 110.879 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.65 138.41 5.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.415 . . . . 75.32 110.851 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 11.6 mt -135.44 122.42 34.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 75.22 111.081 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -134.17 117.25 16.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.04 110.911 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.2 145.67 52.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 74.11 111.151 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.24 161.53 41.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 73.21 110.85 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 63.61 69.68 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 61.41 110.804 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 47.53 56.7 6.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 72.35 110.936 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.0 144.42 31.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 71.32 111.14 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.03 135.87 52.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 75.45 110.848 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 4.1 m -136.24 121.56 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 73.02 111.138 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.67 134.06 54.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 75.31 110.979 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.42 119.07 22.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 72.04 110.867 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.81 -116.07 0.72 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.74 . . . . 70.34 112.498 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.98 139.7 29.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.899 0.38 . . . . 74.13 110.902 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.2 116.27 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 74.41 111.138 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.27 129.05 73.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 74.44 111.151 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.1 p -92.26 175.23 6.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 71.01 111.186 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.06 -42.65 99.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 61.25 111.07 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.73 -38.37 84.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 74.44 111.126 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 72.42 111.098 179.945 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.88 0.371 . . . . 70.23 110.821 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.83 137.77 33.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 74.55 111.134 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 96.5 m -130.85 111.92 12.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 75.22 111.133 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -89.43 127.28 35.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 74.32 110.959 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 3.6 m -130.31 123.59 30.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 75.22 110.86 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.48 125.28 72.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 72.12 111.116 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.97 -76.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 74.43 110.905 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 94.6 m -137.01 137.65 39.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 73.34 111.093 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.8 128.35 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 74.33 111.177 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 25.6 t -127.64 117.16 45.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 72.32 111.101 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.39 132.53 9.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.723 -0.751 . . . . 73.24 112.498 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -133.27 125.08 28.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.863 0.363 . . . . 74.04 110.889 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.76 83.91 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 64.15 112.508 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 54.35 84.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 70.42 110.843 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 22.8 t -119.25 145.63 45.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 64.3 110.831 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -135.34 127.32 29.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 75.53 110.903 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 61.9 t -135.35 124.55 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 74.13 111.122 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.07 111.69 17.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 75.25 110.875 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 27.3 mm -103.86 104.53 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.455 . . . . 73.23 111.149 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.83 -160.21 28.51 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 74.21 112.486 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -115.91 147.87 40.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.324 . . . . 74.12 110.909 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.82 118.88 31.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 75.54 110.9 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -112.27 127.46 55.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 71.43 110.954 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 145.9 -48.59 0.68 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.808 -0.71 . . . . 73.44 112.47 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 74.06 11.32 81.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.725 -0.75 . . . . 73.12 112.48 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.96 60.86 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 65.44 110.868 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 96.26 120.26 3.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.763 -0.732 . . . . 62.45 112.487 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -50.95 108.45 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.324 . . . . 74.13 110.912 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.155 -0.475 . . . . 74.34 110.889 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.798 0.332 . . . . 72.31 110.831 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -83.98 110.07 18.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 75.54 110.834 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.34 137.91 50.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 63.33 110.849 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -123.35 150.55 43.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 72.54 111.117 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -102.37 -26.2 13.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 75.13 110.875 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -165.04 138.79 4.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 63.35 110.809 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.61 117.68 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 72.53 111.183 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.94 119.32 21.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 74.42 110.882 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.52 150.4 52.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 55.41 111.142 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -156.71 166.68 32.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 64.22 110.854 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.59 67.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 74.31 110.946 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 48.31 58.23 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 75.3 110.908 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.33 148.37 26.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 74.25 111.102 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -129.36 135.86 49.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 74.24 110.903 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 28.3 m -135.27 121.56 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 72.14 111.141 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.09 137.54 52.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 73.22 110.954 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.05 118.4 21.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 73.23 110.927 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 139.36 -168.91 24.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.777 -0.725 . . . . 71.14 112.461 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -91.93 145.03 24.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 74.44 110.921 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 56.1 t -125.98 124.89 67.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 75.34 111.129 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 48.4 t -122.83 118.28 54.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 74.51 111.063 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 6.4 t -77.84 174.96 10.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 72.54 111.163 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.83 -45.56 89.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 63.25 111.097 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.05 -35.77 67.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 75.01 111.082 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 74.14 111.069 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.882 0.372 . . . . 73.32 110.854 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 70.0 p -100.86 137.58 39.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 74.25 111.154 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 2.1 t -108.45 137.05 47.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 72.33 111.141 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -119.99 139.01 53.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 74.11 110.931 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 22.8 m -130.68 123.74 30.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 73.35 110.925 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.01 126.86 69.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 72.33 111.083 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.8 -74.0 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.49 . . . . 73.34 110.88 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 92.5 m -140.8 136.65 32.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 71.11 111.189 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 94.4 t -117.96 127.02 75.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 72.44 111.111 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 40.1 t -127.5 126.79 67.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 72.1 111.039 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.25 133.0 8.24 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.767 -0.73 . . . . 73.11 112.502 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -132.62 140.96 48.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.832 0.349 . . . . 74.04 110.924 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.11 70.15 0.94 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.781 -0.723 . . . . 64.51 112.434 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 64.85 97.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 74.25 110.881 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 70.2 m -131.7 145.94 51.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 74.24 110.879 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 36.2 mtt85 -131.48 127.09 36.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 73.53 110.837 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.43 123.89 47.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 74.1 111.134 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.23 111.59 17.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 73.21 110.972 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 30.8 mm -105.65 104.34 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 74.44 111.181 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 152.97 -152.49 24.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 72.41 112.482 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -116.75 138.17 51.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.758 0.313 . . . . 71.34 110.941 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -111.79 118.83 36.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.457 . . . . 74.22 110.832 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -114.45 124.63 52.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 75.03 111.008 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 161.5 -58.53 0.3 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 51.12 112.463 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 91.31 -42.0 2.85 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.717 -0.754 . . . . 74.24 112.426 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -30.21 14.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 74.24 110.859 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -147.05 106.45 0.36 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.694 -0.765 . . . . 62.43 112.455 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -55.34 -23.35 23.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 74.2 110.898 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.456 . . . . 75.5 110.934 -179.94 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 . . . . . 0 C--O 1.23 0.04 0 CA-C-O 120.85 0.357 . . . . 75.35 110.827 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -109.56 115.52 30.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 55.43 110.891 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.83 140.9 52.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 72.02 110.869 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.45 147.88 49.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 72.3 111.115 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -100.72 -26.16 13.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 75.22 110.929 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.98 138.26 4.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 73.5 110.922 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 12.3 mt -137.03 117.89 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 73.21 111.178 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -133.06 118.41 18.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 75.1 110.878 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.49 150.76 52.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 74.03 111.144 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -157.0 167.29 30.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 73.04 110.898 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.54 66.45 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 74.35 110.851 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 50.08 43.97 25.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 74.22 110.874 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.1 152.38 21.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.34 111.079 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -135.34 135.25 40.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 63.32 110.869 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.58 121.19 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 74.51 111.126 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -108.07 134.63 50.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 74.02 110.914 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.28 118.03 20.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 74.04 110.924 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.16 -118.3 1.35 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.778 -0.725 . . . . 74.34 112.497 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -145.97 133.26 20.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.891 0.377 . . . . 73.43 110.866 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 74.4 t -110.2 121.18 62.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 65.52 111.165 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.47 119.96 58.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 74.23 111.134 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -69.99 175.36 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 72.13 111.103 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.47 -46.1 69.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 75.24 111.114 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.2 -49.52 77.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 73.22 111.076 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 72.21 111.112 179.933 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.885 0.374 . . . . 73.35 111.08 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 49.9 m -112.71 108.88 18.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.34 111.149 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -90.77 131.98 36.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 75.44 110.861 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.97 123.87 38.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 73.0 110.924 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.39 129.1 75.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.143 -0.48 . . . . 72.01 111.064 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.52 -75.23 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 62.12 110.929 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 48.9 m -136.52 135.6 38.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 74.22 111.138 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 97.5 t -117.89 127.06 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 75.43 111.184 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 28.1 t -127.22 122.93 61.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 72.33 111.101 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.29 132.44 8.55 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.771 -0.728 . . . . 73.15 112.507 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.13 144.89 50.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.808 0.337 . . . . 71.32 110.934 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.79 70.38 0.79 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.726 . . . . 73.45 112.478 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.47 94.3 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 74.02 110.924 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 30.9 t -126.27 145.02 50.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 71.23 110.892 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -131.68 126.35 34.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.909 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 16.6 t -132.1 132.42 61.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.08 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.55 111.11 12.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.104 -0.498 . . . . 72.02 110.903 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 24.5 mm -108.03 106.59 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 74.2 111.107 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.27 -146.15 17.42 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.788 -0.72 . . . . 72.02 112.523 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.98 156.11 17.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 74.24 110.88 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.25 122.56 11.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 70.33 110.803 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -119.93 124.45 46.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 73.42 110.937 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . -149.59 -140.09 3.2 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.783 -0.722 . . . . 75.34 112.531 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -139.16 -98.36 0.41 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 73.11 112.494 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.52 101.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.818 0.342 . . . . 74.44 110.937 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 71.49 -116.06 5.95 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 74.32 112.462 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.63 152.31 21.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.815 0.341 . . . . 74.25 110.898 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 74.02 110.881 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.803 0.335 . . . . 73.44 110.895 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -84.32 117.57 23.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 71.12 110.9 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 93.0 p -131.8 140.16 49.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 75.43 110.893 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -120.43 146.21 46.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 71.23 111.116 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -95.89 -26.73 15.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.924 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.31 138.88 5.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 70.25 110.944 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 10.8 mt -137.15 117.71 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 74.02 111.122 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -131.77 121.47 24.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 73.0 110.884 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.4 147.61 49.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 70.24 111.151 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -157.05 161.11 39.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 71.21 110.936 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 64.89 72.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 75.55 110.883 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.25 37.9 12.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 64.21 110.849 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.83 141.48 29.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 71.41 111.148 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.73 135.46 52.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 74.34 110.931 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.12 122.01 21.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 72.21 111.146 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -119.48 134.06 55.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 74.54 110.882 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 6.5 mp -130.74 118.06 20.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 72.1 110.946 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 145.52 -108.99 0.49 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.79 -0.719 . . . . 73.43 112.483 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.37 150.24 37.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.847 0.356 . . . . 74.2 110.895 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 80.0 t -133.42 122.73 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 75.32 111.131 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 79.6 t -124.15 112.83 34.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 72.41 111.095 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 74.3 p -69.08 175.25 3.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 75.33 111.17 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.01 75.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 74.02 111.142 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.78 -52.18 66.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 73.32 111.1 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 71.12 111.118 179.945 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 94.1 m . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.85 0.357 . . . . 60.24 111.114 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.41 142.53 51.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 73.23 110.883 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.88 133.45 39.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 74.44 110.839 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 4.9 p -124.11 118.51 54.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.139 -0.482 . . . . 72.21 111.136 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.96 -75.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 73.5 110.926 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.1 138.9 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 54.54 111.09 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 40.2 t -117.43 128.46 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 74.32 111.092 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 38.9 t -127.12 118.58 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 75.21 111.159 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.63 132.28 10.18 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.77 -0.728 . . . . 73.15 112.481 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -133.7 116.56 15.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 74.24 110.868 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 74.71 86.77 0.26 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.707 -0.759 . . . . 64.24 112.498 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 51.09 81.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 65.51 110.876 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 16.3 m -117.3 145.42 44.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 73.42 110.873 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -134.11 127.29 31.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 73.35 110.79 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 46.6 t -133.2 130.5 57.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 73.14 111.142 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -128.34 107.85 10.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 73.33 110.833 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 23.1 mm -114.27 109.19 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 71.42 111.069 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.62 -137.36 6.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.84 -0.695 . . . . 75.05 112.557 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -111.24 133.24 53.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 70.41 110.902 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.34 133.66 55.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.44 110.905 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.26 123.88 29.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 73.03 110.937 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.64 -0.791 . . . . 63.4 112.494 179.968 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.79 0.329 . . . . 73.02 110.861 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.21 130.08 52.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 74.32 110.823 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.1 m -128.57 144.31 51.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 74.54 110.872 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.7 124.01 19.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 72.44 111.091 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -76.09 -37.2 58.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 73.14 110.916 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -164.68 138.46 5.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 62.53 110.878 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 9.7 pt -137.82 118.01 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 74.4 111.067 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -128.39 126.91 41.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 75.31 110.909 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.7 p -135.56 149.49 49.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 74.34 111.142 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -144.97 168.37 20.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 73.24 110.925 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 65.47 74.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 75.31 110.922 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 41.89 59.11 2.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 73.02 110.811 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.11 155.99 18.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 65.43 111.099 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -135.05 145.92 48.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 75.15 110.905 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.97 137.39 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 74.21 111.113 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -137.2 129.42 29.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.45 110.917 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.9 mp -122.94 130.34 52.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 75.35 110.846 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.72 -121.42 1.56 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 71.01 112.446 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -144.86 132.7 21.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.87 0.367 . . . . 74.33 110.903 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 18.0 m -120.02 120.9 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.138 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 94.5 t -122.07 129.02 75.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 64.45 111.189 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 74.05 111.196 -179.937 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.851 0.358 . . . . 73.0 111.123 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 98.0 m -127.62 111.04 13.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 73.33 111.117 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.52 135.48 41.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 63.3 110.899 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 9.4 t -140.73 123.18 15.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 71.54 110.797 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 4.2 p -113.63 150.17 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 73.11 111.156 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -88.19 -73.31 0.49 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.483 . . . . 73.41 110.956 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 18.5 m -124.06 133.67 53.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 72.54 111.169 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 9.8 t -118.01 128.87 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 64.13 111.139 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 48.8 t -127.4 117.17 46.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 60.44 111.108 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.74 133.62 10.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.687 -0.768 . . . . 75.31 112.456 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -132.33 148.12 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 75.41 110.96 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.39 88.05 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.817 -0.706 . . . . 64.43 112.429 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 44.45 65.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 75.21 110.913 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 43.4 t -93.82 145.21 24.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.47 . . . . 73.14 110.86 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -123.02 128.45 50.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 74.35 110.835 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.3 123.62 71.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 73.21 111.144 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.0 111.48 17.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 72.23 110.976 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 20.4 mm -111.79 104.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.188 -0.46 . . . . 72.32 111.174 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.7 -160.22 26.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 72.43 112.468 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -107.01 151.51 25.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 72.11 110.878 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.26 131.93 45.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 71.31 110.893 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -113.17 125.86 54.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 64.13 110.933 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 131.37 166.55 11.71 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.735 -0.745 . . . . 63.44 112.519 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -82.42 -108.93 0.44 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 33.33 112.524 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.31 51.01 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 75.23 110.907 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.15 30.87 32.48 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.787 -0.721 . . . . 62.12 112.464 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 58.47 83.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.882 0.372 . . . . 74.14 110.882 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 23.0 t90 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 74.35 110.909 -179.928 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.833 0.349 . . . . 72.1 110.862 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.22 131.13 48.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.911 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.1 145.32 49.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 75.14 110.876 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -139.5 124.68 18.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.478 . . . . 72.42 111.075 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.39 -36.05 53.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.483 . . . . 72.22 110.969 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.36 137.6 4.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 72.45 110.856 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 5.9 pt -138.69 117.64 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 73.2 111.179 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.35 123.72 32.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 74.54 110.875 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.7 p -135.61 142.71 45.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 75.51 111.18 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -143.37 167.56 21.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 73.42 110.879 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 68.63 73.6 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 74.3 110.881 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 45.83 54.8 7.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 74.01 110.844 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.27 156.17 18.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 65.41 111.138 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.31 146.54 42.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.829 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.46 140.85 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 74.51 111.208 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -138.14 122.55 18.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 61.41 110.964 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.6 118.94 33.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.209 -0.45 . . . . 74.01 110.93 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.92 -170.84 24.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.798 -0.715 . . . . 54.41 112.523 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.99 129.05 34.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 74.33 110.909 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 17.5 m -118.99 121.12 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 72.31 111.175 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 26.6 t -122.15 129.02 75.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 74.34 111.105 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -85.34 175.08 9.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 75.12 111.157 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.05 -42.35 90.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 73.3 111.145 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.96 67.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 73.53 111.08 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 74.45 111.074 179.946 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.905 0.383 . . . . 75.11 110.857 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 27.8 p -100.69 122.05 42.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 73.22 111.17 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 96.7 m -133.91 124.92 27.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 73.24 111.152 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -115.97 134.6 54.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 71.11 110.866 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.89 123.54 19.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.02 110.828 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 4.9 p -110.22 150.04 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.501 . . . . 75.54 111.123 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -86.61 -77.1 0.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 62.41 110.835 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 13.8 m -120.16 132.71 55.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 75.54 111.169 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 5.0 t -118.13 121.0 66.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.304 -0.407 . . . . 63.25 111.107 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.51 117.24 51.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.487 . . . . 72.22 111.138 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.79 133.79 11.09 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 72.02 112.516 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.99 148.12 52.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 74.32 110.933 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.35 82.95 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.75 -0.738 . . . . 73.44 112.545 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 46.8 69.04 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 74.3 110.893 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.92 145.7 26.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 74.44 110.884 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.46 128.38 52.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 72.31 110.891 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.98 123.91 72.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 64.53 111.139 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.36 111.66 16.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 75.2 110.951 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 24.0 mm -112.09 104.1 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.54 111.165 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.24 -164.62 27.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 71.1 112.443 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -101.25 151.91 21.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 74.52 110.872 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -130.91 142.51 50.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.842 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -127.53 125.92 41.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 73.14 110.914 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 157.7 146.24 4.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.72 -0.752 . . . . 63.02 112.509 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -102.98 -170.23 26.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 45.12 112.462 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? 56.27 25.18 9.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 72.24 110.893 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 141.77 117.86 1.36 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.724 -0.751 . . . . 54.44 112.541 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -55.71 -26.1 43.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 71.23 110.886 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 3.6 t90 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 74.25 110.882 -179.918 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.82 0.343 . . . . 75.33 110.87 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -84.43 118.44 24.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 73.25 110.877 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 14.9 t -136.68 147.74 46.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.816 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -135.83 129.0 31.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 74.22 111.145 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.22 -35.24 36.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 73.52 110.91 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.8 136.81 3.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 74.2 110.89 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 4.6 pt -139.17 117.72 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 73.43 111.156 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.1 124.3 32.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 72.54 110.939 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -135.39 144.21 46.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 72.4 111.105 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 13.1 pm0 -143.53 167.82 21.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 62.03 110.927 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 68.68 70.72 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 73.25 110.926 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? 47.0 57.39 5.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 73.35 110.835 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.57 156.18 18.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 73.0 111.106 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -136.58 141.63 43.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 74.11 110.871 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.07 140.81 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 74.22 111.105 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -138.02 129.54 27.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 75.23 110.906 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 5.2 mp -123.98 118.65 27.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 75.14 110.957 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.8 -176.74 21.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.767 -0.73 . . . . 74.2 112.506 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -85.92 128.91 34.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 73.33 110.851 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 32.2 m -111.67 127.4 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 72.45 111.166 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 22.4 t -122.29 129.07 75.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 70.51 111.132 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 18.3 p -84.18 175.08 9.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 75.52 111.102 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.81 -34.85 70.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.476 . . . . 74.21 111.046 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -70.87 -51.73 24.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 45.14 111.07 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.284 -0.416 . . . . 63.12 111.07 179.907 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.877 0.37 . . . . 75.13 110.914 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 51.3 p -67.13 128.88 38.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 73.51 111.142 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 22.6 m -125.46 109.01 12.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 74.55 111.111 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.26 135.87 48.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.44 110.856 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.05 123.61 14.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 61.23 110.883 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 3.5 p -110.27 145.11 17.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.151 -0.477 . . . . 73.45 111.139 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.43 -75.82 0.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 72.3 110.798 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 25.2 m -126.12 134.28 51.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.179 -0.464 . . . . 72.44 111.061 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 8.7 t -118.64 127.06 75.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.488 . . . . 72.41 111.134 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.91 116.11 43.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 74.24 111.128 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.69 133.77 10.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.722 . . . . 74.1 112.484 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.29 148.01 52.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 73.22 110.902 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.84 85.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.735 -0.745 . . . . 63.43 112.52 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 47.82 73.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 72.34 110.87 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 38.6 t -103.12 145.48 29.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 63.21 110.817 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -119.65 128.49 53.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 74.31 110.899 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.55 123.93 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.124 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.18 111.15 14.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.935 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 38.7 mm -112.18 104.05 16.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 74.32 111.165 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.04 -157.53 27.36 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 72.11 112.477 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -114.52 156.12 25.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 65.31 110.855 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.6 139.29 53.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.08 -0.509 . . . . 72.53 110.877 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -129.19 125.99 38.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.941 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 148.1 153.9 6.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.768 -0.73 . . . . 73.04 112.502 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -99.01 103.81 2.8 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.717 -0.754 . . . . 74.14 112.526 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -179.41 41.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.877 0.37 . . . . 74.55 110.944 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.66 -135.05 11.98 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.75 -0.738 . . . . 73.35 112.488 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -124.32 -1.85 8.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 75.44 110.866 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 3.7 t90 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 75.5 110.909 -179.948 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.06 0 CA-C-O 120.788 0.327 . . . . 72.21 110.814 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -86.53 110.07 19.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 74.5 110.916 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 2.3 t -124.09 138.15 54.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 74.11 110.847 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.41 129.02 52.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 74.04 111.139 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.03 -33.12 51.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 73.54 110.899 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -167.77 136.59 2.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 75.13 110.85 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 4.2 pt -140.41 116.98 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 72.32 111.157 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -131.41 124.65 30.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 74.24 110.823 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 2.7 p -136.06 143.48 44.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 72.33 111.14 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 17.9 pm0 -142.83 167.7 21.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.25 110.867 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 67.7 78.21 0.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.492 . . . . 75.13 110.893 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 43.92 50.64 7.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 75.03 110.93 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.02 156.1 18.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 63.42 111.137 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.95 155.65 49.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 61.53 110.888 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 17.5 m -141.16 140.06 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 72.41 111.088 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -138.1 119.2 14.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 71.14 110.854 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 mp -118.78 135.19 54.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 72.51 110.913 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.17 -116.9 1.53 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 73.31 112.499 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -143.62 128.79 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.865 0.365 . . . . 70.13 110.882 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.55 115.54 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 74.43 111.109 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 80.5 t -122.03 125.95 73.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 72.13 111.087 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 18.2 p -86.25 174.99 8.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 64.15 111.11 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.92 -42.62 68.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 74.23 111.123 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.97 -44.94 96.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.433 . . . . 70.14 111.072 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 74.22 111.063 179.87 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.859 0.361 . . . . 73.51 111.152 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 90.0 m -99.0 109.33 22.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 74.41 111.122 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -108.9 144.6 36.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 75.22 110.923 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.36 136.06 35.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 64.32 110.846 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.17 133.83 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 74.31 111.112 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -70.16 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 75.41 110.888 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 87.1 m -150.85 133.64 15.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 74.33 111.14 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 13.5 t -117.17 129.19 74.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 73.41 111.178 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 61.2 t -127.2 115.8 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 73.11 111.107 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.0 133.06 11.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 54.12 112.49 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.31 116.62 18.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 73.3 110.936 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.57 87.66 0.17 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.69 -0.767 . . . . 73.33 112.477 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 52.25 88.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 73.31 110.869 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.37 145.68 50.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 64.43 110.914 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -121.35 128.83 52.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.826 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.24 126.6 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 71.35 111.079 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.24 111.3 13.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.51 110.98 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 45.8 mm -112.6 104.8 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.158 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 138.02 -176.9 20.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.776 -0.726 . . . . 75.35 112.495 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -91.33 156.17 17.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 75.45 110.849 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -131.66 139.02 48.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 73.01 110.887 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -125.61 125.89 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 72.52 110.836 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . -170.66 -87.69 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 74.44 112.476 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 136.84 -50.68 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.669 -0.777 . . . . 53.53 112.487 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 103.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.325 . . . . 74.35 110.917 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 56.07 -101.51 0.14 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.793 -0.718 . . . . 73.13 112.411 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -175.13 122.44 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.814 0.34 . . . . 72.43 110.925 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 7.7 t90 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 75.22 110.906 -179.962 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.888 0.375 . . . . 72.43 110.842 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -83.52 109.74 17.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 61.21 110.876 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 3.3 m -131.86 137.62 48.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.03 110.845 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -108.25 155.01 20.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 70.32 111.09 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -109.56 -26.03 10.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 74.4 110.902 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.88 137.24 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 73.34 110.898 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.43 115.9 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.52 111.115 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -132.29 118.46 19.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 73.52 110.862 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 1.3 p -136.21 152.83 51.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 74.35 111.104 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.5 167.29 30.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 75.23 110.896 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 63.75 80.47 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 75.23 110.929 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 45.54 51.81 9.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 74.11 110.825 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.54 156.66 17.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 72.13 111.196 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -139.16 154.34 48.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 71.42 110.845 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 19.0 m -142.63 135.68 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 74.53 111.119 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -138.52 129.8 27.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 74.12 110.934 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.51 135.19 50.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 74.3 110.915 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.16 -124.37 2.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.739 -0.743 . . . . 65.22 112.49 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -144.1 128.95 18.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.367 . . . . 75.53 110.93 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 11.0 t -99.91 119.4 47.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 71.12 111.121 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 57.6 t -122.28 112.91 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 74.21 111.131 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 43.9 p -71.92 175.05 6.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 63.04 111.145 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.5 97.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 61.12 111.155 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.01 -51.97 67.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 74.52 111.112 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 72.14 111.125 179.943 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 98.6 m . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.795 0.331 . . . . 74.2 111.132 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -126.19 125.54 42.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 74.21 110.881 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.24 119.71 35.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 74.54 110.856 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 75.4 t -107.8 115.46 48.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 64.41 111.172 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . 0.572 ' CD ' ' N ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -64.6 -133.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 71.12 110.906 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 7.1 p -94.71 130.03 41.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 71.25 111.139 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 26.4 t -116.47 123.33 71.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 62.22 111.118 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 38.6 t -110.6 118.36 57.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.082 -0.508 . . . . 75.54 111.107 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.81 133.58 11.7 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.715 -0.755 . . . . 71.24 112.563 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.69 116.55 19.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.881 0.372 . . . . 72.1 110.969 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.88 97.74 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.771 -0.728 . . . . 71.54 112.578 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 51.71 89.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 62.44 110.887 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 31.3 t -124.87 146.54 49.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 70.12 110.868 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -127.19 128.69 46.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 74.05 110.895 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 21.9 t -114.89 122.88 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 61.52 111.159 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.16 110.75 12.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.261 -0.427 . . . . 70.21 110.948 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 26.7 mm -113.76 104.87 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.45 111.088 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.92 -161.8 27.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 74.53 112.513 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.22 156.28 26.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 55.53 110.851 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.77 147.26 44.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 73.22 110.882 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -130.09 125.81 36.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 75.2 110.905 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 C-N-CA 120.739 -0.743 . . . . 74.34 112.478 179.98 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.804 0.335 . . . . 72.4 110.869 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -83.93 119.51 24.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.903 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.97 137.98 53.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 75.11 110.808 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.53 141.11 46.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 71.51 111.104 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -97.36 -35.64 10.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.87 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -164.33 138.96 5.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.299 -0.41 . . . . 73.23 110.864 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 11.0 mt -137.61 117.79 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 74.54 111.069 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.68 120.28 24.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 75.22 110.819 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.32 146.9 48.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 71.51 111.111 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -148.89 167.09 26.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 75.24 110.939 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 66.82 56.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 65.11 110.954 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 14.9 mtm-85 50.41 64.65 1.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.856 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 156.25 18.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 45.1 111.132 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -129.33 135.68 49.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 74.51 110.884 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 20.4 m -139.73 130.13 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 63.21 111.146 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -122.24 132.73 54.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 72.02 110.905 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.43 135.1 47.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 73.43 110.862 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.54 -130.92 6.32 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.805 -0.712 . . . . 50.53 112.539 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -144.56 128.89 17.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.866 0.365 . . . . 64.42 110.899 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 m -110.26 126.15 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 73.34 111.129 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.2 m -122.47 129.11 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 75.14 111.063 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 34.9 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 74.44 111.154 179.984 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 21.7 p . . . . . 0 C--O 1.233 0.184 0 CA-C-O 120.882 0.372 . . . . 73.14 111.125 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.78 108.87 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 71.24 111.136 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -101.86 129.05 48.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 74.24 110.92 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 34.7 m -140.44 123.81 16.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 65.22 110.854 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.6 p -120.28 136.7 56.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 73.3 111.109 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -78.65 -76.13 0.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.809 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.1 m -127.04 130.6 50.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 72.01 111.131 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.2 125.01 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 64.13 111.116 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.25 122.2 63.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 74.45 111.073 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.17 133.76 9.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 63.35 112.478 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.97 147.89 52.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.372 . . . . 73.2 110.889 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.13 78.61 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.688 -0.768 . . . . 71.22 112.449 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 47.28 63.71 1.86 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.855 0.36 . . . . 72.3 110.887 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 46.3 t -90.25 145.66 24.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 54.35 110.815 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.18 128.04 44.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 73.1 110.841 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 17.4 t -134.54 123.74 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 64.42 111.114 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.69 111.56 18.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 64.32 110.809 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 2.1 mp -111.61 104.82 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 72.41 111.155 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.06 -161.17 29.86 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 74.35 112.469 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -120.15 150.24 40.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.783 0.325 . . . . 71.02 110.881 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -124.21 128.6 49.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 74.53 110.894 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.05 125.8 53.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.105 -0.498 . . . . 73.43 110.926 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 125.06 159.8 10.49 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.721 -0.752 . . . . 52.05 112.561 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -108.82 -8.3 28.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.711 -0.757 . . . . 74.22 112.514 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -77.32 60.58 2.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.874 0.369 . . . . 75.44 110.892 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.33 97.39 2.46 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.722 -0.751 . . . . 62.0 112.533 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.85 -68.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 74.53 110.819 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 15.6 t90 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 73.21 110.956 -179.955 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 . . . . . 0 C--O 1.23 0.038 0 CA-C-O 120.892 0.377 . . . . 72.15 110.876 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -90.65 121.44 32.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 74.1 110.86 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 47.6 t -130.14 138.04 50.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 53.54 110.875 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.27 161.91 30.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 73.32 111.099 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.7 -31.91 5.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 72.02 110.904 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -164.39 138.79 5.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 33.44 110.911 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 12.9 mt -137.66 119.1 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 74.15 111.152 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 -131.71 119.15 20.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 74.4 110.899 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.59 140.71 46.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 64.25 111.189 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -144.67 167.57 22.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.855 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 61.86 63.37 1.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.086 -0.506 . . . . 72.15 110.959 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 47.99 61.05 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 73.22 110.878 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.57 153.29 21.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 74.31 111.113 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 8.3 mtt-85 -129.19 135.6 49.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 75.43 110.863 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 24.2 m -140.69 123.91 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 73.31 111.137 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.52 137.2 53.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 72.51 110.974 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.06 118.89 22.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 71.45 110.851 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.27 173.7 13.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.704 -0.76 . . . . 71.11 112.477 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -87.8 137.99 31.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 64.52 110.908 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 30.6 m -120.68 125.68 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 74.53 111.132 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.48 129.2 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.31 111.142 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.7 t -71.55 175.1 5.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 72.44 111.149 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.57 91.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 71.42 111.165 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.02 -36.37 70.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 63.13 111.11 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.199 -0.455 . . . . 65.41 111.129 179.921 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.837 0.351 . . . . 71.41 110.828 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 30.5 p -100.53 121.99 42.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 72.13 111.196 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.33 133.73 47.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 64.03 111.171 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -125.85 130.01 50.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 71.44 110.905 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.27 123.8 20.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 70.13 110.846 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -119.26 133.18 66.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 72.22 111.109 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.12 -74.97 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.837 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 97.3 m -135.44 133.71 38.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 54.55 111.13 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.25 125.88 74.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 72.44 111.099 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 63.4 t -127.31 125.43 65.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 74.02 111.097 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.5 133.82 8.05 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.725 -0.75 . . . . 65.34 112.48 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -130.98 147.62 52.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.816 0.341 . . . . 62.54 110.906 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.43 64.64 3.25 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.83 -0.7 . . . . 62.42 112.439 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.03 96.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.872 0.367 . . . . 71.41 110.874 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 65.1 m -125.36 145.82 49.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 74.24 110.859 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -127.22 127.51 44.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 75.1 110.799 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 19.3 t -134.6 123.41 41.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 63.34 111.148 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.64 113.39 21.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.252 -0.431 . . . . 64.15 110.922 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.07 127.11 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 73.35 111.036 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 127.33 -164.46 20.81 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.691 -0.766 . . . . 74.24 112.468 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -115.05 148.46 38.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 74.34 110.871 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.72 131.38 55.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 62.01 110.904 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -116.87 125.99 52.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.959 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 129.58 -175.3 19.07 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.727 . . . . 73.11 112.514 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -136.39 51.44 0.81 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.785 -0.722 . . . . 72.15 112.494 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -98.5 25.98 5.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.342 . . . . 73.25 110.914 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 109.9 18.09 9.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.794 -0.717 . . . . 73.41 112.516 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 69.35 -75.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.938 0.399 . . . . 72.52 110.868 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 15.9 t90 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.5 . . . . 75.15 110.868 -179.955 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.781 0.324 . . . . 72.44 110.883 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -92.15 110.03 21.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 60.23 110.855 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 72.7 m -136.75 139.52 41.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 63.5 110.898 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.84 159.67 31.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 74.23 111.119 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -112.82 -29.28 7.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 74.21 110.921 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.7 138.09 4.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 72.4 110.867 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 9.6 mt -137.88 117.77 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 75.2 111.107 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -133.48 118.98 18.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.475 . . . . 74.43 110.926 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.21 146.4 51.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.02 111.118 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -150.18 167.15 27.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 75.44 110.911 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.38 64.56 1.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 74.35 110.853 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 47.87 60.26 3.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 71.44 110.846 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.21 150.58 24.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 64.43 111.077 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 35.1 mtt85 -126.07 135.38 51.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 74.44 110.875 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.52 121.57 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 72.4 111.175 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.87 137.13 52.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.51 110.952 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 mp -127.49 118.69 24.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 74.24 110.982 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 134.83 -179.99 17.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.777 -0.725 . . . . 62.52 112.496 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -92.11 135.81 33.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 73.03 110.946 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 14.6 m -116.37 126.11 73.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 74.14 111.128 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.83 129.55 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 71.24 111.163 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.7 t -69.05 171.13 8.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 72.54 111.178 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.7 -33.79 49.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 65.24 111.123 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.59 -35.82 68.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 75.04 111.143 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 71.54 111.109 179.921 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.891 0.377 . . . . 53.04 110.919 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 30.8 p -97.83 129.29 44.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 74.4 111.118 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.27 124.99 28.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 74.35 111.179 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -126.23 127.11 45.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 60.33 110.853 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.51 123.23 33.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 62.14 110.83 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 10.5 p -109.48 144.34 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 75.42 111.096 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.68 -65.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 71.53 110.893 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 30.5 p -147.01 138.36 24.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 65.12 111.216 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 23.3 t -117.61 124.93 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 75.31 111.144 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.66 116.02 41.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 73.22 111.117 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.41 133.01 9.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 64.32 112.475 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -132.44 141.27 48.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 75.14 110.866 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.99 68.67 1.39 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 74.22 112.478 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.83 93.72 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.789 0.328 . . . . 73.03 110.964 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 34.3 t -126.06 145.63 50.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 75.05 110.903 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 13.2 mtm-85 -129.55 127.87 41.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.825 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 17.7 t -137.63 131.54 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 75.51 111.16 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.36 111.66 13.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 74.14 110.947 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 2.6 mp -106.55 104.73 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 74.21 111.124 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.93 -179.88 23.53 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.763 -0.732 . . . . 64.4 112.471 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -89.74 156.11 18.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 75.11 110.887 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -136.36 143.3 43.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 74.5 110.926 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -130.02 125.46 35.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.42 110.916 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 149.41 116.87 0.84 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 72.21 112.456 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -62.82 -32.78 84.94 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.686 -0.768 . . . . 62.25 112.508 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -73.44 78.19 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.86 0.362 . . . . 71.43 110.912 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 73.77 104.78 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 72.24 112.458 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -58.23 -29.3 65.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 75.11 110.907 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 17.4 t90 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.142 -0.481 . . . . 74.21 110.983 -179.984 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.814 0.34 . . . . 73.42 110.861 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -82.91 110.57 18.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 73.31 110.865 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 27.0 m -139.74 147.59 41.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 74.12 110.843 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.17 162.36 24.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 64.0 111.099 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.72 -30.79 5.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 65.3 110.918 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.37 139.15 3.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 70.12 110.874 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 14.3 mt -137.76 116.37 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 75.44 111.112 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.0 117.86 15.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 72.32 110.931 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.7 152.27 51.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 74.2 111.165 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -156.62 167.12 31.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 73.42 110.899 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 64.93 66.27 0.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 75.14 110.828 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? 50.24 45.21 26.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 75.21 110.921 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.6 151.53 20.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 74.33 111.084 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 35.0 mtt85 -132.39 135.59 46.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 75.4 110.845 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -133.51 121.49 41.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 75.33 111.165 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.44 135.47 49.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 63.13 110.958 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -126.46 118.59 25.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 74.12 110.872 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 123.05 175.0 14.42 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.792 -0.718 . . . . 53.03 112.468 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.66 144.79 25.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 73.21 110.904 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 34.9 m -118.14 134.82 60.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 72.53 111.139 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 2.5 m -117.44 130.33 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 72.45 111.169 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.2 t -68.52 174.68 3.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 74.24 111.103 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.86 -36.63 59.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 75.11 111.019 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.07 -35.46 67.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.21 111.14 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 75.43 111.108 179.94 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 77.4 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.883 0.373 . . . . 72.44 111.121 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 68.8 m -132.63 118.13 18.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 72.14 111.105 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.6 126.6 46.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 51.35 110.881 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.66 122.91 29.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 61.32 110.808 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.36 144.15 22.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 63.23 111.128 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . 0.443 ' HG3' ' HA ' ' E' ' 229' ' ' LYS . 12.8 mt-10 -86.61 -83.13 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 73.23 110.85 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.59 137.89 47.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 74.15 111.108 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 99.0 t -117.38 119.74 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 70.45 111.124 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.07 121.65 67.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 65.01 111.086 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.94 133.3 9.31 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.731 -0.747 . . . . 75.22 112.495 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.27 143.72 50.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 75.24 110.828 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 45.41 85.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 74.11 112.434 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 49.93 78.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.371 . . . . 61.02 110.863 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.88 144.67 36.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 73.42 110.879 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -132.78 126.24 31.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.897 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 44.9 t -139.12 123.24 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.094 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.53 110.55 19.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 73.21 110.938 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 10.0 mt -104.83 107.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 72.45 111.133 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.21 173.63 15.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 71.31 112.516 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -93.46 137.09 33.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 75.54 110.897 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.86 141.56 45.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.896 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -130.28 124.73 33.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.943 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 166.9 37.61 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.747 . . . . 75.54 112.452 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 50.31 -132.06 29.73 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.74 -0.743 . . . . 63.2 112.515 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -29.35 22.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.802 0.334 . . . . 74.54 110.873 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -58.96 97.12 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.75 -0.738 . . . . 71.23 112.52 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.0 -176.43 3.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.938 0.399 . . . . 72.5 110.829 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 15.6 t90 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 73.43 110.902 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.777 0.322 . . . . 75.52 110.873 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -145.19 104.16 3.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 73.24 110.858 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.25 143.59 44.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 72.1 110.871 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.99 164.55 19.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 71.04 111.103 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . 0.443 ' HA ' ' HG3' ' D' ' 265' ' ' GLU . 0.9 OUTLIER -119.2 -36.39 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 74.53 110.914 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.26 138.62 3.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 73.4 110.856 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 3.1 mp -137.81 113.54 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 72.41 111.139 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -137.85 114.69 10.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.21 110.889 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.67 150.78 45.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 74.31 111.135 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -156.16 160.28 39.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.816 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 65.44 68.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 73.25 110.906 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 48.83 54.14 11.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.925 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.89 149.08 26.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 70.41 111.083 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -130.47 135.57 48.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 74.24 110.86 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 31.9 m -139.86 129.11 28.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 75.32 111.192 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.95 137.59 53.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 74.22 110.952 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.66 118.91 29.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 73.44 110.869 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 125.85 174.17 13.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.726 -0.749 . . . . 74.43 112.509 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -100.7 163.03 12.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.902 0.382 . . . . 74.53 110.89 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 2.6 m -121.88 140.47 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 72.1 111.084 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.81 127.99 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 72.31 111.124 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 10.7 t -69.17 168.78 13.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 75.32 111.152 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.01 -33.9 53.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 71.51 111.088 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.2 -50.12 73.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 73.2 111.133 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 63.02 111.131 179.952 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.854 0.359 . . . . 74.23 111.083 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -129.15 116.42 19.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 74.51 110.891 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 3.1 p -119.7 123.87 44.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 70.41 110.79 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.75 137.17 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 75.04 111.163 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . 0.417 ' N ' ' CD ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -74.1 -146.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 43.11 110.912 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 4.1 t -96.56 137.61 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 65.2 111.171 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 95.9 t -115.01 121.64 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 75.24 111.159 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 5.7 p -120.96 120.16 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 74.12 111.108 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.36 133.36 11.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.792 -0.718 . . . . 73.03 112.47 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -131.38 116.45 17.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.338 . . . . 74.24 110.907 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 65.67 80.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 72.34 112.517 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 58.66 88.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 73.2 110.92 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 8.9 t -121.29 145.61 47.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 62.22 110.842 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.5 128.05 34.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 74.13 110.858 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 41.7 t -136.97 123.5 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 62.02 111.142 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.25 110.93 16.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 74.12 110.994 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 54.1 mt -107.89 137.53 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 75.45 111.096 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 121.31 -161.57 15.34 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.731 -0.747 . . . . 71.04 112.467 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -128.47 156.96 42.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 71.31 110.857 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.03 118.24 31.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 74.53 110.871 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -103.72 124.77 49.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 65.3 110.917 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.401 0 C-N-CA 120.785 -0.722 . . . . 74.23 112.529 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.789 0.328 . . . . 64.53 110.921 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -107.01 122.81 47.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 65.41 110.884 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 68.7 m -121.85 138.03 54.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 71.32 110.833 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.65 121.01 13.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 74.3 111.068 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.04 -35.95 23.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.235 -0.439 . . . . 73.41 110.913 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -164.17 139.19 5.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 75.44 110.926 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 10.1 mt -137.46 117.72 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.4 111.078 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -127.39 119.97 27.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 63.24 110.87 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.58 148.66 52.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.34 111.179 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -148.73 167.55 25.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 75.12 110.863 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 66.5 55.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 73.41 110.854 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.96 64.38 1.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 74.14 110.913 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.19 156.34 17.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 71.24 111.061 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -129.4 135.83 49.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.33 110.878 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 34.4 m -143.16 130.17 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 73.03 111.11 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -131.06 137.19 49.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 75.54 110.9 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.93 118.8 25.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 75.2 110.925 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 154.02 175.16 24.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.72 . . . . 71.43 112.599 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -85.88 131.15 34.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.936 0.398 . . . . 74.54 110.874 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 29.5 t -110.34 124.24 66.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 72.4 111.152 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 49.2 t -118.84 113.01 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 74.41 111.068 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.098 -0.501 . . . . 64.15 111.193 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.809 0.338 . . . . 74.31 111.228 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.78 110.72 22.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 73.35 111.21 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.29 120.28 34.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 75.34 110.929 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 41.3 t -131.58 123.8 28.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 73.31 110.81 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.26 137.03 57.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 72.33 111.144 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -83.03 -71.71 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 61.2 110.951 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 38.8 m -125.88 130.26 50.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.13 111.13 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 27.6 t -118.2 126.11 74.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 74.15 111.14 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 22.1 t -127.29 117.09 46.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 65.41 111.162 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.04 134.04 9.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.778 -0.725 . . . . 63.11 112.491 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -132.14 147.21 52.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.845 0.355 . . . . 74.34 110.904 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 57.94 73.9 0.4 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 33.44 112.479 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 48.42 59.54 4.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.867 0.365 . . . . 74.52 110.914 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 38.4 t -83.86 145.81 28.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 74.35 110.894 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -123.33 127.69 48.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 75.05 110.883 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 13.8 t -130.79 125.7 58.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 65.42 111.114 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.71 111.84 16.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 75.41 110.914 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.08 104.74 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 74.43 111.133 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.15 168.36 15.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 62.43 112.397 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -94.27 152.78 18.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.737 0.304 . . . . 72.13 110.835 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -123.2 118.87 28.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.906 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -117.6 148.37 41.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 75.41 110.942 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.11 -107.63 0.63 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.794 -0.717 . . . . 64.24 112.507 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -172.33 94.49 0.1 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 75.54 112.472 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -179.49 -34.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 74.14 110.844 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.09 -110.32 3.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 70.01 112.52 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.36 -172.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.371 . . . . 75.31 110.809 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 75.0 110.938 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 16.7 ttt-85 . . . . . 0 CA--C 1.526 0.058 0 CA-C-O 120.881 0.372 . . . . 73.42 110.81 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -110.26 123.66 50.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 74.43 110.907 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.83 138.31 54.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 71.14 110.903 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -142.35 120.28 12.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 74.24 111.099 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -31.6 21.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 74.41 110.921 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.46 139.18 5.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 63.05 110.818 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 9.4 mt -137.22 117.85 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 74.43 111.165 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -130.89 119.63 22.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.861 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.41 146.84 52.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 74.3 111.153 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -147.1 167.28 24.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 62.34 110.878 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 65.6 54.63 1.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 74.42 110.89 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 19.1 mtt85 51.68 62.62 2.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 73.32 110.807 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -103.57 156.42 17.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 63.21 111.061 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.89 136.02 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 74.54 110.865 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 19.2 m -141.22 121.74 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 73.42 111.161 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -123.03 137.19 55.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 74.11 110.955 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.74 118.83 28.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.236 -0.438 . . . . 73.23 110.939 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 150.51 171.15 18.49 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 41.31 112.504 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -86.03 139.06 31.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.893 0.377 . . . . 74.23 110.891 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -117.72 124.32 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 74.44 111.107 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.02 128.88 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 64.14 111.105 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 15.5 p -86.81 170.64 11.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 73.1 111.173 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.08 93.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 75.23 111.123 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.88 69.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 71.44 111.101 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 75.11 111.079 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.885 0.374 . . . . 71.44 110.922 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.92 123.9 45.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 72.42 111.134 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 6.1 m -95.29 108.89 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 73.44 111.098 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.86 125.04 40.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 70.5 110.827 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 2.9 p -135.59 123.69 22.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 65.34 110.864 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 9.9 p -119.78 135.78 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 75.42 111.082 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -74.66 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 75.33 110.913 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 76.8 m -122.29 130.05 52.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 64.42 111.152 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 39.3 t -118.34 123.46 71.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 71.33 111.094 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.33 118.84 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 75.32 111.087 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.1 134.93 9.73 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.681 -0.771 . . . . 60.15 112.457 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -131.58 147.3 52.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 75.34 110.896 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 59.66 72.39 0.62 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.748 -0.739 . . . . 70.2 112.471 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 49.13 59.16 4.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.951 0.405 . . . . 74.22 110.867 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 33.2 t -83.81 145.52 28.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 63.04 110.836 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.95 127.36 47.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 74.34 110.783 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 10.5 t -131.8 128.22 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 75.32 111.115 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -128.02 111.93 14.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.504 . . . . 71.01 110.959 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.15 104.6 17.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 71.23 111.14 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.64 179.03 29.56 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.765 -0.731 . . . . 72.23 112.527 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.33 146.17 24.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.774 0.321 . . . . 73.3 110.949 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.86 119.01 34.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 70.24 110.892 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -118.19 125.85 51.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 72.24 110.904 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 137.37 -43.51 1.21 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 73.25 112.494 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 92.91 135.99 7.51 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 73.33 112.515 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -179.33 -34.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.866 0.365 . . . . 72.21 110.924 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 146.51 -90.98 0.15 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.693 -0.765 . . . . 55.31 112.454 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.03 -49.46 3.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 73.51 110.927 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 75.54 110.913 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.813 0.339 . . . . 75.42 110.896 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -122.75 131.25 53.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 73.23 110.886 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.88 137.87 54.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 55.2 110.862 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.39 141.02 41.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 65.23 111.065 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.94 -32.82 8.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 74.2 110.898 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.61 138.32 5.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 73.32 110.847 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 7.3 mt -137.53 117.62 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 75.41 111.1 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -128.37 120.47 27.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 75.23 110.88 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.63 149.34 52.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 75.33 111.127 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -147.83 168.03 23.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 73.5 110.858 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 61.39 54.4 3.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 70.43 110.844 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 51.1 66.65 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 73.25 110.858 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -103.58 156.95 17.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 71.33 111.099 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -125.29 135.18 52.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 74.31 110.807 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.9 121.92 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 73.13 111.171 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -122.12 137.34 54.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 75.05 110.861 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.7 mp -126.24 118.87 26.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.953 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.53 176.07 15.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 71.33 112.517 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -91.34 128.97 37.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.889 0.376 . . . . 71.54 110.893 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.93 116.53 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 73.41 111.119 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 25.8 t -119.93 118.9 58.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 74.02 111.098 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -70.22 174.24 5.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.172 -0.467 . . . . 74.04 111.157 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.76 -37.99 88.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 63.0 111.088 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.84 -52.04 66.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 74.53 111.101 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 75.42 111.107 179.901 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.903 0.382 . . . . 73.35 110.913 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.33 131.06 40.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.485 . . . . 75.43 111.108 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 64.0 m -91.95 124.94 36.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 73.02 111.168 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.18 129.33 48.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.426 . . . . 54.34 110.856 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 28.9 t -140.86 123.39 16.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 72.2 110.83 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.53 136.52 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 74.22 111.18 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.01 -74.91 0.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 73.33 110.883 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 31.6 m -116.57 127.66 54.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 63.52 111.105 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 46.8 t -118.68 123.07 70.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 75.32 111.118 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 24.5 t -126.93 127.64 70.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 65.0 111.109 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -131.18 135.3 8.15 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.748 . . . . 61.32 112.528 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -132.45 148.37 52.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.873 0.368 . . . . 74.34 110.866 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.62 76.17 0.21 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.727 -0.749 . . . . 71.33 112.452 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 47.31 58.82 4.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.875 0.369 . . . . 73.41 110.88 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 37.7 t -83.4 145.4 29.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 74.44 110.835 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -124.53 127.92 48.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 72.3 110.899 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 17.0 t -134.13 123.68 44.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 74.04 111.156 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.97 119.3 29.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 72.32 110.93 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 4.2 mt -112.08 104.52 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 75.11 111.103 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.35 -159.32 28.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 71.4 112.42 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -110.11 155.99 21.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 75.54 110.907 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -131.24 124.39 30.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.139 -0.482 . . . . 70.24 110.913 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -120.92 125.92 48.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 73.44 110.893 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 135.71 161.66 9.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.789 -0.719 . . . . 74.33 112.483 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -96.99 110.11 3.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.772 -0.728 . . . . 73.35 112.488 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -179.24 37.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 73.3 110.972 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 53.49 -110.64 1.46 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 63.32 112.514 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.03 -175.96 5.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 73.22 110.888 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 1.7 p90 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 74.12 110.898 -179.973 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.88 0.371 . . . . 75.53 110.874 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -128.13 112.42 14.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 63.14 110.828 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.53 142.66 49.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 62.02 110.856 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -139.73 133.24 30.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 53.24 111.048 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -97.49 -37.11 10.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 73.43 110.881 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -164.3 137.36 5.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 74.31 110.914 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 6.6 mt -137.92 117.66 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 74.24 111.116 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -123.6 115.46 21.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.876 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.4 148.21 48.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 74.32 111.13 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.59 166.22 30.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 60.13 110.88 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 65.54 52.3 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 73.4 110.917 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 54.46 59.62 4.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 75.22 110.834 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -98.27 155.75 17.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 73.22 111.059 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 38.2 mtt180 -125.95 135.34 51.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.86 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.89 121.81 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 73.24 111.122 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.42 137.12 52.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.897 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -120.96 118.24 29.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 74.22 110.923 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.44 -173.32 19.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.795 -0.717 . . . . 65.22 112.483 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.38 149.9 21.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 62.34 110.898 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.23 116.37 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 73.42 111.14 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 50.3 t -115.02 128.98 71.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 72.23 111.137 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 11.8 t -70.65 174.47 5.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 65.21 111.126 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.14 -41.83 99.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 71.15 111.04 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.0 -43.42 81.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 73.43 111.13 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.32 111.063 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.816 0.341 . . . . 74.24 111.252 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.9 109.03 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 74.13 111.148 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.35 120.55 42.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 74.24 110.844 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 57.9 m -132.11 124.06 28.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 72.42 110.819 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -106.55 138.87 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.116 -0.493 . . . . 73.42 111.08 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . 0.426 ' HB2' ' HA ' ' E' ' 229' ' ' LYS . 3.0 tt0 -94.52 -29.53 14.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 75.02 110.863 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 266' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' E' ' 230' ' ' ASP . 1.1 m -152.69 129.22 10.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 74.44 111.147 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 94.1 t -127.18 120.5 55.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 72.33 111.143 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 40.6 t -127.74 128.0 68.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 64.41 111.097 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -135.23 133.31 6.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.738 . . . . 63.04 112.517 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.47 149.36 51.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 73.23 110.908 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.22 81.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.744 -0.741 . . . . 74.24 112.439 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 45.59 57.66 4.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 72.04 110.892 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 29.7 t -83.84 145.14 28.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 63.23 110.816 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -125.94 127.4 45.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 70.24 110.842 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 17.1 t -137.02 123.79 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 75.33 111.114 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 1.1 tt -128.17 111.72 13.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 72.13 110.907 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 16.5 mt -102.42 104.54 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 75.23 111.141 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.02 -168.18 32.91 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.746 -0.74 . . . . 72.42 112.491 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -103.39 140.0 38.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 73.32 110.914 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -111.95 134.85 53.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 62.35 110.928 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -120.04 125.8 49.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 71.03 110.879 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.52 -160.73 40.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.686 -0.768 . . . . 70.03 112.474 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 52.2 39.24 50.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 63.33 112.455 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 5.6 mptt 68.77 -76.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.351 . . . . 75.4 110.914 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -173.99 29.32 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.624 -0.798 . . . . 63.31 112.435 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.51 -168.75 2.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.907 0.384 . . . . 73.42 110.831 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 75.41 110.934 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.765 0.317 . . . . 72.32 110.874 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -82.2 114.81 20.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 62.12 110.894 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.03 133.59 55.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 65.13 110.875 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -122.41 170.04 10.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 72.43 111.135 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . 0.636 ' N ' ' HE3' ' E' ' 229' ' ' LYS . 0.0 OUTLIER -140.45 -34.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 73.13 110.893 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . 0.596 ' N ' ' HD2' ' E' ' 229' ' ' LYS . 8.8 t0 -175.62 131.71 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 75.54 110.821 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 15.5 mt -132.58 115.78 26.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 71.24 111.128 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -110.99 115.26 29.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 74.55 110.937 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.99 128.59 45.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 72.24 111.148 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -136.9 166.55 23.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 74.13 110.878 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 61.68 61.11 1.5 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 74.03 110.884 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 40.2 mtt85 49.35 63.93 1.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.45 110.844 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.74 156.48 17.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 75.05 111.057 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -128.06 135.85 50.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 74.21 110.92 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 4.5 m -139.25 121.7 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 74.54 111.181 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.83 137.47 54.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 74.32 110.913 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.61 117.92 26.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.932 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.8 168.18 11.76 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 72.43 112.551 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.84 133.77 33.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.898 0.38 . . . . 72.24 110.92 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 97.3 t -109.71 135.51 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 71.42 111.13 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 73.4 t -122.17 129.1 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 73.41 111.163 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.7 t -69.77 171.6 8.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 75.22 111.115 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.26 -33.91 75.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 75.43 111.082 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.22 66.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.274 -0.421 . . . . 75.15 111.063 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 63.11 111.118 179.964 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 93.1 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.814 0.34 . . . . 64.42 111.146 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -108.68 119.34 39.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 71.34 110.933 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.04 132.77 40.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 72.52 110.82 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 9.4 p -116.8 153.82 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 64.03 111.123 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . 0.607 ' O ' ' HD3' ' E' ' 229' ' ' LYS . 0.2 OUTLIER -112.02 -11.0 13.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 75.44 110.866 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.46 126.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.24 111.122 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 41.0 t -132.16 117.36 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 73.22 111.104 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.21 139.2 52.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 74.42 111.138 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -144.74 133.41 5.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 70.13 112.5 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -134.02 148.06 51.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 73.23 110.838 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 56.29 86.5 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.701 -0.761 . . . . 63.25 112.503 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 44.98 56.76 5.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.898 0.38 . . . . 61.52 110.895 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.42 145.23 29.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 70.41 110.924 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.93 126.96 39.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.893 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.05 123.56 34.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 74.14 111.127 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.03 111.44 12.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 75.22 110.905 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 37.3 mt -104.12 104.62 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 74.42 111.05 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 156.85 -174.5 34.51 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.773 -0.727 . . . . 73.02 112.485 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -103.53 153.05 20.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 75.3 110.867 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -116.27 136.35 53.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 73.42 110.825 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -117.46 125.78 51.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 71.35 110.886 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 54.54 112.509 179.968 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 . . . . . 0 N--CA 1.458 -0.039 0 CA-C-O 120.859 0.361 . . . . 75.35 110.861 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -87.78 112.28 22.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 71.11 110.93 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.65 148.4 49.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 75.11 110.871 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.17 119.3 10.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 73.53 111.057 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.43 -43.99 88.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 74.5 110.921 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -165.48 136.68 3.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 74.32 110.886 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 9.1 pt -139.07 131.78 37.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 72.43 111.144 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -135.05 139.8 45.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 74.12 110.873 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.31 153.82 51.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 74.43 111.154 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -142.72 168.71 19.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 43.32 110.881 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 74.2 -70.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 70.14 110.886 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.73 53.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 73.32 110.818 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.5 156.82 17.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.03 111.076 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -130.98 138.21 49.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 72.44 110.894 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.43 125.47 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 75.31 111.146 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -123.24 118.9 28.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 71.32 110.862 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.64 119.34 36.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 74.2 110.952 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 150.86 169.71 17.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 53.3 112.448 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -85.95 133.36 33.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 75.32 110.886 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.7 t -103.96 133.37 48.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 74.41 111.201 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 97.4 t -119.73 121.97 67.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 73.53 111.093 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 74.14 111.158 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.844 0.354 . . . . 71.5 111.115 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.3 t -125.18 121.8 35.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 73.14 111.189 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -91.24 127.21 36.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.54 110.877 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.4 p -142.41 123.07 14.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 72.43 110.896 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.7 p -118.99 134.47 62.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.45 111.125 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -78.33 -75.78 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.5 . . . . 75.4 110.879 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.91 127.13 53.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 75.11 111.199 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.96 120.85 65.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 72.45 111.142 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 74.5 t -123.47 115.29 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 71.51 111.106 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.72 133.6 11.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 75.13 112.5 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 139.92 48.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 74.34 110.854 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.19 81.1 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.733 -0.746 . . . . 64.12 112.545 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 44.7 62.51 2.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.836 0.35 . . . . 72.24 110.96 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.47 145.06 29.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 74.25 110.857 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -113.27 128.05 56.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 75.4 110.883 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 19.9 t -129.53 123.29 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 74.25 111.129 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.43 111.6 13.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 65.44 110.968 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.33 103.89 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 74.22 111.047 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.54 168.69 15.69 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.736 -0.745 . . . . 74.23 112.503 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -89.72 154.22 20.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 70.32 110.908 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.65 123.78 36.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 72.3 110.877 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -103.51 128.55 50.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 64.5 110.872 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.97 134.74 6.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 65.11 112.456 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.494 ' H ' ' N ' ' B' ' 247' ' ' ALA . . . -83.33 -112.0 0.53 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.811 -0.709 . . . . 63.45 112.525 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.45 25.45 14.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.728 0.299 . . . . 72.41 110.815 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 145.12 -12.97 1.88 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.748 -0.739 . . . . 71.23 112.486 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 7.7 t80 72.39 -68.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 75.21 110.867 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 14.5 t90 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 73.11 110.939 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.787 0.327 . . . . 72.54 110.889 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -93.75 112.7 24.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 70.32 110.908 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 32.4 t -127.61 152.32 47.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.851 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.03 124.27 17.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 75.55 111.064 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.07 -40.24 62.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 73.53 110.936 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -166.26 135.87 3.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 72.33 110.824 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 8.1 pt -139.15 130.01 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.481 . . . . 73.24 111.16 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.09 137.28 40.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 75.24 110.894 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.1 150.44 48.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 75.34 111.071 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -142.01 168.63 19.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 73.53 110.869 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 73.19 -71.84 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.883 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -177.93 59.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 72.11 110.898 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.88 156.61 16.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 60.44 111.112 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -130.7 135.87 48.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 74.3 110.843 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.22 132.15 71.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 71.21 111.166 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -130.22 119.28 22.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 73.55 110.881 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 4.4 mp -111.69 118.4 35.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 74.03 110.892 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 145.23 175.48 18.4 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.777 -0.725 . . . . 71.4 112.491 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.83 129.37 34.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.394 . . . . 70.1 110.879 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 92.1 t -102.19 114.74 42.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 73.33 111.195 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 85.0 t -106.76 129.26 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.169 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.3 t -74.96 169.58 17.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 75.24 111.166 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.494 ' N ' ' H ' ' A' ' 283' ' ' GLY . . . -63.34 -41.8 98.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 72.12 111.084 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.61 -35.85 68.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 73.45 111.101 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 63.41 111.072 179.981 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.851 0.358 . . . . 75.35 110.862 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 18.0 p -79.89 121.85 25.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 73.15 111.238 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 91.2 m -97.28 108.84 21.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 73.03 111.163 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.26 126.22 41.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 73.11 110.914 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 5.5 t -141.99 123.46 14.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 73.31 110.802 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.19 136.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.041 -0.527 . . . . 73.55 111.18 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -81.83 -77.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 72.43 110.894 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.5 m -121.08 127.94 52.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 75.43 111.104 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 15.7 t -118.18 120.32 64.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 74.34 111.106 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 41.3 t -123.38 115.04 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 71.23 111.13 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.52 133.09 10.52 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 55.42 112.496 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -132.48 146.97 52.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.751 0.31 . . . . 73.15 110.967 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.04 75.12 0.22 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.761 -0.733 . . . . 43.0 112.468 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 52.82 78.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.88 0.371 . . . . 72.03 110.893 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 1.4 t -103.66 144.7 31.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 70.1 110.906 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.43 127.58 56.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 71.11 110.818 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 97.0 t -130.5 123.62 55.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 74.04 111.16 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.88 111.85 13.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 73.33 110.846 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 3.4 mp -107.7 104.34 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 75.23 111.09 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.29 -171.75 29.44 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.745 -0.74 . . . . 75.11 112.519 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.77 147.95 26.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 74.33 110.975 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -116.8 121.68 42.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 75.34 110.822 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -112.41 125.72 54.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 75.15 110.967 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 140.08 164.58 9.95 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.743 . . . . 74.41 112.485 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -103.83 -143.5 12.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 53.31 112.503 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 9.9 mttp 56.87 25.3 10.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 72.33 110.866 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 128.75 -117.49 2.5 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.725 -0.75 . . . . 72.22 112.497 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -173.9 -44.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.882 0.372 . . . . 75.31 110.911 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 3.7 t90 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 74.14 110.844 -179.902 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.815 0.34 . . . . 74.12 110.842 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -94.08 109.86 21.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 73.44 110.903 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 60.7 p -137.02 148.17 46.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 71.25 110.854 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.22 137.56 47.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.501 . . . . 74.42 111.112 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -86.45 -40.49 15.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 75.11 110.911 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -165.47 136.5 3.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 73.55 110.895 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 8.3 pt -140.13 117.1 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 75.52 111.12 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -124.48 116.24 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 74.4 110.885 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.46 136.86 54.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 75.53 111.171 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -121.44 166.95 13.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 73.11 110.872 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 60.84 -162.91 0.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.496 . . . . 74.25 110.954 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 -72.65 63.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 75.1 110.877 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.62 156.37 18.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 53.34 111.047 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -135.9 135.95 40.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 65.32 110.839 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.35 134.41 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 72.44 111.11 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -130.13 137.37 50.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.501 . . . . 73.32 110.888 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.12 118.35 31.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 74.0 110.857 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 140.47 -177.77 20.48 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.7 -0.762 . . . . 70.4 112.47 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -85.84 153.06 22.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.797 0.332 . . . . 75.15 110.906 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 63.8 t -122.08 114.92 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 73.53 111.106 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 3.8 t -108.0 127.7 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 72.41 111.104 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 6.5 t -69.84 175.07 4.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 73.03 111.045 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.05 93.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 70.03 111.116 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.92 -35.89 69.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.24 111.072 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 72.21 111.065 179.91 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.847 0.356 . . . . 75.55 110.924 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -100.93 135.07 42.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 72.43 111.152 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 4.3 t -115.66 140.89 48.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 72.41 111.142 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.39 124.42 46.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 63.23 110.881 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.6 131.91 36.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 70.55 110.867 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.46 139.98 39.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.505 . . . . 73.42 111.122 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -83.03 -76.0 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 71.4 110.945 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 25.7 m -137.48 130.64 30.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 74.45 111.119 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.41 130.64 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.4 111.187 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 25.9 t -127.49 125.92 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 71.11 111.159 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.03 134.13 10.3 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.788 -0.72 . . . . 74.34 112.474 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.95 117.05 20.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 73.3 110.941 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 61.05 81.88 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.766 -0.73 . . . . 64.12 112.447 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 61.98 110.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.876 0.37 . . . . 72.54 110.888 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 5.1 m -148.43 145.12 27.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 74.53 110.873 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -117.61 126.36 52.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 72.04 110.895 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 16.4 t -127.06 123.05 61.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 74.15 111.095 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.14 117.9 22.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 72.51 110.896 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 5.1 mp -111.68 103.35 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 71.1 111.153 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.06 -173.87 28.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 74.53 112.509 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -106.36 156.22 18.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 75.31 110.9 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -115.71 128.45 55.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 65.55 110.897 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -110.8 129.72 55.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 63.03 110.895 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 120.78 167.25 13.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 72.21 112.471 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -110.9 -161.48 17.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.805 -0.712 . . . . 75.11 112.524 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt 50.9 79.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.794 0.331 . . . . 73.21 110.883 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 86.29 86.9 1.03 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 51.24 112.508 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -50.05 -42.13 49.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 74.33 110.83 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 15.7 t90 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 75.03 110.882 -179.926 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.846 0.355 . . . . 71.23 110.9 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -88.12 112.36 22.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 75.35 110.901 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.34 137.48 37.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 73.4 110.892 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -117.85 119.48 35.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 71.04 111.081 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -75.25 -29.46 60.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 75.13 110.911 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -166.19 136.15 3.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 73.22 110.876 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.66 117.98 14.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 72.52 111.113 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -126.96 125.25 41.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 74.01 110.881 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.33 155.4 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 63.14 111.119 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -152.99 168.68 25.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 72.13 110.888 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 68.71 -80.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 71.35 110.863 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -159.56 55.58 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 75.44 110.822 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.8 146.5 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 74.52 111.147 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -125.78 135.37 51.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 74.41 110.836 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.94 121.69 63.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 62.54 111.147 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -116.55 125.83 52.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 73.24 110.885 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -111.78 117.72 33.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 75.45 110.86 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.71 179.55 17.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 71.44 112.46 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -86.78 163.09 17.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 75.12 110.899 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 78.2 t -133.16 123.67 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 72.44 111.166 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.57 129.26 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.25 111.119 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.4 t -69.59 175.07 4.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 73.13 111.117 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.26 -41.57 89.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 65.02 111.144 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.71 -48.85 76.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 73.11 111.189 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 74.31 111.179 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.872 0.368 . . . . 75.24 111.187 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 98.7 m -91.76 140.98 29.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 73.52 111.191 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.64 119.6 29.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.317 -0.401 . . . . 73.54 110.94 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 15.1 m -132.02 122.62 25.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 72.14 110.88 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.32 128.33 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 74.13 111.118 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.96 -74.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 75.13 110.824 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 19.3 p -147.37 133.35 19.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 75.11 111.087 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 14.3 t -117.05 133.17 64.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 71.11 111.171 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 45.7 t -127.01 117.79 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 74.53 111.138 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.04 133.01 10.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.803 -0.713 . . . . 54.01 112.56 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -132.39 115.37 15.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 63.24 110.911 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.75 72.58 0.95 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.799 -0.715 . . . . 74.43 112.487 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 65.52 100.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.805 0.336 . . . . 75.5 110.923 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 2.6 m -135.98 145.0 45.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 72.13 110.861 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.88 127.15 51.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.51 . . . . 74.02 110.859 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 15.5 t -133.67 123.08 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 74.21 111.165 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.63 121.88 29.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 75.04 110.857 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.36 104.56 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 75.21 111.073 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.86 169.5 13.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 65.11 112.568 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -89.94 153.87 20.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 75.44 110.906 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -115.01 135.77 53.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 75.54 110.831 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -112.51 125.54 54.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 74.44 110.929 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 92.13 -142.04 15.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 73.12 112.547 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 65.8 111.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 74.4 112.537 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -51.81 -36.93 49.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 74.32 110.882 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -107.48 -83.24 1.55 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.757 -0.735 . . . . 65.32 112.494 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -177.52 171.96 1.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.371 . . . . 75.2 110.863 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 28.3 t90 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 72.42 110.813 -179.95 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.752 0.311 . . . . 74.22 110.848 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -95.42 111.04 23.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 72.2 110.854 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.37 151.01 44.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.091 -0.504 . . . . 74.33 110.813 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -127.13 119.03 25.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 74.1 111.112 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.48 -36.83 83.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.41 110.895 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.85 141.2 3.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.14 110.874 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 6.8 mt -136.56 116.83 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 75.24 111.152 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -123.76 125.35 44.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 74.4 110.836 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.18 153.39 51.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 75.34 111.128 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -156.27 166.5 33.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 74.53 110.858 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 70.22 -73.67 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 74.42 110.844 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 8.1 mtt85 -167.62 57.85 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.884 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.81 150.48 24.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 64.43 111.14 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.76 135.65 47.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.296 -0.411 . . . . 74.12 110.805 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.22 128.65 70.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 65.51 111.075 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.49 131.64 53.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 73.34 110.898 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.5 118.61 33.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 75.14 110.922 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.49 176.48 14.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.64 -0.791 . . . . 62.34 112.422 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -85.73 162.67 18.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.858 0.361 . . . . 75.23 110.893 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 86.2 t -132.58 128.93 58.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 65.45 111.129 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 14.8 p -122.31 129.17 75.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 73.25 111.093 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.9 t -69.51 170.98 9.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 73.31 111.182 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.49 -33.78 68.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 75.1 111.097 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.62 -35.87 68.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 73.43 111.135 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 74.24 111.083 179.891 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 24.9 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.882 0.373 . . . . 74.53 111.13 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -118.42 118.27 31.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 75.21 110.874 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.31 116.9 24.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.02 110.859 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 13.8 p -105.16 117.83 51.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 75.21 111.072 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . 0.551 ' CD ' ' N ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -62.04 -134.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 74.22 110.869 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.99 126.19 40.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 73.24 111.126 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 19.3 t -116.28 135.14 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 64.53 111.146 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.82 115.27 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 72.01 111.131 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.01 132.64 10.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 73.12 112.457 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -132.21 114.23 14.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.358 . . . . 73.14 110.833 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.46 73.42 1.1 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.753 -0.736 . . . . 70.12 112.46 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.42 103.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.804 0.335 . . . . 73.44 110.94 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 3.9 t -138.31 145.37 41.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 74.33 110.874 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.0 128.59 43.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 74.43 110.867 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 19.3 t -136.27 123.3 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 74.04 111.172 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -128.14 122.26 31.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.269 -0.423 . . . . 71.22 110.89 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 5.0 mp -113.74 125.1 70.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 73.32 111.143 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 128.27 -172.17 19.28 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.653 -0.784 . . . . 71.14 112.43 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.53 156.04 16.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 73.11 110.933 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -124.84 139.22 54.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 74.22 110.94 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -130.54 125.16 33.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 74.35 110.984 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.69 -0.767 . . . . 73.14 112.453 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.052 0 CA-C-O 120.828 0.347 . . . . 72.41 110.846 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -142.21 137.56 30.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 63.35 110.92 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.31 148.67 50.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 70.44 110.888 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.26 119.31 10.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.4 111.058 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.59 -49.29 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 71.14 110.898 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -165.22 136.9 4.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 75.41 110.875 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 5.9 pt -135.49 130.77 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 74.4 111.127 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.7 125.41 27.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 75.13 110.882 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.6 p -136.86 149.59 47.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 73.25 111.126 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.27 168.51 19.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 72.15 110.869 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 64.63 74.73 0.39 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 73.14 110.893 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 40.85 59.29 2.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 74.2 110.905 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -103.36 157.19 17.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 73.34 111.04 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.97 143.94 47.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 75.5 110.926 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 14.8 m -134.73 120.6 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 75.3 111.033 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -116.34 129.68 56.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 72.25 110.936 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.5 mp -111.86 117.91 34.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 75.24 110.947 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.25 -166.51 24.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.786 -0.721 . . . . 64.24 112.516 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -108.25 141.7 39.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.971 0.415 . . . . 61.12 110.838 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 32.0 m -115.52 118.0 57.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.138 -0.483 . . . . 51.5 111.13 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.5 m -123.43 123.03 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 74.51 111.129 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 75.02 111.173 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 56.6 m . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.742 0.306 . . . . 64.44 111.198 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.0 t -106.07 122.35 46.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 71.05 111.15 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.02 136.34 52.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 73.45 110.917 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 8.2 t -142.55 123.6 14.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 65.21 110.822 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.58 134.98 54.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 70.02 111.136 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.74 -77.76 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 73.44 110.851 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.22 127.68 53.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 60.43 111.115 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.89 131.46 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 71.25 111.111 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.46 116.06 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 72.43 111.115 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.12 133.29 10.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.802 -0.713 . . . . 74.25 112.517 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -133.35 148.51 51.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 63.45 110.872 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.55 79.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.785 -0.721 . . . . 64.14 112.493 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 46.83 66.37 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 75.01 110.907 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 29.6 t -92.78 145.14 24.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 72.33 110.82 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.56 128.19 54.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 70.31 110.856 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 19.3 t -119.25 123.15 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 75.34 111.139 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -129.45 111.49 12.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 73.12 110.937 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 7.2 mm -106.97 110.39 31.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 73.32 111.088 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.15 -178.34 18.84 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 73.33 112.482 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -88.96 156.59 18.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 70.31 110.916 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -135.23 146.7 48.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 72.43 110.902 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -123.06 122.45 38.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 73.3 110.901 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -127.83 -155.99 8.92 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.726 -0.749 . . . . 71.44 112.497 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -144.32 18.5 2.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 73.11 112.478 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.67 -51.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 71.13 110.942 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -102.28 -169.11 26.92 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.729 . . . . 72.05 112.5 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -136.54 31.74 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.911 0.386 . . . . 75.54 110.895 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 75.34 110.975 -179.914 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.838 0.351 . . . . 74.05 110.854 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -134.28 110.58 9.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 74.12 110.925 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.95 138.74 54.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 73.43 110.895 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.99 120.01 20.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 72.0 111.175 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -74.88 -35.69 62.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 74.24 110.844 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -166.05 135.8 3.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 71.21 110.864 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . 0.406 ' HA ' HG21 ' B' ' 267' ' ' VAL . 7.4 pt -141.07 131.58 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 74.13 111.155 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.72 126.8 27.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.837 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 2.3 p -135.05 140.38 45.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 74.31 111.095 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.19 167.56 21.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 71.04 110.852 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 68.09 69.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 74.43 110.861 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 46.88 35.2 3.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 75.15 110.935 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.42 156.14 20.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 75.24 111.057 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.65 144.6 47.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 74.21 110.823 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.71 121.31 62.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 75.25 111.162 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.24 117.45 29.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.33 110.911 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mp -111.48 117.71 33.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 74.15 110.898 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.37 -165.69 26.65 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 54.42 112.505 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -109.07 135.5 50.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 63.31 110.907 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.62 123.04 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 62.43 111.142 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.54 121.52 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 73.52 111.136 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.3 t -87.76 161.68 17.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 65.31 111.139 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.16 90.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 72.14 111.172 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.11 -34.9 64.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 73.51 111.131 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 74.42 111.136 179.894 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.88 0.372 . . . . 74.03 110.936 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 1.3 m -99.17 136.52 39.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 71.3 111.113 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 97.2 m -134.14 108.82 8.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.426 . . . . 73.2 111.133 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -111.36 132.73 54.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.862 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.9 p -140.0 123.6 17.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 73.1 110.89 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 3.7 p -115.07 144.71 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 75.45 111.095 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.14 -52.09 5.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 74.43 110.875 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 25.1 m -150.33 126.98 10.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 62.2 111.185 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . 0.406 HG21 ' HA ' ' B' ' 231' ' ' ILE . 32.6 m -123.14 136.85 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 62.31 111.11 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 37.8 t -127.22 129.62 70.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 72.14 111.128 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.24 133.4 8.42 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.8 -0.714 . . . . 74.4 112.517 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -133.18 148.92 52.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 74.21 110.89 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.4 87.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.697 -0.763 . . . . 73.42 112.477 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 41.39 50.73 3.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 73.02 110.873 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 47.9 t -83.21 144.87 29.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 73.42 110.833 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 129.85 48.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.098 -0.501 . . . . 73.32 110.871 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 11.9 t -114.14 130.67 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 73.11 111.147 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.73 111.24 12.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 64.34 110.886 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 21.9 mm -110.15 103.43 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 74.31 111.126 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 142.01 -172.45 24.11 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.725 -0.75 . . . . 75.11 112.507 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -91.42 156.35 17.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.708 0.29 . . . . 65.23 110.954 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.16 142.27 50.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 71.31 110.864 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -127.19 122.83 35.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 65.01 110.936 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -129.97 -158.64 9.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 71.45 112.486 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -111.77 -20.72 6.72 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 51.11 112.465 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.59 34.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 74.24 110.944 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -142.8 176.51 22.41 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.708 -0.758 . . . . 72.24 112.472 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -116.68 -22.88 8.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.837 0.351 . . . . 71.22 110.894 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 72.3 110.913 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.834 0.349 . . . . 75.43 110.835 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -88.06 124.28 33.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.871 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.5 142.9 50.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 71.41 110.87 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.88 119.17 14.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 73.24 111.097 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.53 -45.83 35.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 73.41 110.905 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -165.97 135.6 3.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 74.03 110.836 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 5.5 pt -138.14 132.1 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 75.53 111.12 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.61 121.44 19.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 74.11 110.827 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.8 p -135.87 138.17 42.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 73.34 111.104 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -138.8 167.71 21.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 71.3 110.877 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 68.95 73.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 71.23 110.838 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 45.07 54.21 7.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 72.53 110.881 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 156.25 18.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 74.44 111.097 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.94 143.7 38.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 63.43 110.804 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 14.8 m -129.5 133.83 64.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 75.23 111.107 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -130.35 120.7 24.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 73.11 110.96 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 5.9 mp -111.64 118.36 35.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 72.3 110.907 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.65 -178.4 19.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.726 -0.75 . . . . 35.45 112.457 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -97.47 128.81 44.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.853 0.359 . . . . 63.24 110.905 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 32.5 m -96.18 127.79 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 75.23 111.154 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.49 129.23 74.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 64.22 111.112 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.4 t -83.83 165.07 19.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 75.41 111.109 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.14 -34.09 76.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 70.01 111.111 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.72 -36.21 69.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 73.22 111.102 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 74.42 111.054 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 11.0 mp0 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.85 0.357 . . . . 73.14 110.937 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 1.7 m -100.78 136.06 41.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 74.34 111.145 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 96.1 m -125.15 116.83 22.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 72.15 111.121 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -126.05 149.8 48.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 72.53 110.916 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 1.8 m -141.72 123.71 15.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 72.42 110.886 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 5.9 p -109.99 138.93 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 72.3 111.071 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.6 -74.19 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 72.55 110.935 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 7.4 m -126.26 127.79 46.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 64.42 111.156 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.74 129.69 73.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.21 111.145 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 19.4 t -127.98 115.97 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 74.04 111.132 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.75 133.56 10.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.692 -0.766 . . . . 72.2 112.485 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.06 147.6 52.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.342 . . . . 72.51 110.867 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.43 84.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.785 -0.721 . . . . 64.45 112.43 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 48.06 75.74 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 74.04 110.958 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.69 145.06 32.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 73.43 110.865 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.47 128.42 48.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 73.03 110.822 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.32 123.41 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 75.35 111.124 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.75 113.42 15.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 73.13 110.964 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 19.0 mm -112.17 104.08 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 72.0 111.093 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.74 -177.07 27.22 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.711 -0.757 . . . . 71.04 112.439 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -95.04 156.19 16.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 74.12 110.971 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.12 130.93 52.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 75.31 110.847 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -119.23 125.65 49.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 73.43 110.958 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.93 171.91 13.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.692 -0.766 . . . . 63.34 112.466 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -70.92 -139.73 0.19 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.782 -0.723 . . . . 72.03 112.487 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 63.15 24.81 14.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.34 . . . . 72.23 110.908 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 61.9 -95.21 0.1 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.685 -0.769 . . . . 62.22 112.441 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -112.58 -175.3 2.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 74.12 110.95 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 21.0 t90 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.236 -0.438 . . . . 74.43 110.93 -179.897 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.83 0.347 . . . . 75.11 110.843 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -83.28 111.23 18.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 73.21 110.87 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 4.3 m -126.31 138.13 53.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 75.42 110.852 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.58 123.49 39.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 71.15 111.095 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -40.29 58.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 74.33 110.946 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -165.96 135.95 3.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 73.04 110.895 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 9.0 pt -141.36 117.66 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.11 111.111 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 122.86 27.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.473 . . . . 74.32 110.928 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 3.0 p -135.94 149.17 48.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 72.35 111.154 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -145.66 167.19 23.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 71.31 110.904 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 67.22 79.86 0.22 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 73.04 110.92 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 42.62 52.28 4.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 75.43 110.857 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.22 156.31 18.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 72.43 111.08 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.16 142.03 25.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.829 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 19.7 m -128.89 139.75 51.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 74.43 111.134 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -128.75 126.03 39.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 72.54 110.915 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 10.8 mp -111.73 135.21 52.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 74.14 110.875 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 114.74 -176.16 16.6 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.713 -0.756 . . . . 62.32 112.433 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -100.36 135.21 42.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.876 0.37 . . . . 71.21 110.88 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 22.7 m -104.07 133.48 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 74.31 111.137 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 39.9 t -122.22 129.47 75.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 75.32 111.05 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 10.9 t -69.55 175.1 4.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 74.31 111.213 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.79 -42.92 99.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 74.14 111.078 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.85 74.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 74.13 111.106 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 73.31 111.023 179.88 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.815 0.341 . . . . 61.44 111.143 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 90.2 m -93.24 113.45 25.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 72.42 111.206 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -126.25 145.55 50.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 75.23 110.924 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 21.9 t -135.53 123.8 23.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 73.21 110.8 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 14.2 p -112.35 133.2 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 75.43 111.167 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.91 -75.18 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 74.42 110.872 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 26.5 m -133.73 132.65 40.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 74.34 111.161 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 13.6 t -117.78 127.36 75.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 73.51 111.076 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.12 116.04 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 71.43 111.129 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.29 132.94 10.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.788 -0.72 . . . . 60.3 112.547 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.4 143.93 50.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 75.24 110.891 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 47.15 85.31 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.716 -0.754 . . . . 74.33 112.483 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 52.74 89.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.847 0.356 . . . . 71.44 110.927 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 47.8 t -126.12 145.01 50.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 73.4 110.829 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 11.8 mtt85 -127.7 128.23 45.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 74.4 110.862 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.36 123.68 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 65.33 111.129 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.47 113.05 17.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 74.34 110.863 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 17.8 mm -112.33 104.21 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 65.35 111.144 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.61 -146.59 16.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.758 -0.734 . . . . 72.24 112.525 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -128.19 150.04 50.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 75.13 110.853 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -111.76 127.16 55.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.965 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -120.21 125.4 48.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.22 110.898 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 122.99 160.16 10.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 64.44 112.41 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 62.26 163.55 0.32 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 32.23 112.479 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -110.34 48.42 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 75.34 110.927 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -137.04 -92.62 0.31 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.738 -0.744 . . . . 73.43 112.518 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -179.6 -64.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 73.43 110.849 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 10.4 t90 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 75.4 110.919 -179.956 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.822 0.344 . . . . 73.45 110.904 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.9 112.31 19.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 73.4 110.878 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 19.3 m -131.23 138.7 49.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.31 110.838 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -120.52 132.74 55.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 61.54 111.092 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.6 -32.39 41.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.867 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.79 139.03 4.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.415 . . . . 71.42 110.91 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.71 116.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 73.13 111.151 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -129.89 117.77 20.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 75.25 110.861 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 7.8 p -135.43 151.91 50.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 73.42 111.105 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -157.47 167.27 30.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.907 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 67.54 75.13 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 63.41 110.848 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 45.78 42.9 9.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 74.15 110.864 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.09 150.61 24.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 73.24 111.045 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . 0.477 HH12 ' N ' ' E' ' 240' ' ' GLN . 0.0 OUTLIER -133.7 148.11 51.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 72.21 110.902 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 6.8 m -130.47 124.13 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 74.5 111.134 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . 0.477 ' N ' HH12 ' E' ' 238' ' ' ARG . 8.6 tm0? -114.65 126.12 54.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.43 110.933 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.87 121.4 43.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 72.04 110.941 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 122.03 175.61 14.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 53.4 112.513 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -85.63 139.53 31.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 71.32 110.824 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 30.1 m -104.84 139.17 26.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 53.44 111.135 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 87.1 t -122.41 129.43 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 64.45 111.095 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.7 t -69.0 174.28 4.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 72.05 111.143 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.0 -43.54 91.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 73.42 111.09 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.98 -48.63 77.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 55.3 111.05 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 74.34 111.042 179.971 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.773 0.321 . . . . 72.1 111.09 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.42 150.88 48.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 75.33 110.845 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 68.3 m -139.33 131.98 28.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 74.15 110.887 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.28 122.07 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 71.31 111.157 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.25 -78.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 71.33 110.862 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 72.5 p -143.48 135.83 27.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 71.4 111.212 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 18.0 t -117.44 134.6 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 75.13 111.141 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 47.4 t -126.74 119.97 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.3 111.126 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.89 133.27 10.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 73.44 112.548 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.79 126.4 32.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.815 0.34 . . . . 72.52 110.893 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.7 94.44 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 52.34 112.477 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 50.05 75.14 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.92 0.391 . . . . 75.44 110.86 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 7.6 t -114.79 145.6 41.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.474 . . . . 63.22 110.802 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 24.2 mtm-85 -130.85 127.3 38.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 75.14 110.913 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 21.3 t -116.53 125.3 73.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 73.13 111.165 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.72 111.73 15.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 74.34 110.953 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 31.6 mm -112.9 103.69 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 63.43 111.155 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 137.66 -178.66 18.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.8 -0.714 . . . . 61.4 112.52 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -89.92 156.19 18.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 63.24 110.859 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -121.37 134.31 55.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 64.5 110.879 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -114.35 124.74 52.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 55.23 110.92 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 C-N-CA 120.795 -0.717 . . . . 72.45 112.512 -179.996 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.794 0.331 . . . . 73.41 110.917 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -85.15 135.18 34.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 73.53 110.87 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 1.7 m -118.91 136.94 53.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 62.45 110.854 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.35 139.72 39.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.482 . . . . 73.55 111.063 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.95 -73.11 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 72.12 110.931 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -130.43 138.53 50.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 72.45 110.845 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.41 116.71 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 75.3 111.1 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -118.74 115.85 25.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 72.15 110.861 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.75 146.45 52.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.194 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.05 154.96 31.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 74.31 110.883 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 64.23 82.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 72.03 110.934 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 41.85 43.57 2.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 75.13 110.848 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.25 137.93 31.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.092 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 141.9 51.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 73.32 110.809 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.0 p -143.58 121.68 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 75.01 111.134 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -122.0 136.61 54.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 72.05 110.888 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.75 118.87 21.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 73.34 110.94 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.72 -120.39 1.05 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.739 . . . . 52.31 112.503 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -144.77 130.28 18.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 72.23 110.86 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -101.95 136.29 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 72.45 111.136 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 38.5 t -122.15 129.12 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 74.42 111.122 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 73.42 111.136 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.882 0.373 . . . . 73.54 111.084 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.9 m -112.79 108.85 18.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 75.23 111.186 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -104.96 138.91 40.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 74.32 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 92.4 p -140.48 123.87 16.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.53 110.833 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.26 149.77 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 74.23 111.137 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -102.44 -39.79 6.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 73.35 110.866 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.4 m -150.41 127.31 11.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.453 . . . . 73.42 111.099 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 80.9 t -121.28 120.19 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 73.23 111.08 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.02 129.48 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 73.13 111.206 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -139.73 133.26 5.98 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.764 -0.732 . . . . 71.31 112.49 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.89 147.39 51.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.877 0.37 . . . . 61.33 110.896 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 53.94 89.91 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.665 -0.779 . . . . 72.11 112.533 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 45.23 60.18 3.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 73.21 110.817 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 6.4 t -91.25 145.54 24.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 75.42 110.862 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -132.32 127.8 36.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 74.21 110.884 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 20.3 t -131.85 123.66 51.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 74.15 111.119 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.71 111.59 17.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 74.52 110.931 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 2.3 mp -107.17 104.29 16.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 75.34 111.117 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.04 -152.29 24.42 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.749 -0.738 . . . . 74.14 112.496 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -127.81 151.52 48.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 75.31 110.878 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.03 124.69 48.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 72.4 110.886 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -106.91 125.86 51.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 74.54 110.923 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 112.65 -68.97 0.23 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.724 . . . . 74.35 112.522 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 101.33 -101.71 2.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.768 -0.729 . . . . 72.24 112.499 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.83 45.93 4.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 73.4 110.828 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.79 17.57 11.8 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.782 -0.723 . . . . 63.1 112.511 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.69 170.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.817 0.341 . . . . 73.34 110.828 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.488 . . . . 75.22 110.915 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.812 0.339 . . . . 72.33 110.861 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -123.15 138.52 54.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 71.42 110.911 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.98 137.7 54.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 73.32 110.804 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.87 140.39 47.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 65.15 111.064 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.07 -31.5 9.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 74.1 110.89 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -164.74 138.77 5.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 73.41 110.826 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 5.7 mt -137.25 121.5 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 71.41 111.099 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -134.06 118.23 17.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 73.23 110.828 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 128.89 32.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.055 -0.521 . . . . 75.4 111.169 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.03 166.86 22.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 74.44 110.888 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.71 71.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.43 110.899 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 46.16 48.19 12.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 73.34 110.804 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -98.48 149.46 22.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 71.22 111.104 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.44 142.88 47.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 75.44 110.843 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.58 132.08 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 70.14 111.164 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -127.01 137.23 53.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 65.52 110.827 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.19 118.56 28.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 73.11 110.915 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.68 -168.62 18.77 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 72.13 112.475 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -85.76 135.21 33.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.908 0.385 . . . . 74.45 110.881 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 3.3 m -117.72 118.83 59.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 73.31 111.115 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.82 120.17 54.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 74.02 111.124 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.0 t -90.76 172.17 8.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 74.0 111.115 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.74 -41.81 64.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 73.54 111.055 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.79 -36.05 69.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 74.43 111.08 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 71.43 111.114 179.982 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.903 0.382 . . . . 74.13 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 7.0 t -99.3 137.44 37.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 74.34 111.142 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 26.2 m -129.2 132.66 47.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 73.54 111.129 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -120.43 121.87 39.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.943 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 2.0 t -118.91 123.69 45.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 54.33 110.826 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -116.07 139.0 44.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 74.4 111.095 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.39 -75.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 74.12 110.86 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 24.3 m -124.09 130.47 52.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 74.51 111.127 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 94.0 t -118.06 122.8 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 74.2 111.121 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.39 129.14 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 64.21 111.199 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.74 132.76 6.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.699 -0.762 . . . . 61.42 112.412 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.7 147.52 51.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.873 0.368 . . . . 64.41 110.898 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.25 86.39 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.767 -0.73 . . . . 61.43 112.539 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 46.37 66.23 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 65.43 110.863 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 17.4 t -99.2 145.37 27.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 72.11 110.819 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 4.4 ttm-85 -129.76 127.88 41.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 74.5 110.805 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 18.7 t -129.49 123.58 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 74.32 111.134 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -126.88 111.93 14.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 75.31 110.919 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 2.2 mp -108.05 104.32 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 74.52 111.145 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.79 -141.49 8.88 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 71.42 112.472 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -127.99 156.1 43.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.776 0.322 . . . . 63.43 110.908 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -122.57 126.31 47.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 73.32 110.961 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -109.82 127.93 54.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 74.12 110.952 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 104.84 155.36 22.88 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.752 -0.737 . . . . 75.2 112.519 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -114.03 132.88 10.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.709 -0.758 . . . . 60.12 112.501 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -175.02 44.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.359 . . . . 74.21 110.875 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.04 26.87 27.62 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.72 -0.752 . . . . 62.32 112.523 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 62.34 165.26 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 73.44 110.855 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 38.6 p-90 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 75.43 110.924 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 . . . . . 0 CA--C 1.527 0.058 0 CA-C-O 120.83 0.347 . . . . 64.03 110.841 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.47 131.88 39.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 74.12 110.878 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.1 m -140.09 137.86 34.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 70.22 110.88 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.63 144.58 49.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 72.31 111.121 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -101.41 -25.78 13.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 75.51 110.935 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -164.86 138.58 4.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 74.33 110.811 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 10.8 mt -137.74 117.57 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 71.44 111.102 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -133.27 116.13 15.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 73.52 110.946 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.09 136.19 41.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.55 111.141 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -143.15 167.05 23.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.855 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 60.91 75.49 0.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 74.32 110.894 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 44.48 53.82 6.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 73.25 110.909 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.5 145.86 29.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 72.25 111.127 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.0 137.06 52.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 75.31 110.823 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.12 136.51 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 72.01 111.117 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -132.42 135.49 46.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 74.51 110.864 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.3 mp -126.8 118.79 25.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.42 110.933 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.8 -169.58 18.71 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 61.21 112.545 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -99.0 143.06 29.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 74.42 110.876 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 19.0 m -120.81 139.27 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 72.35 111.156 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 38.6 t -121.93 120.67 62.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 55.13 111.146 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 24.9 p -73.68 173.79 9.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 73.42 111.121 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.63 87.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 72.02 111.107 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.07 66.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 71.31 111.163 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 72.03 111.164 179.901 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.884 0.373 . . . . 74.42 110.881 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 14.7 t -80.64 136.94 36.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 74.1 111.166 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.16 117.56 28.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 73.21 111.109 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.55 134.22 50.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 74.11 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 2.8 t -135.66 123.49 22.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 73.34 110.931 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.49 130.12 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 73.2 111.098 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -64.9 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 75.22 110.945 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 89.3 m -149.9 135.33 18.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 71.13 111.16 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 98.7 t -117.96 124.85 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 74.23 111.171 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.34 128.2 69.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 72.14 111.127 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.14 132.95 7.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.768 -0.729 . . . . 72.24 112.509 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -132.95 139.67 47.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.827 0.346 . . . . 74.33 110.873 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.08 73.52 0.37 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 74.12 112.495 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 63.35 100.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.852 0.358 . . . . 73.53 110.937 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 14.4 m -138.62 145.35 40.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 50.5 110.895 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -129.91 127.68 40.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 75.14 110.917 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 31.5 t -131.38 124.89 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 75.35 111.109 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.59 111.47 15.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.23 -0.441 . . . . 75.3 110.969 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 2.6 mp -104.94 133.64 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 74.01 111.161 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.11 -146.67 18.85 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.761 -0.733 . . . . 73.21 112.452 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -128.11 146.27 50.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.338 . . . . 74.43 110.878 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -113.42 123.66 50.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 71.15 110.903 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -103.95 125.65 50.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 65.53 110.913 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 111.62 -54.73 0.53 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.715 -0.755 . . . . 70.3 112.51 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 63.88 -116.66 9.46 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.711 -0.757 . . . . 72.4 112.493 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? 63.41 105.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.343 . . . . 64.51 110.896 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 62.39 60.39 7.95 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.745 -0.74 . . . . 75.12 112.477 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 51.74 -168.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.783 0.325 . . . . 74.53 110.909 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 31.8 m0 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.185 -0.461 . . . . 73.04 110.915 -179.984 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.229 0.025 0 CA-C-O 120.874 0.369 . . . . 74.12 110.839 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -83.53 140.63 32.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 72.14 110.893 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 1.4 p -139.95 139.0 36.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 75.42 110.871 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.63 159.77 29.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 62.4 111.087 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.32 -29.61 7.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.9 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -166.48 137.99 3.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 64.05 110.875 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 13.8 mt -137.42 117.53 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 74.12 111.204 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -134.69 120.39 19.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.947 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.18 150.45 50.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 74.43 111.175 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -157.15 167.29 30.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.34 110.917 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 61.22 72.21 0.53 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 75.23 110.885 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 45.28 40.86 5.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 74.3 110.881 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.52 144.16 26.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 73.41 111.146 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -125.63 135.83 52.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 72.1 110.89 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.42 139.59 35.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 73.4 111.14 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -131.0 137.28 49.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 64.03 110.942 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.3 118.72 32.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 73.35 110.874 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.79 175.45 15.78 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.759 -0.734 . . . . 74.42 112.549 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -86.02 150.06 24.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.937 0.399 . . . . 75.13 110.822 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.87 138.32 53.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 63.32 111.193 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.14 128.94 75.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 72.1 111.094 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 12.3 t -74.0 175.25 7.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 63.51 111.081 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.84 -44.4 77.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 73.32 111.071 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.45 -52.03 67.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.422 . . . . 73.32 111.122 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 74.02 111.095 179.932 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.802 0.334 . . . . 75.25 111.181 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 94.0 m -132.57 134.74 45.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 62.11 111.127 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.04 121.48 39.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 75.3 110.873 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.57 123.99 42.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 75.05 110.795 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 8.6 p -120.05 146.49 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 71.52 111.163 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -88.76 -73.79 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 75.21 110.876 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 73.2 m -139.85 129.88 24.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 72.02 111.142 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 16.9 t -117.31 120.59 65.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 72.43 111.134 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.59 124.13 72.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 55.25 111.176 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.51 132.21 9.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 73.51 112.512 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -134.04 140.24 46.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 75.54 110.911 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 46.7 87.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 73.24 112.494 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 50.04 75.74 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.914 0.388 . . . . 71.41 110.93 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 35.9 t -107.1 145.45 32.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.07 -0.514 . . . . 64.45 110.844 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -132.67 127.64 35.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 74.53 110.903 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.81 124.1 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 74.44 111.119 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.45 111.61 17.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 74.45 110.917 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 22.4 mt -103.99 114.38 43.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 74.4 111.145 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.6 -162.12 24.07 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.663 -0.78 . . . . 73.1 112.469 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -116.47 145.58 43.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.786 0.327 . . . . 72.02 110.932 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -111.89 132.37 54.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.907 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -110.02 125.38 52.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 75.31 110.918 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 132.06 177.99 15.24 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.725 . . . . 63.21 112.516 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -138.21 111.3 0.8 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.722 -0.751 . . . . 75.32 112.459 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -156.78 22.74 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.339 . . . . 73.13 110.874 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 67.49 121.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.824 -0.703 . . . . 72.52 112.488 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 51.77 -169.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.873 0.368 . . . . 74.41 110.841 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 4.9 m0 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.108 -0.496 . . . . 74.22 110.916 -179.949 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.834 0.35 . . . . 71.41 110.914 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -83.93 112.51 20.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 72.24 110.8 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 6.3 p -129.34 158.96 37.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 70.43 110.878 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.69 164.73 25.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 75.31 111.113 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.42 -39.32 4.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 72.5 110.921 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.79 141.43 4.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 61.11 110.901 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 3.4 mp -137.22 116.26 15.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 74.21 111.135 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -131.24 118.83 20.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 74.14 110.889 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.99 128.96 31.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 72.25 111.125 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -140.49 158.32 44.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 74.43 110.944 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 63.08 79.31 0.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 75.31 110.918 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.2 50.04 9.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 75.22 110.899 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.71 141.55 36.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 75.02 111.094 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -126.39 139.6 53.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 75.41 110.868 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.71 141.48 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 74.52 111.124 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -138.33 137.16 37.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 74.02 110.892 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 1.8 mp -120.43 118.61 30.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.89 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 124.43 168.28 12.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 63.12 112.472 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -86.84 163.14 17.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.907 0.385 . . . . 75.22 110.881 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.16 139.39 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 71.41 111.117 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.63 127.95 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 63.53 111.08 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t -70.03 171.18 9.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 74.41 111.179 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.12 -38.72 92.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 54.53 111.168 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.94 -36.05 69.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 72.53 111.093 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 53.54 111.019 179.885 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 60.6 m . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.747 0.308 . . . . 73.25 111.088 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -125.98 131.22 52.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 71.44 110.922 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 23.1 t -128.51 121.02 27.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.906 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.8 p -104.37 123.09 58.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 72.23 111.127 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -65.59 -143.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 70.34 110.828 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' E' E ' 266' ' ' THR . . . . . 0.412 ' N ' ' CG ' ' E' ' 265' ' ' GLU . 14.8 p -92.46 130.02 38.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 74.43 111.126 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 19.5 t -114.84 131.15 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 75.21 111.075 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 52.4 t -122.73 116.76 49.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.135 -0.484 . . . . 73.34 111.112 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -108.06 132.68 11.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.808 -0.71 . . . . 73.41 112.512 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -132.3 115.46 15.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.84 0.352 . . . . 74.33 110.903 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.08 94.12 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.734 -0.746 . . . . 73.22 112.452 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 52.02 87.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.895 0.378 . . . . 63.41 110.909 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 33.3 t -125.66 145.85 49.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 75.14 110.877 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -136.63 128.16 28.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 75.44 110.906 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 96.8 t -136.62 125.34 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 74.0 111.099 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -123.36 116.11 22.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.98 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 2.0 mp -109.01 140.8 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 73.1 111.168 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 112.58 -158.06 14.54 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.792 -0.718 . . . . 75.32 112.495 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -128.19 156.54 42.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.352 . . . . 73.41 110.904 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -111.69 121.81 46.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 75.41 110.882 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -106.23 125.94 51.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.116 -0.493 . . . . 73.5 110.946 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.67 -0.776 . . . . 74.3 112.501 -179.958 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.846 0.355 . . . . 72.45 110.863 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.24 136.44 29.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 70.21 110.924 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.46 137.09 54.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 72.0 110.901 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.28 131.07 41.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 61.03 111.099 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.81 -28.35 13.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.21 110.867 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -166.01 137.3 3.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 74.45 110.899 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 11.1 mt -137.97 117.81 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 63.22 111.139 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -127.67 123.14 34.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.499 . . . . 75.03 110.846 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -135.56 162.28 33.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 72.13 111.091 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -153.66 167.96 27.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 75.53 110.873 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.66 -69.83 0.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 75.45 110.858 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -178.68 37.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 75.02 110.873 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -70.52 152.17 44.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 74.14 111.087 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.38 135.64 51.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 72.52 110.868 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 18.7 m -129.45 121.52 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 75.45 111.144 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -119.56 134.15 55.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 75.42 110.884 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 6.0 mp -125.65 118.83 26.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 74.44 110.9 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.35 -170.88 22.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.73 . . . . 71.13 112.474 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.88 128.82 34.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 72.04 110.859 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 1.6 p -123.61 121.98 63.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 73.45 111.134 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.8 p -119.23 129.04 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 70.2 111.107 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 72.12 111.205 179.986 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.883 0.373 . . . . 70.12 111.121 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 95.4 m -107.13 132.59 52.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 72.1 111.151 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.11 119.93 36.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 74.14 110.902 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.1 p -130.09 123.43 30.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 74.2 110.853 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.5 p -109.3 134.43 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 74.23 111.19 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -74.28 -78.17 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 62.31 110.886 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 36.8 m -136.7 132.18 34.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.33 111.128 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 33.3 t -118.42 120.9 65.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.23 -0.441 . . . . 73.5 111.143 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.22 119.46 60.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 75.02 111.153 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.8 133.52 10.91 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.752 -0.737 . . . . 73.22 112.514 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -116.06 116.28 27.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 73.44 110.989 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.83 83.25 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.757 -0.735 . . . . 74.42 112.537 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 67.08 120.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 74.44 110.898 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.5 t -156.32 145.27 20.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 73.52 110.831 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.73 126.65 46.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 71.51 110.876 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.54 123.75 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 74.42 111.079 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.8 120.15 32.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 75.44 110.901 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 24.9 mm -112.32 103.74 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 72.35 111.144 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.9 -154.95 25.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.772 -0.728 . . . . 41.12 112.512 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -111.06 151.88 27.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.732 0.301 . . . . 73.13 110.901 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.1 134.86 49.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 72.41 110.831 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -122.22 134.61 54.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 73.33 110.941 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.21 164.03 33.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 40.34 112.441 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 141.26 136.54 3.3 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.788 -0.72 . . . . 61.22 112.522 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -51.79 -45.87 63.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.861 0.362 . . . . 74.44 110.889 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -132.48 -43.24 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.777 -0.725 . . . . 70.2 112.517 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -174.3 -165.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 73.53 110.837 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 15.8 t90 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.503 . . . . 74.32 110.915 -179.949 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.908 0.385 . . . . 74.23 110.852 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.07 109.95 18.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 74.23 110.808 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.31 137.77 54.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 74.32 110.892 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.71 150.05 46.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 74.21 111.026 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -113.94 -32.78 5.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 71.43 110.977 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.43 137.82 4.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 63.23 110.873 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 7.7 mt -138.15 117.38 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 65.14 111.167 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -129.52 124.45 33.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 64.34 110.849 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.32 163.58 29.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 74.3 111.157 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -148.94 167.99 24.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 75.44 110.948 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.58 -72.19 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 72.55 110.9 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.99 40.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 75.01 110.84 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -69.9 156.71 38.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.446 . . . . 73.13 111.058 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.41 135.12 52.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 74.3 110.871 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.81 133.09 61.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 70.2 111.146 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -127.95 137.03 52.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 70.43 110.883 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.85 118.28 25.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 74.1 110.905 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.62 -168.14 23.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.802 -0.713 . . . . 73.41 112.512 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -85.86 142.48 28.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.357 . . . . 74.22 110.926 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.68 120.58 57.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 62.13 111.171 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 5.5 p -122.08 120.19 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.13 111.147 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 11.0 t -74.1 165.67 24.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 71.42 111.142 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.92 76.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 50.03 111.09 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.33 74.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 73.52 111.064 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 74.32 111.075 179.963 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.868 0.366 . . . . 63.54 110.958 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 27.6 m -100.96 126.86 47.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 73.23 111.176 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 4.4 t -92.65 133.48 35.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.51 111.151 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -126.56 129.77 49.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 73.34 110.887 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 12.9 t -132.98 123.58 26.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 64.02 110.77 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 10.3 p -105.86 135.21 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 74.53 111.211 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -77.71 -77.41 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 71.24 110.863 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 18.5 m -134.7 132.26 38.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.44 111.207 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 23.9 t -118.0 120.84 65.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 72.44 111.169 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.54 120.37 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 75.32 111.117 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.63 133.2 11.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.692 -0.766 . . . . 70.14 112.475 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -116.92 116.5 27.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.809 0.338 . . . . 74.43 110.94 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.96 83.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 63.3 112.505 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 66.5 119.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.826 0.346 . . . . 75.24 110.883 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 22.9 t -156.27 146.77 21.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 74.01 110.847 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -124.24 127.03 47.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 75.03 110.803 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 87.8 t -137.6 123.15 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 75.21 111.059 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.97 122.41 40.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 75.51 110.887 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 27.4 mm -112.55 103.68 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 74.22 111.137 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 152.05 -139.96 7.42 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.758 -0.734 . . . . 74.33 112.53 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . 0.425 ' ND2' ' H ' ' C' ' 243' ' ' ASN . 9.8 m120 -128.31 145.56 51.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 75.25 110.876 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.03 135.91 53.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 72.34 110.837 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.64 125.7 48.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 75.22 110.933 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 65.57 174.14 4.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 74.11 112.497 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 137.59 -6.94 3.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 71.01 112.521 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.37 70.93 0.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.367 . . . . 74.13 110.883 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 127.27 -109.33 1.06 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 62.4 112.507 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -121.58 -75.1 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.792 0.33 . . . . 64.3 110.883 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 72.44 110.896 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 4.3 mmt85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.764 0.316 . . . . 75.3 110.878 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -140.08 119.58 13.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 74.43 110.898 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 58.8 m -129.87 141.79 50.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 73.15 110.911 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.95 146.54 49.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 64.24 111.108 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.26 -37.86 5.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 75.45 110.899 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -165.24 137.29 4.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.845 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.97 117.45 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.455 . . . . 73.04 111.189 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -130.73 126.1 35.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 75.35 110.855 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.22 164.02 28.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 75.34 111.156 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -144.61 168.6 19.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 74.33 110.828 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.54 -74.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 75.51 110.871 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.27 38.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 74.35 110.824 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -69.64 157.09 37.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.301 -0.409 . . . . 72.44 111.116 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.76 134.55 52.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 73.4 110.852 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 18.2 m -127.25 122.09 59.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 74.0 111.091 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.94 123.61 49.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 75.5 110.921 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.66 119.14 37.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 73.22 110.919 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 122.2 -168.14 14.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.773 -0.727 . . . . 72.21 112.522 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . 0.425 ' H ' ' ND2' ' B' ' 279' ' ' ASN . 2.7 t30 -86.14 149.71 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 63.34 110.94 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 78.9 t -126.35 122.19 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 72.3 111.126 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.63 129.27 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 74.43 111.099 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 12.8 p -78.68 165.07 24.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.491 . . . . 72.3 111.103 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.21 -34.0 76.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 75.53 111.071 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.81 -40.4 75.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 71.34 111.062 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 61.51 111.166 179.901 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.823 0.344 . . . . 61.11 110.908 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.26 137.55 32.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 73.52 111.148 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 96.1 m -105.41 131.38 52.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 75.52 111.178 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.05 136.99 53.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 64.33 110.831 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 46.5 t -142.11 123.8 15.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 74.42 110.911 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.0 p -106.15 138.28 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 74.43 111.139 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -78.49 -76.63 0.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 74.54 110.927 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 40.9 p -134.95 132.25 38.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.093 -0.503 . . . . 73.15 111.111 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.44 120.68 65.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 72.14 111.171 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.95 119.65 61.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 74.01 111.141 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.52 133.27 11.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.682 -0.77 . . . . 62.0 112.513 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -115.66 116.39 28.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.791 0.329 . . . . 73.43 110.919 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.49 86.52 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.731 -0.747 . . . . 52.41 112.493 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.68 118.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 74.34 110.91 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 37.4 t -157.22 149.1 22.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 70.25 110.818 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 -126.58 127.02 44.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 75.44 110.897 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 98.7 t -138.2 123.85 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 75.52 111.146 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.98 122.51 36.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 73.43 110.942 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 13.7 mm -112.4 104.18 16.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.262 -0.426 . . . . 72.02 111.077 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.02 -178.38 26.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.682 -0.77 . . . . 65.23 112.483 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -89.63 145.02 25.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.783 0.325 . . . . 73.34 110.889 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -120.43 125.79 48.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.52 110.896 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -115.55 140.13 49.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 74.3 110.939 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.55 59.12 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.71 -0.757 . . . . 54.24 112.473 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -68.29 87.29 0.19 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.75 -0.738 . . . . 61.42 112.441 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -58.66 98.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 72.14 110.967 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 62.95 104.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 64.41 112.457 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.83 -166.45 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.799 0.333 . . . . 74.52 110.872 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 74.25 110.945 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.785 0.326 . . . . 74.05 110.887 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.59 121.94 27.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 70.41 110.844 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.68 137.85 45.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 71.43 110.82 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.13 133.31 45.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.052 -0.522 . . . . 75.23 111.072 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -96.9 -30.97 12.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 75.15 110.872 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -166.35 137.08 3.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 73.13 110.865 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 10.4 mt -139.48 117.07 11.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 75.33 111.081 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.4 126.38 38.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 74.22 110.885 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 2.1 p -135.81 164.36 28.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 75.44 111.147 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -145.57 168.76 19.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 72.23 110.921 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 73.35 -75.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 71.33 110.912 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.73 47.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 74.1 110.881 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -77.32 156.82 31.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 70.52 111.105 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.05 134.46 52.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 75.3 110.883 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 6.2 m -126.87 121.45 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 72.23 111.194 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.92 127.88 55.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 72.23 110.898 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.0 117.89 31.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 73.02 110.932 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.98 -166.89 21.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 44.54 112.479 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -98.85 128.95 45.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 64.14 110.934 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 95.5 t -102.8 124.97 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.14 111.152 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.08 128.0 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 64.25 111.199 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -69.63 175.03 4.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 65.23 111.235 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.43 97.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 62.11 111.056 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.17 -40.09 76.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 63.53 111.088 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 71.13 111.142 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.853 0.359 . . . . 71.24 111.138 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 29.2 m -96.39 120.81 37.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 65.04 111.099 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.66 135.93 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 71.23 110.897 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 3.8 m -142.16 124.92 15.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 72.34 110.798 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 7.2 p -104.95 122.04 57.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 75.15 111.125 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -56.38 -82.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.924 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 10.7 m -128.4 137.45 51.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.163 -0.471 . . . . 71.51 111.157 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 64.4 t -118.21 120.68 65.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 72.45 111.154 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 15.0 t -117.45 116.89 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 73.02 111.121 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.24 133.03 11.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.716 -0.754 . . . . 42.32 112.456 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.36 119.28 35.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.828 0.347 . . . . 72.14 110.866 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.09 78.52 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 75.42 112.459 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 68.76 125.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 75.24 110.904 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 12.8 t -156.52 160.59 39.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 73.55 110.891 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.21 127.04 32.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 75.12 110.879 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 89.8 t -137.76 123.64 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 73.11 111.188 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.73 124.12 37.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 74.21 110.934 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 20.0 mm -112.27 104.88 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.44 111.101 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.21 -144.21 11.83 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.753 -0.737 . . . . 73.11 112.507 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -123.51 139.99 53.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 75.52 110.893 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -111.89 134.27 53.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 73.54 110.962 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -125.42 125.11 42.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 73.43 110.897 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.3 -150.18 16.96 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.76 -0.734 . . . . 51.45 112.479 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 59.74 18.2 44.92 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.737 -0.744 . . . . 70.32 112.52 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 7.2 mttp 52.46 29.44 7.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.901 0.381 . . . . 73.22 110.93 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.77 127.59 6.14 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.735 -0.745 . . . . 64.34 112.423 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 t80 59.09 175.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.828 0.347 . . . . 71.32 110.88 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 74.43 110.951 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 45.5 mmt-85 . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.859 0.361 . . . . 72.54 110.913 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -83.76 116.39 22.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 64.01 110.92 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.22 143.07 50.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 72.52 110.895 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.82 136.22 48.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 64.35 111.146 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . 0.405 ' HG3' ' HA ' ' E' ' 265' ' ' GLU . 37.9 mttp -88.08 -41.72 12.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 75.5 110.879 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -173.44 138.52 0.7 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 72.11 110.873 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 5.8 mt -132.61 117.8 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 55.15 111.105 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.96 124.27 39.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 75.52 110.824 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 5.0 p -135.86 164.73 27.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 65.24 111.086 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -142.13 167.97 20.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.134 -0.484 . . . . 75.34 110.874 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 72.96 -75.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.804 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -179.76 71.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.13 110.857 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.64 157.02 17.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 62.42 111.095 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.15 134.29 53.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 73.4 110.964 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 4.9 m -128.96 121.81 55.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 72.43 111.075 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.96 129.7 56.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.914 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -115.25 118.24 32.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 75.12 110.988 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.55 -149.78 18.42 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.749 -0.739 . . . . 73.02 112.478 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -106.68 130.45 54.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.869 0.366 . . . . 74.21 110.877 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 84.4 t -105.89 127.4 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.168 -0.469 . . . . 73.3 111.134 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 5.0 p -122.68 124.34 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 72.21 111.169 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 8.8 t -70.03 169.64 12.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 72.42 111.129 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.83 -33.9 51.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 61.34 111.159 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.73 -52.1 66.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 75.43 111.108 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 60.21 111.082 179.902 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.796 0.332 . . . . 75.02 111.155 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.65 123.14 49.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 74.32 110.931 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 13.6 t -132.59 136.93 46.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 75.13 110.859 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.5 136.59 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.102 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . 0.405 ' HA ' ' HG3' ' E' ' 229' ' ' LYS . 4.0 tp10 -65.49 -105.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 75.24 110.937 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 85.5 m -117.11 138.05 51.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 73.44 111.152 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 73.8 t -117.78 118.23 57.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 73.34 111.149 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.22 114.56 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 75.24 111.091 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.58 131.59 10.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.704 -0.76 . . . . 74.01 112.467 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -114.43 124.29 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 73.42 110.841 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 57.47 68.15 1.85 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 63.1 112.457 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 67.46 129.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.846 0.355 . . . . 71.44 110.849 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 10.5 t -156.92 161.22 39.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 74.41 110.877 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -129.9 127.82 40.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.23 110.846 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 90.5 t -138.88 128.83 32.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 74.24 111.163 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.71 127.68 42.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 63.44 110.933 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 43.7 mm -112.23 118.19 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 72.24 111.128 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 121.63 -157.7 16.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 52.11 112.487 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -91.76 156.02 17.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 64.03 110.865 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -134.18 135.71 43.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 74.24 110.947 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -125.64 124.62 41.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 75.01 110.97 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.782 -0.723 . . . . 65.14 112.505 -179.947 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.815 0.34 . . . . 72.05 110.893 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -127.78 122.59 33.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.52 110.906 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.54 138.58 54.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 71.44 110.836 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.32 119.92 11.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.066 -0.515 . . . . 72.32 111.1 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.83 -34.42 45.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.441 . . . . 74.51 110.879 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -165.55 138.81 4.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 72.44 110.928 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 36.5 pt -136.32 132.99 49.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 70.21 111.068 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -134.19 123.52 24.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 75.3 110.921 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -135.52 128.52 31.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 61.31 111.143 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -138.2 166.43 24.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 72.34 110.903 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 66.4 68.75 0.43 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 72.54 110.859 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 49.81 32.9 5.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 64.34 110.921 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.45 156.01 20.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 63.11 111.09 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -139.28 148.04 42.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.821 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -134.86 121.72 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 75.22 111.058 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.77 135.75 53.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.54 110.938 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 mp -130.09 118.87 22.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.914 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 140.81 177.42 16.15 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.741 . . . . 75.51 112.511 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -88.2 128.85 35.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 72.22 110.821 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.09 133.37 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 70.32 111.111 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.04 129.08 75.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 75.24 111.071 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 73.13 111.182 179.934 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 96.2 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.913 0.387 . . . . 52.3 111.139 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.3 t -132.56 132.09 42.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 71.22 111.134 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -126.1 149.17 49.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 74.45 110.903 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.3 t -142.36 123.1 14.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 64.13 110.835 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.08 124.1 70.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 73.21 111.08 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.45 -70.65 0.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 74.14 110.85 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 95.1 m -131.63 128.29 38.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 63.1 111.166 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.23 125.19 71.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 75.03 111.208 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.58 135.64 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 74.01 111.103 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.43 133.81 7.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 54.02 112.427 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.08 148.34 52.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 72.25 110.902 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.7 88.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.75 -0.738 . . . . 72.3 112.468 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 43.26 57.42 3.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.879 0.371 . . . . 73.24 110.852 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.74 145.3 28.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 62.21 110.829 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.12 127.33 47.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 75.52 110.896 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 10.0 t -120.61 123.66 70.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 74.33 111.159 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.13 111.23 14.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 75.54 110.898 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.17 104.79 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 73.22 111.134 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.42 -161.65 26.93 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 74.14 112.493 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.62 156.18 21.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.301 . . . . 75.42 110.961 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -130.37 147.32 52.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.854 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -126.73 125.83 42.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 70.53 110.912 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 144.19 147.94 4.78 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.745 -0.741 . . . . 72.15 112.477 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -121.75 25.59 6.8 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 73.52 112.502 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 43.01 1.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 74.3 110.917 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 146.88 -19.85 1.61 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.836 -0.697 . . . . 75.52 112.549 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 11.3 t80 72.26 -68.93 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 72.53 110.84 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 11.5 t90 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 72.22 110.905 -179.965 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.767 0.318 . . . . 71.31 110.791 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -142.21 128.5 19.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.879 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.95 137.62 54.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 71.14 110.843 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.35 119.99 12.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 73.45 111.091 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -34.8 52.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 75.43 110.849 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -165.67 136.56 3.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 71.14 110.868 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 27.6 pt -138.57 129.87 36.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 73.54 111.163 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.97 125.69 32.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 74.21 110.906 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 2.7 p -135.67 128.65 31.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 72.04 111.114 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -136.93 166.77 22.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 75.12 110.9 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 64.51 75.06 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 74.01 110.906 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 45.43 36.17 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.55 110.849 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.2 155.63 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 74.13 111.083 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -140.95 153.74 45.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 74.21 110.901 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 6.0 p -139.55 121.78 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 75.33 111.174 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -117.08 134.9 54.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 72.13 110.837 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mp -130.44 135.33 47.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 75.23 110.92 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.55 -124.86 3.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 73.13 112.514 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -145.49 131.38 19.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.915 0.388 . . . . 63.52 110.909 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 18.1 m -114.07 122.8 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 73.43 111.12 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 98.4 t -122.37 129.51 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 75.35 111.086 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -69.6 162.59 27.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 71.44 111.12 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.88 76.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 63.51 111.101 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.12 81.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 72.33 111.068 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 71.43 111.11 179.95 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.835 0.35 . . . . 75.23 110.925 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 58.3 m -100.61 133.51 44.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 72.35 111.135 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 87.3 m -134.27 133.19 40.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 62.41 111.12 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -126.48 134.26 50.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 73.23 110.906 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 15.1 m -128.75 123.55 33.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 74.53 110.906 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.47 141.49 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 73.32 111.155 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.75 -57.63 3.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.86 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 72.3 p -150.2 126.83 10.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 74.0 111.171 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 12.2 p -123.81 135.11 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 73.14 111.11 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 60.5 t -127.14 132.91 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 75.54 111.161 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.79 134.58 8.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.781 -0.723 . . . . 72.12 112.541 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -132.96 148.59 52.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.744 0.306 . . . . 72.55 110.925 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.58 88.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.746 . . . . 54.14 112.451 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 45.18 62.72 2.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.387 . . . . 64.24 110.867 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 17.0 t -94.67 145.52 24.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 73.34 110.817 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.12 127.48 41.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 64.31 110.925 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 6.2 t -122.67 122.75 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.15 111.141 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.35 114.26 20.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.955 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.41 104.29 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.4 111.12 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.93 -163.48 26.97 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.691 -0.766 . . . . 71.55 112.519 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -110.64 156.18 21.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 53.44 110.841 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.38 145.72 50.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 64.21 110.891 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -123.06 125.84 45.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 71.22 110.916 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.63 147.11 4.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.666 -0.778 . . . . 74.43 112.449 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.74 -22.75 7.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 62.25 112.541 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -52.07 -29.71 22.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.729 0.299 . . . . 75.44 110.862 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -161.85 112.78 0.53 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.68 -0.772 . . . . 62.43 112.456 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -51.79 -29.82 20.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.842 0.353 . . . . 75.32 110.837 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 4.5 t90 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.47 . . . . 75.11 110.935 -179.964 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 69.2 mmt-85 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.845 0.355 . . . . 72.33 110.859 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -82.74 121.03 26.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 73.34 110.949 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.4 m -121.23 144.47 48.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 75.24 110.893 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.78 153.93 46.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 73.2 111.153 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.19 -34.75 4.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 71.41 110.948 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -165.09 139.3 4.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 64.33 110.877 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -136.02 117.2 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 71.34 111.052 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.91 115.86 21.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 74.44 110.903 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.78 128.8 39.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 70.34 111.087 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -137.65 166.42 23.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 75.14 110.944 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 61.48 74.43 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 71.33 110.909 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 45.38 49.94 10.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 74.42 110.817 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.24 147.11 27.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 71.31 111.114 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -134.54 141.16 46.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 71.34 110.885 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 5.7 p -135.01 121.55 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 75.33 111.138 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -116.27 124.68 50.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 74.54 110.896 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.38 118.98 36.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.21 -0.45 . . . . 74.51 110.852 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.41 179.94 17.73 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.745 -0.741 . . . . 73.13 112.455 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -89.66 150.06 22.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 71.01 110.886 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 33.2 m -127.97 129.33 69.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 71.15 111.133 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 89.2 t -122.2 129.45 75.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 74.54 111.129 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 13.2 t -69.92 175.17 4.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 73.31 111.172 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.37 -41.38 98.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 73.34 111.077 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.9 -52.54 64.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 64.35 111.12 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 70.04 111.072 179.867 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.879 0.371 . . . . 75.33 110.922 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 7.6 p -100.98 122.4 43.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 74.21 111.16 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 88.8 m -100.55 114.78 28.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 74.13 111.151 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -126.29 144.35 50.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.933 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 47.3 t -139.03 123.02 17.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 62.33 110.818 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.11 126.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 72.34 111.097 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.83 -77.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 71.15 110.898 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 16.3 m -131.39 130.27 42.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 72.54 111.094 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.27 130.92 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 72.25 111.108 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.51 133.08 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 74.21 111.106 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -133.25 132.78 6.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.689 -0.767 . . . . 64.4 112.516 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -132.17 142.38 49.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 74.04 110.926 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.76 78.78 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.768 -0.73 . . . . 73.11 112.483 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 58.66 96.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.858 0.361 . . . . 75.32 110.883 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 14.1 m -134.42 145.39 48.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.44 110.867 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.01 128.13 35.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 75.35 110.897 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 7.2 t -125.84 123.6 64.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 65.55 111.082 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.06 117.29 25.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 72.43 110.908 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.84 131.01 65.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 74.23 111.158 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 123.44 -152.02 17.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.798 -0.715 . . . . 72.21 112.445 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -124.58 156.37 37.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.795 0.331 . . . . 73.31 110.877 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -121.03 139.04 53.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 72.14 110.852 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -123.41 126.43 46.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 73.14 110.934 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.84 -34.28 2.23 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 74.33 112.488 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 52.32 47.76 55.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.756 -0.735 . . . . 71.53 112.45 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 57.89 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 74.33 110.864 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.81 -79.21 0.8 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.719 -0.753 . . . . 75.54 112.454 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -179.4 108.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.805 0.336 . . . . 75.42 110.859 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 74.33 110.976 -179.975 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.856 0.36 . . . . 71.21 110.867 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -142.13 128.46 19.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 73.52 110.884 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 3.8 m -121.68 139.61 53.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 74.01 110.822 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.63 129.84 37.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 71.34 111.084 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -97.5 -33.63 11.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 75.32 110.897 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.01 138.16 4.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 72.45 110.881 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.33 128.72 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 75.22 111.155 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -134.26 115.89 14.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.472 . . . . 71.44 110.908 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 3.5 p -129.82 149.59 51.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 73.13 111.147 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -156.98 166.71 32.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 72.13 110.883 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 63.26 67.56 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 71.14 110.87 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 36.6 mtt85 49.45 31.76 4.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 74.31 110.932 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.55 145.77 29.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 63.43 111.071 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -129.76 135.77 48.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 73.1 110.852 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 6.3 p -130.84 121.7 50.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 74.2 111.075 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -109.12 137.25 47.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.472 . . . . 74.51 110.928 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.72 118.61 28.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.12 110.913 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.41 177.85 15.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.769 -0.729 . . . . 70.1 112.509 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.82 149.36 23.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 64.43 110.927 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.94 132.49 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 72.43 111.14 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.83 129.41 75.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 74.42 111.075 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.3 t -70.09 174.89 4.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 70.45 111.105 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.5 83.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 72.42 111.074 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.93 -52.05 66.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 75.35 111.046 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 73.02 111.18 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.889 0.376 . . . . 73.43 111.18 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.56 116.65 29.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 71.24 111.121 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.89 137.09 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 72.5 110.821 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.06 123.41 18.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 65.4 110.821 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.89 138.5 43.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 75.44 111.109 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.48 -52.47 7.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 74.1 110.916 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.96 129.35 12.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 74.33 111.099 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 1.2 t -118.35 130.62 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 74.22 111.183 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.49 127.75 69.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 63.53 111.146 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -131.06 133.94 7.5 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.763 -0.732 . . . . 65.25 112.473 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.1 148.89 52.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 72.41 110.916 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.34 89.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 71.43 112.468 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 43.75 59.69 2.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.887 0.375 . . . . 54.13 110.849 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 11.0 t -85.85 145.5 27.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 71.13 110.846 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.48 127.75 35.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 75.1 110.887 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.87 123.18 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 75.42 111.096 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.21 111.74 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 74.44 110.926 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 1.1 mt -107.88 110.96 33.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 75.42 111.136 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.08 174.7 13.47 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.777 -0.725 . . . . 71.05 112.49 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -89.87 144.91 25.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.358 . . . . 74.31 110.887 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -113.87 131.73 56.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 74.43 110.874 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -116.83 125.85 52.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 75.43 110.933 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 127.14 150.32 7.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.767 -0.73 . . . . 72.13 112.453 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 58.33 173.56 0.42 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.769 -0.729 . . . . 73.04 112.456 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.04 31.66 5.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.349 . . . . 73.22 110.885 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -112.54 -119.46 3.68 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.805 -0.712 . . . . 72.14 112.5 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -163.4 119.51 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 75.1 110.893 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.137 -0.483 . . . . 74.1 110.938 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.797 0.332 . . . . 75.12 110.918 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -83.52 123.97 30.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 73.34 110.833 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.58 144.52 48.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 70.23 110.872 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.12 118.9 12.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 75.22 111.078 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' E' ' 265' ' ' GLU . 0.1 OUTLIER -79.09 -42.02 27.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 71.23 110.905 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -168.18 138.19 2.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 62.2 110.883 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 10.8 mt -129.11 117.07 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 72.25 111.089 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -119.12 115.1 23.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 75.24 110.858 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.61 128.27 32.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 72.44 111.192 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.35 162.26 33.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.878 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.54 76.55 0.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 62.41 110.885 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 43.66 42.09 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.877 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.98 142.61 27.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 74.52 111.171 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -125.42 137.67 54.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 74.34 110.902 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.5 121.92 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 75.43 111.1 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -112.88 137.48 51.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.92 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -120.34 118.27 29.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 71.34 110.912 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 123.5 169.14 13.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.727 -0.749 . . . . 71.51 112.472 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.65 146.0 27.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.929 0.395 . . . . 75.24 110.849 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 24.3 m -111.83 139.72 34.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 74.21 111.153 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 45.3 t -120.98 129.58 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 73.34 111.115 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.2 t -69.04 175.07 3.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.114 -0.494 . . . . 73.42 111.172 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.1 -44.83 79.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 63.43 111.163 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.06 -52.17 66.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 73.13 111.068 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 74.13 111.118 179.942 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 99.1 m . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.789 0.328 . . . . 74.11 111.173 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -124.63 119.6 29.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 71.41 110.956 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.76 120.1 30.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 74.42 110.852 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.4 p -111.52 137.4 44.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 72.42 111.09 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 3.4 tt0 -71.06 -95.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 73.43 110.852 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 93.8 m -119.8 126.2 50.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 72.5 111.167 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 3.5 p -116.07 120.1 63.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 74.24 111.136 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 39.9 t -117.94 119.21 60.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 71.41 111.089 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.51 133.52 9.55 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 74.44 112.502 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.57 147.91 45.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 72.2 110.897 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.6 89.63 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 64.11 112.489 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 41.59 77.58 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 63.41 110.886 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 6.2 t -105.48 145.18 31.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 74.23 110.838 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.06 128.23 49.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 73.42 110.935 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 85.1 t -132.98 123.96 49.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.44 111.129 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.51 125.82 41.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 73.14 110.942 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 20.9 mm -112.18 124.85 69.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 75.33 111.138 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 113.82 -170.97 13.55 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.682 -0.771 . . . . 50.04 112.458 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -102.68 155.98 17.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 75.42 110.914 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -121.81 132.67 54.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 74.33 110.856 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -115.35 125.16 52.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 73.14 110.868 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.718 -0.753 . . . . 73.1 112.455 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.837 0.351 . . . . 72.54 110.863 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -83.95 111.64 19.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 75.31 110.872 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.77 150.72 41.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 51.01 110.826 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -144.0 119.1 10.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 72.23 111.122 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -76.05 -48.53 20.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 73.41 110.887 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -164.92 135.8 4.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 72.33 110.908 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 8.8 pt -139.3 134.36 40.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 72.44 111.154 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -130.93 138.54 49.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 75.34 110.853 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.07 147.14 47.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 71.13 111.133 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -134.04 167.02 21.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 71.41 110.869 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.43 -70.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 74.52 110.927 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.38 66.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 75.15 110.879 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -102.7 157.5 16.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 72.11 111.145 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.25 139.02 50.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 64.51 110.856 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.2 p -122.28 121.65 64.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 74.25 111.09 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.04 116.01 29.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 74.44 110.919 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.1 mp -111.99 118.61 35.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 63.54 110.903 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.32 160.79 8.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 60.51 112.476 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -85.77 134.75 33.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 62.24 110.835 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 17.8 m -106.69 133.63 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.476 . . . . 61.33 111.125 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 39.1 t -122.74 113.06 36.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 72.41 111.038 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 70.44 111.177 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.858 0.361 . . . . 75.01 111.15 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.19 108.97 13.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 62.13 111.157 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -92.65 127.61 38.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 74.53 110.84 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.2 t -142.18 123.32 14.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 75.51 110.896 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 4.8 p -105.93 137.33 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.5 . . . . 52.21 111.175 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -88.74 -66.57 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 75.34 110.865 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 26.3 m -125.45 126.6 45.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 75.14 111.069 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.69 131.3 70.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 72.23 111.139 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 30.2 t -127.15 115.31 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.134 -0.484 . . . . 65.31 111.167 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.76 132.82 11.25 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 75.32 112.465 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 134.41 45.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 75.42 110.921 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.44 85.36 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.76 -0.733 . . . . 75.11 112.523 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 47.74 79.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.892 0.377 . . . . 64.32 110.958 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.47 145.05 30.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 75.33 110.887 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -113.4 128.44 56.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.877 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.18 123.67 53.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 74.34 111.11 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 25.5 tp -128.15 111.54 13.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.942 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 73.6 mt -109.23 103.92 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 63.02 111.123 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.53 -159.02 28.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.796 -0.716 . . . . 63.31 112.498 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -128.21 156.28 43.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 72.43 110.894 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -115.26 134.71 54.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 70.01 110.883 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -118.81 126.84 52.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 74.43 110.91 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.82 159.3 26.62 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.799 -0.715 . . . . 63.53 112.516 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -68.07 -130.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.811 -0.709 . . . . 72.24 112.475 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.62 28.19 16.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.77 0.319 . . . . 75.33 110.904 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 92.5 152.38 28.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.783 -0.723 . . . . 73.04 112.504 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -67.47 -35.05 78.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 73.02 110.899 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 15.6 t90 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 75.22 110.96 179.98 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.845 0.355 . . . . 74.52 110.804 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -109.24 119.25 38.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 73.24 110.962 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.63 148.87 51.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.866 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -139.26 119.92 14.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 62.54 111.16 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.07 -44.58 30.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.812 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -165.75 134.89 3.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 64.24 110.799 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 7.6 pt -140.17 133.67 34.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 75.22 111.153 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.92 136.72 42.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 75.12 110.819 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.29 147.97 47.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 72.43 111.098 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -136.1 167.9 20.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 72.51 110.904 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.83 -71.47 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 71.14 110.861 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -179.3 62.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 75.34 110.937 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -102.3 157.19 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 71.33 111.115 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -129.85 135.26 48.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.829 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 6.4 p -122.93 129.57 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 75.02 111.151 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? -120.11 124.73 46.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 71.4 110.901 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 4.5 mt -111.74 118.88 36.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 74.32 110.929 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.88 176.44 14.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.704 -0.76 . . . . 51.2 112.46 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -85.92 134.06 33.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.373 . . . . 64.42 110.876 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 1.7 t -104.69 115.25 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 74.34 111.111 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 44.7 t -106.91 122.76 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 63.15 111.13 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -96.14 163.26 13.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 72.4 111.19 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.73 -33.88 70.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 75.1 111.107 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -35.99 69.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 62.41 111.088 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 64.31 111.134 179.98 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.881 0.372 . . . . 74.21 110.882 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.85 137.57 32.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 72.02 111.161 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 96.4 m -131.82 122.33 25.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.286 -0.415 . . . . 74.24 111.162 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.79 124.98 50.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 74.3 110.947 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.2 t -141.95 123.68 15.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 75.13 110.841 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 4.4 p -106.41 137.72 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.477 . . . . 75.24 111.207 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -85.52 -72.67 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.882 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 19.0 p -122.24 126.48 48.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 72.51 111.111 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.28 127.77 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 71.35 111.157 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 58.5 t -127.17 115.23 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 72.52 111.113 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.3 133.19 11.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.74 . . . . 61.22 112.478 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -130.54 139.54 50.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.831 0.348 . . . . 75.13 110.892 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.67 85.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 64.44 112.482 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 45.76 74.34 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 71.44 110.908 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.69 145.68 26.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 72.32 110.872 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 11.0 mtm-85 -113.68 128.17 56.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 75.31 110.912 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 36.1 t -130.17 123.31 55.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 71.51 111.085 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 14.5 tp -128.12 111.32 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 74.51 110.914 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 4.5 mp -107.91 104.55 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 71.24 111.074 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.76 -173.55 27.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.694 -0.765 . . . . 74.22 112.445 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -110.33 154.52 23.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.732 0.301 . . . . 74.12 110.96 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -111.94 137.22 50.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 74.23 110.881 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.95 129.96 54.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 75.54 110.947 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 107.95 148.13 13.7 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.835 -0.698 . . . . 75.42 112.496 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -68.53 -132.4 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.743 -0.741 . . . . 75.42 112.5 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.7 tptp 62.11 35.54 15.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 75.41 110.865 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 74.89 141.71 0.79 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 75.14 112.464 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -75.44 111.26 10.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.85 0.357 . . . . 71.23 110.924 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 7.0 t90 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 73.31 110.877 -179.995 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.795 0.331 . . . . 73.25 110.822 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -83.89 110.83 18.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 74.11 110.885 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.99 148.13 52.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 72.31 110.892 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -135.21 124.48 24.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 64.22 111.089 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -42.61 16.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.443 . . . . 75.11 110.892 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -166.32 133.89 2.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 73.14 110.839 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 6.4 pt -140.65 132.07 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 72.3 111.216 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -136.1 135.64 39.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 72.24 110.888 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.67 150.82 48.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 71.24 111.146 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -139.9 168.7 19.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.33 110.931 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.68 -70.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.905 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -179.32 57.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 65.35 110.9 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -98.46 156.97 16.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 74.24 111.068 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -130.18 135.69 48.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.12 110.86 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.64 128.51 75.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 74.3 111.079 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -121.14 125.55 47.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 72.42 110.926 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.59 118.76 36.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 74.34 110.897 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.07 175.38 13.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.633 -0.794 . . . . 73.22 112.448 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -90.45 153.82 20.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.34 . . . . 63.42 110.948 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 20.1 t -119.83 116.83 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 75.31 111.155 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 48.7 t -108.96 115.33 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 75.23 111.109 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 12.1 t -69.86 175.11 4.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 75.43 111.145 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.31 -45.16 76.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 62.45 111.09 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.34 80.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 72.34 111.121 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 74.44 111.148 179.952 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.948 0.404 . . . . 74.22 110.911 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 5.1 m -65.56 125.03 23.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 62.41 111.117 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 29.0 m -96.15 108.81 21.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 73.33 111.071 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.8 124.23 38.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.478 . . . . 73.33 110.844 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.06 123.21 14.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 73.54 110.828 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 4.1 p -107.38 139.21 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.081 -0.509 . . . . 73.21 111.15 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -89.56 -65.21 1.04 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 72.03 110.913 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 1.7 p -129.8 126.93 39.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.479 . . . . 74.23 111.132 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.04 126.57 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 64.5 111.155 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 83.4 t -123.07 115.31 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 63.12 111.166 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.37 131.96 10.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.701 -0.761 . . . . 62.15 112.58 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.24 136.29 45.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.786 0.327 . . . . 73.42 110.944 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.56 83.51 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.749 -0.738 . . . . 64.32 112.452 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 46.59 69.99 0.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 74.14 110.929 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.24 145.38 24.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 71.51 110.894 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -113.31 128.4 56.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 73.54 110.84 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 77.1 t -129.14 121.98 55.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 73.24 111.129 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 2.2 tp -128.86 111.17 12.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 73.42 110.906 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 2.7 mp -112.59 104.3 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 61.12 111.096 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.35 -179.46 27.07 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.653 -0.784 . . . . 74.32 112.451 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.34 156.08 18.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.316 . . . . 64.2 110.873 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.84 119.14 27.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 74.21 110.852 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -112.55 125.46 54.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 71.13 110.905 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.15 158.62 7.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 74.3 112.454 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -103.95 -161.85 24.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 71.05 112.503 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt 53.33 34.39 17.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 74.21 110.93 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 131.63 135.4 3.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.649 -0.786 . . . . 54.52 112.463 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -83.7 -26.18 30.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.348 . . . . 70.14 110.91 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 17.0 t90 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 73.13 110.919 -179.971 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.841 0.353 . . . . 75.21 110.864 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -99.88 117.75 34.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 75.53 110.84 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.72 151.97 49.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 72.33 110.837 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -142.36 129.85 21.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 74.13 111.087 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.47 -42.22 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 75.23 110.92 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -166.73 134.92 2.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.11 110.814 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 7.2 pt -141.02 133.01 29.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 73.11 111.117 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -135.7 136.45 40.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 72.22 110.894 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.86 146.35 45.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 72.05 111.099 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -135.19 168.79 18.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 73.4 110.89 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.12 -72.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 64.31 110.859 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.91 59.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 74.31 110.837 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.89 157.17 16.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 55.34 111.06 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.61 135.72 46.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 74.5 110.85 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 5.7 p -122.21 121.93 65.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 74.23 111.179 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -118.17 120.92 39.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.899 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.59 118.8 36.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.947 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.92 165.74 10.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.726 -0.749 . . . . 72.25 112.516 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -85.77 131.0 34.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 63.53 110.908 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 26.5 t -99.09 130.01 48.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 71.22 111.164 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.09 122.48 66.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 74.15 111.137 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.0 t -69.71 165.9 20.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.21 111.119 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.86 -36.38 62.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 73.42 111.16 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.96 -51.94 67.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 72.43 111.113 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 71.24 111.114 179.932 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.912 0.387 . . . . 74.3 111.128 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 94.3 m -108.47 129.17 55.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.218 -0.446 . . . . 71.24 111.208 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.11 127.28 53.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.43 110.873 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 25.7 p -142.53 123.66 14.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 64.21 110.833 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 5.2 p -106.48 134.27 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 73.44 111.131 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -82.22 -77.14 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 72.45 110.849 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.61 126.88 53.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 75.23 111.19 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 94.9 t -117.62 124.76 73.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 73.42 111.168 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.5 114.22 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 72.44 111.163 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.71 133.04 10.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.749 . . . . 75.0 112.456 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.04 143.05 49.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 74.45 110.874 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.96 84.82 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 73.22 112.458 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 45.75 69.65 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.36 . . . . 72.31 110.932 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.4 144.53 25.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 73.4 110.873 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.01 128.42 56.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 72.33 110.866 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 76.6 t -127.41 122.17 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 75.23 111.132 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 2.5 tp -128.56 111.46 13.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 71.22 110.89 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 5.8 mt -112.42 104.13 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 75.31 111.098 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.78 -165.51 28.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.763 -0.732 . . . . 71.11 112.485 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -110.05 155.98 21.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.806 0.336 . . . . 72.42 110.899 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.02 131.5 53.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 73.02 110.842 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -124.84 125.73 44.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.129 -0.487 . . . . 74.21 110.929 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 145.27 179.46 21.58 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 51.1 112.487 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -100.62 -149.05 23.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 73.23 112.49 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.51 26.12 13.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 75.21 110.906 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.46 -156.99 15.23 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.721 -0.752 . . . . 52.5 112.503 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -116.54 -28.07 6.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.873 0.368 . . . . 73.03 110.892 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 14.8 t90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 65.41 110.928 -179.973 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.815 0.341 . . . . 74.44 110.886 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -86.55 113.26 22.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 73.41 110.879 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.87 139.35 53.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 65.44 110.831 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.21 118.71 27.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 74.23 111.055 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -75.63 -45.62 36.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 71.21 110.911 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -168.35 135.97 2.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 65.14 110.841 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 8.9 pt -138.16 134.42 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 74.54 111.113 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -135.86 132.7 36.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.908 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.94 151.51 49.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.21 111.12 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.25 167.56 22.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 75.33 110.904 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 72.78 -69.95 0.18 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 73.41 110.9 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -178.5 63.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 72.41 110.869 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.86 156.3 18.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 63.33 111.074 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.15 135.61 47.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 72.41 110.889 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.0 126.47 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 75.11 111.195 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -122.71 123.05 40.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 73.32 110.834 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.85 118.7 36.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 74.42 110.914 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 134.56 169.32 11.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 73.3 112.52 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -85.87 145.41 27.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.849 0.357 . . . . 73.22 110.903 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.99 135.33 50.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.12 111.118 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 23.4 t -122.12 128.54 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 74.34 111.136 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -69.95 174.96 4.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 74.33 111.141 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.32 94.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 73.45 111.138 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.12 76.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 74.54 111.132 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 65.11 111.134 179.897 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 92.4 m . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.848 0.356 . . . . 64.15 111.09 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.24 119.01 33.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 74.51 110.877 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 98.7 p -133.19 133.24 42.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 74.45 110.871 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 1.2 p -104.46 153.44 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 74.5 111.112 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -92.22 -51.0 5.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.42 110.902 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 1.4 m -154.43 145.16 22.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 75.34 111.122 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 86.6 t -136.17 120.54 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 75.53 111.172 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 5.3 p -127.3 115.55 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 75.44 111.11 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.65 133.62 10.82 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.733 . . . . 72.41 112.456 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.57 144.5 44.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 74.13 110.913 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 42.27 76.14 0.12 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.722 -0.752 . . . . 54.04 112.522 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 64.04 116.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 64.03 110.877 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 12.1 m -146.41 145.25 30.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 74.43 110.802 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -114.62 127.69 55.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 74.42 110.86 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 24.2 t -127.1 121.9 58.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 73.25 111.09 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.24 112.53 13.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.204 -0.453 . . . . 74.01 110.934 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 55.9 mt -112.26 104.56 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 74.12 111.141 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.46 -154.1 25.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.678 -0.772 . . . . 32.43 112.472 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -122.61 156.1 34.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 65.35 110.88 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -116.4 128.97 55.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 72.24 110.896 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -121.85 126.01 47.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 74.43 110.905 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.705 -0.759 . . . . 72.22 112.448 179.966 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 9.3 ptt? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.848 0.356 . . . . 75.03 110.85 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 16.6 mttt 62.04 98.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 75.32 110.901 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.5 mm -123.65 130.54 74.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.434 . . . . 63.01 111.168 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -166.99 157.44 11.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 75.35 110.892 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.44 122.34 20.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 73.54 111.111 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 3.9 mp 57.14 67.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 73.22 111.117 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 93.5 t -149.88 125.37 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 70.52 111.127 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -53.15 147.46 16.52 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 42.54 112.491 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -166.44 99.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.354 . . . . 73.13 110.899 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -83.94 114.16 21.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 62.22 110.858 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 2.6 m -133.97 144.42 48.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 64.34 110.853 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.05 127.27 41.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 74.55 111.076 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -42.96 37.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 73.43 110.952 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -164.99 138.34 4.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 75.31 110.906 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 3.1 mp -138.43 117.14 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 75.35 111.113 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -113.59 123.31 49.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 75.33 110.874 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.8 p -135.4 141.74 45.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 74.13 111.175 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.6 pm0 -149.2 167.69 25.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.4 110.886 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 68.56 68.85 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 75.21 110.89 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 47.43 55.68 7.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 65.24 110.844 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.4 156.78 17.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 60.31 111.064 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -125.79 142.77 51.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 73.15 110.896 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 5.4 p -142.99 131.28 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 74.04 111.127 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -138.02 137.26 37.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 73.13 110.89 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.69 118.23 33.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.454 . . . . 75.13 110.876 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 146.67 -176.74 25.41 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.701 -0.761 . . . . 74.42 112.481 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -85.92 140.38 30.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.903 0.382 . . . . 64.0 110.882 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 30.1 t -111.82 115.33 49.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 75.33 111.146 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 64.7 t -103.96 128.84 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.41 111.136 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.6 m -98.0 162.97 12.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 74.32 111.121 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.88 98.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 73.32 111.077 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.21 74.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 75.35 111.075 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -87.54 51.1 2.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 62.31 111.124 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.25 -177.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 71.34 110.921 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.65 -170.09 2.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 73.23 110.859 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -68.79 86.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 74.2 112.468 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -88.82 -40.0 6.4 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.75 -0.738 . . . . 61.23 112.446 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 24.7 mt 65.33 151.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.799 0.333 . . . . 74.31 111.178 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.35 101.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 75.51 110.904 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 5.3 mp -130.75 -40.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 64.24 111.168 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.24 -73.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 75.53 110.879 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 57.61 93.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 72.23 110.885 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -130.86 -40.41 1.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 72.34 110.938 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 15.4 t -82.16 135.25 35.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 72.31 111.115 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 84.7 m -92.03 120.36 32.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 71.04 111.157 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -101.75 119.52 38.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 74.34 110.931 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 17.6 t -142.06 123.98 15.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.43 110.806 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.9 p -110.75 137.77 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 73.34 111.107 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.44 -76.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 73.04 110.857 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 17.5 p -129.41 129.5 44.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 72.45 111.136 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 19.3 t -118.39 120.75 65.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 74.13 111.11 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 26.0 t -111.32 126.49 68.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 63.02 111.1 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.75 132.94 8.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.743 -0.741 . . . . 71.54 112.466 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.73 147.41 52.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.832 0.348 . . . . 73.25 110.87 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 59.66 71.76 0.72 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.713 -0.756 . . . . 75.24 112.451 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 50.06 61.05 3.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.886 0.374 . . . . 72.31 110.868 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 15.9 t -85.99 147.99 25.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 73.15 110.841 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -110.57 128.67 55.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 75.35 110.854 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 92.2 t -115.59 123.03 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 60.34 111.125 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.53 111.74 13.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 71.44 110.888 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 18.1 mm -106.35 104.35 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 63.13 111.115 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.3 179.76 17.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.731 . . . . 75.32 112.48 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -89.84 156.04 18.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 73.41 110.879 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -130.31 140.29 50.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 71.12 110.868 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -119.24 126.01 50.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 73.42 110.9 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 161.08 142.55 3.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.731 . . . . 75.51 112.494 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.27 -18.83 10.62 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.733 -0.746 . . . . 64.34 112.491 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.4 79.33 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 74.13 110.888 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 67.22 112.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.768 -0.73 . . . . 64.52 112.483 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -52.32 111.52 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 74.24 110.877 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 3.1 t90 72.16 -69.19 0.19 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.486 . . . . 74.31 110.931 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -172.95 83.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.288 -0.414 . . . . 74.24 110.895 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.84 163.1 17.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 72.13 110.893 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -167.08 30.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 75.52 110.834 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -58.57 176.3 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 72.45 110.848 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -163.82 -41.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 75.55 110.898 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -52.41 141.79 18.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 74.13 110.868 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -121.34 130.88 53.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 72.12 110.847 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 5.0 p80 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 62.53 110.849 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.839 0.352 . . . . 75.43 110.86 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.78 -58.41 1.9 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 74.23 110.892 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 13.1 tt -150.72 148.78 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 72.3 111.124 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -133.18 -175.75 3.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 71.24 110.876 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.13 130.63 46.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 70.43 111.111 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 2.2 pp -139.09 148.65 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 75.33 111.13 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 36.0 m -123.58 132.97 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 70.53 111.098 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 67.44 119.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.786 -0.721 . . . . 64.24 112.477 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -158.7 110.39 2.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.341 . . . . 74.34 110.919 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -105.09 114.23 28.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 72.21 110.927 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.68 143.68 48.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 73.04 110.86 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.09 136.73 53.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 71.24 111.116 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.13 -36.28 16.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 65.13 110.927 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -165.12 137.74 4.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 75.52 110.848 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 7.7 mt -138.43 117.88 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 62.45 111.134 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -111.53 125.14 53.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 72.11 110.891 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 4.8 p -135.26 134.83 40.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.476 . . . . 72.05 111.148 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -150.94 167.4 27.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 75.14 110.92 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 66.98 64.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.864 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 77.9 mtm-85 50.46 55.34 9.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 71.33 110.869 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.04 156.57 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 74.04 111.126 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.27 140.79 52.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.87 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 3.0 p -132.62 130.43 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 75.12 111.139 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -136.6 130.85 32.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 74.3 110.956 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.54 117.9 30.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 72.44 110.973 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.56 175.85 23.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 42.24 112.508 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.88 128.87 34.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.836 0.35 . . . . 73.12 110.925 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -97.15 126.17 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 71.45 111.154 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 93.4 t -122.11 112.89 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 61.04 111.111 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 78.1 p -76.84 170.28 16.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 74.42 111.115 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.75 81.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 75.41 111.13 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.67 77.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 62.44 111.131 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.96 -30.22 23.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 72.34 111.101 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.0 133.02 51.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 74.44 110.933 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 59.2 t60 61.19 86.37 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 73.12 110.854 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 177.12 -117.86 0.61 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 73.23 112.537 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -154.77 126.27 1.85 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.785 -0.722 . . . . 73.24 112.491 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.95 -60.17 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 74.45 111.108 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -56.23 102.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 75.12 110.884 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.84 39.22 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 72.24 111.15 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 23.3 t 58.95 66.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 73.32 110.841 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.92 152.83 34.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 74.55 110.854 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -170.82 48.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 73.15 110.908 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 15.1 t -100.77 137.27 39.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 71.13 111.119 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 23.7 m -98.45 110.76 23.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 71.11 111.172 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -93.21 119.56 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 71.23 110.886 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 24.8 p -142.17 123.68 14.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 71.3 110.857 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.35 137.45 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 61.45 111.128 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.05 -76.78 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 74.02 110.849 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -133.71 130.69 38.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 74.04 111.127 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.52 120.53 64.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 73.3 111.148 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 30.4 t -105.04 121.41 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 71.05 111.11 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.47 132.94 10.61 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 64.34 112.449 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.95 147.3 52.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.351 . . . . 75.25 110.895 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.02 78.66 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 73.51 112.461 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 49.68 73.48 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.845 0.355 . . . . 73.35 110.907 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 14.8 t -96.66 147.84 23.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 74.34 110.881 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 24.2 mtm-85 -113.8 128.27 56.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 65.14 110.893 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 84.6 t -115.75 122.96 70.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 74.4 111.171 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.59 112.61 13.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 74.23 110.917 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 27.1 mm -109.44 103.98 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 70.24 111.145 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.16 -178.39 19.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 71.14 112.479 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -89.85 156.09 18.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.78 0.324 . . . . 71.2 110.858 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -126.8 139.1 53.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.22 110.862 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -120.9 125.87 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 74.24 110.913 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 161.76 149.91 5.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.734 -0.746 . . . . 61.04 112.517 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -105.25 -29.84 4.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 75.12 112.505 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -69.68 86.22 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 75.54 110.902 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 69.65 133.13 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.764 -0.731 . . . . 64.14 112.494 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -77.37 89.54 3.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.379 . . . . 72.24 110.858 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 4.9 t90 71.51 -69.66 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 75.44 110.956 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.81 -175.49 2.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 75.53 110.834 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -88.43 153.61 21.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 75.33 110.888 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -173.65 125.48 0.38 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.859 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.74 158.3 37.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 65.14 110.869 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.16 176.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 73.01 110.851 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.62 154.87 20.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 73.44 110.855 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -119.94 -176.14 3.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 74.5 110.877 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 74.41 110.892 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.824 0.345 . . . . 72.12 110.923 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 4.1 tptt 59.37 34.45 22.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 72.42 110.886 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 20.6 tt -152.86 144.34 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 75.13 111.096 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -103.79 -30.65 10.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 72.23 110.894 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.43 151.18 7.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 60.0 111.096 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 20.2 pt -136.04 28.1 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 73.24 111.109 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 7.7 p -158.85 125.0 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 61.33 111.131 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.43 102.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.694 -0.765 . . . . 72.42 112.474 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -178.56 123.62 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.351 . . . . 74.33 110.88 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.85 116.78 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 75.12 110.872 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.93 146.36 51.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 43.54 110.866 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.22 134.87 48.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 74.01 111.093 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.73 -34.66 21.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 74.53 110.887 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -165.52 137.57 4.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 64.02 110.885 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 8.7 mt -138.36 121.19 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 71.44 111.14 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 21.9 ttm-85 -111.57 125.5 54.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 75.1 110.814 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 3.8 p -135.1 131.74 37.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 74.34 111.157 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -147.82 167.77 23.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 74.23 110.836 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 63.36 72.71 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 75.43 110.898 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? 47.29 40.32 10.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 75.44 110.882 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.28 156.1 18.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 70.1 111.091 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -134.57 144.09 47.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 73.11 110.87 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 3.5 p -130.66 121.88 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 74.52 111.15 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -124.81 126.68 45.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 74.31 110.938 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.35 117.43 29.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 74.53 110.911 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 153.35 176.23 25.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.771 -0.728 . . . . 74.45 112.519 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -85.89 128.75 34.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 70.2 110.911 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.91 128.18 46.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 75.22 111.088 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.44 113.43 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 75.21 111.129 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 23.3 p -69.67 169.03 13.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 75.31 111.115 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.17 93.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 72.24 111.043 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.06 82.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 63.34 111.075 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.82 107.16 0.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 63.12 111.08 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 8.3 mt -138.29 -50.26 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.33 110.905 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.14 129.07 33.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 74.13 110.894 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 149.74 93.9 0.11 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.734 . . . . 74.23 112.497 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -67.67 -144.59 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 71.21 112.499 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 13.6 tt -122.34 133.5 68.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.795 0.331 . . . . 72.41 111.164 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.55 -178.35 4.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 74.23 110.871 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 1.2 tt -152.59 132.66 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 74.53 111.18 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.49 -175.01 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 75.11 110.883 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -59.13 178.99 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.151 -0.477 . . . . 74.23 110.88 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -176.45 160.89 2.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 70.24 110.922 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 8.6 t -70.87 131.45 43.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 71.24 111.15 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.41 139.66 36.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 74.41 111.166 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -124.5 128.65 49.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 73.12 110.836 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 5.5 p -141.56 123.77 15.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 75.24 110.887 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.27 137.65 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 74.25 111.132 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.58 -76.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.167 -0.469 . . . . 73.45 110.908 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.72 130.53 43.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 70.45 111.144 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 19.5 t -118.64 129.6 74.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 75.15 111.146 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.68 119.06 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 65.44 111.149 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.39 132.47 10.34 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.767 -0.73 . . . . 74.1 112.488 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -134.05 147.58 50.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.361 . . . . 71.54 110.871 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.39 87.2 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.717 -0.754 . . . . 54.21 112.482 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 45.66 64.4 1.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 74.51 110.915 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 4.1 t -88.27 145.78 25.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 63.22 110.871 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 4.0 mtm-85 -117.45 127.8 54.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.505 . . . . 75.33 110.851 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 83.9 t -116.13 123.5 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.42 111.108 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.5 113.65 15.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.861 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 24.7 mm -112.14 104.41 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 73.04 111.132 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.36 -175.08 22.19 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.753 . . . . 72.53 112.512 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.47 156.22 16.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.846 0.355 . . . . 72.14 110.861 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -126.8 138.04 53.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 72.24 110.887 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -120.63 125.11 46.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.472 . . . . 75.12 110.923 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 164.84 147.7 5.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.752 -0.737 . . . . 73.23 112.503 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -80.77 -48.99 5.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.749 -0.739 . . . . 73.41 112.509 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -51.67 103.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.357 . . . . 65.44 110.868 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 53.69 -147.36 19.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 53.43 112.473 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -122.35 -35.31 3.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 74.33 110.859 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -163.78 -47.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 72.51 110.891 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.88 116.02 18.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 64.4 110.882 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -69.29 88.14 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 72.21 110.882 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -125.96 -66.96 0.9 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 65.44 110.845 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.46 177.6 4.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 74.45 110.878 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 62.79 163.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 74.42 110.823 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -168.59 -171.9 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 71.43 110.85 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -70.69 170.29 12.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 71.42 110.867 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 74.13 110.866 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.826 0.346 . . . . 73.13 110.853 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.77 120.69 23.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 74.24 110.88 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 3.1 pt -118.1 41.82 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 65.23 111.137 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -128.12 105.47 8.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 71.11 110.833 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -166.35 176.39 7.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 72.44 111.069 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 23.4 pt -72.47 172.5 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 72.33 111.155 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 61.3 t -85.27 -59.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.474 . . . . 75.44 111.142 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 132.27 -168.75 22.47 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.701 -0.761 . . . . 74.14 112.477 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.84 -74.56 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.808 0.337 . . . . 74.25 110.856 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -84.31 114.52 21.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 72.25 110.911 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 3.8 t -134.5 142.71 47.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.41 110.809 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.29 119.99 24.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.505 . . . . 53.41 111.1 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -34.42 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 73.35 110.892 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -166.12 137.51 3.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 63.33 110.865 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 6.3 mt -138.58 121.69 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 71.43 111.151 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -111.45 126.15 54.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 75.42 110.843 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 5.8 p -135.16 130.57 35.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 61.24 111.141 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -146.44 166.84 25.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 73.32 110.9 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 64.99 71.05 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 74.23 110.925 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.33 34.88 4.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 75.34 110.893 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.89 154.21 23.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 71.44 111.13 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.49 144.43 51.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 74.41 110.899 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 6.0 p -131.51 121.91 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 74.21 111.11 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -125.58 125.78 43.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 74.11 110.915 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.51 118.01 31.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 74.02 110.872 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.01 179.48 26.78 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.752 . . . . 33.23 112.454 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -86.02 133.54 33.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.902 0.382 . . . . 74.34 110.88 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 19.9 t -103.67 114.95 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 72.11 111.137 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 21.8 t -110.76 120.7 62.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 73.33 111.168 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 9.6 p -76.56 167.17 22.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.14 111.125 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.26 79.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 72.43 111.109 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.38 -38.25 73.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 63.43 111.046 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.64 103.88 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 75.14 111.101 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 1.4 tp -114.26 -169.96 1.63 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 73.33 110.887 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -64.18 104.24 0.72 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 64.31 110.889 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 176.17 38.14 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.796 -0.716 . . . . 51.41 112.521 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 102.78 24.16 8.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 53.1 112.473 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 16.9 tt -52.95 -31.73 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 72.41 111.112 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -77.05 80.73 3.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 72.43 110.893 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 1.3 tt -56.73 -26.23 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 65.44 111.137 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 1.4 m 62.03 -174.32 0.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.839 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -78.97 133.2 36.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 73.42 110.855 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -146.97 -73.54 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 74.1 110.935 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 14.3 t -100.04 138.08 37.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 74.44 111.121 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 26.8 m -106.68 108.85 20.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 63.3 111.166 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.02 130.53 46.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 72.35 110.885 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 5.5 t -140.95 123.76 16.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 74.44 110.867 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -108.26 141.34 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 73.34 111.126 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -81.07 -76.65 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 75.23 110.9 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.49 128.26 46.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 72.12 111.192 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 17.8 t -118.5 135.05 60.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 73.2 111.126 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 50.7 t -126.41 126.32 68.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.145 -0.479 . . . . 75.11 111.109 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.07 132.42 8.08 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.729 -0.748 . . . . 70.03 112.504 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -133.51 147.3 51.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.828 0.346 . . . . 73.3 110.931 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.19 89.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 75.15 112.469 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 44.06 59.73 3.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 75.35 110.895 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 17.1 t -83.84 145.41 28.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 74.04 110.861 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -118.1 128.09 54.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 75.55 110.883 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 92.0 t -119.44 122.02 67.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 71.24 111.135 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.77 112.11 13.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 75.44 110.949 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 28.3 mm -112.68 104.34 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 71.23 111.106 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.6 -174.24 26.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.678 -0.772 . . . . 75.05 112.509 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -100.37 156.11 17.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.332 . . . . 74.44 110.889 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -121.72 118.9 30.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.905 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -112.42 136.66 51.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 75.23 110.918 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 135.67 175.71 13.98 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 51.32 112.475 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -107.89 107.69 2.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 62.33 112.463 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -166.07 28.05 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 73.13 110.889 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 76.39 -66.48 2.63 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.76 -0.733 . . . . 72.43 112.479 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -174.98 156.74 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 62.32 110.866 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -48.96 -74.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 75.03 110.903 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -144.9 124.25 13.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 70.54 110.894 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -155.52 161.96 40.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 74.14 110.857 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -62.62 -64.84 0.8 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.481 . . . . 74.22 110.854 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -179.17 -176.6 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 73.31 110.856 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -64.19 -169.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 75.53 110.873 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -74.91 144.47 43.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 74.15 110.844 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -108.75 -170.7 1.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 75.32 110.836 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 72.3 110.855 -179.987 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 7.5 ptt? . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.857 0.361 . . . . 73.31 110.869 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.16 88.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 72.03 110.903 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 51.4 mt -147.02 145.0 19.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 74.22 111.17 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -161.25 107.43 1.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 73.41 110.855 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.78 123.97 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 74.31 111.153 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -58.69 123.9 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 64.45 111.115 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 6.3 m -152.82 121.8 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 71.24 111.123 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -71.05 -130.39 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 72.02 112.481 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 63.27 -169.07 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.844 0.354 . . . . 70.45 110.884 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -83.78 113.72 21.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 72.12 110.9 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 73.3 m -131.05 144.74 51.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 72.21 110.864 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.78 134.63 51.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 74.34 111.086 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.13 -37.1 16.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 64.15 110.881 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -164.98 136.98 4.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 71.21 110.876 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 9.8 mt -138.78 119.65 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 64.31 111.171 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -111.23 124.88 53.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 74.54 110.884 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 8.4 p -135.07 132.9 38.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 75.33 111.127 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -152.8 166.6 31.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.21 110.927 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 65.14 69.42 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 74.4 110.907 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.47 53.67 12.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 75.03 110.888 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.66 155.91 18.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 52.23 111.119 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 -131.3 135.94 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 73.32 110.847 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 4.0 p -125.99 129.71 72.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 74.22 111.175 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -137.62 135.66 36.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 72.12 110.912 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 2.0 mp -129.99 118.54 21.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.35 110.918 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 155.25 176.64 27.68 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 54.4 112.505 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -88.95 128.66 35.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 73.44 110.914 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 93.1 t -98.75 123.1 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 60.12 111.14 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.17 117.14 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 65.52 111.134 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.9 t -68.11 174.98 3.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 63.3 111.117 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.05 -32.3 71.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.453 . . . . 74.41 111.081 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.12 -35.25 61.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 63.32 111.137 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 64.84 153.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.11 111.088 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.09 109.34 2.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.444 . . . . 71.23 110.927 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -65.02 124.53 22.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 64.42 110.862 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 62.57 -147.74 49.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 44.12 112.472 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 60.23 69.83 1.18 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 75.23 112.514 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 69.0 mt -54.54 -26.76 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.342 . . . . 75.42 111.145 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.37 115.09 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 75.34 110.877 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 1.2 pt -119.79 71.73 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 73.24 111.107 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 1.5 m -105.56 143.16 34.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 74.5 110.874 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.01 158.23 13.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.095 -0.502 . . . . 70.43 110.853 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -142.95 -65.03 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.928 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 5.8 t -70.71 137.85 50.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 52.42 111.103 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 90.6 m -111.86 130.84 55.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 73.54 111.151 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -126.16 134.41 51.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 74.22 110.866 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.86 123.93 15.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 61.41 110.871 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 11.4 p -108.2 140.72 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 62.35 111.129 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -81.16 -76.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 72.13 110.903 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.6 m -138.03 129.49 27.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 75.41 111.139 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 23.7 t -118.14 120.5 64.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 74.41 111.108 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 52.0 t -104.64 115.82 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 74.41 111.157 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.93 132.58 11.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.743 . . . . 64.34 112.462 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.25 144.25 49.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 74.42 110.943 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.42 87.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.73 . . . . 75.41 112.481 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 48.86 74.84 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 72.4 110.865 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 36.7 t -100.79 145.8 28.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 72.33 110.826 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.66 128.66 54.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 74.23 110.847 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.7 122.68 70.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 75.2 111.144 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.05 111.72 13.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.942 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 37.2 mm -113.39 104.31 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 74.55 111.091 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 138.89 -172.72 22.98 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.713 -0.756 . . . . 73.43 112.484 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -89.02 154.12 20.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.802 0.334 . . . . 65.11 110.843 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -128.29 130.14 47.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 65.33 110.93 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -132.41 121.76 23.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 64.24 110.946 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 164.87 -179.96 39.22 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.68 -0.771 . . . . 72.11 112.447 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -71.3 -151.06 0.86 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.763 -0.732 . . . . 73.34 112.516 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.92 -179.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.844 0.354 . . . . 73.23 110.877 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -110.84 -57.56 0.49 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.778 -0.725 . . . . 62.05 112.508 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -84.01 139.66 32.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 74.24 110.933 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 70.52 7.81 6.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 75.1 110.951 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 1.1 p30 173.81 135.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.53 110.84 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -124.12 154.94 39.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 75.4 110.928 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -147.54 162.53 38.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 71.43 110.849 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.76 -69.64 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 65.1 110.906 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 63.85 -169.92 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 74.24 110.897 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -128.26 174.6 9.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 73.04 110.889 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -143.85 168.75 19.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 73.21 110.852 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 73.04 110.863 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 16.3 mtt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.834 0.35 . . . . 71.2 110.89 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -174.65 174.48 2.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 72.21 110.92 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 9.5 tp -106.9 145.69 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 71.04 111.098 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.01 -170.07 1.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 74.3 110.841 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . 63.86 104.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 55.15 111.065 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 33.7 pt -98.24 -176.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 74.42 111.16 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 19.4 m -51.74 -36.58 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 71.44 111.056 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 108.82 136.35 7.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.702 -0.761 . . . . 74.52 112.461 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.12 159.12 1.27 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.836 0.35 . . . . 75.5 110.863 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -98.31 124.31 42.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 75.23 110.888 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.23 137.85 54.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 75.54 110.82 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.29 123.32 15.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 72.41 111.066 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -84.92 -36.79 21.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.446 . . . . 75.11 110.865 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -164.18 139.29 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 72.45 110.871 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 13.0 mt -137.01 117.68 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 73.21 111.182 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -120.19 115.76 24.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 64.33 110.86 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.23 132.93 47.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 74.55 111.206 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -138.27 157.08 46.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 73.34 110.883 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.468 ' O ' ' C ' ' A' ' 236' ' ' ARG . 6.3 tt0 65.13 88.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 75.03 110.883 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.468 ' C ' ' O ' ' A' ' 235' ' ' GLU . 0.0 OUTLIER 31.68 52.55 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 74.52 110.903 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.79 145.59 24.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 75.35 111.113 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -125.76 136.71 53.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 75.13 110.908 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.9 m -142.5 121.75 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 71.12 111.089 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.26 137.25 54.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 71.4 110.849 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.68 122.05 26.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.196 -0.456 . . . . 71.4 110.968 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.85 -115.83 0.88 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 73.1 112.523 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -145.44 128.96 17.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 74.5 110.879 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 20.9 m -111.79 127.68 68.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 74.1 111.083 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.1 t -122.24 129.08 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 71.51 111.124 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 2.5 m -91.45 162.34 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 73.22 111.125 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.33 -43.1 99.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 63.12 111.063 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -61.1 -36.18 79.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 71.55 111.117 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -63.36 -25.26 68.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 65.32 111.037 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.3 tt -51.95 103.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 74.12 110.942 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.97 -63.32 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 74.05 110.826 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 136.11 138.93 3.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 74.43 112.534 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 168.39 164.69 24.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.752 -0.737 . . . . 61.35 112.495 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 8.9 tp -134.1 141.73 43.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 74.04 111.112 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.46 133.88 35.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 70.35 110.868 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.3 tt -116.6 -26.47 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 75.12 111.203 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 58.8 m -98.87 -178.43 3.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 73.3 110.9 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -63.64 -170.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.472 . . . . 65.21 110.875 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -143.2 179.75 6.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 64.22 110.956 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 30.8 p -87.58 137.49 32.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 74.53 111.145 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -107.75 108.98 20.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.44 111.126 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -94.18 124.97 38.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 73.21 110.907 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.99 123.82 15.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 70.23 110.904 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.4 p -118.66 135.78 57.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 72.42 111.103 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 -75.29 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.469 . . . . 71.21 110.847 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.4 m -123.46 130.29 52.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 73.34 111.108 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 33.7 t -118.12 129.83 73.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 72.53 111.112 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 36.7 t -127.68 124.83 64.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 74.45 111.114 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.01 134.02 8.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 73.5 112.47 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -132.8 141.68 48.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.78 0.324 . . . . 73.31 110.92 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 57.29 85.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 50.35 112.485 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 44.0 60.56 2.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.827 0.346 . . . . 75.3 110.902 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 11.0 t -83.92 145.36 28.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 70.21 110.93 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 3.3 mpp_? -129.49 127.25 40.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.887 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 17.6 t -137.06 124.01 30.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 72.04 111.13 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.0 111.16 17.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 73.23 110.901 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 30.5 mm -103.3 104.63 16.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 73.53 111.11 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.24 -163.61 28.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 64.43 112.467 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -103.43 155.92 18.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 73.41 110.844 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -129.93 147.32 51.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.12 -0.491 . . . . 72.34 110.922 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -129.69 125.84 36.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 73.23 110.927 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 165.69 -86.14 0.1 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.705 -0.76 . . . . 70.13 112.506 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 127.75 -97.79 0.47 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.76 -0.733 . . . . 63.34 112.51 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -51.73 127.85 21.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.794 0.33 . . . . 74.11 110.895 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 93.72 -33.22 5.31 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.753 -0.737 . . . . 74.42 112.474 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.39 -174.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.373 . . . . 74.02 110.865 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -51.86 107.58 0.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 75.33 110.91 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.67 -172.17 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 73.41 110.852 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -102.61 150.09 23.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.971 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -121.84 -178.76 3.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 72.45 110.856 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.37 96.05 5.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 73.45 110.818 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.8 143.4 26.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 70.34 110.85 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -178.28 123.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 75.43 110.86 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.07 124.67 20.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 75.21 110.884 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 74.31 110.837 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.868 0.366 . . . . 70.12 110.884 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -99.72 155.64 17.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 75.11 110.865 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 13.3 tt -52.06 146.25 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 75.1 111.096 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -131.71 164.85 25.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 64.11 110.851 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -116.04 146.75 41.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 74.24 111.105 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.63 178.76 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 74.25 111.144 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 13.8 m -148.43 -179.9 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 75.44 111.162 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 149.19 -162.92 29.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 61.02 112.521 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -162.91 120.47 1.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.714 0.292 . . . . 73.44 110.913 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -106.61 115.63 30.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.42 110.897 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.91 137.93 54.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 63.44 110.779 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.16 129.38 29.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 74.22 111.118 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 4.8 tttm -88.88 -36.32 16.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 71.05 110.869 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.4 139.16 5.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 72.14 110.869 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 13.6 mt -137.31 117.84 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 75.41 111.075 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -127.03 119.65 27.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 72.21 110.84 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.52 140.36 48.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 65.42 111.149 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -140.35 164.38 30.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 72.52 110.874 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' B' ' 236' ' ' ARG . 2.2 tt0 64.07 72.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 74.53 110.809 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' B' ' 235' ' ' GLU . 19.5 ptt-85 37.19 63.43 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 75.23 110.854 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.56 155.06 19.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 60.3 111.107 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.96 135.32 48.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 71.31 110.854 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 21.0 m -143.11 121.9 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 74.43 111.147 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -118.37 137.26 53.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.33 110.845 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 5.2 mp -125.02 118.54 26.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 74.32 110.897 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 143.02 -177.64 21.81 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.739 -0.743 . . . . 63.12 112.473 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.93 139.0 31.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 73.42 110.905 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.82 127.49 74.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 64.32 111.139 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 54.2 t -117.5 129.28 74.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 72.01 111.088 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.18 162.81 24.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 64.32 111.191 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.14 79.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 73.51 111.075 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -62.55 -41.71 99.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.306 -0.407 . . . . 75.05 111.104 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -59.9 117.59 5.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 70.11 111.128 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -175.55 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 74.25 110.967 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -54.35 -28.52 43.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 65.11 110.864 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -52.39 144.8 19.39 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.746 -0.74 . . . . 73.42 112.488 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -138.67 -151.6 5.8 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.717 . . . . 62.2 112.508 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 49.4 mm -52.4 131.35 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 74.41 111.166 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -176.13 -36.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 74.14 110.913 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.5 mp 63.71 84.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 75.24 111.14 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.82 -170.4 3.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 70.54 110.865 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.6 t0 62.77 36.61 13.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.464 . . . . 73.33 110.897 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -92.23 55.52 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 74.41 110.881 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 86.3 m -95.4 122.92 38.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 71.12 111.131 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 5.4 m -94.6 108.84 20.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 74.41 111.149 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -96.59 127.72 42.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 62.31 110.927 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 63.9 p -142.03 123.99 15.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 74.53 110.898 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 8.8 p -115.18 136.83 50.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 65.33 111.062 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.26 -75.71 0.22 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.117 -0.492 . . . . 74.54 110.862 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -127.4 130.8 50.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 71.1 111.147 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 28.6 t -118.32 128.29 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 73.34 111.129 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.56 120.43 54.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 74.24 111.1 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.88 133.69 8.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 74.4 112.46 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -133.09 148.02 52.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 75.23 110.893 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.63 76.58 0.19 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.708 -0.758 . . . . 53.12 112.476 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 48.35 62.19 2.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.342 . . . . 73.24 110.924 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 32.6 t -87.43 145.67 26.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 75.55 110.879 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.74 127.38 43.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 73.34 110.937 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 10.0 t -135.59 124.07 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 74.43 111.148 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.46 116.53 26.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.471 . . . . 71.33 110.872 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 29.0 mm -107.72 135.09 47.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 70.24 111.089 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 118.39 -168.75 13.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 64.32 112.392 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -112.38 155.38 24.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.791 0.329 . . . . 65.4 110.908 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -120.13 137.45 54.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 74.41 110.935 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.94 125.96 50.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 74.35 110.874 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 127.12 159.84 10.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 75.22 112.452 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -101.53 -19.03 16.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.82 -0.705 . . . . 71.23 112.477 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -66.97 89.31 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 72.03 110.948 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 66.86 113.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 71.14 112.506 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -52.85 -66.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.812 0.339 . . . . 75.32 110.865 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -138.13 -49.45 0.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 73.24 110.916 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.27 -171.02 2.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 73.45 110.861 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -133.06 134.93 44.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 74.54 110.909 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 59.52 176.01 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 65.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -171.23 -67.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 71.52 110.892 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -161.15 -68.43 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 72.4 110.868 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -179.2 -179.19 0.55 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 74.12 110.812 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -140.41 26.32 2.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 75.22 110.816 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 75.15 110.871 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.4 mtt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.852 0.358 . . . . 71.13 110.865 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -128.78 165.15 21.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 74.43 110.898 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.53 175.8 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 73.24 111.116 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -166.96 29.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 64.15 110.84 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -151.6 -170.3 3.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 74.13 111.107 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.37 75.91 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 74.31 111.154 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 23.3 m -87.4 145.13 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 74.41 111.122 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -87.91 136.12 13.59 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.769 -0.729 . . . . 71.2 112.437 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -179.45 136.24 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.777 0.322 . . . . 65.22 110.839 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -94.64 134.93 36.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 73.51 110.882 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 8.1 t -132.46 137.84 47.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 64.55 110.894 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.95 138.83 44.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 74.21 111.12 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.86 -33.47 11.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.41 . . . . 74.51 110.897 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.71 138.54 5.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 73.51 110.822 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 11.0 mt -137.59 117.89 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 75.22 111.135 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -127.74 121.9 31.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 74.04 110.918 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 141.67 45.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 65.1 111.167 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.18 166.31 25.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 73.51 110.863 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 65.0 57.68 0.96 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.156 -0.475 . . . . 74.22 110.874 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 50.87 61.2 3.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 73.42 110.887 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 151.97 22.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 72.34 111.168 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -125.92 135.38 51.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 73.01 110.886 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 4.4 m -140.66 121.9 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 75.24 111.155 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -115.68 129.71 56.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.34 110.986 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.91 118.72 34.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.938 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.1 174.28 13.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.759 -0.734 . . . . 71.32 112.471 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.54 147.92 22.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.869 0.366 . . . . 70.12 110.856 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.09 130.42 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 74.44 111.122 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.07 128.97 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 75.23 111.096 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 7.8 p -74.41 162.97 28.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 74.35 111.158 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.08 -33.97 76.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 73.42 111.06 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.81 -41.85 78.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 74.11 111.064 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.73 103.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 73.44 111.097 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 12.4 mt -139.14 -174.39 3.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 73.33 110.875 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -76.34 -170.97 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 73.33 110.894 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 131.69 -21.09 4.52 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.677 -0.773 . . . . 73.11 112.476 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -166.5 -102.43 0.16 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.738 -0.744 . . . . 71.44 112.48 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 15.8 pt -142.99 41.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.853 0.359 . . . . 70.13 111.191 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -80.91 117.24 21.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 71.11 110.94 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 50.5 mt -145.48 145.62 20.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 73.42 111.089 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.92 -37.08 3.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 74.42 110.894 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -59.32 106.26 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 72.13 110.846 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -173.86 -37.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 74.2 110.93 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 26.4 m -76.3 121.98 23.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 75.31 111.175 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.7 m -92.33 125.5 37.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 73.23 111.123 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -113.83 119.99 39.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 75.52 110.878 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 8.3 t -129.9 123.66 31.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 45.53 110.843 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.3 p -117.06 135.97 55.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 72.51 111.128 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -79.12 -76.09 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 72.34 110.884 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 2.1 m -124.53 130.71 52.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 65.53 111.197 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.09 125.27 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 75.44 111.209 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 57.8 t -127.24 118.73 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.24 111.119 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.1 133.78 8.9 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 60.21 112.522 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -132.53 147.66 52.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.337 . . . . 74.22 110.885 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.14 75.46 0.26 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.686 -0.769 . . . . 61.42 112.499 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 48.64 60.43 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 73.42 110.846 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 21.3 t -85.55 145.85 27.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.34 110.846 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -128.32 127.86 43.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 74.14 110.823 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 17.3 t -135.18 123.89 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 72.42 111.126 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.89 112.29 18.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 72.24 110.865 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 24.7 mm -106.17 123.51 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 72.12 111.105 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 129.17 167.11 12.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 63.34 112.55 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -89.97 145.3 25.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.774 0.321 . . . . 74.34 110.91 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.05 134.62 54.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 74.23 110.913 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -119.68 125.95 49.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 73.52 110.986 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 153.55 168.78 17.77 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 74.5 112.523 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -111.68 -18.32 8.03 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.715 -0.755 . . . . 65.4 112.499 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -76.37 67.11 2.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 71.42 110.929 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 78.31 159.63 13.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 71.23 112.518 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -81.27 -74.67 0.32 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.865 0.364 . . . . 73.33 110.859 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -89.56 -65.82 0.98 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 72.04 110.927 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -156.09 -41.59 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 71.0 110.874 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 1.4 m120 63.17 161.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 74.44 110.911 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -179.1 -169.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 73.45 110.914 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -51.99 146.79 8.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.433 . . . . 72.45 110.827 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -136.87 -175.25 3.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 61.31 110.841 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.2 104.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 75.31 110.882 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -165.56 73.37 0.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 74.4 110.865 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 24.1 m170 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 72.31 110.828 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.777 0.322 . . . . 74.31 110.863 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -168.75 43.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 74.53 110.897 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 6.1 tp -118.04 -29.81 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 71.01 111.12 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -70.62 164.79 24.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 72.32 110.859 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -97.0 -174.91 3.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 74.24 111.119 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 21.7 pt -129.23 25.36 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 74.02 111.11 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 20.9 m -85.07 142.36 13.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 75.34 111.121 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 58.85 173.89 0.52 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 42.43 112.462 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.19 -169.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.81 0.338 . . . . 72.33 110.891 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.75 113.1 20.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 73.32 110.861 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 2.6 m -128.3 139.76 52.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 72.43 110.84 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.33 157.63 42.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 72.21 111.158 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -112.6 -34.41 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 73.02 110.895 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -164.53 138.86 5.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 73.53 110.869 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 8.9 mt -137.64 117.74 16.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 72.43 111.196 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -130.54 123.53 29.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 70.13 110.932 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.2 146.64 48.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 74.12 111.118 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -146.51 166.61 25.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 74.51 110.901 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 64.93 55.88 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 75.51 110.877 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.85 62.79 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.477 . . . . 73.13 110.862 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.49 156.06 18.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 71.43 111.123 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -128.05 135.71 50.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 73.11 110.817 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 20.5 m -138.27 122.85 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 75.32 111.148 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.37 136.43 53.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 72.35 110.938 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.96 118.98 32.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 74.42 110.89 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.14 171.61 13.0 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.75 . . . . 63.51 112.495 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -93.28 153.95 18.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 74.42 110.888 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 18.5 m -120.67 136.85 56.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 75.34 111.093 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 97.9 t -122.24 130.09 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 74.34 111.098 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 1.7 p -68.35 168.54 12.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 75.31 111.097 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.57 -34.49 72.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 72.22 111.136 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.44 -37.53 72.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 74.31 111.162 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 63.71 163.46 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 72.5 111.146 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 16.0 tp -121.75 112.8 18.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 72.33 110.916 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -59.49 120.69 9.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 73.13 110.865 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -167.07 -144.77 4.23 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 45.25 112.479 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -57.71 -178.7 0.72 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.746 -0.74 . . . . 74.11 112.515 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 1.5 pp -148.23 155.47 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.838 0.351 . . . . 74.01 111.178 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 69.19 -75.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 73.44 110.882 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 35.6 pt -107.47 154.14 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 74.01 111.066 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 13.0 t -178.79 106.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.076 -0.511 . . . . 61.11 110.814 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -66.56 0.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 73.44 110.861 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.3 -170.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 74.14 110.924 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 1.4 m -66.58 135.27 53.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 63.45 111.141 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 98.0 m -102.61 139.17 38.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 75.24 111.148 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.14 130.98 52.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 74.04 110.807 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 5.8 t -142.07 123.9 15.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 70.32 110.81 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.76 138.34 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 64.21 111.131 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.73 -76.4 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 74.05 110.847 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 6.2 m -128.3 130.46 47.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 71.24 111.081 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.4 120.93 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.144 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 18.1 t -121.68 118.45 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 72.51 111.169 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.52 136.49 12.23 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.715 -0.755 . . . . 62.22 112.456 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.44 147.51 52.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.879 0.371 . . . . 75.11 110.894 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.43 76.22 0.2 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.723 -0.751 . . . . 63.53 112.468 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 47.93 61.95 2.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 72.12 110.866 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 30.5 t -87.15 145.99 26.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 75.0 110.871 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -127.49 127.67 44.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 73.44 110.903 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 14.2 t -132.66 124.15 50.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 74.34 111.071 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.44 112.38 17.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.22 110.889 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 28.0 mm -105.0 129.06 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 74.44 111.111 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 120.03 170.46 14.36 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 63.43 112.561 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -89.68 154.01 20.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.327 . . . . 73.43 110.867 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -127.95 133.17 49.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 74.34 110.858 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -116.22 124.18 49.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 73.14 110.925 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 174.42 -58.32 0.13 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 75.34 112.443 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 91.47 -66.83 2.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.795 -0.717 . . . . 42.12 112.476 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -51.43 -30.32 19.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 75.54 110.917 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -140.34 97.57 0.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.677 -0.773 . . . . 75.23 112.478 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -51.3 -75.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 72.44 110.883 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -140.84 -58.28 0.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 64.5 110.932 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -175.12 -178.23 1.17 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 72.13 110.846 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 58.62 177.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 75.02 110.893 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -114.69 -49.28 2.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 72.04 110.873 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 56.85 -177.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.423 . . . . 74.43 110.876 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 63.25 104.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 74.34 110.838 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -142.07 62.1 1.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 74.4 110.778 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 63.05 162.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 74.3 110.82 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 3.7 p80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 71.53 110.879 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.829 0.347 . . . . 74.31 110.877 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.14 177.76 4.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 64.2 110.87 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 26.4 pt -137.88 -174.49 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 72.11 111.137 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.58 145.2 48.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.218 -0.446 . . . . 72.34 110.852 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -176.13 117.7 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 74.35 111.076 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.65 45.5 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 74.33 111.06 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.83 144.69 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 73.23 111.198 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 153.29 -172.43 32.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.633 -0.794 . . . . 64.4 112.419 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -54.3 -69.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.78 0.324 . . . . 64.24 110.869 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -97.29 111.66 23.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 75.33 110.868 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 14.8 m -121.94 138.96 54.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 72.41 110.839 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.79 132.82 35.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 74.34 111.073 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.06 -29.24 15.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.878 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -164.52 139.33 5.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 63.2 110.896 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 10.5 mt -136.87 117.57 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 70.12 111.162 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.61 121.11 23.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 74.1 110.869 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.51 145.36 48.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 74.52 111.096 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -148.17 167.09 25.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 63.33 110.881 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 65.74 54.41 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 64.43 110.916 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 51.2 62.07 2.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.477 . . . . 74.54 110.852 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.76 156.15 18.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 73.31 111.12 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -128.32 135.83 50.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.33 110.855 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 4.2 m -131.99 121.98 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 60.0 111.109 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.48 137.07 52.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 74.51 110.9 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -126.74 121.17 31.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 74.23 110.958 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.19 163.3 11.5 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 64.03 112.456 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -85.7 156.98 20.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.906 0.384 . . . . 74.4 110.854 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 31.6 m -119.42 134.08 64.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 75.52 111.121 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.53 129.54 75.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 65.22 111.085 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t -69.49 175.54 4.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 74.01 111.112 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.34 86.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 73.42 111.104 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.4 -53.03 62.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 62.4 111.1 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 50.32 29.66 3.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 73.02 111.085 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.39 98.05 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 71.43 110.935 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 19.6 m80 63.35 26.75 15.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 74.41 110.899 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -70.79 -34.86 66.16 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.717 . . . . 64.21 112.458 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.1 -143.63 9.49 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.733 . . . . 73.04 112.484 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 2.0 mp 65.3 151.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 74.34 111.179 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -66.65 -170.78 0.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.434 . . . . 74.35 110.818 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 mp 62.81 63.63 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 72.31 111.118 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.48 -170.31 2.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 73.42 110.823 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.56 -170.13 1.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 62.11 110.792 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.82 103.66 2.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 74.52 110.914 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 31.1 p -100.96 137.9 38.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 62.14 111.194 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 5.3 t -128.93 122.53 30.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.451 . . . . 74.45 111.107 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -105.09 119.93 40.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 71.21 110.932 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 29.2 t -127.27 123.83 37.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 62.34 110.822 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 10.0 p -122.62 137.82 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 75.33 111.152 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.86 -75.07 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 71.44 110.904 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 60.5 m -125.23 133.58 52.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 72.32 111.123 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.23 126.5 75.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 75.24 111.142 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.2 122.89 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 61.41 111.125 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.65 134.43 9.96 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 73.4 112.5 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -133.01 147.75 52.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 70.02 110.884 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.48 78.9 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.843 -0.694 . . . . 71.44 112.444 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 47.18 64.16 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 74.25 110.936 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 41.2 t -86.76 145.88 26.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 75.02 110.852 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -130.73 127.87 39.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 60.41 110.853 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 18.7 t -130.4 123.72 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 72.44 111.189 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.79 111.94 17.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 72.12 110.914 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 50.5 mm -108.55 132.64 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 71.42 111.18 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 124.42 -177.68 16.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.744 . . . . 73.23 112.483 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -103.18 153.67 20.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.787 0.327 . . . . 64.11 110.839 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.91 132.07 55.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 62.33 110.83 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -130.09 123.74 31.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 74.31 110.908 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 163.77 73.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 64.45 112.485 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . 48.23 82.45 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.734 -0.746 . . . . 35.11 112.46 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.43 30.82 2.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.836 0.351 . . . . 73.41 110.946 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -63.53 173.28 12.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.751 -0.737 . . . . 61.33 112.435 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.04 -70.14 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.76 0.314 . . . . 75.3 110.848 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -168.24 31.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.962 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.18 -169.66 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 73.0 110.918 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 3.7 t30 63.49 104.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 72.42 110.943 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -110.61 -176.16 2.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 73.45 110.868 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -99.85 51.0 0.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 73.22 110.938 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -178.06 69.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.871 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -111.5 166.83 10.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.219 -0.446 . . . . 72.12 110.843 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.12 -178.3 3.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.832 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 7.1 m80 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 74.21 110.852 -179.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 4.0 ptp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.828 0.347 . . . . 72.33 110.903 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -179.21 139.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 75.53 110.892 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.9 tt -175.37 149.41 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 74.22 111.115 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -109.7 124.21 50.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 74.52 110.794 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -178.34 -34.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 74.41 111.079 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 48.5 mm -51.75 118.71 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 72.02 111.118 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 15.9 m -124.36 170.26 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.471 . . . . 74.23 111.143 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -52.02 105.9 0.28 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.686 -0.769 . . . . 64.21 112.467 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.2 ptp85 -142.21 -173.54 3.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 74.3 110.843 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.99 129.65 30.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.885 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 2.1 p -134.5 140.25 46.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 70.23 110.897 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.82 149.53 51.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 65.45 111.059 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -106.25 -35.63 7.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 72.23 110.874 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -164.86 137.86 4.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 75.43 110.907 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 17.4 mt -138.91 118.72 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 74.32 111.131 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -134.12 117.74 16.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 72.23 110.847 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.7 p -135.55 142.09 45.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 74.44 111.127 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.0 pm0 -147.01 167.9 22.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 72.31 110.93 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 68.94 57.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 75.55 110.909 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 50.37 57.43 6.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.804 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.2 151.75 22.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 75.41 111.101 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -126.11 135.92 52.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 75.42 110.797 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.1 p -138.38 121.88 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.02 111.096 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.01 136.0 53.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 72.31 110.948 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 tp -130.16 118.88 22.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.199 -0.455 . . . . 75.51 110.888 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 139.57 173.22 13.04 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.699 -0.762 . . . . 74.52 112.478 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -85.67 160.45 19.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 74.54 110.903 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 97.9 t -133.07 121.02 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.475 . . . . 72.44 111.16 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.19 129.04 75.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 70.35 111.131 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 6.1 t -75.41 169.29 18.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 74.3 111.108 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.38 -41.52 98.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 74.45 111.064 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.32 -35.88 68.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 73.04 111.118 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -74.04 -23.6 59.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 72.41 111.16 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.36 85.62 7.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.925 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -178.99 -172.85 0.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 75.32 110.824 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.75 143.25 1.18 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 72.14 112.466 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -100.38 73.76 0.43 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.783 -0.723 . . . . 53.04 112.522 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.45 -176.84 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.863 0.363 . . . . 75.42 111.109 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 12.5 mtt-85 -73.39 108.45 6.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 74.35 110.88 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 44.7 mm -103.38 132.55 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 74.34 111.124 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.4 p -171.63 131.33 0.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.807 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -58.13 141.35 50.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.508 . . . . 72.42 110.869 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.53 -37.54 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 75.33 110.923 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 95.1 m -72.61 122.09 20.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 72.42 111.108 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 26.0 m -116.48 122.41 44.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 73.15 111.147 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -107.41 139.34 42.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 73.14 110.875 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.91 123.25 15.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.509 . . . . 64.22 110.812 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.0 p -119.87 137.59 53.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 74.52 111.127 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.91 -77.39 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 72.11 110.857 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 35.3 p -127.21 130.18 49.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 73.44 111.146 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 20.5 t -118.04 120.69 65.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 74.11 111.125 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.77 118.12 53.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 64.3 111.109 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.17 134.37 10.09 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 71.44 112.49 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.63 147.76 52.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.347 . . . . 75.31 110.895 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.78 78.97 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.79 -0.719 . . . . 54.13 112.45 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 47.9 66.3 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.842 0.353 . . . . 73.41 110.825 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 32.7 t -92.76 145.9 24.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 70.53 110.756 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -125.42 128.29 47.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 74.45 110.9 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 20.6 t -134.1 123.76 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 75.34 111.139 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.42 111.86 17.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.14 110.858 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 3.4 mp -109.78 106.25 20.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.251 -0.431 . . . . 75.45 111.146 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.5 175.56 19.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 63.12 112.488 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -107.14 147.72 29.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.817 0.342 . . . . 75.41 110.879 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -118.97 126.37 51.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 65.05 110.905 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -118.55 125.76 50.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.13 110.921 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 151.33 -39.66 0.8 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.684 -0.769 . . . . 75.23 112.5 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 123.99 -119.8 3.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 75.41 112.442 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 63.34 25.92 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 74.02 110.857 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 77.3 -63.63 3.28 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.705 -0.76 . . . . 72.43 112.49 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -174.49 -167.96 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 73.34 110.893 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -49.44 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 74.11 110.947 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -176.03 143.22 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 75.31 110.882 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -80.28 -170.03 2.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 65.33 110.828 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -157.88 26.15 0.27 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 71.43 110.903 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -144.65 -47.31 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 64.01 110.876 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 72.3 -69.25 0.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.848 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -57.25 179.43 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 74.15 110.908 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.2 161.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.86 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 64.25 110.818 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.801 0.334 . . . . 71.55 110.875 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.57 107.46 1.75 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 75.34 110.937 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.29 165.55 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 73.43 111.109 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -169.88 -170.46 1.02 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.887 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -124.9 150.41 46.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 63.25 111.063 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 8.7 tp -150.43 131.3 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 70.43 111.141 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 7.0 p -114.11 130.35 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 74.52 111.103 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 82.76 126.85 1.07 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 74.03 112.515 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.32 135.9 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.771 0.32 . . . . 75.33 110.93 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.8 137.51 45.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 75.15 110.852 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.59 137.9 38.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 73.25 110.897 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.17 147.85 52.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 74.32 111.104 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.87 -31.46 9.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 75.21 110.917 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.51 137.79 4.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 74.24 110.89 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 15.6 mt -138.19 117.18 14.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 74.23 111.139 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -134.57 115.26 13.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 71.24 110.883 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.3 p -135.86 137.19 41.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 61.14 111.096 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -141.93 167.28 22.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 71.14 110.912 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 66.95 69.51 0.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 73.14 110.792 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 46.06 40.52 7.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 70.34 110.82 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.81 148.79 23.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 72.51 111.096 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.8 140.82 50.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 74.53 110.829 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 6.1 p -138.96 121.99 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.113 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.61 131.76 56.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 74.03 110.865 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 1.2 tp -130.23 118.94 22.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 71.31 110.921 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 154.92 -138.27 6.05 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 64.41 112.42 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -144.54 143.69 30.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.852 0.358 . . . . 75.34 110.863 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 58.2 t -119.11 115.63 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 73.4 111.134 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 63.9 t -122.21 122.73 67.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 74.31 111.117 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 81.2 p -69.85 163.02 26.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.183 -0.462 . . . . 65.24 111.147 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.76 -34.07 76.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 75.14 111.093 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.06 -41.48 78.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 72.01 111.04 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -53.79 -27.65 30.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 75.02 111.107 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.65 101.0 0.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 73.34 110.963 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.39 -55.1 2.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 64.34 110.927 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -130.39 98.59 0.41 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.692 -0.766 . . . . 65.33 112.479 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 73.28 -100.93 1.09 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.788 -0.72 . . . . 74.45 112.49 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.59 -32.85 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 72.43 111.086 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -170.79 -179.1 2.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 74.13 110.846 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 39.1 mm -108.91 -65.46 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 64.43 111.183 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 54.3 p -160.0 70.04 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.01 110.829 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.59 169.99 8.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 74.43 110.915 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -174.51 70.16 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 75.11 110.884 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 76.3 m -100.95 121.95 42.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 73.21 111.119 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 91.3 m -124.06 131.86 53.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.28 -0.418 . . . . 75.33 111.138 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -115.57 132.51 56.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 75.23 110.885 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 36.7 m -132.74 123.32 26.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 60.34 110.867 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.89 137.09 54.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 73.14 111.132 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -78.99 -77.5 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 75.21 110.857 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 39.1 m -129.9 130.48 45.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.166 -0.47 . . . . 63.41 111.141 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.9 120.68 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 73.13 111.168 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.04 121.61 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 73.3 111.17 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.27 133.8 8.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 71.43 112.543 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -132.55 147.52 52.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.824 0.345 . . . . 75.0 110.893 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.92 84.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.688 -0.768 . . . . 72.1 112.525 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 45.15 63.52 1.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 74.24 110.888 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 26.5 t -93.06 145.68 24.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 63.31 110.884 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -128.57 127.7 42.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.919 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.6 123.91 53.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.414 . . . . 72.51 111.144 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.76 111.44 15.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.086 -0.506 . . . . 74.02 110.921 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 2.1 mp -111.66 104.83 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 72.2 111.142 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.28 -168.53 32.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 72.22 112.514 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -123.44 153.59 40.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 74.42 110.939 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.07 121.19 32.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 73.22 110.845 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -109.45 125.71 52.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 73.3 110.928 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 106.21 171.32 23.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.799 -0.715 . . . . 71.51 112.516 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 51.96 -171.68 0.34 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.779 -0.724 . . . . 71.2 112.476 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 131.09 47.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.806 0.336 . . . . 74.22 110.879 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -72.54 78.95 0.7 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.718 . . . . 65.34 112.455 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -178.44 131.22 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 64.34 110.856 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 15.1 t90 -60.94 124.72 21.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 74.12 110.921 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 62.45 -178.14 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.279 -0.419 . . . . 73.41 110.865 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -139.22 176.79 8.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.22 110.905 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 14.6 m170 63.33 104.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 74.45 110.849 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -161.19 109.32 1.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 61.25 110.881 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.05 173.29 14.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 71.44 110.886 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 51.98 43.26 30.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 74.34 110.885 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -163.95 89.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 74.12 110.896 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 45.4 m80 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 73.32 110.9 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 3.6 ptp . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.88 0.371 . . . . 73.02 110.929 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -123.94 25.87 7.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 72.33 110.876 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 15.4 mt 70.64 -70.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 74.31 111.172 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 52.71 29.37 7.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.54 110.861 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 68.95 -77.26 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 75.41 111.126 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 71.3 mt 51.78 88.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 75.23 111.085 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 47.6 t -72.67 -40.86 62.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 73.21 111.132 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 68.83 174.56 9.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.701 -0.762 . . . . 71.23 112.487 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.77 -65.32 1.02 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 71.25 110.813 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -122.78 136.43 54.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 75.51 110.95 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 75.6 m -137.7 145.16 42.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 63.02 110.878 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.05 154.35 49.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 74.14 111.061 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.87 -28.48 10.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 72.23 110.922 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.45 137.59 4.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 74.33 110.867 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 18.1 mt -138.43 116.93 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.142 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.12 115.61 13.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 73.25 110.949 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.8 p -135.81 139.27 43.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 74.25 111.15 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -145.62 166.99 24.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 71.21 110.922 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 66.56 66.97 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 74.4 110.9 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 46.84 51.99 11.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.499 . . . . 74.42 110.897 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.08 151.45 23.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 73.34 111.179 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.24 137.17 47.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 75.25 110.836 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 6.2 p -133.59 121.95 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 73.21 111.126 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -114.15 135.66 53.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 73.1 110.837 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.16 118.86 22.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.13 110.91 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.9 -173.47 22.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.752 -0.737 . . . . 51.42 112.51 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.02 150.4 23.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 70.32 110.931 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 92.7 t -128.87 121.48 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 75.53 111.125 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.06 129.04 75.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 74.31 111.133 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.9 t -77.03 163.66 26.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 73.43 111.248 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.16 -33.65 75.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 74.31 111.106 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.53 -35.98 68.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 74.53 111.056 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -56.71 100.17 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 72.32 111.118 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 33.8 tp -158.38 124.67 4.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 74.0 110.842 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 69.15 -76.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 73.21 110.861 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 52.28 31.86 35.61 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.746 . . . . 74.32 112.476 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 87.24 53.24 2.85 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.719 -0.753 . . . . 63.43 112.504 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 28.8 mm 63.97 75.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 63.41 111.145 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -153.04 114.93 4.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 71.23 110.933 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 39.5 mm -129.97 140.4 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 75.14 111.17 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 6.1 t 58.99 -172.64 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 64.35 110.877 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.27 171.07 14.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 74.32 110.789 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -122.91 57.14 1.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 74.32 110.918 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 20.2 p -99.4 130.51 45.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.199 -0.455 . . . . 75.14 111.097 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 30.2 m -134.06 132.15 39.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 65.42 111.178 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -125.38 135.47 52.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 72.23 110.844 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.06 123.78 26.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 71.51 110.829 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.67 136.84 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 74.35 111.192 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -79.21 -77.0 0.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 74.45 110.907 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 5.0 m -129.82 130.52 45.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 75.33 111.145 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.0 t -117.87 120.64 65.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 71.12 111.114 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 26.2 t -123.84 120.77 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 73.23 111.111 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.02 133.3 8.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.741 . . . . 64.45 112.436 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -133.27 147.47 51.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.82 0.343 . . . . 72.52 110.89 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.2 87.86 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.793 -0.717 . . . . 65.2 112.474 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 44.38 61.04 2.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.889 0.376 . . . . 74.51 110.863 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 35.2 t -92.15 145.33 24.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 74.01 110.909 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.7 127.69 39.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 74.3 110.93 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.03 123.76 51.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 73.14 111.135 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.05 111.8 13.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 73.55 110.9 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.77 119.9 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 74.31 111.109 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.31 -158.34 25.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.735 -0.745 . . . . 73.11 112.467 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -127.98 132.95 49.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.823 0.344 . . . . 74.24 110.851 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.92 137.78 49.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 74.23 110.88 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -129.52 125.46 36.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 74.34 110.899 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 126.56 165.68 12.03 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.768 -0.73 . . . . 65.13 112.497 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 64.7 155.1 0.15 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.717 -0.754 . . . . 60.51 112.432 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -93.26 65.14 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 75.14 110.961 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -160.28 -113.44 0.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.726 -0.75 . . . . 75.24 112.516 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -174.58 -35.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 72.35 110.833 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 7.2 t90 -154.23 26.81 0.47 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 72.0 110.93 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.23 -49.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 54.52 110.916 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 10.4 t30 57.98 88.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 63.14 110.871 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.23 -170.27 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 73.34 110.897 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.96 169.36 18.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 74.21 110.863 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -146.48 -172.6 3.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 74.41 110.874 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 21.1 t60 63.34 161.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.18 -0.464 . . . . 75.24 110.871 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.18 -170.01 2.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 74.34 110.932 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 1.5 m80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 71.15 110.862 -179.987 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.822 0.344 . . . . 74.05 110.901 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.38 -175.02 0.52 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 73.21 110.964 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.78 137.35 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 75.32 111.108 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -147.79 -67.41 0.25 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.159 -0.473 . . . . 75.0 110.825 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -173.03 170.53 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 75.34 111.111 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 9.7 tt -126.03 -37.28 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.23 111.111 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 34.8 m -146.15 -176.91 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 70.44 111.065 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 160.39 -164.39 34.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.737 . . . . 61.33 112.515 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.29 -75.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.35 . . . . 73.24 110.851 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -110.77 127.44 55.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 64.43 110.937 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.3 137.96 49.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 71.12 110.885 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.2 155.25 42.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 63.12 111.126 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.46 -24.69 10.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 71.34 110.91 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.29 137.09 4.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.858 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 16.6 mt -138.66 117.16 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 63.32 111.136 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 -134.6 115.9 14.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 74.53 110.844 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.7 p -135.75 136.63 40.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 74.35 111.094 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -144.44 167.19 23.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 73.33 110.895 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 64.93 68.07 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 71.33 110.831 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 46.35 52.09 10.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 73.3 110.87 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.08 149.98 24.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 74.43 111.126 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -131.47 139.27 49.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 74.14 110.883 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.94 124.24 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 74.05 111.098 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -113.06 132.89 55.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 75.42 110.911 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -122.34 134.69 54.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.941 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 109.0 -174.66 18.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 70.33 112.431 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -99.36 145.57 27.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.897 0.379 . . . . 74.44 110.911 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 88.1 t -122.19 131.54 72.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 74.23 111.132 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 66.7 t -122.16 129.15 75.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 64.35 111.101 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t -69.85 167.68 16.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 74.34 111.147 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.95 -33.91 76.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 73.4 111.129 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.97 -52.06 66.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.4 111.044 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.91 30.49 7.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 74.32 111.073 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.87 -30.4 23.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 75.35 110.987 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -126.65 132.47 51.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.809 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 106.85 -137.58 14.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.658 -0.782 . . . . 72.33 112.447 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 59.87 97.37 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.788 -0.72 . . . . 63.13 112.499 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 1.2 tt -158.26 142.15 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 74.14 111.123 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.56 29.78 7.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 71.3 110.875 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 7.3 pt -148.84 27.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 63.5 111.128 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 1.4 p -131.37 -171.0 2.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 73.21 110.839 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -120.41 106.84 12.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 71.32 110.908 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.93 169.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 70.15 110.876 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 96.1 m -65.0 138.11 58.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.44 111.144 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 7.7 m -114.14 123.1 48.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 73.55 111.111 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -126.37 146.7 49.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.894 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 12.8 m -136.99 123.44 20.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 72.32 110.817 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.47 133.9 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 74.04 111.127 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.64 -69.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 73.35 110.831 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 92.9 m -143.85 133.39 23.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.13 111.169 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.16 125.88 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 73.53 111.181 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 59.9 t -127.11 125.67 66.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 64.12 111.124 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.63 133.74 8.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.769 -0.729 . . . . 71.24 112.532 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.63 138.34 48.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.831 0.348 . . . . 75.04 110.925 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.5 86.28 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.72 -0.752 . . . . 71.04 112.499 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 51.08 81.66 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 74.32 110.871 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 44.8 t -113.54 145.23 41.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 74.0 110.909 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.61 127.5 39.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 64.42 110.833 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.05 123.72 48.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 62.23 111.104 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.37 111.5 13.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 73.15 110.94 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.74 130.17 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 71.54 111.124 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.05 172.47 16.2 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.791 -0.719 . . . . 75.42 112.549 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -89.94 141.97 28.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.329 . . . . 75.02 110.888 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.17 136.74 54.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 70.13 110.884 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -117.26 125.75 51.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 74.25 110.953 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.38 -118.53 6.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 50.12 112.528 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 72.74 157.62 3.9 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.776 -0.726 . . . . 71.3 112.443 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -56.02 -25.33 44.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.803 0.335 . . . . 74.44 110.873 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -171.58 -35.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 74.52 112.513 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -152.93 -72.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.314 . . . . 73.1 110.917 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -142.08 -73.28 0.31 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 74.43 110.831 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -173.02 55.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 55.24 110.837 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -59.12 178.75 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 73.03 110.87 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 -177.66 4.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 74.21 110.859 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -85.22 -170.0 2.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 70.43 110.882 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -54.56 172.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 75.41 110.89 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -88.95 -64.5 1.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 73.5 110.844 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -137.2 -47.74 0.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 74.22 110.861 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 71.25 110.857 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.795 0.331 . . . . 65.45 110.872 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -116.4 -27.09 6.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 75.43 110.915 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 2.7 mt -104.75 127.67 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 75.13 111.136 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -178.65 52.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 71.03 110.908 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -168.58 135.41 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 71.24 111.069 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 30.2 mm -135.39 123.62 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 72.53 111.109 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 16.6 m -147.63 170.51 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 74.43 111.09 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 141.61 -168.07 25.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.829 -0.701 . . . . 74.35 112.501 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.91 -75.55 0.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 75.44 110.939 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -89.19 137.31 32.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.911 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.9 147.21 44.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 73.44 110.839 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.83 162.08 29.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 61.53 111.095 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' E' ' 265' ' ' GLU . 3.5 mttm -116.34 -27.32 6.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 75.32 110.884 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -165.85 137.26 3.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 65.35 110.807 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 15.2 mt -138.07 117.54 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 75.11 111.083 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 15.5 ttt-85 -134.46 118.08 16.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.43 110.825 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 2.3 p -135.52 147.4 48.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 72.44 111.133 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -156.32 166.87 32.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 74.03 110.886 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 64.08 68.91 0.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 75.14 110.901 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 50.42 31.43 5.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 74.24 110.873 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.64 140.65 30.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 71.4 111.064 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.49 137.67 50.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 72.22 110.89 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 6.2 p -130.38 121.95 52.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 64.4 111.084 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.94 136.85 52.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 74.41 110.877 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -124.21 134.16 53.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 75.32 110.869 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 109.18 177.56 21.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.693 -0.765 . . . . 74.3 112.441 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -90.05 148.95 22.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.833 0.349 . . . . 75.3 110.895 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 95.8 t -122.08 131.09 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 63.32 111.145 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 95.4 t -120.8 127.56 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 73.02 111.116 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.6 t -76.84 171.29 14.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 63.53 111.211 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.56 -33.98 76.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 65.42 111.066 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -51.56 68.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 73.55 111.071 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 62.52 -171.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 72.22 111.076 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.61 171.39 1.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 70.23 110.956 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -55.25 -29.61 58.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 75.34 110.83 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -162.34 151.21 21.06 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.757 -0.735 . . . . 44.4 112.485 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -175.14 154.41 18.07 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.761 . . . . 73.04 112.481 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.21 -43.48 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.814 0.34 . . . . 74.35 111.148 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -159.22 69.03 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 74.01 110.857 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.06 173.33 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 72.25 111.069 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -178.68 147.23 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.896 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -109.85 163.16 13.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.115 -0.493 . . . . 75.21 110.879 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -153.04 121.21 6.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 73.14 110.831 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 96.2 m -96.78 134.47 40.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 73.53 111.13 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 85.9 m -91.89 116.06 28.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.137 -0.483 . . . . 65.14 111.153 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -126.12 138.19 53.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.484 . . . . 70.44 110.903 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.42 128.81 53.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 70.24 110.847 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -125.55 137.73 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 73.2 111.188 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . 0.418 ' HA ' ' HB2' ' E' ' 229' ' ' LYS . 17.5 mt-10 -82.97 -74.72 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 75.2 110.928 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 38.9 p -142.54 128.06 19.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.54 111.132 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.76 120.84 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 74.31 111.162 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 81.9 t -115.72 121.57 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 74.15 111.176 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.45 132.54 10.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.758 -0.734 . . . . 74.43 112.521 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.84 139.45 46.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 72.51 110.85 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.84 88.47 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 41.42 112.512 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 49.59 75.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.872 0.368 . . . . 73.41 110.917 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.23 145.38 30.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 55.1 110.863 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -132.83 127.63 34.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 74.02 110.839 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 74.9 t -133.69 122.97 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 71.25 111.135 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.19 111.34 12.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 61.1 110.88 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 9.7 mt -112.59 105.84 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 71.03 111.106 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.9 -158.57 28.19 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.787 -0.721 . . . . 63.23 112.448 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -127.96 145.73 50.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.758 0.314 . . . . 75.52 110.871 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -111.89 122.27 47.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 73.11 110.86 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.25 125.94 51.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 73.22 110.985 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 67.72 150.1 0.2 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.725 -0.75 . . . . 72.32 112.418 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.46 -23.77 1.21 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.683 -0.77 . . . . 74.52 112.434 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 2.2 mttp 52.51 55.28 9.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.363 . . . . 71.44 110.917 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 179.32 -109.47 0.27 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.739 -0.743 . . . . 64.41 112.516 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -175.02 167.82 3.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.847 0.356 . . . . 72.43 110.82 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -51.8 -74.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 73.54 110.917 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -68.53 167.86 14.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 65.51 110.882 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.04 157.45 5.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 73.33 110.916 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -172.82 138.43 0.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 73.54 110.945 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.32 -170.0 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 74.12 110.833 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -127.59 165.15 20.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 73.43 110.885 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.58 174.22 5.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 73.34 110.85 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -155.11 -42.82 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 73.21 110.854 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 74.51 110.899 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 9.4 tpt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.8 0.333 . . . . 74.35 110.877 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -178.18 76.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 73.25 110.962 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 14.4 tt -113.5 -25.52 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 73.33 111.108 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -54.17 145.09 18.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 75.05 110.846 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -89.97 -175.38 4.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 72.34 111.11 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 3.3 pt -151.25 172.76 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.33 111.123 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 24.2 t 53.7 87.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 75.24 111.076 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 69.26 109.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.798 -0.715 . . . . 54.25 112.468 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.54 144.5 24.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 74.31 110.845 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.57 109.83 10.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 74.04 110.879 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 1.5 t -125.43 141.81 51.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 62.32 110.896 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.83 119.68 12.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 73.34 111.053 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -74.65 -33.39 62.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 74.34 110.92 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -164.92 138.93 4.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 71.22 110.872 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 10.3 pt -137.35 119.01 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 73.51 111.116 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.85 120.64 37.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.931 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.1 p -129.44 139.18 51.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.216 -0.447 . . . . 74.25 111.108 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -146.53 167.5 23.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 74.33 110.899 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 66.61 65.87 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 75.21 110.944 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 48.85 36.5 8.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.886 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.24 155.83 21.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 74.5 111.121 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -131.71 145.6 51.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 74.24 110.897 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.05 121.83 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 74.43 111.2 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -114.54 129.74 56.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 74.44 110.927 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 118.53 33.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 62.4 110.891 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.72 174.87 13.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 71.12 112.54 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -90.92 154.79 19.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 71.42 110.897 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.02 123.99 57.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 74.54 111.11 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.07 125.73 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 63.53 111.104 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t -69.98 175.06 4.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 74.43 111.189 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.94 99.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 62.22 111.125 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.21 -47.82 80.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 74.14 111.057 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -80.23 136.71 36.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 70.5 111.085 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.8 tp -118.07 -171.6 2.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 75.02 110.899 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.82 -40.27 72.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.925 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 91.84 -159.37 25.65 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.661 -0.78 . . . . 74.54 112.54 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 156.47 62.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 65.01 112.493 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.77 143.59 40.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.896 0.379 . . . . 75.54 111.119 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 -81.15 57.52 3.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 70.51 110.935 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 13.5 tt -174.73 138.66 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.33 111.099 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.56 -179.8 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 75.02 110.87 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -104.82 -179.25 3.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 74.45 110.844 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -120.81 38.99 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 74.13 110.939 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 24.4 p -65.21 124.79 23.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 73.2 111.127 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 98.0 m -134.02 124.71 26.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.212 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.53 121.04 42.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 74.0 110.857 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.553 ' HG ' ' N ' ' C' ' 217' ' ' MET . 0.1 OUTLIER -141.11 123.81 16.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 72.41 110.842 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.9 p -119.21 139.58 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 72.23 111.177 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.09 -71.28 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 72.11 110.875 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.6 m -124.19 136.09 53.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 74.23 111.081 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 19.4 t -120.27 133.5 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 74.42 111.175 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.49 127.13 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.33 111.165 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.38 133.39 8.38 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.747 . . . . 52.41 112.42 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.61 147.94 51.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 74.33 110.886 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.18 81.6 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 64.23 112.503 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 46.45 65.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 74.51 110.907 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 42.2 t -89.63 145.68 25.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 72.3 110.783 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -119.53 127.9 53.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.088 -0.506 . . . . 74.41 110.88 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 98.8 t -124.38 123.03 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 73.55 111.111 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 27.6 tp -128.71 111.7 13.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.964 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 26.3 mm -110.86 104.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.24 111.131 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.73 170.92 18.4 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 75.51 112.455 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -90.45 137.81 32.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.774 0.321 . . . . 74.22 110.927 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -111.95 120.27 41.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 74.14 110.923 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.6 125.91 51.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 74.21 110.967 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 118.5 169.95 14.71 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.661 -0.781 . . . . 60.23 112.427 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -67.42 -119.81 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.737 -0.744 . . . . 65.41 112.488 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.53 27.07 7.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.336 . . . . 74.41 110.913 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.02 -103.04 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.762 -0.732 . . . . 74.11 112.458 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -132.08 146.02 51.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.361 . . . . 75.21 110.869 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER 67.28 -78.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 75.05 110.904 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -138.04 172.61 12.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 74.13 110.935 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -57.42 149.75 20.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 75.5 110.856 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -157.5 40.77 0.3 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 72.33 110.864 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 59.91 98.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 70.1 110.896 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -109.03 150.54 27.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 75.5 110.87 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.87 175.69 3.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.849 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 61.48 99.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 74.45 110.869 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 23.6 p80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 73.14 110.917 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 2.2 ptm . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.83 0.348 . . . . 74.54 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -109.28 100.87 9.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.424 . . . . 73.43 110.904 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 3.8 mt -99.01 -29.38 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 70.03 111.052 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 59.5 175.63 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 72.13 110.801 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -172.27 45.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 74.25 111.081 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 1.4 pt -105.48 65.07 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 75.34 111.181 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.12 155.23 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 73.42 111.116 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -116.17 -178.67 18.2 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.727 -0.749 . . . . 75.35 112.454 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -171.72 132.26 0.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.752 0.31 . . . . 75.21 110.865 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.06 109.43 6.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 63.51 110.915 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 22.1 t -126.83 145.96 50.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 61.33 110.87 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -139.89 119.76 13.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 73.34 111.076 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -35.76 77.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 65.04 110.968 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -165.4 138.28 4.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 73.33 110.899 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 31.5 pt -132.86 131.25 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 73.44 111.071 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -134.5 125.16 26.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 73.52 110.856 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.75 128.73 37.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 72.44 111.136 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -134.97 167.4 20.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 73.53 110.883 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 63.06 68.99 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.12 110.918 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 2.6 mtm-85 47.65 40.76 12.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 71.52 110.905 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.74 156.14 17.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 73.13 111.086 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.64 148.41 50.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 73.34 110.905 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 4.1 p -138.28 121.53 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 70.12 111.172 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -111.2 129.2 56.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 73.51 110.859 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.79 118.55 34.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.483 . . . . 75.31 110.973 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.24 179.75 16.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.721 . . . . 73.45 112.514 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -87.42 144.51 26.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 73.2 110.918 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 4.7 p -118.88 119.86 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 73.22 111.141 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.35 128.32 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 74.35 111.237 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 48.9 p -80.19 173.92 12.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 72.13 111.172 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.04 96.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 73.23 111.087 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.54 -51.58 68.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 72.4 111.125 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.92 129.2 26.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 73.34 111.151 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 2.0 mt -143.16 -50.5 0.34 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.175 -0.466 . . . . 75.13 110.858 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -157.9 132.48 8.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 74.31 110.881 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -162.19 161.18 33.28 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.747 -0.739 . . . . 74.55 112.518 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 137.64 -72.62 0.44 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.72 -0.752 . . . . 73.13 112.522 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 37.1 mt 63.01 69.87 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.756 0.313 . . . . 63.14 111.101 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 56.9 93.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 75.15 110.89 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.5 pt -143.59 176.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 74.41 111.112 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.79 98.42 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 73.44 110.843 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -150.44 76.83 1.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 75.0 110.857 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.05 98.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 71.44 110.901 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 35.5 p -100.86 121.99 42.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 71.51 111.104 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 2.1 t -126.69 127.27 44.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.429 . . . . 65.11 111.192 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.59 129.03 56.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 75.42 110.887 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.9 t -140.95 122.9 15.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 73.11 110.879 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 4.8 p -112.93 141.97 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.484 . . . . 64.24 111.092 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -80.7 -77.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 74.32 110.886 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 18.9 m -120.87 133.71 55.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 65.21 111.099 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . 0.405 ' HA ' HG13 ' C' ' 231' ' ' ILE . 3.2 t -117.69 124.5 73.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.14 -0.482 . . . . 75.01 111.088 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 59.7 t -123.66 116.02 46.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.495 . . . . 65.25 111.12 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.58 133.33 10.83 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.723 -0.751 . . . . 61.54 112.511 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.35 147.58 51.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.323 . . . . 65.03 110.965 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.94 84.1 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.713 -0.756 . . . . 73.03 112.496 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 46.1 64.98 1.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.808 0.337 . . . . 75.32 110.865 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 27.9 t -93.94 145.61 24.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 74.24 110.838 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.46 128.02 50.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 72.42 110.833 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 78.5 t -122.95 123.7 68.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 75.41 111.133 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.55 111.64 14.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 75.13 110.924 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 27.0 mm -109.59 104.64 17.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 74.31 111.104 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.76 175.87 18.28 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.691 -0.766 . . . . 50.3 112.453 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -89.9 154.99 19.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 72.25 110.834 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -128.72 146.87 50.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 73.12 110.868 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.44 125.85 42.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.932 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 128.97 -147.88 17.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.669 -0.777 . . . . 75.54 112.474 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -128.62 -145.09 5.92 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.837 -0.697 . . . . 61.12 112.508 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 63.27 78.82 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.874 0.368 . . . . 73.35 110.867 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.12 -108.61 0.68 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.761 -0.733 . . . . 70.44 112.458 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.06 -60.06 1.79 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 75.33 110.922 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -143.18 14.56 1.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.02 110.872 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.21 -171.72 1.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.411 . . . . 74.1 110.909 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -123.59 92.1 3.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 64.4 110.904 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 72.9 t60 61.62 100.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 73.11 110.872 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -159.58 146.22 16.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 73.41 110.847 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 61.94 100.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 72.04 110.818 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -147.21 97.19 2.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 74.42 110.823 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -176.07 172.2 2.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 70.12 110.833 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 62.21 110.864 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 217' ' ' MET . . . . . 0.553 ' N ' ' HG ' ' A' ' 263' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.787 0.327 . . . . 74.4 110.884 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -141.79 138.98 32.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 75.34 110.866 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 33.2 mm 59.36 92.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.42 111.124 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.96 116.67 6.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 65.13 110.827 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -92.16 139.54 30.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 73.12 111.13 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 39.1 pt -81.87 156.77 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 74.01 111.152 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 27.7 t 53.33 85.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 73.41 111.13 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -65.59 -162.89 1.0 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.705 -0.76 . . . . 71.43 112.524 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.87 -44.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.868 0.366 . . . . 71.11 110.883 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.58 110.49 6.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.43 110.953 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.4 t -130.86 141.09 50.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 75.52 110.863 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.16 135.16 46.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 74.33 111.127 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -29.92 21.01 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.218 -0.447 . . . . 72.42 110.909 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.81 136.61 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 64.14 110.883 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . 0.405 HG13 ' HA ' ' B' ' 267' ' ' VAL . 3.7 pt -138.4 117.52 14.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 73.41 111.113 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -122.12 116.46 24.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 74.11 110.866 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 2.6 p -124.11 128.76 49.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 72.54 111.143 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.48 167.5 21.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 74.44 110.904 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 64.33 74.72 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 74.53 110.906 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 44.38 38.65 2.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 73.31 110.829 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -93.16 156.17 17.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 74.44 111.1 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.24 156.17 49.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 74.11 110.901 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 7.8 p -138.19 146.92 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 72.54 111.117 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -134.75 137.49 43.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 75.04 110.901 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.88 124.89 40.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 75.01 110.92 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.52 178.09 16.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.676 -0.773 . . . . 72.41 112.489 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -86.47 157.02 19.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 64.45 110.864 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 5.4 p -128.69 135.4 62.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 74.34 111.176 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.09 127.96 75.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 74.23 111.132 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 27.9 p -83.8 162.89 20.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 74.41 111.136 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.23 -34.27 76.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 63.32 111.161 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.95 -51.16 70.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.141 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 63.69 169.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 74.21 111.118 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.41 111.03 4.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.436 . . . . 73.33 110.907 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -107.27 28.24 8.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 70.43 110.798 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -177.46 116.68 0.55 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.735 -0.745 . . . . 73.05 112.499 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 111.72 -21.06 21.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 73.53 112.503 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 15.3 mt 70.72 -70.51 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.866 0.365 . . . . 75.5 111.086 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.83 131.96 8.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 75.35 110.913 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.36 26.38 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 72.45 111.099 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 4.2 m 62.96 162.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 72.01 110.867 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -173.3 136.29 0.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 60.24 110.856 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -160.89 50.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 75.54 110.913 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 27.1 p -90.1 126.08 35.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 64.14 111.124 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.8 m -107.46 108.68 20.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 74.5 111.155 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.15 130.6 46.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 72.12 110.886 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 29.3 t -142.05 123.26 14.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 75.44 110.798 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.04 148.06 18.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 54.15 111.154 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.94 -72.77 0.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 71.32 110.858 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 27.7 m -129.08 137.54 51.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 75.01 111.066 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 4.2 t -118.79 129.54 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 71.25 111.108 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 73.1 t -127.13 115.96 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 74.34 111.183 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.8 133.04 9.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.727 . . . . 75.41 112.475 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -133.74 147.68 51.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.351 . . . . 74.53 110.941 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.56 89.13 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.769 -0.729 . . . . 64.44 112.499 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 44.8 60.59 2.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.804 0.335 . . . . 75.13 110.873 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.28 144.98 25.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 73.33 110.874 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.59 128.07 48.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.487 . . . . 74.04 110.951 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 94.2 t -123.44 123.56 67.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 64.14 111.159 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.58 111.69 14.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 74.3 110.925 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 27.4 mm -108.32 104.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 73.45 111.134 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.42 -164.65 29.04 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.814 -0.708 . . . . 72.55 112.606 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -122.01 156.01 34.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.314 . . . . 72.13 110.91 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -119.51 146.7 45.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 74.53 110.903 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -129.94 134.89 47.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 72.24 110.902 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.49 148.4 20.46 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 64.42 112.549 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 51.77 -161.55 1.89 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 74.43 112.462 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -131.99 -169.47 2.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 74.45 110.934 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 81.2 139.02 2.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.784 -0.722 . . . . 52.3 112.427 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -45.74 -39.64 8.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.782 0.325 . . . . 72.3 110.91 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 4.0 p90 179.67 -29.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.156 -0.475 . . . . 72.41 110.899 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.38 -169.37 1.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 73.21 110.807 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 63.75 106.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 74.31 110.93 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -115.77 -172.09 2.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 74.24 110.9 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -75.07 132.58 41.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.454 . . . . 74.0 110.845 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -119.25 -176.49 3.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 75.51 110.844 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -139.74 -177.76 5.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 71.51 110.877 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.04 -169.88 1.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.22 110.883 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 64.35 110.897 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.885 0.374 . . . . 74.34 110.821 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 161.13 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 74.32 110.811 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 73.6 mt -137.31 -71.45 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 72.33 111.084 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -173.7 -170.12 0.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 75.44 110.856 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.15 -169.81 2.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 75.34 111.144 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 3.7 mp -128.62 118.01 46.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 72.41 111.108 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 22.3 t -145.06 65.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 72.04 111.138 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 79.77 -125.89 7.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.737 -0.745 . . . . 71.53 112.458 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.35 -167.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 72.31 110.863 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.3 115.63 22.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 64.32 110.859 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.16 138.43 48.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 75.34 110.823 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.19 119.81 15.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 63.34 111.09 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.41 -27.46 56.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 63.14 110.933 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.24 136.76 2.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 74.3 110.867 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 4.3 pt -139.35 117.17 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 72.21 111.067 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -126.54 128.98 47.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 73.14 110.882 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.14 128.83 32.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 75.42 111.164 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -133.16 167.34 20.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 75.45 110.943 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 63.88 72.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.469 . . . . 71.24 110.886 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 44.63 47.25 8.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 74.2 110.867 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.98 155.62 17.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 73.02 111.102 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.37 144.4 46.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 73.41 110.866 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 5.6 p -129.11 140.21 49.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 71.33 111.114 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -133.39 121.72 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 74.21 110.927 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.78 118.88 36.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 75.53 110.904 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.77 172.35 13.11 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.754 -0.736 . . . . 74.04 112.451 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -86.0 143.23 28.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.373 . . . . 73.1 110.938 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 4.4 p -110.23 128.76 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 75.1 111.158 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 23.1 t -122.02 128.94 75.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 71.03 111.198 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 30.5 p -86.14 174.17 9.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 73.04 111.154 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.37 -44.58 92.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 51.42 111.069 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.3 -51.23 70.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 73.33 111.121 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 52.07 -169.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 72.42 111.089 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 tp -90.92 -169.94 2.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 73.22 110.925 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -146.5 103.95 3.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.447 . . . . 72.45 110.834 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 111.65 160.96 16.37 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.724 -0.75 . . . . 75.02 112.496 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 101.93 110.82 3.4 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.626 -0.797 . . . . 71.23 112.465 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 16.2 tt -121.72 -34.31 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 74.31 111.195 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.91 170.67 16.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 63.43 110.873 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 18.9 tt -61.28 140.72 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.32 111.136 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.66 -170.33 2.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 74.14 110.831 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 63.26 104.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 74.02 110.838 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . 0.453 ' NE2' ' H ' ' E' ' 257' ' ' SER . 10.1 pm0 -105.15 27.4 8.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 53.34 110.942 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 35.4 p -85.18 129.94 34.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 73.0 111.098 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 76.9 m -134.13 125.54 28.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 73.42 111.165 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.71 122.16 43.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 74.11 110.925 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.1 123.54 14.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 73.11 110.786 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 8.0 p -122.76 138.56 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 72.01 111.149 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -72.09 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 74.41 110.898 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 72.9 p -124.48 135.65 53.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 71.34 111.108 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 7.7 t -119.08 130.51 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 71.23 111.1 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.38 120.79 55.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 73.2 111.108 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.46 132.64 9.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.766 -0.73 . . . . 74.42 112.542 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -134.35 149.15 50.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.79 0.329 . . . . 73.15 110.976 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.45 87.53 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 72.01 112.467 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 43.29 56.87 4.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 65.44 110.814 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 30.5 t -86.71 145.08 26.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 74.41 110.88 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.72 128.28 49.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 75.35 110.861 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 98.6 t -119.97 123.21 70.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.469 . . . . 75.34 111.116 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.46 113.33 15.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 74.24 110.955 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 29.9 mm -112.41 104.73 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 73.31 111.118 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.99 175.89 17.52 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.764 -0.732 . . . . 44.34 112.473 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -89.92 156.12 18.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 74.44 110.909 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -124.7 134.06 52.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 72.21 110.88 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -124.76 125.78 44.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.91 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 168.81 -152.2 19.67 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 72.41 112.51 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -78.83 57.95 4.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.687 -0.768 . . . . 75.11 112.516 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.13 -174.12 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.757 0.313 . . . . 74.44 110.901 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 66.87 144.46 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 71.13 112.534 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -59.73 -172.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 63.12 110.833 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 8.8 p90 -50.57 160.61 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.079 -0.51 . . . . 74.55 110.945 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 12.7 t0 51.75 87.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 65.05 110.929 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -55.5 111.93 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 64.24 110.89 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -95.05 -43.44 8.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 74.52 110.828 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -56.12 124.04 16.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.21 110.848 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -130.25 158.52 39.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 72.2 110.829 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -129.57 169.74 14.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.13 110.853 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 62.91 166.32 0.12 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.222 -0.445 . . . . 75.44 110.885 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 74.23 110.836 -179.963 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.843 0.354 . . . . 74.13 110.836 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -147.29 115.72 6.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 74.24 110.901 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 33.2 mm -131.12 118.18 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.34 111.095 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.58 -74.5 0.44 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 74.05 110.884 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.98 170.46 1.86 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 73.3 111.075 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 46.6 mm -127.58 -71.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 75.22 111.11 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 m -150.29 155.77 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 71.42 111.127 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 174.87 -130.08 1.7 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.754 -0.736 . . . . 74.32 112.455 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.28 -59.6 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 72.54 110.872 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.83 109.94 22.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 73.01 110.859 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 1.8 m -134.28 137.51 44.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 75.24 110.892 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -139.32 124.88 19.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 74.14 111.091 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.41 -25.88 60.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 74.52 110.922 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -167.15 137.26 2.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 75.55 110.91 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 23.5 pt -138.18 128.94 36.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 63.41 111.182 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -133.87 131.41 39.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 74.34 110.906 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.43 128.57 31.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 64.54 111.146 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -132.29 166.47 21.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.419 . . . . 74.51 110.896 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 64.53 69.71 0.5 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.474 . . . . 73.3 110.943 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 47.15 35.18 3.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 71.2 110.941 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.38 156.35 18.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.138 -0.483 . . . . 65.03 111.119 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -140.94 158.89 43.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 72.25 110.856 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 4.8 p -138.08 143.12 33.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 63.11 111.114 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -132.39 125.99 32.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.085 -0.507 . . . . 71.12 110.852 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -111.9 118.74 36.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 75.32 110.943 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.22 -173.83 20.21 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.758 -0.734 . . . . 73.1 112.524 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -104.97 154.76 19.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.925 0.393 . . . . 74.53 110.803 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 4.6 p -115.86 125.02 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 73.1 111.092 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 91.0 t -112.84 129.14 68.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 75.32 111.168 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 1.4 m -85.58 163.47 18.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 72.23 111.165 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.83 -34.85 68.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 71.43 111.132 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.07 -52.0 67.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 74.31 111.085 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 68.88 -77.31 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.23 111.113 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 51.91 82.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 53.14 110.885 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 56.0 64.51 1.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 73.11 110.928 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -70.95 -46.83 42.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.699 -0.762 . . . . 64.32 112.47 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 163.32 178.11 36.79 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.732 -0.747 . . . . 73.43 112.48 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 5.3 mp -139.98 -42.35 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 72.55 111.121 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 12.2 ttt-85 -175.48 103.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 73.2 110.847 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 51.5 mt 55.88 93.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 64.23 111.134 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 257' ' ' SER . . . . . 0.453 ' H ' ' NE2' ' D' ' 259' ' ' GLN . 11.7 t -98.81 -70.32 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 73.1 110.914 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.81 154.78 19.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 73.5 110.876 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.68 25.59 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 73.22 110.955 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 49.7 m -65.51 121.95 16.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 74.32 111.045 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 30.0 m -134.11 127.71 32.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 63.44 111.11 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.69 119.91 39.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 64.54 110.944 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 48.0 t -133.3 125.15 28.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 63.05 110.882 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 5.1 p -128.22 146.68 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 72.0 111.101 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.64 -64.94 1.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.873 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 2.5 m -135.85 138.13 42.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 71.12 111.17 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 7.9 t -126.48 130.84 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 64.23 111.136 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 5.7 p -128.37 124.01 61.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 71.11 111.101 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.77 138.99 15.04 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.718 -0.753 . . . . 60.31 112.475 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -132.93 148.84 52.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.779 0.323 . . . . 70.25 110.963 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.08 88.91 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.726 -0.75 . . . . 62.32 112.494 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 41.84 56.96 3.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.855 0.36 . . . . 53.11 110.925 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 30.2 t -83.92 145.01 28.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 62.15 110.815 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -126.29 127.88 46.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 74.02 110.898 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 99.6 t -116.93 123.52 71.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 73.11 111.155 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.77 111.83 13.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.885 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 29.4 mm -112.14 104.95 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 75.31 111.09 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.73 -165.06 28.82 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.791 -0.719 . . . . 62.42 112.505 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -116.48 156.01 27.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.343 . . . . 73.44 110.893 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -118.01 118.92 33.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 72.04 110.973 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -106.86 126.08 51.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 75.02 110.915 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 105.13 -35.23 5.2 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.724 -0.75 . . . . 75.35 112.466 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -66.59 -152.15 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 73.21 112.501 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.59 -58.34 1.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 73.31 110.812 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -152.84 -40.21 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.706 -0.759 . . . . 71.33 112.515 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -113.18 170.21 8.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.884 0.373 . . . . 74.53 110.901 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -95.31 25.19 4.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 75.42 110.88 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -174.5 49.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 64.24 110.81 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -140.77 125.82 18.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 72.43 110.879 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.71 -174.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 75.5 110.805 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -171.13 -38.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 75.34 110.843 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 61.83 83.01 0.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 74.33 110.865 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.83 152.77 24.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 73.03 110.803 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -56.25 118.49 4.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 73.35 110.846 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 74.52 110.841 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 6.7 mtp . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.856 0.36 . . . . 70.2 110.892 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.23 -169.8 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 64.23 110.831 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.0 mt -120.54 132.99 68.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 75.11 111.074 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -164.26 27.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 75.34 110.826 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.73 167.95 2.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 74.14 111.047 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 62.8 mt -63.7 -57.93 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 75.52 111.135 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 97.4 t -149.87 -72.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 64.32 111.202 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 67.76 122.95 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.759 -0.734 . . . . 51.41 112.516 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.85 60.95 1.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 75.03 110.895 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -142.42 135.72 28.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 75.25 110.821 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.99 137.48 54.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 74.55 110.818 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -127.65 119.64 26.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 71.32 111.096 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.19 -34.04 37.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 75.14 110.915 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.77 132.21 1.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.469 . . . . 72.21 110.907 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 9.9 pt -141.05 134.35 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 71.54 111.149 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -134.08 128.2 33.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 74.54 110.834 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.21 141.34 45.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 74.21 111.192 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -148.87 151.14 34.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 72.54 110.894 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 64.16 91.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 62.32 110.886 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 39.27 41.12 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 75.53 110.817 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -102.49 139.69 37.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 72.43 111.097 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.31 158.62 44.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 72.22 110.874 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 16.3 m -142.72 134.94 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 71.0 111.058 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.45 134.16 52.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 74.31 110.863 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.79 118.78 21.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.948 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.34 -121.16 3.07 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.692 -0.766 . . . . 72.21 112.465 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -144.39 129.15 18.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.931 0.396 . . . . 75.03 110.834 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.44 123.01 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.483 . . . . 71.43 111.169 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.0 m -121.97 129.05 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 75.14 111.154 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 14.6 t -70.0 162.88 27.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 72.54 111.108 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.11 -33.96 76.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 71.52 111.1 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.97 -35.91 69.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 73.11 111.125 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.47 105.55 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 61.51 111.126 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.9 mp 56.98 -179.26 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 71.41 110.871 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.97 -59.59 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 71.41 110.868 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.02 112.93 1.29 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 74.1 112.536 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 102.32 58.63 0.77 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.717 -0.754 . . . . 73.25 112.527 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 6.2 tp -89.98 142.03 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.837 0.351 . . . . 73.35 111.149 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -136.24 117.83 14.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 73.24 110.819 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 1.9 tt -52.1 146.06 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 74.04 111.1 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 17.7 p -114.01 67.02 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.53 110.791 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -54.92 126.94 26.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 64.21 110.888 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -179.12 -36.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 74.04 110.917 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.0 128.17 46.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 52.41 111.137 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 86.2 m -132.01 125.47 31.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 74.15 111.111 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -105.84 143.51 33.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 74.22 110.933 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.6 p -135.72 123.82 22.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 74.4 110.882 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -111.19 146.46 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 74.2 111.197 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.63 -64.73 1.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 74.32 110.852 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.3 m -138.8 127.94 24.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 74.4 111.207 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 13.8 t -118.4 132.12 69.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 74.14 111.133 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.31 115.16 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 74.34 111.13 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.07 133.37 10.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 53.44 112.482 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.72 141.99 48.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.818 0.342 . . . . 63.51 110.896 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.28 86.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 63.34 112.546 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 51.57 81.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 71.23 110.859 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 13.2 t -113.88 144.66 42.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 74.31 110.857 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 49.6 mtt85 -127.79 127.63 43.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 73.42 110.933 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 13.3 t -124.06 123.97 67.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 73.13 111.11 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 1.5 mt -115.15 111.75 21.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 74.33 110.927 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 47.2 mm -112.1 104.92 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 74.45 111.123 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.39 -146.58 18.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.683 -0.77 . . . . 75.43 112.479 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -117.45 150.59 38.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 72.21 110.908 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -129.54 133.76 47.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 71.42 110.821 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -114.42 126.06 54.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.864 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 132.57 150.95 6.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.69 -0.767 . . . . 72.35 112.454 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -116.37 -144.36 8.01 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 61.34 112.499 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.02 -75.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 74.22 110.899 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -117.8 92.63 0.55 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.762 -0.732 . . . . 72.32 112.494 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -52.36 114.05 1.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.35 . . . . 74.01 110.896 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 3.0 t90 72.36 -69.2 0.2 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.197 -0.456 . . . . 72.31 110.88 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -122.24 -169.97 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 72.41 110.808 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -52.21 137.23 28.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 74.21 110.928 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.19 141.22 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 73.43 110.876 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -171.3 142.41 1.72 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 74.53 110.884 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.89 170.29 1.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.784 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -174.32 155.66 2.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 73.51 110.853 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -127.6 -73.79 0.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 73.21 110.808 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 75.53 110.834 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 2.5 tpp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.849 0.357 . . . . 73.31 110.888 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.75 61.01 1.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.923 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 1.9 mp 70.99 -70.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 73.1 111.126 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 53.38 45.42 28.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 63.01 110.888 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -143.12 114.14 7.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 71.4 111.079 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 34.4 mm -136.47 73.09 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 75.24 111.137 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 6.1 m -152.42 179.18 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 72.41 111.075 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -66.03 156.78 49.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.755 -0.736 . . . . 73.43 112.507 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 5.2 mtt85 -179.19 120.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 74.4 110.825 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -103.51 137.01 42.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 73.32 110.911 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.83 137.65 54.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 73.52 110.91 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.35 139.51 49.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 75.52 111.107 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.32 -36.37 9.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 75.44 110.854 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -164.52 138.77 5.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 73.44 110.785 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -137.43 117.77 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 74.43 111.16 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.36 119.51 30.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 70.42 110.919 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.62 135.39 42.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 71.03 111.136 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -144.94 161.88 38.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 71.2 110.865 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 62.37 74.14 0.44 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.148 -0.478 . . . . 64.31 110.844 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 46.96 51.75 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 74.23 110.905 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.25 148.43 26.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 74.32 111.039 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.28 136.31 43.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 75.42 110.872 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.34 123.53 66.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.4 111.071 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -105.74 129.21 53.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 73.52 110.906 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 4.5 mp -125.62 118.65 26.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 74.55 110.892 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.9 -168.93 13.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.716 -0.754 . . . . 74.21 112.488 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -87.73 135.06 33.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.875 0.369 . . . . 74.25 110.842 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 6.8 p -119.0 123.95 72.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 72.43 111.147 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.1 129.14 75.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 72.13 111.126 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.1 t -76.74 168.89 19.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 64.33 111.159 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.07 -33.9 76.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 74.23 111.064 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.91 -35.89 69.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 74.43 111.066 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -57.43 99.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 72.3 111.113 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 24.8 tp -179.32 -48.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 75.44 110.911 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -52.14 151.69 3.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 73.13 110.863 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 91.72 -19.42 48.35 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.752 -0.737 . . . . 64.15 112.481 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 108.4 144.92 11.26 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.77 -0.729 . . . . 73.21 112.562 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 17.6 pt -51.75 131.6 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.864 0.364 . . . . 75.33 111.154 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.25 -74.33 0.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 75.44 110.83 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.1 mp 51.83 69.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 74.33 111.141 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.25 -170.14 2.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 52.43 110.846 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 63.4 161.21 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 74.42 110.844 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.6 82.45 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 75.43 110.909 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 27.8 p -98.64 124.86 43.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 74.52 111.122 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 3.9 t -119.99 139.95 51.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 74.03 111.136 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.3 145.51 48.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.2 110.918 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.3 t -142.11 123.51 14.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 63.0 110.853 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 9.0 p -118.16 139.15 46.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 74.51 111.08 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -83.24 -77.37 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.93 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 23.0 m -122.25 127.9 50.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 74.34 111.133 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 11.9 t -118.53 124.19 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 75.54 111.095 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.7 128.14 69.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 70.24 111.144 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -136.4 133.23 6.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.761 -0.733 . . . . 72.0 112.546 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -133.43 147.93 51.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.843 0.354 . . . . 74.51 110.891 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.24 90.55 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.714 -0.755 . . . . 71.0 112.498 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 43.73 56.3 4.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 75.15 110.888 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 2.3 t -86.85 145.05 26.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 71.4 110.872 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -132.47 127.5 35.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 74.14 110.861 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 5.9 t -125.66 130.15 72.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 75.14 111.149 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.17 112.07 17.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 75.12 110.991 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.81 115.18 49.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 71.43 111.181 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 122.87 -174.31 16.33 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.698 -0.763 . . . . 72.3 112.46 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -89.87 141.55 28.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 70.31 110.825 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -117.49 142.18 47.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 74.43 110.842 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -126.6 126.05 42.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 73.33 110.871 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 158.75 -55.74 0.36 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.782 -0.723 . . . . 71.41 112.504 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 83.93 -60.44 4.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.751 -0.738 . . . . 74.44 112.495 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -51.81 108.7 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.851 0.358 . . . . 74.51 110.903 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.08 95.38 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 32.24 112.503 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -51.72 132.6 31.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.808 0.337 . . . . 61.4 110.918 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 72.36 -69.03 0.2 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.876 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -138.25 -46.06 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 75.54 110.917 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.24 -173.03 4.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.888 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -110.75 140.07 45.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.463 . . . . 70.22 110.881 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -122.33 151.01 41.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 75.44 110.867 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -102.12 152.77 20.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 63.33 110.892 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.1 169.4 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 75.51 110.85 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.21 151.17 36.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 74.14 110.821 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 13.9 m170 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 73.53 110.825 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.878 0.37 . . . . 73.23 110.893 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.16 142.21 21.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 72.53 110.932 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 44.2 mm -117.38 -47.68 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 74.3 111.11 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 61.48 169.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.41 110.85 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 52.68 82.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 75.53 111.089 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 41.0 pt -144.17 148.64 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 74.43 111.109 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 65.8 t 52.98 80.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 65.11 111.112 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -141.57 -41.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 72.45 112.437 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.32 -44.79 4.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 72.11 110.871 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.91 124.99 21.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 64.01 110.879 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 3.6 t -131.71 137.88 48.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 71.34 110.861 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.7 150.8 51.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 73.44 111.114 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.84 -30.41 9.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 73.34 110.849 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -165.89 137.95 3.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 71.32 110.848 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 5.4 mt -138.8 117.44 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 73.4 111.162 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -132.19 121.5 23.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.13 110.888 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.6 144.1 47.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.106 -0.497 . . . . 73.02 111.046 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -146.75 166.74 25.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 71.34 110.89 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.49 67.58 0.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 72.2 110.881 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 46.73 56.96 5.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 75.22 110.863 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.66 149.72 25.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 75.44 111.05 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -130.54 135.82 48.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 74.15 110.871 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.02 123.19 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 74.45 111.156 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -105.58 129.73 53.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.923 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -125.78 118.86 26.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.902 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 121.31 -178.5 16.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.665 -0.778 . . . . 75.34 112.474 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -85.61 147.08 26.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 71.54 110.857 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.39 123.98 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 70.0 111.116 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.11 129.22 75.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 73.33 111.152 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 44.0 p -69.83 172.08 8.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 72.12 111.123 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.82 76.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 74.53 111.093 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.84 -35.84 69.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.418 . . . . 64.34 111.107 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.42 142.09 14.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 70.54 111.126 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.23 -59.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 73.05 110.942 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -168.87 89.48 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 75.54 110.883 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -54.06 -30.26 46.0 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.755 -0.736 . . . . 55.34 112.434 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 172.17 -94.29 0.1 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.738 -0.744 . . . . 72.13 112.45 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 32.1 mt -77.11 148.97 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.837 0.351 . . . . 71.24 111.07 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -88.35 76.99 8.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 72.01 110.835 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 4.4 tt -173.44 131.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 72.24 111.081 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 8.4 t -166.95 -169.97 1.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 65.41 110.868 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -117.31 164.97 14.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.896 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -108.12 138.84 43.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 72.03 110.925 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 45.9 p -101.09 138.04 38.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 70.13 111.111 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 75.9 m -120.45 139.27 53.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 70.34 111.106 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.18 132.13 51.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 72.54 110.901 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.56 123.56 28.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 61.4 110.883 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.09 142.82 40.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 70.32 111.197 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -87.21 -74.62 0.43 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.2 -0.455 . . . . 70.52 110.914 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 87.0 m -128.57 129.17 45.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 74.31 111.171 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.67 120.68 64.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 70.22 111.054 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.89 126.32 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 73.21 111.076 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.63 133.4 7.85 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.744 -0.741 . . . . 74.31 112.496 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -133.02 148.27 52.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.784 0.326 . . . . 72.04 110.925 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.74 84.73 0.02 OUTLIER Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.68 -0.771 . . . . 64.52 112.499 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 45.39 63.19 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 62.14 110.855 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 27.5 t -91.91 145.23 24.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 74.52 110.853 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -131.66 127.61 37.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 74.41 110.882 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 15.1 t -126.74 131.11 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 62.41 111.151 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.47 111.62 17.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 74.0 110.841 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 51.7 mm -112.22 107.72 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 75.53 111.169 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.05 172.73 12.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 71.3 112.459 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -89.9 147.42 23.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.352 . . . . 73.43 110.869 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.13 131.58 56.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 73.21 110.887 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -121.85 133.8 54.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 72.44 110.935 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 134.94 155.76 7.5 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.763 -0.732 . . . . 54.0 112.436 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -93.75 -15.61 48.78 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.818 -0.706 . . . . 54.22 112.445 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -72.42 79.17 1.03 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 74.31 110.898 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 65.52 151.85 0.11 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 64.12 112.488 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -78.91 -32.38 45.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 75.44 110.869 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -150.0 35.7 0.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 62.43 110.913 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -179.36 -176.29 0.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 73.14 110.903 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -66.82 -169.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 73.24 110.904 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.17 -74.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 74.44 110.833 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 13.0 t60 53.75 90.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 71.34 110.944 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.81 114.04 0.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 71.2 110.847 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -178.86 41.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.863 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.16 163.78 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 74.34 110.801 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 13.1 m170 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 72.4 110.88 -179.967 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.834 0.349 . . . . 73.32 110.882 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -75.09 138.92 42.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 75.13 110.918 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 2.5 pp -120.16 -33.65 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 74.35 111.178 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 55.16 90.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 71.45 110.901 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.74 154.41 18.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 53.13 111.137 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 29.1 mm -132.4 118.41 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 72.25 111.116 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 6.4 m -56.77 109.16 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 62.2 111.091 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 68.26 131.77 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.841 -0.695 . . . . 75.53 112.475 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -173.2 -172.06 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.807 0.337 . . . . 73.24 110.86 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.66 110.66 18.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.907 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 12.7 p -126.06 143.12 51.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 75.42 110.832 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.09 156.89 48.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 63.23 111.17 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.47 -31.21 6.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 74.2 110.895 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.43 138.58 5.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 74.44 110.898 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 9.9 mt -137.66 117.81 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 75.22 111.143 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -132.9 120.49 21.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.22 110.826 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.97 139.27 44.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 63.42 111.137 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -144.8 166.45 25.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 74.24 110.895 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 61.17 68.15 0.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 74.3 110.848 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 47.44 55.61 8.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 70.15 110.916 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.07 149.01 25.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 71.43 111.054 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.77 135.98 47.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 74.53 110.898 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 5.3 m -127.07 121.99 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 74.05 111.129 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -105.94 132.83 51.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 75.32 110.844 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -129.94 118.64 21.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 71.45 110.964 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.27 176.59 14.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.737 -0.744 . . . . 53.23 112.508 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -85.99 149.56 25.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 75.32 110.894 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 3.4 t -120.54 115.05 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 75.31 111.159 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 6.1 m -122.16 129.39 75.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 75.14 111.108 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 11.5 t -69.16 175.2 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 75.35 111.133 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.76 -33.72 49.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 74.04 111.097 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.67 -51.94 66.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 71.24 111.062 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 54.93 -175.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.43 . . . . 72.53 111.123 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.51 -39.01 2.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 74.04 110.936 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.26 163.55 37.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 74.44 110.912 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -154.84 116.75 0.74 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.685 -0.769 . . . . 52.43 112.482 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -171.78 -147.49 5.74 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.779 -0.724 . . . . 71.12 112.51 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.92 114.1 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.758 0.313 . . . . 63.31 111.183 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -179.4 -169.73 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 74.12 110.803 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 2.0 pp -136.1 136.73 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 73.33 111.133 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.53 -50.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 72.41 110.876 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.0 107.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 71.11 110.837 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -76.44 -74.5 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 71.4 110.913 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 27.8 m -90.13 125.38 35.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 73.15 111.134 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 81.2 m -105.49 133.18 50.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.448 . . . . 64.12 111.109 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.11 137.17 53.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 71.53 110.868 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 10.0 t -142.05 123.74 15.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 70.24 110.889 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -126.06 145.07 34.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 74.42 111.138 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -88.83 -76.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 74.01 110.927 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 48.0 m -127.05 128.1 45.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 72.51 111.117 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.02 120.86 65.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 73.45 111.195 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.42 125.88 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.251 -0.431 . . . . 73.2 111.125 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.62 133.67 8.18 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.75 -0.738 . . . . 61.15 112.524 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.38 147.82 51.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 74.2 110.878 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.79 86.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 73.02 112.507 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 47.62 69.39 0.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.374 . . . . 70.3 110.899 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 19.3 t -100.19 145.35 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 73.32 110.82 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -135.35 128.02 30.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 74.51 110.855 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 14.2 t -128.87 124.22 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 71.34 111.101 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.54 114.37 25.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 73.54 110.917 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 38.1 mm -112.03 104.95 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 72.44 111.095 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.55 -174.54 22.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.738 . . . . 74.41 112.521 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -106.78 148.35 28.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 73.4 110.833 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.75 133.86 54.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 75.44 110.893 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -129.37 125.27 36.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.524 . . . . 74.2 110.95 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.23 -139.92 11.1 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.65 -0.786 . . . . 64.24 112.448 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -118.57 -120.52 2.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.76 -0.733 . . . . 75.13 112.444 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt 56.95 24.25 9.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 75.13 110.931 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 76.07 -68.26 2.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.753 . . . . 73.53 112.478 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -161.26 -75.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 71.35 110.886 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -118.7 34.63 5.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.502 . . . . 73.11 110.848 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 51.98 83.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 72.43 110.838 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.9 -171.86 0.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 71.44 110.815 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -99.61 -170.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 73.32 110.82 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -77.95 -74.59 0.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 73.02 110.816 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.13 -169.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 74.13 110.895 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -144.65 50.95 1.26 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 72.33 110.825 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -149.74 172.94 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 62.11 110.839 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 73.0 110.809 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.809 0.337 . . . . 73.42 110.874 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -115.57 177.95 4.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 75.34 110.858 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 3.7 mp -136.18 -66.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 73.51 111.118 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.67 -172.3 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 71.55 110.84 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -134.92 154.43 51.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 72.41 111.064 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 2.2 mp -129.59 146.41 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 71.22 111.159 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 23.3 t -117.32 143.12 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 64.33 111.204 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 152.91 155.36 7.08 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.695 -0.764 . . . . 60.25 112.445 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.95 -75.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.361 . . . . 73.24 110.873 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.45 118.5 13.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 45.42 110.867 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.44 146.31 48.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 73.13 110.801 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.57 155.54 49.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 74.32 111.129 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.05 -27.82 10.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 75.23 110.962 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.36 139.03 5.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 73.35 110.911 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 10.5 mt -137.32 117.49 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 72.04 111.13 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -131.92 116.75 17.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 75.2 110.93 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.13 134.29 42.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 74.34 111.172 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.96 160.66 40.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 71.22 110.867 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 65.13 74.9 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 73.14 110.919 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 45.52 52.99 8.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 72.11 110.892 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.48 141.22 36.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.274 -0.421 . . . . 72.24 111.106 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -132.37 137.84 47.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 75.52 110.875 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.16 137.78 51.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 70.14 111.156 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -124.14 134.26 53.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 64.41 110.921 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.28 126.68 44.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 71.24 110.896 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 127.43 179.97 16.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 55.31 112.478 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -88.05 161.56 17.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 55.14 110.882 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 98.9 t -132.68 121.98 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 54.22 111.175 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.24 128.91 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 71.23 111.144 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.8 t -69.77 174.02 5.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 74.43 111.167 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.03 78.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 72.31 111.066 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.83 -35.82 69.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 63.22 111.142 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.36 105.43 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 75.24 111.049 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -175.61 110.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 74.44 110.925 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 63.32 103.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 75.05 110.832 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -93.35 -144.03 14.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.732 . . . . 74.31 112.489 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -150.82 -89.52 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.705 -0.759 . . . . 71.13 112.534 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 2.1 tt -51.81 145.78 2.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.862 0.363 . . . . 75.43 111.08 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.61 120.76 42.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 74.21 110.907 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.19 -27.06 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 73.03 111.084 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 21.4 m 61.18 -171.44 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 75.45 110.892 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 63.49 105.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 54.21 110.869 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -84.44 171.49 12.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 75.42 110.912 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 30.7 m -101.08 138.07 38.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 71.33 111.127 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.23 132.09 53.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 72.3 111.163 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -126.14 122.9 37.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 65.1 110.851 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 3.4 m -127.48 124.06 37.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 61.44 110.866 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.8 125.34 72.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 74.44 111.116 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -61.07 -77.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 72.34 110.888 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.81 135.76 28.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 63.42 111.179 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 39.8 t -118.35 129.35 74.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 74.43 111.053 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 79.4 t -127.32 124.69 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 73.52 111.109 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.02 132.66 8.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 64.14 112.518 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -133.42 116.96 16.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 74.22 110.944 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 71.8 84.46 0.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.739 . . . . 74.34 112.487 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 56.22 86.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 74.14 110.913 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 11.7 t -119.96 145.56 46.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 74.44 110.844 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -137.03 128.22 27.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 71.31 110.878 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 57.4 t -128.93 132.22 67.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 74.04 111.099 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -128.39 111.71 13.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.886 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 24.9 mm -108.74 138.58 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 75.21 111.183 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 110.85 -155.84 15.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 52.51 112.52 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -128.12 149.65 50.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 73.52 110.908 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.91 133.28 54.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 74.04 110.887 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -126.38 125.56 42.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 75.11 110.884 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 153.88 -151.13 22.89 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 63.03 112.528 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -56.69 -178.34 0.43 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.816 -0.707 . . . . 74.45 112.491 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.26 -19.5 61.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.877 0.37 . . . . 75.4 110.918 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -51.8 103.25 0.1 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.707 -0.759 . . . . 71.42 112.535 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -60.0 -75.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.841 0.353 . . . . 71.23 110.919 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -130.32 25.24 5.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 75.42 110.899 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.19 -169.96 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.241 -0.436 . . . . 74.0 110.893 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -58.53 172.97 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 72.42 110.922 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -65.28 -25.98 67.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 73.34 110.844 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.32 175.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 74.54 110.874 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 57.2 t60 62.88 97.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 73.42 110.812 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -103.55 174.85 5.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 71.54 110.871 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -170.18 176.85 4.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 73.2 110.829 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 4.4 m80 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 74.33 110.873 179.975 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.888 0.375 . . . . 72.52 110.859 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.99 149.43 27.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 75.4 110.958 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 10.7 tp -112.53 -30.79 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 74.34 111.179 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -174.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 74.23 110.87 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.05 24.94 5.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 73.13 111.096 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 1.2 pt -130.59 107.12 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 65.43 111.131 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 11.1 p -123.96 147.7 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 74.32 111.089 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -124.9 -87.81 0.74 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.736 -0.745 . . . . 73.03 112.431 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 63.28 93.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.318 . . . . 72.03 110.888 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -112.71 130.98 55.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.269 -0.423 . . . . 63.12 110.9 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 2.3 t -121.8 137.66 54.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 72.43 110.841 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.93 129.63 21.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 75.44 111.027 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.3 -36.1 21.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 70.51 110.904 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -165.6 138.59 4.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 64.14 110.914 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.419 ' HA ' HG21 ' A' ' 267' ' ' VAL . 10.3 pt -138.33 134.49 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.21 111.101 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -134.34 129.26 35.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 74.54 110.923 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.68 148.14 51.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 75.15 111.14 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -150.47 167.45 27.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.453 . . . . 74.34 110.884 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.59 65.48 0.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 74.24 110.906 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 50.3 42.21 25.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 75.32 110.948 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.36 156.82 17.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.13 111.104 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.27 143.71 40.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.3 110.896 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.12 121.16 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.23 111.165 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -117.12 128.34 55.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.462 . . . . 75.32 110.923 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 5.8 mp -124.69 118.2 25.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.907 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.05 165.33 10.4 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 64.14 112.45 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -85.95 135.7 33.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.933 0.397 . . . . 71.54 110.812 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 6.4 p -116.12 122.21 69.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 75.34 111.115 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.08 128.93 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 74.32 111.21 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t -73.13 173.03 9.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 70.23 111.13 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.05 99.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.424 . . . . 72.52 111.149 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.16 -36.0 72.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 61.52 111.045 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.71 -42.77 62.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 70.53 111.086 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 58.17 178.34 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.269 -0.423 . . . . 64.22 110.875 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.62 128.26 46.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 71.23 110.851 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 81.65 160.25 25.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 75.14 112.446 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 112.13 40.0 1.21 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.77 -0.728 . . . . 74.15 112.445 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.62 -65.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.77 0.319 . . . . 73.21 111.077 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.18 104.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.13 110.847 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 16.4 tt -170.18 149.19 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 74.43 111.14 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 9.2 t -104.44 101.31 10.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 74.05 110.891 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -173.01 141.52 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 73.24 110.871 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -120.42 83.69 2.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 71.44 110.85 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 5.5 t -75.16 121.98 22.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 73.21 111.093 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 2.6 t -134.11 120.71 20.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 75.04 111.169 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -99.3 132.65 44.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 75.21 110.915 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.9 p -142.25 123.39 14.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 71.14 110.828 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.8 p -119.68 133.85 65.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 70.44 111.118 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -65.29 -69.84 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.12 110.823 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.2 m -131.64 135.78 47.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.52 111.186 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.419 HG21 ' HA ' ' A' ' 231' ' ' ILE . 15.5 m -127.33 136.04 61.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 72.33 111.17 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 36.6 t -127.19 137.32 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 73.13 111.156 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.43 133.61 7.18 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.676 -0.773 . . . . 74.54 112.489 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.63 148.54 52.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.748 0.308 . . . . 73.44 110.906 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.77 84.33 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 71.42 112.445 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 43.52 55.81 4.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 72.35 110.954 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 45.5 t -83.62 144.83 29.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.095 -0.502 . . . . 71.14 110.821 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.02 128.41 49.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 72.12 110.838 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 25.0 t -115.03 126.69 72.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 73.05 111.173 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.41 109.85 11.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.457 . . . . 75.41 111.008 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 19.6 mm -112.97 104.49 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 74.21 111.107 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.8 -147.01 17.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.815 -0.707 . . . . 61.12 112.518 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -128.07 155.66 44.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 72.4 110.929 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -122.31 118.94 29.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 63.51 110.926 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -109.45 125.89 52.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 74.12 110.866 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 62.3 176.07 2.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 75.23 112.509 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 120.7 16.12 4.66 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.772 -0.728 . . . . 73.55 112.492 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.1 mttm 59.9 69.41 0.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 74.31 110.891 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.51 174.26 23.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.795 -0.717 . . . . 53.03 112.55 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -60.4 -167.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 75.42 110.851 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -40.07 -77.98 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 71.34 110.887 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -176.68 147.32 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 73.31 110.84 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -113.69 -71.54 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 73.24 110.936 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -179.18 -34.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 71.22 110.819 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 63.55 105.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.34 110.85 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.9 -169.83 1.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 71.31 110.785 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -51.87 -30.1 22.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 74.34 110.918 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -168.43 177.76 5.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 74.31 110.886 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 22.0 m80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 74.14 110.843 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 7.7 ttp . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.874 0.369 . . . . 75.14 110.945 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -159.11 146.75 17.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 75.45 110.904 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 12.4 tt -143.95 142.31 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.102 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -148.97 138.68 21.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 74.21 110.893 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.43 -173.58 3.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 71.1 111.097 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 1.6 pt -139.42 131.48 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 74.25 111.11 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 10.7 p -160.31 152.12 5.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.189 -0.46 . . . . 72.22 111.069 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -54.4 129.9 44.29 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.731 . . . . 55.24 112.465 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -176.94 174.55 1.72 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.76 0.314 . . . . 73.44 110.907 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -125.68 128.06 47.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 72.35 110.857 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.86 141.57 51.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 65.2 110.858 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.17 128.12 25.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 75.33 111.149 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -40.11 39.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 74.33 110.871 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -166.51 138.1 3.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 71.15 110.854 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 5.3 pt -138.71 133.13 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 72.02 111.144 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -135.35 128.55 31.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 75.35 110.944 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.55 137.31 41.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 74.33 111.155 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 13.1 pm0 -141.59 166.65 24.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 72.41 110.903 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 65.96 67.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 75.23 110.79 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 18.9 mtt180 48.65 49.93 17.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.886 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.49 156.72 17.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 73.52 111.114 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 9.5 mtt-85 -134.29 142.9 47.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 73.01 110.872 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.21 124.76 69.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.485 . . . . 74.55 111.092 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.49 128.32 54.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 72.43 110.902 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.87 118.62 31.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 75.45 110.933 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.13 -177.91 16.48 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.748 . . . . 64.32 112.482 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -85.98 148.95 25.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 74.53 110.937 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 6.7 p -131.08 127.87 61.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 70.33 111.1 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 30.8 m -121.93 129.05 75.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 71.32 111.11 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 20.9 p -80.28 175.0 11.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 63.15 111.129 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.01 -45.29 93.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 71.02 111.082 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.55 -36.02 77.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 70.23 111.126 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.05 102.74 1.36 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 73.25 111.127 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 3.5 tt -164.19 -45.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 75.32 110.935 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -61.2 153.5 25.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.192 -0.458 . . . . 72.4 110.843 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 161.33 -107.17 0.3 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.774 -0.727 . . . . 74.4 112.524 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 175.13 -123.71 0.95 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.788 -0.72 . . . . 51.41 112.509 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.81 -35.26 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.857 0.36 . . . . 74.03 111.092 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 54.74 90.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 73.42 110.829 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 5.5 tt -153.61 141.27 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 63.13 111.128 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 27.1 t -151.32 161.23 43.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 71.22 110.896 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -56.23 175.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 72.32 110.823 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -90.18 75.09 7.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 75.42 110.875 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 7.3 t -74.17 130.89 40.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 75.32 111.167 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 90.6 m -133.04 108.89 9.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 75.04 111.115 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.82 136.12 33.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 73.24 110.878 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 19.5 t -142.51 123.15 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 73.34 110.859 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 4.0 p -119.34 140.09 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 70.33 111.116 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -78.1 -73.87 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 65.42 110.869 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.9 m -131.5 127.68 37.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 74.41 111.138 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 19.4 m -122.61 135.33 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 75.54 111.181 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 57.8 t -127.85 133.33 67.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 75.51 111.147 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.82 133.25 7.54 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.757 . . . . 75.01 112.464 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -132.4 148.56 52.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.332 . . . . 71.35 110.937 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.42 91.65 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.749 . . . . 71.01 112.484 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 40.44 51.14 2.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 64.11 110.866 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.05 144.55 29.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 71.53 110.88 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.47 128.19 45.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 72.42 110.907 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 26.2 t -118.79 124.61 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 74.42 111.105 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.52 111.49 14.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 71.24 110.917 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 35.6 mm -110.98 104.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 74.43 111.095 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.91 -142.81 10.68 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.711 -0.757 . . . . 63.13 112.431 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -123.26 147.37 47.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 75.41 110.809 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -111.99 129.77 56.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 73.22 110.895 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.11 130.36 52.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 75.05 110.92 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 81.95 159.25 24.32 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.765 -0.731 . . . . 70.14 112.499 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 126.1 -87.89 0.35 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.818 -0.706 . . . . 74.23 112.539 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.47 -51.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 71.11 110.858 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -130.2 -89.23 0.52 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.744 -0.741 . . . . 62.34 112.488 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -122.19 -34.03 3.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 71.0 110.864 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.68 -169.47 3.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.113 -0.494 . . . . 73.45 110.939 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.38 114.11 9.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.296 -0.411 . . . . 75.42 110.906 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -156.03 -49.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.208 -0.451 . . . . 74.24 110.87 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.34 -170.26 2.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 73.45 110.838 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.08 131.04 40.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 75.32 110.888 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -177.81 162.77 1.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 73.21 110.906 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -174.99 -178.22 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 75.52 110.837 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.77 -170.61 2.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 73.54 110.892 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.0 110.834 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 11.5 ttt . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.877 0.37 . . . . 73.13 110.856 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 6.2 ptpt -178.79 79.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 72.43 110.829 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 1.2 pp -146.76 133.61 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 75.25 111.128 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -176.15 44.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 63.45 110.895 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -173.04 127.39 0.46 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 73.33 111.094 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 30.9 mm -118.04 69.82 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 72.43 111.043 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 20.3 m -141.43 174.12 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 73.04 111.166 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 142.55 -142.63 11.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.736 -0.745 . . . . 70.03 112.466 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 14.4 mmt-85 -103.38 -17.65 15.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.811 0.339 . . . . 72.21 110.848 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -141.98 112.75 7.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 75.11 110.892 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 4.5 t -123.17 137.73 54.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 63.33 110.826 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.06 119.65 20.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 74.25 111.094 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -43.51 74.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 74.23 110.873 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -167.24 136.71 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.247 -0.433 . . . . 72.34 110.887 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 3.8 pt -138.13 131.79 41.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 74.53 111.129 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.09 128.37 30.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 74.12 110.891 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -135.46 144.97 46.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 74.5 111.138 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.88 166.73 25.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 74.21 110.907 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 66.96 68.27 0.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 74.22 110.864 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 46.66 53.92 9.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 74.21 110.871 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.23 156.89 17.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.051 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -132.23 141.3 48.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.34 110.885 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.06 121.01 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.41 111.132 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.78 117.27 30.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 74.3 110.905 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.82 118.94 36.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 64.34 110.943 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 122.75 -177.43 16.52 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.76 . . . . 63.31 112.481 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -85.95 131.94 34.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 61.44 110.834 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 3.1 p -116.34 122.52 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 73.04 111.068 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.88 129.27 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 71.24 111.148 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 59.3 p -69.8 175.2 4.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 75.4 111.093 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.12 -46.1 86.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 73.45 111.078 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -67.96 -36.74 80.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.21 111.114 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -53.34 150.68 6.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 73.45 111.162 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.66 118.75 3.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 65.34 110.849 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -52.2 -58.16 7.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 65.52 110.855 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 100.4 -87.71 0.72 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.678 -0.773 . . . . 71.25 112.493 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -148.7 111.37 0.53 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 75.12 112.552 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 5.4 mp -142.7 138.24 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.848 0.356 . . . . 74.13 111.095 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -170.43 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 75.33 110.785 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 2.6 mp -121.67 106.63 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 74.32 111.129 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 4.8 p -179.26 79.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.44 110.836 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 61.15 98.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 75.45 110.883 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.98 -171.49 2.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 74.31 110.951 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 7.6 t -64.97 124.56 22.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 75.13 111.128 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 6.5 t -134.16 141.4 47.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 73.31 111.118 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -113.88 143.04 45.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 73.43 110.86 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 8.5 t -140.16 123.94 17.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 75.31 110.903 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.7 p -120.81 135.78 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 73.32 111.102 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.72 -75.58 0.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 75.14 110.894 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 2.2 m -127.19 127.76 45.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 73.4 111.162 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.78 128.28 75.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 74.42 111.151 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 41.7 t -127.92 115.93 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 75.51 111.144 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.67 133.98 11.04 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.794 -0.717 . . . . 64.22 112.472 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -132.08 148.2 52.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.897 0.38 . . . . 75.15 110.888 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 53.55 90.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.683 -0.77 . . . . 60.04 112.513 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 40.87 51.41 3.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.878 0.37 . . . . 74.54 110.859 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 39.1 t -84.87 144.98 28.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.04 110.843 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -127.74 127.85 44.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 74.2 110.884 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 23.4 t -122.89 123.63 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 72.2 111.129 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.93 114.35 19.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 70.44 110.949 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 31.5 mm -112.57 104.56 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 74.55 111.133 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.04 -164.05 27.61 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.676 -0.774 . . . . 41.35 112.483 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -89.84 155.99 18.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 75.35 110.87 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -129.84 134.87 47.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 74.54 110.911 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.15 125.38 34.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 73.33 110.967 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . -122.54 -166.86 12.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.727 -0.749 . . . . 75.5 112.487 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -101.27 -23.37 9.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 73.12 112.525 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -172.34 32.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 74.45 110.866 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -173.82 -174.01 40.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.796 -0.716 . . . . 74.03 112.531 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -100.84 -173.54 2.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.804 0.335 . . . . 74.14 110.948 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -56.54 100.22 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 74.55 110.906 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -169.4 142.01 2.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 74.0 110.847 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -172.04 32.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 65.15 110.926 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -175.07 124.56 0.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 73.22 110.776 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.22 168.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 74.12 110.837 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -169.67 177.47 4.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 72.11 110.863 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.33 -173.91 4.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 73.41 110.849 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -171.89 63.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 73.14 110.849 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 53.12 110.839 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 1.5 ptp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.854 0.359 . . . . 74.43 110.934 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.1 48.53 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 74.4 110.871 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 31.6 mm -118.86 144.79 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 75.53 111.113 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -174.51 63.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 75.11 110.927 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.61 144.07 0.37 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 71.03 111.115 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 10.3 tt -166.99 146.1 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 74.33 111.119 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 19.7 m -145.69 -173.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 74.33 111.151 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -66.1 -110.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.785 -0.722 . . . . 63.22 112.433 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.55 -166.46 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 72.35 110.928 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -81.43 109.43 15.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 74.55 110.902 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.01 149.62 51.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 75.31 110.816 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.02 160.93 35.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 73.23 111.08 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.42 -37.05 5.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.907 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -164.6 139.08 5.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.211 -0.45 . . . . 71.35 110.949 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -136.66 117.51 17.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 75.5 111.155 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -130.38 115.59 17.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 73.22 110.865 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 2.7 p -135.65 147.42 48.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 74.34 111.151 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.74 167.52 24.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 74.11 110.866 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 68.34 67.57 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 73.41 110.855 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 46.46 60.35 3.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 73.32 110.824 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.18 155.78 18.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 64.13 111.12 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -133.35 135.94 45.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.884 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.48 121.85 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 64.45 111.153 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -118.06 120.37 37.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.33 110.949 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.37 119.8 40.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 74.21 110.948 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.99 -175.5 19.11 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.723 -0.751 . . . . 71.35 112.498 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -96.29 128.45 43.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 75.42 110.867 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 3.7 p -111.28 115.81 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 73.33 111.121 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.75 124.78 71.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 74.13 111.118 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 6.4 t -70.58 175.23 5.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.181 -0.463 . . . . 63.21 111.197 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.38 90.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 65.25 111.14 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.71 -35.96 69.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 63.24 111.109 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.62 163.65 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 74.31 111.103 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.73 -47.86 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 75.51 110.921 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 62.81 171.06 0.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 73.52 110.88 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -73.69 -158.31 5.18 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.741 -0.742 . . . . 74.2 112.438 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -108.44 19.07 32.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.731 -0.747 . . . . 71.42 112.462 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 72.9 mt 57.92 95.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 72.4 111.069 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -104.94 176.71 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 75.15 110.864 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 6.5 tt -107.77 122.93 62.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 74.23 111.104 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.42 -50.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 75.13 110.86 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -179.01 -50.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 75.44 110.881 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 63.41 160.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 72.12 110.934 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 8.4 t -66.53 133.48 50.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 75.12 111.151 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.05 141.4 47.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 74.01 111.22 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -122.27 144.54 48.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 72.23 110.889 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.22 123.68 14.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.902 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 14.4 p -120.54 131.53 72.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 75.54 111.101 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.2 -76.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 73.01 110.925 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 3.8 m -128.09 132.05 49.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 74.52 111.165 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.59 123.63 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 75.3 111.12 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 23.6 t -122.15 115.88 47.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 74.14 111.187 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.05 133.63 10.75 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.767 -0.73 . . . . 63.24 112.529 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -132.11 148.01 52.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.813 0.34 . . . . 75.25 110.878 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.29 76.38 0.17 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.748 . . . . 73.0 112.478 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 48.44 71.68 0.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.362 . . . . 72.23 110.93 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 20.5 t -102.27 145.41 29.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 63.11 110.893 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -123.03 128.33 50.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 73.52 110.814 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 18.8 t -129.47 123.43 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 74.13 111.103 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 15.5 mt -127.85 116.8 20.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 72.32 110.871 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 34.2 mm -112.18 104.68 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 74.44 111.188 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.84 -159.25 28.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.783 -0.722 . . . . 53.53 112.48 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -96.61 156.1 16.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 74.04 110.892 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -129.18 118.99 23.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 74.2 110.806 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.75 124.17 44.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 71.02 110.905 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.81 -76.55 2.22 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 61.54 112.421 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 51.98 -156.11 4.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.749 -0.739 . . . . 32.5 112.516 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -179.42 -34.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.848 0.356 . . . . 75.43 110.964 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -84.27 -126.0 1.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.762 -0.732 . . . . 64.32 112.459 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -22.4 50.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 74.22 110.91 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -105.34 103.31 12.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 75.35 110.933 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 3.8 t0 64.18 157.52 0.08 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.284 -0.417 . . . . 75.14 110.871 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -150.18 -171.55 3.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.442 . . . . 74.31 110.886 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.48 -172.66 3.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 74.21 110.872 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -52.41 -59.11 4.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 74.41 110.854 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -161.89 150.11 15.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 74.42 110.88 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -177.42 108.39 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 73.45 110.877 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -162.41 -178.9 6.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 75.14 110.842 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 63.51 110.81 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.861 0.362 . . . . 74.23 110.88 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.03 137.54 39.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 71.34 110.887 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 11.7 tt -176.23 143.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 74.42 111.131 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -178.19 81.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 74.3 110.856 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -175.58 118.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 73.21 111.121 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 51.2 mt -145.05 82.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 74.14 111.134 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 12.1 p -173.97 148.02 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 72.33 111.114 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 157.28 179.56 32.29 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.714 -0.755 . . . . 72.43 112.481 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 29.5 mtt-85 -52.02 -74.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.833 0.349 . . . . 72.04 110.908 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.03 109.92 22.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 72.34 110.942 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.89 137.84 54.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.482 . . . . 54.1 110.886 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.13 128.14 37.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.32 111.133 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.52 -30.43 25.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 72.23 110.918 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -165.0 138.16 4.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 75.52 110.813 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 8.4 mt -137.98 116.71 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 74.22 111.116 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -134.76 115.68 14.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 74.43 110.836 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 1.3 p -135.88 145.11 46.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 63.03 111.124 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -143.99 167.72 21.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.147 -0.479 . . . . 74.32 110.886 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 68.07 68.2 0.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 74.44 110.821 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 46.86 61.69 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 71.52 110.937 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.88 156.05 18.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 74.1 111.025 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -136.35 136.25 39.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 72.53 110.868 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.72 138.65 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 71.43 111.149 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -136.98 129.52 30.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 65.23 110.904 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 5.6 mp -114.48 118.71 34.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 74.24 110.839 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.92 179.71 16.21 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.733 -0.746 . . . . 74.31 112.473 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -93.07 143.2 26.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 72.11 110.85 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 5.5 p -118.59 122.36 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 74.44 111.099 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 5.7 m -122.35 122.09 65.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 75.22 111.138 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.0 t -70.09 173.78 6.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 71.15 111.139 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.0 92.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 74.52 111.174 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.19 72.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 75.3 111.078 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . -77.87 59.65 2.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 73.12 111.025 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.64 154.44 34.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 74.32 110.921 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -65.6 118.95 10.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 73.14 110.841 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -79.91 59.76 4.46 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 72.33 112.541 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 148.88 -104.74 0.29 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.793 -0.718 . . . . 73.53 112.533 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 53.1 mt -145.32 -42.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 74.42 111.155 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.15 147.57 51.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 73.42 110.904 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 65.2 mt -147.21 -68.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 62.01 111.118 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 2.0 m 61.71 -179.61 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.853 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -143.93 -175.63 4.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 73.11 110.851 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.4 27.38 2.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 64.31 110.898 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 9.3 t -101.06 137.41 39.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 74.51 111.18 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 94.3 m -130.79 121.62 25.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 71.12 111.12 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -108.63 124.4 50.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 73.43 110.907 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 3.8 m -125.83 123.72 39.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 64.54 110.909 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 12.9 p -123.21 131.73 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 73.13 111.142 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.67 -77.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 73.13 110.913 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 75.4 p -133.52 131.19 39.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 72.21 111.131 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 4.9 m -118.34 120.95 65.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 74.32 111.135 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.63 120.04 63.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 74.21 111.13 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.51 133.76 11.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.776 -0.726 . . . . 75.44 112.477 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -131.87 148.13 52.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 74.42 110.895 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.48 78.74 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.735 -0.745 . . . . 73.24 112.457 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 47.51 68.38 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.372 . . . . 60.43 110.848 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 40.4 t -99.69 145.41 27.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 73.13 110.872 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.96 128.54 43.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 74.14 110.836 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 30.1 t -129.96 123.43 56.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.21 111.115 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 54.8 mt -126.01 111.87 15.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 71.34 110.904 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 27.1 mm -104.21 106.35 20.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 65.52 111.131 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.85 -171.8 29.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.753 -0.737 . . . . 71.43 112.463 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -89.87 154.94 19.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 74.31 110.907 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -127.15 120.58 29.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 71.02 110.902 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.27 125.77 45.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 74.54 110.876 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 126.21 -132.91 7.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.74 -0.743 . . . . 54.21 112.501 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -145.17 157.3 27.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.798 -0.715 . . . . 75.03 112.499 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -175.96 -45.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 74.42 110.874 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 126.52 -74.17 0.43 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.725 -0.75 . . . . 42.23 112.448 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -25.13 50.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 74.2 110.921 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -113.46 26.48 10.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.086 -0.506 . . . . 71.21 110.936 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -176.96 -169.82 0.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 74.03 110.917 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -51.88 150.26 4.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 72.45 110.887 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -62.22 -169.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 75.42 110.856 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 63.37 87.25 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 74.31 110.878 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -177.84 151.51 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 74.21 110.861 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -57.77 125.56 23.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 72.05 110.852 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -165.46 -74.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 73.43 110.868 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 79.2 t60 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 74.44 110.847 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 3.6 ppp? . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.83 0.348 . . . . 75.2 110.915 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -175.24 -65.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 75.1 110.913 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 51.4 mt -137.65 147.41 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 74.01 111.122 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -134.64 -169.88 2.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.21 -0.45 . . . . 75.34 110.936 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . 63.75 96.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 75.32 111.035 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 1.3 tt -96.34 -25.14 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 73.2 111.155 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 21.7 t 63.71 101.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 73.13 111.103 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 98.66 55.47 1.08 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.71 -0.757 . . . . 63.01 112.505 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -126.07 170.27 11.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.354 . . . . 71.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -107.28 132.79 52.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.884 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 46.8 m -140.51 148.06 40.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 75.45 110.932 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.11 119.35 10.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 62.33 111.06 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -36.68 78.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 74.1 110.89 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -165.29 137.76 4.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 72.0 110.909 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 6.3 pt -138.5 116.9 13.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 62.13 111.14 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -126.33 129.75 49.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 75.34 110.838 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 5.4 p -136.05 148.97 48.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 73.0 111.169 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.99 168.41 21.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.272 -0.422 . . . . 61.11 110.894 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 69.69 60.41 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.87 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 48.31 58.93 4.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 74.21 110.883 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.09 156.53 17.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 74.23 111.078 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.55 147.67 49.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 75.32 110.865 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.68 121.69 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 74.0 111.099 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -125.1 125.1 43.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 74.33 110.914 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.77 117.98 29.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 65.04 110.906 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 161.58 162.7 13.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 52.21 112.485 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -85.74 140.66 30.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.875 0.369 . . . . 74.43 110.883 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 97.9 t -114.25 118.56 58.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.48 . . . . 63.42 111.161 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.61 129.07 75.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 72.4 111.121 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 12.9 t -69.85 166.7 18.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 74.2 111.162 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.96 83.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 73.32 111.132 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.0 -44.98 83.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 62.25 111.085 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.31 111.77 7.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 71.33 111.108 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 24.2 tp -177.23 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.11 110.889 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -26.21 47.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 72.42 110.819 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -52.92 -81.7 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.77 -0.729 . . . . 72.53 112.496 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 165.52 -153.89 24.23 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.661 -0.78 . . . . 72.44 112.425 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.45 -34.84 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.864 0.364 . . . . 74.32 111.173 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.76 114.18 2.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 65.33 110.841 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 4.9 mt -130.86 144.03 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 72.52 111.153 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.02 148.82 20.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 71.12 110.913 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 18.5 t0 61.61 61.95 1.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 63.52 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.01 -176.0 2.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 71.54 110.889 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.7 m -92.02 124.51 36.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 74.15 111.125 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.5 t -108.49 120.72 43.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 63.5 111.101 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -102.68 119.79 39.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 71.03 110.903 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.6 t -132.05 123.79 27.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 70.33 110.891 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 4.2 p -116.9 141.38 35.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.143 -0.481 . . . . 75.51 111.082 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.51 -74.8 0.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 71.31 110.869 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.5 m -124.11 136.53 54.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 74.03 111.143 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.84 132.57 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 74.11 111.195 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.23 119.87 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 70.23 111.111 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.11 133.66 11.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.717 -0.754 . . . . 73.43 112.52 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -132.36 148.22 52.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 74.33 110.843 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 53.22 74.24 0.32 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.742 . . . . 73.42 112.489 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 47.57 59.52 4.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.898 0.38 . . . . 73.5 110.945 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.61 145.81 28.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 63.55 110.782 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 57.9 mtt85 -118.03 128.31 54.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 72.55 110.902 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 13.6 t -117.4 123.61 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 75.25 111.215 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.87 112.63 16.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 75.21 110.991 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.11 104.4 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 71.23 111.068 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.23 166.18 14.68 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.718 -0.753 . . . . 63.02 112.489 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -100.1 156.21 17.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.817 0.341 . . . . 75.24 110.889 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -115.71 119.75 37.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.898 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.52 125.97 51.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 63.11 110.933 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 69.37 142.56 0.14 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.775 -0.726 . . . . 65.21 112.471 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 129.36 -28.94 3.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.735 -0.745 . . . . 71.31 112.465 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 62.91 56.95 1.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 73.33 110.954 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -154.07 -119.58 0.73 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.765 -0.731 . . . . 42.42 112.499 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -176.24 -38.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 74.11 110.844 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -127.49 -39.72 1.83 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 73.44 110.954 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 22.4 t0 62.52 94.32 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 73.32 110.924 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -158.64 60.36 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 61.23 110.888 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 63.18 67.79 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 74.23 110.851 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -123.02 162.55 22.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 74.1 110.823 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -173.25 -170.37 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 71.43 110.798 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.21 179.73 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 74.01 110.81 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -141.17 98.23 3.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 75.42 110.824 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 74.31 110.861 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.754 0.311 . . . . 74.05 110.852 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.46 -177.15 3.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 74.42 110.9 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 2.9 mp -124.56 134.03 67.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 73.55 111.155 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -110.37 -173.71 2.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 63.42 110.89 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 62.3 95.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 54.45 111.09 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 10.7 tp -107.95 143.22 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 74.43 111.141 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.27 144.32 8.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 71.43 111.087 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 59.5 96.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.768 -0.73 . . . . 74.13 112.481 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -159.04 127.81 5.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.798 0.332 . . . . 75.05 110.941 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -83.99 130.88 34.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 73.44 110.909 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.0 m -140.39 146.02 37.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 73.13 110.853 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.45 119.93 12.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 52.5 111.074 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -32.2 69.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 74.03 110.918 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -166.69 137.41 3.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.275 -0.42 . . . . 72.11 110.912 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . 0.405 ' HA ' HG23 ' B' ' 267' ' ' VAL . 12.8 pt -138.54 117.61 13.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 75.03 111.149 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -131.07 129.18 41.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.846 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 2.3 p -135.59 148.77 49.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 63.14 111.116 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 15.6 pm0 -144.46 168.29 20.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 72.35 110.898 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 69.6 64.85 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 63.44 110.856 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.33 48.38 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 74.11 110.888 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.69 156.63 16.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 73.41 111.126 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.9 154.91 51.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 74.31 110.897 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.92 138.55 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.22 111.175 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -138.42 123.18 18.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.87 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.65 118.67 33.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 72.24 110.952 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 159.18 161.88 11.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.7 -0.762 . . . . 53.14 112.422 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -86.06 131.12 34.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 64.44 110.935 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 85.9 t -96.97 115.05 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 73.54 111.146 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 91.2 t -109.78 128.99 65.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 73.53 111.099 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -70.25 167.52 17.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 65.11 111.134 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.09 76.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 75.25 111.063 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.51 -50.44 73.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 72.31 111.159 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -62.77 -69.93 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 72.24 111.05 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 63.23 164.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.909 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -83.34 138.13 33.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 75.34 110.904 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 144.8 78.59 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.755 -0.736 . . . . 53.51 112.459 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 174.32 157.65 16.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 60.21 112.523 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 14.6 tt -153.5 138.36 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 75.05 111.098 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -174.18 156.73 2.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 74.11 110.883 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.5 mp -95.7 95.61 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 73.23 111.089 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.42 -170.17 2.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 64.23 110.869 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -99.55 -175.32 2.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 71.11 110.891 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -166.81 168.78 13.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 74.41 110.891 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 2.5 m -100.62 129.32 46.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 72.13 111.182 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 4.8 t -110.53 134.58 52.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 73.43 111.076 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.49 133.38 56.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 72.31 110.854 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.3 m -142.81 123.13 13.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 74.23 110.894 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 8.0 p -119.0 134.43 62.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 73.23 111.161 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -66.51 -75.2 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 75.23 110.885 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 68.8 m -133.32 133.33 42.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 63.33 111.142 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' B' ' 231' ' ' ILE . 0.7 OUTLIER -120.55 138.0 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 74.42 111.148 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.06 124.45 66.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 74.53 111.082 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.31 133.62 11.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.638 -0.792 . . . . 74.42 112.477 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -132.02 148.04 52.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 74.11 110.892 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.3 80.78 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 61.41 112.421 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 44.19 57.79 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.958 0.409 . . . . 72.43 110.923 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.71 145.55 28.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 75.55 110.844 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -119.3 128.77 54.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 74.44 110.901 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 18.0 t -115.16 125.05 72.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 75.34 111.107 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.11 110.9 12.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.145 -0.48 . . . . 73.33 110.96 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 4.7 mp -112.61 104.44 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 73.51 111.14 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.31 170.97 21.44 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.754 -0.736 . . . . 64.13 112.486 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -103.89 156.0 18.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.813 0.34 . . . . 73.54 110.909 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -115.92 119.41 35.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.885 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.94 127.74 51.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 72.4 110.951 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 63.19 160.31 0.24 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.696 -0.764 . . . . 63.33 112.539 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 98.4 104.62 2.44 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.806 -0.711 . . . . 51.41 112.473 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.76 103.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.777 0.322 . . . . 75.12 110.98 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 157.99 -127.87 1.98 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.71 -0.757 . . . . 75.13 112.457 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -178.11 -38.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.801 0.334 . . . . 75.11 110.87 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -175.49 -74.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.155 -0.475 . . . . 74.42 110.916 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.83 153.78 27.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 54.43 110.887 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -68.69 124.15 22.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 73.24 110.912 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -165.56 146.57 7.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.22 110.91 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -163.29 103.06 0.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 72.32 110.833 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -171.29 120.22 0.5 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 73.01 110.802 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -173.47 141.71 0.91 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 74.24 110.814 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -172.78 117.41 0.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 74.24 110.925 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 64.34 110.811 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.871 0.367 . . . . 74.13 110.817 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 2.5 tmmt? -159.27 54.41 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 74.2 110.904 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 3.5 mp -118.43 -65.95 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 75.41 111.133 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -178.18 179.39 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 63.41 110.85 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.51 -172.51 2.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 62.24 111.111 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 8.1 tp -136.85 133.88 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 74.21 111.121 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 10.2 p -172.46 132.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 73.5 111.061 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 173.2 -84.27 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.719 -0.753 . . . . 74.13 112.518 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -150.06 -74.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 72.54 110.837 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -100.49 119.6 38.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 75.24 110.897 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.3 m -140.22 142.73 35.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 72.1 110.857 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -142.29 130.13 21.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 73.02 111.132 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -31.62 39.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 73.25 110.905 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -167.46 135.16 2.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.408 . . . . 65.44 110.851 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . 0.465 ' HA ' HG23 ' C' ' 267' ' ' VAL . 6.3 pt -142.02 117.23 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 74.44 111.13 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.16 133.51 46.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 74.1 110.807 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 5.0 p -136.22 152.43 50.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 75.1 111.169 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -145.88 168.25 21.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 75.44 110.816 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 69.67 63.81 0.26 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 74.24 110.892 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.32 58.47 4.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.872 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.62 156.22 18.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 74.04 111.148 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -131.28 137.33 48.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 74.23 110.848 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 6.5 m -123.68 121.77 63.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 72.35 111.161 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -119.83 115.82 24.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 75.41 110.929 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.51 118.69 36.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 72.11 110.934 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.1 166.05 13.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.673 -0.775 . . . . 72.11 112.471 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -85.8 146.63 26.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.924 0.392 . . . . 65.11 110.874 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 46.2 t -116.37 122.88 70.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 75.24 111.145 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 74.6 t -122.05 128.53 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 65.45 111.117 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.8 t -69.83 173.23 6.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 74.12 111.164 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.54 76.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 54.44 111.059 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.93 -51.87 67.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 73.31 111.107 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -82.22 134.13 35.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 43.41 111.047 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.29 -42.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 74.54 110.952 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -159.1 149.35 19.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 75.41 110.834 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 148.22 160.91 9.26 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.825 -0.702 . . . . 70.33 112.533 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 71.78 119.06 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.698 -0.763 . . . . 62.05 112.506 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -69.97 -26.89 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.338 . . . . 71.44 111.156 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.52 162.46 12.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 73.43 110.916 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 3.2 mp -64.53 141.21 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 73.42 111.142 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 13.9 m -102.25 128.3 48.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 73.24 110.866 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 59.02 -173.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 75.45 110.85 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.54 60.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 74.15 110.857 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.37 137.69 35.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 71.51 111.146 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 87.2 m -128.8 119.83 25.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 65.34 111.094 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -104.86 119.96 40.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 65.21 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 29.2 t -134.32 123.64 24.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.827 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.3 p -119.49 153.32 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 74.45 111.144 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.02 -60.45 1.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 72.02 110.905 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 31.6 p -145.63 127.68 15.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 74.44 111.136 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' C' ' 231' ' ' ILE . 1.0 OUTLIER -122.82 137.38 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 73.11 111.14 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 49.1 t -124.9 125.56 69.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 73.32 111.124 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.77 134.06 11.74 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 73.04 112.52 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -132.36 148.52 52.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.841 0.353 . . . . 74.22 110.864 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.72 85.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.682 -0.77 . . . . 73.13 112.548 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 42.72 59.26 2.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 72.45 110.871 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.8 145.13 28.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 73.32 110.825 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -121.32 128.2 52.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 73.15 110.874 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 31.0 t -116.04 125.19 73.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 72.22 111.14 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.2 111.59 13.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 75.01 110.918 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 57.2 mt -111.14 104.2 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 71.44 111.14 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.39 178.22 24.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.725 -0.75 . . . . 42.42 112.465 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -108.69 150.96 26.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.779 0.323 . . . . 74.42 110.905 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -112.0 127.9 56.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.44 110.894 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -113.63 125.87 54.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 72.1 110.919 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 51.56 -170.45 0.36 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.767 -0.73 . . . . 63.55 112.489 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 84.94 -133.01 11.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.818 -0.705 . . . . 51.13 112.457 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -45.38 66.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.83 0.348 . . . . 74.43 110.876 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 128.02 -9.17 6.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.713 -0.756 . . . . 71.52 112.443 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -171.51 -75.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 73.21 110.87 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 14.6 t90 -178.95 -57.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 74.44 110.908 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -168.89 -178.57 3.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 74.41 110.894 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -154.18 -74.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 75.22 110.859 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.46 -171.88 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 74.31 110.819 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -134.06 42.88 2.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 65.13 110.892 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -155.88 -71.88 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 72.22 110.909 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -84.52 123.18 30.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 74.22 110.857 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.29 29.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 70.42 110.872 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.211 -0.449 . . . . 74.43 110.854 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 20.5 mtp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.79 0.329 . . . . 73.33 110.845 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -136.37 -175.88 4.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 65.13 110.869 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 66.1 mt -79.99 145.28 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 75.11 111.088 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.64 162.6 15.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 72.31 110.872 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -174.98 -170.27 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 72.11 111.088 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.15 149.45 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.423 . . . . 71.52 111.122 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 86.1 t -149.81 120.08 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.16 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -93.96 -122.06 3.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 72.33 112.486 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.11 -168.93 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 72.21 110.837 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -83.66 115.31 22.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 71.53 110.85 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.35 147.33 49.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.912 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.06 119.91 11.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 71.02 111.092 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.49 -39.33 70.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 73.42 110.913 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -165.81 138.89 4.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 74.25 110.844 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.38 116.25 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 74.04 111.149 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -125.59 125.6 43.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 75.14 110.826 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.5 p -135.51 149.0 49.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 64.02 111.096 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 14.9 pm0 -145.65 167.95 21.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 65.1 110.861 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 64.79 76.03 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 73.11 110.899 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 10.5 mtm-85 41.42 56.74 3.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.857 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.54 156.29 18.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 74.11 111.049 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -136.83 151.96 49.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 70.34 110.915 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.23 139.53 43.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 71.24 111.078 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -137.66 121.28 17.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 74.55 110.912 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.21 118.37 35.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 72.14 110.899 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 146.23 169.48 14.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.741 . . . . 75.2 112.534 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -85.95 152.1 23.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 72.42 110.909 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 18.2 t -117.57 114.81 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.33 111.139 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 67.8 t -107.47 124.06 63.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 73.11 111.181 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t -69.73 168.21 15.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 74.3 111.178 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.19 -34.1 73.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 75.34 111.078 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.74 -36.45 72.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 54.41 111.115 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 60.99 170.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 73.11 111.126 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.47 114.31 28.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 74.25 110.897 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -77.64 73.02 4.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 75.31 110.863 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 100.35 167.57 28.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.749 -0.739 . . . . 73.21 112.55 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 71.41 24.34 77.0 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.765 -0.731 . . . . 54.1 112.472 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 15.5 pt -115.11 -25.14 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.848 0.356 . . . . 71.23 111.182 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -101.49 136.66 40.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 74.45 110.942 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 45.7 mm 60.82 83.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 73.42 111.17 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.03 172.74 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 74.13 110.894 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.44 -170.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 74.01 110.834 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -170.92 130.33 0.79 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 71.32 110.913 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 85.8 m -66.51 130.66 43.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 70.24 111.162 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 99.8 m -105.33 125.08 50.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.424 . . . . 64.13 111.127 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.98 129.47 49.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 63.3 110.857 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.23 123.56 14.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 70.32 110.882 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 14.2 p -109.89 128.77 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 74.01 111.122 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.55 -79.55 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 74.32 110.793 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -121.68 129.93 53.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 75.11 111.085 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.75 120.33 64.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 65.42 111.103 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 22.4 t -118.74 115.97 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 73.4 111.154 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.14 133.76 10.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.707 -0.759 . . . . 73.43 112.527 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -131.53 147.81 52.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.766 0.317 . . . . 74.25 110.888 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.16 90.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.761 . . . . 73.22 112.521 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 44.28 61.27 2.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 75.33 110.914 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.56 145.81 24.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 75.14 110.937 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 10.7 mtm-85 -124.04 131.23 53.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 65.44 110.865 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.27 124.9 72.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 72.43 111.106 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -128.4 111.46 13.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 72.43 110.911 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 18.2 mt -114.16 103.99 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 64.41 111.165 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.6 -164.68 30.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 72.33 112.42 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -128.26 150.07 50.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.786 0.327 . . . . 74.44 110.904 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -113.39 145.36 41.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 61.44 110.889 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -129.86 125.93 36.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 74.13 110.927 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 62.28 168.46 0.76 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.76 -0.733 . . . . 75.21 112.449 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 107.63 -124.52 7.6 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 72.23 112.477 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -137.84 91.53 2.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 74.22 110.881 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 71.19 167.29 7.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.748 -0.739 . . . . 33.13 112.518 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -51.92 -31.95 30.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.834 0.349 . . . . 74.12 110.874 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 3.0 t90 176.59 105.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 75.0 110.873 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.46 176.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 63.43 110.794 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -115.58 -179.94 3.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.483 . . . . 72.21 110.92 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -137.92 -71.44 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 75.24 110.849 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -178.08 -171.47 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 74.51 110.869 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -106.62 -33.43 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 74.42 110.836 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 62.97 103.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 75.11 110.85 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -119.27 144.36 46.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 74.41 110.8 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 32.1 p80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 72.3 110.838 -179.963 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.839 0.352 . . . . 74.12 110.896 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -163.78 98.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 75.31 110.881 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 1.1 pp -147.84 157.71 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 75.35 111.115 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.8 140.28 1.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 73.33 110.816 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -178.19 -178.03 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 62.22 111.118 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 47.6 mm -53.22 142.19 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 64.4 111.163 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 17.8 m -98.01 169.29 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.4 111.175 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -95.89 -169.46 35.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.792 -0.718 . . . . 70.2 112.474 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -63.71 -46.98 82.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.349 . . . . 74.04 110.86 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -96.75 109.75 22.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 75.41 110.881 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 31.9 t -134.06 137.85 44.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 71.04 110.802 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.45 136.61 54.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 74.22 111.158 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.44 -35.14 13.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 74.03 110.861 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.39 137.32 3.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 72.23 110.824 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 1.3 mt -138.06 116.55 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 64.31 111.166 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -123.16 121.68 36.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.03 110.861 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 9.6 p -136.74 149.14 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.42 111.227 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.98 166.44 24.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 73.44 110.862 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . 0.466 ' O ' ' C ' ' E' ' 236' ' ' ARG . 2.4 mt-10 62.23 90.46 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 71.33 110.904 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' E' ' 235' ' ' GLU . 0.9 OUTLIER 31.94 63.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 72.34 110.935 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.03 156.28 18.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 71.14 111.087 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -137.4 137.2 38.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 75.24 110.903 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 16.6 m -126.08 137.76 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 70.43 111.092 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -134.78 126.51 29.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 72.15 110.931 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 1.3 mp -116.98 118.64 32.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 73.5 110.859 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.61 172.38 12.55 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.786 -0.721 . . . . 75.12 112.535 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.57 163.39 18.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 73.12 110.914 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.64 135.54 61.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 73.35 111.132 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 70.3 t -122.86 124.11 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 75.53 111.226 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.7 t -68.47 167.03 15.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 73.51 111.172 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.17 75.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 63.21 111.127 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.89 -36.94 70.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 52.32 111.087 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 68.99 -77.22 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 71.3 111.053 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 52.02 63.32 2.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 73.24 110.876 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 36.1 m80 59.0 46.33 13.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 74.04 110.834 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -55.65 -89.8 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.809 -0.71 . . . . 75.1 112.48 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -75.88 113.05 3.77 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.727 -0.749 . . . . 65.04 112.538 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 33.0 pt -98.19 173.01 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.858 0.361 . . . . 74.14 111.091 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.0 -39.75 59.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 73.15 110.833 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 25.7 mm -130.09 100.41 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 75.54 111.149 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 30.7 t -106.88 28.74 7.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 71.33 110.823 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.25 117.57 30.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 74.11 110.855 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -177.59 -55.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 75.34 110.849 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.4 128.31 34.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.26 -0.427 . . . . 70.41 111.148 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.95 126.82 43.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 72.44 111.125 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -123.0 119.75 31.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 70.02 110.903 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 4.2 p -133.12 123.29 25.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.883 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.3 136.64 47.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 72.14 111.168 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -81.36 -75.53 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 74.41 110.904 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.2 m -125.21 129.62 50.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 64.33 111.142 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 17.6 t -117.32 123.9 72.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 75.43 111.142 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 87.4 t -127.07 115.82 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 74.35 111.133 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.58 133.87 8.81 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 73.4 112.516 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.84 147.54 46.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.359 . . . . 74.54 110.897 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.27 84.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.777 -0.725 . . . . 44.43 112.46 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 49.1 88.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.853 0.359 . . . . 73.4 110.905 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 67.2 m -116.25 145.19 43.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.13 110.85 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.82 128.78 55.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 74.42 110.925 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 16.4 t -115.12 122.86 70.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 72.01 111.11 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.25 111.56 13.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 75.54 110.874 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 61.5 mt -113.71 104.09 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 73.02 111.087 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.3 176.88 15.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 73.44 112.445 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -89.35 156.43 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.826 0.345 . . . . 64.33 110.899 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -128.53 137.52 51.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 64.1 110.94 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -120.2 123.75 44.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 74.22 110.923 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 56.42 178.35 0.39 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.686 -0.769 . . . . 75.14 112.536 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . 127.47 165.05 11.8 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.733 -0.746 . . . . 74.14 112.54 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -118.19 -23.22 7.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.823 0.344 . . . . 74.11 110.834 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -62.74 -160.88 0.21 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.734 -0.746 . . . . 73.52 112.525 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -74.82 -28.86 60.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 74.01 110.867 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -98.2 79.28 2.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.156 -0.475 . . . . 73.52 110.881 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 178.47 -177.5 0.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.294 -0.412 . . . . 63.14 110.875 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -156.24 141.9 17.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.84 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -167.99 -169.9 1.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 63.43 110.9 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -88.02 69.37 9.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.839 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.63 -169.98 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 70.24 110.865 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -143.58 -44.76 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 74.21 110.866 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -69.31 161.81 28.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 65.43 110.868 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 71.51 110.919 179.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 5.1 mtm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.78 0.324 . . . . 73.02 110.831 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.13 84.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 74.51 110.901 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.5 tt -63.58 -24.94 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 65.44 111.192 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -52.04 156.78 1.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 75.31 110.869 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -146.72 -175.95 5.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 52.25 111.065 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 15.3 tt -175.2 150.75 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 74.31 111.135 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.3 m -60.55 -177.25 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 63.32 111.069 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 61.67 101.53 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 73.52 112.52 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.7 106.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.363 . . . . 60.01 110.831 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -83.19 145.15 29.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 71.21 110.899 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.57 150.26 47.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 75.02 110.85 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.8 119.13 17.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.497 . . . . 61.12 111.092 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -70.76 -49.98 40.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 74.51 110.927 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -165.25 136.37 3.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 72.34 110.862 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 8.0 pt -138.84 134.39 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 74.44 111.1 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -134.49 128.2 32.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 73.25 110.837 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 11.8 p -136.41 149.79 48.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 71.53 111.107 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -120.54 166.24 13.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 75.43 110.869 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 65.39 -159.27 0.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 72.32 110.914 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -74.33 61.41 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 73.33 110.835 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.23 156.43 16.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 74.25 111.108 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.64 143.49 47.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 75.41 110.869 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.83 120.83 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 74.14 111.161 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.44 137.7 52.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.889 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.41 118.37 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.92 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 149.78 -126.73 2.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 74.21 112.516 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -145.51 143.11 29.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.808 0.337 . . . . 75.0 110.944 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.65 119.9 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 75.35 111.121 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 36.7 t -109.19 116.15 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 72.14 111.12 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.85 171.82 8.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 71.21 111.166 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.1 -42.73 91.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.266 -0.424 . . . . 73.42 111.1 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.03 -35.89 69.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 64.24 111.092 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -88.03 140.14 29.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 74.32 111.058 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -178.76 119.56 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 64.11 110.937 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 63.02 104.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 71.34 110.886 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -71.64 -58.1 5.57 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 42.2 112.432 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 108.4 -95.68 0.96 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.725 -0.75 . . . . 75.32 112.521 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 25.7 pt -59.49 -173.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.826 0.346 . . . . 75.12 111.118 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.02 169.54 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 74.43 110.908 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 3.3 mt -51.7 119.42 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 74.11 111.208 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.8 t -96.24 26.58 4.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 74.03 110.868 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -152.71 85.76 1.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 73.44 110.866 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -96.45 28.7 3.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.454 . . . . 73.01 110.873 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.8 m -98.97 138.08 36.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 75.32 111.077 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 54.0 m -132.5 133.64 44.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 74.15 111.167 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.88 144.45 44.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 71.02 110.862 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.7 m -141.69 127.97 19.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 71.42 110.824 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.7 p -113.57 137.41 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.508 . . . . 74.3 111.088 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -85.61 -78.82 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 75.31 110.829 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 4.0 m -115.71 127.04 54.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 75.33 111.101 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 40.9 t -118.42 124.12 72.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 74.2 111.076 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 78.9 t -124.76 115.21 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.116 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.42 133.08 9.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 53.2 112.499 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -109.03 129.3 55.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.35 . . . . 75.33 110.884 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.92 178.74 10.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.743 . . . . 54.15 112.465 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -47.53 101.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.835 0.35 . . . . 74.32 110.923 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 44.9 t -129.63 154.14 47.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.096 -0.502 . . . . 74.33 110.837 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -112.16 128.05 56.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 75.2 110.827 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.0 123.58 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 73.03 111.137 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.16 111.01 14.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 64.21 110.913 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 31.0 mm -109.96 104.3 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 62.52 111.119 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.74 -163.48 29.67 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.765 -0.731 . . . . 74.14 112.508 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -114.36 156.36 24.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 72.04 110.843 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -129.23 129.24 44.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.114 -0.494 . . . . 64.43 110.88 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.8 128.97 50.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 73.34 110.907 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 151.34 -169.19 30.94 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.808 -0.71 . . . . 74.14 112.494 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -78.72 -173.84 43.66 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.681 -0.771 . . . . 75.12 112.513 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.477 ' N ' ' HZ2' ' A' ' 284' ' ' LYS . 0.0 OUTLIER 69.3 -75.55 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 61.44 110.927 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 286' ' ' PHE . . . 100.58 175.81 29.77 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.689 -0.767 . . . . 74.42 112.489 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.402 ' HB3' ' O ' ' A' ' 285' ' ' GLY . 9.9 t80 64.01 -81.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 75.42 110.883 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -140.69 -41.67 0.4 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.084 -0.507 . . . . 75.12 110.976 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 51.1 t0 63.61 105.5 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 73.42 110.865 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -95.55 -169.82 2.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 73.15 110.922 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -55.55 -26.13 41.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 74.14 110.901 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -169.95 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 75.15 110.942 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -140.48 -169.78 2.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 63.22 110.843 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.33 -170.32 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.845 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.38 103.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.837 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 74.15 110.818 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.813 0.34 . . . . 74.14 110.809 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.7 179.2 7.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 74.45 110.908 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 5.4 pt -152.0 -178.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 64.54 111.106 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.22 -170.24 2.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 74.12 110.915 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -107.44 -75.68 0.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 53.14 111.131 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 1.2 pt -152.86 105.53 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 70.21 111.091 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 14.4 p -175.81 149.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 62.33 111.167 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -52.33 128.7 35.52 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.694 -0.765 . . . . 64.25 112.497 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.54 121.88 2.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 73.32 110.849 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.57 140.17 30.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 75.11 110.942 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 41.4 m -134.05 140.49 46.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 72.12 110.911 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -122.71 119.33 30.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 64.11 111.07 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.93 -44.99 75.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 75.42 110.872 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -156.7 137.53 13.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.53 110.806 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.34 117.34 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 72.13 111.16 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -120.1 123.82 44.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 74.01 110.921 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 17.1 p -136.17 140.8 43.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 75.1 111.135 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -121.7 166.93 13.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.167 -0.469 . . . . 63.33 110.809 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.58 -165.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 74.53 110.894 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -73.5 69.84 1.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 75.13 110.892 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 156.4 17.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 42.33 111.077 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.83 135.48 50.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 70.4 110.844 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 19.0 m -126.45 136.08 61.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.41 111.099 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -134.78 126.4 28.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 73.32 110.867 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 mp -118.46 119.01 33.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 72.52 110.863 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.83 -174.95 21.82 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.727 -0.749 . . . . 75.14 112.471 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -93.53 141.13 28.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 74.31 110.87 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 18.0 m -118.33 122.44 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 73.31 111.125 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 21.3 t -116.54 127.59 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 75.4 111.142 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 57.6 p -87.2 172.79 9.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 74.34 111.131 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.07 -43.1 99.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 72.54 111.129 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -42.68 80.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 71.54 111.16 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.95 -30.36 24.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 71.14 111.091 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.75 87.22 2.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.208 -0.451 . . . . 73.53 110.983 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -145.62 54.6 1.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 75.12 110.894 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.15 73.84 0.93 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.809 -0.71 . . . . 71.14 112.536 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 176.58 113.07 0.33 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.786 -0.721 . . . . 74.43 112.502 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 3.3 mt -80.81 108.46 14.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.853 0.359 . . . . 74.51 111.132 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -159.05 125.78 4.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 73.43 110.901 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -22.55 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 75.04 111.156 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.5 m 66.49 -168.21 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 73.45 110.902 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -75.94 178.85 5.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 74.05 110.885 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -120.83 111.45 17.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 74.13 110.947 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 6.0 m -99.88 121.78 41.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 74.43 111.128 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 96.9 m -105.02 130.4 53.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 64.25 111.213 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.43 147.29 48.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 70.32 110.847 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 28.2 t -142.08 123.45 14.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.44 110.909 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 p -109.36 143.53 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 72.23 111.128 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -84.58 -75.32 0.35 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 75.14 110.865 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 18.5 p -125.12 127.87 47.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 73.1 111.166 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.27 120.99 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 74.22 111.088 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.8 123.68 70.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 62.42 111.14 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -131.38 133.47 7.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.699 -0.762 . . . . 73.01 112.454 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.28 147.21 31.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 72.11 110.809 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.26 -162.43 32.52 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.751 -0.737 . . . . 65.03 112.565 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -69.56 83.17 0.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 74.55 110.899 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 32.1 t -104.63 164.58 11.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 72.21 110.836 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -124.14 128.72 49.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 75.12 110.839 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 56.6 t -117.94 123.86 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 75.42 111.127 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.0 111.32 13.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 74.42 110.952 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 12.7 mm -112.76 103.8 16.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 65.54 111.087 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.26 -154.03 25.24 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.777 -0.725 . . . . 63.34 112.514 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -125.31 149.63 47.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.734 0.302 . . . . 72.24 110.899 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -113.95 136.32 53.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 64.42 110.824 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -130.04 127.31 39.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 74.44 110.955 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.36 172.55 43.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 72.22 112.484 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 80.11 125.99 0.6 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.808 -0.71 . . . . 71.05 112.521 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -75.88 68.2 2.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.861 0.363 . . . . 75.22 110.954 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -174.96 -153.12 9.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.705 -0.76 . . . . 53.51 112.49 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -122.0 -33.8 3.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.834 0.35 . . . . 63.41 110.86 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -133.66 -53.73 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 73.24 110.906 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -177.94 -50.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 70.14 110.891 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -131.74 164.75 25.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 74.31 110.899 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -139.2 -173.34 3.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 74.24 110.862 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -144.29 -179.98 6.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 73.23 110.873 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -147.58 150.19 33.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 73.45 110.816 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.24 -66.72 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.468 . . . . 73.03 110.849 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -175.24 33.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.323 -0.399 . . . . 73.43 110.83 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 74.13 110.891 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.815 0.34 . . . . 71.11 110.821 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -141.89 178.6 7.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 74.11 110.912 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -172.07 125.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 72.23 111.071 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -179.13 84.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 72.13 110.876 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -135.87 -58.32 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 75.41 111.169 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 3.7 mp 63.76 94.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 72.23 111.068 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 33.0 m -149.2 -177.19 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 71.32 111.155 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -52.55 137.33 34.97 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.746 -0.74 . . . . 73.44 112.466 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.77 129.59 0.99 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.718 0.295 . . . . 72.43 110.906 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.43 144.15 30.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 62.34 110.889 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.14 137.99 44.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 65.22 110.832 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . 0.406 ' HA ' HG11 ' C' ' 264' ' ' VAL . . . -116.86 119.91 36.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.055 -0.521 . . . . 74.4 111.124 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -72.72 -42.92 63.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 71.32 110.926 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -158.23 136.58 10.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 72.3 110.805 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 1.7 mt -140.01 116.39 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 75.04 111.077 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 16.0 ttp85 -125.63 125.63 43.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 73.11 110.879 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 21.2 p -136.32 146.3 46.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 62.14 111.099 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -121.21 166.1 14.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 63.22 110.88 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.46 -162.5 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 73.02 110.858 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -72.85 70.83 1.01 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.838 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.25 157.22 17.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 72.32 111.058 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -125.59 149.16 48.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 75.21 110.901 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 12.9 m -141.58 137.84 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 74.02 111.138 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -136.65 132.16 34.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 75.35 110.922 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -117.89 117.91 30.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 72.51 110.957 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.44 -177.5 17.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.727 -0.749 . . . . 71.12 112.473 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -85.76 140.89 30.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 74.24 110.817 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.29 115.85 50.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 73.24 111.139 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.66 123.07 68.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 72.41 111.137 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 13.2 t -79.95 175.1 10.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 74.11 111.202 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.91 97.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 74.52 111.12 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.68 -52.03 66.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 71.41 111.094 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.91 -170.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 75.31 111.072 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 20.1 mt -96.33 136.96 36.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 72.43 110.89 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -53.63 102.35 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 75.52 110.861 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 52.96 -173.11 0.37 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.717 -0.754 . . . . 73.22 112.45 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 131.66 -62.21 0.65 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.727 -0.749 . . . . 74.41 112.454 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 28.4 mm 64.24 69.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.882 0.372 . . . . 74.25 111.157 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 56.84 78.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 75.1 110.921 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 7.5 pt -150.67 45.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 71.54 111.131 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 2.8 p -124.46 -178.71 4.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 71.34 110.84 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -73.58 162.16 29.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 72.44 110.907 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -107.95 98.2 7.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.945 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 38.1 p -99.09 137.88 36.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 74.44 111.205 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.7 t -134.13 133.75 41.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 75.24 111.135 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.13 147.7 49.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 64.41 110.898 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.17 123.21 13.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 74.3 110.878 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' C' ' 228' ' ' ALA . 9.0 p -105.52 153.56 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 73.2 111.156 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -97.45 -49.34 4.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 74.42 110.857 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.74 127.96 14.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 73.44 111.157 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 29.1 t -125.0 120.95 59.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 73.43 111.184 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 52.1 t -126.51 134.86 65.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 75.11 111.156 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.65 133.41 6.39 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.789 -0.719 . . . . 71.23 112.489 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.17 147.38 28.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 73.2 110.863 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 61.93 -152.64 42.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.728 -0.749 . . . . 74.02 112.507 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -73.64 73.78 1.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.359 . . . . 73.23 110.865 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 58.8 m -97.68 157.8 15.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 72.12 110.847 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -119.56 132.72 55.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 64.34 110.82 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 78.7 t -115.32 122.26 68.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 74.42 111.172 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.14 111.66 15.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 74.42 110.899 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 20.1 mm -112.63 104.15 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 75.44 111.12 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.58 -159.16 26.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.741 . . . . 70.13 112.459 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.48 156.22 24.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 74.11 110.901 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -113.94 144.61 42.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 74.01 110.848 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -130.14 125.61 35.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 75.43 110.907 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 67.06 150.69 0.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 62.01 112.499 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 138.33 150.67 5.67 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.792 -0.718 . . . . 70.32 112.486 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . 0.437 ' HZ1' ' ND2' ' D' ' 289' ' ' ASN . 0.0 OUTLIER -60.35 -64.74 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 74.32 110.896 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -100.81 174.9 25.98 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.748 . . . . 72.52 112.515 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -52.02 -30.37 25.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.868 0.366 . . . . 75.41 110.852 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -126.46 -65.09 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 74.33 110.836 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.51 -169.83 2.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.316 -0.402 . . . . 71.22 110.869 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.28 -170.0 2.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 75.31 110.9 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -142.36 -74.82 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 75.42 110.879 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.26 -169.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 74.3 110.886 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 -170.18 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 75.12 110.914 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.05 151.89 28.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.298 -0.41 . . . . 63.34 110.862 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -172.46 154.94 3.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 71.32 110.889 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 1.6 t60 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 71.01 110.868 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 3.4 tpt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.798 0.332 . . . . 73.41 110.905 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.77 29.08 5.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 74.33 110.883 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.06 126.11 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 73.41 111.163 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -173.17 130.59 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 74.44 110.775 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -87.87 162.85 16.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 65.24 111.029 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.2 28.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 75.33 111.201 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 38.9 t -53.65 -65.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 74.35 111.14 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -142.47 -113.26 0.95 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.739 . . . . 75.12 112.536 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.98 -168.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.849 0.356 . . . . 73.21 110.843 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -83.03 110.01 17.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 71.43 110.907 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 60.5 p -133.22 156.9 46.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 63.41 110.844 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.72 146.79 51.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 75.03 111.029 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.56 -39.91 12.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 74.31 110.847 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -165.3 137.26 4.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 74.03 110.854 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 5.2 mt -139.35 117.19 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 72.42 111.135 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -119.8 130.26 54.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 75.44 110.859 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 18.6 p -135.9 142.63 44.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 74.02 111.152 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -121.52 163.68 18.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 74.4 110.948 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 63.86 -164.34 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 71.11 110.891 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 38.6 mtt85 -73.77 69.41 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 74.21 110.84 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.15 156.98 17.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 73.14 111.088 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.57 135.69 52.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 75.24 110.851 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.53 136.0 61.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 75.12 111.063 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -136.8 127.53 27.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 75.21 110.862 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 1.2 mt -111.86 118.2 34.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.959 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.74 174.35 13.65 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 61.5 112.479 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.54 149.45 25.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 74.42 110.867 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.49 134.42 62.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 73.35 111.166 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 19.5 t -122.55 123.19 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.24 111.117 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 5.0 t -73.37 165.0 25.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 74.42 111.159 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.81 92.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 74.41 111.043 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.63 -35.72 68.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.14 111.043 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -55.67 100.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 64.3 111.054 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 2.2 mp -68.88 -69.35 0.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 73.22 110.894 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -177.39 -36.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.823 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 95.94 -49.02 1.78 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.76 -0.733 . . . . 75.02 112.5 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 170.71 -92.91 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.763 -0.732 . . . . 74.14 112.528 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 9.3 tt -108.36 150.99 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.847 0.356 . . . . 70.14 111.137 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -52.38 169.82 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 75.21 110.9 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 36.4 mt 59.04 97.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 73.43 111.118 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 60.1 p -162.13 130.96 4.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 75.51 110.89 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 1.9 t70 63.67 105.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.158 -0.474 . . . . 74.12 110.851 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -141.38 93.52 2.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 75.03 110.901 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 6.9 p -95.91 121.93 38.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 74.03 111.181 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 23.9 m -92.0 113.77 26.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 71.01 111.18 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -122.08 151.12 41.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 64.33 110.88 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.72 121.98 13.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 74.14 110.848 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 10.6 p -106.48 142.47 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.072 -0.513 . . . . 75.24 111.132 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -84.06 -79.78 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 72.33 110.831 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 48.9 m -127.44 131.97 50.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 74.32 111.099 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 20.1 t -124.06 120.12 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 62.45 111.16 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 26.6 t -118.25 122.99 70.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 63.52 111.116 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.62 133.19 8.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.655 -0.784 . . . . 60.3 112.476 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.0 147.29 31.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 74.42 110.836 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 60.51 -142.62 48.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 73.21 112.468 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.38 60.28 2.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.827 0.346 . . . . 72.23 110.88 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 12.7 m -83.83 152.83 24.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.901 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.78 132.41 54.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 74.44 110.866 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 92.5 t -115.71 122.75 70.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 75.3 111.129 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.05 115.91 18.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 73.05 110.913 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 30.7 mm -113.15 103.52 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 70.13 111.109 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.96 -163.15 26.68 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 64.52 112.483 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.97 156.83 25.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.72 0.295 . . . . 63.44 110.876 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.9 118.85 34.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 72.34 110.884 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -103.83 128.64 51.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 72.13 110.93 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 88.94 145.65 11.88 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 71.42 112.515 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 95.16 84.19 1.65 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 63.2 112.478 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -58.02 98.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.798 0.332 . . . . 75.12 110.873 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -174.73 -102.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.723 -0.751 . . . . 63.52 112.491 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -173.71 -37.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.863 0.363 . . . . 74.22 110.854 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -144.53 -61.98 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 73.55 110.906 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -164.22 -170.02 1.98 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 62.1 110.874 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . 0.437 ' ND2' ' HZ1' ' C' ' 284' ' ' LYS . 4.6 m120 -64.85 98.59 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 75.11 110.919 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.28 -170.04 3.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 74.2 110.852 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -154.51 175.52 13.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 75.13 110.836 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -175.43 170.18 3.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 72.3 110.829 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -118.77 -175.62 2.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 73.42 110.851 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -129.99 -174.29 3.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.866 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 73.33 110.896 179.972 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.906 0.384 . . . . 60.32 110.876 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -140.57 -176.23 4.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 73.11 110.907 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 3.3 tt -148.95 144.78 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 64.31 111.11 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.98 178.5 9.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 75.54 110.908 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.79 150.79 48.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 62.53 111.144 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.96 110.27 31.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 74.31 111.13 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 7.2 p -177.17 142.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 72.23 111.159 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 151.84 -174.68 30.85 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 53.02 112.515 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -71.7 -74.96 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.806 0.336 . . . . 74.24 110.854 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.45 138.01 52.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 75.12 110.897 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 73.9 p -140.65 160.88 39.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 71.02 110.843 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.52 127.95 46.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.501 . . . . 72.41 111.116 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -35.44 65.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 61.35 110.922 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.53 137.18 3.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 64.42 110.888 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 9.8 mt -139.67 116.4 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 73.32 111.04 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.6 126.29 48.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 72.43 110.904 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 32.6 p -135.82 139.57 43.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 74.1 111.205 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -120.96 167.08 12.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 73.24 110.851 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 65.17 -162.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 75.21 110.877 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -75.23 61.16 1.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.52 110.85 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.32 156.76 17.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 63.44 111.151 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -129.88 135.65 48.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 71.34 110.884 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 20.2 m -122.92 134.89 64.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 74.41 111.189 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -135.81 128.99 31.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 75.31 110.868 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 9.9 tp -111.38 118.0 34.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 75.3 110.949 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.31 171.91 12.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 65.13 112.446 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.91 163.05 18.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 74.33 110.881 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.99 134.06 60.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 75.43 111.142 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 7.2 t -122.08 121.18 63.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 74.33 111.105 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 12.9 t -69.47 173.45 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 62.44 111.171 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.91 89.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 73.52 111.087 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.72 -36.38 69.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 65.34 111.063 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.71 -169.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 53.42 111.098 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 1.7 tp -95.93 27.45 3.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 64.14 110.99 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 60.79 173.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 73.43 110.88 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -63.04 99.2 0.25 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 55.51 112.543 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 162.89 97.19 0.12 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.719 -0.753 . . . . 65.21 112.477 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 10.3 tt -51.8 132.22 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.841 0.353 . . . . 75.02 111.184 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.06 -171.23 1.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 75.4 110.844 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 1.1 pt -108.12 67.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 73.25 111.13 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 1.7 t -56.5 -26.36 54.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 64.01 110.852 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -76.47 122.68 24.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.123 -0.489 . . . . 63.01 110.86 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -179.33 -37.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 75.41 110.955 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 7.5 p -100.04 138.03 37.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 75.25 111.173 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 1.3 p -124.8 127.04 46.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.257 -0.428 . . . . 73.4 111.165 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.01 119.93 28.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 63.44 110.908 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.73 122.86 40.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 75.13 110.807 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -105.19 145.5 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.21 111.099 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -80.59 -76.61 0.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.885 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.38 126.67 17.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 75.21 111.165 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.32 120.59 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 72.13 111.132 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 23.4 t -119.69 115.07 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 74.33 111.155 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.02 133.97 11.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.782 -0.723 . . . . 52.44 112.442 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.73 131.45 52.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 65.31 110.871 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.44 -149.65 30.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 73.33 112.484 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -74.97 68.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 72.55 110.894 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 10.3 t -94.01 162.39 13.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 72.24 110.918 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.53 136.0 47.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 71.31 110.852 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 90.8 t -115.57 124.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 74.15 111.135 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.66 117.99 21.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 73.43 110.96 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 24.7 mm -113.47 102.19 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 73.33 111.15 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 131.85 178.89 15.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.789 -0.719 . . . . 51.42 112.509 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -95.69 156.9 16.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 72.24 110.872 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.57 138.68 54.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 74.34 110.869 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -124.8 124.52 42.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.492 . . . . 72.13 110.88 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 170.74 -152.26 18.19 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.796 -0.716 . . . . 72.54 112.563 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -57.75 -175.61 0.45 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.751 -0.737 . . . . 54.04 112.448 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -61.39 -169.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 65.33 110.851 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 83.47 138.58 3.49 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.711 -0.757 . . . . 60.31 112.556 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -73.64 -7.32 51.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 75.2 110.895 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -151.75 -42.35 0.11 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.935 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -164.22 166.4 21.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.42 . . . . 74.35 110.814 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.98 -169.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 75.24 110.869 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -79.92 -170.2 2.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 74.31 110.859 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -95.62 153.84 17.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 73.35 110.849 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -121.75 -172.9 2.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 74.22 110.918 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.59 -171.67 2.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 75.23 110.872 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.07 179.61 2.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 71.32 110.881 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.854 179.955 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.821 0.343 . . . . 70.42 110.875 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.84 154.3 25.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.912 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 43.8 mm -132.24 143.98 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 75.14 111.112 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.0 173.09 17.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 74.42 110.827 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -111.18 -75.54 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 74.15 111.138 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.3 pt -125.37 124.14 66.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 70.44 111.104 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 6.5 p -177.75 122.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 73.31 111.171 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -61.78 169.99 11.24 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.807 -0.711 . . . . 64.2 112.515 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.43 107.56 0.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.816 0.341 . . . . 74.33 110.911 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -142.07 120.94 12.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 72.43 110.911 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 76.7 p -121.96 151.65 40.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 73.21 110.876 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.63 119.38 16.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 74.35 111.116 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -67.51 -51.64 48.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 73.3 110.875 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.78 135.47 4.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.276 -0.42 . . . . 73.22 110.834 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 6.4 pt -140.12 134.05 35.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 74.14 111.145 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.19 141.64 48.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 72.54 110.926 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.41 152.84 50.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 74.4 111.133 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -138.35 168.62 19.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 65.01 110.887 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.5 -70.7 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 73.44 110.886 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.8 ptt-85 177.88 63.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 75.02 110.857 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.0 157.21 16.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 75.21 111.145 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -126.41 135.32 51.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 74.42 110.913 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 31.2 m -124.43 124.74 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 72.21 111.13 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -114.12 137.49 51.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.877 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 6.0 mp -127.88 118.88 24.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.878 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.07 178.38 15.39 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.794 -0.717 . . . . 74.03 112.557 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -87.97 142.95 27.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 75.42 110.882 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.3 m -122.2 123.63 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 74.15 111.118 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.91 129.19 75.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 74.45 111.156 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.3 t -100.86 162.3 13.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 74.14 111.16 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.07 -33.93 54.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 73.14 111.115 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.03 69.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 72.1 111.034 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -52.78 -76.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 72.23 111.097 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -179.36 34.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 72.43 110.878 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 71.29 -70.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.855 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -109.16 -102.5 2.76 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 73.53 112.466 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -173.59 138.63 4.67 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.625 -0.798 . . . . 65.32 112.445 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 61.9 mt -148.06 -41.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.835 0.35 . . . . 75.33 111.185 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -52.07 156.51 1.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 71.33 110.895 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 1.3 pt -132.21 155.11 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 74.51 111.114 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.33 -170.01 0.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 72.33 110.814 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.02 -169.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 74.01 110.885 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.26 112.24 14.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 72.32 110.876 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 9.9 t -69.09 134.78 49.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 72.21 111.143 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.59 109.75 16.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 75.34 111.154 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -106.21 137.89 43.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 75.03 110.874 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 14.7 m -135.71 123.26 22.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 74.32 110.871 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 50.8 t -115.54 115.87 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 72.44 111.118 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -75.17 -75.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.021 0.439 . . . . 73.53 110.903 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.41 126.78 45.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 73.42 111.166 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 1.6 t -117.47 132.56 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 73.22 111.154 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 72.1 t -127.08 114.97 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 74.31 111.126 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.04 131.71 10.69 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.81 -0.71 . . . . 53.01 112.448 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.81 139.94 47.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.866 0.365 . . . . 73.41 110.924 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 47.71 79.5 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.669 -0.777 . . . . 75.34 112.554 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 49.3 77.66 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 75.12 110.86 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.08 145.26 26.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 74.35 110.853 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -111.06 127.41 55.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 75.12 110.906 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 73.0 t -131.06 122.58 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 74.43 111.133 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.92 111.84 17.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 75.24 110.853 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 25.9 mm -110.24 103.94 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 74.23 111.144 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 142.61 -169.53 25.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.725 -0.75 . . . . 45.44 112.481 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -112.59 155.95 23.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.78 0.324 . . . . 71.53 110.851 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.04 141.3 50.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.43 110.842 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -125.61 133.35 52.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 74.31 110.92 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 109.3 149.89 13.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.69 -0.767 . . . . 72.3 112.475 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -68.15 -127.83 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 61.31 112.468 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.28 25.67 14.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.801 0.334 . . . . 62.41 110.875 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.4 133.41 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.685 -0.769 . . . . 61.15 112.523 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -52.44 131.48 33.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.783 0.325 . . . . 71.43 110.853 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 2.0 t90 60.44 59.66 2.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.88 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -51.56 103.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.296 -0.411 . . . . 70.04 110.849 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -172.37 31.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 64.33 110.872 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -155.27 -176.81 6.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 71.01 110.841 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -51.91 -74.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 64.22 110.774 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.3 -170.06 0.27 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 65.14 110.829 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -141.39 -169.85 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 75.02 110.889 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.44 -170.08 2.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 72.31 110.88 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 2.0 t60 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 72.24 110.848 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.839 0.352 . . . . 73.14 110.875 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.35 141.7 46.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 73.14 110.866 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 4.0 mp -139.59 68.83 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 63.12 111.087 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -95.21 116.62 28.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 70.43 110.826 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -178.32 151.04 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 71.4 111.114 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 16.4 pt -121.79 66.01 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 64.14 111.035 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.59 137.32 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 65.54 111.208 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -128.78 90.71 0.32 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.782 -0.723 . . . . 75.04 112.463 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 16.3 ttt-85 -101.88 124.51 47.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.856 0.36 . . . . 73.34 110.842 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -121.68 129.67 52.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.24 110.886 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.2 p -124.04 145.19 49.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 63.45 110.868 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.19 119.71 23.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 74.22 111.073 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.73 -46.11 76.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 74.25 110.867 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -166.1 137.1 3.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 75.04 110.849 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 6.4 pt -140.08 132.88 34.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 75.34 111.16 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -135.33 138.43 43.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 74.31 110.883 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.47 151.92 50.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.236 -0.438 . . . . 71.32 111.153 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -141.96 167.59 21.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.423 . . . . 71.33 110.908 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 72.81 -71.2 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.882 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -178.68 67.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 75.3 110.867 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.45 156.42 18.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 73.31 111.084 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -130.38 135.19 47.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.885 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 25.3 m -126.68 130.2 71.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 73.53 111.112 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -119.07 119.89 35.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 75.52 110.942 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.82 118.57 35.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 73.32 110.945 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.07 175.09 13.81 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 75.05 112.462 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -85.99 136.2 33.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.894 0.378 . . . . 71.21 110.847 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 18.2 m -118.51 121.63 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 71.05 111.11 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 41.0 t -119.52 129.06 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 62.43 111.124 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 12.3 t -83.32 175.19 10.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 74.43 111.164 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.09 99.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 74.5 111.047 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.85 77.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 71.12 111.126 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -74.3 90.94 2.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 73.32 111.052 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 6.9 mt -118.64 -47.34 2.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 63.2 110.911 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -83.45 142.07 31.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 75.55 110.853 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -100.01 -69.69 0.9 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 63.42 112.513 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 178.97 -165.82 35.04 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.724 -0.75 . . . . 71.52 112.496 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.56 -48.63 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.871 0.367 . . . . 75.15 111.152 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . 0.416 HH12 ' NE ' ' C' ' 255' ' ' ARG . 14.8 ptt85 -147.14 85.62 1.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 73.15 110.918 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 26.0 pt -135.69 140.86 43.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 64.34 111.105 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.5 t -133.83 98.05 4.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 64.13 110.851 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -129.07 163.27 25.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 71.25 110.928 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -149.38 80.32 1.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 74.52 110.851 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 8.7 t -66.17 126.18 27.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 73.2 111.13 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 94.2 m -131.84 108.98 9.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 74.03 111.144 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -108.96 136.56 48.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.85 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.84 123.76 21.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.483 . . . . 71.13 110.87 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 70.5 t -110.34 118.53 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 73.4 111.108 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -67.8 -75.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 73.44 110.884 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 24.7 p -129.56 133.69 47.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 74.14 111.229 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.37 129.37 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 73.11 111.164 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.36 114.79 37.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 73.24 111.099 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.78 132.42 10.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.678 -0.772 . . . . 51.54 112.45 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -132.09 143.25 49.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 74.42 110.934 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 42.98 69.11 0.67 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 33.32 112.429 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 63.57 101.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.836 0.35 . . . . 71.31 110.911 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 3.6 t -130.33 145.77 51.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 60.24 110.898 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -117.28 127.85 54.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 75.23 110.858 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 85.8 t -130.48 123.65 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 75.24 111.165 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.49 112.13 22.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 73.43 110.936 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 14.4 mm -108.47 104.94 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 75.32 111.108 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 135.7 -157.89 23.51 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.774 -0.727 . . . . 51.25 112.527 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.5 156.04 27.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 74.43 110.878 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -129.39 141.8 50.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 74.11 110.881 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -129.98 125.73 36.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 74.34 110.888 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 152.35 156.14 7.37 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.685 -0.769 . . . . 64.4 112.474 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -96.11 -53.19 1.52 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 73.55 112.521 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -52.08 103.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 73.53 110.833 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.52 116.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.751 -0.737 . . . . 74.33 112.457 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -52.1 -33.44 39.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.347 . . . . 75.21 110.903 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -172.26 -47.58 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 75.01 110.962 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.54 102.44 0.25 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 64.12 110.844 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.72 149.7 49.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 74.33 110.785 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -134.62 155.28 50.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 73.24 110.868 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -153.82 100.1 2.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 63.43 110.875 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.83 152.25 0.94 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.215 -0.448 . . . . 73.14 110.877 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 62.61 165.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 75.23 110.839 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -152.17 26.2 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 75.23 110.919 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 63.03 110.856 -179.928 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.849 0.357 . . . . 75.42 110.832 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.09 -39.68 5.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 74.23 110.896 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 4.0 mp 63.05 70.67 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 71.22 111.079 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 63.4 161.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 73.21 110.881 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -173.32 52.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 72.21 111.102 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 2.1 pt -106.72 31.43 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 73.52 111.124 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 33.7 m -149.6 151.77 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 75.23 111.107 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 155.09 150.73 5.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.74 . . . . 73.34 112.494 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.26 -65.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 74.24 110.85 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.05 120.63 41.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 75.14 110.864 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 3.3 t -129.67 138.69 51.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 71.02 110.894 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -119.04 131.98 56.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 73.21 111.133 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -33.05 34.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 71.13 110.901 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -166.01 138.0 3.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 73.31 110.864 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -138.69 117.31 13.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 73.54 111.143 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -131.82 130.23 41.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 70.24 110.898 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.25 155.44 50.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 74.51 111.144 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -144.35 168.06 20.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 72.22 110.885 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.78 -72.23 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 73.31 110.856 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -177.99 64.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 75.55 110.85 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.69 156.46 18.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 52.13 111.087 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -128.79 135.25 48.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 73.31 110.892 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 20.9 m -126.14 121.6 59.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.469 . . . . 70.32 111.117 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -115.63 120.65 40.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 73.24 110.913 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.96 118.72 34.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 72.44 110.935 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.48 178.23 15.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 74.34 112.503 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -85.65 128.52 34.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.857 0.36 . . . . 72.02 110.891 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 28.5 m -114.07 128.4 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 75.21 111.136 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 46.8 t -122.17 129.02 75.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 73.21 111.086 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -77.5 174.27 11.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 75.23 111.126 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.04 -41.03 77.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 74.33 111.045 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.1 -51.91 67.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 65.03 111.044 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 71.88 -70.58 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 64.3 111.088 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.58 178.13 7.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 75.44 110.911 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -106.63 -64.23 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.873 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 167.07 37.22 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.77 -0.729 . . . . 71.11 112.534 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -176.44 31.47 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 61.34 112.572 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 2.2 tt -138.11 145.69 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 75.44 111.18 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . 0.416 ' NE ' HH12 ' B' ' 255' ' ' ARG . 0.0 OUTLIER -94.16 -26.12 16.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 63.01 110.852 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 65.5 mt 61.31 101.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 75.05 111.147 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.29 136.97 52.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.815 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -92.93 81.88 4.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 64.44 110.914 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.73 26.13 9.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 75.04 110.925 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 4.9 t -100.94 130.01 46.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 71.22 111.125 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 18.7 m -126.58 118.96 25.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.261 -0.427 . . . . 75.32 111.121 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -120.63 144.63 48.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 62.11 110.866 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 9.4 t -141.62 123.85 15.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 71.53 110.905 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 46.2 t -108.07 145.86 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 64.34 111.205 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.92 -55.69 3.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 74.32 110.84 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.46 128.51 11.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 73.35 111.165 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 54.4 t -118.75 120.42 64.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 73.01 111.106 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.14 118.06 47.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 74.33 111.16 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.9 133.23 10.1 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.715 -0.755 . . . . 62.11 112.502 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -125.44 147.75 49.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 74.23 110.869 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 47.2 67.85 1.35 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.812 -0.709 . . . . 63.42 112.474 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 64.14 107.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.883 0.373 . . . . 73.4 110.899 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 3.3 m -139.8 150.16 44.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 73.2 110.865 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -124.72 128.24 48.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.831 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 89.8 t -132.28 123.34 50.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 75.25 111.134 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.98 117.14 28.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 75.12 110.921 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 24.9 mm -110.63 104.24 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 74.41 111.134 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.03 -162.74 25.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.743 . . . . 55.43 112.491 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -106.66 155.97 19.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.787 0.327 . . . . 72.33 110.897 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -131.22 150.15 52.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 73.41 110.852 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -130.05 126.03 36.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 72.14 110.905 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 145.75 141.97 3.73 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.745 -0.741 . . . . 73.21 112.499 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -112.2 -169.5 18.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.732 . . . . 64.22 112.463 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 7.8 tttt 53.89 29.44 9.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 73.25 110.879 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -179.11 -35.26 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.683 -0.77 . . . . 72.34 112.415 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 5.4 t80 71.9 -69.25 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.898 0.38 . . . . 75.22 110.912 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -156.3 -63.46 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 74.53 110.87 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.01 178.06 8.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 72.31 110.85 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -141.0 177.04 8.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 75.15 110.863 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -174.12 -171.21 0.6 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 75.45 110.899 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -175.95 158.3 2.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.12 110.81 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -168.34 -44.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 74.14 110.874 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.41 -175.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 75.11 110.901 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -115.13 -69.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 71.15 110.877 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 73.04 110.877 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 4.3 ptp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.855 0.36 . . . . 72.11 110.916 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 15.7 pttt -132.82 134.5 44.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 71.51 110.91 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 45.0 pt -127.17 160.62 35.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 75.33 111.164 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -166.01 147.07 6.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 74.54 110.883 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -139.7 81.87 1.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 64.22 111.076 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 22.5 pt -105.99 166.44 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 75.15 111.106 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 24.9 t 57.62 93.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 74.03 111.178 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -145.52 135.53 6.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.672 -0.775 . . . . 74.04 112.446 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.78 -73.35 0.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.882 0.372 . . . . 73.11 110.879 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.44 111.98 23.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 73.32 110.887 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.77 137.58 54.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 64.33 110.786 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.09 155.94 37.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.114 -0.493 . . . . 75.21 111.094 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.88 -29.8 8.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 75.01 110.895 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.49 138.31 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 73.31 110.884 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 2.4 mt -138.91 117.28 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.144 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -131.64 131.23 43.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 75.2 110.936 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.28 155.9 49.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 72.53 111.086 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -148.28 166.91 26.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 72.44 110.876 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.9 -71.99 0.12 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.104 -0.498 . . . . 73.02 110.861 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -177.0 63.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 74.44 110.845 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.76 154.51 19.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 65.55 111.158 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -130.01 134.98 47.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 73.34 110.93 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 21.6 m -127.89 121.19 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 70.31 111.154 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -121.31 128.58 52.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 74.32 110.964 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 mp -120.66 118.79 31.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 73.23 110.917 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 143.14 179.0 19.48 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.752 -0.737 . . . . 73.52 112.474 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -85.83 129.11 34.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.919 0.39 . . . . 74.2 110.864 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 35.1 m -111.39 129.52 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 74.4 111.138 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.31 129.03 75.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 71.25 111.138 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 21.5 p -77.6 174.84 10.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 63.34 111.138 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.1 85.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 74.33 111.144 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.03 -52.01 66.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 74.34 111.136 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 68.83 -77.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 74.11 111.105 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.78 94.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 72.44 110.907 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 63.41 173.32 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 74.53 110.887 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 112.15 119.34 3.73 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.704 -0.76 . . . . 74.11 112.49 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -167.14 -159.81 13.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.813 -0.708 . . . . 63.0 112.528 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 29.9 mm 63.68 106.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.825 0.345 . . . . 73.43 111.128 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 57.1 ttp85 -81.87 98.74 8.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 75.33 110.893 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 2.1 pt -153.14 90.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.12 111.108 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.71 100.58 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 72.31 110.88 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -174.3 -168.99 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 75.03 110.864 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.7 -74.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 74.14 110.949 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 5.4 t -86.31 121.56 29.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 72.22 111.151 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 3.1 m -134.53 126.77 30.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 73.43 111.192 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -126.08 139.61 53.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.295 -0.411 . . . . 75.34 110.955 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 7.9 t -142.09 123.81 15.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 74.43 110.844 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.34 149.61 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 75.44 111.172 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.84 -77.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 72.44 110.939 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 1.5 m -127.71 127.83 44.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 63.3 111.108 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 98.2 t -118.69 120.41 64.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 75.02 111.122 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 4.7 p -126.53 117.81 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 74.44 111.102 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.72 132.65 10.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 63.03 112.427 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -126.02 147.13 49.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 73.12 110.84 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 44.86 76.75 0.11 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.769 -0.729 . . . . 74.54 112.475 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.74 98.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.802 0.334 . . . . 70.23 110.899 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 4.1 t -130.18 145.33 51.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 61.41 110.908 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -123.97 127.97 48.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 72.23 110.849 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 94.3 t -135.56 123.38 37.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 73.32 111.106 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -121.72 119.57 32.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 75.41 110.893 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 27.5 mm -112.29 104.24 16.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 75.32 111.165 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.3 -159.07 27.44 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.75 -0.738 . . . . 71.14 112.52 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -115.92 156.12 26.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.77 0.319 . . . . 71.44 110.917 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -126.03 134.92 51.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 74.13 110.803 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -120.32 125.94 49.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 74.33 110.958 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.01 158.36 7.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.79 -0.719 . . . . 60.13 112.544 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -104.57 63.93 0.34 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 62.1 112.416 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.94 32.91 1.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.8 0.333 . . . . 74.12 110.876 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 78.98 -67.82 3.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 52.34 112.459 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -178.81 108.75 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 71.05 110.852 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 72.0 -69.44 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 74.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -163.37 160.57 23.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.1 110.859 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.08 111.61 21.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 75.4 110.88 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.54 -61.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 74.22 110.869 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -52.19 159.26 0.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 72.5 110.836 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -165.87 -74.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 74.23 110.908 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -74.3 159.34 32.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 71.23 110.896 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -178.96 -175.9 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 70.54 110.883 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.807 179.939 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.857 0.36 . . . . 71.24 110.883 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 172.7 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 73.13 110.918 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 9.7 tp -160.46 142.77 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 70.02 111.165 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -128.68 133.91 48.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.52 110.895 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -111.38 -179.13 3.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 73.44 111.142 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 2.1 pt -152.18 149.41 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 74.23 111.171 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 12.5 p -96.13 131.34 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 75.41 111.174 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.21 -153.29 51.99 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.728 -0.749 . . . . 71.54 112.535 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 62.1 -169.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.824 0.345 . . . . 75.2 110.874 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -83.8 109.92 17.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 74.25 110.857 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.43 139.85 45.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.2 110.824 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.38 162.06 26.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 75.44 111.151 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.05 -26.87 7.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 73.24 110.887 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.82 138.62 4.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.43 . . . . 75.12 110.841 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 5.0 mt -138.55 117.35 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 73.43 111.127 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.32 131.23 39.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 73.2 110.791 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.29 157.81 45.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 63.03 111.128 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -150.29 167.55 26.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 62.51 110.933 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 72.09 -73.35 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 74.51 110.846 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -178.29 62.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 74.53 110.85 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.34 156.45 17.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 63.0 111.196 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.19 135.15 47.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 74.02 110.856 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 18.0 m -122.74 121.84 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 72.32 111.143 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -119.59 114.41 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.23 110.921 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.84 135.09 54.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 71.43 110.976 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.06 -120.18 2.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.718 -0.754 . . . . 62.21 112.508 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -144.0 128.85 18.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.884 0.373 . . . . 71.43 110.851 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.86 119.6 51.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 74.35 111.16 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.05 123.52 69.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 72.2 111.138 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.1 t -74.43 174.88 8.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 71.02 111.133 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.22 -45.64 68.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 75.44 111.099 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.92 -49.8 74.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 71.53 111.132 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 52.69 -169.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 44.4 111.073 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.46 89.57 3.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 72.43 110.958 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -52.31 122.82 9.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 74.54 110.819 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -167.58 -117.45 0.4 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 62.11 112.529 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 152.64 120.19 0.83 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.776 -0.726 . . . . 75.42 112.559 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.56 -177.04 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.862 0.363 . . . . 74.51 111.095 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.96 -47.34 1.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 73.11 110.878 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 3.9 tt -177.07 126.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 75.54 111.131 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.21 -171.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 75.14 110.891 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -159.57 155.06 25.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 73.43 110.922 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -146.49 -74.32 0.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 70.24 110.9 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 4.1 t -67.17 135.78 54.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 75.13 111.168 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 34.9 m -133.4 123.56 25.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 73.14 111.129 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.12 123.45 38.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 72.34 110.858 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 43.2 t -127.18 123.81 37.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 64.12 110.878 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.32 150.34 28.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 75.03 111.102 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.01 -77.5 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 74.02 110.865 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 9.4 m -126.37 127.83 46.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 75.14 111.162 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.08 120.16 63.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 65.11 111.156 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 4.1 p -123.78 118.18 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 74.53 111.154 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.28 136.18 13.39 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.756 -0.735 . . . . 74.55 112.399 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -132.58 133.54 43.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.756 0.313 . . . . 74.24 110.897 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.81 93.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 53.25 112.522 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 44.1 69.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 70.22 110.826 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.34 145.25 26.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 64.15 110.817 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -127.24 128.19 45.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 74.22 110.872 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 84.2 t -136.85 123.92 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 74.32 111.134 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.64 122.55 36.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 74.31 110.899 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 30.4 mm -112.0 104.53 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 74.41 111.169 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 135.07 -169.84 23.14 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.755 . . . . 74.53 112.518 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -99.82 155.96 17.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 71.52 110.897 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -130.6 132.03 45.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.491 . . . . 73.43 110.856 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -113.8 125.9 54.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 73.42 110.874 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 133.48 104.29 0.86 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.742 -0.742 . . . . 73.32 112.485 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -67.63 -121.05 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.797 -0.716 . . . . 73.24 112.465 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp 62.71 25.79 15.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.815 0.34 . . . . 74.55 110.921 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 126.64 -162.5 20.78 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.757 . . . . 54.25 112.471 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -110.99 118.11 35.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.857 0.36 . . . . 74.22 110.868 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 1.6 t90 72.32 -69.0 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 74.11 110.92 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -113.87 151.61 31.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 74.41 110.846 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -100.06 81.63 2.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 75.41 110.95 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -67.44 174.99 3.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 75.15 110.875 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.07 -171.14 2.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 70.01 110.915 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -121.35 159.24 26.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 74.22 110.835 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -125.43 -37.51 2.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 74.14 110.851 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -153.17 -71.34 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 72.44 110.826 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 60.5 t60 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 75.33 110.887 179.98 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 17.8 ptm . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.734 0.302 . . . . 72.3 110.876 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -120.04 -74.14 0.62 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.445 . . . . 73.15 110.906 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -166.43 -75.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 71.33 111.167 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.03 -171.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 74.12 110.932 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -166.94 139.64 3.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 74.33 111.117 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 1.9 tt -55.12 124.15 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 74.0 111.18 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 17.1 m -151.46 -177.88 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 63.2 111.112 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 152.35 113.67 0.56 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.764 -0.732 . . . . 45.11 112.515 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -179.29 -175.85 0.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.867 0.365 . . . . 74.42 110.879 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.27 130.35 26.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 72.32 110.876 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 48.4 t -121.81 137.69 54.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.478 . . . . 74.1 110.843 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.62 128.18 34.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 74.34 111.111 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.67 -37.14 13.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 75.21 110.938 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -164.38 138.9 5.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 75.45 110.878 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 7.7 mt -137.25 117.53 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 74.02 111.116 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -124.98 117.04 23.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 75.42 110.839 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.31 131.2 36.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 74.32 111.123 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -132.95 164.9 25.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 74.1 110.906 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 236' ' ' ARG . 2.7 tt0 65.0 79.53 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 72.43 110.897 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 235' ' ' GLU . 16.9 ptt180 35.29 60.46 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 74.52 110.918 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.29 152.75 21.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 75.54 111.136 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -129.28 142.52 50.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 74.35 110.831 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.1 p -143.02 121.65 7.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 64.41 111.124 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -108.84 137.46 46.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 72.5 110.98 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.58 118.65 22.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 72.22 110.891 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.37 -172.61 20.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.708 -0.758 . . . . 75.12 112.504 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -92.24 139.19 30.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.909 0.385 . . . . 74.54 110.909 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.02 129.7 65.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 75.54 111.21 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 89.5 t -122.07 127.28 75.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 72.41 111.127 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 53.6 p -82.9 163.21 21.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 75.44 111.155 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.48 -41.47 98.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 74.12 111.127 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.85 80.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 71.33 111.061 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -55.64 -75.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 65.43 111.113 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.32 126.92 33.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.895 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -167.87 29.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.14 110.867 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 136.3 -20.29 3.56 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 74.32 112.534 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -60.42 -178.51 1.97 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.739 . . . . 64.41 112.492 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.1 pp -149.63 -174.96 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.851 0.358 . . . . 74.21 111.121 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 63.25 104.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 73.32 110.875 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 2.9 mp -99.57 -39.65 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 75.1 111.126 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.7 t 62.29 -174.65 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 65.02 110.901 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -60.63 -172.28 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.103 -0.499 . . . . 75.42 110.81 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.76 175.61 9.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.486 . . . . 62.5 110.902 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 99.6 m -101.01 137.96 38.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.262 -0.426 . . . . 72.31 111.132 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 98.4 m -112.91 111.74 22.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 73.5 111.159 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -111.48 150.3 30.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 71.54 110.805 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.4 t -138.31 123.97 19.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 72.55 110.951 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.81 135.77 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 75.43 111.135 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.32 -75.96 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 71.24 110.952 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 1.6 m -130.14 131.98 45.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 73.42 111.153 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 96.7 t -117.89 131.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 55.24 111.147 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 58.6 t -127.55 128.03 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 72.54 111.117 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.98 133.62 7.87 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.735 -0.745 . . . . 70.25 112.515 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -132.8 147.77 52.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.793 0.33 . . . . 71.11 110.877 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.28 78.17 0.11 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.761 -0.733 . . . . 71.25 112.459 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 47.59 64.58 1.55 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.882 0.372 . . . . 71.23 110.941 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 26.3 t -92.93 145.65 24.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 62.43 110.873 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -126.39 128.31 46.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 74.52 110.929 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 20.6 t -128.92 123.59 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 73.54 111.137 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.07 117.24 32.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 71.21 110.917 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.15 112.41 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 71.05 111.152 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 133.01 -164.91 24.11 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 70.15 112.443 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -103.8 152.61 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 62.42 110.84 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -131.49 134.51 46.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 74.11 110.968 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.4 125.94 54.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 73.45 110.915 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.84 135.8 3.17 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.717 -0.754 . . . . 72.3 112.521 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -111.22 177.11 18.94 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.691 -0.766 . . . . 73.53 112.441 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt 52.0 53.4 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 70.31 110.871 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 177.56 -69.02 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.822 -0.704 . . . . 74.11 112.521 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 2.1 t80 64.34 109.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 75.32 110.823 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER 72.93 -67.77 0.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 74.03 110.875 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -156.23 179.22 9.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 64.15 110.828 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.24 149.72 5.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 75.04 110.88 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.91 176.05 8.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 75.41 110.846 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -151.41 -66.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 72.5 110.903 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.02 150.13 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 75.34 110.842 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -177.0 49.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 72.05 110.846 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -171.95 149.58 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 75.14 110.877 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 74.5 110.843 179.998 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 9.0 mtt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.832 0.348 . . . . 72.52 110.912 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.56 141.06 37.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 73.34 110.922 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.43 178.67 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 73.35 111.124 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -95.52 63.13 2.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 73.24 110.841 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -171.77 104.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 75.54 111.15 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 5.2 mp -142.18 144.05 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.426 . . . . 71.34 111.143 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 22.7 t 62.55 100.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 74.35 111.08 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 164.61 88.02 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.741 . . . . 64.05 112.51 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -179.49 118.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.806 0.336 . . . . 74.14 110.922 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.34 123.44 14.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 75.21 110.93 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 1.4 t -121.51 137.71 54.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 64.3 110.86 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -127.7 129.16 46.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 72.15 111.082 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.26 -35.28 23.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 74.02 110.953 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.56 138.42 5.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.31 110.869 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 11.2 mt -137.64 117.6 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 74.33 111.059 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -130.64 119.3 22.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 73.24 110.846 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.02 131.41 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 74.31 111.148 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -132.04 167.3 19.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 73.55 110.837 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' B' ' 236' ' ' ARG . 0.1 OUTLIER 64.24 78.43 0.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 71.24 110.868 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' B' ' 235' ' ' GLU . 11.0 ptt180 36.34 54.84 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 73.34 110.931 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -100.61 156.15 17.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 71.03 111.137 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -132.59 136.3 46.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 73.54 110.877 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 6.2 p -137.24 121.71 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 70.42 111.177 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.22 137.48 51.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.891 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.71 118.6 23.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 75.05 110.897 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.7 176.45 14.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.718 -0.753 . . . . 65.44 112.536 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -85.95 133.48 33.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.882 0.372 . . . . 75.02 110.841 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 33.7 m -116.51 132.18 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 74.33 111.105 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 60.1 t -122.04 120.26 60.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 74.15 111.123 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 33.6 p -84.68 163.21 19.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 73.14 111.126 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.47 -36.95 84.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 64.23 111.13 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -62.06 -36.51 81.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 65.53 111.138 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -52.31 -75.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 51.41 111.017 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -178.3 174.8 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 74.2 110.969 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -103.07 -26.14 13.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.844 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 172.17 85.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.781 -0.723 . . . . 63.24 112.526 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 174.32 147.43 6.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.735 -0.745 . . . . 75.44 112.53 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 46.1 pt -137.68 -178.02 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.348 . . . . 73.33 111.111 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.23 -64.25 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 74.51 110.869 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 11.0 tt -125.14 124.61 67.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 75.24 111.176 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 14.9 p -179.04 164.81 1.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 71.2 110.824 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.51 163.85 31.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 75.43 110.841 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.33 101.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.24 110.933 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 49.2 p -101.09 122.55 43.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.438 . . . . 75.14 111.147 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 1.1 t -134.14 108.95 8.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 75.54 111.172 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -95.94 149.52 21.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 65.14 110.897 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 44.6 m -140.22 124.08 17.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 74.34 110.852 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 13.4 p -109.58 131.62 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.48 . . . . 71.41 111.125 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -73.63 -76.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 74.42 110.835 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -131.52 135.38 47.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 71.34 111.118 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 85.5 t -117.67 128.4 74.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 74.22 111.151 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 68.8 t -127.23 119.47 52.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 73.54 111.104 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.3 132.98 9.05 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.743 -0.742 . . . . 74.22 112.461 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.65 147.93 51.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 72.52 110.902 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.44 82.66 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.753 . . . . 55.23 112.478 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 46.3 63.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 75.14 110.849 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 25.7 t -96.78 145.66 25.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 72.42 110.867 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.12 127.99 46.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 74.13 110.859 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.85 123.77 55.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 75.53 111.135 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.86 116.76 29.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 72.2 110.887 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 25.4 mm -110.79 104.18 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.24 111.146 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.49 -176.91 21.54 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.781 -0.723 . . . . 72.43 112.463 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -92.17 147.12 23.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.727 0.299 . . . . 71.41 110.91 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.45 141.7 51.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 74.22 110.858 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -127.1 125.99 42.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.181 -0.463 . . . . 75.11 110.952 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 168.26 151.22 6.98 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.769 -0.729 . . . . 72.13 112.496 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -53.82 176.23 0.31 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.781 -0.723 . . . . 72.31 112.497 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.88 104.76 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 75.41 110.883 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -159.05 -38.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 73.44 112.541 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 10.6 t80 64.43 111.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.858 0.361 . . . . 73.42 110.881 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 71.61 -72.14 0.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 75.3 110.885 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -135.09 126.05 27.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 65.1 110.939 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.61 100.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 73.33 110.849 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -175.49 139.45 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 72.22 110.905 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -178.49 157.01 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 73.3 110.871 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.58 130.93 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.885 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -154.61 169.09 24.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 75.23 110.869 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.54 -177.83 3.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 62.45 110.829 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 75.14 110.933 179.944 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.4 mtp . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.919 0.39 . . . . 72.0 110.867 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 21.2 mttt 58.62 69.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 73.22 110.897 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 2.1 mp -127.43 147.07 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 73.24 111.187 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -148.14 171.17 16.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 75.33 110.864 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -76.42 74.33 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 74.41 111.088 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 1.5 pt -84.67 -177.33 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.189 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.71 150.57 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 74.03 111.078 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 70.6 62.43 3.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 73.43 112.485 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.52 111.38 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 73.23 110.844 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -83.91 139.69 32.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 70.22 110.917 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.88 144.64 50.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.35 110.82 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.94 143.09 51.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 73.35 111.134 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.35 -32.61 12.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 75.32 110.898 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.04 137.85 4.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 74.53 110.924 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 16.7 mt -137.34 117.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 74.22 111.078 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -132.71 115.87 15.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 74.44 110.861 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -135.41 135.48 40.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.461 . . . . 74.31 111.123 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.48 166.99 23.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 72.2 110.88 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 66.87 72.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 74.43 110.93 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 44.32 53.26 6.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 72.15 110.84 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.2 147.9 26.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 72.41 111.047 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.0 135.75 52.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.868 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 6.0 p -133.78 121.86 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.54 111.098 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -108.77 136.55 48.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 73.21 110.946 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.17 119.21 22.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 74.54 110.888 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.15 173.66 13.46 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.758 -0.734 . . . . 73.01 112.439 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -85.81 134.22 33.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 73.34 110.865 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 30.9 m -113.45 131.95 63.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.082 -0.508 . . . . 60.33 111.156 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.18 129.24 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 74.35 111.145 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 12.9 p -86.71 169.33 12.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 73.44 111.185 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.03 76.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 73.34 111.174 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.37 76.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 71.41 111.106 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.96 103.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 63.53 111.126 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 19.1 mt -140.47 -45.12 0.41 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 73.11 110.867 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.76 167.89 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 61.43 110.87 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -65.95 -77.02 0.29 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.734 -0.746 . . . . 61.24 112.471 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -170.37 71.84 0.12 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 74.44 112.467 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 5.0 pt -137.31 146.86 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 63.43 111.114 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -135.75 76.96 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 74.24 110.884 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.44 178.0 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.162 -0.472 . . . . 73.13 111.103 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 76.5 p -124.44 73.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 71.45 110.899 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.55 178.38 8.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 75.0 110.847 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -178.77 174.33 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 74.52 110.951 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 29.3 m -100.85 137.89 38.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 75.5 111.127 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.5 t -125.01 133.17 53.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 74.43 111.149 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.8 145.73 50.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 71.14 110.893 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.69 123.39 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 63.21 110.885 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -110.48 127.77 67.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 71.1 111.081 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.91 -71.83 0.26 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.107 -0.497 . . . . 74.44 110.847 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 5.7 p -140.48 137.18 33.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 72.02 111.081 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 19.2 t -116.8 128.36 74.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 71.05 111.18 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 2.0 t -127.24 117.91 48.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 73.43 111.137 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.1 132.74 9.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.736 -0.745 . . . . 62.45 112.452 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.81 140.94 48.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 72.44 110.931 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 46.58 84.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.701 -0.761 . . . . 71.44 112.49 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 51.1 82.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.885 0.374 . . . . 70.0 110.87 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 29.2 t -116.44 145.61 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 72.31 110.881 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -128.97 127.62 42.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.488 . . . . 72.44 110.825 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 48.2 t -132.07 123.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 74.33 111.125 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.54 111.58 22.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.221 -0.445 . . . . 74.53 110.952 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 23.4 mm -111.0 104.71 17.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 74.3 111.134 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.5 -154.58 25.6 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 72.41 112.48 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -128.14 145.25 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.347 . . . . 74.44 110.92 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -113.06 129.72 56.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 72.02 110.946 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -119.8 126.02 49.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 65.13 110.846 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 103.28 101.68 2.66 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.692 -0.765 . . . . 74.55 112.415 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 95.16 -167.45 26.44 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.712 -0.756 . . . . 61.31 112.478 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -172.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 74.12 110.893 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -86.01 -18.62 59.16 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.754 -0.736 . . . . 71.22 112.45 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.96 124.0 22.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 73.05 110.925 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 16.1 p90 -74.73 -27.38 60.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.926 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -101.29 77.33 1.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 65.54 110.886 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -52.1 155.15 1.99 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 73.14 110.914 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -143.09 36.15 1.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 62.24 110.841 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -123.75 -171.34 2.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 72.54 110.895 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -138.21 92.5 2.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 74.2 110.893 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -93.71 164.84 12.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 70.04 110.836 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -80.94 95.62 6.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 72.05 110.883 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 72.31 110.865 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.878 0.37 . . . . 75.43 110.909 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -113.59 51.36 0.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 73.34 110.818 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.94 141.77 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 73.14 111.092 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -173.36 86.32 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 51.41 110.865 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.25 151.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 73.32 111.028 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 7.4 tt -175.66 130.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.23 111.055 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 84.1 t -117.98 -72.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 75.43 111.139 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -141.98 113.5 0.82 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.747 -0.74 . . . . 74.44 112.498 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 179.07 -175.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.33 . . . . 72.31 110.908 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.78 132.17 38.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 62.43 110.847 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.09 150.76 44.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 71.4 110.842 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.1 158.86 36.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 73.05 111.154 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -109.15 -32.94 7.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.29 -0.414 . . . . 72.1 110.938 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -164.63 138.18 5.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 72.25 110.834 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 13.8 mt -138.85 117.82 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 70.53 111.141 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -133.22 121.39 22.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 72.12 110.859 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.7 p -136.39 148.41 47.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.177 -0.465 . . . . 73.22 111.135 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.79 166.52 33.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 74.31 110.915 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 64.09 72.76 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 72.04 110.959 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 47.8 33.86 3.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 74.24 110.853 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.8 142.57 27.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 74.35 111.155 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -126.88 135.87 51.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 74.35 110.902 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 5.3 p -128.54 137.51 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 73.23 111.114 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -117.32 135.91 53.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 63.34 110.935 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.19 129.75 43.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 74.02 110.898 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 121.74 -131.3 8.44 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.699 -0.762 . . . . 72.32 112.464 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -144.99 150.8 37.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 72.5 110.815 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 13.7 m -122.73 124.36 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 74.44 111.133 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 28.4 t -121.23 129.05 76.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 72.11 111.194 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 68.4 p -72.26 174.57 7.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 65.34 111.17 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.48 -45.9 73.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.277 -0.419 . . . . 71.53 111.103 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.27 -50.38 73.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 61.43 111.071 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.39 -169.99 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 64.42 111.091 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 28.2 tp -71.86 129.03 37.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 74.11 110.978 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -75.06 80.29 2.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 70.44 110.881 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 149.88 -71.34 0.3 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.713 -0.756 . . . . 72.44 112.474 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 142.5 127.75 2.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.751 -0.738 . . . . 63.45 112.528 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 50.5 pt -72.44 167.33 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 70.43 111.116 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -54.35 161.35 1.39 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 70.44 110.914 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 1.1 tt -51.96 -29.7 11.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 70.21 111.119 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 20.0 m -102.9 -170.16 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 72.21 110.833 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -169.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 74.34 110.874 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -133.97 -66.67 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 74.1 110.922 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 75.8 m -101.32 121.96 42.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 72.35 111.142 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 261' ' ' THR . . . . . 0.588 ' H ' ' NE ' ' E' ' 225' ' ' ARG . 95.1 m -100.33 108.95 21.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 74.2 111.17 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -116.31 150.32 37.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 73.41 110.892 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.37 123.79 16.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 73.52 110.859 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 11.4 p -107.55 134.23 49.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 65.22 111.094 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.45 -75.44 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 75.31 110.855 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 44.8 p -148.74 135.38 19.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 73.11 111.153 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 14.5 t -117.67 128.24 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 62.53 111.07 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.19 122.87 60.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 73.1 111.204 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.57 133.84 10.54 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.698 -0.763 . . . . 63.42 112.473 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -132.48 136.48 46.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.808 0.337 . . . . 75.44 110.849 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.68 87.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 64.42 112.506 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 51.95 80.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 75.4 110.883 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 40.7 t -114.61 145.29 42.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 75.25 110.828 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -130.62 127.12 38.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 72.25 110.873 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 85.1 t -136.17 126.74 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 75.04 111.163 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.2 111.22 15.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 72.15 110.917 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 31.1 mm -109.68 104.85 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 63.53 111.167 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 159.25 -165.36 34.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.795 -0.717 . . . . 75.5 112.522 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -123.66 156.19 36.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.774 0.321 . . . . 70.55 110.92 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -111.77 119.24 37.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 70.31 110.959 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -103.68 125.82 50.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 64.13 110.89 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 62.88 31.63 81.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.718 -0.753 . . . . 72.04 112.471 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -95.75 -116.46 3.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 74.31 112.546 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -179.41 34.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 71.24 110.868 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.25 -113.18 3.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 73.23 112.455 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.85 -179.35 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.853 0.358 . . . . 71.23 110.844 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 12.0 p90 -94.44 -25.01 17.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 74.15 110.911 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -101.92 141.12 35.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 71.02 110.901 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.44 -177.85 6.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 73.45 110.926 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -147.43 161.47 40.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 75.44 110.925 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.47 -45.29 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 72.44 110.851 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.49 69.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 72.04 110.862 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 61.46 173.36 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 74.23 110.808 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 54.9 87.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 75.2 110.836 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 75.42 110.899 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 2.2 mtt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.792 0.329 . . . . 70.11 110.858 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.4 173.72 12.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 75.13 110.953 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 2.9 mt 61.07 99.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 64.34 111.097 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -126.15 158.84 34.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 64.12 110.841 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -131.89 148.23 52.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.02 111.107 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.24 85.41 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 72.11 111.12 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 13.2 p -168.72 139.64 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 73.05 111.139 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 145.69 144.73 4.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 74.12 112.501 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . 0.588 ' NE ' ' H ' ' D' ' 261' ' ' THR . 1.5 ptp180 -54.19 -51.3 64.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 72.51 110.934 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -105.42 108.83 20.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 63.44 110.895 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.59 152.41 45.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 61.41 110.873 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.8 163.01 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 63.5 111.123 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.49 -33.31 6.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 75.43 110.942 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.27 140.44 3.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 74.45 110.804 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 17.3 mt -136.98 114.9 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 72.34 111.118 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -132.27 119.93 21.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 75.55 110.917 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.69 144.35 45.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 72.44 111.129 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -156.4 166.13 34.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 73.23 110.883 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 59.42 72.3 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 70.33 110.88 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 50.0 43.57 25.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 73.15 110.923 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.09 144.93 29.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 74.44 111.071 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -128.92 141.66 51.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.53 110.881 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.77 134.48 53.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 75.23 111.158 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? -119.42 137.22 53.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.428 . . . . 73.11 110.864 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.31 118.72 21.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 75.41 110.935 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 123.73 177.88 15.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.696 -0.764 . . . . 73.25 112.481 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -89.65 145.38 25.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.787 0.327 . . . . 73.42 110.941 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 9.6 m -120.16 139.16 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 74.12 111.114 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.5 128.32 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 74.14 111.177 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.5 t -69.77 175.2 4.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 71.32 111.17 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.43 76.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 62.04 111.124 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.13 -51.72 68.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 63.45 111.116 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 54.63 -171.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 75.45 111.088 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 1.7 tt -154.61 121.2 5.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.448 . . . . 74.55 110.992 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -102.42 165.48 11.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 64.22 110.861 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 145.28 160.07 8.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.681 -0.771 . . . . 74.41 112.449 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -130.38 -123.37 2.51 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.731 -0.747 . . . . 71.41 112.522 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 2.0 mp 63.38 105.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 74.52 111.115 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.5 140.99 32.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 75.53 110.86 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 16.8 tt -168.22 148.99 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 74.11 111.147 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.12 105.99 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 72.12 110.84 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -163.14 132.64 4.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 72.01 110.878 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -165.55 109.68 0.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 73.41 110.888 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 67.4 p -101.08 121.86 42.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 75.33 111.123 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.36 116.51 15.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 72.51 111.177 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.3 136.18 52.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 75.5 110.936 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 1.3 t -126.8 121.88 33.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.841 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.0 p -102.41 123.0 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 75.13 111.134 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . 0.432 ' CD ' ' N ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -65.23 -142.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 73.52 110.907 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 266' ' ' THR . . . . . 0.401 ' N ' ' CG ' ' E' ' 265' ' ' GLU . 3.2 p -92.14 128.79 38.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 71.22 111.122 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 8.9 t -115.35 133.34 61.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 75.24 111.119 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 6.1 p -125.45 121.53 60.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 75.44 111.188 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.44 132.87 11.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.785 -0.721 . . . . 75.04 112.493 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -132.82 116.05 16.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 74.43 110.897 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 64.49 88.14 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 75.44 112.455 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 56.99 86.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 65.41 110.857 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 16.9 t -124.35 145.49 49.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 54.0 110.851 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -136.7 127.13 26.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 75.4 110.892 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 57.9 t -132.73 134.67 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 74.42 111.094 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.39 114.85 17.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 63.33 110.926 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 28.4 mm -111.13 141.16 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 75.3 111.1 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 113.1 -171.86 14.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.694 -0.765 . . . . 72.32 112.442 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -106.82 153.52 22.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.797 0.332 . . . . 71.51 110.868 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -111.85 144.47 41.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 72.33 110.826 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.12 125.35 43.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 75.42 110.902 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 51.83 29.17 25.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.756 -0.735 . . . . 62.01 112.484 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -99.25 18.72 56.14 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.763 -0.732 . . . . 60.25 112.499 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? 53.63 35.17 20.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.884 0.373 . . . . 74.14 110.91 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.27 -103.85 2.98 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.759 -0.734 . . . . 73.51 112.474 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -52.03 157.81 1.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.837 0.351 . . . . 73.45 110.843 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -71.96 148.3 46.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 63.11 110.955 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 6.2 t0 60.93 -179.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 75.25 110.875 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 63.18 104.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 72.52 110.917 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -103.43 -175.06 2.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 74.34 110.884 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.71 134.67 47.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 75.22 110.833 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -133.21 -59.45 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 74.21 110.844 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 56.87 85.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 73.23 110.867 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.22 137.67 47.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 70.45 110.89 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 75.5 110.846 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.844 0.354 . . . . 72.22 110.843 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -176.74 174.81 1.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 71.43 110.891 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.42 173.9 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.32 111.07 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.47 177.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 74.34 110.892 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -156.12 148.59 23.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 64.42 111.034 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 65.8 mt -147.27 -72.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 72.15 111.157 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 10.3 p -175.54 152.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 74.15 111.116 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 168.25 159.79 14.63 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.744 -0.741 . . . . 55.55 112.466 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -179.12 33.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.808 0.337 . . . . 74.41 110.885 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -142.41 143.63 32.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 70.32 110.852 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 34.5 p -121.72 137.5 54.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 63.44 110.859 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.94 139.92 48.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.486 . . . . 74.23 111.088 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.15 -28.18 13.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 75.22 110.879 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -166.17 137.93 3.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 73.31 110.879 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.39 117.29 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 73.45 111.157 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -129.55 122.48 29.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 75.23 110.861 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.8 152.12 50.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 75.23 111.163 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.98 158.94 37.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 70.11 110.948 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 236' ' ' ARG . 1.6 tt0 64.11 83.35 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 71.25 110.892 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 235' ' ' GLU . 0.0 OUTLIER 36.15 59.89 0.89 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 75.01 110.883 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.21 144.02 32.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 73.23 111.087 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -125.79 135.81 52.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 75.03 110.923 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 19.7 m -143.01 121.29 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 64.42 111.137 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -124.88 137.64 54.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 74.13 110.895 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 mp -129.4 118.26 21.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 75.34 110.909 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 148.23 -161.87 28.69 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 61.44 112.51 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -91.11 137.86 32.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 74.35 110.992 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -120.54 131.77 71.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 72.4 111.092 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 61.7 t -122.17 128.97 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 65.32 111.133 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.78 175.15 6.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 72.22 111.189 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.15 -34.56 77.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 75.05 111.117 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.97 -37.54 71.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 75.31 111.087 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -67.67 -75.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 73.2 111.087 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.3 tp 62.53 -169.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 75.31 110.907 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -52.31 109.32 0.37 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.916 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 151.09 177.93 25.41 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.77 -0.729 . . . . 64.31 112.485 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 112.19 116.48 3.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 64.31 112.561 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 33.6 pt -150.22 -175.8 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.829 0.347 . . . . 72.15 111.103 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.19 104.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 73.55 110.852 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 1.5 pp -150.5 171.07 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 72.52 111.101 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.04 -170.05 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 73.13 110.895 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.4 167.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 71.31 110.867 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -120.4 84.0 2.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 74.42 110.911 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 52.0 p -99.77 122.49 42.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 74.43 111.151 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.7 t -131.07 140.59 50.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 71.4 111.144 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -99.31 126.2 45.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.87 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 87.4 p -134.56 123.65 24.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 62.24 110.849 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.67 125.68 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.084 -0.507 . . . . 74.41 111.136 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -74.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.839 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 25.8 m -136.45 135.06 38.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 71.52 111.193 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.48 126.52 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 73.13 111.124 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 23.2 t -127.48 118.14 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.14 111.162 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.68 133.06 8.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.747 . . . . 62.04 112.489 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 147.6 52.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.906 0.384 . . . . 71.32 110.892 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.52 84.21 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 70.13 112.444 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 51.35 80.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 75.03 110.865 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 31.6 t -113.34 145.69 40.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 65.41 110.842 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -132.77 127.59 34.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 73.24 110.88 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 19.0 t -137.7 123.62 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 73.41 111.156 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.4 112.36 18.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 74.35 110.906 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 35.6 mm -103.93 104.51 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 74.41 111.158 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.2 -169.43 28.88 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.67 -0.776 . . . . 72.4 112.486 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -111.12 149.89 30.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.784 0.326 . . . . 71.24 110.88 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.6 119.1 30.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 75.4 110.923 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -108.14 154.01 22.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 72.31 110.903 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 122.88 -120.16 4.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.72 -0.752 . . . . 62.1 112.496 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -171.3 -143.8 4.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 45.04 112.565 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 69.03 -75.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 71.33 110.888 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -144.48 143.53 12.18 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.728 . . . . 65.14 112.481 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -61.1 -20.71 62.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 64.41 110.881 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -164.82 -69.43 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.129 -0.487 . . . . 73.22 110.982 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.94 -6.82 12.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 70.41 110.906 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.62 -75.18 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 74.45 110.847 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -97.41 136.04 38.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 71.43 110.839 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -133.04 -69.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.468 . . . . 75.23 110.83 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -174.75 167.15 3.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 64.41 110.839 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -94.55 171.82 8.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 73.52 110.844 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -166.86 173.92 9.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 70.22 110.89 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 3.8 m80 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 72.42 110.791 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.83 0.348 . . . . 75.45 110.87 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.47 104.33 5.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 74.5 110.933 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 7.9 pt -135.07 179.5 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.15 111.145 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -140.21 139.32 35.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 70.44 110.858 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -150.2 169.98 20.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 73.53 111.197 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 2.6 pt -143.25 -178.37 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.294 -0.412 . . . . 73.32 111.034 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 34.4 m -147.95 172.53 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 74.2 111.183 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 176.8 -100.15 0.14 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.765 -0.731 . . . . 72.13 112.502 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.18 87.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.783 0.325 . . . . 75.23 110.818 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -115.25 120.66 40.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 71.32 110.938 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.33 137.93 51.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 74.31 110.825 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.95 152.34 45.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 73.44 111.108 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -28.02 10.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 74.32 110.879 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.65 138.41 5.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.415 . . . . 75.32 110.851 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 11.6 mt -135.44 122.42 34.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 75.22 111.081 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -134.17 117.25 16.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.04 110.911 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.2 145.67 52.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 74.11 111.151 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.24 161.53 41.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 73.21 110.85 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 63.61 69.68 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 61.41 110.804 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 47.53 56.7 6.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 72.35 110.936 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.0 144.42 31.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 71.32 111.14 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.03 135.87 52.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 75.45 110.848 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 4.1 m -136.24 121.56 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 73.02 111.138 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.67 134.06 54.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 75.31 110.979 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.42 119.07 22.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 72.04 110.867 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.81 -116.07 0.72 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.74 . . . . 70.34 112.498 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.98 139.7 29.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.899 0.38 . . . . 74.13 110.902 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.2 116.27 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 74.41 111.138 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.27 129.05 73.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 74.44 111.151 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.1 p -92.26 175.23 6.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 71.01 111.186 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.06 -42.65 99.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 61.25 111.07 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.73 -38.37 84.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 74.44 111.126 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.66 116.84 2.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 72.42 111.098 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.81 -58.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 75.15 110.885 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -117.48 120.88 39.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 75.52 110.808 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -100.26 -137.68 9.91 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 74.42 112.534 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -74.28 177.95 45.13 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.694 -0.765 . . . . 52.2 112.515 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 3.3 mp -111.29 116.73 53.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 63.24 111.164 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.69 97.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 74.14 110.859 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.3 tt -151.52 145.43 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 71.12 111.089 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.5 t -145.59 103.64 3.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 75.12 110.81 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -127.94 178.79 5.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 74.24 110.846 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -157.54 71.02 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 70.23 110.821 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.83 137.77 33.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 74.55 111.134 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 96.5 m -130.85 111.92 12.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 75.22 111.133 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -89.43 127.28 35.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 74.32 110.959 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 3.6 m -130.31 123.59 30.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 75.22 110.86 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.48 125.28 72.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 72.12 111.116 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.97 -76.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 74.43 110.905 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 94.6 m -137.01 137.65 39.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 73.34 111.093 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.8 128.35 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 74.33 111.177 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 25.6 t -127.64 117.16 45.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 72.32 111.101 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.39 132.53 9.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.723 -0.751 . . . . 73.24 112.498 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -133.27 125.08 28.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.863 0.363 . . . . 74.04 110.889 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.76 83.91 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 64.15 112.508 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 54.35 84.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 70.42 110.843 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 22.8 t -119.25 145.63 45.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 64.3 110.831 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -135.34 127.32 29.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 75.53 110.903 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 61.9 t -135.35 124.55 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 74.13 111.122 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.07 111.69 17.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 75.25 110.875 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 27.3 mm -103.86 104.53 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.455 . . . . 73.23 111.149 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.83 -160.21 28.51 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 74.21 112.486 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -115.91 147.87 40.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.324 . . . . 74.12 110.909 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.82 118.88 31.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 75.54 110.9 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -112.27 127.46 55.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 71.43 110.954 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 145.9 -48.59 0.68 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.808 -0.71 . . . . 73.44 112.47 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 74.06 11.32 81.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.725 -0.75 . . . . 73.12 112.48 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.96 60.86 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 65.44 110.868 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 96.26 120.26 3.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.763 -0.732 . . . . 62.45 112.487 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -50.95 108.45 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.324 . . . . 74.13 110.912 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 71.79 -69.57 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.155 -0.475 . . . . 74.34 110.889 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -121.27 -170.01 1.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 71.03 110.886 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -54.47 -42.94 71.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 72.43 110.888 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.35 105.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 75.31 110.748 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -128.54 84.88 2.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.492 . . . . 75.43 110.852 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -117.88 179.65 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 72.35 110.871 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -152.44 31.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 73.24 110.846 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -134.77 172.33 13.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 72.01 110.873 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 8.1 p80 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 74.24 110.874 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 4.2 mtp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.776 0.322 . . . . 64.41 110.805 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.51 114.83 20.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 74.32 110.882 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 6.2 tt -173.32 135.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 73.51 111.158 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.94 -73.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 74.12 110.859 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -169.6 83.09 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 73.41 111.065 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 2.7 mp -77.67 70.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 64.25 111.109 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.33 174.3 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 73.0 111.151 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 139.69 -155.31 24.17 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.722 -0.751 . . . . 72.15 112.466 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -127.78 -72.32 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.332 . . . . 72.31 110.831 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -83.98 110.07 18.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 75.54 110.834 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.34 137.91 50.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 63.33 110.849 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -123.35 150.55 43.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 72.54 111.117 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -102.37 -26.2 13.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 75.13 110.875 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -165.04 138.79 4.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 63.35 110.809 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.61 117.68 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 72.53 111.183 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.94 119.32 21.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 74.42 110.882 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.52 150.4 52.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 55.41 111.142 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -156.71 166.68 32.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 64.22 110.854 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.59 67.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 74.31 110.946 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 48.31 58.23 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 75.3 110.908 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.33 148.37 26.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 74.25 111.102 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -129.36 135.86 49.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 74.24 110.903 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 28.3 m -135.27 121.56 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 72.14 111.141 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.09 137.54 52.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 73.22 110.954 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.05 118.4 21.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 73.23 110.927 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 139.36 -168.91 24.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.777 -0.725 . . . . 71.14 112.461 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -91.93 145.03 24.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 74.44 110.921 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 56.1 t -125.98 124.89 67.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 75.34 111.129 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 48.4 t -122.83 118.28 54.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 74.51 111.063 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 6.4 t -77.84 174.96 10.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 72.54 111.163 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.83 -45.56 89.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 63.25 111.097 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.05 -35.77 67.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 75.01 111.082 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -58.67 98.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 74.14 111.069 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.71 25.46 4.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 70.23 110.943 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -125.38 177.18 6.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 73.22 110.88 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -144.45 -108.27 0.6 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.637 -0.792 . . . . 74.03 112.422 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -160.31 -60.81 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.672 -0.775 . . . . 64.01 112.437 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 2.0 mp 62.95 74.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.79 0.328 . . . . 75.42 111.083 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.65 -70.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 71.24 110.895 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 30.9 mm -119.59 149.82 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 63.13 111.134 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 2.5 p -110.48 55.16 0.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 65.55 110.862 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.57 -179.62 7.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 73.43 110.838 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.13 135.63 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 73.32 110.854 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 70.0 p -100.86 137.58 39.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 74.25 111.154 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 2.1 t -108.45 137.05 47.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 72.33 111.141 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -119.99 139.01 53.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 74.11 110.931 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 22.8 m -130.68 123.74 30.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 73.35 110.925 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.01 126.86 69.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 72.33 111.083 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.8 -74.0 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.49 . . . . 73.34 110.88 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 92.5 m -140.8 136.65 32.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 71.11 111.189 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 94.4 t -117.96 127.02 75.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 72.44 111.111 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 40.1 t -127.5 126.79 67.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 72.1 111.039 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.25 133.0 8.24 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.767 -0.73 . . . . 73.11 112.502 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -132.62 140.96 48.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.832 0.349 . . . . 74.04 110.924 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.11 70.15 0.94 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.781 -0.723 . . . . 64.51 112.434 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 64.85 97.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 74.25 110.881 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 70.2 m -131.7 145.94 51.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 74.24 110.879 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 36.2 mtt85 -131.48 127.09 36.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 73.53 110.837 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.43 123.89 47.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 74.1 111.134 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.23 111.59 17.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 73.21 110.972 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 30.8 mm -105.65 104.34 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 74.44 111.181 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 152.97 -152.49 24.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 72.41 112.482 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -116.75 138.17 51.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.758 0.313 . . . . 71.34 110.941 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -111.79 118.83 36.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.457 . . . . 74.22 110.832 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -114.45 124.63 52.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 75.03 111.008 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 161.5 -58.53 0.3 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 51.12 112.463 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 91.31 -42.0 2.85 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.717 -0.754 . . . . 74.24 112.426 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -30.21 14.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 74.24 110.859 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -147.05 106.45 0.36 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.694 -0.765 . . . . 62.43 112.455 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -55.34 -23.35 23.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 74.2 110.898 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -153.81 -52.16 0.1 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.456 . . . . 75.5 110.934 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -132.59 149.25 52.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.412 . . . . 72.13 110.849 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -78.75 86.56 4.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 74.23 110.916 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -167.55 -174.86 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 75.22 110.927 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -93.03 154.84 17.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 75.52 110.862 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -176.26 118.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.877 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.74 174.68 1.78 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.233 -0.44 . . . . 75.13 110.888 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -130.02 176.9 7.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 71.33 110.847 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 12.0 p80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.32 110.778 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.88 0.371 . . . . 74.3 110.859 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -161.96 112.78 1.62 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 73.04 110.896 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 3.6 tt -53.65 -27.98 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 75.42 111.14 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.42 143.12 55.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 74.14 110.909 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -125.08 165.57 17.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 71.1 111.141 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -137.86 108.45 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 72.12 111.141 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 35.9 m -94.13 162.74 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 72.32 111.123 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -169.09 -172.86 36.26 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.752 -0.737 . . . . 53.05 112.507 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -52.25 -59.88 3.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.85 0.357 . . . . 75.35 110.827 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -109.56 115.52 30.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 55.43 110.891 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.83 140.9 52.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 72.02 110.869 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.45 147.88 49.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 72.3 111.115 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -100.72 -26.16 13.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 75.22 110.929 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.98 138.26 4.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 73.5 110.922 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 12.3 mt -137.03 117.89 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 73.21 111.178 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -133.06 118.41 18.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 75.1 110.878 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.49 150.76 52.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 74.03 111.144 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -157.0 167.29 30.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 73.04 110.898 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.54 66.45 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 74.35 110.851 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 50.08 43.97 25.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 74.22 110.874 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.1 152.38 21.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.34 111.079 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -135.34 135.25 40.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 63.32 110.869 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.58 121.19 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 74.51 111.126 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -108.07 134.63 50.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 74.02 110.914 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.28 118.03 20.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 74.04 110.924 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.16 -118.3 1.35 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.778 -0.725 . . . . 74.34 112.497 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -145.97 133.26 20.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.891 0.377 . . . . 73.43 110.866 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 74.4 t -110.2 121.18 62.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 65.52 111.165 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.47 119.96 58.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 74.23 111.134 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -69.99 175.36 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 72.13 111.103 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.47 -46.1 69.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 75.24 111.114 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.2 -49.52 77.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 73.22 111.076 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 63.21 -174.89 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 72.21 111.112 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.02 107.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 73.54 110.879 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -52.91 164.97 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 74.22 110.88 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 90.8 -44.4 2.87 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 60.43 112.515 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 134.12 -55.19 0.75 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 70.34 112.512 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 14.7 tt -58.32 144.11 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.36 . . . . 74.51 111.164 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -57.23 178.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 75.55 110.913 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 6.1 pt -58.71 177.98 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 75.33 111.145 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 36.6 p -150.99 92.55 1.83 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 71.24 110.883 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -173.42 139.42 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 72.5 110.868 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.88 30.51 6.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 71.0 110.813 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.19 138.23 58.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 73.35 111.08 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 49.9 m -112.71 108.88 18.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.34 111.149 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -90.77 131.98 36.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 75.44 110.861 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.97 123.87 38.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 73.0 110.924 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.39 129.1 75.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.143 -0.48 . . . . 72.01 111.064 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.52 -75.23 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 62.12 110.929 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 48.9 m -136.52 135.6 38.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 74.22 111.138 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 97.5 t -117.89 127.06 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 75.43 111.184 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 28.1 t -127.22 122.93 61.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 72.33 111.101 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.29 132.44 8.55 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.771 -0.728 . . . . 73.15 112.507 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.13 144.89 50.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.808 0.337 . . . . 71.32 110.934 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.79 70.38 0.79 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.726 . . . . 73.45 112.478 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.47 94.3 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 74.02 110.924 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 30.9 t -126.27 145.02 50.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 71.23 110.892 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -131.68 126.35 34.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.909 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 16.6 t -132.1 132.42 61.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.08 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.55 111.11 12.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.104 -0.498 . . . . 72.02 110.903 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 24.5 mm -108.03 106.59 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 74.2 111.107 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.27 -146.15 17.42 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.788 -0.72 . . . . 72.02 112.523 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.98 156.11 17.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 74.24 110.88 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.25 122.56 11.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 70.33 110.803 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -119.93 124.45 46.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 73.42 110.937 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . -149.59 -140.09 3.2 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.783 -0.722 . . . . 75.34 112.531 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -139.16 -98.36 0.41 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 73.11 112.494 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.52 101.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.818 0.342 . . . . 74.44 110.937 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 71.49 -116.06 5.95 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 74.32 112.462 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.63 152.31 21.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.815 0.341 . . . . 74.25 110.898 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 72.95 -69.76 0.18 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 74.02 110.881 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -100.35 170.41 8.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 73.32 110.891 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -143.1 64.45 1.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 75.53 110.886 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -125.24 -171.44 2.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 72.22 110.796 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -110.53 110.07 20.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 73.13 110.855 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -179.06 119.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 74.34 110.893 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -124.84 -68.39 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 72.31 110.863 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 53.42 -171.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 75.23 110.872 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.158 -0.474 . . . . 72.24 110.904 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.787 0.327 . . . . 72.43 110.919 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -135.26 -67.1 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.436 . . . . 75.1 110.88 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 40.3 mm 61.05 100.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 74.11 111.086 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.55 98.25 1.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 70.22 110.87 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.91 103.37 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 73.04 111.122 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -151.61 171.74 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 75.24 111.133 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 65.5 t -127.07 -71.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 75.12 111.092 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -129.03 -130.36 3.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.795 -0.717 . . . . 65.12 112.505 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.18 -169.92 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.803 0.335 . . . . 73.44 110.895 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -84.32 117.57 23.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 71.12 110.9 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 93.0 p -131.8 140.16 49.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 75.43 110.893 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -120.43 146.21 46.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 71.23 111.116 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -95.89 -26.73 15.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.924 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.31 138.88 5.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 70.25 110.944 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 10.8 mt -137.15 117.71 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 74.02 111.122 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -131.77 121.47 24.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 73.0 110.884 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.4 147.61 49.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 70.24 111.151 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -157.05 161.11 39.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 71.21 110.936 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 64.89 72.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 75.55 110.883 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.25 37.9 12.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 64.21 110.849 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.83 141.48 29.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 71.41 111.148 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.73 135.46 52.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 74.34 110.931 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.12 122.01 21.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 72.21 111.146 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -119.48 134.06 55.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 74.54 110.882 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 6.5 mp -130.74 118.06 20.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 72.1 110.946 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 145.52 -108.99 0.49 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.79 -0.719 . . . . 73.43 112.483 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.37 150.24 37.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.847 0.356 . . . . 74.2 110.895 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 80.0 t -133.42 122.73 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 75.32 111.131 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 79.6 t -124.15 112.83 34.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 72.41 111.095 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 74.3 p -69.08 175.25 3.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 75.33 111.17 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.01 75.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 74.02 111.142 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.78 -52.18 66.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 73.32 111.1 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.24 -169.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 71.12 111.118 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 59.7 tp -147.58 149.63 32.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 65.33 110.917 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -53.44 140.35 28.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 74.12 110.907 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -55.34 176.46 0.61 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.694 -0.765 . . . . 71.14 112.549 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -128.57 -120.69 2.31 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.696 -0.764 . . . . 74.51 112.465 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 3.2 tt -145.3 149.44 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.816 0.341 . . . . 74.03 111.192 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.18 99.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.428 . . . . 74.34 110.881 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 mp -91.59 -27.79 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 75.22 111.093 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 2.3 m -79.08 60.95 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 74.32 110.815 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -177.73 142.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 75.23 110.86 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -174.56 165.79 3.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 71.24 110.919 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 17.0 p -72.6 136.66 45.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 63.23 111.166 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 94.1 m -92.25 128.74 38.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 60.24 111.114 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.41 142.53 51.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 73.23 110.883 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.88 133.45 39.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 74.44 110.839 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 4.9 p -124.11 118.51 54.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.139 -0.482 . . . . 72.21 111.136 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.96 -75.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 73.5 110.926 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.1 138.9 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 54.54 111.09 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 40.2 t -117.43 128.46 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 74.32 111.092 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 38.9 t -127.12 118.58 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 75.21 111.159 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.63 132.28 10.18 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.77 -0.728 . . . . 73.15 112.481 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -133.7 116.56 15.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 74.24 110.868 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 74.71 86.77 0.26 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.707 -0.759 . . . . 64.24 112.498 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 51.09 81.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 65.51 110.876 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 16.3 m -117.3 145.42 44.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 73.42 110.873 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -134.11 127.29 31.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 73.35 110.79 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 46.6 t -133.2 130.5 57.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 73.14 111.142 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -128.34 107.85 10.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 73.33 110.833 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 23.1 mm -114.27 109.19 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 71.42 111.069 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.62 -137.36 6.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.84 -0.695 . . . . 75.05 112.557 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -111.24 133.24 53.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 70.41 110.902 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.34 133.66 55.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.44 110.905 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.26 123.88 29.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 73.03 110.937 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 110.44 -77.65 0.23 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.64 -0.791 . . . . 63.4 112.494 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -50.79 125.66 23.71 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.71 -0.757 . . . . 75.03 112.453 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -84.97 -68.88 0.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.346 . . . . 73.31 110.953 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -50.27 -79.35 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.744 -0.741 . . . . 73.41 112.462 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -62.99 1.34 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.845 0.355 . . . . 73.35 110.847 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 4.1 p90 178.34 -31.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 75.13 110.91 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -87.84 60.12 5.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.301 -0.409 . . . . 74.31 110.942 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -51.64 136.34 27.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 70.11 110.871 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -107.29 -171.18 1.83 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 74.31 110.879 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -87.61 145.73 26.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 72.33 110.841 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -56.02 142.73 35.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 74.22 110.807 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -161.51 -172.24 3.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 75.53 110.875 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -97.35 -170.49 2.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.0 110.925 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 75.55 110.816 -179.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 4.3 mmt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.813 0.34 . . . . 75.03 110.867 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.74 -179.33 4.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 73.32 110.92 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 18.4 pt -124.31 26.59 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 75.03 111.144 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -176.76 111.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.52 110.899 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -129.34 29.61 5.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 72.54 111.006 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.3 118.05 7.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 74.43 111.143 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.96 146.11 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 75.54 111.159 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 174.37 174.95 41.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.762 -0.732 . . . . 74.4 112.437 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -156.32 153.95 29.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.79 0.329 . . . . 73.02 110.861 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.21 130.08 52.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 74.32 110.823 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.1 m -128.57 144.31 51.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 74.54 110.872 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.7 124.01 19.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 72.44 111.091 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -76.09 -37.2 58.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 73.14 110.916 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -164.68 138.46 5.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 62.53 110.878 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 9.7 pt -137.82 118.01 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 74.4 111.067 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -128.39 126.91 41.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 75.31 110.909 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.7 p -135.56 149.49 49.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 74.34 111.142 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -144.97 168.37 20.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 73.24 110.925 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 65.47 74.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 75.31 110.922 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 41.89 59.11 2.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 73.02 110.811 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.11 155.99 18.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 65.43 111.099 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -135.05 145.92 48.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 75.15 110.905 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.97 137.39 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 74.21 111.113 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -137.2 129.42 29.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.45 110.917 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.9 mp -122.94 130.34 52.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 75.35 110.846 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.72 -121.42 1.56 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 71.01 112.446 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -144.86 132.7 21.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.87 0.367 . . . . 74.33 110.903 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 18.0 m -120.02 120.9 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.138 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 94.5 t -122.07 129.02 75.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 64.45 111.189 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t -78.19 166.67 22.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 74.05 111.196 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.07 -33.89 76.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 72.31 111.133 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.82 -37.97 71.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 73.34 111.129 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -66.05 -23.44 66.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 75.52 111.061 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 6.9 tp -76.73 64.91 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 72.42 110.965 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -179.16 34.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.445 . . . . 74.22 110.77 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 152.15 -159.7 28.49 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.716 -0.754 . . . . 71.23 112.479 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 175.6 172.23 40.25 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 64.12 112.507 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 3.4 pt -120.5 175.04 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 73.42 111.124 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -126.75 84.41 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 75.32 110.867 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 44.9 mm -140.09 135.69 37.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 65.34 111.108 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.06 -49.4 71.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 72.34 110.848 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.98 -76.21 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 74.53 110.897 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 51.61 42.35 29.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 62.41 110.97 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.52 121.79 30.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 73.0 111.123 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 98.0 m -127.62 111.04 13.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 73.33 111.117 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.52 135.48 41.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 63.3 110.899 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 9.4 t -140.73 123.18 15.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 71.54 110.797 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 4.2 p -113.63 150.17 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 73.11 111.156 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -88.19 -73.31 0.49 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.483 . . . . 73.41 110.956 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 18.5 m -124.06 133.67 53.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 72.54 111.169 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 9.8 t -118.01 128.87 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 64.13 111.139 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 48.8 t -127.4 117.17 46.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 60.44 111.108 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.74 133.62 10.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.687 -0.768 . . . . 75.31 112.456 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -132.33 148.12 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 75.41 110.96 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.39 88.05 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.817 -0.706 . . . . 64.43 112.429 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 44.45 65.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 75.21 110.913 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 43.4 t -93.82 145.21 24.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.47 . . . . 73.14 110.86 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -123.02 128.45 50.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 74.35 110.835 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.3 123.62 71.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 73.21 111.144 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.0 111.48 17.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 72.23 110.976 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 20.4 mm -111.79 104.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.188 -0.46 . . . . 72.32 111.174 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.7 -160.22 26.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 72.43 112.468 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -107.01 151.51 25.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 72.11 110.878 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.26 131.93 45.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 71.31 110.893 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -113.17 125.86 54.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 64.13 110.933 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 131.37 166.55 11.71 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.735 -0.745 . . . . 63.44 112.519 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -82.42 -108.93 0.44 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 33.33 112.524 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.31 51.01 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 75.23 110.907 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.15 30.87 32.48 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.787 -0.721 . . . . 62.12 112.464 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 58.47 83.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.882 0.372 . . . . 74.14 110.882 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 23.0 t90 55.45 63.14 2.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 74.35 110.909 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.16 -169.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 73.52 110.938 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -119.75 161.71 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 74.1 110.974 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -51.93 116.53 2.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 75.52 110.934 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -152.57 -73.1 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 73.5 110.889 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 8.4 m170 63.09 168.2 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 71.41 110.806 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -154.85 178.01 10.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 73.13 110.844 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -84.41 137.14 33.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.889 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 8.5 m170 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 75.44 110.863 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.828 0.347 . . . . 74.13 110.941 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.04 -170.56 2.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 62.11 110.887 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 2.5 tt -71.02 150.31 9.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 71.52 111.151 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -55.73 175.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.89 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -95.44 24.56 5.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 72.54 111.07 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 12.5 tt -111.06 136.18 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 62.34 111.122 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 92.7 t -149.86 105.51 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 75.41 111.13 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -80.46 164.75 47.62 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 73.14 112.467 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -170.76 127.42 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.833 0.349 . . . . 72.1 110.862 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.22 131.13 48.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.911 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.1 145.32 49.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 75.14 110.876 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -139.5 124.68 18.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.478 . . . . 72.42 111.075 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.39 -36.05 53.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.483 . . . . 72.22 110.969 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.36 137.6 4.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 72.45 110.856 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 5.9 pt -138.69 117.64 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 73.2 111.179 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.35 123.72 32.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 74.54 110.875 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.7 p -135.61 142.71 45.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 75.51 111.18 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -143.37 167.56 21.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 73.42 110.879 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 68.63 73.6 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 74.3 110.881 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 45.83 54.8 7.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 74.01 110.844 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.27 156.17 18.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 65.41 111.138 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.31 146.54 42.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.829 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.46 140.85 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 74.51 111.208 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -138.14 122.55 18.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 61.41 110.964 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.6 118.94 33.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.209 -0.45 . . . . 74.01 110.93 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.92 -170.84 24.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.798 -0.715 . . . . 54.41 112.523 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.99 129.05 34.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 74.33 110.909 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 17.5 m -118.99 121.12 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 72.31 111.175 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 26.6 t -122.15 129.02 75.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 74.34 111.105 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -85.34 175.08 9.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 75.12 111.157 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.05 -42.35 90.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 73.3 111.145 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.96 67.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 73.53 111.08 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -60.2 -25.36 65.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 74.45 111.074 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 1.2 tp -55.64 -25.85 41.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 75.44 110.947 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -115.14 58.36 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.33 110.889 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -168.59 -161.37 18.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.652 -0.785 . . . . 74.34 112.414 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 112.84 136.59 6.67 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.76 -0.733 . . . . 71.14 112.464 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.92 50.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.857 0.361 . . . . 65.02 111.219 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.64 -74.83 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 72.41 110.886 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 44.4 mm 60.83 81.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.179 -0.464 . . . . 74.11 111.126 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.0 t -83.16 115.24 21.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 74.42 110.816 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -178.77 105.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 74.01 110.863 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -68.71 93.76 0.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 75.11 110.857 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 27.8 p -100.69 122.05 42.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 73.22 111.17 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 96.7 m -133.91 124.92 27.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 73.24 111.152 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -115.97 134.6 54.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 71.11 110.866 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.89 123.54 19.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.02 110.828 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 4.9 p -110.22 150.04 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.501 . . . . 75.54 111.123 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -86.61 -77.1 0.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 62.41 110.835 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 13.8 m -120.16 132.71 55.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 75.54 111.169 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 5.0 t -118.13 121.0 66.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.304 -0.407 . . . . 63.25 111.107 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.51 117.24 51.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.487 . . . . 72.22 111.138 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.79 133.79 11.09 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 72.02 112.516 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.99 148.12 52.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 74.32 110.933 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.35 82.95 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.75 -0.738 . . . . 73.44 112.545 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 46.8 69.04 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 74.3 110.893 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.92 145.7 26.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 74.44 110.884 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.46 128.38 52.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 72.31 110.891 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.98 123.91 72.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 64.53 111.139 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.36 111.66 16.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 75.2 110.951 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 24.0 mm -112.09 104.1 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.54 111.165 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.24 -164.62 27.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 71.1 112.443 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -101.25 151.91 21.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 74.52 110.872 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -130.91 142.51 50.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.842 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -127.53 125.92 41.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 73.14 110.914 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 157.7 146.24 4.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.72 -0.752 . . . . 63.02 112.509 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -102.98 -170.23 26.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 45.12 112.462 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? 56.27 25.18 9.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 72.24 110.893 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 141.77 117.86 1.36 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.724 -0.751 . . . . 54.44 112.541 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -55.71 -26.1 43.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 71.23 110.886 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -139.43 -65.0 0.48 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 74.25 110.882 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.45 124.26 35.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 61.41 110.844 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -51.93 141.75 17.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 74.3 110.884 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -158.65 165.61 34.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 74.2 110.898 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -89.97 -172.21 3.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 74.15 110.834 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -130.51 -169.89 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 73.32 110.896 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.87 -171.32 3.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 73.01 110.816 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -77.65 -170.24 1.76 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.216 -0.447 . . . . 61.13 110.915 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 75.35 110.833 179.951 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.816 0.341 . . . . 74.54 110.86 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.51 172.43 8.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 73.23 110.942 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.55 145.28 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.291 -0.413 . . . . 75.41 111.11 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.0 132.92 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 62.53 110.86 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.6 73.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 75.34 111.122 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.9 145.07 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 62.31 111.088 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 32.7 m -62.59 -176.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 75.51 111.131 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -175.69 176.47 47.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.805 -0.712 . . . . 53.44 112.534 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -71.0 -67.05 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 75.33 110.87 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -84.43 118.44 24.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 73.25 110.877 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 14.9 t -136.68 147.74 46.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.816 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -135.83 129.0 31.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 74.22 111.145 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.22 -35.24 36.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 73.52 110.91 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.8 136.81 3.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 74.2 110.89 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 4.6 pt -139.17 117.72 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 73.43 111.156 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.1 124.3 32.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 72.54 110.939 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -135.39 144.21 46.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 72.4 111.105 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 13.1 pm0 -143.53 167.82 21.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 62.03 110.927 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 68.68 70.72 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 73.25 110.926 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? 47.0 57.39 5.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 73.35 110.835 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.57 156.18 18.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 73.0 111.106 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -136.58 141.63 43.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 74.11 110.871 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.07 140.81 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 74.22 111.105 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -138.02 129.54 27.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 75.23 110.906 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 5.2 mp -123.98 118.65 27.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 75.14 110.957 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.8 -176.74 21.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.767 -0.73 . . . . 74.2 112.506 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -85.92 128.91 34.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 73.33 110.851 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 32.2 m -111.67 127.4 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 72.45 111.166 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 22.4 t -122.29 129.07 75.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 70.51 111.132 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 18.3 p -84.18 175.08 9.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 75.52 111.102 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.81 -34.85 70.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.476 . . . . 74.21 111.046 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -70.87 -51.73 24.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 45.14 111.07 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 52.36 -170.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.284 -0.416 . . . . 63.12 111.07 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.03 -177.34 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 70.22 110.913 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -168.89 67.01 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.448 . . . . 75.2 110.888 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 178.47 88.09 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.767 -0.73 . . . . 63.4 112.473 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 52.68 -144.85 20.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 72.04 112.446 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 13.4 pt -117.82 -36.29 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 75.44 111.155 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 55.96 -176.47 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.867 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 42.3 mt -139.31 69.26 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 73.31 111.113 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 2.6 p -52.09 157.62 1.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.947 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -59.96 178.54 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 75.33 110.886 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -105.95 79.55 1.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 75.13 110.914 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 51.3 p -67.13 128.88 38.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 73.51 111.142 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 22.6 m -125.46 109.01 12.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 74.55 111.111 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.26 135.87 48.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.44 110.856 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.05 123.61 14.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 61.23 110.883 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 3.5 p -110.27 145.11 17.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.151 -0.477 . . . . 73.45 111.139 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.43 -75.82 0.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 72.3 110.798 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 25.2 m -126.12 134.28 51.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.179 -0.464 . . . . 72.44 111.061 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 8.7 t -118.64 127.06 75.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.488 . . . . 72.41 111.134 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.91 116.11 43.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 74.24 111.128 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.69 133.77 10.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.722 . . . . 74.1 112.484 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.29 148.01 52.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 73.22 110.902 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.84 85.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.735 -0.745 . . . . 63.43 112.52 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 47.82 73.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 72.34 110.87 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 38.6 t -103.12 145.48 29.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 63.21 110.817 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -119.65 128.49 53.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 74.31 110.899 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.55 123.93 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.124 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.18 111.15 14.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.935 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 38.7 mm -112.18 104.05 16.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 74.32 111.165 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.04 -157.53 27.36 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 72.11 112.477 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -114.52 156.12 25.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 65.31 110.855 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.6 139.29 53.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.08 -0.509 . . . . 72.53 110.877 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -129.19 125.99 38.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.941 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 148.1 153.9 6.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.768 -0.73 . . . . 73.04 112.502 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -99.01 103.81 2.8 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.717 -0.754 . . . . 74.14 112.526 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -179.41 41.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.877 0.37 . . . . 74.55 110.944 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.66 -135.05 11.98 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.75 -0.738 . . . . 73.35 112.488 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -124.32 -1.85 8.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 75.44 110.866 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -174.29 -65.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 75.5 110.909 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -122.12 -171.34 2.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 75.32 110.932 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -52.56 127.84 24.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 73.2 110.906 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -52.08 139.21 23.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 74.2 110.879 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -163.67 49.5 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 74.41 110.892 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -129.04 -73.67 0.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 73.43 110.869 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.56 126.81 31.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 74.43 110.888 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 71.28 -70.02 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 64.12 110.911 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 74.34 110.813 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.881 0.372 . . . . 65.04 110.909 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -162.2 -177.32 5.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.884 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 6.2 pt -141.9 168.12 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 73.3 111.15 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -172.5 139.07 0.94 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 74.42 110.835 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -174.38 112.52 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 52.22 111.106 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 4.0 mp -139.65 146.99 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 75.52 111.123 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 12.3 p -124.22 147.39 28.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.187 -0.461 . . . . 73.23 111.097 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -144.3 -152.77 5.71 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.753 -0.736 . . . . 54.52 112.436 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -72.5 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.327 . . . . 72.21 110.814 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -86.53 110.07 19.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 74.5 110.916 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 2.3 t -124.09 138.15 54.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 74.11 110.847 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.41 129.02 52.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 74.04 111.139 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.03 -33.12 51.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 73.54 110.899 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -167.77 136.59 2.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 75.13 110.85 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 4.2 pt -140.41 116.98 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 72.32 111.157 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -131.41 124.65 30.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 74.24 110.823 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 2.7 p -136.06 143.48 44.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 72.33 111.14 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 17.9 pm0 -142.83 167.7 21.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.25 110.867 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 67.7 78.21 0.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.492 . . . . 75.13 110.893 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 43.92 50.64 7.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 75.03 110.93 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.02 156.1 18.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 63.42 111.137 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.95 155.65 49.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 61.53 110.888 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 17.5 m -141.16 140.06 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 72.41 111.088 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -138.1 119.2 14.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 71.14 110.854 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 mp -118.78 135.19 54.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 72.51 110.913 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.17 -116.9 1.53 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 73.31 112.499 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -143.62 128.79 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.865 0.365 . . . . 70.13 110.882 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.55 115.54 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 74.43 111.109 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 80.5 t -122.03 125.95 73.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 72.13 111.087 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 18.2 p -86.25 174.99 8.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 64.15 111.11 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.92 -42.62 68.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 74.23 111.123 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.97 -44.94 96.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.433 . . . . 70.14 111.072 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.81 -169.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 74.22 111.063 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.77 -170.67 3.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 71.05 110.896 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -72.61 -175.16 1.57 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.21 -0.45 . . . . 75.43 110.804 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -135.26 -145.96 5.24 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.749 -0.739 . . . . 72.42 112.538 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 169.6 166.62 28.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.787 -0.721 . . . . 64.31 112.492 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 2.2 tt -51.93 146.01 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.847 0.356 . . . . 71.53 111.147 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -77.84 98.74 5.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 63.24 110.857 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 3.1 pt -151.11 168.27 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 70.34 111.13 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.63 99.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 73.42 110.931 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -173.65 102.74 0.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 60.53 110.892 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -176.62 159.88 1.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 64.23 110.952 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 25.8 p -77.34 125.72 29.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.303 -0.408 . . . . 73.51 111.152 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 90.0 m -99.0 109.33 22.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 74.41 111.122 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -108.9 144.6 36.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 75.22 110.923 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.36 136.06 35.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 64.32 110.846 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.17 133.83 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 74.31 111.112 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -70.16 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 75.41 110.888 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 87.1 m -150.85 133.64 15.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 74.33 111.14 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 13.5 t -117.17 129.19 74.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 73.41 111.178 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 61.2 t -127.2 115.8 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 73.11 111.107 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.0 133.06 11.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 54.12 112.49 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.31 116.62 18.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 73.3 110.936 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.57 87.66 0.17 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.69 -0.767 . . . . 73.33 112.477 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 52.25 88.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 73.31 110.869 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.37 145.68 50.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 64.43 110.914 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -121.35 128.83 52.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.826 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.24 126.6 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 71.35 111.079 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.24 111.3 13.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.51 110.98 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 45.8 mm -112.6 104.8 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.158 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 138.02 -176.9 20.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.776 -0.726 . . . . 75.35 112.495 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -91.33 156.17 17.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 75.45 110.849 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -131.66 139.02 48.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 73.01 110.887 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -125.61 125.89 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 72.52 110.836 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . -170.66 -87.69 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 74.44 112.476 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 136.84 -50.68 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.669 -0.777 . . . . 53.53 112.487 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 103.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.325 . . . . 74.35 110.917 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 56.07 -101.51 0.14 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.793 -0.718 . . . . 73.13 112.411 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -175.13 122.44 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.814 0.34 . . . . 72.43 110.925 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 7.7 t90 51.17 32.83 8.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 75.22 110.906 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.19 -171.42 0.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 73.21 110.86 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -110.87 176.75 4.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.13 110.916 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -127.95 99.87 5.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 71.41 110.823 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.45 161.29 1.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 75.25 110.792 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -162.42 -74.11 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 75.4 110.828 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.08 111.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 75.14 110.815 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -177.69 -174.8 0.48 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 72.45 110.907 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 5.2 t60 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 63.13 110.919 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.829 0.347 . . . . 73.43 110.912 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -177.22 142.12 0.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 71.31 110.929 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 8.7 tp -172.85 139.15 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.262 -0.427 . . . . 71.54 111.129 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.0 140.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 72.53 110.851 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -105.35 -68.54 0.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 52.24 111.078 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.65 121.86 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 74.11 111.127 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 6.2 m -140.76 111.04 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 74.43 111.209 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -71.87 -128.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.824 -0.703 . . . . 73.42 112.504 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.46 -168.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 72.43 110.842 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -83.52 109.74 17.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 61.21 110.876 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 3.3 m -131.86 137.62 48.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.03 110.845 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -108.25 155.01 20.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 70.32 111.09 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -109.56 -26.03 10.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 74.4 110.902 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.88 137.24 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 73.34 110.898 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.43 115.9 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.52 111.115 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -132.29 118.46 19.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 73.52 110.862 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 1.3 p -136.21 152.83 51.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 74.35 111.104 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.5 167.29 30.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 75.23 110.896 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 63.75 80.47 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 75.23 110.929 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 45.54 51.81 9.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 74.11 110.825 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.54 156.66 17.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 72.13 111.196 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -139.16 154.34 48.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 71.42 110.845 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 19.0 m -142.63 135.68 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 74.53 111.119 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -138.52 129.8 27.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 74.12 110.934 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.51 135.19 50.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 74.3 110.915 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.16 -124.37 2.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.739 -0.743 . . . . 65.22 112.49 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -144.1 128.95 18.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.367 . . . . 75.53 110.93 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 11.0 t -99.91 119.4 47.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 71.12 111.121 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 57.6 t -122.28 112.91 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 74.21 111.131 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 43.9 p -71.92 175.05 6.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 63.04 111.145 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.0 -40.5 97.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 61.12 111.155 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.01 -51.97 67.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 74.52 111.112 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.83 -169.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 72.14 111.125 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 12.6 tp -71.84 -66.7 0.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 71.25 110.876 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -177.2 169.4 2.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 71.54 110.845 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -52.77 111.44 1.65 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 63.11 112.485 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 69.76 138.83 0.12 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.734 -0.746 . . . . 64.32 112.469 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 6.2 tp -160.89 143.51 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.776 0.322 . . . . 74.31 111.141 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -61.7 -170.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.181 -0.463 . . . . 72.54 110.839 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.26 178.6 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 74.44 111.154 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.62 111.35 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 73.54 110.852 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -173.41 127.25 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 74.21 110.849 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -178.19 -36.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.932 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 11.0 p -72.04 137.1 46.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 72.44 111.128 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 98.6 m -121.1 125.68 47.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.2 111.132 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -126.19 125.54 42.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 74.21 110.881 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.24 119.71 35.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 74.54 110.856 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 75.4 t -107.8 115.46 48.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 64.41 111.172 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . 0.572 ' CD ' ' N ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -64.6 -133.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 71.12 110.906 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 7.1 p -94.71 130.03 41.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 71.25 111.139 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 26.4 t -116.47 123.33 71.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 62.22 111.118 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 38.6 t -110.6 118.36 57.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.082 -0.508 . . . . 75.54 111.107 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.81 133.58 11.7 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.715 -0.755 . . . . 71.24 112.563 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.69 116.55 19.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.881 0.372 . . . . 72.1 110.969 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.88 97.74 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.771 -0.728 . . . . 71.54 112.578 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 51.71 89.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 62.44 110.887 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 31.3 t -124.87 146.54 49.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 70.12 110.868 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -127.19 128.69 46.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 74.05 110.895 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 21.9 t -114.89 122.88 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 61.52 111.159 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.16 110.75 12.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.261 -0.427 . . . . 70.21 110.948 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 26.7 mm -113.76 104.87 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.45 111.088 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.92 -161.8 27.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 74.53 112.513 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.22 156.28 26.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 55.53 110.851 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.77 147.26 44.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 73.22 110.882 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -130.09 125.81 36.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 75.2 110.905 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 163.5 167.03 23.34 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.739 -0.743 . . . . 74.34 112.478 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -67.79 -138.01 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.698 -0.763 . . . . 73.12 112.506 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -51.71 140.48 18.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 74.45 110.934 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 108.49 86.22 1.78 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 75.12 112.53 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -51.82 -35.08 43.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.349 . . . . 72.33 110.883 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 14.8 t90 -176.14 -44.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 74.24 110.886 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -127.15 160.57 30.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 73.31 110.845 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -127.17 -170.19 2.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 72.45 110.942 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -152.46 113.48 4.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 65.32 110.826 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -178.15 129.66 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.13 110.823 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -150.97 25.92 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 75.3 110.794 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 52.51 88.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.866 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.24 -169.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 72.25 110.874 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 74.15 110.846 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 29.0 ttm . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.861 0.363 . . . . 75.32 110.954 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -179.23 -35.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 71.44 110.899 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.1 tt -51.78 150.94 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 72.42 111.137 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -95.89 26.32 4.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.487 . . . . 74.41 110.862 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -151.75 98.81 2.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 62.33 111.05 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 9.2 tt -159.22 150.95 6.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 74.05 111.162 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.91 153.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 75.43 111.14 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 106.62 106.01 3.08 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 74.1 112.44 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -179.55 146.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.804 0.335 . . . . 72.4 110.869 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -83.93 119.51 24.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.903 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.97 137.98 53.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 75.11 110.808 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.53 141.11 46.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 71.51 111.104 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -97.36 -35.64 10.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.87 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -164.33 138.96 5.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.299 -0.41 . . . . 73.23 110.864 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 11.0 mt -137.61 117.79 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 74.54 111.069 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.68 120.28 24.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 75.22 110.819 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.32 146.9 48.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 71.51 111.111 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -148.89 167.09 26.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 75.24 110.939 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 66.82 56.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 65.11 110.954 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 14.9 mtm-85 50.41 64.65 1.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.856 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 156.25 18.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 45.1 111.132 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -129.33 135.68 49.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 74.51 110.884 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 20.4 m -139.73 130.13 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 63.21 111.146 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -122.24 132.73 54.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 72.02 110.905 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.43 135.1 47.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 73.43 110.862 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.54 -130.92 6.32 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.805 -0.712 . . . . 50.53 112.539 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -144.56 128.89 17.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.866 0.365 . . . . 64.42 110.899 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 m -110.26 126.15 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 73.34 111.129 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.2 m -122.47 129.11 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 75.14 111.063 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 34.9 p -71.74 174.65 6.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 74.44 111.154 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.61 80.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 62.42 111.09 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.99 -35.92 69.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 73.12 111.168 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.71 -29.95 20.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 64.41 111.102 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.18 85.38 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 73.41 110.945 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -178.2 34.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 73.1 110.888 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 65.65 -167.42 33.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.759 -0.734 . . . . 75.13 112.451 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -168.67 -75.97 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.683 -0.77 . . . . 74.14 112.426 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 29.2 mm 63.25 72.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.343 . . . . 75.42 111.193 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.51 140.74 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.869 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 11.5 tt -66.78 131.05 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 74.24 111.133 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.5 p -179.33 -35.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 73.52 110.84 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.19 107.58 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 73.11 110.88 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -178.04 34.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.231 -0.441 . . . . 60.14 110.927 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 21.7 p -100.32 121.97 42.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 73.14 111.125 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.78 108.87 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 71.24 111.136 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -101.86 129.05 48.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 74.24 110.92 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 34.7 m -140.44 123.81 16.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 65.22 110.854 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.6 p -120.28 136.7 56.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 73.3 111.109 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -78.65 -76.13 0.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.809 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.1 m -127.04 130.6 50.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 72.01 111.131 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.2 125.01 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 64.13 111.116 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.25 122.2 63.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 74.45 111.073 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.17 133.76 9.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 63.35 112.478 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.97 147.89 52.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.372 . . . . 73.2 110.889 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.13 78.61 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.688 -0.768 . . . . 71.22 112.449 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 47.28 63.71 1.86 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.855 0.36 . . . . 72.3 110.887 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 46.3 t -90.25 145.66 24.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 54.35 110.815 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.18 128.04 44.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 73.1 110.841 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 17.4 t -134.54 123.74 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 64.42 111.114 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.69 111.56 18.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 64.32 110.809 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 2.1 mp -111.61 104.82 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 72.41 111.155 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.06 -161.17 29.86 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 74.35 112.469 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -120.15 150.24 40.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.783 0.325 . . . . 71.02 110.881 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -124.21 128.6 49.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 74.53 110.894 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.05 125.8 53.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.105 -0.498 . . . . 73.43 110.926 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 125.06 159.8 10.49 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.721 -0.752 . . . . 52.05 112.561 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -108.82 -8.3 28.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.711 -0.757 . . . . 74.22 112.514 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -77.32 60.58 2.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.874 0.369 . . . . 75.44 110.892 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.33 97.39 2.46 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.722 -0.751 . . . . 62.0 112.533 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.85 -68.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 74.53 110.819 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -142.25 -69.66 0.35 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 73.21 110.956 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -104.38 -169.83 1.68 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 74.34 110.91 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -55.09 174.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 74.51 110.87 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.09 179.36 6.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 64.51 110.805 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 7.2 m80 59.97 174.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 75.45 110.822 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 63.19 101.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 70.15 110.866 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -112.49 -170.22 1.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.886 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.96 -72.69 0.57 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 73.45 110.859 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 74.12 110.928 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.807 0.337 . . . . 73.23 110.908 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.17 -40.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 74.52 110.903 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.89 124.58 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.291 -0.413 . . . . 63.14 111.082 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.18 117.35 0.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 53.1 110.881 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -155.82 173.72 16.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 75.32 111.16 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 64.6 mt -70.1 138.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 72.51 111.127 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 21.9 t -128.9 135.31 62.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 74.33 111.187 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 172.76 113.29 0.3 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.697 -0.763 . . . . 62.2 112.419 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -179.49 148.83 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.892 0.377 . . . . 72.15 110.876 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -90.65 121.44 32.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 74.1 110.86 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 47.6 t -130.14 138.04 50.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 53.54 110.875 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.27 161.91 30.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 73.32 111.099 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.7 -31.91 5.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 72.02 110.904 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -164.39 138.79 5.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 33.44 110.911 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 12.9 mt -137.66 119.1 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 74.15 111.152 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 -131.71 119.15 20.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 74.4 110.899 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.59 140.71 46.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 64.25 111.189 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -144.67 167.57 22.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.855 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 61.86 63.37 1.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.086 -0.506 . . . . 72.15 110.959 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 47.99 61.05 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 73.22 110.878 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.57 153.29 21.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 74.31 111.113 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 8.3 mtt-85 -129.19 135.6 49.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 75.43 110.863 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 24.2 m -140.69 123.91 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 73.31 111.137 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.52 137.2 53.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 72.51 110.974 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.06 118.89 22.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 71.45 110.851 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.27 173.7 13.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.704 -0.76 . . . . 71.11 112.477 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -87.8 137.99 31.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 64.52 110.908 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 30.6 m -120.68 125.68 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 74.53 111.132 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.48 129.2 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.31 111.142 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.7 t -71.55 175.1 5.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 72.44 111.149 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.57 91.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 71.42 111.165 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.02 -36.37 70.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 63.13 111.11 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -52.33 -29.83 25.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.199 -0.455 . . . . 65.41 111.129 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.92 57.55 3.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 74.41 110.963 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -117.22 -67.24 1.01 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 74.44 110.86 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -144.08 -145.01 4.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.736 -0.745 . . . . 74.21 112.468 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -173.93 104.53 0.2 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.778 -0.725 . . . . 75.2 112.503 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 28.2 mm -83.06 148.9 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 72.43 111.161 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 11.1 ttp85 -71.52 82.67 0.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 72.41 110.865 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 27.0 mm -134.21 149.41 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 74.43 111.1 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 62.2 p -66.07 106.41 1.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.838 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -114.58 77.29 1.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 74.53 110.911 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -114.19 79.69 1.29 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 71.41 110.828 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 30.5 p -100.53 121.99 42.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 72.13 111.196 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.33 133.73 47.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 64.03 111.171 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -125.85 130.01 50.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 71.44 110.905 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.27 123.8 20.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 70.13 110.846 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -119.26 133.18 66.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 72.22 111.109 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.12 -74.97 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.837 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 97.3 m -135.44 133.71 38.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 54.55 111.13 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.25 125.88 74.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 72.44 111.099 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 63.4 t -127.31 125.43 65.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 74.02 111.097 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.5 133.82 8.05 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.725 -0.75 . . . . 65.34 112.48 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -130.98 147.62 52.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.816 0.341 . . . . 62.54 110.906 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.43 64.64 3.25 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.83 -0.7 . . . . 62.42 112.439 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.03 96.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.872 0.367 . . . . 71.41 110.874 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 65.1 m -125.36 145.82 49.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 74.24 110.859 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -127.22 127.51 44.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 75.1 110.799 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 19.3 t -134.6 123.41 41.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 63.34 111.148 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.64 113.39 21.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.252 -0.431 . . . . 64.15 110.922 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.07 127.11 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 73.35 111.036 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 127.33 -164.46 20.81 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.691 -0.766 . . . . 74.24 112.468 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -115.05 148.46 38.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 74.34 110.871 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.72 131.38 55.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 62.01 110.904 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -116.87 125.99 52.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.959 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 129.58 -175.3 19.07 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.727 . . . . 73.11 112.514 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -136.39 51.44 0.81 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.785 -0.722 . . . . 72.15 112.494 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -98.5 25.98 5.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.342 . . . . 73.25 110.914 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 109.9 18.09 9.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.794 -0.717 . . . . 73.41 112.516 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 69.35 -75.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.938 0.399 . . . . 72.52 110.868 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -141.95 -73.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.5 . . . . 75.15 110.868 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.66 -172.08 3.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 74.45 110.846 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -83.75 -64.59 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 73.1 110.88 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -121.84 -175.66 3.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 72.55 110.886 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -178.87 -176.86 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 65.15 110.874 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 19.7 t60 63.02 163.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 72.34 110.838 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -166.92 159.05 13.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 75.31 110.857 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -53.26 167.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 74.22 110.872 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 72.23 110.914 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 4.1 mtm . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.837 0.351 . . . . 75.34 110.89 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -105.74 86.19 2.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.903 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 3.2 mt -124.56 139.65 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 74.44 111.101 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -95.0 44.33 1.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 64.21 110.899 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -168.67 76.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 73.14 111.066 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 31.9 mm -104.58 83.79 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 61.42 111.186 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 6.6 p -51.68 122.63 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 72.14 111.169 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -146.2 -107.97 0.54 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.728 -0.748 . . . . 65.32 112.471 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.24 -57.57 0.9 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.781 0.324 . . . . 72.44 110.883 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -92.15 110.03 21.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 60.23 110.855 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 72.7 m -136.75 139.52 41.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 63.5 110.898 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.84 159.67 31.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 74.23 111.119 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -112.82 -29.28 7.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 74.21 110.921 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.7 138.09 4.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 72.4 110.867 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 9.6 mt -137.88 117.77 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 75.2 111.107 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -133.48 118.98 18.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.475 . . . . 74.43 110.926 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.21 146.4 51.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 75.02 111.118 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -150.18 167.15 27.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 75.44 110.911 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.38 64.56 1.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 74.35 110.853 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 47.87 60.26 3.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 71.44 110.846 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.21 150.58 24.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 64.43 111.077 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 35.1 mtt85 -126.07 135.38 51.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 74.44 110.875 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.52 121.57 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 72.4 111.175 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.87 137.13 52.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.51 110.952 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 mp -127.49 118.69 24.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 74.24 110.982 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 134.83 -179.99 17.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.777 -0.725 . . . . 62.52 112.496 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -92.11 135.81 33.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 73.03 110.946 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 14.6 m -116.37 126.11 73.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 74.14 111.128 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.83 129.55 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 71.24 111.163 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.7 t -69.05 171.13 8.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 72.54 111.178 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.7 -33.79 49.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 65.24 111.123 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.59 -35.82 68.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 75.04 111.143 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 69.21 -76.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 71.54 111.109 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.8 mt -119.94 -34.72 3.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.939 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 52.04 78.08 0.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 74.42 110.904 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 129.79 174.82 13.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.67 -0.776 . . . . 72.43 112.49 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -102.79 19.35 47.45 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.818 -0.706 . . . . 74.34 112.537 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.42 178.63 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.869 0.366 . . . . 74.43 111.111 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -132.73 141.9 48.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 73.33 110.89 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 12.6 pt -127.08 151.25 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 71.4 111.144 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -157.18 50.54 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.23 110.903 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.88 148.52 30.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 73.33 110.889 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.27 109.95 20.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 53.04 110.919 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 30.8 p -97.83 129.29 44.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 74.4 111.118 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.27 124.99 28.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 74.35 111.179 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -126.23 127.11 45.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 60.33 110.853 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.51 123.23 33.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 62.14 110.83 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 10.5 p -109.48 144.34 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 75.42 111.096 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.68 -65.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 71.53 110.893 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 30.5 p -147.01 138.36 24.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 65.12 111.216 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 23.3 t -117.61 124.93 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 75.31 111.144 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.66 116.02 41.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 73.22 111.117 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.41 133.01 9.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 64.32 112.475 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -132.44 141.27 48.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 75.14 110.866 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.99 68.67 1.39 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 74.22 112.478 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.83 93.72 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.789 0.328 . . . . 73.03 110.964 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 34.3 t -126.06 145.63 50.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 75.05 110.903 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 13.2 mtm-85 -129.55 127.87 41.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.825 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 17.7 t -137.63 131.54 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 75.51 111.16 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.36 111.66 13.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 74.14 110.947 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 2.6 mp -106.55 104.73 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 74.21 111.124 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.93 -179.88 23.53 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.763 -0.732 . . . . 64.4 112.471 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -89.74 156.11 18.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 75.11 110.887 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -136.36 143.3 43.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 74.5 110.926 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -130.02 125.46 35.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.42 110.916 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 149.41 116.87 0.84 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 72.21 112.456 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -62.82 -32.78 84.94 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.686 -0.768 . . . . 62.25 112.508 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -73.44 78.19 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.86 0.362 . . . . 71.43 110.912 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 73.77 104.78 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 72.24 112.458 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -58.23 -29.3 65.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 75.11 110.907 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 17.4 t90 -164.13 -41.77 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.142 -0.481 . . . . 74.21 110.983 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -129.48 -66.71 0.79 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 74.35 110.897 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 1.6 t30 62.91 163.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 71.25 110.889 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -174.42 37.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 74.35 110.876 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -80.75 100.36 8.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 75.12 110.891 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -174.4 114.1 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 74.41 110.862 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.8 -175.35 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 72.23 110.909 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -93.1 106.9 18.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 74.03 110.87 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.195 -0.457 . . . . 72.43 110.9 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.844 0.354 . . . . 75.44 110.854 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -59.59 160.14 7.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 75.54 110.824 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -173.47 145.48 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 70.43 111.168 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.26 174.25 4.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.945 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -151.8 168.01 26.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.286 -0.415 . . . . 75.44 111.066 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 4.8 mp 61.26 90.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 72.12 111.166 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 13.8 p -65.8 145.71 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 73.33 111.167 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 130.99 -144.79 16.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.681 -0.771 . . . . 70.43 112.502 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.67 -168.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.814 0.34 . . . . 73.42 110.861 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -82.91 110.57 18.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 73.31 110.865 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 27.0 m -139.74 147.59 41.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 74.12 110.843 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.17 162.36 24.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 64.0 111.099 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.72 -30.79 5.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 65.3 110.918 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.37 139.15 3.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 70.12 110.874 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 14.3 mt -137.76 116.37 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 75.44 111.112 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.0 117.86 15.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 72.32 110.931 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.7 152.27 51.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 74.2 111.165 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -156.62 167.12 31.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 73.42 110.899 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 64.93 66.27 0.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 75.14 110.828 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? 50.24 45.21 26.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 75.21 110.921 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.6 151.53 20.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 74.33 111.084 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 35.0 mtt85 -132.39 135.59 46.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 75.4 110.845 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -133.51 121.49 41.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 75.33 111.165 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.44 135.47 49.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 63.13 110.958 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -126.46 118.59 25.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 74.12 110.872 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 123.05 175.0 14.42 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.792 -0.718 . . . . 53.03 112.468 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.66 144.79 25.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 73.21 110.904 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 34.9 m -118.14 134.82 60.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 72.53 111.139 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 2.5 m -117.44 130.33 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 72.45 111.169 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.2 t -68.52 174.68 3.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 74.24 111.103 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.86 -36.63 59.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 75.11 111.019 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.07 -35.46 67.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.21 111.14 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 64.39 158.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 75.43 111.108 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.73 166.03 18.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 75.53 110.865 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -179.27 120.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 71.32 110.887 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 153.13 176.41 25.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.779 -0.724 . . . . 74.34 112.484 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 145.94 120.03 1.26 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.714 -0.755 . . . . 65.35 112.497 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 62.5 mt -147.68 -72.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 75.33 111.115 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -133.35 -74.34 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 75.41 110.911 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 10.3 tp -52.09 145.9 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 74.5 111.148 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.33 -178.09 1.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 73.21 110.873 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.77 110.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 75.1 110.871 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.36 135.19 55.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 75.34 110.981 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 77.4 p -95.03 124.84 39.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 72.44 111.121 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 68.8 m -132.63 118.13 18.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 72.14 111.105 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.6 126.6 46.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 51.35 110.881 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.66 122.91 29.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 61.32 110.808 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.36 144.15 22.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 63.23 111.128 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . 0.443 ' HG3' ' HA ' ' E' ' 229' ' ' LYS . 12.8 mt-10 -86.61 -83.13 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 73.23 110.85 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.59 137.89 47.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 74.15 111.108 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 99.0 t -117.38 119.74 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 70.45 111.124 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.07 121.65 67.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 65.01 111.086 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.94 133.3 9.31 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.731 -0.747 . . . . 75.22 112.495 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.27 143.72 50.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 75.24 110.828 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 45.41 85.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 74.11 112.434 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 49.93 78.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.371 . . . . 61.02 110.863 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.88 144.67 36.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 73.42 110.879 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -132.78 126.24 31.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.897 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 44.9 t -139.12 123.24 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.094 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.53 110.55 19.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 73.21 110.938 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 10.0 mt -104.83 107.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 72.45 111.133 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.21 173.63 15.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 71.31 112.516 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -93.46 137.09 33.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 75.54 110.897 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.86 141.56 45.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.896 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -130.28 124.73 33.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.943 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 166.9 37.61 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.747 . . . . 75.54 112.452 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 50.31 -132.06 29.73 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.74 -0.743 . . . . 63.2 112.515 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -29.35 22.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.802 0.334 . . . . 74.54 110.873 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -58.96 97.12 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.75 -0.738 . . . . 71.23 112.52 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.0 -176.43 3.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.938 0.399 . . . . 72.5 110.829 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -61.92 -59.21 5.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 73.43 110.902 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.14 170.07 23.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 63.52 110.905 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -140.87 146.46 37.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 70.5 110.89 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.49 155.86 26.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 74.2 110.868 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -157.41 70.84 0.62 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.255 -0.429 . . . . 75.44 110.774 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.78 166.96 21.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 54.14 110.812 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -159.29 138.65 11.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 74.02 110.841 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -113.69 161.39 17.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.84 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 75.23 110.821 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 2.1 ptp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.86 0.362 . . . . 74.23 110.894 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -148.47 -173.34 4.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 72.55 110.924 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 2.1 mp 63.73 93.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 74.52 111.179 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.65 -174.75 0.39 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 73.33 110.893 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -167.94 80.5 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 73.23 111.066 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 21.1 mm -136.55 144.57 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 73.5 111.127 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER 49.62 -168.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 75.43 111.13 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -148.59 120.04 1.14 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 73.23 112.546 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -63.21 -160.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.777 0.322 . . . . 75.52 110.873 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -145.19 104.16 3.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 73.24 110.858 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.25 143.59 44.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 72.1 110.871 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.99 164.55 19.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 71.04 111.103 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . 0.443 ' HA ' ' HG3' ' D' ' 265' ' ' GLU . 0.9 OUTLIER -119.2 -36.39 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 74.53 110.914 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.26 138.62 3.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 73.4 110.856 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 3.1 mp -137.81 113.54 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 72.41 111.139 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -137.85 114.69 10.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.21 110.889 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.67 150.78 45.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 74.31 111.135 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -156.16 160.28 39.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.816 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 65.44 68.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 73.25 110.906 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 48.83 54.14 11.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.925 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.89 149.08 26.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 70.41 111.083 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -130.47 135.57 48.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 74.24 110.86 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 31.9 m -139.86 129.11 28.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 75.32 111.192 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.95 137.59 53.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 74.22 110.952 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.66 118.91 29.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 73.44 110.869 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 125.85 174.17 13.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.726 -0.749 . . . . 74.43 112.509 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -100.7 163.03 12.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.902 0.382 . . . . 74.53 110.89 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 2.6 m -121.88 140.47 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 72.1 111.084 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.81 127.99 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 72.31 111.124 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 10.7 t -69.17 168.78 13.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 75.32 111.152 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.01 -33.9 53.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 71.51 111.088 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.2 -50.12 73.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 73.2 111.133 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 53.48 -173.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 63.02 111.131 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.58 153.08 32.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 75.21 110.886 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -51.54 133.13 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 75.42 110.906 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -115.5 -161.61 13.09 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.757 -0.735 . . . . 74.22 112.553 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 111.52 90.49 1.97 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 71.23 112.519 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 19.5 tt -157.04 150.65 9.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 74.31 111.123 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.99 -74.71 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 75.22 110.811 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 14.5 pt -150.33 -177.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 74.35 111.117 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.9 145.62 1.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 72.51 110.773 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -120.63 43.88 2.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 70.43 110.875 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.21 -19.66 10.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 64.24 110.903 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.55 120.14 39.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.24 111.199 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.46 107.54 5.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 74.23 111.083 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -129.15 116.42 19.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 74.51 110.891 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 3.1 p -119.7 123.87 44.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 70.41 110.79 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.75 137.17 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 75.04 111.163 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . 0.417 ' N ' ' CD ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -74.1 -146.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 43.11 110.912 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 4.1 t -96.56 137.61 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 65.2 111.171 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 95.9 t -115.01 121.64 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 75.24 111.159 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 5.7 p -120.96 120.16 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 74.12 111.108 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.36 133.36 11.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.792 -0.718 . . . . 73.03 112.47 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -131.38 116.45 17.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.338 . . . . 74.24 110.907 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 65.67 80.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 72.34 112.517 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 58.66 88.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 73.2 110.92 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 8.9 t -121.29 145.61 47.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 62.22 110.842 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.5 128.05 34.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 74.13 110.858 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 41.7 t -136.97 123.5 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 62.02 111.142 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.25 110.93 16.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 74.12 110.994 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 54.1 mt -107.89 137.53 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 75.45 111.096 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 121.31 -161.57 15.34 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.731 -0.747 . . . . 71.04 112.467 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -128.47 156.96 42.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 71.31 110.857 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.03 118.24 31.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 74.53 110.871 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -103.72 124.77 49.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 65.3 110.917 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 149.19 178.43 24.21 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.785 -0.722 . . . . 74.23 112.529 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -105.8 129.47 9.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.739 -0.743 . . . . 71.11 112.447 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 11.5 mtmm 50.8 67.9 0.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 73.45 110.918 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -151.87 40.09 0.76 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.706 -0.759 . . . . 65.14 112.507 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -51.47 146.23 7.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 64.44 110.849 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -50.48 -57.14 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 74.21 110.912 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -65.13 99.32 0.36 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 71.03 110.889 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -131.08 91.1 2.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 73.21 110.927 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -164.47 162.92 22.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 70.44 110.81 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -52.15 129.8 28.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 71.02 110.881 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -101.78 -27.38 13.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 74.21 110.829 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 59.54 -170.09 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 74.3 110.892 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -52.57 110.51 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 72.42 110.906 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.469 . . . . 70.54 110.825 -179.932 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.828 0.347 . . . . 74.4 110.901 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.16 -170.07 0.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 62.34 110.91 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.74 179.59 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 72.1 111.149 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.77 179.19 9.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 62.14 110.896 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -79.82 114.95 19.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 65.15 111.077 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.9 mp -113.39 -26.6 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 75.42 111.129 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 6.8 m -55.57 159.58 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 62.23 111.083 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 87.24 73.6 1.28 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.724 -0.751 . . . . 75.33 112.532 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -163.25 160.69 24.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 64.53 110.921 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -107.01 122.81 47.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 65.41 110.884 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 68.7 m -121.85 138.03 54.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 71.32 110.833 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.65 121.01 13.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 74.3 111.068 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.04 -35.95 23.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.235 -0.439 . . . . 73.41 110.913 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -164.17 139.19 5.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 75.44 110.926 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 10.1 mt -137.46 117.72 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.4 111.078 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -127.39 119.97 27.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 63.24 110.87 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.58 148.66 52.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.34 111.179 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -148.73 167.55 25.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 75.12 110.863 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 66.5 55.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 73.41 110.854 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.96 64.38 1.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 74.14 110.913 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.19 156.34 17.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 71.24 111.061 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -129.4 135.83 49.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.33 110.878 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 34.4 m -143.16 130.17 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 73.03 111.11 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -131.06 137.19 49.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 75.54 110.9 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.93 118.8 25.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 75.2 110.925 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 154.02 175.16 24.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.72 . . . . 71.43 112.599 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -85.88 131.15 34.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.936 0.398 . . . . 74.54 110.874 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 29.5 t -110.34 124.24 66.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 72.4 111.152 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 49.2 t -118.84 113.01 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 74.41 111.068 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.94 168.29 15.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.098 -0.501 . . . . 64.15 111.193 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.06 -36.69 84.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 75.22 111.083 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.1 -39.8 75.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 74.33 111.133 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.76 -30.82 24.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 65.43 111.07 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.72 -38.06 71.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 71.25 110.873 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -77.15 176.06 9.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 74.24 110.898 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 94.23 154.03 30.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.78 -0.724 . . . . 74.15 112.476 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -78.03 -71.58 1.21 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 70.11 112.506 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 4.4 mt -96.51 110.31 24.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.853 0.358 . . . . 75.53 111.132 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.65 144.21 28.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 74.03 110.874 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.99 131.4 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 73.13 111.132 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.5 p -177.31 -175.54 0.57 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 74.25 110.812 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 18.2 t0 61.94 55.14 2.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 42.23 110.883 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -124.66 -37.31 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 74.35 110.956 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.6 123.11 20.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.173 -0.467 . . . . 74.31 111.228 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.78 110.72 22.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 73.35 111.21 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.29 120.28 34.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 75.34 110.929 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 41.3 t -131.58 123.8 28.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 73.31 110.81 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.26 137.03 57.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 72.33 111.144 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -83.03 -71.71 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 61.2 110.951 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 38.8 m -125.88 130.26 50.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.13 111.13 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 27.6 t -118.2 126.11 74.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 74.15 111.14 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 22.1 t -127.29 117.09 46.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 65.41 111.162 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.04 134.04 9.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.778 -0.725 . . . . 63.11 112.491 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -132.14 147.21 52.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.845 0.355 . . . . 74.34 110.904 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 57.94 73.9 0.4 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 33.44 112.479 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 48.42 59.54 4.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.867 0.365 . . . . 74.52 110.914 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 38.4 t -83.86 145.81 28.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 74.35 110.894 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -123.33 127.69 48.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 75.05 110.883 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 13.8 t -130.79 125.7 58.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 65.42 111.114 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.71 111.84 16.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 75.41 110.914 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.08 104.74 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 74.43 111.133 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.15 168.36 15.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 62.43 112.397 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -94.27 152.78 18.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.737 0.304 . . . . 72.13 110.835 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -123.2 118.87 28.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.906 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -117.6 148.37 41.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 75.41 110.942 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.11 -107.63 0.63 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.794 -0.717 . . . . 64.24 112.507 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -172.33 94.49 0.1 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 75.54 112.472 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -179.49 -34.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 74.14 110.844 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.09 -110.32 3.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 70.01 112.52 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.36 -172.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.371 . . . . 75.31 110.809 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -72.54 -9.01 58.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 75.0 110.938 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.75 -179.78 5.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 74.41 110.862 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -55.89 -69.32 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 74.55 110.876 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -165.74 176.67 7.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 74.24 110.829 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -148.44 177.75 9.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 63.3 110.867 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.52 117.52 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 74.0 110.865 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -172.6 114.33 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 72.31 110.854 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.493 ' N ' HH22 ' C' ' 238' ' ' ARG . 31.2 p80 -157.54 130.08 7.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 75.15 110.872 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 8.5 t60 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 74.2 110.873 179.954 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 6.2 mtp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.841 0.353 . . . . 74.53 110.86 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -115.73 139.66 49.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 75.43 110.893 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 13.4 tt -176.03 144.18 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 74.11 111.108 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.08 174.06 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 72.41 110.877 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -170.77 97.62 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 64.23 111.108 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.65 124.2 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 75.25 111.118 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 96.4 t -149.94 -72.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 75.15 111.093 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 58.51 174.97 0.54 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.769 -0.729 . . . . 62.43 112.475 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 16.7 ttt-85 -173.56 139.07 0.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 73.42 110.81 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -110.26 123.66 50.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 74.43 110.907 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.83 138.31 54.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 71.14 110.903 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -142.35 120.28 12.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 74.24 111.099 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -31.6 21.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 74.41 110.921 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.46 139.18 5.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 63.05 110.818 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 9.4 mt -137.22 117.85 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 74.43 111.165 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -130.89 119.63 22.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.861 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.41 146.84 52.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 74.3 111.153 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -147.1 167.28 24.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 62.34 110.878 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 65.6 54.63 1.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 74.42 110.89 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 19.1 mtt85 51.68 62.62 2.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 73.32 110.807 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -103.57 156.42 17.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 63.21 111.061 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.89 136.02 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 74.54 110.865 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 19.2 m -141.22 121.74 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 73.42 111.161 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -123.03 137.19 55.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 74.11 110.955 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.74 118.83 28.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.236 -0.438 . . . . 73.23 110.939 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 150.51 171.15 18.49 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 41.31 112.504 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -86.03 139.06 31.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.893 0.377 . . . . 74.23 110.891 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -117.72 124.32 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 74.44 111.107 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.02 128.88 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 64.14 111.105 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 15.5 p -86.81 170.64 11.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 73.1 111.173 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.08 93.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 75.23 111.123 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.88 69.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 71.44 111.101 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -88.58 49.88 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 75.11 111.079 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 65.6 tp -112.22 -63.6 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 70.13 110.934 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -138.31 172.78 12.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 70.1 110.884 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 96.98 71.76 1.07 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.731 . . . . 70.31 112.482 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 58.32 49.67 73.91 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.752 . . . . 64.43 112.516 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 48.7 mm -73.35 -70.91 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.866 0.365 . . . . 75.0 111.143 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 57.07 33.16 22.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.082 -0.508 . . . . 75.42 110.88 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 13.8 tt -61.03 147.5 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 74.23 111.107 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.6 p -168.32 77.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 75.35 110.825 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -146.23 120.21 9.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.479 . . . . 72.31 110.841 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -120.83 91.72 3.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 71.44 110.922 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.92 123.9 45.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 72.42 111.134 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 6.1 m -95.29 108.89 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 73.44 111.098 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.86 125.04 40.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 70.5 110.827 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 2.9 p -135.59 123.69 22.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 65.34 110.864 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 9.9 p -119.78 135.78 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 75.42 111.082 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -74.66 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 75.33 110.913 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 76.8 m -122.29 130.05 52.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 64.42 111.152 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 39.3 t -118.34 123.46 71.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 71.33 111.094 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.33 118.84 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 75.32 111.087 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.1 134.93 9.73 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.681 -0.771 . . . . 60.15 112.457 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -131.58 147.3 52.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 75.34 110.896 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 59.66 72.39 0.62 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.748 -0.739 . . . . 70.2 112.471 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 49.13 59.16 4.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.951 0.405 . . . . 74.22 110.867 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 33.2 t -83.81 145.52 28.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 63.04 110.836 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.95 127.36 47.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 74.34 110.783 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 10.5 t -131.8 128.22 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 75.32 111.115 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -128.02 111.93 14.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.504 . . . . 71.01 110.959 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.15 104.6 17.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 71.23 111.14 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.64 179.03 29.56 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.765 -0.731 . . . . 72.23 112.527 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.33 146.17 24.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.774 0.321 . . . . 73.3 110.949 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.86 119.01 34.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 70.24 110.892 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -118.19 125.85 51.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 72.24 110.904 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 137.37 -43.51 1.21 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 73.25 112.494 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 92.91 135.99 7.51 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 73.33 112.515 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -179.33 -34.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.866 0.365 . . . . 72.21 110.924 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 146.51 -90.98 0.15 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.693 -0.765 . . . . 55.31 112.454 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.03 -49.46 3.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 73.51 110.927 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -179.24 35.32 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 75.54 110.913 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.1 176.11 0.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 74.31 110.824 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -104.31 91.59 3.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 73.22 110.918 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -131.46 -175.74 3.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 72.55 110.909 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 61.8 168.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.305 -0.407 . . . . 72.41 110.886 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -175.03 94.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 75.44 110.808 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.83 -172.19 2.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 71.23 110.888 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -165.84 -170.36 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 65.15 110.899 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.432 . . . . 74.52 110.847 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.754 0.311 . . . . 65.34 110.874 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.19 -75.31 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 71.44 110.869 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 2.2 tt -61.55 132.57 27.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 64.14 111.083 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -93.43 44.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 64.51 110.911 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -90.54 142.7 27.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 64.54 111.076 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 4.8 tp -169.63 135.68 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 73.22 111.121 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 22.3 t -144.26 148.15 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 73.41 111.142 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 91.61 -107.17 3.47 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 64.35 112.439 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 63.45 160.34 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.813 0.339 . . . . 75.42 110.896 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -122.75 131.25 53.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 73.23 110.886 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.88 137.87 54.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 55.2 110.862 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.39 141.02 41.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 65.23 111.065 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.94 -32.82 8.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 74.2 110.898 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.61 138.32 5.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 73.32 110.847 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 7.3 mt -137.53 117.62 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 75.41 111.1 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -128.37 120.47 27.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 75.23 110.88 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.63 149.34 52.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 75.33 111.127 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -147.83 168.03 23.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 73.5 110.858 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 61.39 54.4 3.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 70.43 110.844 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 51.1 66.65 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 73.25 110.858 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -103.58 156.95 17.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 71.33 111.099 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.493 HH22 ' N ' ' A' ' 294' ' ' HIS . 1.0 OUTLIER -125.29 135.18 52.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 74.31 110.807 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.9 121.92 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 73.13 111.171 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -122.12 137.34 54.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 75.05 110.861 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.7 mp -126.24 118.87 26.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.953 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.53 176.07 15.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 71.33 112.517 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -91.34 128.97 37.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.889 0.376 . . . . 71.54 110.893 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.93 116.53 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 73.41 111.119 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 25.8 t -119.93 118.9 58.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 74.02 111.098 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -70.22 174.24 5.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.172 -0.467 . . . . 74.04 111.157 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.76 -37.99 88.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 63.0 111.088 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.84 -52.04 66.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 74.53 111.101 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -64.19 -25.32 68.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 75.42 111.107 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 9.3 mt -81.9 -27.1 33.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 72.33 110.94 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.97 -178.87 4.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 73.3 110.841 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 61.02 -117.61 12.25 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.714 -0.755 . . . . 73.52 112.497 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 161.94 70.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 70.3 112.521 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.9 24.43 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 74.21 111.114 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 51.9 82.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 74.23 110.936 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 3.6 pt -63.47 178.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 72.32 111.107 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 2.5 t -158.84 39.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 74.31 110.874 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -75.06 76.12 2.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.078 -0.51 . . . . 72.43 110.883 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -139.15 37.26 2.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 73.35 110.913 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.33 131.06 40.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.485 . . . . 75.43 111.108 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 64.0 m -91.95 124.94 36.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 73.02 111.168 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.18 129.33 48.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.426 . . . . 54.34 110.856 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 28.9 t -140.86 123.39 16.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 72.2 110.83 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.53 136.52 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 74.22 111.18 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.01 -74.91 0.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 73.33 110.883 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 31.6 m -116.57 127.66 54.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 63.52 111.105 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 46.8 t -118.68 123.07 70.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 75.32 111.118 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 24.5 t -126.93 127.64 70.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 65.0 111.109 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -131.18 135.3 8.15 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.748 . . . . 61.32 112.528 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -132.45 148.37 52.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.873 0.368 . . . . 74.34 110.866 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.62 76.17 0.21 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.727 -0.749 . . . . 71.33 112.452 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 47.31 58.82 4.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.875 0.369 . . . . 73.41 110.88 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 37.7 t -83.4 145.4 29.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 74.44 110.835 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -124.53 127.92 48.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 72.3 110.899 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 17.0 t -134.13 123.68 44.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 74.04 111.156 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.97 119.3 29.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 72.32 110.93 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 4.2 mt -112.08 104.52 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 75.11 111.103 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.35 -159.32 28.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 71.4 112.42 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -110.11 155.99 21.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 75.54 110.907 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -131.24 124.39 30.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.139 -0.482 . . . . 70.24 110.913 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -120.92 125.92 48.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 73.44 110.893 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 135.71 161.66 9.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.789 -0.719 . . . . 74.33 112.483 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -96.99 110.11 3.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.772 -0.728 . . . . 73.35 112.488 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -179.24 37.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 73.3 110.972 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 53.49 -110.64 1.46 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 63.32 112.514 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.03 -175.96 5.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 73.22 110.888 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -59.14 -21.76 59.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 74.12 110.898 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -175.25 158.05 2.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 73.14 110.884 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 53.62 90.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 74.44 110.966 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -76.16 120.78 21.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 75.11 110.829 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -52.84 147.56 8.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 74.4 110.912 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.12 -169.91 1.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 74.22 110.901 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -96.31 165.54 12.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 73.31 110.879 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.32 161.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 64.32 110.802 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 4.3 t60 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 75.21 110.907 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 5.9 mtm . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.821 0.343 . . . . 73.54 110.872 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -132.77 96.59 3.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 74.02 110.884 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 10.5 tt -115.83 -36.55 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.243 -0.435 . . . . 75.11 111.187 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 52.04 50.37 18.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 74.43 110.878 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.39 131.78 42.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 73.44 111.114 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 2.6 mp -125.18 136.79 59.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 73.23 111.165 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 27.6 m -98.13 172.97 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 75.32 111.133 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 129.07 166.29 11.9 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.7 -0.762 . . . . 74.21 112.505 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 69.31 -75.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 75.53 110.874 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -128.13 112.42 14.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 63.14 110.828 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.53 142.66 49.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 62.02 110.856 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -139.73 133.24 30.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 53.24 111.048 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -97.49 -37.11 10.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 73.43 110.881 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -164.3 137.36 5.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 74.31 110.914 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 6.6 mt -137.92 117.66 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 74.24 111.116 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -123.6 115.46 21.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.876 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.4 148.21 48.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 74.32 111.13 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.59 166.22 30.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 60.13 110.88 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 65.54 52.3 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 73.4 110.917 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 54.46 59.62 4.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 75.22 110.834 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -98.27 155.75 17.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 73.22 111.059 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 38.2 mtt180 -125.95 135.34 51.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.86 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.89 121.81 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 73.24 111.122 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.42 137.12 52.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.897 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -120.96 118.24 29.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 74.22 110.923 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.44 -173.32 19.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.795 -0.717 . . . . 65.22 112.483 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.38 149.9 21.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 62.34 110.898 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.23 116.37 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 73.42 111.14 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 50.3 t -115.02 128.98 71.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 72.23 111.137 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 11.8 t -70.65 174.47 5.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 65.21 111.126 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.14 -41.83 99.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 71.15 111.04 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.0 -43.42 81.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 73.43 111.13 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.81 -169.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.32 111.063 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.1 132.68 54.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 74.31 110.908 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -77.77 92.47 4.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 74.4 110.826 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 139.59 -54.18 0.67 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.828 -0.701 . . . . 63.21 112.494 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 112.69 -179.05 19.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.7 . . . . 71.33 112.474 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 29.8 mt 64.42 108.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.309 . . . . 74.42 111.152 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.85 172.63 12.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 75.15 110.851 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 20.0 tt -128.58 142.44 43.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 70.43 111.135 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 54.9 p -109.16 -173.95 2.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.31 110.868 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 21.4 t0 60.43 99.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 75.31 110.866 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.7 -46.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 74.52 110.9 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.83 137.78 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 74.24 111.252 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.9 109.03 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 74.13 111.148 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.35 120.55 42.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 74.24 110.844 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 57.9 m -132.11 124.06 28.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 72.42 110.819 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -106.55 138.87 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.116 -0.493 . . . . 73.42 111.08 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . 0.426 ' HB2' ' HA ' ' E' ' 229' ' ' LYS . 3.0 tt0 -94.52 -29.53 14.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 75.02 110.863 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 266' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' E' ' 230' ' ' ASP . 1.1 m -152.69 129.22 10.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 74.44 111.147 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 94.1 t -127.18 120.5 55.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 72.33 111.143 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 40.6 t -127.74 128.0 68.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 64.41 111.097 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -135.23 133.31 6.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.738 . . . . 63.04 112.517 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.47 149.36 51.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 73.23 110.908 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.22 81.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.744 -0.741 . . . . 74.24 112.439 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 45.59 57.66 4.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 72.04 110.892 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 29.7 t -83.84 145.14 28.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 63.23 110.816 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -125.94 127.4 45.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 70.24 110.842 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 17.1 t -137.02 123.79 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 75.33 111.114 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 1.1 tt -128.17 111.72 13.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 72.13 110.907 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 16.5 mt -102.42 104.54 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 75.23 111.141 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.02 -168.18 32.91 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.746 -0.74 . . . . 72.42 112.491 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -103.39 140.0 38.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 73.32 110.914 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -111.95 134.85 53.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 62.35 110.928 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -120.04 125.8 49.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 71.03 110.879 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.52 -160.73 40.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.686 -0.768 . . . . 70.03 112.474 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 52.2 39.24 50.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 63.33 112.455 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 5.6 mptt 68.77 -76.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.351 . . . . 75.4 110.914 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -173.99 29.32 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.624 -0.798 . . . . 63.31 112.435 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.51 -168.75 2.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.907 0.384 . . . . 73.42 110.831 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -111.97 23.72 13.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 75.41 110.934 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.48 -171.77 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 54.11 110.864 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -112.97 29.82 7.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 75.41 110.881 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.97 -170.06 0.54 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.814 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -132.02 -171.39 2.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 74.44 110.856 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.66 165.65 25.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 71.33 110.877 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -171.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 74.13 110.813 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -100.97 26.17 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 74.24 110.862 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 75.15 110.872 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.839 0.352 . . . . 75.03 110.867 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -57.01 -26.12 59.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 74.24 110.882 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 51.2 mm -82.89 142.75 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 73.43 111.119 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -131.5 45.44 2.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 63.41 110.866 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . 62.32 91.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 71.53 111.088 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 3.4 pt -151.11 49.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 74.51 111.109 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 8.1 p -174.77 159.75 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 74.55 111.12 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -68.11 -134.9 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.709 -0.758 . . . . 73.31 112.49 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 63.42 -167.13 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 72.32 110.874 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -82.2 114.81 20.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 62.12 110.894 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.03 133.59 55.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 65.13 110.875 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -122.41 170.04 10.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 72.43 111.135 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . 0.636 ' N ' ' HE3' ' E' ' 229' ' ' LYS . 0.0 OUTLIER -140.45 -34.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 73.13 110.893 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . 0.596 ' N ' ' HD2' ' E' ' 229' ' ' LYS . 8.8 t0 -175.62 131.71 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 75.54 110.821 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 15.5 mt -132.58 115.78 26.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 71.24 111.128 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -110.99 115.26 29.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 74.55 110.937 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.99 128.59 45.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 72.24 111.148 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -136.9 166.55 23.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 74.13 110.878 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 61.68 61.11 1.5 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 74.03 110.884 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 40.2 mtt85 49.35 63.93 1.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.45 110.844 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.74 156.48 17.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 75.05 111.057 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -128.06 135.85 50.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 74.21 110.92 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 4.5 m -139.25 121.7 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 74.54 111.181 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.83 137.47 54.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 74.32 110.913 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.61 117.92 26.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.932 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.8 168.18 11.76 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 72.43 112.551 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.84 133.77 33.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.898 0.38 . . . . 72.24 110.92 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 97.3 t -109.71 135.51 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 71.42 111.13 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 73.4 t -122.17 129.1 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 73.41 111.163 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.7 t -69.77 171.6 8.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 75.22 111.115 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.26 -33.91 75.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 75.43 111.082 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.22 66.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.274 -0.421 . . . . 75.15 111.063 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.54 -169.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 63.11 111.118 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 7.1 tp -173.52 81.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 75.21 110.964 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -129.7 100.72 5.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.884 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -103.9 -30.11 5.28 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 53.11 112.449 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 138.29 42.41 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.783 -0.722 . . . . 73.41 112.473 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 4.0 pt -144.35 -178.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.816 0.341 . . . . 74.42 111.154 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -164.81 151.15 10.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 74.32 110.892 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 8.2 tt -156.06 144.94 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 73.12 111.108 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 3.4 m 60.16 177.77 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 73.5 110.814 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -107.26 168.15 9.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 65.42 110.843 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -68.09 165.71 17.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.891 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.46 121.83 42.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 74.21 111.141 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 93.1 m -92.13 111.07 22.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 64.42 111.146 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -108.68 119.34 39.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 71.34 110.933 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.04 132.77 40.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 72.52 110.82 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 9.4 p -116.8 153.82 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 64.03 111.123 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . 0.607 ' O ' ' HD3' ' E' ' 229' ' ' LYS . 0.2 OUTLIER -112.02 -11.0 13.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 75.44 110.866 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.46 126.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.24 111.122 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 41.0 t -132.16 117.36 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 73.22 111.104 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.21 139.2 52.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 74.42 111.138 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -144.74 133.41 5.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 70.13 112.5 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -134.02 148.06 51.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 73.23 110.838 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 56.29 86.5 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.701 -0.761 . . . . 63.25 112.503 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 44.98 56.76 5.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.898 0.38 . . . . 61.52 110.895 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.42 145.23 29.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 70.41 110.924 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.93 126.96 39.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.893 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.05 123.56 34.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 74.14 111.127 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.03 111.44 12.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 75.22 110.905 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 37.3 mt -104.12 104.62 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 74.42 111.05 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 156.85 -174.5 34.51 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.773 -0.727 . . . . 73.02 112.485 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -103.53 153.05 20.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 75.3 110.867 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -116.27 136.35 53.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 73.42 110.825 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -117.46 125.78 51.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 71.35 110.886 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 52.97 26.71 27.79 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 54.54 112.509 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -83.98 -16.49 67.41 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.794 -0.717 . . . . 54.01 112.468 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 7.3 mttt 63.35 41.65 7.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 75.34 110.944 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 67.93 137.97 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 62.52 112.483 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.05 119.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.777 0.323 . . . . 73.33 110.939 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -50.5 118.47 3.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.137 -0.483 . . . . 74.23 110.839 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 9.2 t70 63.96 91.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 65.12 110.914 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -113.08 -176.52 2.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.45 110.89 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.54 -176.29 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 72.44 110.927 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -62.29 -177.82 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 72.32 110.901 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -60.08 152.84 23.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 73.14 110.879 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -173.73 107.92 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 74.32 110.851 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -154.88 -169.89 3.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 73.51 110.887 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 65.31 110.866 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.813 0.339 . . . . 71.33 110.914 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.1 pttt -161.01 -47.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 64.45 110.93 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 45.4 mm 52.39 84.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 74.45 111.089 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.86 85.4 2.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 75.53 110.857 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -178.21 140.89 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 75.23 111.107 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 1.1 tt -142.23 90.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 74.41 111.104 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.0 p -177.5 143.26 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.5 . . . . 74.43 111.158 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -55.52 171.32 1.66 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.767 -0.73 . . . . 73.43 112.478 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -172.66 100.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 75.35 110.861 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -87.78 112.28 22.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 71.11 110.93 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.65 148.4 49.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 75.11 110.871 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.17 119.3 10.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 73.53 111.057 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.43 -43.99 88.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 74.5 110.921 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -165.48 136.68 3.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 74.32 110.886 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 9.1 pt -139.07 131.78 37.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 72.43 111.144 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -135.05 139.8 45.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 74.12 110.873 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.31 153.82 51.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 74.43 111.154 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -142.72 168.71 19.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 43.32 110.881 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 74.2 -70.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 70.14 110.886 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.73 53.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 73.32 110.818 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.5 156.82 17.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.03 111.076 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -130.98 138.21 49.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 72.44 110.894 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.43 125.47 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 75.31 111.146 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -123.24 118.9 28.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 71.32 110.862 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.64 119.34 36.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 74.2 110.952 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 150.86 169.71 17.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 53.3 112.448 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -85.95 133.36 33.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 75.32 110.886 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.7 t -103.96 133.37 48.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 74.41 111.201 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 97.4 t -119.73 121.97 67.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 73.53 111.093 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.0 m -69.88 161.71 29.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 74.14 111.158 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.74 99.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 71.2 111.09 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.01 69.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 65.31 111.135 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -54.38 -27.11 34.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 45.33 111.122 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.7 tp -66.5 89.76 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 74.42 110.904 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -177.57 -66.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 75.41 110.863 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -104.0 -100.77 2.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.772 -0.728 . . . . 71.11 112.482 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 129.46 -153.79 20.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.764 -0.731 . . . . 75.55 112.492 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 15.2 mt 70.64 -70.44 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 74.52 111.206 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.49 -170.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 75.25 110.921 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 8.4 tp -71.24 139.59 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 74.1 111.095 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -74.37 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 71.35 110.903 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.24 -170.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 62.2 110.898 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -173.93 42.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.975 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.03 133.84 52.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 71.5 111.115 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.3 t -125.18 121.8 35.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 73.14 111.189 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -91.24 127.21 36.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.54 110.877 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.4 p -142.41 123.07 14.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 72.43 110.896 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.7 p -118.99 134.47 62.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.45 111.125 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -78.33 -75.78 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.5 . . . . 75.4 110.879 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.91 127.13 53.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 75.11 111.199 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.96 120.85 65.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 72.45 111.142 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 74.5 t -123.47 115.29 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 71.51 111.106 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.72 133.6 11.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 75.13 112.5 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 139.92 48.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 74.34 110.854 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.19 81.1 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.733 -0.746 . . . . 64.12 112.545 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 44.7 62.51 2.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.836 0.35 . . . . 72.24 110.96 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.47 145.06 29.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 74.25 110.857 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -113.27 128.05 56.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 75.4 110.883 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 19.9 t -129.53 123.29 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 74.25 111.129 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.43 111.6 13.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 65.44 110.968 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.33 103.89 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 74.22 111.047 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.54 168.69 15.69 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.736 -0.745 . . . . 74.23 112.503 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -89.72 154.22 20.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 70.32 110.908 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.65 123.78 36.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 72.3 110.877 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -103.51 128.55 50.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 64.5 110.872 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.97 134.74 6.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 65.11 112.456 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.494 ' H ' ' N ' ' B' ' 247' ' ' ALA . . . -83.33 -112.0 0.53 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.811 -0.709 . . . . 63.45 112.525 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.45 25.45 14.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.728 0.299 . . . . 72.41 110.815 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 145.12 -12.97 1.88 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.748 -0.739 . . . . 71.23 112.486 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 7.7 t80 72.39 -68.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 75.21 110.867 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -147.39 -48.09 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 73.11 110.939 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -134.27 -175.84 4.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.236 -0.438 . . . . 74.44 110.898 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.75 146.86 33.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 74.43 110.955 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.02 170.79 15.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 73.24 110.879 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -119.02 -74.36 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 73.34 110.889 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -176.37 -177.96 0.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.442 . . . . 74.03 110.859 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -176.48 107.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 73.05 110.942 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -97.16 143.1 28.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 72.32 110.842 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 75.41 110.856 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 75.8 mmm . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.805 0.336 . . . . 75.32 110.908 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -156.3 -170.02 3.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 75.25 110.911 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 28.1 mm 64.19 90.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 75.31 111.136 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.29 152.81 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 74.54 110.876 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -51.78 138.92 22.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 71.01 111.117 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 2.1 mp -130.32 149.04 33.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 73.11 111.142 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 19.2 t -64.54 151.32 9.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 75.14 111.148 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -51.58 115.5 3.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.696 -0.764 . . . . 65.44 112.516 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.48 143.44 49.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.787 0.327 . . . . 72.54 110.889 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -93.75 112.7 24.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 70.32 110.908 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 32.4 t -127.61 152.32 47.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.851 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.03 124.27 17.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 75.55 111.064 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.07 -40.24 62.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 73.53 110.936 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -166.26 135.87 3.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 72.33 110.824 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 8.1 pt -139.15 130.01 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.481 . . . . 73.24 111.16 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.09 137.28 40.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 75.24 110.894 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.1 150.44 48.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 75.34 111.071 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -142.01 168.63 19.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 73.53 110.869 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 73.19 -71.84 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.883 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -177.93 59.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 72.11 110.898 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.88 156.61 16.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 60.44 111.112 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -130.7 135.87 48.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 74.3 110.843 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.22 132.15 71.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 71.21 111.166 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -130.22 119.28 22.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 73.55 110.881 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 4.4 mp -111.69 118.4 35.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 74.03 110.892 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 145.23 175.48 18.4 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.777 -0.725 . . . . 71.4 112.491 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.83 129.37 34.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.394 . . . . 70.1 110.879 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 92.1 t -102.19 114.74 42.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 73.33 111.195 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 85.0 t -106.76 129.26 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.169 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.3 t -74.96 169.58 17.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 75.24 111.166 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.494 ' N ' ' H ' ' A' ' 283' ' ' GLY . . . -63.34 -41.8 98.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 72.12 111.084 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.61 -35.85 68.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 73.45 111.101 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -74.65 -24.18 58.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 63.41 111.072 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.98 -24.89 22.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 74.42 110.857 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -132.89 50.11 2.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 72.01 110.878 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 168.61 -97.48 0.13 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.775 -0.726 . . . . 75.42 112.462 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -56.51 144.69 36.82 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.694 -0.765 . . . . 62.45 112.523 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 3.2 pt -147.2 -177.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 73.51 111.172 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 58.8 86.54 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 72.24 110.807 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.25 43.08 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 72.41 111.066 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.87 159.64 6.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 74.33 110.881 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.81 159.74 16.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.819 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.4 29.0 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 75.35 110.862 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 18.0 p -79.89 121.85 25.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 73.15 111.238 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 91.2 m -97.28 108.84 21.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 73.03 111.163 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.26 126.22 41.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 73.11 110.914 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 5.5 t -141.99 123.46 14.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 73.31 110.802 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.19 136.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.041 -0.527 . . . . 73.55 111.18 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -81.83 -77.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 72.43 110.894 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.5 m -121.08 127.94 52.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 75.43 111.104 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 15.7 t -118.18 120.32 64.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 74.34 111.106 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 41.3 t -123.38 115.04 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 71.23 111.13 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.52 133.09 10.52 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 55.42 112.496 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -132.48 146.97 52.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.751 0.31 . . . . 73.15 110.967 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.04 75.12 0.22 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.761 -0.733 . . . . 43.0 112.468 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 52.82 78.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.88 0.371 . . . . 72.03 110.893 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 1.4 t -103.66 144.7 31.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 70.1 110.906 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.43 127.58 56.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 71.11 110.818 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 97.0 t -130.5 123.62 55.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 74.04 111.16 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.88 111.85 13.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 73.33 110.846 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 3.4 mp -107.7 104.34 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 75.23 111.09 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.29 -171.75 29.44 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.745 -0.74 . . . . 75.11 112.519 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.77 147.95 26.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 74.33 110.975 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -116.8 121.68 42.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 75.34 110.822 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -112.41 125.72 54.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 75.15 110.967 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 140.08 164.58 9.95 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.743 . . . . 74.41 112.485 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -103.83 -143.5 12.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 53.31 112.503 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 9.9 mttp 56.87 25.3 10.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 72.33 110.866 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 128.75 -117.49 2.5 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.725 -0.75 . . . . 72.22 112.497 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -173.9 -44.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.882 0.372 . . . . 75.31 110.911 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -125.51 -68.45 0.83 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 74.14 110.844 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -142.31 -169.93 3.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 73.2 110.916 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -56.31 144.53 30.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 75.14 110.874 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -170.47 157.54 6.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 73.4 110.879 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -151.33 146.86 26.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 74.14 110.897 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.95 158.77 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 74.4 110.816 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -164.01 134.57 4.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 73.03 110.88 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -150.38 179.52 8.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 72.24 110.864 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 75.45 110.912 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.5 mtp . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.776 0.322 . . . . 62.51 110.955 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt 61.06 179.17 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 75.55 110.938 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 3.1 mp 62.3 70.46 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.242 -0.436 . . . . 74.53 111.125 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -177.58 133.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 72.3 110.873 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -173.95 70.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 74.14 111.094 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 1.9 pt -150.75 136.09 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 72.41 111.124 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 91.2 t -103.19 -69.85 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 75.43 111.14 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 74.11 -112.92 3.94 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.744 -0.741 . . . . 75.13 112.479 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.21 -69.77 0.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.815 0.34 . . . . 74.12 110.842 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -94.08 109.86 21.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 73.44 110.903 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 60.7 p -137.02 148.17 46.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 71.25 110.854 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.22 137.56 47.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.501 . . . . 74.42 111.112 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -86.45 -40.49 15.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 75.11 110.911 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -165.47 136.5 3.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 73.55 110.895 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 8.3 pt -140.13 117.1 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 75.52 111.12 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -124.48 116.24 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 74.4 110.885 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.46 136.86 54.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 75.53 111.171 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -121.44 166.95 13.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 73.11 110.872 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 60.84 -162.91 0.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.496 . . . . 74.25 110.954 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 -72.65 63.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 75.1 110.877 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.62 156.37 18.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 53.34 111.047 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -135.9 135.95 40.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 65.32 110.839 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.35 134.41 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 72.44 111.11 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -130.13 137.37 50.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.501 . . . . 73.32 110.888 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.12 118.35 31.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 74.0 110.857 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 140.47 -177.77 20.48 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.7 -0.762 . . . . 70.4 112.47 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -85.84 153.06 22.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.797 0.332 . . . . 75.15 110.906 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 63.8 t -122.08 114.92 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 73.53 111.106 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 3.8 t -108.0 127.7 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 72.41 111.104 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 6.5 t -69.84 175.07 4.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 73.03 111.045 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.05 93.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 70.03 111.116 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.92 -35.89 69.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.24 111.072 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.25 -174.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 72.21 111.065 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.61 -176.09 3.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 72.22 110.915 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -54.23 -50.61 66.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 73.03 110.864 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 135.16 -165.43 24.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.835 -0.697 . . . . 64.1 112.508 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 65.91 -141.56 41.97 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.695 -0.764 . . . . 72.24 112.485 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 28.0 mm 61.65 99.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.934 0.397 . . . . 71.23 111.135 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -88.02 -74.35 0.45 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.138 -0.483 . . . . 72.52 110.949 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 5.2 mp -78.15 129.78 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 73.04 111.065 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.47 120.67 24.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 74.21 110.846 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -168.3 64.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 73.4 110.862 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -104.44 -68.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 75.55 110.924 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -100.93 135.07 42.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 72.43 111.152 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 4.3 t -115.66 140.89 48.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 72.41 111.142 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.39 124.42 46.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 63.23 110.881 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.6 131.91 36.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 70.55 110.867 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.46 139.98 39.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.505 . . . . 73.42 111.122 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -83.03 -76.0 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 71.4 110.945 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 25.7 m -137.48 130.64 30.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 74.45 111.119 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.41 130.64 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.4 111.187 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 25.9 t -127.49 125.92 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 71.11 111.159 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.03 134.13 10.3 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.788 -0.72 . . . . 74.34 112.474 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.95 117.05 20.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 73.3 110.941 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 61.05 81.88 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.766 -0.73 . . . . 64.12 112.447 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 61.98 110.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.876 0.37 . . . . 72.54 110.888 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 5.1 m -148.43 145.12 27.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 74.53 110.873 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -117.61 126.36 52.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 72.04 110.895 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 16.4 t -127.06 123.05 61.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 74.15 111.095 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.14 117.9 22.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 72.51 110.896 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 5.1 mp -111.68 103.35 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 71.1 111.153 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.06 -173.87 28.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 74.53 112.509 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -106.36 156.22 18.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 75.31 110.9 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -115.71 128.45 55.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 65.55 110.897 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -110.8 129.72 55.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 63.03 110.895 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 120.78 167.25 13.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 72.21 112.471 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -110.9 -161.48 17.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.805 -0.712 . . . . 75.11 112.524 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt 50.9 79.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.794 0.331 . . . . 73.21 110.883 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 86.29 86.9 1.03 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 51.24 112.508 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -50.05 -42.13 49.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 74.33 110.83 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -158.04 68.42 0.5 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 75.03 110.882 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -168.02 -170.93 1.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.28 -0.418 . . . . 74.45 110.845 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -112.57 111.99 23.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 72.43 110.873 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -55.49 101.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 72.02 110.811 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.09 -170.11 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 73.04 110.863 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 164.03 3.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 73.35 110.878 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.07 -42.39 2.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 70.45 110.928 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -52.12 -31.94 33.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 73.33 110.88 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 73.45 110.802 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 32.0 mtt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.896 0.379 . . . . 73.45 110.846 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.36 91.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 71.22 110.852 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 1.1 pp -112.14 169.23 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 73.32 111.139 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -170.4 125.57 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 72.45 110.853 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -170.57 131.34 0.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 74.45 111.121 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 17.6 tt -174.17 138.32 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 73.23 111.145 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 58.2 t 58.32 91.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.229 -0.442 . . . . 74.24 111.133 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -152.07 -167.53 15.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.712 -0.756 . . . . 72.42 112.459 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -120.07 -76.73 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 71.23 110.9 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -88.12 112.36 22.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 75.35 110.901 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.34 137.48 37.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 73.4 110.892 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -117.85 119.48 35.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 71.04 111.081 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -75.25 -29.46 60.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 75.13 110.911 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -166.19 136.15 3.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 73.22 110.876 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.66 117.98 14.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 72.52 111.113 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -126.96 125.25 41.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 74.01 110.881 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.33 155.4 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 63.14 111.119 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -152.99 168.68 25.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 72.13 110.888 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 68.71 -80.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 71.35 110.863 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -159.56 55.58 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 75.44 110.822 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.8 146.5 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 74.52 111.147 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -125.78 135.37 51.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 74.41 110.836 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.94 121.69 63.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 62.54 111.147 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -116.55 125.83 52.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 73.24 110.885 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -111.78 117.72 33.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 75.45 110.86 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.71 179.55 17.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 71.44 112.46 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -86.78 163.09 17.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 75.12 110.899 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 78.2 t -133.16 123.67 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 72.44 111.166 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.57 129.26 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.25 111.119 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.4 t -69.59 175.07 4.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 73.13 111.117 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.26 -41.57 89.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 65.02 111.144 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.71 -48.85 76.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 73.11 111.189 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.57 -179.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 74.31 111.179 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.8 167.78 20.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 74.4 110.857 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -86.61 52.65 2.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 65.42 110.819 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.72 -28.21 56.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 63.42 112.517 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 90.42 147.8 18.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.708 -0.758 . . . . 72.01 112.457 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.68 -172.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.799 0.333 . . . . 73.1 111.112 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.39 -169.57 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 74.23 110.795 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 50.4 mm -51.23 119.26 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 75.14 111.142 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 35.3 m -119.65 -9.21 9.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 75.11 110.806 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.99 165.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 73.5 110.915 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -148.66 -75.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 74.32 110.929 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 2.8 t -101.43 138.27 38.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 75.24 111.187 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 98.7 m -91.76 140.98 29.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 73.52 111.191 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.64 119.6 29.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.317 -0.401 . . . . 73.54 110.94 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 15.1 m -132.02 122.62 25.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 72.14 110.88 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.32 128.33 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 74.13 111.118 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.96 -74.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 75.13 110.824 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 19.3 p -147.37 133.35 19.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 75.11 111.087 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 14.3 t -117.05 133.17 64.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 71.11 111.171 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 45.7 t -127.01 117.79 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 74.53 111.138 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.04 133.01 10.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.803 -0.713 . . . . 54.01 112.56 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -132.39 115.37 15.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 63.24 110.911 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.75 72.58 0.95 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.799 -0.715 . . . . 74.43 112.487 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 65.52 100.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.805 0.336 . . . . 75.5 110.923 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 2.6 m -135.98 145.0 45.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 72.13 110.861 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.88 127.15 51.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.51 . . . . 74.02 110.859 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 15.5 t -133.67 123.08 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 74.21 111.165 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.63 121.88 29.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 75.04 110.857 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.36 104.56 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 75.21 111.073 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.86 169.5 13.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 65.11 112.568 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -89.94 153.87 20.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 75.44 110.906 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -115.01 135.77 53.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 75.54 110.831 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -112.51 125.54 54.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 74.44 110.929 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 92.13 -142.04 15.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 73.12 112.547 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 65.8 111.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 74.4 112.537 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -51.81 -36.93 49.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 74.32 110.882 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -107.48 -83.24 1.55 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.757 -0.735 . . . . 65.32 112.494 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -177.52 171.96 1.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.371 . . . . 75.2 110.863 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -56.6 99.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 72.42 110.813 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.56 -54.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.421 . . . . 75.13 110.871 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -179.47 34.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 70.5 110.862 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 8.2 m80 52.55 69.01 0.74 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 74.42 110.817 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -53.7 141.67 25.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 74.21 110.89 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.83 -169.99 2.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 75.13 110.847 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -62.53 155.02 26.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.453 . . . . 74.21 110.845 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.33 -171.83 1.0 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 74.43 110.884 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 74.55 110.848 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 2.6 ttt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.901 0.382 . . . . 64.01 110.93 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.25 -175.39 5.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 73.54 110.882 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 2.0 tt -130.47 143.11 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 75.04 111.156 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.31 -173.64 4.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 73.11 110.85 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -114.07 174.4 5.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 75.03 111.121 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 46.3 mm -137.73 134.95 46.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 74.51 111.19 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.96 158.19 38.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 71.44 111.084 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -174.59 151.96 13.43 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.778 -0.725 . . . . 74.0 112.492 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.44 -46.09 69.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.752 0.311 . . . . 74.22 110.848 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -95.42 111.04 23.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 72.2 110.854 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.37 151.01 44.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.091 -0.504 . . . . 74.33 110.813 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -127.13 119.03 25.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 74.1 111.112 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.48 -36.83 83.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.41 110.895 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.85 141.2 3.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.14 110.874 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 6.8 mt -136.56 116.83 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 75.24 111.152 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -123.76 125.35 44.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 74.4 110.836 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.18 153.39 51.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 75.34 111.128 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -156.27 166.5 33.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 74.53 110.858 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 70.22 -73.67 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 74.42 110.844 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 8.1 mtt85 -167.62 57.85 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.884 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.81 150.48 24.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 64.43 111.14 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.76 135.65 47.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.296 -0.411 . . . . 74.12 110.805 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.22 128.65 70.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 65.51 111.075 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.49 131.64 53.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 73.34 110.898 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.5 118.61 33.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 75.14 110.922 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.49 176.48 14.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.64 -0.791 . . . . 62.34 112.422 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -85.73 162.67 18.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.858 0.361 . . . . 75.23 110.893 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 86.2 t -132.58 128.93 58.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 65.45 111.129 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 14.8 p -122.31 129.17 75.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 73.25 111.093 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.9 t -69.51 170.98 9.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 73.31 111.182 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.49 -33.78 68.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 75.1 111.097 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.62 -35.87 68.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 73.43 111.135 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.39 -169.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 74.24 111.083 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.18 140.13 44.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 71.41 110.986 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -172.04 31.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 74.12 110.838 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -162.62 23.88 0.2 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.715 -0.755 . . . . 73.1 112.467 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -143.79 -160.15 8.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.729 -0.748 . . . . 75.31 112.527 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 1.4 tt -117.99 -38.99 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.339 . . . . 63.52 111.149 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 59.73 98.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.865 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 tt -118.39 -41.83 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 75.31 111.177 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.38 163.81 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 75.4 110.829 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -104.41 -169.02 1.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 65.12 110.835 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.49 -36.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 74.25 110.993 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 2.9 t -64.74 127.92 33.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.192 -0.458 . . . . 72.44 111.179 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 24.9 p -115.61 141.41 48.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 74.53 111.13 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -118.42 118.27 31.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 75.21 110.874 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.31 116.9 24.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.02 110.859 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 13.8 p -105.16 117.83 51.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 75.21 111.072 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . 0.551 ' CD ' ' N ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -62.04 -134.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 74.22 110.869 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.99 126.19 40.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 73.24 111.126 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 19.3 t -116.28 135.14 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 64.53 111.146 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.82 115.27 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 72.01 111.131 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.01 132.64 10.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 73.12 112.457 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -132.21 114.23 14.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.358 . . . . 73.14 110.833 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.46 73.42 1.1 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.753 -0.736 . . . . 70.12 112.46 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.42 103.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.804 0.335 . . . . 73.44 110.94 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 3.9 t -138.31 145.37 41.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 74.33 110.874 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.0 128.59 43.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 74.43 110.867 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 19.3 t -136.27 123.3 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 74.04 111.172 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -128.14 122.26 31.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.269 -0.423 . . . . 71.22 110.89 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 5.0 mp -113.74 125.1 70.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 73.32 111.143 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 128.27 -172.17 19.28 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.653 -0.784 . . . . 71.14 112.43 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.53 156.04 16.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 73.11 110.933 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -124.84 139.22 54.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 74.22 110.94 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -130.54 125.16 33.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 74.35 110.984 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 153.43 -151.89 23.59 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.69 -0.767 . . . . 73.14 112.453 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -168.29 121.81 0.98 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.72 -0.752 . . . . 75.4 112.479 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 180.0 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 75.21 110.906 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 145.64 -132.23 4.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.712 -0.756 . . . . 31.44 112.477 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.2 145.2 32.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.784 0.326 . . . . 75.14 110.881 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 65.6 13.55 8.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.156 -0.475 . . . . 75.42 110.904 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -178.72 47.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 75.22 110.856 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -51.17 166.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 73.05 110.885 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.19 -169.49 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 71.21 110.837 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -127.58 -38.6 1.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 72.33 110.899 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -72.57 79.13 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 74.41 110.878 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -68.26 178.95 1.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 75.41 110.774 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -152.57 -42.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 74.25 110.91 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 75.21 110.826 179.968 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 1.9 mtt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.823 0.344 . . . . 75.35 110.88 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.04 85.78 0.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 73.24 110.879 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 25.0 mm -129.24 149.94 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.259 -0.428 . . . . 75.21 111.162 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -80.08 59.02 3.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 75.41 110.822 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -172.68 -178.86 2.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 74.53 111.065 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 79.3 mt -138.79 -72.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 73.23 111.099 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 8.8 p -175.16 152.91 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 74.45 111.182 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -64.77 -155.3 0.16 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.675 -0.774 . . . . 64.3 112.51 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.38 100.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.828 0.347 . . . . 72.41 110.846 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -142.21 137.56 30.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 63.35 110.92 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.31 148.67 50.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 70.44 110.888 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.26 119.31 10.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.4 111.058 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.59 -49.29 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 71.14 110.898 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -165.22 136.9 4.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 75.41 110.875 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 5.9 pt -135.49 130.77 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 74.4 111.127 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.7 125.41 27.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 75.13 110.882 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.6 p -136.86 149.59 47.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 73.25 111.126 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.27 168.51 19.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 72.15 110.869 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 64.63 74.73 0.39 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 73.14 110.893 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 40.85 59.29 2.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 74.2 110.905 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -103.36 157.19 17.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 73.34 111.04 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.97 143.94 47.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 75.5 110.926 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 14.8 m -134.73 120.6 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 75.3 111.033 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -116.34 129.68 56.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 72.25 110.936 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.5 mp -111.86 117.91 34.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 75.24 110.947 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.25 -166.51 24.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.786 -0.721 . . . . 64.24 112.516 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -108.25 141.7 39.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.971 0.415 . . . . 61.12 110.838 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 32.0 m -115.52 118.0 57.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.138 -0.483 . . . . 51.5 111.13 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.5 m -123.43 123.03 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 74.51 111.129 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.2 t -91.78 161.06 15.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 75.02 111.173 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.15 -43.9 93.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 71.01 111.079 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.11 -35.02 66.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 75.22 111.084 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -64.99 -14.83 61.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 74.55 111.101 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 62.76 -176.36 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 73.35 110.867 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -145.87 -46.64 0.21 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.148 -0.478 . . . . 71.44 110.817 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 66.54 68.27 1.72 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 73.01 112.507 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 129.21 -137.42 9.57 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.802 -0.713 . . . . 63.42 112.502 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.5 tt -126.22 -37.62 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.833 0.349 . . . . 73.44 111.182 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -179.3 -170.01 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 74.41 110.859 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.22 165.38 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 74.22 111.131 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.53 148.95 36.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 72.51 110.841 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.65 -170.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 72.11 110.894 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -173.84 176.16 2.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.979 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 56.6 m -76.99 135.56 38.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 64.44 111.198 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.0 t -106.07 122.35 46.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 71.05 111.15 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.02 136.34 52.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 73.45 110.917 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 8.2 t -142.55 123.6 14.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 65.21 110.822 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.58 134.98 54.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 70.02 111.136 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.74 -77.76 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 73.44 110.851 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.22 127.68 53.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 60.43 111.115 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.89 131.46 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 71.25 111.111 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.46 116.06 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 72.43 111.115 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.12 133.29 10.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.802 -0.713 . . . . 74.25 112.517 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -133.35 148.51 51.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 63.45 110.872 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.55 79.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.785 -0.721 . . . . 64.14 112.493 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 46.83 66.37 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 75.01 110.907 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 29.6 t -92.78 145.14 24.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 72.33 110.82 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.56 128.19 54.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 70.31 110.856 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 19.3 t -119.25 123.15 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 75.34 111.139 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -129.45 111.49 12.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 73.12 110.937 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 7.2 mm -106.97 110.39 31.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 73.32 111.088 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.15 -178.34 18.84 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 73.33 112.482 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -88.96 156.59 18.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 70.31 110.916 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -135.23 146.7 48.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 72.43 110.902 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -123.06 122.45 38.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 73.3 110.901 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -127.83 -155.99 8.92 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.726 -0.749 . . . . 71.44 112.497 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -144.32 18.5 2.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 73.11 112.478 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.67 -51.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 71.13 110.942 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -102.28 -169.11 26.92 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.729 . . . . 72.05 112.5 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -136.54 31.74 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.911 0.386 . . . . 75.54 110.895 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 -179.31 -37.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 75.34 110.975 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.52 -170.37 2.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 75.33 110.856 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -88.14 79.29 7.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 63.33 110.864 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -93.68 136.07 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.845 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -175.47 152.65 1.38 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 75.33 110.818 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 60.84 56.16 2.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 74.15 110.913 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -172.43 123.77 0.47 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 74.3 110.913 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -105.49 138.54 41.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.33 110.882 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 1.1 t60 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 70.45 110.898 -179.989 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.774 0.321 . . . . 75.22 110.902 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.39 133.21 48.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 72.21 110.876 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 4.0 mp -138.7 147.81 24.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 71.41 111.09 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -161.57 86.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 73.41 110.861 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -171.62 -170.56 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 64.31 111.124 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 6.4 tp -52.28 139.28 9.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.279 -0.419 . . . . 74.31 111.054 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 14.9 p -147.14 139.28 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 74.31 111.139 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -92.79 -175.93 41.26 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.774 -0.727 . . . . 71.55 112.477 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -169.11 105.76 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.838 0.351 . . . . 74.05 110.854 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -134.28 110.58 9.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 74.12 110.925 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.95 138.74 54.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 73.43 110.895 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.99 120.01 20.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 72.0 111.175 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -74.88 -35.69 62.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 74.24 110.844 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -166.05 135.8 3.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 71.21 110.864 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . 0.406 ' HA ' HG21 ' B' ' 267' ' ' VAL . 7.4 pt -141.07 131.58 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 74.13 111.155 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.72 126.8 27.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.837 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 2.3 p -135.05 140.38 45.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 74.31 111.095 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.19 167.56 21.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 71.04 110.852 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 68.09 69.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 74.43 110.861 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 46.88 35.2 3.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 75.15 110.935 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.42 156.14 20.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 75.24 111.057 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.65 144.6 47.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 74.21 110.823 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.71 121.31 62.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 75.25 111.162 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.24 117.45 29.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.33 110.911 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mp -111.48 117.71 33.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 74.15 110.898 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.37 -165.69 26.65 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 54.42 112.505 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -109.07 135.5 50.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 63.31 110.907 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.62 123.04 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 62.43 111.142 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.54 121.52 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 73.52 111.136 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.3 t -87.76 161.68 17.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 65.31 111.139 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.16 90.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 72.14 111.172 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.11 -34.9 64.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 73.51 111.131 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -91.8 115.46 28.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 74.42 111.136 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 24.0 tp -166.06 -66.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.901 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.27 30.89 8.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 74.2 110.842 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 66.4 174.45 5.87 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.733 -0.746 . . . . 50.11 112.429 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -57.87 161.03 10.71 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.781 -0.723 . . . . 52.11 112.523 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.48 179.59 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 72.12 111.145 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.41 160.72 31.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.15 110.914 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 mt 60.5 99.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 74.33 111.111 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.23 -178.47 4.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 73.42 110.876 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -113.36 -28.79 7.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 74.32 110.838 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.96 98.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 74.03 110.936 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 1.3 m -99.17 136.52 39.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 71.3 111.113 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 97.2 m -134.14 108.82 8.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.426 . . . . 73.2 111.133 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -111.36 132.73 54.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.862 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.9 p -140.0 123.6 17.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 73.1 110.89 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 3.7 p -115.07 144.71 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 75.45 111.095 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.14 -52.09 5.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 74.43 110.875 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 25.1 m -150.33 126.98 10.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 62.2 111.185 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . 0.406 HG21 ' HA ' ' B' ' 231' ' ' ILE . 32.6 m -123.14 136.85 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 62.31 111.11 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 37.8 t -127.22 129.62 70.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 72.14 111.128 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.24 133.4 8.42 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.8 -0.714 . . . . 74.4 112.517 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -133.18 148.92 52.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 74.21 110.89 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.4 87.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.697 -0.763 . . . . 73.42 112.477 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 41.39 50.73 3.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 73.02 110.873 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 47.9 t -83.21 144.87 29.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 73.42 110.833 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 129.85 48.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.098 -0.501 . . . . 73.32 110.871 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 11.9 t -114.14 130.67 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 73.11 111.147 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.73 111.24 12.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 64.34 110.886 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 21.9 mm -110.15 103.43 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 74.31 111.126 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 142.01 -172.45 24.11 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.725 -0.75 . . . . 75.11 112.507 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -91.42 156.35 17.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.708 0.29 . . . . 65.23 110.954 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.16 142.27 50.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 71.31 110.864 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -127.19 122.83 35.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 65.01 110.936 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -129.97 -158.64 9.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 71.45 112.486 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -111.77 -20.72 6.72 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 51.11 112.465 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.59 34.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 74.24 110.944 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -142.8 176.51 22.41 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.708 -0.758 . . . . 72.24 112.472 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -116.68 -22.88 8.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.837 0.351 . . . . 71.22 110.894 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -156.13 -41.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 72.3 110.913 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -174.07 85.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 74.12 110.832 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -110.47 -170.38 1.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 75.52 110.921 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -167.47 -70.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 75.3 110.883 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.02 -171.64 1.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.814 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -96.65 32.82 1.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 73.32 110.816 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.12 173.24 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 61.41 110.892 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -76.43 -169.87 1.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 74.15 110.926 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 37.6 t60 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 72.21 110.827 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 16.5 mtt . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.81 0.338 . . . . 72.55 110.894 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -106.09 125.92 51.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 74.41 110.903 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 3.5 mp -117.0 -28.88 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 73.15 111.142 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 56.34 -173.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.101 -0.499 . . . . 71.41 110.851 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -135.61 -73.04 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 70.4 111.121 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 2.2 pt -150.85 67.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 74.23 111.068 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 25.6 m -106.78 -31.49 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 72.43 111.097 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -145.93 100.62 0.23 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.705 -0.76 . . . . 50.11 112.458 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -153.37 118.36 5.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.834 0.349 . . . . 75.43 110.835 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -88.06 124.28 33.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.871 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.5 142.9 50.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 71.41 110.87 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.88 119.17 14.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 73.24 111.097 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.53 -45.83 35.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 73.41 110.905 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -165.97 135.6 3.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 74.03 110.836 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 5.5 pt -138.14 132.1 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 75.53 111.12 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.61 121.44 19.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 74.11 110.827 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.8 p -135.87 138.17 42.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 73.34 111.104 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -138.8 167.71 21.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 71.3 110.877 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 68.95 73.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 71.23 110.838 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 45.07 54.21 7.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 72.53 110.881 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 156.25 18.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 74.44 111.097 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.94 143.7 38.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 63.43 110.804 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 14.8 m -129.5 133.83 64.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 75.23 111.107 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -130.35 120.7 24.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 73.11 110.96 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 5.9 mp -111.64 118.36 35.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 72.3 110.907 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.65 -178.4 19.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.726 -0.75 . . . . 35.45 112.457 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -97.47 128.81 44.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.853 0.359 . . . . 63.24 110.905 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 32.5 m -96.18 127.79 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 75.23 111.154 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.49 129.23 74.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 64.22 111.112 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.4 t -83.83 165.07 19.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 75.41 111.109 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.14 -34.09 76.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 70.01 111.111 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.72 -36.21 69.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 73.22 111.102 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 69.09 -77.23 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 74.42 111.054 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.48 51.91 1.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 75.2 110.906 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 72.15 -69.33 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 73.13 110.903 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -137.58 34.36 2.18 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.778 -0.725 . . . . 75.45 112.457 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -163.03 -168.88 25.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.793 -0.718 . . . . 75.42 112.576 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 4.1 mp -135.63 109.67 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 74.51 111.057 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -132.73 -174.86 3.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 73.32 110.848 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 36.1 pt -77.68 176.55 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 75.31 111.111 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.72 -172.04 2.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 73.32 110.818 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.5 169.74 8.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.89 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 11.0 mp0 -111.11 104.01 12.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 73.14 110.937 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 1.7 m -100.78 136.06 41.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 74.34 111.145 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 96.1 m -125.15 116.83 22.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 72.15 111.121 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -126.05 149.8 48.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 72.53 110.916 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 1.8 m -141.72 123.71 15.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 72.42 110.886 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 5.9 p -109.99 138.93 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 72.3 111.071 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.6 -74.19 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 72.55 110.935 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 7.4 m -126.26 127.79 46.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 64.42 111.156 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.74 129.69 73.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.21 111.145 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 19.4 t -127.98 115.97 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 74.04 111.132 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.75 133.56 10.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.692 -0.766 . . . . 72.2 112.485 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.06 147.6 52.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.342 . . . . 72.51 110.867 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.43 84.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.785 -0.721 . . . . 64.45 112.43 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 48.06 75.74 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 74.04 110.958 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.69 145.06 32.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 73.43 110.865 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.47 128.42 48.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 73.03 110.822 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.32 123.41 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 75.35 111.124 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.75 113.42 15.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 73.13 110.964 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 19.0 mm -112.17 104.08 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 72.0 111.093 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.74 -177.07 27.22 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.711 -0.757 . . . . 71.04 112.439 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -95.04 156.19 16.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 74.12 110.971 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.12 130.93 52.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 75.31 110.847 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -119.23 125.65 49.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 73.43 110.958 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.93 171.91 13.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.692 -0.766 . . . . 63.34 112.466 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -70.92 -139.73 0.19 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.782 -0.723 . . . . 72.03 112.487 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 63.15 24.81 14.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.34 . . . . 72.23 110.908 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 61.9 -95.21 0.1 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.685 -0.769 . . . . 62.22 112.441 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -112.58 -175.3 2.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 74.12 110.95 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 21.0 t90 -50.13 -74.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.236 -0.438 . . . . 74.43 110.93 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -71.21 -175.73 1.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.432 . . . . 72.03 110.848 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -109.78 179.66 4.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 73.51 110.932 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.85 -169.98 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 63.44 110.894 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -138.24 -171.65 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.874 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -68.51 144.22 54.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 73.32 110.889 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.36 -174.41 4.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 73.4 110.851 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -137.5 -170.06 2.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 74.43 110.839 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 73.12 110.877 -179.946 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 18.6 ptp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.82 0.343 . . . . 72.23 110.933 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.12 102.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 75.55 110.894 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 5.9 pt -88.66 -177.59 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 73.23 111.113 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -133.24 -74.31 0.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 63.32 110.822 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -155.19 -170.02 3.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 52.11 111.115 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 10.5 tt -169.44 146.18 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 73.2 111.12 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 63.4 t -129.52 -72.0 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 72.23 111.156 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -91.59 -138.5 8.04 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 74.34 112.503 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.43 -168.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.83 0.347 . . . . 75.11 110.843 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -83.28 111.23 18.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 73.21 110.87 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 4.3 m -126.31 138.13 53.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 75.42 110.852 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.58 123.49 39.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 71.15 111.095 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -40.29 58.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 74.33 110.946 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -165.96 135.95 3.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 73.04 110.895 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 9.0 pt -141.36 117.66 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.11 111.111 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 122.86 27.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.473 . . . . 74.32 110.928 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 3.0 p -135.94 149.17 48.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 72.35 111.154 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -145.66 167.19 23.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 71.31 110.904 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 67.22 79.86 0.22 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 73.04 110.92 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 42.62 52.28 4.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 75.43 110.857 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.22 156.31 18.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 72.43 111.08 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.16 142.03 25.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.829 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 19.7 m -128.89 139.75 51.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 74.43 111.134 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -128.75 126.03 39.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 72.54 110.915 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 10.8 mp -111.73 135.21 52.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 74.14 110.875 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 114.74 -176.16 16.6 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.713 -0.756 . . . . 62.32 112.433 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -100.36 135.21 42.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.876 0.37 . . . . 71.21 110.88 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 22.7 m -104.07 133.48 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 74.31 111.137 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 39.9 t -122.22 129.47 75.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 75.32 111.05 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 10.9 t -69.55 175.1 4.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 74.31 111.213 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.79 -42.92 99.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 74.14 111.078 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.85 74.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 74.13 111.106 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 53.88 -171.34 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 73.31 111.023 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.11 91.52 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.476 . . . . 74.44 110.925 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -76.89 -174.88 3.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 73.22 110.882 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 109.43 -20.23 28.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.697 -0.764 . . . . 74.13 112.458 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 167.95 -104.74 0.22 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.788 -0.72 . . . . 74.25 112.494 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 13.6 pt -144.64 44.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.76 0.314 . . . . 71.32 111.132 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -93.72 174.84 6.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 71.54 110.946 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 4.1 pt -110.87 -179.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 73.44 111.172 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.91 -172.35 2.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 73.41 110.918 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -119.63 173.63 6.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 70.11 110.824 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.62 119.99 19.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 73.41 110.989 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 29.3 m -95.98 137.92 34.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 61.44 111.143 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 90.2 m -93.24 113.45 25.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 72.42 111.206 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -126.25 145.55 50.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 75.23 110.924 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 21.9 t -135.53 123.8 23.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 73.21 110.8 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 14.2 p -112.35 133.2 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 75.43 111.167 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.91 -75.18 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 74.42 110.872 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 26.5 m -133.73 132.65 40.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 74.34 111.161 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 13.6 t -117.78 127.36 75.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 73.51 111.076 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.12 116.04 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 71.43 111.129 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.29 132.94 10.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.788 -0.72 . . . . 60.3 112.547 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.4 143.93 50.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 75.24 110.891 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 47.15 85.31 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.716 -0.754 . . . . 74.33 112.483 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 52.74 89.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.847 0.356 . . . . 71.44 110.927 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 47.8 t -126.12 145.01 50.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 73.4 110.829 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 11.8 mtt85 -127.7 128.23 45.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 74.4 110.862 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.36 123.68 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 65.33 111.129 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.47 113.05 17.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 74.34 110.863 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 17.8 mm -112.33 104.21 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 65.35 111.144 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.61 -146.59 16.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.758 -0.734 . . . . 72.24 112.525 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -128.19 150.04 50.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 75.13 110.853 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -111.76 127.16 55.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.965 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -120.21 125.4 48.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.22 110.898 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 122.99 160.16 10.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 64.44 112.41 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 62.26 163.55 0.32 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 32.23 112.479 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -110.34 48.42 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 75.34 110.927 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -137.04 -92.62 0.31 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.738 -0.744 . . . . 73.43 112.518 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -179.6 -64.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 73.43 110.849 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -168.9 39.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 75.4 110.919 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -179.63 -38.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.837 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.14 157.32 1.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 74.11 110.937 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -140.17 -174.28 3.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 75.52 110.875 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -51.88 -72.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 73.13 110.882 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.34 105.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 54.3 110.861 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -91.43 -26.05 19.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 70.2 110.89 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.16 -179.93 4.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 74.24 110.84 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 6.9 p80 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 64.2 110.893 -179.968 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.883 0.373 . . . . 74.42 110.864 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -178.85 122.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.54 110.887 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 4.8 mt -126.75 135.13 64.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 74.11 111.156 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -71.11 144.48 50.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 64.34 110.87 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -125.67 -75.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 61.43 111.153 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 3.6 mp 52.23 75.2 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 74.33 111.162 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 21.2 m -149.26 -173.92 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 73.11 111.098 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -83.89 -131.47 2.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.765 -0.731 . . . . 73.11 112.468 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.92 -167.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 73.45 110.904 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.9 112.31 19.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 73.4 110.878 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 19.3 m -131.23 138.7 49.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.31 110.838 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -120.52 132.74 55.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 61.54 111.092 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.6 -32.39 41.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.867 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.79 139.03 4.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.415 . . . . 71.42 110.91 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.71 116.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 73.13 111.151 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -129.89 117.77 20.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 75.25 110.861 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 7.8 p -135.43 151.91 50.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 73.42 111.105 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -157.47 167.27 30.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.907 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 67.54 75.13 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 63.41 110.848 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 45.78 42.9 9.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 74.15 110.864 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.09 150.61 24.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 73.24 111.045 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . 0.477 HH12 ' N ' ' E' ' 240' ' ' GLN . 0.0 OUTLIER -133.7 148.11 51.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 72.21 110.902 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 6.8 m -130.47 124.13 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 74.5 111.134 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . 0.477 ' N ' HH12 ' E' ' 238' ' ' ARG . 8.6 tm0? -114.65 126.12 54.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.43 110.933 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.87 121.4 43.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 72.04 110.941 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 122.03 175.61 14.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 53.4 112.513 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -85.63 139.53 31.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 71.32 110.824 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 30.1 m -104.84 139.17 26.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 53.44 111.135 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 87.1 t -122.41 129.43 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 64.45 111.095 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.7 t -69.0 174.28 4.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 72.05 111.143 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.0 -43.54 91.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 73.42 111.09 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.98 -48.63 77.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 55.3 111.05 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 52.5 -170.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 74.34 111.042 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 4.6 tp -177.1 154.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 74.25 110.919 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -159.48 156.65 28.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 65.04 110.829 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.74 137.54 4.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 64.43 112.517 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -166.68 -179.16 39.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.751 . . . . 71.31 112.483 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.6 25.64 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.903 0.383 . . . . 74.42 111.14 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -160.14 143.32 13.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 71.11 110.872 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.87 177.74 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 65.33 111.141 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 1.1 t -179.46 -37.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 71.41 110.858 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 29.7 t0 63.5 161.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.106 -0.497 . . . . 72.35 110.806 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -74.47 131.09 40.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 73.21 110.903 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 20.5 m -66.85 138.26 57.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 60.24 111.111 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 2.8 t -103.55 134.31 47.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 72.1 111.09 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.42 150.88 48.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 75.33 110.845 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 68.3 m -139.33 131.98 28.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 74.15 110.887 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.28 122.07 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 71.31 111.157 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.25 -78.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 71.33 110.862 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 72.5 p -143.48 135.83 27.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 71.4 111.212 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 18.0 t -117.44 134.6 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 75.13 111.141 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 47.4 t -126.74 119.97 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.3 111.126 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.89 133.27 10.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 73.44 112.548 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.79 126.4 32.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.815 0.34 . . . . 72.52 110.893 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.7 94.44 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 52.34 112.477 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 50.05 75.14 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.92 0.391 . . . . 75.44 110.86 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 7.6 t -114.79 145.6 41.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.474 . . . . 63.22 110.802 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 24.2 mtm-85 -130.85 127.3 38.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 75.14 110.913 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 21.3 t -116.53 125.3 73.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 73.13 111.165 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.72 111.73 15.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 74.34 110.953 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 31.6 mm -112.9 103.69 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 63.43 111.155 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 137.66 -178.66 18.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.8 -0.714 . . . . 61.4 112.52 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -89.92 156.19 18.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 63.24 110.859 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -121.37 134.31 55.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 64.5 110.879 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -114.35 124.74 52.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 55.23 110.92 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 96.45 -20.79 48.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.795 -0.717 . . . . 72.45 112.512 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -72.96 -22.59 79.0 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 54.31 112.472 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 51.85 83.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 75.11 110.909 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 65.2 109.76 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 70.11 112.522 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 57.73 -168.02 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.351 . . . . 75.11 110.857 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -47.78 -57.85 5.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 72.42 110.951 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -147.35 171.94 14.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 72.43 110.911 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -123.73 96.62 5.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 71.12 110.883 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -170.0 49.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.916 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -145.9 -178.93 6.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 74.24 110.885 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -156.73 142.14 17.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 73.12 110.868 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.67 -174.92 3.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 63.24 110.876 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.18 -175.0 1.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 74.51 110.874 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 74.55 110.921 -179.942 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.873 0.368 . . . . 74.13 110.92 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.89 107.06 13.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.873 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 25.3 mm -135.43 150.0 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 74.15 111.053 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.49 -170.61 1.93 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 75.44 110.873 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -172.27 168.56 5.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 62.34 111.137 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.5 pt -152.18 179.37 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 73.22 111.142 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 38.6 t -58.05 141.11 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 75.21 111.083 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 52.99 76.84 0.16 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.742 . . . . 63.11 112.47 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -175.76 121.11 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.794 0.331 . . . . 73.41 110.917 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -85.15 135.18 34.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 73.53 110.87 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 1.7 m -118.91 136.94 53.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 62.45 110.854 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.35 139.72 39.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.482 . . . . 73.55 111.063 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.95 -73.11 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 72.12 110.931 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -130.43 138.53 50.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 72.45 110.845 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.41 116.71 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 75.3 111.1 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -118.74 115.85 25.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 72.15 110.861 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.75 146.45 52.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.194 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.05 154.96 31.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 74.31 110.883 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 64.23 82.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 72.03 110.934 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 41.85 43.57 2.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 75.13 110.848 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.25 137.93 31.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.092 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 141.9 51.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 73.32 110.809 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.0 p -143.58 121.68 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 75.01 111.134 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -122.0 136.61 54.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 72.05 110.888 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.75 118.87 21.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 73.34 110.94 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.72 -120.39 1.05 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.739 . . . . 52.31 112.503 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -144.77 130.28 18.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 72.23 110.86 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -101.95 136.29 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 72.45 111.136 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 38.5 t -122.15 129.12 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 74.42 111.122 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.92 163.1 12.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 73.42 111.136 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.03 -42.09 99.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 74.23 111.132 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.06 -36.01 70.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 74.32 111.083 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -52.45 -75.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 72.23 111.18 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.2 -170.16 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 70.42 110.961 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -68.82 -38.15 79.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 73.23 110.818 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -169.34 -43.36 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.75 -0.738 . . . . 71.33 112.464 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 164.93 171.81 31.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.693 -0.765 . . . . 74.23 112.501 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.35 -62.39 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.875 0.369 . . . . 72.22 111.211 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -169.6 140.94 2.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 75.01 110.875 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 15.8 tt -163.05 143.77 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 75.32 111.132 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.6 148.97 21.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 73.52 110.929 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 55.46 -173.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 71.24 110.825 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.33 137.96 1.53 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 73.44 110.86 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 7.0 t -65.65 125.48 25.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 73.54 111.084 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 91.9 m -112.79 108.85 18.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 75.23 111.186 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -104.96 138.91 40.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 74.32 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 92.4 p -140.48 123.87 16.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.53 110.833 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.26 149.77 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 74.23 111.137 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -102.44 -39.79 6.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 73.35 110.866 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.4 m -150.41 127.31 11.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.453 . . . . 73.42 111.099 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 80.9 t -121.28 120.19 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 73.23 111.08 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.02 129.48 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 73.13 111.206 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -139.73 133.26 5.98 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.764 -0.732 . . . . 71.31 112.49 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.89 147.39 51.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.877 0.37 . . . . 61.33 110.896 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 53.94 89.91 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.665 -0.779 . . . . 72.11 112.533 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 45.23 60.18 3.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 73.21 110.817 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 6.4 t -91.25 145.54 24.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 75.42 110.862 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -132.32 127.8 36.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 74.21 110.884 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 20.3 t -131.85 123.66 51.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 74.15 111.119 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.71 111.59 17.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 74.52 110.931 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 2.3 mp -107.17 104.29 16.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 75.34 111.117 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.04 -152.29 24.42 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.749 -0.738 . . . . 74.14 112.496 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -127.81 151.52 48.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 75.31 110.878 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.03 124.69 48.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 72.4 110.886 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -106.91 125.86 51.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 74.54 110.923 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 112.65 -68.97 0.23 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.724 . . . . 74.35 112.522 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 101.33 -101.71 2.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.768 -0.729 . . . . 72.24 112.499 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.83 45.93 4.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 73.4 110.828 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.79 17.57 11.8 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.782 -0.723 . . . . 63.1 112.511 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.69 170.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.817 0.341 . . . . 73.34 110.828 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -61.38 -172.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.488 . . . . 75.22 110.915 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -58.69 98.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 74.02 110.857 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -147.74 -73.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 54.42 110.911 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -178.98 -170.54 0.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 73.43 110.923 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -73.19 -170.29 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 73.12 110.808 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -73.06 -68.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 72.44 110.839 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 55.07 -175.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 75.21 110.84 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -145.7 -70.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 74.03 110.858 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 75.13 110.831 -179.953 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 7.0 ttp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.784 0.326 . . . . 70.32 110.866 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.67 143.21 57.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 74.1 110.836 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.21 68.4 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 73.3 111.11 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.48 91.51 3.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 73.33 110.886 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -109.39 131.79 54.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 71.25 111.115 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 4.5 mp 51.82 69.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.51 111.151 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 6.7 p -176.81 122.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 74.13 111.151 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 152.46 -138.24 6.32 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.685 -0.769 . . . . 72.04 112.468 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.64 133.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 72.33 110.861 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -123.15 138.52 54.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 71.42 110.911 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.98 137.7 54.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 73.32 110.804 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.87 140.39 47.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 65.15 111.064 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.07 -31.5 9.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 74.1 110.89 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -164.74 138.77 5.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 73.41 110.826 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 5.7 mt -137.25 121.5 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 71.41 111.099 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -134.06 118.23 17.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 73.23 110.828 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 128.89 32.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.055 -0.521 . . . . 75.4 111.169 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.03 166.86 22.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 74.44 110.888 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.71 71.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.43 110.899 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 46.16 48.19 12.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 73.34 110.804 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -98.48 149.46 22.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 71.22 111.104 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.44 142.88 47.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 75.44 110.843 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.58 132.08 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 70.14 111.164 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -127.01 137.23 53.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 65.52 110.827 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.19 118.56 28.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 73.11 110.915 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.68 -168.62 18.77 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 72.13 112.475 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -85.76 135.21 33.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.908 0.385 . . . . 74.45 110.881 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 3.3 m -117.72 118.83 59.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 73.31 111.115 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.82 120.17 54.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 74.02 111.124 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.0 t -90.76 172.17 8.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 74.0 111.115 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.74 -41.81 64.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 73.54 111.055 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.79 -36.05 69.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 74.43 111.08 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -82.08 93.21 6.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 71.43 111.114 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 1.4 tp -76.97 -169.96 1.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 75.51 110.924 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -52.13 119.61 4.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 70.03 110.897 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -169.1 -176.08 38.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.747 . . . . 71.24 112.469 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 86.9 104.95 0.82 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 74.22 112.507 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 18.4 tt -175.02 150.77 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.804 0.335 . . . . 72.32 111.101 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 63.06 -170.08 0.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 74.53 110.924 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 26.8 mt 64.27 107.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 74.14 111.055 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.93 -170.27 0.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 72.13 110.84 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 63.31 103.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 74.4 110.91 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -101.89 164.8 11.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.13 110.911 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 7.0 t -99.3 137.44 37.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 74.34 111.142 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 26.2 m -129.2 132.66 47.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 73.54 111.129 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -120.43 121.87 39.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.943 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 2.0 t -118.91 123.69 45.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 54.33 110.826 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -116.07 139.0 44.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 74.4 111.095 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.39 -75.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 74.12 110.86 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 24.3 m -124.09 130.47 52.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 74.51 111.127 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 94.0 t -118.06 122.8 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 74.2 111.121 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.39 129.14 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 64.21 111.199 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.74 132.76 6.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.699 -0.762 . . . . 61.42 112.412 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.7 147.52 51.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.873 0.368 . . . . 64.41 110.898 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.25 86.39 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.767 -0.73 . . . . 61.43 112.539 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 46.37 66.23 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 65.43 110.863 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 17.4 t -99.2 145.37 27.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 72.11 110.819 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 4.4 ttm-85 -129.76 127.88 41.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 74.5 110.805 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 18.7 t -129.49 123.58 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 74.32 111.134 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -126.88 111.93 14.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 75.31 110.919 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 2.2 mp -108.05 104.32 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 74.52 111.145 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.79 -141.49 8.88 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 71.42 112.472 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -127.99 156.1 43.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.776 0.322 . . . . 63.43 110.908 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -122.57 126.31 47.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 73.32 110.961 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -109.82 127.93 54.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 74.12 110.952 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 104.84 155.36 22.88 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.752 -0.737 . . . . 75.2 112.519 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -114.03 132.88 10.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.709 -0.758 . . . . 60.12 112.501 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -175.02 44.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.359 . . . . 74.21 110.875 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.04 26.87 27.62 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.72 -0.752 . . . . 62.32 112.523 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 62.34 165.26 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 73.44 110.855 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 38.6 p-90 -52.0 -32.56 34.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 75.43 110.924 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -75.95 149.01 37.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.844 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -89.89 -73.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 64.32 110.847 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -94.59 140.3 30.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.857 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -99.99 -68.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 75.23 110.872 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 51.84 87.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 75.35 110.789 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -102.3 -74.77 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 74.3 110.908 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.25 -169.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 65.51 110.879 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 75.51 110.879 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 2.5 tmm? . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.917 0.389 . . . . 74.33 110.849 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt 63.03 28.61 16.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 71.24 110.906 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 59.5 mt 61.35 80.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 75.22 111.137 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -159.76 89.33 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 74.34 110.843 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -172.56 -170.0 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 74.34 111.141 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 2.1 tt -100.42 -33.11 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 65.51 111.134 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 22.1 t 52.28 69.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 71.23 111.133 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 172.18 123.41 0.71 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.725 -0.75 . . . . 71.51 112.51 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -150.5 -74.61 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.347 . . . . 64.03 110.841 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.47 131.88 39.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 74.12 110.878 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.1 m -140.09 137.86 34.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 70.22 110.88 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.63 144.58 49.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 72.31 111.121 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -101.41 -25.78 13.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 75.51 110.935 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -164.86 138.58 4.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 74.33 110.811 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 10.8 mt -137.74 117.57 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 71.44 111.102 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -133.27 116.13 15.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 73.52 110.946 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.09 136.19 41.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.55 111.141 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -143.15 167.05 23.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.855 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 60.91 75.49 0.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 74.32 110.894 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 44.48 53.82 6.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 73.25 110.909 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.5 145.86 29.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 72.25 111.127 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.0 137.06 52.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 75.31 110.823 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.12 136.51 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 72.01 111.117 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -132.42 135.49 46.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 74.51 110.864 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.3 mp -126.8 118.79 25.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.42 110.933 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.8 -169.58 18.71 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 61.21 112.545 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -99.0 143.06 29.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 74.42 110.876 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 19.0 m -120.81 139.27 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 72.35 111.156 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 38.6 t -121.93 120.67 62.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 55.13 111.146 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 24.9 p -73.68 173.79 9.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 73.42 111.121 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.63 87.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 72.02 111.107 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.07 66.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 71.31 111.163 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -56.62 -24.95 51.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 72.03 111.164 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.21 -42.14 99.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.929 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.19 138.99 33.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 72.31 110.793 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 129.04 -158.7 22.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.744 -0.741 . . . . 72.22 112.528 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -129.71 -119.49 2.15 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 75.52 112.52 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 15.2 mt 70.68 -70.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 72.33 111.148 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 63.17 104.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.835 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 18.5 tt -124.17 150.84 28.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 65.44 111.069 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.07 -39.44 11.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 71.44 110.825 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.86 170.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 75.13 110.87 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -176.46 36.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.881 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 14.7 t -80.64 136.94 36.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 74.1 111.166 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.16 117.56 28.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 73.21 111.109 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.55 134.22 50.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 74.11 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 2.8 t -135.66 123.49 22.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 73.34 110.931 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.49 130.12 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 73.2 111.098 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -64.9 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 75.22 110.945 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 89.3 m -149.9 135.33 18.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 71.13 111.16 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 98.7 t -117.96 124.85 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 74.23 111.171 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.34 128.2 69.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 72.14 111.127 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.14 132.95 7.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.768 -0.729 . . . . 72.24 112.509 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -132.95 139.67 47.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.827 0.346 . . . . 74.33 110.873 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.08 73.52 0.37 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 74.12 112.495 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 63.35 100.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.852 0.358 . . . . 73.53 110.937 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 14.4 m -138.62 145.35 40.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 50.5 110.895 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -129.91 127.68 40.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 75.14 110.917 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 31.5 t -131.38 124.89 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 75.35 111.109 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.59 111.47 15.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.23 -0.441 . . . . 75.3 110.969 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 2.6 mp -104.94 133.64 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 74.01 111.161 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.11 -146.67 18.85 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.761 -0.733 . . . . 73.21 112.452 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -128.11 146.27 50.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.338 . . . . 74.43 110.878 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -113.42 123.66 50.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 71.15 110.903 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -103.95 125.65 50.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 65.53 110.913 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 111.62 -54.73 0.53 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.715 -0.755 . . . . 70.3 112.51 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 63.88 -116.66 9.46 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.711 -0.757 . . . . 72.4 112.493 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? 63.41 105.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.343 . . . . 64.51 110.896 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 62.39 60.39 7.95 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.745 -0.74 . . . . 75.12 112.477 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 51.74 -168.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.783 0.325 . . . . 74.53 110.909 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 31.8 m0 -50.69 -55.37 16.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.185 -0.461 . . . . 73.04 110.915 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -116.56 131.49 56.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 54.12 110.828 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -51.82 120.47 5.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 65.11 110.9 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -173.26 171.27 4.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 75.43 110.858 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -128.93 135.11 48.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 60.44 110.836 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -169.6 129.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 74.13 110.891 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -177.82 149.18 0.58 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 72.42 110.885 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -178.93 -170.76 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 74.11 110.894 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 73.52 110.879 179.93 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.857 0.36 . . . . 73.1 110.894 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . 0.411 ' O ' ' CG1' ' D' ' 219' ' ' ILE . 0.5 OUTLIER -179.23 -45.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 63.2 110.903 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . 0.411 ' CG1' ' O ' ' D' ' 218' ' ' LYS . 22.3 pt 43.38 -164.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 73.34 111.085 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.0 -72.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 75.4 110.869 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -153.73 122.32 6.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 71.51 111.068 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.39 179.12 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 75.53 111.16 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 62.2 t -115.67 -71.25 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 73.42 111.13 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -91.14 153.51 22.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 64.21 112.512 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -179.41 133.48 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 74.12 110.839 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -83.53 140.63 32.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 72.14 110.893 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 1.4 p -139.95 139.0 36.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 75.42 110.871 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.63 159.77 29.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 62.4 111.087 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.32 -29.61 7.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.9 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -166.48 137.99 3.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 64.05 110.875 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 13.8 mt -137.42 117.53 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 74.12 111.204 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -134.69 120.39 19.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.947 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.18 150.45 50.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 74.43 111.175 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -157.15 167.29 30.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.34 110.917 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 61.22 72.21 0.53 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 75.23 110.885 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 45.28 40.86 5.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 74.3 110.881 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.52 144.16 26.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 73.41 111.146 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -125.63 135.83 52.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 72.1 110.89 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.42 139.59 35.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 73.4 111.14 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -131.0 137.28 49.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 64.03 110.942 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.3 118.72 32.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 73.35 110.874 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.79 175.45 15.78 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.759 -0.734 . . . . 74.42 112.549 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -86.02 150.06 24.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.937 0.399 . . . . 75.13 110.822 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.87 138.32 53.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 63.32 111.193 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.14 128.94 75.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 72.1 111.094 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 12.3 t -74.0 175.25 7.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 63.51 111.081 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.84 -44.4 77.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 73.32 111.071 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.45 -52.03 67.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.422 . . . . 73.32 111.122 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.72 30.04 6.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 74.02 111.095 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.67 148.25 47.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 75.05 110.93 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -179.09 155.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 74.44 110.866 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -52.53 -27.66 26.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 61.11 112.492 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -170.63 175.12 44.55 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.696 -0.764 . . . . 54.13 112.486 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 4.6 pt -51.73 167.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 75.11 111.16 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.3 153.65 2.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.843 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 23.8 mm -114.41 61.41 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 72.42 111.095 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 14.4 m 51.65 40.18 26.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 73.2 110.827 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 72.44 -69.33 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 74.02 110.809 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 72.21 -68.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 73.23 110.958 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 3.3 t -64.83 137.49 57.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 75.25 111.181 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 94.0 m -132.57 134.74 45.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 62.11 111.127 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.04 121.48 39.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 75.3 110.873 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.57 123.99 42.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 75.05 110.795 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 8.6 p -120.05 146.49 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 71.52 111.163 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -88.76 -73.79 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 75.21 110.876 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 73.2 m -139.85 129.88 24.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 72.02 111.142 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 16.9 t -117.31 120.59 65.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 72.43 111.134 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.59 124.13 72.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 55.25 111.176 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.51 132.21 9.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 73.51 112.512 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -134.04 140.24 46.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 75.54 110.911 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 46.7 87.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 73.24 112.494 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 50.04 75.74 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.914 0.388 . . . . 71.41 110.93 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 35.9 t -107.1 145.45 32.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.07 -0.514 . . . . 64.45 110.844 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -132.67 127.64 35.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 74.53 110.903 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.81 124.1 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 74.44 111.119 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.45 111.61 17.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 74.45 110.917 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 22.4 mt -103.99 114.38 43.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 74.4 111.145 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.6 -162.12 24.07 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.663 -0.78 . . . . 73.1 112.469 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -116.47 145.58 43.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.786 0.327 . . . . 72.02 110.932 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -111.89 132.37 54.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.907 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -110.02 125.38 52.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 75.31 110.918 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 132.06 177.99 15.24 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.725 . . . . 63.21 112.516 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -138.21 111.3 0.8 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.722 -0.751 . . . . 75.32 112.459 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -156.78 22.74 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.339 . . . . 73.13 110.874 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 67.49 121.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.824 -0.703 . . . . 72.52 112.488 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 51.77 -169.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.873 0.368 . . . . 74.41 110.841 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -76.34 -25.56 54.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.108 -0.496 . . . . 74.22 110.916 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -119.06 155.3 31.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 63.02 110.85 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -52.08 -32.25 34.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 73.42 110.835 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.92 132.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 75.43 110.836 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -167.12 138.44 3.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 74.14 110.806 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 56.51 -177.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 63.35 110.788 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -131.81 -169.99 2.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.821 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 10.3 m170 62.82 171.79 0.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.811 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 71.12 110.793 -179.98 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 1.3 ptp . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.878 0.37 . . . . 74.22 110.842 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.58 143.29 45.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 71.25 110.948 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 1.1 pp -149.83 151.32 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 70.32 111.137 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.44 -171.84 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 73.42 110.831 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -143.64 156.72 44.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.41 111.104 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 45.9 mm -138.02 143.37 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 75.43 111.081 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 91.6 t -146.4 99.98 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 75.22 111.099 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 71.78 -128.48 14.87 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.818 -0.706 . . . . 73.44 112.518 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 58.85 -170.15 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.35 . . . . 71.41 110.914 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -83.93 112.51 20.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 72.24 110.8 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 6.3 p -129.34 158.96 37.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 70.43 110.878 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.69 164.73 25.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 75.31 111.113 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.42 -39.32 4.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 72.5 110.921 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.79 141.43 4.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 61.11 110.901 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 3.4 mp -137.22 116.26 15.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 74.21 111.135 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -131.24 118.83 20.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 74.14 110.889 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.99 128.96 31.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 72.25 111.125 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -140.49 158.32 44.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 74.43 110.944 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 63.08 79.31 0.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 75.31 110.918 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.2 50.04 9.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 75.22 110.899 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.71 141.55 36.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 75.02 111.094 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -126.39 139.6 53.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 75.41 110.868 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.71 141.48 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 74.52 111.124 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -138.33 137.16 37.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 74.02 110.892 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 1.8 mp -120.43 118.61 30.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.89 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 124.43 168.28 12.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 63.12 112.472 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -86.84 163.14 17.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.907 0.385 . . . . 75.22 110.881 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.16 139.39 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 71.41 111.117 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.63 127.95 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 63.53 111.08 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t -70.03 171.18 9.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 74.41 111.179 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.12 -38.72 92.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 54.53 111.168 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.94 -36.05 69.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 72.53 111.093 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 60.55 -179.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 53.54 111.019 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.87 170.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 73.04 110.922 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -51.91 -68.89 0.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 74.33 110.896 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -172.98 162.89 34.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.796 -0.716 . . . . 75.45 112.489 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 75.46 157.61 6.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.769 -0.729 . . . . 75.34 112.455 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.8 125.25 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.796 0.331 . . . . 75.13 111.123 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.88 112.46 25.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 73.43 110.858 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 44.5 mt -146.59 97.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 75.34 111.107 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -178.57 139.5 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 71.42 110.83 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 64.11 157.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 73.54 110.881 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -149.86 128.26 12.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 74.35 110.884 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 8.8 t -101.39 129.15 47.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.435 . . . . 65.52 111.2 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 60.6 m -105.39 128.44 53.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 73.25 111.088 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -125.98 131.22 52.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 71.44 110.922 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 23.1 t -128.51 121.02 27.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.906 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.8 p -104.37 123.09 58.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 72.23 111.127 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -65.59 -143.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 70.34 110.828 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 266' ' ' THR . . . . . 0.412 ' N ' ' CG ' ' E' ' 265' ' ' GLU . 14.8 p -92.46 130.02 38.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 74.43 111.126 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 19.5 t -114.84 131.15 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 75.21 111.075 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 52.4 t -122.73 116.76 49.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.135 -0.484 . . . . 73.34 111.112 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -108.06 132.68 11.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.808 -0.71 . . . . 73.41 112.512 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -132.3 115.46 15.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.84 0.352 . . . . 74.33 110.903 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.08 94.12 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.734 -0.746 . . . . 73.22 112.452 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 52.02 87.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.895 0.378 . . . . 63.41 110.909 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 33.3 t -125.66 145.85 49.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 75.14 110.877 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -136.63 128.16 28.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 75.44 110.906 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 96.8 t -136.62 125.34 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 74.0 111.099 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -123.36 116.11 22.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.98 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 2.0 mp -109.01 140.8 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 73.1 111.168 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 112.58 -158.06 14.54 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.792 -0.718 . . . . 75.32 112.495 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -128.19 156.54 42.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.352 . . . . 73.41 110.904 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -111.69 121.81 46.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 75.41 110.882 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -106.23 125.94 51.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.116 -0.493 . . . . 73.5 110.946 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 134.57 172.21 12.74 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.67 -0.776 . . . . 74.3 112.501 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -74.4 -164.37 11.07 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.771 -0.728 . . . . 65.05 112.519 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.07 -75.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 74.13 110.862 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.6 174.78 29.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.707 -0.759 . . . . 74.42 112.539 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 1.5 t80 63.95 158.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 74.23 110.816 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -81.54 57.06 3.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 74.31 110.894 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -179.11 -171.86 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 73.33 110.858 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -109.7 -170.14 1.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 75.54 110.847 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -51.96 112.97 0.87 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 74.24 110.917 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.48 -170.59 3.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 63.33 110.864 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -60.54 -175.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 74.14 110.854 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -55.34 128.49 34.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 64.14 110.803 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -176.36 123.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 74.41 110.898 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 74.25 110.863 179.984 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.853 0.359 . . . . 54.23 110.903 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -178.5 -35.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 72.12 110.923 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.7 tt -152.17 150.37 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 74.12 111.144 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 1.3 t0 63.29 161.81 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 75.03 110.857 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -79.52 133.52 36.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 63.34 111.129 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 24.8 mm -120.96 151.1 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 72.22 111.144 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 4.9 m -149.74 173.88 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 73.11 111.161 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 133.47 89.73 0.39 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.781 -0.723 . . . . 62.4 112.489 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -69.17 85.33 0.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.846 0.355 . . . . 72.45 110.863 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.24 136.44 29.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 70.21 110.924 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.46 137.09 54.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 72.0 110.901 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.28 131.07 41.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 61.03 111.099 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.81 -28.35 13.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.21 110.867 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -166.01 137.3 3.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 74.45 110.899 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 11.1 mt -137.97 117.81 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 63.22 111.139 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -127.67 123.14 34.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.499 . . . . 75.03 110.846 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -135.56 162.28 33.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 72.13 111.091 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -153.66 167.96 27.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 75.53 110.873 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.66 -69.83 0.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 75.45 110.858 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -178.68 37.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 75.02 110.873 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -70.52 152.17 44.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 74.14 111.087 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.38 135.64 51.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 72.52 110.868 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 18.7 m -129.45 121.52 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 75.45 111.144 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -119.56 134.15 55.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 75.42 110.884 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 6.0 mp -125.65 118.83 26.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 74.44 110.9 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.35 -170.88 22.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.73 . . . . 71.13 112.474 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.88 128.82 34.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 72.04 110.859 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 1.6 p -123.61 121.98 63.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 73.45 111.134 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.8 p -119.23 129.04 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 70.2 111.107 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 14.2 t -87.03 162.89 17.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 72.12 111.205 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.14 -34.0 67.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 74.2 111.08 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.94 -36.27 70.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.3 -0.409 . . . . 71.43 111.089 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -61.8 96.62 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 64.35 111.101 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.79 97.24 0.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 74.4 110.915 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 59.76 73.35 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 74.23 110.787 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -77.02 88.15 0.98 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.799 -0.715 . . . . 74.34 112.463 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.51 37.68 3.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.731 -0.747 . . . . 61.31 112.443 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.1 mp 52.06 68.83 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.846 0.355 . . . . 74.31 111.166 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -91.34 66.06 5.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 74.35 110.843 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 12.4 tt -172.47 -37.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 74.34 111.131 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.07 89.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 75.41 110.855 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.46 -32.13 7.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 72.41 110.86 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 56.76 57.54 4.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 74.33 110.923 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 20.7 p -99.14 138.07 36.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 70.12 111.121 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 95.4 m -107.13 132.59 52.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 72.1 111.151 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.11 119.93 36.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 74.14 110.902 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.1 p -130.09 123.43 30.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 74.2 110.853 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.5 p -109.3 134.43 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 74.23 111.19 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -74.28 -78.17 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 62.31 110.886 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 36.8 m -136.7 132.18 34.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.33 111.128 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 33.3 t -118.42 120.9 65.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.23 -0.441 . . . . 73.5 111.143 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.22 119.46 60.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 75.02 111.153 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.8 133.52 10.91 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.752 -0.737 . . . . 73.22 112.514 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -116.06 116.28 27.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 73.44 110.989 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.83 83.25 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.757 -0.735 . . . . 74.42 112.537 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 67.08 120.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 74.44 110.898 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.5 t -156.32 145.27 20.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 73.52 110.831 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.73 126.65 46.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 71.51 110.876 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.54 123.75 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 74.42 111.079 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.8 120.15 32.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 75.44 110.901 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 24.9 mm -112.32 103.74 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 72.35 111.144 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.9 -154.95 25.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.772 -0.728 . . . . 41.12 112.512 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -111.06 151.88 27.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.732 0.301 . . . . 73.13 110.901 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.1 134.86 49.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 72.41 110.831 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -122.22 134.61 54.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 73.33 110.941 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.21 164.03 33.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 40.34 112.441 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 141.26 136.54 3.3 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.788 -0.72 . . . . 61.22 112.522 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -51.79 -45.87 63.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.861 0.362 . . . . 74.44 110.889 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -132.48 -43.24 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.777 -0.725 . . . . 70.2 112.517 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -174.3 -165.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 73.53 110.837 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 15.8 t90 -46.29 -74.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.503 . . . . 74.32 110.915 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.42 66.05 2.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 71.22 110.898 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -51.62 110.01 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 74.25 110.941 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -142.07 -48.94 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 74.32 110.859 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 62.93 104.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.834 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.99 149.48 32.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 52.44 110.847 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -165.01 173.71 11.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 62.34 110.832 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.16 -173.92 0.3 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.254 -0.43 . . . . 74.23 110.784 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 73.51 110.843 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 1.5 ptt? . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.877 0.37 . . . . 74.32 110.851 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -175.82 153.14 1.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 75.3 110.911 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 24.9 mm -135.43 150.14 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 75.41 111.162 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.37 -58.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.14 110.861 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.34 -176.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 52.53 111.121 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 10.0 pt -51.8 168.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 75.42 111.075 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 5.4 m -138.57 106.34 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 75.23 111.088 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 68.13 128.0 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.694 -0.765 . . . . 65.55 112.572 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -155.93 87.6 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.908 0.385 . . . . 74.23 110.852 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.07 109.95 18.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 74.23 110.808 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.31 137.77 54.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 74.32 110.892 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.71 150.05 46.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 74.21 111.026 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -113.94 -32.78 5.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 71.43 110.977 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.43 137.82 4.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 63.23 110.873 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 7.7 mt -138.15 117.38 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 65.14 111.167 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -129.52 124.45 33.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 64.34 110.849 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.32 163.58 29.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 74.3 111.157 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -148.94 167.99 24.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 75.44 110.948 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.58 -72.19 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 72.55 110.9 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.99 40.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 75.01 110.84 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -69.9 156.71 38.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.446 . . . . 73.13 111.058 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.41 135.12 52.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 74.3 110.871 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.81 133.09 61.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 70.2 111.146 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -127.95 137.03 52.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 70.43 110.883 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 6.5 mp -125.85 118.28 25.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 74.1 110.905 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.62 -168.14 23.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.802 -0.713 . . . . 73.41 112.512 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -85.86 142.48 28.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.357 . . . . 74.22 110.926 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.68 120.58 57.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 62.13 111.171 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 5.5 p -122.08 120.19 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.13 111.147 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 11.0 t -74.1 165.67 24.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 71.42 111.142 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.92 76.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 50.03 111.09 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.33 74.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 73.52 111.064 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -54.06 -28.28 37.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 74.32 111.075 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 1.4 tt -88.16 132.13 34.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 72.41 110.927 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -176.77 -35.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 75.33 110.898 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 113.0 131.68 5.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.762 -0.732 . . . . 62.43 112.483 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 167.06 -26.56 0.15 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.744 -0.741 . . . . 54.41 112.51 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 37.4 mt 63.49 86.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 72.0 111.123 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -178.38 110.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 75.33 110.918 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 pp -150.18 174.11 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 64.25 111.097 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -178.92 131.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 73.25 110.908 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.88 142.42 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 72.04 110.85 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -174.11 40.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 63.54 110.958 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 27.6 m -100.96 126.86 47.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 73.23 111.176 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 4.4 t -92.65 133.48 35.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.51 111.151 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -126.56 129.77 49.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 73.34 110.887 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 12.9 t -132.98 123.58 26.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 64.02 110.77 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 10.3 p -105.86 135.21 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 74.53 111.211 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -77.71 -77.41 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 71.24 110.863 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 18.5 m -134.7 132.26 38.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.44 111.207 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 23.9 t -118.0 120.84 65.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 72.44 111.169 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.54 120.37 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 75.32 111.117 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.63 133.2 11.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.692 -0.766 . . . . 70.14 112.475 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -116.92 116.5 27.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.809 0.338 . . . . 74.43 110.94 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.96 83.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 63.3 112.505 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 66.5 119.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.826 0.346 . . . . 75.24 110.883 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 22.9 t -156.27 146.77 21.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 74.01 110.847 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -124.24 127.03 47.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 75.03 110.803 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 87.8 t -137.6 123.15 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 75.21 111.059 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.97 122.41 40.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 75.51 110.887 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 27.4 mm -112.55 103.68 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 74.22 111.137 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 152.05 -139.96 7.42 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.758 -0.734 . . . . 74.33 112.53 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . 0.425 ' ND2' ' H ' ' C' ' 243' ' ' ASN . 9.8 m120 -128.31 145.56 51.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 75.25 110.876 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.03 135.91 53.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 72.34 110.837 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.64 125.7 48.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 75.22 110.933 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 65.57 174.14 4.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 74.11 112.497 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 137.59 -6.94 3.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 71.01 112.521 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.37 70.93 0.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.367 . . . . 74.13 110.883 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 127.27 -109.33 1.06 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 62.4 112.507 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -121.58 -75.1 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.792 0.33 . . . . 64.3 110.883 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -96.06 -64.85 1.01 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 72.44 110.896 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -122.53 -41.95 2.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 73.1 110.871 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -177.82 -67.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 75.02 110.886 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 16.0 t60 61.78 85.19 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 74.01 110.848 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.82 -178.07 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 75.34 110.89 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -164.38 -178.79 5.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 71.11 110.803 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -155.03 160.78 41.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 65.33 110.817 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.83 -175.2 2.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 71.23 110.809 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 5.3 t60 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 75.22 110.857 -179.975 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 12.5 ttt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.781 0.324 . . . . 74.24 110.826 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -90.54 109.18 20.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 73.42 110.875 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 2.2 mp -105.66 118.65 53.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 61.52 111.054 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.67 -173.81 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 71.4 110.859 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -83.2 136.09 34.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 74.01 111.067 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 62.3 mt -82.57 121.53 35.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 73.24 111.091 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 33.4 m -74.18 -32.26 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 73.44 111.152 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 94.36 116.02 2.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.734 . . . . 65.44 112.442 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 4.3 mmt85 -137.19 -42.07 0.57 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.764 0.316 . . . . 75.3 110.878 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -140.08 119.58 13.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 74.43 110.898 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 58.8 m -129.87 141.79 50.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 73.15 110.911 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.95 146.54 49.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 64.24 111.108 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.26 -37.86 5.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 75.45 110.899 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -165.24 137.29 4.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.845 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.97 117.45 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.455 . . . . 73.04 111.189 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -130.73 126.1 35.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 75.35 110.855 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.22 164.02 28.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 75.34 111.156 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -144.61 168.6 19.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 74.33 110.828 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.54 -74.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 75.51 110.871 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.27 38.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 74.35 110.824 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -69.64 157.09 37.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.301 -0.409 . . . . 72.44 111.116 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.76 134.55 52.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 73.4 110.852 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 18.2 m -127.25 122.09 59.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 74.0 111.091 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.94 123.61 49.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 75.5 110.921 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.66 119.14 37.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 73.22 110.919 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 122.2 -168.14 14.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.773 -0.727 . . . . 72.21 112.522 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . 0.425 ' H ' ' ND2' ' B' ' 279' ' ' ASN . 2.7 t30 -86.14 149.71 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 63.34 110.94 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 78.9 t -126.35 122.19 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 72.3 111.126 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.63 129.27 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 74.43 111.099 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 12.8 p -78.68 165.07 24.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.491 . . . . 72.3 111.103 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.21 -34.0 76.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 75.53 111.071 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.81 -40.4 75.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 71.34 111.062 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.74 104.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 61.51 111.166 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -178.75 -69.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 63.31 110.883 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.03 -175.52 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 70.05 110.836 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 70.16 53.68 13.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.783 -0.722 . . . . 71.24 112.462 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 142.9 -52.4 0.64 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.685 -0.769 . . . . 64.11 112.466 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 32.8 mt 55.55 75.73 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.369 . . . . 75.31 111.146 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -167.5 98.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 73.41 110.936 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.59 135.53 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 74.31 111.159 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 1.6 t -177.66 158.67 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 74.44 110.838 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.4 145.06 1.6 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 75.51 110.846 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -146.91 29.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 61.11 110.908 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.26 137.55 32.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 73.52 111.148 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 96.1 m -105.41 131.38 52.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 75.52 111.178 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.05 136.99 53.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 64.33 110.831 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 46.5 t -142.11 123.8 15.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 74.42 110.911 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.0 p -106.15 138.28 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 74.43 111.139 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -78.49 -76.63 0.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 74.54 110.927 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 40.9 p -134.95 132.25 38.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.093 -0.503 . . . . 73.15 111.111 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.44 120.68 65.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 72.14 111.171 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.95 119.65 61.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 74.01 111.141 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.52 133.27 11.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.682 -0.77 . . . . 62.0 112.513 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -115.66 116.39 28.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.791 0.329 . . . . 73.43 110.919 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.49 86.52 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.731 -0.747 . . . . 52.41 112.493 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.68 118.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 74.34 110.91 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 37.4 t -157.22 149.1 22.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 70.25 110.818 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 -126.58 127.02 44.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 75.44 110.897 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 98.7 t -138.2 123.85 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 75.52 111.146 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.98 122.51 36.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 73.43 110.942 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 13.7 mm -112.4 104.18 16.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.262 -0.426 . . . . 72.02 111.077 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.02 -178.38 26.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.682 -0.77 . . . . 65.23 112.483 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -89.63 145.02 25.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.783 0.325 . . . . 73.34 110.889 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -120.43 125.79 48.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.52 110.896 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -115.55 140.13 49.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 74.3 110.939 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.55 59.12 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.71 -0.757 . . . . 54.24 112.473 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -68.29 87.29 0.19 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.75 -0.738 . . . . 61.42 112.441 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -58.66 98.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 72.14 110.967 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 62.95 104.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 64.41 112.457 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.83 -166.45 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.799 0.333 . . . . 74.52 110.872 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -50.62 -43.68 56.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 74.25 110.945 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -173.79 -170.03 0.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 72.05 110.824 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -144.73 -74.34 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 70.2 110.918 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.07 -171.51 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.899 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -98.29 -32.71 11.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 74.22 110.894 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.58 -177.36 4.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 70.24 110.808 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -157.53 132.7 8.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 74.14 110.848 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -166.76 113.07 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 75.44 110.865 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 74.41 110.838 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.808 0.337 . . . . 75.32 110.883 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.03 99.85 2.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.405 . . . . 71.44 110.921 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 2.2 mp -115.4 142.91 26.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.296 -0.411 . . . . 74.43 111.161 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -173.44 142.75 1.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 63.2 110.811 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . 62.12 102.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 74.21 111.094 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 4.2 mp -139.08 67.35 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 74.31 111.174 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 12.3 m -152.16 163.21 2.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.149 -0.478 . . . . 72.43 111.087 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 162.13 -179.34 37.52 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.7 -0.762 . . . . 62.34 112.507 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -54.66 -64.31 0.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.785 0.326 . . . . 74.05 110.887 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.59 121.94 27.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 70.41 110.844 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.68 137.85 45.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 71.43 110.82 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.13 133.31 45.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.052 -0.522 . . . . 75.23 111.072 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -96.9 -30.97 12.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 75.15 110.872 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -166.35 137.08 3.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 73.13 110.865 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 10.4 mt -139.48 117.07 11.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 75.33 111.081 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.4 126.38 38.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 74.22 110.885 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 2.1 p -135.81 164.36 28.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 75.44 111.147 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -145.57 168.76 19.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 72.23 110.921 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 73.35 -75.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 71.33 110.912 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.73 47.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 74.1 110.881 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -77.32 156.82 31.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 70.52 111.105 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.05 134.46 52.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 75.3 110.883 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 6.2 m -126.87 121.45 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 72.23 111.194 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.92 127.88 55.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 72.23 110.898 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.0 117.89 31.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 73.02 110.932 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.98 -166.89 21.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 44.54 112.479 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -98.85 128.95 45.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 64.14 110.934 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 95.5 t -102.8 124.97 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.14 111.152 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.08 128.0 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 64.25 111.199 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -69.63 175.03 4.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 65.23 111.235 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.43 97.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 62.11 111.056 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.17 -40.09 76.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 63.53 111.088 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 56.64 -175.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 71.13 111.142 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.91 115.13 10.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 74.35 110.94 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -101.67 27.0 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.786 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -112.4 -46.97 0.72 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.809 -0.71 . . . . 64.32 112.496 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -147.85 158.31 27.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 73.44 112.487 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 1.1 pt -92.24 148.42 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.84 0.352 . . . . 74.21 111.157 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.46 -170.3 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 73.41 110.836 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 29.7 mm 64.0 106.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 74.11 111.135 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.37 -170.54 1.66 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.103 -0.499 . . . . 54.21 110.878 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.85 178.96 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 75.44 110.791 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.92 25.36 0.49 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.138 -0.483 . . . . 74.12 110.834 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.18 129.52 46.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 71.24 111.138 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 29.2 m -96.39 120.81 37.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 65.04 111.099 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.66 135.93 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 71.23 110.897 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 3.8 m -142.16 124.92 15.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 72.34 110.798 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 7.2 p -104.95 122.04 57.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 75.15 111.125 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -56.38 -82.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.924 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 10.7 m -128.4 137.45 51.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.163 -0.471 . . . . 71.51 111.157 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 64.4 t -118.21 120.68 65.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 72.45 111.154 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 15.0 t -117.45 116.89 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 73.02 111.121 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.24 133.03 11.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.716 -0.754 . . . . 42.32 112.456 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.36 119.28 35.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.828 0.347 . . . . 72.14 110.866 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.09 78.52 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 75.42 112.459 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 68.76 125.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 75.24 110.904 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 12.8 t -156.52 160.59 39.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 73.55 110.891 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.21 127.04 32.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 75.12 110.879 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 89.8 t -137.76 123.64 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 73.11 111.188 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.73 124.12 37.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 74.21 110.934 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 20.0 mm -112.27 104.88 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.44 111.101 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.21 -144.21 11.83 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.753 -0.737 . . . . 73.11 112.507 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -123.51 139.99 53.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 75.52 110.893 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -111.89 134.27 53.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 73.54 110.962 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -125.42 125.11 42.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 73.43 110.897 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.3 -150.18 16.96 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.76 -0.734 . . . . 51.45 112.479 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 59.74 18.2 44.92 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.737 -0.744 . . . . 70.32 112.52 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 7.2 mttp 52.46 29.44 7.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.901 0.381 . . . . 73.22 110.93 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.77 127.59 6.14 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.735 -0.745 . . . . 64.34 112.423 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 t80 59.09 175.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.828 0.347 . . . . 71.32 110.88 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -51.47 -34.94 37.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 74.43 110.951 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -142.12 165.56 27.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 64.41 110.893 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -106.66 157.89 17.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 72.24 110.925 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -171.99 152.75 3.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 74.23 110.868 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -131.6 166.97 20.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 73.1 110.865 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -147.77 -65.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 64.43 110.82 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.62 134.21 34.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 74.01 110.857 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.36 130.31 40.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 75.12 110.906 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 74.34 110.82 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 1.3 tpt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.844 0.354 . . . . 71.2 110.864 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.58 116.87 29.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 74.02 110.877 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.64 175.41 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 74.2 111.148 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -177.57 79.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 75.23 110.828 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -178.19 130.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 72.55 111.081 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 6.7 tp -174.99 131.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 70.45 111.103 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 7.4 p -177.39 138.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 70.44 111.163 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -175.52 -176.97 44.21 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.776 -0.726 . . . . 72.12 112.535 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 45.5 mmt-85 -73.4 -57.26 4.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 72.54 110.913 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -83.76 116.39 22.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 64.01 110.92 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.22 143.07 50.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 72.52 110.895 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.82 136.22 48.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 64.35 111.146 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . 0.405 ' HG3' ' HA ' ' E' ' 265' ' ' GLU . 37.9 mttp -88.08 -41.72 12.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 75.5 110.879 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -173.44 138.52 0.7 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 72.11 110.873 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 5.8 mt -132.61 117.8 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 55.15 111.105 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.96 124.27 39.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 75.52 110.824 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 5.0 p -135.86 164.73 27.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 65.24 111.086 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -142.13 167.97 20.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.134 -0.484 . . . . 75.34 110.874 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 72.96 -75.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.804 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -179.76 71.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.13 110.857 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.64 157.02 17.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 62.42 111.095 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.15 134.29 53.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 73.4 110.964 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 4.9 m -128.96 121.81 55.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 72.43 111.075 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.96 129.7 56.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.914 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -115.25 118.24 32.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 75.12 110.988 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.55 -149.78 18.42 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.749 -0.739 . . . . 73.02 112.478 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -106.68 130.45 54.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.869 0.366 . . . . 74.21 110.877 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 84.4 t -105.89 127.4 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.168 -0.469 . . . . 73.3 111.134 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 5.0 p -122.68 124.34 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 72.21 111.169 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 8.8 t -70.03 169.64 12.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 72.42 111.129 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.83 -33.9 51.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 61.34 111.159 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.73 -52.1 66.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 75.43 111.108 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 61.76 -178.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 60.21 111.082 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.85 120.15 28.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 74.41 110.939 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -55.09 154.48 5.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 73.14 110.877 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 165.34 166.97 25.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 73.23 112.451 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -102.94 -72.77 0.94 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.702 -0.761 . . . . 54.43 112.475 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 16.9 tt -143.83 130.5 16.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 71.43 111.107 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.14 166.76 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 73.32 110.87 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 30.6 mm -126.27 134.48 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 73.3 111.16 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 3.7 m -59.38 -178.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 71.24 110.83 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.61 179.95 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 71.53 110.888 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -126.9 25.38 6.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 74.02 110.945 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 27.8 p -72.13 137.84 47.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 75.42 111.121 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.18 108.79 21.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.02 111.155 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.65 123.14 49.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 74.32 110.931 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 13.6 t -132.59 136.93 46.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 75.13 110.859 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.5 136.59 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.102 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . 0.405 ' HA ' ' HG3' ' E' ' 229' ' ' LYS . 4.0 tp10 -65.49 -105.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 75.24 110.937 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 85.5 m -117.11 138.05 51.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 73.44 111.152 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 73.8 t -117.78 118.23 57.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 73.34 111.149 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.22 114.56 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 75.24 111.091 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.58 131.59 10.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.704 -0.76 . . . . 74.01 112.467 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -114.43 124.29 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 73.42 110.841 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 57.47 68.15 1.85 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 63.1 112.457 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 67.46 129.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.846 0.355 . . . . 71.44 110.849 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 10.5 t -156.92 161.22 39.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 74.41 110.877 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -129.9 127.82 40.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.23 110.846 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 90.5 t -138.88 128.83 32.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 74.24 111.163 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.71 127.68 42.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 63.44 110.933 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 43.7 mm -112.23 118.19 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 72.24 111.128 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 121.63 -157.7 16.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 52.11 112.487 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -91.76 156.02 17.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 64.03 110.865 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -134.18 135.71 43.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 74.24 110.947 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -125.64 124.62 41.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 75.01 110.97 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . -121.76 175.26 16.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.782 -0.723 . . . . 65.14 112.505 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -94.98 7.65 70.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.73 . . . . 43.5 112.507 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.53 -44.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.833 0.349 . . . . 72.12 110.929 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 147.66 148.47 4.76 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.697 -0.763 . . . . 71.15 112.431 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 1.2 t80 56.45 -175.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 73.22 110.853 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -51.85 -30.71 24.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.136 -0.484 . . . . 75.33 110.892 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -153.55 -74.54 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 65.13 110.868 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 6.2 t30 56.69 -170.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 74.4 110.952 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -135.69 -169.99 2.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 75.5 110.846 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 2.0 t60 63.3 161.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 63.04 110.832 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.73 63.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.21 110.882 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -92.65 44.02 1.14 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 73.1 110.853 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -158.61 26.34 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 72.32 110.818 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 19.1 m170 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 73.32 110.839 -179.988 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.859 0.361 . . . . 74.02 110.89 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -147.38 119.97 8.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 74.25 110.884 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.7 tt -157.18 23.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 70.34 111.113 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.16 -170.09 0.16 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.21 -0.45 . . . . 75.23 110.883 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -170.39 -174.9 1.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 75.34 111.103 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 1.9 mp 62.11 46.65 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 74.54 111.142 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.2 t -150.23 142.63 17.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.15 111.134 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -52.74 135.27 38.61 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.751 . . . . 60.15 112.491 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -174.51 154.79 2.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.34 . . . . 72.05 110.893 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -127.78 122.59 33.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.52 110.906 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.54 138.58 54.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 71.44 110.836 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.32 119.92 11.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.066 -0.515 . . . . 72.32 111.1 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.83 -34.42 45.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.441 . . . . 74.51 110.879 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -165.55 138.81 4.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 72.44 110.928 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 36.5 pt -136.32 132.99 49.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 70.21 111.068 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -134.19 123.52 24.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 75.3 110.921 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -135.52 128.52 31.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 61.31 111.143 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -138.2 166.43 24.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 72.34 110.903 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 66.4 68.75 0.43 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 72.54 110.859 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 49.81 32.9 5.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 64.34 110.921 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.45 156.01 20.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 63.11 111.09 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -139.28 148.04 42.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.821 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -134.86 121.72 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 75.22 111.058 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.77 135.75 53.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.54 110.938 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 mp -130.09 118.87 22.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.914 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 140.81 177.42 16.15 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.741 . . . . 75.51 112.511 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -88.2 128.85 35.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 72.22 110.821 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.09 133.37 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 70.32 111.111 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.04 129.08 75.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 75.24 111.071 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t -72.93 164.02 27.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 73.13 111.182 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.93 -33.84 76.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 75.23 111.095 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.74 -35.89 69.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 73.2 111.097 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.02 -24.67 61.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 64.2 111.147 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 22.2 tp -51.94 103.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 71.43 110.975 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -162.95 -63.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 72.2 110.865 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -96.33 162.23 22.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.678 -0.772 . . . . 61.12 112.452 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.65 34.4 5.15 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.706 -0.759 . . . . 73.23 112.438 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 7.9 tp -56.95 -25.41 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 75.33 111.09 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 63.17 104.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 71.34 110.865 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 5.2 mp 61.24 93.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 74.33 111.183 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 77.8 p -102.32 26.5 7.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 64.24 110.88 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -137.19 -178.02 5.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 64.1 110.822 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.13 25.29 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 71.24 110.952 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 96.2 m -81.54 135.45 35.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 52.3 111.139 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.3 t -132.56 132.09 42.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 71.22 111.134 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -126.1 149.17 49.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 74.45 110.903 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.3 t -142.36 123.1 14.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 64.13 110.835 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.08 124.1 70.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 73.21 111.08 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.45 -70.65 0.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 74.14 110.85 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 95.1 m -131.63 128.29 38.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 63.1 111.166 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.23 125.19 71.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 75.03 111.208 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.58 135.64 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 74.01 111.103 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.43 133.81 7.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 54.02 112.427 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.08 148.34 52.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 72.25 110.902 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.7 88.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.75 -0.738 . . . . 72.3 112.468 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 43.26 57.42 3.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.879 0.371 . . . . 73.24 110.852 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.74 145.3 28.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 62.21 110.829 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.12 127.33 47.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 75.52 110.896 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 10.0 t -120.61 123.66 70.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 74.33 111.159 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.13 111.23 14.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 75.54 110.898 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.17 104.79 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 73.22 111.134 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.42 -161.65 26.93 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 74.14 112.493 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.62 156.18 21.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.301 . . . . 75.42 110.961 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -130.37 147.32 52.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.854 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -126.73 125.83 42.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 70.53 110.912 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 144.19 147.94 4.78 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.745 -0.741 . . . . 72.15 112.477 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -121.75 25.59 6.8 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 73.52 112.502 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 43.01 1.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 74.3 110.917 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 146.88 -19.85 1.61 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.836 -0.697 . . . . 75.52 112.549 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 11.3 t80 72.26 -68.93 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 72.53 110.84 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -141.91 -44.09 0.35 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 72.22 110.905 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.44 174.35 3.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 75.11 110.867 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -52.39 152.37 3.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 72.14 110.815 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.43 -170.89 3.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 74.42 110.905 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -83.24 -169.98 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 75.21 110.865 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -168.03 66.39 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.891 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -175.96 131.43 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 61.45 110.863 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.1 176.18 0.9 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 73.12 110.791 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.152 -0.476 . . . . 75.11 110.94 179.937 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.804 0.335 . . . . 62.12 110.921 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 -169.92 2.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 74.12 110.872 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 7.7 tt -51.67 123.84 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 72.4 111.103 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.17 -169.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 64.13 110.892 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.56 -169.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 64.02 111.114 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.52 -75.27 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 72.12 111.149 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 6.8 p -177.51 144.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.31 111.164 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -131.43 147.71 18.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 74.23 112.512 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.77 134.96 25.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.767 0.318 . . . . 71.31 110.791 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -142.21 128.5 19.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.879 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.95 137.62 54.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 71.14 110.843 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.35 119.99 12.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 73.45 111.091 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -34.8 52.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 75.43 110.849 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -165.67 136.56 3.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 71.14 110.868 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 27.6 pt -138.57 129.87 36.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 73.54 111.163 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.97 125.69 32.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 74.21 110.906 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 2.7 p -135.67 128.65 31.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 72.04 111.114 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -136.93 166.77 22.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 75.12 110.9 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 64.51 75.06 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 74.01 110.906 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 45.43 36.17 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.55 110.849 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.2 155.63 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 74.13 111.083 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -140.95 153.74 45.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 74.21 110.901 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 6.0 p -139.55 121.78 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 75.33 111.174 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -117.08 134.9 54.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 72.13 110.837 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mp -130.44 135.33 47.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 75.23 110.92 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.55 -124.86 3.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 73.13 112.514 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -145.49 131.38 19.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.915 0.388 . . . . 63.52 110.909 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 18.1 m -114.07 122.8 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 73.43 111.12 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 98.4 t -122.37 129.51 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 75.35 111.086 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -69.6 162.59 27.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 71.44 111.12 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.88 76.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 63.51 111.101 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.12 81.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 72.33 111.068 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.55 -32.88 29.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 71.43 111.11 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 47.3 mt -51.82 -45.06 63.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 75.22 110.918 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -104.93 141.24 36.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 72.51 110.853 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 153.26 -125.76 1.84 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.703 -0.761 . . . . 71.15 112.434 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 164.8 73.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.68 -0.771 . . . . 60.53 112.468 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 26.4 pt -146.12 136.95 18.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 74.31 111.157 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -78.24 136.2 37.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 72.53 110.88 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 32.4 mm -109.1 149.47 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.02 111.121 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.35 -175.18 5.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 72.5 110.868 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 13.6 t70 58.15 86.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 72.44 110.877 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.04 135.54 49.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 75.23 110.925 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 58.3 m -100.61 133.51 44.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 72.35 111.135 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 87.3 m -134.27 133.19 40.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 62.41 111.12 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -126.48 134.26 50.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 73.23 110.906 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 15.1 m -128.75 123.55 33.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 74.53 110.906 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.47 141.49 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 73.32 111.155 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.75 -57.63 3.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.86 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 72.3 p -150.2 126.83 10.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 74.0 111.171 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 12.2 p -123.81 135.11 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 73.14 111.11 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 60.5 t -127.14 132.91 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 75.54 111.161 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.79 134.58 8.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.781 -0.723 . . . . 72.12 112.541 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -132.96 148.59 52.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.744 0.306 . . . . 72.55 110.925 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.58 88.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.746 . . . . 54.14 112.451 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 45.18 62.72 2.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.387 . . . . 64.24 110.867 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 17.0 t -94.67 145.52 24.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 73.34 110.817 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.12 127.48 41.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 64.31 110.925 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 6.2 t -122.67 122.75 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.15 111.141 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.35 114.26 20.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.955 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.41 104.29 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.4 111.12 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.93 -163.48 26.97 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.691 -0.766 . . . . 71.55 112.519 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -110.64 156.18 21.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 53.44 110.841 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.38 145.72 50.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 64.21 110.891 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -123.06 125.84 45.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 71.22 110.916 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.63 147.11 4.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.666 -0.778 . . . . 74.43 112.449 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.74 -22.75 7.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 62.25 112.541 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -52.07 -29.71 22.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.729 0.299 . . . . 75.44 110.862 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -161.85 112.78 0.53 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.68 -0.772 . . . . 62.43 112.456 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -51.79 -29.82 20.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.842 0.353 . . . . 75.32 110.837 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -157.5 84.28 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.47 . . . . 75.11 110.935 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.2 t0 62.88 -169.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 64.24 110.842 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -64.24 123.1 18.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 62.01 110.897 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -156.29 26.98 0.35 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.888 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 52.47 -170.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 74.32 110.841 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -127.18 123.59 37.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 64.34 110.887 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -60.13 -175.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 71.5 110.857 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -170.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 62.24 110.834 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 22.3 m170 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.892 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.872 0.368 . . . . 72.42 110.927 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -120.78 -51.35 2.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 75.12 110.907 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 4.3 mp 62.22 82.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 74.53 111.122 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -117.35 71.28 0.8 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 73.12 110.853 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -167.76 39.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.52 111.095 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 1.2 pt -138.52 -179.32 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 71.4 111.082 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 86.8 t 60.53 92.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 75.53 111.148 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 103.57 44.77 1.63 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 73.34 112.512 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 69.2 mmt-85 -140.58 -167.85 2.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.845 0.355 . . . . 72.33 110.859 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -82.74 121.03 26.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 73.34 110.949 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.4 m -121.23 144.47 48.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 75.24 110.893 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.78 153.93 46.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 73.2 111.153 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.19 -34.75 4.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 71.41 110.948 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -165.09 139.3 4.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 64.33 110.877 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -136.02 117.2 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 71.34 111.052 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.91 115.86 21.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 74.44 110.903 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.78 128.8 39.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 70.34 111.087 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -137.65 166.42 23.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 75.14 110.944 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 61.48 74.43 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 71.33 110.909 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 45.38 49.94 10.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 74.42 110.817 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.24 147.11 27.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 71.31 111.114 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -134.54 141.16 46.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 71.34 110.885 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 5.7 p -135.01 121.55 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 75.33 111.138 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -116.27 124.68 50.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 74.54 110.896 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.38 118.98 36.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.21 -0.45 . . . . 74.51 110.852 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.41 179.94 17.73 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.745 -0.741 . . . . 73.13 112.455 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -89.66 150.06 22.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 71.01 110.886 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 33.2 m -127.97 129.33 69.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 71.15 111.133 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 89.2 t -122.2 129.45 75.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 74.54 111.129 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 13.2 t -69.92 175.17 4.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 73.31 111.172 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.37 -41.38 98.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 73.34 111.077 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.9 -52.54 64.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 64.35 111.12 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 52.2 26.94 4.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 70.04 111.072 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.9 -169.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 74.13 110.862 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -175.72 -53.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 72.54 110.879 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.57 -36.71 0.28 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 75.15 112.502 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -68.27 -151.8 0.35 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 71.51 112.47 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 3.8 mp -134.71 -41.14 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.339 . . . . 75.44 111.138 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 2.4 ptt-85 -125.63 163.65 22.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 75.51 110.896 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 45.4 pt -139.9 175.53 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 73.23 111.154 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 20.0 m -156.08 -74.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 71.24 110.898 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 59.73 97.62 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 72.03 110.86 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -117.99 81.23 1.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 75.33 110.922 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 7.6 p -100.98 122.4 43.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 74.21 111.16 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 88.8 m -100.55 114.78 28.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 74.13 111.151 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -126.29 144.35 50.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.933 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 47.3 t -139.03 123.02 17.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 62.33 110.818 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.11 126.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 72.34 111.097 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.83 -77.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 71.15 110.898 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 16.3 m -131.39 130.27 42.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 72.54 111.094 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.27 130.92 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 72.25 111.108 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.51 133.08 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 74.21 111.106 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -133.25 132.78 6.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.689 -0.767 . . . . 64.4 112.516 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -132.17 142.38 49.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 74.04 110.926 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.76 78.78 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.768 -0.73 . . . . 73.11 112.483 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 58.66 96.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.858 0.361 . . . . 75.32 110.883 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 14.1 m -134.42 145.39 48.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.44 110.867 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.01 128.13 35.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 75.35 110.897 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 7.2 t -125.84 123.6 64.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 65.55 111.082 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.06 117.29 25.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 72.43 110.908 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.84 131.01 65.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 74.23 111.158 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 123.44 -152.02 17.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.798 -0.715 . . . . 72.21 112.445 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -124.58 156.37 37.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.795 0.331 . . . . 73.31 110.877 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -121.03 139.04 53.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 72.14 110.852 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -123.41 126.43 46.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 73.14 110.934 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.84 -34.28 2.23 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 74.33 112.488 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 52.32 47.76 55.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.756 -0.735 . . . . 71.53 112.45 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 57.89 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 74.33 110.864 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.81 -79.21 0.8 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.719 -0.753 . . . . 75.54 112.454 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -179.4 108.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.805 0.336 . . . . 75.42 110.859 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 72.31 -68.92 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 74.33 110.976 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -111.74 147.95 34.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 73.52 110.904 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -52.22 151.57 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 74.31 110.891 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.68 -74.51 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 73.24 110.863 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.51 -169.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 74.23 110.849 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.08 -170.21 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.887 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -62.8 116.17 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 73.12 110.824 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -173.62 114.89 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 74.53 110.896 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.782 -179.953 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.875 0.369 . . . . 70.1 110.896 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.68 153.71 48.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 72.33 110.892 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 5.4 mp -143.03 144.11 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 74.44 111.179 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -145.59 87.98 1.82 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 74.25 110.852 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -170.88 44.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 63.33 111.063 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 26.4 mm -135.25 149.53 28.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 65.31 111.155 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 10.5 p -52.34 150.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 72.45 111.162 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -142.38 148.37 20.07 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.723 -0.751 . . . . 75.51 112.431 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -55.59 -30.08 60.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 71.21 110.867 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -142.13 128.46 19.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 73.52 110.884 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 3.8 m -121.68 139.61 53.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 74.01 110.822 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.63 129.84 37.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 71.34 111.084 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -97.5 -33.63 11.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 75.32 110.897 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.01 138.16 4.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 72.45 110.881 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.33 128.72 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 75.22 111.155 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -134.26 115.89 14.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.472 . . . . 71.44 110.908 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 3.5 p -129.82 149.59 51.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 73.13 111.147 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -156.98 166.71 32.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 72.13 110.883 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 63.26 67.56 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 71.14 110.87 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 36.6 mtt85 49.45 31.76 4.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 74.31 110.932 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.55 145.77 29.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 63.43 111.071 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -129.76 135.77 48.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 73.1 110.852 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 6.3 p -130.84 121.7 50.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 74.2 111.075 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -109.12 137.25 47.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.472 . . . . 74.51 110.928 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.72 118.61 28.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.12 110.913 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.41 177.85 15.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.769 -0.729 . . . . 70.1 112.509 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.82 149.36 23.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 64.43 110.927 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.94 132.49 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 72.43 111.14 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.83 129.41 75.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 74.42 111.075 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.3 t -70.09 174.89 4.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 70.45 111.105 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.5 83.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 72.42 111.074 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.93 -52.05 66.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 75.35 111.046 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 59.1 -169.79 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 73.02 111.18 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.66 108.53 0.4 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 75.24 110.913 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -52.31 157.49 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 75.24 110.837 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 71.04 -177.03 36.07 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.725 -0.75 . . . . 55.22 112.492 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -73.79 78.44 0.89 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.747 -0.74 . . . . 52.31 112.515 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 2.6 tt -170.07 144.63 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 71.22 111.125 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.45 -173.88 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 73.32 110.827 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 29.5 mt 63.94 106.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 73.31 111.152 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 4.8 p -85.34 -170.86 3.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 73.44 110.88 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.44 167.2 1.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 62.31 110.818 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -140.09 100.03 3.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 75.45 110.918 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 13.0 t -96.47 138.4 34.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 73.43 111.18 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.56 116.65 29.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 71.24 111.121 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.89 137.09 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 72.5 110.821 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.06 123.41 18.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 65.4 110.821 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.89 138.5 43.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 75.44 111.109 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.48 -52.47 7.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 74.1 110.916 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.96 129.35 12.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 74.33 111.099 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 1.2 t -118.35 130.62 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 74.22 111.183 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.49 127.75 69.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 63.53 111.146 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -131.06 133.94 7.5 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.763 -0.732 . . . . 65.25 112.473 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.1 148.89 52.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 72.41 110.916 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.34 89.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 71.43 112.468 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 43.75 59.69 2.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.887 0.375 . . . . 54.13 110.849 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 11.0 t -85.85 145.5 27.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 71.13 110.846 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.48 127.75 35.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 75.1 110.887 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.87 123.18 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 75.42 111.096 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.21 111.74 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 74.44 110.926 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 1.1 mt -107.88 110.96 33.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 75.42 111.136 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.08 174.7 13.47 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.777 -0.725 . . . . 71.05 112.49 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -89.87 144.91 25.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.358 . . . . 74.31 110.887 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -113.87 131.73 56.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 74.43 110.874 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -116.83 125.85 52.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 75.43 110.933 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 127.14 150.32 7.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.767 -0.73 . . . . 72.13 112.453 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 58.33 173.56 0.42 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.769 -0.729 . . . . 73.04 112.456 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.04 31.66 5.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.349 . . . . 73.22 110.885 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -112.54 -119.46 3.68 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.805 -0.712 . . . . 72.14 112.5 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -163.4 119.51 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 75.1 110.893 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 63.13 21.87 13.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.137 -0.483 . . . . 74.1 110.938 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.48 -169.7 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 63.42 110.813 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -105.3 -172.82 2.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 74.45 110.923 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -54.33 137.55 41.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 75.14 110.858 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -171.24 -174.97 1.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.875 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.03 -170.43 2.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 72.12 110.87 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -170.48 -175.74 1.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 61.21 110.854 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -149.3 -175.34 4.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 72.12 110.88 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 74.3 110.832 -179.913 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.853 0.358 . . . . 73.23 110.893 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -156.56 122.46 4.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 74.54 110.91 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 36.1 mt -143.48 148.38 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 74.41 111.11 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -154.77 176.55 12.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 75.4 110.905 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . 61.16 179.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 74.31 111.02 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 1.1 pt -113.46 107.34 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 63.32 111.139 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.9 148.0 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 74.44 111.104 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -76.35 -131.67 0.41 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.665 -0.778 . . . . 62.13 112.539 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 16.8 ptt-85 179.93 178.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 75.12 110.918 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -83.52 123.97 30.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 73.34 110.833 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.58 144.52 48.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 70.23 110.872 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.12 118.9 12.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 75.22 111.078 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' E' ' 265' ' ' GLU . 0.1 OUTLIER -79.09 -42.02 27.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 71.23 110.905 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -168.18 138.19 2.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 62.2 110.883 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 10.8 mt -129.11 117.07 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 72.25 111.089 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -119.12 115.1 23.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 75.24 110.858 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.61 128.27 32.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 72.44 111.192 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.35 162.26 33.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.878 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.54 76.55 0.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 62.41 110.885 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 43.66 42.09 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.877 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.98 142.61 27.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 74.52 111.171 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -125.42 137.67 54.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 74.34 110.902 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.5 121.92 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 75.43 111.1 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -112.88 137.48 51.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.92 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -120.34 118.27 29.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 71.34 110.912 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 123.5 169.14 13.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.727 -0.749 . . . . 71.51 112.472 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.65 146.0 27.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.929 0.395 . . . . 75.24 110.849 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 24.3 m -111.83 139.72 34.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 74.21 111.153 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 45.3 t -120.98 129.58 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 73.34 111.115 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.2 t -69.04 175.07 3.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.114 -0.494 . . . . 73.42 111.172 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.1 -44.83 79.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 63.43 111.163 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.06 -52.17 66.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 73.13 111.068 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 59.38 -177.7 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 74.13 111.118 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 10.2 tp -51.96 107.59 0.21 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 74.41 110.943 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -79.59 149.43 31.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 75.02 110.824 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.55 -58.57 4.45 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.732 -0.747 . . . . 52.45 112.485 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.48 -143.48 12.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.743 -0.741 . . . . 75.35 112.478 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 10.2 tt -175.33 130.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 72.4 111.135 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.62 152.53 18.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.889 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 13.8 pt -150.23 51.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 73.53 111.126 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.09 167.54 1.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 74.33 110.878 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -55.89 174.19 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 65.25 110.876 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -138.0 -75.07 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.955 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.0 t -101.11 137.34 39.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 74.15 111.134 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 99.1 m -92.5 111.59 23.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 74.11 111.173 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -124.63 119.6 29.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 71.41 110.956 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.76 120.1 30.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 74.42 110.852 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.4 p -111.52 137.4 44.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 72.42 111.09 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 3.4 tt0 -71.06 -95.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 73.43 110.852 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 93.8 m -119.8 126.2 50.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 72.5 111.167 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 3.5 p -116.07 120.1 63.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 74.24 111.136 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 39.9 t -117.94 119.21 60.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 71.41 111.089 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.51 133.52 9.55 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 74.44 112.502 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.57 147.91 45.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 72.2 110.897 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.6 89.63 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 64.11 112.489 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 41.59 77.58 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 63.41 110.886 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 6.2 t -105.48 145.18 31.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 74.23 110.838 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.06 128.23 49.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 73.42 110.935 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 85.1 t -132.98 123.96 49.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.44 111.129 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.51 125.82 41.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 73.14 110.942 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 20.9 mm -112.18 124.85 69.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 75.33 111.138 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 113.82 -170.97 13.55 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.682 -0.771 . . . . 50.04 112.458 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -102.68 155.98 17.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 75.42 110.914 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -121.81 132.67 54.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 74.33 110.856 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -115.35 125.16 52.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 73.14 110.868 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 162.39 -178.22 38.25 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.718 -0.753 . . . . 73.1 112.455 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -51.99 168.91 0.61 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.73 -0.748 . . . . 72.23 112.444 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -51.8 109.74 0.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.858 0.361 . . . . 73.22 110.897 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -164.71 118.98 0.84 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.704 -0.76 . . . . 75.4 112.491 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -59.72 -20.91 59.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 73.24 110.881 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -155.94 -49.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 75.55 110.951 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -112.66 -74.67 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 73.21 110.874 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -148.55 176.93 9.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 73.15 110.89 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -52.04 123.54 10.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 72.41 110.869 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -171.82 168.15 6.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.856 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -164.93 112.54 1.02 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 75.24 110.785 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -177.75 127.17 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 74.42 110.884 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -126.89 -68.58 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 71.43 110.861 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 28.6 p80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.878 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 2.8 mpp? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.88 0.372 . . . . 74.23 110.855 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.28 173.74 6.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 74.34 110.856 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.7 pt -147.93 -178.24 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 71.42 111.177 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -133.8 -170.68 2.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 74.21 110.867 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -104.72 168.23 9.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 60.34 111.074 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 34.8 mm -135.7 141.47 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 75.44 111.117 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.6 m -80.38 151.88 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 75.43 111.158 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.68 111.32 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.709 -0.758 . . . . 53.21 112.481 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 -142.67 95.89 2.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 72.54 110.863 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -83.95 111.64 19.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 75.31 110.872 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.77 150.72 41.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 51.01 110.826 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -144.0 119.1 10.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 72.23 111.122 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -76.05 -48.53 20.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 73.41 110.887 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -164.92 135.8 4.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 72.33 110.908 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 8.8 pt -139.3 134.36 40.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 72.44 111.154 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -130.93 138.54 49.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 75.34 110.853 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.07 147.14 47.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 71.13 111.133 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -134.04 167.02 21.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 71.41 110.869 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.43 -70.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 74.52 110.927 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.38 66.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 75.15 110.879 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -102.7 157.5 16.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 72.11 111.145 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.25 139.02 50.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 64.51 110.856 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.2 p -122.28 121.65 64.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 74.25 111.09 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.04 116.01 29.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 74.44 110.919 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.1 mp -111.99 118.61 35.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 63.54 110.903 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.32 160.79 8.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 60.51 112.476 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -85.77 134.75 33.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 62.24 110.835 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 17.8 m -106.69 133.63 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.476 . . . . 61.33 111.125 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 39.1 t -122.74 113.06 36.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 72.41 111.038 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 5.3 t -93.46 162.66 13.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 70.44 111.177 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.61 -33.88 64.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.186 -0.461 . . . . 72.4 111.069 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -35.91 69.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 61.31 111.122 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -58.75 102.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.45 111.137 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -177.45 -176.81 0.64 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 73.23 110.917 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -165.67 -68.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 70.43 110.845 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 151.07 -44.97 0.65 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.778 -0.725 . . . . 55.5 112.501 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -90.04 -147.26 16.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.727 -0.749 . . . . 72.13 112.445 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 42.6 pt -61.06 161.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.778 0.323 . . . . 74.42 111.16 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.8 ttm-85 -109.3 140.08 43.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.196 -0.456 . . . . 75.3 110.905 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 14.5 pt -132.39 178.7 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.1 111.162 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 19.2 p -177.93 164.33 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 54.12 110.836 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -96.89 -176.16 3.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 75.12 110.884 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -120.74 44.42 2.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.977 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.8 134.78 40.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 75.01 111.15 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.19 108.97 13.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 62.13 111.157 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -92.65 127.61 38.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 74.53 110.84 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.2 t -142.18 123.32 14.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 75.51 110.896 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 4.8 p -105.93 137.33 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.5 . . . . 52.21 111.175 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -88.74 -66.57 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 75.34 110.865 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 26.3 m -125.45 126.6 45.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 75.14 111.069 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.69 131.3 70.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 72.23 111.139 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 30.2 t -127.15 115.31 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.134 -0.484 . . . . 65.31 111.167 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.76 132.82 11.25 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 75.32 112.465 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 134.41 45.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 75.42 110.921 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.44 85.36 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.76 -0.733 . . . . 75.11 112.523 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 47.74 79.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.892 0.377 . . . . 64.32 110.958 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.47 145.05 30.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 75.33 110.887 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -113.4 128.44 56.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.877 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.18 123.67 53.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 74.34 111.11 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 25.5 tp -128.15 111.54 13.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.942 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 73.6 mt -109.23 103.92 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 63.02 111.123 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.53 -159.02 28.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.796 -0.716 . . . . 63.31 112.498 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -128.21 156.28 43.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 72.43 110.894 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -115.26 134.71 54.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 70.01 110.883 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -118.81 126.84 52.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 74.43 110.91 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.82 159.3 26.62 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.799 -0.715 . . . . 63.53 112.516 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -68.07 -130.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.811 -0.709 . . . . 72.24 112.475 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.62 28.19 16.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.77 0.319 . . . . 75.33 110.904 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 92.5 152.38 28.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.783 -0.723 . . . . 73.04 112.504 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -67.47 -35.05 78.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 73.02 110.899 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -174.96 -68.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 75.22 110.96 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -175.47 65.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 65.44 110.841 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -119.16 -43.67 2.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.425 . . . . 73.35 110.904 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 2.2 t60 63.41 105.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.493 . . . . 74.01 110.84 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -74.04 -169.83 0.83 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 73.01 110.891 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.54 -175.07 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.828 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 31.2 m80 63.14 103.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 74.52 110.877 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 59.09 76.61 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.05 110.855 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 22.0 m170 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 72.53 110.811 -179.982 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.852 0.358 . . . . 43.2 110.922 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.97 169.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 70.33 110.902 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 40.9 mm -71.16 -40.72 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 74.12 111.111 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.15 -171.55 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 61.2 110.886 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 62.26 179.06 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 73.34 111.128 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 5.2 tt -156.26 135.71 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 75.53 111.076 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 7.0 p -113.65 135.51 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 75.12 111.145 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.44 108.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.675 -0.774 . . . . 74.2 112.604 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.48 119.04 8.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 74.52 110.804 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -109.24 119.25 38.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 73.24 110.962 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.63 148.87 51.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.866 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -139.26 119.92 14.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 62.54 111.16 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.07 -44.58 30.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.812 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -165.75 134.89 3.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 64.24 110.799 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 7.6 pt -140.17 133.67 34.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 75.22 111.153 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.92 136.72 42.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 75.12 110.819 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.29 147.97 47.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 72.43 111.098 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -136.1 167.9 20.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 72.51 110.904 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.83 -71.47 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 71.14 110.861 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -179.3 62.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 75.34 110.937 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -102.3 157.19 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 71.33 111.115 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -129.85 135.26 48.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.829 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . . . . . . . . . 6.4 p -122.93 129.57 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 75.02 111.151 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? -120.11 124.73 46.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 71.4 110.901 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 4.5 mt -111.74 118.88 36.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 74.32 110.929 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.88 176.44 14.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.704 -0.76 . . . . 51.2 112.46 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -85.92 134.06 33.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.373 . . . . 64.42 110.876 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 1.7 t -104.69 115.25 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 74.34 111.111 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 44.7 t -106.91 122.76 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 63.15 111.13 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -96.14 163.26 13.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 72.4 111.19 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.73 -33.88 70.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 75.1 111.107 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -35.99 69.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 62.41 111.088 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -59.12 -41.44 88.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 64.31 111.134 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 6.9 mt 56.36 -177.91 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.42 110.928 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -125.39 70.81 1.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 75.41 110.816 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -61.69 -59.7 9.33 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 75.45 112.443 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 177.46 154.86 12.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.706 -0.759 . . . . 73.33 112.477 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 2.3 tt -52.47 133.18 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.824 0.345 . . . . 75.23 111.112 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.99 144.01 27.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 75.24 110.888 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.4 pp -55.18 155.57 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 74.44 111.094 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 14.8 p -161.34 144.11 12.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 73.22 110.833 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.14 175.61 0.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 74.24 110.86 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -110.58 81.74 1.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 74.21 110.882 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.85 137.57 32.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 72.02 111.161 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 96.4 m -131.82 122.33 25.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.286 -0.415 . . . . 74.24 111.162 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.79 124.98 50.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 74.3 110.947 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.2 t -141.95 123.68 15.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 75.13 110.841 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 4.4 p -106.41 137.72 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.477 . . . . 75.24 111.207 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -85.52 -72.67 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.882 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 19.0 p -122.24 126.48 48.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 72.51 111.111 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 46.1 t -118.28 127.77 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 71.35 111.157 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 58.5 t -127.17 115.23 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 72.52 111.113 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.3 133.19 11.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.74 . . . . 61.22 112.478 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -130.54 139.54 50.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.831 0.348 . . . . 75.13 110.892 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.67 85.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 64.44 112.482 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 45.76 74.34 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 71.44 110.908 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.69 145.68 26.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 72.32 110.872 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 11.0 mtm-85 -113.68 128.17 56.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 75.31 110.912 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 36.1 t -130.17 123.31 55.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 71.51 111.085 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 14.5 tp -128.12 111.32 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 74.51 110.914 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 4.5 mp -107.91 104.55 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 71.24 111.074 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.76 -173.55 27.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.694 -0.765 . . . . 74.22 112.445 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -110.33 154.52 23.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.732 0.301 . . . . 74.12 110.96 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -111.94 137.22 50.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 74.23 110.881 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.95 129.96 54.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 75.54 110.947 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 107.95 148.13 13.7 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.835 -0.698 . . . . 75.42 112.496 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -68.53 -132.4 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.743 -0.741 . . . . 75.42 112.5 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.7 tptp 62.11 35.54 15.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 75.41 110.865 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 74.89 141.71 0.79 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 75.14 112.464 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -75.44 111.26 10.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.85 0.357 . . . . 71.23 110.924 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 7.0 t90 52.12 29.91 7.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 73.31 110.877 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.53 94.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 74.2 110.923 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.88 -177.16 3.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 75.11 110.934 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -118.89 -176.64 3.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 75.34 110.833 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -84.51 -59.12 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 74.42 110.849 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 59.68 -170.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 74.42 110.911 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -123.38 151.83 42.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 64.44 110.886 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.33 157.1 23.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 75.15 110.862 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 63.12 110.879 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.8 0.333 . . . . 71.5 110.818 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.43 100.81 4.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 70.23 110.892 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 17.4 tt -174.74 144.03 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 73.12 111.141 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -178.18 130.38 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 62.32 110.874 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -173.42 124.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 74.53 111.15 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 2.0 pt -149.34 136.49 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.34 111.043 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 22.9 t 63.45 101.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.115 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -147.66 158.15 27.61 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.709 -0.758 . . . . 75.35 112.458 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -74.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.795 0.331 . . . . 73.25 110.822 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -83.89 110.83 18.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 74.11 110.885 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.99 148.13 52.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 72.31 110.892 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -135.21 124.48 24.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 64.22 111.089 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -42.61 16.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.443 . . . . 75.11 110.892 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -166.32 133.89 2.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 73.14 110.839 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 6.4 pt -140.65 132.07 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 72.3 111.216 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -136.1 135.64 39.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 72.24 110.888 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.67 150.82 48.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 71.24 111.146 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -139.9 168.7 19.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.33 110.931 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.68 -70.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.905 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -179.32 57.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 65.35 110.9 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -98.46 156.97 16.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 74.24 111.068 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -130.18 135.69 48.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.12 110.86 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.64 128.51 75.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 74.3 111.079 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -121.14 125.55 47.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 72.42 110.926 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.59 118.76 36.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 74.34 110.897 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.07 175.38 13.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.633 -0.794 . . . . 73.22 112.448 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -90.45 153.82 20.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.34 . . . . 63.42 110.948 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 20.1 t -119.83 116.83 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 75.31 111.155 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 48.7 t -108.96 115.33 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 75.23 111.109 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 12.1 t -69.86 175.11 4.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 75.43 111.145 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.31 -45.16 76.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 62.45 111.09 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.34 80.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 72.34 111.121 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.98 -169.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 74.44 111.148 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.96 176.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 75.22 110.873 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.09 -58.97 2.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 74.21 110.872 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -151.48 120.6 1.11 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.723 -0.751 . . . . 53.32 112.437 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -151.8 -173.73 21.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 72.24 112.529 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 13.2 pt -148.84 25.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.857 0.361 . . . . 73.43 111.166 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.46 -170.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 74.23 110.846 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 29.3 mt 64.16 82.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 71.2 111.073 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.21 157.63 1.38 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.876 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.67 -169.92 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.881 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -175.01 155.63 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 74.22 110.911 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 5.1 m -65.56 125.03 23.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 62.41 111.117 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 29.0 m -96.15 108.81 21.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 73.33 111.071 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.8 124.23 38.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.478 . . . . 73.33 110.844 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.06 123.21 14.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 73.54 110.828 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 4.1 p -107.38 139.21 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.081 -0.509 . . . . 73.21 111.15 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -89.56 -65.21 1.04 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 72.03 110.913 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 1.7 p -129.8 126.93 39.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.479 . . . . 74.23 111.132 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.04 126.57 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 64.5 111.155 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 83.4 t -123.07 115.31 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 63.12 111.166 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.37 131.96 10.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.701 -0.761 . . . . 62.15 112.58 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.24 136.29 45.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.786 0.327 . . . . 73.42 110.944 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.56 83.51 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.749 -0.738 . . . . 64.32 112.452 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 46.59 69.99 0.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 74.14 110.929 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.24 145.38 24.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 71.51 110.894 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -113.31 128.4 56.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 73.54 110.84 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 77.1 t -129.14 121.98 55.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 73.24 111.129 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 2.2 tp -128.86 111.17 12.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 73.42 110.906 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 2.7 mp -112.59 104.3 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 61.12 111.096 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.35 -179.46 27.07 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.653 -0.784 . . . . 74.32 112.451 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.34 156.08 18.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.316 . . . . 64.2 110.873 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.84 119.14 27.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 74.21 110.852 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -112.55 125.46 54.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 71.13 110.905 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.15 158.62 7.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 74.3 112.454 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -103.95 -161.85 24.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 71.05 112.503 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt 53.33 34.39 17.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 74.21 110.93 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 131.63 135.4 3.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.649 -0.786 . . . . 54.52 112.463 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -83.7 -26.18 30.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.348 . . . . 70.14 110.91 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 17.0 t90 -171.57 -42.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 73.13 110.919 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -114.43 97.55 6.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 75.11 110.841 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -55.44 171.7 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 74.25 110.904 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.41 -57.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 74.34 110.832 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.02 156.86 1.43 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 74.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -160.36 -179.94 8.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 72.34 110.821 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -98.3 177.4 5.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.459 . . . . 72.32 110.861 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 57.51 -170.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 72.12 110.91 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.272 -0.422 . . . . 74.41 110.797 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 1.2 mtm . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.863 0.363 . . . . 75.54 110.898 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 5.6 mttt 59.04 93.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 73.4 110.863 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 2.1 pp -142.28 -177.68 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 64.44 111.13 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -150.11 -74.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 75.12 110.845 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.82 165.51 2.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 74.45 111.045 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 3.9 tt -175.68 140.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 73.32 111.094 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 19.1 m -105.02 -175.66 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 64.35 111.151 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 146.83 -175.43 26.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 74.13 112.477 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -88.09 -55.0 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 75.21 110.864 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -99.88 117.75 34.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 75.53 110.84 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.72 151.97 49.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 72.33 110.837 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -142.36 129.85 21.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 74.13 111.087 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.47 -42.22 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 75.23 110.92 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -166.73 134.92 2.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.11 110.814 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 7.2 pt -141.02 133.01 29.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 73.11 111.117 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -135.7 136.45 40.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 72.22 110.894 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.86 146.35 45.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 72.05 111.099 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -135.19 168.79 18.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 73.4 110.89 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.12 -72.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 64.31 110.859 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.91 59.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 74.31 110.837 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.89 157.17 16.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 55.34 111.06 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.61 135.72 46.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 74.5 110.85 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 5.7 p -122.21 121.93 65.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 74.23 111.179 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -118.17 120.92 39.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.899 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.59 118.8 36.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.947 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.92 165.74 10.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.726 -0.749 . . . . 72.25 112.516 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -85.77 131.0 34.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 63.53 110.908 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 26.5 t -99.09 130.01 48.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 71.22 111.164 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.09 122.48 66.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 74.15 111.137 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.0 t -69.71 165.9 20.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.21 111.119 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.86 -36.38 62.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 73.42 111.16 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.96 -51.94 67.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 72.43 111.113 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 52.08 -170.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 71.24 111.114 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.18 121.58 14.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 71.3 110.906 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -72.11 145.28 48.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.31 110.839 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 111.6 142.36 8.83 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.708 -0.758 . . . . 72.14 112.503 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.66 -60.98 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.749 -0.738 . . . . 71.13 112.538 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 25.8 mm 63.55 76.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.358 . . . . 74.1 111.202 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 53.81 -170.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 70.55 110.878 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 1.2 pt -82.2 175.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 74.51 111.118 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 2.7 p -176.9 155.88 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 74.31 110.879 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -84.39 -177.85 6.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 64.05 110.849 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -172.33 -170.5 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.932 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.59 135.08 54.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 74.3 111.128 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 94.3 m -108.47 129.17 55.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.218 -0.446 . . . . 71.24 111.208 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.11 127.28 53.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.43 110.873 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 25.7 p -142.53 123.66 14.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 64.21 110.833 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 5.2 p -106.48 134.27 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 73.44 111.131 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -82.22 -77.14 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 72.45 110.849 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.61 126.88 53.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 75.23 111.19 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 94.9 t -117.62 124.76 73.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 73.42 111.168 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.5 114.22 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 72.44 111.163 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.71 133.04 10.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.749 . . . . 75.0 112.456 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.04 143.05 49.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 74.45 110.874 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.96 84.82 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 73.22 112.458 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 45.75 69.65 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.36 . . . . 72.31 110.932 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.4 144.53 25.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 73.4 110.873 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.01 128.42 56.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 72.33 110.866 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 76.6 t -127.41 122.17 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 75.23 111.132 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 2.5 tp -128.56 111.46 13.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 71.22 110.89 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 5.8 mt -112.42 104.13 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 75.31 111.098 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.78 -165.51 28.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.763 -0.732 . . . . 71.11 112.485 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -110.05 155.98 21.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.806 0.336 . . . . 72.42 110.899 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.02 131.5 53.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 73.02 110.842 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -124.84 125.73 44.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.129 -0.487 . . . . 74.21 110.929 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 145.27 179.46 21.58 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 51.1 112.487 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -100.62 -149.05 23.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 73.23 112.49 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.51 26.12 13.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 75.21 110.906 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.46 -156.99 15.23 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.721 -0.752 . . . . 52.5 112.503 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -116.54 -28.07 6.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.873 0.368 . . . . 73.03 110.892 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 14.8 t90 -164.01 59.44 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 65.41 110.928 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -137.7 -169.81 2.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 64.33 110.833 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -104.58 171.85 7.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 75.2 110.84 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -179.03 -169.86 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.493 . . . . 75.21 110.863 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -145.54 -50.22 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.449 . . . . 73.32 110.824 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 63.31 -171.14 0.17 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.425 . . . . 75.41 110.837 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -69.36 122.71 19.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 73.43 110.882 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -179.09 -179.17 0.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 73.52 110.889 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 28.2 p80 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 73.51 110.804 -179.988 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.81 0.338 . . . . 71.23 110.901 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -130.53 176.98 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.21 110.913 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.95 151.47 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.15 111.117 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.15 132.37 13.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 72.54 110.85 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -107.72 141.79 38.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.34 111.15 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.53 -24.88 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 75.14 111.06 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 21.6 t 63.79 106.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 75.44 111.133 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -149.14 -176.74 22.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.804 -0.712 . . . . 75.13 112.531 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -55.86 -71.07 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.341 . . . . 74.44 110.886 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -86.55 113.26 22.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 73.41 110.879 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.87 139.35 53.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 65.44 110.831 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.21 118.71 27.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 74.23 111.055 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -75.63 -45.62 36.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 71.21 110.911 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -168.35 135.97 2.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 65.14 110.841 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 8.9 pt -138.16 134.42 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 74.54 111.113 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -135.86 132.7 36.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.908 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.94 151.51 49.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.21 111.12 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.25 167.56 22.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 75.33 110.904 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 72.78 -69.95 0.18 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 73.41 110.9 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -178.5 63.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 72.41 110.869 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.86 156.3 18.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 63.33 111.074 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.15 135.61 47.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 72.41 110.889 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.0 126.47 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 75.11 111.195 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -122.71 123.05 40.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 73.32 110.834 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.85 118.7 36.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 74.42 110.914 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 134.56 169.32 11.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 73.3 112.52 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -85.87 145.41 27.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.849 0.357 . . . . 73.22 110.903 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.99 135.33 50.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.12 111.118 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 23.4 t -122.12 128.54 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 74.34 111.136 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -69.95 174.96 4.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 74.33 111.141 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.32 94.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 73.45 111.138 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.12 76.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 74.54 111.132 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 60.76 -175.44 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 65.11 111.134 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.82 -171.54 1.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 74.43 110.891 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -108.44 34.67 3.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 65.21 110.84 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 129.75 -172.33 20.05 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.688 -0.768 . . . . 72.2 112.501 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -174.54 140.31 5.32 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.665 -0.778 . . . . 61.24 112.479 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 2.8 mp -98.36 -61.83 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.763 0.316 . . . . 74.02 111.13 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -166.3 -40.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 64.32 110.84 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.57 135.63 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 72.13 111.158 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.67 -42.27 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 75.52 110.811 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.72 -173.97 4.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 75.32 110.798 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -156.8 25.8 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 71.21 110.869 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 1.5 p -92.29 129.95 38.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 74.02 111.151 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 92.4 m -109.63 121.5 45.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 64.15 111.09 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.24 119.01 33.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 74.51 110.877 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 98.7 p -133.19 133.24 42.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 74.45 110.871 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 1.2 p -104.46 153.44 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 74.5 111.112 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -92.22 -51.0 5.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.42 110.902 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 1.4 m -154.43 145.16 22.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 75.34 111.122 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 86.6 t -136.17 120.54 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 75.53 111.172 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 5.3 p -127.3 115.55 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 75.44 111.11 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.65 133.62 10.82 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.733 . . . . 72.41 112.456 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.57 144.5 44.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 74.13 110.913 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 42.27 76.14 0.12 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.722 -0.752 . . . . 54.04 112.522 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 64.04 116.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 64.03 110.877 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 12.1 m -146.41 145.25 30.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 74.43 110.802 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -114.62 127.69 55.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 74.42 110.86 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 275' ' ' VAL . . . . . . . . . . . . . 24.2 t -127.1 121.9 58.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 73.25 111.09 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.24 112.53 13.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.204 -0.453 . . . . 74.01 110.934 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 55.9 mt -112.26 104.56 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 74.12 111.141 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.46 -154.1 25.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.678 -0.772 . . . . 32.43 112.472 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -122.61 156.1 34.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 65.35 110.88 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -116.4 128.97 55.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 72.24 110.896 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -121.85 126.01 47.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 74.43 110.905 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 152.54 -176.51 30.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.705 -0.759 . . . . 72.22 112.448 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -51.99 148.75 10.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.761 . . . . 72.41 112.536 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? 72.28 -68.79 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 75.31 110.885 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.68 67.44 0.98 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 72.0 112.497 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -176.1 172.6 2.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.744 0.307 . . . . 62.55 110.93 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -51.47 -37.63 49.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.185 -0.462 . . . . 73.33 110.978 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -91.55 -173.57 3.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 72.1 110.861 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 63.1 163.77 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 74.15 110.909 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -169.4 -170.25 1.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 75.24 110.875 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -52.07 160.26 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 62.13 110.854 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.31 -174.72 3.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 71.24 110.876 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -148.65 156.44 42.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 71.44 110.815 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -62.55 -35.07 78.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 70.44 110.9 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 75.44 110.878 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.503 ' HB3' HG23 ' A' ' 261' ' ' THR . 1.6 tmm_? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.842 0.354 . . . . 64.53 110.899 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -83.94 114.16 21.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 62.22 110.858 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 2.6 m -133.97 144.42 48.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 64.34 110.853 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.86 ' HB1' HD11 ' A' ' 231' ' ' ILE . . . -129.05 127.27 41.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 73.24 111.076 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -42.96 37.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 73.43 110.952 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -164.99 138.34 4.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 63.23 110.906 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.86 HD11 ' HB1' ' A' ' 228' ' ' ALA . 3.1 mp -138.43 117.14 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 75.35 111.113 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.724 ' HD2' HG22 ' A' ' 268' ' ' VAL . 7.6 ptp85 -113.59 123.31 49.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 72.44 110.874 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.8 p -135.4 141.74 45.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 72.32 111.175 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.6 pm0 -149.2 167.69 25.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.4 110.886 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 68.56 68.85 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 75.21 110.89 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 47.43 55.68 7.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 65.24 110.844 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.4 156.78 17.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 44.43 111.064 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -125.79 142.77 51.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 73.15 110.896 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.482 HG23 ' CG1' ' A' ' 275' ' ' VAL . 5.4 p -142.99 131.28 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 61.0 111.127 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -138.02 137.26 37.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 73.13 110.89 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.604 HD12 HG13 ' A' ' 277' ' ' ILE . 0.3 OUTLIER -114.69 118.23 33.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.454 . . . . 62.43 110.876 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 146.67 -176.74 25.41 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.701 -0.761 . . . . 61.23 112.481 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -85.92 140.38 30.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.903 0.382 . . . . 64.0 110.882 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.49 ' CG2' HD11 ' A' ' 276' ' ' LEU . 30.1 t -111.82 115.33 49.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 75.33 111.146 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 64.7 t -103.96 128.84 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.41 111.136 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 72.24 111.121 -179.924 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.877 0.37 . . . . 72.31 111.115 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.503 HG23 ' HB3' ' A' ' 225' ' ' ARG . 84.7 m -92.03 120.36 32.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 64.53 111.157 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -101.75 119.52 38.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 74.34 110.931 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 17.6 t -142.06 123.98 15.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.43 110.806 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.548 HG21 HG22 ' A' ' 267' ' ' VAL . 8.9 p -110.75 137.77 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 73.34 111.107 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.44 -76.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 73.04 110.857 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 17.5 p -129.41 129.5 44.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 63.14 111.136 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.716 ' HB ' HG23 ' A' ' 231' ' ' ILE . 19.3 t -118.39 120.75 65.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 74.13 111.11 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.724 HG22 ' HD2' ' A' ' 232' ' ' ARG . 26.0 t -111.32 126.49 68.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 60.41 111.1 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.75 132.94 8.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.743 -0.741 . . . . 71.54 112.466 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.73 147.41 52.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.832 0.348 . . . . 73.25 110.87 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 59.66 71.76 0.72 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.713 -0.756 . . . . 63.43 112.451 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 50.06 61.05 3.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.886 0.374 . . . . 72.31 110.868 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 15.9 t -85.99 147.99 25.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 73.15 110.841 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -110.57 128.67 55.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 72.42 110.854 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.687 HG11 HG21 ' A' ' 231' ' ' ILE . 92.2 t -115.59 123.03 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 52.24 111.125 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.49 HD11 ' CG2' ' A' ' 244' ' ' VAL . 0.2 OUTLIER -128.53 111.74 13.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 64.42 110.888 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.604 HG13 HD12 ' A' ' 241' ' ' LEU . 18.1 mm -106.35 104.35 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 62.21 111.115 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.3 179.76 17.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.731 . . . . 75.32 112.48 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -89.84 156.04 18.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 73.41 110.879 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -130.31 140.29 50.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 71.12 110.868 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.453 ' CZ ' HG21 ' B' ' 245' ' ' VAL . 7.1 m-85 -119.24 126.01 50.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 73.42 110.9 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 161.08 142.55 3.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.731 . . . . 23.1 112.494 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.27 -18.83 10.62 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.733 -0.746 . . . . 64.34 112.491 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.4 79.33 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 70.34 110.888 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 67.22 112.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.768 -0.73 . . . . 64.52 112.483 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -52.32 111.52 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 72.11 110.877 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 3.1 t90 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.486 . . . . 70.23 110.931 -179.933 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.499 ' HB3' HG23 ' B' ' 261' ' ' THR . 4.5 ttm-85 . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.817 0.341 . . . . 74.34 110.919 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.696 ' HB3' HG22 ' B' ' 277' ' ' ILE . 1.2 m-20 -105.09 114.23 28.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 72.21 110.927 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.68 143.68 48.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 73.04 110.86 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.09 136.73 53.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 54.15 111.116 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.13 -36.28 16.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 64.21 110.927 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 230' ' ' ASP . . . . . 0.497 ' HB3' HG23 ' B' ' 266' ' ' THR . 26.6 t70 -165.12 137.74 4.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 72.14 110.848 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.593 HG21 HG11 ' B' ' 275' ' ' VAL . 7.7 mt -138.43 117.88 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 55.0 111.134 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -111.53 125.14 53.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 63.15 110.891 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 4.8 p -135.26 134.83 40.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.476 . . . . 72.05 111.148 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -150.94 167.4 27.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 74.3 110.92 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 66.98 64.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.864 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 77.9 mtm-85 50.46 55.34 9.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 71.31 110.869 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.04 156.57 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 64.4 111.126 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.27 140.79 52.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.87 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.556 HG23 ' HB ' ' B' ' 275' ' ' VAL . 3.0 p -132.62 130.43 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 72.02 111.139 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.714 ' C ' HD13 ' B' ' 241' ' ' LEU . 1.8 tm0? -136.6 130.85 32.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 72.05 110.956 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.714 HD13 ' C ' ' B' ' 240' ' ' GLN . 0.1 OUTLIER -118.54 117.9 30.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 72.44 110.973 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.56 175.85 23.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 34.55 112.508 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.88 128.87 34.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.836 0.35 . . . . 73.12 110.925 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -97.15 126.17 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 71.05 111.154 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.453 HG21 ' CZ ' ' A' ' 281' ' ' TYR . 93.4 t -122.11 112.89 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 61.04 111.111 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.457 HG23 ' O ' ' B' ' 281' ' ' TYR . 78.1 p -76.84 170.28 16.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 74.42 111.115 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.75 81.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 64.34 111.13 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.67 77.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 62.44 111.131 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 60.42 111.101 179.923 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.905 0.383 . . . . 73.15 110.908 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 15.1 t -100.77 137.27 39.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 71.13 111.119 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.499 HG23 ' HB3' ' B' ' 225' ' ' ARG . 23.7 m -98.45 110.76 23.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 71.11 111.172 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.44 ' ND2' ' HA2' ' C' ' 242' ' ' GLY . 70.9 m-80 -93.21 119.56 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 71.23 110.886 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 24.8 p -142.17 123.68 14.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 61.01 110.857 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.506 HG21 ' CG2' ' B' ' 267' ' ' VAL . 7.4 p -112.35 137.45 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 60.24 111.128 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.05 -76.78 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 60.53 110.849 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.497 HG23 ' HB3' ' B' ' 230' ' ' ASP . 1.2 m -133.71 130.69 38.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 74.04 111.127 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.506 ' CG2' HG21 ' B' ' 264' ' ' VAL . 21.7 t -118.52 120.53 64.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 73.3 111.148 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 30.4 t -105.04 121.41 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 63.25 111.11 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.47 132.94 10.61 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 52.54 112.449 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.95 147.3 52.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.351 . . . . 74.21 110.895 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.02 78.66 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 73.51 112.461 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 49.68 73.48 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.845 0.355 . . . . 73.35 110.907 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 14.8 t -96.66 147.84 23.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 74.34 110.881 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 24.2 mtm-85 -113.8 128.27 56.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 65.14 110.893 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.593 HG11 HG21 ' B' ' 231' ' ' ILE . 84.6 t -115.75 122.96 70.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 74.4 111.171 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.489 HD23 ' HZ2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -129.59 112.61 13.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 74.23 110.917 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 1.091 HD13 HD23 ' C' ' 241' ' ' LEU . 27.1 mm -109.44 103.98 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 70.01 111.145 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.16 -178.39 19.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 71.14 112.479 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -89.85 156.09 18.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.78 0.324 . . . . 71.2 110.858 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -126.8 139.1 53.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 72.34 110.862 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.457 ' O ' HG23 ' B' ' 246' ' ' THR . 2.0 t80 -120.9 125.87 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 74.24 110.913 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 161.76 149.91 5.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.734 -0.746 . . . . 61.04 112.517 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -105.25 -29.84 4.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 75.12 112.505 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -69.68 86.22 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 73.31 110.902 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 69.65 133.13 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.764 -0.731 . . . . 60.03 112.494 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -77.37 89.54 3.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.379 . . . . 64.32 110.858 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.489 ' HZ2' HD23 ' B' ' 276' ' ' LEU . 4.9 t90 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 73.52 110.956 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.568 ' N ' HG23 ' C' ' 261' ' ' THR . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.836 0.351 . . . . 74.24 110.88 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.678 ' HB3' HG22 ' C' ' 277' ' ' ILE . 0.7 OUTLIER -83.85 116.78 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 75.12 110.872 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.93 146.36 51.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 41.0 110.866 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.22 134.87 48.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 74.01 111.093 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.73 -34.66 21.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 64.4 110.887 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 230' ' ' ASP . . . . . 0.618 ' HB3' HG23 ' C' ' 266' ' ' THR . 4.4 t70 -165.52 137.57 4.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 64.02 110.885 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.537 HG21 HG11 ' C' ' 275' ' ' VAL . 8.7 mt -138.36 121.19 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 71.44 111.14 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 21.9 ttm-85 -111.57 125.5 54.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.814 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 3.8 p -135.1 131.74 37.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 74.34 111.157 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -147.82 167.77 23.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 74.11 110.836 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 63.36 72.71 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 75.43 110.898 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? 47.29 40.32 10.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 75.44 110.882 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.28 156.1 18.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 50.42 111.091 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -134.57 144.09 47.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 63.43 110.87 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.508 HG23 ' CG1' ' C' ' 275' ' ' VAL . 3.5 p -130.66 121.88 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 74.52 111.15 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.719 ' C ' HD13 ' C' ' 241' ' ' LEU . 2.5 tm0? -124.81 126.68 45.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 71.53 110.938 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 1.091 HD23 HD13 ' B' ' 277' ' ' ILE . 0.1 OUTLIER -117.35 117.43 29.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 74.53 110.911 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.44 ' HA2' ' ND2' ' B' ' 262' ' ' ASN . . . 153.35 176.23 25.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.771 -0.728 . . . . 61.32 112.519 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -85.89 128.75 34.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 62.03 110.911 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.91 128.18 46.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 75.22 111.088 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.44 113.43 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 52.52 111.129 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 23.3 p -69.67 169.03 13.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 75.31 111.115 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.17 93.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 71.33 111.043 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.06 82.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 63.05 111.075 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 63.12 111.08 179.955 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.84 0.352 . . . . 53.31 110.922 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 260' ' ' THR . . . . . 0.675 HG21 ' HB3' ' D' ' 243' ' ' ASN . 8.6 t -70.87 131.45 43.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 61.02 111.15 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.568 HG23 ' N ' ' C' ' 225' ' ' ARG . 0.2 OUTLIER -101.41 139.66 36.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 73.32 111.166 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -124.5 128.65 49.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 64.54 110.836 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 5.5 p -141.56 123.77 15.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 75.24 110.887 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.494 HG21 ' CG2' ' C' ' 267' ' ' VAL . 7.5 p -111.27 137.65 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 74.25 111.132 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.58 -76.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.167 -0.469 . . . . 73.45 110.908 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 266' ' ' THR . . . . . 0.618 HG23 ' HB3' ' C' ' 230' ' ' ASP . 0.2 OUTLIER -130.72 130.53 43.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 44.43 111.144 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.494 ' CG2' HG21 ' C' ' 264' ' ' VAL . 19.5 t -118.64 129.6 74.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 75.15 111.146 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.68 119.06 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 52.33 111.149 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.39 132.47 10.34 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.767 -0.73 . . . . 52.33 112.488 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -134.05 147.58 50.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.361 . . . . 71.21 110.871 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.39 87.2 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.717 -0.754 . . . . 45.02 112.482 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 45.66 64.4 1.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 74.51 110.915 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 4.1 t -88.27 145.78 25.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 60.44 110.871 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 4.0 mtm-85 -117.45 127.8 54.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.505 . . . . 71.22 110.851 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.537 HG11 HG21 ' C' ' 231' ' ' ILE . 83.9 t -116.13 123.5 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.42 111.108 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.532 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.3 OUTLIER -128.5 113.65 15.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 73.01 110.861 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 1.026 HD13 HD23 ' D' ' 241' ' ' LEU . 24.7 mm -112.14 104.41 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 73.04 111.132 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.36 -175.08 22.19 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.753 . . . . 72.53 112.512 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -94.47 156.22 16.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.846 0.355 . . . . 72.14 110.861 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.407 ' CG ' HG13 ' D' ' 244' ' ' VAL . 6.7 pt-20 -126.8 138.04 53.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 72.24 110.887 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -120.63 125.11 46.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.472 . . . . 75.12 110.923 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 164.84 147.7 5.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.752 -0.737 . . . . 73.23 112.503 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -80.77 -48.99 5.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.749 -0.739 . . . . 73.41 112.509 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -51.67 103.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.357 . . . . 65.44 110.868 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 53.69 -147.36 19.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 53.43 112.473 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -122.35 -35.31 3.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 64.14 110.859 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.532 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 13.2 t90 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 72.51 110.891 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 225' ' ' ARG . . . . . 0.569 ' HA ' HG23 ' D' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.808 0.337 . . . . 74.25 110.856 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 226' ' ' ASN . . . . . 0.749 ' HB3' HG22 ' D' ' 277' ' ' ILE . 2.0 m120 -84.31 114.52 21.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 63.44 110.911 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 3.8 t -134.5 142.71 47.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.41 110.809 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 228' ' ' ALA . . . . . 0.583 ' CB ' HD11 ' D' ' 231' ' ' ILE . . . -129.29 119.99 24.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.505 . . . . 50.24 111.1 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -34.42 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 63.14 110.892 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -166.12 137.51 3.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 61.52 110.865 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 231' ' ' ILE . . . . . 0.583 HD11 ' CB ' ' D' ' 228' ' ' ALA . 6.3 mt -138.58 121.69 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 71.43 111.151 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -111.45 126.15 54.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 74.12 110.843 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 233' ' ' THR . . . . . 0.439 HG21 ' HB ' ' D' ' 239' ' ' VAL . 5.8 p -135.16 130.57 35.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 61.21 111.141 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -146.44 166.84 25.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 71.34 110.9 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 64.99 71.05 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 74.23 110.925 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.33 34.88 4.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 75.34 110.893 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.89 154.21 23.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 71.44 111.13 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.49 144.43 51.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 74.32 110.899 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.522 HG23 ' CG1' ' D' ' 275' ' ' VAL . 6.0 p -131.51 121.91 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 62.31 111.11 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 240' ' ' GLN . . . . . 0.694 ' C ' HD13 ' D' ' 241' ' ' LEU . 2.4 tm0? -125.58 125.78 43.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 74.11 110.915 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 1.026 HD23 HD13 ' C' ' 277' ' ' ILE . 0.1 OUTLIER -117.51 118.01 31.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 61.15 110.872 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.01 179.48 26.78 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.752 . . . . 25.21 112.454 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 243' ' ' ASN . . . . . 0.675 ' HB3' HG21 ' C' ' 260' ' ' THR . 6.6 p30 -86.02 133.54 33.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.902 0.382 . . . . 64.15 110.88 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 244' ' ' VAL . . . . . 0.407 HG13 ' CG ' ' C' ' 280' ' ' GLU . 19.9 t -103.67 114.95 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 72.11 111.137 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 245' ' ' VAL . . . . . 0.416 HG23 ' OD1' ' D' ' 243' ' ' ASN . 21.8 t -110.76 120.7 62.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 71.41 111.168 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 9.6 p -76.56 167.17 22.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.14 111.125 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.26 79.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 72.43 111.109 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.38 -38.25 73.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 55.41 111.046 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 54.44 111.101 179.956 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 14.3 t . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.89 0.376 . . . . 64.12 111.121 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 261' ' ' THR . . . . . 0.569 HG23 ' HA ' ' D' ' 225' ' ' ARG . 26.8 m -106.68 108.85 20.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 63.3 111.166 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 262' ' ' ASN . . . . . 0.409 HD22 ' N ' ' D' ' 263' ' ' SER . 0.1 OUTLIER -100.02 130.53 46.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 72.35 110.885 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 263' ' ' SER . . . . . 0.409 ' N ' HD22 ' D' ' 262' ' ' ASN . 5.5 t -140.95 123.76 16.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 42.43 110.867 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.616 HG21 HG22 ' D' ' 267' ' ' VAL . 7.9 p -108.26 141.34 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 65.42 111.126 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -81.07 -76.65 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 75.23 110.9 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.49 128.26 46.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 61.41 111.192 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.616 HG22 HG21 ' D' ' 264' ' ' VAL . 17.8 t -118.5 135.05 60.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 73.2 111.126 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 50.7 t -126.41 126.32 68.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.145 -0.479 . . . . 40.51 111.109 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.07 132.42 8.08 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.729 -0.748 . . . . 70.03 112.504 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -133.51 147.3 51.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.828 0.346 . . . . 64.44 110.931 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.19 89.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 75.15 112.469 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 44.06 59.73 3.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 75.35 110.895 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 17.1 t -83.84 145.41 28.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 40.04 110.861 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -118.1 128.09 54.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 75.55 110.883 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.542 HG11 HG21 ' D' ' 231' ' ' ILE . 92.0 t -119.44 122.02 67.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 71.24 111.135 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.451 HD21 ' OE1' ' D' ' 240' ' ' GLN . 0.2 OUTLIER -129.77 112.11 13.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 71.02 110.949 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.749 HG22 ' HB3' ' D' ' 226' ' ' ASN . 28.3 mm -112.68 104.34 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 71.23 111.106 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.6 -174.24 26.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.678 -0.772 . . . . 75.05 112.509 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -100.37 156.11 17.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.332 . . . . 61.34 110.889 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 280' ' ' GLU . . . . . 0.543 ' CD ' HG13 ' E' ' 244' ' ' VAL . 2.1 pt-20 -121.72 118.9 30.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 64.44 110.905 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 281' ' ' TYR . . . . . 0.492 ' OH ' ' HB2' ' E' ' 249' ' ' ALA . 17.9 t80 -112.42 136.66 51.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 60.01 110.918 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 135.67 175.71 13.98 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 51.32 112.475 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 283' ' ' GLY . . . . . 0.617 ' CA ' ' HB2' ' E' ' 247' ' ' ALA . . . -107.89 107.69 2.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 62.33 112.463 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -166.07 28.05 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 64.04 110.889 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 76.39 -66.48 2.63 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.76 -0.733 . . . . 42.52 112.479 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 286' ' ' PHE . . . . . 0.734 ' CE1' HG21 ' E' ' 244' ' ' VAL . 59.8 t80 -174.98 156.74 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 62.32 110.866 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 33.8 t90 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 72.45 110.903 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.458 -0.048 0 CA-C-O 120.844 0.354 . . . . 54.12 110.884 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 226' ' ' ASN . . . . . 0.642 ' HB3' HG22 ' E' ' 277' ' ' ILE . 5.2 m120 -83.78 113.72 21.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 71.43 110.9 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 73.3 m -131.05 144.74 51.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 72.15 110.864 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 228' ' ' ALA . . . . . 0.489 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -125.78 134.63 51.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 74.34 111.086 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.13 -37.1 16.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 64.12 110.881 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -164.98 136.98 4.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 71.21 110.876 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 231' ' ' ILE . . . . . 0.494 HG21 HG11 ' E' ' 275' ' ' VAL . 9.8 mt -138.78 119.65 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 63.02 111.171 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -111.23 124.88 53.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 62.43 110.884 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 8.4 p -135.07 132.9 38.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 73.31 111.127 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -152.8 166.6 31.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.21 110.927 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 65.14 69.42 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 74.4 110.907 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.47 53.67 12.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 75.03 110.888 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.66 155.91 18.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 41.44 111.119 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 -131.3 135.94 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 50.3 110.847 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.549 HG23 ' HB ' ' E' ' 275' ' ' VAL . 4.0 p -125.99 129.71 72.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 73.31 111.175 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -137.62 135.66 36.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 53.31 110.912 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' D' ' 277' ' ' ILE . 2.0 mp -129.99 118.54 21.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.35 110.918 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 155.25 176.64 27.68 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 54.4 112.505 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -88.95 128.66 35.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 62.54 110.914 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.734 HG21 ' CE1' ' D' ' 286' ' ' PHE . 93.1 t -98.75 123.1 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 60.04 111.14 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 245' ' ' VAL . . . . . 0.493 HG13 ' HD2' ' E' ' 281' ' ' TYR . 21.8 t -122.17 117.14 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 65.2 111.134 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.9 t -68.11 174.98 3.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 62.42 111.117 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 247' ' ' ALA . . . . . 0.617 ' HB2' ' CA ' ' D' ' 283' ' ' GLY . . . -61.05 -32.3 71.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.453 . . . . 74.41 111.081 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.12 -35.25 61.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 54.32 111.137 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 249' ' ' ALA . . . . . 0.492 ' HB2' ' OH ' ' D' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 60.42 111.088 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 90.6 m . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.789 0.328 . . . . 73.54 111.151 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -126.16 134.41 51.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 74.22 110.866 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.86 123.93 15.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 45.33 110.871 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 264' ' ' VAL . . . . . 0.538 HG21 ' CG2' ' E' ' 267' ' ' VAL . 11.4 p -108.2 140.72 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 62.35 111.129 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -81.16 -76.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 72.13 110.903 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.6 m -138.03 129.49 27.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 64.34 111.139 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 267' ' ' VAL . . . . . 0.538 ' CG2' HG21 ' E' ' 264' ' ' VAL . 23.7 t -118.14 120.5 64.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 74.41 111.108 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 52.0 t -104.64 115.82 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 54.13 111.157 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.93 132.58 11.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.743 . . . . 23.24 112.462 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.25 144.25 49.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 74.15 110.943 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.42 87.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.73 . . . . 75.41 112.481 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 48.86 74.84 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 50.33 110.865 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 36.7 t -100.79 145.8 28.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 60.45 110.826 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.66 128.66 54.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 73.2 110.847 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.549 ' HB ' HG23 ' E' ' 239' ' ' VAL . 87.5 t -117.7 122.68 70.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 75.2 111.144 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 276' ' ' LEU . . . . . 0.442 HD21 ' HZ ' ' D' ' 286' ' ' PHE . 0.4 OUTLIER -129.05 111.72 13.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.942 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.642 HG22 ' HB3' ' E' ' 226' ' ' ASN . 37.2 mm -113.39 104.31 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 61.51 111.091 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 138.89 -172.72 22.98 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.713 -0.756 . . . . 73.43 112.484 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 279' ' ' ASN . . . . . 0.452 ' H ' ' ND2' ' E' ' 279' ' ' ASN . 1.8 p30 -89.02 154.12 20.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.802 0.334 . . . . 65.11 110.843 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -128.29 130.14 47.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 65.33 110.93 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 281' ' ' TYR . . . . . 0.493 ' HD2' HG13 ' E' ' 245' ' ' VAL . 1.3 t80 -132.41 121.76 23.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 64.24 110.946 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.68 -0.771 . . . . 72.11 112.447 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.836 0.35 . . . . 75.5 110.863 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -98.31 124.31 42.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 74.31 110.888 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.23 137.85 54.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 72.53 110.82 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.29 123.32 15.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 65.24 111.066 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -84.92 -36.79 21.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.446 . . . . 73.05 110.865 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -164.18 139.29 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 64.43 110.871 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 13.0 mt -137.01 117.68 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 70.22 111.182 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -120.19 115.76 24.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 64.24 110.86 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.23 132.93 47.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 73.24 111.206 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -138.27 157.08 46.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 72.24 110.883 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.468 ' O ' ' C ' ' A' ' 236' ' ' ARG . 6.3 tt0 65.13 88.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 71.44 110.883 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.468 ' C ' ' O ' ' A' ' 235' ' ' GLU . 0.0 OUTLIER 31.68 52.55 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 74.52 110.903 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.79 145.59 24.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 72.31 111.113 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -125.76 136.71 53.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 75.13 110.908 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.602 HG12 ' HB ' ' A' ' 275' ' ' VAL . 6.9 m -142.5 121.75 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 71.12 111.089 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.26 137.25 54.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 64.25 110.849 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.68 122.05 26.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.196 -0.456 . . . . 71.23 110.968 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.85 -115.83 0.88 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 52.42 112.523 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -145.44 128.96 17.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 74.5 110.879 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.416 HG23 ' HA ' ' A' ' 280' ' ' GLU . 20.9 m -111.79 127.68 68.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 64.42 111.083 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.1 t -122.24 129.08 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 71.12 111.124 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 64.2 111.125 -179.945 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 30.8 p . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.883 0.373 . . . . 61.24 111.145 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -107.75 108.98 20.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.14 111.126 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -94.18 124.97 38.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 55.21 110.907 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.99 123.82 15.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 34.34 110.904 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.631 HG21 HG22 ' A' ' 267' ' ' VAL . 10.4 p -118.66 135.78 57.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 72.42 111.103 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 -75.29 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.469 . . . . 71.21 110.847 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.4 m -123.46 130.29 52.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 71.31 111.108 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.631 HG22 HG21 ' A' ' 264' ' ' VAL . 33.7 t -118.12 129.83 73.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 63.21 111.112 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 36.7 t -127.68 124.83 64.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 71.32 111.114 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.01 134.02 8.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 73.5 112.47 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -132.8 141.68 48.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.78 0.324 . . . . 72.22 110.92 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 57.29 85.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 41.43 112.485 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 44.0 60.56 2.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.827 0.346 . . . . 75.3 110.902 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 11.0 t -83.92 145.36 28.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 61.44 110.93 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 3.3 mpp_? -129.49 127.25 40.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.887 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.602 ' HB ' HG12 ' A' ' 239' ' ' VAL . 17.6 t -137.06 124.01 30.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 63.31 111.13 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.0 111.16 17.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 72.21 110.901 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.674 ' CD1' HD13 ' B' ' 241' ' ' LEU . 30.5 mm -103.3 104.63 16.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 73.53 111.11 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.24 -163.61 28.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 53.21 112.467 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -103.43 155.92 18.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 72.13 110.844 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.6 ' HG3' HG12 ' B' ' 244' ' ' VAL . 2.0 pp20? -129.93 147.32 51.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.12 -0.491 . . . . 72.34 110.922 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -129.69 125.84 36.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 73.23 110.927 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 165.69 -86.14 0.1 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.705 -0.76 . . . . 70.13 112.506 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 127.75 -97.79 0.47 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.76 -0.733 . . . . 52.21 112.51 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -51.73 127.85 21.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.794 0.33 . . . . 73.24 110.895 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 93.72 -33.22 5.31 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.753 -0.737 . . . . 52.42 112.474 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.39 -174.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.373 . . . . 74.02 110.865 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 19.3 t90 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 75.33 110.91 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.728 ' CB ' HG23 ' B' ' 261' ' ' THR . 1.7 mtt-85 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.714 0.292 . . . . 72.13 110.913 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.412 ' ND2' ' HA2' ' B' ' 242' ' ' GLY . 1.2 m-80 -106.61 115.63 30.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.42 110.897 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.91 137.93 54.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 63.44 110.779 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.16 129.38 29.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 55.04 111.118 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 4.8 tttm -88.88 -36.32 16.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 62.32 110.869 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 230' ' ' ASP . . . . . 0.456 ' HB3' HG23 ' B' ' 266' ' ' THR . 0.6 OUTLIER -164.4 139.16 5.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 51.11 110.869 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.513 HD13 HD11 ' B' ' 241' ' ' LEU . 13.6 mt -137.31 117.84 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 75.41 111.075 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -127.03 119.65 27.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 63.32 110.84 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.52 140.36 48.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 65.42 111.149 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -140.35 164.38 30.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 72.52 110.874 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' B' ' 236' ' ' ARG . 2.2 tt0 64.07 72.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 74.53 110.809 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' B' ' 235' ' ' GLU . 19.5 ptt-85 37.19 63.43 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 64.12 110.854 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.56 155.06 19.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 34.51 111.107 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.96 135.32 48.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 64.03 110.854 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.56 HG23 HG13 ' A' ' 275' ' ' VAL . 21.0 m -143.11 121.9 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 64.53 111.147 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -118.37 137.26 53.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.33 110.845 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.674 HD13 ' CD1' ' A' ' 277' ' ' ILE . 5.2 mp -125.02 118.54 26.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 72.35 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.412 ' HA2' ' ND2' ' B' ' 226' ' ' ASN . . . 143.02 -177.64 21.81 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.739 -0.743 . . . . 60.03 112.473 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.93 139.0 31.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 73.42 110.905 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.6 HG12 ' HG3' ' A' ' 280' ' ' GLU . 27.3 m -116.82 127.49 74.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 64.32 111.139 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 54.2 t -117.5 129.28 74.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 70.42 111.088 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.533 HG21 ' HB2' ' B' ' 284' ' ' LYS . 0.7 OUTLIER -80.18 162.81 24.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 63.35 111.191 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.14 79.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 73.51 111.075 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -62.55 -41.71 99.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.306 -0.407 . . . . 75.05 111.104 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 70.11 111.128 179.87 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.854 0.359 . . . . 74.31 110.881 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 86.3 m -95.4 122.92 38.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 61.02 111.131 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.728 HG23 ' CB ' ' B' ' 225' ' ' ARG . 5.4 m -94.6 108.84 20.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 65.23 111.149 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.59 127.72 42.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 62.31 110.927 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 63.9 p -142.03 123.99 15.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 73.14 110.898 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.556 HG21 HG22 ' B' ' 267' ' ' VAL . 8.8 p -115.18 136.83 50.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 55.35 111.062 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.26 -75.71 0.22 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.117 -0.492 . . . . 74.54 110.862 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.456 HG23 ' HB3' ' B' ' 230' ' ' ASP . 1.7 m -127.4 130.8 50.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 61.2 111.147 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.556 HG22 HG21 ' B' ' 264' ' ' VAL . 28.6 t -118.32 128.29 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 72.03 111.129 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.56 120.43 54.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 70.02 111.1 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.88 133.69 8.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 74.4 112.46 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -133.09 148.02 52.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 74.42 110.893 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.63 76.58 0.19 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.708 -0.758 . . . . 42.43 112.476 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 48.35 62.19 2.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.342 . . . . 73.24 110.924 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 32.6 t -87.43 145.67 26.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 75.55 110.879 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.74 127.38 43.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 73.34 110.937 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.65 HG13 HG23 ' C' ' 239' ' ' VAL . 10.0 t -135.59 124.07 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 74.43 111.148 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.46 116.53 26.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.471 . . . . 61.34 110.872 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 29.0 mm -107.72 135.09 47.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 61.23 111.089 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 118.39 -168.75 13.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 64.32 112.392 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -112.38 155.38 24.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.791 0.329 . . . . 65.4 110.908 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.456 ' HG2' HG12 ' C' ' 244' ' ' VAL . 15.7 pt-20 -120.13 137.45 54.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 71.11 110.935 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.94 125.96 50.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 74.35 110.874 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' C' ' 247' ' ' ALA . . . 127.12 159.84 10.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 51.03 112.452 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -101.53 -19.03 16.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.82 -0.705 . . . . 44.15 112.477 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 284' ' ' LYS . . . . . 0.533 ' HB2' HG21 ' B' ' 246' ' ' THR . 1.4 mmtt -66.97 89.31 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 65.14 110.948 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 66.86 113.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 71.14 112.506 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -52.85 -66.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.812 0.339 . . . . 61.42 110.865 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 15.4 t90 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 73.24 110.916 -179.947 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.777 0.322 . . . . 62.42 110.839 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.418 ' ND2' ' HA2' ' C' ' 242' ' ' GLY . 4.3 m-80 -94.64 134.93 36.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 73.11 110.882 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 8.1 t -132.46 137.84 47.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 64.55 110.894 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.95 138.83 44.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 74.21 111.12 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.86 -33.47 11.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.41 . . . . 63.3 110.897 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.71 138.54 5.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 73.51 110.822 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 11.0 mt -137.59 117.89 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 75.22 111.135 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -127.74 121.9 31.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 73.41 110.918 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 141.67 45.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 43.12 111.167 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.18 166.31 25.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 73.51 110.863 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 65.0 57.68 0.96 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.156 -0.475 . . . . 62.31 110.874 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 50.87 61.2 3.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 73.42 110.887 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 151.97 22.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 64.15 111.168 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -125.92 135.38 51.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 64.14 110.886 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.774 HG12 ' HB ' ' C' ' 275' ' ' VAL . 4.4 m -140.66 121.9 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 75.24 111.155 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -115.68 129.71 56.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 71.31 110.986 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.808 HD13 ' HB ' ' C' ' 277' ' ' ILE . 3.3 mm? -114.91 118.72 34.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 54.55 110.938 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.418 ' HA2' ' ND2' ' C' ' 226' ' ' ASN . . . 135.1 174.28 13.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.759 -0.734 . . . . 71.32 112.471 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.54 147.92 22.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.869 0.366 . . . . 63.22 110.856 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.456 HG12 ' HG2' ' B' ' 280' ' ' GLU . 34.9 m -119.09 130.42 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 73.02 111.122 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.407 HG12 ' HB3' ' C' ' 249' ' ' ALA . 21.7 t -122.07 128.97 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 34.53 111.096 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 7.8 p -74.41 162.97 28.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 64.14 111.158 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.503 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -63.08 -33.97 76.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 73.42 111.06 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.81 -41.85 78.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 45.23 111.064 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 249' ' ' ALA . . . . . 0.697 ' HB2' ' CD1' ' C' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 64.21 111.097 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.917 0.389 . . . . 74.2 110.93 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 26.4 m -76.3 121.98 23.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 63.22 111.175 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.7 m -92.33 125.5 37.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 73.23 111.123 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -113.83 119.99 39.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 75.52 110.878 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 8.3 t -129.9 123.66 31.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 45.53 110.843 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.591 HG21 HG22 ' C' ' 267' ' ' VAL . 9.3 p -117.06 135.97 55.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 71.15 111.128 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -79.12 -76.09 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 72.34 110.884 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 2.1 m -124.53 130.71 52.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 65.53 111.197 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.591 HG22 HG21 ' C' ' 264' ' ' VAL . 21.9 t -118.09 125.27 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.11 111.209 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 57.8 t -127.24 118.73 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 61.34 111.119 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.1 133.78 8.9 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 42.2 112.522 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -132.53 147.66 52.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.337 . . . . 74.13 110.885 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.14 75.46 0.26 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.686 -0.769 . . . . 52.01 112.499 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 48.64 60.43 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 61.3 110.846 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 21.3 t -85.55 145.85 27.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.34 110.846 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -128.32 127.86 43.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 65.33 110.823 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.774 ' HB ' HG12 ' C' ' 239' ' ' VAL . 17.3 t -135.18 123.89 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 72.42 111.126 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.48 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -121.89 112.29 18.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 72.24 110.865 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.808 ' HB ' HD13 ' C' ' 241' ' ' LEU . 24.7 mm -106.17 123.51 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 65.33 111.105 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 129.17 167.11 12.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 63.34 112.55 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -89.97 145.3 25.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.774 0.321 . . . . 71.21 110.91 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.05 134.62 54.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 72.23 110.913 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.697 ' CD1' ' HB2' ' C' ' 249' ' ' ALA . 27.2 t80 -119.68 125.95 49.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 73.52 110.986 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 153.55 168.78 17.77 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 34.25 112.523 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 283' ' ' GLY . . . . . 0.597 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . -111.68 -18.32 8.03 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.715 -0.755 . . . . 65.4 112.499 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -76.37 67.11 2.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 63.24 110.929 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 78.31 159.63 13.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 62.32 112.518 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -81.27 -74.67 0.32 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.865 0.364 . . . . 65.21 110.859 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.48 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 3.7 t90 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 72.04 110.927 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.81 0.338 . . . . 71.42 110.891 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.75 113.1 20.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 73.32 110.861 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 2.6 m -128.3 139.76 52.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 71.53 110.84 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.33 157.63 42.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 72.21 111.158 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -112.6 -34.41 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 72.43 110.895 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 230' ' ' ASP . . . . . 0.491 ' HB3' HG23 ' D' ' 266' ' ' THR . 8.1 t0 -164.53 138.86 5.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 73.53 110.869 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 8.9 mt -137.64 117.74 16.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 72.35 111.196 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -130.54 123.53 29.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 70.13 110.932 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 233' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' D' ' 237' ' ' ALA . 0.1 OUTLIER -135.2 146.64 48.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 73.24 111.118 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -146.51 166.61 25.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 74.51 110.901 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 64.93 55.88 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 75.51 110.877 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.85 62.79 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.477 . . . . 73.13 110.862 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 237' ' ' ALA . . . . . 0.44 ' HB3' ' OG1' ' D' ' 233' ' ' THR . . . -104.49 156.06 18.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 43.42 111.123 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -128.05 135.71 50.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 73.11 110.817 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.713 HG23 HG13 ' C' ' 275' ' ' VAL . 20.5 m -138.27 122.85 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.11 111.148 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 240' ' ' GLN . . . . . 0.495 ' C ' HD22 ' D' ' 241' ' ' LEU . 0.0 OUTLIER -116.37 136.43 53.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 72.35 110.938 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.563 HD23 ' CD1' ' C' ' 277' ' ' ILE . 3.8 mm? -119.96 118.98 32.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 50.51 110.89 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.14 171.61 13.0 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.75 . . . . 63.51 112.495 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -93.28 153.95 18.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 74.42 110.888 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 18.5 m -120.67 136.85 56.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 75.34 111.093 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 97.9 t -122.24 130.09 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 72.32 111.098 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 1.7 p -68.35 168.54 12.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 75.31 111.097 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 247' ' ' ALA . . . . . 0.597 ' HB2' ' N ' ' C' ' 283' ' ' GLY . . . -59.57 -34.49 72.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 72.22 111.136 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.44 -37.53 72.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 64.43 111.162 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 249' ' ' ALA . . . . . 0.622 ' HB2' ' OH ' ' C' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 35.14 111.146 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.851 0.358 . . . . 33.41 111.141 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 98.0 m -102.61 139.17 38.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 75.24 111.148 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.14 130.98 52.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 74.04 110.807 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 5.8 t -142.07 123.9 15.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 62.33 110.81 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.506 HG21 HG22 ' D' ' 267' ' ' VAL . 7.6 p -123.76 138.34 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 63.11 111.131 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.73 -76.4 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 74.05 110.847 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 266' ' ' THR . . . . . 0.491 HG23 ' HB3' ' D' ' 230' ' ' ASP . 6.2 m -128.3 130.46 47.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 71.24 111.081 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.506 HG22 HG21 ' D' ' 264' ' ' VAL . 21.3 t -118.4 120.93 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.144 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 18.1 t -121.68 118.45 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 72.51 111.169 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.52 136.49 12.23 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.715 -0.755 . . . . 62.22 112.456 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.44 147.51 52.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.879 0.371 . . . . 75.11 110.894 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.43 76.22 0.2 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.723 -0.751 . . . . 42.43 112.468 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 47.93 61.95 2.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 71.53 110.866 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 30.5 t -87.15 145.99 26.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 52.34 110.871 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -127.49 127.67 44.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 60.44 110.903 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.632 HG13 HG23 ' E' ' 239' ' ' VAL . 14.2 t -132.66 124.15 50.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 71.33 111.071 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.2 OUTLIER -123.44 112.38 17.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.22 110.889 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.466 ' HB ' HD13 ' D' ' 241' ' ' LEU . 28.0 mm -105.0 129.06 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 72.13 111.111 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 120.03 170.46 14.36 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 63.43 112.561 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -89.68 154.01 20.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.327 . . . . 71.35 110.867 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 280' ' ' GLU . . . . . 0.69 ' CG ' HG12 ' E' ' 244' ' ' VAL . 6.5 pt-20 -127.95 133.17 49.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 64.4 110.858 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 281' ' ' TYR . . . . . 0.476 ' HE1' ' HB2' ' E' ' 249' ' ' ALA . 34.3 t80 -116.22 124.18 49.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 73.14 110.925 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 174.42 -58.32 0.13 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 61.23 112.443 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 91.47 -66.83 2.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.795 -0.717 . . . . 24.25 112.476 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -51.43 -30.32 19.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 75.54 110.917 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -140.34 97.57 0.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.677 -0.773 . . . . 71.4 112.478 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -51.3 -75.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 72.44 110.883 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 15.4 t90 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 64.5 110.932 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? . . . . . 0 CA--C 1.526 0.045 0 CA-C-O 120.78 0.324 . . . . 43.2 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -97.29 111.66 23.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 72.13 110.868 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 14.8 m -121.94 138.96 54.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 72.41 110.839 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.79 132.82 35.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 73.31 111.073 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.06 -29.24 15.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.878 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -164.52 139.33 5.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 60.42 110.896 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 10.5 mt -136.87 117.57 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 70.12 111.162 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.61 121.11 23.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 72.13 110.869 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 233' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' E' ' 237' ' ' ALA . 0.7 OUTLIER -134.51 145.36 48.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 65.34 111.096 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -148.17 167.09 25.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 60.11 110.881 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 65.74 54.41 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 64.43 110.916 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 51.2 62.07 2.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.477 . . . . 74.03 110.852 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 237' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' E' ' 233' ' ' THR . . . -104.76 156.15 18.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 73.31 111.12 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -128.32 135.83 50.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.33 110.855 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.632 HG23 HG13 ' D' ' 275' ' ' VAL . 4.2 m -131.99 121.98 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 43.14 111.109 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 240' ' ' GLN . . . . . 0.653 ' HB3' HD22 ' E' ' 276' ' ' LEU . 0.0 OUTLIER -115.48 137.07 52.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 60.0 110.9 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.826 HD13 ' HB ' ' E' ' 277' ' ' ILE . 4.1 mm? -126.74 121.17 31.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 64.44 110.958 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.19 163.3 11.5 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 64.03 112.456 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -85.7 156.98 20.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.906 0.384 . . . . 74.1 110.854 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.69 HG12 ' CG ' ' D' ' 280' ' ' GLU . 31.6 m -119.42 134.08 64.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 71.13 111.121 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.53 129.54 75.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 51.33 111.085 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 246' ' ' THR . . . . . 0.426 HG21 ' HA2' ' E' ' 282' ' ' GLY . 13.6 t -69.49 175.54 4.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 74.01 111.112 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.34 86.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 24.2 111.104 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.4 -53.03 62.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 55.03 111.1 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 249' ' ' ALA . . . . . 0.476 ' HB2' ' HE1' ' D' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 62.33 111.085 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.851 0.358 . . . . 73.14 111.107 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -105.09 119.93 40.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 63.23 110.932 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 29.2 t -127.27 123.83 37.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 62.34 110.822 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 264' ' ' VAL . . . . . 0.516 HG21 HG22 ' E' ' 267' ' ' VAL . 10.0 p -122.62 137.82 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 71.45 111.152 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.86 -75.07 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 71.44 110.904 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 60.5 m -125.23 133.58 52.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 62.32 111.123 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 267' ' ' VAL . . . . . 0.516 HG22 HG21 ' E' ' 264' ' ' VAL . 21.9 t -118.23 126.5 75.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 75.24 111.142 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.2 122.89 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 45.24 111.125 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.65 134.43 9.96 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 73.4 112.5 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -133.01 147.75 52.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 70.02 110.884 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.48 78.9 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.843 -0.694 . . . . 71.44 112.444 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 47.18 64.16 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 71.04 110.936 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 41.2 t -86.76 145.88 26.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 73.32 110.852 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -130.73 127.87 39.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 55.51 110.853 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.405 ' HB ' HG12 ' E' ' 239' ' ' VAL . 18.7 t -130.4 123.72 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 65.42 111.189 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 276' ' ' LEU . . . . . 0.653 HD22 ' HB3' ' E' ' 240' ' ' GLN . 0.2 OUTLIER -121.79 111.94 17.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 72.12 110.914 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.826 ' HB ' HD13 ' E' ' 241' ' ' LEU . 50.5 mm -108.55 132.64 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 63.24 111.18 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 124.42 -177.68 16.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.744 . . . . 73.23 112.483 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -103.18 153.67 20.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.787 0.327 . . . . 64.11 110.839 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.91 132.07 55.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 62.33 110.83 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -130.09 123.74 31.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 73.25 110.908 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 282' ' ' GLY . . . . . 0.426 ' HA2' HG21 ' E' ' 246' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 61.1 112.485 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.6 ' HG3' HG23 ' A' ' 261' ' ' THR . 9.2 ptp85 . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.797 0.332 . . . . 74.3 110.843 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.99 129.65 30.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.885 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 2.1 p -134.5 140.25 46.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 63.43 110.897 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.82 149.53 51.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 65.45 111.059 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -106.25 -35.63 7.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 71.15 110.874 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -164.86 137.86 4.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 75.43 110.907 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 17.4 mt -138.91 118.72 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 63.54 111.131 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -134.12 117.74 16.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 72.13 110.847 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.7 p -135.55 142.09 45.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 73.41 111.127 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.0 pm0 -147.01 167.9 22.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 72.31 110.93 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 68.94 57.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 75.55 110.909 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 50.37 57.43 6.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.804 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.2 151.75 22.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 44.31 111.101 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -126.11 135.92 52.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 73.54 110.797 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.477 HG23 ' HB ' ' A' ' 275' ' ' VAL . 6.1 p -138.38 121.88 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 63.33 111.096 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.511 ' OE1' HD11 ' A' ' 276' ' ' LEU . 0.5 OUTLIER -114.01 136.0 53.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 72.31 110.948 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.535 HD12 ' HB ' ' A' ' 277' ' ' ILE . 1.6 tp -130.16 118.88 22.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.199 -0.455 . . . . 54.31 110.888 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 139.57 173.22 13.04 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.699 -0.762 . . . . 74.52 112.478 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -85.67 160.45 19.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 74.54 110.903 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 97.9 t -133.07 121.02 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.475 . . . . 72.44 111.16 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.19 129.04 75.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 70.35 111.131 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 72.11 111.108 -179.945 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 95.1 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.805 0.336 . . . . 72.42 111.108 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.6 HG23 ' HG3' ' A' ' 225' ' ' ARG . 26.0 m -116.48 122.41 44.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 73.15 111.147 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.476 ' HB2' HG22 ' A' ' 277' ' ' ILE . 17.5 p30 -107.41 139.34 42.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 63.42 110.875 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.91 123.25 15.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.509 . . . . 64.22 110.812 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.485 HG21 HG22 ' A' ' 267' ' ' VAL . 7.0 p -119.87 137.59 53.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 64.33 111.127 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.91 -77.39 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 72.11 110.857 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 35.3 p -127.21 130.18 49.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 55.0 111.146 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.485 HG22 HG21 ' A' ' 264' ' ' VAL . 20.5 t -118.04 120.69 65.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 70.14 111.125 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.77 118.12 53.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 41.24 111.109 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.17 134.37 10.09 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 71.44 112.49 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.63 147.76 52.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.347 . . . . 72.34 110.895 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.78 78.97 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.79 -0.719 . . . . 54.13 112.45 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 47.9 66.3 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.842 0.353 . . . . 73.41 110.825 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 32.7 t -92.76 145.9 24.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 65.12 110.756 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -125.42 128.29 47.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 74.24 110.9 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.477 ' HB ' HG23 ' A' ' 239' ' ' VAL . 20.6 t -134.1 123.76 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 60.03 111.139 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.511 HD11 ' OE1' ' A' ' 240' ' ' GLN . 0.2 OUTLIER -122.42 111.86 17.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.14 110.858 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.535 ' HB ' HD12 ' A' ' 241' ' ' LEU . 3.4 mp -109.78 106.25 20.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.251 -0.431 . . . . 75.45 111.146 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.5 175.56 19.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 63.12 112.488 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -107.14 147.72 29.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.817 0.342 . . . . 75.41 110.879 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.435 ' HG2' HG22 ' B' ' 244' ' ' VAL . 12.7 pt-20 -118.97 126.37 51.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 65.05 110.905 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.409 ' CE2' HG11 ' B' ' 245' ' ' VAL . 1.8 t80 -118.55 125.76 50.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 64.21 110.921 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' B' ' 247' ' ' ALA . . . 151.33 -39.66 0.8 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.684 -0.769 . . . . 75.23 112.5 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 123.99 -119.8 3.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 52.24 112.442 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 63.34 25.92 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 44.34 110.857 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 77.3 -63.63 3.28 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.705 -0.76 . . . . 72.43 112.49 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -174.49 -167.96 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 73.34 110.893 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.419 ' CZ2' HD23 ' A' ' 276' ' ' LEU . 15.6 t90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 74.11 110.947 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.44 ' O ' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.771 0.32 . . . . 60.44 110.93 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.8 137.51 45.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 75.15 110.852 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.59 137.9 38.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 71.03 110.897 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.17 147.85 52.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 74.32 111.104 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.87 -31.46 9.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 73.11 110.917 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.51 137.79 4.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 54.04 110.89 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 15.6 mt -138.19 117.18 14.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 64.14 111.139 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -134.57 115.26 13.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 64.02 110.883 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.3 p -135.86 137.19 41.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 52.32 111.096 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -141.93 167.28 22.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 62.55 110.912 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 66.95 69.51 0.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 73.14 110.792 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 46.06 40.52 7.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 62.21 110.82 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.81 148.79 23.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 45.23 111.096 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.8 140.82 50.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 73.43 110.829 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.404 HG13 ' O ' ' B' ' 239' ' ' VAL . 6.1 p -138.96 121.99 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.113 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.61 131.76 56.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 74.03 110.865 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.652 HD12 ' HB ' ' B' ' 277' ' ' ILE . 1.2 tp -130.23 118.94 22.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 71.31 110.921 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 154.92 -138.27 6.05 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 52.32 112.42 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 243' ' ' ASN . . . . . 0.448 ' OD1' HG23 ' B' ' 245' ' ' VAL . 4.0 t-20 -144.54 143.69 30.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.852 0.358 . . . . 65.34 110.863 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.435 HG22 ' HG2' ' A' ' 280' ' ' GLU . 58.2 t -119.11 115.63 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 73.4 111.134 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.448 HG23 ' OD1' ' B' ' 243' ' ' ASN . 63.9 t -122.21 122.73 67.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 54.1 111.117 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 81.2 p -69.85 163.02 26.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.183 -0.462 . . . . 53.13 111.147 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 282' ' ' GLY . . . -62.76 -34.07 76.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 75.14 111.093 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.06 -41.48 78.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 72.01 111.04 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 75.02 111.107 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.939 0.4 . . . . 72.23 110.884 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 260' ' ' THR . . . . . 0.541 HG23 ' CG ' ' C' ' 225' ' ' ARG . 76.3 m -100.95 121.95 42.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 73.21 111.119 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.44 HG23 ' O ' ' B' ' 225' ' ' ARG . 91.3 m -124.06 131.86 53.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.28 -0.418 . . . . 75.33 111.138 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.543 ' HB2' HG22 ' B' ' 277' ' ' ILE . 13.7 p30 -115.57 132.51 56.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 75.23 110.885 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 36.7 m -132.74 123.32 26.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 60.34 110.867 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.49 HG21 ' CG2' ' B' ' 267' ' ' VAL . 7.6 p -119.89 137.09 54.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 63.3 111.132 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -78.99 -77.5 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 75.21 110.857 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 39.1 m -129.9 130.48 45.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.166 -0.47 . . . . 63.41 111.141 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.511 ' CG1' HG21 ' B' ' 275' ' ' VAL . 21.3 t -117.9 120.68 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 63.42 111.168 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.04 121.61 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 73.3 111.17 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.27 133.8 8.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 55.1 112.543 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -132.55 147.52 52.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.824 0.345 . . . . 65.14 110.893 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.92 84.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.688 -0.768 . . . . 72.1 112.525 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 45.15 63.52 1.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 74.24 110.888 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 26.5 t -93.06 145.68 24.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 63.31 110.884 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -128.57 127.7 42.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 73.53 110.919 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.511 HG21 ' CG1' ' B' ' 267' ' ' VAL . 21.4 t -131.6 123.91 53.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.414 . . . . 72.51 111.144 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.458 HD23 ' CZ2' ' B' ' 287' ' ' TRP . 0.1 OUTLIER -124.76 111.44 15.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.086 -0.506 . . . . 40.33 110.921 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.652 ' HB ' HD12 ' B' ' 241' ' ' LEU . 2.1 mp -111.66 104.83 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 64.24 111.142 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.28 -168.53 32.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 72.22 112.514 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -123.44 153.59 40.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 74.42 110.939 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.574 ' CD ' HG13 ' C' ' 244' ' ' VAL . 0.5 OUTLIER -126.07 121.19 32.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 73.22 110.845 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -109.45 125.71 52.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 72.03 110.928 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 106.21 171.32 23.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.799 -0.715 . . . . 71.51 112.516 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 283' ' ' GLY . . . . . 0.693 ' H ' ' HB2' ' C' ' 247' ' ' ALA . . . 51.96 -171.68 0.34 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.779 -0.724 . . . . 44.31 112.476 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 131.09 47.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.806 0.336 . . . . 73.43 110.879 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -72.54 78.95 0.7 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.718 . . . . 65.34 112.455 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -178.44 131.22 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 64.34 110.856 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.458 ' CZ2' HD23 ' B' ' 276' ' ' LEU . 15.1 t90 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 74.12 110.921 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.565 ' O ' HG23 ' C' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.852 0.358 . . . . 71.25 110.813 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.464 HD22 HD23 ' C' ' 241' ' ' LEU . 21.9 p-10 -122.78 136.43 54.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 75.51 110.95 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 75.6 m -137.7 145.16 42.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 55.52 110.878 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.05 154.35 49.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 50.03 111.061 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.87 -28.48 10.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 72.23 110.922 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.45 137.59 4.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 74.33 110.867 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 18.1 mt -138.43 116.93 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 73.02 111.142 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.12 115.61 13.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 70.54 110.949 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.8 p -135.81 139.27 43.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 64.3 111.15 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -145.62 166.99 24.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 71.21 110.922 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 66.56 66.97 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 71.02 110.9 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 46.84 51.99 11.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.499 . . . . 61.22 110.897 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.08 151.45 23.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 72.12 111.179 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.24 137.17 47.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 75.25 110.836 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.459 HG13 HG13 ' B' ' 275' ' ' VAL . 6.2 p -133.59 121.95 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 72.24 111.126 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -114.15 135.66 53.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 63.45 110.837 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 1.037 HD12 HD13 ' C' ' 277' ' ' ILE . 0.6 OUTLIER -130.16 118.86 22.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 72.23 110.91 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.9 -173.47 22.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.752 -0.737 . . . . 51.42 112.51 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.02 150.4 23.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 50.23 110.931 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.574 HG13 ' CD ' ' B' ' 280' ' ' GLU . 92.7 t -128.87 121.48 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 55.11 111.125 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.06 129.04 75.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 73.03 111.133 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.9 t -77.03 163.66 26.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 62.41 111.248 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.693 ' HB2' ' H ' ' B' ' 283' ' ' GLY . . . -63.16 -33.65 75.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 74.31 111.106 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.53 -35.98 68.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 74.53 111.056 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 249' ' ' ALA . . . . . 0.418 ' HB2' ' CD2' ' C' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 72.12 111.118 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.91 0.385 . . . . 74.32 110.918 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 20.2 p -99.4 130.51 45.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.199 -0.455 . . . . 75.14 111.097 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.565 HG23 ' O ' ' C' ' 225' ' ' ARG . 30.2 m -134.06 132.15 39.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 54.21 111.178 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.619 ' HB2' HG22 ' C' ' 277' ' ' ILE . 9.9 p-10 -125.38 135.47 52.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 72.23 110.844 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.06 123.78 26.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 71.51 110.829 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.491 HG21 ' CG2' ' C' ' 267' ' ' VAL . 7.4 p -117.67 136.84 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 74.35 111.192 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -79.21 -77.0 0.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 74.45 110.907 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 5.0 m -129.82 130.52 45.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 75.33 111.145 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.491 ' CG2' HG21 ' C' ' 264' ' ' VAL . 21.0 t -117.87 120.64 65.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 55.25 111.114 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 26.2 t -123.84 120.77 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 50.24 111.111 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.02 133.3 8.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.741 . . . . 43.0 112.436 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -133.27 147.47 51.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.82 0.343 . . . . 61.14 110.89 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.2 87.86 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.793 -0.717 . . . . 65.2 112.474 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 44.38 61.04 2.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.889 0.376 . . . . 74.51 110.863 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 35.2 t -92.15 145.33 24.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 74.01 110.909 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.7 127.69 39.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 74.3 110.93 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.497 HG12 HD11 ' C' ' 277' ' ' ILE . 19.5 t -132.03 123.76 51.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 22.21 111.135 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.478 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.1 OUTLIER -128.05 111.8 13.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 64.43 110.9 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 1.037 HD13 HD12 ' C' ' 241' ' ' LEU . 3.4 mp -111.77 119.9 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 73.41 111.109 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.31 -158.34 25.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.735 -0.745 . . . . 35.4 112.467 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -127.98 132.95 49.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.823 0.344 . . . . 74.24 110.851 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.776 ' HG3' HG13 ' D' ' 244' ' ' VAL . 0.0 OUTLIER -111.92 137.78 49.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 74.23 110.88 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.444 ' HE1' ' HB2' ' D' ' 249' ' ' ALA . 14.1 t80 -129.52 125.46 36.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 74.34 110.899 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 126.56 165.68 12.03 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.768 -0.73 . . . . 63.23 112.497 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 283' ' ' GLY . . . . . 0.746 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . 64.7 155.1 0.15 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.717 -0.754 . . . . 60.51 112.432 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -93.26 65.14 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 61.25 110.961 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -160.28 -113.44 0.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.726 -0.75 . . . . 75.24 112.516 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.454 ' HA ' HG11 ' D' ' 244' ' ' VAL . 5.5 p90 -174.58 -35.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 72.11 110.833 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.478 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 7.2 t90 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 72.0 110.93 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 225' ' ' ARG . . . . . 0.441 ' O ' HG23 ' D' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.04 0 CA-C-O 120.836 0.35 . . . . 73.24 110.851 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -110.77 127.44 55.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 61.41 110.937 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.3 137.96 49.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 71.12 110.885 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.2 155.25 42.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 60.42 111.126 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.46 -24.69 10.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 54.33 110.91 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 230' ' ' ASP . . . . . 0.484 ' HB3' HG23 ' D' ' 266' ' ' THR . 0.3 OUTLIER -165.29 137.09 4.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.858 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 16.6 mt -138.66 117.16 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 63.32 111.136 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 -134.6 115.9 14.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 74.53 110.844 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.7 p -135.75 136.63 40.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 62.3 111.094 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -144.44 167.19 23.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 64.31 110.895 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 64.93 68.07 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 71.33 110.831 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 46.35 52.09 10.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 71.23 110.87 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.08 149.98 24.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 73.04 111.126 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -131.47 139.27 49.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 74.14 110.883 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.465 HG13 HG13 ' C' ' 275' ' ' VAL . 7.2 p -133.94 124.24 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 74.05 111.098 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 240' ' ' GLN . . . . . 0.432 ' HB2' HD22 ' D' ' 276' ' ' LEU . 1.2 tm0? -113.06 132.89 55.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 74.2 110.911 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.761 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.2 mm? -122.34 134.69 54.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 72.31 110.941 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 109.0 -174.66 18.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 70.33 112.431 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -99.36 145.57 27.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.897 0.379 . . . . 74.44 110.911 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 244' ' ' VAL . . . . . 0.776 HG13 ' HG3' ' C' ' 280' ' ' GLU . 88.1 t -122.19 131.54 72.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 74.23 111.132 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 66.7 t -122.16 129.15 75.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 64.35 111.101 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t -69.85 167.68 16.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 74.34 111.147 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 247' ' ' ALA . . . . . 0.746 ' HB2' ' N ' ' C' ' 283' ' ' GLY . . . -62.95 -33.91 76.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 73.4 111.129 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.97 -52.06 66.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.4 111.044 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 249' ' ' ALA . . . . . 0.444 ' HB2' ' HE1' ' C' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 74.13 111.073 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 96.1 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.879 0.371 . . . . 74.13 111.144 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 261' ' ' THR . . . . . 0.441 HG23 ' O ' ' D' ' 225' ' ' ARG . 7.7 m -114.14 123.1 48.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 73.55 111.111 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -126.37 146.7 49.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.894 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 12.8 m -136.99 123.44 20.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 72.32 110.817 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.558 HG21 ' CG2' ' D' ' 267' ' ' VAL . 11.9 p -116.47 133.9 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 72.34 111.127 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.64 -69.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 51.35 110.831 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 266' ' ' THR . . . . . 0.484 HG23 ' HB3' ' D' ' 230' ' ' ASP . 92.9 m -143.85 133.39 23.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.13 111.169 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.6 ' CG1' HG21 ' D' ' 275' ' ' VAL . 53.8 t -118.16 125.88 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 73.53 111.181 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 59.9 t -127.11 125.67 66.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 43.13 111.124 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.63 133.74 8.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.769 -0.729 . . . . 71.24 112.532 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.63 138.34 48.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.831 0.348 . . . . 75.04 110.925 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.5 86.28 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.72 -0.752 . . . . 71.04 112.499 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 51.08 81.66 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 73.12 110.871 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 44.8 t -113.54 145.23 41.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 73.54 110.909 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.61 127.5 39.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 64.42 110.833 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.6 HG21 ' CG1' ' D' ' 267' ' ' VAL . 21.7 t -133.05 123.72 48.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 55.42 111.104 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.444 HD23 ' CZ2' ' D' ' 287' ' ' TRP . 0.1 OUTLIER -128.37 111.5 13.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 65.4 110.94 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.773 HG13 HD23 ' E' ' 241' ' ' LEU . 5.0 mp -109.74 130.17 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 64.53 111.124 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.05 172.47 16.2 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.791 -0.719 . . . . 75.42 112.549 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -89.94 141.97 28.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.329 . . . . 74.52 110.888 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 280' ' ' GLU . . . . . 0.654 ' HG3' HG13 ' E' ' 244' ' ' VAL . 0.0 OUTLIER -121.17 136.74 54.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 64.44 110.884 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -117.26 125.75 51.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 74.25 110.953 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.38 -118.53 6.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 45.35 112.528 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 72.74 157.62 3.9 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.776 -0.726 . . . . 61.31 112.443 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -56.02 -25.33 44.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.803 0.335 . . . . 74.44 110.873 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -171.58 -35.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 63.53 112.513 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -152.93 -72.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.314 . . . . 73.1 110.917 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 287' ' ' TRP . . . . . 0.444 ' CZ2' HD23 ' D' ' 276' ' ' LEU . 14.7 t90 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 72.44 110.831 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 225' ' ' ARG . . . . . 0.762 ' O ' HG23 ' E' ' 261' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.899 0.38 . . . . 73.33 110.939 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -89.19 137.31 32.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.911 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.9 147.21 44.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 71.35 110.839 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.83 162.08 29.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 32.31 111.095 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 229' ' ' LYS . . . . . 0.436 ' HB2' ' HA ' ' E' ' 265' ' ' GLU . 3.5 mttm -116.34 -27.32 6.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 72.54 110.884 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 230' ' ' ASP . . . . . 0.559 ' CB ' HG22 ' E' ' 266' ' ' THR . 1.2 t70 -165.85 137.26 3.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 65.35 110.807 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 15.2 mt -138.07 117.54 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 65.24 111.083 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 15.5 ttt-85 -134.46 118.08 16.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 72.23 110.825 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 2.3 p -135.52 147.4 48.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 72.44 111.133 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 234' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' E' ' 237' ' ' ALA . 10.7 pt-20 -156.32 166.87 32.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 74.03 110.886 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 64.08 68.91 0.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 71.43 110.901 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 50.42 31.43 5.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 74.24 110.873 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 237' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' E' ' 234' ' ' GLU . . . -85.64 140.65 30.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 71.4 111.064 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.49 137.67 50.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 72.22 110.89 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.46 HG23 ' HB ' ' E' ' 275' ' ' VAL . 6.2 p -130.38 121.95 52.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 62.05 111.084 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 240' ' ' GLN . . . . . 0.572 ' O ' HD13 ' E' ' 241' ' ' LEU . 0.0 OUTLIER -112.94 136.85 52.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 74.41 110.877 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.773 HD23 HG13 ' D' ' 277' ' ' ILE . 2.0 mm? -124.21 134.16 53.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 62.11 110.869 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 109.18 177.56 21.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.693 -0.765 . . . . 74.3 112.441 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -90.05 148.95 22.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.833 0.349 . . . . 71.31 110.895 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.654 HG13 ' HG3' ' D' ' 280' ' ' GLU . 95.8 t -122.08 131.09 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 42.22 111.145 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 95.4 t -120.8 127.56 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 71.33 111.116 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.6 t -76.84 171.29 14.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 61.25 111.211 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.56 -33.98 76.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 61.21 111.066 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -51.56 68.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 73.55 111.071 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 72.22 111.076 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 261' ' ' THR . . . . . 0.762 HG23 ' O ' ' E' ' 225' ' ' ARG . 85.9 m . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.855 0.36 . . . . 60.54 111.153 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -126.12 138.19 53.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.484 . . . . 64.13 110.903 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.42 128.81 53.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 70.24 110.847 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 264' ' ' VAL . . . . . 0.462 HG21 ' CG2' ' E' ' 267' ' ' VAL . 7.9 p -125.55 137.73 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 73.2 111.188 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 265' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' E' ' 229' ' ' LYS . 17.5 mt-10 -82.97 -74.72 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 63.41 110.928 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 266' ' ' THR . . . . . 0.559 HG22 ' CB ' ' E' ' 230' ' ' ASP . 38.9 p -142.54 128.06 19.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 72.25 111.132 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 267' ' ' VAL . . . . . 0.746 HG11 HG21 ' E' ' 275' ' ' VAL . 58.7 t -117.76 120.84 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 73.01 111.162 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 81.9 t -115.72 121.57 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 45.01 111.176 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.45 132.54 10.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.758 -0.734 . . . . 54.31 112.521 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.84 139.45 46.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 54.52 110.85 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.84 88.47 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 12.22 112.512 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 49.59 75.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.872 0.368 . . . . 73.41 110.917 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.23 145.38 30.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 43.14 110.863 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -132.83 127.63 34.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 62.22 110.839 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.746 HG21 HG11 ' E' ' 267' ' ' VAL . 74.9 t -133.69 122.97 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 63.22 111.135 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.19 111.34 12.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 61.1 110.88 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.54 HD12 HD12 ' E' ' 241' ' ' LEU . 9.7 mt -112.59 105.84 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 51.45 111.106 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.9 -158.57 28.19 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.787 -0.721 . . . . 63.23 112.448 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -127.96 145.73 50.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.758 0.314 . . . . 75.52 110.871 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -111.89 122.27 47.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 73.11 110.86 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.25 125.94 51.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 65.43 110.985 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.725 -0.75 . . . . 72.32 112.418 179.91 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.691 ' CB ' HG23 ' A' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.862 0.363 . . . . 72.42 110.845 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.701 ' HB3' HG22 ' A' ' 277' ' ' ILE . 0.1 OUTLIER -130.57 109.83 10.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 73.41 110.879 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 1.5 t -125.43 141.81 51.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 52.53 110.896 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.83 119.68 12.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 73.34 111.053 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -74.65 -33.39 62.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 70.43 110.92 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -164.92 138.93 4.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 71.22 110.872 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 10.3 pt -137.35 119.01 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 51.54 111.116 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.85 120.64 37.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 64.11 110.931 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.1 p -129.44 139.18 51.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.216 -0.447 . . . . 74.25 111.108 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -146.53 167.5 23.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 73.35 110.899 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 66.61 65.87 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 75.21 110.944 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 48.85 36.5 8.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.886 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.24 155.83 21.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 73.01 111.121 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -131.71 145.6 51.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 72.51 110.897 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.536 HG23 ' HB ' ' A' ' 275' ' ' VAL . 5.5 p -140.05 121.83 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 71.33 111.2 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -114.54 129.74 56.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 74.12 110.927 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.462 HD22 ' HB ' ' A' ' 277' ' ' ILE . 0.2 OUTLIER -114.83 118.53 33.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 53.55 110.891 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.72 174.87 13.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 50.14 112.54 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -90.92 154.79 19.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 63.34 110.897 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.473 HG13 ' HA ' ' A' ' 280' ' ' GLU . 4.2 p -130.02 123.99 57.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 74.23 111.11 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.07 125.73 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 61.51 111.104 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 73.11 111.189 -179.971 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 24.4 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.914 0.388 . . . . 73.2 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.691 HG23 ' CB ' ' A' ' 225' ' ' ARG . 98.0 m -134.02 124.71 26.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.212 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.632 ' CB ' HD12 ' B' ' 241' ' ' LEU . 0.7 OUTLIER -103.53 121.04 42.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 74.0 110.857 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.11 123.81 16.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 72.41 110.842 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.616 HG21 ' CD1' ' B' ' 231' ' ' ILE . 8.9 p -119.21 139.58 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 50.32 111.177 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.09 -71.28 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 72.11 110.875 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.6 m -124.19 136.09 53.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 74.23 111.081 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.801 HG22 HD11 ' B' ' 231' ' ' ILE . 19.4 t -120.27 133.5 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 74.42 111.175 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.49 127.13 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 74.33 111.165 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.38 133.39 8.38 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.747 . . . . 41.44 112.42 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.61 147.94 51.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 63.33 110.886 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.18 81.6 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 42.21 112.503 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 46.45 65.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 61.52 110.907 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 42.2 t -89.63 145.68 25.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 54.15 110.783 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -119.53 127.9 53.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.088 -0.506 . . . . 71.45 110.88 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.536 ' HB ' HG23 ' A' ' 239' ' ' VAL . 98.8 t -124.38 123.03 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 73.55 111.111 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 27.6 tp -128.71 111.7 13.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.964 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.701 HG22 ' HB3' ' A' ' 226' ' ' ASN . 26.3 mm -110.86 104.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.24 111.131 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.73 170.92 18.4 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 75.51 112.455 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -90.45 137.81 32.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.774 0.321 . . . . 63.24 110.927 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.73 ' HG3' HG23 ' B' ' 244' ' ' VAL . 4.9 pt-20 -111.95 120.27 41.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 74.14 110.923 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.6 125.91 51.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 74.21 110.967 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 118.5 169.95 14.71 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.661 -0.781 . . . . 45.2 112.427 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -67.42 -119.81 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.737 -0.744 . . . . 40.34 112.488 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.53 27.07 7.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.336 . . . . 74.41 110.913 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.02 -103.04 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.762 -0.732 . . . . 74.11 112.458 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -132.08 146.02 51.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.361 . . . . 64.12 110.869 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 71.41 110.904 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.752 0.31 . . . . 74.45 110.865 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.524 ' HB3' HG22 ' B' ' 277' ' ' ILE . 0.8 OUTLIER -138.06 109.43 6.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 63.51 110.915 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 22.1 t -126.83 145.96 50.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 61.33 110.87 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.468 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -139.89 119.76 13.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 73.34 111.076 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -35.76 77.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 54.55 110.968 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -165.4 138.28 4.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 73.33 110.899 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.801 HD11 HG22 ' A' ' 267' ' ' VAL . 31.5 pt -132.86 131.25 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 73.44 111.071 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -134.5 125.16 26.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 71.43 110.856 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.75 128.73 37.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 60.24 111.136 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -134.97 167.4 20.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 73.53 110.883 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 63.06 68.99 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.12 110.918 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 2.6 mtm-85 47.65 40.76 12.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 71.52 110.905 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.74 156.14 17.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 73.13 111.086 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.64 148.41 50.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 73.34 110.905 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' B' ' 275' ' ' VAL . 4.1 p -138.28 121.53 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 70.12 111.172 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -111.2 129.2 56.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 71.42 110.859 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.632 HD12 ' CB ' ' A' ' 262' ' ' ASN . 0.2 OUTLIER -113.79 118.55 34.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.483 . . . . 64.05 110.973 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.24 179.75 16.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.721 . . . . 34.44 112.514 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -87.42 144.51 26.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 72.23 110.918 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.73 HG23 ' HG3' ' A' ' 280' ' ' GLU . 4.7 p -118.88 119.86 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 65.24 111.141 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.35 128.32 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 72.45 111.237 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 48.9 p -80.19 173.92 12.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 61.22 111.172 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.04 96.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 73.23 111.087 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.54 -51.58 68.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 53.14 111.125 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 73.34 111.151 179.884 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.863 0.363 . . . . 71.44 110.901 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 35.5 p -100.86 121.99 42.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 64.21 111.104 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 2.1 t -126.69 127.27 44.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.429 . . . . 65.11 111.192 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.59 129.03 56.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 75.42 110.887 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.9 t -140.95 122.9 15.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 73.11 110.879 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.628 HG21 ' CD1' ' C' ' 231' ' ' ILE . 4.8 p -112.93 141.97 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.484 . . . . 64.13 111.092 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -80.7 -77.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 74.32 110.886 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 18.9 m -120.87 133.71 55.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 63.35 111.099 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.762 HG22 HD11 ' C' ' 231' ' ' ILE . 3.2 t -117.69 124.5 73.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.14 -0.482 . . . . 75.01 111.088 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 59.7 t -123.66 116.02 46.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.495 . . . . 65.01 111.12 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.58 133.33 10.83 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.723 -0.751 . . . . 61.54 112.511 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.35 147.58 51.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.323 . . . . 65.03 110.965 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.94 84.1 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.713 -0.756 . . . . 72.21 112.496 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 46.1 64.98 1.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.808 0.337 . . . . 75.32 110.865 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 27.9 t -93.94 145.61 24.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 74.24 110.838 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.46 128.02 50.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 72.42 110.833 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' B' ' 239' ' ' VAL . 78.5 t -122.95 123.7 68.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 75.41 111.133 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.723 HD22 ' CE3' ' B' ' 287' ' ' TRP . 0.4 OUTLIER -126.55 111.64 14.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 73.45 110.924 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.524 HG22 ' HB3' ' B' ' 226' ' ' ASN . 27.0 mm -109.59 104.64 17.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 72.13 111.104 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.76 175.87 18.28 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.691 -0.766 . . . . 45.34 112.453 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -89.9 154.99 19.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 71.31 110.834 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.691 ' HG3' HG23 ' C' ' 244' ' ' VAL . 12.6 pt-20 -128.72 146.87 50.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 73.12 110.868 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.41 ' CZ ' HG11 ' C' ' 245' ' ' VAL . 0.6 OUTLIER -126.44 125.85 42.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.932 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 128.97 -147.88 17.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.669 -0.777 . . . . 54.54 112.474 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -128.62 -145.09 5.92 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.837 -0.697 . . . . 61.12 112.508 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 63.27 78.82 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.874 0.368 . . . . 53.54 110.867 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.12 -108.61 0.68 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.761 -0.733 . . . . 64.1 112.458 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.06 -60.06 1.79 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 75.33 110.922 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.723 ' CE3' HD22 ' B' ' 276' ' ' LEU . 5.9 p90 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.02 110.872 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.868 0.366 . . . . 53.12 110.883 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.58 110.49 6.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.43 110.953 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.4 t -130.86 141.09 50.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 72.32 110.863 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.16 135.16 46.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 74.33 111.127 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -29.92 21.01 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.218 -0.447 . . . . 72.42 110.909 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.81 136.61 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 62.45 110.883 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.762 HD11 HG22 ' B' ' 267' ' ' VAL . 3.7 pt -138.4 117.52 14.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 73.41 111.113 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -122.12 116.46 24.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 74.11 110.866 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.415 HG21 ' HB ' ' C' ' 239' ' ' VAL . 2.6 p -124.11 128.76 49.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 62.11 111.143 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.48 167.5 21.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 74.44 110.904 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 64.33 74.72 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 74.53 110.906 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 44.38 38.65 2.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 73.31 110.829 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -93.16 156.17 17.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 72.12 111.1 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.24 156.17 49.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 71.54 110.901 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.415 ' HB ' HG21 ' C' ' 233' ' ' THR . 7.8 p -138.19 146.92 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 72.54 111.117 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -134.75 137.49 43.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 72.52 110.901 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.589 HD22 ' HB ' ' C' ' 277' ' ' ILE . 0.3 OUTLIER -126.88 124.89 40.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 45.42 110.92 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.52 178.09 16.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.676 -0.773 . . . . 72.41 112.489 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -86.47 157.02 19.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 54.34 110.864 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.691 HG23 ' HG3' ' B' ' 280' ' ' GLU . 5.4 p -128.69 135.4 62.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 64.42 111.176 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' B' ' 281' ' ' TYR . 39.3 t -122.09 127.96 75.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 73.03 111.132 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 27.9 p -83.8 162.89 20.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 63.44 111.136 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.23 -34.27 76.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 42.34 111.161 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.95 -51.16 70.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.141 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 53.15 111.118 179.944 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.87 0.367 . . . . 75.54 110.913 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 260' ' ' THR . . . . . 0.499 HG21 ' HB3' ' D' ' 243' ' ' ASN . 27.1 p -90.1 126.08 35.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 61.14 111.124 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.8 m -107.46 108.68 20.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 74.5 111.155 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.733 ' HB2' HD12 ' D' ' 241' ' ' LEU . 0.0 OUTLIER -100.15 130.6 46.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 64.45 110.886 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 29.3 t -142.05 123.26 14.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 75.44 110.798 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.633 HG21 HD11 ' D' ' 231' ' ' ILE . 5.9 p -115.04 148.06 18.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 54.15 111.154 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.94 -72.77 0.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 64.45 110.858 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 27.7 m -129.08 137.54 51.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 73.14 111.066 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.824 HG22 HD11 ' D' ' 231' ' ' ILE . 4.2 t -118.79 129.54 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 71.25 111.108 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 73.1 t -127.13 115.96 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 74.34 111.183 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.8 133.04 9.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.727 . . . . 34.05 112.475 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -133.74 147.68 51.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.351 . . . . 73.45 110.941 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.56 89.13 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.769 -0.729 . . . . 64.44 112.499 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 44.8 60.59 2.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.804 0.335 . . . . 65.22 110.873 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.28 144.98 25.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 73.33 110.874 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.59 128.07 48.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.487 . . . . 73.52 110.951 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 94.2 t -123.44 123.56 67.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 64.12 111.159 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.682 HD13 ' CE3' ' C' ' 287' ' ' TRP . 0.5 OUTLIER -126.58 111.69 14.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 74.3 110.925 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.589 ' HB ' HD22 ' C' ' 241' ' ' LEU . 27.4 mm -108.32 104.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 73.45 111.134 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.42 -164.65 29.04 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.814 -0.708 . . . . 53.23 112.606 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -122.01 156.01 34.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.314 . . . . 70.12 110.91 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.75 ' CG ' HG23 ' D' ' 244' ' ' VAL . 9.5 pt-20 -119.51 146.7 45.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 74.53 110.903 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -129.94 134.89 47.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 72.24 110.902 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.49 148.4 20.46 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 62.51 112.549 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 283' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' D' ' 247' ' ' ALA . . . 51.77 -161.55 1.89 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 74.43 112.462 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -131.99 -169.47 2.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 61.21 110.934 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 81.2 139.02 2.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.784 -0.722 . . . . 52.3 112.427 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -45.74 -39.64 8.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.782 0.325 . . . . 62.25 110.91 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.682 ' CE3' HD13 ' C' ' 276' ' ' LEU . 4.0 p90 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.156 -0.475 . . . . 72.41 110.899 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.853 0.359 . . . . 63.04 110.863 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.3 115.63 22.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 64.32 110.859 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.16 138.43 48.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 72.4 110.823 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 228' ' ' ALA . . . . . 0.402 ' HB3' HG23 ' C' ' 264' ' ' VAL . . . -138.19 119.81 15.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 63.23 111.09 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.41 -27.46 56.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 63.14 110.933 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.24 136.76 2.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 62.33 110.867 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 231' ' ' ILE . . . . . 0.824 HD11 HG22 ' C' ' 267' ' ' VAL . 4.3 pt -139.35 117.17 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 72.21 111.067 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -126.54 128.98 47.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 73.14 110.882 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.14 128.83 32.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 75.42 111.164 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -133.16 167.34 20.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 73.11 110.943 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 63.88 72.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.469 . . . . 71.24 110.886 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 44.63 47.25 8.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 64.1 110.867 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.98 155.62 17.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 73.02 111.102 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.37 144.4 46.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 70.25 110.866 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 5.6 p -129.11 140.21 49.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 71.33 111.114 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -133.39 121.72 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 74.21 110.927 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' C' ' 262' ' ' ASN . 0.1 OUTLIER -111.78 118.88 36.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 75.53 110.904 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.77 172.35 13.11 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.754 -0.736 . . . . 74.04 112.451 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 243' ' ' ASN . . . . . 0.499 ' HB3' HG21 ' C' ' 260' ' ' THR . 2.9 p-10 -86.0 143.23 28.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.373 . . . . 73.1 110.938 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 244' ' ' VAL . . . . . 0.75 HG23 ' CG ' ' C' ' 280' ' ' GLU . 4.4 p -110.23 128.76 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 62.55 111.158 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 23.1 t -122.02 128.94 75.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 61.51 111.198 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 30.5 p -86.14 174.17 9.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 72.22 111.154 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 247' ' ' ALA . . . . . 0.504 ' HB2' ' H ' ' C' ' 283' ' ' GLY . . . -59.37 -44.58 92.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 51.42 111.069 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.3 -51.23 70.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 55.3 111.121 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 72.42 111.089 179.878 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 260' ' ' THR . . . . . 0.723 HG21 ' CG ' ' E' ' 243' ' ' ASN . 35.4 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.861 0.363 . . . . 63.34 111.098 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 76.9 m -134.13 125.54 28.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 72.44 111.165 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 262' ' ' ASN . . . . . 0.457 ' OD1' HG22 ' D' ' 277' ' ' ILE . 0.4 OUTLIER -116.71 122.16 43.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 74.11 110.925 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.1 123.54 14.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 73.11 110.786 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.75 HG21 ' CD1' ' E' ' 231' ' ' ILE . 8.0 p -122.76 138.56 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 72.01 111.149 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -72.09 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 74.41 110.898 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 72.9 p -124.48 135.65 53.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 70.32 111.108 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.676 HG22 HD11 ' E' ' 231' ' ' ILE . 7.7 t -119.08 130.51 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 71.23 111.1 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 268' ' ' VAL . . . . . 0.437 HG11 ' NE ' ' E' ' 232' ' ' ARG . 2.1 t -127.38 120.79 55.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 55.44 111.108 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.46 132.64 9.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.766 -0.73 . . . . 74.42 112.542 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -134.35 149.15 50.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.79 0.329 . . . . 73.15 110.976 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.45 87.53 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 72.01 112.467 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 43.29 56.87 4.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 63.41 110.814 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 30.5 t -86.71 145.08 26.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 74.41 110.88 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.72 128.28 49.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 75.35 110.861 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 98.6 t -119.97 123.21 70.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.469 . . . . 73.14 111.116 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.63 HD23 ' HG2' ' E' ' 240' ' ' GLN . 0.8 OUTLIER -128.46 113.33 15.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 74.24 110.955 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.553 ' HB ' HD22 ' D' ' 241' ' ' LEU . 29.9 mm -112.41 104.73 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 71.45 111.118 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.99 175.89 17.52 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.764 -0.732 . . . . 44.34 112.473 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -89.92 156.12 18.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 74.44 110.909 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 280' ' ' GLU . . . . . 0.771 ' HG3' HG23 ' E' ' 244' ' ' VAL . 19.8 pt-20 -124.7 134.06 52.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 54.42 110.88 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -124.76 125.78 44.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.91 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 168.81 -152.2 19.67 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 72.41 112.51 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -78.83 57.95 4.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.687 -0.768 . . . . 75.11 112.516 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 284' ' ' LYS . . . . . 0.519 ' N ' HG23 ' E' ' 246' ' ' THR . 0.0 OUTLIER 54.13 -174.12 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.757 0.313 . . . . 73.53 110.901 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 66.87 144.46 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 34.13 112.534 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -59.73 -172.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 63.12 110.833 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 287' ' ' TRP . . . . . 0.591 ' CE3' HD13 ' D' ' 276' ' ' LEU . 8.8 p90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.079 -0.51 . . . . 74.55 110.945 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 225' ' ' ARG . . . . . 0.648 ' HA ' HG23 ' E' ' 261' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.824 0.345 . . . . 72.54 110.872 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.83 109.94 22.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 73.01 110.859 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 1.8 m -134.28 137.51 44.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 75.24 110.892 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 228' ' ' ALA . . . . . 0.518 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -139.32 124.88 19.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 74.14 111.091 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.41 -25.88 60.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 63.4 110.922 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 230' ' ' ASP . . . . . 0.685 ' HB3' HG23 ' E' ' 266' ' ' THR . 27.9 t0 -167.15 137.26 2.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 55.54 110.91 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 231' ' ' ILE . . . . . 0.75 ' CD1' HG21 ' D' ' 264' ' ' VAL . 23.5 pt -138.18 128.94 36.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 61.32 111.182 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 232' ' ' ARG . . . . . 0.437 ' NE ' HG11 ' D' ' 268' ' ' VAL . 26.2 ttm180 -133.87 131.41 39.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 60.4 110.906 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.43 128.57 31.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 64.54 111.146 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -132.29 166.47 21.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.419 . . . . 63.32 110.896 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 64.53 69.71 0.5 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.474 . . . . 70.35 110.943 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 47.15 35.18 3.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 63.53 110.941 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.38 156.35 18.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.138 -0.483 . . . . 52.1 111.119 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -140.94 158.89 43.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 72.14 110.856 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.525 HG23 ' HB ' ' E' ' 275' ' ' VAL . 4.8 p -138.08 143.12 33.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 63.11 111.114 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 240' ' ' GLN . . . . . 0.63 ' HG2' HD23 ' D' ' 276' ' ' LEU . 5.7 tm0? -132.39 125.99 32.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.085 -0.507 . . . . 71.12 110.852 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.812 HD13 ' HB ' ' E' ' 277' ' ' ILE . 3.9 mm? -111.9 118.74 36.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 75.32 110.943 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.22 -173.83 20.21 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.758 -0.734 . . . . 73.1 112.524 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 243' ' ' ASN . . . . . 0.723 ' CG ' HG21 ' D' ' 260' ' ' THR . 5.6 p-10 -104.97 154.76 19.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.925 0.393 . . . . 74.52 110.803 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.771 HG23 ' HG3' ' D' ' 280' ' ' GLU . 4.6 p -115.86 125.02 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 73.01 111.092 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 91.0 t -112.84 129.14 68.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 55.4 111.168 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 246' ' ' THR . . . . . 0.519 HG23 ' N ' ' D' ' 284' ' ' LYS . 1.4 m -85.58 163.47 18.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 65.25 111.165 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.83 -34.85 68.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 71.43 111.132 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 248' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' E' ' 249' ' ' ALA . . . -57.07 -52.0 67.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 74.31 111.085 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 249' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' E' ' 248' ' ' ALA . . . . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 73.4 111.113 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 261' ' ' THR . . . . . 0.648 HG23 ' HA ' ' E' ' 225' ' ' ARG . 30.0 m . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.745 0.307 . . . . 62.25 111.11 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.69 119.91 39.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 64.54 110.944 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 48.0 t -133.3 125.15 28.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 63.05 110.882 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 264' ' ' VAL . . . . . 0.465 HG11 ' CG2' ' E' ' 267' ' ' VAL . 5.1 p -128.22 146.68 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 42.44 111.101 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.64 -64.94 1.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 73.45 110.873 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 266' ' ' THR . . . . . 0.685 HG23 ' HB3' ' E' ' 230' ' ' ASP . 2.5 m -135.85 138.13 42.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 64.05 111.17 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 267' ' ' VAL . . . . . 0.465 ' CG2' HG11 ' E' ' 264' ' ' VAL . 7.9 t -126.48 130.84 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 64.23 111.136 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 5.7 p -128.37 124.01 61.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 64.34 111.101 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.77 138.99 15.04 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.718 -0.753 . . . . 60.31 112.475 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -132.93 148.84 52.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.779 0.323 . . . . 62.44 110.963 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.08 88.91 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.726 -0.75 . . . . 54.33 112.494 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 41.84 56.96 3.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.855 0.36 . . . . 52.12 110.925 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 30.2 t -83.92 145.01 28.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 54.14 110.815 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -126.29 127.88 46.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 74.02 110.898 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.525 ' HB ' HG23 ' E' ' 239' ' ' VAL . 99.6 t -116.93 123.52 71.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 73.11 111.155 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.77 111.83 13.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 73.04 110.885 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.812 ' HB ' HD13 ' E' ' 241' ' ' LEU . 29.4 mm -112.14 104.95 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 72.35 111.09 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.73 -165.06 28.82 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.791 -0.719 . . . . 40.44 112.505 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -116.48 156.01 27.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.343 . . . . 73.44 110.893 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -118.01 118.92 33.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 72.04 110.973 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -106.86 126.08 51.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 75.02 110.915 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 C-N-CA 120.724 -0.75 . . . . 61.31 112.466 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.668 ' O ' HG23 ' A' ' 261' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.058 0 CA-C-O 120.837 0.351 . . . . 74.32 110.895 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.585 ' OD1' HG22 ' A' ' 277' ' ' ILE . 5.8 m-80 -142.42 135.72 28.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 75.25 110.821 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.99 137.48 54.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 71.1 110.818 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.772 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -127.65 119.64 26.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 64.42 111.096 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.19 -34.04 37.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 64.52 110.915 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.77 132.21 1.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.469 . . . . 70.14 110.907 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.809 HD12 HG21 ' A' ' 239' ' ' VAL . 9.9 pt -141.05 134.35 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 63.44 111.149 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -134.08 128.2 33.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 73.14 110.834 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.479 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.2 OUTLIER -135.21 141.34 45.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 72.25 111.192 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -148.87 151.14 34.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 72.54 110.894 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 64.16 91.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 62.32 110.886 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 39.27 41.12 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 75.53 110.817 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.479 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -102.49 139.69 37.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 72.43 111.097 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.31 158.62 44.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 65.41 110.874 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.809 HG21 HD12 ' A' ' 231' ' ' ILE . 16.3 m -142.72 134.94 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 71.0 111.058 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.458 ' HB3' HD23 ' A' ' 276' ' ' LEU . 0.0 OUTLIER -110.45 134.16 52.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 55.23 110.863 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.772 HD21 ' HB2' ' A' ' 228' ' ' ALA . 0.5 OUTLIER -130.79 118.78 21.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 72.22 110.948 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.34 -121.16 3.07 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.692 -0.766 . . . . 60.33 112.465 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -144.39 129.15 18.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.931 0.396 . . . . 75.03 110.834 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.482 HG13 ' HA ' ' A' ' 280' ' ' GLU . 7.1 p -116.44 123.01 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.483 . . . . 71.33 111.169 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.0 m -121.97 129.05 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 73.15 111.154 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 64.43 111.108 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.857 0.36 . . . . 41.3 111.137 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 225' ' ' ARG . 86.2 m -132.01 125.47 31.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 74.15 111.111 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.71 ' OD1' HG23 ' A' ' 277' ' ' ILE . 7.6 t-20 -105.84 143.51 33.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 74.22 110.933 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.6 p -135.72 123.82 22.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 71.32 110.882 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.626 HG23 HD11 ' B' ' 231' ' ' ILE . 8.1 p -111.19 146.46 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 43.14 111.197 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.63 -64.73 1.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 63.13 110.852 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.3 m -138.8 127.94 24.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 74.01 111.207 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.596 HG11 HG21 ' A' ' 275' ' ' VAL . 13.8 t -118.4 132.12 69.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 74.14 111.133 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.424 HG12 ' HD2' ' A' ' 270' ' ' LYS . 61.5 t -128.31 115.16 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 71.13 111.13 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.07 133.37 10.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 45.12 112.482 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.424 ' HD2' HG12 ' A' ' 268' ' ' VAL . 0.0 OUTLIER -132.72 141.99 48.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.818 0.342 . . . . 63.51 110.896 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.28 86.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 63.15 112.546 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 51.57 81.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 71.23 110.859 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 13.2 t -113.88 144.66 42.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 74.31 110.857 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 49.6 mtt85 -127.79 127.63 43.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 72.35 110.933 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.596 HG21 HG11 ' A' ' 267' ' ' VAL . 13.3 t -124.06 123.97 67.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 73.13 111.11 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 240' ' ' GLN . 1.5 mt -115.15 111.75 21.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 74.33 110.927 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.71 HG23 ' OD1' ' A' ' 262' ' ' ASN . 47.2 mm -112.1 104.92 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 74.45 111.123 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.39 -146.58 18.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.683 -0.77 . . . . 71.32 112.479 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -117.45 150.59 38.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 72.21 110.908 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.788 ' HG3' HG23 ' B' ' 244' ' ' VAL . 14.8 pt-20 -129.54 133.76 47.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 71.42 110.821 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.432 ' HA ' HG23 ' B' ' 245' ' ' VAL . 0.5 OUTLIER -114.42 126.06 54.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.864 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 132.57 150.95 6.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.69 -0.767 . . . . 72.35 112.454 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.423 ' H ' ' HB2' ' B' ' 247' ' ' ALA . . . -116.37 -144.36 8.01 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 32.03 112.499 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.02 -75.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 74.22 110.899 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -117.8 92.63 0.55 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.762 -0.732 . . . . 71.11 112.494 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.404 ' HE1' HG21 ' B' ' 244' ' ' VAL . 71.1 t80 -52.36 114.05 1.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.35 . . . . 74.01 110.896 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 3.0 t90 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.197 -0.456 . . . . 72.31 110.88 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 5.2 mtt85 . . . . . 0 CA--C 1.526 0.047 0 CA-C-O 120.856 0.36 . . . . 74.4 110.825 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.478 ' OD1' HG22 ' B' ' 277' ' ' ILE . 1.0 OUTLIER -103.51 137.01 42.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 73.32 110.911 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.83 137.65 54.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 73.52 110.91 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.35 139.51 49.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 60.04 111.107 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.32 -36.37 9.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 75.44 110.854 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -164.52 138.77 5.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 73.44 110.785 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.626 HD11 HG23 ' A' ' 264' ' ' VAL . 0.5 OUTLIER -137.43 117.77 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 74.04 111.16 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.36 119.51 30.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 65.43 110.919 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.62 135.39 42.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 50.53 111.136 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -144.94 161.88 38.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 71.2 110.865 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 62.37 74.14 0.44 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.148 -0.478 . . . . 64.31 110.844 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 46.96 51.75 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 74.23 110.905 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.25 148.43 26.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 62.41 111.039 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.28 136.31 43.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 75.42 110.872 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.527 HG11 HG22 ' B' ' 231' ' ' ILE . 2.8 m -124.34 123.53 66.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 70.25 111.071 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.684 ' HB3' HD22 ' B' ' 276' ' ' LEU . 6.5 tm0? -105.74 129.21 53.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 73.52 110.906 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.596 HD13 ' CD1' ' A' ' 277' ' ' ILE . 4.5 mp -125.62 118.65 26.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 61.23 110.892 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.9 -168.93 13.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.716 -0.754 . . . . 74.21 112.488 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.73 135.06 33.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.875 0.369 . . . . 74.15 110.842 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.788 HG23 ' HG3' ' A' ' 280' ' ' GLU . 6.8 p -119.0 123.95 72.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 63.3 111.147 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.432 HG23 ' HA ' ' A' ' 281' ' ' TYR . 15.7 m -122.1 129.14 75.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 65.43 111.126 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.1 t -76.74 168.89 19.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 64.02 111.159 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.423 ' HB2' ' H ' ' A' ' 283' ' ' GLY . . . -63.07 -33.9 76.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 74.11 111.064 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.91 -35.89 69.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 70.33 111.066 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.64 ' HB2' ' CD1' ' B' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 32.3 111.113 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.838 0.352 . . . . 74.11 110.909 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 260' ' ' THR . . . . . 0.466 HG21 ' OD1' ' C' ' 243' ' ' ASN . 27.8 p -98.64 124.86 43.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 62.44 111.122 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 3.9 t -119.99 139.95 51.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 64.01 111.136 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.3 145.51 48.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.2 110.918 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.3 t -142.11 123.51 14.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 42.13 110.853 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.632 HG21 HG22 ' B' ' 267' ' ' VAL . 9.0 p -118.16 139.15 46.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 72.34 111.08 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -83.24 -77.37 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.93 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 23.0 m -122.25 127.9 50.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 64.02 111.133 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.689 HG11 HG11 ' B' ' 275' ' ' VAL . 11.9 t -118.53 124.19 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 75.54 111.095 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.7 128.14 69.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 65.42 111.144 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -136.4 133.23 6.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.761 -0.733 . . . . 41.42 112.546 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -133.43 147.93 51.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.843 0.354 . . . . 74.43 110.891 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.24 90.55 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.714 -0.755 . . . . 71.0 112.498 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 43.73 56.3 4.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 75.15 110.888 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 2.3 t -86.85 145.05 26.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 71.4 110.872 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -132.47 127.5 35.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 74.14 110.861 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.689 HG11 HG11 ' B' ' 267' ' ' VAL . 5.9 t -125.66 130.15 72.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 75.14 111.149 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.684 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.7 OUTLIER -122.17 112.07 17.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 75.12 110.991 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.478 HG22 ' OD1' ' B' ' 226' ' ' ASN . 45.8 mm -111.81 115.18 49.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 61.44 111.181 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 122.87 -174.31 16.33 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.698 -0.763 . . . . 72.3 112.46 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -89.87 141.55 28.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 64.54 110.825 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.642 ' HG3' HG23 ' C' ' 244' ' ' VAL . 10.5 pt-20 -117.49 142.18 47.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 74.43 110.842 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.64 ' CD1' ' HB2' ' B' ' 249' ' ' ALA . 12.8 t80 -126.6 126.05 42.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 73.33 110.871 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 158.75 -55.74 0.36 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.782 -0.723 . . . . 71.41 112.504 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 83.93 -60.44 4.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.751 -0.738 . . . . 74.44 112.495 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -51.81 108.7 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.851 0.358 . . . . 72.44 110.903 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.08 95.38 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 31.12 112.503 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -51.72 132.6 31.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.808 0.337 . . . . 61.4 110.918 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.876 179.971 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.06 0 CA-C-O 120.802 0.334 . . . . 64.22 110.871 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.91 124.99 21.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 41.41 110.879 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 3.6 t -131.71 137.88 48.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 71.34 110.861 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.7 150.8 51.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 73.44 111.114 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.84 -30.41 9.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 51.23 110.849 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -165.89 137.95 3.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 65.23 110.848 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 5.4 mt -138.8 117.44 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 73.4 111.162 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.669 ' HD2' HG22 ' C' ' 268' ' ' VAL . 13.0 ptp180 -132.19 121.5 23.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.13 110.888 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.407 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.1 OUTLIER -134.6 144.1 47.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.106 -0.497 . . . . 73.02 111.046 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -146.75 166.74 25.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 71.34 110.89 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.49 67.58 0.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 72.2 110.881 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 46.73 56.96 5.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 73.43 110.863 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.407 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -104.66 149.72 25.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 75.44 111.05 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -130.54 135.82 48.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 73.15 110.871 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.464 HG12 ' HB ' ' C' ' 275' ' ' VAL . 2.9 m -127.02 123.19 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 63.14 111.156 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.74 ' HB3' HD22 ' C' ' 276' ' ' LEU . 9.3 tm0? -105.58 129.73 53.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.923 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.709 HD13 ' HB ' ' C' ' 277' ' ' ILE . 3.9 mm? -125.78 118.86 26.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.902 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 121.31 -178.5 16.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.665 -0.778 . . . . 75.34 112.474 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 243' ' ' ASN . . . . . 0.466 ' OD1' HG21 ' B' ' 260' ' ' THR . 0.8 OUTLIER -85.61 147.08 26.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 71.54 110.857 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.642 HG23 ' HG3' ' B' ' 280' ' ' GLU . 2.4 p -126.39 123.98 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 62.14 111.116 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.526 HG12 ' HB3' ' C' ' 281' ' ' TYR . 5.4 m -122.11 129.22 75.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 72.43 111.152 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 44.0 p -69.83 172.08 8.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 72.12 111.123 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.82 76.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 74.53 111.093 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.84 -35.84 69.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.418 . . . . 64.34 111.107 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 70.54 111.126 179.95 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.862 0.363 . . . . 70.41 110.925 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 260' ' ' THR . . . . . 0.696 HG21 ' OD1' ' D' ' 243' ' ' ASN . 45.9 p -101.09 138.04 38.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 70.13 111.111 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 75.9 m -120.45 139.27 53.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 70.34 111.106 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.18 132.13 51.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 72.54 110.901 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.56 123.56 28.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 61.1 110.883 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.516 HG21 HG22 ' C' ' 267' ' ' VAL . 7.3 p -125.09 142.82 40.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 70.32 111.197 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -87.21 -74.62 0.43 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.2 -0.455 . . . . 70.52 110.914 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 87.0 m -128.57 129.17 45.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 74.31 111.171 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.516 HG22 HG21 ' C' ' 264' ' ' VAL . 21.4 t -118.67 120.68 64.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 61.21 111.054 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 268' ' ' VAL . . . . . 0.669 HG22 ' HD2' ' C' ' 232' ' ' ARG . 21.3 t -121.89 126.32 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 73.21 111.076 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.63 133.4 7.85 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.744 -0.741 . . . . 73.12 112.496 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -133.02 148.27 52.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.784 0.326 . . . . 70.24 110.925 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.74 84.73 0.02 OUTLIER Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.68 -0.771 . . . . 64.52 112.499 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 45.39 63.19 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 62.14 110.855 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 27.5 t -91.91 145.23 24.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 74.52 110.853 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -131.66 127.61 37.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 74.41 110.882 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.478 HG13 HG23 ' D' ' 239' ' ' VAL . 15.1 t -126.74 131.11 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 62.41 111.151 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.74 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.7 OUTLIER -122.47 111.62 17.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 55.24 110.841 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.709 ' HB ' HD13 ' C' ' 241' ' ' LEU . 51.7 mm -112.22 107.72 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 75.53 111.169 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.05 172.73 12.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 71.3 112.459 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -89.9 147.42 23.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.352 . . . . 64.15 110.869 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.736 ' CG ' HG22 ' D' ' 244' ' ' VAL . 0.5 OUTLIER -118.13 131.58 56.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 73.21 110.887 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.71 ' CE1' ' HB2' ' D' ' 249' ' ' ALA . 12.5 t80 -121.85 133.8 54.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 72.44 110.935 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 134.94 155.76 7.5 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.763 -0.732 . . . . 54.0 112.436 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 283' ' ' GLY . . . . . 0.496 ' H ' ' HB2' ' D' ' 247' ' ' ALA . . . -93.75 -15.61 48.78 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.818 -0.706 . . . . 54.22 112.445 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -72.42 79.17 1.03 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 74.31 110.898 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 65.52 151.85 0.11 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 64.12 112.488 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -78.91 -32.38 45.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 64.12 110.869 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.455 ' CE2' HD23 ' C' ' 276' ' ' LEU . 6.5 t90 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 62.13 110.913 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 225' ' ' ARG . . . . . 0.519 ' N ' HG23 ' D' ' 261' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.807 0.337 . . . . 73.24 110.86 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.66 110.66 18.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 55.12 110.907 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 12.7 p -126.06 143.12 51.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 72.45 110.832 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.09 156.89 48.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 63.23 111.17 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.47 -31.21 6.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 74.2 110.895 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.43 138.58 5.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 74.44 110.898 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 9.9 mt -137.66 117.81 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 72.53 111.143 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -132.9 120.49 21.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.22 110.826 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.97 139.27 44.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 60.23 111.137 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -144.8 166.45 25.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 74.24 110.895 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 61.17 68.15 0.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 65.0 110.848 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 47.44 55.61 8.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 64.2 110.916 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.07 149.01 25.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 34.43 111.054 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.77 135.98 47.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 74.53 110.898 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.478 HG23 HG13 ' C' ' 275' ' ' VAL . 5.3 m -127.07 121.99 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 65.22 111.129 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 240' ' ' GLN . . . . . 0.76 ' HB3' HD22 ' D' ' 276' ' ' LEU . 6.7 tm0? -105.94 132.83 51.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 70.21 110.844 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.701 HD13 ' HB ' ' D' ' 277' ' ' ILE . 4.1 mm? -129.94 118.64 21.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 65.4 110.964 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.27 176.59 14.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.737 -0.744 . . . . 53.05 112.508 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 243' ' ' ASN . . . . . 0.696 ' OD1' HG21 ' C' ' 260' ' ' THR . 1.7 p-10 -85.99 149.56 25.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 71.03 110.894 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 244' ' ' VAL . . . . . 0.736 HG22 ' CG ' ' C' ' 280' ' ' GLU . 3.4 t -120.54 115.05 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 75.31 111.159 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 245' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' C' ' 281' ' ' TYR . 6.1 m -122.16 129.39 75.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 64.53 111.108 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 246' ' ' THR . . . . . 0.654 HG23 ' H ' ' D' ' 248' ' ' ALA . 11.5 t -69.16 175.2 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 75.35 111.133 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 247' ' ' ALA . . . . . 0.496 ' HB2' ' H ' ' C' ' 283' ' ' GLY . . . -52.76 -33.72 49.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 53.33 111.097 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 248' ' ' ALA . . . . . 0.654 ' H ' HG23 ' D' ' 246' ' ' THR . . . -56.67 -51.94 66.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 42.35 111.062 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 249' ' ' ALA . . . . . 0.71 ' HB2' ' CE1' ' C' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.43 . . . . 72.43 111.123 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 260' ' ' THR . . . . . 0.649 HG23 ' HG2' ' E' ' 225' ' ' ARG . 27.8 m . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.888 0.375 . . . . 73.15 111.134 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 261' ' ' THR . . . . . 0.519 HG23 ' N ' ' D' ' 225' ' ' ARG . 81.2 m -105.49 133.18 50.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.448 . . . . 63.34 111.109 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 262' ' ' ASN . . . . . 0.42 ' ND2' HG23 ' D' ' 277' ' ' ILE . 0.1 OUTLIER -126.11 137.17 53.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 43.2 110.868 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 10.0 t -142.05 123.74 15.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 70.24 110.889 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.505 HG21 ' CG2' ' D' ' 267' ' ' VAL . 8.1 p -126.06 145.07 34.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 74.42 111.138 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -88.83 -76.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 74.01 110.927 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 48.0 m -127.05 128.1 45.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 72.51 111.117 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.512 ' CG1' HG21 ' D' ' 275' ' ' VAL . 21.7 t -118.02 120.86 65.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 73.45 111.195 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.42 125.88 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.251 -0.431 . . . . 73.2 111.125 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.62 133.67 8.18 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.75 -0.738 . . . . 52.35 112.524 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.38 147.82 51.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 71.44 110.878 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.79 86.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 73.02 112.507 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 47.62 69.39 0.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.374 . . . . 51.11 110.899 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 19.3 t -100.19 145.35 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 73.32 110.82 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -135.35 128.02 30.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 74.51 110.855 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.512 HG21 ' CG1' ' D' ' 267' ' ' VAL . 14.2 t -128.87 124.22 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 71.33 111.101 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.76 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.8 OUTLIER -114.54 114.37 25.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 73.54 110.917 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.701 ' HB ' HD13 ' D' ' 241' ' ' LEU . 38.1 mm -112.03 104.95 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 72.44 111.095 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.55 -174.54 22.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.738 . . . . 65.13 112.521 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -106.78 148.35 28.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 55.34 110.833 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 280' ' ' GLU . . . . . 0.463 ' CG ' HG13 ' E' ' 244' ' ' VAL . 0.0 OUTLIER -112.75 133.86 54.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 75.44 110.893 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 281' ' ' TYR . . . . . 0.444 ' HD1' HG23 ' E' ' 245' ' ' VAL . 21.1 t80 -129.37 125.27 36.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.524 . . . . 74.2 110.95 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.23 -139.92 11.1 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.65 -0.786 . . . . 64.24 112.448 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -118.57 -120.52 2.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.76 -0.733 . . . . 75.13 112.444 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt 56.95 24.25 9.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 70.12 110.931 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 76.07 -68.26 2.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.753 . . . . 73.53 112.478 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -161.26 -75.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 71.35 110.886 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 287' ' ' TRP . . . . . 0.636 ' CZ2' HD23 ' D' ' 276' ' ' LEU . 6.4 t90 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.502 . . . . 73.11 110.848 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 225' ' ' ARG . . . . . 0.649 ' HG2' HG23 ' D' ' 260' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.857 0.361 . . . . 73.24 110.873 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.45 118.5 13.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 45.42 110.867 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.44 146.31 48.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 43.54 110.801 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.57 155.54 49.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 64.22 111.129 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.05 -27.82 10.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 63.14 110.962 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.36 139.03 5.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 65.45 110.911 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 10.5 mt -137.32 117.49 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 45.44 111.13 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -131.92 116.75 17.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 75.2 110.93 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.13 134.29 42.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 74.34 111.172 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.96 160.66 40.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 71.22 110.867 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 65.13 74.9 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 73.14 110.919 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 45.52 52.99 8.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 72.11 110.892 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.48 141.22 36.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.274 -0.421 . . . . 72.24 111.106 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -132.37 137.84 47.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 75.52 110.875 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.16 137.78 51.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 64.34 111.156 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 240' ' ' GLN . . . . . 0.477 ' HB3' HD22 ' E' ' 276' ' ' LEU . 1.8 tm0? -124.14 134.26 53.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 64.12 110.921 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.28 126.68 44.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 62.25 110.896 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 127.43 179.97 16.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 54.43 112.478 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.05 161.56 17.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 53.0 110.882 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.463 HG13 ' CG ' ' D' ' 280' ' ' GLU . 98.9 t -132.68 121.98 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 43.35 111.175 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 245' ' ' VAL . . . . . 0.444 HG23 ' HD1' ' D' ' 281' ' ' TYR . 5.4 m -122.24 128.91 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 71.23 111.144 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 246' ' ' THR . . . . . 0.416 HG21 ' HA2' ' E' ' 282' ' ' GLY . 14.8 t -69.77 174.02 5.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 74.43 111.167 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.03 78.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 43.34 111.066 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.83 -35.82 69.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 63.01 111.142 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 61.42 111.049 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.82 0.343 . . . . 72.3 111.163 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -126.14 122.9 37.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 65.1 110.851 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 3.4 m -127.48 124.06 37.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 53.41 110.866 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 264' ' ' VAL . . . . . 0.522 HG21 ' CG2' ' E' ' 267' ' ' VAL . 7.1 p -115.8 125.34 72.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 74.44 111.116 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -61.07 -77.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 72.34 110.888 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.81 135.76 28.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 60.02 111.179 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 267' ' ' VAL . . . . . 1.001 HG11 HG21 ' E' ' 275' ' ' VAL . 39.8 t -118.35 129.35 74.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 73.4 111.053 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 79.4 t -127.32 124.69 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 73.52 111.109 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.02 132.66 8.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 64.14 112.518 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -133.42 116.96 16.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 74.22 110.944 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 71.8 84.46 0.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.739 . . . . 64.21 112.487 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 56.22 86.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 74.14 110.913 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 11.7 t -119.96 145.56 46.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 74.44 110.844 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -137.03 128.22 27.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 71.21 110.878 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 1.001 HG21 HG11 ' E' ' 267' ' ' VAL . 57.4 t -128.93 132.22 67.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 72.44 111.099 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 276' ' ' LEU . . . . . 0.477 HD22 ' HB3' ' E' ' 240' ' ' GLN . 2.2 tm? -128.39 111.71 13.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.886 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 24.9 mm -108.74 138.58 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 71.22 111.183 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 110.85 -155.84 15.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 31.03 112.52 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -128.12 149.65 50.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 73.52 110.908 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.91 133.28 54.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 74.04 110.887 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -126.38 125.56 42.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.884 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 282' ' ' GLY . . . . . 0.416 ' HA2' HG21 ' E' ' 246' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 63.03 112.528 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.769 0.318 . . . . 70.12 110.888 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.755 ' OD1' HG22 ' A' ' 277' ' ' ILE . 70.2 m-80 -112.71 130.98 55.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.269 -0.423 . . . . 61.33 110.9 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 2.3 t -121.8 137.66 54.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 51.34 110.841 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.93 129.63 21.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 75.44 111.027 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.3 -36.1 21.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 62.13 110.904 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -165.6 138.59 4.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 64.14 110.914 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.573 HG22 HG22 ' A' ' 267' ' ' VAL . 10.3 pt -138.33 134.49 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.21 111.101 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.635 ' HD3' HG22 ' A' ' 268' ' ' VAL . 9.2 ptm180 -134.34 129.26 35.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 65.41 110.923 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.523 HG21 HG13 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -133.68 148.14 51.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 63.21 111.14 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -150.47 167.45 27.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.453 . . . . 73.43 110.884 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.59 65.48 0.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 74.24 110.906 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 50.3 42.21 25.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 72.15 110.948 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.36 156.82 17.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.13 111.104 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.27 143.71 40.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 50.0 110.896 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.733 HG12 ' HB ' ' A' ' 275' ' ' VAL . 0.3 OUTLIER -124.12 121.16 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.23 111.165 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.629 ' HB3' HD22 ' A' ' 276' ' ' LEU . 4.0 tm0? -117.12 128.34 55.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.462 . . . . 75.32 110.923 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 5.8 mp -124.69 118.2 25.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.907 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.05 165.33 10.4 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 64.14 112.45 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -85.95 135.7 33.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.933 0.397 . . . . 71.54 110.812 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 244' ' ' VAL . 6.4 p -116.12 122.21 69.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 75.34 111.115 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.72 HG12 ' CB ' ' A' ' 281' ' ' TYR . 36.0 m -122.08 128.93 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 52.13 111.21 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.487 HG22 ' HA3' ' A' ' 282' ' ' GLY . 13.6 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 70.23 111.13 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' THR . . . . . 0.5 HG21 ' ND2' ' B' ' 243' ' ' ASN . 5.5 t . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.857 0.361 . . . . 73.21 111.093 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.429 HG23 ' HB2' ' B' ' 225' ' ' ARG . 2.6 t -134.11 120.71 20.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 71.05 111.169 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.51 ' HB3' HD23 ' B' ' 241' ' ' LEU . 1.2 m120 -99.3 132.65 44.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 75.21 110.915 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.9 p -142.25 123.39 14.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 65.33 110.828 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.55 HG21 HG12 ' A' ' 267' ' ' VAL . 8.8 p -119.68 133.85 65.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 63.33 111.118 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -65.29 -69.84 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.12 110.823 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.2 m -131.64 135.78 47.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 72.45 111.186 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.573 HG22 HG22 ' A' ' 231' ' ' ILE . 15.5 m -127.33 136.04 61.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 72.33 111.17 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.635 HG22 ' HD3' ' A' ' 232' ' ' ARG . 36.6 t -127.19 137.32 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 73.13 111.156 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.43 133.61 7.18 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.676 -0.773 . . . . 74.54 112.489 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.63 148.54 52.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.748 0.308 . . . . 73.33 110.906 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.77 84.33 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 55.31 112.445 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 43.52 55.81 4.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 72.35 110.954 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 45.5 t -83.62 144.83 29.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.095 -0.502 . . . . 71.14 110.821 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.02 128.41 49.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 72.12 110.838 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.733 ' HB ' HG12 ' A' ' 239' ' ' VAL . 25.0 t -115.03 126.69 72.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 73.05 111.173 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' A' ' 240' ' ' GLN . 0.2 OUTLIER -128.41 109.85 11.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.457 . . . . 75.41 111.008 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.755 HG22 ' OD1' ' A' ' 226' ' ' ASN . 19.6 mm -112.97 104.49 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 74.21 111.107 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.8 -147.01 17.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.815 -0.707 . . . . 60.52 112.518 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -128.07 155.66 44.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 72.4 110.929 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.772 ' HB3' HG23 ' B' ' 244' ' ' VAL . 1.3 tt0 -122.31 118.94 29.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 63.51 110.926 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.72 ' CB ' HG12 ' A' ' 245' ' ' VAL . 0.5 OUTLIER -109.45 125.89 52.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 74.12 110.866 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.487 ' HA3' HG22 ' A' ' 246' ' ' THR . . . 62.3 176.07 2.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 75.23 112.509 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 120.7 16.12 4.66 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.772 -0.728 . . . . 73.55 112.492 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.1 mttm 59.9 69.41 0.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 74.31 110.891 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.51 174.26 23.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.795 -0.717 . . . . 24.43 112.55 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -60.4 -167.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 75.42 110.851 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 9.4 t90 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 53.44 110.887 179.966 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.429 ' HB2' HG23 ' A' ' 261' ' ' THR . 17.4 ptt180 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.76 0.314 . . . . 64.3 110.907 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -125.68 128.06 47.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 72.34 110.857 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.86 141.57 51.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 65.2 110.858 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.503 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -138.17 128.12 25.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 61.21 111.149 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -40.11 39.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 72.15 110.871 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -166.51 138.1 3.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 71.15 110.854 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.565 HG12 HG12 ' A' ' 267' ' ' VAL . 5.3 pt -138.71 133.13 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 72.02 111.144 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -135.35 128.55 31.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 75.35 110.944 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.513 HG21 HG13 ' B' ' 239' ' ' VAL . 0.3 OUTLIER -135.55 137.31 41.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 71.54 111.155 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 13.1 pm0 -141.59 166.65 24.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 62.43 110.903 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 65.96 67.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 75.23 110.79 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 18.9 mtt180 48.65 49.93 17.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 63.12 110.886 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.49 156.72 17.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 73.52 111.114 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 9.5 mtt-85 -134.29 142.9 47.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 73.01 110.872 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.59 HG12 ' HB ' ' B' ' 275' ' ' VAL . 0.0 OUTLIER -124.21 124.76 69.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.485 . . . . 71.52 111.092 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.595 ' HB3' HD22 ' B' ' 276' ' ' LEU . 0.0 OUTLIER -117.49 128.32 54.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 71.55 110.902 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 262' ' ' ASN . 0.2 OUTLIER -119.87 118.62 31.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 75.45 110.933 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.13 -177.91 16.48 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.748 . . . . 64.32 112.482 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 243' ' ' ASN . . . . . 0.5 ' ND2' HG21 ' A' ' 260' ' ' THR . 9.2 p30 -85.98 148.95 25.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 53.55 110.937 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.772 HG23 ' HB3' ' A' ' 280' ' ' GLU . 6.7 p -131.08 127.87 61.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 70.33 111.1 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.72 HG12 ' CB ' ' B' ' 281' ' ' TYR . 30.8 m -121.93 129.05 75.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 70.13 111.11 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 20.9 p -80.28 175.0 11.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 54.21 111.129 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.01 -45.29 93.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 71.02 111.082 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.55 -36.02 77.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 44.32 111.126 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.641 ' HB2' ' HA3' ' B' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 73.25 111.127 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.803 0.335 . . . . 75.42 110.875 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 7.3 t -74.17 130.89 40.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 75.32 111.167 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 90.6 m -133.04 108.89 9.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 70.12 111.115 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.542 ' OD1' HD12 ' C' ' 241' ' ' LEU . 0.9 OUTLIER -88.82 136.12 33.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 73.24 110.878 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 19.5 t -142.51 123.15 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 73.34 110.859 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.764 HG23 ' HB3' ' C' ' 228' ' ' ALA . 4.0 p -119.34 140.09 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 62.33 111.116 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -78.1 -73.87 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 65.42 110.869 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.9 m -131.5 127.68 37.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 53.45 111.138 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.583 ' CG1' HG21 ' B' ' 264' ' ' VAL . 19.4 m -122.61 135.33 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 72.04 111.181 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 57.8 t -127.85 133.33 67.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 44.13 111.147 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.82 133.25 7.54 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.757 . . . . 75.01 112.464 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -132.4 148.56 52.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.332 . . . . 44.25 110.937 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.42 91.65 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.749 . . . . 71.01 112.484 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 40.44 51.14 2.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 64.11 110.866 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.05 144.55 29.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 63.31 110.88 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.47 128.19 45.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 63.23 110.907 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.59 ' HB ' HG12 ' B' ' 239' ' ' VAL . 26.2 t -118.79 124.61 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 74.42 111.105 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.595 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.4 OUTLIER -126.52 111.49 14.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 71.24 110.917 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.529 HG23 ' ND2' ' B' ' 262' ' ' ASN . 35.6 mm -110.98 104.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 74.43 111.095 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.91 -142.81 10.68 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.711 -0.757 . . . . 21.24 112.431 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -123.26 147.37 47.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 65.04 110.809 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.742 ' HB2' HG23 ' C' ' 244' ' ' VAL . 3.9 mm-40 -111.99 129.77 56.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 70.41 110.895 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.72 ' CB ' HG12 ' B' ' 245' ' ' VAL . 0.1 OUTLIER -123.11 130.36 52.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 70.4 110.92 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.641 ' HA3' ' HB2' ' B' ' 249' ' ' ALA . . . 81.95 159.25 24.32 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.765 -0.731 . . . . 64.41 112.499 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 126.1 -87.89 0.35 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.818 -0.706 . . . . 72.54 112.539 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.47 -51.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 62.4 110.858 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -130.2 -89.23 0.52 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.744 -0.741 . . . . 62.34 112.488 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.59 ' HA ' HG21 ' C' ' 244' ' ' VAL . 10.9 p90 -122.19 -34.03 3.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 55.45 110.864 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.113 -0.494 . . . . 73.44 110.939 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 14.4 mmt-85 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.811 0.339 . . . . 72.21 110.848 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -141.98 112.75 7.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 75.11 110.892 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 4.5 t -123.17 137.73 54.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 62.43 110.826 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.764 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -133.06 119.65 20.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 33.32 111.094 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -43.51 74.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 60.53 110.873 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -167.24 136.71 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.247 -0.433 . . . . 72.34 110.887 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.599 HG22 ' CG2' ' C' ' 267' ' ' VAL . 3.8 pt -138.13 131.79 41.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 61.51 111.129 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.09 128.37 30.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 74.12 110.891 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.681 HG21 HG13 ' C' ' 239' ' ' VAL . 1.4 p -135.46 144.97 46.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 50.53 111.138 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.88 166.73 25.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 74.21 110.907 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 66.96 68.27 0.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 74.22 110.864 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 46.66 53.92 9.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 72.21 110.871 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.23 156.89 17.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.051 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -132.23 141.3 48.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.34 110.885 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.69 HG12 ' HB ' ' C' ' 275' ' ' VAL . 0.0 OUTLIER -126.06 121.01 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.41 111.132 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.78 117.27 30.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 74.3 110.905 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.542 HD12 ' OD1' ' B' ' 262' ' ' ASN . 0.2 OUTLIER -111.82 118.94 36.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 62.53 110.943 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 122.75 -177.43 16.52 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.76 . . . . 63.31 112.481 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -85.95 131.94 34.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 42.43 110.834 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.742 HG23 ' HB2' ' B' ' 280' ' ' GLU . 3.1 p -116.34 122.52 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 62.32 111.068 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.763 HG12 ' HB2' ' C' ' 281' ' ' TYR . 28.7 m -122.88 129.27 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 65.53 111.148 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 246' ' ' THR . . . . . 0.433 HG23 ' O ' ' C' ' 281' ' ' TYR . 59.3 p -69.8 175.2 4.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 75.4 111.093 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.542 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -58.12 -46.1 86.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 73.45 111.078 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -67.96 -36.74 80.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.21 111.114 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 73.45 111.162 179.865 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.898 0.38 . . . . 74.31 110.951 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 7.6 t -64.97 124.56 22.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 75.13 111.128 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.546 HG22 ' HG2' ' D' ' 225' ' ' ARG . 6.5 t -134.16 141.4 47.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 64.11 111.118 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.5 ' OD1' HG23 ' C' ' 277' ' ' ILE . 2.9 t-20 -113.88 143.04 45.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 73.43 110.86 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 8.5 t -140.16 123.94 17.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 75.31 110.903 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.591 HG23 HD11 ' D' ' 231' ' ' ILE . 8.7 p -120.81 135.78 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 73.32 111.102 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.72 -75.58 0.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 75.14 110.894 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 2.2 m -127.19 127.76 45.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 73.4 111.162 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.854 HG11 HG11 ' C' ' 275' ' ' VAL . 0.0 OUTLIER -118.78 128.28 75.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 63.11 111.151 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 41.7 t -127.92 115.93 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 75.51 111.144 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.67 133.98 11.04 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.794 -0.717 . . . . 64.22 112.472 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -132.08 148.2 52.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.897 0.38 . . . . 73.54 110.888 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 53.55 90.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.683 -0.77 . . . . 60.04 112.513 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 40.87 51.41 3.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.878 0.37 . . . . 74.54 110.859 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 39.1 t -84.87 144.98 28.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.04 110.843 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -127.74 127.85 44.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 71.5 110.884 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.854 HG11 HG11 ' C' ' 267' ' ' VAL . 23.4 t -122.89 123.63 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 64.24 111.129 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.93 114.35 19.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 60.11 110.949 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.5 HG23 ' OD1' ' C' ' 262' ' ' ASN . 31.5 mm -112.57 104.56 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 74.5 111.133 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.04 -164.05 27.61 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.676 -0.774 . . . . 41.35 112.483 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -89.84 155.99 18.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 50.53 110.87 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.466 ' HB3' HG23 ' D' ' 244' ' ' VAL . 5.2 tp10 -129.84 134.87 47.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 63.44 110.911 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.763 ' HB2' HG12 ' C' ' 245' ' ' VAL . 0.1 OUTLIER -130.15 125.38 34.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 73.33 110.967 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 282' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' D' ' 247' ' ' ALA . . . -122.54 -166.86 12.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.727 -0.749 . . . . 74.3 112.487 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 283' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' D' ' 247' ' ' ALA . . . -101.27 -23.37 9.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 73.12 112.525 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -172.34 32.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 70.15 110.866 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -173.82 -174.01 40.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.796 -0.716 . . . . 74.03 112.531 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -100.84 -173.54 2.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.804 0.335 . . . . 74.14 110.948 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 11.6 t90 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 73.15 110.906 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 225' ' ' ARG . . . . . 0.747 ' N ' ' HG1' ' D' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.816 0.341 . . . . 64.21 110.928 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -81.43 109.43 15.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 74.55 110.902 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.01 149.62 51.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.816 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 228' ' ' ALA . . . . . 0.511 ' HB2' HD11 ' D' ' 241' ' ' LEU . . . -133.02 160.93 35.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 73.23 111.08 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.42 -37.05 5.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.907 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 230' ' ' ASP . . . . . 0.407 ' O ' HG23 ' D' ' 267' ' ' VAL . 39.9 t0 -164.6 139.08 5.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.211 -0.45 . . . . 71.23 110.949 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 231' ' ' ILE . . . . . 0.591 HD11 HG23 ' C' ' 264' ' ' VAL . 0.8 OUTLIER -136.66 117.51 17.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 73.41 111.155 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -130.38 115.59 17.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 70.14 110.865 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 233' ' ' THR . . . . . 0.586 HG21 ' CG1' ' D' ' 239' ' ' VAL . 2.7 p -135.65 147.42 48.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 74.34 111.151 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.74 167.52 24.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 72.2 110.866 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 68.34 67.57 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 73.41 110.855 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 46.46 60.35 3.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 72.33 110.824 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.18 155.78 18.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 62.31 111.12 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -133.35 135.94 45.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.884 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.586 ' CG1' HG21 ' D' ' 233' ' ' THR . 10.2 m -131.48 121.85 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 64.32 111.153 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 240' ' ' GLN . . . . . 0.448 ' HB3' HD22 ' D' ' 276' ' ' LEU . 7.3 tm0? -118.06 120.37 37.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.33 110.949 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' D' ' 228' ' ' ALA . 0.7 OUTLIER -111.37 119.8 40.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 74.21 110.948 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.99 -175.5 19.11 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.723 -0.751 . . . . 71.35 112.498 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -96.29 128.45 43.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 75.42 110.867 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 244' ' ' VAL . . . . . 0.466 HG23 ' HB3' ' C' ' 280' ' ' GLU . 3.7 p -111.28 115.81 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 73.33 111.121 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 245' ' ' VAL . . . . . 0.802 HG12 ' HB2' ' D' ' 281' ' ' TYR . 19.0 m -122.75 124.78 71.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 63.42 111.118 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 6.4 t -70.58 175.23 5.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.181 -0.463 . . . . 53.31 111.197 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 247' ' ' ALA . . . . . 0.431 ' HB2' ' HA2' ' C' ' 283' ' ' GLY . . . -61.56 -46.38 90.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 63.23 111.14 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.71 -35.96 69.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 61.34 111.109 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 74.31 111.103 179.962 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 260' ' ' THR . . . . . 0.475 HG21 ' ND2' ' D' ' 279' ' ' ASN . 8.4 t . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.812 0.339 . . . . 75.12 111.151 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 261' ' ' THR . . . . . 0.747 ' HG1' ' N ' ' D' ' 225' ' ' ARG . 0.1 OUTLIER -134.05 141.4 47.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 73.53 111.22 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -122.27 144.54 48.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 72.23 110.889 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.22 123.68 14.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 55.32 110.902 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.413 HG21 HG22 ' D' ' 267' ' ' VAL . 14.4 p -120.54 131.53 72.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 75.54 111.101 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.2 -76.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 42.23 110.925 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 3.8 m -128.09 132.05 49.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 74.52 111.165 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 1.069 HG11 HG11 ' D' ' 275' ' ' VAL . 0.2 OUTLIER -117.59 123.63 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 75.3 111.12 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 23.6 t -122.15 115.88 47.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 55.05 111.187 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.05 133.63 10.75 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.767 -0.73 . . . . 61.44 112.529 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -132.11 148.01 52.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.813 0.34 . . . . 62.02 110.878 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.29 76.38 0.17 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.748 . . . . 73.0 112.478 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 48.44 71.68 0.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.362 . . . . 72.23 110.93 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 20.5 t -102.27 145.41 29.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 63.11 110.893 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -123.03 128.33 50.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 73.52 110.814 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 1.069 HG11 HG11 ' D' ' 267' ' ' VAL . 18.8 t -129.47 123.43 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 74.13 111.103 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.732 HD23 ' O ' ' D' ' 275' ' ' VAL . 15.5 mt -127.85 116.8 20.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 55.03 110.871 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.649 ' CD1' HD13 ' E' ' 241' ' ' LEU . 34.2 mm -112.18 104.68 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 73.21 111.188 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.84 -159.25 28.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.783 -0.722 . . . . 52.33 112.48 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 279' ' ' ASN . . . . . 0.475 ' ND2' HG21 ' D' ' 260' ' ' THR . 15.5 m120 -96.61 156.1 16.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 72.41 110.892 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 280' ' ' GLU . . . . . 0.587 ' HB3' HG23 ' E' ' 244' ' ' VAL . 12.0 tp10 -129.18 118.99 23.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 74.2 110.806 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 281' ' ' TYR . . . . . 0.802 ' HB2' HG12 ' D' ' 245' ' ' VAL . 0.2 OUTLIER -120.75 124.17 44.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 64.22 110.905 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.81 -76.55 2.22 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 44.42 112.421 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 51.98 -156.11 4.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.749 -0.739 . . . . 32.5 112.516 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -179.42 -34.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.848 0.356 . . . . 63.53 110.964 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -84.27 -126.0 1.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.762 -0.732 . . . . 64.32 112.459 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -22.4 50.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 74.22 110.91 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 287' ' ' TRP . . . . . 0.414 ' CD2' HD12 ' D' ' 276' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 74.45 110.933 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 29.5 mtt-85 . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.833 0.349 . . . . 64.4 110.908 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.03 109.92 22.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 64.44 110.942 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.89 137.84 54.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.482 . . . . 44.4 110.886 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 228' ' ' ALA . . . . . 0.753 ' HB2' HD21 ' E' ' 241' ' ' LEU . . . -132.13 128.14 37.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.32 111.133 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.52 -30.43 25.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 70.43 110.918 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 230' ' ' ASP . . . . . 0.533 ' CB ' HG22 ' E' ' 266' ' ' THR . 0.6 OUTLIER -165.0 138.16 4.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 75.52 110.813 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 231' ' ' ILE . . . . . 0.705 HG23 ' CG2' ' E' ' 267' ' ' VAL . 8.4 mt -137.98 116.71 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 71.23 111.116 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -134.76 115.68 14.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 74.32 110.836 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 233' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' E' ' 237' ' ' ALA . 1.3 p -135.88 145.11 46.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 52.11 111.124 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -143.99 167.72 21.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.147 -0.479 . . . . 74.32 110.886 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 68.07 68.2 0.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 74.2 110.821 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 46.86 61.69 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 71.52 110.937 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 237' ' ' ALA . . . . . 0.483 ' HB3' ' OG1' ' E' ' 233' ' ' THR . . . -104.88 156.05 18.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 74.1 111.025 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -136.35 136.25 39.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 72.42 110.868 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.506 HG12 ' HB ' ' E' ' 275' ' ' VAL . 13.4 m -135.72 138.65 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 42.02 111.149 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -136.98 129.52 30.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 65.23 110.904 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.753 HD21 ' HB2' ' E' ' 228' ' ' ALA . 5.6 mp -114.48 118.71 34.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 74.24 110.839 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.92 179.71 16.21 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.733 -0.746 . . . . 74.25 112.473 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -93.07 143.2 26.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 72.11 110.85 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' D' ' 280' ' ' GLU . 5.5 p -118.59 122.36 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 74.44 111.099 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 5.7 m -122.35 122.09 65.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 75.22 111.138 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.0 t -70.09 173.78 6.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 71.15 111.139 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.0 92.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 52.45 111.174 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.19 72.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 74.44 111.078 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 55.24 111.025 -179.994 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 94.3 m . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.747 0.308 . . . . 31.43 111.12 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 262' ' ' ASN . . . . . 0.42 ' CB ' HG22 ' E' ' 277' ' ' ILE . 3.7 m120 -108.63 124.4 50.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 72.11 110.907 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 3.8 m -125.83 123.72 39.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 43.34 110.909 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 264' ' ' VAL . . . . . 0.624 HG21 HG13 ' E' ' 267' ' ' VAL . 12.9 p -123.21 131.73 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 73.13 111.142 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.67 -77.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 72.24 110.913 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 266' ' ' THR . . . . . 0.533 HG22 ' CB ' ' E' ' 230' ' ' ASP . 75.4 p -133.52 131.19 39.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 64.44 111.131 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 267' ' ' VAL . . . . . 0.705 ' CG2' HG23 ' E' ' 231' ' ' ILE . 4.9 m -118.34 120.95 65.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 71.02 111.135 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.63 120.04 63.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 71.13 111.13 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.51 133.76 11.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.776 -0.726 . . . . 75.44 112.477 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -131.87 148.13 52.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 52.44 110.895 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.48 78.74 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.735 -0.745 . . . . 55.0 112.457 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 47.51 68.38 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.372 . . . . 54.33 110.848 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 40.4 t -99.69 145.41 27.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 71.22 110.872 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.96 128.54 43.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 74.14 110.836 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.506 ' HB ' HG12 ' E' ' 239' ' ' VAL . 30.1 t -129.96 123.43 56.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 65.53 111.115 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 276' ' ' LEU . . . . . 0.446 HD23 ' O ' ' E' ' 275' ' ' VAL . 54.8 mt -126.01 111.87 15.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 64.21 110.904 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.42 HG22 ' CB ' ' E' ' 262' ' ' ASN . 27.1 mm -104.21 106.35 20.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 65.52 111.131 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.85 -171.8 29.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.753 -0.737 . . . . 71.43 112.463 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -89.87 154.94 19.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 74.31 110.907 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -127.15 120.58 29.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 64.01 110.902 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.27 125.77 45.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 70.4 110.876 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.74 -0.743 . . . . 44.51 112.501 179.972 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.842 0.354 . . . . 71.0 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.451 ' HB3' HG22 ' A' ' 277' ' ' ILE . 69.4 m-80 -107.28 132.79 52.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.884 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 46.8 m -140.51 148.06 40.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 75.45 110.932 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.11 119.35 10.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 31.1 111.06 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -36.68 78.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 70.44 110.89 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -165.29 137.76 4.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 70.45 110.909 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.597 HG22 ' CG2' ' A' ' 267' ' ' VAL . 6.3 pt -138.5 116.9 13.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 61.23 111.14 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -126.33 129.75 49.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 75.34 110.838 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.632 HG21 ' CG1' ' A' ' 239' ' ' VAL . 5.4 p -136.05 148.97 48.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 73.0 111.169 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.99 168.41 21.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.272 -0.422 . . . . 55.52 110.894 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 69.69 60.41 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.87 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 48.31 58.93 4.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 65.13 110.883 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.09 156.53 17.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 70.01 111.078 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.55 147.67 49.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 75.32 110.865 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.665 HG12 ' HB ' ' A' ' 275' ' ' VAL . 18.7 m -140.68 121.69 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 61.01 111.099 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -125.1 125.1 43.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 74.33 110.914 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.822 HD23 HD13 ' A' ' 277' ' ' ILE . 0.1 OUTLIER -119.77 117.98 29.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 62.44 110.906 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 161.58 162.7 13.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 52.21 112.485 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -85.74 140.66 30.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.875 0.369 . . . . 72.55 110.883 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 97.9 t -114.25 118.56 58.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.48 . . . . 63.42 111.161 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.61 129.07 75.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 72.4 111.121 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 74.2 111.162 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.829 0.347 . . . . 62.25 111.125 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.5 t -108.49 120.72 43.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 63.5 111.101 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -102.68 119.79 39.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 71.03 110.903 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.6 t -132.05 123.79 27.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 70.33 110.891 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.86 HG23 ' HB3' ' B' ' 228' ' ' ALA . 4.2 p -116.9 141.38 35.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.143 -0.481 . . . . 75.42 111.082 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.51 -74.8 0.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 64.34 110.869 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.5 m -124.11 136.53 54.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 62.44 111.143 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.597 ' CG2' HG22 ' A' ' 231' ' ' ILE . 3.5 t -120.84 132.57 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 74.11 111.195 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.23 119.87 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 70.23 111.111 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.11 133.66 11.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.717 -0.754 . . . . 73.43 112.52 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -132.36 148.22 52.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 71.51 110.843 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 53.22 74.24 0.32 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.742 . . . . 63.51 112.489 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 47.57 59.52 4.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.898 0.38 . . . . 73.5 110.945 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.61 145.81 28.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 63.55 110.782 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 57.9 mtt85 -118.03 128.31 54.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 72.55 110.902 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.665 ' HB ' HG12 ' A' ' 239' ' ' VAL . 13.6 t -117.4 123.61 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 75.25 111.215 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.605 ' O ' HD12 ' B' ' 241' ' ' LEU . 0.8 OUTLIER -124.87 112.63 16.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 74.42 110.991 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.822 HD13 HD23 ' A' ' 241' ' ' LEU . 3.6 mp -112.11 104.4 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 63.54 111.068 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.23 166.18 14.68 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.718 -0.753 . . . . 63.02 112.489 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -100.1 156.21 17.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.817 0.341 . . . . 75.24 110.889 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -115.71 119.75 37.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.898 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.52 125.97 51.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 62.11 110.933 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 69.37 142.56 0.14 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.775 -0.726 . . . . 44.3 112.471 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 129.36 -28.94 3.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.735 -0.745 . . . . 71.31 112.465 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 62.91 56.95 1.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 73.33 110.954 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.525 ' O ' HG11 ' B' ' 244' ' ' VAL . . . -154.07 -119.58 0.73 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.765 -0.731 . . . . 41.31 112.499 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -176.24 -38.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 74.11 110.844 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.426 ' CE2' HD12 ' A' ' 276' ' ' LEU . 2.9 t-105 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 72.44 110.954 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.798 0.332 . . . . 74.23 110.941 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.446 ' HB3' HG22 ' B' ' 277' ' ' ILE . 22.9 m120 -83.99 130.88 34.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 73.44 110.909 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.0 m -140.39 146.02 37.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 73.13 110.853 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.86 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -141.45 119.93 12.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 35.43 111.074 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -32.2 69.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 72.13 110.918 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -166.69 137.41 3.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.275 -0.42 . . . . 62.31 110.912 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.76 ' CD1' HG21 ' A' ' 264' ' ' VAL . 12.8 pt -138.54 117.61 13.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 64.13 111.149 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -131.07 129.18 41.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.846 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.615 HG21 ' CG1' ' B' ' 239' ' ' VAL . 2.3 p -135.59 148.77 49.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 63.14 111.116 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 15.6 pm0 -144.46 168.29 20.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 72.35 110.898 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 69.6 64.85 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 54.35 110.856 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.33 48.38 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 74.11 110.888 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.69 156.63 16.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 73.41 111.126 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.9 154.91 51.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 71.54 110.897 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.615 ' CG1' HG21 ' B' ' 233' ' ' THR . 17.8 m -140.92 138.55 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.22 111.175 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.476 ' HG3' HD13 ' A' ' 276' ' ' LEU . 1.5 tt0 -138.42 123.18 18.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.87 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.605 HD12 ' O ' ' A' ' 276' ' ' LEU . 0.3 OUTLIER -115.65 118.67 33.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 71.32 110.952 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 159.18 161.88 11.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.7 -0.762 . . . . 51.53 112.422 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -86.06 131.12 34.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 64.44 110.935 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.525 HG11 ' O ' ' A' ' 285' ' ' GLY . 85.9 t -96.97 115.05 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 32.34 111.146 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.579 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 91.2 t -109.78 128.99 65.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 50.12 111.099 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.419 HG23 ' H ' ' B' ' 249' ' ' ALA . 13.9 t -70.25 167.52 17.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 64.01 111.134 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.09 76.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 75.25 111.063 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.51 -50.44 73.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 71.53 111.159 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.579 ' HB3' ' CG1' ' B' ' 245' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 72.24 111.05 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.931 0.396 . . . . 74.41 110.891 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 2.5 m -100.62 129.32 46.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 72.13 111.182 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 4.8 t -110.53 134.58 52.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 64.12 111.076 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.49 133.38 56.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 71.35 110.854 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.3 m -142.81 123.13 13.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 74.23 110.894 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.799 HG21 HD11 ' C' ' 231' ' ' ILE . 8.0 p -119.0 134.43 62.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 54.3 111.161 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -66.51 -75.2 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 73.32 110.885 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 68.8 m -133.32 133.33 42.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 63.33 111.142 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' B' ' 231' ' ' ILE . 0.7 OUTLIER -120.55 138.0 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 74.42 111.148 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.06 124.45 66.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 74.53 111.082 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.31 133.62 11.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.638 -0.792 . . . . 40.24 112.477 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -132.02 148.04 52.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 74.11 110.892 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.3 80.78 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 61.41 112.421 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 44.19 57.79 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.958 0.409 . . . . 64.34 110.923 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.71 145.55 28.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 75.55 110.844 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -119.3 128.77 54.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 73.31 110.901 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.65 HG12 HD11 ' B' ' 277' ' ' ILE . 18.0 t -115.16 125.05 72.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 75.21 111.107 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.431 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.2 OUTLIER -128.11 110.9 12.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.145 -0.48 . . . . 73.33 110.96 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.65 HD11 HG12 ' B' ' 275' ' ' VAL . 4.7 mp -112.61 104.44 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 64.24 111.14 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.31 170.97 21.44 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.754 -0.736 . . . . 60.25 112.486 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -103.89 156.0 18.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.813 0.34 . . . . 73.54 110.909 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -115.92 119.41 35.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 52.22 110.885 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.94 127.74 51.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 71.4 110.951 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 63.19 160.31 0.24 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.696 -0.764 . . . . 20.0 112.539 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 98.4 104.62 2.44 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.806 -0.711 . . . . 23.51 112.473 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.76 103.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.777 0.322 . . . . 75.12 110.98 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 157.99 -127.87 1.98 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.71 -0.757 . . . . 75.13 112.457 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -178.11 -38.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.801 0.334 . . . . 75.11 110.87 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 18.0 t90 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.916 -179.929 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.797 0.332 . . . . 72.44 110.837 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -100.49 119.6 38.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 72.05 110.897 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.3 m -140.22 142.73 35.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 72.1 110.857 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.691 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -142.29 130.13 21.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 73.02 111.132 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -31.62 39.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 73.12 110.905 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -167.46 135.16 2.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.408 . . . . 65.44 110.851 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.802 HG22 HG22 ' C' ' 267' ' ' VAL . 6.3 pt -142.02 117.23 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 74.44 111.13 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.16 133.51 46.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 73.45 110.807 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.562 HG21 HG13 ' C' ' 239' ' ' VAL . 5.0 p -136.22 152.43 50.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 75.1 111.169 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -145.88 168.25 21.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 74.54 110.816 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 69.67 63.81 0.26 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 74.24 110.892 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.32 58.47 4.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.872 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.62 156.22 18.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 74.04 111.148 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -131.28 137.33 48.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 62.42 110.848 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.673 HG12 ' CG2' ' C' ' 275' ' ' VAL . 6.5 m -123.68 121.77 63.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 61.14 111.161 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.574 ' C ' HD13 ' C' ' 241' ' ' LEU . 0.5 OUTLIER -119.83 115.82 24.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 75.41 110.929 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.858 HD12 HD12 ' C' ' 277' ' ' ILE . 0.2 OUTLIER -111.51 118.69 36.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 62.11 110.934 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.1 166.05 13.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.673 -0.775 . . . . 72.11 112.471 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 243' ' ' ASN . . . . . 0.535 ' ND2' HG23 ' C' ' 245' ' ' VAL . 1.2 p-10 -85.8 146.63 26.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.924 0.392 . . . . 65.11 110.874 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 46.2 t -116.37 122.88 70.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 65.54 111.145 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.595 HG13 ' HB3' ' C' ' 249' ' ' ALA . 74.6 t -122.05 128.53 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 51.03 111.117 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.8 t -69.83 173.23 6.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 73.44 111.164 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.54 76.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 54.44 111.059 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.93 -51.87 67.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 73.31 111.107 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 249' ' ' ALA . . . . . 0.595 ' HB3' HG13 ' C' ' 245' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 42.14 111.047 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.854 0.359 . . . . 70.01 110.857 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.37 137.69 35.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 71.51 111.146 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 87.2 m -128.8 119.83 25.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 65.34 111.094 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -104.86 119.96 40.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 63.04 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 29.2 t -134.32 123.64 24.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 72.2 110.827 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.715 HG21 HG12 ' C' ' 267' ' ' VAL . 8.3 p -119.49 153.32 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 74.45 111.144 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.02 -60.45 1.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 52.34 110.905 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 31.6 p -145.63 127.68 15.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 74.44 111.136 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.802 HG22 HG22 ' C' ' 231' ' ' ILE . 1.0 OUTLIER -122.82 137.38 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 73.11 111.14 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 49.1 t -124.9 125.56 69.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 52.51 111.124 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.77 134.06 11.74 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 41.4 112.52 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -132.36 148.52 52.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.841 0.353 . . . . 74.22 110.864 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.72 85.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.682 -0.77 . . . . 53.54 112.548 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 42.72 59.26 2.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 72.45 110.871 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.8 145.13 28.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 63.21 110.825 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -121.32 128.2 52.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 71.42 110.874 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.673 ' CG2' HG12 ' C' ' 239' ' ' VAL . 31.0 t -116.04 125.19 73.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 72.22 111.14 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.552 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.1 OUTLIER -128.2 111.59 13.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 75.01 110.918 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.858 HD12 HD12 ' C' ' 241' ' ' LEU . 57.2 mt -111.14 104.2 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 71.44 111.14 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.39 178.22 24.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.725 -0.75 . . . . 42.42 112.465 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -108.69 150.96 26.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.779 0.323 . . . . 74.42 110.905 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -112.0 127.9 56.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.44 110.894 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.513 ' CZ ' HG11 ' D' ' 245' ' ' VAL . 1.9 t80 -113.63 125.87 54.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 61.24 110.919 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 51.56 -170.45 0.36 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.767 -0.73 . . . . 63.55 112.489 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 84.94 -133.01 11.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.818 -0.705 . . . . 51.13 112.457 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -45.38 66.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.83 0.348 . . . . 60.31 110.876 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 128.02 -9.17 6.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.713 -0.756 . . . . 71.52 112.443 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.786 ' CE1' HD11 ' D' ' 276' ' ' LEU . 7.8 t80 -171.51 -75.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 73.21 110.87 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.552 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 14.6 t90 . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 71.35 110.908 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.856 0.36 . . . . 63.45 110.837 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -83.66 115.31 22.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 70.4 110.85 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.35 147.33 49.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.912 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.06 119.91 11.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 63.23 111.092 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.49 -39.33 70.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 71.34 110.913 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -165.81 138.89 4.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 74.25 110.844 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 231' ' ' ILE . . . . . 0.475 HG23 ' CG2' ' D' ' 267' ' ' VAL . 0.1 OUTLIER -135.38 116.25 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 64.45 111.149 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -125.59 125.6 43.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 61.45 110.826 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 233' ' ' THR . . . . . 0.593 HG21 ' CG1' ' D' ' 239' ' ' VAL . 1.5 p -135.51 149.0 49.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 64.02 111.096 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 14.9 pm0 -145.65 167.95 21.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 65.1 110.861 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 64.79 76.03 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 54.3 110.899 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 10.5 mtm-85 41.42 56.74 3.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.857 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.54 156.29 18.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 74.11 111.049 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -136.83 151.96 49.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 64.11 110.915 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.646 HG12 ' CG2' ' D' ' 275' ' ' VAL . 18.6 m -137.23 139.53 43.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 71.05 111.078 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 240' ' ' GLN . . . . . 0.62 ' C ' HD13 ' D' ' 241' ' ' LEU . 19.8 tm0? -137.66 121.28 17.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 74.55 110.912 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.645 HD12 HD12 ' D' ' 277' ' ' ILE . 0.2 OUTLIER -112.21 118.37 35.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 72.14 110.899 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 146.23 169.48 14.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.741 . . . . 52.13 112.534 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 243' ' ' ASN . . . . . 0.447 ' ND2' HG23 ' D' ' 245' ' ' VAL . 5.8 p-10 -85.95 152.1 23.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 45.44 110.909 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 18.2 t -117.57 114.81 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 72.04 111.139 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 245' ' ' VAL . . . . . 0.513 HG11 ' CZ ' ' C' ' 281' ' ' TYR . 67.8 t -107.47 124.06 63.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 60.0 111.181 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t -69.73 168.21 15.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 65.42 111.178 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.19 -34.1 73.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 75.34 111.078 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.74 -36.45 72.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 54.41 111.115 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 73.11 111.126 179.939 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 260' ' ' THR . . . . . 0.66 HG23 ' HD2' ' E' ' 225' ' ' ARG . 85.8 m . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.843 0.354 . . . . 70.24 111.162 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 99.8 m -105.33 125.08 50.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.424 . . . . 53.41 111.127 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 262' ' ' ASN . . . . . 0.524 ' OD1' HG22 ' D' ' 260' ' ' THR . 0.1 OUTLIER -125.98 129.47 49.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 63.3 110.857 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.23 123.56 14.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 53.21 110.882 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.496 HG23 HD11 ' E' ' 231' ' ' ILE . 14.2 p -109.89 128.77 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 73.33 111.122 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.55 -79.55 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 72.25 110.793 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -121.68 129.93 53.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 75.11 111.085 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.475 ' CG2' HG23 ' D' ' 231' ' ' ILE . 0.5 OUTLIER -117.75 120.33 64.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 65.42 111.103 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 22.4 t -118.74 115.97 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 73.4 111.154 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.14 133.76 10.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.707 -0.759 . . . . 34.31 112.527 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -131.53 147.81 52.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.766 0.317 . . . . 74.25 110.888 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.16 90.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.761 . . . . 73.22 112.521 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 44.28 61.27 2.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 75.33 110.914 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.56 145.81 24.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 75.14 110.937 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 10.7 mtm-85 -124.04 131.23 53.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 65.44 110.865 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.646 ' CG2' HG12 ' D' ' 239' ' ' VAL . 21.8 t -115.27 124.9 72.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 64.04 111.106 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.786 HD11 ' CE1' ' C' ' 286' ' ' PHE . 2.8 mm? -128.4 111.46 13.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 63.31 110.911 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.645 HD12 HD12 ' D' ' 241' ' ' LEU . 18.2 mt -114.16 103.99 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 62.51 111.165 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.6 -164.68 30.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 53.23 112.42 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -128.26 150.07 50.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.786 0.327 . . . . 74.44 110.904 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -113.39 145.36 41.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 61.44 110.889 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -129.86 125.93 36.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 73.41 110.927 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 62.28 168.46 0.76 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.76 -0.733 . . . . 75.21 112.449 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 107.63 -124.52 7.6 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 72.23 112.477 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -137.84 91.53 2.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 55.54 110.881 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 71.19 167.29 7.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.748 -0.739 . . . . 32.53 112.518 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 286' ' ' PHE . . . . . 0.405 ' HB3' HG21 ' E' ' 244' ' ' VAL . 2.6 p90 -51.92 -31.95 30.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.834 0.349 . . . . 74.12 110.874 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 3.0 t90 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 75.0 110.873 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 225' ' ' ARG . . . . . 0.66 ' HD2' HG23 ' D' ' 260' ' ' THR . 5.6 ptp180 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.834 0.349 . . . . 74.04 110.86 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 226' ' ' ASN . . . . . 0.465 ' HB3' HG22 ' E' ' 277' ' ' ILE . 7.7 m-20 -96.75 109.75 22.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 73.44 110.881 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 31.9 t -134.06 137.85 44.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 54.13 110.802 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.45 136.61 54.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 74.22 111.158 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.44 -35.14 13.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 74.03 110.861 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.39 137.32 3.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 72.23 110.824 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 231' ' ' ILE . . . . . 0.496 HD11 HG23 ' D' ' 264' ' ' VAL . 1.3 mt -138.06 116.55 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 64.31 111.166 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -123.16 121.68 36.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.02 110.861 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 9.6 p -136.74 149.14 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.14 111.227 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.98 166.44 24.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 73.44 110.862 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 235' ' ' GLU . . . . . 0.466 ' O ' ' C ' ' E' ' 236' ' ' ARG . 2.4 mt-10 62.23 90.46 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 64.44 110.904 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 236' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' E' ' 235' ' ' GLU . 0.9 OUTLIER 31.94 63.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 72.34 110.935 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.03 156.28 18.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 60.03 111.087 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -137.4 137.2 38.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 73.03 110.903 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.561 HG12 ' CG2' ' E' ' 275' ' ' VAL . 16.6 m -126.08 137.76 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 70.43 111.092 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -134.78 126.51 29.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 62.33 110.931 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.471 HD22 ' HB ' ' D' ' 264' ' ' VAL . 1.3 mp -116.98 118.64 32.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.859 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.61 172.38 12.55 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.786 -0.721 . . . . 74.24 112.535 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 243' ' ' ASN . . . . . 0.488 ' HB3' HG21 ' D' ' 260' ' ' THR . 1.2 p-10 -85.57 163.39 18.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 71.04 110.914 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' D' ' 286' ' ' PHE . 21.4 t -129.64 135.54 61.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 73.35 111.132 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 70.3 t -122.86 124.11 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 75.53 111.226 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.7 t -68.47 167.03 15.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 53.02 111.172 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.17 75.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 62.22 111.127 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 248' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' E' ' 249' ' ' ALA . . . -56.89 -36.94 70.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 52.32 111.087 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 249' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' E' ' 248' ' ' ALA . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 55.41 111.053 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 261' ' ' THR . . . . . 0.615 HG22 ' HA ' ' E' ' 225' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.794 0.33 . . . . 72.44 111.125 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -123.0 119.75 31.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 44.44 110.903 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 4.2 p -133.12 123.29 25.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.883 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 264' ' ' VAL . . . . . 0.617 HG21 HG22 ' E' ' 267' ' ' VAL . 7.4 p -112.3 136.64 47.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 72.14 111.168 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -81.36 -75.53 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 71.42 110.904 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.2 m -125.21 129.62 50.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 64.33 111.142 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 267' ' ' VAL . . . . . 0.617 HG22 HG21 ' E' ' 264' ' ' VAL . 17.6 t -117.32 123.9 72.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 75.43 111.142 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 87.4 t -127.07 115.82 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 54.34 111.133 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.58 133.87 8.81 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 73.4 112.516 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.84 147.54 46.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.359 . . . . 74.54 110.897 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.27 84.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.777 -0.725 . . . . 44.43 112.46 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 49.1 88.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.853 0.359 . . . . 71.31 110.905 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 67.2 m -116.25 145.19 43.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.13 110.85 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.82 128.78 55.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 74.42 110.925 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.561 ' CG2' HG12 ' E' ' 239' ' ' VAL . 16.4 t -115.12 122.86 70.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 72.01 111.11 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.25 111.56 13.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 72.21 110.874 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.465 HG22 ' HB3' ' E' ' 226' ' ' ASN . 61.5 mt -113.71 104.09 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 73.02 111.087 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.3 176.88 15.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 73.33 112.445 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -89.35 156.43 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.826 0.345 . . . . 64.33 110.899 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -128.53 137.52 51.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 61.23 110.94 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -120.2 123.75 44.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 72.45 110.923 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 C-N-CA 120.686 -0.769 . . . . 75.14 112.536 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.861 0.363 . . . . 55.11 110.831 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -83.19 145.15 29.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 71.21 110.899 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.57 150.26 47.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 75.02 110.85 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.8 119.13 17.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.497 . . . . 61.12 111.092 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -70.76 -49.98 40.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 72.22 110.927 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -165.25 136.37 3.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 45.13 110.862 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.424 HG22 ' CG2' ' A' ' 267' ' ' VAL . 8.0 pt -138.84 134.39 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 74.44 111.1 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -134.49 128.2 32.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 73.25 110.837 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 11.8 p -136.41 149.79 48.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 71.23 111.107 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -120.54 166.24 13.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 75.43 110.869 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 65.39 -159.27 0.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 72.32 110.914 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -74.33 61.41 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 73.33 110.835 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.23 156.43 16.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 70.13 111.108 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.64 143.49 47.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 75.41 110.869 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.672 HG12 ' HB ' ' A' ' 275' ' ' VAL . 16.0 m -135.83 120.83 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 73.3 111.161 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.44 137.7 52.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.889 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.41 118.37 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 72.13 110.92 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 149.78 -126.73 2.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 74.21 112.516 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -145.51 143.11 29.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.808 0.337 . . . . 75.0 110.944 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.65 119.9 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 75.35 111.121 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 36.7 t -109.19 116.15 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 54.2 111.12 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 65.33 111.166 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.823 0.344 . . . . 63.44 111.077 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 225' ' ' ARG . 54.0 m -132.5 133.64 44.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 53.25 111.167 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.611 HD22 HD23 ' B' ' 241' ' ' LEU . 0.6 OUTLIER -115.88 144.45 44.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 70.11 110.862 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.7 m -141.69 127.97 19.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 71.42 110.824 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.743 HG23 HD11 ' B' ' 231' ' ' ILE . 8.7 p -113.57 137.41 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.508 . . . . 74.3 111.088 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -85.61 -78.82 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 52.54 110.829 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 4.0 m -115.71 127.04 54.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 75.33 111.101 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.562 HG22 HG21 ' A' ' 264' ' ' VAL . 40.9 t -118.42 124.12 72.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 62.01 111.076 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 78.9 t -124.76 115.21 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.116 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.42 133.08 9.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 53.2 112.499 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -109.03 129.3 55.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.35 . . . . 72.02 110.884 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.92 178.74 10.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.743 . . . . 21.12 112.465 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -47.53 101.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.835 0.35 . . . . 74.32 110.923 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 44.9 t -129.63 154.14 47.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.096 -0.502 . . . . 65.1 110.837 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -112.16 128.05 56.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 65.11 110.827 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.672 ' HB ' HG12 ' A' ' 239' ' ' VAL . 59.2 t -121.0 123.58 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 73.03 111.137 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.726 HD12 ' CE2' ' A' ' 287' ' ' TRP . 0.4 OUTLIER -125.16 111.01 14.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 53.04 110.913 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.615 ' CD1' HD13 ' B' ' 241' ' ' LEU . 31.0 mm -109.96 104.3 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 62.52 111.119 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.74 -163.48 29.67 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.765 -0.731 . . . . 74.14 112.508 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -114.36 156.36 24.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 72.04 110.843 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.725 ' HG2' HG12 ' B' ' 244' ' ' VAL . 8.9 pt-20 -129.23 129.24 44.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.114 -0.494 . . . . 63.34 110.88 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.566 ' CZ ' HG11 ' B' ' 245' ' ' VAL . 0.3 OUTLIER -123.8 128.97 50.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 72.01 110.907 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 151.34 -169.19 30.94 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.808 -0.71 . . . . 74.14 112.494 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' B' ' 247' ' ' ALA . . . -78.72 -173.84 43.66 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.681 -0.771 . . . . 75.12 112.513 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.3 -75.55 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 61.44 110.927 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 286' ' ' PHE . . . 100.58 175.81 29.77 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.689 -0.767 . . . . 74.42 112.489 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.41 ' HB3' ' O ' ' A' ' 285' ' ' GLY . 9.9 t80 64.01 -81.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 75.42 110.883 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.726 ' CE2' HD12 ' A' ' 276' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.084 -0.507 . . . . 75.12 110.976 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.731 ' O ' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.827 0.346 . . . . 61.21 110.849 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.807 ' HB3' HG22 ' B' ' 277' ' ' ILE . 0.9 OUTLIER -86.57 140.17 30.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 73.11 110.942 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 41.4 m -134.05 140.49 46.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 70.42 110.911 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 264' ' ' VAL . . . -122.71 119.33 30.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 64.11 111.07 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 0.5 OUTLIER -67.93 -44.99 75.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 75.42 110.872 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -156.7 137.53 13.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.53 110.806 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.743 HD11 HG23 ' A' ' 264' ' ' VAL . 0.1 OUTLIER -138.34 117.34 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 71.14 111.16 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -120.1 123.82 44.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 74.01 110.921 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 17.1 p -136.17 140.8 43.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 75.1 111.135 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -121.7 166.93 13.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.167 -0.469 . . . . 63.33 110.809 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.58 -165.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 54.03 110.894 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -73.5 69.84 1.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 72.2 110.892 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 156.4 17.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 41.12 111.077 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.83 135.48 50.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 62.41 110.844 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.645 HG12 ' HB ' ' B' ' 275' ' ' VAL . 19.0 m -126.45 136.08 61.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.41 111.099 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -134.78 126.4 28.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 71.12 110.867 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.615 HD13 ' CD1' ' A' ' 277' ' ' ILE . 3.4 mp -118.46 119.01 33.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 63.04 110.863 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.83 -174.95 21.82 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.727 -0.749 . . . . 75.14 112.471 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -93.53 141.13 28.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 74.31 110.87 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.725 HG12 ' HG2' ' A' ' 280' ' ' GLU . 18.0 m -118.33 122.44 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 72.01 111.125 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.566 HG11 ' CZ ' ' A' ' 281' ' ' TYR . 21.3 t -116.54 127.59 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 64.21 111.142 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 57.6 p -87.2 172.79 9.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 74.34 111.131 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.46 ' HB2' ' HA2' ' A' ' 283' ' ' GLY . . . -63.07 -43.1 99.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 63.34 111.129 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -42.68 80.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 63.1 111.16 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.632 ' HB2' ' HA3' ' B' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 65.43 111.091 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.862 0.363 . . . . 74.13 110.947 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 260' ' ' THR . . . . . 0.484 HG21 ' HB2' ' C' ' 243' ' ' ASN . 6.0 m -99.88 121.78 41.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 62.33 111.128 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.731 HG23 ' O ' ' B' ' 225' ' ' ARG . 96.9 m -105.02 130.4 53.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 63.33 111.213 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.43 147.29 48.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 61.3 110.847 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 28.2 t -142.08 123.45 14.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.44 110.909 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.655 HG21 HG22 ' B' ' 267' ' ' VAL . 11.8 p -109.36 143.53 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 72.23 111.128 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.418 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 4.0 mt-10 -84.58 -75.32 0.35 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 75.14 110.865 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 18.5 p -125.12 127.87 47.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 73.1 111.166 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.655 HG22 HG21 ' B' ' 264' ' ' VAL . 21.2 t -118.27 120.99 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 74.22 111.088 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.8 123.68 70.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 55.33 111.14 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -131.38 133.47 7.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.699 -0.762 . . . . 73.01 112.454 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.28 147.21 31.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 72.11 110.809 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.26 -162.43 32.52 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.751 -0.737 . . . . 65.03 112.565 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -69.56 83.17 0.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 74.55 110.899 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 32.1 t -104.63 164.58 11.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 72.21 110.836 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -124.14 128.72 49.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 75.12 110.839 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.645 ' HB ' HG12 ' B' ' 239' ' ' VAL . 56.6 t -117.94 123.86 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 75.42 111.127 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.661 HD12 ' CE2' ' B' ' 287' ' ' TRP . 0.4 OUTLIER -128.0 111.32 13.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 74.42 110.952 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.807 HG22 ' HB3' ' B' ' 226' ' ' ASN . 12.7 mm -112.76 103.8 16.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 52.55 111.087 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.26 -154.03 25.24 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.777 -0.725 . . . . 63.34 112.514 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -125.31 149.63 47.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.734 0.302 . . . . 63.3 110.899 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -113.95 136.32 53.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 44.04 110.824 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -130.04 127.31 39.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 74.44 110.955 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.632 ' HA3' ' HB2' ' B' ' 249' ' ' ALA . . . 91.36 172.55 43.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 61.51 112.484 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 283' ' ' GLY . . . . . 0.528 ' N ' ' HB2' ' C' ' 247' ' ' ALA . . . 80.11 125.99 0.6 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.808 -0.71 . . . . 45.31 112.521 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -75.88 68.2 2.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.861 0.363 . . . . 73.23 110.954 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -174.96 -153.12 9.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.705 -0.76 . . . . 53.51 112.49 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -122.0 -33.8 3.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.834 0.35 . . . . 63.41 110.86 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.661 ' CE2' HD12 ' B' ' 276' ' ' LEU . 1.4 t90 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 65.5 110.906 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.718 0.295 . . . . 64.42 110.906 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.454 ' HB3' HG22 ' C' ' 277' ' ' ILE . 0.1 OUTLIER -101.43 144.15 30.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 62.34 110.889 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.14 137.99 44.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 65.22 110.832 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.681 ' CB ' HD11 ' C' ' 231' ' ' ILE . . . -116.86 119.91 36.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.055 -0.521 . . . . 54.43 111.124 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -72.72 -42.92 63.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 70.1 110.926 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -158.23 136.58 10.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 72.3 110.805 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.681 HD11 ' CB ' ' C' ' 228' ' ' ALA . 1.7 mt -140.01 116.39 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 75.04 111.077 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 16.0 ttp85 -125.63 125.63 43.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 70.32 110.879 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 21.2 p -136.32 146.3 46.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 51.3 111.099 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -121.21 166.1 14.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 60.23 110.88 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.46 -162.5 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 73.02 110.858 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -72.85 70.83 1.01 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.838 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.25 157.22 17.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 72.32 111.058 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -125.59 149.16 48.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 63.44 110.901 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.591 HG12 ' HB ' ' C' ' 275' ' ' VAL . 12.9 m -141.58 137.84 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 71.22 111.138 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -136.65 132.16 34.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 75.35 110.922 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.645 HD13 ' HB ' ' C' ' 277' ' ' ILE . 1.6 mm? -117.89 117.91 30.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 72.51 110.957 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.44 -177.5 17.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.727 -0.749 . . . . 71.12 112.473 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 243' ' ' ASN . . . . . 0.484 ' HB2' HG21 ' B' ' 260' ' ' THR . 2.8 t-20 -85.76 140.89 30.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 74.24 110.817 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.29 115.85 50.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 55.03 111.139 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.412 HG22 ' HB2' ' C' ' 281' ' ' TYR . 21.4 t -113.66 123.07 68.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 72.41 111.137 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 13.2 t -79.95 175.1 10.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 74.11 111.202 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.528 ' HB2' ' N ' ' B' ' 283' ' ' GLY . . . -62.15 -40.91 97.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 74.52 111.12 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.68 -52.03 66.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 35.54 111.094 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 75.31 111.072 179.953 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.871 0.367 . . . . 74.21 110.945 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 260' ' ' THR . . . . . 0.513 HG21 ' CB ' ' D' ' 243' ' ' ASN . 38.1 p -99.09 137.88 36.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 74.44 111.205 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.7 t -134.13 133.75 41.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 75.24 111.135 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.13 147.7 49.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 61.25 110.898 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.17 123.21 13.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 74.3 110.878 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.645 HG21 HG22 ' C' ' 267' ' ' VAL . 9.0 p -105.52 153.56 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 71.23 111.156 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -97.45 -49.34 4.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 74.42 110.857 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.74 127.96 14.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 73.44 111.157 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.645 HG22 HG21 ' C' ' 264' ' ' VAL . 29.1 t -125.0 120.95 59.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 73.43 111.184 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 52.1 t -126.51 134.86 65.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 73.34 111.156 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.65 133.41 6.39 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.789 -0.719 . . . . 71.23 112.489 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.17 147.38 28.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 73.2 110.863 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 61.93 -152.64 42.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.728 -0.749 . . . . 54.0 112.507 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -73.64 73.78 1.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.359 . . . . 73.23 110.865 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 58.8 m -97.68 157.8 15.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 42.45 110.847 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -119.56 132.72 55.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 64.34 110.82 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.591 ' HB ' HG12 ' C' ' 239' ' ' VAL . 78.7 t -115.32 122.26 68.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 62.25 111.172 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.57 HD23 ' HZ2' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -125.14 111.66 15.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 71.34 110.899 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.645 ' HB ' HD13 ' C' ' 241' ' ' LEU . 20.1 mm -112.63 104.15 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 71.2 111.12 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.58 -159.16 26.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.741 . . . . 70.13 112.459 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.48 156.22 24.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 72.13 110.901 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -113.94 144.61 42.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 74.01 110.848 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.412 ' HB2' HG22 ' C' ' 245' ' ' VAL . 2.6 m-85 -130.14 125.61 35.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 75.12 110.907 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 67.06 150.69 0.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 62.01 112.499 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 138.33 150.67 5.67 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.792 -0.718 . . . . 70.32 112.486 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -64.74 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 74.32 110.896 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -100.81 174.9 25.98 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.748 . . . . 51.02 112.515 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -52.02 -30.37 25.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.868 0.366 . . . . 74.11 110.852 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.57 ' HZ2' HD23 ' C' ' 276' ' ' LEU . 2.0 t90 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 74.33 110.836 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 225' ' ' ARG . . . . . 0.53 ' N ' HG23 ' D' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.849 0.356 . . . . 73.21 110.843 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -83.03 110.01 17.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 71.43 110.907 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 60.5 p -133.22 156.9 46.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 63.41 110.844 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 228' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' D' ' 264' ' ' VAL . . . -129.72 146.79 51.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 75.03 111.029 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.56 -39.91 12.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 61.25 110.847 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -165.3 137.26 4.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 74.03 110.854 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 231' ' ' ILE . . . . . 0.614 HG21 HG11 ' D' ' 275' ' ' VAL . 5.2 mt -139.35 117.19 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 72.42 111.135 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 232' ' ' ARG . . . . . 0.449 ' CD ' HG22 ' D' ' 268' ' ' VAL . 8.1 ptp180 -119.8 130.26 54.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 74.24 110.859 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 233' ' ' THR . . . . . 0.476 HG21 ' CG1' ' D' ' 239' ' ' VAL . 18.6 p -135.9 142.63 44.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 70.22 111.152 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -121.52 163.68 18.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 74.4 110.948 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 63.86 -164.34 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 71.11 110.891 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 38.6 mtt85 -73.77 69.41 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 70.35 110.84 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.15 156.98 17.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 62.21 111.088 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.57 135.69 52.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 63.42 110.851 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.516 HG12 ' HB ' ' D' ' 275' ' ' VAL . 18.0 m -128.53 136.0 61.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 65.33 111.063 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 240' ' ' GLN . . . . . 0.452 ' HB3' HD22 ' D' ' 276' ' ' LEU . 2.3 tm0? -136.8 127.53 27.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 75.21 110.862 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 1.2 mt -111.86 118.2 34.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 61.25 110.959 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.74 174.35 13.65 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 61.5 112.479 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 243' ' ' ASN . . . . . 0.513 ' CB ' HG21 ' C' ' 260' ' ' THR . 0.7 OUTLIER -85.54 149.45 25.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 74.42 110.867 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.49 134.42 62.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 64.31 111.166 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 245' ' ' VAL . . . . . 0.46 HG12 ' HB3' ' D' ' 249' ' ' ALA . 19.5 t -122.55 123.19 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 71.1 111.117 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 246' ' ' THR . . . . . 0.689 HG22 ' HA3' ' D' ' 282' ' ' GLY . 5.0 t -73.37 165.0 25.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 55.25 111.159 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.81 92.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 74.25 111.043 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.63 -35.72 68.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 54.05 111.043 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 249' ' ' ALA . . . . . 0.518 ' HB1' ' CE2' ' D' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 64.3 111.054 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 260' ' ' THR . . . . . 0.546 HG21 ' HB3' ' E' ' 243' ' ' ASN . 6.9 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.904 0.383 . . . . 74.03 111.181 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 261' ' ' THR . . . . . 0.53 HG23 ' N ' ' D' ' 225' ' ' ARG . 23.9 m -92.0 113.77 26.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 71.01 111.18 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -122.08 151.12 41.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 62.14 110.88 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.72 121.98 13.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 72.4 110.848 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.567 ' HB ' HD22 ' E' ' 241' ' ' LEU . 10.6 p -106.48 142.47 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.072 -0.513 . . . . 75.24 111.132 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -84.06 -79.78 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 72.33 110.831 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 48.9 m -127.44 131.97 50.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 74.32 111.099 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.612 ' HB ' HG23 ' D' ' 231' ' ' ILE . 20.1 t -124.06 120.12 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 60.14 111.16 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 268' ' ' VAL . . . . . 0.449 HG22 ' CD ' ' D' ' 232' ' ' ARG . 26.6 t -118.25 122.99 70.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 63.52 111.116 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.62 133.19 8.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.655 -0.784 . . . . 42.22 112.476 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.0 147.29 31.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 74.42 110.836 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 60.51 -142.62 48.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 73.21 112.468 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.38 60.28 2.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.827 0.346 . . . . 72.21 110.88 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 12.7 m -83.83 152.83 24.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.901 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.78 132.41 54.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 74.44 110.866 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.614 HG11 HG21 ' D' ' 231' ' ' ILE . 92.5 t -115.71 122.75 70.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 65.21 111.129 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.1 OUTLIER -129.05 115.91 18.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 65.2 110.913 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 30.7 mm -113.15 103.52 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 62.34 111.109 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.96 -163.15 26.68 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 64.52 112.483 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.97 156.83 25.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.72 0.295 . . . . 63.01 110.876 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.9 118.85 34.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 64.41 110.884 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 281' ' ' TYR . . . . . 0.518 ' CE2' ' HB1' ' D' ' 249' ' ' ALA . 11.0 t80 -103.83 128.64 51.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 65.53 110.93 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 282' ' ' GLY . . . . . 0.689 ' HA3' HG22 ' D' ' 246' ' ' THR . . . 88.94 145.65 11.88 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 71.42 112.515 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 95.16 84.19 1.65 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 63.2 112.478 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -58.02 98.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.798 0.332 . . . . 52.0 110.873 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -174.73 -102.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.723 -0.751 . . . . 63.52 112.491 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -173.71 -37.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.863 0.363 . . . . 74.22 110.854 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 73.55 110.906 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 225' ' ' ARG . . . . . 0.593 ' O ' HG22 ' E' ' 261' ' ' THR . 5.1 mmp_? . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.806 0.336 . . . . 72.52 110.854 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.45 138.01 52.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 75.12 110.897 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 73.9 p -140.65 160.88 39.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 71.02 110.843 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 228' ' ' ALA . . . . . 0.601 ' CB ' HD11 ' E' ' 231' ' ' ILE . . . -126.52 127.95 46.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.501 . . . . 62.54 111.116 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 229' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -73.44 -35.44 65.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 61.35 110.922 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.53 137.18 3.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 62.51 110.888 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 231' ' ' ILE . . . . . 0.601 HD11 ' CB ' ' E' ' 228' ' ' ALA . 9.8 mt -139.67 116.4 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 62.02 111.04 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.6 126.29 48.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 70.14 110.904 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 233' ' ' THR . . . . . 0.577 HG21 ' CG1' ' E' ' 239' ' ' VAL . 32.6 p -135.82 139.57 43.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 73.41 111.205 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -120.96 167.08 12.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 73.24 110.851 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 65.17 -162.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 75.21 110.877 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -75.23 61.16 1.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.52 110.85 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.32 156.76 17.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 63.44 111.151 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -129.88 135.65 48.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 71.34 110.884 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.577 ' CG1' HG21 ' E' ' 233' ' ' THR . 20.2 m -122.92 134.89 64.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 74.41 111.189 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -135.81 128.99 31.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 52.13 110.868 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.802 HD12 ' HB ' ' E' ' 277' ' ' ILE . 9.9 tp -111.38 118.0 34.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 73.3 110.949 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.31 171.91 12.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 43.34 112.446 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 243' ' ' ASN . . . . . 0.546 ' HB3' HG21 ' D' ' 260' ' ' THR . 0.0 OUTLIER -85.91 163.05 18.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 74.02 110.881 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.99 134.06 60.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 70.21 111.142 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 7.2 t -122.08 121.18 63.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 64.41 111.105 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 12.9 t -69.47 173.45 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 62.44 111.171 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.91 89.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 60.31 111.087 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.72 -36.38 69.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 65.34 111.063 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 249' ' ' ALA . . . . . 0.453 ' HB2' ' HE1' ' D' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 51.42 111.098 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 261' ' ' THR . . . . . 0.593 HG22 ' O ' ' E' ' 225' ' ' ARG . 1.3 p . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.764 0.316 . . . . 73.4 111.165 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -126.01 119.93 28.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 63.11 110.908 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.73 122.86 40.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 73.34 110.807 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 264' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' E' ' 228' ' ' ALA . 0.3 OUTLIER -105.19 145.5 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.21 111.099 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 265' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' E' ' 229' ' ' LYS . 2.5 mt-10 -80.59 -76.61 0.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.885 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.38 126.67 17.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 75.21 111.165 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.32 120.59 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 72.13 111.132 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 23.4 t -119.69 115.07 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 74.33 111.155 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.02 133.97 11.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.782 -0.723 . . . . 52.44 112.442 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.73 131.45 52.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 65.31 110.871 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.44 -149.65 30.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 73.33 112.484 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -74.97 68.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 72.55 110.894 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 10.3 t -94.01 162.39 13.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 72.24 110.918 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.53 136.0 47.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 71.31 110.852 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.574 ' CG2' HG12 ' E' ' 239' ' ' VAL . 90.8 t -115.57 124.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 45.32 111.135 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.66 117.99 21.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 52.15 110.96 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.802 ' HB ' HD12 ' E' ' 241' ' ' LEU . 24.7 mm -113.47 102.19 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 73.33 111.15 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 131.85 178.89 15.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.789 -0.719 . . . . 51.42 112.509 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -95.69 156.9 16.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 63.51 110.872 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.57 138.68 54.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 74.34 110.869 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -124.8 124.52 42.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.492 . . . . 72.13 110.88 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 C-N-CA 120.796 -0.716 . . . . 55.12 112.563 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.439 ' HB3' HG23 ' A' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.816 0.341 . . . . 74.33 110.911 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.433 ' HB2' HG22 ' A' ' 277' ' ' ILE . 3.3 p30 -142.07 120.94 12.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 72.43 110.911 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 76.7 p -121.96 151.65 40.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 73.21 110.876 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.63 119.38 16.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 74.35 111.116 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -67.51 -51.64 48.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 71.44 110.875 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.78 135.47 4.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.276 -0.42 . . . . 73.22 110.834 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 6.4 pt -140.12 134.05 35.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 31.03 111.145 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.19 141.64 48.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 72.54 110.926 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.732 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.3 OUTLIER -137.41 152.84 50.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 74.4 111.133 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -138.35 168.62 19.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 52.12 110.887 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.5 -70.7 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 61.05 110.886 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.8 ptt-85 177.88 63.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 72.13 110.857 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.732 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -99.0 157.21 16.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 75.21 111.145 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -126.41 135.32 51.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 64.44 110.913 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.739 HG12 ' HB ' ' A' ' 275' ' ' VAL . 31.2 m -124.43 124.74 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 72.21 111.13 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -114.12 137.49 51.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.877 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 6.0 mp -127.88 118.88 24.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 61.31 110.878 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.07 178.38 15.39 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.794 -0.717 . . . . 61.31 112.557 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -87.97 142.95 27.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 75.42 110.882 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 244' ' ' VAL . 22.3 m -122.2 123.63 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 73.15 111.118 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 281' ' ' TYR . 21.6 t -119.91 129.19 75.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 74.45 111.156 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 73.42 111.16 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 260' ' ' THR . . . . . 0.558 HG21 ' HB3' ' A' ' 279' ' ' ASN . 9.9 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.845 0.355 . . . . 60.41 111.143 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.439 HG23 ' HB3' ' A' ' 225' ' ' ARG . 0.2 OUTLIER -119.59 109.75 16.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 75.34 111.154 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -106.21 137.89 43.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 75.03 110.874 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 14.7 m -135.71 123.26 22.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 63.04 110.871 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.672 HG21 HD12 ' A' ' 277' ' ' ILE . 50.8 t -115.54 115.87 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 54.25 111.118 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -75.17 -75.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.021 0.439 . . . . 73.53 110.903 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.41 126.78 45.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 73.42 111.166 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.599 HG22 HD11 ' B' ' 231' ' ' ILE . 1.6 t -117.47 132.56 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 45.12 111.154 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 72.1 t -127.08 114.97 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 65.24 111.126 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.04 131.71 10.69 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.81 -0.71 . . . . 32.52 112.448 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.81 139.94 47.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.866 0.365 . . . . 63.54 110.924 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 47.71 79.5 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.669 -0.777 . . . . 75.34 112.554 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 49.3 77.66 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 73.34 110.86 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.421 ' H ' ' HB2' ' A' ' 237' ' ' ALA . 0.6 OUTLIER -98.08 145.26 26.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 72.33 110.853 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -111.06 127.41 55.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 75.12 110.906 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.739 ' HB ' HG12 ' A' ' 239' ' ' VAL . 73.0 t -131.06 122.58 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 74.43 111.133 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.685 HD12 ' CD2' ' A' ' 287' ' ' TRP . 0.5 OUTLIER -121.92 111.84 17.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 64.04 110.853 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.672 HD12 HG21 ' A' ' 264' ' ' VAL . 25.9 mm -110.24 103.94 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 72.44 111.144 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 142.61 -169.53 25.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.725 -0.75 . . . . 45.32 112.481 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.558 ' HB3' HG21 ' A' ' 260' ' ' THR . 2.5 p30 -112.59 155.95 23.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.78 0.324 . . . . 71.53 110.851 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.553 ' HG2' HG12 ' B' ' 244' ' ' VAL . 0.3 OUTLIER -121.04 141.3 50.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.43 110.842 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.447 ' HB2' HG22 ' A' ' 245' ' ' VAL . 2.3 m-85 -125.61 133.35 52.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 63.42 110.92 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 109.3 149.89 13.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.69 -0.767 . . . . 32.45 112.475 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.599 ' H ' ' HB2' ' B' ' 247' ' ' ALA . . . -68.15 -127.83 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 61.31 112.468 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.28 25.67 14.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.801 0.334 . . . . 53.42 110.875 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.4 133.41 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.685 -0.769 . . . . 41.55 112.523 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -52.44 131.48 33.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.783 0.325 . . . . 55.35 110.853 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.685 ' CD2' HD12 ' A' ' 276' ' ' LEU . 2.0 t90 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.88 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 16.3 ttt-85 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.856 0.36 . . . . 71.33 110.842 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.585 ' HB2' HG22 ' B' ' 277' ' ' ILE . 0.1 OUTLIER -121.68 129.67 52.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.24 110.886 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.2 p -124.04 145.19 49.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 63.45 110.868 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.19 119.71 23.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 74.22 111.073 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.73 -46.11 76.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 60.45 110.867 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -166.1 137.1 3.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 75.04 110.849 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.599 HD11 HG22 ' A' ' 267' ' ' VAL . 6.4 pt -140.08 132.88 34.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 73.43 111.16 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -135.33 138.43 43.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 55.11 110.883 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.755 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.5 OUTLIER -136.47 151.92 50.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.236 -0.438 . . . . 71.32 111.153 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -141.96 167.59 21.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.423 . . . . 71.33 110.908 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 72.81 -71.2 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.882 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -178.68 67.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 75.3 110.867 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.755 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -105.45 156.42 18.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 65.3 111.084 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -130.38 135.19 47.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 63.54 110.885 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.759 HG12 ' HB ' ' B' ' 275' ' ' VAL . 25.3 m -126.68 130.2 71.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 73.53 111.112 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.449 ' HB3' HD22 ' B' ' 276' ' ' LEU . 2.1 tt0 -119.07 119.89 35.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 75.52 110.942 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.82 118.57 35.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 71.12 110.945 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.07 175.09 13.81 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 61.44 112.462 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -85.99 136.2 33.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.894 0.378 . . . . 63.12 110.847 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.553 HG12 ' HG2' ' A' ' 280' ' ' GLU . 18.2 m -118.51 121.63 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 42.41 111.11 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.463 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 41.0 t -119.52 129.06 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 42.52 111.124 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.423 HG23 ' H ' ' B' ' 249' ' ' ALA . 12.3 t -83.32 175.19 10.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 63.42 111.164 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.599 ' HB2' ' H ' ' A' ' 283' ' ' GLY . . . -63.0 -42.09 99.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 70.44 111.047 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.85 77.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 71.12 111.126 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.463 ' HB3' ' CG1' ' B' ' 245' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 44.1 111.052 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.827 0.346 . . . . 74.52 110.851 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 8.7 t -66.17 126.18 27.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 73.2 111.13 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 94.2 m -131.84 108.98 9.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 71.23 111.144 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' C' ' 241' ' ' LEU . 1.9 t-20 -108.96 136.56 48.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.85 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.84 123.76 21.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.483 . . . . 62.41 110.87 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.964 HG21 HD12 ' B' ' 277' ' ' ILE . 70.5 t -110.34 118.53 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 70.23 111.108 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -67.8 -75.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 73.41 110.884 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 24.7 p -129.56 133.69 47.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 73.3 111.229 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.755 HG23 HG11 ' B' ' 264' ' ' VAL . 2.9 t -118.37 129.37 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 70.23 111.164 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 268' ' ' VAL . . . . . 0.43 ' O ' HG12 ' B' ' 268' ' ' VAL . 2.2 t -127.36 114.79 37.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 61.41 111.099 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.78 132.42 10.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.678 -0.772 . . . . 51.54 112.45 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -132.09 143.25 49.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 72.54 110.934 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 42.98 69.11 0.67 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 33.32 112.429 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 63.57 101.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.836 0.35 . . . . 71.31 110.911 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 3.6 t -130.33 145.77 51.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 54.45 110.898 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -117.28 127.85 54.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 74.42 110.858 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.759 ' HB ' HG12 ' B' ' 239' ' ' VAL . 85.8 t -130.48 123.65 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 75.24 111.165 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.606 HD23 ' CZ2' ' B' ' 287' ' ' TRP . 0.3 OUTLIER -114.49 112.13 22.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 73.3 110.936 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.964 HD12 HG21 ' B' ' 264' ' ' VAL . 14.4 mm -108.47 104.94 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 74.34 111.108 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 135.7 -157.89 23.51 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.774 -0.727 . . . . 35.41 112.527 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.5 156.04 27.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 74.43 110.878 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.551 ' HG2' HG12 ' C' ' 244' ' ' VAL . 15.2 pt-20 -129.39 141.8 50.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 74.11 110.881 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -129.98 125.73 36.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 74.34 110.888 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 152.35 156.14 7.37 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.685 -0.769 . . . . 64.4 112.474 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 283' ' ' GLY . . . . . 0.469 ' N ' ' HB2' ' C' ' 247' ' ' ALA . . . -96.11 -53.19 1.52 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 72.43 112.521 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -52.08 103.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 73.53 110.833 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.52 116.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.751 -0.737 . . . . 22.52 112.457 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' C' ' 244' ' ' VAL . 5.0 t80 -52.1 -33.44 39.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.347 . . . . 75.21 110.903 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.606 ' CZ2' HD23 ' B' ' 276' ' ' LEU . 15.9 t90 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 75.01 110.962 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.039 0 CA-C-O 120.884 0.373 . . . . 73.53 110.85 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.05 120.63 41.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 75.14 110.864 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 3.3 t -129.67 138.69 51.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 71.02 110.894 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -119.04 131.98 56.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 73.21 111.133 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -33.05 34.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 70.12 110.901 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -166.01 138.0 3.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 72.33 110.864 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -138.69 117.31 13.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 73.54 111.143 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -131.82 130.23 41.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 63.35 110.898 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 0.2 OUTLIER -136.25 155.44 50.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 72.43 111.144 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -144.35 168.06 20.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 72.22 110.885 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.78 -72.23 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 73.31 110.856 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -177.99 64.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 75.55 110.85 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.607 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -105.69 156.46 18.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 35.3 111.087 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -128.79 135.25 48.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 71.23 110.892 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.828 HG12 ' HB ' ' C' ' 275' ' ' VAL . 20.9 m -126.14 121.6 59.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.469 . . . . 62.33 111.117 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.611 ' HB3' HD22 ' C' ' 276' ' ' LEU . 1.8 tt0 -115.63 120.65 40.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 54.11 110.913 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.74 HD22 HG22 ' B' ' 264' ' ' VAL . 3.3 mp -114.96 118.72 34.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 72.44 110.935 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.48 178.23 15.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 74.34 112.503 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -85.65 128.52 34.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.857 0.36 . . . . 71.02 110.891 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.551 HG12 ' HG2' ' B' ' 280' ' ' GLU . 28.5 m -114.07 128.4 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 75.21 111.136 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 46.8 t -122.17 129.02 75.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 73.21 111.086 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -77.5 174.27 11.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 74.41 111.126 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.469 ' HB2' ' N ' ' B' ' 283' ' ' GLY . . . -57.04 -41.03 77.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 73.53 111.045 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 248' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' C' ' 249' ' ' ALA . . . -57.1 -51.91 67.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 44.04 111.044 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 249' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' C' ' 248' ' ' ALA . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 62.22 111.088 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.973 0.416 . . . . 75.04 110.925 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 260' ' ' THR . . . . . 0.794 HG21 ' HB3' ' C' ' 279' ' ' ASN . 4.9 t -100.94 130.01 46.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 71.22 111.125 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 18.7 m -126.58 118.96 25.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.261 -0.427 . . . . 74.42 111.121 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.602 ' OD1' HG23 ' C' ' 277' ' ' ILE . 6.7 t-20 -120.63 144.63 48.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 62.11 110.866 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 9.4 t -141.62 123.85 15.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 71.53 110.905 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.796 HG21 HD12 ' C' ' 277' ' ' ILE . 46.2 t -108.07 145.86 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 64.12 111.205 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.92 -55.69 3.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 74.32 110.84 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.46 128.51 11.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 73.35 111.165 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.761 HG23 HG11 ' C' ' 264' ' ' VAL . 54.4 t -118.75 120.42 64.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 72.02 111.106 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.14 118.06 47.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 74.33 111.16 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.9 133.23 10.1 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.715 -0.755 . . . . 35.45 112.502 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -125.44 147.75 49.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 74.23 110.869 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 47.2 67.85 1.35 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.812 -0.709 . . . . 43.24 112.474 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 64.14 107.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.883 0.373 . . . . 72.24 110.899 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 3.3 m -139.8 150.16 44.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 73.2 110.865 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -124.72 128.24 48.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.831 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.828 ' HB ' HG12 ' C' ' 239' ' ' VAL . 89.8 t -132.28 123.34 50.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 75.25 111.134 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.2 OUTLIER -116.98 117.14 28.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 70.34 110.921 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.796 HD12 HG21 ' C' ' 264' ' ' VAL . 24.9 mm -110.63 104.24 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 74.01 111.134 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.03 -162.74 25.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.743 . . . . 55.43 112.491 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 279' ' ' ASN . . . . . 0.794 ' HB3' HG21 ' C' ' 260' ' ' THR . 8.1 p-10 -106.66 155.97 19.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.787 0.327 . . . . 72.33 110.897 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.642 ' HG3' HG12 ' D' ' 244' ' ' VAL . 2.7 pp20? -131.22 150.15 52.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 71.32 110.852 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -130.05 126.03 36.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 52.11 110.905 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 145.75 141.97 3.73 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.745 -0.741 . . . . 73.21 112.499 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -112.2 -169.5 18.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.732 . . . . 44.23 112.463 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 7.8 tttt 53.89 29.44 9.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 73.25 110.879 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -179.11 -35.26 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.683 -0.77 . . . . 72.34 112.415 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.448 ' CE1' HG21 ' D' ' 244' ' ' VAL . 5.4 t80 71.9 -69.25 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.898 0.38 . . . . 75.22 110.912 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 15.9 t90 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 74.53 110.87 179.993 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.882 0.372 . . . . 72.15 110.879 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 226' ' ' ASN . . . . . 0.637 ' HB3' HG22 ' D' ' 277' ' ' ILE . 0.1 OUTLIER -89.44 111.98 23.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 73.32 110.887 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.77 137.58 54.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 62.23 110.786 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.09 155.94 37.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.114 -0.493 . . . . 75.21 111.094 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.88 -29.8 8.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 75.01 110.895 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 230' ' ' ASP . . . . . 0.46 ' HB3' HG23 ' D' ' 266' ' ' THR . 0.3 OUTLIER -165.49 138.31 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 63.32 110.884 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 2.4 mt -138.91 117.28 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.144 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 232' ' ' ARG . . . . . 0.457 ' HD2' HG23 ' D' ' 268' ' ' VAL . 0.8 OUTLIER -131.64 131.23 43.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.14 110.936 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 233' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' D' ' 237' ' ' ALA . 0.2 OUTLIER -136.28 155.9 49.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 70.41 111.086 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -148.28 166.91 26.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 72.44 110.876 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.9 -71.99 0.12 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.104 -0.498 . . . . 73.02 110.861 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -177.0 63.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 74.05 110.845 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 237' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -104.76 154.51 19.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 62.45 111.158 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -130.01 134.98 47.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 71.53 110.93 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.782 HG12 ' HB ' ' D' ' 275' ' ' VAL . 21.6 m -127.89 121.19 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 70.31 111.154 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -121.31 128.58 52.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 74.32 110.964 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 mp -120.66 118.79 31.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 65.53 110.917 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 143.14 179.0 19.48 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.752 -0.737 . . . . 73.52 112.474 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -85.83 129.11 34.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.919 0.39 . . . . 71.33 110.864 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 244' ' ' VAL . . . . . 0.642 HG12 ' HG3' ' C' ' 280' ' ' GLU . 35.1 m -111.39 129.52 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 64.15 111.138 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.31 129.03 75.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 61.02 111.138 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 21.5 p -77.6 174.84 10.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 63.34 111.138 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.1 85.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 74.33 111.144 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 248' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' D' ' 249' ' ' ALA . . . -57.03 -52.01 66.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 70.13 111.136 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 249' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' D' ' 248' ' ' ALA . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 74.11 111.105 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.869 0.366 . . . . 72.21 111.151 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 3.1 m -134.53 126.77 30.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 72.31 111.192 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 262' ' ' ASN . . . . . 0.525 ' ND2' HG23 ' D' ' 277' ' ' ILE . 3.1 t30 -126.08 139.61 53.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.295 -0.411 . . . . 74.01 110.955 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 7.9 t -142.09 123.81 15.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 74.43 110.844 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.721 HG21 HD12 ' D' ' 277' ' ' ILE . 21.7 t -114.34 149.61 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 70.3 111.172 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.84 -77.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 72.44 110.939 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 266' ' ' THR . . . . . 0.46 HG23 ' HB3' ' D' ' 230' ' ' ASP . 1.5 m -127.71 127.83 44.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 63.14 111.108 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.568 ' CG2' HG11 ' D' ' 264' ' ' VAL . 98.2 t -118.69 120.41 64.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 75.02 111.122 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 268' ' ' VAL . . . . . 0.457 HG23 ' HD2' ' D' ' 232' ' ' ARG . 4.7 p -126.53 117.81 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 74.44 111.102 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.72 132.65 10.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 44.24 112.427 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -126.02 147.13 49.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 73.12 110.84 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 44.86 76.75 0.11 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.769 -0.729 . . . . 65.55 112.475 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.74 98.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.802 0.334 . . . . 70.23 110.899 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 4.1 t -130.18 145.33 51.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 53.52 110.908 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -123.97 127.97 48.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 60.24 110.849 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.782 ' HB ' HG12 ' D' ' 239' ' ' VAL . 94.3 t -135.56 123.38 37.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 73.32 111.106 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.438 HD13 ' N ' ' D' ' 277' ' ' ILE . 1.1 tm? -121.72 119.57 32.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 73.51 110.893 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.721 HD12 HG21 ' D' ' 264' ' ' VAL . 27.5 mm -112.29 104.24 16.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 71.34 111.165 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.3 -159.07 27.44 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.75 -0.738 . . . . 52.01 112.52 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -115.92 156.12 26.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.77 0.319 . . . . 64.4 110.917 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 280' ' ' GLU . . . . . 0.506 ' HG2' HG13 ' E' ' 244' ' ' VAL . 10.4 pt-20 -126.03 134.92 51.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 74.13 110.803 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 281' ' ' TYR . . . . . 0.468 ' CZ ' HG21 ' E' ' 245' ' ' VAL . 7.5 m-85 -120.32 125.94 49.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 72.21 110.958 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.01 158.36 7.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.79 -0.719 . . . . 60.13 112.544 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 283' ' ' GLY . . . . . 0.575 ' N ' ' HB2' ' E' ' 247' ' ' ALA . . . -104.57 63.93 0.34 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 62.1 112.416 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.94 32.91 1.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.8 0.333 . . . . 73.11 110.876 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 78.98 -67.82 3.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 35.44 112.459 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -178.81 108.75 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 71.05 110.852 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 74.0 110.921 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 225' ' ' ARG . . . . . 0.501 ' N ' HG23 ' E' ' 261' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.824 0.345 . . . . 51.11 110.874 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -83.8 109.92 17.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 72.51 110.857 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.43 139.85 45.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.2 110.824 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.38 162.06 26.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 75.44 111.151 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.05 -26.87 7.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 61.13 110.887 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 230' ' ' ASP . . . . . 0.439 ' HB3' HG23 ' E' ' 266' ' ' THR . 0.4 OUTLIER -164.82 138.62 4.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.43 . . . . 75.12 110.841 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 231' ' ' ILE . . . . . 0.409 HD11 HG13 ' D' ' 264' ' ' VAL . 5.0 mt -138.55 117.35 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 73.43 111.127 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.32 131.23 39.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 72.13 110.791 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.29 157.81 45.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 50.41 111.128 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -150.29 167.55 26.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 62.51 110.933 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 72.09 -73.35 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 74.51 110.846 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -178.29 62.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 70.03 110.85 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.34 156.45 17.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 61.32 111.196 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.19 135.15 47.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 73.11 110.856 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.795 HG12 ' HB ' ' E' ' 275' ' ' VAL . 18.0 m -122.74 121.84 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 72.32 111.143 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 240' ' ' GLN . . . . . 0.625 ' O ' HD23 ' E' ' 276' ' ' LEU . 2.0 tt0 -119.59 114.41 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.23 110.921 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.481 HD13 ' CD1' ' D' ' 277' ' ' ILE . 3.3 mp -114.84 135.09 54.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 61.51 110.976 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.06 -120.18 2.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.718 -0.754 . . . . 62.21 112.508 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -144.0 128.85 18.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.884 0.373 . . . . 71.43 110.851 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.506 HG13 ' HG2' ' D' ' 280' ' ' GLU . 0.4 OUTLIER -102.86 119.6 51.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 74.35 111.16 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 245' ' ' VAL . . . . . 0.468 HG21 ' CZ ' ' D' ' 281' ' ' TYR . 41.2 t -122.05 123.52 69.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 72.2 111.138 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.1 t -74.43 174.88 8.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 61.34 111.133 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 247' ' ' ALA . . . . . 0.575 ' HB2' ' N ' ' D' ' 283' ' ' GLY . . . -53.22 -45.64 68.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 75.44 111.099 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.92 -49.8 74.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 71.53 111.132 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 44.4 111.073 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 261' ' ' THR . . . . . 0.501 HG23 ' N ' ' E' ' 225' ' ' ARG . 34.9 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.821 0.343 . . . . 63.34 111.129 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 262' ' ' ASN . . . . . 0.488 ' OD1' HG23 ' E' ' 277' ' ' ILE . 1.8 t-20 -126.12 123.45 38.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 71.32 110.858 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 43.2 t -127.18 123.81 37.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 60.14 110.878 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 264' ' ' VAL . . . . . 0.566 HG21 HD12 ' E' ' 277' ' ' ILE . 21.2 t -124.32 150.34 28.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 55.05 111.102 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.01 -77.5 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 72.04 110.865 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 266' ' ' THR . . . . . 0.439 HG23 ' HB3' ' E' ' 230' ' ' ASP . 9.4 m -126.37 127.83 46.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 64.22 111.162 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 267' ' ' VAL . . . . . 0.544 ' CG2' HG11 ' E' ' 264' ' ' VAL . 22.0 t -119.08 120.16 63.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 63.4 111.156 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 268' ' ' VAL . . . . . 0.417 ' O ' HG13 ' E' ' 268' ' ' VAL . 4.1 p -123.78 118.18 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 73.34 111.154 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.28 136.18 13.39 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.756 -0.735 . . . . 74.23 112.399 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -132.58 133.54 43.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.756 0.313 . . . . 74.24 110.897 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.81 93.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 53.25 112.522 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 44.1 69.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 70.22 110.826 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.34 145.25 26.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 62.13 110.817 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -127.24 128.19 45.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 73.32 110.872 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.795 ' HB ' HG12 ' E' ' 239' ' ' VAL . 84.2 t -136.85 123.92 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 74.32 111.134 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 276' ' ' LEU . . . . . 0.625 HD23 ' O ' ' E' ' 240' ' ' GLN . 0.5 OUTLIER -125.64 122.55 36.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 70.52 110.899 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.566 HD12 HG21 ' E' ' 264' ' ' VAL . 30.4 mm -112.0 104.53 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 74.4 111.169 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 135.07 -169.84 23.14 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.755 . . . . 74.53 112.518 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -99.82 155.96 17.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 71.43 110.897 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -130.6 132.03 45.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.491 . . . . 50.22 110.856 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -113.8 125.9 54.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 73.42 110.874 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.742 -0.742 . . . . 73.32 112.485 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.651 ' HG3' HG23 ' A' ' 261' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.867 0.365 . . . . 74.42 110.879 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.27 130.35 26.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 62.35 110.876 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 48.4 t -121.81 137.69 54.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.478 . . . . 74.1 110.843 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.62 128.18 34.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 64.23 111.111 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.67 -37.14 13.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.938 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.535 ' HB3' HG23 ' A' ' 266' ' ' THR . 0.7 OUTLIER -164.38 138.9 5.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 63.51 110.878 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.485 HG21 HG21 ' A' ' 239' ' ' VAL . 7.7 mt -137.25 117.53 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 63.5 111.116 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -124.98 117.04 23.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 75.42 110.839 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.31 131.2 36.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 45.13 111.123 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -132.95 164.9 25.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 51.14 110.906 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 236' ' ' ARG . 2.7 tt0 65.0 79.53 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 72.43 110.897 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 235' ' ' GLU . 16.9 ptt180 35.29 60.46 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 74.52 110.918 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.29 152.75 21.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 44.42 111.136 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -129.28 142.52 50.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 74.35 110.831 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.485 HG21 HG21 ' A' ' 231' ' ' ILE . 6.1 p -143.02 121.65 7.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 63.43 111.124 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -108.84 137.46 46.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 72.5 110.98 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.58 118.65 22.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 64.33 110.891 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.37 -172.61 20.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.708 -0.758 . . . . 75.12 112.504 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -92.24 139.19 30.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.909 0.385 . . . . 74.54 110.909 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.02 129.7 65.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 75.54 111.21 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 89.5 t -122.07 127.28 75.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 72.11 111.127 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 281' ' ' TYR . 53.6 p . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 71.11 111.155 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' THR . . . . . 0.567 HG23 ' N ' ' B' ' 225' ' ' ARG . 99.6 m . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.819 0.342 . . . . 52.21 111.132 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.651 HG23 ' HG3' ' A' ' 225' ' ' ARG . 98.4 m -112.91 111.74 22.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 73.5 111.159 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -111.48 150.3 30.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 44.41 110.805 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.4 t -138.31 123.97 19.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 53.24 110.951 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.513 HG21 ' CG2' ' A' ' 267' ' ' VAL . 9.7 p -108.81 135.77 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.45 111.135 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.32 -75.96 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 53.15 110.952 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.535 HG23 ' HB3' ' A' ' 230' ' ' ASP . 1.6 m -130.14 131.98 45.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 73.42 111.153 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.513 ' CG2' HG21 ' A' ' 264' ' ' VAL . 96.7 t -117.89 131.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 55.24 111.147 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 58.6 t -127.55 128.03 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 71.33 111.117 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.98 133.62 7.87 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.735 -0.745 . . . . 42.13 112.515 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -132.8 147.77 52.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.793 0.33 . . . . 65.44 110.877 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.28 78.17 0.11 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.761 -0.733 . . . . 63.0 112.459 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 47.59 64.58 1.55 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.882 0.372 . . . . 71.23 110.941 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 26.3 t -92.93 145.65 24.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 62.43 110.873 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -126.39 128.31 46.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 70.54 110.929 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.693 HG13 HG13 ' B' ' 239' ' ' VAL . 20.6 t -128.92 123.59 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 62.44 111.137 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.425 HD23 ' CZ2' ' A' ' 287' ' ' TRP . 0.2 OUTLIER -111.07 117.24 32.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 64.34 110.917 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.15 112.41 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 71.05 111.152 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 133.01 -164.91 24.11 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 52.2 112.443 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -103.8 152.61 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 62.42 110.84 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.537 ' HG3' HG12 ' B' ' 244' ' ' VAL . 1.4 pp20? -131.49 134.51 46.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 73.24 110.968 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.457 ' O ' HG23 ' A' ' 246' ' ' THR . 0.2 OUTLIER -112.4 125.94 54.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 73.45 110.915 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.84 135.8 3.17 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.717 -0.754 . . . . 71.42 112.521 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -111.22 177.11 18.94 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.691 -0.766 . . . . 73.53 112.441 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt 52.0 53.4 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 55.11 110.871 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 177.56 -69.02 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.822 -0.704 . . . . 40.25 112.521 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 2.1 t80 64.34 109.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 75.32 110.823 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.425 ' CZ2' HD23 ' A' ' 276' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 62.41 110.875 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.567 ' N ' HG23 ' A' ' 260' ' ' THR . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.806 0.336 . . . . 74.14 110.922 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.34 123.44 14.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 75.21 110.93 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 1.4 t -121.51 137.71 54.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 64.3 110.86 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.549 ' HB2' HD11 ' B' ' 241' ' ' LEU . . . -127.7 129.16 46.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 72.15 111.082 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.26 -35.28 23.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 72.02 110.953 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 230' ' ' ASP . . . . . 0.611 ' HB3' HG23 ' B' ' 266' ' ' THR . 0.3 OUTLIER -164.56 138.42 5.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.869 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.736 HG21 HG21 ' B' ' 239' ' ' VAL . 11.2 mt -137.64 117.6 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 63.41 111.059 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -130.64 119.3 22.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 73.03 110.846 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.02 131.41 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 70.51 111.148 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -132.04 167.3 19.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 73.55 110.837 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' B' ' 236' ' ' ARG . 0.1 OUTLIER 64.24 78.43 0.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 71.24 110.868 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' B' ' 235' ' ' GLU . 11.0 ptt180 36.34 54.84 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 73.34 110.931 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -100.61 156.15 17.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 52.03 111.137 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -132.59 136.3 46.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 53.13 110.877 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.736 HG21 HG21 ' B' ' 231' ' ' ILE . 6.2 p -137.24 121.71 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 70.42 111.177 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.495 ' OE1' HD11 ' B' ' 276' ' ' LEU . 0.5 OUTLIER -114.22 137.48 51.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 72.15 110.891 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' B' ' 228' ' ' ALA . 0.3 OUTLIER -128.71 118.6 23.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 74.12 110.897 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.7 176.45 14.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.718 -0.753 . . . . 65.44 112.536 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -85.95 133.48 33.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.882 0.372 . . . . 75.02 110.841 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.537 HG12 ' HG3' ' A' ' 280' ' ' GLU . 33.7 m -116.51 132.18 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 74.33 111.105 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 60.1 t -122.04 120.26 60.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 65.31 111.123 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.505 HG23 ' O ' ' B' ' 281' ' ' TYR . 33.6 p -84.68 163.21 19.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 73.14 111.126 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.47 -36.95 84.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 64.23 111.13 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -62.06 -36.51 81.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 65.53 111.138 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 51.41 111.017 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.895 0.378 . . . . 74.24 110.933 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 49.2 p -101.09 122.55 43.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.438 . . . . 75.14 111.147 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 1.1 t -134.14 108.95 8.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 75.54 111.172 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.544 ' ND2' HG22 ' B' ' 277' ' ' ILE . 11.4 p-10 -95.94 149.52 21.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 60.43 110.897 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 44.6 m -140.22 124.08 17.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 61.12 110.852 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.486 HG21 ' CG2' ' B' ' 267' ' ' VAL . 13.4 p -109.58 131.62 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.48 . . . . 71.41 111.125 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -73.63 -76.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 73.14 110.835 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.611 HG23 ' HB3' ' B' ' 230' ' ' ASP . 1.3 m -131.52 135.38 47.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 71.11 111.118 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.659 ' CG1' HG21 ' B' ' 275' ' ' VAL . 85.5 t -117.67 128.4 74.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 74.22 111.151 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 68.8 t -127.23 119.47 52.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 53.22 111.104 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.3 132.98 9.05 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.743 -0.742 . . . . 64.42 112.461 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.65 147.93 51.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 72.34 110.902 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.44 82.66 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.753 . . . . 55.23 112.478 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 46.3 63.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 75.14 110.849 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 25.7 t -96.78 145.66 25.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 72.42 110.867 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.12 127.99 46.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 65.11 110.859 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.659 HG21 ' CG1' ' B' ' 267' ' ' VAL . 21.6 t -130.85 123.77 55.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 71.24 111.135 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.495 HD11 ' OE1' ' B' ' 240' ' ' GLN . 0.4 OUTLIER -114.86 116.76 29.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 63.12 110.887 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.544 HG22 ' ND2' ' B' ' 262' ' ' ASN . 25.4 mm -110.79 104.18 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.24 111.146 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.49 -176.91 21.54 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.781 -0.723 . . . . 72.43 112.463 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -92.17 147.12 23.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.727 0.299 . . . . 71.41 110.91 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.597 ' HG3' HG12 ' C' ' 244' ' ' VAL . 0.0 OUTLIER -128.45 141.7 51.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 65.51 110.858 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.505 ' O ' HG23 ' B' ' 246' ' ' THR . 0.8 OUTLIER -127.1 125.99 42.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.181 -0.463 . . . . 75.11 110.952 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 168.26 151.22 6.98 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.769 -0.729 . . . . 72.13 112.496 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -53.82 176.23 0.31 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.781 -0.723 . . . . 62.32 112.497 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.88 104.76 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 75.41 110.883 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -159.05 -38.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 61.31 112.541 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.66 ' CE1' HD21 ' C' ' 276' ' ' LEU . 10.6 t80 64.43 111.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.858 0.361 . . . . 61.44 110.881 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.441 ' HE1' HD23 ' B' ' 276' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 75.3 110.885 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.824 0.345 . . . . 73.23 110.844 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -83.91 139.69 32.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 70.22 110.917 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.88 144.64 50.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.35 110.82 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.94 143.09 51.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 73.35 111.134 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.35 -32.61 12.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 75.32 110.898 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 230' ' ' ASP . . . . . 0.622 ' HB3' HG22 ' C' ' 266' ' ' THR . 0.2 OUTLIER -165.04 137.85 4.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 72.13 110.924 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.462 HG21 HG21 ' C' ' 239' ' ' VAL . 16.7 mt -137.34 117.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 74.22 111.078 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -132.71 115.87 15.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 74.25 110.861 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -135.41 135.48 40.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.461 . . . . 74.31 111.123 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.48 166.99 23.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 72.2 110.88 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 66.87 72.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 74.43 110.93 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 44.32 53.26 6.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 72.15 110.84 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.2 147.9 26.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 72.41 111.047 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.0 135.75 52.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.868 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.56 HG13 HG13 ' B' ' 275' ' ' VAL . 6.0 p -133.78 121.86 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.54 111.098 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -108.77 136.55 48.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 73.21 110.946 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.17 119.21 22.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 65.05 110.888 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.15 173.66 13.46 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.758 -0.734 . . . . 73.01 112.439 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -85.81 134.22 33.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 73.34 110.865 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.597 HG12 ' HG3' ' B' ' 280' ' ' GLU . 30.9 m -113.45 131.95 63.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.082 -0.508 . . . . 60.33 111.156 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.18 129.24 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 74.35 111.145 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 12.9 p -86.71 169.33 12.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 61.44 111.185 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.03 76.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 73.21 111.174 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.37 76.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 71.41 111.106 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 63.53 111.126 179.939 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.838 0.352 . . . . 74.52 110.951 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 260' ' ' THR . . . . . 0.533 HG21 ' CG ' ' D' ' 243' ' ' ASN . 29.3 m -100.85 137.89 38.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 75.5 111.127 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.612 HG23 ' CB ' ' D' ' 225' ' ' ARG . 1.5 t -125.01 133.17 53.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 31.22 111.149 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.604 HD22 ' HA2' ' C' ' 278' ' ' GLY . 0.4 OUTLIER -126.8 145.73 50.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 71.14 110.893 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.69 123.39 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 63.21 110.885 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.462 HG21 ' CG2' ' C' ' 267' ' ' VAL . 7.9 p -110.48 127.77 67.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 60.35 111.081 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.91 -71.83 0.26 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.107 -0.497 . . . . 71.14 110.847 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 266' ' ' THR . . . . . 0.622 HG22 ' HB3' ' C' ' 230' ' ' ASP . 5.7 p -140.48 137.18 33.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 52.3 111.081 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.694 ' CG1' HG21 ' C' ' 275' ' ' VAL . 19.2 t -116.8 128.36 74.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 60.21 111.18 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 268' ' ' VAL . . . . . 0.405 ' O ' HG12 ' C' ' 268' ' ' VAL . 2.0 t -127.24 117.91 48.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 73.43 111.137 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.1 132.74 9.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.736 -0.745 . . . . 62.45 112.452 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.81 140.94 48.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 71.52 110.931 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 46.58 84.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.701 -0.761 . . . . 64.34 112.49 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 51.1 82.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.885 0.374 . . . . 53.24 110.87 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 29.2 t -116.44 145.61 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 63.42 110.881 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -128.97 127.62 42.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.488 . . . . 72.44 110.825 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.694 HG21 ' CG1' ' C' ' 267' ' ' VAL . 48.2 t -132.07 123.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 64.43 111.125 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.66 HD21 ' CE1' ' B' ' 286' ' ' PHE . 0.1 OUTLIER -112.54 111.58 22.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.221 -0.445 . . . . 64.24 110.952 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 23.4 mm -111.0 104.71 17.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 74.3 111.134 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 278' ' ' GLY . . . . . 0.604 ' HA2' HD22 ' C' ' 262' ' ' ASN . . . 153.5 -154.58 25.6 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 51.31 112.48 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -128.14 145.25 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.347 . . . . 74.44 110.92 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -113.06 129.72 56.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 72.02 110.946 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -119.8 126.02 49.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 64.33 110.846 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 103.28 101.68 2.66 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.692 -0.765 . . . . 33.5 112.415 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 95.16 -167.45 26.44 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.712 -0.756 . . . . 55.23 112.478 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -172.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 74.12 110.893 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -86.01 -18.62 59.16 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.754 -0.736 . . . . 71.22 112.45 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.96 124.0 22.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 65.23 110.925 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 16.1 p90 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.926 -179.948 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 225' ' ' ARG . . . . . 0.612 ' CB ' HG23 ' C' ' 261' ' ' THR . 3.7 ptt180 . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.792 0.33 . . . . 72.14 110.908 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.78 132.17 38.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 62.43 110.847 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.09 150.76 44.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 63.14 110.842 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.1 158.86 36.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 73.05 111.154 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -109.15 -32.94 7.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.29 -0.414 . . . . 72.1 110.938 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -164.63 138.18 5.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 64.44 110.834 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 231' ' ' ILE . . . . . 0.403 HD12 HG23 ' C' ' 264' ' ' VAL . 13.8 mt -138.85 117.82 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 65.44 111.141 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -133.22 121.39 22.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 65.22 110.859 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.7 p -136.39 148.41 47.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.177 -0.465 . . . . 73.22 111.135 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.79 166.52 33.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 74.31 110.915 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 64.09 72.76 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 71.25 110.959 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 47.8 33.86 3.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 74.11 110.853 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.8 142.57 27.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 74.35 111.155 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -126.88 135.87 51.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 60.32 110.902 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.54 HG13 HG13 ' C' ' 275' ' ' VAL . 5.3 p -128.54 137.51 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 64.3 111.114 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 240' ' ' GLN . . . . . 0.732 ' HB3' HD13 ' D' ' 276' ' ' LEU . 3.7 tm0? -117.32 135.91 53.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 63.03 110.935 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.19 129.75 43.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 71.14 110.898 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 121.74 -131.3 8.44 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.699 -0.762 . . . . 72.32 112.464 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 243' ' ' ASN . . . . . 0.533 ' CG ' HG21 ' C' ' 260' ' ' THR . 1.8 p-10 -144.99 150.8 37.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 72.5 110.815 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 244' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' D' ' 280' ' ' GLU . 13.7 m -122.73 124.36 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 63.5 111.133 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 245' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' D' ' 281' ' ' TYR . 28.4 t -121.23 129.05 76.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 62.31 111.194 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 246' ' ' THR . . . . . 0.434 HG21 ' HA2' ' D' ' 283' ' ' GLY . 68.4 p -72.26 174.57 7.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 65.34 111.17 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.48 -45.9 73.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.277 -0.419 . . . . 71.53 111.103 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.27 -50.38 73.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 35.23 111.071 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 42.41 111.091 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 260' ' ' THR . . . . . 0.664 HG23 ' HD2' ' E' ' 225' ' ' ARG . 75.8 m . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.878 0.371 . . . . 72.35 111.142 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 261' ' ' THR . . . . . 0.628 ' H ' ' NE ' ' E' ' 225' ' ' ARG . 95.1 m -100.33 108.95 21.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 64.2 111.17 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -116.31 150.32 37.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 73.41 110.892 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.37 123.79 16.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 54.21 110.859 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 11.4 p -107.55 134.23 49.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 65.22 111.094 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.45 -75.44 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 75.31 110.855 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 44.8 p -148.74 135.38 19.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 73.11 111.153 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.686 ' CG1' HG21 ' D' ' 275' ' ' VAL . 14.5 t -117.67 128.24 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 62.53 111.07 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 268' ' ' VAL . . . . . 0.4 HG11 ' HD3' ' E' ' 232' ' ' ARG . 5.9 p -127.19 122.87 60.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 65.33 111.204 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.57 133.84 10.54 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.698 -0.763 . . . . 63.42 112.473 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -132.48 136.48 46.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.808 0.337 . . . . 71.5 110.849 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.68 87.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 64.42 112.506 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 51.95 80.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 74.14 110.883 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 40.7 t -114.61 145.29 42.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 75.25 110.828 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -130.62 127.12 38.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 71.02 110.873 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.686 HG21 ' CG1' ' D' ' 267' ' ' VAL . 85.1 t -136.17 126.74 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 75.04 111.163 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.732 HD13 ' HB3' ' D' ' 240' ' ' GLN . 0.5 OUTLIER -124.2 111.22 15.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 72.15 110.917 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 31.1 mm -109.68 104.85 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 63.53 111.167 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 159.25 -165.36 34.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.795 -0.717 . . . . 52.12 112.522 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -123.66 156.19 36.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.774 0.321 . . . . 70.55 110.92 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 280' ' ' GLU . . . . . 0.4 ' HA ' HG23 ' D' ' 244' ' ' VAL . 19.3 tt0 -111.77 119.24 37.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 70.31 110.959 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 281' ' ' TYR . . . . . 0.598 ' HB3' HG13 ' D' ' 245' ' ' VAL . 2.0 m-85 -103.68 125.82 50.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 55.3 110.89 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 62.88 31.63 81.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.718 -0.753 . . . . 52.04 112.471 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 283' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' D' ' 246' ' ' THR . . . -95.75 -116.46 3.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 71.01 112.546 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -179.41 34.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 62.31 110.868 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.25 -113.18 3.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 73.23 112.455 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.85 -179.35 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.853 0.358 . . . . 71.23 110.844 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 12.0 p90 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 74.15 110.911 -179.933 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 225' ' ' ARG . . . . . 0.664 ' HD2' HG23 ' D' ' 260' ' ' THR . 1.5 ptp180 . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.844 0.354 . . . . 65.41 110.934 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -105.42 108.83 20.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 53.31 110.895 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.59 152.41 45.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 61.41 110.873 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.8 163.01 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 63.13 111.123 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.49 -33.31 6.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 74.21 110.942 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 230' ' ' ASP . . . . . 0.616 ' HB2' HG22 ' E' ' 266' ' ' THR . 0.2 OUTLIER -167.27 140.44 3.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 74.45 110.804 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 231' ' ' ILE . . . . . 0.525 HG23 HG21 ' E' ' 239' ' ' VAL . 17.3 mt -136.98 114.9 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 55.03 111.118 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 232' ' ' ARG . . . . . 0.4 ' HD3' HG11 ' D' ' 268' ' ' VAL . 2.9 ttp180 -132.27 119.93 21.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 63.34 110.917 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.69 144.35 45.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 72.44 111.129 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -156.4 166.13 34.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 73.23 110.883 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 59.42 72.3 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 70.33 110.88 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 50.0 43.57 25.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 63.41 110.923 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.09 144.93 29.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 63.44 111.071 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -128.92 141.66 51.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.53 110.881 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.679 ' CG1' HG22 ' D' ' 275' ' ' VAL . 7.8 p -134.77 134.48 53.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 64.22 111.158 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 240' ' ' GLN . . . . . 0.473 ' HB3' HD13 ' E' ' 276' ' ' LEU . 7.2 tm0? -119.42 137.22 53.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.428 . . . . 71.3 110.864 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.746 HD22 ' HB ' ' E' ' 277' ' ' ILE . 0.1 OUTLIER -130.31 118.72 21.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 73.22 110.935 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 123.73 177.88 15.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.696 -0.764 . . . . 62.43 112.481 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -89.65 145.38 25.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.787 0.327 . . . . 71.3 110.941 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 9.6 m -120.16 139.16 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 71.44 111.114 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.5 128.32 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 74.14 111.177 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.5 t -69.77 175.2 4.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 71.32 111.17 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.43 76.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 62.04 111.124 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.13 -51.72 68.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 35.13 111.116 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 70.13 111.088 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 261' ' ' THR . . . . . 0.498 HG23 ' HA ' ' E' ' 225' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.765 0.317 . . . . 65.51 111.177 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.3 136.18 52.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 65.54 110.936 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 1.3 t -126.8 121.88 33.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.841 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 264' ' ' VAL . . . . . 0.454 HG11 HD21 ' E' ' 241' ' ' LEU . 8.0 p -102.41 123.0 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 41.31 111.134 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 265' ' ' GLU . . . . . 0.432 ' CD ' ' N ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -65.23 -142.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 73.52 110.907 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 266' ' ' THR . . . . . 0.616 HG22 ' HB2' ' E' ' 230' ' ' ASP . 3.2 p -92.14 128.79 38.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 71.22 111.122 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 267' ' ' VAL . . . . . 0.973 HG11 HG21 ' E' ' 275' ' ' VAL . 8.9 t -115.35 133.34 61.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 54.11 111.119 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 268' ' ' VAL . . . . . 0.407 ' O ' HG13 ' E' ' 268' ' ' VAL . 6.1 p -125.45 121.53 60.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 75.44 111.188 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.44 132.87 11.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.785 -0.721 . . . . 75.04 112.493 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -132.82 116.05 16.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 74.43 110.897 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 64.49 88.14 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 75.44 112.455 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 56.99 86.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 61.51 110.857 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 16.9 t -124.35 145.49 49.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 54.0 110.851 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -136.7 127.13 26.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 64.02 110.892 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.973 HG21 HG11 ' E' ' 267' ' ' VAL . 57.9 t -132.73 134.67 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 33.41 111.094 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 276' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' E' ' 240' ' ' GLN . 0.2 OUTLIER -128.39 114.85 17.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 24.21 110.926 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.746 ' HB ' HD22 ' E' ' 241' ' ' LEU . 28.4 mm -111.13 141.16 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 75.3 111.1 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 113.1 -171.86 14.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.694 -0.765 . . . . 72.32 112.442 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -106.82 153.52 22.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.797 0.332 . . . . 71.51 110.868 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -111.85 144.47 41.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 72.33 110.826 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.12 125.35 43.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 75.42 110.902 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.756 -0.735 . . . . 54.21 112.484 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 . . . . . 0 N--CA 1.458 -0.056 0 CA-C-O 120.808 0.337 . . . . 74.41 110.885 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.435 ' ND2' ' HA2' ' A' ' 242' ' ' GLY . 0.4 OUTLIER -142.41 143.63 32.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 32.01 110.852 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 34.5 p -121.72 137.5 54.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 52.52 110.859 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.94 139.92 48.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.486 . . . . 74.23 111.088 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.15 -28.18 13.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 72.34 110.879 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.413 ' HB3' HG23 ' A' ' 266' ' ' THR . 1.1 m-20 -166.17 137.93 3.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 72.21 110.879 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.39 117.29 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 73.45 111.157 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -129.55 122.48 29.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 72.34 110.861 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.8 152.12 50.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 73.44 111.163 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.98 158.94 37.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 70.11 110.948 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 236' ' ' ARG . 1.6 tt0 64.11 83.35 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 71.25 110.892 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 235' ' ' GLU . 0.0 OUTLIER 36.15 59.89 0.89 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 75.01 110.883 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.21 144.02 32.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 73.23 111.087 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -125.79 135.81 52.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 71.3 110.923 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.53 HG12 ' HB ' ' A' ' 275' ' ' VAL . 19.7 m -143.01 121.29 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 64.42 111.137 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -124.88 137.64 54.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 73.12 110.895 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 mp -129.4 118.26 21.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 75.34 110.909 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.435 ' HA2' ' ND2' ' A' ' 226' ' ' ASN . . . 148.23 -161.87 28.69 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 60.14 112.51 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -91.11 137.86 32.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 74.35 110.992 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -120.54 131.77 71.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 72.4 111.092 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 61.7 t -122.17 128.97 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 65.32 111.133 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 72.22 111.189 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.854 0.359 . . . . 74.43 111.151 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.7 t -131.07 140.59 50.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 71.4 111.144 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -99.31 126.2 45.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.87 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 87.4 p -134.56 123.65 24.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 62.24 110.849 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.437 HG21 HG22 ' A' ' 267' ' ' VAL . 7.1 p -118.67 125.68 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.084 -0.507 . . . . 74.41 111.136 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -74.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.839 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 230' ' ' ASP . 25.8 m -136.45 135.06 38.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 71.52 111.193 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.779 HG11 HG11 ' A' ' 275' ' ' VAL . 0.1 OUTLIER -118.48 126.52 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 73.13 111.124 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 23.2 t -127.48 118.14 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 63.45 111.162 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.68 133.06 8.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.747 . . . . 62.04 112.489 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 147.6 52.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.906 0.384 . . . . 53.23 110.892 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.52 84.21 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 70.13 112.444 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 51.35 80.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 75.03 110.865 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 31.6 t -113.34 145.69 40.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 63.54 110.842 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -132.77 127.59 34.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 73.24 110.88 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.779 HG11 HG11 ' A' ' 267' ' ' VAL . 19.0 t -137.7 123.62 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 72.51 111.156 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.671 HD23 ' CZ2' ' A' ' 287' ' ' TRP . 0.6 OUTLIER -121.4 112.36 18.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 73.13 110.906 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 35.6 mm -103.93 104.51 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 74.41 111.158 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.2 -169.43 28.88 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.67 -0.776 . . . . 63.41 112.486 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -111.12 149.89 30.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.784 0.326 . . . . 71.24 110.88 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.456 ' OE2' HG13 ' B' ' 244' ' ' VAL . 0.1 OUTLIER -121.6 119.1 30.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 75.4 110.923 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -108.14 154.01 22.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 62.12 110.903 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 122.88 -120.16 4.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.72 -0.752 . . . . 50.12 112.496 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' B' ' 247' ' ' ALA . . . -171.3 -143.8 4.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 22.03 112.565 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 69.03 -75.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 71.33 110.888 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -144.48 143.53 12.18 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.728 . . . . 63.21 112.481 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.503 ' HB2' HG11 ' B' ' 244' ' ' VAL . 14.4 p90 -61.1 -20.71 62.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 64.41 110.881 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.671 ' CZ2' HD23 ' A' ' 276' ' ' LEU . 5.0 t90 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.129 -0.487 . . . . 73.22 110.982 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.483 ' HG2' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.783 0.325 . . . . 75.23 110.818 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -115.25 120.66 40.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 64.34 110.938 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.33 137.93 51.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 74.31 110.825 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.95 152.34 45.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 70.42 111.108 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -28.02 10.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 74.32 110.879 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 230' ' ' ASP . . . . . 0.541 ' HB3' HG23 ' B' ' 266' ' ' THR . 1.0 OUTLIER -164.65 138.41 5.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.415 . . . . 75.32 110.851 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 11.6 mt -135.44 122.42 34.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 75.22 111.081 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -134.17 117.25 16.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.04 110.911 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.2 145.67 52.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 74.11 111.151 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.24 161.53 41.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 73.21 110.85 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 63.61 69.68 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 61.41 110.804 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 47.53 56.7 6.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 70.24 110.936 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.0 144.42 31.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 61.31 111.14 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.03 135.87 52.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 75.45 110.848 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.801 HG12 ' HB ' ' B' ' 275' ' ' VAL . 4.1 m -136.24 121.56 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 73.02 111.138 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.67 134.06 54.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 75.31 110.979 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.578 HD12 ' HB ' ' B' ' 277' ' ' ILE . 0.3 OUTLIER -130.42 119.07 22.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 62.44 110.867 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.81 -116.07 0.72 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.74 . . . . 62.11 112.498 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.98 139.7 29.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.899 0.38 . . . . 73.24 110.902 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 286' ' ' PHE . 46.1 t -118.2 116.27 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 74.41 111.138 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.27 129.05 73.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 74.44 111.151 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.1 p -92.26 175.23 6.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 71.01 111.186 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.487 ' HB2' ' HA3' ' A' ' 283' ' ' GLY . . . -63.06 -42.65 99.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 25.2 111.07 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.73 -38.37 84.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 64.03 111.126 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' B' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 70.34 111.098 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.88 0.371 . . . . 70.23 110.821 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.83 137.77 33.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 74.1 111.134 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.483 HG23 ' HG2' ' B' ' 225' ' ' ARG . 96.5 m -130.85 111.92 12.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 75.22 111.133 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -89.43 127.28 35.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 54.42 110.959 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 3.6 m -130.31 123.59 30.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 75.22 110.86 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.476 HG21 HG22 ' B' ' 267' ' ' VAL . 7.3 p -115.48 125.28 72.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 72.12 111.116 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.97 -76.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 61.5 110.905 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.541 HG23 ' HB3' ' B' ' 230' ' ' ASP . 94.6 m -137.01 137.65 39.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 73.34 111.093 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.684 ' CG1' HG21 ' B' ' 275' ' ' VAL . 4.4 t -117.8 128.35 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 74.33 111.177 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 25.6 t -127.64 117.16 45.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 44.45 111.101 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.39 132.53 9.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.723 -0.751 . . . . 71.34 112.498 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -133.27 125.08 28.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.863 0.363 . . . . 74.04 110.889 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.76 83.91 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 55.42 112.508 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 54.35 84.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 70.42 110.843 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 22.8 t -119.25 145.63 45.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 54.43 110.831 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -135.34 127.32 29.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 75.53 110.903 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.801 ' HB ' HG12 ' B' ' 239' ' ' VAL . 61.9 t -135.35 124.55 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 64.33 111.122 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.07 111.69 17.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 65.44 110.875 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' B' ' 241' ' ' LEU . 27.3 mm -103.86 104.53 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.455 . . . . 73.22 111.149 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.83 -160.21 28.51 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 74.21 112.486 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -115.91 147.87 40.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.324 . . . . 74.12 110.909 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.633 ' HG3' HG13 ' C' ' 244' ' ' VAL . 1.0 OUTLIER -120.82 118.88 31.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.9 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.476 ' CD2' ' HB1' ' B' ' 249' ' ' ALA . 11.4 t80 -112.27 127.46 55.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 71.43 110.954 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.555 ' O ' ' HB2' ' C' ' 247' ' ' ALA . . . 145.9 -48.59 0.68 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.808 -0.71 . . . . 61.45 112.47 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 74.06 11.32 81.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.725 -0.75 . . . . 73.12 112.48 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.96 60.86 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 53.32 110.868 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 96.26 120.26 3.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.763 -0.732 . . . . 62.45 112.487 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -50.95 108.45 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.324 . . . . 74.13 110.912 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.155 -0.475 . . . . 74.34 110.889 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.798 0.332 . . . . 64.3 110.831 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -83.98 110.07 18.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 62.22 110.834 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.34 137.91 50.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 63.33 110.849 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -123.35 150.55 43.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 54.11 111.117 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -102.37 -26.2 13.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 72.5 110.875 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 230' ' ' ASP . . . . . 0.502 ' HB3' HG23 ' C' ' 266' ' ' THR . 0.5 OUTLIER -165.04 138.79 4.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 52.44 110.809 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.467 ' CD1' HG23 ' B' ' 264' ' ' VAL . 11.5 mt -136.61 117.68 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 72.53 111.183 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.94 119.32 21.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 74.42 110.882 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.52 150.4 52.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 55.41 111.142 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -156.71 166.68 32.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 63.03 110.854 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.59 67.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 74.31 110.946 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 48.31 58.23 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 71.21 110.908 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.33 148.37 26.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 74.25 111.102 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -129.36 135.86 49.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 73.23 110.903 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.644 ' CG2' HG22 ' B' ' 275' ' ' VAL . 28.3 m -135.27 121.56 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 72.14 111.141 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.09 137.54 52.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 73.12 110.954 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.05 118.4 21.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 71.22 110.927 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 139.36 -168.91 24.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.777 -0.725 . . . . 61.45 112.461 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -91.93 145.03 24.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 64.52 110.921 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.633 HG13 ' HG3' ' B' ' 280' ' ' GLU . 56.1 t -125.98 124.89 67.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 75.34 111.129 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 48.4 t -122.83 118.28 54.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 44.05 111.063 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 6.4 t -77.84 174.96 10.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 62.35 111.163 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' B' ' 282' ' ' GLY . . . -63.83 -45.56 89.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 63.25 111.097 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.05 -35.77 67.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 74.24 111.082 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 249' ' ' ALA . . . . . 0.553 ' HB1' ' CD2' ' C' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 45.24 111.069 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.882 0.372 . . . . 61.33 110.854 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 260' ' ' THR . . . . . 0.464 HG22 ' HG3' ' D' ' 225' ' ' ARG . 70.0 p -100.86 137.58 39.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 74.25 111.154 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 2.1 t -108.45 137.05 47.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 72.33 111.141 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -119.99 139.01 53.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 73.14 110.931 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 22.8 m -130.68 123.74 30.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 72.31 110.925 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.542 HG21 ' CG2' ' C' ' 267' ' ' VAL . 7.1 p -112.01 126.86 69.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 72.31 111.083 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.8 -74.0 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.49 . . . . 73.34 110.88 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 266' ' ' THR . . . . . 0.502 HG23 ' HB3' ' C' ' 230' ' ' ASP . 92.5 m -140.8 136.65 32.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 64.42 111.189 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.656 ' CG1' HG21 ' C' ' 275' ' ' VAL . 94.4 t -117.96 127.02 75.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 70.43 111.111 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 40.1 t -127.5 126.79 67.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 72.1 111.039 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.25 133.0 8.24 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.767 -0.73 . . . . 73.11 112.502 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -132.62 140.96 48.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.832 0.349 . . . . 61.14 110.924 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.11 70.15 0.94 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.781 -0.723 . . . . 64.51 112.434 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 64.85 97.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 70.55 110.881 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 70.2 m -131.7 145.94 51.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 55.14 110.879 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 36.2 mtt85 -131.48 127.09 36.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 73.13 110.837 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.656 HG21 ' CG1' ' C' ' 267' ' ' VAL . 21.7 t -133.43 123.89 47.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 61.22 111.134 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.23 111.59 17.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 62.22 110.972 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 30.8 mm -105.65 104.34 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 74.44 111.181 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 152.97 -152.49 24.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 72.41 112.482 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -116.75 138.17 51.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.758 0.313 . . . . 50.43 110.941 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.661 ' CG ' HG22 ' D' ' 244' ' ' VAL . 4.4 pt-20 -111.79 118.83 36.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.457 . . . . 74.22 110.832 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.553 ' CD2' ' HB1' ' C' ' 249' ' ' ALA . 9.1 t80 -114.45 124.63 52.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 71.01 111.008 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 282' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' D' ' 247' ' ' ALA . . . 161.5 -58.53 0.3 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 23.1 112.463 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 91.31 -42.0 2.85 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.717 -0.754 . . . . 74.24 112.426 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -30.21 14.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 74.24 110.859 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -147.05 106.45 0.36 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.694 -0.765 . . . . 62.43 112.455 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -55.34 -23.35 23.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 74.2 110.898 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.456 . . . . 75.24 110.934 -179.94 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 225' ' ' ARG . . . . . 0.464 ' HG3' HG22 ' C' ' 260' ' ' THR . 1.6 mmt85 . . . . . 0 C--O 1.23 0.04 0 CA-C-O 120.85 0.357 . . . . 75.35 110.827 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -109.56 115.52 30.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 55.43 110.891 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.83 140.9 52.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 72.02 110.869 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.45 147.88 49.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 72.3 111.115 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -100.72 -26.16 13.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 70.11 110.929 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.98 138.26 4.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 73.5 110.922 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 231' ' ' ILE . . . . . 0.451 ' CD1' HG23 ' C' ' 264' ' ' VAL . 12.3 mt -137.03 117.89 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 73.21 111.178 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -133.06 118.41 18.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 70.52 110.878 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.49 150.76 52.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 74.03 111.144 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -157.0 167.29 30.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 73.04 110.898 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.54 66.45 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 74.35 110.851 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 50.08 43.97 25.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 73.44 110.874 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.1 152.38 21.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.34 111.079 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -135.34 135.25 40.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 63.32 110.869 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.602 HG23 HG13 ' C' ' 275' ' ' VAL . 18.1 m -133.58 121.19 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 61.23 111.126 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -108.07 134.63 50.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 74.02 110.914 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.28 118.03 20.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 74.04 110.924 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.16 -118.3 1.35 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.778 -0.725 . . . . 53.24 112.497 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -145.97 133.26 20.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.891 0.377 . . . . 73.43 110.866 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 244' ' ' VAL . . . . . 0.661 HG22 ' CG ' ' C' ' 280' ' ' GLU . 74.4 t -110.2 121.18 62.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 65.52 111.165 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.47 119.96 58.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 74.23 111.134 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -69.99 175.36 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 64.52 111.103 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 247' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' C' ' 282' ' ' GLY . . . -53.47 -46.1 69.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 75.24 111.114 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.2 -49.52 77.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 71.54 111.076 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 63.14 111.112 179.933 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 260' ' ' THR . . . . . 0.419 HG21 HD21 ' E' ' 243' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.885 0.374 . . . . 73.35 111.08 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 261' ' ' THR . . . . . 0.426 HG23 ' O ' ' D' ' 225' ' ' ARG . 49.9 m -112.71 108.88 18.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.34 111.149 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 262' ' ' ASN . . . . . 0.556 ' OD1' HG23 ' D' ' 277' ' ' ILE . 1.3 t-20 -90.77 131.98 36.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 75.44 110.861 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.97 123.87 38.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 53.13 110.924 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.523 HG21 ' CG2' ' D' ' 267' ' ' VAL . 9.7 p -118.39 129.1 75.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.143 -0.48 . . . . 42.21 111.064 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.52 -75.23 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 62.12 110.929 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 48.9 m -136.52 135.6 38.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 63.21 111.138 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.533 ' CG1' HG21 ' D' ' 275' ' ' VAL . 97.5 t -117.89 127.06 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 72.11 111.184 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 28.1 t -127.22 122.93 61.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 72.33 111.101 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.29 132.44 8.55 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.771 -0.728 . . . . 73.15 112.507 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.13 144.89 50.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.808 0.337 . . . . 65.03 110.934 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.79 70.38 0.79 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.726 . . . . 73.04 112.478 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.47 94.3 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 34.23 110.924 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 30.9 t -126.27 145.02 50.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 60.34 110.892 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -131.68 126.35 34.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 74.24 110.909 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.683 HG13 HG23 ' E' ' 239' ' ' VAL . 16.6 t -132.1 132.42 61.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 60.15 111.08 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.55 111.11 12.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.104 -0.498 . . . . 72.02 110.903 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.556 HG23 ' OD1' ' D' ' 262' ' ' ASN . 24.5 mm -108.03 106.59 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 74.2 111.107 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.27 -146.15 17.42 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.788 -0.72 . . . . 72.02 112.523 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.98 156.11 17.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 73.33 110.88 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 280' ' ' GLU . . . . . 0.759 ' CG ' HG22 ' E' ' 244' ' ' VAL . 0.0 OUTLIER -145.25 122.56 11.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 63.44 110.803 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -119.93 124.45 46.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 73.42 110.937 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . -149.59 -140.09 3.2 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.783 -0.722 . . . . 75.34 112.531 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 283' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' E' ' 247' ' ' ALA . . . -139.16 -98.36 0.41 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 35.42 112.494 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.52 101.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.818 0.342 . . . . 71.24 110.937 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 71.49 -116.06 5.95 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 74.32 112.462 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.63 152.31 21.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.815 0.341 . . . . 63.51 110.898 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 72.51 110.881 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.803 0.335 . . . . 73.44 110.895 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -84.32 117.57 23.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 71.12 110.9 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 93.0 p -131.8 140.16 49.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 75.43 110.893 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -120.43 146.21 46.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 51.2 111.116 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -95.89 -26.73 15.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 71.53 110.924 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.31 138.88 5.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 70.25 110.944 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 231' ' ' ILE . . . . . 0.471 ' CD1' HG23 ' D' ' 264' ' ' VAL . 10.8 mt -137.15 117.71 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 71.33 111.122 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -131.77 121.47 24.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 73.0 110.884 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.4 147.61 49.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 70.21 111.151 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -157.05 161.11 39.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 64.4 110.936 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 64.89 72.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 75.55 110.883 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.25 37.9 12.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 64.21 110.849 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.83 141.48 29.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 61.42 111.148 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.73 135.46 52.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 74.34 110.931 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.683 HG23 HG13 ' D' ' 275' ' ' VAL . 25.2 m -138.12 122.01 21.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 72.21 111.146 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 240' ' ' GLN . . . . . 0.503 ' C ' HD12 ' E' ' 241' ' ' LEU . 2.5 tp60 -119.48 134.06 55.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 71.34 110.882 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.503 HD12 ' C ' ' E' ' 240' ' ' GLN . 6.5 mp -130.74 118.06 20.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 61.34 110.946 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 145.52 -108.99 0.49 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.79 -0.719 . . . . 73.43 112.483 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 243' ' ' ASN . . . . . 0.419 HD21 HG21 ' D' ' 260' ' ' THR . 0.0 OUTLIER -144.37 150.24 37.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.847 0.356 . . . . 73.45 110.895 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.759 HG22 ' CG ' ' D' ' 280' ' ' GLU . 80.0 t -133.42 122.73 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 75.32 111.131 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 79.6 t -124.15 112.83 34.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 72.41 111.095 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 246' ' ' THR . . . . . 0.474 HG23 ' O ' ' E' ' 281' ' ' TYR . 74.3 p -69.08 175.25 3.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 73.14 111.17 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 247' ' ' ALA . . . . . 0.523 ' HB2' ' HA2' ' D' ' 283' ' ' GLY . . . -55.09 -46.01 75.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 44.14 111.142 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.78 -52.18 66.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 73.32 111.1 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 63.41 111.118 179.945 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 94.1 m . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.85 0.357 . . . . 60.24 111.114 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -126.41 142.53 51.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 72.4 110.883 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.88 133.45 39.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 63.35 110.839 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 264' ' ' VAL . . . . . 0.428 ' O ' HG13 ' E' ' 264' ' ' VAL . 4.9 p -124.11 118.51 54.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.139 -0.482 . . . . 72.21 111.136 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.96 -75.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 73.3 110.926 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.1 138.9 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 53.44 111.09 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 267' ' ' VAL . . . . . 0.86 HG11 HG21 ' E' ' 275' ' ' VAL . 40.2 t -117.43 128.46 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 64.51 111.092 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 38.9 t -127.12 118.58 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 71.04 111.159 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.63 132.28 10.18 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.77 -0.728 . . . . 73.15 112.481 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -133.7 116.56 15.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 74.24 110.868 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 74.71 86.77 0.26 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.707 -0.759 . . . . 52.52 112.498 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 51.09 81.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 65.51 110.876 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 16.3 m -117.3 145.42 44.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 73.42 110.873 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -134.11 127.29 31.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 63.23 110.79 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.86 HG21 HG11 ' E' ' 267' ' ' VAL . 46.6 t -133.2 130.5 57.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 64.43 111.142 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 276' ' ' LEU . . . . . 0.629 HD22 ' O ' ' E' ' 275' ' ' VAL . 3.2 mm? -128.34 107.85 10.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 63.54 110.833 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 23.1 mm -114.27 109.19 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 71.11 111.069 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.62 -137.36 6.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.84 -0.695 . . . . 75.05 112.557 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -111.24 133.24 53.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 70.41 110.902 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.34 133.66 55.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.44 110.905 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 281' ' ' TYR . . . . . 0.474 ' O ' HG23 ' E' ' 246' ' ' THR . 0.1 OUTLIER -131.26 123.88 29.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 73.03 110.937 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.64 -0.791 . . . . 22.14 112.494 179.968 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.615 ' HG3' HG23 ' A' ' 261' ' ' THR . 13.0 ptm180 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.79 0.329 . . . . 73.02 110.861 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.724 ' HB3' HG22 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -123.21 130.08 52.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 62.43 110.823 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.1 m -128.57 144.31 51.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 74.54 110.872 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.7 124.01 19.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 71.21 111.091 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -76.09 -37.2 58.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 73.11 110.916 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -164.68 138.46 5.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 62.23 110.878 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.597 HG22 ' CG2' ' A' ' 267' ' ' VAL . 9.7 pt -137.82 118.01 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 74.14 111.067 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -128.39 126.91 41.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 75.31 110.909 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.602 HG21 ' CG1' ' A' ' 239' ' ' VAL . 1.7 p -135.56 149.49 49.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 72.52 111.142 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -144.97 168.37 20.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 43.51 110.925 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 65.47 74.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 64.01 110.922 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 41.89 59.11 2.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 73.02 110.811 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.435 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -104.11 155.99 18.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 54.14 111.099 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -135.05 145.92 48.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 72.33 110.905 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.602 ' CG1' HG21 ' A' ' 233' ' ' THR . 16.1 m -139.97 137.39 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 74.21 111.113 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -137.2 129.42 29.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.13 110.917 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.9 mp -122.94 130.34 52.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 75.35 110.846 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.72 -121.42 1.56 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 63.33 112.446 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -144.86 132.7 21.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.87 0.367 . . . . 74.33 110.903 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.517 HG23 ' HA ' ' A' ' 280' ' ' GLU . 18.0 m -120.02 120.9 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.138 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 94.5 t -122.07 129.02 75.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 64.45 111.189 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 74.05 111.196 -179.937 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.851 0.358 . . . . 73.0 111.123 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.615 HG23 ' HG3' ' A' ' 225' ' ' ARG . 98.0 m -127.62 111.04 13.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 61.51 111.117 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.67 HD22 ' HB3' ' A' ' 226' ' ' ASN . 1.7 p30 -100.52 135.48 41.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 63.3 110.899 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 9.4 t -140.73 123.18 15.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 71.54 110.797 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.678 HG21 ' CD1' ' B' ' 231' ' ' ILE . 4.2 p -113.63 150.17 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 73.11 111.156 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -88.19 -73.31 0.49 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.483 . . . . 73.41 110.956 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 18.5 m -124.06 133.67 53.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 62.51 111.169 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.794 HG22 HD11 ' B' ' 231' ' ' ILE . 9.8 t -118.01 128.87 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 45.22 111.139 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 48.8 t -127.4 117.17 46.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 44.35 111.108 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.74 133.62 10.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.687 -0.768 . . . . 75.31 112.456 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -132.33 148.12 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 75.41 110.96 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.39 88.05 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.817 -0.706 . . . . 63.43 112.429 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 44.45 65.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 63.11 110.913 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 43.4 t -93.82 145.21 24.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.47 . . . . 73.14 110.86 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -123.02 128.45 50.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 74.35 110.835 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.543 ' HB ' HG12 ' A' ' 239' ' ' VAL . 21.2 t -119.3 123.62 71.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 73.21 111.144 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.603 HD23 ' CZ2' ' A' ' 287' ' ' TRP . 0.2 OUTLIER -121.0 111.48 17.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 72.23 110.976 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.724 HG22 ' HB3' ' A' ' 226' ' ' ASN . 20.4 mm -111.79 104.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.188 -0.46 . . . . 72.32 111.174 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.7 -160.22 26.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 72.43 112.468 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -107.01 151.51 25.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 70.23 110.878 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.711 ' HG3' HG12 ' B' ' 244' ' ' VAL . 0.5 OUTLIER -130.26 131.93 45.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 71.31 110.893 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -113.17 125.86 54.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 64.13 110.933 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 131.37 166.55 11.71 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.735 -0.745 . . . . 63.44 112.519 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -82.42 -108.93 0.44 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 33.33 112.524 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.31 51.01 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 75.23 110.907 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.15 30.87 32.48 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.787 -0.721 . . . . 51.32 112.464 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 58.47 83.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.882 0.372 . . . . 74.14 110.882 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.603 ' CZ2' HD23 ' A' ' 276' ' ' LEU . 23.0 t90 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 61.54 110.909 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.57 ' HB3' HG23 ' B' ' 261' ' ' THR . 5.7 mtp180 . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.833 0.349 . . . . 72.1 110.862 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.788 ' HB3' HG22 ' B' ' 277' ' ' ILE . 0.5 OUTLIER -128.22 131.13 48.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.911 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.1 145.32 49.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 75.14 110.876 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.559 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -139.5 124.68 18.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.478 . . . . 72.42 111.075 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.39 -36.05 53.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.483 . . . . 60.25 110.969 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.36 137.6 4.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 72.45 110.856 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.794 HD11 HG22 ' A' ' 267' ' ' VAL . 5.9 pt -138.69 117.64 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 65.43 111.179 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.35 123.72 32.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 74.54 110.875 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.589 HG21 ' CG1' ' B' ' 239' ' ' VAL . 1.7 p -135.61 142.71 45.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 73.13 111.18 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -143.37 167.56 21.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 70.22 110.879 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 68.63 73.6 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 74.15 110.881 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 45.83 54.8 7.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 64.13 110.844 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.27 156.17 18.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 63.3 111.138 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.31 146.54 42.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.829 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.589 ' CG1' HG21 ' B' ' 233' ' ' THR . 18.6 m -136.46 140.85 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 74.14 111.208 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.561 ' HB3' HD22 ' B' ' 276' ' ' LEU . 1.9 tt0 -138.14 122.55 18.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 60.1 110.964 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.6 118.94 33.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.209 -0.45 . . . . 72.1 110.93 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.92 -170.84 24.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.798 -0.715 . . . . 54.41 112.523 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -85.99 129.05 34.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 74.33 110.909 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.711 HG12 ' HG3' ' A' ' 280' ' ' GLU . 17.5 m -118.99 121.12 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 71.04 111.175 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.471 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 26.6 t -122.15 129.02 75.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 73.31 111.105 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -85.34 175.08 9.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 75.12 111.157 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.05 -42.35 90.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 61.34 111.145 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.96 67.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 73.53 111.08 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.471 ' HB3' ' CG1' ' B' ' 245' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 61.22 111.074 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.905 0.383 . . . . 75.11 110.857 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 260' ' ' THR . . . . . 0.562 HG21 ' HB2' ' C' ' 243' ' ' ASN . 27.8 p -100.69 122.05 42.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 73.22 111.17 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.57 HG23 ' HB3' ' B' ' 225' ' ' ARG . 96.7 m -133.91 124.92 27.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 73.24 111.152 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -115.97 134.6 54.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 71.11 110.866 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.89 123.54 19.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 53.34 110.828 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.68 HG21 ' CD1' ' C' ' 231' ' ' ILE . 4.9 p -110.22 150.04 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.501 . . . . 64.53 111.123 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -86.61 -77.1 0.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 62.41 110.835 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 13.8 m -120.16 132.71 55.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 75.54 111.169 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.78 HG22 HD11 ' C' ' 231' ' ' ILE . 5.0 t -118.13 121.0 66.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.304 -0.407 . . . . 63.25 111.107 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.51 117.24 51.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.487 . . . . 64.04 111.138 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.79 133.79 11.09 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 72.02 112.516 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.99 148.12 52.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 63.43 110.933 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.35 82.95 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.75 -0.738 . . . . 43.53 112.545 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 46.8 69.04 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 63.4 110.893 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.92 145.7 26.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 73.23 110.884 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.46 128.38 52.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 72.31 110.891 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.548 ' HB ' HG12 ' B' ' 239' ' ' VAL . 21.7 t -118.98 123.91 72.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 63.13 111.139 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.561 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.2 OUTLIER -124.36 111.66 16.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 75.2 110.951 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.788 HG22 ' HB3' ' B' ' 226' ' ' ASN . 24.0 mm -112.09 104.1 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 72.44 111.165 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.24 -164.62 27.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 45.54 112.443 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -101.25 151.91 21.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 74.52 110.872 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.687 ' HG3' HG12 ' C' ' 244' ' ' VAL . 1.6 pp20? -130.91 142.51 50.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.842 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -127.53 125.92 41.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 73.14 110.914 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 157.7 146.24 4.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.72 -0.752 . . . . 63.02 112.509 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -102.98 -170.23 26.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 45.12 112.462 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? 56.27 25.18 9.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 72.24 110.893 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 141.77 117.86 1.36 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.724 -0.751 . . . . 51.33 112.541 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.51 ' CE2' HG21 ' C' ' 244' ' ' VAL . 3.0 m-85 -55.71 -26.1 43.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 71.23 110.886 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 3.6 t90 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 74.25 110.882 -179.918 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.615 ' HA ' HG23 ' C' ' 261' ' ' THR . 23.9 mmt85 . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.82 0.343 . . . . 75.33 110.87 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.563 ' HB3' HG22 ' C' ' 277' ' ' ILE . 2.0 m-20 -84.43 118.44 24.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 73.25 110.877 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 14.9 t -136.68 147.74 46.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.816 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.599 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -135.83 129.0 31.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 62.42 111.145 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.22 -35.24 36.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 62.0 110.91 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.8 136.81 3.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 61.21 110.89 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.78 HD11 HG22 ' B' ' 267' ' ' VAL . 4.6 pt -139.17 117.72 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 73.43 111.156 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.1 124.3 32.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 72.54 110.939 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.579 HG21 ' CG1' ' C' ' 239' ' ' VAL . 1.4 p -135.39 144.21 46.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 62.3 111.105 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 13.1 pm0 -143.53 167.82 21.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 62.03 110.927 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 68.68 70.72 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 73.25 110.926 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? 47.0 57.39 5.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 73.35 110.835 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.418 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -104.57 156.18 18.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 73.0 111.106 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -136.58 141.63 43.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 72.24 110.871 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.579 ' CG1' HG21 ' C' ' 233' ' ' THR . 19.3 m -131.07 140.81 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 74.22 111.105 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.536 ' HB3' HD22 ' C' ' 276' ' ' LEU . 2.0 tp60 -138.02 129.54 27.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 75.23 110.906 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.578 HD13 ' CD1' ' B' ' 277' ' ' ILE . 5.2 mp -123.98 118.65 27.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 72.44 110.957 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.8 -176.74 21.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.767 -0.73 . . . . 74.2 112.506 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 243' ' ' ASN . . . . . 0.562 ' HB2' HG21 ' B' ' 260' ' ' THR . 25.7 t-20 -85.92 128.91 34.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 70.45 110.851 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.687 HG12 ' HG3' ' B' ' 280' ' ' GLU . 32.2 m -111.67 127.4 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 64.41 111.166 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 22.4 t -122.29 129.07 75.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 70.51 111.132 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 18.3 p -84.18 175.08 9.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 62.54 111.102 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.81 -34.85 70.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.476 . . . . 74.21 111.046 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -70.87 -51.73 24.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 41.23 111.07 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.284 -0.416 . . . . 63.12 111.07 179.907 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.877 0.37 . . . . 74.04 110.914 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 51.3 p -67.13 128.88 38.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 53.41 111.142 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.615 HG23 ' HA ' ' C' ' 225' ' ' ARG . 22.6 m -125.46 109.01 12.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 70.44 111.111 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.437 ' ND2' ' HB3' ' D' ' 241' ' ' LEU . 0.2 OUTLIER -107.26 135.87 48.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.44 110.856 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.05 123.61 14.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 43.42 110.883 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.63 HG21 HD11 ' D' ' 231' ' ' ILE . 3.5 p -110.27 145.11 17.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.151 -0.477 . . . . 73.45 111.139 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.43 -75.82 0.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 64.41 110.798 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 25.2 m -126.12 134.28 51.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.179 -0.464 . . . . 72.44 111.061 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.877 HG22 HD11 ' D' ' 231' ' ' ILE . 8.7 t -118.64 127.06 75.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.488 . . . . 72.12 111.134 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.91 116.11 43.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 74.24 111.128 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.69 133.77 10.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.722 . . . . 43.24 112.484 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.29 148.01 52.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 73.22 110.902 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.84 85.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.735 -0.745 . . . . 63.43 112.52 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 47.82 73.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 72.34 110.87 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 38.6 t -103.12 145.48 29.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 63.21 110.817 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -119.65 128.49 53.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 61.45 110.899 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.533 ' CG2' HG12 ' C' ' 239' ' ' VAL . 21.8 t -119.55 123.93 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.124 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.621 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -126.18 111.15 14.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 74.01 110.935 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.653 ' CD1' HD13 ' D' ' 241' ' ' LEU . 38.7 mm -112.18 104.05 16.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 51.45 111.165 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.04 -157.53 27.36 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 72.11 112.477 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -114.52 156.12 25.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 65.31 110.855 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.517 ' HG2' HG13 ' D' ' 244' ' ' VAL . 0.0 OUTLIER -126.6 139.29 53.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.08 -0.509 . . . . 72.53 110.877 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -129.19 125.99 38.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.941 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 148.1 153.9 6.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.768 -0.73 . . . . 73.04 112.502 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 283' ' ' GLY . . . . . 0.45 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . -99.01 103.81 2.8 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.717 -0.754 . . . . 74.14 112.526 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -179.41 41.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.877 0.37 . . . . 74.55 110.944 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.66 -135.05 11.98 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.75 -0.738 . . . . 73.35 112.488 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -124.32 -1.85 8.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 63.14 110.866 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.621 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 3.7 t90 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 73.3 110.909 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.06 0 CA-C-O 120.788 0.327 . . . . 72.21 110.814 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 226' ' ' ASN . . . . . 0.579 ' HB3' HG22 ' D' ' 277' ' ' ILE . 1.9 m120 -86.53 110.07 19.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 74.5 110.916 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 2.3 t -124.09 138.15 54.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 72.53 110.847 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 228' ' ' ALA . . . . . 0.407 ' HB3' HG23 ' C' ' 264' ' ' VAL . . . -121.41 129.02 52.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 74.04 111.139 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.03 -33.12 51.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 73.54 110.899 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -167.77 136.59 2.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 75.13 110.85 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 231' ' ' ILE . . . . . 0.877 HD11 HG22 ' C' ' 267' ' ' VAL . 4.2 pt -140.41 116.98 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 72.32 111.157 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 232' ' ' ARG . . . . . 0.463 ' HD2' HG22 ' D' ' 268' ' ' VAL . 11.5 ptp180 -131.41 124.65 30.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 74.24 110.823 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 233' ' ' THR . . . . . 0.493 HG21 ' CG1' ' D' ' 239' ' ' VAL . 2.7 p -136.06 143.48 44.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 72.33 111.14 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 17.9 pm0 -142.83 167.7 21.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.25 110.867 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 67.7 78.21 0.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.492 . . . . 71.02 110.893 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 43.92 50.64 7.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 70.41 110.93 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.02 156.1 18.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 63.42 111.137 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.95 155.65 49.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 54.32 110.888 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.564 HG12 ' HB ' ' D' ' 275' ' ' VAL . 17.5 m -141.16 140.06 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 55.32 111.088 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 240' ' ' GLN . . . . . 0.533 ' HB3' HD22 ' D' ' 276' ' ' LEU . 2.0 tt0 -138.1 119.2 14.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 71.14 110.854 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.653 HD13 ' CD1' ' C' ' 277' ' ' ILE . 3.4 mp -118.78 135.19 54.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 51.14 110.913 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.17 -116.9 1.53 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 73.31 112.499 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -143.62 128.79 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.865 0.365 . . . . 70.13 110.882 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 244' ' ' VAL . . . . . 0.517 HG13 ' HG2' ' C' ' 280' ' ' GLU . 0.4 OUTLIER -104.55 115.54 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 65.22 111.109 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 80.5 t -122.03 125.95 73.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 61.44 111.087 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 246' ' ' THR . . . . . 0.511 HG23 ' O ' ' D' ' 281' ' ' TYR . 18.2 p -86.25 174.99 8.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 64.15 111.11 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 247' ' ' ALA . . . . . 0.45 ' HB2' ' N ' ' C' ' 283' ' ' GLY . . . -53.92 -42.62 68.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 64.23 111.123 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.97 -44.94 96.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.433 . . . . 63.44 111.072 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 74.22 111.063 179.87 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.859 0.361 . . . . 73.51 111.152 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 90.0 m -99.0 109.33 22.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 73.42 111.122 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -108.9 144.6 36.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 61.22 110.923 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.36 136.06 35.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 64.32 110.846 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.836 HG22 HD11 ' E' ' 231' ' ' ILE . 0.9 OUTLIER -120.17 133.83 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 61.43 111.112 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -70.16 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 75.41 110.888 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 87.1 m -150.85 133.64 15.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 73.32 111.14 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.846 HG22 HD12 ' E' ' 231' ' ' ILE . 13.5 t -117.17 129.19 74.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 64.13 111.178 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 268' ' ' VAL . . . . . 0.463 HG22 ' HD2' ' D' ' 232' ' ' ARG . 61.2 t -127.2 115.8 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 63.13 111.107 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.0 133.06 11.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 54.12 112.49 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.31 116.62 18.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 72.32 110.936 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.57 87.66 0.17 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.69 -0.767 . . . . 73.33 112.477 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 52.25 88.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 73.31 110.869 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.37 145.68 50.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 61.21 110.914 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -121.35 128.83 52.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.161 -0.472 . . . . 72.32 110.826 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.564 ' HB ' HG12 ' D' ' 239' ' ' VAL . 21.8 t -116.24 126.6 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 71.35 111.079 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.642 HD23 ' CZ2' ' D' ' 287' ' ' TRP . 0.2 OUTLIER -128.24 111.3 13.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.22 110.98 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.579 HG22 ' HB3' ' D' ' 226' ' ' ASN . 45.8 mm -112.6 104.8 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.158 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 138.02 -176.9 20.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.776 -0.726 . . . . 41.31 112.495 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -91.33 156.17 17.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 75.45 110.849 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -131.66 139.02 48.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 61.11 110.887 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 281' ' ' TYR . . . . . 0.511 ' O ' HG23 ' D' ' 246' ' ' THR . 12.3 m-85 -125.61 125.89 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 72.52 110.836 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 282' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' E' ' 247' ' ' ALA . . . -170.66 -87.69 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 74.44 112.476 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 136.84 -50.68 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.669 -0.777 . . . . 34.35 112.487 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 103.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.325 . . . . 51.2 110.917 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 56.07 -101.51 0.14 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.793 -0.718 . . . . 73.13 112.411 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -175.13 122.44 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.814 0.34 . . . . 72.14 110.925 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 287' ' ' TRP . . . . . 0.642 ' CZ2' HD23 ' D' ' 276' ' ' LEU . 7.7 t90 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 75.22 110.906 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.888 0.375 . . . . 72.43 110.842 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 226' ' ' ASN . . . . . 0.598 ' HB3' HG22 ' E' ' 277' ' ' ILE . 2.9 m-20 -83.52 109.74 17.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 61.21 110.876 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 3.3 m -131.86 137.62 48.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 53.11 110.845 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -108.25 155.01 20.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 70.32 111.09 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -109.56 -26.03 10.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 74.4 110.902 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 230' ' ' ASP . . . . . 0.688 ' HB2' HG22 ' E' ' 266' ' ' THR . 0.4 OUTLIER -167.88 137.24 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 73.34 110.898 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 231' ' ' ILE . . . . . 0.846 HD12 HG22 ' D' ' 267' ' ' VAL . 0.4 OUTLIER -139.43 115.9 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.31 111.115 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -132.29 118.46 19.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 73.52 110.862 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 233' ' ' THR . . . . . 0.593 HG21 ' CG1' ' E' ' 239' ' ' VAL . 1.3 p -136.21 152.83 51.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 74.35 111.104 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.5 167.29 30.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 75.23 110.896 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 63.75 80.47 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 72.04 110.929 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 45.54 51.81 9.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 74.11 110.825 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 237' ' ' ALA . . . . . 0.405 ' HB1' ' HB ' ' E' ' 233' ' ' THR . . . -104.54 156.66 17.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 65.45 111.196 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -139.16 154.34 48.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 71.42 110.845 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.63 HG12 ' CG2' ' E' ' 275' ' ' VAL . 19.0 m -142.63 135.68 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 74.53 111.119 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -138.52 129.8 27.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 74.12 110.934 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.831 HD22 HG23 ' D' ' 264' ' ' VAL . 5.4 mp -127.51 135.19 50.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 74.3 110.915 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.16 -124.37 2.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.739 -0.743 . . . . 35.43 112.49 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -144.1 128.95 18.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.367 . . . . 75.53 110.93 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 11.0 t -99.91 119.4 47.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 64.2 111.121 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 57.6 t -122.28 112.91 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 74.21 111.131 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 246' ' ' THR . . . . . 0.466 HG23 ' O ' ' E' ' 281' ' ' TYR . 43.9 p -71.92 175.05 6.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 63.04 111.145 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 247' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' D' ' 282' ' ' GLY . . . -63.0 -40.5 97.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 21.13 111.155 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.01 -51.97 67.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 74.52 111.112 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 72.14 111.125 179.943 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 98.6 m . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.795 0.331 . . . . 74.2 111.132 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -126.19 125.54 42.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 73.11 110.881 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.24 119.71 35.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 74.42 110.856 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 264' ' ' VAL . . . . . 1.075 HG21 HD12 ' E' ' 277' ' ' ILE . 75.4 t -107.8 115.46 48.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 64.15 111.172 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 265' ' ' GLU . . . . . 0.572 ' CD ' ' N ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -64.6 -133.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 71.12 110.906 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 266' ' ' THR . . . . . 0.688 HG22 ' HB2' ' E' ' 230' ' ' ASP . 7.1 p -94.71 130.03 41.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 71.25 111.139 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 26.4 t -116.47 123.33 71.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 52.03 111.118 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 38.6 t -110.6 118.36 57.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.082 -0.508 . . . . 70.43 111.107 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.81 133.58 11.7 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.715 -0.755 . . . . 71.24 112.563 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.69 116.55 19.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.881 0.372 . . . . 62.32 110.969 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.88 97.74 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.771 -0.728 . . . . 64.34 112.578 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 51.71 89.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 62.44 110.887 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 31.3 t -124.87 146.54 49.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 70.12 110.868 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -127.19 128.69 46.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 74.04 110.895 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.63 ' CG2' HG12 ' E' ' 239' ' ' VAL . 21.9 t -114.89 122.88 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 61.52 111.159 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.16 110.75 12.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.261 -0.427 . . . . 55.43 110.948 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 1.075 HD12 HG21 ' E' ' 264' ' ' VAL . 26.7 mm -113.76 104.87 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.45 111.088 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.92 -161.8 27.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 73.25 112.513 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.22 156.28 26.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 54.44 110.851 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.77 147.26 44.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 73.22 110.882 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 281' ' ' TYR . . . . . 0.466 ' O ' HG23 ' E' ' 246' ' ' THR . 17.8 m-85 -130.09 125.81 36.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 75.2 110.905 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 C-N-CA 120.739 -0.743 . . . . 63.14 112.478 179.98 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.447 ' N ' HG23 ' A' ' 261' ' ' THR . 21.3 ptt180 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.804 0.335 . . . . 53.4 110.869 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -83.93 119.51 24.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.903 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.97 137.98 53.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 72.2 110.808 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.53 141.11 46.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 55.11 111.104 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -97.36 -35.64 10.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 63.2 110.87 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.461 ' HB3' HG23 ' A' ' 266' ' ' THR . 7.2 t0 -164.33 138.96 5.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.299 -0.41 . . . . 73.23 110.864 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.456 HD13 HD21 ' A' ' 241' ' ' LEU . 11.0 mt -137.61 117.79 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.11 111.069 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.68 120.28 24.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 71.43 110.819 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.32 146.9 48.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 71.51 111.111 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -148.89 167.09 26.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 71.12 110.939 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 66.82 56.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 65.11 110.954 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 14.9 mtm-85 50.41 64.65 1.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.856 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 156.25 18.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 45.1 111.132 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -129.33 135.68 49.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 74.51 110.884 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.462 HG12 ' HB ' ' A' ' 275' ' ' VAL . 20.4 m -139.73 130.13 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 63.21 111.146 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -122.24 132.73 54.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 72.02 110.905 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.456 HD21 HD13 ' A' ' 231' ' ' ILE . 0.7 OUTLIER -130.43 135.1 47.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 53.41 110.862 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.54 -130.92 6.32 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.805 -0.712 . . . . 50.53 112.539 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -144.56 128.89 17.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.866 0.365 . . . . 64.42 110.899 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' A' ' 280' ' ' GLU . 27.0 m -110.26 126.15 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 71.5 111.129 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.2 m -122.47 129.11 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 64.12 111.063 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 281' ' ' TYR . 34.9 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 71.34 111.154 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 21.7 p . . . . . 0 C--O 1.233 0.184 0 CA-C-O 120.882 0.372 . . . . 73.14 111.125 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.447 HG23 ' N ' ' A' ' 225' ' ' ARG . 0.9 OUTLIER -129.78 108.87 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 71.24 111.136 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -101.86 129.05 48.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 74.24 110.92 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 34.7 m -140.44 123.81 16.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 65.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.578 HG21 HG22 ' A' ' 267' ' ' VAL . 8.6 p -120.28 136.7 56.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 73.3 111.109 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -78.65 -76.13 0.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 70.14 110.809 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 230' ' ' ASP . 3.1 m -127.04 130.6 50.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 70.14 111.131 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.578 HG22 HG21 ' A' ' 264' ' ' VAL . 21.6 t -118.2 125.01 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 64.13 111.116 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.25 122.2 63.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 74.45 111.073 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.17 133.76 9.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 43.54 112.478 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.97 147.89 52.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.372 . . . . 73.2 110.889 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.13 78.61 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.688 -0.768 . . . . 71.22 112.449 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 47.28 63.71 1.86 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.855 0.36 . . . . 72.3 110.887 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 46.3 t -90.25 145.66 24.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 54.35 110.815 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.18 128.04 44.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 71.44 110.841 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.738 HG13 HG23 ' B' ' 239' ' ' VAL . 17.4 t -134.54 123.74 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 64.42 111.114 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.69 111.56 18.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 64.32 110.809 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.404 HD13 HD23 ' A' ' 241' ' ' LEU . 2.1 mp -111.61 104.82 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 65.55 111.155 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.06 -161.17 29.86 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 74.35 112.469 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -120.15 150.24 40.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.783 0.325 . . . . 71.02 110.881 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.5 ' HG2' HG12 ' B' ' 244' ' ' VAL . 7.3 pt-20 -124.21 128.6 49.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.894 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.452 ' O ' HG23 ' A' ' 246' ' ' THR . 0.1 OUTLIER -110.05 125.8 53.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.105 -0.498 . . . . 73.21 110.926 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 125.06 159.8 10.49 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.721 -0.752 . . . . 40.23 112.561 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.613 ' H ' ' HB2' ' B' ' 247' ' ' ALA . . . -108.82 -8.3 28.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.711 -0.757 . . . . 74.22 112.514 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -77.32 60.58 2.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.874 0.369 . . . . 71.43 110.892 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.33 97.39 2.46 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.722 -0.751 . . . . 32.13 112.533 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' B' ' 244' ' ' VAL . 0.1 OUTLIER -51.85 -68.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 74.53 110.819 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 15.6 t90 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 71.23 110.956 -179.955 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.432 ' N ' HG23 ' B' ' 261' ' ' THR . 1.6 ptp180 . . . . . 0 C--O 1.23 0.038 0 CA-C-O 120.892 0.377 . . . . 72.15 110.876 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -90.65 121.44 32.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 74.1 110.86 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 47.6 t -130.14 138.04 50.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 43.42 110.875 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.27 161.91 30.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 73.32 111.099 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.7 -31.91 5.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 52.23 110.904 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -164.39 138.79 5.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 24.35 110.911 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 12.9 mt -137.66 119.1 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 65.3 111.152 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 -131.71 119.15 20.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 74.4 110.899 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.1 OUTLIER -134.59 140.71 46.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 52.11 111.189 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -144.67 167.57 22.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 64.44 110.855 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 61.86 63.37 1.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.086 -0.506 . . . . 72.15 110.959 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 47.99 61.05 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 72.21 110.878 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.419 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -104.57 153.29 21.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 64.14 111.113 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 8.3 mtt-85 -129.19 135.6 49.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 75.11 110.863 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.738 HG23 HG13 ' A' ' 275' ' ' VAL . 24.2 m -140.69 123.91 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 73.31 111.137 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.614 ' HB3' HD22 ' B' ' 276' ' ' LEU . 0.1 OUTLIER -118.52 137.2 53.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 64.21 110.974 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.827 HD23 HD13 ' B' ' 277' ' ' ILE . 0.6 OUTLIER -130.06 118.89 22.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 71.45 110.851 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.27 173.7 13.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.704 -0.76 . . . . 71.11 112.477 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -87.8 137.99 31.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 43.13 110.908 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.5 HG12 ' HG2' ' A' ' 280' ' ' GLU . 30.6 m -120.68 125.68 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 64.11 111.132 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.48 129.2 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.31 111.142 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.7 t -71.55 175.1 5.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 72.44 111.149 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.613 ' HB2' ' H ' ' A' ' 283' ' ' GLY . . . -60.41 -40.57 91.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 71.42 111.165 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.02 -36.37 70.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 51.34 111.11 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.623 ' HB2' ' CD1' ' B' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.199 -0.455 . . . . 65.41 111.129 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.837 0.351 . . . . 71.41 110.828 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 30.5 p -100.53 121.99 42.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 72.13 111.196 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.432 HG23 ' N ' ' B' ' 225' ' ' ARG . 0.7 OUTLIER -129.33 133.73 47.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 64.03 111.171 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -125.85 130.01 50.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 62.43 110.905 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.27 123.8 20.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 70.13 110.846 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.502 HG21 ' CG2' ' B' ' 267' ' ' VAL . 13.5 p -119.26 133.18 66.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 60.53 111.109 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.12 -74.97 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.837 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 97.3 m -135.44 133.71 38.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 43.33 111.13 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.502 ' CG2' HG21 ' B' ' 264' ' ' VAL . 21.7 t -118.25 125.88 74.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 63.43 111.099 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 63.4 t -127.31 125.43 65.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 55.04 111.097 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.5 133.82 8.05 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.725 -0.75 . . . . 65.34 112.48 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -130.98 147.62 52.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.816 0.341 . . . . 62.54 110.906 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.43 64.64 3.25 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.83 -0.7 . . . . 62.42 112.439 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.03 96.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.872 0.367 . . . . 71.41 110.874 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 65.1 m -125.36 145.82 49.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 74.24 110.859 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -127.22 127.51 44.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 61.01 110.799 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.674 HG13 HG23 ' C' ' 239' ' ' VAL . 19.3 t -134.6 123.41 41.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 63.34 111.148 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.614 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.2 OUTLIER -118.64 113.39 21.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.252 -0.431 . . . . 61.14 110.922 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.827 HD13 HD23 ' B' ' 241' ' ' LEU . 2.6 mp -110.07 127.11 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 64.12 111.036 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 127.33 -164.46 20.81 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.691 -0.766 . . . . 74.24 112.468 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -115.05 148.46 38.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 73.33 110.871 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.552 ' CG ' HG12 ' C' ' 244' ' ' VAL . 0.9 OUTLIER -119.72 131.38 55.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 62.01 110.904 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.623 ' CD1' ' HB2' ' B' ' 249' ' ' ALA . 26.1 t80 -116.87 125.99 52.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.959 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 129.58 -175.3 19.07 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.727 . . . . 73.11 112.514 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -136.39 51.44 0.81 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.785 -0.722 . . . . 72.15 112.494 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -98.5 25.98 5.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.342 . . . . 72.35 110.914 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 109.9 18.09 9.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.794 -0.717 . . . . 73.41 112.516 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' C' ' 244' ' ' VAL . 0.2 OUTLIER 69.35 -75.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.938 0.399 . . . . 62.23 110.868 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 15.9 t90 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.5 . . . . 74.3 110.868 -179.955 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.781 0.324 . . . . 72.44 110.883 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -92.15 110.03 21.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 60.23 110.855 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 72.7 m -136.75 139.52 41.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 63.5 110.898 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.84 159.67 31.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 63.45 111.119 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -112.82 -29.28 7.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 74.21 110.921 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.7 138.09 4.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 72.34 110.867 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 9.6 mt -137.88 117.77 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 75.2 111.107 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -133.48 118.98 18.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.475 . . . . 74.43 110.926 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.1 OUTLIER -133.21 146.4 51.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 74.45 111.118 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -150.18 167.15 27.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 75.44 110.911 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.38 64.56 1.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 74.35 110.853 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 47.87 60.26 3.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 65.12 110.846 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.445 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -104.21 150.58 24.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 64.43 111.077 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 35.1 mtt85 -126.07 135.38 51.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 72.15 110.875 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.674 HG23 HG13 ' B' ' 275' ' ' VAL . 17.0 m -139.52 121.57 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 72.4 111.175 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.87 137.13 52.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.51 110.952 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 mp -127.49 118.69 24.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 64.42 110.982 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 134.83 -179.99 17.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.777 -0.725 . . . . 32.51 112.496 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -92.11 135.81 33.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 73.03 110.946 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.552 HG12 ' CG ' ' B' ' 280' ' ' GLU . 14.6 m -116.37 126.11 73.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 71.12 111.128 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.425 HG23 ' HA ' ' B' ' 281' ' ' TYR . 32.8 m -117.83 129.55 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 70.11 111.163 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 246' ' ' THR . . . . . 0.73 HG22 ' CD2' ' C' ' 281' ' ' TYR . 11.7 t -69.05 171.13 8.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 72.54 111.178 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.7 -33.79 49.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 41.42 111.123 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 248' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' C' ' 249' ' ' ALA . . . -56.59 -35.82 68.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 75.04 111.143 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 249' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' C' ' 248' ' ' ALA . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 70.2 111.109 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.891 0.377 . . . . 53.04 110.919 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 30.8 p -97.83 129.29 44.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 74.4 111.118 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.637 HG23 ' HB3' ' D' ' 225' ' ' ARG . 0.3 OUTLIER -133.27 124.99 28.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 74.35 111.179 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -126.23 127.11 45.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 60.33 110.853 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.51 123.23 33.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 62.14 110.83 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' D' ' 231' ' ' ILE . 10.5 p -109.48 144.34 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 75.42 111.096 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.68 -65.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 71.53 110.893 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 30.5 p -147.01 138.36 24.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 64.4 111.216 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.502 ' CG1' HG21 ' C' ' 275' ' ' VAL . 23.3 t -117.61 124.93 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 63.54 111.144 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.66 116.02 41.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 72.42 111.117 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.41 133.01 9.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 64.32 112.475 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -132.44 141.27 48.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 75.14 110.866 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.99 68.67 1.39 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 74.22 112.478 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.83 93.72 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.789 0.328 . . . . 72.53 110.964 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 34.3 t -126.06 145.63 50.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 75.05 110.903 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 13.2 mtm-85 -129.55 127.87 41.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 71.43 110.825 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.646 HG22 ' CG2' ' D' ' 239' ' ' VAL . 17.7 t -137.63 131.54 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 74.32 111.16 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.671 HD12 ' CD1' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -128.36 111.66 13.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 64.22 110.947 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 2.6 mp -106.55 104.73 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 74.21 111.124 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.93 -179.88 23.53 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.763 -0.732 . . . . 64.4 112.471 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -89.74 156.11 18.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 75.11 110.887 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.538 ' HG3' HG12 ' D' ' 244' ' ' VAL . 2.6 pp20? -136.36 143.3 43.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 74.5 110.926 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.73 ' CD2' HG22 ' C' ' 246' ' ' THR . 63.3 t80 -130.02 125.46 35.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.42 110.916 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 149.41 116.87 0.84 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 72.21 112.456 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 283' ' ' GLY . . . . . 0.527 ' H ' ' HB2' ' D' ' 247' ' ' ALA . . . -62.82 -32.78 84.94 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.686 -0.768 . . . . 62.25 112.508 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -73.44 78.19 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.86 0.362 . . . . 64.34 110.912 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 73.77 104.78 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 72.24 112.458 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -58.23 -29.3 65.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 71.43 110.907 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.671 ' CD1' HD12 ' C' ' 276' ' ' LEU . 17.4 t90 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.142 -0.481 . . . . 74.21 110.983 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 225' ' ' ARG . . . . . 0.637 ' HB3' HG23 ' C' ' 261' ' ' THR . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.814 0.34 . . . . 73.42 110.861 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -82.91 110.57 18.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 73.31 110.865 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 27.0 m -139.74 147.59 41.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 74.12 110.843 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.17 162.36 24.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 64.0 111.099 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.72 -30.79 5.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 65.3 110.918 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.37 139.15 3.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 70.12 110.874 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 231' ' ' ILE . . . . . 0.423 ' CD1' HG23 ' C' ' 264' ' ' VAL . 14.3 mt -137.76 116.37 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 62.04 111.112 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.0 117.86 15.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 65.3 110.931 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.7 152.27 51.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 74.2 111.165 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -156.62 167.12 31.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 64.25 110.899 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 64.93 66.27 0.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 75.14 110.828 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? 50.24 45.21 26.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 71.02 110.921 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.6 151.53 20.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 72.42 111.084 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 35.0 mtt85 -132.39 135.59 46.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 74.35 110.845 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.646 ' CG2' HG22 ' C' ' 275' ' ' VAL . 0.4 OUTLIER -133.51 121.49 41.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 75.33 111.165 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 240' ' ' GLN . . . . . 0.523 ' O ' HD22 ' D' ' 241' ' ' LEU . 0.1 OUTLIER -108.44 135.47 49.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 53.33 110.958 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.55 HD21 HD12 ' D' ' 277' ' ' ILE . 3.5 mm? -126.46 118.59 25.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 72.11 110.872 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 123.05 175.0 14.42 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.792 -0.718 . . . . 33.24 112.468 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.66 144.79 25.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 73.21 110.904 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 244' ' ' VAL . . . . . 0.538 HG12 ' HG3' ' C' ' 280' ' ' GLU . 34.9 m -118.14 134.82 60.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 64.42 111.139 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 2.5 m -117.44 130.33 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 72.45 111.169 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 246' ' ' THR . . . . . 0.418 HG21 ' HA2' ' D' ' 282' ' ' GLY . 14.2 t -68.52 174.68 3.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 74.12 111.103 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 247' ' ' ALA . . . . . 0.527 ' HB2' ' H ' ' C' ' 283' ' ' GLY . . . -52.86 -36.63 59.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 75.11 111.019 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 248' ' ' ALA . . . . . 0.403 ' H ' HG23 ' D' ' 246' ' ' THR . . . -56.07 -35.46 67.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.21 111.14 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 249' ' ' ALA . . . . . 0.591 ' HB2' ' HE1' ' C' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 75.43 111.108 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 77.4 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.883 0.373 . . . . 72.44 111.121 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 261' ' ' THR . . . . . 0.558 HG23 ' N ' ' D' ' 225' ' ' ARG . 68.8 m -132.63 118.13 18.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 72.14 111.105 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 262' ' ' ASN . . . . . 0.51 HD21 HG23 ' D' ' 277' ' ' ILE . 1.8 t-20 -124.6 126.6 46.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 44.42 110.881 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.66 122.91 29.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 61.32 110.808 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.545 HG23 HD13 ' E' ' 231' ' ' ILE . 9.3 p -114.36 144.15 22.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 60.14 111.128 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 265' ' ' GLU . . . . . 0.445 ' HG3' ' HA ' ' E' ' 229' ' ' LYS . 12.8 mt-10 -86.61 -83.13 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 73.23 110.85 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.59 137.89 47.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 72.53 111.108 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.494 HG21 HD11 ' D' ' 277' ' ' ILE . 99.0 t -117.38 119.74 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 65.51 111.124 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.07 121.65 67.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 65.01 111.086 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.94 133.3 9.31 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.731 -0.747 . . . . 75.22 112.495 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.27 143.72 50.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 74.21 110.828 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 45.41 85.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 71.02 112.434 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 49.93 78.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.371 . . . . 61.02 110.863 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.88 144.67 36.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 52.12 110.879 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -132.78 126.24 31.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 74.14 110.897 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.823 HG13 HG23 ' E' ' 239' ' ' VAL . 44.9 t -139.12 123.24 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 72.42 111.094 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.735 HD12 ' CD1' ' D' ' 287' ' ' TRP . 0.5 OUTLIER -114.53 110.55 19.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 54.31 110.938 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.55 HD12 HD21 ' D' ' 241' ' ' LEU . 10.0 mt -104.83 107.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 72.44 111.133 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.21 173.63 15.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 71.31 112.516 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -93.46 137.09 33.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 75.54 110.897 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.86 141.56 45.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.896 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 281' ' ' TYR . . . . . 0.413 ' CE2' HG22 ' D' ' 246' ' ' THR . 3.0 t80 -130.28 124.73 33.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.943 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 282' ' ' GLY . . . . . 0.418 ' HA2' HG21 ' D' ' 246' ' ' THR . . . 166.9 37.61 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.747 . . . . 75.54 112.452 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 50.31 -132.06 29.73 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.74 -0.743 . . . . 63.2 112.515 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -29.35 22.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.802 0.334 . . . . 71.21 110.873 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -58.96 97.12 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.75 -0.738 . . . . 71.23 112.52 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 286' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' E' ' 244' ' ' VAL . 0.2 OUTLIER -100.0 -176.43 3.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.938 0.399 . . . . 60.21 110.829 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 287' ' ' TRP . . . . . 0.735 ' CD1' HD12 ' D' ' 276' ' ' LEU . 15.6 t90 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 62.32 110.902 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 225' ' ' ARG . . . . . 0.406 ' O ' ' HB3' ' E' ' 262' ' ' ASN . 2.4 ttp180 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.777 0.322 . . . . 75.43 110.873 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -145.19 104.16 3.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 72.11 110.858 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.25 143.59 44.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 25.44 110.871 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.99 164.55 19.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 40.35 111.103 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 229' ' ' LYS . . . . . 0.445 ' HA ' ' HG3' ' D' ' 265' ' ' GLU . 0.9 OUTLIER -119.2 -36.39 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 74.53 110.914 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.26 138.62 3.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 62.12 110.856 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 231' ' ' ILE . . . . . 0.545 HD13 HG23 ' D' ' 264' ' ' VAL . 3.1 mp -137.81 113.54 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 72.41 111.139 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 232' ' ' ARG . . . . . 0.4 ' HG3' ' HA ' ' E' ' 268' ' ' VAL . 8.4 ptm180 -137.85 114.69 10.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 72.12 110.889 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.67 150.78 45.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 74.31 111.135 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -156.16 160.28 39.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.816 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 65.44 68.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 62.23 110.906 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 48.83 54.14 11.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.925 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.89 149.08 26.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 70.41 111.083 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -130.47 135.57 48.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 74.24 110.86 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.823 HG23 HG13 ' D' ' 275' ' ' VAL . 31.9 m -139.86 129.11 28.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 75.32 111.192 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 240' ' ' GLN . . . . . 0.65 ' O ' HD13 ' E' ' 241' ' ' LEU . 0.0 OUTLIER -119.95 137.59 53.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 70.12 110.952 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.961 HD12 HD12 ' E' ' 277' ' ' ILE . 0.9 OUTLIER -122.66 118.91 29.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 71.31 110.869 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 125.85 174.17 13.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.726 -0.749 . . . . 74.43 112.509 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -100.7 163.03 12.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.902 0.382 . . . . 72.03 110.89 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' D' ' 286' ' ' PHE . 2.6 m -121.88 140.47 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 61.32 111.084 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.81 127.99 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 64.12 111.124 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 246' ' ' THR . . . . . 0.487 HG21 ' HA2' ' E' ' 282' ' ' GLY . 10.7 t -69.17 168.78 13.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 75.32 111.152 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.01 -33.9 53.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 71.51 111.088 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.2 -50.12 73.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 73.2 111.133 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 61.05 111.131 179.952 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.854 0.359 . . . . 74.23 111.083 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 262' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' E' ' 225' ' ' ARG . 3.7 t-20 -129.15 116.42 19.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 61.0 110.891 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 3.1 p -119.7 123.87 44.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 70.41 110.79 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 264' ' ' VAL . . . . . 0.966 HG21 HD13 ' E' ' 277' ' ' ILE . 1.0 OUTLIER -104.75 137.17 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 64.13 111.163 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 265' ' ' GLU . . . . . 0.417 ' N ' ' CD ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -74.1 -146.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 34.54 110.912 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 4.1 t -96.56 137.61 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 65.2 111.171 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 267' ' ' VAL . . . . . 0.751 ' CG1' HG21 ' E' ' 275' ' ' VAL . 95.9 t -115.01 121.64 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 64.14 111.159 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 268' ' ' VAL . . . . . 0.422 ' O ' HG13 ' E' ' 268' ' ' VAL . 5.7 p -120.96 120.16 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 72.32 111.108 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.36 133.36 11.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.792 -0.718 . . . . 63.11 112.47 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -131.38 116.45 17.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.338 . . . . 72.41 110.907 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 65.67 80.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 71.42 112.517 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 58.66 88.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 73.2 110.92 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 8.9 t -121.29 145.61 47.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 62.22 110.842 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.5 128.05 34.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 73.45 110.858 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.751 HG21 ' CG1' ' E' ' 267' ' ' VAL . 41.7 t -136.97 123.5 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 50.21 111.142 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 276' ' ' LEU . . . . . 0.592 HD22 ' HB3' ' E' ' 240' ' ' GLN . 0.8 OUTLIER -121.25 110.93 16.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 72.31 110.994 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.966 HD13 HG21 ' E' ' 264' ' ' VAL . 54.1 mt -107.89 137.53 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 75.45 111.096 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 121.31 -161.57 15.34 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.731 -0.747 . . . . 64.24 112.467 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -128.47 156.96 42.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 71.31 110.857 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.03 118.24 31.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 63.42 110.871 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -103.72 124.77 49.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 65.3 110.917 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 282' ' ' GLY . . . . . 0.487 ' HA2' HG21 ' E' ' 246' ' ' THR . . . . . . . . 0 N--CA 1.45 -0.401 0 C-N-CA 120.785 -0.722 . . . . 50.02 112.529 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.413 ' N ' HG23 ' A' ' 261' ' ' THR . 15.2 ptt180 . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.789 0.328 . . . . 53.32 110.921 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -107.01 122.81 47.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 64.45 110.884 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 68.7 m -121.85 138.03 54.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 71.32 110.833 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.65 121.01 13.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 74.3 111.068 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.04 -35.95 23.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.235 -0.439 . . . . 63.45 110.913 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -164.17 139.19 5.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 75.44 110.926 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 10.1 mt -137.46 117.72 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.4 111.078 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -127.39 119.97 27.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 63.24 110.87 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.58 148.66 52.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 63.15 111.179 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -148.73 167.55 25.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 73.43 110.863 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 66.5 55.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 73.41 110.854 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.96 64.38 1.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 64.43 110.913 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.19 156.34 17.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 62.15 111.061 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -129.4 135.83 49.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.33 110.878 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.485 HG12 ' HB ' ' A' ' 275' ' ' VAL . 34.4 m -143.16 130.17 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 64.41 111.11 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.581 ' OE1' HD21 ' A' ' 276' ' ' LEU . 1.8 tt0 -131.06 137.19 49.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 75.54 110.9 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.702 ' CD2' HD13 ' A' ' 277' ' ' ILE . 0.7 OUTLIER -126.93 118.8 25.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 75.2 110.925 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 154.02 175.16 24.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.72 . . . . 71.43 112.599 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -85.88 131.15 34.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.936 0.398 . . . . 65.21 110.874 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 29.5 t -110.34 124.24 66.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 62.44 111.152 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 49.2 t -118.84 113.01 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 74.41 111.068 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.098 -0.501 . . . . 64.15 111.193 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' THR . . . . . 0.435 HG22 ' N ' ' B' ' 225' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.809 0.338 . . . . 74.31 111.228 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 225' ' ' ARG . 0.2 OUTLIER -92.78 110.72 22.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 73.35 111.21 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.441 ' HB2' HG22 ' A' ' 277' ' ' ILE . 1.0 OUTLIER -94.29 120.28 34.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 63.04 110.929 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 41.3 t -131.58 123.8 28.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 73.31 110.81 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.636 HG21 HG22 ' A' ' 267' ' ' VAL . 7.8 p -122.26 137.03 57.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 72.33 111.144 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -83.03 -71.71 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 61.2 110.951 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 38.8 m -125.88 130.26 50.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.13 111.13 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.636 HG22 HG21 ' A' ' 264' ' ' VAL . 27.6 t -118.2 126.11 74.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 74.15 111.14 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 22.1 t -127.29 117.09 46.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 65.41 111.162 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.04 134.04 9.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.778 -0.725 . . . . 52.55 112.491 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -132.14 147.21 52.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.845 0.355 . . . . 74.34 110.904 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 57.94 73.9 0.4 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 31.34 112.479 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 48.42 59.54 4.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.867 0.365 . . . . 64.1 110.914 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 38.4 t -83.86 145.81 28.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 74.35 110.894 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -123.33 127.69 48.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 75.05 110.883 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.485 ' HB ' HG12 ' A' ' 239' ' ' VAL . 13.8 t -130.79 125.7 58.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 65.42 111.114 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.581 HD21 ' OE1' ' A' ' 240' ' ' GLN . 0.5 OUTLIER -124.71 111.84 16.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 75.41 110.914 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.702 HD13 ' CD2' ' A' ' 241' ' ' LEU . 4.7 mp -108.08 104.74 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 61.44 111.133 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.15 168.36 15.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 55.23 112.397 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -94.27 152.78 18.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.737 0.304 . . . . 72.13 110.835 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -123.2 118.87 28.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.906 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.406 ' CE1' HG11 ' B' ' 245' ' ' VAL . 29.1 t80 -117.6 148.37 41.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 63.11 110.942 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.11 -107.63 0.63 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.794 -0.717 . . . . 64.24 112.507 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' B' ' 247' ' ' ALA . . . -172.33 94.49 0.1 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 75.54 112.472 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -179.49 -34.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 74.14 110.844 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.09 -110.32 3.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 70.01 112.52 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.36 -172.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.371 . . . . 53.03 110.809 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 75.0 110.938 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.757 ' HB3' HG23 ' B' ' 261' ' ' THR . 16.7 ttt-85 . . . . . 0 CA--C 1.526 0.058 0 CA-C-O 120.881 0.372 . . . . 73.42 110.81 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -110.26 123.66 50.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 74.33 110.907 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.83 138.31 54.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 64.33 110.903 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -142.35 120.28 12.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 74.24 111.099 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -31.6 21.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 64.31 110.921 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.46 139.18 5.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 60.21 110.818 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 9.4 mt -137.22 117.85 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 74.43 111.165 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -130.89 119.63 22.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.861 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.1 OUTLIER -132.41 146.84 52.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 74.3 111.153 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -147.1 167.28 24.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 62.34 110.878 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 65.6 54.63 1.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 74.42 110.89 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 19.1 mtt85 51.68 62.62 2.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 62.51 110.807 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.443 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -103.57 156.42 17.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 63.21 111.061 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.89 136.02 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 74.54 110.865 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.648 HG12 ' HB ' ' B' ' 275' ' ' VAL . 19.2 m -141.22 121.74 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 73.42 111.161 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.494 ' O ' HD22 ' B' ' 276' ' ' LEU . 1.7 tt0 -123.03 137.19 55.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 71.01 110.955 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.601 HD23 HD13 ' B' ' 277' ' ' ILE . 0.8 OUTLIER -123.74 118.83 28.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.236 -0.438 . . . . 73.23 110.939 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 150.51 171.15 18.49 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 41.31 112.504 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -86.03 139.06 31.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.893 0.377 . . . . 70.42 110.891 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -117.72 124.32 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 54.41 111.107 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.406 HG11 ' CE1' ' A' ' 281' ' ' TYR . 39.5 t -122.02 128.88 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 53.31 111.105 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 15.5 p -86.81 170.64 11.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 73.1 111.173 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.449 ' HB2' ' HA3' ' A' ' 283' ' ' GLY . . . -63.2 -39.08 93.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 72.04 111.123 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.88 69.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 42.52 111.101 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 72.54 111.079 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.885 0.374 . . . . 71.44 110.922 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.92 123.9 45.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 61.41 111.134 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.757 HG23 ' HB3' ' B' ' 225' ' ' ARG . 6.1 m -95.29 108.89 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 73.44 111.098 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.497 ' HB2' HG22 ' B' ' 277' ' ' ILE . 0.7 OUTLIER -95.86 125.04 40.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 70.5 110.827 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 2.9 p -135.59 123.69 22.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 65.34 110.864 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.637 HG21 HG22 ' B' ' 267' ' ' VAL . 9.9 p -119.78 135.78 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 73.35 111.082 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -74.66 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 75.33 110.913 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 76.8 m -122.29 130.05 52.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 62.51 111.152 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.637 HG22 HG21 ' B' ' 264' ' ' VAL . 39.3 t -118.34 123.46 71.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 71.33 111.094 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.33 118.84 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 64.12 111.087 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.1 134.93 9.73 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.681 -0.771 . . . . 53.02 112.457 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -131.58 147.3 52.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 70.5 110.896 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 59.66 72.39 0.62 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.748 -0.739 . . . . 64.44 112.471 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 49.13 59.16 4.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.951 0.405 . . . . 73.14 110.867 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 33.2 t -83.81 145.52 28.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 63.04 110.836 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.95 127.36 47.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 62.45 110.783 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.648 ' HB ' HG12 ' B' ' 239' ' ' VAL . 10.5 t -131.8 128.22 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 75.32 111.115 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.494 HD22 ' O ' ' B' ' 240' ' ' GLN . 2.7 tm? -128.02 111.93 14.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.504 . . . . 52.22 110.959 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.601 HD13 HD23 ' B' ' 241' ' ' LEU . 4.7 mp -106.15 104.6 17.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 61.13 111.14 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.64 179.03 29.56 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.765 -0.731 . . . . 72.23 112.527 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.33 146.17 24.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.774 0.321 . . . . 73.3 110.949 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.86 119.01 34.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 64.03 110.892 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -118.19 125.85 51.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 72.24 110.904 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 137.37 -43.51 1.21 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 73.25 112.494 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 92.91 135.99 7.51 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 65.55 112.515 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -179.33 -34.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.866 0.365 . . . . 63.52 110.924 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 146.51 -90.98 0.15 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.693 -0.765 . . . . 54.21 112.454 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.03 -49.46 3.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 73.23 110.927 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 74.33 110.913 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.813 0.339 . . . . 74.4 110.896 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -122.75 131.25 53.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 65.43 110.886 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.88 137.87 54.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 55.2 110.862 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' B' ' 264' ' ' VAL . . . -137.39 141.02 41.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 65.13 111.065 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.94 -32.82 8.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 64.24 110.898 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.61 138.32 5.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 72.14 110.847 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 7.3 mt -137.53 117.62 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 63.42 111.1 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -128.37 120.47 27.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.88 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.0 OUTLIER -130.63 149.34 52.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 63.4 111.127 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -147.83 168.03 23.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 73.5 110.858 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 61.39 54.4 3.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 70.43 110.844 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 51.1 66.65 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 72.4 110.858 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.596 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -103.58 156.95 17.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 63.31 111.099 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -125.29 135.18 52.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 72.14 110.807 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.612 HG12 ' HB ' ' C' ' 275' ' ' VAL . 6.4 m -137.9 121.92 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 73.13 111.171 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -122.12 137.34 54.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 63.42 110.861 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.548 HD13 HG13 ' B' ' 277' ' ' ILE . 2.7 mp -126.24 118.87 26.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 70.04 110.953 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.53 176.07 15.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 63.53 112.517 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -91.34 128.97 37.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.889 0.376 . . . . 64.33 110.893 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.93 116.53 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 62.51 111.119 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.502 ' CG1' ' HB3' ' C' ' 249' ' ' ALA . 25.8 t -119.93 118.9 58.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 72.44 111.098 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -70.22 174.24 5.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.172 -0.467 . . . . 74.04 111.157 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.76 -37.99 88.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 51.35 111.088 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.84 -52.04 66.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 74.53 111.101 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 249' ' ' ALA . . . . . 0.502 ' HB3' ' CG1' ' C' ' 245' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 75.42 111.107 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.903 0.382 . . . . 70.35 110.913 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 260' ' ' THR . . . . . 0.418 HG22 ' CG ' ' D' ' 225' ' ' ARG . 0.2 OUTLIER -94.33 131.06 40.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.485 . . . . 75.04 111.108 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 64.0 m -91.95 124.94 36.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 54.03 111.168 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.422 ' ND2' ' HA2' ' C' ' 278' ' ' GLY . 0.5 OUTLIER -126.18 129.33 48.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.426 . . . . 51.25 110.856 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 28.9 t -140.86 123.39 16.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 43.54 110.83 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.665 HG21 HG22 ' C' ' 267' ' ' VAL . 7.5 p -116.53 136.52 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 70.14 111.18 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.01 -74.91 0.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 53.05 110.883 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 31.6 m -116.57 127.66 54.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 63.52 111.105 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.665 HG22 HG21 ' C' ' 264' ' ' VAL . 46.8 t -118.68 123.07 70.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 75.32 111.118 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 24.5 t -126.93 127.64 70.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 65.0 111.109 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -131.18 135.3 8.15 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.748 . . . . 61.32 112.528 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -132.45 148.37 52.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.873 0.368 . . . . 73.45 110.866 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.62 76.17 0.21 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.727 -0.749 . . . . 71.33 112.452 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 47.31 58.82 4.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.875 0.369 . . . . 73.41 110.88 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 37.7 t -83.4 145.4 29.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 63.31 110.835 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -124.53 127.92 48.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 71.5 110.899 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.612 ' HB ' HG12 ' C' ' 239' ' ' VAL . 17.0 t -134.13 123.68 44.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 74.04 111.156 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.661 HD12 ' CE3' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -123.97 119.3 29.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 72.32 110.93 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 4.2 mt -112.08 104.52 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 75.11 111.103 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 278' ' ' GLY . . . . . 0.422 ' HA2' ' ND2' ' C' ' 262' ' ' ASN . . . 154.35 -159.32 28.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 71.4 112.42 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -110.11 155.99 21.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 63.34 110.907 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -131.24 124.39 30.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.139 -0.482 . . . . 70.24 110.913 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -120.92 125.92 48.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 73.44 110.893 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 135.71 161.66 9.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.789 -0.719 . . . . 30.42 112.483 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 283' ' ' GLY . . . . . 0.589 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . -96.99 110.11 3.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.772 -0.728 . . . . 63.34 112.488 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -179.24 37.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 72.22 110.972 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 53.49 -110.64 1.46 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 44.22 112.514 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.03 -175.96 5.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 71.51 110.888 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.661 ' CE3' HD12 ' C' ' 276' ' ' LEU . 1.7 p90 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 72.34 110.898 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 225' ' ' ARG . . . . . 0.418 ' CG ' HG22 ' C' ' 260' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.88 0.371 . . . . 75.4 110.874 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -128.13 112.42 14.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 61.03 110.828 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.53 142.66 49.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 62.02 110.856 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 228' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' C' ' 264' ' ' VAL . . . -139.73 133.24 30.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 35.11 111.048 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -97.49 -37.11 10.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 64.01 110.881 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -164.3 137.36 5.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 74.31 110.914 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 231' ' ' ILE . . . . . 0.449 HG23 ' HB ' ' D' ' 267' ' ' VAL . 6.6 mt -137.92 117.66 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 53.2 111.116 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -123.6 115.46 21.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.876 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 233' ' ' THR . . . . . 0.576 ' OG1' ' HB3' ' D' ' 237' ' ' ALA . 0.1 OUTLIER -125.4 148.21 48.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 71.33 111.13 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.59 166.22 30.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 60.13 110.88 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 65.54 52.3 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 73.4 110.917 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 54.46 59.62 4.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 75.22 110.834 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 237' ' ' ALA . . . . . 0.576 ' HB3' ' OG1' ' D' ' 233' ' ' THR . . . -98.27 155.75 17.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.55 111.059 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 38.2 mtt180 -125.95 135.34 51.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 53.11 110.86 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.617 HG12 ' HB ' ' D' ' 275' ' ' VAL . 6.1 m -137.89 121.81 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 73.24 111.122 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.42 137.12 52.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.897 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.633 HD21 HD12 ' D' ' 277' ' ' ILE . 1.1 mm? -120.96 118.24 29.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 72.43 110.923 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.44 -173.32 19.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.795 -0.717 . . . . 51.32 112.483 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.38 149.9 21.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 53.22 110.898 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.23 116.37 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 72.15 111.14 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 245' ' ' VAL . . . . . 0.666 HG13 ' HB3' ' D' ' 281' ' ' TYR . 50.3 t -115.02 128.98 71.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 72.23 111.137 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 11.8 t -70.65 174.47 5.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 53.33 111.126 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 247' ' ' ALA . . . . . 0.589 ' HB2' ' N ' ' C' ' 283' ' ' GLY . . . -63.14 -41.83 99.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 71.14 111.04 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.0 -43.42 81.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 73.43 111.13 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.32 111.063 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.816 0.341 . . . . 64.23 111.252 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 261' ' ' THR . . . . . 0.4 HG23 ' N ' ' D' ' 225' ' ' ARG . 0.7 OUTLIER -133.9 109.03 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 61.41 111.148 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 262' ' ' ASN . . . . . 0.563 ' HB2' HG22 ' D' ' 277' ' ' ILE . 0.2 OUTLIER -107.35 120.55 42.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 74.24 110.844 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 57.9 m -132.11 124.06 28.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 72.33 110.819 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.88 ' HA ' ' HB3' ' E' ' 228' ' ' ALA . 7.9 p -106.55 138.87 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.116 -0.493 . . . . 73.42 111.08 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 265' ' ' GLU . . . . . 0.457 ' HB2' ' HA ' ' E' ' 229' ' ' LYS . 3.0 tt0 -94.52 -29.53 14.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 72.22 110.863 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 266' ' ' THR . . . . . 0.492 ' HB ' ' HA ' ' E' ' 230' ' ' ASP . 1.1 m -152.69 129.22 10.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 52.42 111.147 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.658 HG22 HG21 ' D' ' 264' ' ' VAL . 94.1 t -127.18 120.5 55.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 72.33 111.143 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 40.6 t -127.74 128.0 68.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 54.1 111.097 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -135.23 133.31 6.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.738 . . . . 63.04 112.517 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.47 149.36 51.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 70.14 110.908 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.22 81.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.744 -0.741 . . . . 74.24 112.439 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 45.59 57.66 4.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 72.04 110.892 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 29.7 t -83.84 145.14 28.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 63.23 110.816 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -125.94 127.4 45.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 64.35 110.842 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.619 HG13 HG23 ' E' ' 239' ' ' VAL . 17.1 t -137.02 123.79 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 75.33 111.114 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 1.1 tt -128.17 111.72 13.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 65.33 110.907 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.633 HD12 HD21 ' D' ' 241' ' ' LEU . 16.5 mt -102.42 104.54 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 44.51 111.141 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 278' ' ' GLY . . . . . 0.404 ' HA2' ' ND2' ' D' ' 262' ' ' ASN . . . 155.02 -168.18 32.91 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.746 -0.74 . . . . 72.42 112.491 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -103.39 140.0 38.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 64.32 110.914 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -111.95 134.85 53.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 55.4 110.928 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 281' ' ' TYR . . . . . 0.666 ' HB3' HG13 ' D' ' 245' ' ' VAL . 1.2 t80 -120.04 125.8 49.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 61.14 110.879 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.52 -160.73 40.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.686 -0.768 . . . . 70.03 112.474 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 52.2 39.24 50.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 62.13 112.455 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 5.6 mptt 68.77 -76.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.351 . . . . 45.01 110.914 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -173.99 29.32 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.624 -0.798 . . . . 63.31 112.435 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.51 -168.75 2.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.907 0.384 . . . . 72.24 110.831 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 75.41 110.934 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.765 0.317 . . . . 72.32 110.874 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -82.2 114.81 20.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 51.35 110.894 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.03 133.59 55.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 65.13 110.875 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 228' ' ' ALA . . . . . 0.88 ' HB3' ' HA ' ' D' ' 264' ' ' VAL . . . -122.41 170.04 10.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 72.43 111.135 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 229' ' ' LYS . . . . . 0.644 ' HE3' ' N ' ' E' ' 229' ' ' LYS . 0.0 OUTLIER -140.45 -34.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 62.24 110.893 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 230' ' ' ASP . . . . . 0.58 ' N ' ' HD2' ' E' ' 229' ' ' LYS . 8.8 t0 -175.62 131.71 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 70.51 110.821 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 231' ' ' ILE . . . . . 0.643 HG23 HG11 ' E' ' 267' ' ' VAL . 15.5 mt -132.58 115.78 26.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 71.24 111.128 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -110.99 115.26 29.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 74.55 110.937 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 233' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' E' ' 237' ' ' ALA . 0.1 OUTLIER -127.99 128.59 45.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 72.24 111.148 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -136.9 166.55 23.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 74.13 110.878 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 61.68 61.11 1.5 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 73.25 110.884 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 40.2 mtt85 49.35 63.93 1.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.45 110.844 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 237' ' ' ALA . . . . . 0.459 ' HB3' ' OG1' ' E' ' 233' ' ' THR . . . -104.74 156.48 17.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 75.05 111.057 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -128.06 135.85 50.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 64.03 110.92 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.64 HG12 ' HB ' ' E' ' 275' ' ' VAL . 4.5 m -139.25 121.7 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 74.54 111.181 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.83 137.47 54.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.41 110.913 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.502 HD11 ' CD1' ' E' ' 231' ' ' ILE . 4.8 mp -122.61 117.92 26.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.932 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.8 168.18 11.76 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 72.43 112.551 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -85.84 133.77 33.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.898 0.38 . . . . 60.03 110.92 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 97.3 t -109.71 135.51 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 71.32 111.13 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 245' ' ' VAL . . . . . 0.43 HG13 ' HB3' ' E' ' 281' ' ' TYR . 73.4 t -122.17 129.1 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 73.41 111.163 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.7 t -69.77 171.6 8.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 75.22 111.115 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.26 -33.91 75.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 51.41 111.082 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.22 66.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.274 -0.421 . . . . 75.15 111.063 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 42.34 111.118 179.964 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 93.1 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.814 0.34 . . . . 54.52 111.146 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -108.68 119.34 39.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 65.11 110.933 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.04 132.77 40.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 72.52 110.82 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 264' ' ' VAL . . . . . 0.724 HG22 ' H ' ' E' ' 266' ' ' THR . 9.4 p -116.8 153.82 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 54.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 265' ' ' GLU . . . . . 0.599 ' O ' ' HD3' ' E' ' 229' ' ' LYS . 0.2 OUTLIER -112.02 -11.0 13.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 75.44 110.866 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 266' ' ' THR . . . . . 0.724 ' H ' HG22 ' E' ' 264' ' ' VAL . 0.2 OUTLIER -167.46 126.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.24 111.122 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 267' ' ' VAL . . . . . 0.643 HG11 HG23 ' E' ' 231' ' ' ILE . 41.0 t -132.16 117.36 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 72.42 111.104 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.21 139.2 52.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 72.22 111.138 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -144.74 133.41 5.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 35.02 112.5 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -134.02 148.06 51.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 52.51 110.838 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 56.29 86.5 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.701 -0.761 . . . . 54.35 112.503 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 44.98 56.76 5.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.898 0.38 . . . . 61.52 110.895 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.42 145.23 29.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 51.24 110.924 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.93 126.96 39.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.893 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.64 ' HB ' HG12 ' E' ' 239' ' ' VAL . 21.2 t -136.05 123.56 34.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 55.32 111.127 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.03 111.44 12.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 75.22 110.905 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 37.3 mt -104.12 104.62 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 72.11 111.05 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 156.85 -174.5 34.51 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.773 -0.727 . . . . 73.02 112.485 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -103.53 153.05 20.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 75.3 110.867 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -116.27 136.35 53.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 71.23 110.825 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 281' ' ' TYR . . . . . 0.43 ' HB3' HG13 ' E' ' 245' ' ' VAL . 2.7 t80 -117.46 125.78 51.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 65.53 110.886 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 54.54 112.509 179.968 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 . . . . . 0 N--CA 1.458 -0.039 0 CA-C-O 120.859 0.361 . . . . 71.44 110.861 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.409 ' HB3' HG22 ' A' ' 277' ' ' ILE . 8.8 m-20 -87.78 112.28 22.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 71.11 110.93 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.65 148.4 49.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 75.11 110.871 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.17 119.3 10.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 62.24 111.057 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.43 -43.99 88.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 74.5 110.921 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -165.48 136.68 3.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 71.24 110.886 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 9.1 pt -139.07 131.78 37.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 72.43 111.144 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -135.05 139.8 45.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 74.12 110.873 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.738 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.5 OUTLIER -136.31 153.82 51.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 74.43 111.154 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -142.72 168.71 19.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 43.32 110.881 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 74.2 -70.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 64.24 110.886 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.73 53.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 73.05 110.818 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.738 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -91.5 156.82 17.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.03 111.076 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -130.98 138.21 49.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 72.44 110.894 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.771 HG12 ' HB ' ' A' ' 275' ' ' VAL . 27.5 m -122.43 125.47 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 75.31 111.146 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -123.24 118.9 28.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 65.12 110.862 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.64 119.34 36.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 65.13 110.952 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 150.86 169.71 17.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 53.3 112.448 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -85.95 133.36 33.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 75.32 110.886 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.7 t -103.96 133.37 48.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 73.33 111.201 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 97.4 t -119.73 121.97 67.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 73.53 111.093 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.469 HG21 ' HG3' ' A' ' 284' ' ' LYS . 3.0 m . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 74.14 111.158 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' THR . . . . . 0.502 HG22 ' ND2' ' B' ' 226' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.844 0.354 . . . . 50.3 111.115 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.428 HG23 ' HB2' ' B' ' 225' ' ' ARG . 3.3 t -125.18 121.8 35.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 72.32 111.189 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -91.24 127.21 36.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 34.15 110.877 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.4 p -142.41 123.07 14.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 72.43 110.896 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.639 HG21 HG22 ' A' ' 267' ' ' VAL . 8.7 p -118.99 134.47 62.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.45 111.125 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -78.33 -75.78 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.5 . . . . 75.31 110.879 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.91 127.13 53.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 60.42 111.199 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.639 HG22 HG21 ' A' ' 264' ' ' VAL . 47.0 t -118.96 120.85 65.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 72.45 111.142 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 74.5 t -123.47 115.29 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 71.51 111.106 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.72 133.6 11.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 75.13 112.5 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 139.92 48.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 74.34 110.854 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.19 81.1 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.733 -0.746 . . . . 63.44 112.545 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 44.7 62.51 2.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.836 0.35 . . . . 72.24 110.96 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.47 145.06 29.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 74.11 110.857 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -113.27 128.05 56.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 61.2 110.883 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.771 ' HB ' HG12 ' A' ' 239' ' ' VAL . 19.9 t -129.53 123.29 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 74.25 111.129 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.43 111.6 13.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 45.11 110.968 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.409 HG22 ' HB3' ' A' ' 226' ' ' ASN . 2.5 mp -110.33 103.89 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 74.22 111.047 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.54 168.69 15.69 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.736 -0.745 . . . . 74.23 112.503 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -89.72 154.22 20.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 61.51 110.908 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.655 ' CD ' HG13 ' B' ' 244' ' ' VAL . 0.0 OUTLIER -127.65 123.78 36.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 60.41 110.877 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -103.51 128.55 50.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 55.35 110.872 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.97 134.74 6.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 65.11 112.456 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.554 ' H ' ' N ' ' B' ' 247' ' ' ALA . . . -83.33 -112.0 0.53 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.811 -0.709 . . . . 63.45 112.525 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.469 ' HG3' HG21 ' A' ' 246' ' ' THR . 0.1 OUTLIER 63.45 25.45 14.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.728 0.299 . . . . 54.4 110.815 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 145.12 -12.97 1.88 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.748 -0.739 . . . . 52.43 112.486 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.74 ' CZ ' HG11 ' B' ' 244' ' ' VAL . 7.7 t80 72.39 -68.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 75.21 110.867 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 14.5 t90 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 73.11 110.939 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.747 ' HG2' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.787 0.327 . . . . 63.24 110.889 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.502 ' ND2' HG22 ' A' ' 260' ' ' THR . 2.4 m-20 -93.75 112.7 24.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 62.3 110.908 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 32.4 t -127.61 152.32 47.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.851 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.03 124.27 17.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 35.14 111.064 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.07 -40.24 62.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 73.53 110.936 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -166.26 135.87 3.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 72.33 110.824 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 267' ' ' VAL . 8.1 pt -139.15 130.01 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.481 . . . . 73.24 111.16 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.09 137.28 40.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 61.34 110.894 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.758 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.5 OUTLIER -137.1 150.44 48.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 75.34 111.071 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -142.01 168.63 19.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 55.44 110.869 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 73.19 -71.84 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.883 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -177.93 59.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 64.3 110.898 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.758 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -97.88 156.61 16.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 60.44 111.112 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -130.7 135.87 48.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 73.23 110.843 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.729 HG12 ' HB ' ' B' ' 275' ' ' VAL . 27.7 m -122.22 132.15 71.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 70.21 111.166 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -130.22 119.28 22.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.881 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.401 ' HG ' HD13 ' B' ' 277' ' ' ILE . 4.4 mp -111.69 118.4 35.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 70.15 110.892 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 145.23 175.48 18.4 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.777 -0.725 . . . . 71.33 112.491 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.83 129.37 34.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.394 . . . . 70.1 110.879 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.74 HG11 ' CZ ' ' A' ' 286' ' ' PHE . 92.1 t -102.19 114.74 42.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 72.55 111.195 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.519 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 85.0 t -106.76 129.26 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 71.11 111.169 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.425 HG23 ' H ' ' B' ' 249' ' ' ALA . 6.3 t -74.96 169.58 17.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 75.24 111.166 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.554 ' N ' ' H ' ' A' ' 283' ' ' GLY . . . -63.34 -41.8 98.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 72.12 111.084 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.61 -35.85 68.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 73.45 111.101 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.519 ' HB3' ' CG1' ' B' ' 245' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 51.21 111.072 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.851 0.358 . . . . 61.51 110.862 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 260' ' ' THR . . . . . 0.596 HG22 ' NH1' ' C' ' 225' ' ' ARG . 18.0 p -79.89 121.85 25.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 73.15 111.238 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.747 HG23 ' HG2' ' B' ' 225' ' ' ARG . 91.2 m -97.28 108.84 21.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 73.03 111.163 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.794 ' HB3' HD23 ' C' ' 241' ' ' LEU . 0.2 OUTLIER -96.26 126.22 41.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 60.34 110.914 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 5.5 t -141.99 123.46 14.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 73.31 110.802 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.711 HG21 HD11 ' C' ' 231' ' ' ILE . 9.8 p -108.19 136.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.041 -0.527 . . . . 73.21 111.18 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -81.83 -77.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 72.43 110.894 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.5 m -121.08 127.94 52.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 75.43 111.104 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.716 HG22 HD11 ' C' ' 231' ' ' ILE . 15.7 t -118.18 120.32 64.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 74.34 111.106 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 41.3 t -123.38 115.04 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 71.23 111.13 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.52 133.09 10.52 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 55.42 112.496 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -132.48 146.97 52.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.751 0.31 . . . . 64.32 110.967 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.04 75.12 0.22 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.761 -0.733 . . . . 43.0 112.468 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 52.82 78.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.88 0.371 . . . . 72.03 110.893 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 1.4 t -103.66 144.7 31.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 70.1 110.906 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.418 ' O ' HG22 ' C' ' 239' ' ' VAL . 0.9 OUTLIER -112.43 127.58 56.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 60.43 110.818 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.729 ' HB ' HG12 ' B' ' 239' ' ' VAL . 97.0 t -130.5 123.62 55.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 70.2 111.16 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.598 HD23 ' CZ2' ' B' ' 287' ' ' TRP . 0.9 OUTLIER -128.88 111.85 13.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 62.22 110.846 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.401 HD13 ' HG ' ' B' ' 241' ' ' LEU . 3.4 mp -107.7 104.34 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 73.5 111.09 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.426 ' HA2' ' ND2' ' B' ' 262' ' ' ASN . . . 149.29 -171.75 29.44 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.745 -0.74 . . . . 75.11 112.519 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.77 147.95 26.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 74.33 110.975 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.527 ' OE1' HG13 ' C' ' 244' ' ' VAL . 1.8 pt-20 -116.8 121.68 42.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 63.34 110.822 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -112.41 125.72 54.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 75.15 110.967 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 140.08 164.58 9.95 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.743 . . . . 74.41 112.485 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 283' ' ' GLY . . . . . 0.524 ' HA3' ' HB2' ' C' ' 247' ' ' ALA . . . -103.83 -143.5 12.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 53.31 112.503 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 9.9 mttp 56.87 25.3 10.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 72.33 110.866 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 128.75 -117.49 2.5 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.725 -0.75 . . . . 72.22 112.497 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -173.9 -44.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.882 0.372 . . . . 74.25 110.911 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.598 ' CZ2' HD23 ' B' ' 276' ' ' LEU . 3.7 t90 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 55.41 110.844 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.596 ' NH1' HG22 ' B' ' 260' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.815 0.34 . . . . 74.12 110.842 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -94.08 109.86 21.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 73.44 110.903 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 60.7 p -137.02 148.17 46.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 62.01 110.854 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.22 137.56 47.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.501 . . . . 55.13 111.112 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -86.45 -40.49 15.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 72.5 110.911 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -165.47 136.5 3.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 73.55 110.895 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.716 HD11 HG22 ' B' ' 267' ' ' VAL . 8.3 pt -140.13 117.1 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.54 111.12 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -124.48 116.24 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 71.23 110.885 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.626 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.6 OUTLIER -124.46 136.86 54.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 75.53 111.171 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 234' ' ' GLU . . . . . 0.401 ' HG3' ' HG3' ' C' ' 235' ' ' GLU . 3.8 pt-20 -121.44 166.95 13.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 71.15 110.872 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.401 ' HG3' ' HG3' ' C' ' 234' ' ' GLU . 2.6 mt-10 60.84 -162.91 0.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.496 . . . . 74.25 110.954 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 -72.65 63.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 75.1 110.877 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.626 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -105.62 156.37 18.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 53.34 111.047 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -135.9 135.95 40.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 65.32 110.839 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.449 HG12 ' CG2' ' C' ' 275' ' ' VAL . 17.4 m -134.35 134.41 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 72.44 111.11 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.428 ' HB3' HD22 ' C' ' 276' ' ' LEU . 1.2 tt0 -130.13 137.37 50.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.501 . . . . 73.32 110.888 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.794 HD23 ' HB3' ' B' ' 262' ' ' ASN . 0.3 OUTLIER -119.12 118.35 31.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 73.22 110.857 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 140.47 -177.77 20.48 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.7 -0.762 . . . . 70.4 112.47 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 243' ' ' ASN . . . . . 0.494 ' HB3' HG21 ' B' ' 260' ' ' THR . 7.5 p30 -85.84 153.06 22.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.797 0.332 . . . . 74.24 110.906 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.527 HG13 ' OE1' ' B' ' 280' ' ' GLU . 63.8 t -122.08 114.92 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 73.53 111.106 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.571 HG22 ' HB2' ' C' ' 281' ' ' TYR . 3.8 t -108.0 127.7 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 72.41 111.104 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 6.5 t -69.84 175.07 4.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 64.33 111.045 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.524 ' HB2' ' HA3' ' B' ' 283' ' ' GLY . . . -63.15 -45.05 93.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 70.03 111.116 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.92 -35.89 69.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 54.31 111.072 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 51.45 111.065 179.91 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.847 0.356 . . . . 74.4 110.924 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -100.93 135.07 42.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 52.32 111.152 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 4.3 t -115.66 140.89 48.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 72.41 111.142 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.39 124.42 46.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 54.42 110.881 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.6 131.91 36.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 70.55 110.867 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.799 HG23 HD11 ' D' ' 231' ' ' ILE . 13.6 p -115.46 139.98 39.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.505 . . . . 73.42 111.122 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -83.03 -76.0 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 71.4 110.945 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 25.7 m -137.48 130.64 30.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 74.45 111.119 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.53 ' CG2' HG21 ' C' ' 264' ' ' VAL . 21.4 t -118.41 130.64 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.4 111.187 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 25.9 t -127.49 125.92 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 55.35 111.159 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.03 134.13 10.3 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.788 -0.72 . . . . 74.34 112.474 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.95 117.05 20.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 71.32 110.941 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 61.05 81.88 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.766 -0.73 . . . . 64.12 112.447 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 61.98 110.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.876 0.37 . . . . 72.54 110.888 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 5.1 m -148.43 145.12 27.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 74.43 110.873 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -117.61 126.36 52.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 70.52 110.895 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.449 ' CG2' HG12 ' C' ' 239' ' ' VAL . 16.4 t -127.06 123.05 61.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 70.44 111.095 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.446 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.1 OUTLIER -128.14 117.9 22.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.01 110.896 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.76 HD13 HD12 ' C' ' 241' ' ' LEU . 5.1 mp -111.68 103.35 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 71.1 111.153 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.06 -173.87 28.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 74.53 112.509 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -106.36 156.22 18.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 73.4 110.9 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.661 ' CG ' HG22 ' D' ' 244' ' ' VAL . 1.1 pt-20 -115.71 128.45 55.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 65.55 110.897 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.571 ' HB2' HG22 ' C' ' 245' ' ' VAL . 5.0 m-85 -110.8 129.72 55.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 60.32 110.895 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 120.78 167.25 13.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 72.21 112.471 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 283' ' ' GLY . . . . . 0.548 ' H ' ' HB2' ' D' ' 247' ' ' ALA . . . -110.9 -161.48 17.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.805 -0.712 . . . . 51.53 112.524 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt 50.9 79.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.794 0.331 . . . . 70.35 110.883 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 86.29 86.9 1.03 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 44.44 112.508 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -50.05 -42.13 49.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 74.33 110.83 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.446 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 15.7 t90 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 65.34 110.882 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.846 0.355 . . . . 71.23 110.9 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -88.12 112.36 22.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 75.35 110.901 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.34 137.48 37.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 73.4 110.892 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 228' ' ' ALA . . . . . 0.73 ' HB2' HD11 ' D' ' 241' ' ' LEU . . . -117.85 119.48 35.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 52.4 111.081 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -75.25 -29.46 60.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 64.23 110.911 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 230' ' ' ASP . . . . . 0.421 ' HB2' HG22 ' D' ' 266' ' ' THR . 1.6 t0 -166.19 136.15 3.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 73.22 110.876 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 231' ' ' ILE . . . . . 0.799 HD11 HG23 ' C' ' 264' ' ' VAL . 0.3 OUTLIER -138.66 117.98 14.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 72.52 111.113 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -126.96 125.25 41.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 73.12 110.881 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 233' ' ' THR . . . . . 0.535 ' CB ' ' HB3' ' D' ' 237' ' ' ALA . 0.4 OUTLIER -136.33 155.4 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 63.14 111.119 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -152.99 168.68 25.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 72.13 110.888 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 68.71 -80.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 71.22 110.863 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -159.56 55.58 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 75.44 110.822 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 237' ' ' ALA . . . . . 0.535 ' HB3' ' CB ' ' D' ' 233' ' ' THR . . . -104.8 146.5 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 74.52 111.147 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -125.78 135.37 51.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 64.43 110.836 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.745 HG11 HG22 ' D' ' 231' ' ' ILE . 18.3 m -122.94 121.69 63.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 34.41 111.147 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -116.55 125.83 52.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 73.24 110.885 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.836 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.9 mm? -111.78 117.72 33.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 74.41 110.86 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.71 179.55 17.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 71.44 112.46 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.78 163.09 17.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 75.12 110.899 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 244' ' ' VAL . . . . . 0.661 HG22 ' CG ' ' C' ' 280' ' ' GLU . 78.2 t -133.16 123.67 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 52.54 111.166 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.57 129.26 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.14 111.119 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.4 t -69.59 175.07 4.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 73.13 111.117 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 247' ' ' ALA . . . . . 0.548 ' HB2' ' H ' ' C' ' 283' ' ' GLY . . . -59.26 -41.57 89.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 62.54 111.144 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.71 -48.85 76.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 73.11 111.189 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 64.42 111.179 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.872 0.368 . . . . 73.53 111.187 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 98.7 m -91.76 140.98 29.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 61.4 111.191 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.64 119.6 29.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.317 -0.401 . . . . 73.54 110.94 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 15.1 m -132.02 122.62 25.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 72.14 110.88 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.547 HG21 ' CG2' ' D' ' 267' ' ' VAL . 7.7 p -108.32 128.33 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 74.13 111.118 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.96 -74.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 75.13 110.824 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 266' ' ' THR . . . . . 0.421 HG22 ' HB2' ' D' ' 230' ' ' ASP . 19.3 p -147.37 133.35 19.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 75.11 111.087 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.659 HG11 HG21 ' D' ' 275' ' ' VAL . 14.3 t -117.05 133.17 64.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 71.01 111.171 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 45.7 t -127.01 117.79 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 74.32 111.138 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.04 133.01 10.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.803 -0.713 . . . . 54.01 112.56 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -132.39 115.37 15.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 63.24 110.911 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.75 72.58 0.95 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.799 -0.715 . . . . 71.04 112.487 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 65.52 100.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.805 0.336 . . . . 74.54 110.923 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 2.6 m -135.98 145.0 45.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 64.55 110.861 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.88 127.15 51.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.51 . . . . 70.22 110.859 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.659 HG21 HG11 ' D' ' 267' ' ' VAL . 15.5 t -133.67 123.08 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 74.21 111.165 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.63 121.88 29.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 75.04 110.857 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.836 ' HB ' HD13 ' D' ' 241' ' ' LEU . 5.2 mp -112.36 104.56 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 75.21 111.073 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.86 169.5 13.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 65.11 112.568 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -89.94 153.87 20.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 75.44 110.906 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 280' ' ' GLU . . . . . 0.602 ' HG3' HG13 ' E' ' 244' ' ' VAL . 2.1 pt-20 -115.01 135.77 53.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 75.54 110.831 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -112.51 125.54 54.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 74.44 110.929 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 92.13 -142.04 15.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 43.4 112.547 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 65.8 111.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 74.4 112.537 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -51.81 -36.93 49.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 74.32 110.882 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -107.48 -83.24 1.55 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.757 -0.735 . . . . 65.32 112.494 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -177.52 171.96 1.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.371 . . . . 75.2 110.863 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 287' ' ' TRP . . . . . 0.425 ' HB3' ' NE2' ' E' ' 240' ' ' GLN . 28.3 t90 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 72.42 110.813 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 225' ' ' ARG . . . . . 0.486 ' CB ' HG22 ' E' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.752 0.311 . . . . 72.25 110.848 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -95.42 111.04 23.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 63.02 110.854 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.37 151.01 44.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.091 -0.504 . . . . 74.33 110.813 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -127.13 119.03 25.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 74.1 111.112 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.48 -36.83 83.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.41 110.895 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.85 141.2 3.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.14 110.874 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 231' ' ' ILE . . . . . 0.689 ' CG2' HG11 ' E' ' 239' ' ' VAL . 6.8 mt -136.56 116.83 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 75.24 111.152 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -123.76 125.35 44.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 74.4 110.836 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 233' ' ' THR . . . . . 0.546 ' CB ' ' HB3' ' E' ' 237' ' ' ALA . 0.5 OUTLIER -136.18 153.39 51.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 44.43 111.128 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -156.27 166.5 33.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 74.45 110.858 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 70.22 -73.67 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 74.42 110.844 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 8.1 mtt85 -167.62 57.85 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 73.34 110.884 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 237' ' ' ALA . . . . . 0.546 ' HB3' ' CB ' ' E' ' 233' ' ' THR . . . -104.81 150.48 24.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 64.43 111.14 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.76 135.65 47.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.296 -0.411 . . . . 74.12 110.805 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.689 HG11 ' CG2' ' E' ' 231' ' ' ILE . 26.8 m -127.22 128.65 70.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 64.44 111.075 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 240' ' ' GLN . . . . . 0.425 ' NE2' ' HB3' ' D' ' 287' ' ' TRP . 0.3 OUTLIER -123.49 131.64 53.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 73.34 110.898 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.775 HD13 ' HB ' ' E' ' 277' ' ' ILE . 3.7 mm? -115.5 118.61 33.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 43.4 110.922 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.49 176.48 14.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.64 -0.791 . . . . 53.25 112.422 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -85.73 162.67 18.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.858 0.361 . . . . 75.23 110.893 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.602 HG13 ' HG3' ' D' ' 280' ' ' GLU . 86.2 t -132.58 128.93 58.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 65.45 111.129 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 245' ' ' VAL . . . . . 0.404 ' O ' HG13 ' E' ' 245' ' ' VAL . 14.8 p -122.31 129.17 75.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 73.25 111.093 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 246' ' ' THR . . . . . 0.415 HG21 ' HA2' ' E' ' 282' ' ' GLY . 14.9 t -69.51 170.98 9.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 63.53 111.182 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.49 -33.78 68.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 75.1 111.097 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.62 -35.87 68.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 73.43 111.135 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 33.01 111.083 179.891 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' E' E ' 261' ' ' THR . . . . . 0.486 HG22 ' CB ' ' E' ' 225' ' ' ARG . 24.9 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.882 0.373 . . . . 74.53 111.13 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -118.42 118.27 31.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 74.45 110.874 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.31 116.9 24.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.02 110.859 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 264' ' ' VAL . . . . . 0.551 ' O ' HG13 ' E' ' 264' ' ' VAL . 13.8 p -105.16 117.83 51.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 45.43 111.072 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 265' ' ' GLU . . . . . 0.551 ' CD ' ' N ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -62.04 -134.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 74.05 110.869 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.99 126.19 40.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 65.22 111.126 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 19.3 t -116.28 135.14 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 64.53 111.146 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.82 115.27 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 41.32 111.131 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.01 132.64 10.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 73.12 112.457 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -132.21 114.23 14.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.358 . . . . 73.05 110.833 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.46 73.42 1.1 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.753 -0.736 . . . . 70.12 112.46 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.42 103.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.804 0.335 . . . . 62.42 110.94 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 3.9 t -138.31 145.37 41.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 72.54 110.874 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.0 128.59 43.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 74.32 110.867 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.502 ' HB ' HG12 ' E' ' 239' ' ' VAL . 19.3 t -136.27 123.3 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 74.04 111.172 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 276' ' ' LEU . . . . . 0.413 HD22 ' O ' ' E' ' 275' ' ' VAL . 1.2 mm? -128.14 122.26 31.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.269 -0.423 . . . . 71.22 110.89 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.775 ' HB ' HD13 ' E' ' 241' ' ' LEU . 5.0 mp -113.74 125.1 70.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 73.32 111.143 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 128.27 -172.17 19.28 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.653 -0.784 . . . . 71.14 112.43 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.53 156.04 16.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 71.22 110.933 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -124.84 139.22 54.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 74.22 110.94 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -130.54 125.16 33.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 73.13 110.984 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 282' ' ' GLY . . . . . 0.415 ' HA2' HG21 ' E' ' 246' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.69 -0.767 . . . . 73.14 112.453 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.052 0 CA-C-O 120.828 0.347 . . . . 63.24 110.846 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.541 ' OD1' HG22 ' A' ' 277' ' ' ILE . 9.0 t30 -142.21 137.56 30.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 52.01 110.92 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.31 148.67 50.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 54.34 110.888 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.26 119.31 10.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.4 111.058 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.59 -49.29 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 71.14 110.898 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -165.22 136.9 4.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 75.11 110.875 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.677 HG22 ' CG2' ' A' ' 267' ' ' VAL . 5.9 pt -135.49 130.77 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 71.24 111.127 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.7 125.41 27.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 74.42 110.882 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.557 HG21 HG13 ' A' ' 239' ' ' VAL . 1.6 p -136.86 149.59 47.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 73.25 111.126 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.27 168.51 19.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 62.33 110.869 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 64.63 74.73 0.39 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 73.14 110.893 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 40.85 59.29 2.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 72.12 110.905 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.499 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -103.36 157.19 17.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 72.44 111.04 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.97 143.94 47.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 75.5 110.926 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.707 HG12 ' HB ' ' A' ' 275' ' ' VAL . 14.8 m -134.73 120.6 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 70.54 111.033 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -116.34 129.68 56.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 72.25 110.936 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.5 mp -111.86 117.91 34.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 71.22 110.947 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.25 -166.51 24.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.786 -0.721 . . . . 54.12 112.516 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -108.25 141.7 39.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.971 0.415 . . . . 61.12 110.838 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 244' ' ' VAL . 32.0 m -115.52 118.0 57.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.138 -0.483 . . . . 51.5 111.13 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.708 HG12 ' HB2' ' A' ' 281' ' ' TYR . 6.5 m -123.43 123.03 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 74.33 111.129 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 281' ' ' TYR . 3.2 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 75.02 111.173 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 56.6 m . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.742 0.306 . . . . 64.25 111.198 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 261' ' ' THR . 6.0 t -106.07 122.35 46.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 60.42 111.15 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.02 136.34 52.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 73.45 110.917 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 8.2 t -142.55 123.6 14.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 65.21 110.822 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.58 134.98 54.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 61.24 111.136 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.74 -77.76 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 71.0 110.851 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.22 127.68 53.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 60.43 111.115 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.909 HG13 HD11 ' B' ' 231' ' ' ILE . 0.4 OUTLIER -117.89 131.46 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 71.25 111.111 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.46 116.06 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 62.25 111.115 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.12 133.29 10.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.802 -0.713 . . . . 72.21 112.517 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -133.35 148.51 51.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 63.45 110.872 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.55 79.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.785 -0.721 . . . . 61.21 112.493 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 46.83 66.37 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 75.01 110.907 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 29.6 t -92.78 145.14 24.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 65.34 110.82 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.56 128.19 54.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 70.31 110.856 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.707 ' HB ' HG12 ' A' ' 239' ' ' VAL . 19.3 t -119.25 123.15 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 72.3 111.139 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -129.45 111.49 12.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 73.12 110.937 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.634 ' CD1' HD13 ' B' ' 241' ' ' LEU . 7.2 mm -106.97 110.39 31.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 64.12 111.088 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.15 -178.34 18.84 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 73.33 112.482 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -88.96 156.59 18.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 70.31 110.916 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.769 ' CG ' HG12 ' B' ' 244' ' ' VAL . 0.9 OUTLIER -135.23 146.7 48.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 64.14 110.902 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.767 ' O ' HG22 ' A' ' 246' ' ' THR . 9.2 m-85 -123.06 122.45 38.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 63.32 110.901 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -127.83 -155.99 8.92 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.726 -0.749 . . . . 71.44 112.497 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -144.32 18.5 2.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 72.31 112.478 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.67 -51.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 71.13 110.942 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -102.28 -169.11 26.92 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.729 . . . . 71.34 112.5 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -136.54 31.74 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.911 0.386 . . . . 75.54 110.895 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 75.34 110.975 -179.914 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.726 ' HB3' HG23 ' B' ' 261' ' ' THR . 2.8 mtp180 . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.838 0.351 . . . . 54.0 110.854 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -134.28 110.58 9.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 74.12 110.925 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.95 138.74 54.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 73.43 110.895 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.99 120.01 20.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 72.0 111.175 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -74.88 -35.69 62.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 63.13 110.844 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -166.05 135.8 3.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 71.21 110.864 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.909 HD11 HG13 ' A' ' 267' ' ' VAL . 7.4 pt -141.07 131.58 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 74.13 111.155 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.72 126.8 27.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.837 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.733 HG21 HG13 ' B' ' 239' ' ' VAL . 2.3 p -135.05 140.38 45.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 55.52 111.095 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.19 167.56 21.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 62.11 110.852 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 68.09 69.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 73.41 110.861 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 46.88 35.2 3.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 73.31 110.935 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.42 156.14 20.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 75.23 111.057 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.65 144.6 47.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.25 110.823 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.739 HG12 ' HB ' ' B' ' 275' ' ' VAL . 0.0 OUTLIER -123.71 121.31 62.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 75.25 111.162 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.413 ' HB3' HD22 ' B' ' 276' ' ' LEU . 0.9 OUTLIER -118.24 117.45 29.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.04 110.911 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.634 HD13 ' CD1' ' A' ' 277' ' ' ILE . 4.2 mp -111.48 117.71 33.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 74.15 110.898 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.37 -165.69 26.65 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 54.42 112.505 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -109.07 135.5 50.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 55.21 110.907 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.769 HG12 ' CG ' ' A' ' 280' ' ' GLU . 33.6 m -106.62 123.04 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 54.43 111.142 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' B' ' 281' ' ' TYR . 0.1 OUTLIER -124.54 121.52 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 62.33 111.136 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.3 t -87.76 161.68 17.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 65.31 111.139 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.16 90.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 51.33 111.172 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.11 -34.9 64.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 73.51 111.131 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 74.42 111.136 179.894 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.88 0.372 . . . . 61.02 110.936 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 1.3 m -99.17 136.52 39.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 70.55 111.113 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.726 HG23 ' HB3' ' B' ' 225' ' ' ARG . 97.2 m -134.14 108.82 8.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.426 . . . . 73.15 111.133 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -111.36 132.73 54.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.862 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.9 p -140.0 123.6 17.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 63.23 110.89 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.736 HG21 ' CG1' ' B' ' 267' ' ' VAL . 3.7 p -115.07 144.71 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 64.12 111.095 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.14 -52.09 5.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 74.43 110.875 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 25.1 m -150.33 126.98 10.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 53.55 111.185 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.736 ' CG1' HG21 ' B' ' 264' ' ' VAL . 32.6 m -123.14 136.85 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 62.31 111.11 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 37.8 t -127.22 129.62 70.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 62.32 111.128 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.24 133.4 8.42 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.8 -0.714 . . . . 74.4 112.517 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -133.18 148.92 52.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 74.21 110.89 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.4 87.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.697 -0.763 . . . . 64.21 112.477 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 41.39 50.73 3.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 62.0 110.873 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 47.9 t -83.21 144.87 29.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 73.42 110.833 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 129.85 48.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.098 -0.501 . . . . 73.32 110.871 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.739 ' HB ' HG12 ' B' ' 239' ' ' VAL . 11.9 t -114.14 130.67 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 73.11 111.147 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.413 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.8 OUTLIER -128.73 111.24 12.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 64.34 110.886 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.704 ' CD1' HD13 ' C' ' 241' ' ' LEU . 21.9 mm -110.15 103.43 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 71.12 111.126 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 142.01 -172.45 24.11 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.725 -0.75 . . . . 75.11 112.507 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -91.42 156.35 17.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.708 0.29 . . . . 65.23 110.954 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.648 ' CG ' HG12 ' C' ' 244' ' ' VAL . 0.0 OUTLIER -131.16 142.27 50.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 71.31 110.864 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.498 ' HB2' HG13 ' B' ' 245' ' ' VAL . 8.7 m-85 -127.19 122.83 35.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 64.44 110.936 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -129.97 -158.64 9.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 50.44 112.486 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -111.77 -20.72 6.72 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 33.33 112.465 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.59 34.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 64.41 110.944 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -142.8 176.51 22.41 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.708 -0.758 . . . . 72.24 112.472 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -116.68 -22.88 8.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.837 0.351 . . . . 71.22 110.894 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 72.3 110.913 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.579 ' O ' HG23 ' C' ' 261' ' ' THR . 58.6 ttp180 . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.834 0.349 . . . . 74.3 110.835 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.527 ' OD1' HG22 ' C' ' 277' ' ' ILE . 3.2 t30 -88.06 124.28 33.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.457 . . . . 52.13 110.871 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.5 142.9 50.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 55.31 110.87 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.67 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -137.88 119.17 14.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 52.31 111.097 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.53 -45.83 35.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 73.41 110.905 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -165.97 135.6 3.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 74.03 110.836 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.592 HG22 ' CG2' ' C' ' 267' ' ' VAL . 5.5 pt -138.14 132.1 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 70.15 111.12 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.61 121.44 19.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.827 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.584 HG21 HG13 ' C' ' 239' ' ' VAL . 1.8 p -135.87 138.17 42.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 73.34 111.104 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -138.8 167.71 21.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 61.02 110.877 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 68.95 73.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 71.23 110.838 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 45.07 54.21 7.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 72.14 110.881 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 156.25 18.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 74.44 111.097 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.94 143.7 38.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 61.24 110.804 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.66 HG12 ' HB ' ' C' ' 275' ' ' VAL . 14.8 m -129.5 133.83 64.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 75.23 111.107 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.496 ' OE1' HD21 ' C' ' 276' ' ' LEU . 3.7 tm0? -130.35 120.7 24.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 65.22 110.96 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.704 HD13 ' CD1' ' B' ' 277' ' ' ILE . 5.9 mp -111.64 118.36 35.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 70.03 110.907 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.65 -178.4 19.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.726 -0.75 . . . . 30.32 112.457 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -97.47 128.81 44.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.853 0.359 . . . . 63.24 110.905 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.648 HG12 ' CG ' ' B' ' 280' ' ' GLU . 32.5 m -96.18 127.79 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 71.52 111.154 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.49 129.23 74.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 60.03 111.112 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.4 t -83.83 165.07 19.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 54.41 111.109 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.14 -34.09 76.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 70.01 111.111 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 248' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' C' ' 249' ' ' ALA . . . -56.72 -36.21 69.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 73.02 111.102 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 249' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' C' ' 248' ' ' ALA . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 74.42 111.054 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 11.0 mp0 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.85 0.357 . . . . 63.35 110.937 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 260' ' ' THR . . . . . 0.406 HG22 HD21 ' C' ' 262' ' ' ASN . 1.7 m -100.78 136.06 41.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 53.3 111.145 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.579 HG23 ' O ' ' C' ' 225' ' ' ARG . 96.1 m -125.15 116.83 22.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 72.15 111.121 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.406 HD21 HG22 ' C' ' 260' ' ' THR . 3.0 m120 -126.05 149.8 48.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 62.33 110.916 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 1.8 m -141.72 123.71 15.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 72.42 110.886 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.784 HG21 HD11 ' D' ' 231' ' ' ILE . 5.9 p -109.99 138.93 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 62.42 111.071 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.6 -74.19 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 72.55 110.935 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 7.4 m -126.26 127.79 46.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 52.02 111.156 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.592 ' CG2' HG22 ' C' ' 231' ' ' ILE . 0.3 OUTLIER -117.74 129.69 73.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.21 111.145 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 19.4 t -127.98 115.97 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 74.04 111.132 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.75 133.56 10.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.692 -0.766 . . . . 72.2 112.485 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.06 147.6 52.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.342 . . . . 65.15 110.867 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.43 84.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.785 -0.721 . . . . 64.45 112.43 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 48.06 75.74 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 74.04 110.958 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.69 145.06 32.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 73.43 110.865 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.47 128.42 48.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 73.03 110.822 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.66 ' HB ' HG12 ' C' ' 239' ' ' VAL . 21.3 t -121.32 123.41 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 75.35 111.124 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.788 HD12 ' CE2' ' C' ' 287' ' ' TRP . 0.1 OUTLIER -128.75 113.42 15.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 71.15 110.964 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.723 HD12 HD22 ' D' ' 241' ' ' LEU . 19.0 mm -112.17 104.08 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 52.21 111.093 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.74 -177.07 27.22 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.711 -0.757 . . . . 71.04 112.439 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -95.04 156.19 16.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 74.12 110.971 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.402 ' HG2' HG12 ' D' ' 244' ' ' VAL . 0.0 OUTLIER -126.12 130.93 52.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 75.31 110.847 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -119.23 125.65 49.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 72.52 110.958 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.93 171.91 13.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.692 -0.766 . . . . 63.34 112.466 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 283' ' ' GLY . . . . . 0.506 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . -70.92 -139.73 0.19 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.782 -0.723 . . . . 40.25 112.487 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 63.15 24.81 14.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.34 . . . . 72.23 110.908 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 61.9 -95.21 0.1 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.685 -0.769 . . . . 62.22 112.441 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -112.58 -175.3 2.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 71.14 110.95 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.788 ' CE2' HD12 ' C' ' 276' ' ' LEU . 21.0 t90 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.236 -0.438 . . . . 74.43 110.93 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 225' ' ' ARG . . . . . 0.537 ' N ' HG23 ' D' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.83 0.347 . . . . 75.11 110.843 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 226' ' ' ASN . . . . . 0.507 ' OD1' HG22 ' D' ' 277' ' ' ILE . 2.2 t30 -83.28 111.23 18.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 54.14 110.87 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 4.3 m -126.31 138.13 53.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 60.35 110.852 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.58 123.49 39.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 71.15 111.095 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -40.29 58.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 72.42 110.946 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -165.96 135.95 3.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 73.04 110.895 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 231' ' ' ILE . . . . . 0.784 HD11 HG21 ' C' ' 264' ' ' VAL . 9.0 pt -141.36 117.66 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 73.03 111.111 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 232' ' ' ARG . . . . . 0.634 HH11 HG22 ' D' ' 268' ' ' VAL . 0.0 OUTLIER -130.78 122.86 27.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.473 . . . . 62.51 110.928 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 233' ' ' THR . . . . . 0.457 HG21 ' CG1' ' D' ' 239' ' ' VAL . 3.0 p -135.94 149.17 48.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 54.21 111.154 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -145.66 167.19 23.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 70.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 67.22 79.86 0.22 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 73.04 110.92 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 42.62 52.28 4.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 75.43 110.857 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.22 156.31 18.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 63.42 111.08 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.16 142.03 25.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.829 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.537 HG12 ' HB ' ' D' ' 275' ' ' VAL . 19.7 m -128.89 139.75 51.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 74.43 111.134 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -128.75 126.03 39.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 52.23 110.915 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.723 HD22 HD12 ' C' ' 277' ' ' ILE . 10.8 mp -111.73 135.21 52.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 74.14 110.875 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 114.74 -176.16 16.6 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.713 -0.756 . . . . 62.32 112.433 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -100.36 135.21 42.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.876 0.37 . . . . 71.21 110.88 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 244' ' ' VAL . . . . . 0.402 HG12 ' HG2' ' C' ' 280' ' ' GLU . 22.7 m -104.07 133.48 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 52.03 111.137 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 39.9 t -122.22 129.47 75.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 54.3 111.05 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 246' ' ' THR . . . . . 0.403 HG23 ' H ' ' D' ' 249' ' ' ALA . 10.9 t -69.55 175.1 4.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 73.21 111.213 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 247' ' ' ALA . . . . . 0.506 ' HB2' ' N ' ' C' ' 283' ' ' GLY . . . -62.79 -42.92 99.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 52.33 111.078 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.85 74.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 64.33 111.106 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 249' ' ' ALA . . . . . 0.403 ' H ' HG23 ' D' ' 246' ' ' THR . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 73.31 111.023 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.815 0.341 . . . . 53.41 111.143 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 261' ' ' THR . . . . . 0.537 HG23 ' N ' ' D' ' 225' ' ' ARG . 90.2 m -93.24 113.45 25.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 71.41 111.206 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -126.25 145.55 50.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 75.23 110.924 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 21.9 t -135.53 123.8 23.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 73.21 110.8 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.724 HG23 HD11 ' E' ' 231' ' ' ILE . 14.2 p -112.35 133.2 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 75.43 111.167 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.91 -75.18 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 72.41 110.872 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 26.5 m -133.73 132.65 40.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 65.34 111.161 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.645 ' CG2' HG22 ' D' ' 231' ' ' ILE . 13.6 t -117.78 127.36 75.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 44.31 111.076 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 268' ' ' VAL . . . . . 0.634 HG22 HH11 ' D' ' 232' ' ' ARG . 21.2 t -125.12 116.04 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 34.23 111.129 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.29 132.94 10.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.788 -0.72 . . . . 60.2 112.547 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.4 143.93 50.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 53.05 110.891 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 47.15 85.31 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.716 -0.754 . . . . 74.33 112.483 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 52.74 89.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.847 0.356 . . . . 63.53 110.927 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 47.8 t -126.12 145.01 50.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 73.4 110.829 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 11.8 mtt85 -127.7 128.23 45.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 74.4 110.862 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.537 ' HB ' HG12 ' D' ' 239' ' ' VAL . 23.2 t -119.36 123.68 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 65.33 111.129 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.617 HD12 ' CE2' ' D' ' 287' ' ' TRP . 0.4 OUTLIER -124.47 113.05 17.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 74.34 110.863 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.507 HG22 ' OD1' ' D' ' 226' ' ' ASN . 17.8 mm -112.33 104.21 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 65.35 111.144 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.61 -146.59 16.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.758 -0.734 . . . . 72.24 112.525 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -128.19 150.04 50.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 75.13 110.853 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -111.76 127.16 55.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.965 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 281' ' ' TYR . . . . . 0.44 ' CZ ' HG21 ' E' ' 245' ' ' VAL . 10.8 m-85 -120.21 125.4 48.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.22 110.898 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 122.99 160.16 10.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 60.32 112.41 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 283' ' ' GLY . . . . . 0.63 ' N ' ' HB2' ' E' ' 247' ' ' ALA . . . 62.26 163.55 0.32 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 32.23 112.479 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -110.34 48.42 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 71.34 110.927 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -137.04 -92.62 0.31 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.738 -0.744 . . . . 44.32 112.518 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 286' ' ' PHE . . . . . 0.741 ' CE1' HG11 ' E' ' 244' ' ' VAL . 40.4 t80 -179.6 -64.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 61.22 110.849 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 287' ' ' TRP . . . . . 0.617 ' CE2' HD12 ' D' ' 276' ' ' LEU . 10.4 t90 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 75.4 110.919 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 225' ' ' ARG . . . . . 0.658 ' N ' ' HG1' ' E' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.822 0.344 . . . . 71.15 110.904 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.9 112.31 19.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 70.35 110.878 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 19.3 m -131.23 138.7 49.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.31 110.838 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 228' ' ' ALA . . . . . 0.416 ' HA ' HG13 ' E' ' 264' ' ' VAL . . . -120.52 132.74 55.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 61.54 111.092 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.6 -32.39 41.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 73.1 110.867 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 230' ' ' ASP . . . . . 0.526 ' CB ' HG22 ' E' ' 266' ' ' THR . 0.7 OUTLIER -165.79 139.03 4.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.415 . . . . 64.31 110.91 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' E' E ' 231' ' ' ILE . . . . . 0.724 HD11 HG23 ' D' ' 264' ' ' VAL . 0.4 OUTLIER -138.71 116.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 72.15 111.151 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' E' E ' 232' ' ' ARG . . . . . 0.407 ' CD ' HG22 ' E' ' 268' ' ' VAL . 8.6 ptm180 -129.89 117.77 20.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.861 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 233' ' ' THR . . . . . 0.582 HG21 HG13 ' E' ' 239' ' ' VAL . 7.8 p -135.43 151.91 50.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 73.42 111.105 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -157.47 167.27 30.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.907 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 67.54 75.13 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 63.41 110.848 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 45.78 42.9 9.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 63.44 110.864 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 237' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' E' ' 233' ' ' THR . . . -104.09 150.61 24.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 73.24 111.045 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 238' ' ' ARG . . . . . 0.497 HH12 ' N ' ' E' ' 240' ' ' GLN . 0.0 OUTLIER -133.7 148.11 51.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 71.04 110.902 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.674 HG12 ' CG2' ' E' ' 275' ' ' VAL . 6.8 m -130.47 124.13 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 74.5 111.134 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 240' ' ' GLN . . . . . 0.497 ' N ' HH12 ' E' ' 238' ' ' ARG . 8.6 tm0? -114.65 126.12 54.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 53.33 110.933 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.87 121.4 43.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 72.04 110.941 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 122.03 175.61 14.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 53.4 112.513 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.63 139.53 31.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 70.4 110.824 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.741 HG11 ' CE1' ' D' ' 286' ' ' PHE . 30.1 m -104.84 139.17 26.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 53.44 111.135 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 245' ' ' VAL . . . . . 0.44 HG21 ' CZ ' ' D' ' 281' ' ' TYR . 87.1 t -122.41 129.43 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 64.45 111.095 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.7 t -69.0 174.28 4.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 62.14 111.143 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 247' ' ' ALA . . . . . 0.63 ' HB2' ' N ' ' D' ' 283' ' ' GLY . . . -59.0 -43.54 91.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 73.42 111.09 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.98 -48.63 77.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 55.3 111.05 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 72.43 111.042 179.971 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' E' E ' 261' ' ' THR . . . . . 0.658 ' HG1' ' N ' ' E' ' 225' ' ' ARG . 2.8 t . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.773 0.321 . . . . 63.22 111.09 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -126.42 150.88 48.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 63.41 110.845 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 68.3 m -139.33 131.98 28.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 73.44 110.887 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 264' ' ' VAL . . . . . 0.519 HG21 ' CG2' ' E' ' 267' ' ' VAL . 3.6 p -129.28 122.07 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 71.31 111.157 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.25 -78.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 71.33 110.862 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 266' ' ' THR . . . . . 0.526 HG22 ' CB ' ' E' ' 230' ' ' ASP . 72.5 p -143.48 135.83 27.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 64.42 111.212 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 267' ' ' VAL . . . . . 0.519 ' CG2' HG21 ' E' ' 264' ' ' VAL . 18.0 t -117.44 134.6 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 75.13 111.141 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 268' ' ' VAL . . . . . 0.407 HG22 ' CD ' ' E' ' 232' ' ' ARG . 47.4 t -126.74 119.97 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.3 111.126 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.89 133.27 10.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 73.44 112.548 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.79 126.4 32.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.815 0.34 . . . . 64.54 110.893 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.7 94.44 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 52.34 112.477 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 50.05 75.14 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.92 0.391 . . . . 75.44 110.86 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 7.6 t -114.79 145.6 41.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.474 . . . . 63.22 110.802 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 24.2 mtm-85 -130.85 127.3 38.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 75.14 110.913 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.674 ' CG2' HG12 ' E' ' 239' ' ' VAL . 21.3 t -116.53 125.3 73.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 62.34 111.165 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' E' E ' 276' ' ' LEU . . . . . 0.514 HD21 ' HE1' ' D' ' 286' ' ' PHE . 0.3 OUTLIER -125.72 111.73 15.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 73.41 110.953 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 31.6 mm -112.9 103.69 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 51.23 111.155 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 137.66 -178.66 18.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.8 -0.714 . . . . 55.55 112.52 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -89.92 156.19 18.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 63.24 110.859 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -121.37 134.31 55.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 64.5 110.879 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -114.35 124.74 52.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 55.23 110.92 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 C-N-CA 120.795 -0.717 . . . . 44.15 112.512 -179.996 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.639 ' O ' HG23 ' A' ' 261' ' ' THR . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.794 0.331 . . . . 72.13 110.917 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -85.15 135.18 34.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 73.53 110.87 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 1.7 m -118.91 136.94 53.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 51.11 110.854 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.35 139.72 39.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.482 . . . . 72.54 111.063 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.95 -73.11 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 64.4 110.931 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -130.43 138.53 50.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 63.4 110.845 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.41 116.71 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 71.32 111.1 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -118.74 115.85 25.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 44.45 110.861 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.75 146.45 52.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.194 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.05 154.96 31.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 74.31 110.883 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 64.23 82.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 55.22 110.934 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 41.85 43.57 2.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.848 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.25 137.93 31.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.092 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 141.9 51.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 73.12 110.809 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.539 HG23 ' HB ' ' A' ' 275' ' ' VAL . 6.0 p -143.58 121.68 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 74.02 111.134 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -122.0 136.61 54.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 61.44 110.888 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.75 118.87 21.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 73.34 110.94 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.72 -120.39 1.05 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.739 . . . . 52.31 112.503 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -144.77 130.28 18.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 72.1 110.86 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -101.95 136.29 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 72.45 111.136 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 38.5 t -122.15 129.12 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 74.42 111.122 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.591 HG21 ' HB2' ' A' ' 284' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 73.42 111.136 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' THR . . . . . 0.606 HG21 ' HB3' ' A' ' 279' ' ' ASN . 7.0 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.882 0.373 . . . . 73.54 111.084 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 225' ' ' ARG . 91.9 m -112.79 108.85 18.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 75.23 111.186 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -104.96 138.91 40.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 73.12 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 92.4 p -140.48 123.87 16.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.53 110.833 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.65 HG21 ' CG2' ' A' ' 267' ' ' VAL . 9.6 p -108.26 149.77 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 74.23 111.137 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -102.44 -39.79 6.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 65.11 110.866 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.4 m -150.41 127.31 11.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.453 . . . . 62.1 111.099 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.65 ' CG2' HG21 ' A' ' 264' ' ' VAL . 80.9 t -121.28 120.19 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 61.13 111.08 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.02 129.48 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 73.13 111.206 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -139.73 133.26 5.98 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.764 -0.732 . . . . 71.22 112.49 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.89 147.39 51.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.877 0.37 . . . . 53.33 110.896 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 53.94 89.91 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.665 -0.779 . . . . 61.35 112.533 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 45.23 60.18 3.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 70.15 110.817 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 6.4 t -91.25 145.54 24.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 75.42 110.862 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -132.32 127.8 36.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 74.21 110.884 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.539 ' HB ' HG23 ' A' ' 239' ' ' VAL . 20.3 t -131.85 123.66 51.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 50.41 111.119 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.71 111.59 17.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 73.33 110.931 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 2.3 mp -107.17 104.29 16.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 75.11 111.117 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.04 -152.29 24.42 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.749 -0.738 . . . . 73.22 112.496 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.606 ' HB3' HG21 ' A' ' 260' ' ' THR . 11.4 p-10 -127.81 151.52 48.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 75.31 110.878 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.03 124.69 48.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 72.4 110.886 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -106.91 125.86 51.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 74.54 110.923 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 112.65 -68.97 0.23 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.724 . . . . 74.35 112.522 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 101.33 -101.71 2.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.768 -0.729 . . . . 72.24 112.499 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.591 ' HB2' HG21 ' A' ' 246' ' ' THR . 0.0 OUTLIER 63.83 45.93 4.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 73.12 110.828 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.79 17.57 11.8 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.782 -0.723 . . . . 35.31 112.511 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.69 170.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.817 0.341 . . . . 71.32 110.828 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.488 . . . . 75.22 110.915 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.599 ' O ' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.812 0.339 . . . . 64.21 110.861 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -123.15 138.52 54.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 64.42 110.911 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.98 137.7 54.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 70.02 110.804 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 264' ' ' VAL . . . -132.87 140.39 47.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 65.01 111.064 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.07 -31.5 9.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 74.1 110.89 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -164.74 138.77 5.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 73.41 110.826 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 5.7 mt -137.25 121.5 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 71.41 111.099 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -134.06 118.23 17.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 70.01 110.828 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 128.89 32.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.055 -0.521 . . . . 75.4 111.169 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.03 166.86 22.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 74.44 110.888 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.71 71.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.43 110.899 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 46.16 48.19 12.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 72.21 110.804 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -98.48 149.46 22.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 71.22 111.104 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.44 142.88 47.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 75.44 110.843 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.58 HG23 ' HB ' ' B' ' 275' ' ' VAL . 7.3 p -139.58 132.08 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 53.43 111.164 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.546 ' C ' HD23 ' B' ' 241' ' ' LEU . 2.9 tt0 -127.01 137.23 53.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 63.3 110.827 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.546 HD23 ' C ' ' B' ' 240' ' ' GLN . 0.3 OUTLIER -122.19 118.56 28.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 73.11 110.915 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.68 -168.62 18.77 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 62.32 112.475 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -85.76 135.21 33.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.908 0.385 . . . . 73.12 110.881 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 3.3 m -117.72 118.83 59.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 71.35 111.115 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.445 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 21.6 t -104.82 120.17 54.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 74.02 111.124 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.615 HG22 ' HA3' ' B' ' 282' ' ' GLY . 6.0 t -90.76 172.17 8.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 74.0 111.115 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.444 ' HB2' ' H ' ' A' ' 284' ' ' LYS . . . -52.74 -41.81 64.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 72.43 111.055 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 248' ' ' ALA . . . . . 0.467 ' H ' HG23 ' B' ' 246' ' ' THR . . . -56.79 -36.05 69.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 74.2 111.08 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.464 ' HB2' ' CA ' ' B' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 45.44 111.114 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.903 0.382 . . . . 74.13 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 7.0 t -99.3 137.44 37.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 71.14 111.142 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.599 HG23 ' O ' ' B' ' 225' ' ' ARG . 26.2 m -129.2 132.66 47.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 73.54 111.129 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -120.43 121.87 39.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.943 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 2.0 t -118.91 123.69 45.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 54.31 110.826 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.512 HG21 ' CG2' ' B' ' 267' ' ' VAL . 8.1 p -116.07 139.0 44.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 74.4 111.095 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.39 -75.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 74.12 110.86 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 24.3 m -124.09 130.47 52.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 72.22 111.127 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.512 ' CG2' HG21 ' B' ' 264' ' ' VAL . 94.0 t -118.06 122.8 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 74.2 111.121 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.39 129.14 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 62.21 111.199 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.74 132.76 6.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.699 -0.762 . . . . 53.11 112.412 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.7 147.52 51.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.873 0.368 . . . . 64.41 110.898 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.25 86.39 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.767 -0.73 . . . . 61.43 112.539 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 46.37 66.23 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 65.43 110.863 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 17.4 t -99.2 145.37 27.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 63.42 110.819 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 4.4 ttm-85 -129.76 127.88 41.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 74.5 110.805 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.58 ' HB ' HG23 ' B' ' 239' ' ' VAL . 18.7 t -129.49 123.58 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 65.45 111.134 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -126.88 111.93 14.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 72.45 110.919 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.501 ' CG1' HD13 ' C' ' 241' ' ' LEU . 2.2 mp -108.05 104.32 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 74.52 111.145 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.79 -141.49 8.88 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 71.42 112.472 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -127.99 156.1 43.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.776 0.322 . . . . 63.43 110.908 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -122.57 126.31 47.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 73.32 110.961 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -109.82 127.93 54.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 60.23 110.952 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.615 ' HA3' HG22 ' B' ' 246' ' ' THR . . . 104.84 155.36 22.88 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.752 -0.737 . . . . 72.22 112.519 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 283' ' ' GLY . . . . . 0.691 ' H ' ' HB2' ' C' ' 247' ' ' ALA . . . -114.03 132.88 10.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.709 -0.758 . . . . 60.12 112.501 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -175.02 44.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.359 . . . . 73.51 110.875 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.04 26.87 27.62 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.72 -0.752 . . . . 62.32 112.523 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 62.34 165.26 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 73.44 110.855 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 38.6 p-90 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 75.43 110.924 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 . . . . . 0 CA--C 1.527 0.058 0 CA-C-O 120.83 0.347 . . . . 64.03 110.841 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.47 131.88 39.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 71.21 110.878 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.1 m -140.09 137.86 34.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 64.1 110.88 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.63 144.58 49.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 72.31 111.121 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -101.41 -25.78 13.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 70.24 110.935 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -164.86 138.58 4.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 74.33 110.811 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.562 ' CD1' HD21 ' C' ' 241' ' ' LEU . 10.8 mt -137.74 117.57 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 54.53 111.102 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -133.27 116.13 15.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 65.33 110.946 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.09 136.19 41.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.55 111.141 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -143.15 167.05 23.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.855 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 60.91 75.49 0.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 70.35 110.894 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 44.48 53.82 6.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 64.14 110.909 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.5 145.86 29.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 30.41 111.127 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.0 137.06 52.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 75.31 110.823 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.443 HG13 HG13 ' B' ' 275' ' ' VAL . 7.6 p -132.12 136.51 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 70.42 111.117 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.453 ' HB3' HD13 ' C' ' 276' ' ' LEU . 3.3 tp60 -132.42 135.49 46.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 73.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.562 HD21 ' CD1' ' C' ' 231' ' ' ILE . 1.3 mp -126.8 118.79 25.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.42 110.933 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.8 -169.58 18.71 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 53.3 112.545 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -99.0 143.06 29.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 74.42 110.876 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 19.0 m -120.81 139.27 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 62.23 111.156 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.511 ' CG1' ' HB3' ' C' ' 249' ' ' ALA . 38.6 t -121.93 120.67 62.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 55.13 111.146 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 246' ' ' THR . . . . . 0.609 HG23 ' O ' ' C' ' 281' ' ' TYR . 24.9 p -73.68 173.79 9.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 73.42 111.121 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.691 ' HB2' ' H ' ' B' ' 283' ' ' GLY . . . -63.16 -37.63 87.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 72.02 111.107 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.07 66.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 71.02 111.163 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 249' ' ' ALA . . . . . 0.511 ' HB3' ' CG1' ' C' ' 245' ' ' VAL . . . . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 61.13 111.164 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.884 0.373 . . . . 65.02 110.881 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 14.7 t -80.64 136.94 36.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 74.1 111.166 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.16 117.56 28.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 73.21 111.109 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.55 134.22 50.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.54 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 2.8 t -135.66 123.49 22.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 73.34 110.931 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.606 HG21 ' CG2' ' C' ' 267' ' ' VAL . 11.8 p -115.49 130.12 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 73.2 111.098 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -64.9 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 75.22 110.945 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 89.3 m -149.9 135.33 18.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 22.44 111.16 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.719 ' CG1' HG21 ' C' ' 275' ' ' VAL . 98.7 t -117.96 124.85 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 53.12 111.171 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.34 128.2 69.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 62.22 111.127 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.14 132.95 7.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.768 -0.729 . . . . 72.24 112.509 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -132.95 139.67 47.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.827 0.346 . . . . 70.43 110.873 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.08 73.52 0.37 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 74.12 112.495 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 63.35 100.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.852 0.358 . . . . 73.53 110.937 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 14.4 m -138.62 145.35 40.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 50.5 110.895 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -129.91 127.68 40.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 64.31 110.917 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.719 HG21 ' CG1' ' C' ' 267' ' ' VAL . 31.5 t -131.38 124.89 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 61.21 111.109 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.453 HD13 ' HB3' ' C' ' 240' ' ' GLN . 0.8 OUTLIER -124.59 111.47 15.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.23 -0.441 . . . . 70.22 110.969 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.713 HG13 HD23 ' D' ' 241' ' ' LEU . 2.6 mp -104.94 133.64 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 74.01 111.161 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.11 -146.67 18.85 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.761 -0.733 . . . . 72.51 112.452 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -128.11 146.27 50.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.338 . . . . 74.43 110.878 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -113.42 123.66 50.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 71.15 110.903 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.609 ' O ' HG23 ' C' ' 246' ' ' THR . 0.3 OUTLIER -103.95 125.65 50.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 65.53 110.913 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 111.62 -54.73 0.53 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.715 -0.755 . . . . 70.3 112.51 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 63.88 -116.66 9.46 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.711 -0.757 . . . . 60.23 112.493 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? 63.41 105.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.343 . . . . 64.51 110.896 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 62.39 60.39 7.95 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.745 -0.74 . . . . 70.23 112.477 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 51.74 -168.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.783 0.325 . . . . 74.53 110.909 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 31.8 m0 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.185 -0.461 . . . . 73.04 110.915 -179.984 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 225' ' ' ARG . . . . . 0.71 ' O ' HG23 ' D' ' 261' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.229 0.025 0 CA-C-O 120.874 0.369 . . . . 74.12 110.839 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -83.53 140.63 32.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 64.32 110.893 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 1.4 p -139.95 139.0 36.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 62.13 110.871 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.63 159.77 29.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 62.4 111.087 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 229' ' ' LYS . . . . . 0.419 ' HB2' ' HA ' ' D' ' 265' ' ' GLU . 0.3 OUTLIER -112.32 -29.61 7.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 64.35 110.9 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 230' ' ' ASP . . . . . 0.498 ' HB3' HG23 ' D' ' 266' ' ' THR . 5.1 t0 -166.48 137.99 3.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 64.05 110.875 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 231' ' ' ILE . . . . . 0.415 ' CD1' HG23 ' C' ' 264' ' ' VAL . 13.8 mt -137.42 117.53 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 74.12 111.204 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -134.69 120.39 19.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.947 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.18 150.45 50.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 64.31 111.175 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 234' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' D' ' 237' ' ' ALA . 9.7 pm0 -157.15 167.29 30.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 64.41 110.917 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 61.22 72.21 0.53 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 75.23 110.885 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 45.28 40.86 5.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 74.3 110.881 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 237' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' D' ' 234' ' ' GLU . . . -88.52 144.16 26.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 73.41 111.146 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -125.63 135.83 52.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 72.1 110.89 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.42 139.59 35.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 73.4 111.14 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 240' ' ' GLN . . . . . 0.634 ' HB3' HD13 ' D' ' 276' ' ' LEU . 2.7 tt0 -131.0 137.28 49.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 64.03 110.942 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 1.029 HD12 HD12 ' D' ' 277' ' ' ILE . 0.6 OUTLIER -118.3 118.72 32.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 64.32 110.874 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.79 175.45 15.78 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.759 -0.734 . . . . 74.42 112.549 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -86.02 150.06 24.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.937 0.399 . . . . 74.14 110.822 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 244' ' ' VAL . . . . . 0.467 HG23 ' HA ' ' D' ' 280' ' ' GLU . 16.9 m -123.87 138.32 53.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 63.32 111.193 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.14 128.94 75.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 62.13 111.094 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 12.3 t -74.0 175.25 7.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 63.51 111.081 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.84 -44.4 77.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 73.32 111.071 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.45 -52.03 67.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.422 . . . . 73.32 111.122 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 74.02 111.095 179.932 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.802 0.334 . . . . 63.02 111.181 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 261' ' ' THR . . . . . 0.71 HG23 ' O ' ' D' ' 225' ' ' ARG . 94.0 m -132.57 134.74 45.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 60.34 111.127 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 262' ' ' ASN . . . . . 0.479 ' HB3' HG22 ' D' ' 277' ' ' ILE . 0.4 OUTLIER -119.04 121.48 39.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 70.22 110.873 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.57 123.99 42.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 75.05 110.795 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.645 HG23 ' CD1' ' E' ' 231' ' ' ILE . 8.6 p -120.05 146.49 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 71.12 111.163 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 265' ' ' GLU . . . . . 0.419 ' HA ' ' HB2' ' D' ' 229' ' ' LYS . 15.1 mt-10 -88.76 -73.79 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 72.14 110.876 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 266' ' ' THR . . . . . 0.498 HG23 ' HB3' ' D' ' 230' ' ' ASP . 73.2 m -139.85 129.88 24.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 52.31 111.142 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.713 ' CG1' HG21 ' D' ' 275' ' ' VAL . 16.9 t -117.31 120.59 65.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 72.43 111.134 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.59 124.13 72.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 53.51 111.176 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.51 132.21 9.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 71.31 112.512 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -134.04 140.24 46.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 75.54 110.911 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 46.7 87.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 73.24 112.494 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 50.04 75.74 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.914 0.388 . . . . 71.41 110.93 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 35.9 t -107.1 145.45 32.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.07 -0.514 . . . . 60.34 110.844 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -132.67 127.64 35.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 74.42 110.903 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.713 HG21 ' CG1' ' D' ' 267' ' ' VAL . 61.6 t -136.81 124.1 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 63.14 111.119 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.634 HD13 ' HB3' ' D' ' 240' ' ' GLN . 3.6 mm? -121.45 111.61 17.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 70.5 110.917 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 1.029 HD12 HD12 ' D' ' 241' ' ' LEU . 22.4 mt -103.99 114.38 43.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 65.13 111.145 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.6 -162.12 24.07 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.663 -0.78 . . . . 42.45 112.469 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -116.47 145.58 43.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.786 0.327 . . . . 72.02 110.932 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 280' ' ' GLU . . . . . 0.467 ' HA ' HG23 ' D' ' 244' ' ' VAL . 35.8 tt0 -111.89 132.37 54.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 70.42 110.907 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -110.02 125.38 52.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 75.31 110.918 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 132.06 177.99 15.24 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.725 . . . . 63.21 112.516 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -138.21 111.3 0.8 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.722 -0.751 . . . . 33.24 112.459 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -156.78 22.74 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.339 . . . . 73.13 110.874 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 67.49 121.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.824 -0.703 . . . . 72.52 112.488 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 51.77 -169.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.873 0.368 . . . . 74.41 110.841 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 4.9 m0 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.108 -0.496 . . . . 62.54 110.916 -179.949 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.834 0.35 . . . . 63.43 110.914 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -83.93 112.51 20.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 72.24 110.8 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 6.3 p -129.34 158.96 37.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 70.43 110.878 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 228' ' ' ALA . . . . . 0.48 ' HB2' HD22 ' E' ' 241' ' ' LEU . . . -131.69 164.73 25.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 75.31 111.113 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.42 -39.32 4.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 70.01 110.921 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 230' ' ' ASP . . . . . 0.649 ' HB2' HG22 ' E' ' 266' ' ' THR . 0.3 OUTLIER -166.79 141.43 4.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 44.43 110.901 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' E' E ' 231' ' ' ILE . . . . . 0.645 ' CD1' HG23 ' D' ' 264' ' ' VAL . 3.4 mp -137.22 116.26 15.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 71.43 111.135 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -131.24 118.83 20.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 72.23 110.889 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 233' ' ' THR . . . . . 0.411 ' HB ' ' HB1' ' E' ' 237' ' ' ALA . 0.0 OUTLIER -135.99 128.96 31.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 71.34 111.125 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -140.49 158.32 44.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 74.43 110.944 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 63.08 79.31 0.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 75.31 110.918 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.2 50.04 9.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 75.22 110.899 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 237' ' ' ALA . . . . . 0.411 ' HB1' ' HB ' ' E' ' 233' ' ' THR . . . -104.71 141.55 36.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 74.13 111.094 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -126.39 139.6 53.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 75.41 110.868 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.712 HG23 ' HB ' ' E' ' 275' ' ' VAL . 8.9 p -143.71 141.48 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 71.42 111.124 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 240' ' ' GLN . . . . . 0.579 ' HB3' HD13 ' E' ' 276' ' ' LEU . 2.5 tt0 -138.33 137.16 37.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 74.02 110.892 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.632 HD23 HG11 ' E' ' 264' ' ' VAL . 1.8 mp -120.43 118.61 30.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.226 -0.443 . . . . 62.53 110.89 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 124.43 168.28 12.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 33.0 112.472 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -86.84 163.14 17.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.907 0.385 . . . . 75.22 110.881 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.16 139.39 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 71.41 111.117 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.63 127.95 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 52.1 111.08 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t -70.03 171.18 9.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 53.22 111.179 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.12 -38.72 92.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 53.44 111.168 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.94 -36.05 69.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 72.53 111.093 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 53.54 111.019 179.885 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 60.6 m . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.747 0.308 . . . . 73.25 111.088 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -125.98 131.22 52.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 70.44 110.922 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 23.1 t -128.51 121.02 27.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 72.23 110.906 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 264' ' ' VAL . . . . . 0.632 HG11 HD23 ' E' ' 241' ' ' LEU . 8.8 p -104.37 123.09 58.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 72.23 111.127 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 265' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -65.59 -143.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 70.34 110.828 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' E' E ' 266' ' ' THR . . . . . 0.649 HG22 ' HB2' ' E' ' 230' ' ' ASP . 14.8 p -92.46 130.02 38.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 74.43 111.126 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 267' ' ' VAL . . . . . 1.028 HG11 HG21 ' E' ' 275' ' ' VAL . 19.5 t -114.84 131.15 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 70.43 111.075 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 52.4 t -122.73 116.76 49.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.135 -0.484 . . . . 73.34 111.112 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -108.06 132.68 11.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.808 -0.71 . . . . 73.11 112.512 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -132.3 115.46 15.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.84 0.352 . . . . 62.34 110.903 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.08 94.12 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.734 -0.746 . . . . 61.41 112.452 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 52.02 87.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.895 0.378 . . . . 61.02 110.909 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 33.3 t -125.66 145.85 49.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 64.31 110.877 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -136.63 128.16 28.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 60.33 110.906 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 1.028 HG21 HG11 ' E' ' 267' ' ' VAL . 96.8 t -136.62 125.34 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 74.0 111.099 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 276' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' E' ' 240' ' ' GLN . 3.7 mm? -123.36 116.11 22.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.98 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.497 HD12 ' O ' ' E' ' 240' ' ' GLN . 2.0 mp -109.01 140.8 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.43 111.168 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 112.58 -158.06 14.54 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.792 -0.718 . . . . 71.13 112.495 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -128.19 156.54 42.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.352 . . . . 73.41 110.904 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -111.69 121.81 46.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 73.21 110.882 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -106.23 125.94 51.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.116 -0.493 . . . . 73.5 110.946 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.67 -0.776 . . . . 74.3 112.501 -179.958 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.846 0.355 . . . . 55.43 110.863 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.498 ' HB3' HG22 ' A' ' 277' ' ' ILE . 0.0 OUTLIER -142.24 136.44 29.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 65.01 110.924 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.46 137.09 54.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 72.0 110.901 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.28 131.07 41.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 52.44 111.099 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.81 -28.35 13.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.21 110.867 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.552 ' HB3' HG23 ' A' ' 266' ' ' THR . 1.8 m-20 -166.01 137.3 3.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 74.45 110.899 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 11.1 mt -137.97 117.81 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 62.43 111.139 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -127.67 123.14 34.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.499 . . . . 70.44 110.846 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.632 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.5 OUTLIER -135.56 162.28 33.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 72.13 111.091 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -153.66 167.96 27.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 75.53 110.873 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.66 -69.83 0.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 75.45 110.858 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -178.68 37.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 62.42 110.873 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.632 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -70.52 152.17 44.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 74.14 111.087 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.38 135.64 51.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 45.01 110.868 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.634 HG12 ' HB ' ' A' ' 275' ' ' VAL . 18.7 m -129.45 121.52 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 75.45 111.144 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -119.56 134.15 55.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 75.42 110.884 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 241' ' ' LEU . 6.0 mp -125.65 118.83 26.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 74.44 110.9 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.35 -170.88 22.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.73 . . . . 64.3 112.474 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.88 128.82 34.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 63.22 110.859 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.538 HG11 HD11 ' A' ' 276' ' ' LEU . 1.6 p -123.61 121.98 63.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 73.45 111.134 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.8 p -119.23 129.04 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 70.2 111.107 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 72.12 111.205 179.986 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.883 0.373 . . . . 53.12 111.121 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 95.4 m -107.13 132.59 52.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 72.1 111.151 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.11 119.93 36.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 64.4 110.902 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.1 p -130.09 123.43 30.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 72.34 110.853 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.617 ' HA ' ' HB3' ' B' ' 228' ' ' ALA . 11.5 p -109.3 134.43 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 74.23 111.19 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -74.28 -78.17 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 62.31 110.886 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.552 HG23 ' HB3' ' A' ' 230' ' ' ASP . 36.8 m -136.7 132.18 34.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.33 111.128 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 1.061 HG11 HG21 ' A' ' 275' ' ' VAL . 33.3 t -118.42 120.9 65.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.23 -0.441 . . . . 63.21 111.143 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.22 119.46 60.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 74.21 111.153 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.8 133.52 10.91 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.752 -0.737 . . . . 64.41 112.514 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -116.06 116.28 27.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 73.41 110.989 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.83 83.25 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.757 -0.735 . . . . 65.32 112.537 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 67.08 120.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 74.44 110.898 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.5 t -156.32 145.27 20.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 64.22 110.831 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.73 126.65 46.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 62.31 110.876 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 1.061 HG21 HG11 ' A' ' 267' ' ' VAL . 98.5 t -137.54 123.75 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 64.35 111.079 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.538 HD11 HG11 ' A' ' 244' ' ' VAL . 1.0 OUTLIER -122.8 120.15 32.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 75.23 110.901 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.739 ' CD1' HD13 ' B' ' 241' ' ' LEU . 24.9 mm -112.32 103.74 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 72.35 111.144 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.9 -154.95 25.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.772 -0.728 . . . . 41.12 112.512 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -111.06 151.88 27.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.732 0.301 . . . . 73.13 110.901 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.744 ' HG2' HG22 ' B' ' 244' ' ' VAL . 0.0 OUTLIER -128.1 134.86 49.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 72.34 110.831 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.471 ' HA ' HG13 ' B' ' 245' ' ' VAL . 0.4 OUTLIER -122.22 134.61 54.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 73.33 110.941 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.21 164.03 33.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 40.34 112.441 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 141.26 136.54 3.3 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.788 -0.72 . . . . 61.22 112.522 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -51.79 -45.87 63.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.861 0.362 . . . . 61.22 110.889 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -132.48 -43.24 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.777 -0.725 . . . . 64.51 112.517 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -174.3 -165.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 73.53 110.837 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.47 ' NE1' HD12 ' A' ' 276' ' ' LEU . 15.8 t90 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.503 . . . . 74.32 110.915 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.908 0.385 . . . . 74.23 110.852 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.07 109.95 18.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 74.2 110.808 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.31 137.77 54.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 74.32 110.892 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 264' ' ' VAL . . . -124.71 150.05 46.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 73.14 111.026 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -113.94 -32.78 5.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 62.11 110.977 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 230' ' ' ASP . . . . . 0.575 ' HB3' HG23 ' B' ' 266' ' ' THR . 0.4 OUTLIER -165.43 137.82 4.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 63.23 110.873 179.834 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 7.7 mt -138.15 117.38 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 65.14 111.167 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -129.52 124.45 33.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 64.34 110.849 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.624 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 0.1 OUTLIER -135.32 163.58 29.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 74.3 111.157 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -148.94 167.99 24.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 75.44 110.948 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.58 -72.19 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 72.55 110.9 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.99 40.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 75.01 110.84 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -69.9 156.71 38.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.446 . . . . 62.25 111.058 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.41 135.12 52.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 74.3 110.871 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.652 ' CG2' HG22 ' A' ' 275' ' ' VAL . 30.0 m -131.81 133.09 61.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 70.15 111.146 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.442 ' C ' HD12 ' B' ' 241' ' ' LEU . 1.9 tt0 -127.95 137.03 52.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 70.43 110.883 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.739 HD13 ' CD1' ' A' ' 277' ' ' ILE . 6.5 mp -125.85 118.28 25.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 74.1 110.905 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.62 -168.14 23.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.802 -0.713 . . . . 73.41 112.512 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -85.86 142.48 28.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.357 . . . . 73.04 110.926 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.744 HG22 ' HG2' ' A' ' 280' ' ' GLU . 2.9 t -125.68 120.58 57.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 52.52 111.171 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.471 HG13 ' HA ' ' A' ' 281' ' ' TYR . 5.5 p -122.08 120.19 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 63.24 111.147 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 11.0 t -74.1 165.67 24.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 71.24 111.142 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.92 76.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 42.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.33 74.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 43.44 111.064 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 63.23 111.075 179.963 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.868 0.366 . . . . 60.4 110.958 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 260' ' ' THR . . . . . 0.715 HG23 ' HB3' ' C' ' 225' ' ' ARG . 27.6 m -100.96 126.86 47.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 73.23 111.176 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 4.4 t -92.65 133.48 35.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.51 111.151 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.418 ' ND2' ' HA2' ' B' ' 278' ' ' GLY . 0.6 OUTLIER -126.56 129.77 49.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 64.32 110.887 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 12.9 t -132.98 123.58 26.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 64.02 110.77 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.772 ' HA ' ' HB3' ' C' ' 228' ' ' ALA . 10.3 p -105.86 135.21 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 74.53 111.211 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -77.71 -77.41 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 71.24 110.863 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.575 HG23 ' HB3' ' B' ' 230' ' ' ASP . 18.5 m -134.7 132.26 38.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.44 111.207 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.902 HG11 HG21 ' B' ' 275' ' ' VAL . 23.9 t -118.0 120.84 65.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 54.4 111.169 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.54 120.37 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 75.32 111.117 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.63 133.2 11.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.692 -0.766 . . . . 70.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -116.92 116.5 27.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.809 0.338 . . . . 74.43 110.94 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.96 83.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 55.53 112.505 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 66.5 119.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.826 0.346 . . . . 75.24 110.883 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 22.9 t -156.27 146.77 21.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 73.01 110.847 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -124.24 127.03 47.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 73.22 110.803 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.902 HG21 HG11 ' B' ' 267' ' ' VAL . 87.8 t -137.6 123.15 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 75.21 111.059 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.55 HD12 ' CZ2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -120.97 122.41 40.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 75.14 110.887 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 27.4 mm -112.55 103.68 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 62.13 111.137 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.418 ' HA2' ' ND2' ' B' ' 262' ' ' ASN . . . 152.05 -139.96 7.42 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.758 -0.734 . . . . 74.33 112.53 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -128.31 145.56 51.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 71.43 110.876 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.737 ' CG ' HG13 ' C' ' 244' ' ' VAL . 0.4 OUTLIER -117.03 135.91 53.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 70.15 110.837 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.412 ' HA ' HG13 ' C' ' 245' ' ' VAL . 0.3 OUTLIER -120.64 125.7 48.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 75.22 110.933 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 65.57 174.14 4.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 74.11 112.497 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 137.59 -6.94 3.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 71.01 112.521 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.37 70.93 0.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.367 . . . . 74.13 110.883 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 127.27 -109.33 1.06 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 53.44 112.507 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -121.58 -75.1 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.792 0.33 . . . . 52.41 110.883 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.55 ' CZ2' HD12 ' B' ' 276' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 62.31 110.896 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.715 ' HB3' HG23 ' B' ' 260' ' ' THR . 4.3 mmt85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.764 0.316 . . . . 72.1 110.878 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.465 HD21 HD12 ' C' ' 241' ' ' LEU . 3.3 t-20 -140.08 119.58 13.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 74.43 110.898 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 58.8 m -129.87 141.79 50.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 54.45 110.911 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.772 ' HB3' ' HA ' ' B' ' 264' ' ' VAL . . . -124.95 146.54 49.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 64.24 111.108 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' C' ' 265' ' ' GLU . 0.1 OUTLIER -110.26 -37.86 5.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 75.45 110.899 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 230' ' ' ASP . . . . . 0.674 ' HB3' HG22 ' C' ' 266' ' ' THR . 4.5 t0 -165.24 137.29 4.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 71.23 110.845 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.97 117.45 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.455 . . . . 73.04 111.189 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -130.73 126.1 35.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 63.23 110.855 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.671 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 0.1 OUTLIER -135.22 164.02 28.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 70.34 111.156 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -144.61 168.6 19.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 73.4 110.828 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.54 -74.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 75.51 110.871 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.27 38.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 74.35 110.824 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.671 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -69.64 157.09 37.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.301 -0.409 . . . . 72.44 111.116 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.76 134.55 52.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 72.3 110.852 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.659 ' CG2' HG22 ' B' ' 275' ' ' VAL . 18.2 m -127.25 122.09 59.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 55.31 111.091 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.94 123.61 49.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 75.5 110.921 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.465 HD12 HD21 ' C' ' 226' ' ' ASN . 4.2 mm? -111.66 119.14 37.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 40.22 110.919 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 122.2 -168.14 14.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.773 -0.727 . . . . 24.43 112.522 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -86.14 149.71 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 60.21 110.94 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.737 HG13 ' CG ' ' B' ' 280' ' ' GLU . 78.9 t -126.35 122.19 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 72.3 111.126 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.412 HG13 ' HA ' ' B' ' 281' ' ' TYR . 7.2 p -116.63 129.27 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 74.43 111.099 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 12.8 p -78.68 165.07 24.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.491 . . . . 72.3 111.103 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.21 -34.0 76.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 73.53 111.071 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.81 -40.4 75.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 63.12 111.062 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 53.11 111.166 179.901 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.823 0.344 . . . . 61.11 110.908 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.26 137.55 32.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 73.23 111.148 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 96.1 m -105.41 131.38 52.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 75.52 111.178 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.411 ' ND2' ' HA2' ' C' ' 278' ' ' GLY . 0.3 OUTLIER -126.05 136.99 53.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 64.33 110.831 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 46.5 t -142.11 123.8 15.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 70.42 110.911 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.492 ' HA ' ' HB3' ' D' ' 228' ' ' ALA . 9.0 p -106.15 138.28 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 74.32 111.139 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' C' ' 229' ' ' LYS . 2.9 tt0 -78.49 -76.63 0.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 74.54 110.927 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 266' ' ' THR . . . . . 0.674 HG22 ' HB3' ' C' ' 230' ' ' ASP . 40.9 p -134.95 132.25 38.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.093 -0.503 . . . . 73.15 111.111 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.731 HG11 HG21 ' C' ' 275' ' ' VAL . 97.6 t -117.44 120.68 65.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 70.14 111.171 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.95 119.65 61.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 74.01 111.141 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.52 133.27 11.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.682 -0.77 . . . . 61.52 112.513 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -115.66 116.39 28.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.791 0.329 . . . . 73.43 110.919 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.49 86.52 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.731 -0.747 . . . . 35.42 112.493 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.68 118.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 74.32 110.91 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 37.4 t -157.22 149.1 22.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 70.25 110.818 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 -126.58 127.02 44.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 74.5 110.897 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.731 HG21 HG11 ' C' ' 267' ' ' VAL . 98.7 t -138.2 123.85 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 44.41 111.146 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.636 HD12 ' HE1' ' C' ' 287' ' ' TRP . 0.9 OUTLIER -125.98 122.51 36.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 73.43 110.942 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.468 ' N ' HD23 ' C' ' 276' ' ' LEU . 13.7 mm -112.4 104.18 16.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.262 -0.426 . . . . 72.02 111.077 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 278' ' ' GLY . . . . . 0.411 ' HA2' ' ND2' ' C' ' 262' ' ' ASN . . . 149.02 -178.38 26.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.682 -0.77 . . . . 65.23 112.483 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -89.63 145.02 25.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.783 0.325 . . . . 73.34 110.889 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.637 ' CG ' HG22 ' D' ' 244' ' ' VAL . 5.5 pt-20 -120.43 125.79 48.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 51.5 110.896 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.471 ' HA ' HG13 ' D' ' 245' ' ' VAL . 26.2 t80 -115.55 140.13 49.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 74.3 110.939 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.55 59.12 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.71 -0.757 . . . . 53.11 112.473 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -68.29 87.29 0.19 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.75 -0.738 . . . . 61.42 112.441 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -58.66 98.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 71.24 110.967 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 62.95 104.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 44.53 112.457 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.83 -166.45 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.799 0.333 . . . . 74.52 110.872 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.636 ' HE1' HD12 ' C' ' 276' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 74.25 110.945 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 225' ' ' ARG . . . . . 0.555 ' HA ' HG23 ' D' ' 261' ' ' THR . 3.5 mmt85 . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.785 0.326 . . . . 61.54 110.887 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -83.59 121.94 27.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 70.41 110.844 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.68 137.85 45.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 62.33 110.82 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 228' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' C' ' 264' ' ' VAL . . . -131.13 133.31 45.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.052 -0.522 . . . . 52.33 111.072 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -96.9 -30.97 12.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 75.15 110.872 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 230' ' ' ASP . . . . . 0.729 ' HB3' HG23 ' D' ' 266' ' ' THR . 3.6 t0 -166.35 137.08 3.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 73.13 110.865 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 10.4 mt -139.48 117.07 11.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 63.5 111.081 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.4 126.38 38.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 70.53 110.885 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 233' ' ' THR . . . . . 0.738 ' HB ' ' HB3' ' D' ' 237' ' ' ALA . 2.1 p -135.81 164.36 28.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 75.44 111.147 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -145.57 168.76 19.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 72.23 110.921 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 73.35 -75.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 71.33 110.912 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.73 47.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 71.54 110.881 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 237' ' ' ALA . . . . . 0.738 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -77.32 156.82 31.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 70.43 111.105 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.05 134.46 52.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.883 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.773 HG12 ' HB ' ' D' ' 275' ' ' VAL . 6.2 m -126.87 121.45 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 72.23 111.194 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.92 127.88 55.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 62.22 110.898 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.8 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.1 mm? -116.0 117.89 31.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 55.32 110.932 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.98 -166.89 21.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 44.54 112.479 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -98.85 128.95 45.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 52.34 110.934 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 244' ' ' VAL . . . . . 0.637 HG22 ' CG ' ' C' ' 280' ' ' GLU . 95.5 t -102.8 124.97 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.14 111.152 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 245' ' ' VAL . . . . . 0.471 HG13 ' HA ' ' C' ' 281' ' ' TYR . 7.1 p -122.08 128.0 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 64.25 111.199 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -69.63 175.03 4.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 65.23 111.235 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.43 97.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 62.11 111.056 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.17 -40.09 76.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 61.33 111.088 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 42.24 111.142 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 260' ' ' THR . . . . . 0.552 HG21 ' OD1' ' E' ' 243' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.853 0.359 . . . . 71.24 111.138 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 261' ' ' THR . . . . . 0.555 HG23 ' HA ' ' D' ' 225' ' ' ARG . 29.2 m -96.39 120.81 37.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 62.31 111.099 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 262' ' ' ASN . . . . . 0.739 ' OD1' HG22 ' D' ' 277' ' ' ILE . 0.5 OUTLIER -121.66 135.93 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 53.44 110.897 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 3.8 m -142.16 124.92 15.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 64.03 110.798 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.612 ' HA ' ' HB3' ' E' ' 228' ' ' ALA . 7.2 p -104.95 122.04 57.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 75.15 111.125 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -56.38 -82.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.924 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 266' ' ' THR . . . . . 0.729 HG23 ' HB3' ' D' ' 230' ' ' ASP . 10.7 m -128.4 137.45 51.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.163 -0.471 . . . . 31.44 111.157 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.757 HG11 HG21 ' D' ' 275' ' ' VAL . 64.4 t -118.21 120.68 65.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 72.35 111.154 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 15.0 t -117.45 116.89 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 62.45 111.121 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.24 133.03 11.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.716 -0.754 . . . . 42.32 112.456 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.36 119.28 35.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.828 0.347 . . . . 65.42 110.866 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.09 78.52 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 73.22 112.459 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 68.76 125.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 64.24 110.904 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 12.8 t -156.52 160.59 39.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 73.55 110.891 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.21 127.04 32.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 75.12 110.879 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.773 ' HB ' HG12 ' D' ' 239' ' ' VAL . 89.8 t -137.76 123.64 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 64.22 111.188 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.694 HD12 ' HE1' ' D' ' 287' ' ' TRP . 0.9 OUTLIER -127.73 124.12 37.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 74.21 110.934 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.8 ' HB ' HD13 ' D' ' 241' ' ' LEU . 20.0 mm -112.27 104.88 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.44 111.101 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.21 -144.21 11.83 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.753 -0.737 . . . . 73.11 112.507 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -123.51 139.99 53.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 75.52 110.893 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 280' ' ' GLU . . . . . 0.758 ' CG ' HG13 ' E' ' 244' ' ' VAL . 11.0 pt-20 -111.89 134.27 53.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 73.54 110.962 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 281' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' E' ' 249' ' ' ALA . 17.0 t80 -125.42 125.11 42.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 73.12 110.897 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.3 -150.18 16.96 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.76 -0.734 . . . . 34.22 112.479 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 59.74 18.2 44.92 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.737 -0.744 . . . . 70.32 112.52 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 7.2 mttp 52.46 29.44 7.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.901 0.381 . . . . 73.14 110.93 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.77 127.59 6.14 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.735 -0.745 . . . . 64.34 112.423 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 t80 59.09 175.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.828 0.347 . . . . 71.32 110.88 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 287' ' ' TRP . . . . . 0.694 ' HE1' HD12 ' D' ' 276' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 74.43 110.951 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 45.5 mmt-85 . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.859 0.361 . . . . 72.54 110.913 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' E' E ' 226' ' ' ASN . . . . . 0.592 ' HB3' HD12 ' E' ' 241' ' ' LEU . 21.5 m-80 -83.76 116.39 22.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 62.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.22 143.07 50.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 72.52 110.895 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 228' ' ' ALA . . . . . 0.612 ' HB3' ' HA ' ' D' ' 264' ' ' VAL . . . -130.82 136.22 48.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 64.35 111.146 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -88.08 -41.72 12.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 75.5 110.879 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -173.44 138.52 0.7 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 71.5 110.873 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 231' ' ' ILE . . . . . 0.538 HG23 ' HB ' ' E' ' 267' ' ' VAL . 5.8 mt -132.61 117.8 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 53.43 111.105 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 232' ' ' ARG . . . . . 0.679 ' HD2' HG13 ' E' ' 268' ' ' VAL . 0.1 OUTLIER -126.96 124.27 39.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 73.4 110.824 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' E' E ' 233' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' E' ' 237' ' ' ALA . 5.0 p -135.86 164.73 27.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 65.24 111.086 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -142.13 167.97 20.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.134 -0.484 . . . . 75.34 110.874 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 72.96 -75.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.804 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -179.76 71.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 63.32 110.857 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 237' ' ' ALA . . . . . 0.591 ' HB3' ' HB ' ' E' ' 233' ' ' THR . . . -101.64 157.02 17.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 62.42 111.095 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.15 134.29 53.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.964 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.753 HG12 ' HB ' ' E' ' 275' ' ' VAL . 4.9 m -128.96 121.81 55.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 71.23 111.075 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -113.96 129.7 56.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.914 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.654 HD13 ' HB ' ' E' ' 277' ' ' ILE . 1.3 mm? -115.25 118.24 32.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 75.12 110.988 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 242' ' ' GLY . . . . . 0.432 ' HA2' ' ND2' ' E' ' 226' ' ' ASN . . . 128.55 -149.78 18.42 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.749 -0.739 . . . . 73.02 112.478 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 243' ' ' ASN . . . . . 0.552 ' OD1' HG21 ' D' ' 260' ' ' THR . 4.9 m120 -106.68 130.45 54.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.869 0.366 . . . . 74.21 110.877 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.758 HG13 ' CG ' ' D' ' 280' ' ' GLU . 84.4 t -105.89 127.4 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.168 -0.469 . . . . 54.22 111.134 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 245' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' D' ' 281' ' ' TYR . 5.0 p -122.68 124.34 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 72.21 111.169 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 246' ' ' THR . . . . . 0.544 HG21 ' C ' ' E' ' 282' ' ' GLY . 8.8 t -70.03 169.64 12.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 72.42 111.129 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.83 -33.9 51.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 44.44 111.159 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.73 -52.1 66.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.42 111.108 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 249' ' ' ALA . . . . . 0.51 ' HB2' ' CE2' ' D' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 55.54 111.082 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.796 0.332 . . . . 75.02 111.155 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.65 123.14 49.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 74.32 110.931 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 13.6 t -132.59 136.93 46.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 75.13 110.859 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.5 136.59 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.102 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -65.49 -105.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 74.03 110.937 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 85.5 m -117.11 138.05 51.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 73.44 111.152 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 267' ' ' VAL . . . . . 0.724 HG11 HG21 ' E' ' 275' ' ' VAL . 73.8 t -117.78 118.23 57.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 71.42 111.149 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 268' ' ' VAL . . . . . 0.679 HG13 ' HD2' ' E' ' 232' ' ' ARG . 0.6 OUTLIER -118.22 114.56 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 71.4 111.091 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.58 131.59 10.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.704 -0.76 . . . . 74.01 112.467 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -114.43 124.29 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 73.42 110.841 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 57.47 68.15 1.85 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 63.1 112.457 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 67.46 129.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.846 0.355 . . . . 62.43 110.849 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 10.5 t -156.92 161.22 39.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 74.13 110.877 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -129.9 127.82 40.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.23 110.846 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.753 ' HB ' HG12 ' E' ' 239' ' ' VAL . 90.5 t -138.88 128.83 32.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 42.33 111.163 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 276' ' ' LEU . . . . . 0.487 HD11 HG21 ' E' ' 244' ' ' VAL . 0.4 OUTLIER -128.71 127.68 42.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 63.44 110.933 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.654 ' HB ' HD13 ' E' ' 241' ' ' LEU . 43.7 mm -112.23 118.19 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 71.03 111.128 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 121.63 -157.7 16.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 44.24 112.487 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -91.76 156.02 17.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 64.03 110.865 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -134.18 135.71 43.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 73.45 110.947 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' E' E ' 281' ' ' TYR . . . . . 0.536 ' CD1' HG22 ' E' ' 246' ' ' THR . 50.2 t80 -125.64 124.62 41.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 75.01 110.97 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' E' E ' 282' ' ' GLY . . . . . 0.544 ' C ' HG21 ' E' ' 246' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.782 -0.723 . . . . 50.3 112.505 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.815 0.34 . . . . 70.4 110.893 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.733 ' OD1' HG22 ' A' ' 277' ' ' ILE . 44.3 m-80 -127.78 122.59 33.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.52 110.906 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.54 138.58 54.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 62.15 110.836 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.32 119.92 11.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.066 -0.515 . . . . 62.24 111.1 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.83 -34.42 45.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.441 . . . . 64.24 110.879 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -165.55 138.81 4.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 62.11 110.928 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.692 HG22 ' CG1' ' A' ' 267' ' ' VAL . 36.5 pt -136.32 132.99 49.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 70.21 111.068 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -134.19 123.52 24.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 75.3 110.921 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -135.52 128.52 31.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 61.31 111.143 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -138.2 166.43 24.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 72.34 110.903 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 66.4 68.75 0.43 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 72.54 110.859 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 49.81 32.9 5.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 64.34 110.921 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.45 156.01 20.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 51.33 111.09 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -139.28 148.04 42.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 70.5 110.821 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.585 HG23 ' HB ' ' A' ' 275' ' ' VAL . 3.1 p -134.86 121.72 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 75.14 111.058 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.77 135.75 53.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.54 110.938 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 mp -130.09 118.87 22.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 70.11 110.914 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 140.81 177.42 16.15 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.741 . . . . 62.2 112.511 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -88.2 128.85 35.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 72.22 110.821 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.09 133.37 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 63.44 111.111 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.04 129.08 75.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 33.35 111.071 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 73.13 111.182 179.934 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 260' ' ' THR . . . . . 0.441 HG21 ' C ' ' B' ' 242' ' ' GLY . 96.2 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.913 0.387 . . . . 51.04 111.139 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.3 t -132.56 132.09 42.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 71.22 111.134 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.76 ' OD1' HG23 ' A' ' 277' ' ' ILE . 4.2 t-20 -126.1 149.17 49.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 73.12 110.903 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.3 t -142.36 123.1 14.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 64.13 110.835 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.661 HG21 ' CD1' ' B' ' 231' ' ' ILE . 9.2 p -122.08 124.1 70.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 72.44 111.08 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.45 -70.65 0.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 74.14 110.85 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 95.1 m -131.63 128.29 38.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 63.1 111.166 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.692 ' CG1' HG22 ' A' ' 231' ' ' ILE . 7.2 p -123.23 125.19 71.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 64.44 111.208 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.58 135.64 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 74.01 111.103 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.43 133.81 7.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 51.12 112.427 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.08 148.34 52.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 71.24 110.902 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.7 88.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.75 -0.738 . . . . 72.3 112.468 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 43.26 57.42 3.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.879 0.371 . . . . 73.24 110.852 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.74 145.3 28.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 52.03 110.829 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.12 127.33 47.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 52.02 110.896 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.585 ' HB ' HG23 ' A' ' 239' ' ' VAL . 10.0 t -120.61 123.66 70.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 74.33 111.159 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.13 111.23 14.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 75.3 110.898 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.76 HG23 ' OD1' ' A' ' 262' ' ' ASN . 4.5 mp -113.17 104.79 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 62.32 111.134 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.42 -161.65 26.93 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 74.02 112.493 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.62 156.18 21.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.301 . . . . 72.25 110.961 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.642 ' CG ' HG12 ' B' ' 244' ' ' VAL . 2.2 pp20? -130.37 147.32 52.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.854 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -126.73 125.83 42.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 55.21 110.912 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 144.19 147.94 4.78 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.745 -0.741 . . . . 72.15 112.477 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.438 ' N ' ' H ' ' B' ' 247' ' ' ALA . . . -121.75 25.59 6.8 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 73.52 112.502 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 43.01 1.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 45.41 110.917 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 146.88 -19.85 1.61 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.836 -0.697 . . . . 75.52 112.549 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.441 ' CZ ' HG21 ' B' ' 244' ' ' VAL . 11.3 t80 72.26 -68.93 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 70.12 110.84 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 11.5 t90 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 72.22 110.905 -179.965 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.767 0.318 . . . . 71.31 110.791 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.712 ' OD1' HG22 ' B' ' 277' ' ' ILE . 14.7 m-80 -142.21 128.5 19.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.879 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.95 137.62 54.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 71.14 110.843 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.35 119.99 12.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 73.45 111.091 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -34.8 52.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 62.44 110.849 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -165.67 136.56 3.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 71.03 110.868 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.715 HG22 HG12 ' B' ' 267' ' ' VAL . 27.6 pt -138.57 129.87 36.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 60.14 111.163 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.97 125.69 32.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 74.21 110.906 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 2.7 p -135.67 128.65 31.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 72.04 111.114 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -136.93 166.77 22.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 75.12 110.9 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 64.51 75.06 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 65.44 110.906 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 45.43 36.17 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.55 110.849 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.2 155.63 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.21 111.083 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -140.95 153.74 45.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 74.21 110.901 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.516 HG23 ' HB ' ' B' ' 275' ' ' VAL . 6.0 p -139.55 121.78 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 62.24 111.174 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -117.08 134.9 54.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 72.13 110.837 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.549 HD22 HD21 ' A' ' 262' ' ' ASN . 2.5 mp -130.44 135.33 47.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 75.23 110.92 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.441 ' C ' HG21 ' A' ' 260' ' ' THR . . . 133.55 -124.86 3.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 65.43 112.514 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 243' ' ' ASN . . . . . 0.44 ' N ' HG21 ' A' ' 260' ' ' THR . 26.8 t30 -145.49 131.38 19.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.915 0.388 . . . . 60.25 110.909 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.642 HG12 ' CG ' ' A' ' 280' ' ' GLU . 18.1 m -114.07 122.8 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 73.43 111.12 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 98.4 t -122.37 129.51 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 51.14 111.086 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.493 HG23 ' H ' ' B' ' 249' ' ' ALA . 13.9 t -69.6 162.59 27.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 71.44 111.12 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.438 ' H ' ' N ' ' A' ' 283' ' ' GLY . . . -63.34 -33.88 76.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 63.51 111.101 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.12 81.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 72.33 111.068 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.493 ' H ' HG23 ' B' ' 246' ' ' THR . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 71.43 111.11 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.835 0.35 . . . . 72.12 110.925 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 260' ' ' THR . . . . . 0.689 HG21 ' H ' ' C' ' 243' ' ' ASN . 58.3 m -100.61 133.51 44.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 72.35 111.135 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 87.3 m -134.27 133.19 40.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 62.41 111.12 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.724 ' OD1' HG23 ' B' ' 277' ' ' ILE . 12.5 t-20 -126.48 134.26 50.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 73.23 110.906 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 15.1 m -128.75 123.55 33.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 74.53 110.906 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.488 ' HA ' ' HB3' ' C' ' 228' ' ' ALA . 7.6 p -119.47 141.49 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 73.32 111.155 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.75 -57.63 3.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.86 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 72.3 p -150.2 126.83 10.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 65.02 111.171 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.784 HG23 ' HB ' ' C' ' 231' ' ' ILE . 12.2 p -123.81 135.11 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 73.14 111.11 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 60.5 t -127.14 132.91 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.11 111.161 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.79 134.58 8.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.781 -0.723 . . . . 72.12 112.541 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -132.96 148.59 52.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.744 0.306 . . . . 72.55 110.925 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.58 88.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.746 . . . . 43.41 112.451 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 45.18 62.72 2.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.387 . . . . 64.24 110.867 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 17.0 t -94.67 145.52 24.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 64.4 110.817 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.12 127.48 41.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 64.31 110.925 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.626 HG12 ' CD1' ' B' ' 277' ' ' ILE . 6.2 t -122.67 122.75 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.15 111.141 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.35 114.26 20.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 64.13 110.955 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.724 HG23 ' OD1' ' B' ' 262' ' ' ASN . 3.8 mp -112.41 104.29 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.4 111.12 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.93 -163.48 26.97 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.691 -0.766 . . . . 61.34 112.519 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -110.64 156.18 21.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 53.44 110.841 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.614 ' HG3' HG12 ' C' ' 244' ' ' VAL . 0.4 OUTLIER -127.38 145.72 50.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 62.12 110.891 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -123.06 125.84 45.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 71.22 110.916 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.63 147.11 4.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.666 -0.778 . . . . 74.43 112.449 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 283' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' C' ' 247' ' ' ALA . . . -106.74 -22.75 7.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 62.25 112.541 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -52.07 -29.71 22.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.729 0.299 . . . . 75.44 110.862 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -161.85 112.78 0.53 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.68 -0.772 . . . . 43.01 112.456 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -51.79 -29.82 20.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.842 0.353 . . . . 75.32 110.837 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 4.5 t90 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.47 . . . . 71.23 110.935 -179.964 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 69.2 mmt-85 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.845 0.355 . . . . 72.33 110.859 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -82.74 121.03 26.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 73.34 110.949 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.4 m -121.23 144.47 48.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 75.24 110.893 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.488 ' HB3' ' HA ' ' B' ' 264' ' ' VAL . . . -140.78 153.93 46.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 73.2 111.153 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.19 -34.75 4.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 71.41 110.948 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 230' ' ' ASP . . . . . 0.615 ' HB3' HG23 ' C' ' 266' ' ' THR . 4.9 t0 -165.09 139.3 4.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 64.33 110.877 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.784 ' HB ' HG23 ' B' ' 267' ' ' VAL . 0.5 OUTLIER -136.02 117.2 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 70.14 111.052 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.91 115.86 21.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 74.33 110.903 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.78 128.8 39.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 70.34 111.087 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -137.65 166.42 23.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 62.42 110.944 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 61.48 74.43 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 71.33 110.909 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 45.38 49.94 10.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 64.33 110.817 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.24 147.11 27.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 54.42 111.114 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -134.54 141.16 46.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 71.33 110.885 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.661 HG23 ' HB ' ' C' ' 275' ' ' VAL . 5.7 p -135.01 121.55 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 75.33 111.138 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.606 ' HB3' HD22 ' C' ' 276' ' ' LEU . 4.3 tm0? -116.27 124.68 50.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 74.54 110.896 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.665 HD12 HD13 ' C' ' 277' ' ' ILE . 0.2 OUTLIER -112.38 118.98 36.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.21 -0.45 . . . . 65.51 110.852 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.41 179.94 17.73 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.745 -0.741 . . . . 73.13 112.455 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 243' ' ' ASN . . . . . 0.689 ' H ' HG21 ' B' ' 260' ' ' THR . 4.6 t30 -89.66 150.06 22.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 61.31 110.886 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.614 HG12 ' HG3' ' B' ' 280' ' ' GLU . 33.2 m -127.97 129.33 69.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 71.15 111.133 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 89.2 t -122.2 129.45 75.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 74.54 111.129 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 13.2 t -69.92 175.17 4.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 55.34 111.172 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.413 ' HB2' ' H ' ' B' ' 283' ' ' GLY . . . -62.37 -41.38 98.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 55.5 111.077 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.9 -52.54 64.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 64.35 111.12 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 54.24 111.072 179.867 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.879 0.371 . . . . 75.33 110.922 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 260' ' ' THR . . . . . 0.457 HG21 ' HB3' ' C' ' 279' ' ' ASN . 7.6 p -100.98 122.4 43.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 74.21 111.16 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 88.8 m -100.55 114.78 28.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 74.13 111.151 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.746 ' OD1' HG23 ' C' ' 277' ' ' ILE . 6.4 t-20 -126.29 144.35 50.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.43 110.933 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 47.3 t -139.03 123.02 17.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 61.32 110.818 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.739 ' HA ' ' HB3' ' D' ' 228' ' ' ALA . 7.6 p -111.11 126.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 72.23 111.097 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.83 -77.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 71.15 110.898 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 266' ' ' THR . . . . . 0.615 HG23 ' HB3' ' C' ' 230' ' ' ASP . 16.3 m -131.39 130.27 42.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 72.54 111.094 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.617 HG22 ' HB ' ' D' ' 231' ' ' ILE . 0.9 OUTLIER -118.27 130.92 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 72.25 111.108 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.51 133.08 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 42.43 111.106 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -133.25 132.78 6.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.689 -0.767 . . . . 64.4 112.516 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -132.17 142.38 49.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 72.34 110.926 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.76 78.78 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.768 -0.73 . . . . 73.11 112.483 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 58.66 96.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.858 0.361 . . . . 74.41 110.883 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 14.1 m -134.42 145.39 48.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.867 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.01 128.13 35.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 75.35 110.897 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.661 ' HB ' HG23 ' C' ' 239' ' ' VAL . 7.2 t -125.84 123.6 64.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 62.22 111.082 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.2 OUTLIER -123.06 117.29 25.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 72.11 110.908 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.746 HG23 ' OD1' ' C' ' 262' ' ' ASN . 3.1 mp -112.84 131.01 65.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 74.13 111.158 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 123.44 -152.02 17.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.798 -0.715 . . . . 72.21 112.445 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 279' ' ' ASN . . . . . 0.457 ' HB3' HG21 ' C' ' 260' ' ' THR . 9.5 p-10 -124.58 156.37 37.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.795 0.331 . . . . 73.31 110.877 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -121.03 139.04 53.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 64.25 110.852 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -123.41 126.43 46.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 71.02 110.934 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 282' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' D' ' 247' ' ' ALA . . . 136.84 -34.28 2.23 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 74.33 112.488 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 52.32 47.76 55.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.756 -0.735 . . . . 71.53 112.45 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 57.89 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 74.33 110.864 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.81 -79.21 0.8 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.719 -0.753 . . . . 61.34 112.454 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -179.4 108.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.805 0.336 . . . . 75.42 110.859 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 74.33 110.976 -179.975 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.856 0.36 . . . . 64.21 110.867 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 226' ' ' ASN . . . . . 0.454 HD22 HG22 ' D' ' 277' ' ' ILE . 6.0 m120 -142.13 128.46 19.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 73.52 110.884 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 3.8 m -121.68 139.61 53.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 74.01 110.822 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 228' ' ' ALA . . . . . 0.739 ' HB3' ' HA ' ' C' ' 264' ' ' VAL . . . -133.63 129.84 37.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 71.34 111.084 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 229' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' D' ' 265' ' ' GLU . 9.5 mtmm -97.5 -33.63 11.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 73.05 110.897 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 230' ' ' ASP . . . . . 0.658 ' HB3' HG23 ' D' ' 266' ' ' THR . 0.2 OUTLIER -165.01 138.16 4.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 72.45 110.881 179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 231' ' ' ILE . . . . . 0.617 ' HB ' HG22 ' C' ' 267' ' ' VAL . 6.1 mt -137.33 128.72 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 74.22 111.155 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -134.26 115.89 14.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.472 . . . . 71.44 110.908 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 3.5 p -129.82 149.59 51.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 73.13 111.147 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 234' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' D' ' 237' ' ' ALA . 5.2 pm0 -156.98 166.71 32.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 72.13 110.883 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 63.26 67.56 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 71.14 110.87 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 36.6 mtt85 49.45 31.76 4.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 74.31 110.932 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 237' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' D' ' 234' ' ' GLU . . . -82.55 145.77 29.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 63.43 111.071 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -129.76 135.77 48.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 73.1 110.852 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.429 HG23 ' HB ' ' D' ' 275' ' ' VAL . 6.3 p -130.84 121.7 50.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 73.25 111.075 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 240' ' ' GLN . . . . . 0.681 ' HB3' HD22 ' D' ' 276' ' ' LEU . 2.5 tm0? -109.12 137.25 47.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.472 . . . . 62.02 110.928 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.529 HD22 ' C ' ' D' ' 240' ' ' GLN . 3.5 mm? -122.72 118.61 28.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.12 110.913 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.41 177.85 15.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.769 -0.729 . . . . 70.1 112.509 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.82 149.36 23.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 64.43 110.927 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 244' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' D' ' 280' ' ' GLU . 17.3 m -124.94 132.49 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 40.1 111.14 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.83 129.41 75.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 74.42 111.075 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.3 t -70.09 174.89 4.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 70.45 111.105 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 247' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' C' ' 282' ' ' GLY . . . -59.34 -39.5 83.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 71.15 111.074 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.93 -52.05 66.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 75.35 111.046 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 73.02 111.18 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.889 0.376 . . . . 73.43 111.18 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.56 116.65 29.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 55.35 111.121 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 262' ' ' ASN . . . . . 0.532 ' OD1' HD12 ' E' ' 241' ' ' LEU . 0.5 OUTLIER -126.89 137.09 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 72.5 110.821 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.06 123.41 18.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 65.4 110.821 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.819 HG21 HG23 ' D' ' 267' ' ' VAL . 7.3 p -113.89 138.5 43.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 72.52 111.109 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 265' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' D' ' 229' ' ' LYS . 0.7 OUTLIER -81.48 -52.47 7.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 74.1 110.916 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 266' ' ' THR . . . . . 0.658 HG23 ' HB3' ' D' ' 230' ' ' ASP . 0.2 OUTLIER -150.96 129.35 12.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 73.32 111.099 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.819 HG23 HG21 ' D' ' 264' ' ' VAL . 1.2 t -118.35 130.62 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 74.22 111.183 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.49 127.75 69.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 63.52 111.146 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -131.06 133.94 7.5 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.763 -0.732 . . . . 65.25 112.473 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.1 148.89 52.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 70.24 110.916 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.34 89.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 71.43 112.468 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 43.75 59.69 2.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.887 0.375 . . . . 51.1 110.849 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 11.0 t -85.85 145.5 27.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 32.13 110.846 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.48 127.75 35.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 75.1 110.887 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 275' ' ' VAL . . . . . 0.448 HG22 ' CG1' ' E' ' 239' ' ' VAL . 57.9 t -131.87 123.18 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 75.42 111.096 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.4 OUTLIER -121.21 111.74 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 62.31 110.926 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.454 HG22 HD22 ' D' ' 226' ' ' ASN . 1.1 mt -107.88 110.96 33.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 71.44 111.136 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.08 174.7 13.47 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.777 -0.725 . . . . 71.05 112.49 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -89.87 144.91 25.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.358 . . . . 74.31 110.887 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 280' ' ' GLU . . . . . 0.475 ' HA ' HG23 ' D' ' 244' ' ' VAL . 15.8 pt-20 -113.87 131.73 56.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 74.43 110.874 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -116.83 125.85 52.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 75.43 110.933 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 127.14 150.32 7.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.767 -0.73 . . . . 72.13 112.453 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 58.33 173.56 0.42 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.769 -0.729 . . . . 73.04 112.456 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.04 31.66 5.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.349 . . . . 72.2 110.885 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -112.54 -119.46 3.68 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.805 -0.712 . . . . 72.14 112.5 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -163.4 119.51 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 75.1 110.893 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.137 -0.483 . . . . 73.4 110.938 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 225' ' ' ARG . . . . . 0.423 ' O ' HG23 ' E' ' 261' ' ' THR . 16.8 ptt-85 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.797 0.332 . . . . 75.12 110.918 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -83.52 123.97 30.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 71.43 110.833 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.58 144.52 48.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 70.23 110.872 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 228' ' ' ALA . . . . . 0.501 ' HB3' ' HA ' ' D' ' 264' ' ' VAL . . . -140.12 118.9 12.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 73.14 111.078 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 229' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' E' ' 265' ' ' GLU . 0.1 OUTLIER -79.09 -42.02 27.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 61.1 110.905 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -168.18 138.19 2.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 62.2 110.883 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 231' ' ' ILE . . . . . 0.768 HG21 HG21 ' E' ' 239' ' ' VAL . 10.8 mt -129.11 117.07 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 55.23 111.089 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -119.12 115.1 23.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 75.24 110.858 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.61 128.27 32.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 72.44 111.192 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.35 162.26 33.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.878 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.54 76.55 0.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 62.41 110.885 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 43.66 42.09 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.877 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.98 142.61 27.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 63.03 111.171 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -125.42 137.67 54.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 51.32 110.902 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.768 HG21 HG21 ' E' ' 231' ' ' ILE . 7.6 p -136.5 121.92 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 63.2 111.1 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -112.88 137.48 51.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.92 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.658 HD13 ' HB ' ' E' ' 277' ' ' ILE . 1.5 mm? -120.34 118.27 29.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 71.34 110.912 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 123.5 169.14 13.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.727 -0.749 . . . . 71.51 112.472 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.65 146.0 27.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.929 0.395 . . . . 75.24 110.849 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' E' ' 280' ' ' GLU . 24.3 m -111.83 139.72 34.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 65.04 111.153 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 45.3 t -120.98 129.58 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 73.34 111.115 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.2 t -69.04 175.07 3.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.114 -0.494 . . . . 63.11 111.172 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.1 -44.83 79.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 52.34 111.163 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.06 -52.17 66.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.5 111.068 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 74.13 111.118 179.942 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' E' E ' 261' ' ' THR . . . . . 0.423 HG23 ' O ' ' E' ' 225' ' ' ARG . 99.1 m . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.789 0.328 . . . . 54.33 111.173 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -124.63 119.6 29.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 42.24 110.956 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.76 120.1 30.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 74.42 110.852 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.4 p -111.52 137.4 44.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 53.25 111.09 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 265' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 3.4 tt0 -71.06 -95.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 73.43 110.852 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 93.8 m -119.8 126.2 50.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 72.42 111.167 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 267' ' ' VAL . . . . . 0.686 ' CG1' HG23 ' E' ' 231' ' ' ILE . 3.5 p -116.07 120.1 63.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 74.24 111.136 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 39.9 t -117.94 119.21 60.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 71.41 111.089 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.51 133.52 9.55 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 74.44 112.502 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.57 147.91 45.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 72.2 110.897 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.6 89.63 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 64.11 112.489 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 41.59 77.58 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 54.12 110.886 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 6.2 t -105.48 145.18 31.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 71.22 110.838 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.06 128.23 49.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 62.31 110.935 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.623 HG21 HG21 ' E' ' 267' ' ' VAL . 85.1 t -132.98 123.96 49.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.44 111.129 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.51 125.82 41.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 72.35 110.942 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.658 ' HB ' HD13 ' E' ' 241' ' ' LEU . 20.9 mm -112.18 124.85 69.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 75.33 111.138 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 113.82 -170.97 13.55 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.682 -0.771 . . . . 50.04 112.458 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -102.68 155.98 17.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 74.4 110.914 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 280' ' ' GLU . . . . . 0.408 ' HA ' HG22 ' E' ' 244' ' ' VAL . 5.4 pt-20 -121.81 132.67 54.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 74.33 110.856 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -115.35 125.16 52.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 64.51 110.868 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.718 -0.753 . . . . 73.1 112.455 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.594 ' CB ' HG22 ' A' ' 261' ' ' THR . 13.7 ttp85 . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.837 0.351 . . . . 72.54 110.863 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.429 HD22 ' N ' ' A' ' 242' ' ' GLY . 12.4 m-20 -83.95 111.64 19.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 73.32 110.872 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.77 150.72 41.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 45.54 110.826 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -144.0 119.1 10.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 72.23 111.122 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -76.05 -48.53 20.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 70.12 110.887 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -164.92 135.8 4.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 72.33 110.908 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.579 HG22 ' CG2' ' A' ' 267' ' ' VAL . 8.8 pt -139.3 134.36 40.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 41.54 111.154 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -130.93 138.54 49.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 75.34 110.853 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.708 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.5 OUTLIER -136.07 147.14 47.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 71.13 111.133 -179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -134.04 167.02 21.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 71.41 110.869 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.43 -70.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 74.52 110.927 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.38 66.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 75.15 110.879 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.708 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -102.7 157.5 16.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 64.14 111.145 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.25 139.02 50.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 63.51 110.856 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.463 HG21 HD12 ' A' ' 231' ' ' ILE . 4.2 p -122.28 121.65 64.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 72.33 111.09 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.04 116.01 29.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 61.12 110.919 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.1 mp -111.99 118.61 35.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 43.51 110.903 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.429 ' N ' HD22 ' A' ' 226' ' ' ASN . . . 141.32 160.79 8.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 52.31 112.476 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -85.77 134.75 33.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 62.24 110.835 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 17.8 m -106.69 133.63 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.476 . . . . 61.33 111.125 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 39.1 t -122.74 113.06 36.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 62.14 111.038 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 281' ' ' TYR . 5.3 t . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 70.44 111.177 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' THR . . . . . 0.516 HG21 ' HB3' ' B' ' 243' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.858 0.361 . . . . 75.01 111.15 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.594 HG22 ' CB ' ' A' ' 225' ' ' ARG . 0.9 OUTLIER -123.19 108.97 13.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 62.13 111.157 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -92.65 127.61 38.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 52.01 110.84 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.2 t -142.18 123.32 14.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 34.02 110.896 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.633 HG21 HG22 ' A' ' 267' ' ' VAL . 4.8 p -105.93 137.33 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.5 . . . . 52.21 111.175 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -88.74 -66.57 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 75.34 110.865 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 26.3 m -125.45 126.6 45.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 74.44 111.069 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 264' ' ' VAL . 41.3 t -117.69 131.3 70.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 72.23 111.139 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 30.2 t -127.15 115.31 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.134 -0.484 . . . . 62.3 111.167 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.76 132.82 11.25 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 72.1 112.465 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 134.41 45.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 65.43 110.921 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.44 85.36 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.76 -0.733 . . . . 55.31 112.523 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 47.74 79.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.892 0.377 . . . . 34.33 110.958 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.47 145.05 30.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 75.33 110.887 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -113.4 128.44 56.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.877 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.18 123.67 53.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 71.31 111.11 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.411 HD22 ' CE2' ' A' ' 287' ' ' TRP . 25.5 tp -128.15 111.54 13.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 72.2 110.942 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 73.6 mt -109.23 103.92 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 62.04 111.123 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.53 -159.02 28.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.796 -0.716 . . . . 63.31 112.498 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -128.21 156.28 43.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 65.32 110.894 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -115.26 134.71 54.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 70.01 110.883 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.465 ' O ' HG22 ' A' ' 246' ' ' THR . 17.2 m-85 -118.81 126.84 52.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 74.43 110.91 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.82 159.3 26.62 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.799 -0.715 . . . . 63.53 112.516 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.743 ' H ' ' HB2' ' B' ' 247' ' ' ALA . . . -68.07 -130.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.811 -0.709 . . . . 63.24 112.475 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.62 28.19 16.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.77 0.319 . . . . 74.22 110.904 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 92.5 152.38 28.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.783 -0.723 . . . . 73.04 112.504 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -67.47 -35.05 78.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 73.02 110.899 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.411 ' CE2' HD22 ' A' ' 276' ' ' LEU . 15.6 t90 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 75.22 110.96 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.665 ' HB3' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.845 0.355 . . . . 74.52 110.804 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.645 ' OD1' HG22 ' B' ' 277' ' ' ILE . 17.1 m-80 -109.24 119.25 38.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 73.24 110.962 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.63 148.87 51.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.866 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.612 ' HB2' HD21 ' B' ' 241' ' ' LEU . . . -139.26 119.92 14.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 62.54 111.16 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.07 -44.58 30.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 73.53 110.812 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -165.75 134.89 3.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 64.24 110.799 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.633 HD12 HG21 ' B' ' 239' ' ' VAL . 7.6 pt -140.17 133.67 34.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 75.22 111.153 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.92 136.72 42.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 75.12 110.819 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.729 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.5 OUTLIER -136.29 147.97 47.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 72.43 111.098 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -136.1 167.9 20.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 72.51 110.904 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.83 -71.47 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 71.14 110.861 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -179.3 62.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 75.15 110.937 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.729 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -102.3 157.19 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 71.33 111.115 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -129.85 135.26 48.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.829 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.633 HG21 HD12 ' B' ' 231' ' ' ILE . 6.4 p -122.93 129.57 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 75.02 111.151 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.564 ' HB3' HD12 ' B' ' 276' ' ' LEU . 8.8 tm0? -120.11 124.73 46.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 65.25 110.901 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.612 HD21 ' HB2' ' B' ' 228' ' ' ALA . 4.5 mt -111.74 118.88 36.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 74.32 110.929 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.88 176.44 14.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.704 -0.76 . . . . 51.2 112.46 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 243' ' ' ASN . . . . . 0.516 ' HB3' HG21 ' A' ' 260' ' ' THR . 2.0 p30 -85.92 134.06 33.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.373 . . . . 64.42 110.876 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 1.7 t -104.69 115.25 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 74.34 111.111 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 44.7 t -106.91 122.76 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 55.43 111.13 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.469 HG22 ' O ' ' B' ' 281' ' ' TYR . 14.5 t -96.14 163.26 13.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 71.11 111.19 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.743 ' HB2' ' H ' ' A' ' 283' ' ' GLY . . . -58.73 -33.88 70.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 75.1 111.107 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -35.99 69.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 62.41 111.088 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.5 ' HB2' ' CA ' ' B' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 64.31 111.134 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.881 0.372 . . . . 73.24 110.882 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.85 137.57 32.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 64.03 111.161 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.665 HG23 ' HB3' ' B' ' 225' ' ' ARG . 96.4 m -131.82 122.33 25.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.286 -0.415 . . . . 74.24 111.162 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.79 124.98 50.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 74.3 110.947 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.2 t -141.95 123.68 15.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 72.22 110.841 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.574 HG21 HG22 ' B' ' 267' ' ' VAL . 4.4 p -106.41 137.72 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.477 . . . . 72.53 111.207 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -85.52 -72.67 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 61.1 110.882 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 19.0 p -122.24 126.48 48.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 72.51 111.111 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.574 HG22 HG21 ' B' ' 264' ' ' VAL . 46.1 t -118.28 127.77 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 71.35 111.157 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 58.5 t -127.17 115.23 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 43.41 111.113 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.3 133.19 11.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.74 . . . . 41.41 112.478 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -130.54 139.54 50.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.831 0.348 . . . . 72.15 110.892 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.67 85.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 64.44 112.482 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 45.76 74.34 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 71.44 110.908 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.69 145.68 26.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 63.52 110.872 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 11.0 mtm-85 -113.68 128.17 56.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 74.43 110.912 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 36.1 t -130.17 123.31 55.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 71.51 111.085 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.589 HD23 ' CG ' ' C' ' 240' ' ' GLN . 14.5 tp -128.12 111.32 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 55.11 110.914 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.645 HG22 ' OD1' ' B' ' 226' ' ' ASN . 4.5 mp -107.91 104.55 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 71.24 111.074 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.76 -173.55 27.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.694 -0.765 . . . . 74.22 112.445 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -110.33 154.52 23.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.732 0.301 . . . . 74.12 110.96 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.423 ' HB3' HG13 ' C' ' 244' ' ' VAL . 13.8 tm-20 -111.94 137.22 50.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 74.13 110.881 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.469 ' O ' HG22 ' B' ' 246' ' ' THR . 0.2 OUTLIER -119.95 129.96 54.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 74.51 110.947 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.5 ' CA ' ' HB2' ' B' ' 249' ' ' ALA . . . 107.95 148.13 13.7 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.835 -0.698 . . . . 71.4 112.496 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 283' ' ' GLY . . . . . 0.59 ' H ' ' HB2' ' C' ' 247' ' ' ALA . . . -68.53 -132.4 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.743 -0.741 . . . . 54.4 112.5 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.7 tptp 62.11 35.54 15.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 75.41 110.865 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 74.89 141.71 0.79 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 75.14 112.464 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -75.44 111.26 10.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.85 0.357 . . . . 64.4 110.924 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.54 ' CE2' HD22 ' B' ' 276' ' ' LEU . 7.0 t90 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 73.31 110.877 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.64 ' HA ' HG23 ' C' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.795 0.331 . . . . 73.25 110.822 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -83.89 110.83 18.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 72.52 110.885 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.99 148.13 52.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 65.32 110.892 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' B' ' 264' ' ' VAL . . . -135.21 124.48 24.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 64.22 111.089 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -42.61 16.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.443 . . . . 62.01 110.892 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -166.32 133.89 2.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 72.44 110.839 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.612 HD12 HG11 ' C' ' 239' ' ' VAL . 6.4 pt -140.65 132.07 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 70.23 111.216 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -136.1 135.64 39.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 60.45 110.888 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.733 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.5 OUTLIER -136.67 150.82 48.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 70.11 111.146 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -139.9 168.7 19.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.33 110.931 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.68 -70.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.905 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -179.32 57.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 55.3 110.9 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.733 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -98.46 156.97 16.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 74.24 111.068 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -130.18 135.69 48.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.12 110.86 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.612 HG11 HD12 ' C' ' 231' ' ' ILE . 7.3 p -122.64 128.51 75.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.23 111.079 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.589 ' CG ' HD23 ' B' ' 276' ' ' LEU . 1.2 tm0? -121.14 125.55 47.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 60.23 110.926 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.634 HD13 ' HB ' ' C' ' 277' ' ' ILE . 3.8 mm? -111.59 118.76 36.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 73.54 110.897 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.07 175.38 13.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.633 -0.794 . . . . 61.13 112.448 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -90.45 153.82 20.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.34 . . . . 63.42 110.948 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' B' ' 280' ' ' GLU . 20.1 t -119.83 116.83 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 75.31 111.155 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 48.7 t -108.96 115.33 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 75.23 111.109 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 12.1 t -69.86 175.11 4.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 75.43 111.145 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.59 ' HB2' ' H ' ' B' ' 283' ' ' GLY . . . -55.31 -45.16 76.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 62.45 111.09 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.34 80.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 63.15 111.121 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 44.34 111.148 179.952 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.948 0.404 . . . . 71.02 110.911 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 260' ' ' THR . . . . . 0.506 HG23 ' CB ' ' D' ' 225' ' ' ARG . 5.1 m -65.56 125.03 23.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 62.41 111.117 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.64 HG23 ' HA ' ' C' ' 225' ' ' ARG . 29.0 m -96.15 108.81 21.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 73.33 111.071 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.8 124.23 38.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.478 . . . . 73.33 110.844 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.06 123.21 14.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 71.11 110.828 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.593 HG21 HG22 ' C' ' 267' ' ' VAL . 4.1 p -107.38 139.21 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.081 -0.509 . . . . 73.21 111.15 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -89.56 -65.21 1.04 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 72.03 110.913 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 1.7 p -129.8 126.93 39.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.479 . . . . 55.34 111.132 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.593 HG22 HG21 ' C' ' 264' ' ' VAL . 47.0 t -118.04 126.57 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 64.5 111.155 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 83.4 t -123.07 115.31 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 52.41 111.166 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.37 131.96 10.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.701 -0.761 . . . . 55.44 112.58 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.24 136.29 45.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.786 0.327 . . . . 62.42 110.944 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.56 83.51 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.749 -0.738 . . . . 62.32 112.452 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 46.59 69.99 0.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 74.14 110.929 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.24 145.38 24.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 71.51 110.894 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -113.31 128.4 56.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 73.11 110.84 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.48 HG21 HG11 ' C' ' 267' ' ' VAL . 77.1 t -129.14 121.98 55.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 73.24 111.129 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.465 ' O ' HD12 ' D' ' 241' ' ' LEU . 2.2 tp -128.86 111.17 12.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 43.25 110.906 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.634 ' HB ' HD13 ' C' ' 241' ' ' LEU . 2.7 mp -112.59 104.3 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 61.12 111.096 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.35 -179.46 27.07 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.653 -0.784 . . . . 70.1 112.451 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.34 156.08 18.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.316 . . . . 64.2 110.873 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.84 119.14 27.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 74.21 110.852 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -112.55 125.46 54.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 70.04 110.905 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.15 158.62 7.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 74.3 112.454 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -103.95 -161.85 24.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 71.05 112.503 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt 53.33 34.39 17.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 74.21 110.93 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 131.63 135.4 3.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.649 -0.786 . . . . 54.52 112.463 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -83.7 -26.18 30.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.348 . . . . 70.14 110.91 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.444 ' CE2' HD22 ' C' ' 276' ' ' LEU . 17.0 t90 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 73.13 110.919 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 225' ' ' ARG . . . . . 0.506 ' CB ' HG23 ' C' ' 260' ' ' THR . 11.4 mpt_? . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.841 0.353 . . . . 51.55 110.864 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 226' ' ' ASN . . . . . 0.543 ' OD1' HG22 ' D' ' 277' ' ' ILE . 9.9 m-20 -99.88 117.75 34.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 75.53 110.84 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.72 151.97 49.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 54.33 110.837 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -142.36 129.85 21.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 74.13 111.087 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.47 -42.22 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 75.23 110.92 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -166.73 134.92 2.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.11 110.814 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 231' ' ' ILE . . . . . 0.664 HD12 HG11 ' D' ' 239' ' ' VAL . 7.2 pt -141.02 133.01 29.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 73.11 111.117 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -135.7 136.45 40.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 64.21 110.894 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 233' ' ' THR . . . . . 0.665 ' CB ' ' HB3' ' D' ' 237' ' ' ALA . 0.4 OUTLIER -136.86 146.35 45.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 72.05 111.099 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -135.19 168.79 18.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 63.25 110.89 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.12 -72.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 64.31 110.859 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.91 59.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 74.31 110.837 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 237' ' ' ALA . . . . . 0.665 ' HB3' ' CB ' ' D' ' 233' ' ' THR . . . -99.89 157.17 16.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 55.34 111.06 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.61 135.72 46.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 70.44 110.85 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 239' ' ' VAL . . . . . 0.664 HG11 HD12 ' D' ' 231' ' ' ILE . 5.7 p -122.21 121.93 65.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 71.51 111.179 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -118.17 120.92 39.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.899 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 241' ' ' LEU . . . . . 0.465 HD12 ' O ' ' C' ' 276' ' ' LEU . 1.2 mp -112.59 118.8 36.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.947 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 242' ' ' GLY . . . . . 0.419 ' HA2' ' ND2' ' D' ' 226' ' ' ASN . . . 142.92 165.74 10.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.726 -0.749 . . . . 72.25 112.516 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.77 131.0 34.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 62.22 110.908 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 26.5 t -99.09 130.01 48.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 71.22 111.164 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.09 122.48 66.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 61.34 111.137 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.0 t -69.71 165.9 20.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.21 111.119 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.86 -36.38 62.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 53.33 111.16 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.96 -51.94 67.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 52.42 111.113 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 71.24 111.114 179.932 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.912 0.387 . . . . 74.3 111.128 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 94.3 m -108.47 129.17 55.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.218 -0.446 . . . . 71.24 111.208 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.11 127.28 53.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.43 110.873 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 25.7 p -142.53 123.66 14.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 64.21 110.833 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 264' ' ' VAL . . . . . 0.508 HG21 HG22 ' D' ' 267' ' ' VAL . 5.2 p -106.48 134.27 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 73.44 111.131 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -82.22 -77.14 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 72.45 110.849 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.61 126.88 53.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 75.23 111.19 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 267' ' ' VAL . . . . . 0.508 HG22 HG21 ' D' ' 264' ' ' VAL . 94.9 t -117.62 124.76 73.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 73.42 111.168 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.5 114.22 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 62.32 111.163 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.71 133.04 10.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.749 . . . . 75.0 112.456 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.04 143.05 49.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 72.21 110.874 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.96 84.82 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 73.22 112.458 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 45.75 69.65 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.36 . . . . 72.31 110.932 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.4 144.53 25.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 73.4 110.873 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.01 128.42 56.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 72.33 110.866 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 76.6 t -127.41 122.17 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 75.23 111.132 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 276' ' ' LEU . . . . . 0.513 HD13 ' CZ2' ' D' ' 287' ' ' TRP . 2.5 tp -128.56 111.46 13.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 61.52 110.89 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 277' ' ' ILE . . . . . 0.543 HG22 ' OD1' ' D' ' 226' ' ' ASN . 5.8 mt -112.42 104.13 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 63.53 111.098 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.78 -165.51 28.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.763 -0.732 . . . . 71.11 112.485 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -110.05 155.98 21.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.806 0.336 . . . . 71.3 110.899 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.02 131.5 53.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 72.24 110.842 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 281' ' ' TYR . . . . . 0.496 ' HE1' ' HB2' ' E' ' 249' ' ' ALA . 12.7 t80 -124.84 125.73 44.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.129 -0.487 . . . . 74.21 110.929 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 145.27 179.46 21.58 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 51.1 112.487 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -100.62 -149.05 23.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 65.11 112.49 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.51 26.12 13.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 74.3 110.906 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.46 -156.99 15.23 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.721 -0.752 . . . . 52.5 112.503 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 286' ' ' PHE . . . . . 0.606 ' HB3' HG11 ' E' ' 244' ' ' VAL . 27.5 m-85 -116.54 -28.07 6.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.873 0.368 . . . . 71.41 110.892 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 287' ' ' TRP . . . . . 0.513 ' CZ2' HD13 ' D' ' 276' ' ' LEU . 14.8 t90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 65.41 110.928 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.815 0.341 . . . . 74.44 110.886 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -86.55 113.26 22.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.879 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.87 139.35 53.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 55.15 110.831 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 228' ' ' ALA . . . . . 0.471 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -124.21 118.71 27.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 74.03 111.055 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 229' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' E' ' 265' ' ' GLU . 12.5 mttm -75.63 -45.62 36.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 71.21 110.911 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -168.35 135.97 2.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 65.14 110.841 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 231' ' ' ILE . . . . . 0.922 HD12 HG11 ' E' ' 239' ' ' VAL . 8.9 pt -138.16 134.42 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 73.43 111.113 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -135.86 132.7 36.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.908 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 233' ' ' THR . . . . . 0.679 ' OG1' ' HB3' ' E' ' 237' ' ' ALA . 0.5 OUTLIER -136.94 151.51 49.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.21 111.12 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.25 167.56 22.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.904 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 72.78 -69.95 0.18 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 73.41 110.9 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -178.5 63.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 72.41 110.869 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 237' ' ' ALA . . . . . 0.679 ' HB3' ' OG1' ' E' ' 233' ' ' THR . . . -105.86 156.3 18.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 63.33 111.074 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.15 135.61 47.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 72.32 110.889 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 239' ' ' VAL . . . . . 0.922 HG11 HD12 ' E' ' 231' ' ' ILE . 7.2 p -125.0 126.47 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 75.11 111.195 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 240' ' ' GLN . . . . . 0.575 ' C ' HD13 ' E' ' 241' ' ' LEU . 4.7 tm0? -122.71 123.05 40.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 71.2 110.834 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 241' ' ' LEU . . . . . 0.928 HD12 HD12 ' E' ' 277' ' ' ILE . 0.3 OUTLIER -111.85 118.7 36.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 74.42 110.914 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 134.56 169.32 11.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 73.3 112.52 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -85.87 145.41 27.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.849 0.357 . . . . 64.22 110.903 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 244' ' ' VAL . . . . . 0.606 HG11 ' HB3' ' D' ' 286' ' ' PHE . 21.6 t -110.99 135.33 50.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.11 111.118 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 23.4 t -122.12 128.54 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 73.03 111.136 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -69.95 174.96 4.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 74.05 111.141 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.32 94.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 73.45 111.138 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.12 76.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 72.45 111.132 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 249' ' ' ALA . . . . . 0.496 ' HB2' ' HE1' ' D' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 65.11 111.134 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 92.4 m . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.848 0.356 . . . . 44.12 111.09 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.24 119.01 33.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 74.51 110.877 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 98.7 p -133.19 133.24 42.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 74.45 110.871 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 1.2 p -104.46 153.44 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 74.5 111.112 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 265' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 1.6 tt0 -92.22 -51.0 5.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.42 110.902 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 1.4 m -154.43 145.16 22.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 60.24 111.122 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 267' ' ' VAL . . . . . 0.463 HG11 HG21 ' E' ' 275' ' ' VAL . 86.6 t -136.17 120.54 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 63.35 111.172 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 268' ' ' VAL . . . . . 0.451 ' O ' HG13 ' E' ' 268' ' ' VAL . 5.3 p -127.3 115.55 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 72.41 111.11 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.65 133.62 10.82 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.733 . . . . 52.15 112.456 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.57 144.5 44.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 62.52 110.913 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 42.27 76.14 0.12 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.722 -0.752 . . . . 54.04 112.522 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 64.04 116.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 64.03 110.877 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 12.1 m -146.41 145.25 30.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 71.51 110.802 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -114.62 127.69 55.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 71.01 110.86 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 275' ' ' VAL . . . . . 0.516 ' HB ' HG23 ' E' ' 239' ' ' VAL . 24.2 t -127.1 121.9 58.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 70.33 111.09 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.24 112.53 13.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.204 -0.453 . . . . 74.01 110.934 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 277' ' ' ILE . . . . . 0.928 HD12 HD12 ' E' ' 241' ' ' LEU . 55.9 mt -112.26 104.56 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 74.12 111.141 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.46 -154.1 25.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.678 -0.772 . . . . 22.43 112.472 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -122.61 156.1 34.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 65.35 110.88 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -116.4 128.97 55.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 72.22 110.896 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -121.85 126.01 47.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 74.43 110.905 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.705 -0.759 . . . . 51.52 112.448 179.966 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 9.3 ptt? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.848 0.356 . . . . 75.03 110.85 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 16.6 mttt 62.04 98.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 72.51 110.901 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.5 mm -123.65 130.54 74.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.434 . . . . 52.45 111.168 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -166.99 157.44 11.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 75.35 110.892 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.578 ' HB1' HD12 ' A' ' 222' ' ' ILE . . . -136.44 122.34 20.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 63.04 111.111 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.67 HG12 HG22 ' B' ' 223' ' ' VAL . 3.9 mp 57.14 67.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 73.22 111.117 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 93.5 t -149.88 125.37 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 70.33 111.127 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -53.15 147.46 16.52 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 33.03 112.491 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.503 ' HB3' HG23 ' A' ' 261' ' ' THR . 1.6 tmm_? -166.44 99.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.354 . . . . 64.53 110.899 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -83.94 114.16 21.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 62.22 110.858 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 2.6 m -133.97 144.42 48.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 64.34 110.853 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.86 ' HB1' HD11 ' A' ' 231' ' ' ILE . . . -129.05 127.27 41.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 73.24 111.076 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -42.96 37.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 73.43 110.952 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -164.99 138.34 4.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 63.23 110.906 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.86 HD11 ' HB1' ' A' ' 228' ' ' ALA . 3.1 mp -138.43 117.14 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 75.35 111.113 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.724 ' HD2' HG22 ' A' ' 268' ' ' VAL . 7.6 ptp85 -113.59 123.31 49.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 72.44 110.874 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.8 p -135.4 141.74 45.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 72.32 111.175 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.6 pm0 -149.2 167.69 25.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.4 110.886 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 68.56 68.85 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 75.21 110.89 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 47.43 55.68 7.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 65.24 110.844 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.4 156.78 17.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 44.43 111.064 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -125.79 142.77 51.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 73.15 110.896 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.482 HG23 ' CG1' ' A' ' 275' ' ' VAL . 5.4 p -142.99 131.28 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 61.0 111.127 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -138.02 137.26 37.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 73.13 110.89 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.604 HD12 HG13 ' A' ' 277' ' ' ILE . 0.3 OUTLIER -114.69 118.23 33.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.454 . . . . 62.43 110.876 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 146.67 -176.74 25.41 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.701 -0.761 . . . . 61.23 112.481 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -85.92 140.38 30.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.903 0.382 . . . . 64.0 110.882 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.49 ' CG2' HD11 ' A' ' 276' ' ' LEU . 30.1 t -111.82 115.33 49.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 75.33 111.146 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 64.7 t -103.96 128.84 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.41 111.136 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.6 m -98.0 162.97 12.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 72.24 111.121 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.88 98.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 73.32 111.077 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' A' ' 284' ' ' LYS . . . -59.01 -36.21 74.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 74.45 111.075 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.508 ' HB2' ' HA2' ' A' ' 282' ' ' GLY . . . -87.54 51.1 2.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 62.31 111.124 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.25 -177.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 64.23 110.921 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.65 -170.09 2.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 62.03 110.859 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -68.79 86.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 74.2 112.468 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -88.82 -40.0 6.4 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.75 -0.738 . . . . 51.3 112.446 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 24.7 mt 65.33 151.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.799 0.333 . . . . 74.31 111.178 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.35 101.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 75.51 110.904 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.596 HG21 ' HE2' ' A' ' 281' ' ' TYR . 5.3 mp -130.75 -40.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 62.04 111.168 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.24 -73.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 75.53 110.879 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 57.61 93.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 71.03 110.885 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -130.86 -40.41 1.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 62.25 110.938 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 15.4 t -82.16 135.25 35.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 72.31 111.115 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.503 HG23 ' HB3' ' A' ' 225' ' ' ARG . 84.7 m -92.03 120.36 32.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 64.53 111.157 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -101.75 119.52 38.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 74.34 110.931 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 17.6 t -142.06 123.98 15.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.43 110.806 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.548 HG21 HG22 ' A' ' 267' ' ' VAL . 8.9 p -110.75 137.77 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 73.34 111.107 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.44 -76.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 73.04 110.857 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 17.5 p -129.41 129.5 44.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 63.14 111.136 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.716 ' HB ' HG23 ' A' ' 231' ' ' ILE . 19.3 t -118.39 120.75 65.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 74.13 111.11 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.724 HG22 ' HD2' ' A' ' 232' ' ' ARG . 26.0 t -111.32 126.49 68.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 60.41 111.1 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.75 132.94 8.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.743 -0.741 . . . . 71.54 112.466 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.73 147.41 52.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.832 0.348 . . . . 73.25 110.87 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 59.66 71.76 0.72 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.713 -0.756 . . . . 63.43 112.451 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 50.06 61.05 3.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.886 0.374 . . . . 72.31 110.868 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 15.9 t -85.99 147.99 25.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 73.15 110.841 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -110.57 128.67 55.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 72.42 110.854 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.687 HG11 HG21 ' A' ' 231' ' ' ILE . 92.2 t -115.59 123.03 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 52.24 111.125 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.49 HD11 ' CG2' ' A' ' 244' ' ' VAL . 0.2 OUTLIER -128.53 111.74 13.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 64.42 110.888 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.604 HG13 HD12 ' A' ' 241' ' ' LEU . 18.1 mm -106.35 104.35 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 62.21 111.115 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.3 179.76 17.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.731 . . . . 75.32 112.48 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -89.84 156.04 18.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 73.41 110.879 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -130.31 140.29 50.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 71.12 110.868 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.596 ' HE2' HG21 ' A' ' 256' ' ' ILE . 7.1 m-85 -119.24 126.01 50.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 73.42 110.9 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.508 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 161.08 142.55 3.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.731 . . . . 23.1 112.494 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.27 -18.83 10.62 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.733 -0.746 . . . . 64.34 112.491 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 248' ' ' ALA . 0.5 OUTLIER -72.4 79.33 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 70.34 110.888 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 67.22 112.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.768 -0.73 . . . . 64.52 112.483 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -52.32 111.52 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 72.11 110.877 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 3.1 t90 72.16 -69.19 0.19 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.486 . . . . 70.23 110.931 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -172.95 83.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.288 -0.414 . . . . 74.24 110.895 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.84 163.1 17.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 63.34 110.893 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -167.08 30.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 74.11 110.834 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -58.57 176.3 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 72.45 110.848 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -163.82 -41.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 71.44 110.898 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -52.41 141.79 18.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 64.32 110.868 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -121.34 130.88 53.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 72.12 110.847 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 62.53 110.849 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.839 0.352 . . . . 52.33 110.86 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.78 -58.41 1.9 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 74.23 110.892 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 219' ' ' ILE . . . . . 0.435 HD13 ' HB2' ' C' ' 220' ' ' ASP . 13.1 tt -150.72 148.78 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 72.3 111.124 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -133.18 -175.75 3.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 71.24 110.876 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.13 130.63 46.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 70.43 111.111 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 2.2 pp -139.09 148.65 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 74.13 111.13 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.67 HG22 HG12 ' A' ' 222' ' ' ILE . 36.0 m -123.58 132.97 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 62.15 111.098 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 67.44 119.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.786 -0.721 . . . . 64.24 112.477 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.499 ' HB3' HG23 ' B' ' 261' ' ' THR . 4.5 ttm-85 -158.7 110.39 2.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.341 . . . . 74.34 110.919 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.696 ' HB3' HG22 ' B' ' 277' ' ' ILE . 1.2 m-20 -105.09 114.23 28.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 72.21 110.927 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.68 143.68 48.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 73.04 110.86 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.09 136.73 53.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 54.15 111.116 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.13 -36.28 16.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 64.21 110.927 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ASP . . . . . 0.497 ' HB3' HG23 ' B' ' 266' ' ' THR . 26.6 t70 -165.12 137.74 4.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 72.14 110.848 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.593 HG21 HG11 ' B' ' 275' ' ' VAL . 7.7 mt -138.43 117.88 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 55.0 111.134 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -111.53 125.14 53.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 63.15 110.891 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 4.8 p -135.26 134.83 40.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.476 . . . . 72.05 111.148 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -150.94 167.4 27.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 74.3 110.92 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 66.98 64.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.864 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 77.9 mtm-85 50.46 55.34 9.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 71.31 110.869 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.04 156.57 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 64.4 111.126 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.27 140.79 52.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.87 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.556 HG23 ' HB ' ' B' ' 275' ' ' VAL . 3.0 p -132.62 130.43 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 72.02 111.139 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.714 ' C ' HD13 ' B' ' 241' ' ' LEU . 1.8 tm0? -136.6 130.85 32.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 72.05 110.956 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.714 HD13 ' C ' ' B' ' 240' ' ' GLN . 0.1 OUTLIER -118.54 117.9 30.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 72.44 110.973 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.56 175.85 23.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 34.55 112.508 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.88 128.87 34.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.836 0.35 . . . . 73.12 110.925 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -97.15 126.17 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 71.05 111.154 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.453 HG21 ' CZ ' ' A' ' 281' ' ' TYR . 93.4 t -122.11 112.89 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 61.04 111.111 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.457 HG23 ' O ' ' B' ' 281' ' ' TYR . 78.1 p -76.84 170.28 16.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 74.42 111.115 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.75 81.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 64.34 111.13 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.67 77.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 62.44 111.131 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.96 -30.22 23.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 60.42 111.101 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.0 133.02 51.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 74.14 110.933 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 59.2 t60 61.19 86.37 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 73.12 110.854 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 177.12 -117.86 0.61 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 60.5 112.537 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -154.77 126.27 1.85 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.785 -0.722 . . . . 60.24 112.491 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.95 -60.17 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 72.14 111.108 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -56.23 102.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 73.42 110.884 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.84 39.22 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 71.3 111.15 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 23.3 t 58.95 66.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 52.24 110.841 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.92 152.83 34.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 74.55 110.854 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 259' ' ' GLN . . . . . 0.644 ' HG3' HG12 ' B' ' 223' ' ' VAL . 2.0 tm0? -170.82 48.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 73.15 110.908 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 15.1 t -100.77 137.27 39.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 71.13 111.119 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.931 HG21 HD12 ' C' ' 219' ' ' ILE . 23.7 m -98.45 110.76 23.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 71.11 111.172 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.44 ' ND2' ' HA2' ' C' ' 242' ' ' GLY . 70.9 m-80 -93.21 119.56 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 71.23 110.886 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 24.8 p -142.17 123.68 14.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 61.01 110.857 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.506 HG21 ' CG2' ' B' ' 267' ' ' VAL . 7.4 p -112.35 137.45 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 60.24 111.128 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.05 -76.78 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 60.53 110.849 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.497 HG23 ' HB3' ' B' ' 230' ' ' ASP . 1.2 m -133.71 130.69 38.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 74.04 111.127 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.506 ' CG2' HG21 ' B' ' 264' ' ' VAL . 21.7 t -118.52 120.53 64.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 73.3 111.148 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 30.4 t -105.04 121.41 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 63.25 111.11 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.47 132.94 10.61 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 52.54 112.449 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.95 147.3 52.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.351 . . . . 74.21 110.895 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.02 78.66 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 73.51 112.461 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 49.68 73.48 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.845 0.355 . . . . 73.35 110.907 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 14.8 t -96.66 147.84 23.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 74.34 110.881 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 24.2 mtm-85 -113.8 128.27 56.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 65.14 110.893 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.593 HG11 HG21 ' B' ' 231' ' ' ILE . 84.6 t -115.75 122.96 70.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 74.4 111.171 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.489 HD23 ' HZ2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -129.59 112.61 13.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 74.23 110.917 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 1.091 HD13 HD23 ' C' ' 241' ' ' LEU . 27.1 mm -109.44 103.98 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 70.01 111.145 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.16 -178.39 19.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 71.14 112.479 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -89.85 156.09 18.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.78 0.324 . . . . 71.2 110.858 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -126.8 139.1 53.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 72.34 110.862 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.457 ' O ' HG23 ' B' ' 246' ' ' THR . 2.0 t80 -120.9 125.87 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 74.24 110.913 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 161.76 149.91 5.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.734 -0.746 . . . . 61.04 112.517 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -105.25 -29.84 4.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 75.12 112.505 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -69.68 86.22 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 73.31 110.902 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 69.65 133.13 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.764 -0.731 . . . . 60.03 112.494 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -77.37 89.54 3.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.379 . . . . 64.32 110.858 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.489 ' HZ2' HD23 ' B' ' 276' ' ' LEU . 4.9 t90 71.51 -69.66 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 73.52 110.956 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.81 -175.49 2.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 75.04 110.834 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -88.43 153.61 21.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 75.33 110.888 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -173.65 125.48 0.38 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 72.54 110.859 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.74 158.3 37.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 65.14 110.869 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.16 176.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 73.01 110.851 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.62 154.87 20.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 73.44 110.855 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -119.94 -176.14 3.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 74.24 110.877 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 74.31 110.892 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 217' ' ' MET . . . . . 0.417 ' CG ' HG22 ' D' ' 219' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.824 0.345 . . . . 72.12 110.923 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 4.1 tptt 59.37 34.45 22.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 72.24 110.886 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.931 HD12 HG21 ' B' ' 261' ' ' THR . 20.6 tt -152.86 144.34 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 75.13 111.096 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 220' ' ' ASP . . . . . 0.435 ' HB2' HD13 ' B' ' 219' ' ' ILE . 26.2 t0 -103.79 -30.65 10.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 72.23 110.894 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.43 151.18 7.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 25.13 111.096 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 20.2 pt -136.04 28.1 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 60.14 111.109 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 7.7 p -158.85 125.0 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 54.33 111.131 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.43 102.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.694 -0.765 . . . . 72.42 112.474 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.568 ' N ' HG23 ' C' ' 261' ' ' THR . 0.4 OUTLIER -178.56 123.62 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.351 . . . . 74.24 110.88 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.678 ' HB3' HG22 ' C' ' 277' ' ' ILE . 0.7 OUTLIER -83.85 116.78 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 75.12 110.872 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.93 146.36 51.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 41.0 110.866 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.22 134.87 48.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 74.01 111.093 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.73 -34.66 21.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 64.4 110.887 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 230' ' ' ASP . . . . . 0.618 ' HB3' HG23 ' C' ' 266' ' ' THR . 4.4 t70 -165.52 137.57 4.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 64.02 110.885 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.537 HG21 HG11 ' C' ' 275' ' ' VAL . 8.7 mt -138.36 121.19 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 71.44 111.14 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 21.9 ttm-85 -111.57 125.5 54.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.814 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 3.8 p -135.1 131.74 37.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 74.34 111.157 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -147.82 167.77 23.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 74.11 110.836 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 63.36 72.71 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 75.43 110.898 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? 47.29 40.32 10.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 75.44 110.882 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.28 156.1 18.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 50.42 111.091 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -134.57 144.09 47.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 63.43 110.87 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.508 HG23 ' CG1' ' C' ' 275' ' ' VAL . 3.5 p -130.66 121.88 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 74.52 111.15 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.719 ' C ' HD13 ' C' ' 241' ' ' LEU . 2.5 tm0? -124.81 126.68 45.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 71.53 110.938 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 1.091 HD23 HD13 ' B' ' 277' ' ' ILE . 0.1 OUTLIER -117.35 117.43 29.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 74.53 110.911 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.44 ' HA2' ' ND2' ' B' ' 262' ' ' ASN . . . 153.35 176.23 25.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.771 -0.728 . . . . 61.32 112.519 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -85.89 128.75 34.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 62.03 110.911 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.91 128.18 46.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 75.22 111.088 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.44 113.43 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 52.52 111.129 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 23.3 p -69.67 169.03 13.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 75.31 111.115 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.17 93.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 71.33 111.043 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.06 82.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 63.05 111.075 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.82 107.16 0.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 63.12 111.08 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 8.3 mt -138.29 -50.26 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 64.21 110.905 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 251' ' ' HIS . . . . . 0.512 ' ND1' HD11 ' D' ' 250' ' ' LEU . 0.1 OUTLIER -54.14 129.07 33.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 73.12 110.894 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 149.74 93.9 0.11 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.734 . . . . 61.03 112.497 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -67.67 -144.59 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 65.24 112.499 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 13.6 tt -122.34 133.5 68.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.795 0.331 . . . . 72.41 111.164 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.55 -178.35 4.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 64.44 110.871 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 1.2 tt -152.59 132.66 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 74.31 111.18 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.49 -175.01 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 75.11 110.883 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -59.13 178.99 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.151 -0.477 . . . . 74.23 110.88 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -176.45 160.89 2.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 53.31 110.922 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 260' ' ' THR . . . . . 0.675 HG21 ' HB3' ' D' ' 243' ' ' ASN . 8.6 t -70.87 131.45 43.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 61.02 111.15 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.568 HG23 ' N ' ' C' ' 225' ' ' ARG . 0.2 OUTLIER -101.41 139.66 36.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 73.32 111.166 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -124.5 128.65 49.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 64.54 110.836 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 5.5 p -141.56 123.77 15.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 75.24 110.887 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.494 HG21 ' CG2' ' C' ' 267' ' ' VAL . 7.5 p -111.27 137.65 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 74.25 111.132 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.58 -76.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.167 -0.469 . . . . 73.45 110.908 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 266' ' ' THR . . . . . 0.618 HG23 ' HB3' ' C' ' 230' ' ' ASP . 0.2 OUTLIER -130.72 130.53 43.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 44.43 111.144 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.494 ' CG2' HG21 ' C' ' 264' ' ' VAL . 19.5 t -118.64 129.6 74.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 75.15 111.146 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.68 119.06 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 52.33 111.149 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.39 132.47 10.34 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.767 -0.73 . . . . 52.33 112.488 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -134.05 147.58 50.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.361 . . . . 71.21 110.871 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.39 87.2 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.717 -0.754 . . . . 45.02 112.482 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 45.66 64.4 1.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 74.51 110.915 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 4.1 t -88.27 145.78 25.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 60.44 110.871 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 4.0 mtm-85 -117.45 127.8 54.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.505 . . . . 71.22 110.851 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.537 HG11 HG21 ' C' ' 231' ' ' ILE . 83.9 t -116.13 123.5 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.42 111.108 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.532 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.3 OUTLIER -128.5 113.65 15.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 73.01 110.861 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 1.026 HD13 HD23 ' D' ' 241' ' ' LEU . 24.7 mm -112.14 104.41 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 73.04 111.132 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.36 -175.08 22.19 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.753 . . . . 72.53 112.512 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -94.47 156.22 16.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.846 0.355 . . . . 72.14 110.861 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.407 ' CG ' HG13 ' D' ' 244' ' ' VAL . 6.7 pt-20 -126.8 138.04 53.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 72.24 110.887 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -120.63 125.11 46.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.472 . . . . 75.12 110.923 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 164.84 147.7 5.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.752 -0.737 . . . . 73.23 112.503 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -80.77 -48.99 5.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.749 -0.739 . . . . 73.41 112.509 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -51.67 103.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.357 . . . . 65.44 110.868 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 53.69 -147.36 19.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 53.43 112.473 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -122.35 -35.31 3.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 64.14 110.859 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.532 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 13.2 t90 -163.78 -47.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 72.51 110.891 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.88 116.02 18.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 64.4 110.882 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 289' ' ' ASN . . . . . 0.409 ' ND2' ' H ' ' C' ' 289' ' ' ASN . 2.5 p30 -69.29 88.14 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 70.34 110.882 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -125.96 -66.96 0.9 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 65.44 110.845 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.46 177.6 4.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 74.45 110.878 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 62.79 163.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 71.14 110.823 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -168.59 -171.9 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 70.54 110.85 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -70.69 170.29 12.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 71.42 110.867 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 73.12 110.866 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.826 0.346 . . . . 63.0 110.853 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.77 120.69 23.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 73.14 110.88 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 219' ' ' ILE . . . . . 0.417 HG22 ' CG ' ' C' ' 217' ' ' MET . 3.1 pt -118.1 41.82 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 52.11 111.137 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -128.12 105.47 8.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 65.31 110.833 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -166.35 176.39 7.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 72.44 111.069 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 23.4 pt -72.47 172.5 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 72.33 111.155 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 61.3 t -85.27 -59.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.474 . . . . 75.44 111.142 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 132.27 -168.75 22.47 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.701 -0.761 . . . . 74.14 112.477 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.569 ' HA ' HG23 ' D' ' 261' ' ' THR . 0.0 OUTLIER -79.84 -74.56 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.808 0.337 . . . . 74.25 110.856 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 226' ' ' ASN . . . . . 0.749 ' HB3' HG22 ' D' ' 277' ' ' ILE . 2.0 m120 -84.31 114.52 21.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 63.44 110.911 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 3.8 t -134.5 142.71 47.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.41 110.809 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 228' ' ' ALA . . . . . 0.583 ' CB ' HD11 ' D' ' 231' ' ' ILE . . . -129.29 119.99 24.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.505 . . . . 50.24 111.1 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -34.42 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 63.14 110.892 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -166.12 137.51 3.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 61.52 110.865 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 231' ' ' ILE . . . . . 0.583 HD11 ' CB ' ' D' ' 228' ' ' ALA . 6.3 mt -138.58 121.69 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 71.43 111.151 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -111.45 126.15 54.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 74.12 110.843 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 233' ' ' THR . . . . . 0.439 HG21 ' HB ' ' D' ' 239' ' ' VAL . 5.8 p -135.16 130.57 35.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 61.21 111.141 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -146.44 166.84 25.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 71.34 110.9 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 64.99 71.05 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 74.23 110.925 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.33 34.88 4.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 75.34 110.893 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.89 154.21 23.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 71.44 111.13 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.49 144.43 51.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 74.32 110.899 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.522 HG23 ' CG1' ' D' ' 275' ' ' VAL . 6.0 p -131.51 121.91 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 62.31 111.11 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 240' ' ' GLN . . . . . 0.694 ' C ' HD13 ' D' ' 241' ' ' LEU . 2.4 tm0? -125.58 125.78 43.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 74.11 110.915 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 1.026 HD23 HD13 ' C' ' 277' ' ' ILE . 0.1 OUTLIER -117.51 118.01 31.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 61.15 110.872 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.01 179.48 26.78 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.752 . . . . 25.21 112.454 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 243' ' ' ASN . . . . . 0.675 ' HB3' HG21 ' C' ' 260' ' ' THR . 6.6 p30 -86.02 133.54 33.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.902 0.382 . . . . 64.15 110.88 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 244' ' ' VAL . . . . . 0.407 HG13 ' CG ' ' C' ' 280' ' ' GLU . 19.9 t -103.67 114.95 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 72.11 111.137 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 245' ' ' VAL . . . . . 0.448 HG11 HD11 ' D' ' 254' ' ' ILE . 21.8 t -110.76 120.7 62.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 71.41 111.168 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 9.6 p -76.56 167.17 22.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.14 111.125 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.26 79.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 72.43 111.109 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.38 -38.25 73.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 55.41 111.046 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.64 103.88 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 54.44 111.101 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 250' ' ' LEU . . . . . 0.512 HD11 ' ND1' ' C' ' 251' ' ' HIS . 1.4 tp -114.26 -169.96 1.63 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 65.52 110.887 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -64.18 104.24 0.72 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 64.31 110.889 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 176.17 38.14 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.796 -0.716 . . . . 51.41 112.521 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 102.78 24.16 8.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 24.42 112.473 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 254' ' ' ILE . . . . . 0.448 HD11 HG11 ' D' ' 245' ' ' VAL . 16.9 tt -52.95 -31.73 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 61.54 111.112 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -77.05 80.73 3.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 72.23 110.893 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 1.3 tt -56.73 -26.23 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 64.2 111.137 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 1.4 m 62.03 -174.32 0.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.839 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -78.97 133.2 36.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 73.42 110.855 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 259' ' ' GLN . . . . . 0.522 ' HB2' HD12 ' E' ' 256' ' ' ILE . 1.2 tm0? -146.97 -73.54 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 63.32 110.935 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 14.3 t -100.04 138.08 37.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 64.12 111.121 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 261' ' ' THR . . . . . 0.569 HG23 ' HA ' ' D' ' 225' ' ' ARG . 26.8 m -106.68 108.85 20.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 63.3 111.166 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 262' ' ' ASN . . . . . 0.409 HD22 ' N ' ' D' ' 263' ' ' SER . 0.1 OUTLIER -100.02 130.53 46.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 72.35 110.885 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 263' ' ' SER . . . . . 0.409 ' N ' HD22 ' D' ' 262' ' ' ASN . 5.5 t -140.95 123.76 16.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 42.43 110.867 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.616 HG21 HG22 ' D' ' 267' ' ' VAL . 7.9 p -108.26 141.34 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 65.42 111.126 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -81.07 -76.65 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 75.23 110.9 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.49 128.26 46.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 61.41 111.192 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.616 HG22 HG21 ' D' ' 264' ' ' VAL . 17.8 t -118.5 135.05 60.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 73.2 111.126 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 50.7 t -126.41 126.32 68.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.145 -0.479 . . . . 40.51 111.109 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.07 132.42 8.08 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.729 -0.748 . . . . 70.03 112.504 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -133.51 147.3 51.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.828 0.346 . . . . 64.44 110.931 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.19 89.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 75.15 112.469 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 44.06 59.73 3.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 75.35 110.895 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 17.1 t -83.84 145.41 28.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 40.04 110.861 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -118.1 128.09 54.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 75.55 110.883 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.542 HG11 HG21 ' D' ' 231' ' ' ILE . 92.0 t -119.44 122.02 67.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 71.24 111.135 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.451 HD21 ' OE1' ' D' ' 240' ' ' GLN . 0.2 OUTLIER -129.77 112.11 13.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 71.02 110.949 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.749 HG22 ' HB3' ' D' ' 226' ' ' ASN . 28.3 mm -112.68 104.34 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 71.23 111.106 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.6 -174.24 26.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.678 -0.772 . . . . 75.05 112.509 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -100.37 156.11 17.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.332 . . . . 61.34 110.889 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 280' ' ' GLU . . . . . 0.543 ' CD ' HG13 ' E' ' 244' ' ' VAL . 2.1 pt-20 -121.72 118.9 30.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 64.44 110.905 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 281' ' ' TYR . . . . . 0.492 ' OH ' ' HB2' ' E' ' 249' ' ' ALA . 17.9 t80 -112.42 136.66 51.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 60.01 110.918 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 135.67 175.71 13.98 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 51.32 112.475 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 283' ' ' GLY . . . . . 0.617 ' CA ' ' HB2' ' E' ' 247' ' ' ALA . . . -107.89 107.69 2.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 62.33 112.463 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -166.07 28.05 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 64.04 110.889 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 76.39 -66.48 2.63 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.76 -0.733 . . . . 42.52 112.479 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 286' ' ' PHE . . . . . 0.734 ' CE1' HG21 ' E' ' 244' ' ' VAL . 59.8 t80 -174.98 156.74 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 62.32 110.866 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -48.96 -74.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 72.45 110.903 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -144.9 124.25 13.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 70.54 110.894 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -155.52 161.96 40.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 74.14 110.857 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -62.62 -64.84 0.8 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.481 . . . . 70.33 110.854 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -179.17 -176.6 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 73.31 110.856 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -64.19 -169.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 75.53 110.873 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -74.91 144.47 43.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 73.2 110.844 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -108.75 -170.7 1.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 75.32 110.836 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 72.3 110.855 -179.987 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 7.5 ptt? . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.857 0.361 . . . . 73.31 110.869 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.16 88.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 44.24 110.903 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 51.4 mt -147.02 145.0 19.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 74.22 111.17 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -161.25 107.43 1.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 73.41 110.855 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.78 123.97 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 73.03 111.153 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -58.69 123.9 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 64.45 111.115 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 6.3 m -152.82 121.8 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 71.24 111.123 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -71.05 -130.39 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 72.02 112.481 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 63.27 -169.07 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.844 0.354 . . . . 54.12 110.884 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 226' ' ' ASN . . . . . 0.642 ' HB3' HG22 ' E' ' 277' ' ' ILE . 5.2 m120 -83.78 113.72 21.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 71.43 110.9 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 73.3 m -131.05 144.74 51.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 72.15 110.864 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 228' ' ' ALA . . . . . 0.489 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -125.78 134.63 51.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 74.34 111.086 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.13 -37.1 16.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 64.12 110.881 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -164.98 136.98 4.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 71.21 110.876 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 231' ' ' ILE . . . . . 0.494 HG21 HG11 ' E' ' 275' ' ' VAL . 9.8 mt -138.78 119.65 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 63.02 111.171 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -111.23 124.88 53.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 62.43 110.884 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 8.4 p -135.07 132.9 38.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 73.31 111.127 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -152.8 166.6 31.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.21 110.927 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 65.14 69.42 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 74.4 110.907 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.47 53.67 12.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 75.03 110.888 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.66 155.91 18.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 41.44 111.119 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 -131.3 135.94 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 50.3 110.847 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.549 HG23 ' HB ' ' E' ' 275' ' ' VAL . 4.0 p -125.99 129.71 72.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 73.31 111.175 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -137.62 135.66 36.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 53.31 110.912 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' D' ' 277' ' ' ILE . 2.0 mp -129.99 118.54 21.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.35 110.918 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 155.25 176.64 27.68 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 54.4 112.505 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -88.95 128.66 35.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 62.54 110.914 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.734 HG21 ' CE1' ' D' ' 286' ' ' PHE . 93.1 t -98.75 123.1 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 60.04 111.14 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 245' ' ' VAL . . . . . 0.493 HG13 ' HD2' ' E' ' 281' ' ' TYR . 21.8 t -122.17 117.14 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 65.2 111.134 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.9 t -68.11 174.98 3.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 62.42 111.117 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 247' ' ' ALA . . . . . 0.617 ' HB2' ' CA ' ' D' ' 283' ' ' GLY . . . -61.05 -32.3 71.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.453 . . . . 74.41 111.081 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.12 -35.25 61.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 54.32 111.137 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 249' ' ' ALA . . . . . 0.492 ' HB2' ' OH ' ' D' ' 281' ' ' TYR . . . 64.84 153.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 60.42 111.088 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.09 109.34 2.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.444 . . . . 71.23 110.927 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -65.02 124.53 22.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 64.42 110.862 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 62.57 -147.74 49.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 44.12 112.472 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 60.23 69.83 1.18 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 75.23 112.514 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 69.0 mt -54.54 -26.76 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.342 . . . . 55.14 111.145 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.37 115.09 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.21 110.877 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 256' ' ' ILE . . . . . 0.522 HD12 ' HB2' ' D' ' 259' ' ' GLN . 1.2 pt -119.79 71.73 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 73.24 111.107 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 1.5 m -105.56 143.16 34.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 72.44 110.874 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.01 158.23 13.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.095 -0.502 . . . . 70.43 110.853 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -142.95 -65.03 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.928 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 5.8 t -70.71 137.85 50.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 52.42 111.103 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 90.6 m -111.86 130.84 55.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 73.54 111.151 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -126.16 134.41 51.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 74.22 110.866 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.86 123.93 15.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 45.33 110.871 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 264' ' ' VAL . . . . . 0.538 HG21 ' CG2' ' E' ' 267' ' ' VAL . 11.4 p -108.2 140.72 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 62.35 111.129 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -81.16 -76.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 72.13 110.903 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.6 m -138.03 129.49 27.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 64.34 111.139 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 267' ' ' VAL . . . . . 0.538 ' CG2' HG21 ' E' ' 264' ' ' VAL . 23.7 t -118.14 120.5 64.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 74.41 111.108 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 52.0 t -104.64 115.82 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 54.13 111.157 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.93 132.58 11.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.743 . . . . 23.24 112.462 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.25 144.25 49.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 74.15 110.943 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.42 87.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.73 . . . . 75.41 112.481 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 48.86 74.84 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 50.33 110.865 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 36.7 t -100.79 145.8 28.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 60.45 110.826 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.66 128.66 54.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 73.2 110.847 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.549 ' HB ' HG23 ' E' ' 239' ' ' VAL . 87.5 t -117.7 122.68 70.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 75.2 111.144 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.442 HD21 ' HZ ' ' D' ' 286' ' ' PHE . 0.4 OUTLIER -129.05 111.72 13.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.942 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.642 HG22 ' HB3' ' E' ' 226' ' ' ASN . 37.2 mm -113.39 104.31 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 61.51 111.091 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 138.89 -172.72 22.98 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.713 -0.756 . . . . 73.43 112.484 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 279' ' ' ASN . . . . . 0.452 ' H ' ' ND2' ' E' ' 279' ' ' ASN . 1.8 p30 -89.02 154.12 20.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.802 0.334 . . . . 65.11 110.843 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -128.29 130.14 47.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 65.33 110.93 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 281' ' ' TYR . . . . . 0.493 ' HD2' HG13 ' E' ' 245' ' ' VAL . 1.3 t80 -132.41 121.76 23.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 64.24 110.946 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 164.87 -179.96 39.22 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.68 -0.771 . . . . 72.11 112.447 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -71.3 -151.06 0.86 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.763 -0.732 . . . . 73.34 112.516 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.92 -179.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.844 0.354 . . . . 65.21 110.877 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -110.84 -57.56 0.49 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.778 -0.725 . . . . 62.05 112.508 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -84.01 139.66 32.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 74.24 110.933 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 70.52 7.81 6.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 72.54 110.951 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 1.1 p30 173.81 135.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.53 110.84 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -124.12 154.94 39.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 75.4 110.928 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -147.54 162.53 38.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 71.43 110.849 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.76 -69.64 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 65.1 110.906 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 63.85 -169.92 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 74.24 110.897 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -128.26 174.6 9.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 73.04 110.889 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -143.85 168.75 19.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 72.1 110.852 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 64.2 110.863 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 16.3 mtt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.834 0.35 . . . . 52.41 110.89 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -174.65 174.48 2.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 72.21 110.92 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 9.5 tp -106.9 145.69 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 63.44 111.098 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.01 -170.07 1.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 74.01 110.841 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . 63.86 104.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 44.34 111.065 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.949 HD11 HG21 ' A' ' 261' ' ' THR . 33.7 pt -98.24 -176.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 74.42 111.16 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 19.4 m -51.74 -36.58 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 71.44 111.056 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 108.82 136.35 7.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.702 -0.761 . . . . 62.52 112.461 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.12 159.12 1.27 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.836 0.35 . . . . 75.5 110.863 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -98.31 124.31 42.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 74.31 110.888 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.23 137.85 54.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 72.53 110.82 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.29 123.32 15.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 65.24 111.066 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -84.92 -36.79 21.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.446 . . . . 73.05 110.865 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -164.18 139.29 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 64.43 110.871 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 13.0 mt -137.01 117.68 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 70.22 111.182 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -120.19 115.76 24.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 64.24 110.86 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.23 132.93 47.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 73.24 111.206 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -138.27 157.08 46.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 72.24 110.883 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.468 ' O ' ' C ' ' A' ' 236' ' ' ARG . 6.3 tt0 65.13 88.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 71.44 110.883 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.468 ' C ' ' O ' ' A' ' 235' ' ' GLU . 0.0 OUTLIER 31.68 52.55 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 74.52 110.903 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.79 145.59 24.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 72.31 111.113 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -125.76 136.71 53.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 75.13 110.908 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.602 HG12 ' HB ' ' A' ' 275' ' ' VAL . 6.9 m -142.5 121.75 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 71.12 111.089 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.26 137.25 54.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 64.25 110.849 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.68 122.05 26.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.196 -0.456 . . . . 71.23 110.968 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.85 -115.83 0.88 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 52.42 112.523 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -145.44 128.96 17.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 74.5 110.879 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.416 HG23 ' HA ' ' A' ' 280' ' ' GLU . 20.9 m -111.79 127.68 68.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 64.42 111.083 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.1 t -122.24 129.08 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 71.12 111.124 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 2.5 m -91.45 162.34 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 64.2 111.125 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.33 -43.1 99.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 63.12 111.063 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -61.1 -36.18 79.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 71.55 111.117 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.52 ' HB2' ' HA2' ' A' ' 282' ' ' GLY . . . -63.36 -25.26 68.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 65.32 111.037 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.3 tt -51.95 103.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 62.13 110.942 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.97 -63.32 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 54.21 110.826 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 136.11 138.93 3.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 74.43 112.534 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 168.39 164.69 24.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.752 -0.737 . . . . 61.35 112.495 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 8.9 tp -134.1 141.73 43.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 52.45 111.112 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.46 133.88 35.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 63.04 110.868 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.3 tt -116.6 -26.47 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 64.35 111.203 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 58.8 m -98.87 -178.43 3.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 73.3 110.9 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -63.64 -170.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.472 . . . . 63.22 110.875 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.2 179.75 6.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 63.53 110.956 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 30.8 p -87.58 137.49 32.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 61.24 111.145 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.949 HG21 HD11 ' A' ' 222' ' ' ILE . 1.3 m -107.75 108.98 20.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.14 111.126 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -94.18 124.97 38.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 55.21 110.907 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.99 123.82 15.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 34.34 110.904 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.631 HG21 HG22 ' A' ' 267' ' ' VAL . 10.4 p -118.66 135.78 57.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 72.42 111.103 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 -75.29 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.469 . . . . 71.21 110.847 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.4 m -123.46 130.29 52.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 71.31 111.108 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.631 HG22 HG21 ' A' ' 264' ' ' VAL . 33.7 t -118.12 129.83 73.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 63.21 111.112 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 36.7 t -127.68 124.83 64.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 71.32 111.114 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.01 134.02 8.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 73.5 112.47 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -132.8 141.68 48.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.78 0.324 . . . . 72.22 110.92 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 57.29 85.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 41.43 112.485 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 44.0 60.56 2.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.827 0.346 . . . . 75.3 110.902 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 11.0 t -83.92 145.36 28.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 61.44 110.93 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 3.3 mpp_? -129.49 127.25 40.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.887 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.602 ' HB ' HG12 ' A' ' 239' ' ' VAL . 17.6 t -137.06 124.01 30.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 63.31 111.13 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.0 111.16 17.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 72.21 110.901 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.674 ' CD1' HD13 ' B' ' 241' ' ' LEU . 30.5 mm -103.3 104.63 16.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 73.53 111.11 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.24 -163.61 28.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 53.21 112.467 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -103.43 155.92 18.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 72.13 110.844 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.6 ' HG3' HG12 ' B' ' 244' ' ' VAL . 2.0 pp20? -129.93 147.32 51.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.12 -0.491 . . . . 72.34 110.922 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -129.69 125.84 36.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 73.23 110.927 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.52 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 165.69 -86.14 0.1 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.705 -0.76 . . . . 70.13 112.506 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 127.75 -97.79 0.47 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.76 -0.733 . . . . 52.21 112.51 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -51.73 127.85 21.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.794 0.33 . . . . 73.24 110.895 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 93.72 -33.22 5.31 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.753 -0.737 . . . . 52.42 112.474 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.39 -174.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.373 . . . . 74.02 110.865 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -51.86 107.58 0.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 75.33 110.91 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.67 -172.17 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 55.13 110.852 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -102.61 150.09 23.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.971 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -121.84 -178.76 3.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 72.45 110.856 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.37 96.05 5.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 73.45 110.818 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.8 143.4 26.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 70.34 110.85 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -178.28 123.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 75.43 110.86 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.07 124.67 20.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 75.21 110.884 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 73.43 110.837 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.868 0.366 . . . . 63.5 110.884 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -99.72 155.64 17.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 71.53 110.865 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 13.3 tt -52.06 146.25 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 75.1 111.096 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -131.71 164.85 25.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 63.23 110.851 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -116.04 146.75 41.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 54.4 111.105 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.63 178.76 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 44.53 111.144 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.609 HG23 ' HA ' ' B' ' 259' ' ' GLN . 13.8 m -148.43 -179.9 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 75.44 111.162 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 149.19 -162.92 29.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 61.02 112.521 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.728 ' CB ' HG23 ' B' ' 261' ' ' THR . 1.7 mtt-85 -162.91 120.47 1.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.714 0.292 . . . . 72.13 110.913 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.412 ' ND2' ' HA2' ' B' ' 242' ' ' GLY . 1.2 m-80 -106.61 115.63 30.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.42 110.897 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.91 137.93 54.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 63.44 110.779 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.16 129.38 29.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 55.04 111.118 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 4.8 tttm -88.88 -36.32 16.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 62.32 110.869 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ASP . . . . . 0.456 ' HB3' HG23 ' B' ' 266' ' ' THR . 0.6 OUTLIER -164.4 139.16 5.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 51.11 110.869 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.513 HD13 HD11 ' B' ' 241' ' ' LEU . 13.6 mt -137.31 117.84 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 75.41 111.075 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -127.03 119.65 27.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 63.32 110.84 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.52 140.36 48.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 65.42 111.149 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -140.35 164.38 30.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 72.52 110.874 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' B' ' 236' ' ' ARG . 2.2 tt0 64.07 72.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 74.53 110.809 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' B' ' 235' ' ' GLU . 19.5 ptt-85 37.19 63.43 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 64.12 110.854 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.56 155.06 19.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 34.51 111.107 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.96 135.32 48.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 64.03 110.854 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.56 HG23 HG13 ' A' ' 275' ' ' VAL . 21.0 m -143.11 121.9 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 64.53 111.147 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -118.37 137.26 53.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.33 110.845 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.674 HD13 ' CD1' ' A' ' 277' ' ' ILE . 5.2 mp -125.02 118.54 26.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 72.35 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.412 ' HA2' ' ND2' ' B' ' 226' ' ' ASN . . . 143.02 -177.64 21.81 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.739 -0.743 . . . . 60.03 112.473 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.93 139.0 31.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 73.42 110.905 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.6 HG12 ' HG3' ' A' ' 280' ' ' GLU . 27.3 m -116.82 127.49 74.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 64.32 111.139 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 54.2 t -117.5 129.28 74.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 70.42 111.088 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.533 HG21 ' HB2' ' B' ' 284' ' ' LYS . 0.7 OUTLIER -80.18 162.81 24.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 63.35 111.191 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.14 79.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 73.51 111.075 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -62.55 -41.71 99.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.306 -0.407 . . . . 75.05 111.104 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -59.9 117.59 5.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 70.11 111.128 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -175.55 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 74.25 110.967 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -54.35 -28.52 43.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 63.1 110.864 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -52.39 144.8 19.39 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.746 -0.74 . . . . 73.42 112.488 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -138.67 -151.6 5.8 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.717 . . . . 55.42 112.508 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 49.4 mm -52.4 131.35 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 74.34 111.166 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -176.13 -36.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 74.14 110.913 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.5 mp 63.71 84.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 64.25 111.14 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.82 -170.4 3.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 70.54 110.865 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.6 t0 62.77 36.61 13.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.464 . . . . 70.24 110.897 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 259' ' ' GLN . . . . . 0.609 ' HA ' HG23 ' B' ' 223' ' ' VAL . 7.1 tt0 -92.23 55.52 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 74.31 110.881 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 86.3 m -95.4 122.92 38.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 61.02 111.131 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.728 HG23 ' CB ' ' B' ' 225' ' ' ARG . 5.4 m -94.6 108.84 20.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 65.23 111.149 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.59 127.72 42.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 62.31 110.927 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 63.9 p -142.03 123.99 15.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 73.14 110.898 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.556 HG21 HG22 ' B' ' 267' ' ' VAL . 8.8 p -115.18 136.83 50.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 55.35 111.062 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.26 -75.71 0.22 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.117 -0.492 . . . . 74.54 110.862 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.456 HG23 ' HB3' ' B' ' 230' ' ' ASP . 1.7 m -127.4 130.8 50.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 61.2 111.147 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.556 HG22 HG21 ' B' ' 264' ' ' VAL . 28.6 t -118.32 128.29 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 72.03 111.129 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.56 120.43 54.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 70.02 111.1 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.88 133.69 8.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 74.4 112.46 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -133.09 148.02 52.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 74.42 110.893 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.63 76.58 0.19 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.708 -0.758 . . . . 42.43 112.476 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 48.35 62.19 2.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.342 . . . . 73.24 110.924 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 32.6 t -87.43 145.67 26.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 75.55 110.879 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.74 127.38 43.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 73.34 110.937 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.65 HG13 HG23 ' C' ' 239' ' ' VAL . 10.0 t -135.59 124.07 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 74.43 111.148 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.46 116.53 26.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.471 . . . . 61.34 110.872 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 29.0 mm -107.72 135.09 47.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 61.23 111.089 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 118.39 -168.75 13.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 64.32 112.392 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -112.38 155.38 24.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.791 0.329 . . . . 65.4 110.908 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.456 ' HG2' HG12 ' C' ' 244' ' ' VAL . 15.7 pt-20 -120.13 137.45 54.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 71.11 110.935 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.94 125.96 50.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 74.35 110.874 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' C' ' 247' ' ' ALA . . . 127.12 159.84 10.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 51.03 112.452 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -101.53 -19.03 16.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.82 -0.705 . . . . 44.15 112.477 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 284' ' ' LYS . . . . . 0.533 ' HB2' HG21 ' B' ' 246' ' ' THR . 1.4 mmtt -66.97 89.31 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 65.14 110.948 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 66.86 113.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 71.14 112.506 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -52.85 -66.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.812 0.339 . . . . 61.42 110.865 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -138.13 -49.45 0.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 73.24 110.916 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.27 -171.02 2.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 73.45 110.861 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -133.06 134.93 44.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 70.2 110.909 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 59.52 176.01 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 64.43 110.91 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -171.23 -67.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 71.52 110.892 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -161.15 -68.43 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 71.13 110.868 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -179.2 -179.19 0.55 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 74.12 110.812 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -140.41 26.32 2.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 75.22 110.816 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 72.32 110.871 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.4 mtt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.852 0.358 . . . . 71.13 110.865 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -128.78 165.15 21.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 73.13 110.898 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.52 HD13 ' H ' ' C' ' 219' ' ' ILE . 0.1 OUTLIER -143.53 175.8 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 73.24 111.116 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -166.96 29.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 64.15 110.84 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -151.6 -170.3 3.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 74.13 111.107 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.37 75.91 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 64.32 111.154 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 23.3 m -87.4 145.13 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 55.13 111.122 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -87.91 136.12 13.59 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.769 -0.729 . . . . 31.24 112.437 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -179.45 136.24 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.777 0.322 . . . . 62.42 110.839 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.418 ' ND2' ' HA2' ' C' ' 242' ' ' GLY . 4.3 m-80 -94.64 134.93 36.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 73.11 110.882 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 8.1 t -132.46 137.84 47.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 64.55 110.894 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.95 138.83 44.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 74.21 111.12 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.86 -33.47 11.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.41 . . . . 63.3 110.897 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.71 138.54 5.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 73.51 110.822 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 11.0 mt -137.59 117.89 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 75.22 111.135 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -127.74 121.9 31.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 73.41 110.918 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 141.67 45.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 43.12 111.167 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.18 166.31 25.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 73.51 110.863 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 65.0 57.68 0.96 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.156 -0.475 . . . . 62.31 110.874 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 50.87 61.2 3.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 73.42 110.887 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 151.97 22.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 64.15 111.168 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -125.92 135.38 51.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 64.14 110.886 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.774 HG12 ' HB ' ' C' ' 275' ' ' VAL . 4.4 m -140.66 121.9 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 75.24 111.155 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -115.68 129.71 56.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 71.31 110.986 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.808 HD13 ' HB ' ' C' ' 277' ' ' ILE . 3.3 mm? -114.91 118.72 34.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 54.55 110.938 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.418 ' HA2' ' ND2' ' C' ' 226' ' ' ASN . . . 135.1 174.28 13.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.759 -0.734 . . . . 71.32 112.471 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.54 147.92 22.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.869 0.366 . . . . 63.22 110.856 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.456 HG12 ' HG2' ' B' ' 280' ' ' GLU . 34.9 m -119.09 130.42 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 73.02 111.122 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.407 HG12 ' HB3' ' C' ' 249' ' ' ALA . 21.7 t -122.07 128.97 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 34.53 111.096 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 7.8 p -74.41 162.97 28.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 64.14 111.158 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.503 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -63.08 -33.97 76.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 73.42 111.06 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.81 -41.85 78.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 45.23 111.064 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 249' ' ' ALA . . . . . 0.697 ' HB2' ' CD1' ' C' ' 281' ' ' TYR . . . -51.73 103.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 64.21 111.097 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 12.4 mt -139.14 -174.39 3.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 73.33 110.875 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -76.34 -170.97 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 64.14 110.894 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 131.69 -21.09 4.52 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.677 -0.773 . . . . 73.11 112.476 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -166.5 -102.43 0.16 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.738 -0.744 . . . . 63.22 112.48 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 254' ' ' ILE . . . . . 0.617 HD12 ' O ' ' D' ' 252' ' ' GLY . 15.8 pt -142.99 41.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.853 0.359 . . . . 63.25 111.191 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 255' ' ' ARG . . . . . 0.477 ' HD3' ' HB3' ' D' ' 249' ' ' ALA . 6.0 mtt-85 -80.91 117.24 21.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 71.11 110.94 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 50.5 mt -145.48 145.62 20.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 73.42 111.089 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.92 -37.08 3.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 74.42 110.894 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -59.32 106.26 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 70.22 110.846 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -173.86 -37.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 74.2 110.93 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 26.4 m -76.3 121.98 23.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 63.22 111.175 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.7 m -92.33 125.5 37.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 73.23 111.123 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -113.83 119.99 39.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 75.52 110.878 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 8.3 t -129.9 123.66 31.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 45.53 110.843 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.591 HG21 HG22 ' C' ' 267' ' ' VAL . 9.3 p -117.06 135.97 55.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 71.15 111.128 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -79.12 -76.09 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 72.34 110.884 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 2.1 m -124.53 130.71 52.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 65.53 111.197 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.591 HG22 HG21 ' C' ' 264' ' ' VAL . 21.9 t -118.09 125.27 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.11 111.209 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 57.8 t -127.24 118.73 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 61.34 111.119 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.1 133.78 8.9 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 42.2 112.522 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -132.53 147.66 52.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.337 . . . . 74.13 110.885 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.14 75.46 0.26 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.686 -0.769 . . . . 52.01 112.499 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 48.64 60.43 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 61.3 110.846 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 21.3 t -85.55 145.85 27.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.34 110.846 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -128.32 127.86 43.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 65.33 110.823 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.774 ' HB ' HG12 ' C' ' 239' ' ' VAL . 17.3 t -135.18 123.89 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 72.42 111.126 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.48 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -121.89 112.29 18.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 72.24 110.865 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.808 ' HB ' HD13 ' C' ' 241' ' ' LEU . 24.7 mm -106.17 123.51 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 65.33 111.105 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 129.17 167.11 12.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 63.34 112.55 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -89.97 145.3 25.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.774 0.321 . . . . 71.21 110.91 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.05 134.62 54.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 72.23 110.913 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.697 ' CD1' ' HB2' ' C' ' 249' ' ' ALA . 27.2 t80 -119.68 125.95 49.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 73.52 110.986 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 153.55 168.78 17.77 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 34.25 112.523 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 283' ' ' GLY . . . . . 0.597 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . -111.68 -18.32 8.03 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.715 -0.755 . . . . 65.4 112.499 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -76.37 67.11 2.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 63.24 110.929 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 78.31 159.63 13.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 62.32 112.518 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -81.27 -74.67 0.32 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.865 0.364 . . . . 65.21 110.859 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.48 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 3.7 t90 -89.56 -65.82 0.98 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 72.04 110.927 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -156.09 -41.59 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 71.0 110.874 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 1.4 m120 63.17 161.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 74.44 110.911 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -179.1 -169.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 73.45 110.914 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -51.99 146.79 8.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.433 . . . . 64.5 110.827 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -136.87 -175.25 3.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 52.43 110.841 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.2 104.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 75.31 110.882 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -165.56 73.37 0.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 73.24 110.865 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 24.1 m170 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 72.31 110.828 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.777 0.322 . . . . 74.31 110.863 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -168.75 43.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 53.23 110.897 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 6.1 tp -118.04 -29.81 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 71.01 111.12 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -70.62 164.79 24.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 72.32 110.859 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 221' ' ' ALA . . . . . 0.666 ' HB1' HD11 ' E' ' 219' ' ' ILE . . . -97.0 -174.91 3.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 74.24 111.119 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 222' ' ' ILE . . . . . 0.64 HG13 ' HB3' ' E' ' 221' ' ' ALA . 21.7 pt -129.23 25.36 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 74.02 111.11 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 20.9 m -85.07 142.36 13.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 75.03 111.121 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 58.85 173.89 0.52 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 42.43 112.462 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.19 -169.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.81 0.338 . . . . 71.42 110.891 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.75 113.1 20.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 73.32 110.861 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 2.6 m -128.3 139.76 52.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 71.53 110.84 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.33 157.63 42.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 72.21 111.158 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -112.6 -34.41 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 72.43 110.895 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 230' ' ' ASP . . . . . 0.491 ' HB3' HG23 ' D' ' 266' ' ' THR . 8.1 t0 -164.53 138.86 5.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 73.53 110.869 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 8.9 mt -137.64 117.74 16.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 72.35 111.196 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -130.54 123.53 29.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 70.13 110.932 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 233' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' D' ' 237' ' ' ALA . 0.1 OUTLIER -135.2 146.64 48.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 73.24 111.118 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -146.51 166.61 25.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 74.51 110.901 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 64.93 55.88 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 75.51 110.877 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.85 62.79 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.477 . . . . 73.13 110.862 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 237' ' ' ALA . . . . . 0.44 ' HB3' ' OG1' ' D' ' 233' ' ' THR . . . -104.49 156.06 18.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 43.42 111.123 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -128.05 135.71 50.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 73.11 110.817 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.713 HG23 HG13 ' C' ' 275' ' ' VAL . 20.5 m -138.27 122.85 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.11 111.148 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 240' ' ' GLN . . . . . 0.495 ' C ' HD22 ' D' ' 241' ' ' LEU . 0.0 OUTLIER -116.37 136.43 53.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 72.35 110.938 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.563 HD23 ' CD1' ' C' ' 277' ' ' ILE . 3.8 mm? -119.96 118.98 32.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 50.51 110.89 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.14 171.61 13.0 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.75 . . . . 63.51 112.495 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -93.28 153.95 18.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 74.42 110.888 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 18.5 m -120.67 136.85 56.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 75.34 111.093 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 97.9 t -122.24 130.09 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 72.32 111.098 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 1.7 p -68.35 168.54 12.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 75.31 111.097 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 247' ' ' ALA . . . . . 0.597 ' HB2' ' N ' ' C' ' 283' ' ' GLY . . . -59.57 -34.49 72.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 72.22 111.136 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.44 -37.53 72.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 64.43 111.162 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 249' ' ' ALA . . . . . 0.622 ' HB2' ' OH ' ' C' ' 281' ' ' TYR . . . 63.71 163.46 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 35.14 111.146 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 250' ' ' LEU . . . . . 0.462 HD13 ' CB ' ' E' ' 249' ' ' ALA . 16.0 tp -121.75 112.8 18.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 64.3 110.916 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -59.49 120.69 9.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 63.34 110.865 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 252' ' ' GLY . . . . . 0.617 ' O ' HD12 ' C' ' 254' ' ' ILE . . . -167.07 -144.77 4.23 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 41.31 112.479 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -57.71 -178.7 0.72 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.746 -0.74 . . . . 74.11 112.515 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 254' ' ' ILE . . . . . 0.417 HD12 ' HB2' ' D' ' 255' ' ' ARG . 1.5 pp -148.23 155.47 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.838 0.351 . . . . 72.33 111.178 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 255' ' ' ARG . . . . . 0.417 ' HB2' HD12 ' D' ' 254' ' ' ILE . 2.0 mtt180 69.19 -75.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 73.44 110.882 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 35.6 pt -107.47 154.14 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 74.01 111.066 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 13.0 t -178.79 106.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.076 -0.511 . . . . 55.01 110.814 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -66.56 0.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 73.44 110.861 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.3 -170.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 73.21 110.924 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 1.4 m -66.58 135.27 53.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 33.41 111.141 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 98.0 m -102.61 139.17 38.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 75.24 111.148 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.14 130.98 52.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 74.04 110.807 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 5.8 t -142.07 123.9 15.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 62.33 110.81 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.506 HG21 HG22 ' D' ' 267' ' ' VAL . 7.6 p -123.76 138.34 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 63.11 111.131 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.73 -76.4 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 74.05 110.847 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 266' ' ' THR . . . . . 0.491 HG23 ' HB3' ' D' ' 230' ' ' ASP . 6.2 m -128.3 130.46 47.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 71.24 111.081 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.506 HG22 HG21 ' D' ' 264' ' ' VAL . 21.3 t -118.4 120.93 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.144 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 18.1 t -121.68 118.45 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 72.51 111.169 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.52 136.49 12.23 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.715 -0.755 . . . . 62.22 112.456 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.44 147.51 52.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.879 0.371 . . . . 75.11 110.894 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.43 76.22 0.2 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.723 -0.751 . . . . 42.43 112.468 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 47.93 61.95 2.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 71.53 110.866 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 30.5 t -87.15 145.99 26.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 52.34 110.871 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -127.49 127.67 44.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 60.44 110.903 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.632 HG13 HG23 ' E' ' 239' ' ' VAL . 14.2 t -132.66 124.15 50.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 71.33 111.071 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.2 OUTLIER -123.44 112.38 17.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.22 110.889 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.466 ' HB ' HD13 ' D' ' 241' ' ' LEU . 28.0 mm -105.0 129.06 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 72.13 111.111 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 120.03 170.46 14.36 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 63.43 112.561 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -89.68 154.01 20.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.327 . . . . 71.35 110.867 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 280' ' ' GLU . . . . . 0.69 ' CG ' HG12 ' E' ' 244' ' ' VAL . 6.5 pt-20 -127.95 133.17 49.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 64.4 110.858 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 281' ' ' TYR . . . . . 0.476 ' HE1' ' HB2' ' E' ' 249' ' ' ALA . 34.3 t80 -116.22 124.18 49.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 73.14 110.925 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 174.42 -58.32 0.13 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 61.23 112.443 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 91.47 -66.83 2.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.795 -0.717 . . . . 24.25 112.476 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -51.43 -30.32 19.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 75.54 110.917 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -140.34 97.57 0.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.677 -0.773 . . . . 71.4 112.478 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -51.3 -75.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 72.44 110.883 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -140.84 -58.28 0.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 64.5 110.932 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -175.12 -178.23 1.17 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 70.45 110.846 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 58.62 177.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 62.22 110.893 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -114.69 -49.28 2.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 72.04 110.873 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 56.85 -177.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.423 . . . . 72.42 110.876 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 63.25 104.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 64.21 110.838 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -142.07 62.1 1.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 64.22 110.778 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 63.05 162.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 74.3 110.82 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 3.7 p80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 71.53 110.879 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.829 0.347 . . . . 71.53 110.877 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.14 177.76 4.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 44.23 110.87 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 219' ' ' ILE . . . . . 0.666 HD11 ' HB1' ' D' ' 221' ' ' ALA . 26.4 pt -137.88 -174.49 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 72.11 111.137 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.58 145.2 48.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.218 -0.446 . . . . 72.34 110.852 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 221' ' ' ALA . . . . . 0.64 ' HB3' HG13 ' D' ' 222' ' ' ILE . . . -176.13 117.7 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 74.35 111.076 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.65 45.5 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 74.33 111.06 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.83 144.69 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 73.23 111.198 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 153.29 -172.43 32.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.633 -0.794 . . . . 54.13 112.419 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -54.3 -69.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.78 0.324 . . . . 43.2 110.869 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -97.29 111.66 23.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 72.13 110.868 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 14.8 m -121.94 138.96 54.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 72.41 110.839 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.79 132.82 35.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 73.31 111.073 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.06 -29.24 15.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.878 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -164.52 139.33 5.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 60.42 110.896 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 10.5 mt -136.87 117.57 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 70.12 111.162 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.61 121.11 23.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 72.13 110.869 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 233' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' E' ' 237' ' ' ALA . 0.7 OUTLIER -134.51 145.36 48.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 65.34 111.096 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -148.17 167.09 25.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 60.11 110.881 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 65.74 54.41 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 64.43 110.916 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 51.2 62.07 2.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.477 . . . . 74.03 110.852 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 237' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' E' ' 233' ' ' THR . . . -104.76 156.15 18.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 73.31 111.12 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -128.32 135.83 50.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.33 110.855 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.632 HG23 HG13 ' D' ' 275' ' ' VAL . 4.2 m -131.99 121.98 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 43.14 111.109 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 240' ' ' GLN . . . . . 0.653 ' HB3' HD22 ' E' ' 276' ' ' LEU . 0.0 OUTLIER -115.48 137.07 52.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 60.0 110.9 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.826 HD13 ' HB ' ' E' ' 277' ' ' ILE . 4.1 mm? -126.74 121.17 31.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 64.44 110.958 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.19 163.3 11.5 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 64.03 112.456 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -85.7 156.98 20.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.906 0.384 . . . . 74.1 110.854 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.69 HG12 ' CG ' ' D' ' 280' ' ' GLU . 31.6 m -119.42 134.08 64.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 71.13 111.121 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.53 129.54 75.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 51.33 111.085 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 246' ' ' THR . . . . . 0.426 HG21 ' HA2' ' E' ' 282' ' ' GLY . 13.6 t -69.49 175.54 4.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 74.01 111.112 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.34 86.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 24.2 111.104 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.4 -53.03 62.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 55.03 111.1 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 249' ' ' ALA . . . . . 0.476 ' HB2' ' HE1' ' D' ' 281' ' ' TYR . . . 50.32 29.66 3.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 62.33 111.085 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.39 98.05 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 62.45 110.935 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 19.6 m80 63.35 26.75 15.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 74.41 110.899 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -70.79 -34.86 66.16 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.717 . . . . 64.21 112.458 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.1 -143.63 9.49 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.733 . . . . 72.33 112.484 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 2.0 mp 65.3 151.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 71.14 111.179 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 255' ' ' ARG . . . . . 0.405 ' C ' HD12 ' E' ' 256' ' ' ILE . 7.9 mtt180 -66.65 -170.78 0.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.434 . . . . 74.35 110.818 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 256' ' ' ILE . . . . . 0.405 HD12 ' C ' ' E' ' 255' ' ' ARG . 2.7 mp 62.81 63.63 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 62.25 111.118 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.48 -170.31 2.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 73.42 110.823 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.56 -170.13 1.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 62.11 110.792 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.82 103.66 2.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 74.52 110.914 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 31.1 p -100.96 137.9 38.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 62.14 111.194 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 5.3 t -128.93 122.53 30.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.451 . . . . 73.14 111.107 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -105.09 119.93 40.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 63.23 110.932 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 29.2 t -127.27 123.83 37.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 62.34 110.822 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 264' ' ' VAL . . . . . 0.516 HG21 HG22 ' E' ' 267' ' ' VAL . 10.0 p -122.62 137.82 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 71.45 111.152 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.86 -75.07 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 71.44 110.904 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 60.5 m -125.23 133.58 52.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 62.32 111.123 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 267' ' ' VAL . . . . . 0.516 HG22 HG21 ' E' ' 264' ' ' VAL . 21.9 t -118.23 126.5 75.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 75.24 111.142 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.2 122.89 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 45.24 111.125 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.65 134.43 9.96 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 73.4 112.5 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -133.01 147.75 52.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 70.02 110.884 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.48 78.9 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.843 -0.694 . . . . 71.44 112.444 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 47.18 64.16 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 71.04 110.936 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 41.2 t -86.76 145.88 26.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 73.32 110.852 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -130.73 127.87 39.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 55.51 110.853 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.405 ' HB ' HG12 ' E' ' 239' ' ' VAL . 18.7 t -130.4 123.72 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 65.42 111.189 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.653 HD22 ' HB3' ' E' ' 240' ' ' GLN . 0.2 OUTLIER -121.79 111.94 17.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 72.12 110.914 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.826 ' HB ' HD13 ' E' ' 241' ' ' LEU . 50.5 mm -108.55 132.64 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 63.24 111.18 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 124.42 -177.68 16.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.744 . . . . 73.23 112.483 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -103.18 153.67 20.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.787 0.327 . . . . 64.11 110.839 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.91 132.07 55.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 62.33 110.83 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -130.09 123.74 31.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 73.25 110.908 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 282' ' ' GLY . . . . . 0.426 ' HA2' HG21 ' E' ' 246' ' ' THR . . . 163.77 73.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 61.1 112.485 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . 48.23 82.45 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.734 -0.746 . . . . 35.11 112.46 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.43 30.82 2.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.836 0.351 . . . . 73.41 110.946 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -63.53 173.28 12.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.751 -0.737 . . . . 32.32 112.435 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.04 -70.14 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.76 0.314 . . . . 72.05 110.848 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 287' ' ' TRP . . . . . 0.586 ' CZ2' HD23 ' E' ' 276' ' ' LEU . 5.7 t90 -168.24 31.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.962 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.18 -169.66 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 73.0 110.918 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 3.7 t30 63.49 104.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 64.41 110.943 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -110.61 -176.16 2.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 73.45 110.868 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -99.85 51.0 0.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 73.22 110.938 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -178.06 69.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 71.42 110.871 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -111.5 166.83 10.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.219 -0.446 . . . . 72.12 110.843 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.12 -178.3 3.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.832 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 7.1 m80 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 74.21 110.852 -179.985 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 4.0 ptp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.828 0.347 . . . . 72.33 110.903 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -179.21 139.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 64.34 110.892 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.9 tt -175.37 149.41 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 71.1 111.115 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -109.7 124.21 50.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 74.52 110.794 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.428 ' O ' HG13 ' A' ' 223' ' ' VAL . . . -178.34 -34.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 74.41 111.079 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.544 HG23 HH12 ' A' ' 225' ' ' ARG . 48.5 mm -51.75 118.71 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 44.43 111.118 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 221' ' ' ALA . 15.9 m -124.36 170.26 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.471 . . . . 73.2 111.143 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -52.02 105.9 0.28 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.686 -0.769 . . . . 64.21 112.467 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.6 ' HG3' HG23 ' A' ' 261' ' ' THR . 9.2 ptp85 -142.21 -173.54 3.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 74.3 110.843 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.99 129.65 30.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.885 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 2.1 p -134.5 140.25 46.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 63.43 110.897 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.82 149.53 51.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 65.45 111.059 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -106.25 -35.63 7.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 71.15 110.874 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -164.86 137.86 4.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 75.43 110.907 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 17.4 mt -138.91 118.72 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 63.54 111.131 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -134.12 117.74 16.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 72.13 110.847 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.7 p -135.55 142.09 45.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 73.41 111.127 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.0 pm0 -147.01 167.9 22.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 72.31 110.93 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 68.94 57.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 75.55 110.909 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 50.37 57.43 6.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.804 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.2 151.75 22.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 44.31 111.101 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -126.11 135.92 52.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 73.54 110.797 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.477 HG23 ' HB ' ' A' ' 275' ' ' VAL . 6.1 p -138.38 121.88 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 63.33 111.096 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.511 ' OE1' HD11 ' A' ' 276' ' ' LEU . 0.5 OUTLIER -114.01 136.0 53.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 72.31 110.948 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.535 HD12 ' HB ' ' A' ' 277' ' ' ILE . 1.6 tp -130.16 118.88 22.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.199 -0.455 . . . . 54.31 110.888 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 139.57 173.22 13.04 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.699 -0.762 . . . . 74.52 112.478 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -85.67 160.45 19.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 74.54 110.903 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 97.9 t -133.07 121.02 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.475 . . . . 72.44 111.16 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 249' ' ' ALA . 59.5 t -122.19 129.04 75.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 70.35 111.131 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 249' ' ' ALA . 6.1 t -75.41 169.29 18.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 72.11 111.108 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.38 -41.52 98.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 54.45 111.064 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.32 -35.88 68.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 60.33 111.118 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.505 ' HB3' ' CG1' ' A' ' 245' ' ' VAL . . . -74.04 -23.6 59.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 62.35 111.16 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.36 85.62 7.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 65.44 110.925 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -178.99 -172.85 0.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 75.32 110.824 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.75 143.25 1.18 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 44.51 112.466 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -100.38 73.76 0.43 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.783 -0.723 . . . . 53.04 112.522 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.45 -176.84 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.863 0.363 . . . . 75.42 111.109 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 12.5 mtt-85 -73.39 108.45 6.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 74.1 110.88 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 44.7 mm -103.38 132.55 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 74.34 111.124 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.4 p -171.63 131.33 0.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 64.15 110.807 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -58.13 141.35 50.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.508 . . . . 52.51 110.869 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.468 ' HG3' HG13 ' B' ' 223' ' ' VAL . 0.7 OUTLIER -125.53 -37.54 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 72.22 110.923 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 95.1 m -72.61 122.09 20.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 72.42 111.108 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.6 HG23 ' HG3' ' A' ' 225' ' ' ARG . 26.0 m -116.48 122.41 44.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 73.15 111.147 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.476 ' HB2' HG22 ' A' ' 277' ' ' ILE . 17.5 p30 -107.41 139.34 42.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 63.42 110.875 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.91 123.25 15.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.509 . . . . 64.22 110.812 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.485 HG21 HG22 ' A' ' 267' ' ' VAL . 7.0 p -119.87 137.59 53.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 64.33 111.127 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.91 -77.39 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 72.11 110.857 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 35.3 p -127.21 130.18 49.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 55.0 111.146 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.485 HG22 HG21 ' A' ' 264' ' ' VAL . 20.5 t -118.04 120.69 65.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 70.14 111.125 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.77 118.12 53.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 41.24 111.109 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.17 134.37 10.09 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 71.44 112.49 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.63 147.76 52.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.347 . . . . 72.34 110.895 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.78 78.97 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.79 -0.719 . . . . 54.13 112.45 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 47.9 66.3 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.842 0.353 . . . . 73.41 110.825 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 32.7 t -92.76 145.9 24.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 65.12 110.756 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -125.42 128.29 47.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 74.24 110.9 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.477 ' HB ' HG23 ' A' ' 239' ' ' VAL . 20.6 t -134.1 123.76 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 60.03 111.139 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.511 HD11 ' OE1' ' A' ' 240' ' ' GLN . 0.2 OUTLIER -122.42 111.86 17.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.14 110.858 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.535 ' HB ' HD12 ' A' ' 241' ' ' LEU . 3.4 mp -109.78 106.25 20.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.251 -0.431 . . . . 75.45 111.146 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.5 175.56 19.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 63.12 112.488 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -107.14 147.72 29.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.817 0.342 . . . . 75.41 110.879 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.435 ' HG2' HG22 ' B' ' 244' ' ' VAL . 12.7 pt-20 -118.97 126.37 51.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 65.05 110.905 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.409 ' CE2' HG11 ' B' ' 245' ' ' VAL . 1.8 t80 -118.55 125.76 50.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 64.21 110.921 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' B' ' 247' ' ' ALA . . . 151.33 -39.66 0.8 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.684 -0.769 . . . . 75.23 112.5 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 123.99 -119.8 3.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 52.24 112.442 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 63.34 25.92 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 44.34 110.857 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 77.3 -63.63 3.28 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.705 -0.76 . . . . 72.43 112.49 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -174.49 -167.96 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 73.34 110.893 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.419 ' CZ2' HD23 ' A' ' 276' ' ' LEU . 15.6 t90 -49.44 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 74.11 110.947 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -176.03 143.22 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 74.2 110.882 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -80.28 -170.03 2.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 65.33 110.828 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -157.88 26.15 0.27 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 71.43 110.903 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -144.65 -47.31 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 63.04 110.876 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 72.3 -69.25 0.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 71.32 110.848 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -57.25 179.43 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 74.15 110.908 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.2 161.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 70.11 110.86 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 63.13 110.818 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.801 0.334 . . . . 71.55 110.875 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.57 107.46 1.75 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 75.34 110.937 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.29 165.55 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 73.43 111.109 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -169.88 -170.46 1.02 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.887 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -124.9 150.41 46.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 55.33 111.063 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 8.7 tp -150.43 131.3 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 53.2 111.141 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.468 HG13 ' HG3' ' A' ' 259' ' ' GLN . 7.0 p -114.11 130.35 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 74.13 111.103 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 82.76 126.85 1.07 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 71.53 112.515 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.44 ' O ' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER -179.32 135.9 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.771 0.32 . . . . 60.44 110.93 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.8 137.51 45.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 75.15 110.852 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.59 137.9 38.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 71.03 110.897 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.17 147.85 52.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 74.32 111.104 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.87 -31.46 9.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 73.11 110.917 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.51 137.79 4.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 54.04 110.89 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 15.6 mt -138.19 117.18 14.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 64.14 111.139 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -134.57 115.26 13.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 64.02 110.883 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.3 p -135.86 137.19 41.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 52.32 111.096 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -141.93 167.28 22.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 62.55 110.912 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 66.95 69.51 0.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 73.14 110.792 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 46.06 40.52 7.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 62.21 110.82 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.81 148.79 23.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 45.23 111.096 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.8 140.82 50.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 73.43 110.829 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.404 HG13 ' O ' ' B' ' 239' ' ' VAL . 6.1 p -138.96 121.99 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.113 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.61 131.76 56.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 74.03 110.865 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.652 HD12 ' HB ' ' B' ' 277' ' ' ILE . 1.2 tp -130.23 118.94 22.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 71.31 110.921 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 154.92 -138.27 6.05 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 52.32 112.42 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 243' ' ' ASN . . . . . 0.448 ' OD1' HG23 ' B' ' 245' ' ' VAL . 4.0 t-20 -144.54 143.69 30.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.852 0.358 . . . . 65.34 110.863 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.435 HG22 ' HG2' ' A' ' 280' ' ' GLU . 58.2 t -119.11 115.63 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 73.4 111.134 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.448 HG23 ' OD1' ' B' ' 243' ' ' ASN . 63.9 t -122.21 122.73 67.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 54.1 111.117 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 81.2 p -69.85 163.02 26.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.183 -0.462 . . . . 53.13 111.147 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 282' ' ' GLY . . . -62.76 -34.07 76.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 75.14 111.093 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.06 -41.48 78.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 72.01 111.04 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -53.79 -27.65 30.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 75.02 111.107 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.65 101.0 0.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.963 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.39 -55.1 2.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 55.41 110.927 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -130.39 98.59 0.41 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.692 -0.766 . . . . 61.24 112.479 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 73.28 -100.93 1.09 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.788 -0.72 . . . . 74.45 112.49 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.59 -32.85 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 71.15 111.086 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -170.79 -179.1 2.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 70.53 110.846 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 39.1 mm -108.91 -65.46 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 61.52 111.183 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 54.3 p -160.0 70.04 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.01 110.829 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.59 169.99 8.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 74.43 110.915 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -174.51 70.16 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 72.23 110.884 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.541 HG23 ' CG ' ' C' ' 225' ' ' ARG . 76.3 m -100.95 121.95 42.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 73.21 111.119 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.44 HG23 ' O ' ' B' ' 225' ' ' ARG . 91.3 m -124.06 131.86 53.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.28 -0.418 . . . . 75.33 111.138 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.543 ' HB2' HG22 ' B' ' 277' ' ' ILE . 13.7 p30 -115.57 132.51 56.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 75.23 110.885 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 36.7 m -132.74 123.32 26.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 60.34 110.867 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.49 HG21 ' CG2' ' B' ' 267' ' ' VAL . 7.6 p -119.89 137.09 54.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 63.3 111.132 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -78.99 -77.5 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 75.21 110.857 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 39.1 m -129.9 130.48 45.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.166 -0.47 . . . . 63.41 111.141 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.511 ' CG1' HG21 ' B' ' 275' ' ' VAL . 21.3 t -117.9 120.68 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 63.42 111.168 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.04 121.61 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 73.3 111.17 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.27 133.8 8.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 55.1 112.543 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -132.55 147.52 52.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.824 0.345 . . . . 65.14 110.893 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.92 84.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.688 -0.768 . . . . 72.1 112.525 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 45.15 63.52 1.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 74.24 110.888 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 26.5 t -93.06 145.68 24.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 63.31 110.884 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -128.57 127.7 42.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 73.53 110.919 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.511 HG21 ' CG1' ' B' ' 267' ' ' VAL . 21.4 t -131.6 123.91 53.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.414 . . . . 72.51 111.144 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.458 HD23 ' CZ2' ' B' ' 287' ' ' TRP . 0.1 OUTLIER -124.76 111.44 15.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.086 -0.506 . . . . 40.33 110.921 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.652 ' HB ' HD12 ' B' ' 241' ' ' LEU . 2.1 mp -111.66 104.83 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 64.24 111.142 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.28 -168.53 32.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 72.22 112.514 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -123.44 153.59 40.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 74.42 110.939 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.574 ' CD ' HG13 ' C' ' 244' ' ' VAL . 0.5 OUTLIER -126.07 121.19 32.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 73.22 110.845 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -109.45 125.71 52.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 72.03 110.928 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 106.21 171.32 23.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.799 -0.715 . . . . 71.51 112.516 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 283' ' ' GLY . . . . . 0.693 ' H ' ' HB2' ' C' ' 247' ' ' ALA . . . 51.96 -171.68 0.34 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.779 -0.724 . . . . 44.31 112.476 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 131.09 47.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.806 0.336 . . . . 73.43 110.879 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -72.54 78.95 0.7 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.718 . . . . 65.34 112.455 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -178.44 131.22 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 64.34 110.856 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.458 ' CZ2' HD23 ' B' ' 276' ' ' LEU . 15.1 t90 -60.94 124.72 21.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 74.12 110.921 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 62.45 -178.14 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.279 -0.419 . . . . 61.3 110.865 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -139.22 176.79 8.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.22 110.905 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 14.6 m170 63.33 104.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 73.14 110.849 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -161.19 109.32 1.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 61.25 110.881 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.05 173.29 14.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 71.44 110.886 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 51.98 43.26 30.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 74.34 110.885 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -163.95 89.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 74.12 110.896 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 45.4 m80 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 71.35 110.9 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 3.6 ptp . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.88 0.371 . . . . 72.42 110.929 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -123.94 25.87 7.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 65.01 110.876 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.804 HG23 HG12 ' D' ' 219' ' ' ILE . 15.4 mt 70.64 -70.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 74.31 111.172 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 220' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' C' ' 221' ' ' ALA . 11.6 m-20 52.71 29.37 7.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.54 110.861 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 221' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' C' ' 220' ' ' ASP . . . 68.95 -77.26 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 75.41 111.126 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 71.3 mt 51.78 88.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 63.24 111.085 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 47.6 t -72.67 -40.86 62.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 73.21 111.132 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 68.83 174.56 9.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.701 -0.762 . . . . 71.23 112.487 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.565 ' O ' HG23 ' C' ' 261' ' ' THR . 0.0 OUTLIER -91.77 -65.32 1.02 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 71.25 110.813 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.464 HD22 HD23 ' C' ' 241' ' ' LEU . 21.9 p-10 -122.78 136.43 54.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 75.51 110.95 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 75.6 m -137.7 145.16 42.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 55.52 110.878 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.05 154.35 49.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 50.03 111.061 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.87 -28.48 10.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 72.23 110.922 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.45 137.59 4.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 74.33 110.867 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 18.1 mt -138.43 116.93 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 73.02 111.142 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.12 115.61 13.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 70.54 110.949 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.8 p -135.81 139.27 43.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 64.3 111.15 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -145.62 166.99 24.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 71.21 110.922 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 66.56 66.97 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 71.02 110.9 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 46.84 51.99 11.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.499 . . . . 61.22 110.897 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.08 151.45 23.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 72.12 111.179 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.24 137.17 47.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 75.25 110.836 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.459 HG13 HG13 ' B' ' 275' ' ' VAL . 6.2 p -133.59 121.95 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 72.24 111.126 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -114.15 135.66 53.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 63.45 110.837 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 1.037 HD12 HD13 ' C' ' 277' ' ' ILE . 0.6 OUTLIER -130.16 118.86 22.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 72.23 110.91 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.9 -173.47 22.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.752 -0.737 . . . . 51.42 112.51 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.02 150.4 23.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 50.23 110.931 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.574 HG13 ' CD ' ' B' ' 280' ' ' GLU . 92.7 t -128.87 121.48 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 55.11 111.125 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.06 129.04 75.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 73.03 111.133 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.9 t -77.03 163.66 26.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 62.41 111.248 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.693 ' HB2' ' H ' ' B' ' 283' ' ' GLY . . . -63.16 -33.65 75.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 74.31 111.106 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.53 -35.98 68.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 74.53 111.056 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 249' ' ' ALA . . . . . 0.418 ' HB2' ' CD2' ' C' ' 281' ' ' TYR . . . -56.71 100.17 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 72.12 111.118 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 33.8 tp -158.38 124.67 4.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 72.35 110.842 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 69.15 -76.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 73.21 110.861 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 52.28 31.86 35.61 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.746 . . . . 52.53 112.476 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 87.24 53.24 2.85 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.719 -0.753 . . . . 63.43 112.504 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 28.8 mm 63.97 75.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 63.41 111.145 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -153.04 114.93 4.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 70.33 110.933 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 39.5 mm -129.97 140.4 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 63.25 111.17 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 6.1 t 58.99 -172.64 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 63.3 110.877 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.27 171.07 14.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 71.45 110.789 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -122.91 57.14 1.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 74.32 110.918 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 20.2 p -99.4 130.51 45.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.199 -0.455 . . . . 75.14 111.097 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.565 HG23 ' O ' ' C' ' 225' ' ' ARG . 30.2 m -134.06 132.15 39.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 54.21 111.178 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.619 ' HB2' HG22 ' C' ' 277' ' ' ILE . 9.9 p-10 -125.38 135.47 52.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 72.23 110.844 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.06 123.78 26.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 71.51 110.829 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.491 HG21 ' CG2' ' C' ' 267' ' ' VAL . 7.4 p -117.67 136.84 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 74.35 111.192 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -79.21 -77.0 0.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 74.45 110.907 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 5.0 m -129.82 130.52 45.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 75.33 111.145 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.491 ' CG2' HG21 ' C' ' 264' ' ' VAL . 21.0 t -117.87 120.64 65.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 55.25 111.114 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 26.2 t -123.84 120.77 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 50.24 111.111 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.02 133.3 8.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.741 . . . . 43.0 112.436 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -133.27 147.47 51.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.82 0.343 . . . . 61.14 110.89 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.2 87.86 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.793 -0.717 . . . . 65.2 112.474 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 44.38 61.04 2.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.889 0.376 . . . . 74.51 110.863 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 35.2 t -92.15 145.33 24.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 74.01 110.909 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.7 127.69 39.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 74.3 110.93 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.497 HG12 HD11 ' C' ' 277' ' ' ILE . 19.5 t -132.03 123.76 51.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 22.21 111.135 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.478 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.1 OUTLIER -128.05 111.8 13.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 64.43 110.9 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 1.037 HD13 HD12 ' C' ' 241' ' ' LEU . 3.4 mp -111.77 119.9 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 73.41 111.109 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.31 -158.34 25.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.735 -0.745 . . . . 35.4 112.467 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -127.98 132.95 49.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.823 0.344 . . . . 74.24 110.851 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.776 ' HG3' HG13 ' D' ' 244' ' ' VAL . 0.0 OUTLIER -111.92 137.78 49.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 74.23 110.88 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.444 ' HE1' ' HB2' ' D' ' 249' ' ' ALA . 14.1 t80 -129.52 125.46 36.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 74.34 110.899 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 126.56 165.68 12.03 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.768 -0.73 . . . . 63.23 112.497 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 283' ' ' GLY . . . . . 0.746 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . 64.7 155.1 0.15 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.717 -0.754 . . . . 60.51 112.432 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -93.26 65.14 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 61.25 110.961 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -160.28 -113.44 0.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.726 -0.75 . . . . 75.24 112.516 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.454 ' HA ' HG11 ' D' ' 244' ' ' VAL . 5.5 p90 -174.58 -35.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 72.11 110.833 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.478 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 7.2 t90 -154.23 26.81 0.47 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 72.0 110.93 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.23 -49.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 54.14 110.916 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 10.4 t30 57.98 88.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 63.14 110.871 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.23 -170.27 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 72.41 110.897 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.96 169.36 18.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 74.21 110.863 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -146.48 -172.6 3.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 64.15 110.874 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 21.1 t60 63.34 161.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.18 -0.464 . . . . 75.24 110.871 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.18 -170.01 2.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 72.43 110.932 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 1.5 m80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 71.1 110.862 -179.987 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.822 0.344 . . . . 71.42 110.901 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.38 -175.02 0.52 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 73.21 110.964 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 219' ' ' ILE . . . . . 0.804 HG12 HG23 ' C' ' 219' ' ' ILE . 2.4 mp -85.78 137.35 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 73.11 111.108 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -147.79 -67.41 0.25 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.159 -0.473 . . . . 75.0 110.825 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -173.03 170.53 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 75.34 111.111 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 222' ' ' ILE . . . . . 0.521 HG23 HG22 ' D' ' 223' ' ' VAL . 9.7 tt -126.03 -37.28 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.23 111.111 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 223' ' ' VAL . . . . . 0.521 HG22 HG23 ' D' ' 222' ' ' ILE . 34.8 m -146.15 -176.91 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 53.1 111.065 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 160.39 -164.39 34.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.737 . . . . 22.11 112.515 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.441 ' O ' HG23 ' D' ' 261' ' ' THR . 0.0 OUTLIER -52.29 -75.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.35 . . . . 73.24 110.851 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -110.77 127.44 55.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 61.41 110.937 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.3 137.96 49.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 71.12 110.885 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.2 155.25 42.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 60.42 111.126 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.46 -24.69 10.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 54.33 110.91 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 230' ' ' ASP . . . . . 0.484 ' HB3' HG23 ' D' ' 266' ' ' THR . 0.3 OUTLIER -165.29 137.09 4.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.858 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 16.6 mt -138.66 117.16 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 63.32 111.136 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 -134.6 115.9 14.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 74.53 110.844 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.7 p -135.75 136.63 40.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 62.3 111.094 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -144.44 167.19 23.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 64.31 110.895 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 64.93 68.07 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 71.33 110.831 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 46.35 52.09 10.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 71.23 110.87 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.08 149.98 24.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 73.04 111.126 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -131.47 139.27 49.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 74.14 110.883 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.465 HG13 HG13 ' C' ' 275' ' ' VAL . 7.2 p -133.94 124.24 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 74.05 111.098 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 240' ' ' GLN . . . . . 0.432 ' HB2' HD22 ' D' ' 276' ' ' LEU . 1.2 tm0? -113.06 132.89 55.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 74.2 110.911 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.761 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.2 mm? -122.34 134.69 54.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 72.31 110.941 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 109.0 -174.66 18.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 70.33 112.431 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -99.36 145.57 27.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.897 0.379 . . . . 74.44 110.911 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 244' ' ' VAL . . . . . 0.776 HG13 ' HG3' ' C' ' 280' ' ' GLU . 88.1 t -122.19 131.54 72.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 74.23 111.132 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 66.7 t -122.16 129.15 75.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 64.35 111.101 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t -69.85 167.68 16.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 74.34 111.147 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 247' ' ' ALA . . . . . 0.746 ' HB2' ' N ' ' C' ' 283' ' ' GLY . . . -62.95 -33.91 76.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 73.4 111.129 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.97 -52.06 66.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.4 111.044 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 249' ' ' ALA . . . . . 0.444 ' HB2' ' HE1' ' C' ' 281' ' ' TYR . . . 51.91 30.49 7.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 74.13 111.073 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.87 -30.4 23.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 71.42 110.987 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -126.65 132.47 51.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.809 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 106.85 -137.58 14.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.658 -0.782 . . . . 44.43 112.447 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 59.87 97.37 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.788 -0.72 . . . . 51.3 112.499 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 254' ' ' ILE . . . . . 0.525 HD12 ' HB2' ' E' ' 255' ' ' ARG . 1.2 tt -158.26 142.15 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 72.35 111.123 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.56 29.78 7.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 71.3 110.875 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 256' ' ' ILE . . . . . 0.419 ' CG1' HD11 ' D' ' 254' ' ' ILE . 7.3 pt -148.84 27.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 63.5 111.128 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 257' ' ' SER . . . . . 0.415 ' HB3' HG21 ' D' ' 254' ' ' ILE . 1.4 p -131.37 -171.0 2.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 64.44 110.839 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -120.41 106.84 12.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 71.32 110.908 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.93 169.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 64.24 110.876 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 96.1 m -65.0 138.11 58.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.13 111.144 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 261' ' ' THR . . . . . 0.441 HG23 ' O ' ' D' ' 225' ' ' ARG . 7.7 m -114.14 123.1 48.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 73.55 111.111 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -126.37 146.7 49.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.894 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 12.8 m -136.99 123.44 20.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 72.32 110.817 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.558 HG21 ' CG2' ' D' ' 267' ' ' VAL . 11.9 p -116.47 133.9 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 72.34 111.127 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.64 -69.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 51.35 110.831 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 266' ' ' THR . . . . . 0.484 HG23 ' HB3' ' D' ' 230' ' ' ASP . 92.9 m -143.85 133.39 23.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.13 111.169 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.6 ' CG1' HG21 ' D' ' 275' ' ' VAL . 53.8 t -118.16 125.88 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 73.53 111.181 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 59.9 t -127.11 125.67 66.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 43.13 111.124 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.63 133.74 8.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.769 -0.729 . . . . 71.24 112.532 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.63 138.34 48.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.831 0.348 . . . . 75.04 110.925 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.5 86.28 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.72 -0.752 . . . . 71.04 112.499 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 51.08 81.66 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 73.12 110.871 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 44.8 t -113.54 145.23 41.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 73.54 110.909 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.61 127.5 39.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 64.42 110.833 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.6 HG21 ' CG1' ' D' ' 267' ' ' VAL . 21.7 t -133.05 123.72 48.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 55.42 111.104 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.444 HD23 ' CZ2' ' D' ' 287' ' ' TRP . 0.1 OUTLIER -128.37 111.5 13.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 65.4 110.94 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.773 HG13 HD23 ' E' ' 241' ' ' LEU . 5.0 mp -109.74 130.17 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 64.53 111.124 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.05 172.47 16.2 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.791 -0.719 . . . . 75.42 112.549 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -89.94 141.97 28.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.329 . . . . 74.52 110.888 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 280' ' ' GLU . . . . . 0.654 ' HG3' HG13 ' E' ' 244' ' ' VAL . 0.0 OUTLIER -121.17 136.74 54.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 64.44 110.884 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -117.26 125.75 51.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 74.25 110.953 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.38 -118.53 6.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 45.35 112.528 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 72.74 157.62 3.9 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.776 -0.726 . . . . 61.31 112.443 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -56.02 -25.33 44.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.803 0.335 . . . . 74.44 110.873 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -171.58 -35.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 63.53 112.513 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -152.93 -72.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.314 . . . . 73.1 110.917 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 287' ' ' TRP . . . . . 0.444 ' CZ2' HD23 ' D' ' 276' ' ' LEU . 14.7 t90 -142.08 -73.28 0.31 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 72.44 110.831 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -173.02 55.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 51.44 110.837 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -59.12 178.75 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 73.03 110.87 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 -177.66 4.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 73.32 110.859 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -85.22 -170.0 2.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 70.43 110.882 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -54.56 172.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 75.41 110.89 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -88.95 -64.5 1.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 73.5 110.844 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -137.2 -47.74 0.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 74.22 110.861 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 71.25 110.857 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.795 0.331 . . . . 63.14 110.872 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -116.4 -27.09 6.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 74.34 110.915 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 2.7 mt -104.75 127.67 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.32 111.136 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -178.65 52.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 71.03 110.908 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 221' ' ' ALA . . . . . 0.604 ' O ' HD13 ' E' ' 222' ' ' ILE . . . -168.58 135.41 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 43.35 111.069 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 222' ' ' ILE . . . . . 0.604 HD13 ' O ' ' E' ' 221' ' ' ALA . 30.2 mm -135.39 123.62 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 63.5 111.109 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 16.6 m -147.63 170.51 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 64.43 111.09 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 141.61 -168.07 25.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.829 -0.701 . . . . 51.22 112.501 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 225' ' ' ARG . . . . . 0.762 ' O ' HG23 ' E' ' 261' ' ' THR . 0.7 OUTLIER -78.91 -75.55 0.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 73.33 110.939 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -89.19 137.31 32.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.911 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.9 147.21 44.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 71.35 110.839 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.83 162.08 29.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 32.31 111.095 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 229' ' ' LYS . . . . . 0.436 ' HB2' ' HA ' ' E' ' 265' ' ' GLU . 3.5 mttm -116.34 -27.32 6.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 72.54 110.884 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 230' ' ' ASP . . . . . 0.559 ' CB ' HG22 ' E' ' 266' ' ' THR . 1.2 t70 -165.85 137.26 3.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 65.35 110.807 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 15.2 mt -138.07 117.54 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 65.24 111.083 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 15.5 ttt-85 -134.46 118.08 16.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 72.23 110.825 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 2.3 p -135.52 147.4 48.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 72.44 111.133 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 234' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' E' ' 237' ' ' ALA . 10.7 pt-20 -156.32 166.87 32.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 74.03 110.886 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 64.08 68.91 0.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 71.43 110.901 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 50.42 31.43 5.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 74.24 110.873 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 237' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' E' ' 234' ' ' GLU . . . -85.64 140.65 30.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 71.4 111.064 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.49 137.67 50.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 72.22 110.89 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.46 HG23 ' HB ' ' E' ' 275' ' ' VAL . 6.2 p -130.38 121.95 52.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 62.05 111.084 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 240' ' ' GLN . . . . . 0.572 ' O ' HD13 ' E' ' 241' ' ' LEU . 0.0 OUTLIER -112.94 136.85 52.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 74.41 110.877 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.773 HD23 HG13 ' D' ' 277' ' ' ILE . 2.0 mm? -124.21 134.16 53.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 62.11 110.869 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 109.18 177.56 21.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.693 -0.765 . . . . 74.3 112.441 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -90.05 148.95 22.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.833 0.349 . . . . 71.31 110.895 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.654 HG13 ' HG3' ' D' ' 280' ' ' GLU . 95.8 t -122.08 131.09 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 42.22 111.145 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 95.4 t -120.8 127.56 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 71.33 111.116 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.6 t -76.84 171.29 14.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 61.25 111.211 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.56 -33.98 76.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 61.21 111.066 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -51.56 68.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 73.55 111.071 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 62.52 -171.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 72.22 111.076 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.61 171.39 1.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 64.24 110.956 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -55.25 -29.61 58.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 75.34 110.83 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -162.34 151.21 21.06 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.757 -0.735 . . . . 44.4 112.485 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -175.14 154.41 18.07 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.761 . . . . 70.41 112.481 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.21 -43.48 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.814 0.34 . . . . 74.35 111.148 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 255' ' ' ARG . . . . . 0.525 ' HB2' HD12 ' D' ' 254' ' ' ILE . 7.4 ptp85 -159.22 69.03 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 74.01 110.857 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.06 173.33 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 54.45 111.069 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -178.68 147.23 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 62.01 110.896 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -109.85 163.16 13.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.115 -0.493 . . . . 75.21 110.879 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -153.04 121.21 6.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 73.14 110.831 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 96.2 m -96.78 134.47 40.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 73.53 111.13 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 261' ' ' THR . . . . . 0.762 HG23 ' O ' ' E' ' 225' ' ' ARG . 85.9 m -91.89 116.06 28.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.137 -0.483 . . . . 60.54 111.153 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -126.12 138.19 53.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.484 . . . . 64.13 110.903 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.42 128.81 53.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 70.24 110.847 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 264' ' ' VAL . . . . . 0.462 HG21 ' CG2' ' E' ' 267' ' ' VAL . 7.9 p -125.55 137.73 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 73.2 111.188 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 265' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' E' ' 229' ' ' LYS . 17.5 mt-10 -82.97 -74.72 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 63.41 110.928 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 266' ' ' THR . . . . . 0.559 HG22 ' CB ' ' E' ' 230' ' ' ASP . 38.9 p -142.54 128.06 19.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 72.25 111.132 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 267' ' ' VAL . . . . . 0.746 HG11 HG21 ' E' ' 275' ' ' VAL . 58.7 t -117.76 120.84 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 73.01 111.162 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 81.9 t -115.72 121.57 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 45.01 111.176 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.45 132.54 10.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.758 -0.734 . . . . 54.31 112.521 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.84 139.45 46.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 54.52 110.85 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.84 88.47 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 12.22 112.512 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 49.59 75.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.872 0.368 . . . . 73.41 110.917 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.23 145.38 30.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 43.14 110.863 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -132.83 127.63 34.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 62.22 110.839 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.746 HG21 HG11 ' E' ' 267' ' ' VAL . 74.9 t -133.69 122.97 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 63.22 111.135 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.19 111.34 12.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 61.1 110.88 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.54 HD12 HD12 ' E' ' 241' ' ' LEU . 9.7 mt -112.59 105.84 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 51.45 111.106 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.9 -158.57 28.19 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.787 -0.721 . . . . 63.23 112.448 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -127.96 145.73 50.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.758 0.314 . . . . 75.52 110.871 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -111.89 122.27 47.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 73.11 110.86 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.25 125.94 51.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 65.43 110.985 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 67.72 150.1 0.2 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.725 -0.75 . . . . 72.32 112.418 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.46 -23.77 1.21 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.683 -0.77 . . . . 70.33 112.434 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 2.2 mttp 52.51 55.28 9.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.363 . . . . 62.41 110.917 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 179.32 -109.47 0.27 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.739 -0.743 . . . . 64.41 112.516 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -175.02 167.82 3.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.847 0.356 . . . . 72.43 110.82 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -51.8 -74.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 73.54 110.917 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -68.53 167.86 14.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 62.22 110.882 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.04 157.45 5.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 73.33 110.916 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -172.82 138.43 0.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 73.54 110.945 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.32 -170.0 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 74.02 110.833 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -127.59 165.15 20.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 65.01 110.885 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.58 174.22 5.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 70.14 110.85 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -155.11 -42.82 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 73.21 110.854 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 74.51 110.899 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 9.4 tpt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.8 0.333 . . . . 74.35 110.877 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -178.18 76.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 62.12 110.962 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 14.4 tt -113.5 -25.52 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 71.24 111.108 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -54.17 145.09 18.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 71.12 110.846 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.657 ' HB3' ' HD2' ' A' ' 225' ' ' ARG . . . -89.97 -175.38 4.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 72.34 111.11 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 3.3 pt -151.25 172.76 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.33 111.123 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 24.2 t 53.7 87.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 75.24 111.076 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 69.26 109.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.798 -0.715 . . . . 43.11 112.468 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.691 ' CB ' HG23 ' A' ' 261' ' ' THR . 0.0 OUTLIER -151.54 144.5 24.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 72.42 110.845 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.701 ' HB3' HG22 ' A' ' 277' ' ' ILE . 0.1 OUTLIER -130.57 109.83 10.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 73.41 110.879 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 1.5 t -125.43 141.81 51.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 52.53 110.896 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.83 119.68 12.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 73.34 111.053 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -74.65 -33.39 62.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 70.43 110.92 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -164.92 138.93 4.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 71.22 110.872 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 10.3 pt -137.35 119.01 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 51.54 111.116 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.85 120.64 37.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 64.11 110.931 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.1 p -129.44 139.18 51.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.216 -0.447 . . . . 74.25 111.108 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -146.53 167.5 23.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 73.35 110.899 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 66.61 65.87 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 75.21 110.944 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 48.85 36.5 8.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.886 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.24 155.83 21.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 73.01 111.121 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -131.71 145.6 51.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 72.51 110.897 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.536 HG23 ' HB ' ' A' ' 275' ' ' VAL . 5.5 p -140.05 121.83 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 71.33 111.2 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -114.54 129.74 56.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 74.12 110.927 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.462 HD22 ' HB ' ' A' ' 277' ' ' ILE . 0.2 OUTLIER -114.83 118.53 33.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 53.55 110.891 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.72 174.87 13.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 50.14 112.54 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -90.92 154.79 19.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 63.34 110.897 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.473 HG13 ' HA ' ' A' ' 280' ' ' GLU . 4.2 p -130.02 123.99 57.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 74.23 111.11 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' A' ' 249' ' ' ALA . 22.0 t -122.07 125.73 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 61.51 111.104 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t -69.98 175.06 4.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 73.11 111.189 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.94 99.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 32.34 111.125 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.21 -47.82 80.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 74.14 111.057 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.409 ' HB3' ' CG1' ' A' ' 245' ' ' VAL . . . -80.23 136.71 36.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 70.5 111.085 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.8 tp -118.07 -171.6 2.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 62.45 110.899 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.82 -40.27 72.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 73.12 110.925 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 91.84 -159.37 25.65 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.661 -0.78 . . . . 74.54 112.54 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.581 ' H ' HD12 ' A' ' 254' ' ' ILE . . . 156.47 62.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 64.3 112.493 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.757 HG22 HG22 ' A' ' 256' ' ' ILE . 3.9 mp -127.77 143.59 40.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.896 0.379 . . . . 75.54 111.119 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 -81.15 57.52 3.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 70.51 110.935 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.757 HG22 HG22 ' A' ' 254' ' ' ILE . 13.5 tt -174.73 138.66 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.25 111.099 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.56 -179.8 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 75.02 110.87 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -104.82 -179.25 3.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 74.45 110.844 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -120.81 38.99 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 72.2 110.939 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 24.4 p -65.21 124.79 23.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 73.2 111.127 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.691 HG23 ' CB ' ' A' ' 225' ' ' ARG . 98.0 m -134.02 124.71 26.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.212 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.632 ' CB ' HD12 ' B' ' 241' ' ' LEU . 0.7 OUTLIER -103.53 121.04 42.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 74.0 110.857 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.629 ' HG ' ' N ' ' C' ' 217' ' ' MET . 0.1 OUTLIER -141.11 123.81 16.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 72.41 110.842 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.616 HG21 ' CD1' ' B' ' 231' ' ' ILE . 8.9 p -119.21 139.58 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 50.32 111.177 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.09 -71.28 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 72.11 110.875 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.6 m -124.19 136.09 53.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 74.23 111.081 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.801 HG22 HD11 ' B' ' 231' ' ' ILE . 19.4 t -120.27 133.5 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 74.42 111.175 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.49 127.13 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 74.33 111.165 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.38 133.39 8.38 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.747 . . . . 41.44 112.42 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.61 147.94 51.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 63.33 110.886 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.18 81.6 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 42.21 112.503 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 46.45 65.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 61.52 110.907 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 42.2 t -89.63 145.68 25.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 54.15 110.783 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -119.53 127.9 53.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.088 -0.506 . . . . 71.45 110.88 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.536 ' HB ' HG23 ' A' ' 239' ' ' VAL . 98.8 t -124.38 123.03 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 73.55 111.111 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 27.6 tp -128.71 111.7 13.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.964 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.701 HG22 ' HB3' ' A' ' 226' ' ' ASN . 26.3 mm -110.86 104.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.24 111.131 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.73 170.92 18.4 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 75.51 112.455 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -90.45 137.81 32.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.774 0.321 . . . . 63.24 110.927 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.73 ' HG3' HG23 ' B' ' 244' ' ' VAL . 4.9 pt-20 -111.95 120.27 41.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 74.14 110.923 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.6 125.91 51.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 74.21 110.967 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 118.5 169.95 14.71 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.661 -0.781 . . . . 45.2 112.427 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -67.42 -119.81 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.737 -0.744 . . . . 40.34 112.488 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.53 27.07 7.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.336 . . . . 74.41 110.913 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.02 -103.04 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.762 -0.732 . . . . 74.11 112.458 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -132.08 146.02 51.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.361 . . . . 64.12 110.869 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER 67.28 -78.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 71.41 110.904 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -138.04 172.61 12.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 74.13 110.935 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -57.42 149.75 20.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 75.32 110.856 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -157.5 40.77 0.3 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 72.33 110.864 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 59.91 98.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 70.1 110.896 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -109.03 150.54 27.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 75.5 110.87 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.87 175.69 3.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.849 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 61.48 99.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 73.35 110.869 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 23.6 p80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 73.14 110.917 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 2.2 ptm . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.83 0.348 . . . . 74.33 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -109.28 100.87 9.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.424 . . . . 73.43 110.904 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 3.8 mt -99.01 -29.38 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 70.03 111.052 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 59.5 175.63 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 72.13 110.801 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -172.27 45.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 74.25 111.081 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 1.4 pt -105.48 65.07 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 75.34 111.181 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.12 155.23 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 72.14 111.116 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -116.17 -178.67 18.2 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.727 -0.749 . . . . 64.11 112.454 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -171.72 132.26 0.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.752 0.31 . . . . 74.45 110.865 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.524 ' HB3' HG22 ' B' ' 277' ' ' ILE . 0.8 OUTLIER -138.06 109.43 6.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 63.51 110.915 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 22.1 t -126.83 145.96 50.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 61.33 110.87 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.468 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -139.89 119.76 13.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 73.34 111.076 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -35.76 77.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 54.55 110.968 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -165.4 138.28 4.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 73.33 110.899 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.801 HD11 HG22 ' A' ' 267' ' ' VAL . 31.5 pt -132.86 131.25 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 73.44 111.071 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -134.5 125.16 26.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 71.43 110.856 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.75 128.73 37.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 60.24 111.136 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -134.97 167.4 20.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 73.53 110.883 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 63.06 68.99 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.12 110.918 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 2.6 mtm-85 47.65 40.76 12.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 71.52 110.905 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.74 156.14 17.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 73.13 111.086 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.64 148.41 50.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 73.34 110.905 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' B' ' 275' ' ' VAL . 4.1 p -138.28 121.53 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 70.12 111.172 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -111.2 129.2 56.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 71.42 110.859 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.632 HD12 ' CB ' ' A' ' 262' ' ' ASN . 0.2 OUTLIER -113.79 118.55 34.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.483 . . . . 64.05 110.973 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.24 179.75 16.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.721 . . . . 34.44 112.514 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -87.42 144.51 26.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 72.23 110.918 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.73 HG23 ' HG3' ' A' ' 280' ' ' GLU . 4.7 p -118.88 119.86 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 65.24 111.141 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.35 128.32 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 72.45 111.237 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 48.9 p -80.19 173.92 12.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 61.22 111.172 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.04 96.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 73.23 111.087 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.54 -51.58 68.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 53.14 111.125 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.92 129.2 26.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 73.34 111.151 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 2.0 mt -143.16 -50.5 0.34 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.175 -0.466 . . . . 71.5 110.858 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 251' ' ' HIS . . . . . 0.443 ' NE2' HG21 ' A' ' 256' ' ' ILE . 40.5 t-80 -157.9 132.48 8.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.881 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -162.19 161.18 33.28 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.747 -0.739 . . . . 74.55 112.518 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 137.64 -72.62 0.44 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.72 -0.752 . . . . 73.13 112.522 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 37.1 mt 63.01 69.87 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.756 0.313 . . . . 63.14 111.101 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 56.9 93.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 75.15 110.89 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.5 pt -143.59 176.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 74.41 111.112 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.79 98.42 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 73.44 110.843 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.593 ' O ' HG23 ' B' ' 260' ' ' THR . 10.8 m-20 -150.44 76.83 1.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 75.0 110.857 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.05 98.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 71.44 110.901 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.593 HG23 ' O ' ' B' ' 258' ' ' ASP . 35.5 p -100.86 121.99 42.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 64.21 111.104 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 2.1 t -126.69 127.27 44.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.429 . . . . 65.11 111.192 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.59 129.03 56.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 75.42 110.887 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.9 t -140.95 122.9 15.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 73.11 110.879 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.628 HG21 ' CD1' ' C' ' 231' ' ' ILE . 4.8 p -112.93 141.97 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.484 . . . . 64.13 111.092 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -80.7 -77.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 74.32 110.886 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 18.9 m -120.87 133.71 55.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 63.35 111.099 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.762 HG22 HD11 ' C' ' 231' ' ' ILE . 3.2 t -117.69 124.5 73.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.14 -0.482 . . . . 75.01 111.088 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 59.7 t -123.66 116.02 46.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.495 . . . . 65.01 111.12 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.58 133.33 10.83 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.723 -0.751 . . . . 61.54 112.511 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.35 147.58 51.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.323 . . . . 65.03 110.965 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.94 84.1 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.713 -0.756 . . . . 72.21 112.496 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 46.1 64.98 1.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.808 0.337 . . . . 75.32 110.865 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 27.9 t -93.94 145.61 24.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 74.24 110.838 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.46 128.02 50.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 72.42 110.833 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' B' ' 239' ' ' VAL . 78.5 t -122.95 123.7 68.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 75.41 111.133 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.723 HD22 ' CE3' ' B' ' 287' ' ' TRP . 0.4 OUTLIER -126.55 111.64 14.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 73.45 110.924 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.524 HG22 ' HB3' ' B' ' 226' ' ' ASN . 27.0 mm -109.59 104.64 17.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 72.13 111.104 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.76 175.87 18.28 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.691 -0.766 . . . . 45.34 112.453 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -89.9 154.99 19.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 71.31 110.834 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.691 ' HG3' HG23 ' C' ' 244' ' ' VAL . 12.6 pt-20 -128.72 146.87 50.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 73.12 110.868 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.41 ' CZ ' HG11 ' C' ' 245' ' ' VAL . 0.6 OUTLIER -126.44 125.85 42.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.932 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 128.97 -147.88 17.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.669 -0.777 . . . . 54.54 112.474 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -128.62 -145.09 5.92 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.837 -0.697 . . . . 61.12 112.508 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 63.27 78.82 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.874 0.368 . . . . 53.54 110.867 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.12 -108.61 0.68 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.761 -0.733 . . . . 64.1 112.458 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.06 -60.06 1.79 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 75.33 110.922 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.723 ' CE3' HD22 ' B' ' 276' ' ' LEU . 5.9 p90 -143.18 14.56 1.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.02 110.872 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.21 -171.72 1.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.411 . . . . 74.1 110.909 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -123.59 92.1 3.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 55.11 110.904 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 72.9 t60 61.62 100.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 73.11 110.872 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -159.58 146.22 16.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 73.41 110.847 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 61.94 100.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 72.04 110.818 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -147.21 97.19 2.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 74.31 110.823 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -176.07 172.2 2.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 70.12 110.833 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 62.21 110.864 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 217' ' ' MET . . . . . 0.629 ' N ' ' HG ' ' A' ' 263' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.787 0.327 . . . . 74.4 110.884 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -141.79 138.98 32.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 75.13 110.866 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 33.2 mm 59.36 92.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 72.13 111.124 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.96 116.67 6.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 63.54 110.827 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -92.16 139.54 30.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 53.54 111.13 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 39.1 pt -81.87 156.77 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 74.01 111.152 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 27.7 t 53.33 85.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 62.22 111.13 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -65.59 -162.89 1.0 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.705 -0.76 . . . . 61.2 112.524 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.87 -44.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.868 0.366 . . . . 53.12 110.883 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.58 110.49 6.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.43 110.953 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.543 ' HB2' HD13 ' D' ' 219' ' ' ILE . 1.4 t -130.86 141.09 50.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 72.32 110.863 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.16 135.16 46.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 74.33 111.127 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -29.92 21.01 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.218 -0.447 . . . . 72.42 110.909 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.81 136.61 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 62.45 110.883 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.762 HD11 HG22 ' B' ' 267' ' ' VAL . 3.7 pt -138.4 117.52 14.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 73.41 111.113 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -122.12 116.46 24.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 74.11 110.866 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.415 HG21 ' HB ' ' C' ' 239' ' ' VAL . 2.6 p -124.11 128.76 49.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 62.11 111.143 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.48 167.5 21.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 74.44 110.904 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 64.33 74.72 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 74.53 110.906 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 44.38 38.65 2.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 73.31 110.829 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -93.16 156.17 17.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 72.12 111.1 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.24 156.17 49.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 71.54 110.901 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.415 ' HB ' HG21 ' C' ' 233' ' ' THR . 7.8 p -138.19 146.92 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 72.54 111.117 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -134.75 137.49 43.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 72.52 110.901 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.589 HD22 ' HB ' ' C' ' 277' ' ' ILE . 0.3 OUTLIER -126.88 124.89 40.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 45.42 110.92 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.52 178.09 16.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.676 -0.773 . . . . 72.41 112.489 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -86.47 157.02 19.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 54.34 110.864 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.691 HG23 ' HG3' ' B' ' 280' ' ' GLU . 5.4 p -128.69 135.4 62.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 64.42 111.176 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' B' ' 281' ' ' TYR . 39.3 t -122.09 127.96 75.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 73.03 111.132 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 27.9 p -83.8 162.89 20.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 63.44 111.136 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.23 -34.27 76.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 42.34 111.161 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.95 -51.16 70.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.141 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 63.69 169.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 53.15 111.118 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.41 111.03 4.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.436 . . . . 60.04 110.907 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -107.27 28.24 8.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 70.43 110.798 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -177.46 116.68 0.55 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.735 -0.745 . . . . 52.13 112.499 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 111.72 -21.06 21.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 73.53 112.503 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 15.3 mt 70.72 -70.51 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.866 0.365 . . . . 75.5 111.086 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.83 131.96 8.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 70.05 110.913 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.36 26.38 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 72.23 111.099 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 4.2 m 62.96 162.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 13.25 110.867 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -173.3 136.29 0.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 60.24 110.856 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -160.89 50.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 75.54 110.913 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 260' ' ' THR . . . . . 0.499 HG21 ' HB3' ' D' ' 243' ' ' ASN . 27.1 p -90.1 126.08 35.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 61.14 111.124 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.8 m -107.46 108.68 20.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 74.5 111.155 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.733 ' HB2' HD12 ' D' ' 241' ' ' LEU . 0.0 OUTLIER -100.15 130.6 46.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 64.45 110.886 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 29.3 t -142.05 123.26 14.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 75.44 110.798 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.633 HG21 HD11 ' D' ' 231' ' ' ILE . 5.9 p -115.04 148.06 18.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 54.15 111.154 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.94 -72.77 0.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 64.45 110.858 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 27.7 m -129.08 137.54 51.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 73.14 111.066 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.824 HG22 HD11 ' D' ' 231' ' ' ILE . 4.2 t -118.79 129.54 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 71.25 111.108 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 73.1 t -127.13 115.96 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 74.34 111.183 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.8 133.04 9.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.727 . . . . 34.05 112.475 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -133.74 147.68 51.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.351 . . . . 73.45 110.941 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.56 89.13 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.769 -0.729 . . . . 64.44 112.499 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 44.8 60.59 2.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.804 0.335 . . . . 65.22 110.873 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.28 144.98 25.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 73.33 110.874 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.59 128.07 48.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.487 . . . . 73.52 110.951 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 94.2 t -123.44 123.56 67.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 64.12 111.159 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.682 HD13 ' CE3' ' C' ' 287' ' ' TRP . 0.5 OUTLIER -126.58 111.69 14.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 74.3 110.925 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.589 ' HB ' HD22 ' C' ' 241' ' ' LEU . 27.4 mm -108.32 104.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 73.45 111.134 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.42 -164.65 29.04 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.814 -0.708 . . . . 53.23 112.606 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -122.01 156.01 34.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.314 . . . . 70.12 110.91 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.75 ' CG ' HG23 ' D' ' 244' ' ' VAL . 9.5 pt-20 -119.51 146.7 45.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 74.53 110.903 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -129.94 134.89 47.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 72.24 110.902 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.49 148.4 20.46 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 62.51 112.549 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 283' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' D' ' 247' ' ' ALA . . . 51.77 -161.55 1.89 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 74.43 112.462 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -131.99 -169.47 2.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 61.21 110.934 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 81.2 139.02 2.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.784 -0.722 . . . . 52.3 112.427 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -45.74 -39.64 8.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.782 0.325 . . . . 62.25 110.91 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.682 ' CE3' HD13 ' C' ' 276' ' ' LEU . 4.0 p90 179.67 -29.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.156 -0.475 . . . . 72.41 110.899 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.38 -169.37 1.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 70.31 110.807 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 63.75 106.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 72.52 110.93 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -115.77 -172.09 2.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 74.24 110.9 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -75.07 132.58 41.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.454 . . . . 74.0 110.845 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -119.25 -176.49 3.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 75.51 110.844 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -139.74 -177.76 5.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 71.51 110.877 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.04 -169.88 1.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 53.14 110.883 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 64.35 110.897 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.885 0.374 . . . . 60.1 110.821 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 161.13 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 63.54 110.811 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 219' ' ' ILE . . . . . 0.543 HD13 ' HB2' ' C' ' 227' ' ' SER . 73.6 mt -137.31 -71.45 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 72.33 111.084 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -173.7 -170.12 0.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 75.44 110.856 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.15 -169.81 2.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 75.34 111.144 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 3.7 mp -128.62 118.01 46.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 62.41 111.108 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 22.3 t -145.06 65.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 72.04 111.138 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 79.77 -125.89 7.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.737 -0.745 . . . . 71.53 112.458 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.35 -167.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 63.04 110.863 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.3 115.63 22.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 64.32 110.859 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.16 138.43 48.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 72.4 110.823 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 228' ' ' ALA . . . . . 0.402 ' HB3' HG23 ' C' ' 264' ' ' VAL . . . -138.19 119.81 15.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 63.23 111.09 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.41 -27.46 56.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 63.14 110.933 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.24 136.76 2.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 62.33 110.867 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 231' ' ' ILE . . . . . 0.824 HD11 HG22 ' C' ' 267' ' ' VAL . 4.3 pt -139.35 117.17 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 72.21 111.067 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -126.54 128.98 47.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 73.14 110.882 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.14 128.83 32.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 75.42 111.164 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -133.16 167.34 20.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 73.11 110.943 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 63.88 72.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.469 . . . . 71.24 110.886 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 44.63 47.25 8.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 64.1 110.867 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.98 155.62 17.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 73.02 111.102 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.37 144.4 46.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 70.25 110.866 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 5.6 p -129.11 140.21 49.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 71.33 111.114 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -133.39 121.72 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 74.21 110.927 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' C' ' 262' ' ' ASN . 0.1 OUTLIER -111.78 118.88 36.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 75.53 110.904 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.77 172.35 13.11 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.754 -0.736 . . . . 74.04 112.451 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 243' ' ' ASN . . . . . 0.499 ' HB3' HG21 ' C' ' 260' ' ' THR . 2.9 p-10 -86.0 143.23 28.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.373 . . . . 73.1 110.938 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 244' ' ' VAL . . . . . 0.75 HG23 ' CG ' ' C' ' 280' ' ' GLU . 4.4 p -110.23 128.76 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 62.55 111.158 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 23.1 t -122.02 128.94 75.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 61.51 111.198 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 30.5 p -86.14 174.17 9.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 72.22 111.154 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 247' ' ' ALA . . . . . 0.504 ' HB2' ' H ' ' C' ' 283' ' ' GLY . . . -59.37 -44.58 92.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 51.42 111.069 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.3 -51.23 70.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 55.3 111.121 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 52.07 -169.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 72.42 111.089 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 250' ' ' LEU . . . . . 0.841 HD11 ' HB2' ' E' ' 249' ' ' ALA . 3.2 tp -90.92 -169.94 2.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 63.33 110.925 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -146.5 103.95 3.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.447 . . . . 72.45 110.834 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 111.65 160.96 16.37 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.724 -0.75 . . . . 64.02 112.496 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 101.93 110.82 3.4 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.626 -0.797 . . . . 62.44 112.465 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 16.2 tt -121.72 -34.31 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 71.32 111.195 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.91 170.67 16.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 63.43 110.873 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 18.9 tt -61.28 140.72 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.32 111.136 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.66 -170.33 2.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 50.43 110.831 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 63.26 104.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 61.45 110.838 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 259' ' ' GLN . . . . . 0.483 ' NE2' ' H ' ' E' ' 257' ' ' SER . 10.1 pm0 -105.15 27.4 8.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 53.3 110.942 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 260' ' ' THR . . . . . 0.723 HG21 ' CG ' ' E' ' 243' ' ' ASN . 35.4 p -85.18 129.94 34.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 63.34 111.098 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 76.9 m -134.13 125.54 28.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 72.44 111.165 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 262' ' ' ASN . . . . . 0.457 ' OD1' HG22 ' D' ' 277' ' ' ILE . 0.4 OUTLIER -116.71 122.16 43.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 74.11 110.925 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.1 123.54 14.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 73.11 110.786 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.75 HG21 ' CD1' ' E' ' 231' ' ' ILE . 8.0 p -122.76 138.56 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 72.01 111.149 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -72.09 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 74.41 110.898 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 72.9 p -124.48 135.65 53.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 70.32 111.108 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.676 HG22 HD11 ' E' ' 231' ' ' ILE . 7.7 t -119.08 130.51 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 71.23 111.1 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 268' ' ' VAL . . . . . 0.437 HG11 ' NE ' ' E' ' 232' ' ' ARG . 2.1 t -127.38 120.79 55.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 55.44 111.108 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.46 132.64 9.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.766 -0.73 . . . . 74.42 112.542 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -134.35 149.15 50.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.79 0.329 . . . . 73.15 110.976 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.45 87.53 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 72.01 112.467 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 43.29 56.87 4.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 63.41 110.814 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 30.5 t -86.71 145.08 26.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 74.41 110.88 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.72 128.28 49.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 75.35 110.861 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 98.6 t -119.97 123.21 70.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.469 . . . . 73.14 111.116 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.63 HD23 ' HG2' ' E' ' 240' ' ' GLN . 0.8 OUTLIER -128.46 113.33 15.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 74.24 110.955 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.553 ' HB ' HD22 ' D' ' 241' ' ' LEU . 29.9 mm -112.41 104.73 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 71.45 111.118 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.99 175.89 17.52 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.764 -0.732 . . . . 44.34 112.473 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -89.92 156.12 18.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 74.44 110.909 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 280' ' ' GLU . . . . . 0.771 ' HG3' HG23 ' E' ' 244' ' ' VAL . 19.8 pt-20 -124.7 134.06 52.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 54.42 110.88 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -124.76 125.78 44.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.91 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 168.81 -152.2 19.67 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 72.41 112.51 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -78.83 57.95 4.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.687 -0.768 . . . . 75.11 112.516 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 284' ' ' LYS . . . . . 0.519 ' N ' HG23 ' E' ' 246' ' ' THR . 0.0 OUTLIER 54.13 -174.12 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.757 0.313 . . . . 73.53 110.901 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 66.87 144.46 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 34.13 112.534 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -59.73 -172.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 63.12 110.833 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 287' ' ' TRP . . . . . 0.591 ' CE3' HD13 ' D' ' 276' ' ' LEU . 8.8 p90 -50.57 160.61 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.079 -0.51 . . . . 74.55 110.945 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 12.7 t0 51.75 87.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 65.05 110.929 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -55.5 111.93 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 63.53 110.89 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -95.05 -43.44 8.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 74.52 110.828 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -56.12 124.04 16.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.21 110.848 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -130.25 158.52 39.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 53.51 110.829 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -129.57 169.74 14.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 72.11 110.853 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 62.91 166.32 0.12 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.222 -0.445 . . . . 71.54 110.885 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 73.42 110.836 -179.963 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.843 0.354 . . . . 74.13 110.836 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 218' ' ' LYS . . . . . 0.475 ' O ' HD13 ' E' ' 219' ' ' ILE . 5.4 mttp -147.29 115.72 6.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 72.5 110.901 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 219' ' ' ILE . . . . . 0.475 HD13 ' O ' ' E' ' 218' ' ' LYS . 33.2 mm -131.12 118.18 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.34 111.095 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.58 -74.5 0.44 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 74.05 110.884 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.98 170.46 1.86 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 73.3 111.075 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 222' ' ' ILE . . . . . 0.649 HG22 HG13 ' E' ' 223' ' ' VAL . 46.6 mm -127.58 -71.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 74.32 111.11 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 223' ' ' VAL . . . . . 0.649 HG13 HG22 ' E' ' 222' ' ' ILE . 34.0 m -150.29 155.77 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 71.42 111.127 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 174.87 -130.08 1.7 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.754 -0.736 . . . . 74.32 112.455 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 225' ' ' ARG . . . . . 0.648 ' HA ' HG23 ' E' ' 261' ' ' THR . 0.1 OUTLIER -131.28 -59.6 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 72.54 110.872 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.83 109.94 22.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 73.01 110.859 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 1.8 m -134.28 137.51 44.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 75.24 110.892 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 228' ' ' ALA . . . . . 0.518 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -139.32 124.88 19.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 74.14 111.091 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.41 -25.88 60.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 63.4 110.922 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 230' ' ' ASP . . . . . 0.685 ' HB3' HG23 ' E' ' 266' ' ' THR . 27.9 t0 -167.15 137.26 2.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 55.54 110.91 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 231' ' ' ILE . . . . . 0.75 ' CD1' HG21 ' D' ' 264' ' ' VAL . 23.5 pt -138.18 128.94 36.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 61.32 111.182 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 232' ' ' ARG . . . . . 0.437 ' NE ' HG11 ' D' ' 268' ' ' VAL . 26.2 ttm180 -133.87 131.41 39.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 60.4 110.906 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.43 128.57 31.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 64.54 111.146 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -132.29 166.47 21.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.419 . . . . 63.32 110.896 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 64.53 69.71 0.5 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.474 . . . . 70.35 110.943 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 47.15 35.18 3.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 63.53 110.941 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.38 156.35 18.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.138 -0.483 . . . . 52.1 111.119 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -140.94 158.89 43.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 72.14 110.856 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.525 HG23 ' HB ' ' E' ' 275' ' ' VAL . 4.8 p -138.08 143.12 33.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 63.11 111.114 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 240' ' ' GLN . . . . . 0.63 ' HG2' HD23 ' D' ' 276' ' ' LEU . 5.7 tm0? -132.39 125.99 32.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.085 -0.507 . . . . 71.12 110.852 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.812 HD13 ' HB ' ' E' ' 277' ' ' ILE . 3.9 mm? -111.9 118.74 36.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 75.32 110.943 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.22 -173.83 20.21 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.758 -0.734 . . . . 73.1 112.524 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 243' ' ' ASN . . . . . 0.723 ' CG ' HG21 ' D' ' 260' ' ' THR . 5.6 p-10 -104.97 154.76 19.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.925 0.393 . . . . 74.52 110.803 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.771 HG23 ' HG3' ' D' ' 280' ' ' GLU . 4.6 p -115.86 125.02 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 73.01 111.092 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 91.0 t -112.84 129.14 68.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 55.4 111.168 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 246' ' ' THR . . . . . 0.519 HG23 ' N ' ' D' ' 284' ' ' LYS . 1.4 m -85.58 163.47 18.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 65.25 111.165 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.83 -34.85 68.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 71.43 111.132 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 248' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' E' ' 249' ' ' ALA . . . -57.07 -52.0 67.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 74.31 111.085 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 249' ' ' ALA . . . . . 0.841 ' HB2' HD11 ' D' ' 250' ' ' LEU . . . 68.88 -77.31 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 73.4 111.113 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 250' ' ' LEU . . . . . 0.418 HD12 ' HB1' ' E' ' 248' ' ' ALA . 0.2 OUTLIER 51.91 82.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 53.14 110.885 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 56.0 64.51 1.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 73.11 110.928 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -70.95 -46.83 42.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.699 -0.762 . . . . 52.4 112.47 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 163.32 178.11 36.79 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.732 -0.747 . . . . 60.21 112.48 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 5.3 mp -139.98 -42.35 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 72.55 111.121 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 12.2 ttt-85 -175.48 103.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 72.42 110.847 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 51.5 mt 55.88 93.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 64.23 111.134 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 257' ' ' SER . . . . . 0.483 ' H ' ' NE2' ' D' ' 259' ' ' GLN . 11.7 t -98.81 -70.32 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 73.1 110.914 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.81 154.78 19.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 71.03 110.876 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.68 25.59 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 73.22 110.955 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 49.7 m -65.51 121.95 16.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 74.24 111.045 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 261' ' ' THR . . . . . 0.648 HG23 ' HA ' ' E' ' 225' ' ' ARG . 30.0 m -134.11 127.71 32.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 62.25 111.11 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.69 119.91 39.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 64.54 110.944 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 48.0 t -133.3 125.15 28.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 63.05 110.882 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 264' ' ' VAL . . . . . 0.465 HG11 ' CG2' ' E' ' 267' ' ' VAL . 5.1 p -128.22 146.68 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 42.44 111.101 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.64 -64.94 1.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 73.45 110.873 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 266' ' ' THR . . . . . 0.685 HG23 ' HB3' ' E' ' 230' ' ' ASP . 2.5 m -135.85 138.13 42.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 64.05 111.17 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 267' ' ' VAL . . . . . 0.465 ' CG2' HG11 ' E' ' 264' ' ' VAL . 7.9 t -126.48 130.84 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 64.23 111.136 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 5.7 p -128.37 124.01 61.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 64.34 111.101 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.77 138.99 15.04 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.718 -0.753 . . . . 60.31 112.475 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -132.93 148.84 52.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.779 0.323 . . . . 62.44 110.963 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.08 88.91 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.726 -0.75 . . . . 54.33 112.494 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 41.84 56.96 3.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.855 0.36 . . . . 52.12 110.925 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 30.2 t -83.92 145.01 28.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 54.14 110.815 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -126.29 127.88 46.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 74.02 110.898 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.525 ' HB ' HG23 ' E' ' 239' ' ' VAL . 99.6 t -116.93 123.52 71.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 73.11 111.155 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.665 HD13 ' CD2' ' E' ' 287' ' ' TRP . 0.3 OUTLIER -128.77 111.83 13.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 73.04 110.885 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.812 ' HB ' HD13 ' E' ' 241' ' ' LEU . 29.4 mm -112.14 104.95 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 72.35 111.09 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.73 -165.06 28.82 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.791 -0.719 . . . . 40.44 112.505 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -116.48 156.01 27.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.343 . . . . 73.44 110.893 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -118.01 118.92 33.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 72.04 110.973 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -106.86 126.08 51.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 75.02 110.915 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 105.13 -35.23 5.2 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.724 -0.75 . . . . 61.31 112.466 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -66.59 -152.15 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 73.21 112.501 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.59 -58.34 1.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 54.41 110.812 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -152.84 -40.21 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.706 -0.759 . . . . 63.2 112.515 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -113.18 170.21 8.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.884 0.373 . . . . 62.03 110.901 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 287' ' ' TRP . . . . . 0.665 ' CD2' HD13 ' E' ' 276' ' ' LEU . 13.8 p90 -95.31 25.19 4.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 75.42 110.88 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -174.5 49.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 64.24 110.81 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -140.77 125.82 18.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 72.43 110.879 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.71 -174.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 64.05 110.805 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -171.13 -38.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 75.34 110.843 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 61.83 83.01 0.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 74.33 110.865 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.83 152.77 24.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 73.03 110.803 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -56.25 118.49 4.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 73.35 110.846 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 72.45 110.841 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 6.7 mtp . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.856 0.36 . . . . 62.44 110.892 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.23 -169.8 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 64.23 110.831 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.0 mt -120.54 132.99 68.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 75.11 111.074 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -164.26 27.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 70.12 110.826 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.73 167.95 2.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 74.14 111.047 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.789 HG22 HG23 ' A' ' 223' ' ' VAL . 62.8 mt -63.7 -57.93 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 62.54 111.135 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.875 HG21 HG21 ' A' ' 256' ' ' ILE . 97.4 t -149.87 -72.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 63.34 111.202 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 67.76 122.95 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.759 -0.734 . . . . 34.24 112.516 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.668 ' O ' HG23 ' A' ' 261' ' ' THR . 0.5 OUTLIER -142.85 60.95 1.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 74.32 110.895 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.585 ' OD1' HG22 ' A' ' 277' ' ' ILE . 5.8 m-80 -142.42 135.72 28.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 75.25 110.821 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.99 137.48 54.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 71.1 110.818 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.772 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -127.65 119.64 26.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 64.42 111.096 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.19 -34.04 37.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 64.52 110.915 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.77 132.21 1.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.469 . . . . 70.14 110.907 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.809 HD12 HG21 ' A' ' 239' ' ' VAL . 9.9 pt -141.05 134.35 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 63.44 111.149 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -134.08 128.2 33.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 73.14 110.834 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.479 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.2 OUTLIER -135.21 141.34 45.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 72.25 111.192 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -148.87 151.14 34.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 72.54 110.894 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 64.16 91.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 62.32 110.886 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 39.27 41.12 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 75.53 110.817 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.479 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -102.49 139.69 37.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 72.43 111.097 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.31 158.62 44.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 65.41 110.874 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.809 HG21 HD12 ' A' ' 231' ' ' ILE . 16.3 m -142.72 134.94 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 71.0 111.058 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.458 ' HB3' HD23 ' A' ' 276' ' ' LEU . 0.0 OUTLIER -110.45 134.16 52.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 55.23 110.863 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.772 HD21 ' HB2' ' A' ' 228' ' ' ALA . 0.5 OUTLIER -130.79 118.78 21.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 72.22 110.948 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.34 -121.16 3.07 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.692 -0.766 . . . . 60.33 112.465 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -144.39 129.15 18.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.931 0.396 . . . . 75.03 110.834 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.482 HG13 ' HA ' ' A' ' 280' ' ' GLU . 7.1 p -116.44 123.01 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.483 . . . . 71.33 111.169 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.0 m -121.97 129.05 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 73.15 111.154 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 14.6 t -70.0 162.88 27.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 64.43 111.108 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.11 -33.96 76.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 64.44 111.1 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.97 -35.91 69.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 73.11 111.125 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.47 105.55 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 61.51 111.126 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.955 HD13 HD13 ' A' ' 254' ' ' ILE . 4.9 mp 56.98 -179.26 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 71.24 110.871 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.97 -59.59 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 71.41 110.868 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.02 112.93 1.29 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 70.54 112.536 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 102.32 58.63 0.77 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.717 -0.754 . . . . 73.25 112.527 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.955 HD13 HD13 ' A' ' 250' ' ' LEU . 6.2 tp -89.98 142.03 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.837 0.351 . . . . 65.54 111.149 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.438 ' H ' HD12 ' A' ' 254' ' ' ILE . 14.1 ttm180 -136.24 117.83 14.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 73.24 110.819 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.875 HG21 HG21 ' A' ' 223' ' ' VAL . 1.9 tt -52.1 146.06 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 62.44 111.1 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 17.7 p -114.01 67.02 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.53 110.791 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -54.92 126.94 26.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 64.21 110.888 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -179.12 -36.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 74.04 110.917 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.0 128.17 46.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 41.3 111.137 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 225' ' ' ARG . 86.2 m -132.01 125.47 31.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 74.15 111.111 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.71 ' OD1' HG23 ' A' ' 277' ' ' ILE . 7.6 t-20 -105.84 143.51 33.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 74.22 110.933 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.6 p -135.72 123.82 22.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 71.32 110.882 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.626 HG23 HD11 ' B' ' 231' ' ' ILE . 8.1 p -111.19 146.46 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 43.14 111.197 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.63 -64.73 1.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 63.13 110.852 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.3 m -138.8 127.94 24.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 74.01 111.207 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.596 HG11 HG21 ' A' ' 275' ' ' VAL . 13.8 t -118.4 132.12 69.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 74.14 111.133 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.424 HG12 ' HD2' ' A' ' 270' ' ' LYS . 61.5 t -128.31 115.16 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 71.13 111.13 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.07 133.37 10.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 45.12 112.482 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.424 ' HD2' HG12 ' A' ' 268' ' ' VAL . 0.0 OUTLIER -132.72 141.99 48.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.818 0.342 . . . . 63.51 110.896 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.28 86.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 63.15 112.546 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 51.57 81.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 71.23 110.859 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 13.2 t -113.88 144.66 42.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 74.31 110.857 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 49.6 mtt85 -127.79 127.63 43.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 72.35 110.933 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.596 HG21 HG11 ' A' ' 267' ' ' VAL . 13.3 t -124.06 123.97 67.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 73.13 111.11 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 240' ' ' GLN . 1.5 mt -115.15 111.75 21.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 74.33 110.927 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.71 HG23 ' OD1' ' A' ' 262' ' ' ASN . 47.2 mm -112.1 104.92 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 74.45 111.123 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.39 -146.58 18.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.683 -0.77 . . . . 71.32 112.479 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -117.45 150.59 38.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 72.21 110.908 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.788 ' HG3' HG23 ' B' ' 244' ' ' VAL . 14.8 pt-20 -129.54 133.76 47.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 71.42 110.821 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.432 ' HA ' HG23 ' B' ' 245' ' ' VAL . 0.5 OUTLIER -114.42 126.06 54.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.864 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 132.57 150.95 6.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.69 -0.767 . . . . 72.35 112.454 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.423 ' H ' ' HB2' ' B' ' 247' ' ' ALA . . . -116.37 -144.36 8.01 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 32.03 112.499 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.02 -75.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 74.22 110.899 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -117.8 92.63 0.55 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.762 -0.732 . . . . 71.11 112.494 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.404 ' HE1' HG21 ' B' ' 244' ' ' VAL . 71.1 t80 -52.36 114.05 1.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.35 . . . . 74.01 110.896 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 3.0 t90 72.36 -69.2 0.2 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.197 -0.456 . . . . 72.31 110.88 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -122.24 -169.97 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 72.41 110.808 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -52.21 137.23 28.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 72.2 110.928 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.19 141.22 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 73.43 110.876 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -171.3 142.41 1.72 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 74.53 110.884 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.89 170.29 1.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.784 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -174.32 155.66 2.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 73.51 110.853 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -127.6 -73.79 0.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 73.21 110.808 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 75.53 110.834 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 2.5 tpp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.849 0.357 . . . . 73.31 110.888 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.523 ' C ' HD12 ' B' ' 219' ' ' ILE . 0.0 OUTLIER -98.75 61.01 1.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.923 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 219' ' ' ILE . . . . . 0.573 HG23 ' CE ' ' D' ' 217' ' ' MET . 1.9 mp 70.99 -70.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 73.1 111.126 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 53.38 45.42 28.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 63.01 110.888 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.574 ' O ' HD13 ' B' ' 222' ' ' ILE . . . -143.12 114.14 7.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 71.4 111.079 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 222' ' ' ILE . . . . . 0.574 HD13 ' O ' ' B' ' 221' ' ' ALA . 34.4 mm -136.47 73.09 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 75.24 111.137 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 6.1 m -152.42 179.18 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 65.2 111.075 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -66.03 156.78 49.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.755 -0.736 . . . . 73.14 112.507 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 5.2 mtt85 -179.19 120.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 74.4 110.825 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.478 ' OD1' HG22 ' B' ' 277' ' ' ILE . 1.0 OUTLIER -103.51 137.01 42.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 73.32 110.911 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.83 137.65 54.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 73.52 110.91 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.35 139.51 49.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 60.04 111.107 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.32 -36.37 9.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 75.44 110.854 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -164.52 138.77 5.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 73.44 110.785 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.626 HD11 HG23 ' A' ' 264' ' ' VAL . 0.5 OUTLIER -137.43 117.77 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 74.04 111.16 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.36 119.51 30.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 65.43 110.919 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.62 135.39 42.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 50.53 111.136 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -144.94 161.88 38.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 71.2 110.865 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 62.37 74.14 0.44 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.148 -0.478 . . . . 64.31 110.844 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 46.96 51.75 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 74.23 110.905 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.25 148.43 26.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 62.41 111.039 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.28 136.31 43.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 75.42 110.872 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.527 HG11 HG22 ' B' ' 231' ' ' ILE . 2.8 m -124.34 123.53 66.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 70.25 111.071 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.684 ' HB3' HD22 ' B' ' 276' ' ' LEU . 6.5 tm0? -105.74 129.21 53.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 73.52 110.906 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.596 HD13 ' CD1' ' A' ' 277' ' ' ILE . 4.5 mp -125.62 118.65 26.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 61.23 110.892 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.9 -168.93 13.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.716 -0.754 . . . . 74.21 112.488 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.73 135.06 33.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.875 0.369 . . . . 74.15 110.842 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.788 HG23 ' HG3' ' A' ' 280' ' ' GLU . 6.8 p -119.0 123.95 72.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 63.3 111.147 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.432 HG23 ' HA ' ' A' ' 281' ' ' TYR . 15.7 m -122.1 129.14 75.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 65.43 111.126 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.1 t -76.74 168.89 19.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 64.02 111.159 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.423 ' HB2' ' H ' ' A' ' 283' ' ' GLY . . . -63.07 -33.9 76.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 74.11 111.064 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.91 -35.89 69.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 70.33 111.066 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.64 ' HB2' ' CD1' ' B' ' 281' ' ' TYR . . . -57.43 99.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 32.3 111.113 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 24.8 tp -179.32 -48.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 75.44 110.911 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -52.14 151.69 3.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 73.13 110.863 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 91.72 -19.42 48.35 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.752 -0.737 . . . . 64.15 112.481 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 108.4 144.92 11.26 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.77 -0.729 . . . . 55.23 112.562 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 17.6 pt -51.75 131.6 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.864 0.364 . . . . 75.33 111.154 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.25 -74.33 0.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 75.44 110.83 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.1 mp 51.83 69.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 64.51 111.141 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.25 -170.14 2.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 52.43 110.846 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 63.4 161.21 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 74.42 110.844 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.6 82.45 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.909 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.466 HG21 ' OD1' ' C' ' 243' ' ' ASN . 27.8 p -98.64 124.86 43.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 62.44 111.122 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 3.9 t -119.99 139.95 51.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 64.01 111.136 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.3 145.51 48.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.2 110.918 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.3 t -142.11 123.51 14.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 42.13 110.853 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.632 HG21 HG22 ' B' ' 267' ' ' VAL . 9.0 p -118.16 139.15 46.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 72.34 111.08 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -83.24 -77.37 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.93 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 23.0 m -122.25 127.9 50.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 64.02 111.133 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.689 HG11 HG11 ' B' ' 275' ' ' VAL . 11.9 t -118.53 124.19 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 75.54 111.095 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.7 128.14 69.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 65.42 111.144 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -136.4 133.23 6.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.761 -0.733 . . . . 41.42 112.546 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -133.43 147.93 51.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.843 0.354 . . . . 74.43 110.891 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.24 90.55 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.714 -0.755 . . . . 71.0 112.498 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 43.73 56.3 4.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 75.15 110.888 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 2.3 t -86.85 145.05 26.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 71.4 110.872 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -132.47 127.5 35.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 74.14 110.861 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.689 HG11 HG11 ' B' ' 267' ' ' VAL . 5.9 t -125.66 130.15 72.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 75.14 111.149 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.684 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.7 OUTLIER -122.17 112.07 17.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 75.12 110.991 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.478 HG22 ' OD1' ' B' ' 226' ' ' ASN . 45.8 mm -111.81 115.18 49.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 61.44 111.181 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 122.87 -174.31 16.33 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.698 -0.763 . . . . 72.3 112.46 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -89.87 141.55 28.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 64.54 110.825 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.642 ' HG3' HG23 ' C' ' 244' ' ' VAL . 10.5 pt-20 -117.49 142.18 47.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 74.43 110.842 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.64 ' CD1' ' HB2' ' B' ' 249' ' ' ALA . 12.8 t80 -126.6 126.05 42.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 73.33 110.871 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 158.75 -55.74 0.36 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.782 -0.723 . . . . 71.41 112.504 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 83.93 -60.44 4.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.751 -0.738 . . . . 74.44 112.495 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -51.81 108.7 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.851 0.358 . . . . 72.44 110.903 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.08 95.38 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 31.12 112.503 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -51.72 132.6 31.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.808 0.337 . . . . 61.4 110.918 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 72.36 -69.03 0.2 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.876 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -138.25 -46.06 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 72.34 110.917 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.24 -173.03 4.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.888 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -110.75 140.07 45.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.463 . . . . 70.22 110.881 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -122.33 151.01 41.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 75.44 110.867 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -102.12 152.77 20.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 61.15 110.892 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.1 169.4 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 75.51 110.85 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.21 151.17 36.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 73.22 110.821 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 73.53 110.825 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.878 0.37 . . . . 50.05 110.893 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.16 142.21 21.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 64.33 110.932 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 44.2 mm -117.38 -47.68 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 44.22 111.11 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 61.48 169.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.04 110.85 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 52.68 82.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 71.0 111.089 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 41.0 pt -144.17 148.64 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 65.52 111.109 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 223' ' ' VAL . . . . . 0.661 HG13 ' HB2' ' C' ' 227' ' ' SER . 65.8 t 52.98 80.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 62.32 111.112 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -141.57 -41.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 40.42 112.437 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.32 -44.79 4.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 64.22 110.871 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.91 124.99 21.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 41.41 110.879 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.661 ' HB2' HG13 ' C' ' 223' ' ' VAL . 3.6 t -131.71 137.88 48.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 71.34 110.861 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.7 150.8 51.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 73.44 111.114 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.84 -30.41 9.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 51.23 110.849 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -165.89 137.95 3.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 65.23 110.848 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 5.4 mt -138.8 117.44 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 73.4 111.162 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.669 ' HD2' HG22 ' C' ' 268' ' ' VAL . 13.0 ptp180 -132.19 121.5 23.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.13 110.888 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.407 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.1 OUTLIER -134.6 144.1 47.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.106 -0.497 . . . . 73.02 111.046 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -146.75 166.74 25.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 71.34 110.89 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.49 67.58 0.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 72.2 110.881 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 46.73 56.96 5.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 73.43 110.863 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.407 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -104.66 149.72 25.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 75.44 111.05 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -130.54 135.82 48.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 73.15 110.871 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.464 HG12 ' HB ' ' C' ' 275' ' ' VAL . 2.9 m -127.02 123.19 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 63.14 111.156 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.74 ' HB3' HD22 ' C' ' 276' ' ' LEU . 9.3 tm0? -105.58 129.73 53.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.923 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.709 HD13 ' HB ' ' C' ' 277' ' ' ILE . 3.9 mm? -125.78 118.86 26.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.902 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 121.31 -178.5 16.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.665 -0.778 . . . . 75.34 112.474 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.466 ' OD1' HG21 ' B' ' 260' ' ' THR . 0.8 OUTLIER -85.61 147.08 26.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 71.54 110.857 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.642 HG23 ' HG3' ' B' ' 280' ' ' GLU . 2.4 p -126.39 123.98 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 62.14 111.116 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.526 HG12 ' HB3' ' C' ' 281' ' ' TYR . 5.4 m -122.11 129.22 75.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 72.43 111.152 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 44.0 p -69.83 172.08 8.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 72.12 111.123 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.82 76.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 74.53 111.093 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.84 -35.84 69.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.418 . . . . 64.34 111.107 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.42 142.09 14.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 70.54 111.126 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.23 -59.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 73.05 110.942 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -168.87 89.48 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 75.54 110.883 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -54.06 -30.26 46.0 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.755 -0.736 . . . . 55.34 112.434 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 172.17 -94.29 0.1 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.738 -0.744 . . . . 72.13 112.45 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 254' ' ' ILE . . . . . 0.405 HG22 HG22 ' C' ' 256' ' ' ILE . 32.1 mt -77.11 148.97 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.837 0.351 . . . . 71.24 111.07 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -88.35 76.99 8.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 55.41 110.835 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 256' ' ' ILE . . . . . 0.405 HG22 HG22 ' C' ' 254' ' ' ILE . 4.4 tt -173.44 131.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 72.24 111.081 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 8.4 t -166.95 -169.97 1.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 65.41 110.868 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -117.31 164.97 14.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.896 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -108.12 138.84 43.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 70.41 110.925 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 260' ' ' THR . . . . . 0.696 HG21 ' OD1' ' D' ' 243' ' ' ASN . 45.9 p -101.09 138.04 38.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 70.13 111.111 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 75.9 m -120.45 139.27 53.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 70.34 111.106 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.18 132.13 51.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 72.54 110.901 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.56 123.56 28.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 61.1 110.883 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.516 HG21 HG22 ' C' ' 267' ' ' VAL . 7.3 p -125.09 142.82 40.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 70.32 111.197 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -87.21 -74.62 0.43 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.2 -0.455 . . . . 70.52 110.914 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 87.0 m -128.57 129.17 45.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 74.31 111.171 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.516 HG22 HG21 ' C' ' 264' ' ' VAL . 21.4 t -118.67 120.68 64.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 61.21 111.054 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 268' ' ' VAL . . . . . 0.669 HG22 ' HD2' ' C' ' 232' ' ' ARG . 21.3 t -121.89 126.32 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 73.21 111.076 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.63 133.4 7.85 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.744 -0.741 . . . . 73.12 112.496 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -133.02 148.27 52.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.784 0.326 . . . . 70.24 110.925 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.74 84.73 0.02 OUTLIER Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.68 -0.771 . . . . 64.52 112.499 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 45.39 63.19 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 62.14 110.855 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 27.5 t -91.91 145.23 24.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 74.52 110.853 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -131.66 127.61 37.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 74.41 110.882 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.478 HG13 HG23 ' D' ' 239' ' ' VAL . 15.1 t -126.74 131.11 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 62.41 111.151 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.74 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.7 OUTLIER -122.47 111.62 17.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 55.24 110.841 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.709 ' HB ' HD13 ' C' ' 241' ' ' LEU . 51.7 mm -112.22 107.72 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 75.53 111.169 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.05 172.73 12.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 71.3 112.459 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -89.9 147.42 23.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.352 . . . . 64.15 110.869 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.736 ' CG ' HG22 ' D' ' 244' ' ' VAL . 0.5 OUTLIER -118.13 131.58 56.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 73.21 110.887 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.71 ' CE1' ' HB2' ' D' ' 249' ' ' ALA . 12.5 t80 -121.85 133.8 54.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 72.44 110.935 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 134.94 155.76 7.5 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.763 -0.732 . . . . 54.0 112.436 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 283' ' ' GLY . . . . . 0.496 ' H ' ' HB2' ' D' ' 247' ' ' ALA . . . -93.75 -15.61 48.78 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.818 -0.706 . . . . 54.22 112.445 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -72.42 79.17 1.03 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 74.31 110.898 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 65.52 151.85 0.11 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 64.12 112.488 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -78.91 -32.38 45.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 64.12 110.869 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.455 ' CE2' HD23 ' C' ' 276' ' ' LEU . 6.5 t90 -150.0 35.7 0.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 62.13 110.913 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -179.36 -176.29 0.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 63.21 110.903 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -66.82 -169.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 73.24 110.904 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.17 -74.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.833 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 13.0 t60 53.75 90.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 71.34 110.944 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.81 114.04 0.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 71.2 110.847 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -178.86 41.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.863 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.16 163.78 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 74.34 110.801 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 13.1 m170 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 71.43 110.88 -179.967 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 217' ' ' MET . . . . . 0.573 ' CE ' HG23 ' B' ' 219' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.834 0.349 . . . . 71.13 110.882 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -75.09 138.92 42.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 71.12 110.918 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 219' ' ' ILE . . . . . 0.426 HG22 ' O ' ' C' ' 223' ' ' VAL . 2.5 pp -120.16 -33.65 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 74.35 111.178 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 55.16 90.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 71.45 110.901 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 221' ' ' ALA . . . . . 0.625 ' O ' HD13 ' D' ' 222' ' ' ILE . . . -59.74 154.41 18.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 44.31 111.137 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 222' ' ' ILE . . . . . 0.625 HD13 ' O ' ' D' ' 221' ' ' ALA . 29.1 mm -132.4 118.41 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 72.25 111.116 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 223' ' ' VAL . . . . . 0.414 ' O ' HG23 ' D' ' 223' ' ' VAL . 6.4 m -56.77 109.16 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 62.2 111.091 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 68.26 131.77 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.841 -0.695 . . . . 32.21 112.475 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.534 ' H ' HG23 ' D' ' 261' ' ' THR . 0.1 OUTLIER -173.2 -172.06 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.807 0.337 . . . . 73.24 110.86 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.66 110.66 18.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 55.12 110.907 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 12.7 p -126.06 143.12 51.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 72.45 110.832 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.09 156.89 48.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 63.23 111.17 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.47 -31.21 6.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 74.2 110.895 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.43 138.58 5.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 74.44 110.898 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 9.9 mt -137.66 117.81 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 72.53 111.143 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -132.9 120.49 21.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.22 110.826 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.97 139.27 44.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 60.23 111.137 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -144.8 166.45 25.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 74.24 110.895 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 61.17 68.15 0.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 65.0 110.848 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 47.44 55.61 8.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 64.2 110.916 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.07 149.01 25.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 34.43 111.054 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.77 135.98 47.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 74.53 110.898 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.478 HG23 HG13 ' C' ' 275' ' ' VAL . 5.3 m -127.07 121.99 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 65.22 111.129 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 240' ' ' GLN . . . . . 0.76 ' HB3' HD22 ' D' ' 276' ' ' LEU . 6.7 tm0? -105.94 132.83 51.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 70.21 110.844 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.701 HD13 ' HB ' ' D' ' 277' ' ' ILE . 4.1 mm? -129.94 118.64 21.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 65.4 110.964 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.27 176.59 14.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.737 -0.744 . . . . 53.05 112.508 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 243' ' ' ASN . . . . . 0.696 ' OD1' HG21 ' C' ' 260' ' ' THR . 1.7 p-10 -85.99 149.56 25.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 71.03 110.894 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 244' ' ' VAL . . . . . 0.736 HG22 ' CG ' ' C' ' 280' ' ' GLU . 3.4 t -120.54 115.05 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 75.31 111.159 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 245' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' C' ' 281' ' ' TYR . 6.1 m -122.16 129.39 75.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 64.53 111.108 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 246' ' ' THR . . . . . 0.654 HG23 ' H ' ' D' ' 248' ' ' ALA . 11.5 t -69.16 175.2 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 75.35 111.133 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 247' ' ' ALA . . . . . 0.496 ' HB2' ' H ' ' C' ' 283' ' ' GLY . . . -52.76 -33.72 49.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 53.33 111.097 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 248' ' ' ALA . . . . . 0.654 ' H ' HG23 ' D' ' 246' ' ' THR . . . -56.67 -51.94 66.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 42.35 111.062 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 249' ' ' ALA . . . . . 0.71 ' HB2' ' CE1' ' C' ' 281' ' ' TYR . . . 54.93 -175.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.43 . . . . 72.43 111.123 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.51 -39.01 2.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 62.21 110.936 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.26 163.55 37.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 71.32 110.912 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -154.84 116.75 0.74 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.685 -0.769 . . . . 41.45 112.482 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -171.78 -147.49 5.74 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.779 -0.724 . . . . 52.4 112.51 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.92 114.1 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.758 0.313 . . . . 63.31 111.183 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -179.4 -169.73 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 71.34 110.803 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 256' ' ' ILE . . . . . 0.494 ' HB ' HD12 ' D' ' 222' ' ' ILE . 2.0 pp -136.1 136.73 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 73.22 111.133 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.53 -50.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 72.41 110.876 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.0 107.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 64.13 110.837 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -76.44 -74.5 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 71.4 110.913 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 260' ' ' THR . . . . . 0.649 HG23 ' HG2' ' E' ' 225' ' ' ARG . 27.8 m -90.13 125.38 35.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 73.15 111.134 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 261' ' ' THR . . . . . 0.534 HG23 ' H ' ' D' ' 225' ' ' ARG . 81.2 m -105.49 133.18 50.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.448 . . . . 63.34 111.109 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 262' ' ' ASN . . . . . 0.42 ' ND2' HG23 ' D' ' 277' ' ' ILE . 0.1 OUTLIER -126.11 137.17 53.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 43.2 110.868 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 10.0 t -142.05 123.74 15.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 70.24 110.889 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.505 HG21 ' CG2' ' D' ' 267' ' ' VAL . 8.1 p -126.06 145.07 34.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 74.42 111.138 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -88.83 -76.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 74.01 110.927 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 48.0 m -127.05 128.1 45.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 72.51 111.117 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.512 ' CG1' HG21 ' D' ' 275' ' ' VAL . 21.7 t -118.02 120.86 65.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 73.45 111.195 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.42 125.88 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.251 -0.431 . . . . 73.2 111.125 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.62 133.67 8.18 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.75 -0.738 . . . . 52.35 112.524 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.38 147.82 51.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 71.44 110.878 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.79 86.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 73.02 112.507 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 47.62 69.39 0.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.374 . . . . 51.11 110.899 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 19.3 t -100.19 145.35 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 73.32 110.82 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -135.35 128.02 30.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 74.51 110.855 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.512 HG21 ' CG1' ' D' ' 267' ' ' VAL . 14.2 t -128.87 124.22 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 71.33 111.101 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.76 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.8 OUTLIER -114.54 114.37 25.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 73.54 110.917 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.701 ' HB ' HD13 ' D' ' 241' ' ' LEU . 38.1 mm -112.03 104.95 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 72.44 111.095 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.55 -174.54 22.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.738 . . . . 65.13 112.521 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -106.78 148.35 28.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 55.34 110.833 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 280' ' ' GLU . . . . . 0.463 ' CG ' HG13 ' E' ' 244' ' ' VAL . 0.0 OUTLIER -112.75 133.86 54.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 75.44 110.893 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 281' ' ' TYR . . . . . 0.444 ' HD1' HG23 ' E' ' 245' ' ' VAL . 21.1 t80 -129.37 125.27 36.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.524 . . . . 74.2 110.95 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.23 -139.92 11.1 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.65 -0.786 . . . . 64.24 112.448 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -118.57 -120.52 2.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.76 -0.733 . . . . 75.13 112.444 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt 56.95 24.25 9.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 70.12 110.931 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 76.07 -68.26 2.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.753 . . . . 73.53 112.478 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -161.26 -75.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 71.35 110.886 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 287' ' ' TRP . . . . . 0.636 ' CZ2' HD23 ' D' ' 276' ' ' LEU . 6.4 t90 -118.7 34.63 5.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.502 . . . . 73.11 110.848 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 51.98 83.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 72.43 110.838 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.9 -171.86 0.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 71.44 110.815 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -99.61 -170.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 73.32 110.82 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -77.95 -74.59 0.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 73.02 110.816 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.13 -169.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 71.11 110.895 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -144.65 50.95 1.26 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 72.33 110.825 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -149.74 172.94 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 61.54 110.839 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 73.0 110.809 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 217' ' ' MET . . . . . 0.461 ' HB3' HG21 ' C' ' 223' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.809 0.337 . . . . 72.12 110.874 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -115.57 177.95 4.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 72.41 110.858 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 219' ' ' ILE . . . . . 0.563 HD11 ' CG1' ' C' ' 223' ' ' VAL . 3.7 mp -136.18 -66.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 73.23 111.118 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.67 -172.3 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 71.55 110.84 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -134.92 154.43 51.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 63.11 111.064 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 2.2 mp -129.59 146.41 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 64.05 111.159 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 23.3 t -117.32 143.12 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 64.33 111.204 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 152.91 155.36 7.08 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.695 -0.764 . . . . 43.22 112.445 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 225' ' ' ARG . . . . . 0.649 ' HG2' HG23 ' D' ' 260' ' ' THR . 0.0 OUTLIER 68.95 -75.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.361 . . . . 73.24 110.873 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.45 118.5 13.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 45.42 110.867 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.44 146.31 48.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 43.54 110.801 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.57 155.54 49.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 64.22 111.129 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.05 -27.82 10.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 63.14 110.962 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.36 139.03 5.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 65.45 110.911 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 10.5 mt -137.32 117.49 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 45.44 111.13 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -131.92 116.75 17.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 75.2 110.93 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.13 134.29 42.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 74.34 111.172 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.96 160.66 40.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 71.22 110.867 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 65.13 74.9 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 73.14 110.919 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 45.52 52.99 8.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 72.11 110.892 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.48 141.22 36.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.274 -0.421 . . . . 72.24 111.106 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -132.37 137.84 47.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 75.52 110.875 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.16 137.78 51.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 64.34 111.156 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 240' ' ' GLN . . . . . 0.477 ' HB3' HD22 ' E' ' 276' ' ' LEU . 1.8 tm0? -124.14 134.26 53.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 64.12 110.921 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.28 126.68 44.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 62.25 110.896 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 127.43 179.97 16.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 54.43 112.478 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.05 161.56 17.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 53.0 110.882 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.463 HG13 ' CG ' ' D' ' 280' ' ' GLU . 98.9 t -132.68 121.98 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 43.35 111.175 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 245' ' ' VAL . . . . . 0.444 HG23 ' HD1' ' D' ' 281' ' ' TYR . 5.4 m -122.24 128.91 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 71.23 111.144 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 246' ' ' THR . . . . . 0.416 HG21 ' HA2' ' E' ' 282' ' ' GLY . 14.8 t -69.77 174.02 5.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 74.43 111.167 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.03 78.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 43.34 111.066 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.83 -35.82 69.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 63.01 111.142 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.36 105.43 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 61.42 111.049 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -175.61 110.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 74.44 110.925 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 63.32 103.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 73.45 110.832 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -93.35 -144.03 14.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.732 . . . . 42.34 112.489 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -150.82 -89.52 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.705 -0.759 . . . . 61.44 112.534 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 254' ' ' ILE . . . . . 0.601 HG23 HD11 ' E' ' 256' ' ' ILE . 2.1 tt -51.81 145.78 2.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.862 0.363 . . . . 74.43 111.08 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.61 120.76 42.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 61.44 110.907 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 256' ' ' ILE . . . . . 0.601 HD11 HG23 ' E' ' 254' ' ' ILE . 5.3 mp -117.19 -27.06 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 71.21 111.084 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 21.4 m 61.18 -171.44 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 70.44 110.892 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 63.49 105.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 54.21 110.869 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -84.44 171.49 12.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 75.42 110.912 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 30.7 m -101.08 138.07 38.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 60.13 111.127 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 261' ' ' THR . . . . . 0.431 HG23 ' H ' ' E' ' 225' ' ' ARG . 0.1 OUTLIER -123.23 132.09 53.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 72.3 111.163 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -126.14 122.9 37.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 65.1 110.851 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 3.4 m -127.48 124.06 37.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 53.41 110.866 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 264' ' ' VAL . . . . . 0.522 HG21 ' CG2' ' E' ' 267' ' ' VAL . 7.1 p -115.8 125.34 72.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 74.44 111.116 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -61.07 -77.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 72.34 110.888 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.81 135.76 28.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 60.02 111.179 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 267' ' ' VAL . . . . . 1.001 HG11 HG21 ' E' ' 275' ' ' VAL . 39.8 t -118.35 129.35 74.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 73.4 111.053 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 79.4 t -127.32 124.69 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 73.52 111.109 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.02 132.66 8.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 64.14 112.518 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -133.42 116.96 16.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 74.22 110.944 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 71.8 84.46 0.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.739 . . . . 64.21 112.487 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 56.22 86.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 74.14 110.913 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 11.7 t -119.96 145.56 46.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 74.44 110.844 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -137.03 128.22 27.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 71.21 110.878 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 1.001 HG21 HG11 ' E' ' 267' ' ' VAL . 57.4 t -128.93 132.22 67.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 72.44 111.099 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.477 HD22 ' HB3' ' E' ' 240' ' ' GLN . 2.2 tm? -128.39 111.71 13.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.886 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 24.9 mm -108.74 138.58 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 71.22 111.183 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 110.85 -155.84 15.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 31.03 112.52 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -128.12 149.65 50.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 73.52 110.908 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.91 133.28 54.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 74.04 110.887 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -126.38 125.56 42.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.884 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 282' ' ' GLY . . . . . 0.416 ' HA2' HG21 ' E' ' 246' ' ' THR . . . 153.88 -151.13 22.89 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 63.03 112.528 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -56.69 -178.34 0.43 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.816 -0.707 . . . . 74.45 112.491 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.26 -19.5 61.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.877 0.37 . . . . 73.22 110.918 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -51.8 103.25 0.1 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.707 -0.759 . . . . 71.42 112.535 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -60.0 -75.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.841 0.353 . . . . 71.23 110.919 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 287' ' ' TRP . . . . . 0.404 ' NE1' HD23 ' E' ' 276' ' ' LEU . 5.6 t90 -130.32 25.24 5.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 75.42 110.899 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.19 -169.96 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.241 -0.436 . . . . 74.0 110.893 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -58.53 172.97 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 62.21 110.922 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -65.28 -25.98 67.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 73.34 110.844 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.32 175.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 74.54 110.874 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 57.2 t60 62.88 97.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 73.15 110.812 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -103.55 174.85 5.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 63.12 110.871 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -170.18 176.85 4.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 71.22 110.829 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 4.4 m80 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 74.11 110.873 179.975 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.888 0.375 . . . . 72.52 110.859 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.99 149.43 27.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 75.31 110.958 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 10.7 tp -112.53 -30.79 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 74.34 111.179 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -174.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 74.23 110.87 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.572 ' HB1' HG22 ' A' ' 256' ' ' ILE . . . -130.05 24.94 5.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 65.12 111.096 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 1.2 pt -130.59 107.12 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 65.43 111.131 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.797 HG11 ' HA ' ' A' ' 259' ' ' GLN . 11.1 p -123.96 147.7 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 64.21 111.089 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -124.9 -87.81 0.74 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.736 -0.745 . . . . 33.15 112.431 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 63.28 93.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.318 . . . . 70.12 110.888 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.755 ' OD1' HG22 ' A' ' 277' ' ' ILE . 70.2 m-80 -112.71 130.98 55.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.269 -0.423 . . . . 61.33 110.9 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 2.3 t -121.8 137.66 54.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 51.34 110.841 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.93 129.63 21.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 75.44 111.027 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.3 -36.1 21.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 62.13 110.904 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -165.6 138.59 4.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 64.14 110.914 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.573 HG22 HG22 ' A' ' 267' ' ' VAL . 10.3 pt -138.33 134.49 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.21 111.101 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.635 ' HD3' HG22 ' A' ' 268' ' ' VAL . 9.2 ptm180 -134.34 129.26 35.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 65.41 110.923 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.523 HG21 HG13 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -133.68 148.14 51.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 63.21 111.14 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -150.47 167.45 27.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.453 . . . . 73.43 110.884 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.59 65.48 0.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 74.24 110.906 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 50.3 42.21 25.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 72.15 110.948 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.36 156.82 17.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.13 111.104 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.27 143.71 40.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 50.0 110.896 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.733 HG12 ' HB ' ' A' ' 275' ' ' VAL . 0.3 OUTLIER -124.12 121.16 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.23 111.165 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.629 ' HB3' HD22 ' A' ' 276' ' ' LEU . 4.0 tm0? -117.12 128.34 55.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.462 . . . . 75.32 110.923 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 5.8 mp -124.69 118.2 25.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.907 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.05 165.33 10.4 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 64.14 112.45 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -85.95 135.7 33.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.933 0.397 . . . . 71.54 110.812 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 244' ' ' VAL . 6.4 p -116.12 122.21 69.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 75.34 111.115 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.72 HG12 ' CB ' ' A' ' 281' ' ' TYR . 36.0 m -122.08 128.93 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 52.13 111.21 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.487 HG22 ' HA3' ' A' ' 282' ' ' GLY . 13.6 t -73.13 173.03 9.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 70.23 111.13 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.05 99.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.424 . . . . 34.01 111.149 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.16 -36.0 72.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 61.52 111.045 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.476 ' H ' HG23 ' A' ' 246' ' ' THR . . . -51.71 -42.77 62.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 70.53 111.086 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 58.17 178.34 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.269 -0.423 . . . . 64.22 110.875 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.62 128.26 46.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 71.23 110.851 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 81.65 160.25 25.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 55.23 112.446 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 112.13 40.0 1.21 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.77 -0.728 . . . . 74.15 112.445 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 221' ' ' ALA . 4.6 mp -140.62 -65.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.77 0.319 . . . . 62.14 111.077 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.18 104.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 72.45 110.847 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.572 HG22 ' HB1' ' A' ' 221' ' ' ALA . 16.4 tt -170.18 149.19 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 74.43 111.14 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 9.2 t -104.44 101.31 10.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 62.21 110.891 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -173.01 141.52 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 73.24 110.871 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.797 ' HA ' HG11 ' A' ' 223' ' ' VAL . 0.8 OUTLIER -120.42 83.69 2.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 50.34 110.85 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.5 HG21 ' ND2' ' B' ' 243' ' ' ASN . 5.5 t -75.16 121.98 22.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 73.21 111.093 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.429 HG23 ' HB2' ' B' ' 225' ' ' ARG . 2.6 t -134.11 120.71 20.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 71.05 111.169 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.51 ' HB3' HD23 ' B' ' 241' ' ' LEU . 1.2 m120 -99.3 132.65 44.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 75.21 110.915 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.9 p -142.25 123.39 14.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 65.33 110.828 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.55 HG21 HG12 ' A' ' 267' ' ' VAL . 8.8 p -119.68 133.85 65.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 63.33 111.118 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -65.29 -69.84 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.12 110.823 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.2 m -131.64 135.78 47.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 72.45 111.186 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.573 HG22 HG22 ' A' ' 231' ' ' ILE . 15.5 m -127.33 136.04 61.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 72.33 111.17 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.635 HG22 ' HD3' ' A' ' 232' ' ' ARG . 36.6 t -127.19 137.32 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 73.13 111.156 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.43 133.61 7.18 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.676 -0.773 . . . . 74.54 112.489 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.63 148.54 52.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.748 0.308 . . . . 73.33 110.906 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.77 84.33 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 55.31 112.445 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 43.52 55.81 4.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 72.35 110.954 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 45.5 t -83.62 144.83 29.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.095 -0.502 . . . . 71.14 110.821 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.02 128.41 49.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 72.12 110.838 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.733 ' HB ' HG12 ' A' ' 239' ' ' VAL . 25.0 t -115.03 126.69 72.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 73.05 111.173 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' A' ' 240' ' ' GLN . 0.2 OUTLIER -128.41 109.85 11.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.457 . . . . 75.41 111.008 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.755 HG22 ' OD1' ' A' ' 226' ' ' ASN . 19.6 mm -112.97 104.49 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 74.21 111.107 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.8 -147.01 17.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.815 -0.707 . . . . 60.52 112.518 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -128.07 155.66 44.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 72.4 110.929 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.772 ' HB3' HG23 ' B' ' 244' ' ' VAL . 1.3 tt0 -122.31 118.94 29.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 63.51 110.926 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.72 ' CB ' HG12 ' A' ' 245' ' ' VAL . 0.5 OUTLIER -109.45 125.89 52.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 74.12 110.866 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.487 ' HA3' HG22 ' A' ' 246' ' ' THR . . . 62.3 176.07 2.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 75.23 112.509 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 120.7 16.12 4.66 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.772 -0.728 . . . . 73.55 112.492 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.1 mttm 59.9 69.41 0.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 74.31 110.891 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.51 174.26 23.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.795 -0.717 . . . . 24.43 112.55 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -60.4 -167.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 75.42 110.851 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -40.07 -77.98 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 53.44 110.887 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -176.68 147.32 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 73.31 110.84 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -113.69 -71.54 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 64.34 110.936 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -179.18 -34.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 71.22 110.819 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 63.55 105.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.34 110.85 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.9 -169.83 1.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 71.31 110.785 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -51.87 -30.1 22.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 74.34 110.918 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -168.43 177.76 5.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 74.31 110.886 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 22.0 m80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 74.14 110.843 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 7.7 ttp . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.874 0.369 . . . . 75.14 110.945 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -159.11 146.75 17.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 75.45 110.904 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 12.4 tt -143.95 142.31 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.102 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -148.97 138.68 21.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 64.03 110.893 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.43 -173.58 3.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 71.1 111.097 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 1.6 pt -139.42 131.48 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 72.35 111.11 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.482 HG21 ' CG ' ' A' ' 259' ' ' GLN . 10.7 p -160.31 152.12 5.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.189 -0.46 . . . . 64.43 111.069 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -54.4 129.9 44.29 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.731 . . . . 55.24 112.465 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.429 ' HB2' HG23 ' A' ' 261' ' ' THR . 17.4 ptt180 -176.94 174.55 1.72 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.76 0.314 . . . . 64.3 110.907 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -125.68 128.06 47.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 72.34 110.857 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.86 141.57 51.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 65.2 110.858 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.503 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -138.17 128.12 25.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 61.21 111.149 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -40.11 39.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 72.15 110.871 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -166.51 138.1 3.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 71.15 110.854 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.565 HG12 HG12 ' A' ' 267' ' ' VAL . 5.3 pt -138.71 133.13 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 72.02 111.144 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -135.35 128.55 31.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 75.35 110.944 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.513 HG21 HG13 ' B' ' 239' ' ' VAL . 0.3 OUTLIER -135.55 137.31 41.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 71.54 111.155 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 13.1 pm0 -141.59 166.65 24.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 62.43 110.903 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 65.96 67.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 75.23 110.79 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 18.9 mtt180 48.65 49.93 17.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 63.12 110.886 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.49 156.72 17.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 73.52 111.114 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 9.5 mtt-85 -134.29 142.9 47.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 73.01 110.872 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.59 HG12 ' HB ' ' B' ' 275' ' ' VAL . 0.0 OUTLIER -124.21 124.76 69.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.485 . . . . 71.52 111.092 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.595 ' HB3' HD22 ' B' ' 276' ' ' LEU . 0.0 OUTLIER -117.49 128.32 54.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 71.55 110.902 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 262' ' ' ASN . 0.2 OUTLIER -119.87 118.62 31.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 75.45 110.933 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.13 -177.91 16.48 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.748 . . . . 64.32 112.482 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 243' ' ' ASN . . . . . 0.5 ' ND2' HG21 ' A' ' 260' ' ' THR . 9.2 p30 -85.98 148.95 25.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 53.55 110.937 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.772 HG23 ' HB3' ' A' ' 280' ' ' GLU . 6.7 p -131.08 127.87 61.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 70.33 111.1 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.72 HG12 ' CB ' ' B' ' 281' ' ' TYR . 30.8 m -121.93 129.05 75.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 70.13 111.11 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 20.9 p -80.28 175.0 11.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 54.21 111.129 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.01 -45.29 93.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 71.02 111.082 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.55 -36.02 77.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 44.32 111.126 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.641 ' HB2' ' HA3' ' B' ' 282' ' ' GLY . . . -68.05 102.74 1.36 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 73.25 111.127 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 3.5 tt -164.19 -45.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 75.32 110.935 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -61.2 153.5 25.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.192 -0.458 . . . . 45.14 110.843 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 252' ' ' GLY . . . . . 0.453 ' HA2' HD11 ' C' ' 250' ' ' LEU . . . 161.33 -107.17 0.3 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.774 -0.727 . . . . 74.4 112.524 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 175.13 -123.71 0.95 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.788 -0.72 . . . . 51.41 112.509 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.81 -35.26 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.857 0.36 . . . . 73.1 111.092 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 54.74 90.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 73.42 110.829 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 5.5 tt -153.61 141.27 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 44.2 111.128 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 27.1 t -151.32 161.23 43.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 71.22 110.896 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -56.23 175.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 72.32 110.823 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -90.18 75.09 7.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 75.42 110.875 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 7.3 t -74.17 130.89 40.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 75.32 111.167 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 90.6 m -133.04 108.89 9.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 70.12 111.115 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.542 ' OD1' HD12 ' C' ' 241' ' ' LEU . 0.9 OUTLIER -88.82 136.12 33.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 73.24 110.878 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 19.5 t -142.51 123.15 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 73.34 110.859 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.764 HG23 ' HB3' ' C' ' 228' ' ' ALA . 4.0 p -119.34 140.09 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 62.33 111.116 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -78.1 -73.87 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 65.42 110.869 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.9 m -131.5 127.68 37.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 53.45 111.138 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.583 ' CG1' HG21 ' B' ' 264' ' ' VAL . 19.4 m -122.61 135.33 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 72.04 111.181 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 57.8 t -127.85 133.33 67.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 44.13 111.147 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.82 133.25 7.54 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.757 . . . . 75.01 112.464 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -132.4 148.56 52.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.332 . . . . 44.25 110.937 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.42 91.65 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.749 . . . . 71.01 112.484 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 40.44 51.14 2.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 64.11 110.866 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.05 144.55 29.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 63.31 110.88 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.47 128.19 45.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 63.23 110.907 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.59 ' HB ' HG12 ' B' ' 239' ' ' VAL . 26.2 t -118.79 124.61 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 74.42 111.105 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.595 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.4 OUTLIER -126.52 111.49 14.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 71.24 110.917 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.529 HG23 ' ND2' ' B' ' 262' ' ' ASN . 35.6 mm -110.98 104.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 74.43 111.095 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.91 -142.81 10.68 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.711 -0.757 . . . . 21.24 112.431 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -123.26 147.37 47.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 65.04 110.809 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.742 ' HB2' HG23 ' C' ' 244' ' ' VAL . 3.9 mm-40 -111.99 129.77 56.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 70.41 110.895 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.72 ' CB ' HG12 ' B' ' 245' ' ' VAL . 0.1 OUTLIER -123.11 130.36 52.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 70.4 110.92 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.641 ' HA3' ' HB2' ' B' ' 249' ' ' ALA . . . 81.95 159.25 24.32 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.765 -0.731 . . . . 64.41 112.499 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 126.1 -87.89 0.35 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.818 -0.706 . . . . 72.54 112.539 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.47 -51.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 62.4 110.858 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -130.2 -89.23 0.52 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.744 -0.741 . . . . 62.34 112.488 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.59 ' HA ' HG21 ' C' ' 244' ' ' VAL . 10.9 p90 -122.19 -34.03 3.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 55.45 110.864 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.68 -169.47 3.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.113 -0.494 . . . . 73.44 110.939 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.38 114.11 9.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.296 -0.411 . . . . 75.42 110.906 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -156.03 -49.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.208 -0.451 . . . . 65.42 110.87 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.34 -170.26 2.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 73.45 110.838 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.08 131.04 40.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 75.32 110.888 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -177.81 162.77 1.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 65.21 110.906 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -174.99 -178.22 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.52 110.837 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.77 -170.61 2.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 73.11 110.892 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.0 110.834 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 11.5 ttt . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.877 0.37 . . . . 73.13 110.856 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 6.2 ptpt -178.79 79.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 55.41 110.829 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 1.2 pp -146.76 133.61 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 63.2 111.128 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -176.15 44.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 63.45 110.895 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -173.04 127.39 0.46 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 30.33 111.094 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 30.9 mm -118.04 69.82 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 72.43 111.043 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 20.3 m -141.43 174.12 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 73.04 111.166 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 142.55 -142.63 11.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.736 -0.745 . . . . 70.03 112.466 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 14.4 mmt-85 -103.38 -17.65 15.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.811 0.339 . . . . 72.21 110.848 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -141.98 112.75 7.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 75.11 110.892 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 4.5 t -123.17 137.73 54.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 62.43 110.826 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.764 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -133.06 119.65 20.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 33.32 111.094 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -43.51 74.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 60.53 110.873 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -167.24 136.71 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.247 -0.433 . . . . 72.34 110.887 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.599 HG22 ' CG2' ' C' ' 267' ' ' VAL . 3.8 pt -138.13 131.79 41.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 61.51 111.129 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.09 128.37 30.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 74.12 110.891 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.681 HG21 HG13 ' C' ' 239' ' ' VAL . 1.4 p -135.46 144.97 46.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 50.53 111.138 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.88 166.73 25.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 74.21 110.907 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 66.96 68.27 0.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 74.22 110.864 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 46.66 53.92 9.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 72.21 110.871 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.23 156.89 17.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.051 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -132.23 141.3 48.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.34 110.885 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.69 HG12 ' HB ' ' C' ' 275' ' ' VAL . 0.0 OUTLIER -126.06 121.01 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.41 111.132 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.78 117.27 30.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 74.3 110.905 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.542 HD12 ' OD1' ' B' ' 262' ' ' ASN . 0.2 OUTLIER -111.82 118.94 36.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 62.53 110.943 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 122.75 -177.43 16.52 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.76 . . . . 63.31 112.481 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -85.95 131.94 34.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 42.43 110.834 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.742 HG23 ' HB2' ' B' ' 280' ' ' GLU . 3.1 p -116.34 122.52 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 62.32 111.068 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.763 HG12 ' HB2' ' C' ' 281' ' ' TYR . 28.7 m -122.88 129.27 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 65.53 111.148 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 246' ' ' THR . . . . . 0.433 HG23 ' O ' ' C' ' 281' ' ' TYR . 59.3 p -69.8 175.2 4.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 75.4 111.093 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.542 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -58.12 -46.1 86.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 73.45 111.078 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -67.96 -36.74 80.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.21 111.114 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -53.34 150.68 6.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 73.45 111.162 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 250' ' ' LEU . . . . . 0.453 HD11 ' HA2' ' B' ' 252' ' ' GLY . 0.0 OUTLIER -158.66 118.75 3.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 65.34 110.849 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -52.2 -58.16 7.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 65.52 110.855 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 100.4 -87.71 0.72 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.678 -0.773 . . . . 70.13 112.493 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 253' ' ' GLY . . . . . 0.421 ' C ' HD12 ' C' ' 254' ' ' ILE . . . -148.7 111.37 0.53 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 71.34 112.552 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 254' ' ' ILE . . . . . 0.421 HD12 ' C ' ' C' ' 253' ' ' GLY . 5.4 mp -142.7 138.24 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.848 0.356 . . . . 74.0 111.095 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -170.43 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 74.25 110.785 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 2.6 mp -121.67 106.63 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 61.44 111.129 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 4.8 p -179.26 79.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 52.12 110.836 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 61.15 98.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 75.45 110.883 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.98 -171.49 2.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 74.31 110.951 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 7.6 t -64.97 124.56 22.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 75.13 111.128 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.546 HG22 ' HG2' ' D' ' 225' ' ' ARG . 6.5 t -134.16 141.4 47.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 64.11 111.118 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.5 ' OD1' HG23 ' C' ' 277' ' ' ILE . 2.9 t-20 -113.88 143.04 45.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 73.43 110.86 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 8.5 t -140.16 123.94 17.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 75.31 110.903 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.591 HG23 HD11 ' D' ' 231' ' ' ILE . 8.7 p -120.81 135.78 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 73.32 111.102 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.72 -75.58 0.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 75.14 110.894 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 2.2 m -127.19 127.76 45.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 73.4 111.162 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.854 HG11 HG11 ' C' ' 275' ' ' VAL . 0.0 OUTLIER -118.78 128.28 75.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 63.11 111.151 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 41.7 t -127.92 115.93 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 75.51 111.144 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.67 133.98 11.04 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.794 -0.717 . . . . 64.22 112.472 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -132.08 148.2 52.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.897 0.38 . . . . 73.54 110.888 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 53.55 90.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.683 -0.77 . . . . 60.04 112.513 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 40.87 51.41 3.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.878 0.37 . . . . 74.54 110.859 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 39.1 t -84.87 144.98 28.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.04 110.843 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -127.74 127.85 44.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 71.5 110.884 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.854 HG11 HG11 ' C' ' 267' ' ' VAL . 23.4 t -122.89 123.63 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 64.24 111.129 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.93 114.35 19.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 60.11 110.949 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.5 HG23 ' OD1' ' C' ' 262' ' ' ASN . 31.5 mm -112.57 104.56 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 74.5 111.133 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.04 -164.05 27.61 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.676 -0.774 . . . . 41.35 112.483 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -89.84 155.99 18.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 50.53 110.87 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.466 ' HB3' HG23 ' D' ' 244' ' ' VAL . 5.2 tp10 -129.84 134.87 47.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 63.44 110.911 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.763 ' HB2' HG12 ' C' ' 245' ' ' VAL . 0.1 OUTLIER -130.15 125.38 34.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 73.33 110.967 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 282' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' D' ' 247' ' ' ALA . . . -122.54 -166.86 12.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.727 -0.749 . . . . 74.3 112.487 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 283' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' D' ' 247' ' ' ALA . . . -101.27 -23.37 9.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 73.12 112.525 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -172.34 32.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 70.15 110.866 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -173.82 -174.01 40.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.796 -0.716 . . . . 74.03 112.531 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -100.84 -173.54 2.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.804 0.335 . . . . 74.14 110.948 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -56.54 100.22 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 73.15 110.906 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -169.4 142.01 2.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 74.0 110.847 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -172.04 32.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 55.21 110.926 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -175.07 124.56 0.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 72.45 110.776 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.22 168.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 74.12 110.837 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -169.67 177.47 4.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 72.11 110.863 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.33 -173.91 4.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 73.41 110.849 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -171.89 63.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 72.33 110.849 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 53.12 110.839 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 1.5 ptp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.854 0.359 . . . . 74.43 110.934 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.1 48.53 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 74.05 110.871 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 31.6 mm -118.86 144.79 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 75.53 111.113 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -174.51 63.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 75.11 110.927 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.61 144.07 0.37 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 64.04 111.115 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 222' ' ' ILE . . . . . 0.661 HD13 ' H ' ' E' ' 220' ' ' ASP . 10.3 tt -166.99 146.1 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 73.23 111.119 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 19.7 m -145.69 -173.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 51.42 111.151 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -66.1 -110.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.785 -0.722 . . . . 63.22 112.433 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.546 ' HG2' HG22 ' C' ' 261' ' ' THR . 0.0 OUTLIER 51.55 -166.46 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 64.21 110.928 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -81.43 109.43 15.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 74.55 110.902 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.01 149.62 51.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.816 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 228' ' ' ALA . . . . . 0.511 ' HB2' HD11 ' D' ' 241' ' ' LEU . . . -133.02 160.93 35.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 73.23 111.08 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.42 -37.05 5.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.907 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 230' ' ' ASP . . . . . 0.407 ' O ' HG23 ' D' ' 267' ' ' VAL . 39.9 t0 -164.6 139.08 5.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.211 -0.45 . . . . 71.23 110.949 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 231' ' ' ILE . . . . . 0.591 HD11 HG23 ' C' ' 264' ' ' VAL . 0.8 OUTLIER -136.66 117.51 17.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 73.41 111.155 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -130.38 115.59 17.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 70.14 110.865 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 233' ' ' THR . . . . . 0.586 HG21 ' CG1' ' D' ' 239' ' ' VAL . 2.7 p -135.65 147.42 48.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 74.34 111.151 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.74 167.52 24.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 72.2 110.866 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 68.34 67.57 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 73.41 110.855 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 46.46 60.35 3.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 72.33 110.824 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.18 155.78 18.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 62.31 111.12 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -133.35 135.94 45.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.884 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.586 ' CG1' HG21 ' D' ' 233' ' ' THR . 10.2 m -131.48 121.85 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 64.32 111.153 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 240' ' ' GLN . . . . . 0.448 ' HB3' HD22 ' D' ' 276' ' ' LEU . 7.3 tm0? -118.06 120.37 37.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.33 110.949 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' D' ' 228' ' ' ALA . 0.7 OUTLIER -111.37 119.8 40.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 74.21 110.948 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.99 -175.5 19.11 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.723 -0.751 . . . . 71.35 112.498 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -96.29 128.45 43.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 75.42 110.867 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 244' ' ' VAL . . . . . 0.466 HG23 ' HB3' ' C' ' 280' ' ' GLU . 3.7 p -111.28 115.81 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 73.33 111.121 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 245' ' ' VAL . . . . . 0.802 HG12 ' HB2' ' D' ' 281' ' ' TYR . 19.0 m -122.75 124.78 71.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 63.42 111.118 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 6.4 t -70.58 175.23 5.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.181 -0.463 . . . . 53.31 111.197 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 247' ' ' ALA . . . . . 0.431 ' HB2' ' HA2' ' C' ' 283' ' ' GLY . . . -61.56 -46.38 90.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 63.23 111.14 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.71 -35.96 69.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 61.34 111.109 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.62 163.65 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 74.31 111.103 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 250' ' ' LEU . . . . . 0.647 HD13 HD21 ' E' ' 250' ' ' LEU . 0.1 OUTLIER -136.73 -47.86 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 63.13 110.921 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 62.81 171.06 0.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 73.52 110.88 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -73.69 -158.31 5.18 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.741 -0.742 . . . . 53.21 112.438 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -108.44 19.07 32.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.731 -0.747 . . . . 54.54 112.462 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 72.9 mt 57.92 95.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 61.03 111.069 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -104.94 176.71 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 75.15 110.864 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 256' ' ' ILE . . . . . 0.407 HG23 ' O ' ' D' ' 256' ' ' ILE . 6.5 tt -107.77 122.93 62.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 64.4 111.104 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.42 -50.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 51.22 110.86 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -179.01 -50.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 75.44 110.881 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 63.41 160.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 72.05 110.934 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 260' ' ' THR . . . . . 0.475 HG21 ' ND2' ' D' ' 279' ' ' ASN . 8.4 t -66.53 133.48 50.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 75.12 111.151 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.05 141.4 47.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 73.53 111.22 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -122.27 144.54 48.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 72.23 110.889 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.22 123.68 14.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 55.32 110.902 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.413 HG21 HG22 ' D' ' 267' ' ' VAL . 14.4 p -120.54 131.53 72.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 75.54 111.101 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.2 -76.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 42.23 110.925 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 3.8 m -128.09 132.05 49.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 74.52 111.165 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 1.069 HG11 HG11 ' D' ' 275' ' ' VAL . 0.2 OUTLIER -117.59 123.63 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 75.3 111.12 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 23.6 t -122.15 115.88 47.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 55.05 111.187 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.05 133.63 10.75 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.767 -0.73 . . . . 61.44 112.529 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -132.11 148.01 52.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.813 0.34 . . . . 62.02 110.878 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.29 76.38 0.17 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.748 . . . . 73.0 112.478 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 48.44 71.68 0.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.362 . . . . 72.23 110.93 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 20.5 t -102.27 145.41 29.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 63.11 110.893 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -123.03 128.33 50.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 73.52 110.814 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 1.069 HG11 HG11 ' D' ' 267' ' ' VAL . 18.8 t -129.47 123.43 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 74.13 111.103 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.732 HD23 ' O ' ' D' ' 275' ' ' VAL . 15.5 mt -127.85 116.8 20.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 55.03 110.871 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.649 ' CD1' HD13 ' E' ' 241' ' ' LEU . 34.2 mm -112.18 104.68 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 73.21 111.188 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.84 -159.25 28.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.783 -0.722 . . . . 52.33 112.48 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 279' ' ' ASN . . . . . 0.475 ' ND2' HG21 ' D' ' 260' ' ' THR . 15.5 m120 -96.61 156.1 16.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 72.41 110.892 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 280' ' ' GLU . . . . . 0.587 ' HB3' HG23 ' E' ' 244' ' ' VAL . 12.0 tp10 -129.18 118.99 23.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 74.2 110.806 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 281' ' ' TYR . . . . . 0.802 ' HB2' HG12 ' D' ' 245' ' ' VAL . 0.2 OUTLIER -120.75 124.17 44.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 64.22 110.905 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.81 -76.55 2.22 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 44.42 112.421 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 51.98 -156.11 4.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.749 -0.739 . . . . 32.5 112.516 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -179.42 -34.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.848 0.356 . . . . 63.53 110.964 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -84.27 -126.0 1.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.762 -0.732 . . . . 64.32 112.459 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -22.4 50.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 74.22 110.91 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 287' ' ' TRP . . . . . 0.414 ' CD2' HD12 ' D' ' 276' ' ' LEU . 0.1 OUTLIER -105.34 103.31 12.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 74.45 110.933 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 3.8 t0 64.18 157.52 0.08 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.284 -0.417 . . . . 75.14 110.871 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -150.18 -171.55 3.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.442 . . . . 74.31 110.886 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.48 -172.66 3.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 74.21 110.872 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -52.41 -59.11 4.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 70.22 110.854 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -161.89 150.11 15.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 74.42 110.88 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -177.42 108.39 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 64.34 110.877 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -162.41 -178.9 6.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 73.31 110.842 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 62.2 110.81 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.861 0.362 . . . . 63.31 110.88 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.03 137.54 39.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 71.34 110.887 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 11.7 tt -176.23 143.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 74.42 111.131 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 220' ' ' ASP . . . . . 0.661 ' H ' HD13 ' D' ' 222' ' ' ILE . 1.7 p-10 -178.19 81.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 70.12 110.856 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -175.58 118.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 63.42 111.121 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 51.2 mt -145.05 82.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 72.11 111.134 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 12.1 p -173.97 148.02 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 70.11 111.114 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 157.28 179.56 32.29 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.714 -0.755 . . . . 43.13 112.481 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 29.5 mtt-85 -52.02 -74.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.833 0.349 . . . . 64.4 110.908 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.03 109.92 22.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 64.44 110.942 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.89 137.84 54.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.482 . . . . 44.4 110.886 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 228' ' ' ALA . . . . . 0.753 ' HB2' HD21 ' E' ' 241' ' ' LEU . . . -132.13 128.14 37.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.32 111.133 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.52 -30.43 25.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 70.43 110.918 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 230' ' ' ASP . . . . . 0.533 ' CB ' HG22 ' E' ' 266' ' ' THR . 0.6 OUTLIER -165.0 138.16 4.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 75.52 110.813 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 231' ' ' ILE . . . . . 0.705 HG23 ' CG2' ' E' ' 267' ' ' VAL . 8.4 mt -137.98 116.71 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 71.23 111.116 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -134.76 115.68 14.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 74.32 110.836 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 233' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' E' ' 237' ' ' ALA . 1.3 p -135.88 145.11 46.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 52.11 111.124 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -143.99 167.72 21.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.147 -0.479 . . . . 74.32 110.886 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 68.07 68.2 0.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 74.2 110.821 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 46.86 61.69 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 71.52 110.937 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 237' ' ' ALA . . . . . 0.483 ' HB3' ' OG1' ' E' ' 233' ' ' THR . . . -104.88 156.05 18.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 74.1 111.025 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -136.35 136.25 39.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 72.42 110.868 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.506 HG12 ' HB ' ' E' ' 275' ' ' VAL . 13.4 m -135.72 138.65 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 42.02 111.149 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -136.98 129.52 30.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 65.23 110.904 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.753 HD21 ' HB2' ' E' ' 228' ' ' ALA . 5.6 mp -114.48 118.71 34.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 74.24 110.839 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.92 179.71 16.21 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.733 -0.746 . . . . 74.25 112.473 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -93.07 143.2 26.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 72.11 110.85 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' D' ' 280' ' ' GLU . 5.5 p -118.59 122.36 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 74.44 111.099 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 5.7 m -122.35 122.09 65.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 75.22 111.138 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.0 t -70.09 173.78 6.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 71.15 111.139 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.0 92.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 52.45 111.174 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.19 72.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 74.44 111.078 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . -77.87 59.65 2.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 55.24 111.025 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 250' ' ' LEU . . . . . 0.647 HD21 HD13 ' D' ' 250' ' ' LEU . 0.1 OUTLIER -76.64 154.44 34.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 74.32 110.921 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -65.6 118.95 10.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 73.14 110.841 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -79.91 59.76 4.46 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 72.33 112.541 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 148.88 -104.74 0.29 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.793 -0.718 . . . . 72.2 112.533 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 53.1 mt -145.32 -42.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 73.25 111.155 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.15 147.57 51.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 64.32 110.904 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 65.2 mt -147.21 -68.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 62.01 111.118 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 2.0 m 61.71 -179.61 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 74.2 110.853 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -143.93 -175.63 4.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 71.11 110.851 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.4 27.38 2.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 64.31 110.898 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 260' ' ' THR . . . . . 0.542 HG21 ' OD1' ' E' ' 279' ' ' ASN . 9.3 t -101.06 137.41 39.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 74.51 111.18 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 94.3 m -130.79 121.62 25.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 31.43 111.12 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 262' ' ' ASN . . . . . 0.42 ' CB ' HG22 ' E' ' 277' ' ' ILE . 3.7 m120 -108.63 124.4 50.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 72.11 110.907 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 3.8 m -125.83 123.72 39.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 43.34 110.909 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 264' ' ' VAL . . . . . 0.624 HG21 HG13 ' E' ' 267' ' ' VAL . 12.9 p -123.21 131.73 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 73.13 111.142 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.67 -77.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 72.24 110.913 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 266' ' ' THR . . . . . 0.533 HG22 ' CB ' ' E' ' 230' ' ' ASP . 75.4 p -133.52 131.19 39.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 64.44 111.131 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 267' ' ' VAL . . . . . 0.705 ' CG2' HG23 ' E' ' 231' ' ' ILE . 4.9 m -118.34 120.95 65.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 71.02 111.135 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.63 120.04 63.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 71.13 111.13 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.51 133.76 11.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.776 -0.726 . . . . 75.44 112.477 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -131.87 148.13 52.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 52.44 110.895 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.48 78.74 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.735 -0.745 . . . . 55.0 112.457 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 47.51 68.38 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.372 . . . . 54.33 110.848 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 40.4 t -99.69 145.41 27.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 71.22 110.872 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.96 128.54 43.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 74.14 110.836 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.506 ' HB ' HG12 ' E' ' 239' ' ' VAL . 30.1 t -129.96 123.43 56.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 65.53 111.115 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.553 HD12 ' CD2' ' E' ' 287' ' ' TRP . 54.8 mt -126.01 111.87 15.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 64.21 110.904 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.42 HG22 ' CB ' ' E' ' 262' ' ' ASN . 27.1 mm -104.21 106.35 20.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 65.52 111.131 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.85 -171.8 29.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.753 -0.737 . . . . 71.43 112.463 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 279' ' ' ASN . . . . . 0.542 ' OD1' HG21 ' E' ' 260' ' ' THR . 4.1 m120 -89.87 154.94 19.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 74.31 110.907 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -127.15 120.58 29.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 64.01 110.902 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.27 125.77 45.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 70.4 110.876 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 126.21 -132.91 7.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.74 -0.743 . . . . 44.51 112.501 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -145.17 157.3 27.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.798 -0.715 . . . . 75.03 112.499 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -175.96 -45.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 70.14 110.874 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 126.52 -74.17 0.43 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.725 -0.75 . . . . 42.23 112.448 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -25.13 50.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 74.2 110.921 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 287' ' ' TRP . . . . . 0.553 ' CD2' HD12 ' E' ' 276' ' ' LEU . 44.3 m95 -113.46 26.48 10.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.086 -0.506 . . . . 71.21 110.936 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -176.96 -169.82 0.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 74.03 110.917 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -51.88 150.26 4.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 72.45 110.887 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -62.22 -169.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 75.42 110.856 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 63.37 87.25 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 73.33 110.878 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -177.84 151.51 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 73.4 110.861 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -57.77 125.56 23.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 70.25 110.852 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -165.46 -74.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 73.43 110.868 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 79.2 t60 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 74.44 110.847 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 3.6 ppp? . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.83 0.348 . . . . 72.13 110.915 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -175.24 -65.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 72.35 110.913 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 51.4 mt -137.65 147.41 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 64.51 111.122 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -134.64 -169.88 2.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.21 -0.45 . . . . 75.34 110.936 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . 63.75 96.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 62.53 111.035 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 1.3 tt -96.34 -25.14 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 65.45 111.155 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 21.7 t 63.71 101.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 73.13 111.103 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 98.66 55.47 1.08 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.71 -0.757 . . . . 60.32 112.505 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -126.07 170.27 11.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.354 . . . . 71.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.451 ' HB3' HG22 ' A' ' 277' ' ' ILE . 69.4 m-80 -107.28 132.79 52.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.884 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 46.8 m -140.51 148.06 40.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 75.45 110.932 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.11 119.35 10.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 31.1 111.06 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -36.68 78.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 70.44 110.89 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -165.29 137.76 4.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 70.45 110.909 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.597 HG22 ' CG2' ' A' ' 267' ' ' VAL . 6.3 pt -138.5 116.9 13.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 61.23 111.14 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -126.33 129.75 49.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 75.34 110.838 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.632 HG21 ' CG1' ' A' ' 239' ' ' VAL . 5.4 p -136.05 148.97 48.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 73.0 111.169 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.99 168.41 21.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.272 -0.422 . . . . 55.52 110.894 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 69.69 60.41 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.87 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 48.31 58.93 4.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 65.13 110.883 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.09 156.53 17.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 70.01 111.078 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.55 147.67 49.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 75.32 110.865 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.665 HG12 ' HB ' ' A' ' 275' ' ' VAL . 18.7 m -140.68 121.69 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 61.01 111.099 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -125.1 125.1 43.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 74.33 110.914 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.822 HD23 HD13 ' A' ' 277' ' ' ILE . 0.1 OUTLIER -119.77 117.98 29.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 62.44 110.906 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 161.58 162.7 13.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 52.21 112.485 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -85.74 140.66 30.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.875 0.369 . . . . 72.55 110.883 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 97.9 t -114.25 118.56 58.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.48 . . . . 63.42 111.161 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.538 ' CG1' ' HB3' ' A' ' 249' ' ' ALA . 62.0 t -119.61 129.07 75.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 72.4 111.121 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.454 HG23 ' H ' ' A' ' 249' ' ' ALA . 12.9 t -69.85 166.7 18.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 74.2 111.162 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.96 83.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 73.32 111.132 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.0 -44.98 83.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 62.25 111.085 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.564 ' HA ' HD21 ' B' ' 250' ' ' LEU . . . -72.31 111.77 7.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 71.33 111.108 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 24.2 tp -177.23 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.11 110.889 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -26.21 47.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 71.14 110.819 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -52.92 -81.7 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.77 -0.729 . . . . 72.53 112.496 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 165.52 -153.89 24.23 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.661 -0.78 . . . . 72.44 112.425 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.45 -34.84 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.864 0.364 . . . . 73.2 111.173 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.76 114.18 2.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 65.33 110.841 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 4.9 mt -130.86 144.03 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 72.52 111.153 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.02 148.82 20.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 71.12 110.913 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 18.5 t0 61.61 61.95 1.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 62.31 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.01 -176.0 2.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 64.35 110.889 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.7 m -92.02 124.51 36.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 62.25 111.125 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.5 t -108.49 120.72 43.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 63.5 111.101 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -102.68 119.79 39.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 71.03 110.903 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.6 t -132.05 123.79 27.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 70.33 110.891 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.86 HG23 ' HB3' ' B' ' 228' ' ' ALA . 4.2 p -116.9 141.38 35.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.143 -0.481 . . . . 75.42 111.082 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.51 -74.8 0.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 64.34 110.869 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.5 m -124.11 136.53 54.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 62.44 111.143 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.597 ' CG2' HG22 ' A' ' 231' ' ' ILE . 3.5 t -120.84 132.57 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 74.11 111.195 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.23 119.87 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 70.23 111.111 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.11 133.66 11.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.717 -0.754 . . . . 73.43 112.52 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -132.36 148.22 52.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 71.51 110.843 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 53.22 74.24 0.32 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.742 . . . . 63.51 112.489 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 47.57 59.52 4.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.898 0.38 . . . . 73.5 110.945 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.61 145.81 28.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 63.55 110.782 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 57.9 mtt85 -118.03 128.31 54.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 72.55 110.902 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.665 ' HB ' HG12 ' A' ' 239' ' ' VAL . 13.6 t -117.4 123.61 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 75.25 111.215 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.605 ' O ' HD12 ' B' ' 241' ' ' LEU . 0.8 OUTLIER -124.87 112.63 16.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 74.42 110.991 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.822 HD13 HD23 ' A' ' 241' ' ' LEU . 3.6 mp -112.11 104.4 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 63.54 111.068 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.23 166.18 14.68 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.718 -0.753 . . . . 63.02 112.489 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -100.1 156.21 17.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.817 0.341 . . . . 75.24 110.889 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -115.71 119.75 37.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.898 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.52 125.97 51.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 62.11 110.933 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 69.37 142.56 0.14 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.775 -0.726 . . . . 44.3 112.471 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 129.36 -28.94 3.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.735 -0.745 . . . . 71.31 112.465 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 62.91 56.95 1.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 73.33 110.954 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.525 ' O ' HG11 ' B' ' 244' ' ' VAL . . . -154.07 -119.58 0.73 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.765 -0.731 . . . . 41.31 112.499 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -176.24 -38.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 74.11 110.844 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.426 ' CE2' HD12 ' A' ' 276' ' ' LEU . 2.9 t-105 -127.49 -39.72 1.83 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 72.44 110.954 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 22.4 t0 62.52 94.32 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 73.32 110.924 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -158.64 60.36 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 44.45 110.888 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 63.18 67.79 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 74.23 110.851 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -123.02 162.55 22.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 54.33 110.823 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -173.25 -170.37 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 71.43 110.798 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.21 179.73 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 73.4 110.81 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -141.17 98.23 3.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 75.42 110.824 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 74.31 110.861 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.754 0.311 . . . . 74.05 110.852 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.46 -177.15 3.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 74.42 110.9 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 2.9 mp -124.56 134.03 67.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 72.34 111.155 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -110.37 -173.71 2.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 60.24 110.89 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 62.3 95.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 50.12 111.09 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 10.7 tp -107.95 143.22 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 60.23 111.141 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.27 144.32 8.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 64.52 111.087 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 59.5 96.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.768 -0.73 . . . . 64.32 112.481 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -159.04 127.81 5.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.798 0.332 . . . . 74.23 110.941 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.446 ' HB3' HG22 ' B' ' 277' ' ' ILE . 22.9 m120 -83.99 130.88 34.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 73.44 110.909 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.0 m -140.39 146.02 37.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 73.13 110.853 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.86 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -141.45 119.93 12.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 35.43 111.074 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -32.2 69.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 72.13 110.918 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -166.69 137.41 3.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.275 -0.42 . . . . 62.31 110.912 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.76 ' CD1' HG21 ' A' ' 264' ' ' VAL . 12.8 pt -138.54 117.61 13.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 64.13 111.149 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -131.07 129.18 41.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.846 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.615 HG21 ' CG1' ' B' ' 239' ' ' VAL . 2.3 p -135.59 148.77 49.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 63.14 111.116 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 15.6 pm0 -144.46 168.29 20.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 72.35 110.898 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 69.6 64.85 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 54.35 110.856 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.33 48.38 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 74.11 110.888 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.69 156.63 16.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 73.41 111.126 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.9 154.91 51.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 71.54 110.897 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.615 ' CG1' HG21 ' B' ' 233' ' ' THR . 17.8 m -140.92 138.55 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.22 111.175 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.476 ' HG3' HD13 ' A' ' 276' ' ' LEU . 1.5 tt0 -138.42 123.18 18.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.87 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.605 HD12 ' O ' ' A' ' 276' ' ' LEU . 0.3 OUTLIER -115.65 118.67 33.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 71.32 110.952 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 159.18 161.88 11.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.7 -0.762 . . . . 51.53 112.422 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -86.06 131.12 34.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 64.44 110.935 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.525 HG11 ' O ' ' A' ' 285' ' ' GLY . 85.9 t -96.97 115.05 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 32.34 111.146 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.579 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 91.2 t -109.78 128.99 65.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 50.12 111.099 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.419 HG23 ' H ' ' B' ' 249' ' ' ALA . 13.9 t -70.25 167.52 17.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 64.01 111.134 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.09 76.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 75.25 111.063 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.51 -50.44 73.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 71.53 111.159 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.579 ' HB3' ' CG1' ' B' ' 245' ' ' VAL . . . -62.77 -69.93 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 72.24 111.05 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.564 HD21 ' HA ' ' A' ' 249' ' ' ALA . 0.3 OUTLIER 63.23 164.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.909 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 251' ' ' HIS . . . . . 0.402 ' CD2' ' HB1' ' A' ' 249' ' ' ALA . 34.6 p80 -83.34 138.13 33.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 75.34 110.904 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 144.8 78.59 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.755 -0.736 . . . . 53.51 112.459 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 174.32 157.65 16.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 60.21 112.523 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 14.6 tt -153.5 138.36 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 75.05 111.098 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -174.18 156.73 2.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 74.11 110.883 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.5 mp -95.7 95.61 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 73.23 111.089 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.42 -170.17 2.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 64.23 110.869 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -99.55 -175.32 2.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 71.11 110.891 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -166.81 168.78 13.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 74.41 110.891 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 2.5 m -100.62 129.32 46.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 72.13 111.182 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 4.8 t -110.53 134.58 52.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 64.12 111.076 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.49 133.38 56.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 71.35 110.854 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.3 m -142.81 123.13 13.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 74.23 110.894 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.799 HG21 HD11 ' C' ' 231' ' ' ILE . 8.0 p -119.0 134.43 62.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 54.3 111.161 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -66.51 -75.2 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 73.32 110.885 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 68.8 m -133.32 133.33 42.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 63.33 111.142 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' B' ' 231' ' ' ILE . 0.7 OUTLIER -120.55 138.0 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 74.42 111.148 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.06 124.45 66.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 74.53 111.082 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.31 133.62 11.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.638 -0.792 . . . . 40.24 112.477 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -132.02 148.04 52.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 74.11 110.892 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.3 80.78 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 61.41 112.421 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 44.19 57.79 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.958 0.409 . . . . 64.34 110.923 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.71 145.55 28.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 75.55 110.844 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -119.3 128.77 54.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 73.31 110.901 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.65 HG12 HD11 ' B' ' 277' ' ' ILE . 18.0 t -115.16 125.05 72.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 75.21 111.107 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.431 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.2 OUTLIER -128.11 110.9 12.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.145 -0.48 . . . . 73.33 110.96 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.65 HD11 HG12 ' B' ' 275' ' ' VAL . 4.7 mp -112.61 104.44 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 64.24 111.14 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.31 170.97 21.44 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.754 -0.736 . . . . 60.25 112.486 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -103.89 156.0 18.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.813 0.34 . . . . 73.54 110.909 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -115.92 119.41 35.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 52.22 110.885 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.94 127.74 51.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 71.4 110.951 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 63.19 160.31 0.24 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.696 -0.764 . . . . 20.0 112.539 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 98.4 104.62 2.44 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.806 -0.711 . . . . 23.51 112.473 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.76 103.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.777 0.322 . . . . 75.12 110.98 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 157.99 -127.87 1.98 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.71 -0.757 . . . . 75.13 112.457 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -178.11 -38.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.801 0.334 . . . . 75.11 110.87 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -175.49 -74.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.916 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.83 153.78 27.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 45.02 110.887 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -68.69 124.15 22.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 73.24 110.912 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -165.56 146.57 7.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.22 110.91 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -163.29 103.06 0.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 71.34 110.833 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -171.29 120.22 0.5 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 73.01 110.802 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -173.47 141.71 0.91 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 74.24 110.814 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -172.78 117.41 0.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 74.21 110.925 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 64.13 110.811 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.871 0.367 . . . . 71.14 110.817 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 2.5 tmmt? -159.27 54.41 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 74.2 110.904 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 3.5 mp -118.43 -65.95 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 73.4 111.133 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -178.18 179.39 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 63.41 110.85 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.51 -172.51 2.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 62.24 111.111 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 8.1 tp -136.85 133.88 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 70.12 111.121 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 10.2 p -172.46 132.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 72.33 111.061 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 173.2 -84.27 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.719 -0.753 . . . . 73.12 112.518 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -150.06 -74.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 72.44 110.837 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -100.49 119.6 38.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 72.05 110.897 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.3 m -140.22 142.73 35.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 72.1 110.857 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.691 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -142.29 130.13 21.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 73.02 111.132 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -31.62 39.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 73.12 110.905 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -167.46 135.16 2.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.408 . . . . 65.44 110.851 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.802 HG22 HG22 ' C' ' 267' ' ' VAL . 6.3 pt -142.02 117.23 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 74.44 111.13 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.16 133.51 46.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 73.45 110.807 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.562 HG21 HG13 ' C' ' 239' ' ' VAL . 5.0 p -136.22 152.43 50.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 75.1 111.169 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -145.88 168.25 21.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 74.54 110.816 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 69.67 63.81 0.26 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 74.24 110.892 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.32 58.47 4.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.872 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.62 156.22 18.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 74.04 111.148 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -131.28 137.33 48.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 62.42 110.848 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.673 HG12 ' CG2' ' C' ' 275' ' ' VAL . 6.5 m -123.68 121.77 63.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 61.14 111.161 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.574 ' C ' HD13 ' C' ' 241' ' ' LEU . 0.5 OUTLIER -119.83 115.82 24.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 75.41 110.929 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.858 HD12 HD12 ' C' ' 277' ' ' ILE . 0.2 OUTLIER -111.51 118.69 36.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 62.11 110.934 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.1 166.05 13.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.673 -0.775 . . . . 72.11 112.471 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.535 ' ND2' HG23 ' C' ' 245' ' ' VAL . 1.2 p-10 -85.8 146.63 26.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.924 0.392 . . . . 65.11 110.874 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 46.2 t -116.37 122.88 70.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 65.54 111.145 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.595 HG13 ' HB3' ' C' ' 249' ' ' ALA . 74.6 t -122.05 128.53 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 51.03 111.117 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.8 t -69.83 173.23 6.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 73.44 111.164 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.54 76.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 54.44 111.059 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.93 -51.87 67.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 73.31 111.107 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 249' ' ' ALA . . . . . 0.595 ' HB3' HG13 ' C' ' 245' ' ' VAL . . . -82.22 134.13 35.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 42.14 111.047 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.29 -42.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 62.12 110.952 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -159.1 149.35 19.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 75.41 110.834 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 148.22 160.91 9.26 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.825 -0.702 . . . . 70.33 112.533 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 71.78 119.06 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.698 -0.763 . . . . 53.53 112.506 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -69.97 -26.89 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.338 . . . . 71.44 111.156 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.52 162.46 12.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 73.43 110.916 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 3.2 mp -64.53 141.21 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 73.42 111.142 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 13.9 m -102.25 128.3 48.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 62.34 110.866 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 59.02 -173.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 72.33 110.85 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.54 60.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 70.01 110.857 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.37 137.69 35.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 71.51 111.146 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 87.2 m -128.8 119.83 25.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 65.34 111.094 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -104.86 119.96 40.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 63.04 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 29.2 t -134.32 123.64 24.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 72.2 110.827 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.715 HG21 HG12 ' C' ' 267' ' ' VAL . 8.3 p -119.49 153.32 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 74.45 111.144 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.02 -60.45 1.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 52.34 110.905 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 31.6 p -145.63 127.68 15.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 74.44 111.136 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.802 HG22 HG22 ' C' ' 231' ' ' ILE . 1.0 OUTLIER -122.82 137.38 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 73.11 111.14 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 49.1 t -124.9 125.56 69.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 52.51 111.124 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.77 134.06 11.74 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 41.4 112.52 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -132.36 148.52 52.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.841 0.353 . . . . 74.22 110.864 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.72 85.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.682 -0.77 . . . . 53.54 112.548 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 42.72 59.26 2.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 72.45 110.871 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.8 145.13 28.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 63.21 110.825 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -121.32 128.2 52.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 71.42 110.874 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.673 ' CG2' HG12 ' C' ' 239' ' ' VAL . 31.0 t -116.04 125.19 73.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 72.22 111.14 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.552 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.1 OUTLIER -128.2 111.59 13.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 75.01 110.918 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.858 HD12 HD12 ' C' ' 241' ' ' LEU . 57.2 mt -111.14 104.2 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 71.44 111.14 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.39 178.22 24.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.725 -0.75 . . . . 42.42 112.465 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -108.69 150.96 26.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.779 0.323 . . . . 74.42 110.905 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -112.0 127.9 56.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.44 110.894 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.513 ' CZ ' HG11 ' D' ' 245' ' ' VAL . 1.9 t80 -113.63 125.87 54.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 61.24 110.919 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 51.56 -170.45 0.36 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.767 -0.73 . . . . 63.55 112.489 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 84.94 -133.01 11.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.818 -0.705 . . . . 51.13 112.457 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -45.38 66.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.83 0.348 . . . . 60.31 110.876 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 128.02 -9.17 6.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.713 -0.756 . . . . 71.52 112.443 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.786 ' CE1' HD11 ' D' ' 276' ' ' LEU . 7.8 t80 -171.51 -75.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 73.21 110.87 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.552 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 14.6 t90 -178.95 -57.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 71.35 110.908 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -168.89 -178.57 3.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 71.03 110.894 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -154.18 -74.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 74.2 110.859 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.46 -171.88 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 71.31 110.819 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -134.06 42.88 2.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 65.13 110.892 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -155.88 -71.88 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 72.22 110.909 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -84.52 123.18 30.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 74.22 110.857 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.29 29.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 70.42 110.872 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.211 -0.449 . . . . 74.43 110.854 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 20.5 mtp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.79 0.329 . . . . 73.33 110.845 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -136.37 -175.88 4.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 63.54 110.869 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 66.1 mt -79.99 145.28 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 62.2 111.088 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.64 162.6 15.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 72.31 110.872 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -174.98 -170.27 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 72.11 111.088 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 222' ' ' ILE . . . . . 0.466 HD13 ' H ' ' D' ' 222' ' ' ILE . 0.2 OUTLIER -118.15 149.45 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.423 . . . . 71.52 111.122 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 223' ' ' VAL . . . . . 0.525 HG13 ' NH1' ' D' ' 225' ' ' ARG . 86.1 t -149.81 120.08 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 44.01 111.16 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -93.96 -122.06 3.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 72.33 112.486 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.525 ' NH1' HG13 ' D' ' 223' ' ' VAL . 0.0 OUTLIER 63.11 -168.93 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 63.45 110.837 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -83.66 115.31 22.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 70.4 110.85 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.35 147.33 49.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.912 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.06 119.91 11.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 63.23 111.092 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.49 -39.33 70.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 71.34 110.913 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -165.81 138.89 4.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 74.25 110.844 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 231' ' ' ILE . . . . . 0.475 HG23 ' CG2' ' D' ' 267' ' ' VAL . 0.1 OUTLIER -135.38 116.25 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 64.45 111.149 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -125.59 125.6 43.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 61.45 110.826 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 233' ' ' THR . . . . . 0.593 HG21 ' CG1' ' D' ' 239' ' ' VAL . 1.5 p -135.51 149.0 49.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 64.02 111.096 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 14.9 pm0 -145.65 167.95 21.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 65.1 110.861 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 64.79 76.03 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 54.3 110.899 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 10.5 mtm-85 41.42 56.74 3.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.857 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.54 156.29 18.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 74.11 111.049 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -136.83 151.96 49.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 64.11 110.915 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.646 HG12 ' CG2' ' D' ' 275' ' ' VAL . 18.6 m -137.23 139.53 43.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 71.05 111.078 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 240' ' ' GLN . . . . . 0.62 ' C ' HD13 ' D' ' 241' ' ' LEU . 19.8 tm0? -137.66 121.28 17.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 74.55 110.912 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.645 HD12 HD12 ' D' ' 277' ' ' ILE . 0.2 OUTLIER -112.21 118.37 35.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 72.14 110.899 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 146.23 169.48 14.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.741 . . . . 52.13 112.534 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 243' ' ' ASN . . . . . 0.447 ' ND2' HG23 ' D' ' 245' ' ' VAL . 5.8 p-10 -85.95 152.1 23.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 45.44 110.909 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 18.2 t -117.57 114.81 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 72.04 111.139 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 245' ' ' VAL . . . . . 0.513 HG11 ' CZ ' ' C' ' 281' ' ' TYR . 67.8 t -107.47 124.06 63.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 60.0 111.181 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t -69.73 168.21 15.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 65.42 111.178 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.19 -34.1 73.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 75.34 111.078 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.74 -36.45 72.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 54.41 111.115 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 60.99 170.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 73.11 111.126 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.47 114.31 28.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 63.13 110.897 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -77.64 73.02 4.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 64.42 110.863 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 100.35 167.57 28.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.749 -0.739 . . . . 65.34 112.55 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 71.41 24.34 77.0 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.765 -0.731 . . . . 53.03 112.472 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 15.5 pt -115.11 -25.14 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.848 0.356 . . . . 71.23 111.182 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -101.49 136.66 40.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 74.45 110.942 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 45.7 mm 60.82 83.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 63.12 111.17 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.03 172.74 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 44.11 110.894 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.44 -170.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 74.01 110.834 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -170.92 130.33 0.79 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 64.34 110.913 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 260' ' ' THR . . . . . 0.66 HG23 ' HD2' ' E' ' 225' ' ' ARG . 85.8 m -66.51 130.66 43.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 70.24 111.162 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 99.8 m -105.33 125.08 50.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.424 . . . . 53.41 111.127 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 262' ' ' ASN . . . . . 0.524 ' OD1' HG22 ' D' ' 260' ' ' THR . 0.1 OUTLIER -125.98 129.47 49.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 63.3 110.857 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.23 123.56 14.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 53.21 110.882 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.496 HG23 HD11 ' E' ' 231' ' ' ILE . 14.2 p -109.89 128.77 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 73.33 111.122 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.55 -79.55 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 72.25 110.793 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -121.68 129.93 53.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 75.11 111.085 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.475 ' CG2' HG23 ' D' ' 231' ' ' ILE . 0.5 OUTLIER -117.75 120.33 64.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 65.42 111.103 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 22.4 t -118.74 115.97 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 73.4 111.154 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.14 133.76 10.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.707 -0.759 . . . . 34.31 112.527 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -131.53 147.81 52.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.766 0.317 . . . . 74.25 110.888 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.16 90.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.761 . . . . 73.22 112.521 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 44.28 61.27 2.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 75.33 110.914 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.56 145.81 24.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 75.14 110.937 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 10.7 mtm-85 -124.04 131.23 53.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 65.44 110.865 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.646 ' CG2' HG12 ' D' ' 239' ' ' VAL . 21.8 t -115.27 124.9 72.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 64.04 111.106 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.786 HD11 ' CE1' ' C' ' 286' ' ' PHE . 2.8 mm? -128.4 111.46 13.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 63.31 110.911 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.645 HD12 HD12 ' D' ' 241' ' ' LEU . 18.2 mt -114.16 103.99 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 62.51 111.165 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.6 -164.68 30.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 53.23 112.42 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -128.26 150.07 50.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.786 0.327 . . . . 74.44 110.904 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -113.39 145.36 41.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 61.44 110.889 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -129.86 125.93 36.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 73.41 110.927 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 62.28 168.46 0.76 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.76 -0.733 . . . . 75.21 112.449 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 107.63 -124.52 7.6 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 72.23 112.477 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -137.84 91.53 2.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 55.54 110.881 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 71.19 167.29 7.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.748 -0.739 . . . . 32.53 112.518 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 286' ' ' PHE . . . . . 0.405 ' HB3' HG21 ' E' ' 244' ' ' VAL . 2.6 p90 -51.92 -31.95 30.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.834 0.349 . . . . 74.12 110.874 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 3.0 t90 176.59 105.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 75.0 110.873 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.46 176.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 41.03 110.794 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -115.58 -179.94 3.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.483 . . . . 72.21 110.92 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -137.92 -71.44 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 73.5 110.849 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -178.08 -171.47 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 74.51 110.869 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -106.62 -33.43 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 74.42 110.836 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 62.97 103.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 72.23 110.85 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -119.27 144.36 46.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 72.04 110.8 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 32.1 p80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 71.24 110.838 -179.963 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.839 0.352 . . . . 70.45 110.896 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -163.78 98.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 75.31 110.881 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 1.1 pp -147.84 157.71 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 75.35 111.115 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.8 140.28 1.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 54.54 110.816 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -178.19 -178.03 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 62.22 111.118 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 47.6 mm -53.22 142.19 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 60.4 111.163 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 17.8 m -98.01 169.29 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 64.54 111.175 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -95.89 -169.46 35.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.792 -0.718 . . . . 34.35 112.474 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 225' ' ' ARG . . . . . 0.66 ' HD2' HG23 ' D' ' 260' ' ' THR . 5.6 ptp180 -63.71 -46.98 82.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.349 . . . . 74.04 110.86 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 226' ' ' ASN . . . . . 0.465 ' HB3' HG22 ' E' ' 277' ' ' ILE . 7.7 m-20 -96.75 109.75 22.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 73.44 110.881 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 31.9 t -134.06 137.85 44.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 54.13 110.802 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.45 136.61 54.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 74.22 111.158 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.44 -35.14 13.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 74.03 110.861 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.39 137.32 3.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 72.23 110.824 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 231' ' ' ILE . . . . . 0.496 HD11 HG23 ' D' ' 264' ' ' VAL . 1.3 mt -138.06 116.55 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 64.31 111.166 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -123.16 121.68 36.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.02 110.861 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 9.6 p -136.74 149.14 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.14 111.227 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.98 166.44 24.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 73.44 110.862 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 235' ' ' GLU . . . . . 0.466 ' O ' ' C ' ' E' ' 236' ' ' ARG . 2.4 mt-10 62.23 90.46 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 64.44 110.904 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 236' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' E' ' 235' ' ' GLU . 0.9 OUTLIER 31.94 63.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 72.34 110.935 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.03 156.28 18.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 60.03 111.087 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -137.4 137.2 38.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 73.03 110.903 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.561 HG12 ' CG2' ' E' ' 275' ' ' VAL . 16.6 m -126.08 137.76 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 70.43 111.092 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -134.78 126.51 29.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 62.33 110.931 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.471 HD22 ' HB ' ' D' ' 264' ' ' VAL . 1.3 mp -116.98 118.64 32.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.859 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.61 172.38 12.55 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.786 -0.721 . . . . 74.24 112.535 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 243' ' ' ASN . . . . . 0.488 ' HB3' HG21 ' D' ' 260' ' ' THR . 1.2 p-10 -85.57 163.39 18.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 71.04 110.914 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' D' ' 286' ' ' PHE . 21.4 t -129.64 135.54 61.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 73.35 111.132 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 70.3 t -122.86 124.11 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 75.53 111.226 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.7 t -68.47 167.03 15.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 53.02 111.172 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.17 75.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 62.22 111.127 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 248' ' ' ALA . . . . . 0.675 ' HB1' HD12 ' E' ' 250' ' ' LEU . . . -56.89 -36.94 70.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 52.32 111.087 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 249' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' E' ' 248' ' ' ALA . . . 68.99 -77.22 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 55.41 111.053 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 250' ' ' LEU . . . . . 0.675 HD12 ' HB1' ' E' ' 248' ' ' ALA . 0.4 OUTLIER 52.02 63.32 2.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 72.14 110.876 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 36.1 m80 59.0 46.33 13.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 74.04 110.834 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -55.65 -89.8 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.809 -0.71 . . . . 75.1 112.48 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -75.88 113.05 3.77 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.727 -0.749 . . . . 62.04 112.538 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 33.0 pt -98.19 173.01 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.858 0.361 . . . . 74.14 111.091 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 255' ' ' ARG . . . . . 0.483 ' O ' HD13 ' E' ' 256' ' ' ILE . 0.0 OUTLIER -52.0 -39.75 59.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.43 110.833 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 256' ' ' ILE . . . . . 0.483 HD13 ' O ' ' E' ' 255' ' ' ARG . 25.7 mm -130.09 100.41 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 35.35 111.149 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 30.7 t -106.88 28.74 7.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 52.5 110.823 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.25 117.57 30.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 74.11 110.855 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -177.59 -55.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 70.41 110.849 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.4 128.31 34.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.26 -0.427 . . . . 70.41 111.148 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 261' ' ' THR . . . . . 0.615 HG22 ' HA ' ' E' ' 225' ' ' ARG . 0.5 OUTLIER -126.95 126.82 43.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 72.44 111.125 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -123.0 119.75 31.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 44.44 110.903 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 4.2 p -133.12 123.29 25.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.883 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 264' ' ' VAL . . . . . 0.617 HG21 HG22 ' E' ' 267' ' ' VAL . 7.4 p -112.3 136.64 47.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 72.14 111.168 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -81.36 -75.53 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 71.42 110.904 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.2 m -125.21 129.62 50.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 64.33 111.142 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 267' ' ' VAL . . . . . 0.617 HG22 HG21 ' E' ' 264' ' ' VAL . 17.6 t -117.32 123.9 72.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 75.43 111.142 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 87.4 t -127.07 115.82 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 54.34 111.133 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.58 133.87 8.81 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 73.4 112.516 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.84 147.54 46.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.359 . . . . 74.54 110.897 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.27 84.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.777 -0.725 . . . . 44.43 112.46 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 49.1 88.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.853 0.359 . . . . 71.31 110.905 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 67.2 m -116.25 145.19 43.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.13 110.85 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.82 128.78 55.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 74.42 110.925 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.561 ' CG2' HG12 ' E' ' 239' ' ' VAL . 16.4 t -115.12 122.86 70.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 72.01 111.11 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.25 111.56 13.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 72.21 110.874 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.465 HG22 ' HB3' ' E' ' 226' ' ' ASN . 61.5 mt -113.71 104.09 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 73.02 111.087 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.3 176.88 15.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 73.33 112.445 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -89.35 156.43 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.826 0.345 . . . . 64.33 110.899 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -128.53 137.52 51.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 61.23 110.94 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -120.2 123.75 44.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 72.45 110.923 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 56.42 178.35 0.39 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.686 -0.769 . . . . 75.14 112.536 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . 127.47 165.05 11.8 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.733 -0.746 . . . . 63.1 112.54 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -118.19 -23.22 7.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.823 0.344 . . . . 65.25 110.834 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -62.74 -160.88 0.21 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.734 -0.746 . . . . 42.24 112.525 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -74.82 -28.86 60.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 70.34 110.867 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -98.2 79.28 2.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.156 -0.475 . . . . 73.52 110.881 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 178.47 -177.5 0.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.294 -0.412 . . . . 63.14 110.875 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -156.24 141.9 17.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.84 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -167.99 -169.9 1.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 63.43 110.9 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -88.02 69.37 9.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.839 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.63 -169.98 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 65.13 110.865 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -143.58 -44.76 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 74.21 110.866 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -69.31 161.81 28.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 65.43 110.868 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 71.51 110.919 179.96 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 5.1 mtm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.78 0.324 . . . . 73.02 110.831 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.13 84.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 54.04 110.901 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.5 tt -63.58 -24.94 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 65.44 111.192 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -52.04 156.78 1.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 72.44 110.869 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -146.72 -175.95 5.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 34.34 111.065 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.481 HD11 HD11 ' A' ' 256' ' ' ILE . 15.3 tt -175.2 150.75 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 72.33 111.135 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.713 HG22 HD13 ' A' ' 256' ' ' ILE . 28.3 m -60.55 -177.25 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 60.01 111.069 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 61.67 101.53 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 73.52 112.52 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 261' ' ' THR . 0.0 OUTLIER -176.7 106.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.363 . . . . 55.11 110.831 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -83.19 145.15 29.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 71.21 110.899 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.57 150.26 47.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 75.02 110.85 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.8 119.13 17.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.497 . . . . 61.12 111.092 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -70.76 -49.98 40.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 72.22 110.927 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -165.25 136.37 3.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 45.13 110.862 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.424 HG22 ' CG2' ' A' ' 267' ' ' VAL . 8.0 pt -138.84 134.39 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 74.44 111.1 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -134.49 128.2 32.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 73.25 110.837 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 11.8 p -136.41 149.79 48.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 71.23 111.107 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -120.54 166.24 13.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 75.43 110.869 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 65.39 -159.27 0.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 72.32 110.914 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -74.33 61.41 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 73.33 110.835 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.23 156.43 16.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 70.13 111.108 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.64 143.49 47.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 75.41 110.869 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.672 HG12 ' HB ' ' A' ' 275' ' ' VAL . 16.0 m -135.83 120.83 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 73.3 111.161 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.44 137.7 52.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.889 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.41 118.37 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 72.13 110.92 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 149.78 -126.73 2.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 74.21 112.516 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -145.51 143.11 29.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.808 0.337 . . . . 75.0 110.944 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.65 119.9 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 75.35 111.121 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 36.7 t -109.19 116.15 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 54.2 111.12 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 247' ' ' ALA . 0.2 OUTLIER -69.85 171.82 8.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 65.33 111.166 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.458 ' H ' HG22 ' A' ' 246' ' ' THR . . . -59.1 -42.73 91.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.266 -0.424 . . . . 73.42 111.1 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ALA . . . . . 0.641 ' HB3' ' H ' ' A' ' 283' ' ' GLY . . . -57.03 -35.89 69.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 55.11 111.092 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.656 ' HB2' ' HA2' ' A' ' 282' ' ' GLY . . . -88.03 140.14 29.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 64.02 111.058 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -178.76 119.56 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 41.33 110.937 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 63.02 104.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 71.34 110.886 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -71.64 -58.1 5.57 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 32.13 112.432 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 108.4 -95.68 0.96 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.725 -0.75 . . . . 75.32 112.521 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 25.7 pt -59.49 -173.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.826 0.346 . . . . 72.11 111.118 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.02 169.54 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.908 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.713 HD13 HG22 ' A' ' 223' ' ' VAL . 3.3 mt -51.7 119.42 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 74.11 111.208 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.8 t -96.24 26.58 4.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 70.33 110.868 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.705 ' H ' HG22 ' A' ' 256' ' ' ILE . 15.0 t0 -152.71 85.76 1.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 73.44 110.866 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -96.45 28.7 3.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.454 . . . . 73.01 110.873 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.8 m -98.97 138.08 36.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 63.44 111.077 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 225' ' ' ARG . 54.0 m -132.5 133.64 44.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 53.25 111.167 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.611 HD22 HD23 ' B' ' 241' ' ' LEU . 0.6 OUTLIER -115.88 144.45 44.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 70.11 110.862 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.7 m -141.69 127.97 19.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 71.42 110.824 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.743 HG23 HD11 ' B' ' 231' ' ' ILE . 8.7 p -113.57 137.41 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.508 . . . . 74.3 111.088 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -85.61 -78.82 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 52.54 110.829 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 4.0 m -115.71 127.04 54.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 75.33 111.101 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.562 HG22 HG21 ' A' ' 264' ' ' VAL . 40.9 t -118.42 124.12 72.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 62.01 111.076 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 78.9 t -124.76 115.21 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.116 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.42 133.08 9.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 53.2 112.499 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -109.03 129.3 55.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.35 . . . . 72.02 110.884 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.92 178.74 10.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.743 . . . . 21.12 112.465 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -47.53 101.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.835 0.35 . . . . 74.32 110.923 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 44.9 t -129.63 154.14 47.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.096 -0.502 . . . . 65.1 110.837 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -112.16 128.05 56.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 65.11 110.827 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.672 ' HB ' HG12 ' A' ' 239' ' ' VAL . 59.2 t -121.0 123.58 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 73.03 111.137 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.726 HD12 ' CE2' ' A' ' 287' ' ' TRP . 0.4 OUTLIER -125.16 111.01 14.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 53.04 110.913 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.615 ' CD1' HD13 ' B' ' 241' ' ' LEU . 31.0 mm -109.96 104.3 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 62.52 111.119 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.74 -163.48 29.67 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.765 -0.731 . . . . 74.14 112.508 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -114.36 156.36 24.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 72.04 110.843 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.725 ' HG2' HG12 ' B' ' 244' ' ' VAL . 8.9 pt-20 -129.23 129.24 44.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.114 -0.494 . . . . 63.34 110.88 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.566 ' CZ ' HG11 ' B' ' 245' ' ' VAL . 0.3 OUTLIER -123.8 128.97 50.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 72.01 110.907 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.656 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 151.34 -169.19 30.94 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.808 -0.71 . . . . 74.14 112.494 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.641 ' H ' ' HB3' ' A' ' 248' ' ' ALA . . . -78.72 -173.84 43.66 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.681 -0.771 . . . . 75.12 112.513 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.3 -75.55 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 61.44 110.927 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 286' ' ' PHE . . . 100.58 175.81 29.77 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.689 -0.767 . . . . 74.42 112.489 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.41 ' HB3' ' O ' ' A' ' 285' ' ' GLY . 9.9 t80 64.01 -81.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 75.42 110.883 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.726 ' CE2' HD12 ' A' ' 276' ' ' LEU . 0.7 OUTLIER -140.69 -41.67 0.4 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.084 -0.507 . . . . 75.12 110.976 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 51.1 t0 63.61 105.5 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 73.32 110.865 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -95.55 -169.82 2.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 73.15 110.922 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -55.55 -26.13 41.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 74.14 110.901 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -169.95 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 75.15 110.942 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -140.48 -169.78 2.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 62.03 110.843 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.33 -170.32 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.845 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.38 103.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.837 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 2.0 t60 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 61.34 110.818 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.813 0.34 . . . . 74.14 110.809 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.7 179.2 7.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 74.14 110.908 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 5.4 pt -152.0 -178.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 62.1 111.106 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.22 -170.24 2.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 74.12 110.915 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -107.44 -75.68 0.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 53.14 111.131 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 1.2 pt -152.86 105.53 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 20.3 111.091 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 14.4 p -175.81 149.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 62.33 111.167 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -52.33 128.7 35.52 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.694 -0.765 . . . . 64.15 112.497 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.731 ' O ' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER -162.54 121.88 2.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 61.21 110.849 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.807 ' HB3' HG22 ' B' ' 277' ' ' ILE . 0.9 OUTLIER -86.57 140.17 30.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 73.11 110.942 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 227' ' ' SER . . . . . 0.59 ' HG ' ' N ' ' D' ' 217' ' ' MET . 41.4 m -134.05 140.49 46.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 70.42 110.911 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 264' ' ' VAL . . . -122.71 119.33 30.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 64.11 111.07 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 0.5 OUTLIER -67.93 -44.99 75.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 75.42 110.872 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -156.7 137.53 13.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.53 110.806 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.743 HD11 HG23 ' A' ' 264' ' ' VAL . 0.1 OUTLIER -138.34 117.34 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 71.14 111.16 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -120.1 123.82 44.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 74.01 110.921 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 17.1 p -136.17 140.8 43.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 75.1 111.135 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -121.7 166.93 13.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.167 -0.469 . . . . 63.33 110.809 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.58 -165.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 54.03 110.894 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -73.5 69.84 1.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 72.2 110.892 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 156.4 17.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 41.12 111.077 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.83 135.48 50.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 62.41 110.844 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.645 HG12 ' HB ' ' B' ' 275' ' ' VAL . 19.0 m -126.45 136.08 61.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.41 111.099 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -134.78 126.4 28.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 71.12 110.867 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.615 HD13 ' CD1' ' A' ' 277' ' ' ILE . 3.4 mp -118.46 119.01 33.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 63.04 110.863 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.83 -174.95 21.82 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.727 -0.749 . . . . 75.14 112.471 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -93.53 141.13 28.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 74.31 110.87 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.725 HG12 ' HG2' ' A' ' 280' ' ' GLU . 18.0 m -118.33 122.44 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 72.01 111.125 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.566 HG11 ' CZ ' ' A' ' 281' ' ' TYR . 21.3 t -116.54 127.59 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 64.21 111.142 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 57.6 p -87.2 172.79 9.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 74.34 111.131 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.46 ' HB2' ' HA2' ' A' ' 283' ' ' GLY . . . -63.07 -43.1 99.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 63.34 111.129 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -42.68 80.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 63.1 111.16 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.632 ' HB2' ' HA3' ' B' ' 282' ' ' GLY . . . -51.95 -30.36 24.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 65.43 111.091 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.508 HD23 ' OH ' ' A' ' 281' ' ' TYR . 0.5 OUTLIER -116.75 87.22 2.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.208 -0.451 . . . . 73.53 110.983 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -145.62 54.6 1.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.894 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.15 73.84 0.93 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.809 -0.71 . . . . 44.02 112.536 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 176.58 113.07 0.33 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.786 -0.721 . . . . 62.23 112.502 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 3.3 mt -80.81 108.46 14.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.853 0.359 . . . . 65.34 111.132 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -159.05 125.78 4.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 73.43 110.901 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 256' ' ' ILE . . . . . 0.497 ' O ' HD13 ' B' ' 256' ' ' ILE . 0.0 OUTLIER -115.87 -22.55 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 71.44 111.156 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.5 m 66.49 -168.21 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 73.45 110.902 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -75.94 178.85 5.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 64.44 110.885 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -120.83 111.45 17.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 74.13 110.947 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.484 HG21 ' HB2' ' C' ' 243' ' ' ASN . 6.0 m -99.88 121.78 41.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 62.33 111.128 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.731 HG23 ' O ' ' B' ' 225' ' ' ARG . 96.9 m -105.02 130.4 53.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 63.33 111.213 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.43 147.29 48.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 61.3 110.847 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 28.2 t -142.08 123.45 14.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.44 110.909 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.655 HG21 HG22 ' B' ' 267' ' ' VAL . 11.8 p -109.36 143.53 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 72.23 111.128 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.418 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 4.0 mt-10 -84.58 -75.32 0.35 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 75.14 110.865 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 18.5 p -125.12 127.87 47.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 73.1 111.166 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.655 HG22 HG21 ' B' ' 264' ' ' VAL . 21.2 t -118.27 120.99 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 74.22 111.088 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.8 123.68 70.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 55.33 111.14 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -131.38 133.47 7.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.699 -0.762 . . . . 73.01 112.454 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.28 147.21 31.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 72.11 110.809 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.26 -162.43 32.52 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.751 -0.737 . . . . 65.03 112.565 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -69.56 83.17 0.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 74.55 110.899 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 32.1 t -104.63 164.58 11.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 72.21 110.836 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -124.14 128.72 49.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 75.12 110.839 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.645 ' HB ' HG12 ' B' ' 239' ' ' VAL . 56.6 t -117.94 123.86 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 75.42 111.127 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.661 HD12 ' CE2' ' B' ' 287' ' ' TRP . 0.4 OUTLIER -128.0 111.32 13.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 74.42 110.952 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.807 HG22 ' HB3' ' B' ' 226' ' ' ASN . 12.7 mm -112.76 103.8 16.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 52.55 111.087 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.26 -154.03 25.24 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.777 -0.725 . . . . 63.34 112.514 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -125.31 149.63 47.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.734 0.302 . . . . 63.3 110.899 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -113.95 136.32 53.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 44.04 110.824 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -130.04 127.31 39.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 74.44 110.955 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.632 ' HA3' ' HB2' ' B' ' 249' ' ' ALA . . . 91.36 172.55 43.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 61.51 112.484 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 283' ' ' GLY . . . . . 0.528 ' N ' ' HB2' ' C' ' 247' ' ' ALA . . . 80.11 125.99 0.6 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.808 -0.71 . . . . 45.31 112.521 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -75.88 68.2 2.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.861 0.363 . . . . 73.23 110.954 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -174.96 -153.12 9.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.705 -0.76 . . . . 53.51 112.49 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -122.0 -33.8 3.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.834 0.35 . . . . 63.41 110.86 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.661 ' CE2' HD12 ' B' ' 276' ' ' LEU . 1.4 t90 -133.66 -53.73 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 65.5 110.906 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -177.94 -50.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 70.14 110.891 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -131.74 164.75 25.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 54.1 110.899 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -139.2 -173.34 3.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 72.54 110.862 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -144.29 -179.98 6.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 65.22 110.873 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -147.58 150.19 33.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 63.02 110.816 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.24 -66.72 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.468 . . . . 73.03 110.849 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -175.24 33.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.323 -0.399 . . . . 72.22 110.83 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 74.13 110.891 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.815 0.34 . . . . 52.51 110.821 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -141.89 178.6 7.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 74.04 110.912 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -172.07 125.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 72.23 111.071 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -179.13 84.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 72.13 110.876 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 221' ' ' ALA . . . . . 0.562 ' C ' HD12 ' C' ' 222' ' ' ILE . . . -135.87 -58.32 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 75.41 111.169 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 222' ' ' ILE . . . . . 0.562 HD12 ' C ' ' C' ' 221' ' ' ALA . 3.7 mp 63.76 94.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 72.23 111.068 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 33.0 m -149.2 -177.19 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 54.11 111.155 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -52.55 137.33 34.97 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.746 -0.74 . . . . 73.44 112.466 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.77 129.59 0.99 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.718 0.295 . . . . 64.42 110.906 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.454 ' HB3' HG22 ' C' ' 277' ' ' ILE . 0.1 OUTLIER -101.43 144.15 30.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 62.34 110.889 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.14 137.99 44.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 65.22 110.832 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.681 ' CB ' HD11 ' C' ' 231' ' ' ILE . . . -116.86 119.91 36.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.055 -0.521 . . . . 54.43 111.124 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -72.72 -42.92 63.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 70.1 110.926 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -158.23 136.58 10.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 72.3 110.805 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.681 HD11 ' CB ' ' C' ' 228' ' ' ALA . 1.7 mt -140.01 116.39 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 75.04 111.077 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 16.0 ttp85 -125.63 125.63 43.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 70.32 110.879 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 21.2 p -136.32 146.3 46.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 51.3 111.099 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -121.21 166.1 14.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 60.23 110.88 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.46 -162.5 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 73.02 110.858 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -72.85 70.83 1.01 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.838 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.25 157.22 17.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 72.32 111.058 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -125.59 149.16 48.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 63.44 110.901 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.591 HG12 ' HB ' ' C' ' 275' ' ' VAL . 12.9 m -141.58 137.84 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 71.22 111.138 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -136.65 132.16 34.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 75.35 110.922 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.645 HD13 ' HB ' ' C' ' 277' ' ' ILE . 1.6 mm? -117.89 117.91 30.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 72.51 110.957 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.44 -177.5 17.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.727 -0.749 . . . . 71.12 112.473 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.484 ' HB2' HG21 ' B' ' 260' ' ' THR . 2.8 t-20 -85.76 140.89 30.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 74.24 110.817 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.29 115.85 50.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 55.03 111.139 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.412 HG22 ' HB2' ' C' ' 281' ' ' TYR . 21.4 t -113.66 123.07 68.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 72.41 111.137 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 13.2 t -79.95 175.1 10.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 74.11 111.202 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.528 ' HB2' ' N ' ' B' ' 283' ' ' GLY . . . -62.15 -40.91 97.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 74.52 111.12 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.68 -52.03 66.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 35.54 111.094 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.91 -170.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 75.31 111.072 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 250' ' ' LEU . . . . . 0.483 HD22 ' O ' ' D' ' 249' ' ' ALA . 20.1 mt -96.33 136.96 36.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 72.43 110.89 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -53.63 102.35 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 62.0 110.861 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 52.96 -173.11 0.37 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.717 -0.754 . . . . 71.52 112.45 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 131.66 -62.21 0.65 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.727 -0.749 . . . . 74.41 112.454 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 28.4 mm 64.24 69.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.882 0.372 . . . . 64.32 111.157 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 56.84 78.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 75.1 110.921 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 7.5 pt -150.67 45.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 64.32 111.131 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 2.8 p -124.46 -178.71 4.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 71.34 110.84 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -73.58 162.16 29.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 55.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -107.95 98.2 7.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.945 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 260' ' ' THR . . . . . 0.513 HG21 ' CB ' ' D' ' 243' ' ' ASN . 38.1 p -99.09 137.88 36.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 74.44 111.205 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.7 t -134.13 133.75 41.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 75.24 111.135 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.13 147.7 49.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 61.25 110.898 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.17 123.21 13.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 74.3 110.878 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.645 HG21 HG22 ' C' ' 267' ' ' VAL . 9.0 p -105.52 153.56 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 71.23 111.156 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -97.45 -49.34 4.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 74.42 110.857 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.74 127.96 14.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 73.44 111.157 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.645 HG22 HG21 ' C' ' 264' ' ' VAL . 29.1 t -125.0 120.95 59.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 73.43 111.184 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 52.1 t -126.51 134.86 65.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 73.34 111.156 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.65 133.41 6.39 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.789 -0.719 . . . . 71.23 112.489 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.17 147.38 28.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 73.2 110.863 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 61.93 -152.64 42.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.728 -0.749 . . . . 54.0 112.507 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -73.64 73.78 1.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.359 . . . . 73.23 110.865 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 58.8 m -97.68 157.8 15.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 42.45 110.847 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -119.56 132.72 55.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 64.34 110.82 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.591 ' HB ' HG12 ' C' ' 239' ' ' VAL . 78.7 t -115.32 122.26 68.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 62.25 111.172 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.57 HD23 ' HZ2' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -125.14 111.66 15.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 71.34 110.899 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.645 ' HB ' HD13 ' C' ' 241' ' ' LEU . 20.1 mm -112.63 104.15 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 71.2 111.12 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.58 -159.16 26.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.741 . . . . 70.13 112.459 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.48 156.22 24.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 72.13 110.901 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -113.94 144.61 42.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 74.01 110.848 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.412 ' HB2' HG22 ' C' ' 245' ' ' VAL . 2.6 m-85 -130.14 125.61 35.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 75.12 110.907 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 67.06 150.69 0.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 62.01 112.499 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 138.33 150.67 5.67 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.792 -0.718 . . . . 70.32 112.486 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -64.74 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 74.32 110.896 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -100.81 174.9 25.98 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.748 . . . . 51.02 112.515 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -52.02 -30.37 25.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.868 0.366 . . . . 74.11 110.852 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.57 ' HZ2' HD23 ' C' ' 276' ' ' LEU . 2.0 t90 -126.46 -65.09 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 74.33 110.836 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.51 -169.83 2.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.316 -0.402 . . . . 64.41 110.869 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.28 -170.0 2.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.9 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -142.36 -74.82 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 71.42 110.879 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.26 -169.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 74.3 110.886 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 -170.18 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 74.41 110.914 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.05 151.89 28.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.298 -0.41 . . . . 53.33 110.862 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -172.46 154.94 3.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 71.32 110.889 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 1.6 t60 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 63.24 110.868 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 217' ' ' MET . . . . . 0.59 ' N ' ' HG ' ' B' ' 227' ' ' SER . 3.4 tpt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.798 0.332 . . . . 51.0 110.905 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.77 29.08 5.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 74.33 110.883 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.06 126.11 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 72.44 111.163 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -173.17 130.59 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 74.44 110.775 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -87.87 162.85 16.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 34.32 111.029 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.2 28.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 75.33 111.201 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 38.9 t -53.65 -65.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 73.24 111.14 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -142.47 -113.26 0.95 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.739 . . . . 75.12 112.536 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.53 ' N ' HG23 ' D' ' 261' ' ' THR . 0.0 OUTLIER 59.98 -168.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.849 0.356 . . . . 73.21 110.843 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -83.03 110.01 17.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 71.43 110.907 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 60.5 p -133.22 156.9 46.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 63.41 110.844 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 228' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' D' ' 264' ' ' VAL . . . -129.72 146.79 51.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 75.03 111.029 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.56 -39.91 12.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 61.25 110.847 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -165.3 137.26 4.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 74.03 110.854 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 231' ' ' ILE . . . . . 0.614 HG21 HG11 ' D' ' 275' ' ' VAL . 5.2 mt -139.35 117.19 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 72.42 111.135 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 232' ' ' ARG . . . . . 0.449 ' CD ' HG22 ' D' ' 268' ' ' VAL . 8.1 ptp180 -119.8 130.26 54.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 74.24 110.859 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 233' ' ' THR . . . . . 0.476 HG21 ' CG1' ' D' ' 239' ' ' VAL . 18.6 p -135.9 142.63 44.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 70.22 111.152 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -121.52 163.68 18.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 74.4 110.948 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 63.86 -164.34 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 71.11 110.891 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 38.6 mtt85 -73.77 69.41 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 70.35 110.84 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.15 156.98 17.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 62.21 111.088 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.57 135.69 52.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 63.42 110.851 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.516 HG12 ' HB ' ' D' ' 275' ' ' VAL . 18.0 m -128.53 136.0 61.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 65.33 111.063 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 240' ' ' GLN . . . . . 0.452 ' HB3' HD22 ' D' ' 276' ' ' LEU . 2.3 tm0? -136.8 127.53 27.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 75.21 110.862 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 1.2 mt -111.86 118.2 34.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 61.25 110.959 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.74 174.35 13.65 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 61.5 112.479 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 243' ' ' ASN . . . . . 0.513 ' CB ' HG21 ' C' ' 260' ' ' THR . 0.7 OUTLIER -85.54 149.45 25.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 74.42 110.867 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.49 134.42 62.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 64.31 111.166 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 245' ' ' VAL . . . . . 0.46 HG12 ' HB3' ' D' ' 249' ' ' ALA . 19.5 t -122.55 123.19 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 71.1 111.117 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 246' ' ' THR . . . . . 0.689 HG22 ' HA3' ' D' ' 282' ' ' GLY . 5.0 t -73.37 165.0 25.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 55.25 111.159 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 247' ' ' ALA . . . . . 0.41 ' HA ' HD23 ' C' ' 250' ' ' LEU . . . -63.15 -38.81 92.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 74.25 111.043 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.63 -35.72 68.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 54.05 111.043 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 249' ' ' ALA . . . . . 0.518 ' HB1' ' CE2' ' D' ' 281' ' ' TYR . . . -55.67 100.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 64.3 111.054 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 2.2 mp -68.88 -69.35 0.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 71.55 110.894 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -177.39 -36.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 61.52 110.823 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 95.94 -49.02 1.78 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.76 -0.733 . . . . 61.4 112.5 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 170.71 -92.91 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.763 -0.732 . . . . 74.14 112.528 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 9.3 tt -108.36 150.99 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.847 0.356 . . . . 55.32 111.137 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -52.38 169.82 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 75.21 110.9 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 256' ' ' ILE . . . . . 0.546 HG22 HD12 ' E' ' 254' ' ' ILE . 36.4 mt 59.04 97.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 71.01 111.118 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 60.1 p -162.13 130.96 4.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 61.5 110.89 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 1.9 t70 63.67 105.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.158 -0.474 . . . . 74.12 110.851 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -141.38 93.52 2.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 75.03 110.901 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 260' ' ' THR . . . . . 0.546 HG21 ' HB3' ' E' ' 243' ' ' ASN . 6.9 p -95.91 121.93 38.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 74.03 111.181 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 261' ' ' THR . . . . . 0.53 HG23 ' N ' ' D' ' 225' ' ' ARG . 23.9 m -92.0 113.77 26.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 71.01 111.18 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -122.08 151.12 41.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 62.14 110.88 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.72 121.98 13.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 72.4 110.848 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.567 ' HB ' HD22 ' E' ' 241' ' ' LEU . 10.6 p -106.48 142.47 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.072 -0.513 . . . . 75.24 111.132 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -84.06 -79.78 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 72.33 110.831 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 48.9 m -127.44 131.97 50.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 74.32 111.099 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.612 ' HB ' HG23 ' D' ' 231' ' ' ILE . 20.1 t -124.06 120.12 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 60.14 111.16 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 268' ' ' VAL . . . . . 0.449 HG22 ' CD ' ' D' ' 232' ' ' ARG . 26.6 t -118.25 122.99 70.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 63.52 111.116 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.62 133.19 8.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.655 -0.784 . . . . 42.22 112.476 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.0 147.29 31.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 74.42 110.836 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 60.51 -142.62 48.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 73.21 112.468 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.38 60.28 2.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.827 0.346 . . . . 72.21 110.88 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 12.7 m -83.83 152.83 24.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.901 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.78 132.41 54.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 74.44 110.866 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.614 HG11 HG21 ' D' ' 231' ' ' ILE . 92.5 t -115.71 122.75 70.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 65.21 111.129 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.1 OUTLIER -129.05 115.91 18.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 65.2 110.913 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 30.7 mm -113.15 103.52 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 62.34 111.109 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.96 -163.15 26.68 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 64.52 112.483 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.97 156.83 25.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.72 0.295 . . . . 63.01 110.876 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.9 118.85 34.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 64.41 110.884 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 281' ' ' TYR . . . . . 0.518 ' CE2' ' HB1' ' D' ' 249' ' ' ALA . 11.0 t80 -103.83 128.64 51.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 65.53 110.93 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 282' ' ' GLY . . . . . 0.689 ' HA3' HG22 ' D' ' 246' ' ' THR . . . 88.94 145.65 11.88 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 71.42 112.515 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 95.16 84.19 1.65 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 63.2 112.478 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -58.02 98.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.798 0.332 . . . . 52.0 110.873 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -174.73 -102.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.723 -0.751 . . . . 63.52 112.491 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -173.71 -37.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.863 0.363 . . . . 74.22 110.854 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -144.53 -61.98 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 73.55 110.906 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -164.22 -170.02 1.98 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 60.51 110.874 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -64.85 98.59 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 74.42 110.919 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.28 -170.04 3.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 74.2 110.852 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -154.51 175.52 13.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 75.13 110.836 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -175.43 170.18 3.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 72.3 110.829 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -118.77 -175.62 2.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 64.33 110.851 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -129.99 -174.29 3.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.866 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 73.33 110.896 179.972 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.906 0.384 . . . . 60.32 110.876 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -140.57 -176.23 4.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 73.11 110.907 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 3.3 tt -148.95 144.78 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 64.31 111.11 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.98 178.5 9.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 75.14 110.908 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.79 150.79 48.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 62.53 111.144 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.96 110.27 31.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 70.5 111.13 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 7.2 p -177.17 142.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 72.23 111.159 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 151.84 -174.68 30.85 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 53.02 112.515 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 225' ' ' ARG . . . . . 0.593 ' O ' HG22 ' E' ' 261' ' ' THR . 5.1 mmp_? -71.7 -74.96 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.806 0.336 . . . . 72.52 110.854 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.45 138.01 52.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 75.12 110.897 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 73.9 p -140.65 160.88 39.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 71.02 110.843 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 228' ' ' ALA . . . . . 0.601 ' CB ' HD11 ' E' ' 231' ' ' ILE . . . -126.52 127.95 46.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.501 . . . . 62.54 111.116 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 229' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -73.44 -35.44 65.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 61.35 110.922 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.53 137.18 3.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 62.51 110.888 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 231' ' ' ILE . . . . . 0.601 HD11 ' CB ' ' E' ' 228' ' ' ALA . 9.8 mt -139.67 116.4 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 62.02 111.04 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.6 126.29 48.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 70.14 110.904 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 233' ' ' THR . . . . . 0.577 HG21 ' CG1' ' E' ' 239' ' ' VAL . 32.6 p -135.82 139.57 43.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 73.41 111.205 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -120.96 167.08 12.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 73.24 110.851 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 65.17 -162.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 75.21 110.877 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -75.23 61.16 1.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.52 110.85 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.32 156.76 17.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 63.44 111.151 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -129.88 135.65 48.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 71.34 110.884 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.577 ' CG1' HG21 ' E' ' 233' ' ' THR . 20.2 m -122.92 134.89 64.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 74.41 111.189 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -135.81 128.99 31.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 52.13 110.868 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.802 HD12 ' HB ' ' E' ' 277' ' ' ILE . 9.9 tp -111.38 118.0 34.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 73.3 110.949 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.31 171.91 12.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 43.34 112.446 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 243' ' ' ASN . . . . . 0.546 ' HB3' HG21 ' D' ' 260' ' ' THR . 0.0 OUTLIER -85.91 163.05 18.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 74.02 110.881 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.99 134.06 60.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 70.21 111.142 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 7.2 t -122.08 121.18 63.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 64.41 111.105 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 12.9 t -69.47 173.45 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 62.44 111.171 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.91 89.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 60.31 111.087 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.72 -36.38 69.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 65.34 111.063 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 249' ' ' ALA . . . . . 0.453 ' HB2' ' HE1' ' D' ' 281' ' ' TYR . . . 51.71 -169.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 51.42 111.098 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 1.7 tp -95.93 27.45 3.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 64.14 110.99 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 60.79 173.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 73.43 110.88 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -63.04 99.2 0.25 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 53.41 112.543 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 162.89 97.19 0.12 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.719 -0.753 . . . . 65.21 112.477 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 254' ' ' ILE . . . . . 0.546 HD12 HG22 ' D' ' 256' ' ' ILE . 10.3 tt -51.8 132.22 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.841 0.353 . . . . 75.02 111.184 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.06 -171.23 1.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 75.4 110.844 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 1.1 pt -108.12 67.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 54.03 111.13 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 1.7 t -56.5 -26.36 54.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 53.45 110.852 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -76.47 122.68 24.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.123 -0.489 . . . . 63.01 110.86 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -179.33 -37.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.955 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 7.5 p -100.04 138.03 37.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 63.04 111.173 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 261' ' ' THR . . . . . 0.593 HG22 ' O ' ' E' ' 225' ' ' ARG . 1.3 p -124.8 127.04 46.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.257 -0.428 . . . . 73.4 111.165 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -126.01 119.93 28.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 63.11 110.908 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.73 122.86 40.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 73.34 110.807 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 264' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' E' ' 228' ' ' ALA . 0.3 OUTLIER -105.19 145.5 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.21 111.099 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 265' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' E' ' 229' ' ' LYS . 2.5 mt-10 -80.59 -76.61 0.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.885 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.38 126.67 17.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 75.21 111.165 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.32 120.59 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 72.13 111.132 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 23.4 t -119.69 115.07 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 74.33 111.155 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.02 133.97 11.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.782 -0.723 . . . . 52.44 112.442 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.73 131.45 52.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 65.31 110.871 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.44 -149.65 30.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 73.33 112.484 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -74.97 68.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 72.55 110.894 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 10.3 t -94.01 162.39 13.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 72.24 110.918 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.53 136.0 47.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 71.31 110.852 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.574 ' CG2' HG12 ' E' ' 239' ' ' VAL . 90.8 t -115.57 124.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 45.32 111.135 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.66 117.99 21.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 52.15 110.96 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.802 ' HB ' HD12 ' E' ' 241' ' ' LEU . 24.7 mm -113.47 102.19 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 73.33 111.15 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 131.85 178.89 15.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.789 -0.719 . . . . 51.42 112.509 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -95.69 156.9 16.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 63.51 110.872 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.57 138.68 54.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 74.34 110.869 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -124.8 124.52 42.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.492 . . . . 72.13 110.88 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 170.74 -152.26 18.19 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.796 -0.716 . . . . 55.12 112.563 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -57.75 -175.61 0.45 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.751 -0.737 . . . . 53.42 112.448 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -61.39 -169.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 63.21 110.851 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 83.47 138.58 3.49 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.711 -0.757 . . . . 60.31 112.556 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -73.64 -7.32 51.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 73.53 110.895 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -151.75 -42.35 0.11 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.935 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -164.22 166.4 21.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.42 . . . . 72.43 110.814 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.98 -169.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 74.31 110.869 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -79.92 -170.2 2.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 74.31 110.859 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -95.62 153.84 17.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 73.35 110.849 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -121.75 -172.9 2.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 70.35 110.918 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.59 -171.67 2.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 75.23 110.872 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.07 179.61 2.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 70.52 110.881 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.854 179.955 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.821 0.343 . . . . 62.44 110.875 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.84 154.3 25.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 61.12 110.912 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 43.8 mm -132.24 143.98 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 52.12 111.112 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.0 173.09 17.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 74.42 110.827 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -111.18 -75.54 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 74.15 111.138 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.3 pt -125.37 124.14 66.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 63.31 111.104 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 6.5 p -177.75 122.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 65.4 111.171 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -61.78 169.99 11.24 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.807 -0.711 . . . . 53.34 112.515 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.439 ' HB3' HG23 ' A' ' 261' ' ' THR . 0.0 OUTLIER -168.43 107.56 0.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.816 0.341 . . . . 74.33 110.911 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.433 ' HB2' HG22 ' A' ' 277' ' ' ILE . 3.3 p30 -142.07 120.94 12.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 72.43 110.911 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 76.7 p -121.96 151.65 40.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 73.21 110.876 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.63 119.38 16.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 74.35 111.116 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -67.51 -51.64 48.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 71.44 110.875 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.78 135.47 4.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.276 -0.42 . . . . 73.22 110.834 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 6.4 pt -140.12 134.05 35.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 31.03 111.145 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.19 141.64 48.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 72.54 110.926 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.732 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.3 OUTLIER -137.41 152.84 50.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 74.4 111.133 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -138.35 168.62 19.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 52.12 110.887 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.5 -70.7 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 61.05 110.886 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.8 ptt-85 177.88 63.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 72.13 110.857 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.732 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -99.0 157.21 16.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 75.21 111.145 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -126.41 135.32 51.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 64.44 110.913 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.739 HG12 ' HB ' ' A' ' 275' ' ' VAL . 31.2 m -124.43 124.74 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 72.21 111.13 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -114.12 137.49 51.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.877 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 6.0 mp -127.88 118.88 24.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 61.31 110.878 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.07 178.38 15.39 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.794 -0.717 . . . . 61.31 112.557 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -87.97 142.95 27.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 75.42 110.882 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 244' ' ' VAL . 22.3 m -122.2 123.63 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 73.15 111.118 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 281' ' ' TYR . 21.6 t -119.91 129.19 75.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 74.45 111.156 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.3 t -100.86 162.3 13.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 73.42 111.16 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.07 -33.93 54.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 73.14 111.115 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.03 69.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 72.1 111.034 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -52.78 -76.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 72.23 111.097 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -179.36 34.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 52.43 110.878 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 71.29 -70.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.855 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -109.16 -102.5 2.76 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 63.23 112.466 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -173.59 138.63 4.67 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.625 -0.798 . . . . 65.32 112.445 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 61.9 mt -148.06 -41.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.835 0.35 . . . . 74.24 111.185 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -52.07 156.51 1.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 71.33 110.895 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 1.3 pt -132.21 155.11 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 74.32 111.114 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.33 -170.01 0.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 53.41 110.814 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.651 ' OD2' ' HB1' ' B' ' 221' ' ' ALA . 1.1 t70 -63.02 -169.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 74.01 110.885 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.26 112.24 14.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 70.11 110.876 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.558 HG21 ' HB3' ' A' ' 279' ' ' ASN . 9.9 t -69.09 134.78 49.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 60.41 111.143 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.439 HG23 ' HB3' ' A' ' 225' ' ' ARG . 0.2 OUTLIER -119.59 109.75 16.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 75.34 111.154 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -106.21 137.89 43.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 75.03 110.874 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 14.7 m -135.71 123.26 22.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 63.04 110.871 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.672 HG21 HD12 ' A' ' 277' ' ' ILE . 50.8 t -115.54 115.87 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 54.25 111.118 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -75.17 -75.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.021 0.439 . . . . 73.53 110.903 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.41 126.78 45.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 73.42 111.166 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.599 HG22 HD11 ' B' ' 231' ' ' ILE . 1.6 t -117.47 132.56 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 45.12 111.154 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 72.1 t -127.08 114.97 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 65.24 111.126 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.04 131.71 10.69 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.81 -0.71 . . . . 32.52 112.448 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.81 139.94 47.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.866 0.365 . . . . 63.54 110.924 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 47.71 79.5 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.669 -0.777 . . . . 75.34 112.554 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 49.3 77.66 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 73.34 110.86 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.421 ' H ' ' HB2' ' A' ' 237' ' ' ALA . 0.6 OUTLIER -98.08 145.26 26.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 72.33 110.853 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -111.06 127.41 55.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 75.12 110.906 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.739 ' HB ' HG12 ' A' ' 239' ' ' VAL . 73.0 t -131.06 122.58 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 74.43 111.133 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.685 HD12 ' CD2' ' A' ' 287' ' ' TRP . 0.5 OUTLIER -121.92 111.84 17.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 64.04 110.853 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.672 HD12 HG21 ' A' ' 264' ' ' VAL . 25.9 mm -110.24 103.94 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 72.44 111.144 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 142.61 -169.53 25.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.725 -0.75 . . . . 45.32 112.481 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.558 ' HB3' HG21 ' A' ' 260' ' ' THR . 2.5 p30 -112.59 155.95 23.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.78 0.324 . . . . 71.53 110.851 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.553 ' HG2' HG12 ' B' ' 244' ' ' VAL . 0.3 OUTLIER -121.04 141.3 50.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.43 110.842 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.447 ' HB2' HG22 ' A' ' 245' ' ' VAL . 2.3 m-85 -125.61 133.35 52.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 63.42 110.92 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 109.3 149.89 13.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.69 -0.767 . . . . 32.45 112.475 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.599 ' H ' ' HB2' ' B' ' 247' ' ' ALA . . . -68.15 -127.83 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 61.31 112.468 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.28 25.67 14.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.801 0.334 . . . . 53.42 110.875 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.4 133.41 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.685 -0.769 . . . . 41.55 112.523 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -52.44 131.48 33.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.783 0.325 . . . . 55.35 110.853 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.685 ' CD2' HD12 ' A' ' 276' ' ' LEU . 2.0 t90 60.44 59.66 2.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.88 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -51.56 103.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.296 -0.411 . . . . 70.04 110.849 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -172.37 31.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 63.4 110.872 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -155.27 -176.81 6.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 71.01 110.841 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -51.91 -74.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 64.22 110.774 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.3 -170.06 0.27 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 62.3 110.829 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -141.39 -169.85 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 75.02 110.889 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.44 -170.08 2.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 72.31 110.88 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 2.0 t60 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 72.24 110.848 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.839 0.352 . . . . 73.14 110.875 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.35 141.7 46.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 70.44 110.866 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 4.0 mp -139.59 68.83 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 61.44 111.087 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -95.21 116.62 28.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 70.43 110.826 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.651 ' HB1' ' OD2' ' A' ' 258' ' ' ASP . . . -178.32 151.04 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 71.4 111.114 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 16.4 pt -121.79 66.01 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 64.14 111.035 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.59 137.32 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 65.54 111.208 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' GLY . . . . . 0.503 ' HA2' HG23 ' B' ' 260' ' ' THR . . . -128.78 90.71 0.32 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.782 -0.723 . . . . 75.04 112.463 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 16.3 ttt-85 -101.88 124.51 47.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.856 0.36 . . . . 71.33 110.842 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.585 ' HB2' HG22 ' B' ' 277' ' ' ILE . 0.1 OUTLIER -121.68 129.67 52.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.24 110.886 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.2 p -124.04 145.19 49.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 63.45 110.868 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.19 119.71 23.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 74.22 111.073 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.73 -46.11 76.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 60.45 110.867 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -166.1 137.1 3.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 75.04 110.849 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.599 HD11 HG22 ' A' ' 267' ' ' VAL . 6.4 pt -140.08 132.88 34.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 73.43 111.16 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -135.33 138.43 43.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 55.11 110.883 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.755 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.5 OUTLIER -136.47 151.92 50.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.236 -0.438 . . . . 71.32 111.153 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -141.96 167.59 21.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.423 . . . . 71.33 110.908 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 72.81 -71.2 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.882 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -178.68 67.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 75.3 110.867 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.755 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -105.45 156.42 18.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 65.3 111.084 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -130.38 135.19 47.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 63.54 110.885 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.759 HG12 ' HB ' ' B' ' 275' ' ' VAL . 25.3 m -126.68 130.2 71.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 73.53 111.112 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.449 ' HB3' HD22 ' B' ' 276' ' ' LEU . 2.1 tt0 -119.07 119.89 35.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 75.52 110.942 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.82 118.57 35.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 71.12 110.945 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.07 175.09 13.81 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 61.44 112.462 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -85.99 136.2 33.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.894 0.378 . . . . 63.12 110.847 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.553 HG12 ' HG2' ' A' ' 280' ' ' GLU . 18.2 m -118.51 121.63 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 42.41 111.11 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.463 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 41.0 t -119.52 129.06 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 42.52 111.124 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.423 HG23 ' H ' ' B' ' 249' ' ' ALA . 12.3 t -83.32 175.19 10.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 63.42 111.164 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.599 ' HB2' ' H ' ' A' ' 283' ' ' GLY . . . -63.0 -42.09 99.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 70.44 111.047 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.85 77.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 71.12 111.126 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.463 ' HB3' ' CG1' ' B' ' 245' ' ' VAL . . . -74.3 90.94 2.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 44.1 111.052 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 6.9 mt -118.64 -47.34 2.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 62.53 110.911 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -83.45 142.07 31.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 75.55 110.853 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -100.01 -69.69 0.9 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 63.42 112.513 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 178.97 -165.82 35.04 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.724 -0.75 . . . . 71.52 112.496 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.56 -48.63 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.871 0.367 . . . . 64.11 111.152 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 255' ' ' ARG . . . . . 0.432 HH12 ' NE ' ' C' ' 255' ' ' ARG . 14.8 ptt85 -147.14 85.62 1.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 73.15 110.918 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 256' ' ' ILE . . . . . 0.61 HG22 ' O ' ' C' ' 255' ' ' ARG . 26.0 pt -135.69 140.86 43.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 52.12 111.105 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.5 t -133.83 98.05 4.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 64.13 110.851 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -129.07 163.27 25.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 65.4 110.928 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -149.38 80.32 1.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 74.52 110.851 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.503 HG23 ' HA2' ' B' ' 224' ' ' GLY . 8.7 t -66.17 126.18 27.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 73.2 111.13 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 94.2 m -131.84 108.98 9.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 71.23 111.144 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' C' ' 241' ' ' LEU . 1.9 t-20 -108.96 136.56 48.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.85 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.84 123.76 21.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.483 . . . . 62.41 110.87 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.964 HG21 HD12 ' B' ' 277' ' ' ILE . 70.5 t -110.34 118.53 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 70.23 111.108 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -67.8 -75.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 73.41 110.884 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 24.7 p -129.56 133.69 47.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 73.3 111.229 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.755 HG23 HG11 ' B' ' 264' ' ' VAL . 2.9 t -118.37 129.37 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 70.23 111.164 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 268' ' ' VAL . . . . . 0.43 ' O ' HG12 ' B' ' 268' ' ' VAL . 2.2 t -127.36 114.79 37.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 61.41 111.099 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.78 132.42 10.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.678 -0.772 . . . . 51.54 112.45 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -132.09 143.25 49.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 72.54 110.934 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 42.98 69.11 0.67 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 33.32 112.429 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 63.57 101.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.836 0.35 . . . . 71.31 110.911 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 3.6 t -130.33 145.77 51.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 54.45 110.898 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -117.28 127.85 54.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 74.42 110.858 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.759 ' HB ' HG12 ' B' ' 239' ' ' VAL . 85.8 t -130.48 123.65 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 75.24 111.165 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.606 HD23 ' CZ2' ' B' ' 287' ' ' TRP . 0.3 OUTLIER -114.49 112.13 22.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 73.3 110.936 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.964 HD12 HG21 ' B' ' 264' ' ' VAL . 14.4 mm -108.47 104.94 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 74.34 111.108 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 135.7 -157.89 23.51 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.774 -0.727 . . . . 35.41 112.527 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.5 156.04 27.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 74.43 110.878 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.551 ' HG2' HG12 ' C' ' 244' ' ' VAL . 15.2 pt-20 -129.39 141.8 50.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 74.11 110.881 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -129.98 125.73 36.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 74.34 110.888 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 152.35 156.14 7.37 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.685 -0.769 . . . . 64.4 112.474 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 283' ' ' GLY . . . . . 0.469 ' N ' ' HB2' ' C' ' 247' ' ' ALA . . . -96.11 -53.19 1.52 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 72.43 112.521 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -52.08 103.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 73.53 110.833 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.52 116.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.751 -0.737 . . . . 22.52 112.457 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' C' ' 244' ' ' VAL . 5.0 t80 -52.1 -33.44 39.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.347 . . . . 75.21 110.903 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.606 ' CZ2' HD23 ' B' ' 276' ' ' LEU . 15.9 t90 -172.26 -47.58 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 75.01 110.962 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.54 102.44 0.25 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 64.12 110.844 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.72 149.7 49.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 74.33 110.785 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -134.62 155.28 50.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 45.34 110.868 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -153.82 100.1 2.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 63.43 110.875 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.83 152.25 0.94 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.215 -0.448 . . . . 73.14 110.877 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 62.61 165.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 75.23 110.839 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -152.17 26.2 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 75.23 110.919 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 50.43 110.856 -179.928 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.849 0.357 . . . . 71.31 110.832 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 218' ' ' LYS . . . . . 0.571 ' C ' HD12 ' C' ' 219' ' ' ILE . 0.0 OUTLIER -108.09 -39.68 5.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 74.23 110.896 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.571 HD12 ' C ' ' C' ' 218' ' ' LYS . 4.0 mp 63.05 70.67 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 71.22 111.079 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 63.4 161.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 61.32 110.881 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -173.32 52.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 55.13 111.102 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 2.1 pt -106.72 31.43 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 73.44 111.124 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 33.7 m -149.6 151.77 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 74.12 111.107 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 155.09 150.73 5.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.74 . . . . 51.1 112.494 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.26 -65.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 73.53 110.85 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.05 120.63 41.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 75.14 110.864 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 3.3 t -129.67 138.69 51.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 71.02 110.894 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -119.04 131.98 56.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 73.21 111.133 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -33.05 34.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 70.12 110.901 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -166.01 138.0 3.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 72.33 110.864 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -138.69 117.31 13.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 73.54 111.143 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -131.82 130.23 41.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 63.35 110.898 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 0.2 OUTLIER -136.25 155.44 50.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 72.43 111.144 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -144.35 168.06 20.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 72.22 110.885 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.78 -72.23 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 73.31 110.856 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -177.99 64.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 75.55 110.85 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.607 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -105.69 156.46 18.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 35.3 111.087 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -128.79 135.25 48.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 71.23 110.892 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.828 HG12 ' HB ' ' C' ' 275' ' ' VAL . 20.9 m -126.14 121.6 59.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.469 . . . . 62.33 111.117 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.611 ' HB3' HD22 ' C' ' 276' ' ' LEU . 1.8 tt0 -115.63 120.65 40.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 54.11 110.913 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.74 HD22 HG22 ' B' ' 264' ' ' VAL . 3.3 mp -114.96 118.72 34.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 72.44 110.935 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.48 178.23 15.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 74.34 112.503 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -85.65 128.52 34.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.857 0.36 . . . . 71.02 110.891 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.551 HG12 ' HG2' ' B' ' 280' ' ' GLU . 28.5 m -114.07 128.4 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 75.21 111.136 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 46.8 t -122.17 129.02 75.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 73.21 111.086 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -77.5 174.27 11.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 74.41 111.126 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.469 ' HB2' ' N ' ' B' ' 283' ' ' GLY . . . -57.04 -41.03 77.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 73.53 111.045 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 248' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' C' ' 249' ' ' ALA . . . -57.1 -51.91 67.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 44.04 111.044 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 249' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' C' ' 248' ' ' ALA . . . 71.88 -70.58 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 62.22 111.088 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 250' ' ' LEU . . . . . 0.639 ' HB3' HD11 ' C' ' 256' ' ' ILE . 0.6 OUTLIER -137.58 178.13 7.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 73.1 110.911 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -106.63 -64.23 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 71.44 110.873 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 167.07 37.22 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.77 -0.729 . . . . 71.11 112.534 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -176.44 31.47 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 34.21 112.572 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 254' ' ' ILE . . . . . 0.795 HD13 ' HB1' ' D' ' 249' ' ' ALA . 2.2 tt -138.11 145.69 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 74.23 111.18 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 255' ' ' ARG . . . . . 0.61 ' O ' HG22 ' B' ' 256' ' ' ILE . 0.0 OUTLIER -94.16 -26.12 16.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 54.3 110.852 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 256' ' ' ILE . . . . . 0.639 HD11 ' HB3' ' C' ' 250' ' ' LEU . 65.5 mt 61.31 101.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 52.42 111.147 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.29 136.97 52.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.815 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -92.93 81.88 4.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 64.44 110.914 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.73 26.13 9.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 75.04 110.925 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 260' ' ' THR . . . . . 0.794 HG21 ' HB3' ' C' ' 279' ' ' ASN . 4.9 t -100.94 130.01 46.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 71.22 111.125 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 18.7 m -126.58 118.96 25.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.261 -0.427 . . . . 74.42 111.121 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.602 ' OD1' HG23 ' C' ' 277' ' ' ILE . 6.7 t-20 -120.63 144.63 48.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 62.11 110.866 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 9.4 t -141.62 123.85 15.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 71.53 110.905 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.796 HG21 HD12 ' C' ' 277' ' ' ILE . 46.2 t -108.07 145.86 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 64.12 111.205 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.92 -55.69 3.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 74.32 110.84 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.46 128.51 11.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 73.35 111.165 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.761 HG23 HG11 ' C' ' 264' ' ' VAL . 54.4 t -118.75 120.42 64.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 72.02 111.106 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.14 118.06 47.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 74.33 111.16 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.9 133.23 10.1 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.715 -0.755 . . . . 35.45 112.502 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -125.44 147.75 49.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 74.23 110.869 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 47.2 67.85 1.35 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.812 -0.709 . . . . 43.24 112.474 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 64.14 107.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.883 0.373 . . . . 72.24 110.899 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 3.3 m -139.8 150.16 44.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 73.2 110.865 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -124.72 128.24 48.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.831 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.828 ' HB ' HG12 ' C' ' 239' ' ' VAL . 89.8 t -132.28 123.34 50.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 75.25 111.134 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.2 OUTLIER -116.98 117.14 28.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 70.34 110.921 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.796 HD12 HG21 ' C' ' 264' ' ' VAL . 24.9 mm -110.63 104.24 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 74.01 111.134 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.03 -162.74 25.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.743 . . . . 55.43 112.491 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 279' ' ' ASN . . . . . 0.794 ' HB3' HG21 ' C' ' 260' ' ' THR . 8.1 p-10 -106.66 155.97 19.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.787 0.327 . . . . 72.33 110.897 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.642 ' HG3' HG12 ' D' ' 244' ' ' VAL . 2.7 pp20? -131.22 150.15 52.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 71.32 110.852 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.562 ' CE2' HG23 ' C' ' 256' ' ' ILE . 10.8 m-85 -130.05 126.03 36.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 52.11 110.905 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 145.75 141.97 3.73 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.745 -0.741 . . . . 73.21 112.499 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -112.2 -169.5 18.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.732 . . . . 44.23 112.463 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 7.8 tttt 53.89 29.44 9.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 73.25 110.879 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -179.11 -35.26 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.683 -0.77 . . . . 72.34 112.415 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.448 ' CE1' HG21 ' D' ' 244' ' ' VAL . 5.4 t80 71.9 -69.25 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.898 0.38 . . . . 75.22 110.912 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -156.3 -63.46 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 74.53 110.87 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.01 178.06 8.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 72.31 110.85 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -141.0 177.04 8.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 75.15 110.863 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -174.12 -171.21 0.6 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 75.45 110.899 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -175.95 158.3 2.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.12 110.81 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -168.34 -44.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 72.14 110.874 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.41 -175.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 75.11 110.901 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -115.13 -69.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 71.15 110.877 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 54.33 110.877 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 4.3 ptp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.855 0.36 . . . . 70.03 110.916 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 15.7 pttt -132.82 134.5 44.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 71.31 110.91 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 45.0 pt -127.17 160.62 35.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 74.12 111.164 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -166.01 147.07 6.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 74.54 110.883 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -139.7 81.87 1.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 61.51 111.076 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 22.5 pt -105.99 166.44 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 65.4 111.106 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 24.9 t 57.62 93.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 73.32 111.178 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -145.52 135.53 6.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.672 -0.775 . . . . 62.23 112.446 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.78 -73.35 0.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.882 0.372 . . . . 72.15 110.879 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 226' ' ' ASN . . . . . 0.637 ' HB3' HG22 ' D' ' 277' ' ' ILE . 0.1 OUTLIER -89.44 111.98 23.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 73.32 110.887 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.77 137.58 54.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 62.23 110.786 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.09 155.94 37.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.114 -0.493 . . . . 75.21 111.094 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.88 -29.8 8.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 75.01 110.895 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 230' ' ' ASP . . . . . 0.46 ' HB3' HG23 ' D' ' 266' ' ' THR . 0.3 OUTLIER -165.49 138.31 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 63.32 110.884 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 2.4 mt -138.91 117.28 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.144 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 232' ' ' ARG . . . . . 0.457 ' HD2' HG23 ' D' ' 268' ' ' VAL . 0.8 OUTLIER -131.64 131.23 43.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.14 110.936 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 233' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' D' ' 237' ' ' ALA . 0.2 OUTLIER -136.28 155.9 49.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 70.41 111.086 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -148.28 166.91 26.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 72.44 110.876 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.9 -71.99 0.12 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.104 -0.498 . . . . 73.02 110.861 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -177.0 63.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 74.05 110.845 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 237' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -104.76 154.51 19.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 62.45 111.158 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -130.01 134.98 47.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 71.53 110.93 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.782 HG12 ' HB ' ' D' ' 275' ' ' VAL . 21.6 m -127.89 121.19 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 70.31 111.154 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -121.31 128.58 52.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 74.32 110.964 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 mp -120.66 118.79 31.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 65.53 110.917 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 143.14 179.0 19.48 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.752 -0.737 . . . . 73.52 112.474 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -85.83 129.11 34.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.919 0.39 . . . . 71.33 110.864 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 244' ' ' VAL . . . . . 0.642 HG12 ' HG3' ' C' ' 280' ' ' GLU . 35.1 m -111.39 129.52 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 64.15 111.138 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.31 129.03 75.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 61.02 111.138 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 21.5 p -77.6 174.84 10.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 63.34 111.138 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.1 85.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 74.33 111.144 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 248' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' D' ' 249' ' ' ALA . . . -57.03 -52.01 66.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 70.13 111.136 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 249' ' ' ALA . . . . . 0.795 ' HB1' HD13 ' C' ' 254' ' ' ILE . . . 68.83 -77.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 74.11 111.105 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 250' ' ' LEU . . . . . 0.622 HD13 ' HB1' ' E' ' 247' ' ' ALA . 0.2 OUTLIER 56.78 94.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 72.44 110.907 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 251' ' ' HIS . . . . . 0.57 ' O ' HD12 ' C' ' 254' ' ' ILE . 9.3 m-70 63.41 173.32 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 74.53 110.887 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 112.15 119.34 3.73 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.704 -0.76 . . . . 70.43 112.49 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -167.14 -159.81 13.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.813 -0.708 . . . . 63.0 112.528 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 254' ' ' ILE . . . . . 0.651 HG22 HG12 ' D' ' 256' ' ' ILE . 29.9 mm 63.68 106.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.825 0.345 . . . . 70.45 111.128 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 57.1 ttp85 -81.87 98.74 8.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 75.33 110.893 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 256' ' ' ILE . . . . . 0.651 HG12 HG22 ' D' ' 254' ' ' ILE . 2.1 pt -153.14 90.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 64.13 111.108 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.71 100.58 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 70.11 110.88 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 258' ' ' ASP . . . . . 0.639 ' OD2' HD12 ' D' ' 256' ' ' ILE . 2.7 p30 -174.3 -168.99 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 73.24 110.864 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.7 -74.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 74.14 110.949 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 5.4 t -86.31 121.56 29.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 72.21 111.151 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 3.1 m -134.53 126.77 30.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 72.31 111.192 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 262' ' ' ASN . . . . . 0.525 ' ND2' HG23 ' D' ' 277' ' ' ILE . 3.1 t30 -126.08 139.61 53.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.295 -0.411 . . . . 74.01 110.955 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 7.9 t -142.09 123.81 15.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 74.43 110.844 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.721 HG21 HD12 ' D' ' 277' ' ' ILE . 21.7 t -114.34 149.61 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 70.3 111.172 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.84 -77.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 72.44 110.939 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 266' ' ' THR . . . . . 0.46 HG23 ' HB3' ' D' ' 230' ' ' ASP . 1.5 m -127.71 127.83 44.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 63.14 111.108 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.568 ' CG2' HG11 ' D' ' 264' ' ' VAL . 98.2 t -118.69 120.41 64.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 75.02 111.122 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 268' ' ' VAL . . . . . 0.457 HG23 ' HD2' ' D' ' 232' ' ' ARG . 4.7 p -126.53 117.81 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 74.44 111.102 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.72 132.65 10.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 44.24 112.427 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -126.02 147.13 49.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 73.12 110.84 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 44.86 76.75 0.11 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.769 -0.729 . . . . 65.55 112.475 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.74 98.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.802 0.334 . . . . 70.23 110.899 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 4.1 t -130.18 145.33 51.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 53.52 110.908 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -123.97 127.97 48.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 60.24 110.849 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.782 ' HB ' HG12 ' D' ' 239' ' ' VAL . 94.3 t -135.56 123.38 37.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 73.32 111.106 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.438 HD13 ' N ' ' D' ' 277' ' ' ILE . 1.1 tm? -121.72 119.57 32.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 73.51 110.893 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.721 HD12 HG21 ' D' ' 264' ' ' VAL . 27.5 mm -112.29 104.24 16.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 71.34 111.165 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.3 -159.07 27.44 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.75 -0.738 . . . . 52.01 112.52 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -115.92 156.12 26.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.77 0.319 . . . . 64.4 110.917 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 280' ' ' GLU . . . . . 0.506 ' HG2' HG13 ' E' ' 244' ' ' VAL . 10.4 pt-20 -126.03 134.92 51.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 74.13 110.803 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 281' ' ' TYR . . . . . 0.468 ' CZ ' HG21 ' E' ' 245' ' ' VAL . 7.5 m-85 -120.32 125.94 49.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 72.21 110.958 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.01 158.36 7.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.79 -0.719 . . . . 60.13 112.544 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 283' ' ' GLY . . . . . 0.575 ' N ' ' HB2' ' E' ' 247' ' ' ALA . . . -104.57 63.93 0.34 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 62.1 112.416 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.94 32.91 1.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.8 0.333 . . . . 73.11 110.876 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 78.98 -67.82 3.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 35.44 112.459 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -178.81 108.75 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 71.05 110.852 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 72.0 -69.44 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 74.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -163.37 160.57 23.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.1 110.859 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.08 111.61 21.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 70.14 110.88 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.54 -61.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 73.43 110.869 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -52.19 159.26 0.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 62.34 110.836 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -165.87 -74.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 72.43 110.908 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -74.3 159.34 32.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 64.24 110.896 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -178.96 -175.9 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 70.54 110.883 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.807 179.939 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.857 0.36 . . . . 54.22 110.883 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 172.7 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 64.05 110.918 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 9.7 tp -160.46 142.77 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 70.02 111.165 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -128.68 133.91 48.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.52 110.895 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -111.38 -179.13 3.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 73.44 111.142 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 2.1 pt -152.18 149.41 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 64.05 111.171 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 12.5 p -96.13 131.34 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 75.02 111.174 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.21 -153.29 51.99 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.728 -0.749 . . . . 71.54 112.535 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 225' ' ' ARG . . . . . 0.501 ' N ' HG23 ' E' ' 261' ' ' THR . 0.9 OUTLIER 62.1 -169.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.824 0.345 . . . . 51.11 110.874 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -83.8 109.92 17.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 72.51 110.857 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.43 139.85 45.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.2 110.824 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.38 162.06 26.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 75.44 111.151 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.05 -26.87 7.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 61.13 110.887 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 230' ' ' ASP . . . . . 0.439 ' HB3' HG23 ' E' ' 266' ' ' THR . 0.4 OUTLIER -164.82 138.62 4.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.43 . . . . 75.12 110.841 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 231' ' ' ILE . . . . . 0.409 HD11 HG13 ' D' ' 264' ' ' VAL . 5.0 mt -138.55 117.35 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 73.43 111.127 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.32 131.23 39.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 72.13 110.791 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.29 157.81 45.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 50.41 111.128 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -150.29 167.55 26.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 62.51 110.933 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 72.09 -73.35 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 74.51 110.846 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -178.29 62.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 70.03 110.85 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.34 156.45 17.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 61.32 111.196 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.19 135.15 47.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 73.11 110.856 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.795 HG12 ' HB ' ' E' ' 275' ' ' VAL . 18.0 m -122.74 121.84 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 72.32 111.143 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 240' ' ' GLN . . . . . 0.625 ' O ' HD23 ' E' ' 276' ' ' LEU . 2.0 tt0 -119.59 114.41 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.23 110.921 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.481 HD13 ' CD1' ' D' ' 277' ' ' ILE . 3.3 mp -114.84 135.09 54.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 61.51 110.976 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.06 -120.18 2.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.718 -0.754 . . . . 62.21 112.508 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -144.0 128.85 18.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.884 0.373 . . . . 71.43 110.851 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.506 HG13 ' HG2' ' D' ' 280' ' ' GLU . 0.4 OUTLIER -102.86 119.6 51.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 74.35 111.16 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 245' ' ' VAL . . . . . 0.468 HG21 ' CZ ' ' D' ' 281' ' ' TYR . 41.2 t -122.05 123.52 69.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 72.2 111.138 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.1 t -74.43 174.88 8.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 61.34 111.133 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 247' ' ' ALA . . . . . 0.622 ' HB1' HD13 ' D' ' 250' ' ' LEU . . . -53.22 -45.64 68.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 75.44 111.099 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.92 -49.8 74.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 71.53 111.132 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 52.69 -169.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 44.4 111.073 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 250' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' E' ' 250' ' ' LEU . 0.4 OUTLIER -122.46 89.57 3.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 64.51 110.958 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -52.31 122.82 9.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 74.54 110.819 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -167.58 -117.45 0.4 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 62.11 112.529 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 152.64 120.19 0.83 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.776 -0.726 . . . . 75.42 112.559 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.56 -177.04 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.862 0.363 . . . . 51.42 111.095 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.96 -47.34 1.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 64.24 110.878 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 3.9 tt -177.07 126.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 75.14 111.131 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.21 -171.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 75.14 110.891 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -159.57 155.06 25.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 73.43 110.922 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -146.49 -74.32 0.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 50.5 110.9 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 260' ' ' THR . . . . . 0.688 HG21 ' OD1' ' E' ' 279' ' ' ASN . 4.1 t -67.17 135.78 54.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 75.13 111.168 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 261' ' ' THR . . . . . 0.501 HG23 ' N ' ' E' ' 225' ' ' ARG . 34.9 m -133.4 123.56 25.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 63.34 111.129 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 262' ' ' ASN . . . . . 0.488 ' OD1' HG23 ' E' ' 277' ' ' ILE . 1.8 t-20 -126.12 123.45 38.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 71.32 110.858 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 43.2 t -127.18 123.81 37.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 60.14 110.878 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 264' ' ' VAL . . . . . 0.566 HG21 HD12 ' E' ' 277' ' ' ILE . 21.2 t -124.32 150.34 28.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 55.05 111.102 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.01 -77.5 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 72.04 110.865 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 266' ' ' THR . . . . . 0.439 HG23 ' HB3' ' E' ' 230' ' ' ASP . 9.4 m -126.37 127.83 46.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 64.22 111.162 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 267' ' ' VAL . . . . . 0.544 ' CG2' HG11 ' E' ' 264' ' ' VAL . 22.0 t -119.08 120.16 63.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 63.4 111.156 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 268' ' ' VAL . . . . . 0.417 ' O ' HG13 ' E' ' 268' ' ' VAL . 4.1 p -123.78 118.18 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 73.34 111.154 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.28 136.18 13.39 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.756 -0.735 . . . . 74.23 112.399 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -132.58 133.54 43.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.756 0.313 . . . . 74.24 110.897 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.81 93.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 53.25 112.522 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 44.1 69.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 70.22 110.826 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.34 145.25 26.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 62.13 110.817 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -127.24 128.19 45.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 73.32 110.872 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.795 ' HB ' HG12 ' E' ' 239' ' ' VAL . 84.2 t -136.85 123.92 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 74.32 111.134 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.625 HD23 ' O ' ' E' ' 240' ' ' GLN . 0.5 OUTLIER -125.64 122.55 36.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 70.52 110.899 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.566 HD12 HG21 ' E' ' 264' ' ' VAL . 30.4 mm -112.0 104.53 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 74.4 111.169 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 135.07 -169.84 23.14 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.755 . . . . 74.53 112.518 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 279' ' ' ASN . . . . . 0.688 ' OD1' HG21 ' E' ' 260' ' ' THR . 2.3 p-10 -99.82 155.96 17.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 71.43 110.897 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -130.6 132.03 45.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.491 . . . . 50.22 110.856 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -113.8 125.9 54.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 73.42 110.874 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 133.48 104.29 0.86 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.742 -0.742 . . . . 73.32 112.485 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -67.63 -121.05 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.797 -0.716 . . . . 73.24 112.465 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp 62.71 25.79 15.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.815 0.34 . . . . 63.31 110.921 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 126.64 -162.5 20.78 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.757 . . . . 54.25 112.471 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -110.99 118.11 35.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.857 0.36 . . . . 74.22 110.868 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 287' ' ' TRP . . . . . 0.556 ' NE1' HD12 ' E' ' 276' ' ' LEU . 1.6 t90 72.32 -69.0 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 74.11 110.92 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -113.87 151.61 31.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 54.22 110.846 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -100.06 81.63 2.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 75.41 110.95 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -67.44 174.99 3.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 73.22 110.875 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.07 -171.14 2.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 44.43 110.915 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -121.35 159.24 26.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 73.44 110.835 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -125.43 -37.51 2.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 74.14 110.851 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -153.17 -71.34 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 72.44 110.826 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 60.5 t60 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 75.33 110.887 179.98 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 17.8 ptm . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.734 0.302 . . . . 63.02 110.876 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.483 ' O ' HG23 ' A' ' 219' ' ' ILE . 21.0 mmtt -120.04 -74.14 0.62 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.445 . . . . 73.14 110.906 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.529 HD12 ' CG2' ' B' ' 219' ' ' ILE . 0.2 OUTLIER -166.43 -75.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 71.33 111.167 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.03 -171.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 74.0 110.932 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -166.94 139.64 3.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 74.33 111.117 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 1.9 tt -55.12 124.15 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 74.0 111.18 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 17.1 m -151.46 -177.88 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 60.31 111.112 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 152.35 113.67 0.56 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.764 -0.732 . . . . 42.44 112.515 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.651 ' HG3' HG23 ' A' ' 261' ' ' THR . 0.8 OUTLIER -179.29 -175.85 0.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.867 0.365 . . . . 74.42 110.879 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.27 130.35 26.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 62.35 110.876 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 48.4 t -121.81 137.69 54.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.478 . . . . 74.1 110.843 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.62 128.18 34.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 64.23 111.111 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.67 -37.14 13.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.938 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.535 ' HB3' HG23 ' A' ' 266' ' ' THR . 0.7 OUTLIER -164.38 138.9 5.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 63.51 110.878 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.485 HG21 HG21 ' A' ' 239' ' ' VAL . 7.7 mt -137.25 117.53 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 63.5 111.116 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -124.98 117.04 23.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 75.42 110.839 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.31 131.2 36.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 45.13 111.123 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -132.95 164.9 25.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 51.14 110.906 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 236' ' ' ARG . 2.7 tt0 65.0 79.53 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 72.43 110.897 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 235' ' ' GLU . 16.9 ptt180 35.29 60.46 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 74.52 110.918 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.29 152.75 21.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 44.42 111.136 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -129.28 142.52 50.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 74.35 110.831 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.485 HG21 HG21 ' A' ' 231' ' ' ILE . 6.1 p -143.02 121.65 7.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 63.43 111.124 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -108.84 137.46 46.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 72.5 110.98 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.58 118.65 22.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 64.33 110.891 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.37 -172.61 20.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.708 -0.758 . . . . 75.12 112.504 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -92.24 139.19 30.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.909 0.385 . . . . 74.54 110.909 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.02 129.7 65.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 75.54 111.21 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 89.5 t -122.07 127.28 75.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 72.11 111.127 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 281' ' ' TYR . 53.6 p -82.9 163.21 21.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 71.11 111.155 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.48 -41.47 98.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 53.31 111.127 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.85 80.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 71.23 111.061 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -55.64 -75.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 43.51 111.113 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.32 126.92 33.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.895 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -167.87 29.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 53.03 110.867 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 136.3 -20.29 3.56 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 54.01 112.534 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -60.42 -178.51 1.97 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.739 . . . . 23.13 112.492 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.1 pp -149.63 -174.96 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.851 0.358 . . . . 74.21 111.121 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 63.25 104.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 71.23 110.875 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 2.9 mp -99.57 -39.65 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 75.1 111.126 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.7 t 62.29 -174.65 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 65.02 110.901 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -60.63 -172.28 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.103 -0.499 . . . . 64.01 110.81 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.76 175.61 9.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.486 . . . . 50.51 110.902 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.681 HG23 ' C ' ' B' ' 224' ' ' GLY . 99.6 m -101.01 137.96 38.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.262 -0.426 . . . . 52.21 111.132 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.651 HG23 ' HG3' ' A' ' 225' ' ' ARG . 98.4 m -112.91 111.74 22.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 73.5 111.159 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -111.48 150.3 30.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 44.41 110.805 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.4 t -138.31 123.97 19.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 53.24 110.951 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.513 HG21 ' CG2' ' A' ' 267' ' ' VAL . 9.7 p -108.81 135.77 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.45 111.135 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.32 -75.96 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 53.15 110.952 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.535 HG23 ' HB3' ' A' ' 230' ' ' ASP . 1.6 m -130.14 131.98 45.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 73.42 111.153 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.513 ' CG2' HG21 ' A' ' 264' ' ' VAL . 96.7 t -117.89 131.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 55.24 111.147 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 58.6 t -127.55 128.03 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 71.33 111.117 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.98 133.62 7.87 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.735 -0.745 . . . . 42.13 112.515 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -132.8 147.77 52.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.793 0.33 . . . . 65.44 110.877 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.28 78.17 0.11 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.761 -0.733 . . . . 63.0 112.459 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 47.59 64.58 1.55 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.882 0.372 . . . . 71.23 110.941 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 26.3 t -92.93 145.65 24.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 62.43 110.873 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -126.39 128.31 46.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 70.54 110.929 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.693 HG13 HG13 ' B' ' 239' ' ' VAL . 20.6 t -128.92 123.59 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 62.44 111.137 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.425 HD23 ' CZ2' ' A' ' 287' ' ' TRP . 0.2 OUTLIER -111.07 117.24 32.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 64.34 110.917 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.15 112.41 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 71.05 111.152 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 133.01 -164.91 24.11 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 52.2 112.443 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -103.8 152.61 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 62.42 110.84 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.537 ' HG3' HG12 ' B' ' 244' ' ' VAL . 1.4 pp20? -131.49 134.51 46.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 73.24 110.968 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.457 ' O ' HG23 ' A' ' 246' ' ' THR . 0.2 OUTLIER -112.4 125.94 54.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 73.45 110.915 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.84 135.8 3.17 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.717 -0.754 . . . . 71.42 112.521 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -111.22 177.11 18.94 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.691 -0.766 . . . . 73.53 112.441 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt 52.0 53.4 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 55.11 110.871 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 177.56 -69.02 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.822 -0.704 . . . . 40.25 112.521 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 2.1 t80 64.34 109.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 75.32 110.823 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.425 ' CZ2' HD23 ' A' ' 276' ' ' LEU . 0.8 OUTLIER 72.93 -67.77 0.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 62.41 110.875 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -156.23 179.22 9.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 64.15 110.828 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.24 149.72 5.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 53.44 110.88 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.91 176.05 8.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 75.41 110.846 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -151.41 -66.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 72.5 110.903 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.02 150.13 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 64.35 110.842 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -177.0 49.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 72.05 110.846 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -171.95 149.58 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 75.14 110.877 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 74.5 110.843 179.998 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 9.0 mtt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.832 0.348 . . . . 72.52 110.912 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.56 141.06 37.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 73.34 110.922 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 219' ' ' ILE . . . . . 0.529 ' CG2' HD12 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -71.43 178.67 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 62.2 111.124 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -95.52 63.13 2.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 73.24 110.841 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.425 ' C ' HD12 ' B' ' 222' ' ' ILE . . . -171.77 104.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 75.54 111.15 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 222' ' ' ILE . . . . . 0.934 HG22 HG23 ' B' ' 223' ' ' VAL . 5.2 mp -142.18 144.05 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.426 . . . . 65.03 111.143 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.934 HG23 HG22 ' B' ' 222' ' ' ILE . 22.7 t 62.55 100.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 72.52 111.08 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 224' ' ' GLY . . . . . 0.681 ' C ' HG23 ' A' ' 260' ' ' THR . . . 164.61 88.02 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.741 . . . . 64.05 112.51 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.567 ' N ' HG23 ' A' ' 260' ' ' THR . 0.4 OUTLIER -179.49 118.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.806 0.336 . . . . 74.14 110.922 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.34 123.44 14.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 75.21 110.93 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 1.4 t -121.51 137.71 54.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 64.3 110.86 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.549 ' HB2' HD11 ' B' ' 241' ' ' LEU . . . -127.7 129.16 46.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 72.15 111.082 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.26 -35.28 23.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 72.02 110.953 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 230' ' ' ASP . . . . . 0.611 ' HB3' HG23 ' B' ' 266' ' ' THR . 0.3 OUTLIER -164.56 138.42 5.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.869 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.736 HG21 HG21 ' B' ' 239' ' ' VAL . 11.2 mt -137.64 117.6 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 63.41 111.059 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -130.64 119.3 22.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 73.03 110.846 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.02 131.41 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 70.51 111.148 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -132.04 167.3 19.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 73.55 110.837 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' B' ' 236' ' ' ARG . 0.1 OUTLIER 64.24 78.43 0.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 71.24 110.868 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' B' ' 235' ' ' GLU . 11.0 ptt180 36.34 54.84 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 73.34 110.931 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -100.61 156.15 17.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 52.03 111.137 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -132.59 136.3 46.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 53.13 110.877 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.736 HG21 HG21 ' B' ' 231' ' ' ILE . 6.2 p -137.24 121.71 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 70.42 111.177 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.495 ' OE1' HD11 ' B' ' 276' ' ' LEU . 0.5 OUTLIER -114.22 137.48 51.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 72.15 110.891 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' B' ' 228' ' ' ALA . 0.3 OUTLIER -128.71 118.6 23.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 74.12 110.897 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.7 176.45 14.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.718 -0.753 . . . . 65.44 112.536 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -85.95 133.48 33.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.882 0.372 . . . . 75.02 110.841 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.537 HG12 ' HG3' ' A' ' 280' ' ' GLU . 33.7 m -116.51 132.18 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 74.33 111.105 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 60.1 t -122.04 120.26 60.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 65.31 111.123 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.505 HG23 ' O ' ' B' ' 281' ' ' TYR . 33.6 p -84.68 163.21 19.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 73.14 111.126 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.47 -36.95 84.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 64.23 111.13 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -62.06 -36.51 81.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 65.53 111.138 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -52.31 -75.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 51.41 111.017 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -178.3 174.8 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 61.51 110.969 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -103.07 -26.14 13.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 73.04 110.844 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 172.17 85.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.781 -0.723 . . . . 63.24 112.526 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 174.32 147.43 6.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.735 -0.745 . . . . 75.44 112.53 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 46.1 pt -137.68 -178.02 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.348 . . . . 71.12 111.111 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.23 -64.25 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 73.3 110.869 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 11.0 tt -125.14 124.61 67.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 75.24 111.176 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 14.9 p -179.04 164.81 1.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 65.21 110.824 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.642 ' O ' HG23 ' B' ' 260' ' ' THR . 0.3 OUTLIER -139.51 163.85 31.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 75.43 110.841 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.33 101.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.24 110.933 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.642 HG23 ' O ' ' B' ' 258' ' ' ASP . 49.2 p -101.09 122.55 43.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.438 . . . . 75.14 111.147 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 1.1 t -134.14 108.95 8.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 75.54 111.172 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.544 ' ND2' HG22 ' B' ' 277' ' ' ILE . 11.4 p-10 -95.94 149.52 21.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 60.43 110.897 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 44.6 m -140.22 124.08 17.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 61.12 110.852 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.486 HG21 ' CG2' ' B' ' 267' ' ' VAL . 13.4 p -109.58 131.62 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.48 . . . . 71.41 111.125 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -73.63 -76.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 73.14 110.835 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.611 HG23 ' HB3' ' B' ' 230' ' ' ASP . 1.3 m -131.52 135.38 47.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 71.11 111.118 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.659 ' CG1' HG21 ' B' ' 275' ' ' VAL . 85.5 t -117.67 128.4 74.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 74.22 111.151 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 68.8 t -127.23 119.47 52.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 53.22 111.104 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.3 132.98 9.05 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.743 -0.742 . . . . 64.42 112.461 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.65 147.93 51.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 72.34 110.902 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.44 82.66 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.753 . . . . 55.23 112.478 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 46.3 63.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 75.14 110.849 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 25.7 t -96.78 145.66 25.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 72.42 110.867 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.12 127.99 46.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 65.11 110.859 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.659 HG21 ' CG1' ' B' ' 267' ' ' VAL . 21.6 t -130.85 123.77 55.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 71.24 111.135 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.495 HD11 ' OE1' ' B' ' 240' ' ' GLN . 0.4 OUTLIER -114.86 116.76 29.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 63.12 110.887 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.544 HG22 ' ND2' ' B' ' 262' ' ' ASN . 25.4 mm -110.79 104.18 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.24 111.146 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.49 -176.91 21.54 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.781 -0.723 . . . . 72.43 112.463 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -92.17 147.12 23.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.727 0.299 . . . . 71.41 110.91 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.597 ' HG3' HG12 ' C' ' 244' ' ' VAL . 0.0 OUTLIER -128.45 141.7 51.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 65.51 110.858 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.505 ' O ' HG23 ' B' ' 246' ' ' THR . 0.8 OUTLIER -127.1 125.99 42.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.181 -0.463 . . . . 75.11 110.952 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 168.26 151.22 6.98 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.769 -0.729 . . . . 72.13 112.496 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -53.82 176.23 0.31 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.781 -0.723 . . . . 62.32 112.497 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.88 104.76 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 75.41 110.883 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -159.05 -38.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 61.31 112.541 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.66 ' CE1' HD21 ' C' ' 276' ' ' LEU . 10.6 t80 64.43 111.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.858 0.361 . . . . 61.44 110.881 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.441 ' HE1' HD23 ' B' ' 276' ' ' LEU . 0.0 OUTLIER 71.61 -72.14 0.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 75.3 110.885 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -135.09 126.05 27.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 61.52 110.939 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.61 100.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 65.43 110.849 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -175.49 139.45 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 72.22 110.905 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -178.49 157.01 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 73.24 110.871 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.58 130.93 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 71.35 110.885 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -154.61 169.09 24.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 71.33 110.869 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.54 -177.83 3.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 62.45 110.829 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 64.33 110.933 179.944 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 217' ' ' MET . . . . . 0.412 ' N ' HD11 ' C' ' 219' ' ' ILE . 1.4 mtp . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.919 0.39 . . . . 72.0 110.867 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 21.2 mttt 58.62 69.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 71.54 110.897 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.412 HD11 ' N ' ' C' ' 217' ' ' MET . 2.1 mp -127.43 147.07 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 73.12 111.187 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -148.14 171.17 16.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 61.41 110.864 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -76.42 74.33 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 65.43 111.088 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 1.5 pt -84.67 -177.33 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 63.14 111.189 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 223' ' ' VAL . . . . . 0.706 HG21 ' HA ' ' D' ' 257' ' ' SER . 21.6 t -82.71 150.57 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 72.15 111.078 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 70.6 62.43 3.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 70.51 112.485 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.52 111.38 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 73.23 110.844 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -83.91 139.69 32.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 70.22 110.917 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.88 144.64 50.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.35 110.82 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.94 143.09 51.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 73.35 111.134 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.35 -32.61 12.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 75.32 110.898 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 230' ' ' ASP . . . . . 0.622 ' HB3' HG22 ' C' ' 266' ' ' THR . 0.2 OUTLIER -165.04 137.85 4.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 72.13 110.924 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.462 HG21 HG21 ' C' ' 239' ' ' VAL . 16.7 mt -137.34 117.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 74.22 111.078 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -132.71 115.87 15.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 74.25 110.861 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -135.41 135.48 40.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.461 . . . . 74.31 111.123 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.48 166.99 23.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 72.2 110.88 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 66.87 72.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 74.43 110.93 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 44.32 53.26 6.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 72.15 110.84 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.2 147.9 26.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 72.41 111.047 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.0 135.75 52.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.868 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.56 HG13 HG13 ' B' ' 275' ' ' VAL . 6.0 p -133.78 121.86 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.54 111.098 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -108.77 136.55 48.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 73.21 110.946 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.17 119.21 22.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 65.05 110.888 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.15 173.66 13.46 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.758 -0.734 . . . . 73.01 112.439 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -85.81 134.22 33.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 73.34 110.865 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.597 HG12 ' HG3' ' B' ' 280' ' ' GLU . 30.9 m -113.45 131.95 63.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.082 -0.508 . . . . 60.33 111.156 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.18 129.24 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 74.35 111.145 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 12.9 p -86.71 169.33 12.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 61.44 111.185 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.03 76.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 73.21 111.174 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.37 76.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 71.41 111.106 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.96 103.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 63.53 111.126 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 19.1 mt -140.47 -45.12 0.41 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 61.22 110.867 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.76 167.89 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 61.21 110.87 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -65.95 -77.02 0.29 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.734 -0.746 . . . . 61.24 112.471 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -170.37 71.84 0.12 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 74.44 112.467 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 5.0 pt -137.31 146.86 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 63.43 111.114 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -135.75 76.96 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 74.11 110.884 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.44 178.0 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.162 -0.472 . . . . 62.33 111.103 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 76.5 p -124.44 73.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 71.45 110.899 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.55 178.38 8.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 75.0 110.847 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -178.77 174.33 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 74.52 110.951 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 260' ' ' THR . . . . . 0.533 HG21 ' CG ' ' D' ' 243' ' ' ASN . 29.3 m -100.85 137.89 38.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 75.5 111.127 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.612 HG23 ' CB ' ' D' ' 225' ' ' ARG . 1.5 t -125.01 133.17 53.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 31.22 111.149 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.604 HD22 ' HA2' ' C' ' 278' ' ' GLY . 0.4 OUTLIER -126.8 145.73 50.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 71.14 110.893 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.69 123.39 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 63.21 110.885 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.462 HG21 ' CG2' ' C' ' 267' ' ' VAL . 7.9 p -110.48 127.77 67.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 60.35 111.081 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.91 -71.83 0.26 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.107 -0.497 . . . . 71.14 110.847 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 266' ' ' THR . . . . . 0.622 HG22 ' HB3' ' C' ' 230' ' ' ASP . 5.7 p -140.48 137.18 33.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 52.3 111.081 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.694 ' CG1' HG21 ' C' ' 275' ' ' VAL . 19.2 t -116.8 128.36 74.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 60.21 111.18 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 268' ' ' VAL . . . . . 0.405 ' O ' HG12 ' C' ' 268' ' ' VAL . 2.0 t -127.24 117.91 48.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 73.43 111.137 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.1 132.74 9.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.736 -0.745 . . . . 62.45 112.452 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.81 140.94 48.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 71.52 110.931 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 46.58 84.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.701 -0.761 . . . . 64.34 112.49 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 51.1 82.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.885 0.374 . . . . 53.24 110.87 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 29.2 t -116.44 145.61 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 63.42 110.881 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -128.97 127.62 42.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.488 . . . . 72.44 110.825 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.694 HG21 ' CG1' ' C' ' 267' ' ' VAL . 48.2 t -132.07 123.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 64.43 111.125 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.66 HD21 ' CE1' ' B' ' 286' ' ' PHE . 0.1 OUTLIER -112.54 111.58 22.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.221 -0.445 . . . . 64.24 110.952 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 23.4 mm -111.0 104.71 17.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 74.3 111.134 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 278' ' ' GLY . . . . . 0.604 ' HA2' HD22 ' C' ' 262' ' ' ASN . . . 153.5 -154.58 25.6 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 51.31 112.48 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -128.14 145.25 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.347 . . . . 74.44 110.92 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -113.06 129.72 56.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 72.02 110.946 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -119.8 126.02 49.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 64.33 110.846 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 103.28 101.68 2.66 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.692 -0.765 . . . . 33.5 112.415 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 95.16 -167.45 26.44 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.712 -0.756 . . . . 55.23 112.478 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -172.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 74.12 110.893 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -86.01 -18.62 59.16 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.754 -0.736 . . . . 71.22 112.45 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.96 124.0 22.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 65.23 110.925 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 16.1 p90 -74.73 -27.38 60.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.926 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -101.29 77.33 1.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 65.54 110.886 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -52.1 155.15 1.99 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 72.11 110.914 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -143.09 36.15 1.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 54.41 110.841 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -123.75 -171.34 2.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 64.32 110.895 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -138.21 92.5 2.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 65.21 110.893 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -93.71 164.84 12.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 70.04 110.836 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -80.94 95.62 6.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 61.04 110.883 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 64.01 110.865 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.878 0.37 . . . . 74.45 110.909 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -113.59 51.36 0.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 65.13 110.818 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.94 141.77 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 64.54 111.092 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -173.36 86.32 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 51.41 110.865 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.25 151.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 62.33 111.028 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 7.4 tt -175.66 130.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.23 111.055 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 84.1 t -117.98 -72.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 55.33 111.139 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -141.98 113.5 0.82 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.747 -0.74 . . . . 74.44 112.498 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.612 ' CB ' HG23 ' C' ' 261' ' ' THR . 3.7 ptt180 179.07 -175.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.33 . . . . 72.14 110.908 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.78 132.17 38.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 62.43 110.847 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.09 150.76 44.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 63.14 110.842 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.1 158.86 36.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 73.05 111.154 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -109.15 -32.94 7.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.29 -0.414 . . . . 72.1 110.938 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -164.63 138.18 5.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 64.44 110.834 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 231' ' ' ILE . . . . . 0.403 HD12 HG23 ' C' ' 264' ' ' VAL . 13.8 mt -138.85 117.82 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 65.44 111.141 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -133.22 121.39 22.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 65.22 110.859 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.7 p -136.39 148.41 47.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.177 -0.465 . . . . 73.22 111.135 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.79 166.52 33.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 74.31 110.915 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 64.09 72.76 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 71.25 110.959 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 47.8 33.86 3.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 74.11 110.853 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.8 142.57 27.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 74.35 111.155 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -126.88 135.87 51.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 60.32 110.902 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.54 HG13 HG13 ' C' ' 275' ' ' VAL . 5.3 p -128.54 137.51 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 64.3 111.114 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 240' ' ' GLN . . . . . 0.732 ' HB3' HD13 ' D' ' 276' ' ' LEU . 3.7 tm0? -117.32 135.91 53.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 63.03 110.935 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.19 129.75 43.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 71.14 110.898 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 121.74 -131.3 8.44 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.699 -0.762 . . . . 72.32 112.464 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 243' ' ' ASN . . . . . 0.533 ' CG ' HG21 ' C' ' 260' ' ' THR . 1.8 p-10 -144.99 150.8 37.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 72.5 110.815 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 244' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' D' ' 280' ' ' GLU . 13.7 m -122.73 124.36 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 63.5 111.133 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 245' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' D' ' 281' ' ' TYR . 28.4 t -121.23 129.05 76.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 62.31 111.194 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 246' ' ' THR . . . . . 0.434 HG21 ' HA2' ' D' ' 283' ' ' GLY . 68.4 p -72.26 174.57 7.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 65.34 111.17 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.48 -45.9 73.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.277 -0.419 . . . . 71.53 111.103 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.27 -50.38 73.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 35.23 111.071 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.39 -169.99 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 42.41 111.091 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 28.2 tp -71.86 129.03 37.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 55.14 110.978 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -75.06 80.29 2.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 70.44 110.881 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 149.88 -71.34 0.3 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.713 -0.756 . . . . 72.21 112.474 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 142.5 127.75 2.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.751 -0.738 . . . . 63.45 112.528 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 50.5 pt -72.44 167.33 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 70.43 111.116 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -54.35 161.35 1.39 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 62.21 110.914 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 1.1 tt -51.96 -29.7 11.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 55.33 111.119 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 257' ' ' SER . . . . . 0.706 ' HA ' HG21 ' C' ' 223' ' ' VAL . 20.0 m -102.9 -170.16 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 72.21 110.833 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -169.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 74.34 110.874 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -133.97 -66.67 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 64.32 110.922 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 260' ' ' THR . . . . . 0.664 HG23 ' HD2' ' E' ' 225' ' ' ARG . 75.8 m -101.32 121.96 42.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 72.35 111.142 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 261' ' ' THR . . . . . 0.628 ' H ' ' NE ' ' E' ' 225' ' ' ARG . 95.1 m -100.33 108.95 21.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 64.2 111.17 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -116.31 150.32 37.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 73.41 110.892 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.37 123.79 16.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 54.21 110.859 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 11.4 p -107.55 134.23 49.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 65.22 111.094 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.45 -75.44 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 75.31 110.855 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 44.8 p -148.74 135.38 19.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 73.11 111.153 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.686 ' CG1' HG21 ' D' ' 275' ' ' VAL . 14.5 t -117.67 128.24 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 62.53 111.07 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 268' ' ' VAL . . . . . 0.4 HG11 ' HD3' ' E' ' 232' ' ' ARG . 5.9 p -127.19 122.87 60.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 65.33 111.204 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.57 133.84 10.54 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.698 -0.763 . . . . 63.42 112.473 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -132.48 136.48 46.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.808 0.337 . . . . 71.5 110.849 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.68 87.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 64.42 112.506 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 51.95 80.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 74.14 110.883 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 40.7 t -114.61 145.29 42.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 75.25 110.828 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -130.62 127.12 38.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 71.02 110.873 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.686 HG21 ' CG1' ' D' ' 267' ' ' VAL . 85.1 t -136.17 126.74 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 75.04 111.163 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.732 HD13 ' HB3' ' D' ' 240' ' ' GLN . 0.5 OUTLIER -124.2 111.22 15.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 72.15 110.917 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 31.1 mm -109.68 104.85 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 63.53 111.167 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 159.25 -165.36 34.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.795 -0.717 . . . . 52.12 112.522 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -123.66 156.19 36.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.774 0.321 . . . . 70.55 110.92 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 280' ' ' GLU . . . . . 0.4 ' HA ' HG23 ' D' ' 244' ' ' VAL . 19.3 tt0 -111.77 119.24 37.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 70.31 110.959 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 281' ' ' TYR . . . . . 0.598 ' HB3' HG13 ' D' ' 245' ' ' VAL . 2.0 m-85 -103.68 125.82 50.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 55.3 110.89 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 62.88 31.63 81.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.718 -0.753 . . . . 52.04 112.471 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 283' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' D' ' 246' ' ' THR . . . -95.75 -116.46 3.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 71.01 112.546 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -179.41 34.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 62.31 110.868 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.25 -113.18 3.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 73.23 112.455 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.85 -179.35 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.853 0.358 . . . . 71.23 110.844 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 12.0 p90 -94.44 -25.01 17.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 74.15 110.911 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -101.92 141.12 35.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 71.02 110.901 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.44 -177.85 6.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 53.11 110.926 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -147.43 161.47 40.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 74.35 110.925 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.47 -45.29 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 72.33 110.851 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.49 69.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 61.11 110.862 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 61.46 173.36 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 74.23 110.808 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 54.9 87.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 75.2 110.836 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 61.03 110.899 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 217' ' ' MET . . . . . 0.467 ' HG2' HG21 ' C' ' 266' ' ' THR . 2.2 mtt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.792 0.329 . . . . 62.43 110.858 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 218' ' ' LYS . . . . . 0.559 ' HG2' HD12 ' E' ' 219' ' ' ILE . 0.0 OUTLIER -163.4 173.72 12.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 73.24 110.953 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 219' ' ' ILE . . . . . 0.559 HD12 ' HG2' ' E' ' 218' ' ' LYS . 2.9 mt 61.07 99.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 64.12 111.097 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -126.15 158.84 34.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 64.12 110.841 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -131.89 148.23 52.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.02 111.107 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.24 85.41 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 52.42 111.12 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 13.2 p -168.72 139.64 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 42.23 111.139 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 145.69 144.73 4.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 71.21 112.501 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 225' ' ' ARG . . . . . 0.664 ' HD2' HG23 ' D' ' 260' ' ' THR . 1.5 ptp180 -54.19 -51.3 64.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 65.41 110.934 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -105.42 108.83 20.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 53.31 110.895 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.59 152.41 45.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 61.41 110.873 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.8 163.01 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 63.13 111.123 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.49 -33.31 6.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 74.21 110.942 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 230' ' ' ASP . . . . . 0.616 ' HB2' HG22 ' E' ' 266' ' ' THR . 0.2 OUTLIER -167.27 140.44 3.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 74.45 110.804 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 231' ' ' ILE . . . . . 0.525 HG23 HG21 ' E' ' 239' ' ' VAL . 17.3 mt -136.98 114.9 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 55.03 111.118 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 232' ' ' ARG . . . . . 0.4 ' HD3' HG11 ' D' ' 268' ' ' VAL . 2.9 ttp180 -132.27 119.93 21.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 63.34 110.917 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.69 144.35 45.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 72.44 111.129 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -156.4 166.13 34.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 73.23 110.883 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 59.42 72.3 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 70.33 110.88 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 50.0 43.57 25.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 63.41 110.923 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.09 144.93 29.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 63.44 111.071 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -128.92 141.66 51.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.53 110.881 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.679 ' CG1' HG22 ' D' ' 275' ' ' VAL . 7.8 p -134.77 134.48 53.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 64.22 111.158 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 240' ' ' GLN . . . . . 0.473 ' HB3' HD13 ' E' ' 276' ' ' LEU . 7.2 tm0? -119.42 137.22 53.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.428 . . . . 71.3 110.864 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.746 HD22 ' HB ' ' E' ' 277' ' ' ILE . 0.1 OUTLIER -130.31 118.72 21.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 73.22 110.935 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 123.73 177.88 15.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.696 -0.764 . . . . 62.43 112.481 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -89.65 145.38 25.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.787 0.327 . . . . 71.3 110.941 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 9.6 m -120.16 139.16 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 71.44 111.114 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.5 128.32 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 74.14 111.177 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.5 t -69.77 175.2 4.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 71.32 111.17 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.43 76.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 62.04 111.124 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.13 -51.72 68.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 35.13 111.116 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 54.63 -171.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 70.13 111.088 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 1.7 tt -154.61 121.2 5.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.448 . . . . 74.55 110.992 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -102.42 165.48 11.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 64.22 110.861 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 145.28 160.07 8.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.681 -0.771 . . . . 70.33 112.449 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -130.38 -123.37 2.51 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.731 -0.747 . . . . 71.41 112.522 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 2.0 mp 63.38 105.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 74.52 111.115 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.5 140.99 32.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.86 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 16.8 tt -168.22 148.99 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 74.11 111.147 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.12 105.99 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 72.12 110.84 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -163.14 132.64 4.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 72.01 110.878 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -165.55 109.68 0.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 73.41 110.888 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 67.4 p -101.08 121.86 42.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 75.33 111.123 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 261' ' ' THR . . . . . 0.498 HG23 ' HA ' ' E' ' 225' ' ' ARG . 0.8 OUTLIER -134.36 116.51 15.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 65.51 111.177 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.3 136.18 52.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 65.54 110.936 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 1.3 t -126.8 121.88 33.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.841 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 264' ' ' VAL . . . . . 0.454 HG11 HD21 ' E' ' 241' ' ' LEU . 8.0 p -102.41 123.0 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 41.31 111.134 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 265' ' ' GLU . . . . . 0.432 ' CD ' ' N ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -65.23 -142.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 73.52 110.907 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 266' ' ' THR . . . . . 0.616 HG22 ' HB2' ' E' ' 230' ' ' ASP . 3.2 p -92.14 128.79 38.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 71.22 111.122 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 267' ' ' VAL . . . . . 0.973 HG11 HG21 ' E' ' 275' ' ' VAL . 8.9 t -115.35 133.34 61.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 54.11 111.119 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 268' ' ' VAL . . . . . 0.407 ' O ' HG13 ' E' ' 268' ' ' VAL . 6.1 p -125.45 121.53 60.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 75.44 111.188 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.44 132.87 11.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.785 -0.721 . . . . 75.04 112.493 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -132.82 116.05 16.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 74.43 110.897 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 64.49 88.14 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 75.44 112.455 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 56.99 86.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 61.51 110.857 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 16.9 t -124.35 145.49 49.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 54.0 110.851 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -136.7 127.13 26.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 64.02 110.892 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.973 HG21 HG11 ' E' ' 267' ' ' VAL . 57.9 t -132.73 134.67 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 33.41 111.094 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' E' ' 240' ' ' GLN . 0.2 OUTLIER -128.39 114.85 17.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 24.21 110.926 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.746 ' HB ' HD22 ' E' ' 241' ' ' LEU . 28.4 mm -111.13 141.16 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 75.3 111.1 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 113.1 -171.86 14.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.694 -0.765 . . . . 72.32 112.442 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -106.82 153.52 22.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.797 0.332 . . . . 71.51 110.868 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -111.85 144.47 41.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 72.33 110.826 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.12 125.35 43.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 75.42 110.902 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 51.83 29.17 25.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.756 -0.735 . . . . 54.21 112.484 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -99.25 18.72 56.14 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.763 -0.732 . . . . 51.51 112.499 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? 53.63 35.17 20.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.884 0.373 . . . . 73.24 110.91 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.27 -103.85 2.98 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.759 -0.734 . . . . 72.34 112.474 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -52.03 157.81 1.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.837 0.351 . . . . 71.51 110.843 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -71.96 148.3 46.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 63.11 110.955 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 6.2 t0 60.93 -179.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 75.25 110.875 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 63.18 104.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 52.31 110.917 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -103.43 -175.06 2.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 73.22 110.884 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.71 134.67 47.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 75.22 110.833 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -133.21 -59.45 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 71.45 110.844 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 56.87 85.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.12 110.867 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.22 137.67 47.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 70.45 110.89 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 71.05 110.846 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.844 0.354 . . . . 65.05 110.843 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -176.74 174.81 1.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 71.33 110.891 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.42 173.9 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 54.43 111.07 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.47 177.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 74.34 110.892 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -156.12 148.59 23.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 64.42 111.034 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.501 HG22 HG12 ' A' ' 223' ' ' VAL . 65.8 mt -147.27 -72.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 71.22 111.157 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.501 HG12 HG22 ' A' ' 222' ' ' ILE . 10.3 p -175.54 152.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 74.15 111.116 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 168.25 159.79 14.63 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.744 -0.741 . . . . 55.55 112.466 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -179.12 33.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.808 0.337 . . . . 74.41 110.885 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.435 ' ND2' ' HA2' ' A' ' 242' ' ' GLY . 0.4 OUTLIER -142.41 143.63 32.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 32.01 110.852 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 34.5 p -121.72 137.5 54.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 52.52 110.859 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.94 139.92 48.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.486 . . . . 74.23 111.088 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.15 -28.18 13.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 72.34 110.879 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.413 ' HB3' HG23 ' A' ' 266' ' ' THR . 1.1 m-20 -166.17 137.93 3.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 72.21 110.879 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.39 117.29 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 73.45 111.157 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -129.55 122.48 29.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 72.34 110.861 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.8 152.12 50.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 73.44 111.163 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.98 158.94 37.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 70.11 110.948 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 236' ' ' ARG . 1.6 tt0 64.11 83.35 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 71.25 110.892 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 235' ' ' GLU . 0.0 OUTLIER 36.15 59.89 0.89 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 75.01 110.883 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.21 144.02 32.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 73.23 111.087 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -125.79 135.81 52.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 71.3 110.923 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.53 HG12 ' HB ' ' A' ' 275' ' ' VAL . 19.7 m -143.01 121.29 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 64.42 111.137 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -124.88 137.64 54.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 73.12 110.895 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 mp -129.4 118.26 21.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 75.34 110.909 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.435 ' HA2' ' ND2' ' A' ' 226' ' ' ASN . . . 148.23 -161.87 28.69 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 60.14 112.51 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -91.11 137.86 32.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 74.35 110.992 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -120.54 131.77 71.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 72.4 111.092 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 61.7 t -122.17 128.97 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 65.32 111.133 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.78 175.15 6.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 72.22 111.189 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.15 -34.56 77.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 72.43 111.117 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ALA . . . . . 0.672 ' HB3' ' N ' ' A' ' 283' ' ' GLY . . . -56.97 -37.54 71.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 75.31 111.087 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.614 ' HB2' ' CA ' ' A' ' 282' ' ' GLY . . . -67.67 -75.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 73.2 111.087 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.3 tp 62.53 -169.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 73.54 110.907 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -52.31 109.32 0.37 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.916 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 151.09 177.93 25.41 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.77 -0.729 . . . . 64.31 112.485 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 112.19 116.48 3.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 64.31 112.561 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 33.6 pt -150.22 -175.8 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.829 0.347 . . . . 72.15 111.103 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.19 104.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 73.55 110.852 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 1.5 pp -150.5 171.07 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 72.52 111.101 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.04 -170.05 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 71.22 110.895 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.4 167.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 63.32 110.867 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -120.4 84.0 2.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 74.42 110.911 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 52.0 p -99.77 122.49 42.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 74.43 111.151 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.7 t -131.07 140.59 50.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 71.4 111.144 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -99.31 126.2 45.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.87 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 87.4 p -134.56 123.65 24.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 62.24 110.849 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.437 HG21 HG22 ' A' ' 267' ' ' VAL . 7.1 p -118.67 125.68 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.084 -0.507 . . . . 74.41 111.136 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -74.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.839 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 230' ' ' ASP . 25.8 m -136.45 135.06 38.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 71.52 111.193 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.779 HG11 HG11 ' A' ' 275' ' ' VAL . 0.1 OUTLIER -118.48 126.52 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 73.13 111.124 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 23.2 t -127.48 118.14 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 63.45 111.162 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.68 133.06 8.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.747 . . . . 62.04 112.489 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 147.6 52.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.906 0.384 . . . . 53.23 110.892 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.52 84.21 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 70.13 112.444 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 51.35 80.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 75.03 110.865 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 31.6 t -113.34 145.69 40.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 63.54 110.842 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -132.77 127.59 34.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 73.24 110.88 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.779 HG11 HG11 ' A' ' 267' ' ' VAL . 19.0 t -137.7 123.62 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 72.51 111.156 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.671 HD23 ' CZ2' ' A' ' 287' ' ' TRP . 0.6 OUTLIER -121.4 112.36 18.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 73.13 110.906 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 35.6 mm -103.93 104.51 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 74.41 111.158 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.2 -169.43 28.88 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.67 -0.776 . . . . 63.41 112.486 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -111.12 149.89 30.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.784 0.326 . . . . 71.24 110.88 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.456 ' OE2' HG13 ' B' ' 244' ' ' VAL . 0.1 OUTLIER -121.6 119.1 30.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 75.4 110.923 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -108.14 154.01 22.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 62.12 110.903 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.614 ' CA ' ' HB2' ' A' ' 249' ' ' ALA . . . 122.88 -120.16 4.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.72 -0.752 . . . . 50.12 112.496 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.672 ' N ' ' HB3' ' A' ' 248' ' ' ALA . . . -171.3 -143.8 4.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 22.03 112.565 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 69.03 -75.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 71.33 110.888 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -144.48 143.53 12.18 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.728 . . . . 63.21 112.481 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.503 ' HB2' HG11 ' B' ' 244' ' ' VAL . 14.4 p90 -61.1 -20.71 62.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 64.41 110.881 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.671 ' CZ2' HD23 ' A' ' 276' ' ' LEU . 5.0 t90 -164.82 -69.43 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.129 -0.487 . . . . 73.22 110.982 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.94 -6.82 12.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 70.41 110.906 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.62 -75.18 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 74.45 110.847 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -97.41 136.04 38.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 71.43 110.839 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -133.04 -69.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.468 . . . . 74.25 110.83 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -174.75 167.15 3.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 64.41 110.839 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -94.55 171.82 8.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 73.52 110.844 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -166.86 173.92 9.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 70.22 110.89 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 3.8 m80 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 72.42 110.791 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.83 0.348 . . . . 75.45 110.87 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.47 104.33 5.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 62.31 110.933 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 7.9 pt -135.07 179.5 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 50.22 111.145 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -140.21 139.32 35.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 70.44 110.858 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -150.2 169.98 20.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 72.14 111.197 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 2.6 pt -143.25 -178.37 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.294 -0.412 . . . . 70.14 111.034 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 34.4 m -147.95 172.53 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 74.2 111.183 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 176.8 -100.15 0.14 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.765 -0.731 . . . . 72.13 112.502 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.483 ' HG2' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER 52.18 87.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.783 0.325 . . . . 75.23 110.818 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -115.25 120.66 40.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 64.34 110.938 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.33 137.93 51.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 74.31 110.825 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.95 152.34 45.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 70.42 111.108 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -28.02 10.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 74.32 110.879 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 230' ' ' ASP . . . . . 0.541 ' HB3' HG23 ' B' ' 266' ' ' THR . 1.0 OUTLIER -164.65 138.41 5.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.415 . . . . 75.32 110.851 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 11.6 mt -135.44 122.42 34.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 75.22 111.081 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -134.17 117.25 16.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.04 110.911 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.2 145.67 52.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 74.11 111.151 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.24 161.53 41.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 73.21 110.85 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 63.61 69.68 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 61.41 110.804 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 47.53 56.7 6.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 70.24 110.936 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.0 144.42 31.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 61.31 111.14 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.03 135.87 52.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 75.45 110.848 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.801 HG12 ' HB ' ' B' ' 275' ' ' VAL . 4.1 m -136.24 121.56 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 73.02 111.138 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.67 134.06 54.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 75.31 110.979 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.578 HD12 ' HB ' ' B' ' 277' ' ' ILE . 0.3 OUTLIER -130.42 119.07 22.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 62.44 110.867 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.81 -116.07 0.72 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.74 . . . . 62.11 112.498 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.98 139.7 29.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.899 0.38 . . . . 73.24 110.902 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 286' ' ' PHE . 46.1 t -118.2 116.27 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 74.41 111.138 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.27 129.05 73.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 74.44 111.151 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.1 p -92.26 175.23 6.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 71.01 111.186 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.487 ' HB2' ' HA3' ' A' ' 283' ' ' GLY . . . -63.06 -42.65 99.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 25.2 111.07 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.73 -38.37 84.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 64.03 111.126 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' B' ' 281' ' ' TYR . . . -51.66 116.84 2.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 70.34 111.098 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.81 -58.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 74.41 110.885 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -117.48 120.88 39.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 75.52 110.808 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -100.26 -137.68 9.91 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 74.42 112.534 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -74.28 177.95 45.13 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.694 -0.765 . . . . 52.2 112.515 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 3.3 mp -111.29 116.73 53.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 63.24 111.164 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 255' ' ' ARG . . . . . 0.645 ' HD3' HG23 ' C' ' 254' ' ' ILE . 0.1 OUTLIER 62.69 97.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 73.43 110.859 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.3 tt -151.52 145.43 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 71.12 111.089 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.5 t -145.59 103.64 3.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 75.12 110.81 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -127.94 178.79 5.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 43.32 110.846 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -157.54 71.02 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 70.23 110.821 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.83 137.77 33.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 74.1 111.134 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.483 HG23 ' HG2' ' B' ' 225' ' ' ARG . 96.5 m -130.85 111.92 12.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 75.22 111.133 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -89.43 127.28 35.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 54.42 110.959 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 3.6 m -130.31 123.59 30.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 75.22 110.86 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.476 HG21 HG22 ' B' ' 267' ' ' VAL . 7.3 p -115.48 125.28 72.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 72.12 111.116 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.97 -76.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 61.5 110.905 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.541 HG23 ' HB3' ' B' ' 230' ' ' ASP . 94.6 m -137.01 137.65 39.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 73.34 111.093 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.684 ' CG1' HG21 ' B' ' 275' ' ' VAL . 4.4 t -117.8 128.35 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 74.33 111.177 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 25.6 t -127.64 117.16 45.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 44.45 111.101 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.39 132.53 9.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.723 -0.751 . . . . 71.34 112.498 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -133.27 125.08 28.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.863 0.363 . . . . 74.04 110.889 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.76 83.91 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 55.42 112.508 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 54.35 84.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 70.42 110.843 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 22.8 t -119.25 145.63 45.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 54.43 110.831 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -135.34 127.32 29.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 75.53 110.903 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.801 ' HB ' HG12 ' B' ' 239' ' ' VAL . 61.9 t -135.35 124.55 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 64.33 111.122 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.07 111.69 17.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 65.44 110.875 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' B' ' 241' ' ' LEU . 27.3 mm -103.86 104.53 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.455 . . . . 73.22 111.149 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.83 -160.21 28.51 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 74.21 112.486 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -115.91 147.87 40.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.324 . . . . 74.12 110.909 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.633 ' HG3' HG13 ' C' ' 244' ' ' VAL . 1.0 OUTLIER -120.82 118.88 31.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.9 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.476 ' CD2' ' HB1' ' B' ' 249' ' ' ALA . 11.4 t80 -112.27 127.46 55.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 71.43 110.954 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.555 ' O ' ' HB2' ' C' ' 247' ' ' ALA . . . 145.9 -48.59 0.68 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.808 -0.71 . . . . 61.45 112.47 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 74.06 11.32 81.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.725 -0.75 . . . . 73.12 112.48 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.96 60.86 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 53.32 110.868 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 96.26 120.26 3.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.763 -0.732 . . . . 62.45 112.487 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -50.95 108.45 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.324 . . . . 74.13 110.912 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 71.79 -69.57 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.155 -0.475 . . . . 74.34 110.889 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -121.27 -170.01 1.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 71.03 110.886 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -54.47 -42.94 71.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 72.43 110.888 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.35 105.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 75.31 110.748 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -128.54 84.88 2.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.492 . . . . 75.03 110.852 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -117.88 179.65 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 72.24 110.871 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -152.44 31.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 73.24 110.846 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -134.77 172.33 13.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 64.15 110.873 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 8.1 p80 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 74.24 110.874 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 4.2 mtp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.776 0.322 . . . . 64.41 110.805 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.51 114.83 20.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 74.32 110.882 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 6.2 tt -173.32 135.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 55.4 111.158 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.94 -73.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 74.12 110.859 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -169.6 83.09 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 71.44 111.065 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 2.7 mp -77.67 70.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 55.53 111.109 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.33 174.3 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 51.24 111.151 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 139.69 -155.31 24.17 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.722 -0.751 . . . . 33.13 112.466 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -127.78 -72.32 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.332 . . . . 64.3 110.831 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -83.98 110.07 18.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 62.22 110.834 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.34 137.91 50.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 63.33 110.849 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -123.35 150.55 43.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 54.11 111.117 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -102.37 -26.2 13.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 72.5 110.875 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 230' ' ' ASP . . . . . 0.502 ' HB3' HG23 ' C' ' 266' ' ' THR . 0.5 OUTLIER -165.04 138.79 4.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 52.44 110.809 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.467 ' CD1' HG23 ' B' ' 264' ' ' VAL . 11.5 mt -136.61 117.68 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 72.53 111.183 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.94 119.32 21.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 74.42 110.882 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.52 150.4 52.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 55.41 111.142 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -156.71 166.68 32.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 63.03 110.854 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.59 67.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 74.31 110.946 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 48.31 58.23 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 71.21 110.908 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.33 148.37 26.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 74.25 111.102 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -129.36 135.86 49.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 73.23 110.903 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.644 ' CG2' HG22 ' B' ' 275' ' ' VAL . 28.3 m -135.27 121.56 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 72.14 111.141 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.09 137.54 52.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 73.12 110.954 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.05 118.4 21.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 71.22 110.927 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 139.36 -168.91 24.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.777 -0.725 . . . . 61.45 112.461 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -91.93 145.03 24.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 64.52 110.921 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.633 HG13 ' HG3' ' B' ' 280' ' ' GLU . 56.1 t -125.98 124.89 67.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 75.34 111.129 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 48.4 t -122.83 118.28 54.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 44.05 111.063 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 6.4 t -77.84 174.96 10.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 62.35 111.163 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' B' ' 282' ' ' GLY . . . -63.83 -45.56 89.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 63.25 111.097 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 248' ' ' ALA . . . . . 0.586 ' O ' HD23 ' C' ' 250' ' ' LEU . . . -56.05 -35.77 67.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 74.24 111.082 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 249' ' ' ALA . . . . . 0.553 ' HB1' ' CD2' ' C' ' 281' ' ' TYR . . . -58.67 98.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 45.24 111.069 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 250' ' ' LEU . . . . . 0.586 HD23 ' O ' ' C' ' 248' ' ' ALA . 0.6 OUTLIER -131.71 25.46 4.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 64.3 110.943 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -125.38 177.18 6.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 71.2 110.88 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -144.45 -108.27 0.6 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.637 -0.792 . . . . 74.03 112.422 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -160.31 -60.81 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.672 -0.775 . . . . 64.01 112.437 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 254' ' ' ILE . . . . . 0.645 HG23 ' HD3' ' B' ' 255' ' ' ARG . 2.0 mp 62.95 74.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.79 0.328 . . . . 72.24 111.083 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.65 -70.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 71.2 110.895 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 30.9 mm -119.59 149.82 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 55.11 111.134 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 2.5 p -110.48 55.16 0.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 65.55 110.862 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.57 -179.62 7.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 73.43 110.838 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.13 135.63 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 61.33 110.854 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 260' ' ' THR . . . . . 0.464 HG22 ' HG3' ' D' ' 225' ' ' ARG . 70.0 p -100.86 137.58 39.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 74.25 111.154 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.704 HG23 ' HA3' ' D' ' 224' ' ' GLY . 2.1 t -108.45 137.05 47.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 72.33 111.141 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -119.99 139.01 53.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 73.14 110.931 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 22.8 m -130.68 123.74 30.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 72.31 110.925 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.542 HG21 ' CG2' ' C' ' 267' ' ' VAL . 7.1 p -112.01 126.86 69.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 72.31 111.083 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.8 -74.0 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.49 . . . . 73.34 110.88 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 266' ' ' THR . . . . . 0.502 HG23 ' HB3' ' C' ' 230' ' ' ASP . 92.5 m -140.8 136.65 32.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 64.42 111.189 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.656 ' CG1' HG21 ' C' ' 275' ' ' VAL . 94.4 t -117.96 127.02 75.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 70.43 111.111 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 40.1 t -127.5 126.79 67.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 72.1 111.039 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.25 133.0 8.24 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.767 -0.73 . . . . 73.11 112.502 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -132.62 140.96 48.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.832 0.349 . . . . 61.14 110.924 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.11 70.15 0.94 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.781 -0.723 . . . . 64.51 112.434 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 64.85 97.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 70.55 110.881 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 70.2 m -131.7 145.94 51.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 55.14 110.879 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 36.2 mtt85 -131.48 127.09 36.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 73.13 110.837 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.656 HG21 ' CG1' ' C' ' 267' ' ' VAL . 21.7 t -133.43 123.89 47.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 61.22 111.134 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.23 111.59 17.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 62.22 110.972 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 30.8 mm -105.65 104.34 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 74.44 111.181 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 152.97 -152.49 24.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 72.41 112.482 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -116.75 138.17 51.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.758 0.313 . . . . 50.43 110.941 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.661 ' CG ' HG22 ' D' ' 244' ' ' VAL . 4.4 pt-20 -111.79 118.83 36.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.457 . . . . 74.22 110.832 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.553 ' CD2' ' HB1' ' C' ' 249' ' ' ALA . 9.1 t80 -114.45 124.63 52.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 71.01 111.008 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 282' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' D' ' 247' ' ' ALA . . . 161.5 -58.53 0.3 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 23.1 112.463 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 91.31 -42.0 2.85 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.717 -0.754 . . . . 74.24 112.426 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -30.21 14.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 74.24 110.859 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -147.05 106.45 0.36 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.694 -0.765 . . . . 62.43 112.455 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -55.34 -23.35 23.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 74.2 110.898 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -153.81 -52.16 0.1 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.456 . . . . 75.24 110.934 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -132.59 149.25 52.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.412 . . . . 72.11 110.849 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -78.75 86.56 4.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 62.22 110.916 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -167.55 -174.86 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 75.22 110.927 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -93.03 154.84 17.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 75.52 110.862 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -176.26 118.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.877 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.74 174.68 1.78 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.233 -0.44 . . . . 61.54 110.888 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -130.02 176.9 7.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 71.33 110.847 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 12.0 p80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 74.52 110.778 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.88 0.371 . . . . 74.3 110.859 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -161.96 112.78 1.62 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 73.04 110.896 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 3.6 tt -53.65 -27.98 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 75.42 111.14 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.42 143.12 55.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 74.14 110.909 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -125.08 165.57 17.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 33.3 111.141 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -137.86 108.45 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 61.54 111.141 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 35.9 m -94.13 162.74 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 72.32 111.123 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 224' ' ' GLY . . . . . 0.704 ' HA3' HG23 ' C' ' 261' ' ' THR . . . -169.09 -172.86 36.26 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.752 -0.737 . . . . 43.0 112.507 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.464 ' HG3' HG22 ' C' ' 260' ' ' THR . 1.6 mmt85 -52.25 -59.88 3.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.85 0.357 . . . . 75.35 110.827 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -109.56 115.52 30.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 55.43 110.891 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.83 140.9 52.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 72.02 110.869 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.45 147.88 49.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 72.3 111.115 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -100.72 -26.16 13.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 70.11 110.929 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.98 138.26 4.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 73.5 110.922 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 231' ' ' ILE . . . . . 0.451 ' CD1' HG23 ' C' ' 264' ' ' VAL . 12.3 mt -137.03 117.89 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 73.21 111.178 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -133.06 118.41 18.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 70.52 110.878 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.49 150.76 52.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 74.03 111.144 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -157.0 167.29 30.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 73.04 110.898 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.54 66.45 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 74.35 110.851 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 50.08 43.97 25.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 73.44 110.874 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.1 152.38 21.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.34 111.079 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -135.34 135.25 40.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 63.32 110.869 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.602 HG23 HG13 ' C' ' 275' ' ' VAL . 18.1 m -133.58 121.19 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 61.23 111.126 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -108.07 134.63 50.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 74.02 110.914 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.28 118.03 20.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 74.04 110.924 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.16 -118.3 1.35 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.778 -0.725 . . . . 53.24 112.497 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -145.97 133.26 20.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.891 0.377 . . . . 73.43 110.866 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 244' ' ' VAL . . . . . 0.661 HG22 ' CG ' ' C' ' 280' ' ' GLU . 74.4 t -110.2 121.18 62.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 65.52 111.165 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.47 119.96 58.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 74.23 111.134 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -69.99 175.36 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 64.52 111.103 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 247' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' C' ' 282' ' ' GLY . . . -53.47 -46.1 69.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 75.24 111.114 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.2 -49.52 77.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 71.54 111.076 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 63.21 -174.89 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 63.14 111.112 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 250' ' ' LEU . . . . . 0.602 HD23 HG22 ' D' ' 256' ' ' ILE . 0.2 OUTLIER -52.02 107.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 64.22 110.879 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -52.91 164.97 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 74.22 110.88 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 90.8 -44.4 2.87 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 60.43 112.515 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 134.12 -55.19 0.75 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 70.34 112.512 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 14.7 tt -58.32 144.11 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.36 . . . . 74.51 111.164 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -57.23 178.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 75.55 110.913 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 256' ' ' ILE . . . . . 0.602 HG22 HD23 ' D' ' 250' ' ' LEU . 6.1 pt -58.71 177.98 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 75.33 111.145 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 36.6 p -150.99 92.55 1.83 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 63.33 110.883 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -173.42 139.42 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 72.5 110.868 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.88 30.51 6.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 65.34 110.813 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 260' ' ' THR . . . . . 0.419 HG21 HD21 ' E' ' 243' ' ' ASN . 0.2 OUTLIER -65.19 138.23 58.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 73.35 111.08 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 261' ' ' THR . . . . . 0.426 HG23 ' O ' ' D' ' 225' ' ' ARG . 49.9 m -112.71 108.88 18.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.34 111.149 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 262' ' ' ASN . . . . . 0.556 ' OD1' HG23 ' D' ' 277' ' ' ILE . 1.3 t-20 -90.77 131.98 36.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 75.44 110.861 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.97 123.87 38.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 53.13 110.924 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.523 HG21 ' CG2' ' D' ' 267' ' ' VAL . 9.7 p -118.39 129.1 75.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.143 -0.48 . . . . 42.21 111.064 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.52 -75.23 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 62.12 110.929 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 48.9 m -136.52 135.6 38.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 63.21 111.138 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.533 ' CG1' HG21 ' D' ' 275' ' ' VAL . 97.5 t -117.89 127.06 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 72.11 111.184 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 28.1 t -127.22 122.93 61.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 72.33 111.101 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.29 132.44 8.55 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.771 -0.728 . . . . 73.15 112.507 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.13 144.89 50.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.808 0.337 . . . . 65.03 110.934 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.79 70.38 0.79 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.726 . . . . 73.04 112.478 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.47 94.3 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 34.23 110.924 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 30.9 t -126.27 145.02 50.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 60.34 110.892 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -131.68 126.35 34.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 74.24 110.909 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.683 HG13 HG23 ' E' ' 239' ' ' VAL . 16.6 t -132.1 132.42 61.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 60.15 111.08 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.55 111.11 12.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.104 -0.498 . . . . 72.02 110.903 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.556 HG23 ' OD1' ' D' ' 262' ' ' ASN . 24.5 mm -108.03 106.59 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 74.2 111.107 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.27 -146.15 17.42 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.788 -0.72 . . . . 72.02 112.523 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.98 156.11 17.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 73.33 110.88 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 280' ' ' GLU . . . . . 0.759 ' CG ' HG22 ' E' ' 244' ' ' VAL . 0.0 OUTLIER -145.25 122.56 11.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 63.44 110.803 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -119.93 124.45 46.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 73.42 110.937 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . -149.59 -140.09 3.2 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.783 -0.722 . . . . 75.34 112.531 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 283' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' E' ' 247' ' ' ALA . . . -139.16 -98.36 0.41 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 35.42 112.494 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.52 101.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.818 0.342 . . . . 71.24 110.937 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 71.49 -116.06 5.95 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 74.32 112.462 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.63 152.31 21.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.815 0.341 . . . . 63.51 110.898 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 72.95 -69.76 0.18 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 72.51 110.881 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -100.35 170.41 8.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 72.23 110.891 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -143.1 64.45 1.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 75.53 110.886 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -125.24 -171.44 2.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 72.22 110.796 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -110.53 110.07 20.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 73.13 110.855 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -179.06 119.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 74.34 110.893 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -124.84 -68.39 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 72.31 110.863 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 53.42 -171.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 63.15 110.872 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.158 -0.474 . . . . 72.24 110.904 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.787 0.327 . . . . 70.22 110.919 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -135.26 -67.1 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.436 . . . . 63.42 110.88 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 40.3 mm 61.05 100.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 65.53 111.086 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.55 98.25 1.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 63.13 110.87 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.91 103.37 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 63.13 111.122 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -151.61 171.74 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 75.24 111.133 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 65.5 t -127.07 -71.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 75.12 111.092 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -129.03 -130.36 3.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.795 -0.717 . . . . 65.12 112.505 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.18 -169.92 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.803 0.335 . . . . 73.44 110.895 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -84.32 117.57 23.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 71.12 110.9 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 93.0 p -131.8 140.16 49.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 75.43 110.893 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -120.43 146.21 46.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 51.2 111.116 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -95.89 -26.73 15.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 71.53 110.924 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.31 138.88 5.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 70.25 110.944 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 231' ' ' ILE . . . . . 0.471 ' CD1' HG23 ' D' ' 264' ' ' VAL . 10.8 mt -137.15 117.71 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 71.33 111.122 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -131.77 121.47 24.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 73.0 110.884 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.4 147.61 49.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 70.21 111.151 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -157.05 161.11 39.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 64.4 110.936 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 64.89 72.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 75.55 110.883 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.25 37.9 12.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 64.21 110.849 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.83 141.48 29.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 61.42 111.148 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.73 135.46 52.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 74.34 110.931 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.683 HG23 HG13 ' D' ' 275' ' ' VAL . 25.2 m -138.12 122.01 21.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 72.21 111.146 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 240' ' ' GLN . . . . . 0.503 ' C ' HD12 ' E' ' 241' ' ' LEU . 2.5 tp60 -119.48 134.06 55.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 71.34 110.882 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.503 HD12 ' C ' ' E' ' 240' ' ' GLN . 6.5 mp -130.74 118.06 20.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 61.34 110.946 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 145.52 -108.99 0.49 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.79 -0.719 . . . . 73.43 112.483 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 243' ' ' ASN . . . . . 0.419 HD21 HG21 ' D' ' 260' ' ' THR . 0.0 OUTLIER -144.37 150.24 37.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.847 0.356 . . . . 73.45 110.895 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.759 HG22 ' CG ' ' D' ' 280' ' ' GLU . 80.0 t -133.42 122.73 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 75.32 111.131 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 79.6 t -124.15 112.83 34.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 72.41 111.095 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 246' ' ' THR . . . . . 0.474 HG23 ' O ' ' E' ' 281' ' ' TYR . 74.3 p -69.08 175.25 3.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 73.14 111.17 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 247' ' ' ALA . . . . . 0.523 ' HB2' ' HA2' ' D' ' 283' ' ' GLY . . . -55.09 -46.01 75.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 44.14 111.142 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.78 -52.18 66.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 73.32 111.1 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.24 -169.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 63.41 111.118 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 250' ' ' LEU . . . . . 0.645 HD23 ' OH ' ' E' ' 281' ' ' TYR . 59.7 tp -147.58 149.63 32.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 65.33 110.917 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -53.44 140.35 28.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 74.12 110.907 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -55.34 176.46 0.61 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.694 -0.765 . . . . 71.14 112.549 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -128.57 -120.69 2.31 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.696 -0.764 . . . . 74.23 112.465 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 3.2 tt -145.3 149.44 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.816 0.341 . . . . 74.03 111.192 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.18 99.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.428 . . . . 71.43 110.881 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 mp -91.59 -27.79 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 75.22 111.093 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 2.3 m -79.08 60.95 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 74.32 110.815 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -177.73 142.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 75.23 110.86 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 259' ' ' GLN . . . . . 0.413 ' HG3' HG23 ' D' ' 260' ' ' THR . 2.2 pm0 -174.56 165.79 3.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 71.24 110.919 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 17.0 p -72.6 136.66 45.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 63.23 111.166 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 94.1 m -92.25 128.74 38.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 60.24 111.114 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -126.41 142.53 51.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 72.4 110.883 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.88 133.45 39.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 63.35 110.839 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 264' ' ' VAL . . . . . 0.428 ' O ' HG13 ' E' ' 264' ' ' VAL . 4.9 p -124.11 118.51 54.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.139 -0.482 . . . . 72.21 111.136 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.96 -75.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 73.3 110.926 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.1 138.9 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 53.44 111.09 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 267' ' ' VAL . . . . . 0.86 HG11 HG21 ' E' ' 275' ' ' VAL . 40.2 t -117.43 128.46 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 64.51 111.092 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 38.9 t -127.12 118.58 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 71.04 111.159 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.63 132.28 10.18 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.77 -0.728 . . . . 73.15 112.481 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -133.7 116.56 15.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 74.24 110.868 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 74.71 86.77 0.26 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.707 -0.759 . . . . 52.52 112.498 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 51.09 81.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 65.51 110.876 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 16.3 m -117.3 145.42 44.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 73.42 110.873 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -134.11 127.29 31.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 63.23 110.79 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.86 HG21 HG11 ' E' ' 267' ' ' VAL . 46.6 t -133.2 130.5 57.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 64.43 111.142 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.629 HD22 ' O ' ' E' ' 275' ' ' VAL . 3.2 mm? -128.34 107.85 10.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 63.54 110.833 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 23.1 mm -114.27 109.19 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 71.11 111.069 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.62 -137.36 6.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.84 -0.695 . . . . 75.05 112.557 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -111.24 133.24 53.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 70.41 110.902 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.34 133.66 55.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.44 110.905 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 281' ' ' TYR . . . . . 0.645 ' OH ' HD23 ' E' ' 250' ' ' LEU . 0.1 OUTLIER -131.26 123.88 29.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 73.03 110.937 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 110.44 -77.65 0.23 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.64 -0.791 . . . . 22.14 112.494 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -50.79 125.66 23.71 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.71 -0.757 . . . . 75.03 112.453 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -84.97 -68.88 0.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.346 . . . . 64.3 110.953 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -50.27 -79.35 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.744 -0.741 . . . . 73.34 112.462 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -62.99 1.34 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.845 0.355 . . . . 73.35 110.847 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 4.1 p90 178.34 -31.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 70.53 110.91 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -87.84 60.12 5.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.301 -0.409 . . . . 74.31 110.942 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -51.64 136.34 27.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 70.11 110.871 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -107.29 -171.18 1.83 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 74.31 110.879 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -87.61 145.73 26.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 72.33 110.841 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -56.02 142.73 35.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 72.42 110.807 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -161.51 -172.24 3.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 75.53 110.875 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -97.35 -170.49 2.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 72.22 110.925 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 75.55 110.816 -179.992 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 4.3 mmt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.813 0.34 . . . . 75.03 110.867 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.74 -179.33 4.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 73.32 110.92 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 18.4 pt -124.31 26.59 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 64.45 111.144 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -176.76 111.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.52 110.899 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -129.34 29.61 5.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 72.25 111.006 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.3 118.05 7.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 74.43 111.143 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.725 HG13 ' HA ' ' A' ' 259' ' ' GLN . 7.4 p -139.96 146.11 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 75.54 111.159 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 174.37 174.95 41.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.762 -0.732 . . . . 74.4 112.437 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.615 ' HG3' HG23 ' A' ' 261' ' ' THR . 13.0 ptm180 -156.32 153.95 29.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.79 0.329 . . . . 73.02 110.861 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.724 ' HB3' HG22 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -123.21 130.08 52.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 62.43 110.823 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.1 m -128.57 144.31 51.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 74.54 110.872 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.7 124.01 19.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 71.21 111.091 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -76.09 -37.2 58.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 73.11 110.916 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -164.68 138.46 5.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 62.23 110.878 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.597 HG22 ' CG2' ' A' ' 267' ' ' VAL . 9.7 pt -137.82 118.01 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 74.14 111.067 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -128.39 126.91 41.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 75.31 110.909 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.602 HG21 ' CG1' ' A' ' 239' ' ' VAL . 1.7 p -135.56 149.49 49.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 72.52 111.142 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -144.97 168.37 20.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 43.51 110.925 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 65.47 74.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 64.01 110.922 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 41.89 59.11 2.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 73.02 110.811 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.435 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -104.11 155.99 18.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 54.14 111.099 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -135.05 145.92 48.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 72.33 110.905 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.602 ' CG1' HG21 ' A' ' 233' ' ' THR . 16.1 m -139.97 137.39 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 74.21 111.113 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -137.2 129.42 29.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.13 110.917 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.9 mp -122.94 130.34 52.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 75.35 110.846 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.72 -121.42 1.56 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 63.33 112.446 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -144.86 132.7 21.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.87 0.367 . . . . 74.33 110.903 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.517 HG23 ' HA ' ' A' ' 280' ' ' GLU . 18.0 m -120.02 120.9 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.138 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.502 ' CG1' ' HB3' ' A' ' 249' ' ' ALA . 94.5 t -122.07 129.02 75.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 64.45 111.189 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t -78.19 166.67 22.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 74.05 111.196 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.07 -33.89 76.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 60.14 111.133 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.82 -37.97 71.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 73.34 111.129 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.502 ' HB3' ' CG1' ' A' ' 245' ' ' VAL . . . -66.05 -23.44 66.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 42.45 111.061 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 6.9 tp -76.73 64.91 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 72.42 110.965 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -179.16 34.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.445 . . . . 64.44 110.77 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 152.15 -159.7 28.49 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.716 -0.754 . . . . 54.34 112.479 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 175.6 172.23 40.25 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 62.54 112.507 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.496 HG23 ' O ' ' B' ' 250' ' ' LEU . 3.4 pt -120.5 175.04 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 64.13 111.124 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.514 ' O ' HD13 ' A' ' 256' ' ' ILE . 23.6 ttp180 -126.75 84.41 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 52.22 110.867 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.514 HD13 ' O ' ' A' ' 255' ' ' ARG . 44.9 mm -140.09 135.69 37.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 64.23 111.108 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.06 -49.4 71.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 64.05 110.848 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.98 -76.21 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 74.53 110.897 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.725 ' HA ' HG13 ' A' ' 223' ' ' VAL . 1.7 tt0 51.61 42.35 29.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 61.23 110.97 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.52 121.79 30.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 73.0 111.123 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.615 HG23 ' HG3' ' A' ' 225' ' ' ARG . 98.0 m -127.62 111.04 13.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 61.51 111.117 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.67 HD22 ' HB3' ' A' ' 226' ' ' ASN . 1.7 p30 -100.52 135.48 41.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 63.3 110.899 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 9.4 t -140.73 123.18 15.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 71.54 110.797 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.678 HG21 ' CD1' ' B' ' 231' ' ' ILE . 4.2 p -113.63 150.17 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 73.11 111.156 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -88.19 -73.31 0.49 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.483 . . . . 73.41 110.956 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 18.5 m -124.06 133.67 53.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 62.51 111.169 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.794 HG22 HD11 ' B' ' 231' ' ' ILE . 9.8 t -118.01 128.87 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 45.22 111.139 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 48.8 t -127.4 117.17 46.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 44.35 111.108 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.74 133.62 10.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.687 -0.768 . . . . 75.31 112.456 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -132.33 148.12 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 75.41 110.96 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.39 88.05 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.817 -0.706 . . . . 63.43 112.429 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 44.45 65.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 63.11 110.913 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 43.4 t -93.82 145.21 24.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.47 . . . . 73.14 110.86 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -123.02 128.45 50.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 74.35 110.835 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.543 ' HB ' HG12 ' A' ' 239' ' ' VAL . 21.2 t -119.3 123.62 71.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 73.21 111.144 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.603 HD23 ' CZ2' ' A' ' 287' ' ' TRP . 0.2 OUTLIER -121.0 111.48 17.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 72.23 110.976 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.724 HG22 ' HB3' ' A' ' 226' ' ' ASN . 20.4 mm -111.79 104.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.188 -0.46 . . . . 72.32 111.174 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.7 -160.22 26.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 72.43 112.468 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -107.01 151.51 25.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 70.23 110.878 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.711 ' HG3' HG12 ' B' ' 244' ' ' VAL . 0.5 OUTLIER -130.26 131.93 45.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 71.31 110.893 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -113.17 125.86 54.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 64.13 110.933 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 131.37 166.55 11.71 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.735 -0.745 . . . . 63.44 112.519 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -82.42 -108.93 0.44 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 33.33 112.524 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.31 51.01 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 75.23 110.907 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.15 30.87 32.48 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.787 -0.721 . . . . 51.32 112.464 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 58.47 83.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.882 0.372 . . . . 74.14 110.882 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.603 ' CZ2' HD23 ' A' ' 276' ' ' LEU . 23.0 t90 55.45 63.14 2.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 61.54 110.909 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.16 -169.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 73.52 110.938 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -119.75 161.71 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 72.34 110.974 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -51.93 116.53 2.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 75.52 110.934 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -152.57 -73.1 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 73.5 110.889 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 8.4 m170 63.09 168.2 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 71.41 110.806 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -154.85 178.01 10.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 73.13 110.844 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -84.41 137.14 33.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 62.32 110.889 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 8.5 m170 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 75.44 110.863 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.828 0.347 . . . . 63.33 110.941 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.04 -170.56 2.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 62.11 110.887 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 2.5 tt -71.02 150.31 9.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 71.52 111.151 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' ASP . . . . . 0.448 ' HB2' HG22 ' B' ' 222' ' ' ILE . 7.0 m-20 -55.73 175.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.89 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.525 ' HB3' ' OG ' ' B' ' 257' ' ' SER . . . -95.44 24.56 5.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 71.44 111.07 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 222' ' ' ILE . . . . . 0.448 HG22 ' HB2' ' B' ' 220' ' ' ASP . 12.5 tt -111.06 136.18 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 61.13 111.122 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 92.7 t -149.86 105.51 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 75.41 111.13 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -80.46 164.75 47.62 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 70.11 112.467 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.57 ' HB3' HG23 ' B' ' 261' ' ' THR . 5.7 mtp180 -170.76 127.42 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.833 0.349 . . . . 72.1 110.862 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.788 ' HB3' HG22 ' B' ' 277' ' ' ILE . 0.5 OUTLIER -128.22 131.13 48.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.911 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.1 145.32 49.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 75.14 110.876 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.559 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -139.5 124.68 18.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.478 . . . . 72.42 111.075 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.39 -36.05 53.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.483 . . . . 60.25 110.969 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.36 137.6 4.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 72.45 110.856 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.794 HD11 HG22 ' A' ' 267' ' ' VAL . 5.9 pt -138.69 117.64 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 65.43 111.179 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.35 123.72 32.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 74.54 110.875 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.589 HG21 ' CG1' ' B' ' 239' ' ' VAL . 1.7 p -135.61 142.71 45.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 73.13 111.18 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -143.37 167.56 21.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 70.22 110.879 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 68.63 73.6 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 74.15 110.881 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 45.83 54.8 7.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 64.13 110.844 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.27 156.17 18.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 63.3 111.138 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.31 146.54 42.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.829 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.589 ' CG1' HG21 ' B' ' 233' ' ' THR . 18.6 m -136.46 140.85 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 74.14 111.208 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.561 ' HB3' HD22 ' B' ' 276' ' ' LEU . 1.9 tt0 -138.14 122.55 18.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 60.1 110.964 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.6 118.94 33.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.209 -0.45 . . . . 72.1 110.93 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.92 -170.84 24.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.798 -0.715 . . . . 54.41 112.523 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -85.99 129.05 34.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 74.33 110.909 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.711 HG12 ' HG3' ' A' ' 280' ' ' GLU . 17.5 m -118.99 121.12 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 71.04 111.175 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.471 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 26.6 t -122.15 129.02 75.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 73.31 111.105 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -85.34 175.08 9.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 75.12 111.157 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.05 -42.35 90.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 61.34 111.145 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.96 67.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 73.53 111.08 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.471 ' HB3' ' CG1' ' B' ' 245' ' ' VAL . . . -60.2 -25.36 65.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 61.22 111.074 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.496 ' O ' HG23 ' A' ' 254' ' ' ILE . 1.2 tp -55.64 -25.85 41.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 74.14 110.947 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -115.14 58.36 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.33 110.889 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -168.59 -161.37 18.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.652 -0.785 . . . . 74.34 112.414 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 112.84 136.59 6.67 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.76 -0.733 . . . . 71.14 112.464 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.92 50.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.857 0.361 . . . . 65.02 111.219 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 255' ' ' ARG . . . . . 0.506 ' HE ' HG21 ' C' ' 254' ' ' ILE . 0.0 OUTLIER 69.64 -74.83 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 72.41 110.886 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 44.4 mm 60.83 81.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.179 -0.464 . . . . 65.41 111.126 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 257' ' ' SER . . . . . 0.525 ' OG ' ' HB3' ' B' ' 221' ' ' ALA . 2.0 t -83.16 115.24 21.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 74.42 110.816 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.402 ' O ' HG23 ' B' ' 260' ' ' THR . 12.3 t0 -178.77 105.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 74.01 110.863 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -68.71 93.76 0.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 75.11 110.857 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.562 HG21 ' HB2' ' C' ' 243' ' ' ASN . 27.8 p -100.69 122.05 42.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 73.22 111.17 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.57 HG23 ' HB3' ' B' ' 225' ' ' ARG . 96.7 m -133.91 124.92 27.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 73.24 111.152 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -115.97 134.6 54.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 71.11 110.866 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.89 123.54 19.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 53.34 110.828 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.68 HG21 ' CD1' ' C' ' 231' ' ' ILE . 4.9 p -110.22 150.04 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.501 . . . . 64.53 111.123 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -86.61 -77.1 0.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 62.41 110.835 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 13.8 m -120.16 132.71 55.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 75.54 111.169 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.78 HG22 HD11 ' C' ' 231' ' ' ILE . 5.0 t -118.13 121.0 66.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.304 -0.407 . . . . 63.25 111.107 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.51 117.24 51.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.487 . . . . 64.04 111.138 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.79 133.79 11.09 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 72.02 112.516 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.99 148.12 52.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 63.43 110.933 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.35 82.95 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.75 -0.738 . . . . 43.53 112.545 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 46.8 69.04 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 63.4 110.893 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.92 145.7 26.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 73.23 110.884 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.46 128.38 52.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 72.31 110.891 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.548 ' HB ' HG12 ' B' ' 239' ' ' VAL . 21.7 t -118.98 123.91 72.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 63.13 111.139 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.561 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.2 OUTLIER -124.36 111.66 16.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 75.2 110.951 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.788 HG22 ' HB3' ' B' ' 226' ' ' ASN . 24.0 mm -112.09 104.1 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 72.44 111.165 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.24 -164.62 27.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 45.54 112.443 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -101.25 151.91 21.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 74.52 110.872 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.687 ' HG3' HG12 ' C' ' 244' ' ' VAL . 1.6 pp20? -130.91 142.51 50.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.842 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -127.53 125.92 41.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 73.14 110.914 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 157.7 146.24 4.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.72 -0.752 . . . . 63.02 112.509 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -102.98 -170.23 26.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 45.12 112.462 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? 56.27 25.18 9.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 72.24 110.893 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 141.77 117.86 1.36 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.724 -0.751 . . . . 51.33 112.541 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.51 ' CE2' HG21 ' C' ' 244' ' ' VAL . 3.0 m-85 -55.71 -26.1 43.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 71.23 110.886 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -139.43 -65.0 0.48 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 74.25 110.882 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.45 124.26 35.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 61.41 110.844 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -51.93 141.75 17.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 64.22 110.884 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -158.65 165.61 34.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 74.2 110.898 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -89.97 -172.21 3.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 74.15 110.834 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -130.51 -169.89 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 73.32 110.896 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.87 -171.32 3.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 61.41 110.816 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -77.65 -170.24 1.76 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.216 -0.447 . . . . 61.12 110.915 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 63.24 110.833 179.951 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.816 0.341 . . . . 74.54 110.86 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.51 172.43 8.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 73.11 110.942 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.464 HD13 ' N ' ' C' ' 220' ' ' ASP . 0.0 OUTLIER -157.55 145.28 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.291 -0.413 . . . . 73.01 111.11 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 220' ' ' ASP . . . . . 0.464 ' N ' HD13 ' C' ' 219' ' ' ILE . 0.3 OUTLIER -179.0 132.92 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 61.42 110.86 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 221' ' ' ALA . . . . . 0.636 ' H ' HD12 ' C' ' 222' ' ' ILE . . . -177.6 73.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 75.34 111.122 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 222' ' ' ILE . . . . . 0.636 HD12 ' H ' ' C' ' 221' ' ' ALA . 4.6 mp -139.9 145.07 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 40.12 111.088 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 223' ' ' VAL . . . . . 0.459 HG12 HG12 ' D' ' 222' ' ' ILE . 32.7 m -62.59 -176.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 75.51 111.131 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -175.69 176.47 47.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.805 -0.712 . . . . 53.44 112.534 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.615 ' HA ' HG23 ' C' ' 261' ' ' THR . 23.9 mmt85 -71.0 -67.05 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 75.33 110.87 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.563 ' HB3' HG22 ' C' ' 277' ' ' ILE . 2.0 m-20 -84.43 118.44 24.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 73.25 110.877 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 14.9 t -136.68 147.74 46.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.816 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.599 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -135.83 129.0 31.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 62.42 111.145 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.22 -35.24 36.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 62.0 110.91 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.8 136.81 3.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 61.21 110.89 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.78 HD11 HG22 ' B' ' 267' ' ' VAL . 4.6 pt -139.17 117.72 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 73.43 111.156 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.1 124.3 32.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 72.54 110.939 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.579 HG21 ' CG1' ' C' ' 239' ' ' VAL . 1.4 p -135.39 144.21 46.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 62.3 111.105 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 13.1 pm0 -143.53 167.82 21.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 62.03 110.927 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 68.68 70.72 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 73.25 110.926 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? 47.0 57.39 5.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 73.35 110.835 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.418 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -104.57 156.18 18.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 73.0 111.106 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -136.58 141.63 43.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 72.24 110.871 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.579 ' CG1' HG21 ' C' ' 233' ' ' THR . 19.3 m -131.07 140.81 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 74.22 111.105 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.536 ' HB3' HD22 ' C' ' 276' ' ' LEU . 2.0 tp60 -138.02 129.54 27.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 75.23 110.906 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.578 HD13 ' CD1' ' B' ' 277' ' ' ILE . 5.2 mp -123.98 118.65 27.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 72.44 110.957 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.8 -176.74 21.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.767 -0.73 . . . . 74.2 112.506 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.562 ' HB2' HG21 ' B' ' 260' ' ' THR . 25.7 t-20 -85.92 128.91 34.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 70.45 110.851 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.687 HG12 ' HG3' ' B' ' 280' ' ' GLU . 32.2 m -111.67 127.4 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 64.41 111.166 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 22.4 t -122.29 129.07 75.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 70.51 111.132 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 18.3 p -84.18 175.08 9.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 62.54 111.102 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.81 -34.85 70.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.476 . . . . 74.21 111.046 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -70.87 -51.73 24.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 41.23 111.07 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 52.36 -170.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.284 -0.416 . . . . 63.12 111.07 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.03 -177.34 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 70.22 110.913 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -168.89 67.01 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.448 . . . . 75.2 110.888 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 178.47 88.09 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.767 -0.73 . . . . 63.4 112.473 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 52.68 -144.85 20.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 60.4 112.446 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 254' ' ' ILE . . . . . 0.506 HG21 ' HE ' ' B' ' 255' ' ' ARG . 13.4 pt -117.82 -36.29 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 75.44 111.155 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 55.96 -176.47 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 72.14 110.867 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 42.3 mt -139.31 69.26 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 70.34 111.113 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 2.6 p -52.09 157.62 1.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 64.31 110.947 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -59.96 178.54 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 72.4 110.886 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.95 79.55 1.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 74.04 110.914 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 51.3 p -67.13 128.88 38.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 53.41 111.142 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.615 HG23 ' HA ' ' C' ' 225' ' ' ARG . 22.6 m -125.46 109.01 12.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 70.44 111.111 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.437 ' ND2' ' HB3' ' D' ' 241' ' ' LEU . 0.2 OUTLIER -107.26 135.87 48.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.44 110.856 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.05 123.61 14.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 43.42 110.883 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.63 HG21 HD11 ' D' ' 231' ' ' ILE . 3.5 p -110.27 145.11 17.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.151 -0.477 . . . . 73.45 111.139 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.43 -75.82 0.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 64.41 110.798 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 25.2 m -126.12 134.28 51.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.179 -0.464 . . . . 72.44 111.061 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.877 HG22 HD11 ' D' ' 231' ' ' ILE . 8.7 t -118.64 127.06 75.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.488 . . . . 72.12 111.134 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.91 116.11 43.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 74.24 111.128 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.69 133.77 10.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.722 . . . . 43.24 112.484 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.29 148.01 52.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 73.22 110.902 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.84 85.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.735 -0.745 . . . . 63.43 112.52 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 47.82 73.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 72.34 110.87 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 38.6 t -103.12 145.48 29.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 63.21 110.817 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -119.65 128.49 53.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 61.45 110.899 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.533 ' CG2' HG12 ' C' ' 239' ' ' VAL . 21.8 t -119.55 123.93 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.124 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.621 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -126.18 111.15 14.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 74.01 110.935 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.653 ' CD1' HD13 ' D' ' 241' ' ' LEU . 38.7 mm -112.18 104.05 16.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 51.45 111.165 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.04 -157.53 27.36 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 72.11 112.477 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -114.52 156.12 25.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 65.31 110.855 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.517 ' HG2' HG13 ' D' ' 244' ' ' VAL . 0.0 OUTLIER -126.6 139.29 53.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.08 -0.509 . . . . 72.53 110.877 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -129.19 125.99 38.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.941 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 148.1 153.9 6.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.768 -0.73 . . . . 73.04 112.502 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 283' ' ' GLY . . . . . 0.45 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . -99.01 103.81 2.8 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.717 -0.754 . . . . 74.14 112.526 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -179.41 41.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.877 0.37 . . . . 74.55 110.944 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.66 -135.05 11.98 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.75 -0.738 . . . . 73.35 112.488 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -124.32 -1.85 8.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 63.14 110.866 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.621 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 3.7 t90 -174.29 -65.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 73.3 110.909 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -122.12 -171.34 2.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 75.32 110.932 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -52.56 127.84 24.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 73.2 110.906 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -52.08 139.21 23.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 74.2 110.879 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -163.67 49.5 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 74.41 110.892 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -129.04 -73.67 0.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 70.15 110.869 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.56 126.81 31.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 72.23 110.888 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 71.28 -70.02 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 64.12 110.911 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 64.33 110.813 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.881 0.372 . . . . 65.04 110.909 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -162.2 -177.32 5.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 73.23 110.884 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 6.2 pt -141.9 168.12 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 73.3 111.15 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -172.5 139.07 0.94 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 74.42 110.835 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 221' ' ' ALA . . . . . 0.539 ' HB1' ' HE2' ' E' ' 218' ' ' LYS . . . -174.38 112.52 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 42.2 111.106 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 222' ' ' ILE . . . . . 0.459 HG12 HG12 ' C' ' 223' ' ' VAL . 4.0 mp -139.65 146.99 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 75.03 111.123 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 12.3 p -124.22 147.39 28.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.187 -0.461 . . . . 71.44 111.097 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -144.3 -152.77 5.71 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.753 -0.736 . . . . 54.52 112.436 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -72.5 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.327 . . . . 72.21 110.814 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 226' ' ' ASN . . . . . 0.579 ' HB3' HG22 ' D' ' 277' ' ' ILE . 1.9 m120 -86.53 110.07 19.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 74.5 110.916 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 2.3 t -124.09 138.15 54.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 72.53 110.847 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 228' ' ' ALA . . . . . 0.407 ' HB3' HG23 ' C' ' 264' ' ' VAL . . . -121.41 129.02 52.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 74.04 111.139 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.03 -33.12 51.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 73.54 110.899 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -167.77 136.59 2.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 75.13 110.85 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 231' ' ' ILE . . . . . 0.877 HD11 HG22 ' C' ' 267' ' ' VAL . 4.2 pt -140.41 116.98 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 72.32 111.157 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 232' ' ' ARG . . . . . 0.463 ' HD2' HG22 ' D' ' 268' ' ' VAL . 11.5 ptp180 -131.41 124.65 30.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 74.24 110.823 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 233' ' ' THR . . . . . 0.493 HG21 ' CG1' ' D' ' 239' ' ' VAL . 2.7 p -136.06 143.48 44.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 72.33 111.14 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 17.9 pm0 -142.83 167.7 21.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.25 110.867 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 67.7 78.21 0.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.492 . . . . 71.02 110.893 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 43.92 50.64 7.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 70.41 110.93 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.02 156.1 18.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 63.42 111.137 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.95 155.65 49.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 54.32 110.888 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.564 HG12 ' HB ' ' D' ' 275' ' ' VAL . 17.5 m -141.16 140.06 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 55.32 111.088 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 240' ' ' GLN . . . . . 0.533 ' HB3' HD22 ' D' ' 276' ' ' LEU . 2.0 tt0 -138.1 119.2 14.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 71.14 110.854 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.653 HD13 ' CD1' ' C' ' 277' ' ' ILE . 3.4 mp -118.78 135.19 54.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 51.14 110.913 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.17 -116.9 1.53 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 73.31 112.499 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -143.62 128.79 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.865 0.365 . . . . 70.13 110.882 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 244' ' ' VAL . . . . . 0.517 HG13 ' HG2' ' C' ' 280' ' ' GLU . 0.4 OUTLIER -104.55 115.54 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 65.22 111.109 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 80.5 t -122.03 125.95 73.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 61.44 111.087 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 246' ' ' THR . . . . . 0.511 HG23 ' O ' ' D' ' 281' ' ' TYR . 18.2 p -86.25 174.99 8.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 64.15 111.11 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 247' ' ' ALA . . . . . 0.45 ' HB2' ' N ' ' C' ' 283' ' ' GLY . . . -53.92 -42.62 68.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 64.23 111.123 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.97 -44.94 96.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.433 . . . . 63.44 111.072 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.81 -169.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 74.22 111.063 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 250' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' E' ' 249' ' ' ALA . 0.3 OUTLIER -141.77 -170.67 3.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 51.35 110.896 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -72.61 -175.16 1.57 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.21 -0.45 . . . . 70.41 110.804 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -135.26 -145.96 5.24 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.749 -0.739 . . . . 54.41 112.538 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 169.6 166.62 28.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.787 -0.721 . . . . 62.12 112.492 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 254' ' ' ILE . . . . . 0.726 HG23 HG12 ' D' ' 256' ' ' ILE . 2.2 tt -51.93 146.01 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.847 0.356 . . . . 62.02 111.147 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -77.84 98.74 5.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 41.21 110.857 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 256' ' ' ILE . . . . . 0.726 HG12 HG23 ' D' ' 254' ' ' ILE . 3.1 pt -151.11 168.27 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 64.22 111.13 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.63 99.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 64.33 110.931 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -173.65 102.74 0.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 60.53 110.892 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -176.62 159.88 1.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 64.11 110.952 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 25.8 p -77.34 125.72 29.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.303 -0.408 . . . . 73.51 111.152 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 90.0 m -99.0 109.33 22.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 73.42 111.122 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -108.9 144.6 36.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 61.22 110.923 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.36 136.06 35.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 64.32 110.846 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.836 HG22 HD11 ' E' ' 231' ' ' ILE . 0.9 OUTLIER -120.17 133.83 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 61.43 111.112 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -70.16 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 75.41 110.888 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 87.1 m -150.85 133.64 15.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 73.32 111.14 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.846 HG22 HD12 ' E' ' 231' ' ' ILE . 13.5 t -117.17 129.19 74.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 64.13 111.178 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 268' ' ' VAL . . . . . 0.463 HG22 ' HD2' ' D' ' 232' ' ' ARG . 61.2 t -127.2 115.8 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 63.13 111.107 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.0 133.06 11.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 54.12 112.49 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.31 116.62 18.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 72.32 110.936 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.57 87.66 0.17 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.69 -0.767 . . . . 73.33 112.477 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 52.25 88.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 73.31 110.869 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.37 145.68 50.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 61.21 110.914 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -121.35 128.83 52.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.161 -0.472 . . . . 72.32 110.826 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.564 ' HB ' HG12 ' D' ' 239' ' ' VAL . 21.8 t -116.24 126.6 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 71.35 111.079 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.642 HD23 ' CZ2' ' D' ' 287' ' ' TRP . 0.2 OUTLIER -128.24 111.3 13.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.22 110.98 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.579 HG22 ' HB3' ' D' ' 226' ' ' ASN . 45.8 mm -112.6 104.8 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.158 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 138.02 -176.9 20.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.776 -0.726 . . . . 41.31 112.495 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -91.33 156.17 17.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 75.45 110.849 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -131.66 139.02 48.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 61.11 110.887 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 281' ' ' TYR . . . . . 0.511 ' O ' HG23 ' D' ' 246' ' ' THR . 12.3 m-85 -125.61 125.89 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 72.52 110.836 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 282' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' E' ' 247' ' ' ALA . . . -170.66 -87.69 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 74.44 112.476 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 136.84 -50.68 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.669 -0.777 . . . . 34.35 112.487 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 103.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.325 . . . . 51.2 110.917 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 56.07 -101.51 0.14 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.793 -0.718 . . . . 73.13 112.411 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -175.13 122.44 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.814 0.34 . . . . 72.14 110.925 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 287' ' ' TRP . . . . . 0.642 ' CZ2' HD23 ' D' ' 276' ' ' LEU . 7.7 t90 51.17 32.83 8.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 75.22 110.906 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.19 -171.42 0.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 54.54 110.86 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -110.87 176.75 4.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.13 110.916 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -127.95 99.87 5.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 70.24 110.823 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.45 161.29 1.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 75.25 110.792 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -162.42 -74.11 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 75.4 110.828 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.08 111.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 74.41 110.815 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -177.69 -174.8 0.48 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 72.45 110.907 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 5.2 t60 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 61.24 110.919 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.829 0.347 . . . . 73.43 110.912 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 218' ' ' LYS . . . . . 0.539 ' HE2' ' HB1' ' D' ' 221' ' ' ALA . 0.2 OUTLIER -177.22 142.12 0.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 71.31 110.929 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 8.7 tp -172.85 139.15 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.262 -0.427 . . . . 62.43 111.129 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.0 140.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 72.53 110.851 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -105.35 -68.54 0.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 44.41 111.078 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.65 121.86 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 73.4 111.127 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 223' ' ' VAL . . . . . 0.51 HG12 HH12 ' E' ' 225' ' ' ARG . 6.2 m -140.76 111.04 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 61.22 111.209 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -71.87 -128.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.824 -0.703 . . . . 64.34 112.504 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 225' ' ' ARG . . . . . 0.51 HH12 HG12 ' E' ' 223' ' ' VAL . 0.0 OUTLIER 62.46 -168.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 72.43 110.842 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 226' ' ' ASN . . . . . 0.598 ' HB3' HG22 ' E' ' 277' ' ' ILE . 2.9 m-20 -83.52 109.74 17.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 61.21 110.876 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 3.3 m -131.86 137.62 48.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 53.11 110.845 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -108.25 155.01 20.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 70.32 111.09 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -109.56 -26.03 10.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 74.4 110.902 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 230' ' ' ASP . . . . . 0.688 ' HB2' HG22 ' E' ' 266' ' ' THR . 0.4 OUTLIER -167.88 137.24 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 73.34 110.898 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 231' ' ' ILE . . . . . 0.846 HD12 HG22 ' D' ' 267' ' ' VAL . 0.4 OUTLIER -139.43 115.9 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.31 111.115 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -132.29 118.46 19.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 73.52 110.862 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 233' ' ' THR . . . . . 0.593 HG21 ' CG1' ' E' ' 239' ' ' VAL . 1.3 p -136.21 152.83 51.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 74.35 111.104 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.5 167.29 30.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 75.23 110.896 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 63.75 80.47 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 72.04 110.929 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 45.54 51.81 9.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 74.11 110.825 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 237' ' ' ALA . . . . . 0.405 ' HB1' ' HB ' ' E' ' 233' ' ' THR . . . -104.54 156.66 17.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 65.45 111.196 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -139.16 154.34 48.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 71.42 110.845 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.63 HG12 ' CG2' ' E' ' 275' ' ' VAL . 19.0 m -142.63 135.68 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 74.53 111.119 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -138.52 129.8 27.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 74.12 110.934 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.831 HD22 HG23 ' D' ' 264' ' ' VAL . 5.4 mp -127.51 135.19 50.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 74.3 110.915 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.16 -124.37 2.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.739 -0.743 . . . . 35.43 112.49 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -144.1 128.95 18.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.367 . . . . 75.53 110.93 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 11.0 t -99.91 119.4 47.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 64.2 111.121 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 57.6 t -122.28 112.91 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 74.21 111.131 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 246' ' ' THR . . . . . 0.466 HG23 ' O ' ' E' ' 281' ' ' TYR . 43.9 p -71.92 175.05 6.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 63.04 111.145 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 247' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' D' ' 282' ' ' GLY . . . -63.0 -40.5 97.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 21.13 111.155 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.01 -51.97 67.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 74.52 111.112 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 249' ' ' ALA . . . . . 0.65 ' HB2' HD11 ' D' ' 250' ' ' LEU . . . 51.83 -169.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 72.14 111.125 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 12.6 tp -71.84 -66.7 0.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 65.22 110.876 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -177.2 169.4 2.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 71.54 110.845 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -52.77 111.44 1.65 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 62.01 112.485 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 69.76 138.83 0.12 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.734 -0.746 . . . . 64.32 112.469 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 254' ' ' ILE . . . . . 0.457 HD12 ' H ' ' E' ' 255' ' ' ARG . 6.2 tp -160.89 143.51 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.776 0.322 . . . . 73.11 111.141 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 255' ' ' ARG . . . . . 0.457 ' H ' HD12 ' E' ' 254' ' ' ILE . 4.8 mtm180 -61.7 -170.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.181 -0.463 . . . . 72.54 110.839 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.26 178.6 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 74.44 111.154 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.62 111.35 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 71.31 110.852 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -173.41 127.25 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 62.12 110.849 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -178.19 -36.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.932 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 11.0 p -72.04 137.1 46.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 71.53 111.128 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 98.6 m -121.1 125.68 47.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.2 111.132 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -126.19 125.54 42.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 73.11 110.881 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.24 119.71 35.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 74.42 110.856 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 264' ' ' VAL . . . . . 1.075 HG21 HD12 ' E' ' 277' ' ' ILE . 75.4 t -107.8 115.46 48.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 64.15 111.172 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 265' ' ' GLU . . . . . 0.572 ' CD ' ' N ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -64.6 -133.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 71.12 110.906 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 266' ' ' THR . . . . . 0.688 HG22 ' HB2' ' E' ' 230' ' ' ASP . 7.1 p -94.71 130.03 41.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 71.25 111.139 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 26.4 t -116.47 123.33 71.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 52.03 111.118 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 38.6 t -110.6 118.36 57.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.082 -0.508 . . . . 70.43 111.107 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.81 133.58 11.7 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.715 -0.755 . . . . 71.24 112.563 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.69 116.55 19.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.881 0.372 . . . . 62.32 110.969 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.88 97.74 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.771 -0.728 . . . . 64.34 112.578 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 51.71 89.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 62.44 110.887 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 31.3 t -124.87 146.54 49.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 70.12 110.868 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -127.19 128.69 46.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 74.04 110.895 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.63 ' CG2' HG12 ' E' ' 239' ' ' VAL . 21.9 t -114.89 122.88 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 61.52 111.159 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.647 HD23 ' CZ2' ' E' ' 287' ' ' TRP . 0.1 OUTLIER -129.16 110.75 12.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.261 -0.427 . . . . 55.43 110.948 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 1.075 HD12 HG21 ' E' ' 264' ' ' VAL . 26.7 mm -113.76 104.87 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.45 111.088 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.92 -161.8 27.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 73.25 112.513 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.22 156.28 26.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 54.44 110.851 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.77 147.26 44.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 73.22 110.882 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 281' ' ' TYR . . . . . 0.466 ' O ' HG23 ' E' ' 246' ' ' THR . 17.8 m-85 -130.09 125.81 36.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 75.2 110.905 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 163.5 167.03 23.34 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.739 -0.743 . . . . 63.14 112.478 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -67.79 -138.01 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.698 -0.763 . . . . 64.23 112.506 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -51.71 140.48 18.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 74.45 110.934 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 108.49 86.22 1.78 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 72.22 112.53 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -51.82 -35.08 43.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.349 . . . . 72.33 110.883 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 287' ' ' TRP . . . . . 0.647 ' CZ2' HD23 ' E' ' 276' ' ' LEU . 14.8 t90 -176.14 -44.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 74.24 110.886 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -127.15 160.57 30.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 73.31 110.845 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -127.17 -170.19 2.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 71.32 110.942 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -152.46 113.48 4.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 65.32 110.826 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -178.15 129.66 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.13 110.823 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -150.97 25.92 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 74.32 110.794 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 52.51 88.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.866 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.24 -169.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 64.23 110.874 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 72.12 110.846 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 29.0 ttm . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.861 0.363 . . . . 75.32 110.954 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -179.23 -35.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 71.44 110.899 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.1 tt -51.78 150.94 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 62.43 111.137 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -95.89 26.32 4.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.487 . . . . 74.41 110.862 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -151.75 98.81 2.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 55.51 111.05 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 9.2 tt -159.22 150.95 6.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 53.11 111.162 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.91 153.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 53.54 111.14 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 106.62 106.01 3.08 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 54.32 112.44 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.508 ' H ' HG23 ' A' ' 261' ' ' THR . 21.3 ptt180 -179.55 146.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.804 0.335 . . . . 53.4 110.869 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -83.93 119.51 24.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.903 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.97 137.98 53.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 72.2 110.808 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.53 141.11 46.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 55.11 111.104 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -97.36 -35.64 10.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 63.2 110.87 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.461 ' HB3' HG23 ' A' ' 266' ' ' THR . 7.2 t0 -164.33 138.96 5.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.299 -0.41 . . . . 73.23 110.864 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.456 HD13 HD21 ' A' ' 241' ' ' LEU . 11.0 mt -137.61 117.79 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.11 111.069 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.68 120.28 24.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 71.43 110.819 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.32 146.9 48.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 71.51 111.111 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -148.89 167.09 26.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 71.12 110.939 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 66.82 56.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 65.11 110.954 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 14.9 mtm-85 50.41 64.65 1.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.856 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 156.25 18.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 45.1 111.132 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -129.33 135.68 49.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 74.51 110.884 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.462 HG12 ' HB ' ' A' ' 275' ' ' VAL . 20.4 m -139.73 130.13 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 63.21 111.146 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -122.24 132.73 54.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 72.02 110.905 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.456 HD21 HD13 ' A' ' 231' ' ' ILE . 0.7 OUTLIER -130.43 135.1 47.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 53.41 110.862 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.54 -130.92 6.32 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.805 -0.712 . . . . 50.53 112.539 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -144.56 128.89 17.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.866 0.365 . . . . 64.42 110.899 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' A' ' 280' ' ' GLU . 27.0 m -110.26 126.15 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 71.5 111.129 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.2 m -122.47 129.11 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 64.12 111.063 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 281' ' ' TYR . 34.9 p -71.74 174.65 6.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 71.34 111.154 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.61 80.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 62.42 111.09 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.99 -35.92 69.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 73.12 111.168 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.71 -29.95 20.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 33.44 111.102 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.18 85.38 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 73.05 110.945 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -178.2 34.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 73.1 110.888 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 65.65 -167.42 33.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.759 -0.734 . . . . 75.13 112.451 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -168.67 -75.97 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.683 -0.77 . . . . 74.14 112.426 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 29.2 mm 63.25 72.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.343 . . . . 55.13 111.193 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.51 140.74 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 72.03 110.869 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 11.5 tt -66.78 131.05 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 74.24 111.133 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.5 p -179.33 -35.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 62.51 110.84 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.19 107.58 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 73.11 110.88 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -178.04 34.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.231 -0.441 . . . . 60.14 110.927 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 21.7 p -100.32 121.97 42.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 73.14 111.125 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.508 HG23 ' H ' ' A' ' 225' ' ' ARG . 0.9 OUTLIER -129.78 108.87 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 71.24 111.136 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -101.86 129.05 48.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 74.24 110.92 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 34.7 m -140.44 123.81 16.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 65.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.578 HG21 HG22 ' A' ' 267' ' ' VAL . 8.6 p -120.28 136.7 56.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 73.3 111.109 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -78.65 -76.13 0.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 70.14 110.809 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 230' ' ' ASP . 3.1 m -127.04 130.6 50.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 70.14 111.131 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.578 HG22 HG21 ' A' ' 264' ' ' VAL . 21.6 t -118.2 125.01 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 64.13 111.116 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.25 122.2 63.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 74.45 111.073 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.17 133.76 9.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 43.54 112.478 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.97 147.89 52.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.372 . . . . 73.2 110.889 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.13 78.61 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.688 -0.768 . . . . 71.22 112.449 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 47.28 63.71 1.86 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.855 0.36 . . . . 72.3 110.887 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 46.3 t -90.25 145.66 24.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 54.35 110.815 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.18 128.04 44.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 71.44 110.841 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.738 HG13 HG23 ' B' ' 239' ' ' VAL . 17.4 t -134.54 123.74 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 64.42 111.114 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.69 111.56 18.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 64.32 110.809 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.404 HD13 HD23 ' A' ' 241' ' ' LEU . 2.1 mp -111.61 104.82 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 65.55 111.155 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.06 -161.17 29.86 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 74.35 112.469 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -120.15 150.24 40.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.783 0.325 . . . . 71.02 110.881 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.5 ' HG2' HG12 ' B' ' 244' ' ' VAL . 7.3 pt-20 -124.21 128.6 49.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.894 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.452 ' O ' HG23 ' A' ' 246' ' ' THR . 0.1 OUTLIER -110.05 125.8 53.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.105 -0.498 . . . . 73.21 110.926 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 125.06 159.8 10.49 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.721 -0.752 . . . . 40.23 112.561 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.613 ' H ' ' HB2' ' B' ' 247' ' ' ALA . . . -108.82 -8.3 28.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.711 -0.757 . . . . 74.22 112.514 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -77.32 60.58 2.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.874 0.369 . . . . 71.43 110.892 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.33 97.39 2.46 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.722 -0.751 . . . . 32.13 112.533 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' B' ' 244' ' ' VAL . 0.1 OUTLIER -51.85 -68.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 74.53 110.819 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -142.25 -69.66 0.35 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 71.23 110.956 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -104.38 -169.83 1.68 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 73.1 110.91 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -55.09 174.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 74.51 110.87 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.09 179.36 6.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 63.52 110.805 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 7.2 m80 59.97 174.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 72.0 110.822 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 63.19 101.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 70.15 110.866 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -112.49 -170.22 1.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 62.24 110.886 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.96 -72.69 0.57 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 52.42 110.859 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 74.12 110.928 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.807 0.337 . . . . 62.34 110.908 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.17 -40.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 52.35 110.903 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.89 124.58 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.291 -0.413 . . . . 61.12 111.082 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.18 117.35 0.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 53.1 110.881 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -155.82 173.72 16.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 75.32 111.16 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 64.6 mt -70.1 138.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 72.51 111.127 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.437 HG11 ' O ' ' C' ' 223' ' ' VAL . 21.9 t -128.9 135.31 62.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 74.33 111.187 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 172.76 113.29 0.3 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.697 -0.763 . . . . 62.2 112.419 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.535 ' H ' HG23 ' B' ' 261' ' ' THR . 1.6 ptp180 -179.49 148.83 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.892 0.377 . . . . 72.15 110.876 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -90.65 121.44 32.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 74.1 110.86 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 47.6 t -130.14 138.04 50.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 43.42 110.875 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.27 161.91 30.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 73.32 111.099 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.7 -31.91 5.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 52.23 110.904 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -164.39 138.79 5.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 24.35 110.911 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 12.9 mt -137.66 119.1 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 65.3 111.152 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 -131.71 119.15 20.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 74.4 110.899 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.1 OUTLIER -134.59 140.71 46.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 52.11 111.189 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -144.67 167.57 22.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 64.44 110.855 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 61.86 63.37 1.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.086 -0.506 . . . . 72.15 110.959 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 47.99 61.05 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 72.21 110.878 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.419 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -104.57 153.29 21.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 64.14 111.113 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 8.3 mtt-85 -129.19 135.6 49.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 75.11 110.863 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.738 HG23 HG13 ' A' ' 275' ' ' VAL . 24.2 m -140.69 123.91 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 73.31 111.137 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.614 ' HB3' HD22 ' B' ' 276' ' ' LEU . 0.1 OUTLIER -118.52 137.2 53.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 64.21 110.974 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.827 HD23 HD13 ' B' ' 277' ' ' ILE . 0.6 OUTLIER -130.06 118.89 22.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 71.45 110.851 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.27 173.7 13.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.704 -0.76 . . . . 71.11 112.477 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -87.8 137.99 31.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 43.13 110.908 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.5 HG12 ' HG2' ' A' ' 280' ' ' GLU . 30.6 m -120.68 125.68 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 64.11 111.132 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.48 129.2 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.31 111.142 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.7 t -71.55 175.1 5.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 72.44 111.149 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.613 ' HB2' ' H ' ' A' ' 283' ' ' GLY . . . -60.41 -40.57 91.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 71.42 111.165 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.02 -36.37 70.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 51.34 111.11 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.623 ' HB2' ' CD1' ' B' ' 281' ' ' TYR . . . -52.33 -29.83 25.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.199 -0.455 . . . . 65.41 111.129 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.92 57.55 3.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 62.34 110.963 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -117.22 -67.24 1.01 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 71.11 110.86 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -144.08 -145.01 4.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.736 -0.745 . . . . 74.21 112.468 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -173.93 104.53 0.2 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.778 -0.725 . . . . 52.23 112.503 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 28.2 mm -83.06 148.9 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 62.24 111.161 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 255' ' ' ARG . . . . . 0.618 ' O ' HD13 ' B' ' 256' ' ' ILE . 11.1 ttp85 -71.52 82.67 0.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 71.12 110.865 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 256' ' ' ILE . . . . . 0.618 HD13 ' O ' ' B' ' 255' ' ' ARG . 27.0 mm -134.21 149.41 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 63.14 111.1 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 62.2 p -66.07 106.41 1.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.838 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -114.58 77.29 1.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 74.53 110.911 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -114.19 79.69 1.29 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 71.41 110.828 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 30.5 p -100.53 121.99 42.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 72.13 111.196 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.535 HG23 ' H ' ' B' ' 225' ' ' ARG . 0.7 OUTLIER -129.33 133.73 47.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 64.03 111.171 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -125.85 130.01 50.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 62.43 110.905 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.27 123.8 20.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 70.13 110.846 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.502 HG21 ' CG2' ' B' ' 267' ' ' VAL . 13.5 p -119.26 133.18 66.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 60.53 111.109 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.12 -74.97 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.837 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 97.3 m -135.44 133.71 38.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 43.33 111.13 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.502 ' CG2' HG21 ' B' ' 264' ' ' VAL . 21.7 t -118.25 125.88 74.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 63.43 111.099 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 63.4 t -127.31 125.43 65.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 55.04 111.097 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.5 133.82 8.05 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.725 -0.75 . . . . 65.34 112.48 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -130.98 147.62 52.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.816 0.341 . . . . 62.54 110.906 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.43 64.64 3.25 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.83 -0.7 . . . . 62.42 112.439 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.03 96.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.872 0.367 . . . . 71.41 110.874 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 65.1 m -125.36 145.82 49.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 74.24 110.859 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -127.22 127.51 44.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 61.01 110.799 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.674 HG13 HG23 ' C' ' 239' ' ' VAL . 19.3 t -134.6 123.41 41.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 63.34 111.148 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.614 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.2 OUTLIER -118.64 113.39 21.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.252 -0.431 . . . . 61.14 110.922 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.827 HD13 HD23 ' B' ' 241' ' ' LEU . 2.6 mp -110.07 127.11 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 64.12 111.036 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 127.33 -164.46 20.81 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.691 -0.766 . . . . 74.24 112.468 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -115.05 148.46 38.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 73.33 110.871 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.552 ' CG ' HG12 ' C' ' 244' ' ' VAL . 0.9 OUTLIER -119.72 131.38 55.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 62.01 110.904 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.623 ' CD1' ' HB2' ' B' ' 249' ' ' ALA . 26.1 t80 -116.87 125.99 52.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.959 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 129.58 -175.3 19.07 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.727 . . . . 73.11 112.514 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -136.39 51.44 0.81 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.785 -0.722 . . . . 72.15 112.494 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -98.5 25.98 5.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.342 . . . . 72.35 110.914 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 109.9 18.09 9.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.794 -0.717 . . . . 73.41 112.516 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' C' ' 244' ' ' VAL . 0.2 OUTLIER 69.35 -75.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.938 0.399 . . . . 62.23 110.868 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -141.95 -73.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.5 . . . . 74.3 110.868 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.66 -172.08 3.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 74.45 110.846 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -83.75 -64.59 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 71.5 110.88 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -121.84 -175.66 3.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 72.55 110.886 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -178.87 -176.86 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 64.13 110.874 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 19.7 t60 63.02 163.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 71.03 110.838 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -166.92 159.05 13.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 74.01 110.857 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -53.26 167.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 74.22 110.872 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 72.23 110.914 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 4.1 mtm . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.837 0.351 . . . . 75.34 110.89 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -105.74 86.19 2.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.903 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 3.2 mt -124.56 139.65 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 70.31 111.101 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -95.0 44.33 1.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 64.21 110.899 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -168.67 76.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 73.14 111.066 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 31.9 mm -104.58 83.79 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 61.42 111.186 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 223' ' ' VAL . . . . . 0.437 ' O ' HG11 ' B' ' 223' ' ' VAL . 6.6 p -51.68 122.63 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 64.15 111.169 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -146.2 -107.97 0.54 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.728 -0.748 . . . . 65.32 112.471 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.24 -57.57 0.9 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.781 0.324 . . . . 72.44 110.883 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -92.15 110.03 21.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 60.23 110.855 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 72.7 m -136.75 139.52 41.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 63.5 110.898 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.84 159.67 31.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 63.45 111.119 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -112.82 -29.28 7.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 74.21 110.921 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.7 138.09 4.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 72.34 110.867 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 9.6 mt -137.88 117.77 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 75.2 111.107 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -133.48 118.98 18.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.475 . . . . 74.43 110.926 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.1 OUTLIER -133.21 146.4 51.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 74.45 111.118 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -150.18 167.15 27.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 75.44 110.911 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.38 64.56 1.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 74.35 110.853 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 47.87 60.26 3.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 65.12 110.846 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.445 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -104.21 150.58 24.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 64.43 111.077 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 35.1 mtt85 -126.07 135.38 51.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 72.15 110.875 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.674 HG23 HG13 ' B' ' 275' ' ' VAL . 17.0 m -139.52 121.57 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 72.4 111.175 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.87 137.13 52.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.51 110.952 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 mp -127.49 118.69 24.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 64.42 110.982 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 134.83 -179.99 17.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.777 -0.725 . . . . 32.51 112.496 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -92.11 135.81 33.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 73.03 110.946 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.552 HG12 ' CG ' ' B' ' 280' ' ' GLU . 14.6 m -116.37 126.11 73.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 71.12 111.128 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.425 HG23 ' HA ' ' B' ' 281' ' ' TYR . 32.8 m -117.83 129.55 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 70.11 111.163 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 246' ' ' THR . . . . . 0.73 HG22 ' CD2' ' C' ' 281' ' ' TYR . 11.7 t -69.05 171.13 8.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 72.54 111.178 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.7 -33.79 49.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 41.42 111.123 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 248' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' C' ' 251' ' ' HIS . . . -56.59 -35.82 68.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 75.04 111.143 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 249' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' C' ' 248' ' ' ALA . . . 69.21 -76.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 70.2 111.109 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.8 mt -119.94 -34.72 3.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 75.11 110.939 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 251' ' ' HIS . . . . . 0.606 ' HB2' ' HB1' ' C' ' 248' ' ' ALA . 9.9 t-80 52.04 78.08 0.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 72.45 110.904 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 129.79 174.82 13.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.67 -0.776 . . . . 71.03 112.49 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -102.79 19.35 47.45 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.818 -0.706 . . . . 74.34 112.537 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.42 178.63 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.869 0.366 . . . . 74.34 111.111 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -132.73 141.9 48.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 71.42 110.89 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 12.6 pt -127.08 151.25 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 53.32 111.144 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -157.18 50.54 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.33 110.903 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.88 148.52 30.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 71.52 110.889 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.27 109.95 20.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 53.04 110.919 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 30.8 p -97.83 129.29 44.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 74.4 111.118 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.637 HG23 ' HB3' ' D' ' 225' ' ' ARG . 0.3 OUTLIER -133.27 124.99 28.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 74.35 111.179 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -126.23 127.11 45.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 60.33 110.853 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.51 123.23 33.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 62.14 110.83 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' D' ' 231' ' ' ILE . 10.5 p -109.48 144.34 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 75.42 111.096 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.68 -65.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 71.53 110.893 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 30.5 p -147.01 138.36 24.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 64.4 111.216 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.502 ' CG1' HG21 ' C' ' 275' ' ' VAL . 23.3 t -117.61 124.93 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 63.54 111.144 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.66 116.02 41.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 72.42 111.117 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.41 133.01 9.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 64.32 112.475 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -132.44 141.27 48.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 75.14 110.866 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.99 68.67 1.39 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 74.22 112.478 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.83 93.72 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.789 0.328 . . . . 72.53 110.964 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 34.3 t -126.06 145.63 50.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 75.05 110.903 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 13.2 mtm-85 -129.55 127.87 41.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 71.43 110.825 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.646 HG22 ' CG2' ' D' ' 239' ' ' VAL . 17.7 t -137.63 131.54 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 74.32 111.16 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.671 HD12 ' CD1' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -128.36 111.66 13.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 64.22 110.947 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 2.6 mp -106.55 104.73 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 74.21 111.124 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.93 -179.88 23.53 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.763 -0.732 . . . . 64.4 112.471 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -89.74 156.11 18.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 75.11 110.887 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.538 ' HG3' HG12 ' D' ' 244' ' ' VAL . 2.6 pp20? -136.36 143.3 43.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 74.5 110.926 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.73 ' CD2' HG22 ' C' ' 246' ' ' THR . 63.3 t80 -130.02 125.46 35.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.42 110.916 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 149.41 116.87 0.84 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 72.21 112.456 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 283' ' ' GLY . . . . . 0.527 ' H ' ' HB2' ' D' ' 247' ' ' ALA . . . -62.82 -32.78 84.94 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.686 -0.768 . . . . 62.25 112.508 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -73.44 78.19 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.86 0.362 . . . . 64.34 110.912 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 73.77 104.78 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 72.24 112.458 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -58.23 -29.3 65.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 71.43 110.907 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.671 ' CD1' HD12 ' C' ' 276' ' ' LEU . 17.4 t90 -164.13 -41.77 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.142 -0.481 . . . . 74.21 110.983 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -129.48 -66.71 0.79 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 74.35 110.897 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 1.6 t30 62.91 163.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 60.32 110.889 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -174.42 37.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.42 110.876 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -80.75 100.36 8.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 71.23 110.891 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -174.4 114.1 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 73.31 110.862 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.8 -175.35 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 72.23 110.909 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -93.1 106.9 18.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 71.22 110.87 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.195 -0.457 . . . . 72.43 110.9 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.844 0.354 . . . . 75.44 110.854 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -59.59 160.14 7.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 72.04 110.824 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 219' ' ' ILE . . . . . 0.461 HD13 ' N ' ' D' ' 220' ' ' ASP . 0.0 OUTLIER -173.47 145.48 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 70.43 111.168 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 220' ' ' ASP . . . . . 0.461 ' N ' HD13 ' D' ' 219' ' ' ILE . 0.2 OUTLIER -171.26 174.25 4.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.945 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 221' ' ' ALA . . . . . 0.509 ' CB ' HD12 ' D' ' 222' ' ' ILE . . . -151.8 168.01 26.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.286 -0.415 . . . . 75.44 111.066 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 222' ' ' ILE . . . . . 0.509 HD12 ' CB ' ' D' ' 221' ' ' ALA . 4.8 mp 61.26 90.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 72.01 111.166 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 13.8 p -65.8 145.71 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 63.13 111.167 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 130.99 -144.79 16.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.681 -0.771 . . . . 70.43 112.502 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.637 ' HB3' HG23 ' C' ' 261' ' ' THR . 0.4 OUTLIER 62.67 -168.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.814 0.34 . . . . 73.42 110.861 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -82.91 110.57 18.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 73.31 110.865 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 27.0 m -139.74 147.59 41.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 74.12 110.843 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.17 162.36 24.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 64.0 111.099 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.72 -30.79 5.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 65.3 110.918 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.37 139.15 3.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 70.12 110.874 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 231' ' ' ILE . . . . . 0.423 ' CD1' HG23 ' C' ' 264' ' ' VAL . 14.3 mt -137.76 116.37 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 62.04 111.112 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.0 117.86 15.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 65.3 110.931 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.7 152.27 51.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 74.2 111.165 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -156.62 167.12 31.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 64.25 110.899 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 64.93 66.27 0.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 75.14 110.828 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? 50.24 45.21 26.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 71.02 110.921 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.6 151.53 20.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 72.42 111.084 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 35.0 mtt85 -132.39 135.59 46.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 74.35 110.845 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.646 ' CG2' HG22 ' C' ' 275' ' ' VAL . 0.4 OUTLIER -133.51 121.49 41.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 75.33 111.165 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 240' ' ' GLN . . . . . 0.523 ' O ' HD22 ' D' ' 241' ' ' LEU . 0.1 OUTLIER -108.44 135.47 49.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 53.33 110.958 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.55 HD21 HD12 ' D' ' 277' ' ' ILE . 3.5 mm? -126.46 118.59 25.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 72.11 110.872 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 123.05 175.0 14.42 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.792 -0.718 . . . . 33.24 112.468 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.66 144.79 25.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 73.21 110.904 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 244' ' ' VAL . . . . . 0.538 HG12 ' HG3' ' C' ' 280' ' ' GLU . 34.9 m -118.14 134.82 60.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 64.42 111.139 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 2.5 m -117.44 130.33 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 72.45 111.169 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 246' ' ' THR . . . . . 0.418 HG21 ' HA2' ' D' ' 282' ' ' GLY . 14.2 t -68.52 174.68 3.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 74.12 111.103 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 247' ' ' ALA . . . . . 0.527 ' HB2' ' H ' ' C' ' 283' ' ' GLY . . . -52.86 -36.63 59.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 75.11 111.019 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 248' ' ' ALA . . . . . 0.403 ' H ' HG23 ' D' ' 246' ' ' THR . . . -56.07 -35.46 67.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.21 111.14 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 249' ' ' ALA . . . . . 0.591 ' HB2' ' HE1' ' C' ' 281' ' ' TYR . . . 64.39 158.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 75.43 111.108 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.73 166.03 18.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 61.2 110.865 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -179.27 120.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 71.32 110.887 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 153.13 176.41 25.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.779 -0.724 . . . . 74.34 112.484 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 145.94 120.03 1.26 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.714 -0.755 . . . . 54.34 112.497 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 62.5 mt -147.68 -72.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 73.55 111.115 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -133.35 -74.34 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 75.41 110.911 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 10.3 tp -52.09 145.9 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 74.5 111.148 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.33 -178.09 1.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 71.52 110.873 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.77 110.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 75.1 110.871 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.36 135.19 55.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.981 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 77.4 p -95.03 124.84 39.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 72.44 111.121 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 261' ' ' THR . . . . . 0.558 HG23 ' N ' ' D' ' 225' ' ' ARG . 68.8 m -132.63 118.13 18.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 72.14 111.105 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 262' ' ' ASN . . . . . 0.51 HD21 HG23 ' D' ' 277' ' ' ILE . 1.8 t-20 -124.6 126.6 46.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 44.42 110.881 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.66 122.91 29.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 61.32 110.808 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.545 HG23 HD13 ' E' ' 231' ' ' ILE . 9.3 p -114.36 144.15 22.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 60.14 111.128 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 265' ' ' GLU . . . . . 0.445 ' HG3' ' HA ' ' E' ' 229' ' ' LYS . 12.8 mt-10 -86.61 -83.13 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 73.23 110.85 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.59 137.89 47.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 72.53 111.108 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.494 HG21 HD11 ' D' ' 277' ' ' ILE . 99.0 t -117.38 119.74 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 65.51 111.124 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.07 121.65 67.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 65.01 111.086 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.94 133.3 9.31 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.731 -0.747 . . . . 75.22 112.495 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.27 143.72 50.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 74.21 110.828 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 45.41 85.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 71.02 112.434 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 49.93 78.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.371 . . . . 61.02 110.863 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.88 144.67 36.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 52.12 110.879 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -132.78 126.24 31.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 74.14 110.897 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.823 HG13 HG23 ' E' ' 239' ' ' VAL . 44.9 t -139.12 123.24 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 72.42 111.094 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.735 HD12 ' CD1' ' D' ' 287' ' ' TRP . 0.5 OUTLIER -114.53 110.55 19.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 54.31 110.938 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.55 HD12 HD21 ' D' ' 241' ' ' LEU . 10.0 mt -104.83 107.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 72.44 111.133 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.21 173.63 15.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 71.31 112.516 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -93.46 137.09 33.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 75.54 110.897 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.86 141.56 45.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.896 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 281' ' ' TYR . . . . . 0.413 ' CE2' HG22 ' D' ' 246' ' ' THR . 3.0 t80 -130.28 124.73 33.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.943 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 282' ' ' GLY . . . . . 0.418 ' HA2' HG21 ' D' ' 246' ' ' THR . . . 166.9 37.61 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.747 . . . . 75.54 112.452 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 50.31 -132.06 29.73 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.74 -0.743 . . . . 63.2 112.515 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -29.35 22.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.802 0.334 . . . . 71.21 110.873 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -58.96 97.12 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.75 -0.738 . . . . 71.23 112.52 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 286' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' E' ' 244' ' ' VAL . 0.2 OUTLIER -100.0 -176.43 3.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.938 0.399 . . . . 60.21 110.829 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 287' ' ' TRP . . . . . 0.735 ' CD1' HD12 ' D' ' 276' ' ' LEU . 15.6 t90 -61.92 -59.21 5.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 62.32 110.902 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.14 170.07 23.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 63.52 110.905 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -140.87 146.46 37.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 70.5 110.89 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.49 155.86 26.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 64.01 110.868 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -157.41 70.84 0.62 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.255 -0.429 . . . . 75.44 110.774 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.78 166.96 21.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 54.14 110.812 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -159.29 138.65 11.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 74.02 110.841 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -113.69 161.39 17.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.84 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 72.52 110.821 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 2.1 ptp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.86 0.362 . . . . 72.13 110.894 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -148.47 -173.34 4.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 72.55 110.924 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 2.1 mp 63.73 93.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 64.24 111.179 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.65 -174.75 0.39 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 73.33 110.893 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 221' ' ' ALA . . . . . 0.651 ' O ' HD13 ' E' ' 222' ' ' ILE . . . -167.94 80.5 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 73.13 111.066 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 222' ' ' ILE . . . . . 0.671 HG22 ' CG2' ' E' ' 223' ' ' VAL . 21.1 mm -136.55 144.57 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 51.25 111.127 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 223' ' ' VAL . . . . . 0.671 ' CG2' HG22 ' E' ' 222' ' ' ILE . 0.2 OUTLIER 49.62 -168.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 75.43 111.13 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 224' ' ' GLY . . . . . 0.444 ' H ' HG12 ' E' ' 223' ' ' VAL . . . -148.59 120.04 1.14 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 63.02 112.546 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 225' ' ' ARG . . . . . 0.406 ' O ' ' HB3' ' E' ' 262' ' ' ASN . 2.4 ttp180 -63.21 -160.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.777 0.322 . . . . 75.43 110.873 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -145.19 104.16 3.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 72.11 110.858 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.25 143.59 44.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 25.44 110.871 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.99 164.55 19.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 40.35 111.103 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 229' ' ' LYS . . . . . 0.445 ' HA ' ' HG3' ' D' ' 265' ' ' GLU . 0.9 OUTLIER -119.2 -36.39 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 74.53 110.914 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.26 138.62 3.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 62.12 110.856 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 231' ' ' ILE . . . . . 0.545 HD13 HG23 ' D' ' 264' ' ' VAL . 3.1 mp -137.81 113.54 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 72.41 111.139 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 232' ' ' ARG . . . . . 0.4 ' HG3' ' HA ' ' E' ' 268' ' ' VAL . 8.4 ptm180 -137.85 114.69 10.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 72.12 110.889 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.67 150.78 45.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 74.31 111.135 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -156.16 160.28 39.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.816 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 65.44 68.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 62.23 110.906 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 48.83 54.14 11.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.925 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.89 149.08 26.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 70.41 111.083 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -130.47 135.57 48.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 74.24 110.86 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.823 HG23 HG13 ' D' ' 275' ' ' VAL . 31.9 m -139.86 129.11 28.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 75.32 111.192 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 240' ' ' GLN . . . . . 0.65 ' O ' HD13 ' E' ' 241' ' ' LEU . 0.0 OUTLIER -119.95 137.59 53.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 70.12 110.952 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.961 HD12 HD12 ' E' ' 277' ' ' ILE . 0.9 OUTLIER -122.66 118.91 29.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 71.31 110.869 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 125.85 174.17 13.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.726 -0.749 . . . . 74.43 112.509 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -100.7 163.03 12.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.902 0.382 . . . . 72.03 110.89 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' D' ' 286' ' ' PHE . 2.6 m -121.88 140.47 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 61.32 111.084 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.81 127.99 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 64.12 111.124 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 246' ' ' THR . . . . . 0.487 HG21 ' HA2' ' E' ' 282' ' ' GLY . 10.7 t -69.17 168.78 13.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 75.32 111.152 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.01 -33.9 53.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 71.51 111.088 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.2 -50.12 73.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 73.2 111.133 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 53.48 -173.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 61.05 111.131 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 250' ' ' LEU . . . . . 0.488 HD13 ' H ' ' E' ' 251' ' ' HIS . 0.2 OUTLIER -152.58 153.08 32.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 64.2 110.886 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 251' ' ' HIS . . . . . 0.488 ' H ' HD13 ' E' ' 250' ' ' LEU . 22.7 m80 -51.54 133.13 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 73.31 110.906 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -115.5 -161.61 13.09 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.757 -0.735 . . . . 61.01 112.553 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 111.52 90.49 1.97 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 62.43 112.519 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 19.5 tt -157.04 150.65 9.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 72.43 111.123 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.99 -74.71 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 73.24 110.811 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 14.5 pt -150.33 -177.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 73.23 111.117 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.9 145.62 1.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 72.25 110.773 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -120.63 43.88 2.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 70.43 110.875 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.21 -19.66 10.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 62.31 110.903 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.55 120.14 39.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.24 111.199 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.46 107.54 5.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 74.23 111.083 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 262' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' E' ' 225' ' ' ARG . 3.7 t-20 -129.15 116.42 19.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 61.0 110.891 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 3.1 p -119.7 123.87 44.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 70.41 110.79 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 264' ' ' VAL . . . . . 0.966 HG21 HD13 ' E' ' 277' ' ' ILE . 1.0 OUTLIER -104.75 137.17 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 64.13 111.163 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 265' ' ' GLU . . . . . 0.417 ' N ' ' CD ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -74.1 -146.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 34.54 110.912 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 4.1 t -96.56 137.61 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 65.2 111.171 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 267' ' ' VAL . . . . . 0.751 ' CG1' HG21 ' E' ' 275' ' ' VAL . 95.9 t -115.01 121.64 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 64.14 111.159 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 268' ' ' VAL . . . . . 0.422 ' O ' HG13 ' E' ' 268' ' ' VAL . 5.7 p -120.96 120.16 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 72.32 111.108 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.36 133.36 11.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.792 -0.718 . . . . 63.11 112.47 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -131.38 116.45 17.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.338 . . . . 72.41 110.907 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 65.67 80.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 71.42 112.517 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 58.66 88.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 73.2 110.92 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 8.9 t -121.29 145.61 47.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 62.22 110.842 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.5 128.05 34.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 73.45 110.858 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.751 HG21 ' CG1' ' E' ' 267' ' ' VAL . 41.7 t -136.97 123.5 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 50.21 111.142 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.592 HD22 ' HB3' ' E' ' 240' ' ' GLN . 0.8 OUTLIER -121.25 110.93 16.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 72.31 110.994 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.966 HD13 HG21 ' E' ' 264' ' ' VAL . 54.1 mt -107.89 137.53 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 75.45 111.096 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 121.31 -161.57 15.34 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.731 -0.747 . . . . 64.24 112.467 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -128.47 156.96 42.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 71.31 110.857 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.03 118.24 31.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 63.42 110.871 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -103.72 124.77 49.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 65.3 110.917 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 282' ' ' GLY . . . . . 0.487 ' HA2' HG21 ' E' ' 246' ' ' THR . . . 149.19 178.43 24.21 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.785 -0.722 . . . . 50.02 112.529 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -105.8 129.47 9.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.739 -0.743 . . . . 71.11 112.447 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 11.5 mtmm 50.8 67.9 0.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 73.45 110.918 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -151.87 40.09 0.76 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.706 -0.759 . . . . 51.11 112.507 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -51.47 146.23 7.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 55.33 110.849 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -50.48 -57.14 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 74.21 110.912 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -65.13 99.32 0.36 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 54.44 110.889 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -131.08 91.1 2.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 73.21 110.927 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -164.47 162.92 22.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 70.44 110.81 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -52.15 129.8 28.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 71.02 110.881 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -101.78 -27.38 13.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 74.21 110.829 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 59.54 -170.09 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 63.5 110.892 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -52.57 110.51 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 72.42 110.906 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.469 . . . . 70.54 110.825 -179.932 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.828 0.347 . . . . 74.4 110.901 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.16 -170.07 0.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 54.1 110.91 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.74 179.59 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 63.52 111.149 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.77 179.19 9.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 62.14 110.896 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -79.82 114.95 19.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 65.15 111.077 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.9 mp -113.39 -26.6 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 72.52 111.129 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 6.8 m -55.57 159.58 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 53.35 111.083 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 87.24 73.6 1.28 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.724 -0.751 . . . . 31.13 112.532 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.428 ' H ' HG23 ' A' ' 261' ' ' THR . 15.2 ptt180 -163.25 160.69 24.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 53.32 110.921 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -107.01 122.81 47.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 64.45 110.884 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 68.7 m -121.85 138.03 54.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 71.32 110.833 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.65 121.01 13.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 74.3 111.068 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.04 -35.95 23.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.235 -0.439 . . . . 63.45 110.913 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -164.17 139.19 5.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 75.44 110.926 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 10.1 mt -137.46 117.72 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.4 111.078 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -127.39 119.97 27.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 63.24 110.87 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.58 148.66 52.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 63.15 111.179 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -148.73 167.55 25.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 73.43 110.863 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 66.5 55.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 73.41 110.854 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.96 64.38 1.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 64.43 110.913 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.19 156.34 17.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 62.15 111.061 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -129.4 135.83 49.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.33 110.878 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.485 HG12 ' HB ' ' A' ' 275' ' ' VAL . 34.4 m -143.16 130.17 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 64.41 111.11 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.581 ' OE1' HD21 ' A' ' 276' ' ' LEU . 1.8 tt0 -131.06 137.19 49.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 75.54 110.9 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.702 ' CD2' HD13 ' A' ' 277' ' ' ILE . 0.7 OUTLIER -126.93 118.8 25.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 75.2 110.925 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 154.02 175.16 24.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.72 . . . . 71.43 112.599 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -85.88 131.15 34.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.936 0.398 . . . . 65.21 110.874 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 29.5 t -110.34 124.24 66.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 62.44 111.152 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 49.2 t -118.84 113.01 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 74.41 111.068 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.94 168.29 15.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.098 -0.501 . . . . 64.15 111.193 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.06 -36.69 84.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 74.12 111.083 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.1 -39.8 75.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 74.14 111.133 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.76 -30.82 24.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 65.43 111.07 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.72 -38.06 71.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 64.12 110.873 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.4 ' C ' HD21 ' B' ' 250' ' ' LEU . 3.3 t60 -77.15 176.06 9.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 74.24 110.898 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 94.23 154.03 30.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.78 -0.724 . . . . 42.23 112.476 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -78.03 -71.58 1.21 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 70.11 112.506 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 4.4 mt -96.51 110.31 24.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.853 0.358 . . . . 75.53 111.132 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.65 144.21 28.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 63.03 110.874 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.99 131.4 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 61.12 111.132 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.5 p -177.31 -175.54 0.57 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 73.5 110.812 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 18.2 t0 61.94 55.14 2.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 15.45 110.883 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -124.66 -37.31 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 64.22 110.956 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.435 HG22 ' N ' ' B' ' 225' ' ' ARG . 0.0 OUTLIER -69.6 123.11 20.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.173 -0.467 . . . . 74.31 111.228 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 225' ' ' ARG . 0.2 OUTLIER -92.78 110.72 22.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 73.35 111.21 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.441 ' HB2' HG22 ' A' ' 277' ' ' ILE . 1.0 OUTLIER -94.29 120.28 34.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 63.04 110.929 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 41.3 t -131.58 123.8 28.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 73.31 110.81 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.636 HG21 HG22 ' A' ' 267' ' ' VAL . 7.8 p -122.26 137.03 57.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 72.33 111.144 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -83.03 -71.71 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 61.2 110.951 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 38.8 m -125.88 130.26 50.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.13 111.13 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.636 HG22 HG21 ' A' ' 264' ' ' VAL . 27.6 t -118.2 126.11 74.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 74.15 111.14 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 22.1 t -127.29 117.09 46.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 65.41 111.162 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.04 134.04 9.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.778 -0.725 . . . . 52.55 112.491 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -132.14 147.21 52.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.845 0.355 . . . . 74.34 110.904 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 57.94 73.9 0.4 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 31.34 112.479 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 48.42 59.54 4.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.867 0.365 . . . . 64.1 110.914 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 38.4 t -83.86 145.81 28.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 74.35 110.894 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -123.33 127.69 48.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 75.05 110.883 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.485 ' HB ' HG12 ' A' ' 239' ' ' VAL . 13.8 t -130.79 125.7 58.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 65.42 111.114 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.581 HD21 ' OE1' ' A' ' 240' ' ' GLN . 0.5 OUTLIER -124.71 111.84 16.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 75.41 110.914 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.702 HD13 ' CD2' ' A' ' 241' ' ' LEU . 4.7 mp -108.08 104.74 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 61.44 111.133 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.15 168.36 15.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 55.23 112.397 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -94.27 152.78 18.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.737 0.304 . . . . 72.13 110.835 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -123.2 118.87 28.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.906 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.406 ' CE1' HG11 ' B' ' 245' ' ' VAL . 29.1 t80 -117.6 148.37 41.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 63.11 110.942 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.11 -107.63 0.63 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.794 -0.717 . . . . 64.24 112.507 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' B' ' 247' ' ' ALA . . . -172.33 94.49 0.1 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 75.54 112.472 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -179.49 -34.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 74.14 110.844 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.09 -110.32 3.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 70.01 112.52 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.36 -172.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.371 . . . . 53.03 110.809 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -72.54 -9.01 58.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 75.0 110.938 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.75 -179.78 5.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 74.41 110.862 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -55.89 -69.32 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 74.55 110.876 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -165.74 176.67 7.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 74.24 110.829 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -148.44 177.75 9.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 63.3 110.867 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.52 117.52 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 72.4 110.865 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -172.6 114.33 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 72.31 110.854 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.514 ' N ' HH22 ' C' ' 238' ' ' ARG . 31.2 p80 -157.54 130.08 7.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 61.24 110.872 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 8.5 t60 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 63.01 110.873 179.954 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 6.2 mtp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.841 0.353 . . . . 73.41 110.86 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -115.73 139.66 49.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 74.52 110.893 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 13.4 tt -176.03 144.18 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 74.11 111.108 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.08 174.06 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 72.41 110.877 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -170.77 97.62 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 61.43 111.108 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.65 124.2 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 75.13 111.118 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 96.4 t -149.94 -72.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 71.04 111.093 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 58.51 174.97 0.54 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.769 -0.729 . . . . 62.43 112.475 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.757 ' HB3' HG23 ' B' ' 261' ' ' THR . 16.7 ttt-85 -173.56 139.07 0.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 73.42 110.81 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -110.26 123.66 50.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 74.33 110.907 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.83 138.31 54.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 64.33 110.903 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -142.35 120.28 12.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 74.24 111.099 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -31.6 21.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 64.31 110.921 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.46 139.18 5.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 60.21 110.818 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 9.4 mt -137.22 117.85 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 74.43 111.165 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -130.89 119.63 22.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.861 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.1 OUTLIER -132.41 146.84 52.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 74.3 111.153 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -147.1 167.28 24.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 62.34 110.878 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 65.6 54.63 1.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 74.42 110.89 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 19.1 mtt85 51.68 62.62 2.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 62.51 110.807 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.443 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -103.57 156.42 17.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 63.21 111.061 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.89 136.02 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 74.54 110.865 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.648 HG12 ' HB ' ' B' ' 275' ' ' VAL . 19.2 m -141.22 121.74 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 73.42 111.161 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.494 ' O ' HD22 ' B' ' 276' ' ' LEU . 1.7 tt0 -123.03 137.19 55.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 71.01 110.955 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.601 HD23 HD13 ' B' ' 277' ' ' ILE . 0.8 OUTLIER -123.74 118.83 28.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.236 -0.438 . . . . 73.23 110.939 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 150.51 171.15 18.49 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 41.31 112.504 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -86.03 139.06 31.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.893 0.377 . . . . 70.42 110.891 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -117.72 124.32 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 54.41 111.107 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.406 HG11 ' CE1' ' A' ' 281' ' ' TYR . 39.5 t -122.02 128.88 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 53.31 111.105 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 15.5 p -86.81 170.64 11.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 73.1 111.173 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.449 ' HB2' ' HA3' ' A' ' 283' ' ' GLY . . . -63.2 -39.08 93.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 72.04 111.123 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.88 69.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 42.52 111.101 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.645 ' HB2' HD13 ' C' ' 250' ' ' LEU . . . -88.58 49.88 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 72.54 111.079 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.4 HD21 ' C ' ' A' ' 251' ' ' HIS . 65.6 tp -112.22 -63.6 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 62.05 110.934 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.31 172.78 12.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 70.1 110.884 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 96.98 71.76 1.07 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.731 . . . . 54.4 112.482 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 58.32 49.67 73.91 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.752 . . . . 52.03 112.516 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 254' ' ' ILE . . . . . 0.594 HG22 ' H ' ' B' ' 256' ' ' ILE . 48.7 mm -73.35 -70.91 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.866 0.365 . . . . 62.12 111.143 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 57.07 33.16 22.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.082 -0.508 . . . . 71.52 110.88 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 256' ' ' ILE . . . . . 0.594 ' H ' HG22 ' B' ' 254' ' ' ILE . 13.8 tt -61.03 147.5 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 72.03 111.107 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.6 p -168.32 77.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 75.35 110.825 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -146.23 120.21 9.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.479 . . . . 64.31 110.841 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -120.83 91.72 3.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 71.44 110.922 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.92 123.9 45.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 61.41 111.134 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.757 HG23 ' HB3' ' B' ' 225' ' ' ARG . 6.1 m -95.29 108.89 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 73.44 111.098 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.497 ' HB2' HG22 ' B' ' 277' ' ' ILE . 0.7 OUTLIER -95.86 125.04 40.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 70.5 110.827 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 2.9 p -135.59 123.69 22.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 65.34 110.864 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.637 HG21 HG22 ' B' ' 267' ' ' VAL . 9.9 p -119.78 135.78 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 73.35 111.082 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -74.66 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 75.33 110.913 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 76.8 m -122.29 130.05 52.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 62.51 111.152 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.637 HG22 HG21 ' B' ' 264' ' ' VAL . 39.3 t -118.34 123.46 71.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 71.33 111.094 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.33 118.84 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 64.12 111.087 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.1 134.93 9.73 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.681 -0.771 . . . . 53.02 112.457 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -131.58 147.3 52.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 70.5 110.896 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 59.66 72.39 0.62 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.748 -0.739 . . . . 64.44 112.471 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 49.13 59.16 4.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.951 0.405 . . . . 73.14 110.867 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 33.2 t -83.81 145.52 28.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 63.04 110.836 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.95 127.36 47.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 62.45 110.783 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.648 ' HB ' HG12 ' B' ' 239' ' ' VAL . 10.5 t -131.8 128.22 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 75.32 111.115 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.494 HD22 ' O ' ' B' ' 240' ' ' GLN . 2.7 tm? -128.02 111.93 14.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.504 . . . . 52.22 110.959 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.601 HD13 HD23 ' B' ' 241' ' ' LEU . 4.7 mp -106.15 104.6 17.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 61.13 111.14 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.64 179.03 29.56 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.765 -0.731 . . . . 72.23 112.527 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.33 146.17 24.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.774 0.321 . . . . 73.3 110.949 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.86 119.01 34.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 64.03 110.892 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -118.19 125.85 51.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 72.24 110.904 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 137.37 -43.51 1.21 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 73.25 112.494 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 92.91 135.99 7.51 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 65.55 112.515 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -179.33 -34.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.866 0.365 . . . . 63.52 110.924 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 146.51 -90.98 0.15 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.693 -0.765 . . . . 54.21 112.454 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.03 -49.46 3.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 73.23 110.927 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -179.24 35.32 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 74.33 110.913 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.1 176.11 0.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 74.31 110.824 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -104.31 91.59 3.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 72.04 110.918 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -131.46 -175.74 3.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 72.55 110.909 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 61.8 168.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.305 -0.407 . . . . 71.22 110.886 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -175.03 94.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 71.44 110.808 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.83 -172.19 2.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 71.23 110.888 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -165.84 -170.36 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 65.15 110.899 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.432 . . . . 72.22 110.847 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.754 0.311 . . . . 65.34 110.874 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.19 -75.31 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 71.44 110.869 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 2.2 tt -61.55 132.57 27.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 54.44 111.083 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -93.43 44.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 64.51 110.911 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -90.54 142.7 27.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 50.42 111.076 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 4.8 tp -169.63 135.68 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 65.14 111.121 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 22.3 t -144.26 148.15 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 71.34 111.142 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 224' ' ' GLY . . . . . 0.414 ' O ' HG23 ' C' ' 261' ' ' THR . . . 91.61 -107.17 3.47 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 63.04 112.439 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 63.45 160.34 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.813 0.339 . . . . 74.4 110.896 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -122.75 131.25 53.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 65.43 110.886 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.88 137.87 54.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 55.2 110.862 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' B' ' 264' ' ' VAL . . . -137.39 141.02 41.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 65.13 111.065 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.94 -32.82 8.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 64.24 110.898 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.61 138.32 5.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 72.14 110.847 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 7.3 mt -137.53 117.62 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 63.42 111.1 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -128.37 120.47 27.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.88 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.0 OUTLIER -130.63 149.34 52.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 63.4 111.127 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -147.83 168.03 23.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 73.5 110.858 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 61.39 54.4 3.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 70.43 110.844 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 51.1 66.65 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 72.4 110.858 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.596 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -103.58 156.95 17.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 63.31 111.099 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.514 HH22 ' N ' ' A' ' 294' ' ' HIS . 1.0 OUTLIER -125.29 135.18 52.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 72.14 110.807 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.612 HG12 ' HB ' ' C' ' 275' ' ' VAL . 6.4 m -137.9 121.92 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 73.13 111.171 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -122.12 137.34 54.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 63.42 110.861 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.548 HD13 HG13 ' B' ' 277' ' ' ILE . 2.7 mp -126.24 118.87 26.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 70.04 110.953 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.53 176.07 15.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 63.53 112.517 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -91.34 128.97 37.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.889 0.376 . . . . 64.33 110.893 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.93 116.53 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 62.51 111.119 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.502 ' CG1' ' HB3' ' C' ' 249' ' ' ALA . 25.8 t -119.93 118.9 58.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 72.44 111.098 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -70.22 174.24 5.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.172 -0.467 . . . . 74.04 111.157 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.76 -37.99 88.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 51.35 111.088 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.84 -52.04 66.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 74.53 111.101 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 249' ' ' ALA . . . . . 0.502 ' HB3' ' CG1' ' C' ' 245' ' ' VAL . . . -64.19 -25.32 68.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 75.42 111.107 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 250' ' ' LEU . . . . . 0.645 HD13 ' HB2' ' B' ' 249' ' ' ALA . 9.3 mt -81.9 -27.1 33.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 72.33 110.94 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.97 -178.87 4.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 72.41 110.841 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 61.02 -117.61 12.25 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.714 -0.755 . . . . 73.52 112.497 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 161.94 70.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 52.3 112.521 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 254' ' ' ILE . . . . . 0.437 HD13 ' CB ' ' D' ' 249' ' ' ALA . 1.0 OUTLIER -95.9 24.43 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 55.12 111.114 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 51.9 82.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 74.23 110.936 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 3.6 pt -63.47 178.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 64.2 111.107 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 2.5 t -158.84 39.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 64.04 110.874 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -75.06 76.12 2.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.078 -0.51 . . . . 70.04 110.883 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -139.15 37.26 2.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 70.35 110.913 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 260' ' ' THR . . . . . 0.418 HG22 ' CG ' ' D' ' 225' ' ' ARG . 0.2 OUTLIER -94.33 131.06 40.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.485 . . . . 75.04 111.108 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.414 HG23 ' O ' ' C' ' 224' ' ' GLY . 64.0 m -91.95 124.94 36.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 54.03 111.168 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.422 ' ND2' ' HA2' ' C' ' 278' ' ' GLY . 0.5 OUTLIER -126.18 129.33 48.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.426 . . . . 51.25 110.856 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 28.9 t -140.86 123.39 16.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 43.54 110.83 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.665 HG21 HG22 ' C' ' 267' ' ' VAL . 7.5 p -116.53 136.52 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 70.14 111.18 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.01 -74.91 0.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 53.05 110.883 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 31.6 m -116.57 127.66 54.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 63.52 111.105 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.665 HG22 HG21 ' C' ' 264' ' ' VAL . 46.8 t -118.68 123.07 70.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 75.32 111.118 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 24.5 t -126.93 127.64 70.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 65.0 111.109 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -131.18 135.3 8.15 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.748 . . . . 61.32 112.528 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -132.45 148.37 52.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.873 0.368 . . . . 73.45 110.866 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.62 76.17 0.21 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.727 -0.749 . . . . 71.33 112.452 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 47.31 58.82 4.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.875 0.369 . . . . 73.41 110.88 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 37.7 t -83.4 145.4 29.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 63.31 110.835 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -124.53 127.92 48.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 71.5 110.899 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.612 ' HB ' HG12 ' C' ' 239' ' ' VAL . 17.0 t -134.13 123.68 44.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 74.04 111.156 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.661 HD12 ' CE3' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -123.97 119.3 29.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 72.32 110.93 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 4.2 mt -112.08 104.52 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 75.11 111.103 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 278' ' ' GLY . . . . . 0.422 ' HA2' ' ND2' ' C' ' 262' ' ' ASN . . . 154.35 -159.32 28.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 71.4 112.42 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -110.11 155.99 21.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 63.34 110.907 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -131.24 124.39 30.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.139 -0.482 . . . . 70.24 110.913 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -120.92 125.92 48.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 73.44 110.893 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 135.71 161.66 9.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.789 -0.719 . . . . 30.42 112.483 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 283' ' ' GLY . . . . . 0.589 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . -96.99 110.11 3.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.772 -0.728 . . . . 63.34 112.488 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -179.24 37.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 72.22 110.972 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 53.49 -110.64 1.46 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 44.22 112.514 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.03 -175.96 5.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 71.51 110.888 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.661 ' CE3' HD12 ' C' ' 276' ' ' LEU . 1.7 p90 -59.14 -21.76 59.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 72.34 110.898 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -175.25 158.05 2.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 70.03 110.884 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 53.62 90.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 74.44 110.966 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -76.16 120.78 21.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 61.05 110.829 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.84 147.56 8.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.13 110.912 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.12 -169.91 1.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 72.31 110.901 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -96.31 165.54 12.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 73.21 110.879 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.32 161.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 64.32 110.802 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 4.3 t60 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 75.21 110.907 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 5.9 mtm . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.821 0.343 . . . . 73.54 110.872 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -132.77 96.59 3.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 71.1 110.884 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 10.5 tt -115.83 -36.55 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.243 -0.435 . . . . 75.11 111.187 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 52.04 50.37 18.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 74.43 110.878 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.39 131.78 42.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 71.02 111.114 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 2.6 mp -125.18 136.79 59.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 62.12 111.165 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 27.6 m -98.13 172.97 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 70.22 111.133 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 129.07 166.29 11.9 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.7 -0.762 . . . . 74.21 112.505 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.675 ' H ' HG23 ' D' ' 261' ' ' THR . 0.7 OUTLIER 69.31 -75.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 75.4 110.874 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -128.13 112.42 14.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 61.03 110.828 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.53 142.66 49.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 62.02 110.856 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 228' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' C' ' 264' ' ' VAL . . . -139.73 133.24 30.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 35.11 111.048 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -97.49 -37.11 10.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 64.01 110.881 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -164.3 137.36 5.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 74.31 110.914 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 231' ' ' ILE . . . . . 0.449 HG23 ' HB ' ' D' ' 267' ' ' VAL . 6.6 mt -137.92 117.66 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 53.2 111.116 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -123.6 115.46 21.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.876 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 233' ' ' THR . . . . . 0.576 ' OG1' ' HB3' ' D' ' 237' ' ' ALA . 0.1 OUTLIER -125.4 148.21 48.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 71.33 111.13 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.59 166.22 30.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 60.13 110.88 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 65.54 52.3 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 73.4 110.917 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 54.46 59.62 4.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 75.22 110.834 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 237' ' ' ALA . . . . . 0.576 ' HB3' ' OG1' ' D' ' 233' ' ' THR . . . -98.27 155.75 17.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.55 111.059 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 38.2 mtt180 -125.95 135.34 51.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 53.11 110.86 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.617 HG12 ' HB ' ' D' ' 275' ' ' VAL . 6.1 m -137.89 121.81 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 73.24 111.122 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.42 137.12 52.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.897 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.633 HD21 HD12 ' D' ' 277' ' ' ILE . 1.1 mm? -120.96 118.24 29.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 72.43 110.923 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.44 -173.32 19.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.795 -0.717 . . . . 51.32 112.483 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.38 149.9 21.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 53.22 110.898 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.23 116.37 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 72.15 111.14 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 245' ' ' VAL . . . . . 0.666 HG13 ' HB3' ' D' ' 281' ' ' TYR . 50.3 t -115.02 128.98 71.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 72.23 111.137 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 11.8 t -70.65 174.47 5.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 53.33 111.126 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 247' ' ' ALA . . . . . 0.589 ' HB2' ' N ' ' C' ' 283' ' ' GLY . . . -63.14 -41.83 99.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 71.14 111.04 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.0 -43.42 81.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 73.43 111.13 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 249' ' ' ALA . . . . . 0.437 ' CB ' HD13 ' C' ' 254' ' ' ILE . . . 51.81 -169.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.32 111.063 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 250' ' ' LEU . . . . . 0.677 HD13 ' HB3' ' E' ' 249' ' ' ALA . 12.0 tp -61.1 132.68 54.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 60.31 110.908 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 251' ' ' HIS . . . . . 0.576 ' N ' HD12 ' D' ' 250' ' ' LEU . 6.7 m-70 -77.77 92.47 4.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 72.24 110.826 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 139.59 -54.18 0.67 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.828 -0.701 . . . . 63.21 112.494 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 112.69 -179.05 19.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.7 . . . . 70.41 112.474 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 29.8 mt 64.42 108.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.309 . . . . 74.42 111.152 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 255' ' ' ARG . . . . . 0.446 ' HG3' HD23 ' D' ' 250' ' ' LEU . 0.0 OUTLIER -143.85 172.63 12.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 72.02 110.851 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 20.0 tt -128.58 142.44 43.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 70.43 111.135 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 54.9 p -109.16 -173.95 2.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.31 110.868 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 21.4 t0 60.43 99.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 75.31 110.866 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.7 -46.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.0 110.9 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.83 137.78 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 64.23 111.252 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 261' ' ' THR . . . . . 0.675 HG23 ' H ' ' D' ' 225' ' ' ARG . 0.7 OUTLIER -133.9 109.03 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 61.41 111.148 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 262' ' ' ASN . . . . . 0.563 ' HB2' HG22 ' D' ' 277' ' ' ILE . 0.2 OUTLIER -107.35 120.55 42.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 74.24 110.844 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 57.9 m -132.11 124.06 28.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 72.33 110.819 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.88 ' HA ' ' HB3' ' E' ' 228' ' ' ALA . 7.9 p -106.55 138.87 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.116 -0.493 . . . . 73.42 111.08 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 265' ' ' GLU . . . . . 0.457 ' HB2' ' HA ' ' E' ' 229' ' ' LYS . 3.0 tt0 -94.52 -29.53 14.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 72.22 110.863 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 266' ' ' THR . . . . . 0.492 ' HB ' ' HA ' ' E' ' 230' ' ' ASP . 1.1 m -152.69 129.22 10.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 52.42 111.147 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.658 HG22 HG21 ' D' ' 264' ' ' VAL . 94.1 t -127.18 120.5 55.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 72.33 111.143 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 40.6 t -127.74 128.0 68.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 54.1 111.097 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -135.23 133.31 6.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.738 . . . . 63.04 112.517 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.47 149.36 51.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 70.14 110.908 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.22 81.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.744 -0.741 . . . . 74.24 112.439 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 45.59 57.66 4.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 72.04 110.892 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 29.7 t -83.84 145.14 28.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 63.23 110.816 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -125.94 127.4 45.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 64.35 110.842 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.619 HG13 HG23 ' E' ' 239' ' ' VAL . 17.1 t -137.02 123.79 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 75.33 111.114 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 1.1 tt -128.17 111.72 13.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 65.33 110.907 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.633 HD12 HD21 ' D' ' 241' ' ' LEU . 16.5 mt -102.42 104.54 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 44.51 111.141 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 278' ' ' GLY . . . . . 0.404 ' HA2' ' ND2' ' D' ' 262' ' ' ASN . . . 155.02 -168.18 32.91 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.746 -0.74 . . . . 72.42 112.491 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -103.39 140.0 38.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 64.32 110.914 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -111.95 134.85 53.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 55.4 110.928 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 281' ' ' TYR . . . . . 0.666 ' HB3' HG13 ' D' ' 245' ' ' VAL . 1.2 t80 -120.04 125.8 49.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 61.14 110.879 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.52 -160.73 40.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.686 -0.768 . . . . 70.03 112.474 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 52.2 39.24 50.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 62.13 112.455 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 5.6 mptt 68.77 -76.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.351 . . . . 45.01 110.914 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -173.99 29.32 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.624 -0.798 . . . . 63.31 112.435 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.51 -168.75 2.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.907 0.384 . . . . 72.24 110.831 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -111.97 23.72 13.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 75.41 110.934 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.48 -171.77 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 54.11 110.864 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -112.97 29.82 7.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 75.41 110.881 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.97 -170.06 0.54 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.814 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -132.02 -171.39 2.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 74.44 110.856 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.66 165.65 25.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 60.33 110.877 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -171.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 73.13 110.813 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -100.97 26.17 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 74.24 110.862 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 75.15 110.872 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.839 0.352 . . . . 72.24 110.867 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -57.01 -26.12 59.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 73.22 110.882 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 219' ' ' ILE . . . . . 0.471 HG22 ' H ' ' E' ' 221' ' ' ALA . 51.2 mm -82.89 142.75 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 63.2 111.119 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -131.5 45.44 2.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 61.02 110.866 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 221' ' ' ALA . . . . . 0.471 ' H ' HG22 ' E' ' 219' ' ' ILE . . . 62.32 91.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 62.04 111.088 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 3.4 pt -151.11 49.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 74.51 111.109 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 223' ' ' VAL . . . . . 0.431 HG11 HH11 ' E' ' 225' ' ' ARG . 8.1 p -174.77 159.75 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 74.55 111.12 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 224' ' ' GLY . . . . . 0.409 ' N ' HG22 ' E' ' 223' ' ' VAL . . . -68.11 -134.9 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.709 -0.758 . . . . 73.31 112.49 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 225' ' ' ARG . . . . . 0.431 HH11 HG11 ' E' ' 223' ' ' VAL . 0.6 OUTLIER 63.42 -167.13 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 72.32 110.874 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -82.2 114.81 20.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 51.35 110.894 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.03 133.59 55.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 65.13 110.875 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 228' ' ' ALA . . . . . 0.88 ' HB3' ' HA ' ' D' ' 264' ' ' VAL . . . -122.41 170.04 10.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 72.43 111.135 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 229' ' ' LYS . . . . . 0.644 ' HE3' ' N ' ' E' ' 229' ' ' LYS . 0.0 OUTLIER -140.45 -34.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 62.24 110.893 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 230' ' ' ASP . . . . . 0.58 ' N ' ' HD2' ' E' ' 229' ' ' LYS . 8.8 t0 -175.62 131.71 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 70.51 110.821 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 231' ' ' ILE . . . . . 0.643 HG23 HG11 ' E' ' 267' ' ' VAL . 15.5 mt -132.58 115.78 26.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 71.24 111.128 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -110.99 115.26 29.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 74.55 110.937 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 233' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' E' ' 237' ' ' ALA . 0.1 OUTLIER -127.99 128.59 45.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 72.24 111.148 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -136.9 166.55 23.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 74.13 110.878 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 61.68 61.11 1.5 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 73.25 110.884 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 40.2 mtt85 49.35 63.93 1.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.45 110.844 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 237' ' ' ALA . . . . . 0.459 ' HB3' ' OG1' ' E' ' 233' ' ' THR . . . -104.74 156.48 17.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 75.05 111.057 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -128.06 135.85 50.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 64.03 110.92 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.64 HG12 ' HB ' ' E' ' 275' ' ' VAL . 4.5 m -139.25 121.7 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 74.54 111.181 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.83 137.47 54.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.41 110.913 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.502 HD11 ' CD1' ' E' ' 231' ' ' ILE . 4.8 mp -122.61 117.92 26.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.932 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.8 168.18 11.76 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 72.43 112.551 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -85.84 133.77 33.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.898 0.38 . . . . 60.03 110.92 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 97.3 t -109.71 135.51 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 71.32 111.13 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 245' ' ' VAL . . . . . 0.43 HG13 ' HB3' ' E' ' 281' ' ' TYR . 73.4 t -122.17 129.1 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 73.41 111.163 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.7 t -69.77 171.6 8.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 75.22 111.115 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.26 -33.91 75.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 51.41 111.082 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.22 66.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.274 -0.421 . . . . 75.15 111.063 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 249' ' ' ALA . . . . . 0.677 ' HB3' HD13 ' D' ' 250' ' ' LEU . . . 51.54 -169.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 42.34 111.118 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 7.1 tp -173.52 81.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 74.03 110.964 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -129.7 100.72 5.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.884 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -103.9 -30.11 5.28 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 53.11 112.449 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 138.29 42.41 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.783 -0.722 . . . . 73.41 112.473 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 4.0 pt -144.35 -178.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.816 0.341 . . . . 60.05 111.154 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -164.81 151.15 10.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 74.32 110.892 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 8.2 tt -156.06 144.94 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 52.22 111.108 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 3.4 m 60.16 177.77 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 73.5 110.814 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -107.26 168.15 9.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 65.42 110.843 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -68.09 165.71 17.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.891 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.46 121.83 42.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 74.21 111.141 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 93.1 m -92.13 111.07 22.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 54.52 111.146 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -108.68 119.34 39.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 65.11 110.933 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.04 132.77 40.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 72.52 110.82 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 264' ' ' VAL . . . . . 0.724 HG22 ' H ' ' E' ' 266' ' ' THR . 9.4 p -116.8 153.82 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 54.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 265' ' ' GLU . . . . . 0.599 ' O ' ' HD3' ' E' ' 229' ' ' LYS . 0.2 OUTLIER -112.02 -11.0 13.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 75.44 110.866 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 266' ' ' THR . . . . . 0.724 ' H ' HG22 ' E' ' 264' ' ' VAL . 0.2 OUTLIER -167.46 126.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.24 111.122 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 267' ' ' VAL . . . . . 0.643 HG11 HG23 ' E' ' 231' ' ' ILE . 41.0 t -132.16 117.36 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 72.42 111.104 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.21 139.2 52.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 72.22 111.138 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -144.74 133.41 5.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 35.02 112.5 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -134.02 148.06 51.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 52.51 110.838 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 56.29 86.5 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.701 -0.761 . . . . 54.35 112.503 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 44.98 56.76 5.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.898 0.38 . . . . 61.52 110.895 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.42 145.23 29.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 51.24 110.924 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.93 126.96 39.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.893 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.64 ' HB ' HG12 ' E' ' 239' ' ' VAL . 21.2 t -136.05 123.56 34.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 55.32 111.127 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.653 HD13 ' CD2' ' E' ' 287' ' ' TRP . 1.2 mp -129.03 111.44 12.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 75.22 110.905 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 37.3 mt -104.12 104.62 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 72.11 111.05 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 156.85 -174.5 34.51 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.773 -0.727 . . . . 73.02 112.485 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -103.53 153.05 20.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 75.3 110.867 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -116.27 136.35 53.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 71.23 110.825 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 281' ' ' TYR . . . . . 0.43 ' HB3' HG13 ' E' ' 245' ' ' VAL . 2.7 t80 -117.46 125.78 51.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 65.53 110.886 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 52.97 26.71 27.79 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 54.54 112.509 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -83.98 -16.49 67.41 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.794 -0.717 . . . . 43.44 112.468 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 7.3 mttt 63.35 41.65 7.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 72.02 110.944 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 67.93 137.97 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 54.23 112.483 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.05 119.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.777 0.323 . . . . 73.33 110.939 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 287' ' ' TRP . . . . . 0.653 ' CD2' HD13 ' E' ' 276' ' ' LEU . 11.0 p90 -50.5 118.47 3.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.137 -0.483 . . . . 70.23 110.839 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 9.2 t70 63.96 91.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 65.12 110.914 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -113.08 -176.52 2.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.45 110.89 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.54 -176.29 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 72.44 110.927 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -62.29 -177.82 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 72.32 110.901 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -60.08 152.84 23.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 64.2 110.879 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -173.73 107.92 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 74.32 110.851 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -154.88 -169.89 3.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 72.34 110.887 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 65.31 110.866 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.813 0.339 . . . . 71.33 110.914 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.1 pttt -161.01 -47.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 64.45 110.93 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 45.4 mm 52.39 84.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 73.22 111.089 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.86 85.4 2.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 75.53 110.857 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -178.21 140.89 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 75.23 111.107 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 222' ' ' ILE . 1.1 tt -142.23 90.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 74.41 111.104 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.0 p -177.5 143.26 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.5 . . . . 53.1 111.158 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -55.52 171.32 1.66 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.767 -0.73 . . . . 73.43 112.478 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -172.66 100.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 71.44 110.861 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.409 ' HB3' HG22 ' A' ' 277' ' ' ILE . 8.8 m-20 -87.78 112.28 22.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 71.11 110.93 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.65 148.4 49.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 75.11 110.871 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.17 119.3 10.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 62.24 111.057 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.45 ' NZ ' HD13 ' C' ' 219' ' ' ILE . 0.7 OUTLIER -65.43 -43.99 88.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 74.5 110.921 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -165.48 136.68 3.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 71.24 110.886 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 9.1 pt -139.07 131.78 37.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 72.43 111.144 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -135.05 139.8 45.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 74.12 110.873 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.738 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.5 OUTLIER -136.31 153.82 51.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 74.43 111.154 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -142.72 168.71 19.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 43.32 110.881 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 74.2 -70.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 64.24 110.886 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.73 53.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 73.05 110.818 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.738 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -91.5 156.82 17.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.03 111.076 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -130.98 138.21 49.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 72.44 110.894 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.771 HG12 ' HB ' ' A' ' 275' ' ' VAL . 27.5 m -122.43 125.47 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 75.31 111.146 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -123.24 118.9 28.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 65.12 110.862 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.64 119.34 36.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 65.13 110.952 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 150.86 169.71 17.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 53.3 112.448 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -85.95 133.36 33.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 75.32 110.886 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.7 t -103.96 133.37 48.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 73.33 111.201 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 97.4 t -119.73 121.97 67.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 73.53 111.093 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.469 HG21 ' HG3' ' A' ' 284' ' ' LYS . 3.0 m -69.88 161.71 29.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 74.14 111.158 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.74 99.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 71.2 111.09 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ALA . . . . . 0.482 ' HB2' ' HD2' ' A' ' 284' ' ' LYS . . . -56.99 -36.01 69.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 65.31 111.135 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.64 ' HA ' HD12 ' B' ' 250' ' ' LEU . . . -54.38 -27.11 34.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 44.34 111.122 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.7 tp -66.5 89.76 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 73.03 110.904 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -177.57 -66.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 71.45 110.863 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -104.0 -100.77 2.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.772 -0.728 . . . . 70.45 112.482 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 129.46 -153.79 20.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.764 -0.731 . . . . 75.55 112.492 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 15.2 mt 70.64 -70.44 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 55.43 111.206 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.49 -170.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 75.25 110.921 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' B' ' 257' ' ' SER . 8.4 tp -71.24 139.59 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 71.02 111.095 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -74.37 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 51.34 110.903 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.24 -170.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 62.2 110.898 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.627 ' CG ' HG11 ' B' ' 223' ' ' VAL . 0.1 OUTLIER -173.93 42.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 71.1 110.975 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.502 HG22 ' ND2' ' B' ' 226' ' ' ASN . 0.2 OUTLIER -65.03 133.84 52.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 50.3 111.115 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.428 HG23 ' HB2' ' B' ' 225' ' ' ARG . 3.3 t -125.18 121.8 35.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 72.32 111.189 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -91.24 127.21 36.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 34.15 110.877 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.4 p -142.41 123.07 14.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 72.43 110.896 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.639 HG21 HG22 ' A' ' 267' ' ' VAL . 8.7 p -118.99 134.47 62.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.45 111.125 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -78.33 -75.78 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.5 . . . . 75.31 110.879 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.91 127.13 53.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 60.42 111.199 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.639 HG22 HG21 ' A' ' 264' ' ' VAL . 47.0 t -118.96 120.85 65.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 72.45 111.142 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 74.5 t -123.47 115.29 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 71.51 111.106 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.72 133.6 11.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 75.13 112.5 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 139.92 48.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 74.34 110.854 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.19 81.1 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.733 -0.746 . . . . 63.44 112.545 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 44.7 62.51 2.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.836 0.35 . . . . 72.24 110.96 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.47 145.06 29.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 74.11 110.857 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -113.27 128.05 56.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 61.2 110.883 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.771 ' HB ' HG12 ' A' ' 239' ' ' VAL . 19.9 t -129.53 123.29 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 74.25 111.129 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.43 111.6 13.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 45.11 110.968 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.409 HG22 ' HB3' ' A' ' 226' ' ' ASN . 2.5 mp -110.33 103.89 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 74.22 111.047 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.54 168.69 15.69 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.736 -0.745 . . . . 74.23 112.503 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -89.72 154.22 20.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 61.51 110.908 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.655 ' CD ' HG13 ' B' ' 244' ' ' VAL . 0.0 OUTLIER -127.65 123.78 36.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 60.41 110.877 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.576 ' HB3' HD21 ' B' ' 250' ' ' LEU . 43.6 m-85 -103.51 128.55 50.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 55.35 110.872 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.97 134.74 6.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 65.11 112.456 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.554 ' H ' ' N ' ' B' ' 247' ' ' ALA . . . -83.33 -112.0 0.53 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.811 -0.709 . . . . 63.45 112.525 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.482 ' HD2' ' HB2' ' A' ' 248' ' ' ALA . 0.1 OUTLIER 63.45 25.45 14.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.728 0.299 . . . . 54.4 110.815 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 145.12 -12.97 1.88 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.748 -0.739 . . . . 52.43 112.486 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.74 ' CZ ' HG11 ' B' ' 244' ' ' VAL . 7.7 t80 72.39 -68.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 75.21 110.867 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -147.39 -48.09 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 73.11 110.939 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -134.27 -175.84 4.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.236 -0.438 . . . . 74.44 110.898 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.75 146.86 33.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 63.01 110.955 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.02 170.79 15.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 73.23 110.879 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -119.02 -74.36 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 71.42 110.889 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -176.37 -177.96 0.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.442 . . . . 74.03 110.859 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -176.48 107.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 62.43 110.942 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -97.16 143.1 28.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 72.32 110.842 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 75.41 110.856 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 75.8 mmm . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.805 0.336 . . . . 75.32 110.908 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -156.3 -170.02 3.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 75.25 110.911 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 28.1 mm 64.19 90.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 54.2 111.136 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.29 152.81 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 51.51 110.876 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -51.78 138.92 22.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 71.01 111.117 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 2.1 mp -130.32 149.04 33.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 73.11 111.142 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.627 HG11 ' CG ' ' A' ' 259' ' ' GLN . 19.2 t -64.54 151.32 9.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 75.14 111.148 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -51.58 115.5 3.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.696 -0.764 . . . . 30.43 112.516 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.747 ' HG2' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER -132.48 143.44 49.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.787 0.327 . . . . 63.24 110.889 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.502 ' ND2' HG22 ' A' ' 260' ' ' THR . 2.4 m-20 -93.75 112.7 24.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 62.3 110.908 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 32.4 t -127.61 152.32 47.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.851 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.03 124.27 17.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 35.14 111.064 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.07 -40.24 62.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 73.53 110.936 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -166.26 135.87 3.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 72.33 110.824 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 267' ' ' VAL . 8.1 pt -139.15 130.01 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.481 . . . . 73.24 111.16 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.09 137.28 40.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 61.34 110.894 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.758 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.5 OUTLIER -137.1 150.44 48.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 75.34 111.071 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -142.01 168.63 19.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 55.44 110.869 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 73.19 -71.84 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.883 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -177.93 59.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 64.3 110.898 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.758 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -97.88 156.61 16.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 60.44 111.112 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -130.7 135.87 48.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 73.23 110.843 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.729 HG12 ' HB ' ' B' ' 275' ' ' VAL . 27.7 m -122.22 132.15 71.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 70.21 111.166 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -130.22 119.28 22.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.881 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.401 ' HG ' HD13 ' B' ' 277' ' ' ILE . 4.4 mp -111.69 118.4 35.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 70.15 110.892 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 145.23 175.48 18.4 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.777 -0.725 . . . . 71.33 112.491 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.83 129.37 34.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.394 . . . . 70.1 110.879 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.74 HG11 ' CZ ' ' A' ' 286' ' ' PHE . 92.1 t -102.19 114.74 42.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 72.55 111.195 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.519 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 85.0 t -106.76 129.26 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 71.11 111.169 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.425 HG23 ' H ' ' B' ' 249' ' ' ALA . 6.3 t -74.96 169.58 17.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 75.24 111.166 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.554 ' N ' ' H ' ' A' ' 283' ' ' GLY . . . -63.34 -41.8 98.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 72.12 111.084 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.61 -35.85 68.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 73.45 111.101 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.519 ' HB3' ' CG1' ' B' ' 245' ' ' VAL . . . -74.65 -24.18 58.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 51.21 111.072 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.64 HD12 ' HA ' ' A' ' 249' ' ' ALA . 0.2 OUTLIER -88.98 -24.89 22.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 61.45 110.857 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -132.89 50.11 2.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 55.41 110.878 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 168.61 -97.48 0.13 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.775 -0.726 . . . . 54.44 112.462 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -56.51 144.69 36.82 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.694 -0.765 . . . . 61.45 112.523 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 3.2 pt -147.2 -177.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 73.51 111.172 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 58.8 86.54 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 72.24 110.807 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.25 43.08 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 71.12 111.066 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 257' ' ' SER . . . . . 0.409 ' HB2' HD11 ' A' ' 256' ' ' ILE . 0.3 OUTLIER -58.87 159.64 6.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 74.33 110.881 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.81 159.74 16.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.32 110.819 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.4 29.0 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 61.51 110.862 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.596 HG22 ' NH1' ' C' ' 225' ' ' ARG . 18.0 p -79.89 121.85 25.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 73.15 111.238 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.747 HG23 ' HG2' ' B' ' 225' ' ' ARG . 91.2 m -97.28 108.84 21.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 73.03 111.163 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.794 ' HB3' HD23 ' C' ' 241' ' ' LEU . 0.2 OUTLIER -96.26 126.22 41.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 60.34 110.914 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 5.5 t -141.99 123.46 14.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 73.31 110.802 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.711 HG21 HD11 ' C' ' 231' ' ' ILE . 9.8 p -108.19 136.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.041 -0.527 . . . . 73.21 111.18 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -81.83 -77.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 72.43 110.894 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.5 m -121.08 127.94 52.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 75.43 111.104 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.716 HG22 HD11 ' C' ' 231' ' ' ILE . 15.7 t -118.18 120.32 64.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 74.34 111.106 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 41.3 t -123.38 115.04 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 71.23 111.13 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.52 133.09 10.52 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 55.42 112.496 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -132.48 146.97 52.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.751 0.31 . . . . 64.32 110.967 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.04 75.12 0.22 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.761 -0.733 . . . . 43.0 112.468 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 52.82 78.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.88 0.371 . . . . 72.03 110.893 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 1.4 t -103.66 144.7 31.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 70.1 110.906 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.418 ' O ' HG22 ' C' ' 239' ' ' VAL . 0.9 OUTLIER -112.43 127.58 56.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 60.43 110.818 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.729 ' HB ' HG12 ' B' ' 239' ' ' VAL . 97.0 t -130.5 123.62 55.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 70.2 111.16 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.598 HD23 ' CZ2' ' B' ' 287' ' ' TRP . 0.9 OUTLIER -128.88 111.85 13.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 62.22 110.846 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.401 HD13 ' HG ' ' B' ' 241' ' ' LEU . 3.4 mp -107.7 104.34 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 73.5 111.09 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.426 ' HA2' ' ND2' ' B' ' 262' ' ' ASN . . . 149.29 -171.75 29.44 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.745 -0.74 . . . . 75.11 112.519 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.77 147.95 26.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 74.33 110.975 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.527 ' OE1' HG13 ' C' ' 244' ' ' VAL . 1.8 pt-20 -116.8 121.68 42.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 63.34 110.822 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -112.41 125.72 54.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 75.15 110.967 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 140.08 164.58 9.95 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.743 . . . . 74.41 112.485 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 283' ' ' GLY . . . . . 0.524 ' HA3' ' HB2' ' C' ' 247' ' ' ALA . . . -103.83 -143.5 12.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 53.31 112.503 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 9.9 mttp 56.87 25.3 10.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 72.33 110.866 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 128.75 -117.49 2.5 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.725 -0.75 . . . . 72.22 112.497 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -173.9 -44.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.882 0.372 . . . . 74.25 110.911 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.598 ' CZ2' HD23 ' B' ' 276' ' ' LEU . 3.7 t90 -125.51 -68.45 0.83 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 55.41 110.844 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -142.31 -169.93 3.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 73.2 110.916 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -56.31 144.53 30.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 64.2 110.874 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -170.47 157.54 6.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 73.4 110.879 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -151.33 146.86 26.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 74.14 110.897 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.95 158.77 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 74.4 110.816 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -164.01 134.57 4.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 73.03 110.88 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -150.38 179.52 8.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 72.24 110.864 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 75.45 110.912 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.5 mtp . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.776 0.322 . . . . 62.51 110.955 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt 61.06 179.17 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 75.55 110.938 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.45 HD13 ' NZ ' ' A' ' 229' ' ' LYS . 3.1 mp 62.3 70.46 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.242 -0.436 . . . . 71.42 111.125 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -177.58 133.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 72.3 110.873 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 221' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' E' ' 217' ' ' MET . . . -173.95 70.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 73.41 111.094 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 1.9 pt -150.75 136.09 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 72.41 111.124 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 91.2 t -103.19 -69.85 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 75.13 111.14 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 74.11 -112.92 3.94 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.744 -0.741 . . . . 75.13 112.479 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.596 ' NH1' HG22 ' B' ' 260' ' ' THR . 0.1 OUTLIER -121.21 -69.77 0.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.815 0.34 . . . . 74.12 110.842 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -94.08 109.86 21.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 73.44 110.903 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 60.7 p -137.02 148.17 46.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 62.01 110.854 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.22 137.56 47.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.501 . . . . 55.13 111.112 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -86.45 -40.49 15.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 72.5 110.911 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -165.47 136.5 3.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 73.55 110.895 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.716 HD11 HG22 ' B' ' 267' ' ' VAL . 8.3 pt -140.13 117.1 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.54 111.12 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -124.48 116.24 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 71.23 110.885 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.626 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.6 OUTLIER -124.46 136.86 54.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 75.53 111.171 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 234' ' ' GLU . . . . . 0.401 ' HG3' ' HG3' ' C' ' 235' ' ' GLU . 3.8 pt-20 -121.44 166.95 13.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 71.15 110.872 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.401 ' HG3' ' HG3' ' C' ' 234' ' ' GLU . 2.6 mt-10 60.84 -162.91 0.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.496 . . . . 74.25 110.954 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 -72.65 63.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 75.1 110.877 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.626 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -105.62 156.37 18.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 53.34 111.047 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -135.9 135.95 40.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 65.32 110.839 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.449 HG12 ' CG2' ' C' ' 275' ' ' VAL . 17.4 m -134.35 134.41 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 72.44 111.11 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.428 ' HB3' HD22 ' C' ' 276' ' ' LEU . 1.2 tt0 -130.13 137.37 50.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.501 . . . . 73.32 110.888 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.794 HD23 ' HB3' ' B' ' 262' ' ' ASN . 0.3 OUTLIER -119.12 118.35 31.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 73.22 110.857 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 140.47 -177.77 20.48 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.7 -0.762 . . . . 70.4 112.47 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.494 ' HB3' HG21 ' B' ' 260' ' ' THR . 7.5 p30 -85.84 153.06 22.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.797 0.332 . . . . 74.24 110.906 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.527 HG13 ' OE1' ' B' ' 280' ' ' GLU . 63.8 t -122.08 114.92 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 73.53 111.106 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.571 HG22 ' HB2' ' C' ' 281' ' ' TYR . 3.8 t -108.0 127.7 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 72.41 111.104 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 6.5 t -69.84 175.07 4.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 64.33 111.045 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.524 ' HB2' ' HA3' ' B' ' 283' ' ' GLY . . . -63.15 -45.05 93.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 70.03 111.116 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.92 -35.89 69.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 54.31 111.072 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.25 -174.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 51.45 111.065 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.61 -176.09 3.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 71.21 110.915 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -54.23 -50.61 66.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 73.03 110.864 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 135.16 -165.43 24.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.835 -0.697 . . . . 51.34 112.508 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 65.91 -141.56 41.97 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.695 -0.764 . . . . 72.24 112.485 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 28.0 mm 61.65 99.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.934 0.397 . . . . 51.13 111.135 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -88.02 -74.35 0.45 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.138 -0.483 . . . . 72.52 110.949 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 256' ' ' ILE . . . . . 0.432 HG22 ' OD1' ' C' ' 258' ' ' ASP . 5.2 mp -78.15 129.78 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 64.42 111.065 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.47 120.67 24.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 63.5 110.846 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 258' ' ' ASP . . . . . 0.432 ' OD1' HG22 ' C' ' 256' ' ' ILE . 5.5 p-10 -168.3 64.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 73.4 110.862 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -104.44 -68.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 74.4 110.924 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -100.93 135.07 42.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 52.32 111.152 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 4.3 t -115.66 140.89 48.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 72.41 111.142 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.39 124.42 46.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 54.42 110.881 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.6 131.91 36.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 70.55 110.867 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.799 HG23 HD11 ' D' ' 231' ' ' ILE . 13.6 p -115.46 139.98 39.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.505 . . . . 73.42 111.122 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -83.03 -76.0 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 71.4 110.945 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 25.7 m -137.48 130.64 30.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 74.45 111.119 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.53 ' CG2' HG21 ' C' ' 264' ' ' VAL . 21.4 t -118.41 130.64 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.4 111.187 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 25.9 t -127.49 125.92 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 55.35 111.159 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.03 134.13 10.3 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.788 -0.72 . . . . 74.34 112.474 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.95 117.05 20.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 71.32 110.941 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 61.05 81.88 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.766 -0.73 . . . . 64.12 112.447 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 61.98 110.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.876 0.37 . . . . 72.54 110.888 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 5.1 m -148.43 145.12 27.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 74.43 110.873 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -117.61 126.36 52.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 70.52 110.895 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.449 ' CG2' HG12 ' C' ' 239' ' ' VAL . 16.4 t -127.06 123.05 61.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 70.44 111.095 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.446 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.1 OUTLIER -128.14 117.9 22.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.01 110.896 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.76 HD13 HD12 ' C' ' 241' ' ' LEU . 5.1 mp -111.68 103.35 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 71.1 111.153 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.06 -173.87 28.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 74.53 112.509 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -106.36 156.22 18.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 73.4 110.9 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.661 ' CG ' HG22 ' D' ' 244' ' ' VAL . 1.1 pt-20 -115.71 128.45 55.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 65.55 110.897 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.571 ' HB2' HG22 ' C' ' 245' ' ' VAL . 5.0 m-85 -110.8 129.72 55.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 60.32 110.895 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 120.78 167.25 13.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 72.21 112.471 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 283' ' ' GLY . . . . . 0.548 ' H ' ' HB2' ' D' ' 247' ' ' ALA . . . -110.9 -161.48 17.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.805 -0.712 . . . . 51.53 112.524 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt 50.9 79.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.794 0.331 . . . . 70.35 110.883 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 86.29 86.9 1.03 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 44.44 112.508 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -50.05 -42.13 49.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 74.33 110.83 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.446 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 15.7 t90 -158.04 68.42 0.5 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 65.34 110.882 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -168.02 -170.93 1.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.28 -0.418 . . . . 74.45 110.845 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -112.57 111.99 23.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 72.43 110.873 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -55.49 101.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 72.02 110.811 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.09 -170.11 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 73.04 110.863 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 164.03 3.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 73.35 110.878 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.07 -42.39 2.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 70.45 110.928 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -52.12 -31.94 33.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 60.34 110.88 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 73.45 110.802 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 32.0 mtt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.896 0.379 . . . . 71.33 110.846 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.36 91.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 71.22 110.852 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 1.1 pp -112.14 169.23 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 73.32 111.139 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -170.4 125.57 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 72.32 110.853 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -170.57 131.34 0.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 74.45 111.121 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 222' ' ' ILE . . . . . 0.804 HG12 HG23 ' D' ' 223' ' ' VAL . 17.6 tt -174.17 138.32 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 73.15 111.145 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 223' ' ' VAL . . . . . 0.804 HG23 HG12 ' D' ' 222' ' ' ILE . 58.2 t 58.32 91.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.229 -0.442 . . . . 73.03 111.133 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -152.07 -167.53 15.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.712 -0.756 . . . . 72.12 112.459 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -120.07 -76.73 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 71.23 110.9 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -88.12 112.36 22.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 75.35 110.901 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.34 137.48 37.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 73.4 110.892 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 228' ' ' ALA . . . . . 0.73 ' HB2' HD11 ' D' ' 241' ' ' LEU . . . -117.85 119.48 35.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 52.4 111.081 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -75.25 -29.46 60.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 64.23 110.911 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 230' ' ' ASP . . . . . 0.421 ' HB2' HG22 ' D' ' 266' ' ' THR . 1.6 t0 -166.19 136.15 3.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 73.22 110.876 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 231' ' ' ILE . . . . . 0.799 HD11 HG23 ' C' ' 264' ' ' VAL . 0.3 OUTLIER -138.66 117.98 14.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 72.52 111.113 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -126.96 125.25 41.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 73.12 110.881 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 233' ' ' THR . . . . . 0.535 ' CB ' ' HB3' ' D' ' 237' ' ' ALA . 0.4 OUTLIER -136.33 155.4 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 63.14 111.119 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -152.99 168.68 25.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 72.13 110.888 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 68.71 -80.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 71.22 110.863 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -159.56 55.58 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 75.44 110.822 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 237' ' ' ALA . . . . . 0.535 ' HB3' ' CB ' ' D' ' 233' ' ' THR . . . -104.8 146.5 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 74.52 111.147 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -125.78 135.37 51.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 64.43 110.836 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.745 HG11 HG22 ' D' ' 231' ' ' ILE . 18.3 m -122.94 121.69 63.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 34.41 111.147 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -116.55 125.83 52.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 73.24 110.885 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.836 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.9 mm? -111.78 117.72 33.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 74.41 110.86 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.71 179.55 17.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 71.44 112.46 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.78 163.09 17.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 75.12 110.899 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 244' ' ' VAL . . . . . 0.661 HG22 ' CG ' ' C' ' 280' ' ' GLU . 78.2 t -133.16 123.67 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 52.54 111.166 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.57 129.26 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.14 111.119 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.4 t -69.59 175.07 4.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 73.13 111.117 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 247' ' ' ALA . . . . . 0.548 ' HB2' ' H ' ' C' ' 283' ' ' GLY . . . -59.26 -41.57 89.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 62.54 111.144 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.71 -48.85 76.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 73.11 111.189 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.57 -179.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 64.42 111.179 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.8 167.78 20.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 71.34 110.857 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -86.61 52.65 2.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 65.42 110.819 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.72 -28.21 56.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 63.42 112.517 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 90.42 147.8 18.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.708 -0.758 . . . . 35.24 112.457 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.68 -172.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.799 0.333 . . . . 73.01 111.112 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.39 -169.57 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 63.01 110.795 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 256' ' ' ILE . . . . . 0.629 HG23 ' OD2' ' D' ' 258' ' ' ASP . 50.4 mm -51.23 119.26 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 72.45 111.142 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 35.3 m -119.65 -9.21 9.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 71.32 110.806 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 258' ' ' ASP . . . . . 0.629 ' OD2' HG23 ' D' ' 256' ' ' ILE . 0.7 OUTLIER -50.99 165.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 73.5 110.915 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -148.66 -75.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 71.42 110.929 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 2.8 t -101.43 138.27 38.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 73.53 111.187 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 98.7 m -91.76 140.98 29.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 61.4 111.191 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.64 119.6 29.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.317 -0.401 . . . . 73.54 110.94 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 15.1 m -132.02 122.62 25.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 72.14 110.88 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.547 HG21 ' CG2' ' D' ' 267' ' ' VAL . 7.7 p -108.32 128.33 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 74.13 111.118 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.96 -74.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 75.13 110.824 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 266' ' ' THR . . . . . 0.421 HG22 ' HB2' ' D' ' 230' ' ' ASP . 19.3 p -147.37 133.35 19.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 75.11 111.087 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.659 HG11 HG21 ' D' ' 275' ' ' VAL . 14.3 t -117.05 133.17 64.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 71.01 111.171 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 45.7 t -127.01 117.79 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 74.32 111.138 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.04 133.01 10.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.803 -0.713 . . . . 54.01 112.56 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -132.39 115.37 15.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 63.24 110.911 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.75 72.58 0.95 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.799 -0.715 . . . . 71.04 112.487 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 65.52 100.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.805 0.336 . . . . 74.54 110.923 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 2.6 m -135.98 145.0 45.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 64.55 110.861 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.88 127.15 51.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.51 . . . . 70.22 110.859 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.659 HG21 HG11 ' D' ' 267' ' ' VAL . 15.5 t -133.67 123.08 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 74.21 111.165 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.63 121.88 29.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 75.04 110.857 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.836 ' HB ' HD13 ' D' ' 241' ' ' LEU . 5.2 mp -112.36 104.56 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 75.21 111.073 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.86 169.5 13.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 65.11 112.568 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -89.94 153.87 20.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 75.44 110.906 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 280' ' ' GLU . . . . . 0.602 ' HG3' HG13 ' E' ' 244' ' ' VAL . 2.1 pt-20 -115.01 135.77 53.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 75.54 110.831 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -112.51 125.54 54.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 74.44 110.929 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 92.13 -142.04 15.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 43.4 112.547 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 65.8 111.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 74.4 112.537 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -51.81 -36.93 49.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 74.32 110.882 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -107.48 -83.24 1.55 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.757 -0.735 . . . . 65.32 112.494 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -177.52 171.96 1.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.371 . . . . 75.2 110.863 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 287' ' ' TRP . . . . . 0.425 ' HB3' ' NE2' ' E' ' 240' ' ' GLN . 28.3 t90 -56.6 99.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 72.42 110.813 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.56 -54.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.421 . . . . 71.04 110.871 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -179.47 34.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 70.5 110.862 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 8.2 m80 52.55 69.01 0.74 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 72.42 110.817 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -53.7 141.67 25.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 74.21 110.89 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.83 -169.99 2.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 73.44 110.847 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -62.53 155.02 26.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.453 . . . . 74.21 110.845 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.33 -171.83 1.0 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 74.43 110.884 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 74.55 110.848 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 217' ' ' MET . . . . . 0.446 ' HB2' ' HB1' ' C' ' 221' ' ' ALA . 2.6 ttt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.901 0.382 . . . . 63.34 110.93 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.25 -175.39 5.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 61.23 110.882 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 2.0 tt -130.47 143.11 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 64.42 111.156 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.31 -173.64 4.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 71.42 110.85 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 221' ' ' ALA . . . . . 0.56 ' O ' HD13 ' E' ' 222' ' ' ILE . . . -114.07 174.4 5.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 55.13 111.121 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 222' ' ' ILE . . . . . 0.56 HD13 ' O ' ' E' ' 221' ' ' ALA . 46.3 mm -137.73 134.95 46.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 72.42 111.19 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.96 158.19 38.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 70.13 111.084 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -174.59 151.96 13.43 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.778 -0.725 . . . . 70.13 112.492 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 225' ' ' ARG . . . . . 0.486 ' CB ' HG22 ' E' ' 261' ' ' THR . 0.0 OUTLIER -53.44 -46.09 69.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.752 0.311 . . . . 72.25 110.848 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -95.42 111.04 23.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 63.02 110.854 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.37 151.01 44.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.091 -0.504 . . . . 74.33 110.813 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -127.13 119.03 25.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 74.1 111.112 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.48 -36.83 83.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.41 110.895 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.85 141.2 3.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.14 110.874 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 231' ' ' ILE . . . . . 0.689 ' CG2' HG11 ' E' ' 239' ' ' VAL . 6.8 mt -136.56 116.83 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 75.24 111.152 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -123.76 125.35 44.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 74.4 110.836 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 233' ' ' THR . . . . . 0.546 ' CB ' ' HB3' ' E' ' 237' ' ' ALA . 0.5 OUTLIER -136.18 153.39 51.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 44.43 111.128 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -156.27 166.5 33.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 74.45 110.858 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 70.22 -73.67 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 74.42 110.844 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 8.1 mtt85 -167.62 57.85 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 73.34 110.884 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 237' ' ' ALA . . . . . 0.546 ' HB3' ' CB ' ' E' ' 233' ' ' THR . . . -104.81 150.48 24.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 64.43 111.14 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.76 135.65 47.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.296 -0.411 . . . . 74.12 110.805 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.689 HG11 ' CG2' ' E' ' 231' ' ' ILE . 26.8 m -127.22 128.65 70.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 64.44 111.075 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 240' ' ' GLN . . . . . 0.425 ' NE2' ' HB3' ' D' ' 287' ' ' TRP . 0.3 OUTLIER -123.49 131.64 53.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 73.34 110.898 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.775 HD13 ' HB ' ' E' ' 277' ' ' ILE . 3.7 mm? -115.5 118.61 33.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 43.4 110.922 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.49 176.48 14.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.64 -0.791 . . . . 53.25 112.422 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -85.73 162.67 18.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.858 0.361 . . . . 75.23 110.893 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.602 HG13 ' HG3' ' D' ' 280' ' ' GLU . 86.2 t -132.58 128.93 58.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 65.45 111.129 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 245' ' ' VAL . . . . . 0.404 ' O ' HG13 ' E' ' 245' ' ' VAL . 14.8 p -122.31 129.17 75.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 73.25 111.093 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 246' ' ' THR . . . . . 0.415 HG21 ' HA2' ' E' ' 282' ' ' GLY . 14.9 t -69.51 170.98 9.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 63.53 111.182 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.49 -33.78 68.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 75.1 111.097 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.62 -35.87 68.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 73.43 111.135 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.39 -169.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 33.01 111.083 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.18 140.13 44.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 71.41 110.986 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -172.04 31.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 74.12 110.838 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -162.62 23.88 0.2 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.715 -0.755 . . . . 73.1 112.467 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -143.79 -160.15 8.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.729 -0.748 . . . . 74.44 112.527 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 1.4 tt -117.99 -38.99 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.339 . . . . 63.52 111.149 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 59.73 98.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.865 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 tt -118.39 -41.83 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 75.31 111.177 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.38 163.81 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 75.22 110.829 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -104.41 -169.02 1.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 65.12 110.835 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.49 -36.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 70.22 110.993 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 2.9 t -64.74 127.92 33.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.192 -0.458 . . . . 72.44 111.179 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 261' ' ' THR . . . . . 0.486 HG22 ' CB ' ' E' ' 225' ' ' ARG . 24.9 p -115.61 141.41 48.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 74.53 111.13 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -118.42 118.27 31.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 74.45 110.874 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.31 116.9 24.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.02 110.859 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 264' ' ' VAL . . . . . 0.551 ' O ' HG13 ' E' ' 264' ' ' VAL . 13.8 p -105.16 117.83 51.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 45.43 111.072 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 265' ' ' GLU . . . . . 0.551 ' CD ' ' N ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -62.04 -134.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 74.05 110.869 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.99 126.19 40.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 65.22 111.126 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 19.3 t -116.28 135.14 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 64.53 111.146 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.82 115.27 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 41.32 111.131 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.01 132.64 10.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 73.12 112.457 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -132.21 114.23 14.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.358 . . . . 73.05 110.833 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.46 73.42 1.1 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.753 -0.736 . . . . 70.12 112.46 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.42 103.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.804 0.335 . . . . 62.42 110.94 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 3.9 t -138.31 145.37 41.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 72.54 110.874 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.0 128.59 43.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 74.32 110.867 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.502 ' HB ' HG12 ' E' ' 239' ' ' VAL . 19.3 t -136.27 123.3 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 74.04 111.172 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.413 HD22 ' O ' ' E' ' 275' ' ' VAL . 1.2 mm? -128.14 122.26 31.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.269 -0.423 . . . . 71.22 110.89 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.775 ' HB ' HD13 ' E' ' 241' ' ' LEU . 5.0 mp -113.74 125.1 70.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 73.32 111.143 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 128.27 -172.17 19.28 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.653 -0.784 . . . . 71.14 112.43 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.53 156.04 16.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 71.22 110.933 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -124.84 139.22 54.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 74.22 110.94 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -130.54 125.16 33.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 73.13 110.984 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 282' ' ' GLY . . . . . 0.415 ' HA2' HG21 ' E' ' 246' ' ' THR . . . 153.43 -151.89 23.59 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.69 -0.767 . . . . 73.14 112.453 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -168.29 121.81 0.98 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.72 -0.752 . . . . 63.21 112.479 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 180.0 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 63.2 110.906 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 145.64 -132.23 4.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.712 -0.756 . . . . 30.32 112.477 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.2 145.2 32.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.784 0.326 . . . . 63.34 110.881 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 65.6 13.55 8.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.156 -0.475 . . . . 73.32 110.904 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -178.72 47.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 75.22 110.856 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -51.17 166.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 73.05 110.885 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.19 -169.49 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 71.21 110.837 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -127.58 -38.6 1.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 72.33 110.899 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -72.57 79.13 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 61.13 110.878 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -68.26 178.95 1.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 75.41 110.774 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -152.57 -42.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 71.02 110.91 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 75.21 110.826 179.968 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 1.9 mtt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.823 0.344 . . . . 73.31 110.88 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.463 ' O ' HD13 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -71.04 85.78 0.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 73.24 110.879 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.463 HD13 ' O ' ' A' ' 218' ' ' LYS . 25.0 mm -129.24 149.94 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.259 -0.428 . . . . 63.11 111.162 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -80.08 59.02 3.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 73.33 110.822 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.652 ' HB2' ' HB3' ' A' ' 255' ' ' ARG . . . -172.68 -178.86 2.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 74.53 111.065 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.433 HG22 HG12 ' A' ' 223' ' ' VAL . 79.3 mt -138.79 -72.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 60.11 111.099 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.433 HG12 HG22 ' A' ' 222' ' ' ILE . 8.8 p -175.16 152.91 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 74.45 111.182 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -64.77 -155.3 0.16 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.675 -0.774 . . . . 64.3 112.51 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.38 100.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.828 0.347 . . . . 63.24 110.846 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.541 ' OD1' HG22 ' A' ' 277' ' ' ILE . 9.0 t30 -142.21 137.56 30.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 52.01 110.92 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.31 148.67 50.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 54.34 110.888 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.26 119.31 10.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.4 111.058 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.59 -49.29 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 71.14 110.898 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -165.22 136.9 4.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 75.11 110.875 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.677 HG22 ' CG2' ' A' ' 267' ' ' VAL . 5.9 pt -135.49 130.77 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 71.24 111.127 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.7 125.41 27.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 74.42 110.882 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.557 HG21 HG13 ' A' ' 239' ' ' VAL . 1.6 p -136.86 149.59 47.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 73.25 111.126 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.27 168.51 19.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 62.33 110.869 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 64.63 74.73 0.39 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 73.14 110.893 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 40.85 59.29 2.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 72.12 110.905 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.499 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -103.36 157.19 17.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 72.44 111.04 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.97 143.94 47.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 75.5 110.926 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.707 HG12 ' HB ' ' A' ' 275' ' ' VAL . 14.8 m -134.73 120.6 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 70.54 111.033 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -116.34 129.68 56.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 72.25 110.936 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.5 mp -111.86 117.91 34.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 71.22 110.947 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.25 -166.51 24.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.786 -0.721 . . . . 54.12 112.516 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -108.25 141.7 39.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.971 0.415 . . . . 61.12 110.838 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 244' ' ' VAL . 32.0 m -115.52 118.0 57.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.138 -0.483 . . . . 51.5 111.13 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.708 HG12 ' HB2' ' A' ' 281' ' ' TYR . 6.5 m -123.43 123.03 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 74.33 111.129 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 281' ' ' TYR . 3.2 t -91.78 161.06 15.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 75.02 111.173 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.15 -43.9 93.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 63.43 111.079 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.11 -35.02 66.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 53.52 111.084 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.814 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -64.99 -14.83 61.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 74.55 111.101 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 62.76 -176.36 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 72.41 110.867 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -145.87 -46.64 0.21 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.148 -0.478 . . . . 71.32 110.817 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 66.54 68.27 1.72 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 63.43 112.507 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 129.21 -137.42 9.57 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.802 -0.713 . . . . 50.04 112.502 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.5 tt -126.22 -37.62 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.833 0.349 . . . . 73.43 111.182 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.652 ' HB3' ' HB2' ' A' ' 221' ' ' ALA . 1.2 ttm180 -179.3 -170.01 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 64.42 110.859 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.22 165.38 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 74.22 111.131 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.53 148.95 36.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 72.51 110.841 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.68 ' OD1' HG21 ' B' ' 219' ' ' ILE . 0.7 OUTLIER 52.65 -170.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 71.31 110.894 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -173.84 176.16 2.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.979 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 56.6 m -76.99 135.56 38.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 64.25 111.198 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 261' ' ' THR . 6.0 t -106.07 122.35 46.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 60.42 111.15 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.02 136.34 52.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 73.45 110.917 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 8.2 t -142.55 123.6 14.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 65.21 110.822 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.58 134.98 54.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 61.24 111.136 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.74 -77.76 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 71.0 110.851 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.22 127.68 53.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 60.43 111.115 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.909 HG13 HD11 ' B' ' 231' ' ' ILE . 0.4 OUTLIER -117.89 131.46 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 71.25 111.111 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.46 116.06 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 62.25 111.115 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.12 133.29 10.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.802 -0.713 . . . . 72.21 112.517 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -133.35 148.51 51.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 63.45 110.872 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.55 79.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.785 -0.721 . . . . 61.21 112.493 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 46.83 66.37 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 75.01 110.907 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 29.6 t -92.78 145.14 24.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 65.34 110.82 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.56 128.19 54.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 70.31 110.856 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.707 ' HB ' HG12 ' A' ' 239' ' ' VAL . 19.3 t -119.25 123.15 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 72.3 111.139 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -129.45 111.49 12.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 73.12 110.937 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.634 ' CD1' HD13 ' B' ' 241' ' ' LEU . 7.2 mm -106.97 110.39 31.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 64.12 111.088 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.15 -178.34 18.84 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 73.33 112.482 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -88.96 156.59 18.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 70.31 110.916 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.769 ' CG ' HG12 ' B' ' 244' ' ' VAL . 0.9 OUTLIER -135.23 146.7 48.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 64.14 110.902 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.767 ' O ' HG22 ' A' ' 246' ' ' THR . 9.2 m-85 -123.06 122.45 38.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 63.32 110.901 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -127.83 -155.99 8.92 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.726 -0.749 . . . . 71.44 112.497 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -144.32 18.5 2.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 72.31 112.478 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.67 -51.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 71.13 110.942 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -102.28 -169.11 26.92 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.729 . . . . 71.34 112.5 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -136.54 31.74 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.911 0.386 . . . . 75.54 110.895 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 -179.31 -37.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 75.34 110.975 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.52 -170.37 2.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 75.33 110.856 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -88.14 79.29 7.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 62.13 110.864 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -93.68 136.07 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 50.42 110.845 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -175.47 152.65 1.38 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 62.01 110.818 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 60.84 56.16 2.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 72.54 110.913 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -172.43 123.77 0.47 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 55.01 110.913 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -105.49 138.54 41.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 64.11 110.882 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 1.1 t60 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 70.45 110.898 -179.989 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.774 0.321 . . . . 75.22 110.902 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.39 133.21 48.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 65.13 110.876 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 219' ' ' ILE . . . . . 0.68 HG21 ' OD1' ' A' ' 258' ' ' ASP . 4.0 mp -138.7 147.81 24.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 71.41 111.09 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -161.57 86.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 73.41 110.861 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -171.62 -170.56 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 64.31 111.124 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 222' ' ' ILE . . . . . 0.551 HD13 ' HB3' ' B' ' 257' ' ' SER . 6.4 tp -52.28 139.28 9.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.279 -0.419 . . . . 74.31 111.054 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 14.9 p -147.14 139.28 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 74.31 111.139 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -92.79 -175.93 41.26 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.774 -0.727 . . . . 61.21 112.477 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.726 ' HB3' HG23 ' B' ' 261' ' ' THR . 2.8 mtp180 -169.11 105.76 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.838 0.351 . . . . 54.0 110.854 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -134.28 110.58 9.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 74.12 110.925 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.95 138.74 54.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 73.43 110.895 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.99 120.01 20.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 72.0 111.175 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -74.88 -35.69 62.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 63.13 110.844 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -166.05 135.8 3.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 71.21 110.864 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.909 HD11 HG13 ' A' ' 267' ' ' VAL . 7.4 pt -141.07 131.58 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 74.13 111.155 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.72 126.8 27.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.837 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.733 HG21 HG13 ' B' ' 239' ' ' VAL . 2.3 p -135.05 140.38 45.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 55.52 111.095 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.19 167.56 21.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 62.11 110.852 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 68.09 69.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 73.41 110.861 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 46.88 35.2 3.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 73.31 110.935 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.42 156.14 20.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 75.23 111.057 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.65 144.6 47.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.25 110.823 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.739 HG12 ' HB ' ' B' ' 275' ' ' VAL . 0.0 OUTLIER -123.71 121.31 62.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 75.25 111.162 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.413 ' HB3' HD22 ' B' ' 276' ' ' LEU . 0.9 OUTLIER -118.24 117.45 29.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.04 110.911 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.634 HD13 ' CD1' ' A' ' 277' ' ' ILE . 4.2 mp -111.48 117.71 33.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 74.15 110.898 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.37 -165.69 26.65 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 54.42 112.505 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -109.07 135.5 50.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 55.21 110.907 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.769 HG12 ' CG ' ' A' ' 280' ' ' GLU . 33.6 m -106.62 123.04 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 54.43 111.142 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' B' ' 281' ' ' TYR . 0.1 OUTLIER -124.54 121.52 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 62.33 111.136 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.3 t -87.76 161.68 17.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 65.31 111.139 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.814 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.93 -38.16 90.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 51.33 111.172 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.11 -34.9 64.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 73.51 111.131 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -91.8 115.46 28.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 74.42 111.136 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 24.0 tp -166.06 -66.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.901 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 251' ' ' HIS . . . . . 0.486 ' CE1' HD11 ' C' ' 254' ' ' ILE . 0.2 OUTLIER 52.27 30.89 8.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 73.21 110.842 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 66.4 174.45 5.87 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.733 -0.746 . . . . 30.55 112.429 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -57.87 161.03 10.71 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.781 -0.723 . . . . 32.33 112.523 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 254' ' ' ILE . . . . . 0.54 HD13 ' H ' ' B' ' 254' ' ' ILE . 0.1 OUTLIER -143.48 179.59 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 71.33 111.145 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.41 160.72 31.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.01 110.914 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 mt 60.5 99.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 63.43 111.111 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 257' ' ' SER . . . . . 0.551 ' HB3' HD13 ' B' ' 222' ' ' ILE . 0.3 OUTLIER -95.23 -178.47 4.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 73.42 110.876 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -113.36 -28.79 7.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 65.15 110.838 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 62.96 98.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 61.02 110.936 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 1.3 m -99.17 136.52 39.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 70.55 111.113 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.726 HG23 ' HB3' ' B' ' 225' ' ' ARG . 97.2 m -134.14 108.82 8.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.426 . . . . 73.15 111.133 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -111.36 132.73 54.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.862 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.9 p -140.0 123.6 17.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 63.23 110.89 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.736 HG21 ' CG1' ' B' ' 267' ' ' VAL . 3.7 p -115.07 144.71 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 64.12 111.095 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.14 -52.09 5.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 74.43 110.875 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 25.1 m -150.33 126.98 10.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 53.55 111.185 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.736 ' CG1' HG21 ' B' ' 264' ' ' VAL . 32.6 m -123.14 136.85 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 62.31 111.11 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 37.8 t -127.22 129.62 70.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 62.32 111.128 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.24 133.4 8.42 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.8 -0.714 . . . . 74.4 112.517 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -133.18 148.92 52.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 74.21 110.89 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.4 87.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.697 -0.763 . . . . 64.21 112.477 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 41.39 50.73 3.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 62.0 110.873 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 47.9 t -83.21 144.87 29.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 73.42 110.833 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 129.85 48.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.098 -0.501 . . . . 73.32 110.871 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.739 ' HB ' HG12 ' B' ' 239' ' ' VAL . 11.9 t -114.14 130.67 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 73.11 111.147 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.413 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.8 OUTLIER -128.73 111.24 12.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 64.34 110.886 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.704 ' CD1' HD13 ' C' ' 241' ' ' LEU . 21.9 mm -110.15 103.43 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 71.12 111.126 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 142.01 -172.45 24.11 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.725 -0.75 . . . . 75.11 112.507 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -91.42 156.35 17.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.708 0.29 . . . . 65.23 110.954 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.648 ' CG ' HG12 ' C' ' 244' ' ' VAL . 0.0 OUTLIER -131.16 142.27 50.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 71.31 110.864 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.498 ' HB2' HG13 ' B' ' 245' ' ' VAL . 8.7 m-85 -127.19 122.83 35.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 64.44 110.936 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -129.97 -158.64 9.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 50.44 112.486 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -111.77 -20.72 6.72 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 33.33 112.465 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.59 34.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 64.41 110.944 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -142.8 176.51 22.41 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.708 -0.758 . . . . 72.24 112.472 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -116.68 -22.88 8.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.837 0.351 . . . . 71.22 110.894 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -156.13 -41.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 72.3 110.913 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -174.07 85.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 65.44 110.832 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -110.47 -170.38 1.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 75.52 110.921 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -167.47 -70.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 75.3 110.883 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.02 -171.64 1.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.814 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -96.65 32.82 1.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 73.32 110.816 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.12 173.24 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 61.4 110.892 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -76.43 -169.87 1.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 74.15 110.926 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 37.6 t60 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 72.21 110.827 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 16.5 mtt . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.81 0.338 . . . . 72.55 110.894 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -106.09 125.92 51.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 74.41 110.903 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 3.5 mp -117.0 -28.88 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 73.15 111.142 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 56.34 -173.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.101 -0.499 . . . . 71.41 110.851 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -135.61 -73.04 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 70.4 111.121 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 2.2 pt -150.85 67.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 73.21 111.068 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 25.6 m -106.78 -31.49 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 61.24 111.097 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -145.93 100.62 0.23 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.705 -0.76 . . . . 34.13 112.458 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.579 ' O ' HG23 ' C' ' 261' ' ' THR . 58.6 ttp180 -153.37 118.36 5.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.834 0.349 . . . . 74.3 110.835 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.527 ' OD1' HG22 ' C' ' 277' ' ' ILE . 3.2 t30 -88.06 124.28 33.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.457 . . . . 52.13 110.871 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.53 ' OG ' HG21 ' D' ' 219' ' ' ILE . 0.1 OUTLIER -123.5 142.9 50.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 55.31 110.87 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.67 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -137.88 119.17 14.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 52.31 111.097 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.53 -45.83 35.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 73.41 110.905 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -165.97 135.6 3.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 74.03 110.836 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.592 HG22 ' CG2' ' C' ' 267' ' ' VAL . 5.5 pt -138.14 132.1 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 70.15 111.12 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.61 121.44 19.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.827 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.584 HG21 HG13 ' C' ' 239' ' ' VAL . 1.8 p -135.87 138.17 42.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 73.34 111.104 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -138.8 167.71 21.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 61.02 110.877 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 68.95 73.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 71.23 110.838 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 45.07 54.21 7.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 72.14 110.881 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 156.25 18.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 74.44 111.097 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.94 143.7 38.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 61.24 110.804 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.66 HG12 ' HB ' ' C' ' 275' ' ' VAL . 14.8 m -129.5 133.83 64.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 75.23 111.107 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.496 ' OE1' HD21 ' C' ' 276' ' ' LEU . 3.7 tm0? -130.35 120.7 24.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 65.22 110.96 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.704 HD13 ' CD1' ' B' ' 277' ' ' ILE . 5.9 mp -111.64 118.36 35.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 70.03 110.907 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.65 -178.4 19.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.726 -0.75 . . . . 30.32 112.457 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -97.47 128.81 44.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.853 0.359 . . . . 63.24 110.905 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.648 HG12 ' CG ' ' B' ' 280' ' ' GLU . 32.5 m -96.18 127.79 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 71.52 111.154 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.49 129.23 74.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 60.03 111.112 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.4 t -83.83 165.07 19.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 54.41 111.109 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.14 -34.09 76.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 70.01 111.111 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 248' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' C' ' 249' ' ' ALA . . . -56.72 -36.21 69.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 73.02 111.102 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 249' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' C' ' 248' ' ' ALA . . . 69.09 -77.23 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 74.42 111.054 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.48 51.91 1.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 74.45 110.906 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 251' ' ' HIS . . . . . 0.601 ' HA ' ' HB1' ' D' ' 247' ' ' ALA . 9.7 t-80 72.15 -69.33 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 53.55 110.903 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -137.58 34.36 2.18 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.778 -0.725 . . . . 75.45 112.457 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -163.03 -168.88 25.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.793 -0.718 . . . . 75.42 112.576 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 254' ' ' ILE . . . . . 0.486 HD11 ' CE1' ' B' ' 251' ' ' HIS . 4.1 mp -135.63 109.67 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 74.51 111.057 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -132.73 -174.86 3.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 71.33 110.848 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 36.1 pt -77.68 176.55 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 65.33 111.111 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.72 -172.04 2.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 73.32 110.818 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.5 169.74 8.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 64.52 110.89 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 11.0 mp0 -111.11 104.01 12.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 63.35 110.937 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 260' ' ' THR . . . . . 0.406 HG22 HD21 ' C' ' 262' ' ' ASN . 1.7 m -100.78 136.06 41.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 53.3 111.145 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.579 HG23 ' O ' ' C' ' 225' ' ' ARG . 96.1 m -125.15 116.83 22.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 72.15 111.121 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.406 HD21 HG22 ' C' ' 260' ' ' THR . 3.0 m120 -126.05 149.8 48.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 62.33 110.916 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 1.8 m -141.72 123.71 15.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 72.42 110.886 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.784 HG21 HD11 ' D' ' 231' ' ' ILE . 5.9 p -109.99 138.93 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 62.42 111.071 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.669 ' CD ' HD12 ' E' ' 219' ' ' ILE . 0.4 OUTLIER -84.6 -74.19 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 72.55 110.935 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 7.4 m -126.26 127.79 46.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 52.02 111.156 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.592 ' CG2' HG22 ' C' ' 231' ' ' ILE . 0.3 OUTLIER -117.74 129.69 73.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.21 111.145 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 19.4 t -127.98 115.97 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 74.04 111.132 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.75 133.56 10.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.692 -0.766 . . . . 72.2 112.485 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.06 147.6 52.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.342 . . . . 65.15 110.867 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.43 84.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.785 -0.721 . . . . 64.45 112.43 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 48.06 75.74 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 74.04 110.958 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.69 145.06 32.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 73.43 110.865 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.47 128.42 48.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 73.03 110.822 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.66 ' HB ' HG12 ' C' ' 239' ' ' VAL . 21.3 t -121.32 123.41 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 75.35 111.124 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.788 HD12 ' CE2' ' C' ' 287' ' ' TRP . 0.1 OUTLIER -128.75 113.42 15.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 71.15 110.964 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.723 HD12 HD22 ' D' ' 241' ' ' LEU . 19.0 mm -112.17 104.08 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 52.21 111.093 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.74 -177.07 27.22 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.711 -0.757 . . . . 71.04 112.439 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -95.04 156.19 16.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 74.12 110.971 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.402 ' HG2' HG12 ' D' ' 244' ' ' VAL . 0.0 OUTLIER -126.12 130.93 52.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 75.31 110.847 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -119.23 125.65 49.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 72.52 110.958 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.93 171.91 13.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.692 -0.766 . . . . 63.34 112.466 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 283' ' ' GLY . . . . . 0.506 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . -70.92 -139.73 0.19 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.782 -0.723 . . . . 40.25 112.487 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 63.15 24.81 14.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.34 . . . . 72.23 110.908 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 61.9 -95.21 0.1 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.685 -0.769 . . . . 62.22 112.441 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -112.58 -175.3 2.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 71.14 110.95 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.788 ' CE2' HD12 ' C' ' 276' ' ' LEU . 21.0 t90 -50.13 -74.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.236 -0.438 . . . . 74.43 110.93 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -71.21 -175.73 1.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.432 . . . . 72.03 110.848 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -109.78 179.66 4.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 73.51 110.932 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.85 -169.98 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 63.44 110.894 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -138.24 -171.65 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 64.11 110.874 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -68.51 144.22 54.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 64.35 110.889 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.36 -174.41 4.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 73.4 110.851 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -137.5 -170.06 2.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 74.15 110.839 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 72.13 110.877 -179.946 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 18.6 ptp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.82 0.343 . . . . 65.11 110.933 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.12 102.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 63.22 110.894 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 219' ' ' ILE . . . . . 0.53 HG21 ' OG ' ' C' ' 227' ' ' SER . 5.9 pt -88.66 -177.59 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 50.45 111.113 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -133.24 -74.31 0.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 63.32 110.822 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -155.19 -170.02 3.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 52.11 111.115 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 10.5 tt -169.44 146.18 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 65.11 111.12 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 63.4 t -129.52 -72.0 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 63.14 111.156 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -91.59 -138.5 8.04 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 53.51 112.503 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.537 ' N ' HG23 ' D' ' 261' ' ' THR . 0.0 OUTLIER 63.43 -168.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.83 0.347 . . . . 75.11 110.843 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 226' ' ' ASN . . . . . 0.507 ' OD1' HG22 ' D' ' 277' ' ' ILE . 2.2 t30 -83.28 111.23 18.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 54.14 110.87 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 4.3 m -126.31 138.13 53.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 60.35 110.852 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.58 123.49 39.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 71.15 111.095 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -40.29 58.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 72.42 110.946 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -165.96 135.95 3.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 73.04 110.895 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 231' ' ' ILE . . . . . 0.784 HD11 HG21 ' C' ' 264' ' ' VAL . 9.0 pt -141.36 117.66 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 73.03 111.111 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 232' ' ' ARG . . . . . 0.634 HH11 HG22 ' D' ' 268' ' ' VAL . 0.0 OUTLIER -130.78 122.86 27.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.473 . . . . 62.51 110.928 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 233' ' ' THR . . . . . 0.457 HG21 ' CG1' ' D' ' 239' ' ' VAL . 3.0 p -135.94 149.17 48.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 54.21 111.154 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -145.66 167.19 23.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 70.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 67.22 79.86 0.22 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 73.04 110.92 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 42.62 52.28 4.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 75.43 110.857 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.22 156.31 18.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 63.42 111.08 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.16 142.03 25.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.829 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.537 HG12 ' HB ' ' D' ' 275' ' ' VAL . 19.7 m -128.89 139.75 51.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 74.43 111.134 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -128.75 126.03 39.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 52.23 110.915 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.723 HD22 HD12 ' C' ' 277' ' ' ILE . 10.8 mp -111.73 135.21 52.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 74.14 110.875 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 114.74 -176.16 16.6 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.713 -0.756 . . . . 62.32 112.433 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -100.36 135.21 42.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.876 0.37 . . . . 71.21 110.88 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 244' ' ' VAL . . . . . 0.402 HG12 ' HG2' ' C' ' 280' ' ' GLU . 22.7 m -104.07 133.48 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 52.03 111.137 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 39.9 t -122.22 129.47 75.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 54.3 111.05 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 246' ' ' THR . . . . . 0.403 HG23 ' H ' ' D' ' 249' ' ' ALA . 10.9 t -69.55 175.1 4.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 73.21 111.213 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 247' ' ' ALA . . . . . 0.601 ' HB1' ' HA ' ' C' ' 251' ' ' HIS . . . -62.79 -42.92 99.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 52.33 111.078 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.85 74.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 64.33 111.106 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 249' ' ' ALA . . . . . 0.403 ' H ' HG23 ' D' ' 246' ' ' THR . . . 53.88 -171.34 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 73.31 111.023 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.11 91.52 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.476 . . . . 72.31 110.925 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -76.89 -174.88 3.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 73.22 110.882 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 109.43 -20.23 28.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.697 -0.764 . . . . 64.44 112.458 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 167.95 -104.74 0.22 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.788 -0.72 . . . . 74.25 112.494 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 13.6 pt -144.64 44.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.76 0.314 . . . . 71.32 111.132 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -93.72 174.84 6.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 65.03 110.946 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 4.1 pt -110.87 -179.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 62.04 111.172 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.91 -172.35 2.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 73.41 110.918 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -119.63 173.63 6.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 70.11 110.824 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.62 119.99 19.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 73.41 110.989 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 29.3 m -95.98 137.92 34.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 53.41 111.143 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 261' ' ' THR . . . . . 0.537 HG23 ' N ' ' D' ' 225' ' ' ARG . 90.2 m -93.24 113.45 25.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 71.41 111.206 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -126.25 145.55 50.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 75.23 110.924 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 21.9 t -135.53 123.8 23.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 73.21 110.8 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.724 HG23 HD11 ' E' ' 231' ' ' ILE . 14.2 p -112.35 133.2 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 75.43 111.167 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.91 -75.18 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 72.41 110.872 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 26.5 m -133.73 132.65 40.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 65.34 111.161 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.645 ' CG2' HG22 ' D' ' 231' ' ' ILE . 13.6 t -117.78 127.36 75.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 44.31 111.076 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 268' ' ' VAL . . . . . 0.634 HG22 HH11 ' D' ' 232' ' ' ARG . 21.2 t -125.12 116.04 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 34.23 111.129 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.29 132.94 10.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.788 -0.72 . . . . 60.2 112.547 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.4 143.93 50.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 53.05 110.891 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 47.15 85.31 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.716 -0.754 . . . . 74.33 112.483 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 52.74 89.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.847 0.356 . . . . 63.53 110.927 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 47.8 t -126.12 145.01 50.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 73.4 110.829 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 11.8 mtt85 -127.7 128.23 45.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 74.4 110.862 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.537 ' HB ' HG12 ' D' ' 239' ' ' VAL . 23.2 t -119.36 123.68 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 65.33 111.129 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.617 HD12 ' CE2' ' D' ' 287' ' ' TRP . 0.4 OUTLIER -124.47 113.05 17.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 74.34 110.863 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.507 HG22 ' OD1' ' D' ' 226' ' ' ASN . 17.8 mm -112.33 104.21 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 65.35 111.144 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.61 -146.59 16.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.758 -0.734 . . . . 72.24 112.525 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -128.19 150.04 50.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 75.13 110.853 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -111.76 127.16 55.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.965 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 281' ' ' TYR . . . . . 0.44 ' CZ ' HG21 ' E' ' 245' ' ' VAL . 10.8 m-85 -120.21 125.4 48.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.22 110.898 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 122.99 160.16 10.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 60.32 112.41 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 283' ' ' GLY . . . . . 0.63 ' N ' ' HB2' ' E' ' 247' ' ' ALA . . . 62.26 163.55 0.32 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 32.23 112.479 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -110.34 48.42 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 71.34 110.927 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -137.04 -92.62 0.31 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.738 -0.744 . . . . 44.32 112.518 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 286' ' ' PHE . . . . . 0.741 ' CE1' HG11 ' E' ' 244' ' ' VAL . 40.4 t80 -179.6 -64.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 61.22 110.849 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 287' ' ' TRP . . . . . 0.617 ' CE2' HD12 ' D' ' 276' ' ' LEU . 10.4 t90 -168.9 39.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 75.4 110.919 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -179.63 -38.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.837 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.14 157.32 1.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 54.42 110.937 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.17 -174.28 3.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 75.52 110.875 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -51.88 -72.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 65.33 110.882 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 63.34 105.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 52.14 110.861 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -91.43 -26.05 19.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 70.2 110.89 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.16 -179.93 4.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 63.3 110.84 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 6.9 p80 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 64.2 110.893 -179.968 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.883 0.373 . . . . 74.42 110.864 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -178.85 122.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.54 110.887 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 219' ' ' ILE . . . . . 0.669 HD12 ' CD ' ' C' ' 265' ' ' GLU . 4.8 mt -126.75 135.13 64.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 54.34 111.156 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -71.11 144.48 50.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 54.31 110.87 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -125.67 -75.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 55.0 111.153 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 3.6 mp 52.23 75.2 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 62.13 111.162 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 21.2 m -149.26 -173.92 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 73.11 111.098 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -83.89 -131.47 2.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.765 -0.731 . . . . 73.11 112.468 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.92 -167.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 71.15 110.904 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.9 112.31 19.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 70.35 110.878 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 19.3 m -131.23 138.7 49.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.31 110.838 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 228' ' ' ALA . . . . . 0.416 ' HA ' HG13 ' E' ' 264' ' ' VAL . . . -120.52 132.74 55.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 61.54 111.092 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.6 -32.39 41.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 73.1 110.867 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 230' ' ' ASP . . . . . 0.526 ' CB ' HG22 ' E' ' 266' ' ' THR . 0.7 OUTLIER -165.79 139.03 4.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.415 . . . . 64.31 110.91 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 231' ' ' ILE . . . . . 0.724 HD11 HG23 ' D' ' 264' ' ' VAL . 0.4 OUTLIER -138.71 116.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 72.15 111.151 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 232' ' ' ARG . . . . . 0.407 ' CD ' HG22 ' E' ' 268' ' ' VAL . 8.6 ptm180 -129.89 117.77 20.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.861 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 233' ' ' THR . . . . . 0.582 HG21 HG13 ' E' ' 239' ' ' VAL . 7.8 p -135.43 151.91 50.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 73.42 111.105 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -157.47 167.27 30.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.907 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 67.54 75.13 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 63.41 110.848 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 45.78 42.9 9.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 63.44 110.864 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 237' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' E' ' 233' ' ' THR . . . -104.09 150.61 24.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 73.24 111.045 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 238' ' ' ARG . . . . . 0.497 HH12 ' N ' ' E' ' 240' ' ' GLN . 0.0 OUTLIER -133.7 148.11 51.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 71.04 110.902 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.674 HG12 ' CG2' ' E' ' 275' ' ' VAL . 6.8 m -130.47 124.13 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 74.5 111.134 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 240' ' ' GLN . . . . . 0.497 ' N ' HH12 ' E' ' 238' ' ' ARG . 8.6 tm0? -114.65 126.12 54.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 53.33 110.933 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.87 121.4 43.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 72.04 110.941 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 122.03 175.61 14.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 53.4 112.513 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.63 139.53 31.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 70.4 110.824 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.741 HG11 ' CE1' ' D' ' 286' ' ' PHE . 30.1 m -104.84 139.17 26.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 53.44 111.135 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 245' ' ' VAL . . . . . 0.44 HG21 ' CZ ' ' D' ' 281' ' ' TYR . 87.1 t -122.41 129.43 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 64.45 111.095 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.7 t -69.0 174.28 4.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 62.14 111.143 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 247' ' ' ALA . . . . . 0.63 ' HB2' ' N ' ' D' ' 283' ' ' GLY . . . -59.0 -43.54 91.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 73.42 111.09 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.98 -48.63 77.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 55.3 111.05 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 52.5 -170.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 72.43 111.042 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 4.6 tp -177.1 154.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 64.1 110.919 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -159.48 156.65 28.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 65.04 110.829 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.74 137.54 4.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 64.43 112.517 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -166.68 -179.16 39.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.751 . . . . 42.11 112.483 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.6 25.64 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.903 0.383 . . . . 74.42 111.14 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -160.14 143.32 13.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 71.11 110.872 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.87 177.74 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 65.01 111.141 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 1.1 t -179.46 -37.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 71.41 110.858 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 29.7 t0 63.5 161.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.106 -0.497 . . . . 61.32 110.806 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -74.47 131.09 40.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 73.21 110.903 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 20.5 m -66.85 138.26 57.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 54.54 111.111 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 2.8 t -103.55 134.31 47.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 63.22 111.09 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -126.42 150.88 48.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 63.41 110.845 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 68.3 m -139.33 131.98 28.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 73.44 110.887 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 264' ' ' VAL . . . . . 0.519 HG21 ' CG2' ' E' ' 267' ' ' VAL . 3.6 p -129.28 122.07 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 71.31 111.157 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.25 -78.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 71.33 110.862 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 266' ' ' THR . . . . . 0.526 HG22 ' CB ' ' E' ' 230' ' ' ASP . 72.5 p -143.48 135.83 27.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 64.42 111.212 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 267' ' ' VAL . . . . . 0.519 ' CG2' HG21 ' E' ' 264' ' ' VAL . 18.0 t -117.44 134.6 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 75.13 111.141 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 268' ' ' VAL . . . . . 0.407 HG22 ' CD ' ' E' ' 232' ' ' ARG . 47.4 t -126.74 119.97 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.3 111.126 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.89 133.27 10.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 73.44 112.548 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.79 126.4 32.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.815 0.34 . . . . 64.54 110.893 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.7 94.44 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 52.34 112.477 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 50.05 75.14 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.92 0.391 . . . . 75.44 110.86 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 7.6 t -114.79 145.6 41.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.474 . . . . 63.22 110.802 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 24.2 mtm-85 -130.85 127.3 38.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 75.14 110.913 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.674 ' CG2' HG12 ' E' ' 239' ' ' VAL . 21.3 t -116.53 125.3 73.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 62.34 111.165 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.514 HD21 ' HE1' ' D' ' 286' ' ' PHE . 0.3 OUTLIER -125.72 111.73 15.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 73.41 110.953 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 31.6 mm -112.9 103.69 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 51.23 111.155 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 137.66 -178.66 18.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.8 -0.714 . . . . 55.55 112.52 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -89.92 156.19 18.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 63.24 110.859 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -121.37 134.31 55.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 64.5 110.879 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -114.35 124.74 52.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 55.23 110.92 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 96.45 -20.79 48.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.795 -0.717 . . . . 44.15 112.512 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -72.96 -22.59 79.0 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 54.31 112.472 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 51.85 83.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 64.31 110.909 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 65.2 109.76 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 53.53 112.522 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 57.73 -168.02 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.351 . . . . 74.01 110.857 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 287' ' ' TRP . . . . . 0.476 ' CZ3' HD12 ' E' ' 276' ' ' LEU . 1.1 m-90 -47.78 -57.85 5.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 72.15 110.951 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -147.35 171.94 14.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 71.43 110.911 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -123.73 96.62 5.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 61.15 110.883 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -170.0 49.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 64.2 110.916 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -145.9 -178.93 6.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 71.42 110.885 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -156.73 142.14 17.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 73.12 110.868 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.67 -174.92 3.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 50.34 110.876 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.18 -175.0 1.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 73.14 110.874 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 70.44 110.921 -179.942 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.873 0.368 . . . . 74.13 110.92 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.626 ' O ' HD13 ' A' ' 219' ' ' ILE . 0.1 OUTLIER -117.89 107.06 13.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 73.01 110.873 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.626 HD13 ' O ' ' A' ' 218' ' ' LYS . 25.3 mm -135.43 150.0 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 74.15 111.053 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.49 -170.61 1.93 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 75.44 110.873 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -172.27 168.56 5.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 62.34 111.137 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.5 pt -152.18 179.37 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 72.03 111.142 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 38.6 t -58.05 141.11 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 75.21 111.083 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 52.99 76.84 0.16 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.742 . . . . 44.4 112.47 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.639 ' O ' HG23 ' A' ' 261' ' ' THR . 1.0 OUTLIER -175.76 121.11 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.794 0.331 . . . . 72.13 110.917 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -85.15 135.18 34.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 73.53 110.87 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 1.7 m -118.91 136.94 53.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 51.11 110.854 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.35 139.72 39.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.482 . . . . 72.54 111.063 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.95 -73.11 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 64.4 110.931 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -130.43 138.53 50.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 63.4 110.845 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.41 116.71 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 71.32 111.1 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -118.74 115.85 25.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 44.45 110.861 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.75 146.45 52.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.194 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.05 154.96 31.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 74.31 110.883 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 64.23 82.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 55.22 110.934 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 41.85 43.57 2.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.848 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.25 137.93 31.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.092 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 141.9 51.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 73.12 110.809 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.539 HG23 ' HB ' ' A' ' 275' ' ' VAL . 6.0 p -143.58 121.68 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 74.02 111.134 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -122.0 136.61 54.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 61.44 110.888 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.75 118.87 21.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 73.34 110.94 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.72 -120.39 1.05 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.739 . . . . 52.31 112.503 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -144.77 130.28 18.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 72.1 110.86 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -101.95 136.29 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 72.45 111.136 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 38.5 t -122.15 129.12 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 74.42 111.122 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.591 HG21 ' HB2' ' A' ' 284' ' ' LYS . 0.2 OUTLIER -99.92 163.1 12.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 73.42 111.136 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.03 -42.09 99.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 74.23 111.132 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.06 -36.01 70.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 74.25 111.083 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -52.45 -75.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 72.23 111.18 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.598 HD13 HD11 ' A' ' 254' ' ' ILE . 0.1 OUTLIER -179.2 -170.16 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 70.04 110.961 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.408 ' H ' HD23 ' A' ' 250' ' ' LEU . 29.6 m170 -68.82 -38.15 79.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 73.23 110.818 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -169.34 -43.36 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.75 -0.738 . . . . 71.33 112.464 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 164.93 171.81 31.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.693 -0.765 . . . . 74.23 112.501 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.598 HD11 HD13 ' A' ' 250' ' ' LEU . 3.8 mp -139.35 -62.39 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.875 0.369 . . . . 72.12 111.211 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -169.6 140.94 2.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 75.01 110.875 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 15.8 tt -163.05 143.77 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 74.23 111.132 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.6 148.97 21.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 71.12 110.929 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 55.46 -173.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 62.24 110.825 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.33 137.96 1.53 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 73.44 110.86 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.606 HG21 ' HB3' ' A' ' 279' ' ' ASN . 7.0 t -65.65 125.48 25.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 73.54 111.084 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 225' ' ' ARG . 91.9 m -112.79 108.85 18.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 75.23 111.186 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -104.96 138.91 40.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 73.12 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 92.4 p -140.48 123.87 16.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.53 110.833 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.65 HG21 ' CG2' ' A' ' 267' ' ' VAL . 9.6 p -108.26 149.77 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 74.23 111.137 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -102.44 -39.79 6.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 65.11 110.866 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.4 m -150.41 127.31 11.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.453 . . . . 62.1 111.099 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.65 ' CG2' HG21 ' A' ' 264' ' ' VAL . 80.9 t -121.28 120.19 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 61.13 111.08 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.02 129.48 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 73.13 111.206 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -139.73 133.26 5.98 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.764 -0.732 . . . . 71.22 112.49 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.89 147.39 51.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.877 0.37 . . . . 53.33 110.896 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 53.94 89.91 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.665 -0.779 . . . . 61.35 112.533 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 45.23 60.18 3.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 70.15 110.817 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 6.4 t -91.25 145.54 24.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 75.42 110.862 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -132.32 127.8 36.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 74.21 110.884 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.539 ' HB ' HG23 ' A' ' 239' ' ' VAL . 20.3 t -131.85 123.66 51.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 50.41 111.119 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.71 111.59 17.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 73.33 110.931 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 2.3 mp -107.17 104.29 16.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 75.11 111.117 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.04 -152.29 24.42 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.749 -0.738 . . . . 73.22 112.496 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.606 ' HB3' HG21 ' A' ' 260' ' ' THR . 1.6 p30 -127.81 151.52 48.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 75.31 110.878 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.03 124.69 48.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 72.4 110.886 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -106.91 125.86 51.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 74.54 110.923 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 112.65 -68.97 0.23 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.724 . . . . 74.35 112.522 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 101.33 -101.71 2.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.768 -0.729 . . . . 72.24 112.499 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.591 ' HB2' HG21 ' A' ' 246' ' ' THR . 0.0 OUTLIER 63.83 45.93 4.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 73.12 110.828 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.79 17.57 11.8 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.782 -0.723 . . . . 35.31 112.511 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.69 170.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.817 0.341 . . . . 71.32 110.828 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -61.38 -172.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.488 . . . . 75.22 110.915 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -58.69 98.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 72.33 110.857 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -147.74 -73.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 54.42 110.911 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -178.98 -170.54 0.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 73.43 110.923 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -73.19 -170.29 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 71.03 110.808 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -73.06 -68.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 64.34 110.839 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 55.07 -175.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 64.33 110.84 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -145.7 -70.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 74.03 110.858 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 64.43 110.831 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 217' ' ' MET . . . . . 0.713 ' N ' ' HH ' ' C' ' 281' ' ' TYR . 7.0 ttp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.784 0.326 . . . . 64.01 110.866 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.442 ' N ' HG22 ' C' ' 256' ' ' ILE . 0.7 OUTLIER -65.67 143.21 57.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 74.1 110.836 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 219' ' ' ILE . . . . . 0.654 HG13 HD12 ' B' ' 256' ' ' ILE . 1.0 OUTLIER -137.21 68.4 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 73.3 111.11 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.48 91.51 3.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 73.33 110.886 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.61 ' HB1' HD12 ' B' ' 222' ' ' ILE . . . -109.39 131.79 54.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 71.25 111.115 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 222' ' ' ILE . . . . . 0.61 HD12 ' HB1' ' B' ' 221' ' ' ALA . 4.5 mp 51.82 69.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 63.12 111.151 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.405 ' O ' HG13 ' B' ' 223' ' ' VAL . 6.7 p -176.81 122.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 74.13 111.151 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 152.46 -138.24 6.32 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.685 -0.769 . . . . 52.35 112.468 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.599 ' O ' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER -174.64 133.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 64.21 110.861 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -123.15 138.52 54.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 64.42 110.911 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.98 137.7 54.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 70.02 110.804 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 264' ' ' VAL . . . -132.87 140.39 47.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 65.01 111.064 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.07 -31.5 9.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 74.1 110.89 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -164.74 138.77 5.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 73.41 110.826 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 5.7 mt -137.25 121.5 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 71.41 111.099 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -134.06 118.23 17.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 70.01 110.828 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 128.89 32.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.055 -0.521 . . . . 75.4 111.169 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.03 166.86 22.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 74.44 110.888 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.71 71.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.43 110.899 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 46.16 48.19 12.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 72.21 110.804 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -98.48 149.46 22.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 71.22 111.104 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.44 142.88 47.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 75.44 110.843 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.58 HG23 ' HB ' ' B' ' 275' ' ' VAL . 7.3 p -139.58 132.08 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 53.43 111.164 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.546 ' C ' HD23 ' B' ' 241' ' ' LEU . 2.9 tt0 -127.01 137.23 53.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 63.3 110.827 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.546 HD23 ' C ' ' B' ' 240' ' ' GLN . 0.3 OUTLIER -122.19 118.56 28.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 73.11 110.915 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.68 -168.62 18.77 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 62.32 112.475 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -85.76 135.21 33.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.908 0.385 . . . . 73.12 110.881 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 3.3 m -117.72 118.83 59.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 71.35 111.115 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.488 HG21 HD11 ' B' ' 222' ' ' ILE . 21.6 t -104.82 120.17 54.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 74.02 111.124 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.615 HG22 ' HA3' ' B' ' 282' ' ' GLY . 6.0 t -90.76 172.17 8.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 74.0 111.115 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.444 ' HB2' ' H ' ' A' ' 284' ' ' LYS . . . -52.74 -41.81 64.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 72.43 111.055 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 248' ' ' ALA . . . . . 0.467 ' H ' HG23 ' B' ' 246' ' ' THR . . . -56.79 -36.05 69.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 74.2 111.08 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.464 ' HB2' ' CA ' ' B' ' 282' ' ' GLY . . . -82.08 93.21 6.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 45.44 111.114 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 1.4 tp -76.97 -169.96 1.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 75.51 110.924 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -52.13 119.61 4.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 70.03 110.897 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -169.1 -176.08 38.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.747 . . . . 71.04 112.469 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 86.9 104.95 0.82 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 71.22 112.507 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 254' ' ' ILE . . . . . 0.473 ' H ' HD12 ' B' ' 219' ' ' ILE . 18.4 tt -175.02 150.77 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.804 0.335 . . . . 62.21 111.101 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 63.06 -170.08 0.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 71.31 110.924 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 256' ' ' ILE . . . . . 0.654 HD12 HG13 ' B' ' 219' ' ' ILE . 26.8 mt 64.27 107.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 62.51 111.055 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.93 -170.27 0.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 72.13 110.84 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 63.31 103.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 74.4 110.91 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -101.89 164.8 11.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.13 110.911 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 7.0 t -99.3 137.44 37.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 71.14 111.142 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.599 HG23 ' O ' ' B' ' 225' ' ' ARG . 26.2 m -129.2 132.66 47.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 73.54 111.129 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -120.43 121.87 39.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.943 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 2.0 t -118.91 123.69 45.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 54.31 110.826 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.512 HG21 ' CG2' ' B' ' 267' ' ' VAL . 8.1 p -116.07 139.0 44.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 74.4 111.095 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.39 -75.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 74.12 110.86 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 24.3 m -124.09 130.47 52.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 72.22 111.127 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.512 ' CG2' HG21 ' B' ' 264' ' ' VAL . 94.0 t -118.06 122.8 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 74.2 111.121 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.39 129.14 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 62.21 111.199 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.74 132.76 6.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.699 -0.762 . . . . 53.11 112.412 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.7 147.52 51.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.873 0.368 . . . . 64.41 110.898 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.25 86.39 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.767 -0.73 . . . . 61.43 112.539 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 46.37 66.23 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 65.43 110.863 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 17.4 t -99.2 145.37 27.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 63.42 110.819 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 4.4 ttm-85 -129.76 127.88 41.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 74.5 110.805 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.58 ' HB ' HG23 ' B' ' 239' ' ' VAL . 18.7 t -129.49 123.58 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 65.45 111.134 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -126.88 111.93 14.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 72.45 110.919 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.501 ' CG1' HD13 ' C' ' 241' ' ' LEU . 2.2 mp -108.05 104.32 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 74.52 111.145 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.79 -141.49 8.88 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 71.42 112.472 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -127.99 156.1 43.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.776 0.322 . . . . 63.43 110.908 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -122.57 126.31 47.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 73.32 110.961 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.559 ' OH ' HG22 ' B' ' 219' ' ' ILE . 0.4 OUTLIER -109.82 127.93 54.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 60.23 110.952 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.615 ' HA3' HG22 ' B' ' 246' ' ' THR . . . 104.84 155.36 22.88 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.752 -0.737 . . . . 72.22 112.519 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 283' ' ' GLY . . . . . 0.691 ' H ' ' HB2' ' C' ' 247' ' ' ALA . . . -114.03 132.88 10.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.709 -0.758 . . . . 60.12 112.501 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -175.02 44.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.359 . . . . 73.51 110.875 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.04 26.87 27.62 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.72 -0.752 . . . . 62.32 112.523 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 62.34 165.26 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 73.44 110.855 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 38.6 p-90 -52.0 -32.56 34.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 75.43 110.924 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -75.95 149.01 37.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.844 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -89.89 -73.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 64.32 110.847 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -94.59 140.3 30.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.857 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -99.99 -68.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 54.03 110.872 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 51.84 87.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 75.35 110.789 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -102.3 -74.77 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 64.14 110.908 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.25 -169.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 53.2 110.879 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 75.51 110.879 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 2.5 tmm? . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.917 0.389 . . . . 74.33 110.849 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt 63.03 28.61 16.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 71.24 110.906 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 59.5 mt 61.35 80.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 75.22 111.137 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -159.76 89.33 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 74.34 110.843 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -172.56 -170.0 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 70.24 111.141 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 2.1 tt -100.42 -33.11 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 65.51 111.134 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 22.1 t 52.28 69.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 71.23 111.133 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 172.18 123.41 0.71 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.725 -0.75 . . . . 64.32 112.51 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -150.5 -74.61 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.347 . . . . 64.03 110.841 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.47 131.88 39.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 71.21 110.878 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.1 m -140.09 137.86 34.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 64.1 110.88 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.63 144.58 49.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 72.31 111.121 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -101.41 -25.78 13.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 70.24 110.935 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -164.86 138.58 4.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 74.33 110.811 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.562 ' CD1' HD21 ' C' ' 241' ' ' LEU . 10.8 mt -137.74 117.57 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 54.53 111.102 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -133.27 116.13 15.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 65.33 110.946 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.09 136.19 41.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.55 111.141 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -143.15 167.05 23.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.855 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 60.91 75.49 0.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 70.35 110.894 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 44.48 53.82 6.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 64.14 110.909 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.5 145.86 29.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 30.41 111.127 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.0 137.06 52.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 75.31 110.823 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.443 HG13 HG13 ' B' ' 275' ' ' VAL . 7.6 p -132.12 136.51 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 70.42 111.117 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.453 ' HB3' HD13 ' C' ' 276' ' ' LEU . 3.3 tp60 -132.42 135.49 46.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 73.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.562 HD21 ' CD1' ' C' ' 231' ' ' ILE . 1.3 mp -126.8 118.79 25.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.42 110.933 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.8 -169.58 18.71 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 53.3 112.545 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -99.0 143.06 29.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 74.42 110.876 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 19.0 m -120.81 139.27 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 62.23 111.156 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.511 ' CG1' ' HB3' ' C' ' 249' ' ' ALA . 38.6 t -121.93 120.67 62.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 55.13 111.146 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 246' ' ' THR . . . . . 0.609 HG23 ' O ' ' C' ' 281' ' ' TYR . 24.9 p -73.68 173.79 9.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 73.42 111.121 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.691 ' HB2' ' H ' ' B' ' 283' ' ' GLY . . . -63.16 -37.63 87.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 72.02 111.107 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.07 66.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 71.02 111.163 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 249' ' ' ALA . . . . . 0.511 ' HB3' ' CG1' ' C' ' 245' ' ' VAL . . . -56.62 -24.95 51.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 61.13 111.164 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 250' ' ' LEU . . . . . 0.484 HD11 ' CD2' ' B' ' 281' ' ' TYR . 0.1 OUTLIER -62.21 -42.14 99.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 73.32 110.929 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.19 138.99 33.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 65.11 110.793 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 129.04 -158.7 22.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.744 -0.741 . . . . 72.22 112.528 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -129.71 -119.49 2.15 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 63.34 112.52 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 15.2 mt 70.68 -70.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 72.33 111.148 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 255' ' ' ARG . . . . . 0.57 ' CG ' HD11 ' B' ' 256' ' ' ILE . 11.2 ttm180 63.17 104.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.835 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 256' ' ' ILE . . . . . 0.7 HD11 ' HB3' ' D' ' 255' ' ' ARG . 18.5 tt -124.17 150.84 28.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 60.33 111.069 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.07 -39.44 11.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 71.44 110.825 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.86 170.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 75.13 110.87 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -176.46 36.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 65.02 110.881 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 14.7 t -80.64 136.94 36.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 74.1 111.166 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.16 117.56 28.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 73.21 111.109 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.55 134.22 50.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.54 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 2.8 t -135.66 123.49 22.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 73.34 110.931 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.606 HG21 ' CG2' ' C' ' 267' ' ' VAL . 11.8 p -115.49 130.12 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 73.2 111.098 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -64.9 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 75.22 110.945 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 89.3 m -149.9 135.33 18.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 22.44 111.16 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.719 ' CG1' HG21 ' C' ' 275' ' ' VAL . 98.7 t -117.96 124.85 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 53.12 111.171 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.34 128.2 69.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 62.22 111.127 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.14 132.95 7.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.768 -0.729 . . . . 72.24 112.509 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -132.95 139.67 47.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.827 0.346 . . . . 70.43 110.873 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.08 73.52 0.37 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 74.12 112.495 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 63.35 100.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.852 0.358 . . . . 73.53 110.937 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 14.4 m -138.62 145.35 40.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 50.5 110.895 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -129.91 127.68 40.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 64.31 110.917 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.719 HG21 ' CG1' ' C' ' 267' ' ' VAL . 31.5 t -131.38 124.89 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 61.21 111.109 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.453 HD13 ' HB3' ' C' ' 240' ' ' GLN . 0.8 OUTLIER -124.59 111.47 15.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.23 -0.441 . . . . 70.22 110.969 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.713 HG13 HD23 ' D' ' 241' ' ' LEU . 2.6 mp -104.94 133.64 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 74.01 111.161 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.11 -146.67 18.85 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.761 -0.733 . . . . 72.51 112.452 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -128.11 146.27 50.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.338 . . . . 74.43 110.878 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -113.42 123.66 50.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 71.15 110.903 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.713 ' HH ' ' N ' ' B' ' 217' ' ' MET . 0.3 OUTLIER -103.95 125.65 50.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 65.53 110.913 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 111.62 -54.73 0.53 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.715 -0.755 . . . . 70.3 112.51 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 63.88 -116.66 9.46 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.711 -0.757 . . . . 60.23 112.493 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? 63.41 105.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.343 . . . . 64.51 110.896 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 62.39 60.39 7.95 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.745 -0.74 . . . . 70.23 112.477 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 51.74 -168.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.783 0.325 . . . . 74.53 110.909 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 31.8 m0 -50.69 -55.37 16.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.185 -0.461 . . . . 73.04 110.915 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -116.56 131.49 56.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 53.22 110.828 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -51.82 120.47 5.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 65.11 110.9 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -173.26 171.27 4.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 63.1 110.858 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -128.93 135.11 48.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 55.23 110.836 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -169.6 129.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 74.13 110.891 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -177.82 149.18 0.58 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 72.42 110.885 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -178.93 -170.76 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 74.11 110.894 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 64.04 110.879 179.93 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.857 0.36 . . . . 63.11 110.894 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 218' ' ' LYS . . . . . 0.411 ' O ' ' CG1' ' D' ' 219' ' ' ILE . 0.5 OUTLIER -179.23 -45.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 63.2 110.903 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 219' ' ' ILE . . . . . 0.411 ' CG1' ' O ' ' D' ' 218' ' ' LYS . 22.3 pt 43.38 -164.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 73.34 111.085 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.0 -72.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 75.4 110.869 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -153.73 122.32 6.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 71.51 111.068 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 222' ' ' ILE . . . . . 0.537 HD13 ' H ' ' D' ' 222' ' ' ILE . 0.1 OUTLIER -143.39 179.12 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 75.53 111.16 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 62.2 t -115.67 -71.25 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 73.42 111.13 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -91.14 153.51 22.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 64.21 112.512 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.71 ' O ' HG23 ' D' ' 261' ' ' THR . 0.1 OUTLIER -179.41 133.48 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 74.12 110.839 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -83.53 140.63 32.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 64.32 110.893 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 1.4 p -139.95 139.0 36.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 62.13 110.871 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.63 159.77 29.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 62.4 111.087 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 229' ' ' LYS . . . . . 0.419 ' HB2' ' HA ' ' D' ' 265' ' ' GLU . 0.3 OUTLIER -112.32 -29.61 7.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 64.35 110.9 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 230' ' ' ASP . . . . . 0.498 ' HB3' HG23 ' D' ' 266' ' ' THR . 5.1 t0 -166.48 137.99 3.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 64.05 110.875 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 231' ' ' ILE . . . . . 0.415 ' CD1' HG23 ' C' ' 264' ' ' VAL . 13.8 mt -137.42 117.53 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 74.12 111.204 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -134.69 120.39 19.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.947 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.18 150.45 50.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 64.31 111.175 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 234' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' D' ' 237' ' ' ALA . 9.7 pm0 -157.15 167.29 30.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 64.41 110.917 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 61.22 72.21 0.53 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 75.23 110.885 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 45.28 40.86 5.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 74.3 110.881 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 237' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' D' ' 234' ' ' GLU . . . -88.52 144.16 26.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 73.41 111.146 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -125.63 135.83 52.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 72.1 110.89 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.42 139.59 35.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 73.4 111.14 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 240' ' ' GLN . . . . . 0.634 ' HB3' HD13 ' D' ' 276' ' ' LEU . 2.7 tt0 -131.0 137.28 49.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 64.03 110.942 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 1.029 HD12 HD12 ' D' ' 277' ' ' ILE . 0.6 OUTLIER -118.3 118.72 32.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 64.32 110.874 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.79 175.45 15.78 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.759 -0.734 . . . . 74.42 112.549 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -86.02 150.06 24.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.937 0.399 . . . . 74.14 110.822 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 244' ' ' VAL . . . . . 0.467 HG23 ' HA ' ' D' ' 280' ' ' GLU . 16.9 m -123.87 138.32 53.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 63.32 111.193 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.14 128.94 75.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 62.13 111.094 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 12.3 t -74.0 175.25 7.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 63.51 111.081 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.84 -44.4 77.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 73.32 111.071 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 248' ' ' ALA . . . . . 0.876 ' HB1' HD12 ' D' ' 250' ' ' LEU . . . -57.45 -52.03 67.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.422 . . . . 73.32 111.122 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.72 30.04 6.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 74.02 111.095 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 250' ' ' LEU . . . . . 0.876 HD12 ' HB1' ' D' ' 248' ' ' ALA . 0.2 OUTLIER -62.67 148.25 47.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 63.15 110.93 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -179.09 155.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 71.13 110.866 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 252' ' ' GLY . . . . . 0.708 ' HA3' HD11 ' E' ' 250' ' ' LEU . . . -52.53 -27.66 26.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 32.01 112.492 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -170.63 175.12 44.55 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.696 -0.764 . . . . 53.52 112.486 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 4.6 pt -51.73 167.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 72.23 111.16 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 255' ' ' ARG . . . . . 0.7 ' HB3' HD11 ' C' ' 256' ' ' ILE . 0.0 OUTLIER -52.3 153.65 2.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 63.24 110.843 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 256' ' ' ILE . . . . . 0.677 HD12 HD11 ' E' ' 256' ' ' ILE . 23.8 mm -114.41 61.41 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 61.41 111.095 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 14.4 m 51.65 40.18 26.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 55.03 110.827 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 72.44 -69.33 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 73.35 110.809 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 72.21 -68.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 70.24 110.958 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 3.3 t -64.83 137.49 57.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 63.02 111.181 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 261' ' ' THR . . . . . 0.71 HG23 ' O ' ' D' ' 225' ' ' ARG . 94.0 m -132.57 134.74 45.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 60.34 111.127 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 262' ' ' ASN . . . . . 0.479 ' HB3' HG22 ' D' ' 277' ' ' ILE . 0.4 OUTLIER -119.04 121.48 39.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 70.22 110.873 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.57 123.99 42.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 75.05 110.795 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.645 HG23 ' CD1' ' E' ' 231' ' ' ILE . 8.6 p -120.05 146.49 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 71.12 111.163 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 265' ' ' GLU . . . . . 0.419 ' HA ' ' HB2' ' D' ' 229' ' ' LYS . 15.1 mt-10 -88.76 -73.79 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 72.14 110.876 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 266' ' ' THR . . . . . 0.498 HG23 ' HB3' ' D' ' 230' ' ' ASP . 73.2 m -139.85 129.88 24.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 52.31 111.142 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.713 ' CG1' HG21 ' D' ' 275' ' ' VAL . 16.9 t -117.31 120.59 65.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 72.43 111.134 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.59 124.13 72.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 53.51 111.176 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.51 132.21 9.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 71.31 112.512 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -134.04 140.24 46.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 75.54 110.911 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 46.7 87.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 73.24 112.494 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 50.04 75.74 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.914 0.388 . . . . 71.41 110.93 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 35.9 t -107.1 145.45 32.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.07 -0.514 . . . . 60.34 110.844 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -132.67 127.64 35.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 74.42 110.903 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.713 HG21 ' CG1' ' D' ' 267' ' ' VAL . 61.6 t -136.81 124.1 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 63.14 111.119 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.634 HD13 ' HB3' ' D' ' 240' ' ' GLN . 3.6 mm? -121.45 111.61 17.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 70.5 110.917 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 1.029 HD12 HD12 ' D' ' 241' ' ' LEU . 22.4 mt -103.99 114.38 43.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 65.13 111.145 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.6 -162.12 24.07 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.663 -0.78 . . . . 42.45 112.469 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -116.47 145.58 43.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.786 0.327 . . . . 72.02 110.932 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 280' ' ' GLU . . . . . 0.467 ' HA ' HG23 ' D' ' 244' ' ' VAL . 35.8 tt0 -111.89 132.37 54.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 70.42 110.907 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -110.02 125.38 52.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 75.31 110.918 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 132.06 177.99 15.24 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.725 . . . . 63.21 112.516 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -138.21 111.3 0.8 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.722 -0.751 . . . . 33.24 112.459 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -156.78 22.74 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.339 . . . . 73.13 110.874 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 67.49 121.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.824 -0.703 . . . . 72.52 112.488 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 51.77 -169.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.873 0.368 . . . . 74.41 110.841 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -76.34 -25.56 54.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.108 -0.496 . . . . 62.54 110.916 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -119.06 155.3 31.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 63.02 110.85 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -52.08 -32.25 34.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 73.42 110.835 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.92 132.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 75.43 110.836 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -167.12 138.44 3.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 54.4 110.806 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 56.51 -177.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 51.11 110.788 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -131.81 -169.99 2.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.821 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 10.3 m170 62.82 171.79 0.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.811 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 71.12 110.793 -179.98 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 1.3 ptp . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.878 0.37 . . . . 74.22 110.842 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.58 143.29 45.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 60.44 110.948 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 1.1 pp -149.83 151.32 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 70.32 111.137 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.44 -171.84 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 73.42 110.831 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 221' ' ' ALA . . . . . 0.468 ' O ' HD13 ' E' ' 222' ' ' ILE . . . -143.64 156.72 44.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.41 111.104 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 222' ' ' ILE . . . . . 0.468 HD13 ' O ' ' E' ' 221' ' ' ALA . 45.9 mm -138.02 143.37 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 74.43 111.081 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 91.6 t -146.4 99.98 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 75.22 111.099 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 71.78 -128.48 14.87 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.818 -0.706 . . . . 73.44 112.518 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 58.85 -170.15 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.35 . . . . 63.43 110.914 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -83.93 112.51 20.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 72.24 110.8 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 6.3 p -129.34 158.96 37.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 70.43 110.878 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 228' ' ' ALA . . . . . 0.48 ' HB2' HD22 ' E' ' 241' ' ' LEU . . . -131.69 164.73 25.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 75.31 111.113 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.42 -39.32 4.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 70.01 110.921 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 230' ' ' ASP . . . . . 0.649 ' HB2' HG22 ' E' ' 266' ' ' THR . 0.3 OUTLIER -166.79 141.43 4.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 44.43 110.901 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 231' ' ' ILE . . . . . 0.645 ' CD1' HG23 ' D' ' 264' ' ' VAL . 3.4 mp -137.22 116.26 15.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 71.43 111.135 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -131.24 118.83 20.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 72.23 110.889 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 233' ' ' THR . . . . . 0.411 ' HB ' ' HB1' ' E' ' 237' ' ' ALA . 0.0 OUTLIER -135.99 128.96 31.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 71.34 111.125 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -140.49 158.32 44.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 74.43 110.944 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 63.08 79.31 0.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 75.31 110.918 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.2 50.04 9.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 75.22 110.899 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 237' ' ' ALA . . . . . 0.411 ' HB1' ' HB ' ' E' ' 233' ' ' THR . . . -104.71 141.55 36.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 74.13 111.094 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -126.39 139.6 53.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 75.41 110.868 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.712 HG23 ' HB ' ' E' ' 275' ' ' VAL . 8.9 p -143.71 141.48 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 71.42 111.124 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 240' ' ' GLN . . . . . 0.579 ' HB3' HD13 ' E' ' 276' ' ' LEU . 2.5 tt0 -138.33 137.16 37.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 74.02 110.892 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.632 HD23 HG11 ' E' ' 264' ' ' VAL . 1.8 mp -120.43 118.61 30.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.226 -0.443 . . . . 62.53 110.89 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 124.43 168.28 12.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 33.0 112.472 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -86.84 163.14 17.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.907 0.385 . . . . 75.22 110.881 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.16 139.39 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 71.41 111.117 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.63 127.95 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 52.1 111.08 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t -70.03 171.18 9.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 53.22 111.179 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.12 -38.72 92.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 53.44 111.168 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.94 -36.05 69.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 72.53 111.093 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 60.55 -179.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 53.54 111.019 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 250' ' ' LEU . . . . . 0.708 HD11 ' HA3' ' D' ' 252' ' ' GLY . 0.4 OUTLIER -52.87 170.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 73.04 110.922 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -51.91 -68.89 0.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 64.4 110.896 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -172.98 162.89 34.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.796 -0.716 . . . . 75.45 112.489 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 75.46 157.61 6.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.769 -0.729 . . . . 75.34 112.455 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 254' ' ' ILE . . . . . 0.573 HG22 HG13 ' E' ' 256' ' ' ILE . 66.2 mt -64.8 125.25 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.796 0.331 . . . . 72.44 111.123 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.88 112.46 25.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 70.24 110.858 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 256' ' ' ILE . . . . . 0.677 HD11 HD12 ' D' ' 256' ' ' ILE . 44.5 mt -146.59 97.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 75.34 111.107 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -178.57 139.5 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 71.42 110.83 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 64.11 157.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 73.54 110.881 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -149.86 128.26 12.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 74.35 110.884 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 8.8 t -101.39 129.15 47.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.435 . . . . 65.52 111.2 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 60.6 m -105.39 128.44 53.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 73.25 111.088 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -125.98 131.22 52.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 70.44 110.922 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 23.1 t -128.51 121.02 27.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 72.23 110.906 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 264' ' ' VAL . . . . . 0.632 HG11 HD23 ' E' ' 241' ' ' LEU . 8.8 p -104.37 123.09 58.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 72.23 111.127 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 265' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -65.59 -143.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 70.34 110.828 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 266' ' ' THR . . . . . 0.649 HG22 ' HB2' ' E' ' 230' ' ' ASP . 14.8 p -92.46 130.02 38.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 74.43 111.126 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 267' ' ' VAL . . . . . 1.028 HG11 HG21 ' E' ' 275' ' ' VAL . 19.5 t -114.84 131.15 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 70.43 111.075 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 52.4 t -122.73 116.76 49.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.135 -0.484 . . . . 73.34 111.112 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -108.06 132.68 11.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.808 -0.71 . . . . 73.11 112.512 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -132.3 115.46 15.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.84 0.352 . . . . 62.34 110.903 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.08 94.12 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.734 -0.746 . . . . 61.41 112.452 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 52.02 87.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.895 0.378 . . . . 61.02 110.909 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 33.3 t -125.66 145.85 49.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 64.31 110.877 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -136.63 128.16 28.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 60.33 110.906 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 1.028 HG21 HG11 ' E' ' 267' ' ' VAL . 96.8 t -136.62 125.34 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 74.0 111.099 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' E' ' 240' ' ' GLN . 3.7 mm? -123.36 116.11 22.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.98 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.497 HD12 ' O ' ' E' ' 240' ' ' GLN . 2.0 mp -109.01 140.8 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.43 111.168 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 112.58 -158.06 14.54 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.792 -0.718 . . . . 71.13 112.495 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -128.19 156.54 42.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.352 . . . . 73.41 110.904 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -111.69 121.81 46.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 73.21 110.882 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -106.23 125.94 51.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.116 -0.493 . . . . 73.5 110.946 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 134.57 172.21 12.74 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.67 -0.776 . . . . 74.3 112.501 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -74.4 -164.37 11.07 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.771 -0.728 . . . . 65.05 112.519 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.07 -75.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 62.21 110.862 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.6 174.78 29.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.707 -0.759 . . . . 74.42 112.539 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 1.5 t80 63.95 158.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 73.33 110.816 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -81.54 57.06 3.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 74.31 110.894 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -179.11 -171.86 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 71.11 110.858 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -109.7 -170.14 1.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 75.54 110.847 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -51.96 112.97 0.87 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 64.15 110.917 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.48 -170.59 3.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 63.32 110.864 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -60.54 -175.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 72.24 110.854 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -55.34 128.49 34.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 54.23 110.803 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -176.36 123.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 74.41 110.898 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 73.0 110.863 179.984 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.853 0.359 . . . . 54.23 110.903 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -178.5 -35.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 71.13 110.923 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.7 tt -152.17 150.37 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 65.33 111.144 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 1.3 t0 63.29 161.81 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 75.03 110.857 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.432 ' O ' HD13 ' A' ' 222' ' ' ILE . . . -79.52 133.52 36.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 63.34 111.129 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.432 HD13 ' O ' ' A' ' 221' ' ' ALA . 24.8 mm -120.96 151.1 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 60.55 111.144 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 4.9 m -149.74 173.88 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 73.11 111.161 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 133.47 89.73 0.39 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.781 -0.723 . . . . 62.4 112.489 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -69.17 85.33 0.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.846 0.355 . . . . 55.43 110.863 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.498 ' HB3' HG22 ' A' ' 277' ' ' ILE . 0.0 OUTLIER -142.24 136.44 29.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 65.01 110.924 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.46 137.09 54.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 72.0 110.901 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.28 131.07 41.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 52.44 111.099 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.81 -28.35 13.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.21 110.867 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.552 ' HB3' HG23 ' A' ' 266' ' ' THR . 1.8 m-20 -166.01 137.3 3.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 74.45 110.899 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 11.1 mt -137.97 117.81 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 62.43 111.139 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -127.67 123.14 34.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.499 . . . . 70.44 110.846 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.632 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.5 OUTLIER -135.56 162.28 33.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 72.13 111.091 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -153.66 167.96 27.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 75.53 110.873 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.66 -69.83 0.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 75.45 110.858 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -178.68 37.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 62.42 110.873 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.632 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -70.52 152.17 44.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 74.14 111.087 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.38 135.64 51.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 45.01 110.868 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.634 HG12 ' HB ' ' A' ' 275' ' ' VAL . 18.7 m -129.45 121.52 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 75.45 111.144 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -119.56 134.15 55.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 75.42 110.884 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 241' ' ' LEU . 6.0 mp -125.65 118.83 26.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 74.44 110.9 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.35 -170.88 22.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.73 . . . . 64.3 112.474 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.88 128.82 34.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 63.22 110.859 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.538 HG11 HD11 ' A' ' 276' ' ' LEU . 1.6 p -123.61 121.98 63.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 73.45 111.134 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.423 ' CG2' ' HB3' ' A' ' 249' ' ' ALA . 6.8 p -119.23 129.04 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 70.2 111.107 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 14.2 t -87.03 162.89 17.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 72.12 111.205 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.14 -34.0 67.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 74.2 111.08 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.94 -36.27 70.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.3 -0.409 . . . . 65.23 111.089 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.739 ' HB2' ' HA3' ' A' ' 282' ' ' GLY . . . -61.8 96.62 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 64.14 111.101 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.79 97.24 0.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 72.43 110.915 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 59.76 73.35 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 74.23 110.787 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -77.02 88.15 0.98 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.799 -0.715 . . . . 74.34 112.463 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.51 37.68 3.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.731 -0.747 . . . . 61.31 112.443 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.1 mp 52.06 68.83 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.846 0.355 . . . . 65.23 111.166 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -91.34 66.06 5.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 73.23 110.843 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 12.4 tt -172.47 -37.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 74.34 111.131 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.07 89.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 75.41 110.855 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.46 -32.13 7.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 72.41 110.86 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 56.76 57.54 4.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 72.42 110.923 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 20.7 p -99.14 138.07 36.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 53.12 111.121 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 95.4 m -107.13 132.59 52.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 72.1 111.151 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.11 119.93 36.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 64.4 110.902 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.1 p -130.09 123.43 30.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 72.34 110.853 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.617 ' HA ' ' HB3' ' B' ' 228' ' ' ALA . 11.5 p -109.3 134.43 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 74.23 111.19 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -74.28 -78.17 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 62.31 110.886 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.552 HG23 ' HB3' ' A' ' 230' ' ' ASP . 36.8 m -136.7 132.18 34.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.33 111.128 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 1.061 HG11 HG21 ' A' ' 275' ' ' VAL . 33.3 t -118.42 120.9 65.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.23 -0.441 . . . . 63.21 111.143 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.22 119.46 60.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 74.21 111.153 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.8 133.52 10.91 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.752 -0.737 . . . . 64.41 112.514 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -116.06 116.28 27.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 73.41 110.989 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.83 83.25 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.757 -0.735 . . . . 65.32 112.537 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 67.08 120.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 74.44 110.898 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.5 t -156.32 145.27 20.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 64.22 110.831 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.73 126.65 46.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 62.31 110.876 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 1.061 HG21 HG11 ' A' ' 267' ' ' VAL . 98.5 t -137.54 123.75 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 64.35 111.079 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.538 HD11 HG11 ' A' ' 244' ' ' VAL . 1.0 OUTLIER -122.8 120.15 32.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 75.23 110.901 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.739 ' CD1' HD13 ' B' ' 241' ' ' LEU . 24.9 mm -112.32 103.74 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 72.35 111.144 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.9 -154.95 25.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.772 -0.728 . . . . 41.12 112.512 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -111.06 151.88 27.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.732 0.301 . . . . 73.13 110.901 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.744 ' HG2' HG22 ' B' ' 244' ' ' VAL . 0.0 OUTLIER -128.1 134.86 49.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 72.34 110.831 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.471 ' HA ' HG13 ' B' ' 245' ' ' VAL . 0.4 OUTLIER -122.22 134.61 54.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 73.33 110.941 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.739 ' HA3' ' HB2' ' A' ' 249' ' ' ALA . . . 82.21 164.03 33.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 40.34 112.441 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 141.26 136.54 3.3 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.788 -0.72 . . . . 61.22 112.522 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -51.79 -45.87 63.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.861 0.362 . . . . 61.22 110.889 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -132.48 -43.24 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.777 -0.725 . . . . 64.51 112.517 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -174.3 -165.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 73.53 110.837 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.47 ' NE1' HD12 ' A' ' 276' ' ' LEU . 15.8 t90 -46.29 -74.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.503 . . . . 74.32 110.915 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.42 66.05 2.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 71.22 110.898 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -51.62 110.01 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 74.25 110.941 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -142.07 -48.94 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 74.32 110.859 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 62.93 104.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.834 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.99 149.48 32.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 52.44 110.847 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -165.01 173.71 11.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 62.34 110.832 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.16 -173.92 0.3 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.254 -0.43 . . . . 74.23 110.784 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 71.55 110.843 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 217' ' ' MET . . . . . 0.584 ' CE ' HG22 ' C' ' 254' ' ' ILE . 1.5 ptt? . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.877 0.37 . . . . 74.22 110.851 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.634 ' O ' HD13 ' B' ' 219' ' ' ILE . 3.1 mttt -175.82 153.14 1.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 75.3 110.911 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 219' ' ' ILE . . . . . 0.634 HD13 ' O ' ' B' ' 218' ' ' LYS . 24.9 mm -135.43 150.14 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 72.12 111.162 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.37 -58.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.04 110.861 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.34 -176.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 32.51 111.121 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 10.0 pt -51.8 168.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 73.32 111.075 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.812 HG12 ' HB3' ' B' ' 259' ' ' GLN . 5.4 m -138.57 106.34 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 64.31 111.088 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 68.13 128.0 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.694 -0.765 . . . . 65.55 112.572 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -155.93 87.6 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.908 0.385 . . . . 74.23 110.852 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.07 109.95 18.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 74.2 110.808 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.31 137.77 54.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 74.32 110.892 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 264' ' ' VAL . . . -124.71 150.05 46.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 73.14 111.026 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -113.94 -32.78 5.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 62.11 110.977 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 230' ' ' ASP . . . . . 0.575 ' HB3' HG23 ' B' ' 266' ' ' THR . 0.4 OUTLIER -165.43 137.82 4.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 63.23 110.873 179.834 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 7.7 mt -138.15 117.38 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 65.14 111.167 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -129.52 124.45 33.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 64.34 110.849 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.624 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 0.1 OUTLIER -135.32 163.58 29.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 74.3 111.157 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -148.94 167.99 24.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 75.44 110.948 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.58 -72.19 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 72.55 110.9 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.99 40.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 75.01 110.84 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -69.9 156.71 38.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.446 . . . . 62.25 111.058 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.41 135.12 52.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 74.3 110.871 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.652 ' CG2' HG22 ' A' ' 275' ' ' VAL . 30.0 m -131.81 133.09 61.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 70.15 111.146 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.442 ' C ' HD12 ' B' ' 241' ' ' LEU . 1.9 tt0 -127.95 137.03 52.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 70.43 110.883 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.739 HD13 ' CD1' ' A' ' 277' ' ' ILE . 6.5 mp -125.85 118.28 25.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 74.1 110.905 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.62 -168.14 23.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.802 -0.713 . . . . 73.41 112.512 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -85.86 142.48 28.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.357 . . . . 73.04 110.926 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.744 HG22 ' HG2' ' A' ' 280' ' ' GLU . 2.9 t -125.68 120.58 57.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 52.52 111.171 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.471 HG13 ' HA ' ' A' ' 281' ' ' TYR . 5.5 p -122.08 120.19 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 63.24 111.147 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 11.0 t -74.1 165.67 24.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 71.24 111.142 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.92 76.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 42.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.33 74.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 43.44 111.064 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -54.06 -28.28 37.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 63.23 111.075 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 1.4 tt -88.16 132.13 34.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 72.41 110.927 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -176.77 -35.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 75.33 110.898 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 113.0 131.68 5.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.762 -0.732 . . . . 62.43 112.483 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 167.06 -26.56 0.15 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.744 -0.741 . . . . 52.33 112.51 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 37.4 mt 63.49 86.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 72.0 111.123 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -178.38 110.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 73.45 110.918 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 pp -150.18 174.11 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 64.25 111.097 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -178.92 131.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 62.03 110.908 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.88 142.42 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 72.04 110.85 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 259' ' ' GLN . . . . . 0.812 ' HB3' HG12 ' B' ' 223' ' ' VAL . 1.9 pt20 -174.11 40.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 60.4 110.958 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.715 HG23 ' HB3' ' C' ' 225' ' ' ARG . 27.6 m -100.96 126.86 47.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 73.23 111.176 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 4.4 t -92.65 133.48 35.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.51 111.151 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.418 ' ND2' ' HA2' ' B' ' 278' ' ' GLY . 0.6 OUTLIER -126.56 129.77 49.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 64.32 110.887 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 12.9 t -132.98 123.58 26.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 64.02 110.77 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.772 ' HA ' ' HB3' ' C' ' 228' ' ' ALA . 10.3 p -105.86 135.21 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 74.53 111.211 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -77.71 -77.41 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 71.24 110.863 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.575 HG23 ' HB3' ' B' ' 230' ' ' ASP . 18.5 m -134.7 132.26 38.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.44 111.207 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.902 HG11 HG21 ' B' ' 275' ' ' VAL . 23.9 t -118.0 120.84 65.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 54.4 111.169 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.54 120.37 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 75.32 111.117 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.63 133.2 11.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.692 -0.766 . . . . 70.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -116.92 116.5 27.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.809 0.338 . . . . 74.43 110.94 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.96 83.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 55.53 112.505 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 66.5 119.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.826 0.346 . . . . 75.24 110.883 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 22.9 t -156.27 146.77 21.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 73.01 110.847 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -124.24 127.03 47.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 73.22 110.803 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.902 HG21 HG11 ' B' ' 267' ' ' VAL . 87.8 t -137.6 123.15 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 75.21 111.059 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.55 HD12 ' CZ2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -120.97 122.41 40.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 75.14 110.887 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 27.4 mm -112.55 103.68 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 62.13 111.137 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.418 ' HA2' ' ND2' ' B' ' 262' ' ' ASN . . . 152.05 -139.96 7.42 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.758 -0.734 . . . . 74.33 112.53 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -128.31 145.56 51.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 71.43 110.876 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.737 ' CG ' HG13 ' C' ' 244' ' ' VAL . 0.4 OUTLIER -117.03 135.91 53.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 70.15 110.837 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.412 ' HA ' HG13 ' C' ' 245' ' ' VAL . 0.3 OUTLIER -120.64 125.7 48.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 75.22 110.933 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 65.57 174.14 4.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 74.11 112.497 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 137.59 -6.94 3.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 71.01 112.521 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.37 70.93 0.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.367 . . . . 74.13 110.883 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 127.27 -109.33 1.06 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 53.44 112.507 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -121.58 -75.1 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.792 0.33 . . . . 52.41 110.883 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.55 ' CZ2' HD12 ' B' ' 276' ' ' LEU . 0.1 OUTLIER -96.06 -64.85 1.01 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 62.31 110.896 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -122.53 -41.95 2.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 73.1 110.871 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -177.82 -67.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 75.02 110.886 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 16.0 t60 61.78 85.19 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 64.21 110.848 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.82 -178.07 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 75.34 110.89 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -164.38 -178.79 5.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 52.54 110.803 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -155.03 160.78 41.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 63.24 110.817 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.83 -175.2 2.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 64.33 110.809 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 5.3 t60 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 74.21 110.857 -179.975 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 12.5 ttt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.781 0.324 . . . . 70.31 110.826 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -90.54 109.18 20.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 71.51 110.875 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 2.2 mp -105.66 118.65 53.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 54.42 111.054 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.67 -173.81 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 71.4 110.859 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -83.2 136.09 34.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 74.01 111.067 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 62.3 mt -82.57 121.53 35.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 72.22 111.091 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 33.4 m -74.18 -32.26 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 53.35 111.152 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 94.36 116.02 2.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.734 . . . . 65.44 112.442 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.715 ' HB3' HG23 ' B' ' 260' ' ' THR . 4.3 mmt85 -137.19 -42.07 0.57 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.764 0.316 . . . . 72.1 110.878 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.465 HD21 HD12 ' C' ' 241' ' ' LEU . 3.3 t-20 -140.08 119.58 13.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 74.43 110.898 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 58.8 m -129.87 141.79 50.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 54.45 110.911 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.772 ' HB3' ' HA ' ' B' ' 264' ' ' VAL . . . -124.95 146.54 49.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 64.24 111.108 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.72 ' HE3' HG21 ' D' ' 222' ' ' ILE . 0.1 OUTLIER -110.26 -37.86 5.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 75.45 110.899 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 230' ' ' ASP . . . . . 0.674 ' HB3' HG22 ' C' ' 266' ' ' THR . 4.5 t0 -165.24 137.29 4.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 71.23 110.845 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.97 117.45 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.455 . . . . 73.04 111.189 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -130.73 126.1 35.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 63.23 110.855 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.671 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 0.1 OUTLIER -135.22 164.02 28.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 70.34 111.156 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -144.61 168.6 19.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 73.4 110.828 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.54 -74.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 75.51 110.871 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.27 38.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 74.35 110.824 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.671 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -69.64 157.09 37.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.301 -0.409 . . . . 72.44 111.116 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.76 134.55 52.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 72.3 110.852 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.659 ' CG2' HG22 ' B' ' 275' ' ' VAL . 18.2 m -127.25 122.09 59.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 55.31 111.091 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.94 123.61 49.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 75.5 110.921 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.465 HD12 HD21 ' C' ' 226' ' ' ASN . 4.2 mm? -111.66 119.14 37.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 40.22 110.919 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 122.2 -168.14 14.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.773 -0.727 . . . . 24.43 112.522 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -86.14 149.71 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 60.21 110.94 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.737 HG13 ' CG ' ' B' ' 280' ' ' GLU . 78.9 t -126.35 122.19 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 72.3 111.126 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.412 HG13 ' HA ' ' B' ' 281' ' ' TYR . 7.2 p -116.63 129.27 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 74.43 111.099 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 12.8 p -78.68 165.07 24.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.491 . . . . 72.3 111.103 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.21 -34.0 76.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 73.53 111.071 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.81 -40.4 75.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 63.12 111.062 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.74 104.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 53.11 111.166 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -178.75 -69.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 43.22 110.883 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.03 -175.52 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 53.34 110.836 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 70.16 53.68 13.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.783 -0.722 . . . . 71.24 112.462 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 142.9 -52.4 0.64 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.685 -0.769 . . . . 64.11 112.466 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 254' ' ' ILE . . . . . 0.584 HG22 ' CE ' ' B' ' 217' ' ' MET . 32.8 mt 55.55 75.73 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.369 . . . . 75.31 111.146 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -167.5 98.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 73.41 110.936 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.59 135.53 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 73.22 111.159 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 1.6 t -177.66 158.67 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 74.44 110.838 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.4 145.06 1.6 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 75.51 110.846 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -146.91 29.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 61.11 110.908 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.26 137.55 32.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 73.23 111.148 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 96.1 m -105.41 131.38 52.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 75.52 111.178 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.411 ' ND2' ' HA2' ' C' ' 278' ' ' GLY . 0.3 OUTLIER -126.05 136.99 53.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 64.33 110.831 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 46.5 t -142.11 123.8 15.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 70.42 110.911 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.492 ' HA ' ' HB3' ' D' ' 228' ' ' ALA . 9.0 p -106.15 138.28 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 74.32 111.139 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' C' ' 229' ' ' LYS . 2.9 tt0 -78.49 -76.63 0.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 74.54 110.927 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 266' ' ' THR . . . . . 0.674 HG22 ' HB3' ' C' ' 230' ' ' ASP . 40.9 p -134.95 132.25 38.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.093 -0.503 . . . . 73.15 111.111 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.731 HG11 HG21 ' C' ' 275' ' ' VAL . 97.6 t -117.44 120.68 65.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 70.14 111.171 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.95 119.65 61.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 74.01 111.141 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.52 133.27 11.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.682 -0.77 . . . . 61.52 112.513 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -115.66 116.39 28.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.791 0.329 . . . . 73.43 110.919 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.49 86.52 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.731 -0.747 . . . . 35.42 112.493 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.68 118.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 74.32 110.91 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 37.4 t -157.22 149.1 22.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 70.25 110.818 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 -126.58 127.02 44.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 74.5 110.897 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.731 HG21 HG11 ' C' ' 267' ' ' VAL . 98.7 t -138.2 123.85 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 44.41 111.146 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.636 HD12 ' HE1' ' C' ' 287' ' ' TRP . 0.9 OUTLIER -125.98 122.51 36.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 73.43 110.942 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.468 ' N ' HD23 ' C' ' 276' ' ' LEU . 13.7 mm -112.4 104.18 16.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.262 -0.426 . . . . 72.02 111.077 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 278' ' ' GLY . . . . . 0.411 ' HA2' ' ND2' ' C' ' 262' ' ' ASN . . . 149.02 -178.38 26.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.682 -0.77 . . . . 65.23 112.483 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -89.63 145.02 25.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.783 0.325 . . . . 73.34 110.889 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.637 ' CG ' HG22 ' D' ' 244' ' ' VAL . 5.5 pt-20 -120.43 125.79 48.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 51.5 110.896 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.471 ' HA ' HG13 ' D' ' 245' ' ' VAL . 26.2 t80 -115.55 140.13 49.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 74.3 110.939 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.55 59.12 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.71 -0.757 . . . . 53.11 112.473 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -68.29 87.29 0.19 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.75 -0.738 . . . . 61.42 112.441 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -58.66 98.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 71.24 110.967 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 62.95 104.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 44.53 112.457 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.83 -166.45 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.799 0.333 . . . . 74.52 110.872 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.636 ' HE1' HD12 ' C' ' 276' ' ' LEU . 0.1 OUTLIER -50.62 -43.68 56.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 74.25 110.945 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -173.79 -170.03 0.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 43.52 110.824 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -144.73 -74.34 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 70.2 110.918 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.07 -171.51 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 71.25 110.899 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -98.29 -32.71 11.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 74.22 110.894 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.58 -177.36 4.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 70.24 110.808 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -157.53 132.7 8.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 74.14 110.848 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -166.76 113.07 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 75.44 110.865 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 72.54 110.838 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.808 0.337 . . . . 75.32 110.883 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.03 99.85 2.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.405 . . . . 64.53 110.921 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 2.2 mp -115.4 142.91 26.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.296 -0.411 . . . . 74.43 111.161 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -173.44 142.75 1.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 63.2 110.811 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . 62.12 102.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 74.21 111.094 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 222' ' ' ILE . . . . . 0.72 HG21 ' HE3' ' C' ' 229' ' ' LYS . 4.2 mp -139.08 67.35 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 74.31 111.174 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 12.3 m -152.16 163.21 2.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.149 -0.478 . . . . 61.31 111.087 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 162.13 -179.34 37.52 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.7 -0.762 . . . . 62.34 112.507 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.555 ' HA ' HG23 ' D' ' 261' ' ' THR . 3.5 mmt85 -54.66 -64.31 0.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.785 0.326 . . . . 61.54 110.887 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -83.59 121.94 27.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 70.41 110.844 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.68 137.85 45.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 62.33 110.82 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 228' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' C' ' 264' ' ' VAL . . . -131.13 133.31 45.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.052 -0.522 . . . . 52.33 111.072 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -96.9 -30.97 12.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 75.15 110.872 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 230' ' ' ASP . . . . . 0.729 ' HB3' HG23 ' D' ' 266' ' ' THR . 3.6 t0 -166.35 137.08 3.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 73.13 110.865 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 10.4 mt -139.48 117.07 11.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 63.5 111.081 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.4 126.38 38.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 70.53 110.885 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 233' ' ' THR . . . . . 0.738 ' HB ' ' HB3' ' D' ' 237' ' ' ALA . 2.1 p -135.81 164.36 28.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 75.44 111.147 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -145.57 168.76 19.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 72.23 110.921 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 73.35 -75.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 71.33 110.912 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.73 47.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 71.54 110.881 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 237' ' ' ALA . . . . . 0.738 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -77.32 156.82 31.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 70.43 111.105 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.05 134.46 52.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.883 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.773 HG12 ' HB ' ' D' ' 275' ' ' VAL . 6.2 m -126.87 121.45 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 72.23 111.194 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.92 127.88 55.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 62.22 110.898 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.8 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.1 mm? -116.0 117.89 31.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 55.32 110.932 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.98 -166.89 21.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 44.54 112.479 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -98.85 128.95 45.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 52.34 110.934 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 244' ' ' VAL . . . . . 0.637 HG22 ' CG ' ' C' ' 280' ' ' GLU . 95.5 t -102.8 124.97 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.14 111.152 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 245' ' ' VAL . . . . . 0.471 HG13 ' HA ' ' C' ' 281' ' ' TYR . 7.1 p -122.08 128.0 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 64.25 111.199 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -69.63 175.03 4.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 65.23 111.235 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.43 97.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 62.11 111.056 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.17 -40.09 76.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 61.33 111.088 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 56.64 -175.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 42.24 111.142 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.91 115.13 10.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 74.35 110.94 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -101.67 27.0 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.786 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -112.4 -46.97 0.72 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.809 -0.71 . . . . 64.25 112.496 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -147.85 158.31 27.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 73.44 112.487 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 1.1 pt -92.24 148.42 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.84 0.352 . . . . 61.22 111.157 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.46 -170.3 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 73.41 110.836 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 29.7 mm 64.0 106.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 62.12 111.135 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.37 -170.54 1.66 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.103 -0.499 . . . . 54.21 110.878 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.85 178.96 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 75.44 110.791 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.92 25.36 0.49 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.138 -0.483 . . . . 74.12 110.834 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 260' ' ' THR . . . . . 0.552 HG21 ' OD1' ' E' ' 243' ' ' ASN . 0.2 OUTLIER -100.18 129.52 46.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 71.24 111.138 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 261' ' ' THR . . . . . 0.555 HG23 ' HA ' ' D' ' 225' ' ' ARG . 29.2 m -96.39 120.81 37.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 62.31 111.099 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 262' ' ' ASN . . . . . 0.739 ' OD1' HG22 ' D' ' 277' ' ' ILE . 0.5 OUTLIER -121.66 135.93 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 53.44 110.897 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 263' ' ' SER . . . . . 0.526 ' OG ' HD11 ' E' ' 222' ' ' ILE . 3.8 m -142.16 124.92 15.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 64.03 110.798 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.612 ' HA ' ' HB3' ' E' ' 228' ' ' ALA . 7.2 p -104.95 122.04 57.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 75.15 111.125 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -56.38 -82.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.924 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 266' ' ' THR . . . . . 0.729 HG23 ' HB3' ' D' ' 230' ' ' ASP . 10.7 m -128.4 137.45 51.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.163 -0.471 . . . . 31.44 111.157 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.757 HG11 HG21 ' D' ' 275' ' ' VAL . 64.4 t -118.21 120.68 65.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 72.35 111.154 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 15.0 t -117.45 116.89 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 62.45 111.121 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.24 133.03 11.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.716 -0.754 . . . . 42.32 112.456 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.36 119.28 35.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.828 0.347 . . . . 65.42 110.866 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.09 78.52 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 73.22 112.459 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 68.76 125.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 64.24 110.904 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 12.8 t -156.52 160.59 39.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 73.55 110.891 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.21 127.04 32.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 75.12 110.879 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.773 ' HB ' HG12 ' D' ' 239' ' ' VAL . 89.8 t -137.76 123.64 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 64.22 111.188 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.694 HD12 ' HE1' ' D' ' 287' ' ' TRP . 0.9 OUTLIER -127.73 124.12 37.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 74.21 110.934 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.8 ' HB ' HD13 ' D' ' 241' ' ' LEU . 20.0 mm -112.27 104.88 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.44 111.101 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.21 -144.21 11.83 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.753 -0.737 . . . . 73.11 112.507 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -123.51 139.99 53.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 75.52 110.893 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 280' ' ' GLU . . . . . 0.758 ' CG ' HG13 ' E' ' 244' ' ' VAL . 11.0 pt-20 -111.89 134.27 53.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 73.54 110.962 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 281' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' E' ' 249' ' ' ALA . 17.0 t80 -125.42 125.11 42.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 73.12 110.897 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.3 -150.18 16.96 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.76 -0.734 . . . . 34.22 112.479 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 59.74 18.2 44.92 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.737 -0.744 . . . . 70.32 112.52 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 7.2 mttp 52.46 29.44 7.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.901 0.381 . . . . 73.14 110.93 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.77 127.59 6.14 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.735 -0.745 . . . . 64.34 112.423 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 t80 59.09 175.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.828 0.347 . . . . 71.32 110.88 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 287' ' ' TRP . . . . . 0.694 ' HE1' HD12 ' D' ' 276' ' ' LEU . 0.9 OUTLIER -51.47 -34.94 37.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 74.43 110.951 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -142.12 165.56 27.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 61.14 110.893 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -106.66 157.89 17.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 62.33 110.925 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -171.99 152.75 3.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 74.23 110.868 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -131.6 166.97 20.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 73.1 110.865 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -147.77 -65.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 60.14 110.82 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.62 134.21 34.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 74.01 110.857 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.36 130.31 40.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 75.12 110.906 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 74.34 110.82 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 1.3 tpt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.844 0.354 . . . . 55.23 110.864 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.58 116.87 29.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 74.02 110.877 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 219' ' ' ILE . . . . . 0.611 HG22 HD13 ' D' ' 222' ' ' ILE . 1.0 OUTLIER -137.64 175.41 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 72.52 111.148 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -177.57 79.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 60.33 110.828 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -178.19 130.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 70.21 111.081 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 222' ' ' ILE . . . . . 0.526 HD11 ' OG ' ' D' ' 263' ' ' SER . 6.7 tp -174.99 131.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 64.54 111.103 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 7.4 p -177.39 138.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 55.13 111.163 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -175.52 -176.97 44.21 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.776 -0.726 . . . . 72.12 112.535 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 45.5 mmt-85 -73.4 -57.26 4.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 72.54 110.913 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 226' ' ' ASN . . . . . 0.592 ' HB3' HD12 ' E' ' 241' ' ' LEU . 21.5 m-80 -83.76 116.39 22.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 62.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.22 143.07 50.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 72.52 110.895 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 228' ' ' ALA . . . . . 0.612 ' HB3' ' HA ' ' D' ' 264' ' ' VAL . . . -130.82 136.22 48.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 64.35 111.146 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -88.08 -41.72 12.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 75.5 110.879 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -173.44 138.52 0.7 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 71.5 110.873 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 231' ' ' ILE . . . . . 0.538 HG23 ' HB ' ' E' ' 267' ' ' VAL . 5.8 mt -132.61 117.8 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 53.43 111.105 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 232' ' ' ARG . . . . . 0.679 ' HD2' HG13 ' E' ' 268' ' ' VAL . 0.1 OUTLIER -126.96 124.27 39.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 73.4 110.824 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 233' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' E' ' 237' ' ' ALA . 5.0 p -135.86 164.73 27.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 65.24 111.086 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -142.13 167.97 20.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.134 -0.484 . . . . 75.34 110.874 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 72.96 -75.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.804 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -179.76 71.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 63.32 110.857 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 237' ' ' ALA . . . . . 0.591 ' HB3' ' HB ' ' E' ' 233' ' ' THR . . . -101.64 157.02 17.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 62.42 111.095 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.15 134.29 53.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.964 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.753 HG12 ' HB ' ' E' ' 275' ' ' VAL . 4.9 m -128.96 121.81 55.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 71.23 111.075 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -113.96 129.7 56.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.914 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.654 HD13 ' HB ' ' E' ' 277' ' ' ILE . 1.3 mm? -115.25 118.24 32.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 75.12 110.988 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 242' ' ' GLY . . . . . 0.432 ' HA2' ' ND2' ' E' ' 226' ' ' ASN . . . 128.55 -149.78 18.42 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.749 -0.739 . . . . 73.02 112.478 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 243' ' ' ASN . . . . . 0.552 ' OD1' HG21 ' D' ' 260' ' ' THR . 4.9 m120 -106.68 130.45 54.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.869 0.366 . . . . 74.21 110.877 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.758 HG13 ' CG ' ' D' ' 280' ' ' GLU . 84.4 t -105.89 127.4 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.168 -0.469 . . . . 54.22 111.134 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 245' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' D' ' 281' ' ' TYR . 5.0 p -122.68 124.34 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 72.21 111.169 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 246' ' ' THR . . . . . 0.544 HG21 ' C ' ' E' ' 282' ' ' GLY . 8.8 t -70.03 169.64 12.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 72.42 111.129 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.83 -33.9 51.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 44.44 111.159 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.73 -52.1 66.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.42 111.108 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 249' ' ' ALA . . . . . 0.51 ' HB2' ' CE2' ' D' ' 281' ' ' TYR . . . 61.76 -178.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 55.54 111.082 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.85 120.15 28.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.939 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -55.09 154.48 5.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 73.14 110.877 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 165.34 166.97 25.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 73.23 112.451 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -102.94 -72.77 0.94 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.702 -0.761 . . . . 54.43 112.475 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 16.9 tt -143.83 130.5 16.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 71.43 111.107 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 255' ' ' ARG . . . . . 0.552 ' O ' HD13 ' E' ' 256' ' ' ILE . 0.0 OUTLIER -178.14 166.76 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 61.21 110.87 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 256' ' ' ILE . . . . . 0.552 HD13 ' O ' ' E' ' 255' ' ' ARG . 30.6 mm -126.27 134.48 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 63.23 111.16 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 3.7 m -59.38 -178.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 61.04 110.83 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.61 179.95 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 71.53 110.888 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -126.9 25.38 6.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 72.41 110.945 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 27.8 p -72.13 137.84 47.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 75.42 111.121 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.18 108.79 21.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.02 111.155 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.65 123.14 49.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 74.32 110.931 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 13.6 t -132.59 136.93 46.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 75.13 110.859 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.5 136.59 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.102 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -65.49 -105.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 74.03 110.937 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 85.5 m -117.11 138.05 51.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 73.44 111.152 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 267' ' ' VAL . . . . . 0.724 HG11 HG21 ' E' ' 275' ' ' VAL . 73.8 t -117.78 118.23 57.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 71.42 111.149 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 268' ' ' VAL . . . . . 0.679 HG13 ' HD2' ' E' ' 232' ' ' ARG . 0.6 OUTLIER -118.22 114.56 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 71.4 111.091 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.58 131.59 10.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.704 -0.76 . . . . 74.01 112.467 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -114.43 124.29 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 73.42 110.841 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 57.47 68.15 1.85 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 63.1 112.457 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 67.46 129.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.846 0.355 . . . . 62.43 110.849 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 10.5 t -156.92 161.22 39.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 74.13 110.877 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -129.9 127.82 40.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.23 110.846 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.753 ' HB ' HG12 ' E' ' 239' ' ' VAL . 90.5 t -138.88 128.83 32.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 42.33 111.163 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.715 HD12 ' HE1' ' E' ' 287' ' ' TRP . 0.4 OUTLIER -128.71 127.68 42.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 63.44 110.933 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.654 ' HB ' HD13 ' E' ' 241' ' ' LEU . 43.7 mm -112.23 118.19 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 71.03 111.128 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 121.63 -157.7 16.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 44.24 112.487 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -91.76 156.02 17.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 64.03 110.865 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -134.18 135.71 43.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 73.45 110.947 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 281' ' ' TYR . . . . . 0.536 ' CD1' HG22 ' E' ' 246' ' ' THR . 50.2 t80 -125.64 124.62 41.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 75.01 110.97 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 282' ' ' GLY . . . . . 0.544 ' C ' HG21 ' E' ' 246' ' ' THR . . . -121.76 175.26 16.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.782 -0.723 . . . . 50.3 112.505 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 283' ' ' GLY . . . . . 0.526 ' N ' HG21 ' E' ' 246' ' ' THR . . . -94.98 7.65 70.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.73 . . . . 43.5 112.507 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.53 -44.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.833 0.349 . . . . 52.45 110.929 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 147.66 148.47 4.76 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.697 -0.763 . . . . 71.15 112.431 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 1.2 t80 56.45 -175.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 73.22 110.853 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 287' ' ' TRP . . . . . 0.715 ' HE1' HD12 ' E' ' 276' ' ' LEU . 0.4 OUTLIER -51.85 -30.71 24.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.136 -0.484 . . . . 75.33 110.892 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -153.55 -74.54 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 65.13 110.868 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 6.2 t30 56.69 -170.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 62.42 110.952 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -135.69 -169.99 2.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 71.4 110.846 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 2.0 t60 63.3 161.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 61.12 110.832 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.73 63.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.21 110.882 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -92.65 44.02 1.14 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 73.1 110.853 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -158.61 26.34 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 72.32 110.818 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 19.1 m170 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 63.04 110.839 -179.988 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.859 0.361 . . . . 74.02 110.89 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -147.38 119.97 8.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 74.25 110.884 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.7 tt -157.18 23.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 51.41 111.113 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.16 -170.09 0.16 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.21 -0.45 . . . . 75.23 110.883 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.551 ' C ' HD12 ' A' ' 222' ' ' ILE . . . -170.39 -174.9 1.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 75.34 111.103 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.551 HD12 ' C ' ' A' ' 221' ' ' ALA . 1.9 mp 62.11 46.65 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 71.3 111.142 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.2 t -150.23 142.63 17.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.15 111.134 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -52.74 135.27 38.61 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.751 . . . . 54.04 112.491 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -174.51 154.79 2.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.34 . . . . 70.4 110.893 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.733 ' OD1' HG22 ' A' ' 277' ' ' ILE . 44.3 m-80 -127.78 122.59 33.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.52 110.906 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.54 138.58 54.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 62.15 110.836 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.32 119.92 11.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.066 -0.515 . . . . 62.24 111.1 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.83 -34.42 45.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.441 . . . . 64.24 110.879 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -165.55 138.81 4.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 62.11 110.928 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.692 HG22 ' CG1' ' A' ' 267' ' ' VAL . 36.5 pt -136.32 132.99 49.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 70.21 111.068 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -134.19 123.52 24.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 75.3 110.921 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -135.52 128.52 31.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 61.31 111.143 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -138.2 166.43 24.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 72.34 110.903 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 66.4 68.75 0.43 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 72.54 110.859 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 49.81 32.9 5.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 64.34 110.921 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.45 156.01 20.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 51.33 111.09 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -139.28 148.04 42.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 70.5 110.821 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.585 HG23 ' HB ' ' A' ' 275' ' ' VAL . 3.1 p -134.86 121.72 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 75.14 111.058 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.77 135.75 53.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.54 110.938 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 mp -130.09 118.87 22.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 70.11 110.914 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 140.81 177.42 16.15 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.741 . . . . 62.2 112.511 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -88.2 128.85 35.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 72.22 110.821 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.09 133.37 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 63.44 111.111 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.524 ' CG1' ' HB3' ' A' ' 249' ' ' ALA . 97.8 t -122.04 129.08 75.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 33.35 111.071 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t -72.93 164.02 27.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 73.13 111.182 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.93 -33.84 76.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 75.23 111.095 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ALA . . . . . 0.451 ' HB2' ' NZ ' ' A' ' 284' ' ' LYS . . . -56.74 -35.89 69.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 65.42 111.097 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.524 ' HB3' ' CG1' ' A' ' 245' ' ' VAL . . . -72.02 -24.67 61.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 64.2 111.147 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 22.2 tp -51.94 103.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 71.43 110.975 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -162.95 -63.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 72.2 110.865 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -96.33 162.23 22.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.678 -0.772 . . . . 61.12 112.452 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.65 34.4 5.15 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.706 -0.759 . . . . 73.23 112.438 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 7.9 tp -56.95 -25.41 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 62.21 111.09 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.486 ' C ' HD12 ' A' ' 256' ' ' ILE . 13.3 mtm180 63.17 104.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 71.13 110.865 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.486 HD12 ' C ' ' A' ' 255' ' ' ARG . 5.2 mp 61.24 93.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 74.33 111.183 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 77.8 p -102.32 26.5 7.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 64.24 110.88 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -137.19 -178.02 5.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 64.1 110.822 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.13 25.29 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 71.24 110.952 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.441 HG21 ' C ' ' B' ' 242' ' ' GLY . 96.2 m -81.54 135.45 35.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 51.04 111.139 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.3 t -132.56 132.09 42.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 71.22 111.134 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.76 ' OD1' HG23 ' A' ' 277' ' ' ILE . 4.2 t-20 -126.1 149.17 49.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 73.12 110.903 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.3 t -142.36 123.1 14.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 64.13 110.835 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.661 HG21 ' CD1' ' B' ' 231' ' ' ILE . 9.2 p -122.08 124.1 70.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 72.44 111.08 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.45 -70.65 0.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 74.14 110.85 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 95.1 m -131.63 128.29 38.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 63.1 111.166 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.692 ' CG1' HG22 ' A' ' 231' ' ' ILE . 7.2 p -123.23 125.19 71.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 64.44 111.208 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.58 135.64 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 74.01 111.103 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.43 133.81 7.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 51.12 112.427 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.08 148.34 52.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 71.24 110.902 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.7 88.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.75 -0.738 . . . . 72.3 112.468 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 43.26 57.42 3.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.879 0.371 . . . . 73.24 110.852 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.74 145.3 28.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 52.03 110.829 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.12 127.33 47.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 52.02 110.896 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.585 ' HB ' HG23 ' A' ' 239' ' ' VAL . 10.0 t -120.61 123.66 70.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 74.33 111.159 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.13 111.23 14.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 75.3 110.898 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.76 HG23 ' OD1' ' A' ' 262' ' ' ASN . 4.5 mp -113.17 104.79 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 62.32 111.134 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.42 -161.65 26.93 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 74.02 112.493 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.62 156.18 21.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.301 . . . . 72.25 110.961 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.642 ' CG ' HG12 ' B' ' 244' ' ' VAL . 2.2 pp20? -130.37 147.32 52.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.854 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.502 ' CD1' HD21 ' B' ' 250' ' ' LEU . 8.2 m-85 -126.73 125.83 42.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 55.21 110.912 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 144.19 147.94 4.78 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.745 -0.741 . . . . 72.15 112.477 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.438 ' N ' ' H ' ' B' ' 247' ' ' ALA . . . -121.75 25.59 6.8 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 73.52 112.502 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.451 ' NZ ' ' HB2' ' A' ' 248' ' ' ALA . 0.0 OUTLIER -110.03 43.01 1.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 45.41 110.917 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 146.88 -19.85 1.61 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.836 -0.697 . . . . 75.52 112.549 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.441 ' CZ ' HG21 ' B' ' 244' ' ' VAL . 11.3 t80 72.26 -68.93 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 70.12 110.84 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -141.91 -44.09 0.35 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 72.22 110.905 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.44 174.35 3.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 75.11 110.867 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -52.39 152.37 3.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 64.04 110.815 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.43 -170.89 3.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 74.42 110.905 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -83.24 -169.98 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 70.42 110.865 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -168.03 66.39 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.891 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -175.96 131.43 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 61.45 110.863 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.1 176.18 0.9 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 73.12 110.791 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.152 -0.476 . . . . 75.11 110.94 179.937 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.804 0.335 . . . . 60.04 110.921 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 -169.92 2.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 51.24 110.872 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 219' ' ' ILE . . . . . 0.438 HD11 ' N ' ' B' ' 254' ' ' ILE . 7.7 tt -51.67 123.84 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 72.4 111.103 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.17 -169.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 51.43 110.892 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.56 -169.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 64.02 111.114 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 222' ' ' ILE . . . . . 0.568 HG21 ' HA ' ' B' ' 257' ' ' SER . 0.2 OUTLIER -124.52 -75.27 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 61.33 111.149 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.498 HG21 HG23 ' A' ' 222' ' ' ILE . 6.8 p -177.51 144.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.31 111.164 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -131.43 147.71 18.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 74.23 112.512 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.77 134.96 25.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.767 0.318 . . . . 71.31 110.791 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.712 ' OD1' HG22 ' B' ' 277' ' ' ILE . 14.7 m-80 -142.21 128.5 19.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.879 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.95 137.62 54.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 71.14 110.843 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.35 119.99 12.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 73.45 111.091 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -34.8 52.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 62.44 110.849 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -165.67 136.56 3.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 71.03 110.868 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.715 HG22 HG12 ' B' ' 267' ' ' VAL . 27.6 pt -138.57 129.87 36.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 60.14 111.163 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.97 125.69 32.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 74.21 110.906 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 2.7 p -135.67 128.65 31.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 72.04 111.114 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -136.93 166.77 22.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 75.12 110.9 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 64.51 75.06 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 65.44 110.906 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 45.43 36.17 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.55 110.849 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.2 155.63 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.21 111.083 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -140.95 153.74 45.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 74.21 110.901 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.516 HG23 ' HB ' ' B' ' 275' ' ' VAL . 6.0 p -139.55 121.78 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 62.24 111.174 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -117.08 134.9 54.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 72.13 110.837 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.549 HD22 HD21 ' A' ' 262' ' ' ASN . 2.5 mp -130.44 135.33 47.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 75.23 110.92 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.441 ' C ' HG21 ' A' ' 260' ' ' THR . . . 133.55 -124.86 3.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 65.43 112.514 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 243' ' ' ASN . . . . . 0.44 ' N ' HG21 ' A' ' 260' ' ' THR . 26.8 t30 -145.49 131.38 19.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.915 0.388 . . . . 60.25 110.909 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.642 HG12 ' CG ' ' A' ' 280' ' ' GLU . 18.1 m -114.07 122.8 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 73.43 111.12 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 98.4 t -122.37 129.51 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 51.14 111.086 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.493 HG23 ' H ' ' B' ' 249' ' ' ALA . 13.9 t -69.6 162.59 27.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 71.44 111.12 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.438 ' H ' ' N ' ' A' ' 283' ' ' GLY . . . -63.34 -33.88 76.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 63.51 111.101 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.12 81.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 72.33 111.068 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.493 ' H ' HG23 ' B' ' 246' ' ' THR . . . -51.55 -32.88 29.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 71.43 111.11 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.502 HD21 ' CD1' ' A' ' 281' ' ' TYR . 47.3 mt -51.82 -45.06 63.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 75.22 110.918 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -104.93 141.24 36.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 72.51 110.853 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 153.26 -125.76 1.84 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.703 -0.761 . . . . 71.15 112.434 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 164.8 73.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.68 -0.771 . . . . 33.32 112.468 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 254' ' ' ILE . . . . . 0.438 ' N ' HD11 ' B' ' 219' ' ' ILE . 26.4 pt -146.12 136.95 18.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 74.31 111.157 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -78.24 136.2 37.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 72.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 32.4 mm -109.1 149.47 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 24.41 111.121 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 257' ' ' SER . . . . . 0.568 ' HA ' HG21 ' B' ' 222' ' ' ILE . 0.3 OUTLIER -157.35 -175.18 5.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 63.53 110.868 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 13.6 t70 58.15 86.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 72.44 110.877 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 259' ' ' GLN . . . . . 0.454 ' CB ' HG13 ' B' ' 223' ' ' VAL . 3.8 pt20 -70.04 135.54 49.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 72.12 110.925 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.689 HG21 ' H ' ' C' ' 243' ' ' ASN . 58.3 m -100.61 133.51 44.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 72.35 111.135 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 87.3 m -134.27 133.19 40.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 62.41 111.12 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.724 ' OD1' HG23 ' B' ' 277' ' ' ILE . 12.5 t-20 -126.48 134.26 50.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 73.23 110.906 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 15.1 m -128.75 123.55 33.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 74.53 110.906 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.488 ' HA ' ' HB3' ' C' ' 228' ' ' ALA . 7.6 p -119.47 141.49 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 73.32 111.155 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.75 -57.63 3.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.86 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 72.3 p -150.2 126.83 10.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 65.02 111.171 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.784 HG23 ' HB ' ' C' ' 231' ' ' ILE . 12.2 p -123.81 135.11 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 73.14 111.11 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 60.5 t -127.14 132.91 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.11 111.161 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.79 134.58 8.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.781 -0.723 . . . . 72.12 112.541 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -132.96 148.59 52.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.744 0.306 . . . . 72.55 110.925 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.58 88.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.746 . . . . 43.41 112.451 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 45.18 62.72 2.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.387 . . . . 64.24 110.867 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 17.0 t -94.67 145.52 24.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 64.4 110.817 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.12 127.48 41.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 64.31 110.925 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.626 HG12 ' CD1' ' B' ' 277' ' ' ILE . 6.2 t -122.67 122.75 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.15 111.141 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.35 114.26 20.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 64.13 110.955 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.724 HG23 ' OD1' ' B' ' 262' ' ' ASN . 3.8 mp -112.41 104.29 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.4 111.12 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.93 -163.48 26.97 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.691 -0.766 . . . . 61.34 112.519 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -110.64 156.18 21.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 53.44 110.841 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.614 ' HG3' HG12 ' C' ' 244' ' ' VAL . 0.4 OUTLIER -127.38 145.72 50.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 62.12 110.891 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -123.06 125.84 45.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 71.22 110.916 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.63 147.11 4.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.666 -0.778 . . . . 74.43 112.449 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 283' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' C' ' 247' ' ' ALA . . . -106.74 -22.75 7.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 62.25 112.541 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -52.07 -29.71 22.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.729 0.299 . . . . 75.44 110.862 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -161.85 112.78 0.53 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.68 -0.772 . . . . 43.01 112.456 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -51.79 -29.82 20.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.842 0.353 . . . . 75.32 110.837 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -157.5 84.28 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.47 . . . . 71.23 110.935 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.2 t0 62.88 -169.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 62.32 110.842 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -64.24 123.1 18.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 61.21 110.897 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -156.29 26.98 0.35 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.888 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 52.47 -170.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 72.12 110.841 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -127.18 123.59 37.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 63.04 110.887 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -60.13 -175.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 71.5 110.857 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -170.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 62.24 110.834 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 22.3 m170 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.892 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.872 0.368 . . . . 63.04 110.927 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 218' ' ' LYS . . . . . 0.477 ' C ' HD12 ' C' ' 219' ' ' ILE . 33.6 mmtt -120.78 -51.35 2.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 62.01 110.907 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.477 HD12 ' C ' ' C' ' 218' ' ' LYS . 4.3 mp 62.22 82.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 72.12 111.122 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -117.35 71.28 0.8 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 73.12 110.853 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -167.76 39.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 61.31 111.095 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 222' ' ' ILE . . . . . 1.121 HD13 HD13 ' D' ' 219' ' ' ILE . 1.2 pt -138.52 -179.32 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 71.14 111.082 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 223' ' ' VAL . . . . . 0.831 HG23 HD12 ' C' ' 222' ' ' ILE . 86.8 t 60.53 92.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 75.53 111.148 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 103.57 44.77 1.63 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 73.34 112.512 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 69.2 mmt-85 -140.58 -167.85 2.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.845 0.355 . . . . 72.33 110.859 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -82.74 121.03 26.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 73.34 110.949 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.4 m -121.23 144.47 48.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 75.24 110.893 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.488 ' HB3' ' HA ' ' B' ' 264' ' ' VAL . . . -140.78 153.93 46.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 73.2 111.153 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.19 -34.75 4.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 71.41 110.948 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 230' ' ' ASP . . . . . 0.615 ' HB3' HG23 ' C' ' 266' ' ' THR . 4.9 t0 -165.09 139.3 4.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 64.33 110.877 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.784 ' HB ' HG23 ' B' ' 267' ' ' VAL . 0.5 OUTLIER -136.02 117.2 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 70.14 111.052 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.91 115.86 21.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 74.33 110.903 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.78 128.8 39.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 70.34 111.087 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -137.65 166.42 23.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 62.42 110.944 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 61.48 74.43 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 71.33 110.909 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 45.38 49.94 10.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 64.33 110.817 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.24 147.11 27.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 54.42 111.114 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -134.54 141.16 46.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 71.33 110.885 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.661 HG23 ' HB ' ' C' ' 275' ' ' VAL . 5.7 p -135.01 121.55 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 75.33 111.138 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.606 ' HB3' HD22 ' C' ' 276' ' ' LEU . 4.3 tm0? -116.27 124.68 50.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 74.54 110.896 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.665 HD12 HD13 ' C' ' 277' ' ' ILE . 0.2 OUTLIER -112.38 118.98 36.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.21 -0.45 . . . . 65.51 110.852 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.41 179.94 17.73 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.745 -0.741 . . . . 73.13 112.455 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.689 ' H ' HG21 ' B' ' 260' ' ' THR . 4.6 t30 -89.66 150.06 22.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 61.31 110.886 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.614 HG12 ' HG3' ' B' ' 280' ' ' GLU . 33.2 m -127.97 129.33 69.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 71.15 111.133 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 89.2 t -122.2 129.45 75.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 74.54 111.129 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 13.2 t -69.92 175.17 4.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 55.34 111.172 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.413 ' HB2' ' H ' ' B' ' 283' ' ' GLY . . . -62.37 -41.38 98.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 55.5 111.077 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.9 -52.54 64.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 64.35 111.12 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 249' ' ' ALA . . . . . 0.441 ' O ' HD12 ' C' ' 250' ' ' LEU . . . 52.2 26.94 4.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 54.24 111.072 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 250' ' ' LEU . . . . . 0.441 HD12 ' O ' ' C' ' 249' ' ' ALA . 0.2 OUTLIER 179.9 -169.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 70.43 110.862 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -175.72 -53.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 55.34 110.879 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.57 -36.71 0.28 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 64.24 112.502 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -68.27 -151.8 0.35 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 64.01 112.47 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 3.8 mp -134.71 -41.14 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.339 . . . . 75.44 111.138 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 2.4 ptt-85 -125.63 163.65 22.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 70.32 110.896 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 45.4 pt -139.9 175.53 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 73.23 111.154 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 20.0 m -156.08 -74.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 71.24 110.898 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 59.73 97.62 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 64.11 110.86 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -117.99 81.23 1.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 75.33 110.922 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 260' ' ' THR . . . . . 0.457 HG21 ' HB3' ' C' ' 279' ' ' ASN . 7.6 p -100.98 122.4 43.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 74.21 111.16 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 88.8 m -100.55 114.78 28.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 74.13 111.151 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.746 ' OD1' HG23 ' C' ' 277' ' ' ILE . 6.4 t-20 -126.29 144.35 50.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.43 110.933 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 47.3 t -139.03 123.02 17.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 61.32 110.818 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.739 ' HA ' ' HB3' ' D' ' 228' ' ' ALA . 7.6 p -111.11 126.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 72.23 111.097 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.83 -77.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 71.15 110.898 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 266' ' ' THR . . . . . 0.615 HG23 ' HB3' ' C' ' 230' ' ' ASP . 16.3 m -131.39 130.27 42.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 72.54 111.094 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.617 HG22 ' HB ' ' D' ' 231' ' ' ILE . 0.9 OUTLIER -118.27 130.92 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 72.25 111.108 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.51 133.08 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 42.43 111.106 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -133.25 132.78 6.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.689 -0.767 . . . . 64.4 112.516 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -132.17 142.38 49.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 72.34 110.926 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.76 78.78 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.768 -0.73 . . . . 73.11 112.483 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 58.66 96.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.858 0.361 . . . . 74.41 110.883 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 14.1 m -134.42 145.39 48.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.867 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.01 128.13 35.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 75.35 110.897 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.661 ' HB ' HG23 ' C' ' 239' ' ' VAL . 7.2 t -125.84 123.6 64.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 62.22 111.082 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.2 OUTLIER -123.06 117.29 25.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 72.11 110.908 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.746 HG23 ' OD1' ' C' ' 262' ' ' ASN . 3.1 mp -112.84 131.01 65.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 74.13 111.158 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 123.44 -152.02 17.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.798 -0.715 . . . . 72.21 112.445 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 279' ' ' ASN . . . . . 0.457 ' HB3' HG21 ' C' ' 260' ' ' THR . 9.5 p-10 -124.58 156.37 37.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.795 0.331 . . . . 73.31 110.877 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -121.03 139.04 53.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 64.25 110.852 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -123.41 126.43 46.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 71.02 110.934 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 282' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' D' ' 247' ' ' ALA . . . 136.84 -34.28 2.23 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 74.33 112.488 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 52.32 47.76 55.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.756 -0.735 . . . . 71.53 112.45 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 57.89 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 74.33 110.864 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.81 -79.21 0.8 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.719 -0.753 . . . . 61.34 112.454 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -179.4 108.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.805 0.336 . . . . 75.42 110.859 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 72.31 -68.92 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 74.33 110.976 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -111.74 147.95 34.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 72.13 110.904 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -52.22 151.57 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 65.34 110.891 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.68 -74.51 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 73.24 110.863 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.51 -169.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 74.23 110.849 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.08 -170.21 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.887 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -62.8 116.17 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 71.05 110.824 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -173.62 114.89 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 74.32 110.896 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.782 -179.953 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.875 0.369 . . . . 70.1 110.896 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 218' ' ' LYS . . . . . 0.492 ' C ' HD12 ' D' ' 219' ' ' ILE . 0.8 OUTLIER -138.68 153.71 48.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 63.24 110.892 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 219' ' ' ILE . . . . . 1.121 HD13 HD13 ' C' ' 222' ' ' ILE . 5.4 mp -143.03 144.11 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 74.31 111.179 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -145.59 87.98 1.82 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 74.25 110.852 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 221' ' ' ALA . . . . . 0.605 ' O ' HD13 ' D' ' 222' ' ' ILE . . . -170.88 44.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 63.33 111.063 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 222' ' ' ILE . . . . . 0.605 HD13 ' O ' ' D' ' 221' ' ' ALA . 26.4 mm -135.25 149.53 28.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 64.12 111.155 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 10.5 p -52.34 150.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 63.31 111.162 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -142.38 148.37 20.07 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.723 -0.751 . . . . 75.51 112.431 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.465 HH12 HD11 ' E' ' 219' ' ' ILE . 37.3 mmt180 -55.59 -30.08 60.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 64.21 110.867 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 226' ' ' ASN . . . . . 0.454 HD22 HG22 ' D' ' 277' ' ' ILE . 6.0 m120 -142.13 128.46 19.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 73.52 110.884 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 3.8 m -121.68 139.61 53.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 74.01 110.822 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 228' ' ' ALA . . . . . 0.739 ' HB3' ' HA ' ' C' ' 264' ' ' VAL . . . -133.63 129.84 37.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 71.34 111.084 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 229' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' D' ' 265' ' ' GLU . 9.5 mtmm -97.5 -33.63 11.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 73.05 110.897 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 230' ' ' ASP . . . . . 0.658 ' HB3' HG23 ' D' ' 266' ' ' THR . 0.2 OUTLIER -165.01 138.16 4.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 72.45 110.881 179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 231' ' ' ILE . . . . . 0.617 ' HB ' HG22 ' C' ' 267' ' ' VAL . 6.1 mt -137.33 128.72 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 74.22 111.155 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -134.26 115.89 14.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.472 . . . . 71.44 110.908 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 3.5 p -129.82 149.59 51.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 73.13 111.147 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 234' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' D' ' 237' ' ' ALA . 5.2 pm0 -156.98 166.71 32.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 72.13 110.883 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 63.26 67.56 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 71.14 110.87 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 36.6 mtt85 49.45 31.76 4.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 74.31 110.932 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 237' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' D' ' 234' ' ' GLU . . . -82.55 145.77 29.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 63.43 111.071 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -129.76 135.77 48.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 73.1 110.852 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.429 HG23 ' HB ' ' D' ' 275' ' ' VAL . 6.3 p -130.84 121.7 50.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 73.25 111.075 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 240' ' ' GLN . . . . . 0.681 ' HB3' HD22 ' D' ' 276' ' ' LEU . 2.5 tm0? -109.12 137.25 47.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.472 . . . . 62.02 110.928 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.529 HD22 ' C ' ' D' ' 240' ' ' GLN . 3.5 mm? -122.72 118.61 28.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.12 110.913 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.41 177.85 15.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.769 -0.729 . . . . 70.1 112.509 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.82 149.36 23.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 64.43 110.927 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 244' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' D' ' 280' ' ' GLU . 17.3 m -124.94 132.49 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 40.1 111.14 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.83 129.41 75.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 74.42 111.075 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.3 t -70.09 174.89 4.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 70.45 111.105 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 247' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' C' ' 282' ' ' GLY . . . -59.34 -39.5 83.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 71.15 111.074 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.93 -52.05 66.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 75.35 111.046 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 59.1 -169.79 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 73.02 111.18 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 250' ' ' LEU . . . . . 0.75 ' HB3' HG23 ' D' ' 254' ' ' ILE . 0.3 OUTLIER -54.66 108.53 0.4 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 73.25 110.913 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -52.31 157.49 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 72.41 110.837 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 71.04 -177.03 36.07 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.725 -0.75 . . . . 32.43 112.492 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -73.79 78.44 0.89 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.747 -0.74 . . . . 51.12 112.515 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 254' ' ' ILE . . . . . 0.75 HG23 ' HB3' ' D' ' 250' ' ' LEU . 2.6 tt -170.07 144.63 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 51.24 111.125 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.45 -173.88 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 53.3 110.827 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 29.5 mt 63.94 106.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 73.31 111.152 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 257' ' ' SER . . . . . 0.427 ' HA ' HD23 ' D' ' 250' ' ' LEU . 4.8 p -85.34 -170.86 3.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 73.44 110.88 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.44 167.2 1.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 54.52 110.818 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -140.09 100.03 3.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 75.45 110.918 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 13.0 t -96.47 138.4 34.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 73.43 111.18 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.56 116.65 29.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 55.35 111.121 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 262' ' ' ASN . . . . . 0.532 ' OD1' HD12 ' E' ' 241' ' ' LEU . 0.5 OUTLIER -126.89 137.09 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 72.5 110.821 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.06 123.41 18.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 65.4 110.821 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.819 HG21 HG23 ' D' ' 267' ' ' VAL . 7.3 p -113.89 138.5 43.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 72.52 111.109 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 265' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' D' ' 229' ' ' LYS . 0.7 OUTLIER -81.48 -52.47 7.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 74.1 110.916 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 266' ' ' THR . . . . . 0.658 HG23 ' HB3' ' D' ' 230' ' ' ASP . 0.2 OUTLIER -150.96 129.35 12.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 73.32 111.099 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.819 HG23 HG21 ' D' ' 264' ' ' VAL . 1.2 t -118.35 130.62 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 74.22 111.183 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.49 127.75 69.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 63.52 111.146 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -131.06 133.94 7.5 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.763 -0.732 . . . . 65.25 112.473 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.1 148.89 52.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 70.24 110.916 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.34 89.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 71.43 112.468 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 43.75 59.69 2.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.887 0.375 . . . . 51.1 110.849 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 11.0 t -85.85 145.5 27.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 32.13 110.846 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.48 127.75 35.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 75.1 110.887 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 275' ' ' VAL . . . . . 0.448 HG22 ' CG1' ' E' ' 239' ' ' VAL . 57.9 t -131.87 123.18 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 75.42 111.096 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.4 OUTLIER -121.21 111.74 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 62.31 110.926 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.454 HG22 HD22 ' D' ' 226' ' ' ASN . 1.1 mt -107.88 110.96 33.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 71.44 111.136 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.08 174.7 13.47 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.777 -0.725 . . . . 71.05 112.49 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -89.87 144.91 25.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.358 . . . . 74.31 110.887 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 280' ' ' GLU . . . . . 0.475 ' HA ' HG23 ' D' ' 244' ' ' VAL . 15.8 pt-20 -113.87 131.73 56.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 74.43 110.874 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -116.83 125.85 52.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 75.43 110.933 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 127.14 150.32 7.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.767 -0.73 . . . . 72.13 112.453 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 58.33 173.56 0.42 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.769 -0.729 . . . . 73.04 112.456 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.04 31.66 5.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.349 . . . . 72.2 110.885 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -112.54 -119.46 3.68 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.805 -0.712 . . . . 72.14 112.5 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -163.4 119.51 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 75.1 110.893 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 63.13 21.87 13.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.137 -0.483 . . . . 73.4 110.938 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.48 -169.7 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 63.42 110.813 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -105.3 -172.82 2.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 64.23 110.923 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -54.33 137.55 41.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 75.14 110.858 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -171.24 -174.97 1.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.875 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.03 -170.43 2.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 63.52 110.87 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -170.48 -175.74 1.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 61.12 110.854 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -149.3 -175.34 4.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 72.12 110.88 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 25.3 p80 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 74.3 110.832 -179.913 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.853 0.358 . . . . 73.23 110.893 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' 218' ' ' LYS . . . . . 0.694 ' HB2' HD12 ' E' ' 256' ' ' ILE . 5.0 mptt -156.56 122.46 4.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 74.54 110.91 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 219' ' ' ILE . . . . . 0.465 HD11 HH12 ' D' ' 225' ' ' ARG . 36.1 mt -143.48 148.38 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 72.21 111.11 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -154.77 176.55 12.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 75.4 110.905 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . 61.16 179.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 72.34 111.02 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 1.1 pt -113.46 107.34 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 54.15 111.139 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.9 148.0 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 74.44 111.104 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -76.35 -131.67 0.41 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.665 -0.778 . . . . 62.13 112.539 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 225' ' ' ARG . . . . . 0.518 ' H ' HG23 ' E' ' 261' ' ' THR . 16.8 ptt-85 179.93 178.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 75.12 110.918 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -83.52 123.97 30.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 71.43 110.833 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.58 144.52 48.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 70.23 110.872 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 228' ' ' ALA . . . . . 0.501 ' HB3' ' HA ' ' D' ' 264' ' ' VAL . . . -140.12 118.9 12.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 73.14 111.078 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 229' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' E' ' 265' ' ' GLU . 0.1 OUTLIER -79.09 -42.02 27.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 61.1 110.905 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -168.18 138.19 2.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 62.2 110.883 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 231' ' ' ILE . . . . . 0.768 HG21 HG21 ' E' ' 239' ' ' VAL . 10.8 mt -129.11 117.07 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 55.23 111.089 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -119.12 115.1 23.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 75.24 110.858 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.61 128.27 32.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 72.44 111.192 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.35 162.26 33.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.878 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.54 76.55 0.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 62.41 110.885 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 43.66 42.09 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.877 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.98 142.61 27.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 63.03 111.171 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -125.42 137.67 54.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 51.32 110.902 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.768 HG21 HG21 ' E' ' 231' ' ' ILE . 7.6 p -136.5 121.92 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 63.2 111.1 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -112.88 137.48 51.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.92 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.658 HD13 ' HB ' ' E' ' 277' ' ' ILE . 1.5 mm? -120.34 118.27 29.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 71.34 110.912 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 123.5 169.14 13.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.727 -0.749 . . . . 71.51 112.472 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.65 146.0 27.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.929 0.395 . . . . 75.24 110.849 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' E' ' 280' ' ' GLU . 24.3 m -111.83 139.72 34.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 65.04 111.153 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 45.3 t -120.98 129.58 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 73.34 111.115 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.2 t -69.04 175.07 3.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.114 -0.494 . . . . 63.11 111.172 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.1 -44.83 79.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 52.34 111.163 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.06 -52.17 66.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.5 111.068 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 59.38 -177.7 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 74.13 111.118 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 10.2 tp -51.96 107.59 0.21 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 74.21 110.943 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -79.59 149.43 31.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 75.02 110.824 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.55 -58.57 4.45 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.732 -0.747 . . . . 33.14 112.485 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.48 -143.48 12.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.743 -0.741 . . . . 74.23 112.478 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 10.2 tt -175.33 130.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 72.22 111.135 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.62 152.53 18.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.889 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 256' ' ' ILE . . . . . 0.694 HD12 ' HB2' ' E' ' 218' ' ' LYS . 13.8 pt -150.23 51.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 73.53 111.126 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.09 167.54 1.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 74.33 110.878 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -55.89 174.19 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 65.25 110.876 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -138.0 -75.07 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 72.35 110.955 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.0 t -101.11 137.34 39.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 74.15 111.134 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 261' ' ' THR . . . . . 0.518 HG23 ' H ' ' E' ' 225' ' ' ARG . 99.1 m -92.5 111.59 23.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 54.33 111.173 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -124.63 119.6 29.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 42.24 110.956 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.76 120.1 30.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 74.42 110.852 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.4 p -111.52 137.4 44.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 53.25 111.09 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 265' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 3.4 tt0 -71.06 -95.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 73.43 110.852 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 93.8 m -119.8 126.2 50.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 72.42 111.167 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 267' ' ' VAL . . . . . 0.686 ' CG1' HG23 ' E' ' 231' ' ' ILE . 3.5 p -116.07 120.1 63.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 74.24 111.136 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 39.9 t -117.94 119.21 60.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 71.41 111.089 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.51 133.52 9.55 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 74.44 112.502 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.57 147.91 45.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 72.2 110.897 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.6 89.63 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 64.11 112.489 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 41.59 77.58 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 54.12 110.886 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 6.2 t -105.48 145.18 31.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 71.22 110.838 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.06 128.23 49.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 62.31 110.935 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.623 HG21 HG21 ' E' ' 267' ' ' VAL . 85.1 t -132.98 123.96 49.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.44 111.129 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.705 HD12 ' NE1' ' E' ' 287' ' ' TRP . 0.3 OUTLIER -127.51 125.82 41.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 72.35 110.942 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.658 ' HB ' HD13 ' E' ' 241' ' ' LEU . 20.9 mm -112.18 124.85 69.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 75.33 111.138 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 113.82 -170.97 13.55 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.682 -0.771 . . . . 50.04 112.458 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -102.68 155.98 17.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 74.4 110.914 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 280' ' ' GLU . . . . . 0.408 ' HA ' HG22 ' E' ' 244' ' ' VAL . 5.4 pt-20 -121.81 132.67 54.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 74.33 110.856 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -115.35 125.16 52.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 64.51 110.868 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 162.39 -178.22 38.25 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.718 -0.753 . . . . 73.1 112.455 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -51.99 168.91 0.61 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.73 -0.748 . . . . 72.23 112.444 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -51.8 109.74 0.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.858 0.361 . . . . 72.14 110.897 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -164.71 118.98 0.84 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.704 -0.76 . . . . 75.4 112.491 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -59.72 -20.91 59.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 73.24 110.881 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 287' ' ' TRP . . . . . 0.705 ' NE1' HD12 ' E' ' 276' ' ' LEU . 0.1 OUTLIER -155.94 -49.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 72.22 110.951 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -112.66 -74.67 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 73.21 110.874 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -148.55 176.93 9.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 70.15 110.89 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -52.04 123.54 10.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 72.41 110.869 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -171.82 168.15 6.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.856 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -164.93 112.54 1.02 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 75.24 110.785 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -177.75 127.17 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 74.42 110.884 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -126.89 -68.58 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 71.43 110.861 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 28.6 p80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.878 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 2.8 mpp? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.88 0.372 . . . . 74.23 110.855 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.28 173.74 6.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.856 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.7 pt -147.93 -178.24 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 50.41 111.177 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -133.8 -170.68 2.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 73.13 110.867 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.61 ' O ' HD13 ' A' ' 222' ' ' ILE . . . -104.72 168.23 9.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 55.22 111.074 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.61 HD13 ' O ' ' A' ' 221' ' ' ALA . 34.8 mm -135.7 141.47 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 74.11 111.117 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.716 HG12 ' HG3' ' A' ' 259' ' ' GLN . 33.6 m -80.38 151.88 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 75.43 111.158 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.68 111.32 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.709 -0.758 . . . . 53.21 112.481 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.594 ' CB ' HG22 ' A' ' 261' ' ' THR . 13.7 ttp85 -142.67 95.89 2.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 72.54 110.863 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.429 HD22 ' N ' ' A' ' 242' ' ' GLY . 12.4 m-20 -83.95 111.64 19.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 73.32 110.872 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.77 150.72 41.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 45.54 110.826 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -144.0 119.1 10.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 72.23 111.122 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -76.05 -48.53 20.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 70.12 110.887 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -164.92 135.8 4.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 72.33 110.908 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.579 HG22 ' CG2' ' A' ' 267' ' ' VAL . 8.8 pt -139.3 134.36 40.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 41.54 111.154 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -130.93 138.54 49.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 75.34 110.853 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.708 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.5 OUTLIER -136.07 147.14 47.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 71.13 111.133 -179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -134.04 167.02 21.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 71.41 110.869 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.43 -70.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 74.52 110.927 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.38 66.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 75.15 110.879 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.708 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -102.7 157.5 16.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 64.14 111.145 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.25 139.02 50.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 63.51 110.856 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.463 HG21 HD12 ' A' ' 231' ' ' ILE . 4.2 p -122.28 121.65 64.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 72.33 111.09 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.04 116.01 29.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 61.12 110.919 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.1 mp -111.99 118.61 35.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 43.51 110.903 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.429 ' N ' HD22 ' A' ' 226' ' ' ASN . . . 141.32 160.79 8.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 52.31 112.476 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -85.77 134.75 33.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 62.24 110.835 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 17.8 m -106.69 133.63 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.476 . . . . 61.33 111.125 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 39.1 t -122.74 113.06 36.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 62.14 111.038 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 281' ' ' TYR . 5.3 t -93.46 162.66 13.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 70.44 111.177 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.61 -33.88 64.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.186 -0.461 . . . . 72.4 111.069 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -35.91 69.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 61.31 111.122 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.49 ' HB2' ' CA ' ' A' ' 282' ' ' GLY . . . -58.75 102.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 52.1 111.137 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -177.45 -176.81 0.64 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 72.22 110.917 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -165.67 -68.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 70.43 110.845 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 151.07 -44.97 0.65 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.778 -0.725 . . . . 55.5 112.501 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -90.04 -147.26 16.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.727 -0.749 . . . . 63.34 112.445 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.452 HD11 ' HA2' ' B' ' 253' ' ' GLY . 42.6 pt -61.06 161.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.778 0.323 . . . . 73.34 111.16 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.8 ttm-85 -109.3 140.08 43.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.196 -0.456 . . . . 73.33 110.905 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 14.5 pt -132.39 178.7 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.1 111.162 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 19.2 p -177.93 164.33 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 54.12 110.836 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -96.89 -176.16 3.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 75.12 110.884 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.716 ' HG3' HG12 ' A' ' 223' ' ' VAL . 11.3 tt0 -120.74 44.42 2.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 72.34 110.977 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.516 HG21 ' HB3' ' B' ' 243' ' ' ASN . 0.2 OUTLIER -75.8 134.78 40.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 75.01 111.15 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.594 HG22 ' CB ' ' A' ' 225' ' ' ARG . 0.9 OUTLIER -123.19 108.97 13.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 62.13 111.157 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -92.65 127.61 38.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 52.01 110.84 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.2 t -142.18 123.32 14.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 34.02 110.896 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.633 HG21 HG22 ' A' ' 267' ' ' VAL . 4.8 p -105.93 137.33 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.5 . . . . 52.21 111.175 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -88.74 -66.57 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 75.34 110.865 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 26.3 m -125.45 126.6 45.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 74.44 111.069 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 264' ' ' VAL . 41.3 t -117.69 131.3 70.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 72.23 111.139 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 30.2 t -127.15 115.31 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.134 -0.484 . . . . 62.3 111.167 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.76 132.82 11.25 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 72.1 112.465 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 134.41 45.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 65.43 110.921 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.44 85.36 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.76 -0.733 . . . . 55.31 112.523 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 47.74 79.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.892 0.377 . . . . 34.33 110.958 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.47 145.05 30.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 75.33 110.887 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -113.4 128.44 56.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.877 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.18 123.67 53.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 71.31 111.11 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.411 HD22 ' CE2' ' A' ' 287' ' ' TRP . 25.5 tp -128.15 111.54 13.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 72.2 110.942 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 73.6 mt -109.23 103.92 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 62.04 111.123 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.53 -159.02 28.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.796 -0.716 . . . . 63.31 112.498 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -128.21 156.28 43.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 65.32 110.894 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -115.26 134.71 54.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 70.01 110.883 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.465 ' O ' HG22 ' A' ' 246' ' ' THR . 17.2 m-85 -118.81 126.84 52.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 74.43 110.91 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.49 ' CA ' ' HB2' ' A' ' 249' ' ' ALA . . . 101.82 159.3 26.62 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.799 -0.715 . . . . 63.53 112.516 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.743 ' H ' ' HB2' ' B' ' 247' ' ' ALA . . . -68.07 -130.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.811 -0.709 . . . . 63.24 112.475 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.62 28.19 16.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.77 0.319 . . . . 74.22 110.904 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 92.5 152.38 28.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.783 -0.723 . . . . 73.04 112.504 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -67.47 -35.05 78.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 73.02 110.899 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.411 ' CE2' HD22 ' A' ' 276' ' ' LEU . 15.6 t90 -174.96 -68.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 75.22 110.96 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -175.47 65.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 65.44 110.841 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -119.16 -43.67 2.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.425 . . . . 63.54 110.904 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 2.2 t60 63.41 105.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.493 . . . . 74.01 110.84 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -74.04 -169.83 0.83 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 72.33 110.891 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.54 -175.07 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 71.44 110.828 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 31.2 m80 63.14 103.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 74.52 110.877 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 59.09 76.61 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.05 110.855 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 22.0 m170 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 72.53 110.811 -179.982 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.852 0.358 . . . . 43.2 110.922 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.97 169.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 70.23 110.902 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 40.9 mm -71.16 -40.72 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 70.44 111.111 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.15 -171.55 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 53.35 110.886 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 62.26 179.06 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 73.34 111.128 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 5.2 tt -156.26 135.71 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 72.41 111.076 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 258' ' ' ASP . 7.0 p -113.65 135.51 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 71.21 111.145 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.44 108.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.675 -0.774 . . . . 73.32 112.604 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.665 ' HB3' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER -146.48 119.04 8.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 74.52 110.804 -179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.645 ' OD1' HG22 ' B' ' 277' ' ' ILE . 17.1 m-80 -109.24 119.25 38.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 73.24 110.962 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.63 148.87 51.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.866 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.612 ' HB2' HD21 ' B' ' 241' ' ' LEU . . . -139.26 119.92 14.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 62.54 111.16 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.07 -44.58 30.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 73.53 110.812 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -165.75 134.89 3.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 64.24 110.799 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.633 HD12 HG21 ' B' ' 239' ' ' VAL . 7.6 pt -140.17 133.67 34.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 75.22 111.153 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.92 136.72 42.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 75.12 110.819 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.729 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.5 OUTLIER -136.29 147.97 47.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 72.43 111.098 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -136.1 167.9 20.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 72.51 110.904 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.83 -71.47 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 71.14 110.861 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -179.3 62.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 75.15 110.937 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.729 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -102.3 157.19 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 71.33 111.115 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -129.85 135.26 48.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.829 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.633 HG21 HD12 ' B' ' 231' ' ' ILE . 6.4 p -122.93 129.57 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 75.02 111.151 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.564 ' HB3' HD12 ' B' ' 276' ' ' LEU . 8.8 tm0? -120.11 124.73 46.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 65.25 110.901 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.612 HD21 ' HB2' ' B' ' 228' ' ' ALA . 4.5 mt -111.74 118.88 36.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 74.32 110.929 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.88 176.44 14.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.704 -0.76 . . . . 51.2 112.46 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 243' ' ' ASN . . . . . 0.516 ' HB3' HG21 ' A' ' 260' ' ' THR . 2.0 p30 -85.92 134.06 33.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.373 . . . . 64.42 110.876 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 1.7 t -104.69 115.25 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 74.34 111.111 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 44.7 t -106.91 122.76 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 55.43 111.13 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.469 HG22 ' O ' ' B' ' 281' ' ' TYR . 14.5 t -96.14 163.26 13.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 71.11 111.19 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.743 ' HB2' ' H ' ' A' ' 283' ' ' GLY . . . -58.73 -33.88 70.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 75.1 111.107 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -35.99 69.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 62.41 111.088 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.5 ' HB2' ' CA ' ' B' ' 282' ' ' GLY . . . -59.12 -41.44 88.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 64.31 111.134 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 6.9 mt 56.36 -177.91 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.42 110.928 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -125.39 70.81 1.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 74.32 110.816 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -61.69 -59.7 9.33 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 50.22 112.443 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 253' ' ' GLY . . . . . 0.452 ' HA2' HD11 ' A' ' 254' ' ' ILE . . . 177.46 154.86 12.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.706 -0.759 . . . . 73.33 112.477 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 2.3 tt -52.47 133.18 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.824 0.345 . . . . 75.23 111.112 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.99 144.01 27.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 73.43 110.888 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 256' ' ' ILE . . . . . 0.645 HD13 ' H ' ' C' ' 255' ' ' ARG . 2.4 pp -55.18 155.57 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 72.31 111.094 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 14.8 p -161.34 144.11 12.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 73.22 110.833 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.442 ' O ' HG23 ' B' ' 223' ' ' VAL . 5.0 m-20 -58.14 175.61 0.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 64.31 110.86 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -110.58 81.74 1.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 73.24 110.882 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.85 137.57 32.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 64.03 111.161 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.665 HG23 ' HB3' ' B' ' 225' ' ' ARG . 96.4 m -131.82 122.33 25.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.286 -0.415 . . . . 74.24 111.162 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.79 124.98 50.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 74.3 110.947 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.2 t -141.95 123.68 15.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 72.22 110.841 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.574 HG21 HG22 ' B' ' 267' ' ' VAL . 4.4 p -106.41 137.72 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.477 . . . . 72.53 111.207 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -85.52 -72.67 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 61.1 110.882 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 19.0 p -122.24 126.48 48.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 72.51 111.111 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.574 HG22 HG21 ' B' ' 264' ' ' VAL . 46.1 t -118.28 127.77 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 71.35 111.157 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 58.5 t -127.17 115.23 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 43.41 111.113 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.3 133.19 11.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.74 . . . . 41.41 112.478 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -130.54 139.54 50.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.831 0.348 . . . . 72.15 110.892 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.67 85.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 64.44 112.482 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 45.76 74.34 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 71.44 110.908 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.69 145.68 26.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 63.52 110.872 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 11.0 mtm-85 -113.68 128.17 56.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 74.43 110.912 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 36.1 t -130.17 123.31 55.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 71.51 111.085 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.589 HD23 ' CG ' ' C' ' 240' ' ' GLN . 14.5 tp -128.12 111.32 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 55.11 110.914 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.645 HG22 ' OD1' ' B' ' 226' ' ' ASN . 4.5 mp -107.91 104.55 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 71.24 111.074 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.76 -173.55 27.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.694 -0.765 . . . . 74.22 112.445 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -110.33 154.52 23.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.732 0.301 . . . . 74.12 110.96 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.423 ' HB3' HG13 ' C' ' 244' ' ' VAL . 13.8 tm-20 -111.94 137.22 50.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 74.13 110.881 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.469 ' O ' HG22 ' B' ' 246' ' ' THR . 0.2 OUTLIER -119.95 129.96 54.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 74.51 110.947 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.5 ' CA ' ' HB2' ' B' ' 249' ' ' ALA . . . 107.95 148.13 13.7 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.835 -0.698 . . . . 71.4 112.496 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 283' ' ' GLY . . . . . 0.59 ' H ' ' HB2' ' C' ' 247' ' ' ALA . . . -68.53 -132.4 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.743 -0.741 . . . . 54.4 112.5 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.7 tptp 62.11 35.54 15.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 75.41 110.865 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 74.89 141.71 0.79 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 75.14 112.464 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -75.44 111.26 10.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.85 0.357 . . . . 64.4 110.924 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.54 ' CE2' HD22 ' B' ' 276' ' ' LEU . 7.0 t90 52.12 29.91 7.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 73.31 110.877 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.53 94.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 74.2 110.923 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.88 -177.16 3.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 74.45 110.934 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -118.89 -176.64 3.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 75.34 110.833 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -84.51 -59.12 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 74.42 110.849 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 59.68 -170.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 74.42 110.911 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -123.38 151.83 42.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 64.44 110.886 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.33 157.1 23.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 75.15 110.862 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 60.43 110.879 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.8 0.333 . . . . 71.15 110.818 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.43 100.81 4.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 62.42 110.892 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 17.4 tt -174.74 144.03 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 73.12 111.141 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -178.18 130.38 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 62.32 110.874 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -173.42 124.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 71.33 111.15 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 2.0 pt -149.34 136.49 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 72.4 111.043 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 22.9 t 63.45 101.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.115 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -147.66 158.15 27.61 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.709 -0.758 . . . . 75.35 112.458 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.64 ' HA ' HG23 ' C' ' 261' ' ' THR . 0.0 OUTLIER -53.24 -74.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.795 0.331 . . . . 73.25 110.822 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -83.89 110.83 18.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 72.52 110.885 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.99 148.13 52.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 65.32 110.892 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' B' ' 264' ' ' VAL . . . -135.21 124.48 24.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 64.22 111.089 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -42.61 16.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.443 . . . . 62.01 110.892 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -166.32 133.89 2.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 72.44 110.839 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.612 HD12 HG11 ' C' ' 239' ' ' VAL . 6.4 pt -140.65 132.07 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 70.23 111.216 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -136.1 135.64 39.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 60.45 110.888 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.733 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.5 OUTLIER -136.67 150.82 48.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 70.11 111.146 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -139.9 168.7 19.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.33 110.931 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.68 -70.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.905 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -179.32 57.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 55.3 110.9 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.733 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -98.46 156.97 16.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 74.24 111.068 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -130.18 135.69 48.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.12 110.86 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.612 HG11 HD12 ' C' ' 231' ' ' ILE . 7.3 p -122.64 128.51 75.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.23 111.079 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.589 ' CG ' HD23 ' B' ' 276' ' ' LEU . 1.2 tm0? -121.14 125.55 47.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 60.23 110.926 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.634 HD13 ' HB ' ' C' ' 277' ' ' ILE . 3.8 mm? -111.59 118.76 36.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 73.54 110.897 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.07 175.38 13.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.633 -0.794 . . . . 61.13 112.448 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -90.45 153.82 20.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.34 . . . . 63.42 110.948 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' B' ' 280' ' ' GLU . 20.1 t -119.83 116.83 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 75.31 111.155 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 48.7 t -108.96 115.33 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 75.23 111.109 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 12.1 t -69.86 175.11 4.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 75.43 111.145 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.59 ' HB2' ' H ' ' B' ' 283' ' ' GLY . . . -55.31 -45.16 76.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 62.45 111.09 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.34 80.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 63.15 111.121 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.98 -169.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 44.34 111.148 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 250' ' ' LEU . . . . . 0.487 HD12 ' CZ ' ' C' ' 281' ' ' TYR . 0.3 OUTLIER -55.96 176.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 75.21 110.873 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.09 -58.97 2.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 73.3 110.872 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -151.48 120.6 1.11 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.723 -0.751 . . . . 52.44 112.437 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -151.8 -173.73 21.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 54.12 112.529 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 13.2 pt -148.84 25.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.857 0.361 . . . . 73.43 111.166 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 255' ' ' ARG . . . . . 0.645 ' H ' HD13 ' B' ' 256' ' ' ILE . 0.0 OUTLIER 53.46 -170.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 71.34 110.846 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 29.3 mt 64.16 82.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 71.2 111.073 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.21 157.63 1.38 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 73.24 110.876 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 258' ' ' ASP . . . . . 0.478 ' N ' HG22 ' D' ' 256' ' ' ILE . 0.6 OUTLIER -67.67 -169.92 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.881 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -175.01 155.63 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 71.02 110.911 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 260' ' ' THR . . . . . 0.506 HG23 ' CB ' ' D' ' 225' ' ' ARG . 5.1 m -65.56 125.03 23.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 62.41 111.117 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.64 HG23 ' HA ' ' C' ' 225' ' ' ARG . 29.0 m -96.15 108.81 21.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 73.33 111.071 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.8 124.23 38.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.478 . . . . 73.33 110.844 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.06 123.21 14.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 71.11 110.828 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.593 HG21 HG22 ' C' ' 267' ' ' VAL . 4.1 p -107.38 139.21 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.081 -0.509 . . . . 73.21 111.15 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -89.56 -65.21 1.04 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 72.03 110.913 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 266' ' ' THR . . . . . 0.473 HG21 ' HG2' ' E' ' 217' ' ' MET . 1.7 p -129.8 126.93 39.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.479 . . . . 55.34 111.132 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.593 HG22 HG21 ' C' ' 264' ' ' VAL . 47.0 t -118.04 126.57 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 64.5 111.155 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 83.4 t -123.07 115.31 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 52.41 111.166 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.37 131.96 10.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.701 -0.761 . . . . 55.44 112.58 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.24 136.29 45.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.786 0.327 . . . . 62.42 110.944 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.56 83.51 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.749 -0.738 . . . . 62.32 112.452 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 46.59 69.99 0.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 74.14 110.929 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.24 145.38 24.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 71.51 110.894 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -113.31 128.4 56.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 73.11 110.84 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.48 HG21 HG11 ' C' ' 267' ' ' VAL . 77.1 t -129.14 121.98 55.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 73.24 111.129 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.465 ' O ' HD12 ' D' ' 241' ' ' LEU . 2.2 tp -128.86 111.17 12.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 43.25 110.906 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.634 ' HB ' HD13 ' C' ' 241' ' ' LEU . 2.7 mp -112.59 104.3 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 61.12 111.096 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.35 -179.46 27.07 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.653 -0.784 . . . . 70.1 112.451 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.34 156.08 18.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.316 . . . . 64.2 110.873 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.84 119.14 27.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 74.21 110.852 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.487 ' CZ ' HD12 ' C' ' 250' ' ' LEU . 0.4 OUTLIER -112.55 125.46 54.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 70.04 110.905 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.15 158.62 7.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 74.3 112.454 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -103.95 -161.85 24.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 71.05 112.503 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt 53.33 34.39 17.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 74.21 110.93 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 131.63 135.4 3.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.649 -0.786 . . . . 54.52 112.463 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -83.7 -26.18 30.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.348 . . . . 70.14 110.91 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.444 ' CE2' HD22 ' C' ' 276' ' ' LEU . 17.0 t90 -171.57 -42.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 73.13 110.919 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -114.43 97.55 6.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 65.24 110.841 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -55.44 171.7 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 74.25 110.904 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.41 -57.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 74.34 110.832 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.02 156.86 1.43 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 64.34 110.876 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -160.36 -179.94 8.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 71.34 110.821 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -98.3 177.4 5.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.459 . . . . 72.32 110.861 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 57.51 -170.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 72.12 110.91 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.272 -0.422 . . . . 74.33 110.797 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 1.2 mtm . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.863 0.363 . . . . 75.54 110.898 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 5.6 mttt 59.04 93.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 71.32 110.863 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 219' ' ' ILE . . . . . 0.449 HD12 ' N ' ' D' ' 220' ' ' ASP . 2.1 pp -142.28 -177.68 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 63.52 111.13 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 220' ' ' ASP . . . . . 0.449 ' N ' HD12 ' D' ' 219' ' ' ILE . 3.2 m-20 -150.11 -74.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 75.12 110.845 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.82 165.51 2.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 74.45 111.045 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 3.9 tt -175.68 140.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 73.32 111.094 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 19.1 m -105.02 -175.66 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 62.02 111.151 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 146.83 -175.43 26.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 74.13 112.477 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 225' ' ' ARG . . . . . 0.506 ' CB ' HG23 ' C' ' 260' ' ' THR . 11.4 mpt_? -88.09 -55.0 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 51.55 110.864 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 226' ' ' ASN . . . . . 0.543 ' OD1' HG22 ' D' ' 277' ' ' ILE . 9.9 m-20 -99.88 117.75 34.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 75.53 110.84 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.72 151.97 49.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 54.33 110.837 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -142.36 129.85 21.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 74.13 111.087 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.47 -42.22 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 75.23 110.92 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -166.73 134.92 2.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.11 110.814 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 231' ' ' ILE . . . . . 0.664 HD12 HG11 ' D' ' 239' ' ' VAL . 7.2 pt -141.02 133.01 29.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 73.11 111.117 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -135.7 136.45 40.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 64.21 110.894 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 233' ' ' THR . . . . . 0.665 ' CB ' ' HB3' ' D' ' 237' ' ' ALA . 0.4 OUTLIER -136.86 146.35 45.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 72.05 111.099 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -135.19 168.79 18.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 63.25 110.89 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.12 -72.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 64.31 110.859 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.91 59.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 74.31 110.837 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 237' ' ' ALA . . . . . 0.665 ' HB3' ' CB ' ' D' ' 233' ' ' THR . . . -99.89 157.17 16.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 55.34 111.06 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.61 135.72 46.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 70.44 110.85 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 239' ' ' VAL . . . . . 0.664 HG11 HD12 ' D' ' 231' ' ' ILE . 5.7 p -122.21 121.93 65.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 71.51 111.179 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -118.17 120.92 39.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.899 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 241' ' ' LEU . . . . . 0.465 HD12 ' O ' ' C' ' 276' ' ' LEU . 1.2 mp -112.59 118.8 36.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.947 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 242' ' ' GLY . . . . . 0.419 ' HA2' ' ND2' ' D' ' 226' ' ' ASN . . . 142.92 165.74 10.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.726 -0.749 . . . . 72.25 112.516 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.77 131.0 34.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 62.22 110.908 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 26.5 t -99.09 130.01 48.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 71.22 111.164 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.09 122.48 66.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 61.34 111.137 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.0 t -69.71 165.9 20.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.21 111.119 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.86 -36.38 62.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 53.33 111.16 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.96 -51.94 67.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 52.42 111.113 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 52.08 -170.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 71.24 111.114 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.18 121.58 14.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 61.31 110.906 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -72.11 145.28 48.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.31 110.839 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 111.6 142.36 8.83 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.708 -0.758 . . . . 61.3 112.503 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.66 -60.98 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.749 -0.738 . . . . 64.3 112.538 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 25.8 mm 63.55 76.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.358 . . . . 71.45 111.202 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 53.81 -170.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 70.2 110.878 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 256' ' ' ILE . . . . . 0.478 HG22 ' N ' ' C' ' 258' ' ' ASP . 1.2 pt -82.2 175.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 74.51 111.118 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 2.7 p -176.9 155.88 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 74.31 110.879 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -84.39 -177.85 6.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 61.02 110.849 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -172.33 -170.5 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 73.12 110.932 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.59 135.08 54.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 74.3 111.128 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 94.3 m -108.47 129.17 55.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.218 -0.446 . . . . 71.24 111.208 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.11 127.28 53.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.43 110.873 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 263' ' ' SER . . . . . 0.423 ' HB3' HD11 ' E' ' 222' ' ' ILE . 25.7 p -142.53 123.66 14.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 64.21 110.833 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 264' ' ' VAL . . . . . 0.508 HG21 HG22 ' D' ' 267' ' ' VAL . 5.2 p -106.48 134.27 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 73.44 111.131 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -82.22 -77.14 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 72.45 110.849 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.61 126.88 53.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 75.23 111.19 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 267' ' ' VAL . . . . . 0.508 HG22 HG21 ' D' ' 264' ' ' VAL . 94.9 t -117.62 124.76 73.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 73.42 111.168 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.5 114.22 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 62.32 111.163 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.71 133.04 10.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.749 . . . . 75.0 112.456 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.04 143.05 49.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 72.21 110.874 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.96 84.82 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 73.22 112.458 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 45.75 69.65 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.36 . . . . 72.31 110.932 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.4 144.53 25.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 73.4 110.873 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.01 128.42 56.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 72.33 110.866 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 76.6 t -127.41 122.17 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 75.23 111.132 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 276' ' ' LEU . . . . . 0.513 HD13 ' CZ2' ' D' ' 287' ' ' TRP . 2.5 tp -128.56 111.46 13.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 61.52 110.89 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 277' ' ' ILE . . . . . 0.543 HG22 ' OD1' ' D' ' 226' ' ' ASN . 5.8 mt -112.42 104.13 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 63.53 111.098 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.78 -165.51 28.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.763 -0.732 . . . . 71.11 112.485 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -110.05 155.98 21.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.806 0.336 . . . . 71.3 110.899 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.02 131.5 53.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 72.24 110.842 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 281' ' ' TYR . . . . . 0.496 ' HE1' ' HB2' ' E' ' 249' ' ' ALA . 12.7 t80 -124.84 125.73 44.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.129 -0.487 . . . . 74.21 110.929 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 145.27 179.46 21.58 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 51.1 112.487 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -100.62 -149.05 23.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 65.11 112.49 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.51 26.12 13.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 74.3 110.906 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.46 -156.99 15.23 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.721 -0.752 . . . . 52.5 112.503 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 286' ' ' PHE . . . . . 0.606 ' HB3' HG11 ' E' ' 244' ' ' VAL . 27.5 m-85 -116.54 -28.07 6.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.873 0.368 . . . . 71.41 110.892 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 287' ' ' TRP . . . . . 0.513 ' CZ2' HD13 ' D' ' 276' ' ' LEU . 14.8 t90 -164.01 59.44 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 65.41 110.928 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -137.7 -169.81 2.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 64.33 110.833 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -104.58 171.85 7.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 70.42 110.84 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -179.03 -169.86 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.493 . . . . 75.21 110.863 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -145.54 -50.22 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.449 . . . . 65.55 110.824 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 63.31 -171.14 0.17 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.425 . . . . 75.41 110.837 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -69.36 122.71 19.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 73.43 110.882 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -179.09 -179.17 0.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 73.52 110.889 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 28.2 p80 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 73.51 110.804 -179.988 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' E' E ' 217' ' ' MET . . . . . 0.473 ' HG2' HG21 ' C' ' 266' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.81 0.338 . . . . 63.32 110.901 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 218' ' ' LYS . . . . . 0.435 ' HD3' HD11 ' D' ' 219' ' ' ILE . 4.6 mttt -130.53 176.98 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 63.32 110.913 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.95 151.47 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 53.14 111.117 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.15 132.37 13.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 72.41 110.85 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -107.72 141.79 38.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 72.45 111.15 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 222' ' ' ILE . . . . . 0.423 HD11 ' HB3' ' D' ' 263' ' ' SER . 1.0 OUTLIER -114.53 -24.88 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 71.2 111.06 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 21.6 t 63.79 106.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 72.21 111.133 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -149.14 -176.74 22.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.804 -0.712 . . . . 64.14 112.531 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -55.86 -71.07 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.341 . . . . 74.44 110.886 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -86.55 113.26 22.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.879 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.87 139.35 53.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 55.15 110.831 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 228' ' ' ALA . . . . . 0.471 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -124.21 118.71 27.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 74.03 111.055 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 229' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' E' ' 265' ' ' GLU . 12.5 mttm -75.63 -45.62 36.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 71.21 110.911 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -168.35 135.97 2.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 65.14 110.841 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 231' ' ' ILE . . . . . 0.922 HD12 HG11 ' E' ' 239' ' ' VAL . 8.9 pt -138.16 134.42 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 73.43 111.113 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -135.86 132.7 36.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.908 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 233' ' ' THR . . . . . 0.679 ' OG1' ' HB3' ' E' ' 237' ' ' ALA . 0.5 OUTLIER -136.94 151.51 49.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.21 111.12 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.25 167.56 22.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.904 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 72.78 -69.95 0.18 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 73.41 110.9 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -178.5 63.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 72.41 110.869 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 237' ' ' ALA . . . . . 0.679 ' HB3' ' OG1' ' E' ' 233' ' ' THR . . . -105.86 156.3 18.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 63.33 111.074 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.15 135.61 47.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 72.32 110.889 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 239' ' ' VAL . . . . . 0.922 HG11 HD12 ' E' ' 231' ' ' ILE . 7.2 p -125.0 126.47 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 75.11 111.195 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 240' ' ' GLN . . . . . 0.575 ' C ' HD13 ' E' ' 241' ' ' LEU . 4.7 tm0? -122.71 123.05 40.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 71.2 110.834 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 241' ' ' LEU . . . . . 0.928 HD12 HD12 ' E' ' 277' ' ' ILE . 0.3 OUTLIER -111.85 118.7 36.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 74.42 110.914 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 134.56 169.32 11.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 73.3 112.52 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -85.87 145.41 27.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.849 0.357 . . . . 64.22 110.903 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 244' ' ' VAL . . . . . 0.606 HG11 ' HB3' ' D' ' 286' ' ' PHE . 21.6 t -110.99 135.33 50.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.11 111.118 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 23.4 t -122.12 128.54 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 73.03 111.136 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -69.95 174.96 4.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 74.05 111.141 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 247' ' ' ALA . . . . . 0.595 ' HB3' ' CG ' ' E' ' 291' ' ' HIS . . . -59.72 -43.32 94.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 73.45 111.138 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.12 76.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 72.45 111.132 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 249' ' ' ALA . . . . . 0.496 ' HB2' ' HE1' ' D' ' 281' ' ' TYR . . . 60.76 -175.44 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 65.11 111.134 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.82 -171.54 1.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 74.43 110.891 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -108.44 34.67 3.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 64.43 110.84 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 129.75 -172.33 20.05 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.688 -0.768 . . . . 71.42 112.501 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -174.54 140.31 5.32 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.665 -0.778 . . . . 61.24 112.479 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 2.8 mp -98.36 -61.83 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.763 0.316 . . . . 73.05 111.13 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -166.3 -40.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 64.32 110.84 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.57 135.63 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 63.55 111.158 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.67 -42.27 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 75.52 110.811 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.72 -173.97 4.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 75.32 110.798 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -156.8 25.8 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 71.21 110.869 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 1.5 p -92.29 129.95 38.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 74.02 111.151 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 92.4 m -109.63 121.5 45.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 44.12 111.09 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.24 119.01 33.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 74.51 110.877 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 98.7 p -133.19 133.24 42.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 74.45 110.871 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 1.2 p -104.46 153.44 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 74.5 111.112 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 265' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 1.6 tt0 -92.22 -51.0 5.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.42 110.902 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 1.4 m -154.43 145.16 22.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 60.24 111.122 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 267' ' ' VAL . . . . . 0.463 HG11 HG21 ' E' ' 275' ' ' VAL . 86.6 t -136.17 120.54 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 63.35 111.172 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 268' ' ' VAL . . . . . 0.451 ' O ' HG13 ' E' ' 268' ' ' VAL . 5.3 p -127.3 115.55 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 72.41 111.11 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.65 133.62 10.82 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.733 . . . . 52.15 112.456 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.57 144.5 44.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 62.52 110.913 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 42.27 76.14 0.12 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.722 -0.752 . . . . 54.04 112.522 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 64.04 116.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 64.03 110.877 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 12.1 m -146.41 145.25 30.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 71.51 110.802 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -114.62 127.69 55.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 71.01 110.86 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 275' ' ' VAL . . . . . 0.516 ' HB ' HG23 ' E' ' 239' ' ' VAL . 24.2 t -127.1 121.9 58.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 70.33 111.09 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 276' ' ' LEU . . . . . 0.663 HD13 ' CE2' ' E' ' 287' ' ' TRP . 0.2 OUTLIER -130.24 112.53 13.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.204 -0.453 . . . . 74.01 110.934 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' E' E ' 277' ' ' ILE . . . . . 0.928 HD12 HD12 ' E' ' 241' ' ' LEU . 55.9 mt -112.26 104.56 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 74.12 111.141 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.46 -154.1 25.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.678 -0.772 . . . . 22.43 112.472 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -122.61 156.1 34.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 65.35 110.88 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -116.4 128.97 55.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 72.22 110.896 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -121.85 126.01 47.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 74.43 110.905 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 152.54 -176.51 30.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.705 -0.759 . . . . 51.52 112.448 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -51.99 148.75 10.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.761 . . . . 72.41 112.536 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? 72.28 -68.79 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 73.22 110.885 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.68 67.44 0.98 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 64.24 112.497 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -176.1 172.6 2.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.744 0.307 . . . . 61.14 110.93 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 287' ' ' TRP . . . . . 0.663 ' CE2' HD13 ' E' ' 276' ' ' LEU . 1.3 t90 -51.47 -37.63 49.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.185 -0.462 . . . . 73.33 110.978 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -91.55 -173.57 3.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 72.1 110.861 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 63.1 163.77 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 62.44 110.909 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -169.4 -170.25 1.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 63.42 110.875 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 291' ' ' HIS . . . . . 0.595 ' CG ' ' HB3' ' E' ' 247' ' ' ALA . 13.7 t-80 -52.07 160.26 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 62.13 110.854 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.31 -174.72 3.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 71.24 110.876 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -148.65 156.44 42.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 71.44 110.815 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -62.55 -35.07 78.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 70.44 110.9 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 75.44 110.878 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.503 ' HB3' HG23 ' A' ' 261' ' ' THR . 1.6 tmm_? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.842 0.354 . . . . 64.53 110.899 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -83.94 114.16 21.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 62.22 110.858 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 2.6 m -133.97 144.42 48.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 64.34 110.853 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.86 ' HB1' HD11 ' A' ' 231' ' ' ILE . . . -129.05 127.27 41.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 73.24 111.076 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -42.96 37.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 73.43 110.952 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -164.99 138.34 4.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 63.23 110.906 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.86 HD11 ' HB1' ' A' ' 228' ' ' ALA . 3.1 mp -138.43 117.14 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 75.35 111.113 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.724 ' HD2' HG22 ' A' ' 268' ' ' VAL . 7.6 ptp85 -113.59 123.31 49.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 72.44 110.874 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.8 p -135.4 141.74 45.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 72.32 111.175 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.6 pm0 -149.2 167.69 25.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.4 110.886 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 68.56 68.85 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 75.21 110.89 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 47.43 55.68 7.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 65.24 110.844 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.4 156.78 17.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 44.43 111.064 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -125.79 142.77 51.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 73.15 110.896 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.482 HG23 ' CG1' ' A' ' 275' ' ' VAL . 5.4 p -142.99 131.28 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 61.0 111.127 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -138.02 137.26 37.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 73.13 110.89 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.604 HD12 HG13 ' A' ' 277' ' ' ILE . 0.3 OUTLIER -114.69 118.23 33.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.454 . . . . 62.43 110.876 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 146.67 -176.74 25.41 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.701 -0.761 . . . . 61.23 112.481 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -85.92 140.38 30.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.903 0.382 . . . . 64.0 110.882 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.49 ' CG2' HD11 ' A' ' 276' ' ' LEU . 30.1 t -111.82 115.33 49.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 75.33 111.146 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 64.7 t -103.96 128.84 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.41 111.136 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 72.24 111.121 -179.924 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.877 0.37 . . . . 72.31 111.115 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.503 HG23 ' HB3' ' A' ' 225' ' ' ARG . 84.7 m -92.03 120.36 32.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 64.53 111.157 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -101.75 119.52 38.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 74.34 110.931 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 17.6 t -142.06 123.98 15.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.43 110.806 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.548 HG21 HG22 ' A' ' 267' ' ' VAL . 8.9 p -110.75 137.77 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 73.34 111.107 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.44 -76.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 73.04 110.857 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 17.5 p -129.41 129.5 44.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 63.14 111.136 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.716 ' HB ' HG23 ' A' ' 231' ' ' ILE . 19.3 t -118.39 120.75 65.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 74.13 111.11 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.724 HG22 ' HD2' ' A' ' 232' ' ' ARG . 26.0 t -111.32 126.49 68.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 60.41 111.1 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.75 132.94 8.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.743 -0.741 . . . . 71.54 112.466 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.73 147.41 52.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.832 0.348 . . . . 73.25 110.87 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 59.66 71.76 0.72 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.713 -0.756 . . . . 63.43 112.451 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 50.06 61.05 3.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.886 0.374 . . . . 72.31 110.868 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 15.9 t -85.99 147.99 25.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 73.15 110.841 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -110.57 128.67 55.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 72.42 110.854 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.687 HG11 HG21 ' A' ' 231' ' ' ILE . 92.2 t -115.59 123.03 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 52.24 111.125 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.49 HD11 ' CG2' ' A' ' 244' ' ' VAL . 0.2 OUTLIER -128.53 111.74 13.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 64.42 110.888 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.604 HG13 HD12 ' A' ' 241' ' ' LEU . 18.1 mm -106.35 104.35 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 62.21 111.115 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.3 179.76 17.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.731 . . . . 75.32 112.48 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -89.84 156.04 18.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 73.41 110.879 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -130.31 140.29 50.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 71.12 110.868 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.453 ' CZ ' HG21 ' B' ' 245' ' ' VAL . 7.1 m-85 -119.24 126.01 50.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 73.42 110.9 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 161.08 142.55 3.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.731 . . . . 23.1 112.494 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.27 -18.83 10.62 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.733 -0.746 . . . . 64.34 112.491 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.4 79.33 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 70.34 110.888 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 67.22 112.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.768 -0.73 . . . . 64.52 112.483 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -52.32 111.52 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 72.11 110.877 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 3.1 t90 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.486 . . . . 70.23 110.931 -179.933 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.499 ' HB3' HG23 ' B' ' 261' ' ' THR . 4.5 ttm-85 . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.817 0.341 . . . . 74.34 110.919 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.696 ' HB3' HG22 ' B' ' 277' ' ' ILE . 1.2 m-20 -105.09 114.23 28.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 72.21 110.927 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.68 143.68 48.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 73.04 110.86 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.09 136.73 53.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 54.15 111.116 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.13 -36.28 16.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 64.21 110.927 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . 0.497 ' HB3' HG23 ' B' ' 266' ' ' THR . 26.6 t70 -165.12 137.74 4.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 72.14 110.848 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.593 HG21 HG11 ' B' ' 275' ' ' VAL . 7.7 mt -138.43 117.88 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 55.0 111.134 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -111.53 125.14 53.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 63.15 110.891 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 4.8 p -135.26 134.83 40.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.476 . . . . 72.05 111.148 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -150.94 167.4 27.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 74.3 110.92 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 66.98 64.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.864 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 77.9 mtm-85 50.46 55.34 9.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 71.31 110.869 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.04 156.57 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 64.4 111.126 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.27 140.79 52.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.87 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.556 HG23 ' HB ' ' B' ' 275' ' ' VAL . 3.0 p -132.62 130.43 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 72.02 111.139 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.714 ' C ' HD13 ' B' ' 241' ' ' LEU . 1.8 tm0? -136.6 130.85 32.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 72.05 110.956 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.714 HD13 ' C ' ' B' ' 240' ' ' GLN . 0.1 OUTLIER -118.54 117.9 30.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 72.44 110.973 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.56 175.85 23.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 34.55 112.508 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.88 128.87 34.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.836 0.35 . . . . 73.12 110.925 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -97.15 126.17 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 71.05 111.154 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.453 HG21 ' CZ ' ' A' ' 281' ' ' TYR . 93.4 t -122.11 112.89 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 61.04 111.111 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.457 HG23 ' O ' ' B' ' 281' ' ' TYR . 78.1 p -76.84 170.28 16.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 74.42 111.115 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.75 81.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 64.34 111.13 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.67 77.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 62.44 111.131 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 60.42 111.101 179.923 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.905 0.383 . . . . 73.15 110.908 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 15.1 t -100.77 137.27 39.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 71.13 111.119 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.499 HG23 ' HB3' ' B' ' 225' ' ' ARG . 23.7 m -98.45 110.76 23.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 71.11 111.172 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -93.21 119.56 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 71.23 110.886 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 24.8 p -142.17 123.68 14.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 61.01 110.857 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.506 HG21 ' CG2' ' B' ' 267' ' ' VAL . 7.4 p -112.35 137.45 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 60.24 111.128 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.05 -76.78 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 60.53 110.849 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.497 HG23 ' HB3' ' B' ' 230' ' ' ASP . 1.2 m -133.71 130.69 38.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 74.04 111.127 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.506 ' CG2' HG21 ' B' ' 264' ' ' VAL . 21.7 t -118.52 120.53 64.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 73.3 111.148 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 30.4 t -105.04 121.41 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 63.25 111.11 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.47 132.94 10.61 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 52.54 112.449 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.95 147.3 52.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.351 . . . . 74.21 110.895 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.02 78.66 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 73.51 112.461 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 49.68 73.48 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.845 0.355 . . . . 73.35 110.907 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 14.8 t -96.66 147.84 23.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 74.34 110.881 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 24.2 mtm-85 -113.8 128.27 56.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 65.14 110.893 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.593 HG11 HG21 ' B' ' 231' ' ' ILE . 84.6 t -115.75 122.96 70.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 74.4 111.171 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.489 HD23 ' HZ2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -129.59 112.61 13.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 74.23 110.917 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 1.091 HD13 HD23 ' C' ' 241' ' ' LEU . 27.1 mm -109.44 103.98 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 70.01 111.145 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.16 -178.39 19.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 71.14 112.479 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -89.85 156.09 18.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.78 0.324 . . . . 71.2 110.858 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -126.8 139.1 53.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 72.34 110.862 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.457 ' O ' HG23 ' B' ' 246' ' ' THR . 2.0 t80 -120.9 125.87 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 74.24 110.913 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 161.76 149.91 5.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.734 -0.746 . . . . 61.04 112.517 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -105.25 -29.84 4.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 75.12 112.505 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -69.68 86.22 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 73.31 110.902 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 69.65 133.13 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.764 -0.731 . . . . 60.03 112.494 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -77.37 89.54 3.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.379 . . . . 64.32 110.858 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.489 ' HZ2' HD23 ' B' ' 276' ' ' LEU . 4.9 t90 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 73.52 110.956 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.568 ' N ' HG23 ' C' ' 261' ' ' THR . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.836 0.351 . . . . 74.24 110.88 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.678 ' HB3' HG22 ' C' ' 277' ' ' ILE . 0.7 OUTLIER -83.85 116.78 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 75.12 110.872 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.93 146.36 51.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 41.0 110.866 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.22 134.87 48.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 74.01 111.093 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.73 -34.66 21.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 64.4 110.887 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . 0.618 ' HB3' HG23 ' C' ' 266' ' ' THR . 4.4 t70 -165.52 137.57 4.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 64.02 110.885 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.537 HG21 HG11 ' C' ' 275' ' ' VAL . 8.7 mt -138.36 121.19 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 71.44 111.14 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 21.9 ttm-85 -111.57 125.5 54.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.814 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 3.8 p -135.1 131.74 37.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 74.34 111.157 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -147.82 167.77 23.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 74.11 110.836 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 63.36 72.71 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 75.43 110.898 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? 47.29 40.32 10.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 75.44 110.882 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.28 156.1 18.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 50.42 111.091 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -134.57 144.09 47.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 63.43 110.87 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.508 HG23 ' CG1' ' C' ' 275' ' ' VAL . 3.5 p -130.66 121.88 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 74.52 111.15 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.719 ' C ' HD13 ' C' ' 241' ' ' LEU . 2.5 tm0? -124.81 126.68 45.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 71.53 110.938 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 1.091 HD23 HD13 ' B' ' 277' ' ' ILE . 0.1 OUTLIER -117.35 117.43 29.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 74.53 110.911 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 153.35 176.23 25.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.771 -0.728 . . . . 61.32 112.519 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -85.89 128.75 34.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 62.03 110.911 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.91 128.18 46.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 75.22 111.088 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.44 113.43 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 52.52 111.129 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 23.3 p -69.67 169.03 13.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 75.31 111.115 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.17 93.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 71.33 111.043 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.06 82.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 63.05 111.075 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 63.12 111.08 179.955 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.84 0.352 . . . . 53.31 110.922 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . 0.675 HG21 ' HB3' ' D' ' 243' ' ' ASN . 8.6 t -70.87 131.45 43.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 61.02 111.15 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.568 HG23 ' N ' ' C' ' 225' ' ' ARG . 0.2 OUTLIER -101.41 139.66 36.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 73.32 111.166 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -124.5 128.65 49.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 64.54 110.836 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 5.5 p -141.56 123.77 15.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 75.24 110.887 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.494 HG21 ' CG2' ' C' ' 267' ' ' VAL . 7.5 p -111.27 137.65 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 74.25 111.132 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.58 -76.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.167 -0.469 . . . . 73.45 110.908 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . 0.618 HG23 ' HB3' ' C' ' 230' ' ' ASP . 0.2 OUTLIER -130.72 130.53 43.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 44.43 111.144 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.494 ' CG2' HG21 ' C' ' 264' ' ' VAL . 19.5 t -118.64 129.6 74.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 75.15 111.146 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.68 119.06 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 52.33 111.149 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.39 132.47 10.34 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.767 -0.73 . . . . 52.33 112.488 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -134.05 147.58 50.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.361 . . . . 71.21 110.871 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.39 87.2 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.717 -0.754 . . . . 45.02 112.482 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 45.66 64.4 1.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 74.51 110.915 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 4.1 t -88.27 145.78 25.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 60.44 110.871 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 4.0 mtm-85 -117.45 127.8 54.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.505 . . . . 71.22 110.851 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.537 HG11 HG21 ' C' ' 231' ' ' ILE . 83.9 t -116.13 123.5 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.42 111.108 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.532 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.3 OUTLIER -128.5 113.65 15.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 73.01 110.861 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 1.026 HD13 HD23 ' D' ' 241' ' ' LEU . 24.7 mm -112.14 104.41 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 73.04 111.132 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.36 -175.08 22.19 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.753 . . . . 72.53 112.512 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.47 156.22 16.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.846 0.355 . . . . 72.14 110.861 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.407 ' CG ' HG13 ' D' ' 244' ' ' VAL . 6.7 pt-20 -126.8 138.04 53.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 72.24 110.887 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -120.63 125.11 46.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.472 . . . . 75.12 110.923 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 164.84 147.7 5.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.752 -0.737 . . . . 73.23 112.503 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -80.77 -48.99 5.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.749 -0.739 . . . . 73.41 112.509 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -51.67 103.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.357 . . . . 65.44 110.868 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 53.69 -147.36 19.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 53.43 112.473 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -122.35 -35.31 3.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 64.14 110.859 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.532 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 13.2 t90 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 72.51 110.891 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . 0.569 ' HA ' HG23 ' D' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.808 0.337 . . . . 74.25 110.856 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . 0.749 ' HB3' HG22 ' D' ' 277' ' ' ILE . 2.0 m120 -84.31 114.52 21.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 63.44 110.911 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 3.8 t -134.5 142.71 47.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.41 110.809 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . 0.583 ' CB ' HD11 ' D' ' 231' ' ' ILE . . . -129.29 119.99 24.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.505 . . . . 50.24 111.1 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -34.42 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 63.14 110.892 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -166.12 137.51 3.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 61.52 110.865 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . 0.583 HD11 ' CB ' ' D' ' 228' ' ' ALA . 6.3 mt -138.58 121.69 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 71.43 111.151 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -111.45 126.15 54.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 74.12 110.843 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . 0.439 HG21 ' HB ' ' D' ' 239' ' ' VAL . 5.8 p -135.16 130.57 35.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 61.21 111.141 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -146.44 166.84 25.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 71.34 110.9 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 64.99 71.05 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 74.23 110.925 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.33 34.88 4.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 75.34 110.893 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.89 154.21 23.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 71.44 111.13 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.49 144.43 51.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 74.32 110.899 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.522 HG23 ' CG1' ' D' ' 275' ' ' VAL . 6.0 p -131.51 121.91 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 62.31 111.11 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . 0.694 ' C ' HD13 ' D' ' 241' ' ' LEU . 2.4 tm0? -125.58 125.78 43.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 74.11 110.915 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 1.026 HD23 HD13 ' C' ' 277' ' ' ILE . 0.1 OUTLIER -117.51 118.01 31.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 61.15 110.872 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.01 179.48 26.78 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.752 . . . . 25.21 112.454 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . 0.675 ' HB3' HG21 ' C' ' 260' ' ' THR . 6.6 p30 -86.02 133.54 33.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.902 0.382 . . . . 64.15 110.88 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . 0.407 HG13 ' CG ' ' C' ' 280' ' ' GLU . 19.9 t -103.67 114.95 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 72.11 111.137 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . 0.416 HG23 ' OD1' ' D' ' 243' ' ' ASN . 21.8 t -110.76 120.7 62.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 71.41 111.168 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 9.6 p -76.56 167.17 22.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.14 111.125 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.26 79.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 72.43 111.109 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.38 -38.25 73.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 55.41 111.046 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 54.44 111.101 179.956 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 14.3 t . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.89 0.376 . . . . 64.12 111.121 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . 0.569 HG23 ' HA ' ' D' ' 225' ' ' ARG . 26.8 m -106.68 108.85 20.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 63.3 111.166 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . 0.409 HD22 ' N ' ' D' ' 263' ' ' SER . 0.1 OUTLIER -100.02 130.53 46.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 72.35 110.885 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . 0.409 ' N ' HD22 ' D' ' 262' ' ' ASN . 5.5 t -140.95 123.76 16.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 42.43 110.867 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.616 HG21 HG22 ' D' ' 267' ' ' VAL . 7.9 p -108.26 141.34 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 65.42 111.126 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -81.07 -76.65 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 75.23 110.9 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.49 128.26 46.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 61.41 111.192 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.616 HG22 HG21 ' D' ' 264' ' ' VAL . 17.8 t -118.5 135.05 60.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 73.2 111.126 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 50.7 t -126.41 126.32 68.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.145 -0.479 . . . . 40.51 111.109 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.07 132.42 8.08 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.729 -0.748 . . . . 70.03 112.504 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -133.51 147.3 51.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.828 0.346 . . . . 64.44 110.931 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.19 89.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 75.15 112.469 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 44.06 59.73 3.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 75.35 110.895 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 17.1 t -83.84 145.41 28.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 40.04 110.861 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -118.1 128.09 54.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 75.55 110.883 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.542 HG11 HG21 ' D' ' 231' ' ' ILE . 92.0 t -119.44 122.02 67.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 71.24 111.135 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.451 HD21 ' OE1' ' D' ' 240' ' ' GLN . 0.2 OUTLIER -129.77 112.11 13.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 71.02 110.949 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.749 HG22 ' HB3' ' D' ' 226' ' ' ASN . 28.3 mm -112.68 104.34 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 71.23 111.106 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.6 -174.24 26.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.678 -0.772 . . . . 75.05 112.509 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -100.37 156.11 17.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.332 . . . . 61.34 110.889 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . 0.543 ' CD ' HG13 ' E' ' 244' ' ' VAL . 2.1 pt-20 -121.72 118.9 30.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 64.44 110.905 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . 0.492 ' OH ' ' HB2' ' E' ' 249' ' ' ALA . 17.9 t80 -112.42 136.66 51.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 60.01 110.918 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 135.67 175.71 13.98 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 51.32 112.475 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . 0.617 ' CA ' ' HB2' ' E' ' 247' ' ' ALA . . . -107.89 107.69 2.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 62.33 112.463 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -166.07 28.05 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 64.04 110.889 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 76.39 -66.48 2.63 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.76 -0.733 . . . . 42.52 112.479 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . 0.734 ' CE1' HG21 ' E' ' 244' ' ' VAL . 59.8 t80 -174.98 156.74 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 62.32 110.866 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 33.8 t90 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 72.45 110.903 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.458 -0.048 0 CA-C-O 120.844 0.354 . . . . 54.12 110.884 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . 0.642 ' HB3' HG22 ' E' ' 277' ' ' ILE . 5.2 m120 -83.78 113.72 21.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 71.43 110.9 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 73.3 m -131.05 144.74 51.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 72.15 110.864 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . 0.489 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -125.78 134.63 51.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 74.34 111.086 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.13 -37.1 16.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 64.12 110.881 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -164.98 136.98 4.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 71.21 110.876 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . 0.494 HG21 HG11 ' E' ' 275' ' ' VAL . 9.8 mt -138.78 119.65 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 63.02 111.171 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -111.23 124.88 53.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 62.43 110.884 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 8.4 p -135.07 132.9 38.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 73.31 111.127 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -152.8 166.6 31.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.21 110.927 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 65.14 69.42 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 74.4 110.907 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.47 53.67 12.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 75.03 110.888 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.66 155.91 18.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 41.44 111.119 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 -131.3 135.94 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 50.3 110.847 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.549 HG23 ' HB ' ' E' ' 275' ' ' VAL . 4.0 p -125.99 129.71 72.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 73.31 111.175 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -137.62 135.66 36.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 53.31 110.912 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' D' ' 277' ' ' ILE . 2.0 mp -129.99 118.54 21.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.35 110.918 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 155.25 176.64 27.68 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 54.4 112.505 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -88.95 128.66 35.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 62.54 110.914 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.734 HG21 ' CE1' ' D' ' 286' ' ' PHE . 93.1 t -98.75 123.1 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 60.04 111.14 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . 0.493 HG13 ' HD2' ' E' ' 281' ' ' TYR . 21.8 t -122.17 117.14 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 65.2 111.134 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.9 t -68.11 174.98 3.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 62.42 111.117 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . 0.617 ' HB2' ' CA ' ' D' ' 283' ' ' GLY . . . -61.05 -32.3 71.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.453 . . . . 74.41 111.081 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.12 -35.25 61.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 54.32 111.137 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . 0.492 ' HB2' ' OH ' ' D' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 60.42 111.088 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 90.6 m . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.789 0.328 . . . . 73.54 111.151 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -126.16 134.41 51.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 74.22 110.866 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.86 123.93 15.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 45.33 110.871 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . 0.538 HG21 ' CG2' ' E' ' 267' ' ' VAL . 11.4 p -108.2 140.72 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 62.35 111.129 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -81.16 -76.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 72.13 110.903 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.6 m -138.03 129.49 27.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 64.34 111.139 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . 0.538 ' CG2' HG21 ' E' ' 264' ' ' VAL . 23.7 t -118.14 120.5 64.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 74.41 111.108 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 52.0 t -104.64 115.82 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 54.13 111.157 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.93 132.58 11.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.743 . . . . 23.24 112.462 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.25 144.25 49.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 74.15 110.943 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.42 87.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.73 . . . . 75.41 112.481 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 48.86 74.84 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 50.33 110.865 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 36.7 t -100.79 145.8 28.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 60.45 110.826 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.66 128.66 54.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 73.2 110.847 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.549 ' HB ' HG23 ' E' ' 239' ' ' VAL . 87.5 t -117.7 122.68 70.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 75.2 111.144 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . 0.442 HD21 ' HZ ' ' D' ' 286' ' ' PHE . 0.4 OUTLIER -129.05 111.72 13.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.942 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.642 HG22 ' HB3' ' E' ' 226' ' ' ASN . 37.2 mm -113.39 104.31 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 61.51 111.091 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 138.89 -172.72 22.98 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.713 -0.756 . . . . 73.43 112.484 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . 0.452 ' H ' ' ND2' ' E' ' 279' ' ' ASN . 1.8 p30 -89.02 154.12 20.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.802 0.334 . . . . 65.11 110.843 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -128.29 130.14 47.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 65.33 110.93 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . 0.493 ' HD2' HG13 ' E' ' 245' ' ' VAL . 1.3 t80 -132.41 121.76 23.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 64.24 110.946 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.68 -0.771 . . . . 72.11 112.447 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.836 0.35 . . . . 75.5 110.863 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -98.31 124.31 42.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 74.31 110.888 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.23 137.85 54.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 72.53 110.82 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.29 123.32 15.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 65.24 111.066 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -84.92 -36.79 21.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.446 . . . . 73.05 110.865 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -164.18 139.29 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 64.43 110.871 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 13.0 mt -137.01 117.68 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 70.22 111.182 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -120.19 115.76 24.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 64.24 110.86 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.23 132.93 47.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 73.24 111.206 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -138.27 157.08 46.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 72.24 110.883 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.468 ' O ' ' C ' ' A' ' 236' ' ' ARG . 6.3 tt0 65.13 88.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 71.44 110.883 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.468 ' C ' ' O ' ' A' ' 235' ' ' GLU . 0.0 OUTLIER 31.68 52.55 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 74.52 110.903 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.79 145.59 24.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 72.31 111.113 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -125.76 136.71 53.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 75.13 110.908 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.602 HG12 ' HB ' ' A' ' 275' ' ' VAL . 6.9 m -142.5 121.75 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 71.12 111.089 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.26 137.25 54.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 64.25 110.849 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.68 122.05 26.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.196 -0.456 . . . . 71.23 110.968 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.85 -115.83 0.88 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 52.42 112.523 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -145.44 128.96 17.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 74.5 110.879 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.416 HG23 ' HA ' ' A' ' 280' ' ' GLU . 20.9 m -111.79 127.68 68.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 64.42 111.083 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.1 t -122.24 129.08 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 71.12 111.124 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 64.2 111.125 -179.945 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 30.8 p . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.883 0.373 . . . . 61.24 111.145 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 1.3 m -107.75 108.98 20.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.14 111.126 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -94.18 124.97 38.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 55.21 110.907 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.99 123.82 15.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 34.34 110.904 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.631 HG21 HG22 ' A' ' 267' ' ' VAL . 10.4 p -118.66 135.78 57.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 72.42 111.103 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 -75.29 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.469 . . . . 71.21 110.847 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.4 m -123.46 130.29 52.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 71.31 111.108 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.631 HG22 HG21 ' A' ' 264' ' ' VAL . 33.7 t -118.12 129.83 73.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 63.21 111.112 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 36.7 t -127.68 124.83 64.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 71.32 111.114 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.01 134.02 8.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 73.5 112.47 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -132.8 141.68 48.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.78 0.324 . . . . 72.22 110.92 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 57.29 85.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 41.43 112.485 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 44.0 60.56 2.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.827 0.346 . . . . 75.3 110.902 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 11.0 t -83.92 145.36 28.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 61.44 110.93 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 3.3 mpp_? -129.49 127.25 40.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.887 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.602 ' HB ' HG12 ' A' ' 239' ' ' VAL . 17.6 t -137.06 124.01 30.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 63.31 111.13 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.0 111.16 17.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 72.21 110.901 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.674 ' CD1' HD13 ' B' ' 241' ' ' LEU . 30.5 mm -103.3 104.63 16.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 73.53 111.11 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.24 -163.61 28.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 53.21 112.467 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -103.43 155.92 18.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 72.13 110.844 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.6 ' HG3' HG12 ' B' ' 244' ' ' VAL . 2.0 pp20? -129.93 147.32 51.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.12 -0.491 . . . . 72.34 110.922 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -129.69 125.84 36.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 73.23 110.927 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 165.69 -86.14 0.1 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.705 -0.76 . . . . 70.13 112.506 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 127.75 -97.79 0.47 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.76 -0.733 . . . . 52.21 112.51 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -51.73 127.85 21.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.794 0.33 . . . . 73.24 110.895 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 93.72 -33.22 5.31 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.753 -0.737 . . . . 52.42 112.474 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.39 -174.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.373 . . . . 74.02 110.865 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 19.3 t90 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 75.33 110.91 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.728 ' CB ' HG23 ' B' ' 261' ' ' THR . 1.7 mtt-85 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.714 0.292 . . . . 72.13 110.913 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -106.61 115.63 30.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.42 110.897 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.91 137.93 54.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 63.44 110.779 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.16 129.38 29.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 55.04 111.118 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 4.8 tttm -88.88 -36.32 16.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 62.32 110.869 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . 0.456 ' HB3' HG23 ' B' ' 266' ' ' THR . 0.6 OUTLIER -164.4 139.16 5.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 51.11 110.869 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.513 HD13 HD11 ' B' ' 241' ' ' LEU . 13.6 mt -137.31 117.84 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 75.41 111.075 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -127.03 119.65 27.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 63.32 110.84 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.52 140.36 48.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 65.42 111.149 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -140.35 164.38 30.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 72.52 110.874 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' B' ' 236' ' ' ARG . 2.2 tt0 64.07 72.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 74.53 110.809 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' B' ' 235' ' ' GLU . 19.5 ptt-85 37.19 63.43 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 64.12 110.854 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.56 155.06 19.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 34.51 111.107 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.96 135.32 48.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 64.03 110.854 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.56 HG23 HG13 ' A' ' 275' ' ' VAL . 21.0 m -143.11 121.9 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 64.53 111.147 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -118.37 137.26 53.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.33 110.845 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.674 HD13 ' CD1' ' A' ' 277' ' ' ILE . 5.2 mp -125.02 118.54 26.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 72.35 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 143.02 -177.64 21.81 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.739 -0.743 . . . . 60.03 112.473 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.93 139.0 31.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 73.42 110.905 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.6 HG12 ' HG3' ' A' ' 280' ' ' GLU . 27.3 m -116.82 127.49 74.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 64.32 111.139 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 54.2 t -117.5 129.28 74.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 70.42 111.088 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.533 HG21 ' HB2' ' B' ' 284' ' ' LYS . 0.7 OUTLIER -80.18 162.81 24.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 63.35 111.191 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.14 79.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 73.51 111.075 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -62.55 -41.71 99.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.306 -0.407 . . . . 75.05 111.104 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 70.11 111.128 179.87 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.854 0.359 . . . . 74.31 110.881 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 86.3 m -95.4 122.92 38.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 61.02 111.131 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.728 HG23 ' CB ' ' B' ' 225' ' ' ARG . 5.4 m -94.6 108.84 20.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 65.23 111.149 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -96.59 127.72 42.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 62.31 110.927 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 63.9 p -142.03 123.99 15.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 73.14 110.898 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.556 HG21 HG22 ' B' ' 267' ' ' VAL . 8.8 p -115.18 136.83 50.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 55.35 111.062 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.26 -75.71 0.22 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.117 -0.492 . . . . 74.54 110.862 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.456 HG23 ' HB3' ' B' ' 230' ' ' ASP . 1.7 m -127.4 130.8 50.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 61.2 111.147 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.556 HG22 HG21 ' B' ' 264' ' ' VAL . 28.6 t -118.32 128.29 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 72.03 111.129 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.56 120.43 54.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 70.02 111.1 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.88 133.69 8.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 74.4 112.46 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -133.09 148.02 52.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 74.42 110.893 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.63 76.58 0.19 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.708 -0.758 . . . . 42.43 112.476 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 48.35 62.19 2.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.342 . . . . 73.24 110.924 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 32.6 t -87.43 145.67 26.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 75.55 110.879 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.74 127.38 43.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 73.34 110.937 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.65 HG13 HG23 ' C' ' 239' ' ' VAL . 10.0 t -135.59 124.07 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 74.43 111.148 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.46 116.53 26.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.471 . . . . 61.34 110.872 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 29.0 mm -107.72 135.09 47.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 61.23 111.089 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 118.39 -168.75 13.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 64.32 112.392 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -112.38 155.38 24.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.791 0.329 . . . . 65.4 110.908 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.456 ' HG2' HG12 ' C' ' 244' ' ' VAL . 15.7 pt-20 -120.13 137.45 54.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 71.11 110.935 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.94 125.96 50.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 74.35 110.874 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' C' ' 247' ' ' ALA . . . 127.12 159.84 10.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 51.03 112.452 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -101.53 -19.03 16.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.82 -0.705 . . . . 44.15 112.477 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . 0.533 ' HB2' HG21 ' B' ' 246' ' ' THR . 1.4 mmtt -66.97 89.31 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 65.14 110.948 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 66.86 113.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 71.14 112.506 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -52.85 -66.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.812 0.339 . . . . 61.42 110.865 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 15.4 t90 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 73.24 110.916 -179.947 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.777 0.322 . . . . 62.42 110.839 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.416 ' ND2' HG22 ' C' ' 277' ' ' ILE . 4.3 m120 -94.64 134.93 36.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 73.11 110.882 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 8.1 t -132.46 137.84 47.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 64.55 110.894 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.95 138.83 44.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 74.21 111.12 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.86 -33.47 11.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.41 . . . . 63.3 110.897 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.71 138.54 5.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 73.51 110.822 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 11.0 mt -137.59 117.89 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 75.22 111.135 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -127.74 121.9 31.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 73.41 110.918 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 141.67 45.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 43.12 111.167 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.18 166.31 25.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 73.51 110.863 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 65.0 57.68 0.96 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.156 -0.475 . . . . 62.31 110.874 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 50.87 61.2 3.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 73.42 110.887 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 151.97 22.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 64.15 111.168 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -125.92 135.38 51.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 64.14 110.886 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.774 HG12 ' HB ' ' C' ' 275' ' ' VAL . 4.4 m -140.66 121.9 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 75.24 111.155 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -115.68 129.71 56.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 71.31 110.986 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.808 HD13 ' HB ' ' C' ' 277' ' ' ILE . 3.3 mm? -114.91 118.72 34.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 54.55 110.938 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.1 174.28 13.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.759 -0.734 . . . . 71.32 112.471 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.54 147.92 22.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.869 0.366 . . . . 63.22 110.856 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.456 HG12 ' HG2' ' B' ' 280' ' ' GLU . 34.9 m -119.09 130.42 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 73.02 111.122 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.407 HG12 ' HB3' ' C' ' 249' ' ' ALA . 21.7 t -122.07 128.97 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 34.53 111.096 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 7.8 p -74.41 162.97 28.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 64.14 111.158 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.503 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -63.08 -33.97 76.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 73.42 111.06 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.81 -41.85 78.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 45.23 111.064 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . 0.697 ' HB2' ' CD1' ' C' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 64.21 111.097 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.917 0.389 . . . . 74.2 110.93 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 26.4 m -76.3 121.98 23.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 63.22 111.175 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.7 m -92.33 125.5 37.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 73.23 111.123 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -113.83 119.99 39.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 75.52 110.878 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 8.3 t -129.9 123.66 31.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 45.53 110.843 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.591 HG21 HG22 ' C' ' 267' ' ' VAL . 9.3 p -117.06 135.97 55.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 71.15 111.128 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -79.12 -76.09 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 72.34 110.884 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 2.1 m -124.53 130.71 52.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 65.53 111.197 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.591 HG22 HG21 ' C' ' 264' ' ' VAL . 21.9 t -118.09 125.27 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.11 111.209 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 57.8 t -127.24 118.73 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 61.34 111.119 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.1 133.78 8.9 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 42.2 112.522 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -132.53 147.66 52.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.337 . . . . 74.13 110.885 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.14 75.46 0.26 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.686 -0.769 . . . . 52.01 112.499 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 48.64 60.43 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 61.3 110.846 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 21.3 t -85.55 145.85 27.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.34 110.846 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -128.32 127.86 43.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 65.33 110.823 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.774 ' HB ' HG12 ' C' ' 239' ' ' VAL . 17.3 t -135.18 123.89 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 72.42 111.126 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.48 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -121.89 112.29 18.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 72.24 110.865 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.808 ' HB ' HD13 ' C' ' 241' ' ' LEU . 24.7 mm -106.17 123.51 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 65.33 111.105 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 129.17 167.11 12.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 63.34 112.55 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -89.97 145.3 25.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.774 0.321 . . . . 71.21 110.91 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.05 134.62 54.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 72.23 110.913 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.697 ' CD1' ' HB2' ' C' ' 249' ' ' ALA . 27.2 t80 -119.68 125.95 49.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 73.52 110.986 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 153.55 168.78 17.77 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 34.25 112.523 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . 0.597 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . -111.68 -18.32 8.03 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.715 -0.755 . . . . 65.4 112.499 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -76.37 67.11 2.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 63.24 110.929 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 78.31 159.63 13.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 62.32 112.518 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -81.27 -74.67 0.32 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.865 0.364 . . . . 65.21 110.859 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.48 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 3.7 t90 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 72.04 110.927 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.81 0.338 . . . . 71.42 110.891 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.75 113.1 20.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 73.32 110.861 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 2.6 m -128.3 139.76 52.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 71.53 110.84 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.33 157.63 42.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 72.21 111.158 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -112.6 -34.41 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 72.43 110.895 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . 0.491 ' HB3' HG23 ' D' ' 266' ' ' THR . 8.1 t0 -164.53 138.86 5.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 73.53 110.869 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 8.9 mt -137.64 117.74 16.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 72.35 111.196 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -130.54 123.53 29.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 70.13 110.932 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' D' ' 237' ' ' ALA . 0.1 OUTLIER -135.2 146.64 48.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 73.24 111.118 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -146.51 166.61 25.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 74.51 110.901 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 64.93 55.88 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 75.51 110.877 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.85 62.79 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.477 . . . . 73.13 110.862 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . 0.44 ' HB3' ' OG1' ' D' ' 233' ' ' THR . . . -104.49 156.06 18.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 43.42 111.123 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -128.05 135.71 50.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 73.11 110.817 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.713 HG23 HG13 ' C' ' 275' ' ' VAL . 20.5 m -138.27 122.85 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.11 111.148 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . 0.495 ' C ' HD22 ' D' ' 241' ' ' LEU . 0.0 OUTLIER -116.37 136.43 53.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 72.35 110.938 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.563 HD23 ' CD1' ' C' ' 277' ' ' ILE . 3.8 mm? -119.96 118.98 32.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 50.51 110.89 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.14 171.61 13.0 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.75 . . . . 63.51 112.495 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -93.28 153.95 18.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 74.42 110.888 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 18.5 m -120.67 136.85 56.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 75.34 111.093 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 97.9 t -122.24 130.09 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 72.32 111.098 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 1.7 p -68.35 168.54 12.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 75.31 111.097 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . 0.597 ' HB2' ' N ' ' C' ' 283' ' ' GLY . . . -59.57 -34.49 72.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 72.22 111.136 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.44 -37.53 72.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 64.43 111.162 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . 0.622 ' HB2' ' OH ' ' C' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 35.14 111.146 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.851 0.358 . . . . 33.41 111.141 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 98.0 m -102.61 139.17 38.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 75.24 111.148 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.14 130.98 52.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 74.04 110.807 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 5.8 t -142.07 123.9 15.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 62.33 110.81 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.506 HG21 HG22 ' D' ' 267' ' ' VAL . 7.6 p -123.76 138.34 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 63.11 111.131 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.73 -76.4 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 74.05 110.847 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . 0.491 HG23 ' HB3' ' D' ' 230' ' ' ASP . 6.2 m -128.3 130.46 47.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 71.24 111.081 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.506 HG22 HG21 ' D' ' 264' ' ' VAL . 21.3 t -118.4 120.93 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.144 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 18.1 t -121.68 118.45 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 72.51 111.169 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.52 136.49 12.23 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.715 -0.755 . . . . 62.22 112.456 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.44 147.51 52.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.879 0.371 . . . . 75.11 110.894 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.43 76.22 0.2 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.723 -0.751 . . . . 42.43 112.468 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 47.93 61.95 2.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 71.53 110.866 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 30.5 t -87.15 145.99 26.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 52.34 110.871 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -127.49 127.67 44.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 60.44 110.903 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.632 HG13 HG23 ' E' ' 239' ' ' VAL . 14.2 t -132.66 124.15 50.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 71.33 111.071 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.2 OUTLIER -123.44 112.38 17.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.22 110.889 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.466 ' HB ' HD13 ' D' ' 241' ' ' LEU . 28.0 mm -105.0 129.06 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 72.13 111.111 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 120.03 170.46 14.36 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 63.43 112.561 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -89.68 154.01 20.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.327 . . . . 71.35 110.867 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . 0.69 ' CG ' HG12 ' E' ' 244' ' ' VAL . 6.5 pt-20 -127.95 133.17 49.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 64.4 110.858 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . 0.476 ' HE1' ' HB2' ' E' ' 249' ' ' ALA . 34.3 t80 -116.22 124.18 49.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 73.14 110.925 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 174.42 -58.32 0.13 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 61.23 112.443 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 91.47 -66.83 2.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.795 -0.717 . . . . 24.25 112.476 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -51.43 -30.32 19.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 75.54 110.917 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -140.34 97.57 0.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.677 -0.773 . . . . 71.4 112.478 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -51.3 -75.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 72.44 110.883 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 15.4 t90 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 64.5 110.932 -179.975 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? . . . . . 0 CA--C 1.526 0.045 0 CA-C-O 120.78 0.324 . . . . 43.2 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -97.29 111.66 23.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 72.13 110.868 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 14.8 m -121.94 138.96 54.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 72.41 110.839 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.79 132.82 35.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 73.31 111.073 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.06 -29.24 15.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.878 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -164.52 139.33 5.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 60.42 110.896 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 10.5 mt -136.87 117.57 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 70.12 111.162 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.61 121.11 23.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 72.13 110.869 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' E' ' 237' ' ' ALA . 0.7 OUTLIER -134.51 145.36 48.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 65.34 111.096 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -148.17 167.09 25.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 60.11 110.881 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 65.74 54.41 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 64.43 110.916 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 51.2 62.07 2.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.477 . . . . 74.03 110.852 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' E' ' 233' ' ' THR . . . -104.76 156.15 18.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 73.31 111.12 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -128.32 135.83 50.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.33 110.855 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.632 HG23 HG13 ' D' ' 275' ' ' VAL . 4.2 m -131.99 121.98 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 43.14 111.109 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . 0.653 ' HB3' HD22 ' E' ' 276' ' ' LEU . 0.0 OUTLIER -115.48 137.07 52.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 60.0 110.9 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.826 HD13 ' HB ' ' E' ' 277' ' ' ILE . 4.1 mm? -126.74 121.17 31.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 64.44 110.958 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.19 163.3 11.5 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 64.03 112.456 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -85.7 156.98 20.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.906 0.384 . . . . 74.1 110.854 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.69 HG12 ' CG ' ' D' ' 280' ' ' GLU . 31.6 m -119.42 134.08 64.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 71.13 111.121 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.53 129.54 75.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 51.33 111.085 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . 0.426 HG21 ' HA2' ' E' ' 282' ' ' GLY . 13.6 t -69.49 175.54 4.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 74.01 111.112 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.34 86.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 24.2 111.104 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.4 -53.03 62.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 55.03 111.1 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . 0.476 ' HB2' ' HE1' ' D' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 62.33 111.085 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.851 0.358 . . . . 73.14 111.107 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -105.09 119.93 40.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 63.23 110.932 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 29.2 t -127.27 123.83 37.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 62.34 110.822 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . 0.516 HG21 HG22 ' E' ' 267' ' ' VAL . 10.0 p -122.62 137.82 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 71.45 111.152 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.86 -75.07 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 71.44 110.904 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 60.5 m -125.23 133.58 52.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 62.32 111.123 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . 0.516 HG22 HG21 ' E' ' 264' ' ' VAL . 21.9 t -118.23 126.5 75.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 75.24 111.142 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.2 122.89 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 45.24 111.125 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.65 134.43 9.96 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 73.4 112.5 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -133.01 147.75 52.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 70.02 110.884 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.48 78.9 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.843 -0.694 . . . . 71.44 112.444 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 47.18 64.16 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 71.04 110.936 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 41.2 t -86.76 145.88 26.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 73.32 110.852 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -130.73 127.87 39.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 55.51 110.853 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.405 ' HB ' HG12 ' E' ' 239' ' ' VAL . 18.7 t -130.4 123.72 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 65.42 111.189 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . 0.653 HD22 ' HB3' ' E' ' 240' ' ' GLN . 0.2 OUTLIER -121.79 111.94 17.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 72.12 110.914 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.826 ' HB ' HD13 ' E' ' 241' ' ' LEU . 50.5 mm -108.55 132.64 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 63.24 111.18 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 124.42 -177.68 16.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.744 . . . . 73.23 112.483 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -103.18 153.67 20.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.787 0.327 . . . . 64.11 110.839 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.91 132.07 55.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 62.33 110.83 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -130.09 123.74 31.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 73.25 110.908 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . 0.426 ' HA2' HG21 ' E' ' 246' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 61.1 112.485 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.6 ' HG3' HG23 ' A' ' 261' ' ' THR . 9.2 ptp85 . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.797 0.332 . . . . 74.3 110.843 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.99 129.65 30.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.885 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 2.1 p -134.5 140.25 46.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 63.43 110.897 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.82 149.53 51.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 65.45 111.059 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -106.25 -35.63 7.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 71.15 110.874 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -164.86 137.86 4.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 75.43 110.907 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 17.4 mt -138.91 118.72 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 63.54 111.131 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -134.12 117.74 16.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 72.13 110.847 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.7 p -135.55 142.09 45.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 73.41 111.127 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.0 pm0 -147.01 167.9 22.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 72.31 110.93 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 68.94 57.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 75.55 110.909 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 50.37 57.43 6.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.804 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.2 151.75 22.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 44.31 111.101 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -126.11 135.92 52.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 73.54 110.797 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.477 HG23 ' HB ' ' A' ' 275' ' ' VAL . 6.1 p -138.38 121.88 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 63.33 111.096 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.511 ' OE1' HD11 ' A' ' 276' ' ' LEU . 0.5 OUTLIER -114.01 136.0 53.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 72.31 110.948 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.535 HD12 ' HB ' ' A' ' 277' ' ' ILE . 1.6 tp -130.16 118.88 22.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.199 -0.455 . . . . 54.31 110.888 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 139.57 173.22 13.04 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.699 -0.762 . . . . 74.52 112.478 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . 0.446 ' ND2' HD21 ' A' ' 279' ' ' ASN . 8.8 m-20 -85.67 160.45 19.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 74.54 110.903 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 97.9 t -133.07 121.02 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.475 . . . . 72.44 111.16 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.19 129.04 75.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 70.35 111.131 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 72.11 111.108 -179.945 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 95.1 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.805 0.336 . . . . 72.42 111.108 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.6 HG23 ' HG3' ' A' ' 225' ' ' ARG . 26.0 m -116.48 122.41 44.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 73.15 111.147 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.476 ' HB2' HG22 ' A' ' 277' ' ' ILE . 17.5 p30 -107.41 139.34 42.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 63.42 110.875 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.91 123.25 15.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.509 . . . . 64.22 110.812 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.485 HG21 HG22 ' A' ' 267' ' ' VAL . 7.0 p -119.87 137.59 53.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 64.33 111.127 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.91 -77.39 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 72.11 110.857 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 35.3 p -127.21 130.18 49.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 55.0 111.146 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.485 HG22 HG21 ' A' ' 264' ' ' VAL . 20.5 t -118.04 120.69 65.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 70.14 111.125 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.77 118.12 53.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 41.24 111.109 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.17 134.37 10.09 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 71.44 112.49 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.63 147.76 52.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.347 . . . . 72.34 110.895 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.78 78.97 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.79 -0.719 . . . . 54.13 112.45 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 47.9 66.3 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.842 0.353 . . . . 73.41 110.825 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 32.7 t -92.76 145.9 24.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 65.12 110.756 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -125.42 128.29 47.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 74.24 110.9 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.477 ' HB ' HG23 ' A' ' 239' ' ' VAL . 20.6 t -134.1 123.76 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 60.03 111.139 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.511 HD11 ' OE1' ' A' ' 240' ' ' GLN . 0.2 OUTLIER -122.42 111.86 17.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.14 110.858 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.535 ' HB ' HD12 ' A' ' 241' ' ' LEU . 3.4 mp -109.78 106.25 20.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.251 -0.431 . . . . 75.45 111.146 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.5 175.56 19.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 63.12 112.488 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.446 HD21 ' ND2' ' A' ' 243' ' ' ASN . 2.9 p30 -107.14 147.72 29.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.817 0.342 . . . . 75.41 110.879 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.435 ' HG2' HG22 ' B' ' 244' ' ' VAL . 12.7 pt-20 -118.97 126.37 51.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 65.05 110.905 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.409 ' CE2' HG11 ' B' ' 245' ' ' VAL . 1.8 t80 -118.55 125.76 50.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 64.21 110.921 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' B' ' 247' ' ' ALA . . . 151.33 -39.66 0.8 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.684 -0.769 . . . . 75.23 112.5 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 123.99 -119.8 3.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 52.24 112.442 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 63.34 25.92 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 44.34 110.857 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 77.3 -63.63 3.28 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.705 -0.76 . . . . 72.43 112.49 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -174.49 -167.96 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 73.34 110.893 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.419 ' CZ2' HD23 ' A' ' 276' ' ' LEU . 15.6 t90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 74.11 110.947 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.44 ' O ' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.771 0.32 . . . . 60.44 110.93 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.8 137.51 45.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 75.15 110.852 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.59 137.9 38.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 71.03 110.897 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.17 147.85 52.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 74.32 111.104 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.87 -31.46 9.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 73.11 110.917 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.51 137.79 4.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 54.04 110.89 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 15.6 mt -138.19 117.18 14.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 64.14 111.139 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -134.57 115.26 13.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 64.02 110.883 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.3 p -135.86 137.19 41.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 52.32 111.096 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -141.93 167.28 22.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 62.55 110.912 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 66.95 69.51 0.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 73.14 110.792 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 46.06 40.52 7.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 62.21 110.82 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.81 148.79 23.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 45.23 111.096 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.8 140.82 50.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 73.43 110.829 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.404 HG13 ' O ' ' B' ' 239' ' ' VAL . 6.1 p -138.96 121.99 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.113 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.61 131.76 56.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 74.03 110.865 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.652 HD12 ' HB ' ' B' ' 277' ' ' ILE . 1.2 tp -130.23 118.94 22.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 71.31 110.921 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 154.92 -138.27 6.05 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 52.32 112.42 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.448 ' OD1' HG23 ' B' ' 245' ' ' VAL . 4.0 t-20 -144.54 143.69 30.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.852 0.358 . . . . 65.34 110.863 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.435 HG22 ' HG2' ' A' ' 280' ' ' GLU . 58.2 t -119.11 115.63 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 73.4 111.134 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.448 HG23 ' OD1' ' B' ' 243' ' ' ASN . 63.9 t -122.21 122.73 67.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 54.1 111.117 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 81.2 p -69.85 163.02 26.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.183 -0.462 . . . . 53.13 111.147 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 282' ' ' GLY . . . -62.76 -34.07 76.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 75.14 111.093 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.06 -41.48 78.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 72.01 111.04 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 75.02 111.107 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.939 0.4 . . . . 72.23 110.884 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . 0.541 HG23 ' CG ' ' C' ' 225' ' ' ARG . 76.3 m -100.95 121.95 42.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 73.21 111.119 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.44 HG23 ' O ' ' B' ' 225' ' ' ARG . 91.3 m -124.06 131.86 53.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.28 -0.418 . . . . 75.33 111.138 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.543 ' HB2' HG22 ' B' ' 277' ' ' ILE . 13.7 p30 -115.57 132.51 56.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 75.23 110.885 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 36.7 m -132.74 123.32 26.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 60.34 110.867 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.49 HG21 ' CG2' ' B' ' 267' ' ' VAL . 7.6 p -119.89 137.09 54.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 63.3 111.132 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -78.99 -77.5 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 75.21 110.857 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 39.1 m -129.9 130.48 45.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.166 -0.47 . . . . 63.41 111.141 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.511 ' CG1' HG21 ' B' ' 275' ' ' VAL . 21.3 t -117.9 120.68 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 63.42 111.168 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.04 121.61 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 73.3 111.17 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.27 133.8 8.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 55.1 112.543 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -132.55 147.52 52.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.824 0.345 . . . . 65.14 110.893 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.92 84.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.688 -0.768 . . . . 72.1 112.525 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 45.15 63.52 1.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 74.24 110.888 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 26.5 t -93.06 145.68 24.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 63.31 110.884 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -128.57 127.7 42.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 73.53 110.919 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.511 HG21 ' CG1' ' B' ' 267' ' ' VAL . 21.4 t -131.6 123.91 53.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.414 . . . . 72.51 111.144 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.458 HD23 ' CZ2' ' B' ' 287' ' ' TRP . 0.1 OUTLIER -124.76 111.44 15.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.086 -0.506 . . . . 40.33 110.921 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.652 ' HB ' HD12 ' B' ' 241' ' ' LEU . 2.1 mp -111.66 104.83 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 64.24 111.142 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.28 -168.53 32.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 72.22 112.514 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -123.44 153.59 40.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 74.42 110.939 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.574 ' CD ' HG13 ' C' ' 244' ' ' VAL . 0.5 OUTLIER -126.07 121.19 32.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 73.22 110.845 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -109.45 125.71 52.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 72.03 110.928 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 106.21 171.32 23.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.799 -0.715 . . . . 71.51 112.516 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . 0.693 ' H ' ' HB2' ' C' ' 247' ' ' ALA . . . 51.96 -171.68 0.34 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.779 -0.724 . . . . 44.31 112.476 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 131.09 47.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.806 0.336 . . . . 73.43 110.879 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -72.54 78.95 0.7 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.718 . . . . 65.34 112.455 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -178.44 131.22 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 64.34 110.856 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.458 ' CZ2' HD23 ' B' ' 276' ' ' LEU . 15.1 t90 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 74.12 110.921 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.565 ' O ' HG23 ' C' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.852 0.358 . . . . 71.25 110.813 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.464 HD22 HD23 ' C' ' 241' ' ' LEU . 21.9 p-10 -122.78 136.43 54.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 75.51 110.95 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 75.6 m -137.7 145.16 42.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 55.52 110.878 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.05 154.35 49.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 50.03 111.061 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.87 -28.48 10.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 72.23 110.922 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.45 137.59 4.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 74.33 110.867 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 18.1 mt -138.43 116.93 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 73.02 111.142 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.12 115.61 13.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 70.54 110.949 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.8 p -135.81 139.27 43.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 64.3 111.15 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -145.62 166.99 24.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 71.21 110.922 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 66.56 66.97 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 71.02 110.9 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 46.84 51.99 11.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.499 . . . . 61.22 110.897 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.08 151.45 23.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 72.12 111.179 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.24 137.17 47.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 75.25 110.836 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.459 HG13 HG13 ' B' ' 275' ' ' VAL . 6.2 p -133.59 121.95 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 72.24 111.126 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -114.15 135.66 53.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 63.45 110.837 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 1.037 HD12 HD13 ' C' ' 277' ' ' ILE . 0.6 OUTLIER -130.16 118.86 22.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 72.23 110.91 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.9 -173.47 22.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.752 -0.737 . . . . 51.42 112.51 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.02 150.4 23.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 50.23 110.931 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.574 HG13 ' CD ' ' B' ' 280' ' ' GLU . 92.7 t -128.87 121.48 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 55.11 111.125 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.06 129.04 75.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 73.03 111.133 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.9 t -77.03 163.66 26.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 62.41 111.248 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.693 ' HB2' ' H ' ' B' ' 283' ' ' GLY . . . -63.16 -33.65 75.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 74.31 111.106 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.53 -35.98 68.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 74.53 111.056 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . 0.418 ' HB2' ' CD2' ' C' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 72.12 111.118 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.91 0.385 . . . . 74.32 110.918 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 20.2 p -99.4 130.51 45.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.199 -0.455 . . . . 75.14 111.097 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.565 HG23 ' O ' ' C' ' 225' ' ' ARG . 30.2 m -134.06 132.15 39.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 54.21 111.178 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . 0.619 ' HB2' HG22 ' C' ' 277' ' ' ILE . 9.9 p-10 -125.38 135.47 52.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 72.23 110.844 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.06 123.78 26.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 71.51 110.829 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.491 HG21 ' CG2' ' C' ' 267' ' ' VAL . 7.4 p -117.67 136.84 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 74.35 111.192 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -79.21 -77.0 0.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 74.45 110.907 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 5.0 m -129.82 130.52 45.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 75.33 111.145 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.491 ' CG2' HG21 ' C' ' 264' ' ' VAL . 21.0 t -117.87 120.64 65.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 55.25 111.114 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 26.2 t -123.84 120.77 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 50.24 111.111 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.02 133.3 8.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.741 . . . . 43.0 112.436 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -133.27 147.47 51.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.82 0.343 . . . . 61.14 110.89 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.2 87.86 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.793 -0.717 . . . . 65.2 112.474 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 44.38 61.04 2.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.889 0.376 . . . . 74.51 110.863 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 35.2 t -92.15 145.33 24.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 74.01 110.909 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.7 127.69 39.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 74.3 110.93 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.497 HG12 HD11 ' C' ' 277' ' ' ILE . 19.5 t -132.03 123.76 51.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 22.21 111.135 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.478 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.1 OUTLIER -128.05 111.8 13.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 64.43 110.9 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 1.037 HD13 HD12 ' C' ' 241' ' ' LEU . 3.4 mp -111.77 119.9 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 73.41 111.109 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.31 -158.34 25.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.735 -0.745 . . . . 35.4 112.467 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -127.98 132.95 49.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.823 0.344 . . . . 74.24 110.851 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.776 ' HG3' HG13 ' D' ' 244' ' ' VAL . 0.0 OUTLIER -111.92 137.78 49.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 74.23 110.88 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.444 ' HE1' ' HB2' ' D' ' 249' ' ' ALA . 14.1 t80 -129.52 125.46 36.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 74.34 110.899 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 126.56 165.68 12.03 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.768 -0.73 . . . . 63.23 112.497 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . 0.746 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . 64.7 155.1 0.15 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.717 -0.754 . . . . 60.51 112.432 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -93.26 65.14 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 61.25 110.961 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -160.28 -113.44 0.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.726 -0.75 . . . . 75.24 112.516 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.454 ' HA ' HG11 ' D' ' 244' ' ' VAL . 5.5 p90 -174.58 -35.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 72.11 110.833 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.478 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 7.2 t90 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 72.0 110.93 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . 0.441 ' O ' HG23 ' D' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.04 0 CA-C-O 120.836 0.35 . . . . 73.24 110.851 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -110.77 127.44 55.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 61.41 110.937 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.3 137.96 49.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 71.12 110.885 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.2 155.25 42.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 60.42 111.126 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.46 -24.69 10.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 54.33 110.91 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . 0.484 ' HB3' HG23 ' D' ' 266' ' ' THR . 0.3 OUTLIER -165.29 137.09 4.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.858 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 16.6 mt -138.66 117.16 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 63.32 111.136 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 -134.6 115.9 14.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 74.53 110.844 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.7 p -135.75 136.63 40.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 62.3 111.094 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -144.44 167.19 23.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 64.31 110.895 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 64.93 68.07 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 71.33 110.831 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 46.35 52.09 10.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 71.23 110.87 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.08 149.98 24.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 73.04 111.126 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -131.47 139.27 49.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 74.14 110.883 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.465 HG13 HG13 ' C' ' 275' ' ' VAL . 7.2 p -133.94 124.24 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 74.05 111.098 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . 0.432 ' HB2' HD22 ' D' ' 276' ' ' LEU . 1.2 tm0? -113.06 132.89 55.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 74.2 110.911 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.761 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.2 mm? -122.34 134.69 54.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 72.31 110.941 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 109.0 -174.66 18.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 70.33 112.431 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -99.36 145.57 27.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.897 0.379 . . . . 74.44 110.911 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . 0.776 HG13 ' HG3' ' C' ' 280' ' ' GLU . 88.1 t -122.19 131.54 72.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 74.23 111.132 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 66.7 t -122.16 129.15 75.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 64.35 111.101 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t -69.85 167.68 16.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 74.34 111.147 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . 0.746 ' HB2' ' N ' ' C' ' 283' ' ' GLY . . . -62.95 -33.91 76.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 73.4 111.129 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.97 -52.06 66.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.4 111.044 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . 0.444 ' HB2' ' HE1' ' C' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 74.13 111.073 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 96.1 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.879 0.371 . . . . 74.13 111.144 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . 0.441 HG23 ' O ' ' D' ' 225' ' ' ARG . 7.7 m -114.14 123.1 48.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 73.55 111.111 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -126.37 146.7 49.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.894 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 12.8 m -136.99 123.44 20.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 72.32 110.817 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.558 HG21 ' CG2' ' D' ' 267' ' ' VAL . 11.9 p -116.47 133.9 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 72.34 111.127 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.64 -69.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 51.35 110.831 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . 0.484 HG23 ' HB3' ' D' ' 230' ' ' ASP . 92.9 m -143.85 133.39 23.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.13 111.169 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.6 ' CG1' HG21 ' D' ' 275' ' ' VAL . 53.8 t -118.16 125.88 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 73.53 111.181 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 59.9 t -127.11 125.67 66.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 43.13 111.124 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.63 133.74 8.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.769 -0.729 . . . . 71.24 112.532 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.63 138.34 48.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.831 0.348 . . . . 75.04 110.925 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.5 86.28 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.72 -0.752 . . . . 71.04 112.499 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 51.08 81.66 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 73.12 110.871 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 44.8 t -113.54 145.23 41.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 73.54 110.909 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.61 127.5 39.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 64.42 110.833 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.6 HG21 ' CG1' ' D' ' 267' ' ' VAL . 21.7 t -133.05 123.72 48.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 55.42 111.104 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.444 HD23 ' CZ2' ' D' ' 287' ' ' TRP . 0.1 OUTLIER -128.37 111.5 13.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 65.4 110.94 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.773 HG13 HD23 ' E' ' 241' ' ' LEU . 5.0 mp -109.74 130.17 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 64.53 111.124 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.05 172.47 16.2 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.791 -0.719 . . . . 75.42 112.549 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -89.94 141.97 28.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.329 . . . . 74.52 110.888 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . 0.654 ' HG3' HG13 ' E' ' 244' ' ' VAL . 0.0 OUTLIER -121.17 136.74 54.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 64.44 110.884 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -117.26 125.75 51.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 74.25 110.953 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.38 -118.53 6.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 45.35 112.528 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 72.74 157.62 3.9 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.776 -0.726 . . . . 61.31 112.443 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -56.02 -25.33 44.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.803 0.335 . . . . 74.44 110.873 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -171.58 -35.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 63.53 112.513 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -152.93 -72.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.314 . . . . 73.1 110.917 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . 0.444 ' CZ2' HD23 ' D' ' 276' ' ' LEU . 14.7 t90 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 72.44 110.831 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . 0.762 ' O ' HG23 ' E' ' 261' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.899 0.38 . . . . 73.33 110.939 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -89.19 137.31 32.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.911 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.9 147.21 44.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 71.35 110.839 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.83 162.08 29.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 32.31 111.095 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . 0.436 ' HB2' ' HA ' ' E' ' 265' ' ' GLU . 3.5 mttm -116.34 -27.32 6.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 72.54 110.884 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . 0.559 ' CB ' HG22 ' E' ' 266' ' ' THR . 1.2 t70 -165.85 137.26 3.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 65.35 110.807 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 15.2 mt -138.07 117.54 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 65.24 111.083 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 15.5 ttt-85 -134.46 118.08 16.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 72.23 110.825 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 2.3 p -135.52 147.4 48.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 72.44 111.133 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' E' ' 237' ' ' ALA . 10.7 pt-20 -156.32 166.87 32.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 74.03 110.886 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 64.08 68.91 0.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 71.43 110.901 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 50.42 31.43 5.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 74.24 110.873 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' E' ' 234' ' ' GLU . . . -85.64 140.65 30.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 71.4 111.064 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.49 137.67 50.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 72.22 110.89 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.46 HG23 ' HB ' ' E' ' 275' ' ' VAL . 6.2 p -130.38 121.95 52.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 62.05 111.084 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . 0.572 ' O ' HD13 ' E' ' 241' ' ' LEU . 0.0 OUTLIER -112.94 136.85 52.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 74.41 110.877 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.773 HD23 HG13 ' D' ' 277' ' ' ILE . 2.0 mm? -124.21 134.16 53.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 62.11 110.869 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 109.18 177.56 21.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.693 -0.765 . . . . 74.3 112.441 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -90.05 148.95 22.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.833 0.349 . . . . 71.31 110.895 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.654 HG13 ' HG3' ' D' ' 280' ' ' GLU . 95.8 t -122.08 131.09 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 42.22 111.145 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 95.4 t -120.8 127.56 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 71.33 111.116 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.6 t -76.84 171.29 14.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 61.25 111.211 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.56 -33.98 76.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 61.21 111.066 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -51.56 68.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 73.55 111.071 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 72.22 111.076 179.906 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . 0.762 HG23 ' O ' ' E' ' 225' ' ' ARG . 85.9 m . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.855 0.36 . . . . 60.54 111.153 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -126.12 138.19 53.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.484 . . . . 64.13 110.903 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.42 128.81 53.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 70.24 110.847 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . 0.462 HG21 ' CG2' ' E' ' 267' ' ' VAL . 7.9 p -125.55 137.73 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 73.2 111.188 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' E' ' 229' ' ' LYS . 17.5 mt-10 -82.97 -74.72 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 63.41 110.928 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . 0.559 HG22 ' CB ' ' E' ' 230' ' ' ASP . 38.9 p -142.54 128.06 19.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 72.25 111.132 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . 0.746 HG11 HG21 ' E' ' 275' ' ' VAL . 58.7 t -117.76 120.84 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 73.01 111.162 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 81.9 t -115.72 121.57 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 45.01 111.176 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.45 132.54 10.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.758 -0.734 . . . . 54.31 112.521 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.84 139.45 46.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 54.52 110.85 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.84 88.47 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 12.22 112.512 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 49.59 75.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.872 0.368 . . . . 73.41 110.917 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.23 145.38 30.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 43.14 110.863 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -132.83 127.63 34.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 62.22 110.839 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.746 HG21 HG11 ' E' ' 267' ' ' VAL . 74.9 t -133.69 122.97 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 63.22 111.135 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.19 111.34 12.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 61.1 110.88 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.54 HD12 HD12 ' E' ' 241' ' ' LEU . 9.7 mt -112.59 105.84 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 51.45 111.106 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.9 -158.57 28.19 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.787 -0.721 . . . . 63.23 112.448 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -127.96 145.73 50.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.758 0.314 . . . . 75.52 110.871 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -111.89 122.27 47.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 73.11 110.86 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.25 125.94 51.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 65.43 110.985 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.725 -0.75 . . . . 72.32 112.418 179.91 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.691 ' CB ' HG23 ' A' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.862 0.363 . . . . 72.42 110.845 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.701 ' HB3' HG22 ' A' ' 277' ' ' ILE . 0.1 OUTLIER -130.57 109.83 10.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 73.41 110.879 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 1.5 t -125.43 141.81 51.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 52.53 110.896 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.83 119.68 12.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 73.34 111.053 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -74.65 -33.39 62.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 70.43 110.92 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -164.92 138.93 4.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 71.22 110.872 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 10.3 pt -137.35 119.01 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 51.54 111.116 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.85 120.64 37.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 64.11 110.931 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.1 p -129.44 139.18 51.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.216 -0.447 . . . . 74.25 111.108 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -146.53 167.5 23.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 73.35 110.899 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 66.61 65.87 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 75.21 110.944 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 48.85 36.5 8.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.886 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.24 155.83 21.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 73.01 111.121 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -131.71 145.6 51.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 72.51 110.897 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.536 HG23 ' HB ' ' A' ' 275' ' ' VAL . 5.5 p -140.05 121.83 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 71.33 111.2 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -114.54 129.74 56.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 74.12 110.927 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.462 HD22 ' HB ' ' A' ' 277' ' ' ILE . 0.2 OUTLIER -114.83 118.53 33.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 53.55 110.891 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.72 174.87 13.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 50.14 112.54 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -90.92 154.79 19.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 63.34 110.897 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.473 HG13 ' HA ' ' A' ' 280' ' ' GLU . 4.2 p -130.02 123.99 57.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 74.23 111.11 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.07 125.73 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 61.51 111.104 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 73.11 111.189 -179.971 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 24.4 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.914 0.388 . . . . 73.2 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.691 HG23 ' CB ' ' A' ' 225' ' ' ARG . 98.0 m -134.02 124.71 26.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.212 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.632 ' CB ' HD12 ' B' ' 241' ' ' LEU . 0.7 OUTLIER -103.53 121.04 42.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 74.0 110.857 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.11 123.81 16.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 72.41 110.842 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.616 HG21 ' CD1' ' B' ' 231' ' ' ILE . 8.9 p -119.21 139.58 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 50.32 111.177 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.09 -71.28 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 72.11 110.875 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.6 m -124.19 136.09 53.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 74.23 111.081 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.801 HG22 HD11 ' B' ' 231' ' ' ILE . 19.4 t -120.27 133.5 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 74.42 111.175 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.49 127.13 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 74.33 111.165 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.38 133.39 8.38 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.747 . . . . 41.44 112.42 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.61 147.94 51.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 63.33 110.886 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.18 81.6 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 42.21 112.503 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 46.45 65.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 61.52 110.907 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 42.2 t -89.63 145.68 25.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 54.15 110.783 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -119.53 127.9 53.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.088 -0.506 . . . . 71.45 110.88 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.536 ' HB ' HG23 ' A' ' 239' ' ' VAL . 98.8 t -124.38 123.03 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 73.55 111.111 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 27.6 tp -128.71 111.7 13.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.964 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.701 HG22 ' HB3' ' A' ' 226' ' ' ASN . 26.3 mm -110.86 104.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.24 111.131 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.73 170.92 18.4 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 75.51 112.455 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -90.45 137.81 32.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.774 0.321 . . . . 63.24 110.927 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.73 ' HG3' HG23 ' B' ' 244' ' ' VAL . 4.9 pt-20 -111.95 120.27 41.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 74.14 110.923 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.6 125.91 51.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 74.21 110.967 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 118.5 169.95 14.71 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.661 -0.781 . . . . 45.2 112.427 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -67.42 -119.81 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.737 -0.744 . . . . 40.34 112.488 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.53 27.07 7.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.336 . . . . 74.41 110.913 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.02 -103.04 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.762 -0.732 . . . . 74.11 112.458 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -132.08 146.02 51.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.361 . . . . 64.12 110.869 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 71.41 110.904 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.752 0.31 . . . . 74.45 110.865 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.524 ' HB3' HG22 ' B' ' 277' ' ' ILE . 0.8 OUTLIER -138.06 109.43 6.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 63.51 110.915 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 22.1 t -126.83 145.96 50.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 61.33 110.87 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.468 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -139.89 119.76 13.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 73.34 111.076 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -35.76 77.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 54.55 110.968 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -165.4 138.28 4.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 73.33 110.899 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.801 HD11 HG22 ' A' ' 267' ' ' VAL . 31.5 pt -132.86 131.25 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 73.44 111.071 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -134.5 125.16 26.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 71.43 110.856 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.75 128.73 37.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 60.24 111.136 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -134.97 167.4 20.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 73.53 110.883 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 63.06 68.99 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.12 110.918 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 2.6 mtm-85 47.65 40.76 12.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 71.52 110.905 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.74 156.14 17.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 73.13 111.086 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.64 148.41 50.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 73.34 110.905 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' B' ' 275' ' ' VAL . 4.1 p -138.28 121.53 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 70.12 111.172 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -111.2 129.2 56.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 71.42 110.859 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.632 HD12 ' CB ' ' A' ' 262' ' ' ASN . 0.2 OUTLIER -113.79 118.55 34.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.483 . . . . 64.05 110.973 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.24 179.75 16.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.721 . . . . 34.44 112.514 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -87.42 144.51 26.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 72.23 110.918 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.73 HG23 ' HG3' ' A' ' 280' ' ' GLU . 4.7 p -118.88 119.86 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 65.24 111.141 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.35 128.32 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 72.45 111.237 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 48.9 p -80.19 173.92 12.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 61.22 111.172 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.04 96.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 73.23 111.087 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.54 -51.58 68.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 53.14 111.125 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 73.34 111.151 179.884 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.863 0.363 . . . . 71.44 110.901 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 35.5 p -100.86 121.99 42.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 64.21 111.104 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 2.1 t -126.69 127.27 44.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.429 . . . . 65.11 111.192 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.59 129.03 56.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 75.42 110.887 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.9 t -140.95 122.9 15.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 73.11 110.879 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.628 HG21 ' CD1' ' C' ' 231' ' ' ILE . 4.8 p -112.93 141.97 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.484 . . . . 64.13 111.092 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -80.7 -77.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 74.32 110.886 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 18.9 m -120.87 133.71 55.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 63.35 111.099 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.762 HG22 HD11 ' C' ' 231' ' ' ILE . 3.2 t -117.69 124.5 73.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.14 -0.482 . . . . 75.01 111.088 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 59.7 t -123.66 116.02 46.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.495 . . . . 65.01 111.12 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.58 133.33 10.83 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.723 -0.751 . . . . 61.54 112.511 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.35 147.58 51.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.323 . . . . 65.03 110.965 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.94 84.1 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.713 -0.756 . . . . 72.21 112.496 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 46.1 64.98 1.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.808 0.337 . . . . 75.32 110.865 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 27.9 t -93.94 145.61 24.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 74.24 110.838 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.46 128.02 50.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 72.42 110.833 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' B' ' 239' ' ' VAL . 78.5 t -122.95 123.7 68.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 75.41 111.133 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.723 HD22 ' CE3' ' B' ' 287' ' ' TRP . 0.4 OUTLIER -126.55 111.64 14.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 73.45 110.924 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.524 HG22 ' HB3' ' B' ' 226' ' ' ASN . 27.0 mm -109.59 104.64 17.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 72.13 111.104 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.76 175.87 18.28 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.691 -0.766 . . . . 45.34 112.453 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -89.9 154.99 19.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 71.31 110.834 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.691 ' HG3' HG23 ' C' ' 244' ' ' VAL . 12.6 pt-20 -128.72 146.87 50.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 73.12 110.868 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.41 ' CZ ' HG11 ' C' ' 245' ' ' VAL . 0.6 OUTLIER -126.44 125.85 42.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.932 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 128.97 -147.88 17.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.669 -0.777 . . . . 54.54 112.474 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -128.62 -145.09 5.92 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.837 -0.697 . . . . 61.12 112.508 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 63.27 78.82 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.874 0.368 . . . . 53.54 110.867 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.12 -108.61 0.68 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.761 -0.733 . . . . 64.1 112.458 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.06 -60.06 1.79 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 75.33 110.922 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.723 ' CE3' HD22 ' B' ' 276' ' ' LEU . 5.9 p90 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.02 110.872 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.868 0.366 . . . . 53.12 110.883 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.58 110.49 6.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.43 110.953 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.4 t -130.86 141.09 50.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 72.32 110.863 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.16 135.16 46.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 74.33 111.127 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -29.92 21.01 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.218 -0.447 . . . . 72.42 110.909 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.81 136.61 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 62.45 110.883 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.762 HD11 HG22 ' B' ' 267' ' ' VAL . 3.7 pt -138.4 117.52 14.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 73.41 111.113 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -122.12 116.46 24.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 74.11 110.866 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.415 HG21 ' HB ' ' C' ' 239' ' ' VAL . 2.6 p -124.11 128.76 49.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 62.11 111.143 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.48 167.5 21.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 74.44 110.904 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 64.33 74.72 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 74.53 110.906 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 44.38 38.65 2.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 73.31 110.829 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -93.16 156.17 17.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 72.12 111.1 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.24 156.17 49.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 71.54 110.901 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.415 ' HB ' HG21 ' C' ' 233' ' ' THR . 7.8 p -138.19 146.92 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 72.54 111.117 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -134.75 137.49 43.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 72.52 110.901 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.589 HD22 ' HB ' ' C' ' 277' ' ' ILE . 0.3 OUTLIER -126.88 124.89 40.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 45.42 110.92 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.52 178.09 16.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.676 -0.773 . . . . 72.41 112.489 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -86.47 157.02 19.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 54.34 110.864 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.691 HG23 ' HG3' ' B' ' 280' ' ' GLU . 5.4 p -128.69 135.4 62.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 64.42 111.176 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' B' ' 281' ' ' TYR . 39.3 t -122.09 127.96 75.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 73.03 111.132 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 27.9 p -83.8 162.89 20.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 63.44 111.136 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.23 -34.27 76.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 42.34 111.161 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.95 -51.16 70.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.141 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 53.15 111.118 179.944 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.87 0.367 . . . . 75.54 110.913 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . 0.499 HG21 ' HB3' ' D' ' 243' ' ' ASN . 27.1 p -90.1 126.08 35.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 61.14 111.124 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.8 m -107.46 108.68 20.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 74.5 111.155 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . 0.733 ' HB2' HD12 ' D' ' 241' ' ' LEU . 0.0 OUTLIER -100.15 130.6 46.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 64.45 110.886 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 29.3 t -142.05 123.26 14.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 75.44 110.798 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.633 HG21 HD11 ' D' ' 231' ' ' ILE . 5.9 p -115.04 148.06 18.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 54.15 111.154 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.94 -72.77 0.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 64.45 110.858 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 27.7 m -129.08 137.54 51.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 73.14 111.066 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.824 HG22 HD11 ' D' ' 231' ' ' ILE . 4.2 t -118.79 129.54 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 71.25 111.108 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 73.1 t -127.13 115.96 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 74.34 111.183 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.8 133.04 9.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.727 . . . . 34.05 112.475 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -133.74 147.68 51.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.351 . . . . 73.45 110.941 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.56 89.13 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.769 -0.729 . . . . 64.44 112.499 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 44.8 60.59 2.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.804 0.335 . . . . 65.22 110.873 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.28 144.98 25.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 73.33 110.874 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.59 128.07 48.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.487 . . . . 73.52 110.951 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 94.2 t -123.44 123.56 67.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 64.12 111.159 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.682 HD13 ' CE3' ' C' ' 287' ' ' TRP . 0.5 OUTLIER -126.58 111.69 14.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 74.3 110.925 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.589 ' HB ' HD22 ' C' ' 241' ' ' LEU . 27.4 mm -108.32 104.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 73.45 111.134 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.42 -164.65 29.04 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.814 -0.708 . . . . 53.23 112.606 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -122.01 156.01 34.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.314 . . . . 70.12 110.91 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.75 ' CG ' HG23 ' D' ' 244' ' ' VAL . 9.5 pt-20 -119.51 146.7 45.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 74.53 110.903 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -129.94 134.89 47.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 72.24 110.902 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.49 148.4 20.46 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 62.51 112.549 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' D' ' 247' ' ' ALA . . . 51.77 -161.55 1.89 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 74.43 112.462 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -131.99 -169.47 2.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 61.21 110.934 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 81.2 139.02 2.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.784 -0.722 . . . . 52.3 112.427 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -45.74 -39.64 8.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.782 0.325 . . . . 62.25 110.91 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.682 ' CE3' HD13 ' C' ' 276' ' ' LEU . 4.0 p90 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.156 -0.475 . . . . 72.41 110.899 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.853 0.359 . . . . 63.04 110.863 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.3 115.63 22.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 64.32 110.859 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.16 138.43 48.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 72.4 110.823 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . 0.402 ' HB3' HG23 ' C' ' 264' ' ' VAL . . . -138.19 119.81 15.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 63.23 111.09 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.41 -27.46 56.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 63.14 110.933 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.24 136.76 2.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 62.33 110.867 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . 0.824 HD11 HG22 ' C' ' 267' ' ' VAL . 4.3 pt -139.35 117.17 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 72.21 111.067 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -126.54 128.98 47.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 73.14 110.882 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.14 128.83 32.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 75.42 111.164 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -133.16 167.34 20.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 73.11 110.943 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 63.88 72.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.469 . . . . 71.24 110.886 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 44.63 47.25 8.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 64.1 110.867 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.98 155.62 17.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 73.02 111.102 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.37 144.4 46.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 70.25 110.866 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 5.6 p -129.11 140.21 49.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 71.33 111.114 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -133.39 121.72 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 74.21 110.927 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' C' ' 262' ' ' ASN . 0.1 OUTLIER -111.78 118.88 36.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 75.53 110.904 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.77 172.35 13.11 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.754 -0.736 . . . . 74.04 112.451 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . 0.499 ' HB3' HG21 ' C' ' 260' ' ' THR . 2.9 p-10 -86.0 143.23 28.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.373 . . . . 73.1 110.938 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . 0.75 HG23 ' CG ' ' C' ' 280' ' ' GLU . 4.4 p -110.23 128.76 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 62.55 111.158 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 23.1 t -122.02 128.94 75.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 61.51 111.198 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 30.5 p -86.14 174.17 9.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 72.22 111.154 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . 0.504 ' HB2' ' H ' ' C' ' 283' ' ' GLY . . . -59.37 -44.58 92.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 51.42 111.069 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.3 -51.23 70.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 55.3 111.121 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 72.42 111.089 179.878 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . 0.723 HG21 ' CG ' ' E' ' 243' ' ' ASN . 35.4 p . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.861 0.363 . . . . 63.34 111.098 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 76.9 m -134.13 125.54 28.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 72.44 111.165 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . 0.457 ' OD1' HG22 ' D' ' 277' ' ' ILE . 0.4 OUTLIER -116.71 122.16 43.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 74.11 110.925 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.1 123.54 14.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 73.11 110.786 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.75 HG21 ' CD1' ' E' ' 231' ' ' ILE . 8.0 p -122.76 138.56 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 72.01 111.149 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -72.09 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 74.41 110.898 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 72.9 p -124.48 135.65 53.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 70.32 111.108 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.676 HG22 HD11 ' E' ' 231' ' ' ILE . 7.7 t -119.08 130.51 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 71.23 111.1 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . 0.437 HG11 ' NE ' ' E' ' 232' ' ' ARG . 2.1 t -127.38 120.79 55.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 55.44 111.108 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.46 132.64 9.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.766 -0.73 . . . . 74.42 112.542 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -134.35 149.15 50.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.79 0.329 . . . . 73.15 110.976 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.45 87.53 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 72.01 112.467 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 43.29 56.87 4.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 63.41 110.814 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 30.5 t -86.71 145.08 26.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 74.41 110.88 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.72 128.28 49.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 75.35 110.861 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 98.6 t -119.97 123.21 70.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.469 . . . . 73.14 111.116 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.63 HD23 ' HG2' ' E' ' 240' ' ' GLN . 0.8 OUTLIER -128.46 113.33 15.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 74.24 110.955 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.553 ' HB ' HD22 ' D' ' 241' ' ' LEU . 29.9 mm -112.41 104.73 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 71.45 111.118 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.99 175.89 17.52 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.764 -0.732 . . . . 44.34 112.473 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -89.92 156.12 18.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 74.44 110.909 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . 0.771 ' HG3' HG23 ' E' ' 244' ' ' VAL . 19.8 pt-20 -124.7 134.06 52.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 54.42 110.88 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -124.76 125.78 44.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.91 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 168.81 -152.2 19.67 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 72.41 112.51 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -78.83 57.95 4.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.687 -0.768 . . . . 75.11 112.516 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . 0.519 ' N ' HG23 ' E' ' 246' ' ' THR . 0.0 OUTLIER 54.13 -174.12 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.757 0.313 . . . . 73.53 110.901 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 66.87 144.46 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 34.13 112.534 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -59.73 -172.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 63.12 110.833 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . 0.591 ' CE3' HD13 ' D' ' 276' ' ' LEU . 8.8 p90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.079 -0.51 . . . . 74.55 110.945 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . 0.648 ' HA ' HG23 ' E' ' 261' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.824 0.345 . . . . 72.54 110.872 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.83 109.94 22.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 73.01 110.859 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 1.8 m -134.28 137.51 44.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 75.24 110.892 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . 0.518 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -139.32 124.88 19.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 74.14 111.091 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.41 -25.88 60.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 63.4 110.922 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . 0.685 ' HB3' HG23 ' E' ' 266' ' ' THR . 27.9 t0 -167.15 137.26 2.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 55.54 110.91 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . 0.75 ' CD1' HG21 ' D' ' 264' ' ' VAL . 23.5 pt -138.18 128.94 36.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 61.32 111.182 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . 0.437 ' NE ' HG11 ' D' ' 268' ' ' VAL . 26.2 ttm180 -133.87 131.41 39.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 60.4 110.906 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.43 128.57 31.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 64.54 111.146 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -132.29 166.47 21.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.419 . . . . 63.32 110.896 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 64.53 69.71 0.5 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.474 . . . . 70.35 110.943 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 47.15 35.18 3.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 63.53 110.941 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.38 156.35 18.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.138 -0.483 . . . . 52.1 111.119 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -140.94 158.89 43.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 72.14 110.856 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.525 HG23 ' HB ' ' E' ' 275' ' ' VAL . 4.8 p -138.08 143.12 33.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 63.11 111.114 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . 0.63 ' HG2' HD23 ' D' ' 276' ' ' LEU . 5.7 tm0? -132.39 125.99 32.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.085 -0.507 . . . . 71.12 110.852 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.812 HD13 ' HB ' ' E' ' 277' ' ' ILE . 3.9 mm? -111.9 118.74 36.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 75.32 110.943 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.22 -173.83 20.21 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.758 -0.734 . . . . 73.1 112.524 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . 0.723 ' CG ' HG21 ' D' ' 260' ' ' THR . 5.6 p-10 -104.97 154.76 19.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.925 0.393 . . . . 74.52 110.803 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.771 HG23 ' HG3' ' D' ' 280' ' ' GLU . 4.6 p -115.86 125.02 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 73.01 111.092 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 91.0 t -112.84 129.14 68.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 55.4 111.168 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . 0.519 HG23 ' N ' ' D' ' 284' ' ' LYS . 1.4 m -85.58 163.47 18.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 65.25 111.165 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.83 -34.85 68.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 71.43 111.132 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' E' ' 249' ' ' ALA . . . -57.07 -52.0 67.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 74.31 111.085 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' E' ' 248' ' ' ALA . . . . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 73.4 111.113 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . 0.648 HG23 ' HA ' ' E' ' 225' ' ' ARG . 30.0 m . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.745 0.307 . . . . 62.25 111.11 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.69 119.91 39.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 64.54 110.944 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 48.0 t -133.3 125.15 28.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 63.05 110.882 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . 0.465 HG11 ' CG2' ' E' ' 267' ' ' VAL . 5.1 p -128.22 146.68 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 42.44 111.101 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.64 -64.94 1.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 73.45 110.873 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . 0.685 HG23 ' HB3' ' E' ' 230' ' ' ASP . 2.5 m -135.85 138.13 42.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 64.05 111.17 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . 0.465 ' CG2' HG11 ' E' ' 264' ' ' VAL . 7.9 t -126.48 130.84 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 64.23 111.136 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 5.7 p -128.37 124.01 61.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 64.34 111.101 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.77 138.99 15.04 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.718 -0.753 . . . . 60.31 112.475 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -132.93 148.84 52.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.779 0.323 . . . . 62.44 110.963 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.08 88.91 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.726 -0.75 . . . . 54.33 112.494 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 41.84 56.96 3.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.855 0.36 . . . . 52.12 110.925 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 30.2 t -83.92 145.01 28.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 54.14 110.815 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -126.29 127.88 46.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 74.02 110.898 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.525 ' HB ' HG23 ' E' ' 239' ' ' VAL . 99.6 t -116.93 123.52 71.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 73.11 111.155 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.77 111.83 13.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 73.04 110.885 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.812 ' HB ' HD13 ' E' ' 241' ' ' LEU . 29.4 mm -112.14 104.95 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 72.35 111.09 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.73 -165.06 28.82 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.791 -0.719 . . . . 40.44 112.505 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -116.48 156.01 27.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.343 . . . . 73.44 110.893 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -118.01 118.92 33.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 72.04 110.973 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -106.86 126.08 51.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 75.02 110.915 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 C-N-CA 120.724 -0.75 . . . . 61.31 112.466 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.668 ' O ' HG23 ' A' ' 261' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.058 0 CA-C-O 120.837 0.351 . . . . 74.32 110.895 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.585 ' OD1' HG22 ' A' ' 277' ' ' ILE . 5.8 m-80 -142.42 135.72 28.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 75.25 110.821 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.99 137.48 54.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 71.1 110.818 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.772 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -127.65 119.64 26.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 64.42 111.096 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.19 -34.04 37.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 64.52 110.915 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.77 132.21 1.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.469 . . . . 70.14 110.907 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.809 HD12 HG21 ' A' ' 239' ' ' VAL . 9.9 pt -141.05 134.35 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 63.44 111.149 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -134.08 128.2 33.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 73.14 110.834 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.479 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.2 OUTLIER -135.21 141.34 45.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 72.25 111.192 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -148.87 151.14 34.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 72.54 110.894 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 64.16 91.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 62.32 110.886 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 39.27 41.12 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 75.53 110.817 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.479 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -102.49 139.69 37.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 72.43 111.097 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.31 158.62 44.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 65.41 110.874 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.809 HG21 HD12 ' A' ' 231' ' ' ILE . 16.3 m -142.72 134.94 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 71.0 111.058 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.458 ' HB3' HD23 ' A' ' 276' ' ' LEU . 0.0 OUTLIER -110.45 134.16 52.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 55.23 110.863 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.772 HD21 ' HB2' ' A' ' 228' ' ' ALA . 0.5 OUTLIER -130.79 118.78 21.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 72.22 110.948 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.34 -121.16 3.07 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.692 -0.766 . . . . 60.33 112.465 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -144.39 129.15 18.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.931 0.396 . . . . 75.03 110.834 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.482 HG13 ' HA ' ' A' ' 280' ' ' GLU . 7.1 p -116.44 123.01 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.483 . . . . 71.33 111.169 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.0 m -121.97 129.05 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 73.15 111.154 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 64.43 111.108 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . 0.5 HG21 HD22 ' B' ' 243' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.857 0.36 . . . . 41.3 111.137 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 225' ' ' ARG . 86.2 m -132.01 125.47 31.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 74.15 111.111 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.71 ' OD1' HG23 ' A' ' 277' ' ' ILE . 7.6 t-20 -105.84 143.51 33.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 74.22 110.933 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.6 p -135.72 123.82 22.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 71.32 110.882 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.626 HG23 HD11 ' B' ' 231' ' ' ILE . 8.1 p -111.19 146.46 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 43.14 111.197 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.63 -64.73 1.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 63.13 110.852 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.3 m -138.8 127.94 24.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 74.01 111.207 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.596 HG11 HG21 ' A' ' 275' ' ' VAL . 13.8 t -118.4 132.12 69.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 74.14 111.133 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.424 HG12 ' HD2' ' A' ' 270' ' ' LYS . 61.5 t -128.31 115.16 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 71.13 111.13 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.07 133.37 10.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 45.12 112.482 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.424 ' HD2' HG12 ' A' ' 268' ' ' VAL . 0.0 OUTLIER -132.72 141.99 48.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.818 0.342 . . . . 63.51 110.896 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.28 86.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 63.15 112.546 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 51.57 81.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 71.23 110.859 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 13.2 t -113.88 144.66 42.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 74.31 110.857 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 49.6 mtt85 -127.79 127.63 43.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 72.35 110.933 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.596 HG21 HG11 ' A' ' 267' ' ' VAL . 13.3 t -124.06 123.97 67.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 73.13 111.11 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 240' ' ' GLN . 1.5 mt -115.15 111.75 21.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 74.33 110.927 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.71 HG23 ' OD1' ' A' ' 262' ' ' ASN . 47.2 mm -112.1 104.92 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 74.45 111.123 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.39 -146.58 18.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.683 -0.77 . . . . 71.32 112.479 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -117.45 150.59 38.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 72.21 110.908 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.788 ' HG3' HG23 ' B' ' 244' ' ' VAL . 14.8 pt-20 -129.54 133.76 47.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 71.42 110.821 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.432 ' HA ' HG23 ' B' ' 245' ' ' VAL . 0.5 OUTLIER -114.42 126.06 54.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.864 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 132.57 150.95 6.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.69 -0.767 . . . . 72.35 112.454 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.423 ' H ' ' HB2' ' B' ' 247' ' ' ALA . . . -116.37 -144.36 8.01 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 32.03 112.499 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.02 -75.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 74.22 110.899 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -117.8 92.63 0.55 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.762 -0.732 . . . . 71.11 112.494 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.404 ' HE1' HG21 ' B' ' 244' ' ' VAL . 71.1 t80 -52.36 114.05 1.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.35 . . . . 74.01 110.896 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 3.0 t90 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.197 -0.456 . . . . 72.31 110.88 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 5.2 mtt85 . . . . . 0 CA--C 1.526 0.047 0 CA-C-O 120.856 0.36 . . . . 74.4 110.825 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.628 ' ND2' HG22 ' B' ' 277' ' ' ILE . 4.0 m-20 -103.51 137.01 42.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 73.32 110.911 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.83 137.65 54.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 73.52 110.91 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.35 139.51 49.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 60.04 111.107 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.32 -36.37 9.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 75.44 110.854 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -164.52 138.77 5.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 73.44 110.785 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.626 HD11 HG23 ' A' ' 264' ' ' VAL . 0.5 OUTLIER -137.43 117.77 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 74.04 111.16 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.36 119.51 30.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 65.43 110.919 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.62 135.39 42.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 50.53 111.136 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -144.94 161.88 38.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 71.2 110.865 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 62.37 74.14 0.44 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.148 -0.478 . . . . 64.31 110.844 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 46.96 51.75 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 74.23 110.905 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.25 148.43 26.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 62.41 111.039 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.28 136.31 43.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 75.42 110.872 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.527 HG11 HG22 ' B' ' 231' ' ' ILE . 2.8 m -124.34 123.53 66.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 70.25 111.071 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.684 ' HB3' HD22 ' B' ' 276' ' ' LEU . 6.5 tm0? -105.74 129.21 53.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 73.52 110.906 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.596 HD13 ' CD1' ' A' ' 277' ' ' ILE . 4.5 mp -125.62 118.65 26.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 61.23 110.892 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.9 -168.93 13.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.716 -0.754 . . . . 74.21 112.488 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.5 HD22 HG21 ' A' ' 260' ' ' THR . 4.8 p30 -87.73 135.06 33.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.875 0.369 . . . . 74.15 110.842 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.788 HG23 ' HG3' ' A' ' 280' ' ' GLU . 6.8 p -119.0 123.95 72.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 63.3 111.147 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.432 HG23 ' HA ' ' A' ' 281' ' ' TYR . 15.7 m -122.1 129.14 75.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 65.43 111.126 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.1 t -76.74 168.89 19.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 64.02 111.159 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.423 ' HB2' ' H ' ' A' ' 283' ' ' GLY . . . -63.07 -33.9 76.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 74.11 111.064 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.91 -35.89 69.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 70.33 111.066 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.64 ' HB2' ' CD1' ' B' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 32.3 111.113 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.838 0.352 . . . . 74.11 110.909 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . 0.612 HG21 ' ND2' ' C' ' 243' ' ' ASN . 27.8 p -98.64 124.86 43.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 62.44 111.122 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 3.9 t -119.99 139.95 51.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 64.01 111.136 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.3 145.51 48.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.2 110.918 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.3 t -142.11 123.51 14.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 42.13 110.853 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.632 HG21 HG22 ' B' ' 267' ' ' VAL . 9.0 p -118.16 139.15 46.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 72.34 111.08 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -83.24 -77.37 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.93 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 23.0 m -122.25 127.9 50.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 64.02 111.133 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.689 HG11 HG11 ' B' ' 275' ' ' VAL . 11.9 t -118.53 124.19 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 75.54 111.095 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.7 128.14 69.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 65.42 111.144 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -136.4 133.23 6.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.761 -0.733 . . . . 41.42 112.546 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -133.43 147.93 51.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.843 0.354 . . . . 74.43 110.891 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.24 90.55 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.714 -0.755 . . . . 71.0 112.498 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 43.73 56.3 4.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 75.15 110.888 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 2.3 t -86.85 145.05 26.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 71.4 110.872 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -132.47 127.5 35.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 74.14 110.861 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.689 HG11 HG11 ' B' ' 267' ' ' VAL . 5.9 t -125.66 130.15 72.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 75.14 111.149 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.684 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.7 OUTLIER -122.17 112.07 17.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 75.12 110.991 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.628 HG22 ' ND2' ' B' ' 226' ' ' ASN . 45.8 mm -111.81 115.18 49.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 61.44 111.181 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 122.87 -174.31 16.33 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.698 -0.763 . . . . 72.3 112.46 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -89.87 141.55 28.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 64.54 110.825 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.642 ' HG3' HG23 ' C' ' 244' ' ' VAL . 10.5 pt-20 -117.49 142.18 47.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 74.43 110.842 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.64 ' CD1' ' HB2' ' B' ' 249' ' ' ALA . 12.8 t80 -126.6 126.05 42.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 73.33 110.871 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 158.75 -55.74 0.36 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.782 -0.723 . . . . 71.41 112.504 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 83.93 -60.44 4.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.751 -0.738 . . . . 74.44 112.495 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -51.81 108.7 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.851 0.358 . . . . 72.44 110.903 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.08 95.38 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 31.12 112.503 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -51.72 132.6 31.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.808 0.337 . . . . 61.4 110.918 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.876 179.971 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.06 0 CA-C-O 120.802 0.334 . . . . 64.22 110.871 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.91 124.99 21.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 41.41 110.879 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 3.6 t -131.71 137.88 48.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 71.34 110.861 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.7 150.8 51.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 73.44 111.114 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.84 -30.41 9.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 51.23 110.849 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -165.89 137.95 3.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 65.23 110.848 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 5.4 mt -138.8 117.44 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 73.4 111.162 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.669 ' HD2' HG22 ' C' ' 268' ' ' VAL . 13.0 ptp180 -132.19 121.5 23.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.13 110.888 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.407 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.1 OUTLIER -134.6 144.1 47.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.106 -0.497 . . . . 73.02 111.046 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -146.75 166.74 25.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 71.34 110.89 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.49 67.58 0.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 72.2 110.881 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 46.73 56.96 5.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 73.43 110.863 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.407 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -104.66 149.72 25.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 75.44 111.05 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -130.54 135.82 48.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 73.15 110.871 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.464 HG12 ' HB ' ' C' ' 275' ' ' VAL . 2.9 m -127.02 123.19 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 63.14 111.156 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.74 ' HB3' HD22 ' C' ' 276' ' ' LEU . 9.3 tm0? -105.58 129.73 53.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.923 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.709 HD13 ' HB ' ' C' ' 277' ' ' ILE . 3.9 mm? -125.78 118.86 26.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.902 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 121.31 -178.5 16.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.665 -0.778 . . . . 75.34 112.474 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.612 ' ND2' HG21 ' B' ' 260' ' ' THR . 7.7 p30 -85.61 147.08 26.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 71.54 110.857 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.642 HG23 ' HG3' ' B' ' 280' ' ' GLU . 2.4 p -126.39 123.98 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 62.14 111.116 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.526 HG12 ' HB3' ' C' ' 281' ' ' TYR . 5.4 m -122.11 129.22 75.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 72.43 111.152 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 44.0 p -69.83 172.08 8.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 72.12 111.123 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.82 76.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 74.53 111.093 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.84 -35.84 69.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.418 . . . . 64.34 111.107 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 70.54 111.126 179.95 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.862 0.363 . . . . 70.41 110.925 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . 0.696 HG21 ' OD1' ' D' ' 243' ' ' ASN . 45.9 p -101.09 138.04 38.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 70.13 111.111 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 75.9 m -120.45 139.27 53.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 70.34 111.106 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.18 132.13 51.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 72.54 110.901 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.56 123.56 28.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 61.1 110.883 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.516 HG21 HG22 ' C' ' 267' ' ' VAL . 7.3 p -125.09 142.82 40.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 70.32 111.197 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -87.21 -74.62 0.43 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.2 -0.455 . . . . 70.52 110.914 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 87.0 m -128.57 129.17 45.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 74.31 111.171 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.516 HG22 HG21 ' C' ' 264' ' ' VAL . 21.4 t -118.67 120.68 64.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 61.21 111.054 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . 0.669 HG22 ' HD2' ' C' ' 232' ' ' ARG . 21.3 t -121.89 126.32 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 73.21 111.076 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.63 133.4 7.85 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.744 -0.741 . . . . 73.12 112.496 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -133.02 148.27 52.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.784 0.326 . . . . 70.24 110.925 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.74 84.73 0.02 OUTLIER Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.68 -0.771 . . . . 64.52 112.499 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 45.39 63.19 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 62.14 110.855 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 27.5 t -91.91 145.23 24.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 74.52 110.853 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -131.66 127.61 37.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 74.41 110.882 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.478 HG13 HG23 ' D' ' 239' ' ' VAL . 15.1 t -126.74 131.11 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 62.41 111.151 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.74 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.7 OUTLIER -122.47 111.62 17.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 55.24 110.841 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.709 ' HB ' HD13 ' C' ' 241' ' ' LEU . 51.7 mm -112.22 107.72 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 75.53 111.169 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.05 172.73 12.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 71.3 112.459 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -89.9 147.42 23.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.352 . . . . 64.15 110.869 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.736 ' CG ' HG22 ' D' ' 244' ' ' VAL . 0.5 OUTLIER -118.13 131.58 56.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 73.21 110.887 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.71 ' CE1' ' HB2' ' D' ' 249' ' ' ALA . 12.5 t80 -121.85 133.8 54.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 72.44 110.935 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 134.94 155.76 7.5 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.763 -0.732 . . . . 54.0 112.436 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . 0.496 ' H ' ' HB2' ' D' ' 247' ' ' ALA . . . -93.75 -15.61 48.78 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.818 -0.706 . . . . 54.22 112.445 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -72.42 79.17 1.03 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 74.31 110.898 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 65.52 151.85 0.11 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 64.12 112.488 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -78.91 -32.38 45.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 64.12 110.869 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.455 ' CE2' HD23 ' C' ' 276' ' ' LEU . 6.5 t90 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 62.13 110.913 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . 0.519 ' N ' HG23 ' D' ' 261' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.807 0.337 . . . . 73.24 110.86 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.66 110.66 18.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 55.12 110.907 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 12.7 p -126.06 143.12 51.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 72.45 110.832 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.09 156.89 48.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 63.23 111.17 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.47 -31.21 6.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 74.2 110.895 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.43 138.58 5.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 74.44 110.898 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 9.9 mt -137.66 117.81 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 72.53 111.143 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -132.9 120.49 21.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.22 110.826 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.97 139.27 44.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 60.23 111.137 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -144.8 166.45 25.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 74.24 110.895 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 61.17 68.15 0.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 65.0 110.848 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 47.44 55.61 8.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 64.2 110.916 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.07 149.01 25.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 34.43 111.054 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.77 135.98 47.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 74.53 110.898 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.478 HG23 HG13 ' C' ' 275' ' ' VAL . 5.3 m -127.07 121.99 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 65.22 111.129 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . 0.76 ' HB3' HD22 ' D' ' 276' ' ' LEU . 6.7 tm0? -105.94 132.83 51.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 70.21 110.844 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.701 HD13 ' HB ' ' D' ' 277' ' ' ILE . 4.1 mm? -129.94 118.64 21.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 65.4 110.964 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.27 176.59 14.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.737 -0.744 . . . . 53.05 112.508 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . 0.696 ' OD1' HG21 ' C' ' 260' ' ' THR . 1.7 p-10 -85.99 149.56 25.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 71.03 110.894 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . 0.736 HG22 ' CG ' ' C' ' 280' ' ' GLU . 3.4 t -120.54 115.05 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 75.31 111.159 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' C' ' 281' ' ' TYR . 6.1 m -122.16 129.39 75.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 64.53 111.108 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . 0.654 HG23 ' H ' ' D' ' 248' ' ' ALA . 11.5 t -69.16 175.2 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 75.35 111.133 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . 0.496 ' HB2' ' H ' ' C' ' 283' ' ' GLY . . . -52.76 -33.72 49.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 53.33 111.097 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . 0.654 ' H ' HG23 ' D' ' 246' ' ' THR . . . -56.67 -51.94 66.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 42.35 111.062 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . 0.71 ' HB2' ' CE1' ' C' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.43 . . . . 72.43 111.123 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . 0.649 HG23 ' HG2' ' E' ' 225' ' ' ARG . 27.8 m . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.888 0.375 . . . . 73.15 111.134 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . 0.519 HG23 ' N ' ' D' ' 225' ' ' ARG . 81.2 m -105.49 133.18 50.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.448 . . . . 63.34 111.109 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . 0.42 ' ND2' HG23 ' D' ' 277' ' ' ILE . 0.1 OUTLIER -126.11 137.17 53.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 43.2 110.868 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 10.0 t -142.05 123.74 15.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 70.24 110.889 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.505 HG21 ' CG2' ' D' ' 267' ' ' VAL . 8.1 p -126.06 145.07 34.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 74.42 111.138 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -88.83 -76.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 74.01 110.927 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 48.0 m -127.05 128.1 45.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 72.51 111.117 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.512 ' CG1' HG21 ' D' ' 275' ' ' VAL . 21.7 t -118.02 120.86 65.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 73.45 111.195 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.42 125.88 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.251 -0.431 . . . . 73.2 111.125 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.62 133.67 8.18 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.75 -0.738 . . . . 52.35 112.524 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.38 147.82 51.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 71.44 110.878 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.79 86.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 73.02 112.507 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 47.62 69.39 0.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.374 . . . . 51.11 110.899 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 19.3 t -100.19 145.35 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 73.32 110.82 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -135.35 128.02 30.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 74.51 110.855 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.512 HG21 ' CG1' ' D' ' 267' ' ' VAL . 14.2 t -128.87 124.22 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 71.33 111.101 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.76 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.8 OUTLIER -114.54 114.37 25.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 73.54 110.917 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.701 ' HB ' HD13 ' D' ' 241' ' ' LEU . 38.1 mm -112.03 104.95 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 72.44 111.095 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.55 -174.54 22.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.738 . . . . 65.13 112.521 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -106.78 148.35 28.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 55.34 110.833 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . 0.463 ' CG ' HG13 ' E' ' 244' ' ' VAL . 0.0 OUTLIER -112.75 133.86 54.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 75.44 110.893 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . 0.444 ' HD1' HG23 ' E' ' 245' ' ' VAL . 21.1 t80 -129.37 125.27 36.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.524 . . . . 74.2 110.95 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.23 -139.92 11.1 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.65 -0.786 . . . . 64.24 112.448 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -118.57 -120.52 2.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.76 -0.733 . . . . 75.13 112.444 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt 56.95 24.25 9.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 70.12 110.931 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 76.07 -68.26 2.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.753 . . . . 73.53 112.478 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -161.26 -75.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 71.35 110.886 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . 0.636 ' CZ2' HD23 ' D' ' 276' ' ' LEU . 6.4 t90 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.502 . . . . 73.11 110.848 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . 0.649 ' HG2' HG23 ' D' ' 260' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.857 0.361 . . . . 73.24 110.873 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.45 118.5 13.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 45.42 110.867 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.44 146.31 48.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 43.54 110.801 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.57 155.54 49.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 64.22 111.129 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.05 -27.82 10.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 63.14 110.962 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.36 139.03 5.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 65.45 110.911 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 10.5 mt -137.32 117.49 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 45.44 111.13 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -131.92 116.75 17.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 75.2 110.93 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.13 134.29 42.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 74.34 111.172 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.96 160.66 40.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 71.22 110.867 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 65.13 74.9 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 73.14 110.919 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 45.52 52.99 8.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 72.11 110.892 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.48 141.22 36.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.274 -0.421 . . . . 72.24 111.106 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -132.37 137.84 47.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 75.52 110.875 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.16 137.78 51.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 64.34 111.156 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . 0.477 ' HB3' HD22 ' E' ' 276' ' ' LEU . 1.8 tm0? -124.14 134.26 53.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 64.12 110.921 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.28 126.68 44.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 62.25 110.896 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 127.43 179.97 16.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 54.43 112.478 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -88.05 161.56 17.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 53.0 110.882 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.463 HG13 ' CG ' ' D' ' 280' ' ' GLU . 98.9 t -132.68 121.98 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 43.35 111.175 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . 0.444 HG23 ' HD1' ' D' ' 281' ' ' TYR . 5.4 m -122.24 128.91 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 71.23 111.144 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . 0.416 HG21 ' HA2' ' E' ' 282' ' ' GLY . 14.8 t -69.77 174.02 5.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 74.43 111.167 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.03 78.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 43.34 111.066 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.83 -35.82 69.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 63.01 111.142 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 61.42 111.049 179.961 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.82 0.343 . . . . 72.3 111.163 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -126.14 122.9 37.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 65.1 110.851 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 3.4 m -127.48 124.06 37.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 53.41 110.866 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . 0.522 HG21 ' CG2' ' E' ' 267' ' ' VAL . 7.1 p -115.8 125.34 72.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 74.44 111.116 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -61.07 -77.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 72.34 110.888 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.81 135.76 28.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 60.02 111.179 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . 1.001 HG11 HG21 ' E' ' 275' ' ' VAL . 39.8 t -118.35 129.35 74.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 73.4 111.053 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 79.4 t -127.32 124.69 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 73.52 111.109 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.02 132.66 8.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 64.14 112.518 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -133.42 116.96 16.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 74.22 110.944 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 71.8 84.46 0.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.739 . . . . 64.21 112.487 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 56.22 86.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 74.14 110.913 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 11.7 t -119.96 145.56 46.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 74.44 110.844 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -137.03 128.22 27.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 71.21 110.878 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 1.001 HG21 HG11 ' E' ' 267' ' ' VAL . 57.4 t -128.93 132.22 67.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 72.44 111.099 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . 0.477 HD22 ' HB3' ' E' ' 240' ' ' GLN . 2.2 tm? -128.39 111.71 13.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.886 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 24.9 mm -108.74 138.58 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 71.22 111.183 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 110.85 -155.84 15.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 31.03 112.52 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -128.12 149.65 50.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 73.52 110.908 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.91 133.28 54.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 74.04 110.887 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -126.38 125.56 42.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.884 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . 0.416 ' HA2' HG21 ' E' ' 246' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 63.03 112.528 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.769 0.318 . . . . 70.12 110.888 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.755 ' OD1' HG22 ' A' ' 277' ' ' ILE . 70.2 m-80 -112.71 130.98 55.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.269 -0.423 . . . . 61.33 110.9 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 2.3 t -121.8 137.66 54.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 51.34 110.841 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.93 129.63 21.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 75.44 111.027 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.3 -36.1 21.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 62.13 110.904 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -165.6 138.59 4.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 64.14 110.914 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.573 HG22 HG22 ' A' ' 267' ' ' VAL . 10.3 pt -138.33 134.49 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.21 111.101 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.635 ' HD3' HG22 ' A' ' 268' ' ' VAL . 9.2 ptm180 -134.34 129.26 35.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 65.41 110.923 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.523 HG21 HG13 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -133.68 148.14 51.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 63.21 111.14 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -150.47 167.45 27.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.453 . . . . 73.43 110.884 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.59 65.48 0.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 74.24 110.906 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 50.3 42.21 25.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 72.15 110.948 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.36 156.82 17.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.13 111.104 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.27 143.71 40.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 50.0 110.896 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.733 HG12 ' HB ' ' A' ' 275' ' ' VAL . 0.3 OUTLIER -124.12 121.16 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.23 111.165 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.629 ' HB3' HD22 ' A' ' 276' ' ' LEU . 4.0 tm0? -117.12 128.34 55.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.462 . . . . 75.32 110.923 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 5.8 mp -124.69 118.2 25.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.907 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.05 165.33 10.4 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 64.14 112.45 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -85.95 135.7 33.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.933 0.397 . . . . 71.54 110.812 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 244' ' ' VAL . 6.4 p -116.12 122.21 69.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 75.34 111.115 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.72 HG12 ' CB ' ' A' ' 281' ' ' TYR . 36.0 m -122.08 128.93 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 52.13 111.21 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.487 HG22 ' HA3' ' A' ' 282' ' ' GLY . 13.6 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 70.23 111.13 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . 0.5 HG21 ' ND2' ' B' ' 243' ' ' ASN . 5.5 t . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.857 0.361 . . . . 73.21 111.093 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.429 HG23 ' HB2' ' B' ' 225' ' ' ARG . 2.6 t -134.11 120.71 20.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 71.05 111.169 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.51 ' HB3' HD23 ' B' ' 241' ' ' LEU . 1.2 m120 -99.3 132.65 44.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 75.21 110.915 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.9 p -142.25 123.39 14.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 65.33 110.828 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.55 HG21 HG12 ' A' ' 267' ' ' VAL . 8.8 p -119.68 133.85 65.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 63.33 111.118 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -65.29 -69.84 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.12 110.823 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.2 m -131.64 135.78 47.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 72.45 111.186 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.573 HG22 HG22 ' A' ' 231' ' ' ILE . 15.5 m -127.33 136.04 61.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 72.33 111.17 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.635 HG22 ' HD3' ' A' ' 232' ' ' ARG . 36.6 t -127.19 137.32 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 73.13 111.156 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.43 133.61 7.18 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.676 -0.773 . . . . 74.54 112.489 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.63 148.54 52.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.748 0.308 . . . . 73.33 110.906 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.77 84.33 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 55.31 112.445 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 43.52 55.81 4.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 72.35 110.954 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 45.5 t -83.62 144.83 29.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.095 -0.502 . . . . 71.14 110.821 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.02 128.41 49.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 72.12 110.838 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.733 ' HB ' HG12 ' A' ' 239' ' ' VAL . 25.0 t -115.03 126.69 72.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 73.05 111.173 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' A' ' 240' ' ' GLN . 0.2 OUTLIER -128.41 109.85 11.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.457 . . . . 75.41 111.008 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.755 HG22 ' OD1' ' A' ' 226' ' ' ASN . 19.6 mm -112.97 104.49 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 74.21 111.107 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.8 -147.01 17.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.815 -0.707 . . . . 60.52 112.518 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -128.07 155.66 44.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 72.4 110.929 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.772 ' HB3' HG23 ' B' ' 244' ' ' VAL . 1.3 tt0 -122.31 118.94 29.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 63.51 110.926 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.72 ' CB ' HG12 ' A' ' 245' ' ' VAL . 0.5 OUTLIER -109.45 125.89 52.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 74.12 110.866 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.487 ' HA3' HG22 ' A' ' 246' ' ' THR . . . 62.3 176.07 2.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 75.23 112.509 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 120.7 16.12 4.66 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.772 -0.728 . . . . 73.55 112.492 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.1 mttm 59.9 69.41 0.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 74.31 110.891 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.51 174.26 23.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.795 -0.717 . . . . 24.43 112.55 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -60.4 -167.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 75.42 110.851 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 9.4 t90 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 53.44 110.887 179.966 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.429 ' HB2' HG23 ' A' ' 261' ' ' THR . 17.4 ptt180 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.76 0.314 . . . . 64.3 110.907 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -125.68 128.06 47.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 72.34 110.857 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.86 141.57 51.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 65.2 110.858 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.503 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -138.17 128.12 25.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 61.21 111.149 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -40.11 39.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 72.15 110.871 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -166.51 138.1 3.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 71.15 110.854 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.565 HG12 HG12 ' A' ' 267' ' ' VAL . 5.3 pt -138.71 133.13 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 72.02 111.144 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -135.35 128.55 31.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 75.35 110.944 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.513 HG21 HG13 ' B' ' 239' ' ' VAL . 0.3 OUTLIER -135.55 137.31 41.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 71.54 111.155 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 13.1 pm0 -141.59 166.65 24.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 62.43 110.903 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 65.96 67.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 75.23 110.79 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 18.9 mtt180 48.65 49.93 17.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 63.12 110.886 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.49 156.72 17.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 73.52 111.114 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 9.5 mtt-85 -134.29 142.9 47.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 73.01 110.872 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.59 HG12 ' HB ' ' B' ' 275' ' ' VAL . 0.0 OUTLIER -124.21 124.76 69.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.485 . . . . 71.52 111.092 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.595 ' HB3' HD22 ' B' ' 276' ' ' LEU . 0.0 OUTLIER -117.49 128.32 54.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 71.55 110.902 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 262' ' ' ASN . 0.2 OUTLIER -119.87 118.62 31.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 75.45 110.933 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.13 -177.91 16.48 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.748 . . . . 64.32 112.482 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.5 ' ND2' HG21 ' A' ' 260' ' ' THR . 9.2 p30 -85.98 148.95 25.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 53.55 110.937 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.772 HG23 ' HB3' ' A' ' 280' ' ' GLU . 6.7 p -131.08 127.87 61.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 70.33 111.1 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.72 HG12 ' CB ' ' B' ' 281' ' ' TYR . 30.8 m -121.93 129.05 75.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 70.13 111.11 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 20.9 p -80.28 175.0 11.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 54.21 111.129 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.01 -45.29 93.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 71.02 111.082 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.55 -36.02 77.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 44.32 111.126 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.641 ' HB2' ' HA3' ' B' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 73.25 111.127 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.803 0.335 . . . . 75.42 110.875 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 7.3 t -74.17 130.89 40.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 75.32 111.167 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 90.6 m -133.04 108.89 9.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 70.12 111.115 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.542 ' OD1' HD12 ' C' ' 241' ' ' LEU . 0.9 OUTLIER -88.82 136.12 33.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 73.24 110.878 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 19.5 t -142.51 123.15 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 73.34 110.859 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.764 HG23 ' HB3' ' C' ' 228' ' ' ALA . 4.0 p -119.34 140.09 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 62.33 111.116 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -78.1 -73.87 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 65.42 110.869 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.9 m -131.5 127.68 37.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 53.45 111.138 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.583 ' CG1' HG21 ' B' ' 264' ' ' VAL . 19.4 m -122.61 135.33 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 72.04 111.181 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 57.8 t -127.85 133.33 67.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 44.13 111.147 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.82 133.25 7.54 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.757 . . . . 75.01 112.464 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -132.4 148.56 52.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.332 . . . . 44.25 110.937 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.42 91.65 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.749 . . . . 71.01 112.484 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 40.44 51.14 2.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 64.11 110.866 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.05 144.55 29.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 63.31 110.88 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.47 128.19 45.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 63.23 110.907 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.59 ' HB ' HG12 ' B' ' 239' ' ' VAL . 26.2 t -118.79 124.61 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 74.42 111.105 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.595 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.4 OUTLIER -126.52 111.49 14.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 71.24 110.917 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.529 HG23 ' ND2' ' B' ' 262' ' ' ASN . 35.6 mm -110.98 104.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 74.43 111.095 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.91 -142.81 10.68 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.711 -0.757 . . . . 21.24 112.431 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -123.26 147.37 47.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 65.04 110.809 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.742 ' HB2' HG23 ' C' ' 244' ' ' VAL . 3.9 mm-40 -111.99 129.77 56.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 70.41 110.895 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.72 ' CB ' HG12 ' B' ' 245' ' ' VAL . 0.1 OUTLIER -123.11 130.36 52.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 70.4 110.92 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.641 ' HA3' ' HB2' ' B' ' 249' ' ' ALA . . . 81.95 159.25 24.32 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.765 -0.731 . . . . 64.41 112.499 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 126.1 -87.89 0.35 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.818 -0.706 . . . . 72.54 112.539 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.47 -51.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 62.4 110.858 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -130.2 -89.23 0.52 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.744 -0.741 . . . . 62.34 112.488 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.59 ' HA ' HG21 ' C' ' 244' ' ' VAL . 10.9 p90 -122.19 -34.03 3.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 55.45 110.864 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.113 -0.494 . . . . 73.44 110.939 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 14.4 mmt-85 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.811 0.339 . . . . 72.21 110.848 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -141.98 112.75 7.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 75.11 110.892 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 4.5 t -123.17 137.73 54.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 62.43 110.826 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.764 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -133.06 119.65 20.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 33.32 111.094 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -43.51 74.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 60.53 110.873 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -167.24 136.71 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.247 -0.433 . . . . 72.34 110.887 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.599 HG22 ' CG2' ' C' ' 267' ' ' VAL . 3.8 pt -138.13 131.79 41.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 61.51 111.129 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.09 128.37 30.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 74.12 110.891 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.681 HG21 HG13 ' C' ' 239' ' ' VAL . 1.4 p -135.46 144.97 46.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 50.53 111.138 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.88 166.73 25.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 74.21 110.907 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 66.96 68.27 0.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 74.22 110.864 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 46.66 53.92 9.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 72.21 110.871 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.23 156.89 17.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.051 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -132.23 141.3 48.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.34 110.885 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.69 HG12 ' HB ' ' C' ' 275' ' ' VAL . 0.0 OUTLIER -126.06 121.01 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.41 111.132 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.78 117.27 30.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 74.3 110.905 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.542 HD12 ' OD1' ' B' ' 262' ' ' ASN . 0.2 OUTLIER -111.82 118.94 36.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 62.53 110.943 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 122.75 -177.43 16.52 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.76 . . . . 63.31 112.481 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -85.95 131.94 34.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 42.43 110.834 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.742 HG23 ' HB2' ' B' ' 280' ' ' GLU . 3.1 p -116.34 122.52 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 62.32 111.068 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.763 HG12 ' HB2' ' C' ' 281' ' ' TYR . 28.7 m -122.88 129.27 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 65.53 111.148 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . 0.433 HG23 ' O ' ' C' ' 281' ' ' TYR . 59.3 p -69.8 175.2 4.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 75.4 111.093 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.542 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -58.12 -46.1 86.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 73.45 111.078 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -67.96 -36.74 80.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.21 111.114 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 73.45 111.162 179.865 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.898 0.38 . . . . 74.31 110.951 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 7.6 t -64.97 124.56 22.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 75.13 111.128 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.546 HG22 ' HG2' ' D' ' 225' ' ' ARG . 6.5 t -134.16 141.4 47.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 64.11 111.118 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . 0.5 ' OD1' HG23 ' C' ' 277' ' ' ILE . 2.9 t-20 -113.88 143.04 45.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 73.43 110.86 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 8.5 t -140.16 123.94 17.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 75.31 110.903 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.591 HG23 HD11 ' D' ' 231' ' ' ILE . 8.7 p -120.81 135.78 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 73.32 111.102 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.72 -75.58 0.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 75.14 110.894 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 2.2 m -127.19 127.76 45.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 73.4 111.162 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.854 HG11 HG11 ' C' ' 275' ' ' VAL . 0.0 OUTLIER -118.78 128.28 75.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 63.11 111.151 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 41.7 t -127.92 115.93 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 75.51 111.144 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.67 133.98 11.04 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.794 -0.717 . . . . 64.22 112.472 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -132.08 148.2 52.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.897 0.38 . . . . 73.54 110.888 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 53.55 90.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.683 -0.77 . . . . 60.04 112.513 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 40.87 51.41 3.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.878 0.37 . . . . 74.54 110.859 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 39.1 t -84.87 144.98 28.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.04 110.843 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -127.74 127.85 44.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 71.5 110.884 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.854 HG11 HG11 ' C' ' 267' ' ' VAL . 23.4 t -122.89 123.63 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 64.24 111.129 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.93 114.35 19.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 60.11 110.949 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.5 HG23 ' OD1' ' C' ' 262' ' ' ASN . 31.5 mm -112.57 104.56 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 74.5 111.133 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.04 -164.05 27.61 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.676 -0.774 . . . . 41.35 112.483 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -89.84 155.99 18.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 50.53 110.87 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.466 ' HB3' HG23 ' D' ' 244' ' ' VAL . 5.2 tp10 -129.84 134.87 47.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 63.44 110.911 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.763 ' HB2' HG12 ' C' ' 245' ' ' VAL . 0.1 OUTLIER -130.15 125.38 34.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 73.33 110.967 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' D' ' 247' ' ' ALA . . . -122.54 -166.86 12.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.727 -0.749 . . . . 74.3 112.487 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' D' ' 247' ' ' ALA . . . -101.27 -23.37 9.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 73.12 112.525 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -172.34 32.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 70.15 110.866 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -173.82 -174.01 40.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.796 -0.716 . . . . 74.03 112.531 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -100.84 -173.54 2.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.804 0.335 . . . . 74.14 110.948 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 11.6 t90 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 73.15 110.906 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . 0.747 ' N ' ' HG1' ' D' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.816 0.341 . . . . 64.21 110.928 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -81.43 109.43 15.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 74.55 110.902 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.01 149.62 51.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.816 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . 0.511 ' HB2' HD11 ' D' ' 241' ' ' LEU . . . -133.02 160.93 35.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 73.23 111.08 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.42 -37.05 5.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.907 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . 0.407 ' O ' HG23 ' D' ' 267' ' ' VAL . 39.9 t0 -164.6 139.08 5.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.211 -0.45 . . . . 71.23 110.949 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . 0.591 HD11 HG23 ' C' ' 264' ' ' VAL . 0.8 OUTLIER -136.66 117.51 17.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 73.41 111.155 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -130.38 115.59 17.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 70.14 110.865 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . 0.586 HG21 ' CG1' ' D' ' 239' ' ' VAL . 2.7 p -135.65 147.42 48.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 74.34 111.151 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.74 167.52 24.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 72.2 110.866 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 68.34 67.57 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 73.41 110.855 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 46.46 60.35 3.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 72.33 110.824 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.18 155.78 18.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 62.31 111.12 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -133.35 135.94 45.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.884 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.586 ' CG1' HG21 ' D' ' 233' ' ' THR . 10.2 m -131.48 121.85 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 64.32 111.153 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . 0.448 ' HB3' HD22 ' D' ' 276' ' ' LEU . 7.3 tm0? -118.06 120.37 37.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.33 110.949 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' D' ' 228' ' ' ALA . 0.7 OUTLIER -111.37 119.8 40.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 74.21 110.948 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.99 -175.5 19.11 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.723 -0.751 . . . . 71.35 112.498 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -96.29 128.45 43.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 75.42 110.867 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . 0.466 HG23 ' HB3' ' C' ' 280' ' ' GLU . 3.7 p -111.28 115.81 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 73.33 111.121 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . 0.802 HG12 ' HB2' ' D' ' 281' ' ' TYR . 19.0 m -122.75 124.78 71.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 63.42 111.118 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 6.4 t -70.58 175.23 5.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.181 -0.463 . . . . 53.31 111.197 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . 0.431 ' HB2' ' HA2' ' C' ' 283' ' ' GLY . . . -61.56 -46.38 90.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 63.23 111.14 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.71 -35.96 69.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 61.34 111.109 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 74.31 111.103 179.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . 0.475 HG21 ' ND2' ' D' ' 279' ' ' ASN . 8.4 t . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.812 0.339 . . . . 75.12 111.151 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . 0.747 ' HG1' ' N ' ' D' ' 225' ' ' ARG . 0.1 OUTLIER -134.05 141.4 47.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 73.53 111.22 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -122.27 144.54 48.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 72.23 110.889 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.22 123.68 14.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 55.32 110.902 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.413 HG21 HG22 ' D' ' 267' ' ' VAL . 14.4 p -120.54 131.53 72.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 75.54 111.101 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.2 -76.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 42.23 110.925 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 3.8 m -128.09 132.05 49.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 74.52 111.165 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 1.069 HG11 HG11 ' D' ' 275' ' ' VAL . 0.2 OUTLIER -117.59 123.63 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 75.3 111.12 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 23.6 t -122.15 115.88 47.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 55.05 111.187 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.05 133.63 10.75 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.767 -0.73 . . . . 61.44 112.529 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -132.11 148.01 52.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.813 0.34 . . . . 62.02 110.878 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.29 76.38 0.17 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.748 . . . . 73.0 112.478 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 48.44 71.68 0.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.362 . . . . 72.23 110.93 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 20.5 t -102.27 145.41 29.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 63.11 110.893 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -123.03 128.33 50.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 73.52 110.814 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 1.069 HG11 HG11 ' D' ' 267' ' ' VAL . 18.8 t -129.47 123.43 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 74.13 111.103 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.732 HD23 ' O ' ' D' ' 275' ' ' VAL . 15.5 mt -127.85 116.8 20.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 55.03 110.871 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.649 ' CD1' HD13 ' E' ' 241' ' ' LEU . 34.2 mm -112.18 104.68 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 73.21 111.188 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.84 -159.25 28.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.783 -0.722 . . . . 52.33 112.48 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . 0.475 ' ND2' HG21 ' D' ' 260' ' ' THR . 15.5 m120 -96.61 156.1 16.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 72.41 110.892 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . 0.587 ' HB3' HG23 ' E' ' 244' ' ' VAL . 12.0 tp10 -129.18 118.99 23.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 74.2 110.806 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . 0.802 ' HB2' HG12 ' D' ' 245' ' ' VAL . 0.2 OUTLIER -120.75 124.17 44.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 64.22 110.905 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.81 -76.55 2.22 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 44.42 112.421 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 51.98 -156.11 4.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.749 -0.739 . . . . 32.5 112.516 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -179.42 -34.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.848 0.356 . . . . 63.53 110.964 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -84.27 -126.0 1.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.762 -0.732 . . . . 64.32 112.459 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -22.4 50.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 74.22 110.91 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . 0.414 ' CD2' HD12 ' D' ' 276' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 74.45 110.933 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 29.5 mtt-85 . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.833 0.349 . . . . 64.4 110.908 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.03 109.92 22.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 64.44 110.942 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.89 137.84 54.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.482 . . . . 44.4 110.886 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . 0.753 ' HB2' HD21 ' E' ' 241' ' ' LEU . . . -132.13 128.14 37.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.32 111.133 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.52 -30.43 25.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 70.43 110.918 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . 0.533 ' CB ' HG22 ' E' ' 266' ' ' THR . 0.6 OUTLIER -165.0 138.16 4.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 75.52 110.813 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . 0.705 HG23 ' CG2' ' E' ' 267' ' ' VAL . 8.4 mt -137.98 116.71 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 71.23 111.116 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -134.76 115.68 14.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 74.32 110.836 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' E' ' 237' ' ' ALA . 1.3 p -135.88 145.11 46.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 52.11 111.124 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -143.99 167.72 21.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.147 -0.479 . . . . 74.32 110.886 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 68.07 68.2 0.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 74.2 110.821 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 46.86 61.69 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 71.52 110.937 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . 0.483 ' HB3' ' OG1' ' E' ' 233' ' ' THR . . . -104.88 156.05 18.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 74.1 111.025 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -136.35 136.25 39.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 72.42 110.868 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.506 HG12 ' HB ' ' E' ' 275' ' ' VAL . 13.4 m -135.72 138.65 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 42.02 111.149 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -136.98 129.52 30.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 65.23 110.904 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.753 HD21 ' HB2' ' E' ' 228' ' ' ALA . 5.6 mp -114.48 118.71 34.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 74.24 110.839 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.92 179.71 16.21 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.733 -0.746 . . . . 74.25 112.473 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -93.07 143.2 26.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 72.11 110.85 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' D' ' 280' ' ' GLU . 5.5 p -118.59 122.36 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 74.44 111.099 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 5.7 m -122.35 122.09 65.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 75.22 111.138 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.0 t -70.09 173.78 6.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 71.15 111.139 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.0 92.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 52.45 111.174 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.19 72.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 74.44 111.078 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 55.24 111.025 -179.994 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 94.3 m . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.747 0.308 . . . . 31.43 111.12 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . 0.42 ' CB ' HG22 ' E' ' 277' ' ' ILE . 3.7 m120 -108.63 124.4 50.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 72.11 110.907 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 3.8 m -125.83 123.72 39.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 43.34 110.909 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . 0.624 HG21 HG13 ' E' ' 267' ' ' VAL . 12.9 p -123.21 131.73 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 73.13 111.142 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.67 -77.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 72.24 110.913 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . 0.533 HG22 ' CB ' ' E' ' 230' ' ' ASP . 75.4 p -133.52 131.19 39.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 64.44 111.131 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . 0.705 ' CG2' HG23 ' E' ' 231' ' ' ILE . 4.9 m -118.34 120.95 65.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 71.02 111.135 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.63 120.04 63.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 71.13 111.13 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.51 133.76 11.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.776 -0.726 . . . . 75.44 112.477 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -131.87 148.13 52.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 52.44 110.895 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.48 78.74 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.735 -0.745 . . . . 55.0 112.457 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 47.51 68.38 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.372 . . . . 54.33 110.848 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 40.4 t -99.69 145.41 27.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 71.22 110.872 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.96 128.54 43.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 74.14 110.836 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.506 ' HB ' HG12 ' E' ' 239' ' ' VAL . 30.1 t -129.96 123.43 56.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 65.53 111.115 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . 0.446 HD23 ' O ' ' E' ' 275' ' ' VAL . 54.8 mt -126.01 111.87 15.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 64.21 110.904 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.42 HG22 ' CB ' ' E' ' 262' ' ' ASN . 27.1 mm -104.21 106.35 20.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 65.52 111.131 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.85 -171.8 29.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.753 -0.737 . . . . 71.43 112.463 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -89.87 154.94 19.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 74.31 110.907 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -127.15 120.58 29.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 64.01 110.902 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.27 125.77 45.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 70.4 110.876 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.74 -0.743 . . . . 44.51 112.501 179.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.842 0.354 . . . . 71.0 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.451 ' HB3' HG22 ' A' ' 277' ' ' ILE . 69.4 m-80 -107.28 132.79 52.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.884 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 46.8 m -140.51 148.06 40.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 75.45 110.932 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.11 119.35 10.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 31.1 111.06 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -36.68 78.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 70.44 110.89 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -165.29 137.76 4.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 70.45 110.909 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.597 HG22 ' CG2' ' A' ' 267' ' ' VAL . 6.3 pt -138.5 116.9 13.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 61.23 111.14 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -126.33 129.75 49.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 75.34 110.838 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.632 HG21 ' CG1' ' A' ' 239' ' ' VAL . 5.4 p -136.05 148.97 48.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 73.0 111.169 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.99 168.41 21.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.272 -0.422 . . . . 55.52 110.894 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 69.69 60.41 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.87 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 48.31 58.93 4.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 65.13 110.883 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.09 156.53 17.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 70.01 111.078 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.55 147.67 49.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 75.32 110.865 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.665 HG12 ' HB ' ' A' ' 275' ' ' VAL . 18.7 m -140.68 121.69 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 61.01 111.099 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -125.1 125.1 43.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 74.33 110.914 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.822 HD23 HD13 ' A' ' 277' ' ' ILE . 0.1 OUTLIER -119.77 117.98 29.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 62.44 110.906 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 161.58 162.7 13.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 52.21 112.485 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -85.74 140.66 30.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.875 0.369 . . . . 72.55 110.883 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 97.9 t -114.25 118.56 58.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.48 . . . . 63.42 111.161 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.61 129.07 75.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 72.4 111.121 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 74.2 111.162 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.829 0.347 . . . . 62.25 111.125 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.5 t -108.49 120.72 43.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 63.5 111.101 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -102.68 119.79 39.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 71.03 110.903 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.6 t -132.05 123.79 27.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 70.33 110.891 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.86 HG23 ' HB3' ' B' ' 228' ' ' ALA . 4.2 p -116.9 141.38 35.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.143 -0.481 . . . . 75.42 111.082 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.51 -74.8 0.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 64.34 110.869 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.5 m -124.11 136.53 54.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 62.44 111.143 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.597 ' CG2' HG22 ' A' ' 231' ' ' ILE . 3.5 t -120.84 132.57 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 74.11 111.195 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.23 119.87 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 70.23 111.111 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.11 133.66 11.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.717 -0.754 . . . . 73.43 112.52 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -132.36 148.22 52.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 71.51 110.843 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 53.22 74.24 0.32 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.742 . . . . 63.51 112.489 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 47.57 59.52 4.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.898 0.38 . . . . 73.5 110.945 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.61 145.81 28.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 63.55 110.782 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 57.9 mtt85 -118.03 128.31 54.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 72.55 110.902 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.665 ' HB ' HG12 ' A' ' 239' ' ' VAL . 13.6 t -117.4 123.61 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 75.25 111.215 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.605 ' O ' HD12 ' B' ' 241' ' ' LEU . 0.8 OUTLIER -124.87 112.63 16.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 74.42 110.991 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.822 HD13 HD23 ' A' ' 241' ' ' LEU . 3.6 mp -112.11 104.4 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 63.54 111.068 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.23 166.18 14.68 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.718 -0.753 . . . . 63.02 112.489 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -100.1 156.21 17.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.817 0.341 . . . . 75.24 110.889 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -115.71 119.75 37.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.898 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.52 125.97 51.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 62.11 110.933 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 69.37 142.56 0.14 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.775 -0.726 . . . . 44.3 112.471 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 129.36 -28.94 3.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.735 -0.745 . . . . 71.31 112.465 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 62.91 56.95 1.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 73.33 110.954 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.525 ' O ' HG11 ' B' ' 244' ' ' VAL . . . -154.07 -119.58 0.73 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.765 -0.731 . . . . 41.31 112.499 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -176.24 -38.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 74.11 110.844 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.426 ' CE2' HD12 ' A' ' 276' ' ' LEU . 2.9 t-105 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 72.44 110.954 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.798 0.332 . . . . 74.23 110.941 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.446 ' HB3' HG22 ' B' ' 277' ' ' ILE . 22.9 m120 -83.99 130.88 34.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 73.44 110.909 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.0 m -140.39 146.02 37.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 73.13 110.853 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.86 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -141.45 119.93 12.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 35.43 111.074 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -32.2 69.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 72.13 110.918 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -166.69 137.41 3.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.275 -0.42 . . . . 62.31 110.912 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.76 ' CD1' HG21 ' A' ' 264' ' ' VAL . 12.8 pt -138.54 117.61 13.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 64.13 111.149 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -131.07 129.18 41.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.846 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.615 HG21 ' CG1' ' B' ' 239' ' ' VAL . 2.3 p -135.59 148.77 49.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 63.14 111.116 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 15.6 pm0 -144.46 168.29 20.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 72.35 110.898 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 69.6 64.85 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 54.35 110.856 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.33 48.38 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 74.11 110.888 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.69 156.63 16.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 73.41 111.126 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.9 154.91 51.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 71.54 110.897 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.615 ' CG1' HG21 ' B' ' 233' ' ' THR . 17.8 m -140.92 138.55 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.22 111.175 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.476 ' HG3' HD13 ' A' ' 276' ' ' LEU . 1.5 tt0 -138.42 123.18 18.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.87 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.605 HD12 ' O ' ' A' ' 276' ' ' LEU . 0.3 OUTLIER -115.65 118.67 33.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 71.32 110.952 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 159.18 161.88 11.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.7 -0.762 . . . . 51.53 112.422 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -86.06 131.12 34.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 64.44 110.935 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.525 HG11 ' O ' ' A' ' 285' ' ' GLY . 85.9 t -96.97 115.05 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 32.34 111.146 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.579 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 91.2 t -109.78 128.99 65.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 50.12 111.099 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.419 HG23 ' H ' ' B' ' 249' ' ' ALA . 13.9 t -70.25 167.52 17.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 64.01 111.134 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.09 76.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 75.25 111.063 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.51 -50.44 73.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 71.53 111.159 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.579 ' HB3' ' CG1' ' B' ' 245' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 72.24 111.05 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.931 0.396 . . . . 74.41 110.891 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 2.5 m -100.62 129.32 46.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 72.13 111.182 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 4.8 t -110.53 134.58 52.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 64.12 111.076 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.49 133.38 56.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 71.35 110.854 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.3 m -142.81 123.13 13.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 74.23 110.894 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.799 HG21 HD11 ' C' ' 231' ' ' ILE . 8.0 p -119.0 134.43 62.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 54.3 111.161 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -66.51 -75.2 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 73.32 110.885 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 68.8 m -133.32 133.33 42.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 63.33 111.142 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' B' ' 231' ' ' ILE . 0.7 OUTLIER -120.55 138.0 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 74.42 111.148 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.06 124.45 66.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 74.53 111.082 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.31 133.62 11.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.638 -0.792 . . . . 40.24 112.477 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -132.02 148.04 52.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 74.11 110.892 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.3 80.78 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 61.41 112.421 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 44.19 57.79 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.958 0.409 . . . . 64.34 110.923 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.71 145.55 28.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 75.55 110.844 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -119.3 128.77 54.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 73.31 110.901 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.65 HG12 HD11 ' B' ' 277' ' ' ILE . 18.0 t -115.16 125.05 72.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 75.21 111.107 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.431 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.2 OUTLIER -128.11 110.9 12.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.145 -0.48 . . . . 73.33 110.96 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.65 HD11 HG12 ' B' ' 275' ' ' VAL . 4.7 mp -112.61 104.44 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 64.24 111.14 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.31 170.97 21.44 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.754 -0.736 . . . . 60.25 112.486 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -103.89 156.0 18.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.813 0.34 . . . . 73.54 110.909 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -115.92 119.41 35.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 52.22 110.885 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.94 127.74 51.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 71.4 110.951 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 63.19 160.31 0.24 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.696 -0.764 . . . . 20.0 112.539 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 98.4 104.62 2.44 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.806 -0.711 . . . . 23.51 112.473 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.76 103.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.777 0.322 . . . . 75.12 110.98 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 157.99 -127.87 1.98 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.71 -0.757 . . . . 75.13 112.457 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -178.11 -38.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.801 0.334 . . . . 75.11 110.87 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 18.0 t90 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.916 -179.929 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.797 0.332 . . . . 72.44 110.837 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -100.49 119.6 38.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 72.05 110.897 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.3 m -140.22 142.73 35.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 72.1 110.857 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.691 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -142.29 130.13 21.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 73.02 111.132 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -31.62 39.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 73.12 110.905 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -167.46 135.16 2.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.408 . . . . 65.44 110.851 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.802 HG22 HG22 ' C' ' 267' ' ' VAL . 6.3 pt -142.02 117.23 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 74.44 111.13 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.16 133.51 46.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 73.45 110.807 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.562 HG21 HG13 ' C' ' 239' ' ' VAL . 5.0 p -136.22 152.43 50.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 75.1 111.169 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -145.88 168.25 21.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 74.54 110.816 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 69.67 63.81 0.26 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 74.24 110.892 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.32 58.47 4.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.872 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.62 156.22 18.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 74.04 111.148 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -131.28 137.33 48.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 62.42 110.848 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.673 HG12 ' CG2' ' C' ' 275' ' ' VAL . 6.5 m -123.68 121.77 63.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 61.14 111.161 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.574 ' C ' HD13 ' C' ' 241' ' ' LEU . 0.5 OUTLIER -119.83 115.82 24.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 75.41 110.929 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.858 HD12 HD12 ' C' ' 277' ' ' ILE . 0.2 OUTLIER -111.51 118.69 36.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 62.11 110.934 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.1 166.05 13.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.673 -0.775 . . . . 72.11 112.471 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.535 ' ND2' HG23 ' C' ' 245' ' ' VAL . 1.2 p-10 -85.8 146.63 26.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.924 0.392 . . . . 65.11 110.874 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 46.2 t -116.37 122.88 70.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 65.54 111.145 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.595 HG13 ' HB3' ' C' ' 249' ' ' ALA . 74.6 t -122.05 128.53 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 51.03 111.117 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.8 t -69.83 173.23 6.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 73.44 111.164 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.54 76.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 54.44 111.059 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.93 -51.87 67.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 73.31 111.107 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . 0.595 ' HB3' HG13 ' C' ' 245' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 42.14 111.047 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.854 0.359 . . . . 70.01 110.857 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.37 137.69 35.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 71.51 111.146 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 87.2 m -128.8 119.83 25.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 65.34 111.094 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -104.86 119.96 40.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 63.04 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 29.2 t -134.32 123.64 24.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 72.2 110.827 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.715 HG21 HG12 ' C' ' 267' ' ' VAL . 8.3 p -119.49 153.32 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 74.45 111.144 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.02 -60.45 1.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 52.34 110.905 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 31.6 p -145.63 127.68 15.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 74.44 111.136 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.802 HG22 HG22 ' C' ' 231' ' ' ILE . 1.0 OUTLIER -122.82 137.38 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 73.11 111.14 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 49.1 t -124.9 125.56 69.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 52.51 111.124 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.77 134.06 11.74 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 41.4 112.52 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -132.36 148.52 52.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.841 0.353 . . . . 74.22 110.864 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.72 85.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.682 -0.77 . . . . 53.54 112.548 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 42.72 59.26 2.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 72.45 110.871 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.8 145.13 28.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 63.21 110.825 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -121.32 128.2 52.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 71.42 110.874 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.673 ' CG2' HG12 ' C' ' 239' ' ' VAL . 31.0 t -116.04 125.19 73.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 72.22 111.14 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.552 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.1 OUTLIER -128.2 111.59 13.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 75.01 110.918 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.858 HD12 HD12 ' C' ' 241' ' ' LEU . 57.2 mt -111.14 104.2 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 71.44 111.14 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.39 178.22 24.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.725 -0.75 . . . . 42.42 112.465 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -108.69 150.96 26.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.779 0.323 . . . . 74.42 110.905 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -112.0 127.9 56.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.44 110.894 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.513 ' CZ ' HG11 ' D' ' 245' ' ' VAL . 1.9 t80 -113.63 125.87 54.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 61.24 110.919 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 51.56 -170.45 0.36 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.767 -0.73 . . . . 63.55 112.489 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 84.94 -133.01 11.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.818 -0.705 . . . . 51.13 112.457 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -45.38 66.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.83 0.348 . . . . 60.31 110.876 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 128.02 -9.17 6.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.713 -0.756 . . . . 71.52 112.443 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.786 ' CE1' HD11 ' D' ' 276' ' ' LEU . 7.8 t80 -171.51 -75.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 73.21 110.87 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.552 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 14.6 t90 . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 71.35 110.908 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.856 0.36 . . . . 63.45 110.837 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -83.66 115.31 22.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 70.4 110.85 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.35 147.33 49.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.912 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.06 119.91 11.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 63.23 111.092 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.49 -39.33 70.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 71.34 110.913 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -165.81 138.89 4.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 74.25 110.844 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . 0.475 HG23 ' CG2' ' D' ' 267' ' ' VAL . 0.1 OUTLIER -135.38 116.25 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 64.45 111.149 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -125.59 125.6 43.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 61.45 110.826 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . 0.593 HG21 ' CG1' ' D' ' 239' ' ' VAL . 1.5 p -135.51 149.0 49.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 64.02 111.096 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 14.9 pm0 -145.65 167.95 21.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 65.1 110.861 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 64.79 76.03 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 54.3 110.899 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 10.5 mtm-85 41.42 56.74 3.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.857 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.54 156.29 18.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 74.11 111.049 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -136.83 151.96 49.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 64.11 110.915 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.646 HG12 ' CG2' ' D' ' 275' ' ' VAL . 18.6 m -137.23 139.53 43.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 71.05 111.078 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . 0.62 ' C ' HD13 ' D' ' 241' ' ' LEU . 19.8 tm0? -137.66 121.28 17.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 74.55 110.912 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.645 HD12 HD12 ' D' ' 277' ' ' ILE . 0.2 OUTLIER -112.21 118.37 35.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 72.14 110.899 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 146.23 169.48 14.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.741 . . . . 52.13 112.534 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . 0.447 ' ND2' HG23 ' D' ' 245' ' ' VAL . 5.8 p-10 -85.95 152.1 23.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 45.44 110.909 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 18.2 t -117.57 114.81 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 72.04 111.139 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . 0.513 HG11 ' CZ ' ' C' ' 281' ' ' TYR . 67.8 t -107.47 124.06 63.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 60.0 111.181 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t -69.73 168.21 15.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 65.42 111.178 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.19 -34.1 73.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 75.34 111.078 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.74 -36.45 72.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 54.41 111.115 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 73.11 111.126 179.939 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . 0.66 HG23 ' HD2' ' E' ' 225' ' ' ARG . 85.8 m . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.843 0.354 . . . . 70.24 111.162 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 99.8 m -105.33 125.08 50.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.424 . . . . 53.41 111.127 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . 0.524 ' OD1' HG22 ' D' ' 260' ' ' THR . 0.1 OUTLIER -125.98 129.47 49.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 63.3 110.857 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.23 123.56 14.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 53.21 110.882 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.496 HG23 HD11 ' E' ' 231' ' ' ILE . 14.2 p -109.89 128.77 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 73.33 111.122 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.55 -79.55 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 72.25 110.793 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -121.68 129.93 53.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 75.11 111.085 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.475 ' CG2' HG23 ' D' ' 231' ' ' ILE . 0.5 OUTLIER -117.75 120.33 64.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 65.42 111.103 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 22.4 t -118.74 115.97 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 73.4 111.154 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.14 133.76 10.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.707 -0.759 . . . . 34.31 112.527 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -131.53 147.81 52.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.766 0.317 . . . . 74.25 110.888 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.16 90.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.761 . . . . 73.22 112.521 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 44.28 61.27 2.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 75.33 110.914 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.56 145.81 24.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 75.14 110.937 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 10.7 mtm-85 -124.04 131.23 53.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 65.44 110.865 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.646 ' CG2' HG12 ' D' ' 239' ' ' VAL . 21.8 t -115.27 124.9 72.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 64.04 111.106 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.786 HD11 ' CE1' ' C' ' 286' ' ' PHE . 2.8 mm? -128.4 111.46 13.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 63.31 110.911 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.645 HD12 HD12 ' D' ' 241' ' ' LEU . 18.2 mt -114.16 103.99 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 62.51 111.165 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.6 -164.68 30.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 53.23 112.42 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -128.26 150.07 50.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.786 0.327 . . . . 74.44 110.904 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -113.39 145.36 41.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 61.44 110.889 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -129.86 125.93 36.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 73.41 110.927 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 62.28 168.46 0.76 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.76 -0.733 . . . . 75.21 112.449 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 107.63 -124.52 7.6 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 72.23 112.477 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -137.84 91.53 2.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 55.54 110.881 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 71.19 167.29 7.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.748 -0.739 . . . . 32.53 112.518 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . 0.405 ' HB3' HG21 ' E' ' 244' ' ' VAL . 2.6 p90 -51.92 -31.95 30.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.834 0.349 . . . . 74.12 110.874 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 3.0 t90 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 75.0 110.873 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . 0.66 ' HD2' HG23 ' D' ' 260' ' ' THR . 5.6 ptp180 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.834 0.349 . . . . 74.04 110.86 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . 0.465 ' HB3' HG22 ' E' ' 277' ' ' ILE . 3.3 m120 -96.75 109.75 22.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 73.44 110.881 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 31.9 t -134.06 137.85 44.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 54.13 110.802 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.45 136.61 54.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 74.22 111.158 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.44 -35.14 13.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 74.03 110.861 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.39 137.32 3.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 72.23 110.824 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . 0.496 HD11 HG23 ' D' ' 264' ' ' VAL . 1.3 mt -138.06 116.55 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 64.31 111.166 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -123.16 121.68 36.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.02 110.861 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 9.6 p -136.74 149.14 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.14 111.227 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.98 166.44 24.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 73.44 110.862 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . 0.466 ' O ' ' C ' ' E' ' 236' ' ' ARG . 2.4 mt-10 62.23 90.46 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 64.44 110.904 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' E' ' 235' ' ' GLU . 0.9 OUTLIER 31.94 63.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 72.34 110.935 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.03 156.28 18.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 60.03 111.087 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -137.4 137.2 38.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 73.03 110.903 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.561 HG12 ' CG2' ' E' ' 275' ' ' VAL . 16.6 m -126.08 137.76 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 70.43 111.092 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -134.78 126.51 29.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 62.33 110.931 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.471 HD22 ' HB ' ' D' ' 264' ' ' VAL . 1.3 mp -116.98 118.64 32.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.859 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.61 172.38 12.55 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.786 -0.721 . . . . 74.24 112.535 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . 0.488 ' HB3' HG21 ' D' ' 260' ' ' THR . 0.5 OUTLIER -85.57 163.39 18.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 71.04 110.914 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' D' ' 286' ' ' PHE . 21.4 t -129.64 135.54 61.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 73.35 111.132 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 70.3 t -122.86 124.11 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 75.53 111.226 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.7 t -68.47 167.03 15.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 53.02 111.172 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.17 75.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 62.22 111.127 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' E' ' 249' ' ' ALA . . . -56.89 -36.94 70.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 52.32 111.087 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' E' ' 248' ' ' ALA . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 55.41 111.053 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . 0.615 HG22 ' HA ' ' E' ' 225' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.794 0.33 . . . . 72.44 111.125 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -123.0 119.75 31.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 44.44 110.903 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 4.2 p -133.12 123.29 25.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.883 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . 0.617 HG21 HG22 ' E' ' 267' ' ' VAL . 7.4 p -112.3 136.64 47.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 72.14 111.168 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -81.36 -75.53 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 71.42 110.904 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.2 m -125.21 129.62 50.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 64.33 111.142 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . 0.617 HG22 HG21 ' E' ' 264' ' ' VAL . 17.6 t -117.32 123.9 72.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 75.43 111.142 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 87.4 t -127.07 115.82 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 54.34 111.133 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.58 133.87 8.81 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 73.4 112.516 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.84 147.54 46.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.359 . . . . 74.54 110.897 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.27 84.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.777 -0.725 . . . . 44.43 112.46 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 49.1 88.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.853 0.359 . . . . 71.31 110.905 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 67.2 m -116.25 145.19 43.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.13 110.85 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.82 128.78 55.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 74.42 110.925 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.561 ' CG2' HG12 ' E' ' 239' ' ' VAL . 16.4 t -115.12 122.86 70.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 72.01 111.11 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.25 111.56 13.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 72.21 110.874 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.465 HG22 ' HB3' ' E' ' 226' ' ' ASN . 61.5 mt -113.71 104.09 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 73.02 111.087 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.3 176.88 15.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 73.33 112.445 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -89.35 156.43 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.826 0.345 . . . . 64.33 110.899 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -128.53 137.52 51.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 61.23 110.94 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -120.2 123.75 44.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 72.45 110.923 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 C-N-CA 120.686 -0.769 . . . . 75.14 112.536 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.861 0.363 . . . . 55.11 110.831 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -83.19 145.15 29.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 71.21 110.899 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.57 150.26 47.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 75.02 110.85 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.8 119.13 17.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.497 . . . . 61.12 111.092 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -70.76 -49.98 40.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 72.22 110.927 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -165.25 136.37 3.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 45.13 110.862 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.424 HG22 ' CG2' ' A' ' 267' ' ' VAL . 8.0 pt -138.84 134.39 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 74.44 111.1 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -134.49 128.2 32.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 73.25 110.837 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 11.8 p -136.41 149.79 48.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 71.23 111.107 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -120.54 166.24 13.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 75.43 110.869 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 65.39 -159.27 0.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 72.32 110.914 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -74.33 61.41 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 73.33 110.835 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.23 156.43 16.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 70.13 111.108 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.64 143.49 47.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 75.41 110.869 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.672 HG12 ' HB ' ' A' ' 275' ' ' VAL . 16.0 m -135.83 120.83 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 73.3 111.161 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.44 137.7 52.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.889 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.41 118.37 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 72.13 110.92 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 149.78 -126.73 2.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 74.21 112.516 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -145.51 143.11 29.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.808 0.337 . . . . 75.0 110.944 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.65 119.9 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 75.35 111.121 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 36.7 t -109.19 116.15 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 54.2 111.12 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 65.33 111.166 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.823 0.344 . . . . 63.44 111.077 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 225' ' ' ARG . 54.0 m -132.5 133.64 44.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 53.25 111.167 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.611 HD22 HD23 ' B' ' 241' ' ' LEU . 0.6 OUTLIER -115.88 144.45 44.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 70.11 110.862 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.7 m -141.69 127.97 19.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 71.42 110.824 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.743 HG23 HD11 ' B' ' 231' ' ' ILE . 8.7 p -113.57 137.41 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.508 . . . . 74.3 111.088 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -85.61 -78.82 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 52.54 110.829 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 4.0 m -115.71 127.04 54.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 75.33 111.101 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.562 HG22 HG21 ' A' ' 264' ' ' VAL . 40.9 t -118.42 124.12 72.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 62.01 111.076 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 78.9 t -124.76 115.21 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.116 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.42 133.08 9.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 53.2 112.499 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -109.03 129.3 55.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.35 . . . . 72.02 110.884 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.92 178.74 10.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.743 . . . . 21.12 112.465 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -47.53 101.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.835 0.35 . . . . 74.32 110.923 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 44.9 t -129.63 154.14 47.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.096 -0.502 . . . . 65.1 110.837 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -112.16 128.05 56.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 65.11 110.827 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.672 ' HB ' HG12 ' A' ' 239' ' ' VAL . 59.2 t -121.0 123.58 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 73.03 111.137 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.726 HD12 ' CE2' ' A' ' 287' ' ' TRP . 0.4 OUTLIER -125.16 111.01 14.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 53.04 110.913 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.615 ' CD1' HD13 ' B' ' 241' ' ' LEU . 31.0 mm -109.96 104.3 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 62.52 111.119 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.74 -163.48 29.67 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.765 -0.731 . . . . 74.14 112.508 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -114.36 156.36 24.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 72.04 110.843 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.725 ' HG2' HG12 ' B' ' 244' ' ' VAL . 8.9 pt-20 -129.23 129.24 44.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.114 -0.494 . . . . 63.34 110.88 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.566 ' CZ ' HG11 ' B' ' 245' ' ' VAL . 0.3 OUTLIER -123.8 128.97 50.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 72.01 110.907 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 151.34 -169.19 30.94 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.808 -0.71 . . . . 74.14 112.494 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' B' ' 247' ' ' ALA . . . -78.72 -173.84 43.66 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.681 -0.771 . . . . 75.12 112.513 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.3 -75.55 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 61.44 110.927 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 286' ' ' PHE . . . 100.58 175.81 29.77 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.689 -0.767 . . . . 74.42 112.489 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.41 ' HB3' ' O ' ' A' ' 285' ' ' GLY . 9.9 t80 64.01 -81.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 75.42 110.883 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.726 ' CE2' HD12 ' A' ' 276' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.084 -0.507 . . . . 75.12 110.976 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.731 ' O ' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.827 0.346 . . . . 61.21 110.849 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.807 ' HB3' HG22 ' B' ' 277' ' ' ILE . 0.9 OUTLIER -86.57 140.17 30.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 73.11 110.942 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 41.4 m -134.05 140.49 46.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 70.42 110.911 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 264' ' ' VAL . . . -122.71 119.33 30.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 64.11 111.07 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 0.5 OUTLIER -67.93 -44.99 75.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 75.42 110.872 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -156.7 137.53 13.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.53 110.806 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.743 HD11 HG23 ' A' ' 264' ' ' VAL . 0.1 OUTLIER -138.34 117.34 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 71.14 111.16 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -120.1 123.82 44.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 74.01 110.921 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 17.1 p -136.17 140.8 43.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 75.1 111.135 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -121.7 166.93 13.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.167 -0.469 . . . . 63.33 110.809 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.58 -165.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 54.03 110.894 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -73.5 69.84 1.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 72.2 110.892 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 156.4 17.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 41.12 111.077 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.83 135.48 50.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 62.41 110.844 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.645 HG12 ' HB ' ' B' ' 275' ' ' VAL . 19.0 m -126.45 136.08 61.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.41 111.099 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -134.78 126.4 28.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 71.12 110.867 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.615 HD13 ' CD1' ' A' ' 277' ' ' ILE . 3.4 mp -118.46 119.01 33.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 63.04 110.863 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.83 -174.95 21.82 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.727 -0.749 . . . . 75.14 112.471 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -93.53 141.13 28.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 74.31 110.87 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.725 HG12 ' HG2' ' A' ' 280' ' ' GLU . 18.0 m -118.33 122.44 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 72.01 111.125 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.566 HG11 ' CZ ' ' A' ' 281' ' ' TYR . 21.3 t -116.54 127.59 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 64.21 111.142 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 57.6 p -87.2 172.79 9.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 74.34 111.131 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.46 ' HB2' ' HA2' ' A' ' 283' ' ' GLY . . . -63.07 -43.1 99.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 63.34 111.129 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -42.68 80.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 63.1 111.16 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.632 ' HB2' ' HA3' ' B' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 65.43 111.091 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.862 0.363 . . . . 74.13 110.947 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . 0.484 HG21 ' HB2' ' C' ' 243' ' ' ASN . 6.0 m -99.88 121.78 41.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 62.33 111.128 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.731 HG23 ' O ' ' B' ' 225' ' ' ARG . 96.9 m -105.02 130.4 53.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 63.33 111.213 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.43 147.29 48.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 61.3 110.847 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 28.2 t -142.08 123.45 14.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.44 110.909 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.655 HG21 HG22 ' B' ' 267' ' ' VAL . 11.8 p -109.36 143.53 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 72.23 111.128 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.418 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 4.0 mt-10 -84.58 -75.32 0.35 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 75.14 110.865 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 18.5 p -125.12 127.87 47.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 73.1 111.166 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.655 HG22 HG21 ' B' ' 264' ' ' VAL . 21.2 t -118.27 120.99 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 74.22 111.088 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.8 123.68 70.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 55.33 111.14 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -131.38 133.47 7.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.699 -0.762 . . . . 73.01 112.454 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.28 147.21 31.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 72.11 110.809 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.26 -162.43 32.52 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.751 -0.737 . . . . 65.03 112.565 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -69.56 83.17 0.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 74.55 110.899 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 32.1 t -104.63 164.58 11.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 72.21 110.836 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -124.14 128.72 49.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 75.12 110.839 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.645 ' HB ' HG12 ' B' ' 239' ' ' VAL . 56.6 t -117.94 123.86 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 75.42 111.127 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.661 HD12 ' CE2' ' B' ' 287' ' ' TRP . 0.4 OUTLIER -128.0 111.32 13.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 74.42 110.952 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.807 HG22 ' HB3' ' B' ' 226' ' ' ASN . 12.7 mm -112.76 103.8 16.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 52.55 111.087 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.26 -154.03 25.24 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.777 -0.725 . . . . 63.34 112.514 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -125.31 149.63 47.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.734 0.302 . . . . 63.3 110.899 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -113.95 136.32 53.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 44.04 110.824 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -130.04 127.31 39.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 74.44 110.955 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.632 ' HA3' ' HB2' ' B' ' 249' ' ' ALA . . . 91.36 172.55 43.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 61.51 112.484 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . 0.528 ' N ' ' HB2' ' C' ' 247' ' ' ALA . . . 80.11 125.99 0.6 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.808 -0.71 . . . . 45.31 112.521 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -75.88 68.2 2.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.861 0.363 . . . . 73.23 110.954 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -174.96 -153.12 9.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.705 -0.76 . . . . 53.51 112.49 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -122.0 -33.8 3.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.834 0.35 . . . . 63.41 110.86 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.661 ' CE2' HD12 ' B' ' 276' ' ' LEU . 1.4 t90 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 65.5 110.906 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.718 0.295 . . . . 64.42 110.906 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.454 ' HB3' HG22 ' C' ' 277' ' ' ILE . 0.1 OUTLIER -101.43 144.15 30.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 62.34 110.889 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.14 137.99 44.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 65.22 110.832 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.681 ' CB ' HD11 ' C' ' 231' ' ' ILE . . . -116.86 119.91 36.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.055 -0.521 . . . . 54.43 111.124 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -72.72 -42.92 63.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 70.1 110.926 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -158.23 136.58 10.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 72.3 110.805 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.681 HD11 ' CB ' ' C' ' 228' ' ' ALA . 1.7 mt -140.01 116.39 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 75.04 111.077 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 16.0 ttp85 -125.63 125.63 43.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 70.32 110.879 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 21.2 p -136.32 146.3 46.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 51.3 111.099 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -121.21 166.1 14.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 60.23 110.88 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.46 -162.5 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 73.02 110.858 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -72.85 70.83 1.01 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.838 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.25 157.22 17.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 72.32 111.058 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -125.59 149.16 48.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 63.44 110.901 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.591 HG12 ' HB ' ' C' ' 275' ' ' VAL . 12.9 m -141.58 137.84 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 71.22 111.138 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -136.65 132.16 34.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 75.35 110.922 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.645 HD13 ' HB ' ' C' ' 277' ' ' ILE . 1.6 mm? -117.89 117.91 30.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 72.51 110.957 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.44 -177.5 17.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.727 -0.749 . . . . 71.12 112.473 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.484 ' HB2' HG21 ' B' ' 260' ' ' THR . 11.5 t30 -85.76 140.89 30.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 74.24 110.817 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.29 115.85 50.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 55.03 111.139 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.412 HG22 ' HB2' ' C' ' 281' ' ' TYR . 21.4 t -113.66 123.07 68.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 72.41 111.137 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 13.2 t -79.95 175.1 10.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 74.11 111.202 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.528 ' HB2' ' N ' ' B' ' 283' ' ' GLY . . . -62.15 -40.91 97.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 74.52 111.12 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.68 -52.03 66.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 35.54 111.094 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 75.31 111.072 179.953 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.871 0.367 . . . . 74.21 110.945 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . 0.513 HG21 ' CB ' ' D' ' 243' ' ' ASN . 38.1 p -99.09 137.88 36.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 74.44 111.205 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.7 t -134.13 133.75 41.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 75.24 111.135 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.13 147.7 49.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 61.25 110.898 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.17 123.21 13.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 74.3 110.878 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.645 HG21 HG22 ' C' ' 267' ' ' VAL . 9.0 p -105.52 153.56 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 71.23 111.156 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -97.45 -49.34 4.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 74.42 110.857 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.74 127.96 14.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 73.44 111.157 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.645 HG22 HG21 ' C' ' 264' ' ' VAL . 29.1 t -125.0 120.95 59.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 73.43 111.184 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 52.1 t -126.51 134.86 65.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 73.34 111.156 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.65 133.41 6.39 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.789 -0.719 . . . . 71.23 112.489 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.17 147.38 28.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 73.2 110.863 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 61.93 -152.64 42.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.728 -0.749 . . . . 54.0 112.507 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -73.64 73.78 1.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.359 . . . . 73.23 110.865 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 58.8 m -97.68 157.8 15.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 42.45 110.847 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -119.56 132.72 55.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 64.34 110.82 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.591 ' HB ' HG12 ' C' ' 239' ' ' VAL . 78.7 t -115.32 122.26 68.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 62.25 111.172 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.57 HD23 ' HZ2' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -125.14 111.66 15.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 71.34 110.899 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.645 ' HB ' HD13 ' C' ' 241' ' ' LEU . 20.1 mm -112.63 104.15 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 71.2 111.12 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.58 -159.16 26.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.741 . . . . 70.13 112.459 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.48 156.22 24.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 72.13 110.901 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -113.94 144.61 42.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 74.01 110.848 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.412 ' HB2' HG22 ' C' ' 245' ' ' VAL . 2.6 m-85 -130.14 125.61 35.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 75.12 110.907 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 67.06 150.69 0.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 62.01 112.499 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 138.33 150.67 5.67 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.792 -0.718 . . . . 70.32 112.486 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -64.74 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 74.32 110.896 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -100.81 174.9 25.98 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.748 . . . . 51.02 112.515 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -52.02 -30.37 25.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.868 0.366 . . . . 74.11 110.852 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.57 ' HZ2' HD23 ' C' ' 276' ' ' LEU . 2.0 t90 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 74.33 110.836 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . 0.53 ' N ' HG23 ' D' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.849 0.356 . . . . 73.21 110.843 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -83.03 110.01 17.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 71.43 110.907 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 60.5 p -133.22 156.9 46.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 63.41 110.844 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' D' ' 264' ' ' VAL . . . -129.72 146.79 51.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 75.03 111.029 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.56 -39.91 12.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 61.25 110.847 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -165.3 137.26 4.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 74.03 110.854 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . 0.614 HG21 HG11 ' D' ' 275' ' ' VAL . 5.2 mt -139.35 117.19 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 72.42 111.135 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . 0.449 ' CD ' HG22 ' D' ' 268' ' ' VAL . 8.1 ptp180 -119.8 130.26 54.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 74.24 110.859 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . 0.476 HG21 ' CG1' ' D' ' 239' ' ' VAL . 18.6 p -135.9 142.63 44.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 70.22 111.152 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -121.52 163.68 18.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 74.4 110.948 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 63.86 -164.34 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 71.11 110.891 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 38.6 mtt85 -73.77 69.41 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 70.35 110.84 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.15 156.98 17.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 62.21 111.088 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.57 135.69 52.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 63.42 110.851 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.516 HG12 ' HB ' ' D' ' 275' ' ' VAL . 18.0 m -128.53 136.0 61.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 65.33 111.063 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . 0.452 ' HB3' HD22 ' D' ' 276' ' ' LEU . 2.3 tm0? -136.8 127.53 27.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 75.21 110.862 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 1.2 mt -111.86 118.2 34.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 61.25 110.959 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.74 174.35 13.65 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 61.5 112.479 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . 0.513 ' CB ' HG21 ' C' ' 260' ' ' THR . 0.7 OUTLIER -85.54 149.45 25.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 74.42 110.867 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.49 134.42 62.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 64.31 111.166 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . 0.46 HG12 ' HB3' ' D' ' 249' ' ' ALA . 19.5 t -122.55 123.19 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 71.1 111.117 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . 0.689 HG22 ' HA3' ' D' ' 282' ' ' GLY . 5.0 t -73.37 165.0 25.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 55.25 111.159 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.81 92.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 74.25 111.043 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.63 -35.72 68.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 54.05 111.043 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . 0.518 ' HB1' ' CE2' ' D' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 64.3 111.054 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . 0.546 HG21 ' HB3' ' E' ' 243' ' ' ASN . 6.9 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.904 0.383 . . . . 74.03 111.181 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . 0.53 HG23 ' N ' ' D' ' 225' ' ' ARG . 23.9 m -92.0 113.77 26.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 71.01 111.18 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -122.08 151.12 41.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 62.14 110.88 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.72 121.98 13.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 72.4 110.848 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.567 ' HB ' HD22 ' E' ' 241' ' ' LEU . 10.6 p -106.48 142.47 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.072 -0.513 . . . . 75.24 111.132 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -84.06 -79.78 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 72.33 110.831 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 48.9 m -127.44 131.97 50.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 74.32 111.099 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.612 ' HB ' HG23 ' D' ' 231' ' ' ILE . 20.1 t -124.06 120.12 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 60.14 111.16 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . 0.449 HG22 ' CD ' ' D' ' 232' ' ' ARG . 26.6 t -118.25 122.99 70.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 63.52 111.116 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.62 133.19 8.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.655 -0.784 . . . . 42.22 112.476 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.0 147.29 31.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 74.42 110.836 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 60.51 -142.62 48.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 73.21 112.468 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.38 60.28 2.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.827 0.346 . . . . 72.21 110.88 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 12.7 m -83.83 152.83 24.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.901 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.78 132.41 54.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 74.44 110.866 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.614 HG11 HG21 ' D' ' 231' ' ' ILE . 92.5 t -115.71 122.75 70.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 65.21 111.129 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.1 OUTLIER -129.05 115.91 18.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 65.2 110.913 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 30.7 mm -113.15 103.52 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 62.34 111.109 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.96 -163.15 26.68 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 64.52 112.483 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.97 156.83 25.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.72 0.295 . . . . 63.01 110.876 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.9 118.85 34.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 64.41 110.884 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . 0.518 ' CE2' ' HB1' ' D' ' 249' ' ' ALA . 11.0 t80 -103.83 128.64 51.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 65.53 110.93 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . 0.689 ' HA3' HG22 ' D' ' 246' ' ' THR . . . 88.94 145.65 11.88 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 71.42 112.515 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 95.16 84.19 1.65 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 63.2 112.478 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -58.02 98.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.798 0.332 . . . . 52.0 110.873 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -174.73 -102.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.723 -0.751 . . . . 63.52 112.491 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -173.71 -37.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.863 0.363 . . . . 74.22 110.854 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 73.55 110.906 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . 0.593 ' O ' HG22 ' E' ' 261' ' ' THR . 5.1 mmp_? . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.806 0.336 . . . . 72.52 110.854 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.45 138.01 52.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 75.12 110.897 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 73.9 p -140.65 160.88 39.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 71.02 110.843 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . 0.601 ' CB ' HD11 ' E' ' 231' ' ' ILE . . . -126.52 127.95 46.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.501 . . . . 62.54 111.116 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -73.44 -35.44 65.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 61.35 110.922 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.53 137.18 3.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 62.51 110.888 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . 0.601 HD11 ' CB ' ' E' ' 228' ' ' ALA . 9.8 mt -139.67 116.4 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 62.02 111.04 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.6 126.29 48.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 70.14 110.904 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . 0.577 HG21 ' CG1' ' E' ' 239' ' ' VAL . 32.6 p -135.82 139.57 43.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 73.41 111.205 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -120.96 167.08 12.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 73.24 110.851 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 65.17 -162.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 75.21 110.877 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -75.23 61.16 1.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.52 110.85 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.32 156.76 17.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 63.44 111.151 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -129.88 135.65 48.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 71.34 110.884 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.577 ' CG1' HG21 ' E' ' 233' ' ' THR . 20.2 m -122.92 134.89 64.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 74.41 111.189 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -135.81 128.99 31.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 52.13 110.868 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.802 HD12 ' HB ' ' E' ' 277' ' ' ILE . 9.9 tp -111.38 118.0 34.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 73.3 110.949 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.31 171.91 12.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 43.34 112.446 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . 0.546 ' HB3' HG21 ' D' ' 260' ' ' THR . 0.0 OUTLIER -85.91 163.05 18.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 74.02 110.881 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.99 134.06 60.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 70.21 111.142 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 7.2 t -122.08 121.18 63.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 64.41 111.105 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 12.9 t -69.47 173.45 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 62.44 111.171 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.91 89.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 60.31 111.087 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.72 -36.38 69.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 65.34 111.063 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . 0.453 ' HB2' ' HE1' ' D' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 51.42 111.098 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . 0.593 HG22 ' O ' ' E' ' 225' ' ' ARG . 1.3 p . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.764 0.316 . . . . 73.4 111.165 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.01 119.93 28.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 63.11 110.908 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.73 122.86 40.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 73.34 110.807 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' E' ' 228' ' ' ALA . 0.3 OUTLIER -105.19 145.5 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.21 111.099 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' E' ' 229' ' ' LYS . 2.5 mt-10 -80.59 -76.61 0.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.885 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.38 126.67 17.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 75.21 111.165 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.32 120.59 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 72.13 111.132 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 23.4 t -119.69 115.07 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 74.33 111.155 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.02 133.97 11.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.782 -0.723 . . . . 52.44 112.442 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.73 131.45 52.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 65.31 110.871 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.44 -149.65 30.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 73.33 112.484 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -74.97 68.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 72.55 110.894 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 10.3 t -94.01 162.39 13.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 72.24 110.918 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.53 136.0 47.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 71.31 110.852 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.574 ' CG2' HG12 ' E' ' 239' ' ' VAL . 90.8 t -115.57 124.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 45.32 111.135 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.66 117.99 21.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 52.15 110.96 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.802 ' HB ' HD12 ' E' ' 241' ' ' LEU . 24.7 mm -113.47 102.19 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 73.33 111.15 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 131.85 178.89 15.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.789 -0.719 . . . . 51.42 112.509 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -95.69 156.9 16.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 63.51 110.872 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.57 138.68 54.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 74.34 110.869 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -124.8 124.52 42.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.492 . . . . 72.13 110.88 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 C-N-CA 120.796 -0.716 . . . . 55.12 112.563 179.96 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.439 ' HB3' HG23 ' A' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.816 0.341 . . . . 74.33 110.911 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.433 ' HB2' HG22 ' A' ' 277' ' ' ILE . 3.3 p30 -142.07 120.94 12.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 72.43 110.911 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 76.7 p -121.96 151.65 40.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 73.21 110.876 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.63 119.38 16.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 74.35 111.116 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -67.51 -51.64 48.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 71.44 110.875 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.78 135.47 4.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.276 -0.42 . . . . 73.22 110.834 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 6.4 pt -140.12 134.05 35.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 31.03 111.145 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.19 141.64 48.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 72.54 110.926 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.732 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.3 OUTLIER -137.41 152.84 50.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 74.4 111.133 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -138.35 168.62 19.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 52.12 110.887 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.5 -70.7 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 61.05 110.886 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.8 ptt-85 177.88 63.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 72.13 110.857 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.732 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -99.0 157.21 16.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 75.21 111.145 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -126.41 135.32 51.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 64.44 110.913 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.739 HG12 ' HB ' ' A' ' 275' ' ' VAL . 31.2 m -124.43 124.74 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 72.21 111.13 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -114.12 137.49 51.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.877 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 6.0 mp -127.88 118.88 24.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 61.31 110.878 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.07 178.38 15.39 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.794 -0.717 . . . . 61.31 112.557 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -87.97 142.95 27.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 75.42 110.882 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 244' ' ' VAL . 22.3 m -122.2 123.63 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 73.15 111.118 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 281' ' ' TYR . 21.6 t -119.91 129.19 75.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 74.45 111.156 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 73.42 111.16 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . 0.558 HG21 ' HB3' ' A' ' 279' ' ' ASN . 9.9 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.845 0.355 . . . . 60.41 111.143 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.439 HG23 ' HB3' ' A' ' 225' ' ' ARG . 0.2 OUTLIER -119.59 109.75 16.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 75.34 111.154 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -106.21 137.89 43.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 75.03 110.874 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 14.7 m -135.71 123.26 22.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 63.04 110.871 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.672 HG21 HD12 ' A' ' 277' ' ' ILE . 50.8 t -115.54 115.87 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 54.25 111.118 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -75.17 -75.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.021 0.439 . . . . 73.53 110.903 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.41 126.78 45.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 73.42 111.166 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.599 HG22 HD11 ' B' ' 231' ' ' ILE . 1.6 t -117.47 132.56 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 45.12 111.154 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 72.1 t -127.08 114.97 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 65.24 111.126 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.04 131.71 10.69 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.81 -0.71 . . . . 32.52 112.448 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.81 139.94 47.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.866 0.365 . . . . 63.54 110.924 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 47.71 79.5 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.669 -0.777 . . . . 75.34 112.554 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 49.3 77.66 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 73.34 110.86 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.421 ' H ' ' HB2' ' A' ' 237' ' ' ALA . 0.6 OUTLIER -98.08 145.26 26.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 72.33 110.853 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -111.06 127.41 55.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 75.12 110.906 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.739 ' HB ' HG12 ' A' ' 239' ' ' VAL . 73.0 t -131.06 122.58 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 74.43 111.133 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.685 HD12 ' CD2' ' A' ' 287' ' ' TRP . 0.5 OUTLIER -121.92 111.84 17.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 64.04 110.853 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.672 HD12 HG21 ' A' ' 264' ' ' VAL . 25.9 mm -110.24 103.94 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 72.44 111.144 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 142.61 -169.53 25.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.725 -0.75 . . . . 45.32 112.481 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.558 ' HB3' HG21 ' A' ' 260' ' ' THR . 2.5 p30 -112.59 155.95 23.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.78 0.324 . . . . 71.53 110.851 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.553 ' HG2' HG12 ' B' ' 244' ' ' VAL . 0.3 OUTLIER -121.04 141.3 50.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.43 110.842 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.447 ' HB2' HG22 ' A' ' 245' ' ' VAL . 2.3 m-85 -125.61 133.35 52.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 63.42 110.92 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 109.3 149.89 13.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.69 -0.767 . . . . 32.45 112.475 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.599 ' H ' ' HB2' ' B' ' 247' ' ' ALA . . . -68.15 -127.83 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 61.31 112.468 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.28 25.67 14.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.801 0.334 . . . . 53.42 110.875 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.4 133.41 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.685 -0.769 . . . . 41.55 112.523 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -52.44 131.48 33.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.783 0.325 . . . . 55.35 110.853 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.685 ' CD2' HD12 ' A' ' 276' ' ' LEU . 2.0 t90 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.88 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 16.3 ttt-85 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.856 0.36 . . . . 71.33 110.842 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.585 ' HB2' HG22 ' B' ' 277' ' ' ILE . 2.6 p-10 -121.68 129.67 52.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.24 110.886 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.2 p -124.04 145.19 49.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 63.45 110.868 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.19 119.71 23.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 74.22 111.073 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.73 -46.11 76.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 60.45 110.867 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -166.1 137.1 3.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 75.04 110.849 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.599 HD11 HG22 ' A' ' 267' ' ' VAL . 6.4 pt -140.08 132.88 34.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 73.43 111.16 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -135.33 138.43 43.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 55.11 110.883 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.755 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.5 OUTLIER -136.47 151.92 50.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.236 -0.438 . . . . 71.32 111.153 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -141.96 167.59 21.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.423 . . . . 71.33 110.908 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 72.81 -71.2 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.882 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -178.68 67.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 75.3 110.867 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.755 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -105.45 156.42 18.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 65.3 111.084 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -130.38 135.19 47.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 63.54 110.885 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.759 HG12 ' HB ' ' B' ' 275' ' ' VAL . 25.3 m -126.68 130.2 71.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 73.53 111.112 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.449 ' HB3' HD22 ' B' ' 276' ' ' LEU . 2.1 tt0 -119.07 119.89 35.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 75.52 110.942 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.82 118.57 35.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 71.12 110.945 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.07 175.09 13.81 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 61.44 112.462 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -85.99 136.2 33.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.894 0.378 . . . . 63.12 110.847 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.553 HG12 ' HG2' ' A' ' 280' ' ' GLU . 18.2 m -118.51 121.63 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 42.41 111.11 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.463 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 41.0 t -119.52 129.06 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 42.52 111.124 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.423 HG23 ' H ' ' B' ' 249' ' ' ALA . 12.3 t -83.32 175.19 10.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 63.42 111.164 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.599 ' HB2' ' H ' ' A' ' 283' ' ' GLY . . . -63.0 -42.09 99.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 70.44 111.047 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.85 77.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 71.12 111.126 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.463 ' HB3' ' CG1' ' B' ' 245' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 44.1 111.052 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.827 0.346 . . . . 74.52 110.851 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 8.7 t -66.17 126.18 27.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 73.2 111.13 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 94.2 m -131.84 108.98 9.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 71.23 111.144 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -108.96 136.56 48.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.85 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.84 123.76 21.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.483 . . . . 62.41 110.87 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.964 HG21 HD12 ' B' ' 277' ' ' ILE . 70.5 t -110.34 118.53 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 70.23 111.108 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -67.8 -75.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 73.41 110.884 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 24.7 p -129.56 133.69 47.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 73.3 111.229 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.755 HG23 HG11 ' B' ' 264' ' ' VAL . 2.9 t -118.37 129.37 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 70.23 111.164 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . 0.43 ' O ' HG12 ' B' ' 268' ' ' VAL . 2.2 t -127.36 114.79 37.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 61.41 111.099 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.78 132.42 10.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.678 -0.772 . . . . 51.54 112.45 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -132.09 143.25 49.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 72.54 110.934 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 42.98 69.11 0.67 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 33.32 112.429 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 63.57 101.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.836 0.35 . . . . 71.31 110.911 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 3.6 t -130.33 145.77 51.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 54.45 110.898 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -117.28 127.85 54.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 74.42 110.858 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.759 ' HB ' HG12 ' B' ' 239' ' ' VAL . 85.8 t -130.48 123.65 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 75.24 111.165 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.606 HD23 ' CZ2' ' B' ' 287' ' ' TRP . 0.3 OUTLIER -114.49 112.13 22.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 73.3 110.936 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.964 HD12 HG21 ' B' ' 264' ' ' VAL . 14.4 mm -108.47 104.94 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 74.34 111.108 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 135.7 -157.89 23.51 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.774 -0.727 . . . . 35.41 112.527 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.5 156.04 27.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 74.43 110.878 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.551 ' HG2' HG12 ' C' ' 244' ' ' VAL . 15.2 pt-20 -129.39 141.8 50.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 74.11 110.881 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -129.98 125.73 36.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 74.34 110.888 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 152.35 156.14 7.37 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.685 -0.769 . . . . 64.4 112.474 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . 0.469 ' N ' ' HB2' ' C' ' 247' ' ' ALA . . . -96.11 -53.19 1.52 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 72.43 112.521 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -52.08 103.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 73.53 110.833 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.52 116.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.751 -0.737 . . . . 22.52 112.457 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' C' ' 244' ' ' VAL . 5.0 t80 -52.1 -33.44 39.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.347 . . . . 75.21 110.903 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.606 ' CZ2' HD23 ' B' ' 276' ' ' LEU . 15.9 t90 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 75.01 110.962 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.039 0 CA-C-O 120.884 0.373 . . . . 73.53 110.85 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.05 120.63 41.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 75.14 110.864 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 3.3 t -129.67 138.69 51.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 71.02 110.894 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -119.04 131.98 56.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 73.21 111.133 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -33.05 34.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 70.12 110.901 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -166.01 138.0 3.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 72.33 110.864 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -138.69 117.31 13.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 73.54 111.143 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -131.82 130.23 41.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 63.35 110.898 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 0.2 OUTLIER -136.25 155.44 50.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 72.43 111.144 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -144.35 168.06 20.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 72.22 110.885 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.78 -72.23 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 73.31 110.856 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -177.99 64.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 75.55 110.85 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.607 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -105.69 156.46 18.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 35.3 111.087 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -128.79 135.25 48.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 71.23 110.892 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.828 HG12 ' HB ' ' C' ' 275' ' ' VAL . 20.9 m -126.14 121.6 59.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.469 . . . . 62.33 111.117 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.611 ' HB3' HD22 ' C' ' 276' ' ' LEU . 1.8 tt0 -115.63 120.65 40.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 54.11 110.913 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.74 HD22 HG22 ' B' ' 264' ' ' VAL . 3.3 mp -114.96 118.72 34.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 72.44 110.935 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.48 178.23 15.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 74.34 112.503 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -85.65 128.52 34.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.857 0.36 . . . . 71.02 110.891 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.551 HG12 ' HG2' ' B' ' 280' ' ' GLU . 28.5 m -114.07 128.4 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 75.21 111.136 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 46.8 t -122.17 129.02 75.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 73.21 111.086 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -77.5 174.27 11.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 74.41 111.126 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.469 ' HB2' ' N ' ' B' ' 283' ' ' GLY . . . -57.04 -41.03 77.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 73.53 111.045 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' C' ' 249' ' ' ALA . . . -57.1 -51.91 67.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 44.04 111.044 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' C' ' 248' ' ' ALA . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 62.22 111.088 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.973 0.416 . . . . 75.04 110.925 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . 0.794 HG21 ' HB3' ' C' ' 279' ' ' ASN . 4.9 t -100.94 130.01 46.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 71.22 111.125 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 18.7 m -126.58 118.96 25.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.261 -0.427 . . . . 74.42 111.121 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . 0.602 ' OD1' HG23 ' C' ' 277' ' ' ILE . 6.7 t-20 -120.63 144.63 48.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 62.11 110.866 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 9.4 t -141.62 123.85 15.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 71.53 110.905 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.796 HG21 HD12 ' C' ' 277' ' ' ILE . 46.2 t -108.07 145.86 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 64.12 111.205 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.92 -55.69 3.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 74.32 110.84 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.46 128.51 11.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 73.35 111.165 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.761 HG23 HG11 ' C' ' 264' ' ' VAL . 54.4 t -118.75 120.42 64.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 72.02 111.106 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.14 118.06 47.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 74.33 111.16 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.9 133.23 10.1 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.715 -0.755 . . . . 35.45 112.502 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -125.44 147.75 49.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 74.23 110.869 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 47.2 67.85 1.35 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.812 -0.709 . . . . 43.24 112.474 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 64.14 107.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.883 0.373 . . . . 72.24 110.899 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 3.3 m -139.8 150.16 44.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 73.2 110.865 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -124.72 128.24 48.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.831 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.828 ' HB ' HG12 ' C' ' 239' ' ' VAL . 89.8 t -132.28 123.34 50.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 75.25 111.134 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.2 OUTLIER -116.98 117.14 28.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 70.34 110.921 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.796 HD12 HG21 ' C' ' 264' ' ' VAL . 24.9 mm -110.63 104.24 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 74.01 111.134 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.03 -162.74 25.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.743 . . . . 55.43 112.491 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . 0.794 ' HB3' HG21 ' C' ' 260' ' ' THR . 8.1 p-10 -106.66 155.97 19.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.787 0.327 . . . . 72.33 110.897 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.642 ' HG3' HG12 ' D' ' 244' ' ' VAL . 2.7 pp20? -131.22 150.15 52.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 71.32 110.852 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -130.05 126.03 36.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 52.11 110.905 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 145.75 141.97 3.73 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.745 -0.741 . . . . 73.21 112.499 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -112.2 -169.5 18.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.732 . . . . 44.23 112.463 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 7.8 tttt 53.89 29.44 9.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 73.25 110.879 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -179.11 -35.26 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.683 -0.77 . . . . 72.34 112.415 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.448 ' CE1' HG21 ' D' ' 244' ' ' VAL . 5.4 t80 71.9 -69.25 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.898 0.38 . . . . 75.22 110.912 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 15.9 t90 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 74.53 110.87 179.993 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.882 0.372 . . . . 72.15 110.879 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . 0.637 ' HB3' HG22 ' D' ' 277' ' ' ILE . 0.1 OUTLIER -89.44 111.98 23.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 73.32 110.887 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.77 137.58 54.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 62.23 110.786 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.09 155.94 37.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.114 -0.493 . . . . 75.21 111.094 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.88 -29.8 8.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 75.01 110.895 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . 0.46 ' HB3' HG23 ' D' ' 266' ' ' THR . 0.3 OUTLIER -165.49 138.31 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 63.32 110.884 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 2.4 mt -138.91 117.28 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.144 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . 0.457 ' HD2' HG23 ' D' ' 268' ' ' VAL . 0.8 OUTLIER -131.64 131.23 43.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.14 110.936 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' D' ' 237' ' ' ALA . 0.2 OUTLIER -136.28 155.9 49.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 70.41 111.086 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -148.28 166.91 26.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 72.44 110.876 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.9 -71.99 0.12 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.104 -0.498 . . . . 73.02 110.861 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -177.0 63.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 74.05 110.845 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -104.76 154.51 19.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 62.45 111.158 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -130.01 134.98 47.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 71.53 110.93 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.782 HG12 ' HB ' ' D' ' 275' ' ' VAL . 21.6 m -127.89 121.19 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 70.31 111.154 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -121.31 128.58 52.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 74.32 110.964 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 mp -120.66 118.79 31.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 65.53 110.917 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 143.14 179.0 19.48 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.752 -0.737 . . . . 73.52 112.474 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -85.83 129.11 34.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.919 0.39 . . . . 71.33 110.864 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . 0.642 HG12 ' HG3' ' C' ' 280' ' ' GLU . 35.1 m -111.39 129.52 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 64.15 111.138 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.31 129.03 75.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 61.02 111.138 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 21.5 p -77.6 174.84 10.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 63.34 111.138 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.1 85.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 74.33 111.144 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' D' ' 249' ' ' ALA . . . -57.03 -52.01 66.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 70.13 111.136 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' D' ' 248' ' ' ALA . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 74.11 111.105 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.869 0.366 . . . . 72.21 111.151 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 3.1 m -134.53 126.77 30.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 72.31 111.192 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . 0.525 ' ND2' HG23 ' D' ' 277' ' ' ILE . 3.1 t30 -126.08 139.61 53.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.295 -0.411 . . . . 74.01 110.955 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 7.9 t -142.09 123.81 15.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 74.43 110.844 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.721 HG21 HD12 ' D' ' 277' ' ' ILE . 21.7 t -114.34 149.61 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 70.3 111.172 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.84 -77.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 72.44 110.939 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . 0.46 HG23 ' HB3' ' D' ' 230' ' ' ASP . 1.5 m -127.71 127.83 44.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 63.14 111.108 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.568 ' CG2' HG11 ' D' ' 264' ' ' VAL . 98.2 t -118.69 120.41 64.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 75.02 111.122 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . 0.457 HG23 ' HD2' ' D' ' 232' ' ' ARG . 4.7 p -126.53 117.81 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 74.44 111.102 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.72 132.65 10.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 44.24 112.427 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -126.02 147.13 49.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 73.12 110.84 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 44.86 76.75 0.11 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.769 -0.729 . . . . 65.55 112.475 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.74 98.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.802 0.334 . . . . 70.23 110.899 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 4.1 t -130.18 145.33 51.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 53.52 110.908 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -123.97 127.97 48.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 60.24 110.849 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.782 ' HB ' HG12 ' D' ' 239' ' ' VAL . 94.3 t -135.56 123.38 37.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 73.32 111.106 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.438 HD13 ' N ' ' D' ' 277' ' ' ILE . 1.1 tm? -121.72 119.57 32.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 73.51 110.893 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.721 HD12 HG21 ' D' ' 264' ' ' VAL . 27.5 mm -112.29 104.24 16.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 71.34 111.165 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.3 -159.07 27.44 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.75 -0.738 . . . . 52.01 112.52 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -115.92 156.12 26.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.77 0.319 . . . . 64.4 110.917 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . 0.506 ' HG2' HG13 ' E' ' 244' ' ' VAL . 10.4 pt-20 -126.03 134.92 51.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 74.13 110.803 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . 0.468 ' CZ ' HG21 ' E' ' 245' ' ' VAL . 7.5 m-85 -120.32 125.94 49.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 72.21 110.958 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.01 158.36 7.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.79 -0.719 . . . . 60.13 112.544 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . 0.575 ' N ' ' HB2' ' E' ' 247' ' ' ALA . . . -104.57 63.93 0.34 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 62.1 112.416 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.94 32.91 1.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.8 0.333 . . . . 73.11 110.876 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 78.98 -67.82 3.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 35.44 112.459 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -178.81 108.75 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 71.05 110.852 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 74.0 110.921 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . 0.501 ' N ' HG23 ' E' ' 261' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.824 0.345 . . . . 51.11 110.874 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -83.8 109.92 17.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 72.51 110.857 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.43 139.85 45.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.2 110.824 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.38 162.06 26.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 75.44 111.151 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.05 -26.87 7.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 61.13 110.887 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . 0.439 ' HB3' HG23 ' E' ' 266' ' ' THR . 0.4 OUTLIER -164.82 138.62 4.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.43 . . . . 75.12 110.841 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . 0.409 HD11 HG13 ' D' ' 264' ' ' VAL . 5.0 mt -138.55 117.35 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 73.43 111.127 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.32 131.23 39.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 72.13 110.791 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.29 157.81 45.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 50.41 111.128 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -150.29 167.55 26.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 62.51 110.933 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 72.09 -73.35 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 74.51 110.846 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -178.29 62.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 70.03 110.85 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.34 156.45 17.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 61.32 111.196 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.19 135.15 47.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 73.11 110.856 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.795 HG12 ' HB ' ' E' ' 275' ' ' VAL . 18.0 m -122.74 121.84 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 72.32 111.143 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . 0.625 ' O ' HD23 ' E' ' 276' ' ' LEU . 2.0 tt0 -119.59 114.41 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.23 110.921 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.481 HD13 ' CD1' ' D' ' 277' ' ' ILE . 3.3 mp -114.84 135.09 54.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 61.51 110.976 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.06 -120.18 2.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.718 -0.754 . . . . 62.21 112.508 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -144.0 128.85 18.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.884 0.373 . . . . 71.43 110.851 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.506 HG13 ' HG2' ' D' ' 280' ' ' GLU . 0.4 OUTLIER -102.86 119.6 51.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 74.35 111.16 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . 0.468 HG21 ' CZ ' ' D' ' 281' ' ' TYR . 41.2 t -122.05 123.52 69.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 72.2 111.138 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.1 t -74.43 174.88 8.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 61.34 111.133 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . 0.575 ' HB2' ' N ' ' D' ' 283' ' ' GLY . . . -53.22 -45.64 68.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 75.44 111.099 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.92 -49.8 74.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 71.53 111.132 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 44.4 111.073 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . 0.501 HG23 ' N ' ' E' ' 225' ' ' ARG . 34.9 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.821 0.343 . . . . 63.34 111.129 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . 0.638 ' ND2' HG23 ' E' ' 277' ' ' ILE . 0.8 OUTLIER -126.12 123.45 38.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 71.32 110.858 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 43.2 t -127.18 123.81 37.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 60.14 110.878 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . 0.566 HG21 HD12 ' E' ' 277' ' ' ILE . 21.2 t -124.32 150.34 28.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 55.05 111.102 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.01 -77.5 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 72.04 110.865 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . 0.439 HG23 ' HB3' ' E' ' 230' ' ' ASP . 9.4 m -126.37 127.83 46.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 64.22 111.162 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . 0.544 ' CG2' HG11 ' E' ' 264' ' ' VAL . 22.0 t -119.08 120.16 63.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 63.4 111.156 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . 0.417 ' O ' HG13 ' E' ' 268' ' ' VAL . 4.1 p -123.78 118.18 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 73.34 111.154 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.28 136.18 13.39 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.756 -0.735 . . . . 74.23 112.399 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -132.58 133.54 43.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.756 0.313 . . . . 74.24 110.897 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.81 93.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 53.25 112.522 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 44.1 69.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 70.22 110.826 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.34 145.25 26.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 62.13 110.817 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -127.24 128.19 45.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 73.32 110.872 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.795 ' HB ' HG12 ' E' ' 239' ' ' VAL . 84.2 t -136.85 123.92 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 74.32 111.134 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . 0.625 HD23 ' O ' ' E' ' 240' ' ' GLN . 0.5 OUTLIER -125.64 122.55 36.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 70.52 110.899 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.638 HG23 ' ND2' ' E' ' 262' ' ' ASN . 30.4 mm -112.0 104.53 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 74.4 111.169 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 135.07 -169.84 23.14 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.755 . . . . 74.53 112.518 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -99.82 155.96 17.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 71.43 110.897 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -130.6 132.03 45.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.491 . . . . 50.22 110.856 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -113.8 125.9 54.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 73.42 110.874 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.742 -0.742 . . . . 73.32 112.485 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.651 ' HG3' HG23 ' A' ' 261' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.867 0.365 . . . . 74.42 110.879 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.27 130.35 26.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 62.35 110.876 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 48.4 t -121.81 137.69 54.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.478 . . . . 74.1 110.843 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.62 128.18 34.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 64.23 111.111 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.67 -37.14 13.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.938 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.535 ' HB3' HG23 ' A' ' 266' ' ' THR . 0.7 OUTLIER -164.38 138.9 5.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 63.51 110.878 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.485 HG21 HG21 ' A' ' 239' ' ' VAL . 7.7 mt -137.25 117.53 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 63.5 111.116 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -124.98 117.04 23.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 75.42 110.839 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.31 131.2 36.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 45.13 111.123 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -132.95 164.9 25.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 51.14 110.906 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 236' ' ' ARG . 2.7 tt0 65.0 79.53 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 72.43 110.897 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 235' ' ' GLU . 16.9 ptt180 35.29 60.46 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 74.52 110.918 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.29 152.75 21.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 44.42 111.136 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -129.28 142.52 50.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 74.35 110.831 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.485 HG21 HG21 ' A' ' 231' ' ' ILE . 6.1 p -143.02 121.65 7.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 63.43 111.124 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -108.84 137.46 46.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 72.5 110.98 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.58 118.65 22.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 64.33 110.891 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.37 -172.61 20.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.708 -0.758 . . . . 75.12 112.504 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -92.24 139.19 30.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.909 0.385 . . . . 74.54 110.909 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.02 129.7 65.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 75.54 111.21 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 89.5 t -122.07 127.28 75.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 72.11 111.127 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 281' ' ' TYR . 53.6 p . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 71.11 111.155 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . 0.567 HG23 ' N ' ' B' ' 225' ' ' ARG . 99.6 m . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.819 0.342 . . . . 52.21 111.132 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.651 HG23 ' HG3' ' A' ' 225' ' ' ARG . 98.4 m -112.91 111.74 22.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 73.5 111.159 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -111.48 150.3 30.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 44.41 110.805 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.4 t -138.31 123.97 19.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 53.24 110.951 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.513 HG21 ' CG2' ' A' ' 267' ' ' VAL . 9.7 p -108.81 135.77 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.45 111.135 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.32 -75.96 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 53.15 110.952 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.535 HG23 ' HB3' ' A' ' 230' ' ' ASP . 1.6 m -130.14 131.98 45.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 73.42 111.153 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.513 ' CG2' HG21 ' A' ' 264' ' ' VAL . 96.7 t -117.89 131.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 55.24 111.147 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 58.6 t -127.55 128.03 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 71.33 111.117 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.98 133.62 7.87 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.735 -0.745 . . . . 42.13 112.515 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -132.8 147.77 52.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.793 0.33 . . . . 65.44 110.877 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.28 78.17 0.11 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.761 -0.733 . . . . 63.0 112.459 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 47.59 64.58 1.55 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.882 0.372 . . . . 71.23 110.941 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 26.3 t -92.93 145.65 24.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 62.43 110.873 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -126.39 128.31 46.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 70.54 110.929 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.693 HG13 HG13 ' B' ' 239' ' ' VAL . 20.6 t -128.92 123.59 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 62.44 111.137 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.425 HD23 ' CZ2' ' A' ' 287' ' ' TRP . 0.2 OUTLIER -111.07 117.24 32.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 64.34 110.917 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.15 112.41 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 71.05 111.152 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 133.01 -164.91 24.11 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 52.2 112.443 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -103.8 152.61 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 62.42 110.84 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.537 ' HG3' HG12 ' B' ' 244' ' ' VAL . 1.4 pp20? -131.49 134.51 46.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 73.24 110.968 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.457 ' O ' HG23 ' A' ' 246' ' ' THR . 0.2 OUTLIER -112.4 125.94 54.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 73.45 110.915 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.84 135.8 3.17 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.717 -0.754 . . . . 71.42 112.521 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -111.22 177.11 18.94 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.691 -0.766 . . . . 73.53 112.441 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt 52.0 53.4 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 55.11 110.871 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 177.56 -69.02 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.822 -0.704 . . . . 40.25 112.521 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 2.1 t80 64.34 109.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 75.32 110.823 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.425 ' CZ2' HD23 ' A' ' 276' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 62.41 110.875 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.567 ' N ' HG23 ' A' ' 260' ' ' THR . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.806 0.336 . . . . 74.14 110.922 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.34 123.44 14.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 75.21 110.93 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 1.4 t -121.51 137.71 54.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 64.3 110.86 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.549 ' HB2' HD11 ' B' ' 241' ' ' LEU . . . -127.7 129.16 46.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 72.15 111.082 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.26 -35.28 23.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 72.02 110.953 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . 0.611 ' HB3' HG23 ' B' ' 266' ' ' THR . 0.3 OUTLIER -164.56 138.42 5.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.869 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.736 HG21 HG21 ' B' ' 239' ' ' VAL . 11.2 mt -137.64 117.6 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 63.41 111.059 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -130.64 119.3 22.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 73.03 110.846 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.02 131.41 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 70.51 111.148 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -132.04 167.3 19.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 73.55 110.837 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' B' ' 236' ' ' ARG . 0.1 OUTLIER 64.24 78.43 0.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 71.24 110.868 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' B' ' 235' ' ' GLU . 11.0 ptt180 36.34 54.84 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 73.34 110.931 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -100.61 156.15 17.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 52.03 111.137 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -132.59 136.3 46.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 53.13 110.877 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.736 HG21 HG21 ' B' ' 231' ' ' ILE . 6.2 p -137.24 121.71 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 70.42 111.177 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.495 ' OE1' HD11 ' B' ' 276' ' ' LEU . 0.5 OUTLIER -114.22 137.48 51.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 72.15 110.891 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' B' ' 228' ' ' ALA . 0.3 OUTLIER -128.71 118.6 23.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 74.12 110.897 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.7 176.45 14.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.718 -0.753 . . . . 65.44 112.536 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -85.95 133.48 33.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.882 0.372 . . . . 75.02 110.841 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.537 HG12 ' HG3' ' A' ' 280' ' ' GLU . 33.7 m -116.51 132.18 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 74.33 111.105 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 60.1 t -122.04 120.26 60.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 65.31 111.123 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.505 HG23 ' O ' ' B' ' 281' ' ' TYR . 33.6 p -84.68 163.21 19.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 73.14 111.126 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.47 -36.95 84.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 64.23 111.13 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -62.06 -36.51 81.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 65.53 111.138 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 51.41 111.017 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.895 0.378 . . . . 74.24 110.933 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 49.2 p -101.09 122.55 43.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.438 . . . . 75.14 111.147 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 1.1 t -134.14 108.95 8.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 75.54 111.172 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.544 ' ND2' HG22 ' B' ' 277' ' ' ILE . 11.4 p-10 -95.94 149.52 21.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 60.43 110.897 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 44.6 m -140.22 124.08 17.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 61.12 110.852 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.486 HG21 ' CG2' ' B' ' 267' ' ' VAL . 13.4 p -109.58 131.62 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.48 . . . . 71.41 111.125 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -73.63 -76.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 73.14 110.835 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.611 HG23 ' HB3' ' B' ' 230' ' ' ASP . 1.3 m -131.52 135.38 47.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 71.11 111.118 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.659 ' CG1' HG21 ' B' ' 275' ' ' VAL . 85.5 t -117.67 128.4 74.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 74.22 111.151 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 68.8 t -127.23 119.47 52.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 53.22 111.104 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.3 132.98 9.05 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.743 -0.742 . . . . 64.42 112.461 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.65 147.93 51.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 72.34 110.902 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.44 82.66 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.753 . . . . 55.23 112.478 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 46.3 63.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 75.14 110.849 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 25.7 t -96.78 145.66 25.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 72.42 110.867 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.12 127.99 46.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 65.11 110.859 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.659 HG21 ' CG1' ' B' ' 267' ' ' VAL . 21.6 t -130.85 123.77 55.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 71.24 111.135 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.495 HD11 ' OE1' ' B' ' 240' ' ' GLN . 0.4 OUTLIER -114.86 116.76 29.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 63.12 110.887 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.544 HG22 ' ND2' ' B' ' 262' ' ' ASN . 25.4 mm -110.79 104.18 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.24 111.146 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.49 -176.91 21.54 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.781 -0.723 . . . . 72.43 112.463 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -92.17 147.12 23.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.727 0.299 . . . . 71.41 110.91 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.597 ' HG3' HG12 ' C' ' 244' ' ' VAL . 0.0 OUTLIER -128.45 141.7 51.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 65.51 110.858 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.505 ' O ' HG23 ' B' ' 246' ' ' THR . 0.8 OUTLIER -127.1 125.99 42.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.181 -0.463 . . . . 75.11 110.952 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 168.26 151.22 6.98 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.769 -0.729 . . . . 72.13 112.496 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -53.82 176.23 0.31 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.781 -0.723 . . . . 62.32 112.497 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.88 104.76 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 75.41 110.883 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -159.05 -38.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 61.31 112.541 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.66 ' CE1' HD21 ' C' ' 276' ' ' LEU . 10.6 t80 64.43 111.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.858 0.361 . . . . 61.44 110.881 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.441 ' HE1' HD23 ' B' ' 276' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 75.3 110.885 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.824 0.345 . . . . 73.23 110.844 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -83.91 139.69 32.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 70.22 110.917 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.88 144.64 50.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.35 110.82 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.94 143.09 51.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 73.35 111.134 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.35 -32.61 12.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 75.32 110.898 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . 0.622 ' HB3' HG22 ' C' ' 266' ' ' THR . 0.2 OUTLIER -165.04 137.85 4.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 72.13 110.924 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.462 HG21 HG21 ' C' ' 239' ' ' VAL . 16.7 mt -137.34 117.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 74.22 111.078 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -132.71 115.87 15.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 74.25 110.861 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -135.41 135.48 40.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.461 . . . . 74.31 111.123 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.48 166.99 23.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 72.2 110.88 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 66.87 72.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 74.43 110.93 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 44.32 53.26 6.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 72.15 110.84 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.2 147.9 26.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 72.41 111.047 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.0 135.75 52.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.868 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.56 HG13 HG13 ' B' ' 275' ' ' VAL . 6.0 p -133.78 121.86 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.54 111.098 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -108.77 136.55 48.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 73.21 110.946 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.17 119.21 22.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 65.05 110.888 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.15 173.66 13.46 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.758 -0.734 . . . . 73.01 112.439 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -85.81 134.22 33.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 73.34 110.865 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.597 HG12 ' HG3' ' B' ' 280' ' ' GLU . 30.9 m -113.45 131.95 63.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.082 -0.508 . . . . 60.33 111.156 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.18 129.24 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 74.35 111.145 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 12.9 p -86.71 169.33 12.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 61.44 111.185 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.03 76.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 73.21 111.174 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.37 76.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 71.41 111.106 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 63.53 111.126 179.939 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.838 0.352 . . . . 74.52 110.951 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . 0.533 HG21 ' CG ' ' D' ' 243' ' ' ASN . 29.3 m -100.85 137.89 38.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 75.5 111.127 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.612 HG23 ' CB ' ' D' ' 225' ' ' ARG . 1.5 t -125.01 133.17 53.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 31.22 111.149 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . 0.479 ' ND2' HG22 ' C' ' 277' ' ' ILE . 0.8 OUTLIER -126.8 145.73 50.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 71.14 110.893 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.69 123.39 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 63.21 110.885 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.462 HG21 ' CG2' ' C' ' 267' ' ' VAL . 7.9 p -110.48 127.77 67.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 60.35 111.081 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.91 -71.83 0.26 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.107 -0.497 . . . . 71.14 110.847 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . 0.622 HG22 ' HB3' ' C' ' 230' ' ' ASP . 5.7 p -140.48 137.18 33.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 52.3 111.081 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.694 ' CG1' HG21 ' C' ' 275' ' ' VAL . 19.2 t -116.8 128.36 74.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 60.21 111.18 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . 0.405 ' O ' HG12 ' C' ' 268' ' ' VAL . 2.0 t -127.24 117.91 48.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 73.43 111.137 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.1 132.74 9.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.736 -0.745 . . . . 62.45 112.452 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.81 140.94 48.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 71.52 110.931 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 46.58 84.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.701 -0.761 . . . . 64.34 112.49 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 51.1 82.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.885 0.374 . . . . 53.24 110.87 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 29.2 t -116.44 145.61 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 63.42 110.881 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -128.97 127.62 42.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.488 . . . . 72.44 110.825 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.694 HG21 ' CG1' ' C' ' 267' ' ' VAL . 48.2 t -132.07 123.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 64.43 111.125 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.66 HD21 ' CE1' ' B' ' 286' ' ' PHE . 0.1 OUTLIER -112.54 111.58 22.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.221 -0.445 . . . . 64.24 110.952 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.479 HG22 ' ND2' ' C' ' 262' ' ' ASN . 23.4 mm -111.0 104.71 17.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 74.3 111.134 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.5 -154.58 25.6 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 51.31 112.48 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -128.14 145.25 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.347 . . . . 74.44 110.92 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -113.06 129.72 56.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 72.02 110.946 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -119.8 126.02 49.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 64.33 110.846 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 103.28 101.68 2.66 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.692 -0.765 . . . . 33.5 112.415 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 95.16 -167.45 26.44 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.712 -0.756 . . . . 55.23 112.478 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -172.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 74.12 110.893 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -86.01 -18.62 59.16 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.754 -0.736 . . . . 71.22 112.45 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.96 124.0 22.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 65.23 110.925 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 16.1 p90 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.926 -179.948 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . 0.612 ' CB ' HG23 ' C' ' 261' ' ' THR . 3.7 ptt180 . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.792 0.33 . . . . 72.14 110.908 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.78 132.17 38.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 62.43 110.847 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.09 150.76 44.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 63.14 110.842 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.1 158.86 36.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 73.05 111.154 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -109.15 -32.94 7.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.29 -0.414 . . . . 72.1 110.938 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -164.63 138.18 5.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 64.44 110.834 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . 0.403 HD12 HG23 ' C' ' 264' ' ' VAL . 13.8 mt -138.85 117.82 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 65.44 111.141 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -133.22 121.39 22.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 65.22 110.859 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.7 p -136.39 148.41 47.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.177 -0.465 . . . . 73.22 111.135 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.79 166.52 33.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 74.31 110.915 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 64.09 72.76 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 71.25 110.959 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 47.8 33.86 3.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 74.11 110.853 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.8 142.57 27.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 74.35 111.155 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -126.88 135.87 51.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 60.32 110.902 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.54 HG13 HG13 ' C' ' 275' ' ' VAL . 5.3 p -128.54 137.51 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 64.3 111.114 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . 0.732 ' HB3' HD13 ' D' ' 276' ' ' LEU . 3.7 tm0? -117.32 135.91 53.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 63.03 110.935 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.19 129.75 43.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 71.14 110.898 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 121.74 -131.3 8.44 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.699 -0.762 . . . . 72.32 112.464 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . 0.533 ' CG ' HG21 ' C' ' 260' ' ' THR . 1.8 p-10 -144.99 150.8 37.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 72.5 110.815 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' D' ' 280' ' ' GLU . 13.7 m -122.73 124.36 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 63.5 111.133 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' D' ' 281' ' ' TYR . 28.4 t -121.23 129.05 76.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 62.31 111.194 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . 0.434 HG21 ' HA2' ' D' ' 283' ' ' GLY . 68.4 p -72.26 174.57 7.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 65.34 111.17 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.48 -45.9 73.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.277 -0.419 . . . . 71.53 111.103 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.27 -50.38 73.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 35.23 111.071 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 42.41 111.091 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . 0.664 HG23 ' HD2' ' E' ' 225' ' ' ARG . 75.8 m . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.878 0.371 . . . . 72.35 111.142 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . 0.628 ' H ' ' NE ' ' E' ' 225' ' ' ARG . 95.1 m -100.33 108.95 21.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 64.2 111.17 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -116.31 150.32 37.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 73.41 110.892 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.37 123.79 16.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 54.21 110.859 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 11.4 p -107.55 134.23 49.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 65.22 111.094 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.45 -75.44 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 75.31 110.855 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 44.8 p -148.74 135.38 19.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 73.11 111.153 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.686 ' CG1' HG21 ' D' ' 275' ' ' VAL . 14.5 t -117.67 128.24 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 62.53 111.07 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . 0.4 HG11 ' HD3' ' E' ' 232' ' ' ARG . 5.9 p -127.19 122.87 60.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 65.33 111.204 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.57 133.84 10.54 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.698 -0.763 . . . . 63.42 112.473 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -132.48 136.48 46.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.808 0.337 . . . . 71.5 110.849 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.68 87.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 64.42 112.506 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 51.95 80.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 74.14 110.883 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 40.7 t -114.61 145.29 42.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 75.25 110.828 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -130.62 127.12 38.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 71.02 110.873 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.686 HG21 ' CG1' ' D' ' 267' ' ' VAL . 85.1 t -136.17 126.74 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 75.04 111.163 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.732 HD13 ' HB3' ' D' ' 240' ' ' GLN . 0.5 OUTLIER -124.2 111.22 15.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 72.15 110.917 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 31.1 mm -109.68 104.85 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 63.53 111.167 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 159.25 -165.36 34.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.795 -0.717 . . . . 52.12 112.522 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -123.66 156.19 36.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.774 0.321 . . . . 70.55 110.92 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . 0.4 ' HA ' HG23 ' D' ' 244' ' ' VAL . 19.3 tt0 -111.77 119.24 37.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 70.31 110.959 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . 0.598 ' HB3' HG13 ' D' ' 245' ' ' VAL . 2.0 m-85 -103.68 125.82 50.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 55.3 110.89 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 62.88 31.63 81.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.718 -0.753 . . . . 52.04 112.471 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' D' ' 246' ' ' THR . . . -95.75 -116.46 3.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 71.01 112.546 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -179.41 34.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 62.31 110.868 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.25 -113.18 3.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 73.23 112.455 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.85 -179.35 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.853 0.358 . . . . 71.23 110.844 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 12.0 p90 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 74.15 110.911 -179.933 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . 0.664 ' HD2' HG23 ' D' ' 260' ' ' THR . 1.5 ptp180 . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.844 0.354 . . . . 65.41 110.934 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -105.42 108.83 20.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 53.31 110.895 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.59 152.41 45.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 61.41 110.873 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.8 163.01 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 63.13 111.123 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.49 -33.31 6.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 74.21 110.942 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . 0.616 ' HB2' HG22 ' E' ' 266' ' ' THR . 0.2 OUTLIER -167.27 140.44 3.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 74.45 110.804 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . 0.525 HG23 HG21 ' E' ' 239' ' ' VAL . 17.3 mt -136.98 114.9 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 55.03 111.118 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . 0.4 ' HD3' HG11 ' D' ' 268' ' ' VAL . 2.9 ttp180 -132.27 119.93 21.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 63.34 110.917 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.69 144.35 45.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 72.44 111.129 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -156.4 166.13 34.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 73.23 110.883 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 59.42 72.3 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 70.33 110.88 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 50.0 43.57 25.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 63.41 110.923 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.09 144.93 29.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 63.44 111.071 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -128.92 141.66 51.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.53 110.881 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.679 ' CG1' HG22 ' D' ' 275' ' ' VAL . 7.8 p -134.77 134.48 53.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 64.22 111.158 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . 0.473 ' HB3' HD13 ' E' ' 276' ' ' LEU . 7.2 tm0? -119.42 137.22 53.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.428 . . . . 71.3 110.864 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.746 HD22 ' HB ' ' E' ' 277' ' ' ILE . 0.1 OUTLIER -130.31 118.72 21.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 73.22 110.935 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 123.73 177.88 15.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.696 -0.764 . . . . 62.43 112.481 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . 0.415 HD22 HG21 ' D' ' 260' ' ' THR . 2.4 p30 -89.65 145.38 25.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.787 0.327 . . . . 71.3 110.941 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 9.6 m -120.16 139.16 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 71.44 111.114 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.5 128.32 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 74.14 111.177 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.5 t -69.77 175.2 4.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 71.32 111.17 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.43 76.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 62.04 111.124 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.13 -51.72 68.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 35.13 111.116 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 70.13 111.088 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . 0.498 HG23 ' HA ' ' E' ' 225' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.765 0.317 . . . . 65.51 111.177 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.3 136.18 52.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 65.54 110.936 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 1.3 t -126.8 121.88 33.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.841 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . 0.454 HG11 HD21 ' E' ' 241' ' ' LEU . 8.0 p -102.41 123.0 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 41.31 111.134 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . 0.432 ' CD ' ' N ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -65.23 -142.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 73.52 110.907 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . 0.616 HG22 ' HB2' ' E' ' 230' ' ' ASP . 3.2 p -92.14 128.79 38.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 71.22 111.122 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . 0.973 HG11 HG21 ' E' ' 275' ' ' VAL . 8.9 t -115.35 133.34 61.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 54.11 111.119 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . 0.407 ' O ' HG13 ' E' ' 268' ' ' VAL . 6.1 p -125.45 121.53 60.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 75.44 111.188 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.44 132.87 11.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.785 -0.721 . . . . 75.04 112.493 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -132.82 116.05 16.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 74.43 110.897 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 64.49 88.14 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 75.44 112.455 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 56.99 86.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 61.51 110.857 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 16.9 t -124.35 145.49 49.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 54.0 110.851 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -136.7 127.13 26.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 64.02 110.892 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.973 HG21 HG11 ' E' ' 267' ' ' VAL . 57.9 t -132.73 134.67 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 33.41 111.094 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' E' ' 240' ' ' GLN . 0.2 OUTLIER -128.39 114.85 17.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 24.21 110.926 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.746 ' HB ' HD22 ' E' ' 241' ' ' LEU . 28.4 mm -111.13 141.16 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 75.3 111.1 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 113.1 -171.86 14.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.694 -0.765 . . . . 72.32 112.442 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -106.82 153.52 22.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.797 0.332 . . . . 71.51 110.868 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -111.85 144.47 41.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 72.33 110.826 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.12 125.35 43.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 75.42 110.902 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.756 -0.735 . . . . 54.21 112.484 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 . . . . . 0 N--CA 1.458 -0.056 0 CA-C-O 120.808 0.337 . . . . 74.41 110.885 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.516 HD22 HG22 ' A' ' 277' ' ' ILE . 2.3 m120 -142.41 143.63 32.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 32.01 110.852 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 34.5 p -121.72 137.5 54.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 52.52 110.859 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.94 139.92 48.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.486 . . . . 74.23 111.088 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.15 -28.18 13.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 72.34 110.879 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.413 ' HB3' HG23 ' A' ' 266' ' ' THR . 1.1 m-20 -166.17 137.93 3.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 72.21 110.879 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.39 117.29 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 73.45 111.157 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -129.55 122.48 29.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 72.34 110.861 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.8 152.12 50.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 73.44 111.163 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.98 158.94 37.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 70.11 110.948 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 236' ' ' ARG . 1.6 tt0 64.11 83.35 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 71.25 110.892 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 235' ' ' GLU . 0.0 OUTLIER 36.15 59.89 0.89 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 75.01 110.883 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.21 144.02 32.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 73.23 111.087 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -125.79 135.81 52.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 71.3 110.923 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.53 HG12 ' HB ' ' A' ' 275' ' ' VAL . 19.7 m -143.01 121.29 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 64.42 111.137 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -124.88 137.64 54.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 73.12 110.895 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 mp -129.4 118.26 21.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 75.34 110.909 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 148.23 -161.87 28.69 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 60.14 112.51 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -91.11 137.86 32.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 74.35 110.992 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -120.54 131.77 71.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 72.4 111.092 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 61.7 t -122.17 128.97 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 65.32 111.133 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 72.22 111.189 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.854 0.359 . . . . 74.43 111.151 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.7 t -131.07 140.59 50.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 71.4 111.144 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -99.31 126.2 45.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.87 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 87.4 p -134.56 123.65 24.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 62.24 110.849 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.437 HG21 HG22 ' A' ' 267' ' ' VAL . 7.1 p -118.67 125.68 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.084 -0.507 . . . . 74.41 111.136 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -74.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.839 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 230' ' ' ASP . 25.8 m -136.45 135.06 38.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 71.52 111.193 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.779 HG11 HG11 ' A' ' 275' ' ' VAL . 0.1 OUTLIER -118.48 126.52 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 73.13 111.124 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 23.2 t -127.48 118.14 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 63.45 111.162 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.68 133.06 8.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.747 . . . . 62.04 112.489 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 147.6 52.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.906 0.384 . . . . 53.23 110.892 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.52 84.21 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 70.13 112.444 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 51.35 80.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 75.03 110.865 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 31.6 t -113.34 145.69 40.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 63.54 110.842 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -132.77 127.59 34.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 73.24 110.88 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.779 HG11 HG11 ' A' ' 267' ' ' VAL . 19.0 t -137.7 123.62 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 72.51 111.156 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.671 HD23 ' CZ2' ' A' ' 287' ' ' TRP . 0.6 OUTLIER -121.4 112.36 18.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 73.13 110.906 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.516 HG22 HD22 ' A' ' 226' ' ' ASN . 35.6 mm -103.93 104.51 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 74.41 111.158 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.2 -169.43 28.88 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.67 -0.776 . . . . 63.41 112.486 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -111.12 149.89 30.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.784 0.326 . . . . 71.24 110.88 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.456 ' OE2' HG13 ' B' ' 244' ' ' VAL . 0.1 OUTLIER -121.6 119.1 30.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 75.4 110.923 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -108.14 154.01 22.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 62.12 110.903 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 122.88 -120.16 4.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.72 -0.752 . . . . 50.12 112.496 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' B' ' 247' ' ' ALA . . . -171.3 -143.8 4.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 22.03 112.565 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 69.03 -75.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 71.33 110.888 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -144.48 143.53 12.18 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.728 . . . . 63.21 112.481 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.503 ' HB2' HG11 ' B' ' 244' ' ' VAL . 14.4 p90 -61.1 -20.71 62.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 64.41 110.881 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.671 ' CZ2' HD23 ' A' ' 276' ' ' LEU . 5.0 t90 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.129 -0.487 . . . . 73.22 110.982 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.483 ' HG2' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.783 0.325 . . . . 75.23 110.818 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -115.25 120.66 40.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 64.34 110.938 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.33 137.93 51.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 74.31 110.825 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.95 152.34 45.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 70.42 111.108 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -28.02 10.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 74.32 110.879 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . 0.541 ' HB3' HG23 ' B' ' 266' ' ' THR . 1.0 OUTLIER -164.65 138.41 5.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.415 . . . . 75.32 110.851 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 11.6 mt -135.44 122.42 34.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 75.22 111.081 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -134.17 117.25 16.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.04 110.911 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.2 145.67 52.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 74.11 111.151 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.24 161.53 41.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 73.21 110.85 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 63.61 69.68 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 61.41 110.804 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 47.53 56.7 6.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 70.24 110.936 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.0 144.42 31.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 61.31 111.14 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.03 135.87 52.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 75.45 110.848 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.801 HG12 ' HB ' ' B' ' 275' ' ' VAL . 4.1 m -136.24 121.56 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 73.02 111.138 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.67 134.06 54.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 75.31 110.979 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.578 HD12 ' HB ' ' B' ' 277' ' ' ILE . 0.3 OUTLIER -130.42 119.07 22.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 62.44 110.867 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.81 -116.07 0.72 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.74 . . . . 62.11 112.498 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.98 139.7 29.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.899 0.38 . . . . 73.24 110.902 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 286' ' ' PHE . 46.1 t -118.2 116.27 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 74.41 111.138 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.27 129.05 73.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 74.44 111.151 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.1 p -92.26 175.23 6.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 71.01 111.186 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.487 ' HB2' ' HA3' ' A' ' 283' ' ' GLY . . . -63.06 -42.65 99.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 25.2 111.07 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.73 -38.37 84.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 64.03 111.126 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' B' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 70.34 111.098 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.88 0.371 . . . . 70.23 110.821 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.83 137.77 33.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 74.1 111.134 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.483 HG23 ' HG2' ' B' ' 225' ' ' ARG . 96.5 m -130.85 111.92 12.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 75.22 111.133 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -89.43 127.28 35.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 54.42 110.959 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 3.6 m -130.31 123.59 30.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 75.22 110.86 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.476 HG21 HG22 ' B' ' 267' ' ' VAL . 7.3 p -115.48 125.28 72.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 72.12 111.116 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.97 -76.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 61.5 110.905 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.541 HG23 ' HB3' ' B' ' 230' ' ' ASP . 94.6 m -137.01 137.65 39.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 73.34 111.093 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.684 ' CG1' HG21 ' B' ' 275' ' ' VAL . 4.4 t -117.8 128.35 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 74.33 111.177 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 25.6 t -127.64 117.16 45.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 44.45 111.101 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.39 132.53 9.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.723 -0.751 . . . . 71.34 112.498 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -133.27 125.08 28.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.863 0.363 . . . . 74.04 110.889 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.76 83.91 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 55.42 112.508 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 54.35 84.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 70.42 110.843 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 22.8 t -119.25 145.63 45.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 54.43 110.831 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -135.34 127.32 29.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 75.53 110.903 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.801 ' HB ' HG12 ' B' ' 239' ' ' VAL . 61.9 t -135.35 124.55 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 64.33 111.122 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.07 111.69 17.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 65.44 110.875 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' B' ' 241' ' ' LEU . 27.3 mm -103.86 104.53 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.455 . . . . 73.22 111.149 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.83 -160.21 28.51 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 74.21 112.486 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -115.91 147.87 40.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.324 . . . . 74.12 110.909 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.633 ' HG3' HG13 ' C' ' 244' ' ' VAL . 1.0 OUTLIER -120.82 118.88 31.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.9 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.476 ' CD2' ' HB1' ' B' ' 249' ' ' ALA . 11.4 t80 -112.27 127.46 55.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 71.43 110.954 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.555 ' O ' ' HB2' ' C' ' 247' ' ' ALA . . . 145.9 -48.59 0.68 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.808 -0.71 . . . . 61.45 112.47 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 74.06 11.32 81.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.725 -0.75 . . . . 73.12 112.48 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.96 60.86 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 53.32 110.868 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 96.26 120.26 3.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.763 -0.732 . . . . 62.45 112.487 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -50.95 108.45 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.324 . . . . 74.13 110.912 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.155 -0.475 . . . . 74.34 110.889 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.798 0.332 . . . . 64.3 110.831 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -83.98 110.07 18.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 62.22 110.834 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.34 137.91 50.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 63.33 110.849 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -123.35 150.55 43.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 54.11 111.117 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -102.37 -26.2 13.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 72.5 110.875 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . 0.502 ' HB3' HG23 ' C' ' 266' ' ' THR . 0.5 OUTLIER -165.04 138.79 4.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 52.44 110.809 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.467 ' CD1' HG23 ' B' ' 264' ' ' VAL . 11.5 mt -136.61 117.68 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 72.53 111.183 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.94 119.32 21.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 74.42 110.882 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.52 150.4 52.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 55.41 111.142 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -156.71 166.68 32.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 63.03 110.854 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.59 67.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 74.31 110.946 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 48.31 58.23 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 71.21 110.908 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.33 148.37 26.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 74.25 111.102 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -129.36 135.86 49.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 73.23 110.903 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.644 ' CG2' HG22 ' B' ' 275' ' ' VAL . 28.3 m -135.27 121.56 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 72.14 111.141 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.09 137.54 52.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 73.12 110.954 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.05 118.4 21.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 71.22 110.927 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 139.36 -168.91 24.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.777 -0.725 . . . . 61.45 112.461 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -91.93 145.03 24.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 64.52 110.921 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.633 HG13 ' HG3' ' B' ' 280' ' ' GLU . 56.1 t -125.98 124.89 67.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 75.34 111.129 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 48.4 t -122.83 118.28 54.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 44.05 111.063 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 6.4 t -77.84 174.96 10.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 62.35 111.163 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' B' ' 282' ' ' GLY . . . -63.83 -45.56 89.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 63.25 111.097 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.05 -35.77 67.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 74.24 111.082 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . 0.553 ' HB1' ' CD2' ' C' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 45.24 111.069 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.882 0.372 . . . . 61.33 110.854 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . 0.464 HG22 ' HG3' ' D' ' 225' ' ' ARG . 70.0 p -100.86 137.58 39.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 74.25 111.154 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 2.1 t -108.45 137.05 47.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 72.33 111.141 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -119.99 139.01 53.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 73.14 110.931 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 22.8 m -130.68 123.74 30.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 72.31 110.925 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.542 HG21 ' CG2' ' C' ' 267' ' ' VAL . 7.1 p -112.01 126.86 69.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 72.31 111.083 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.8 -74.0 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.49 . . . . 73.34 110.88 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . 0.502 HG23 ' HB3' ' C' ' 230' ' ' ASP . 92.5 m -140.8 136.65 32.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 64.42 111.189 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.656 ' CG1' HG21 ' C' ' 275' ' ' VAL . 94.4 t -117.96 127.02 75.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 70.43 111.111 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 40.1 t -127.5 126.79 67.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 72.1 111.039 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.25 133.0 8.24 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.767 -0.73 . . . . 73.11 112.502 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -132.62 140.96 48.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.832 0.349 . . . . 61.14 110.924 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.11 70.15 0.94 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.781 -0.723 . . . . 64.51 112.434 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 64.85 97.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 70.55 110.881 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 70.2 m -131.7 145.94 51.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 55.14 110.879 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 36.2 mtt85 -131.48 127.09 36.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 73.13 110.837 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.656 HG21 ' CG1' ' C' ' 267' ' ' VAL . 21.7 t -133.43 123.89 47.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 61.22 111.134 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.23 111.59 17.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 62.22 110.972 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 30.8 mm -105.65 104.34 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 74.44 111.181 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 152.97 -152.49 24.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 72.41 112.482 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -116.75 138.17 51.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.758 0.313 . . . . 50.43 110.941 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.661 ' CG ' HG22 ' D' ' 244' ' ' VAL . 4.4 pt-20 -111.79 118.83 36.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.457 . . . . 74.22 110.832 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.553 ' CD2' ' HB1' ' C' ' 249' ' ' ALA . 9.1 t80 -114.45 124.63 52.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 71.01 111.008 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' D' ' 247' ' ' ALA . . . 161.5 -58.53 0.3 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 23.1 112.463 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 91.31 -42.0 2.85 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.717 -0.754 . . . . 74.24 112.426 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -30.21 14.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 74.24 110.859 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -147.05 106.45 0.36 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.694 -0.765 . . . . 62.43 112.455 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -55.34 -23.35 23.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 74.2 110.898 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.456 . . . . 75.24 110.934 -179.94 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . 0.464 ' HG3' HG22 ' C' ' 260' ' ' THR . 1.6 mmt85 . . . . . 0 C--O 1.23 0.04 0 CA-C-O 120.85 0.357 . . . . 75.35 110.827 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -109.56 115.52 30.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 55.43 110.891 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.83 140.9 52.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 72.02 110.869 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.45 147.88 49.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 72.3 111.115 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -100.72 -26.16 13.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 70.11 110.929 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.98 138.26 4.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 73.5 110.922 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . 0.451 ' CD1' HG23 ' C' ' 264' ' ' VAL . 12.3 mt -137.03 117.89 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 73.21 111.178 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -133.06 118.41 18.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 70.52 110.878 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.49 150.76 52.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 74.03 111.144 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -157.0 167.29 30.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 73.04 110.898 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.54 66.45 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 74.35 110.851 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 50.08 43.97 25.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 73.44 110.874 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.1 152.38 21.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.34 111.079 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -135.34 135.25 40.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 63.32 110.869 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.602 HG23 HG13 ' C' ' 275' ' ' VAL . 18.1 m -133.58 121.19 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 61.23 111.126 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -108.07 134.63 50.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 74.02 110.914 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.28 118.03 20.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 74.04 110.924 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.16 -118.3 1.35 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.778 -0.725 . . . . 53.24 112.497 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -145.97 133.26 20.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.891 0.377 . . . . 73.43 110.866 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . 0.661 HG22 ' CG ' ' C' ' 280' ' ' GLU . 74.4 t -110.2 121.18 62.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 65.52 111.165 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.47 119.96 58.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 74.23 111.134 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -69.99 175.36 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 64.52 111.103 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' C' ' 282' ' ' GLY . . . -53.47 -46.1 69.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 75.24 111.114 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.2 -49.52 77.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 71.54 111.076 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 63.14 111.112 179.933 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . 0.419 HG21 HD21 ' E' ' 243' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.885 0.374 . . . . 73.35 111.08 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . 0.426 HG23 ' O ' ' D' ' 225' ' ' ARG . 49.9 m -112.71 108.88 18.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.34 111.149 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . 0.556 ' OD1' HG23 ' D' ' 277' ' ' ILE . 1.3 t-20 -90.77 131.98 36.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 75.44 110.861 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.97 123.87 38.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 53.13 110.924 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.523 HG21 ' CG2' ' D' ' 267' ' ' VAL . 9.7 p -118.39 129.1 75.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.143 -0.48 . . . . 42.21 111.064 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.52 -75.23 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 62.12 110.929 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 48.9 m -136.52 135.6 38.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 63.21 111.138 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.533 ' CG1' HG21 ' D' ' 275' ' ' VAL . 97.5 t -117.89 127.06 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 72.11 111.184 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 28.1 t -127.22 122.93 61.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 72.33 111.101 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.29 132.44 8.55 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.771 -0.728 . . . . 73.15 112.507 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.13 144.89 50.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.808 0.337 . . . . 65.03 110.934 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.79 70.38 0.79 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.726 . . . . 73.04 112.478 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.47 94.3 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 34.23 110.924 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 30.9 t -126.27 145.02 50.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 60.34 110.892 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -131.68 126.35 34.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 74.24 110.909 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.683 HG13 HG23 ' E' ' 239' ' ' VAL . 16.6 t -132.1 132.42 61.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 60.15 111.08 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.55 111.11 12.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.104 -0.498 . . . . 72.02 110.903 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.556 HG23 ' OD1' ' D' ' 262' ' ' ASN . 24.5 mm -108.03 106.59 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 74.2 111.107 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.27 -146.15 17.42 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.788 -0.72 . . . . 72.02 112.523 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.98 156.11 17.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 73.33 110.88 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . 0.759 ' CG ' HG22 ' E' ' 244' ' ' VAL . 0.0 OUTLIER -145.25 122.56 11.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 63.44 110.803 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -119.93 124.45 46.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 73.42 110.937 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . -149.59 -140.09 3.2 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.783 -0.722 . . . . 75.34 112.531 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' E' ' 247' ' ' ALA . . . -139.16 -98.36 0.41 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 35.42 112.494 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.52 101.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.818 0.342 . . . . 71.24 110.937 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 71.49 -116.06 5.95 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 74.32 112.462 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.63 152.31 21.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.815 0.341 . . . . 63.51 110.898 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 72.51 110.881 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.803 0.335 . . . . 73.44 110.895 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -84.32 117.57 23.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 71.12 110.9 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 93.0 p -131.8 140.16 49.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 75.43 110.893 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -120.43 146.21 46.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 51.2 111.116 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -95.89 -26.73 15.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 71.53 110.924 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.31 138.88 5.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 70.25 110.944 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . 0.471 ' CD1' HG23 ' D' ' 264' ' ' VAL . 10.8 mt -137.15 117.71 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 71.33 111.122 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -131.77 121.47 24.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 73.0 110.884 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.4 147.61 49.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 70.21 111.151 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -157.05 161.11 39.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 64.4 110.936 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 64.89 72.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 75.55 110.883 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.25 37.9 12.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 64.21 110.849 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.83 141.48 29.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 61.42 111.148 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.73 135.46 52.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 74.34 110.931 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.683 HG23 HG13 ' D' ' 275' ' ' VAL . 25.2 m -138.12 122.01 21.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 72.21 111.146 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . 0.503 ' C ' HD12 ' E' ' 241' ' ' LEU . 2.5 tp60 -119.48 134.06 55.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 71.34 110.882 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.503 HD12 ' C ' ' E' ' 240' ' ' GLN . 6.5 mp -130.74 118.06 20.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 61.34 110.946 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 145.52 -108.99 0.49 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.79 -0.719 . . . . 73.43 112.483 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . 0.419 HD21 HG21 ' D' ' 260' ' ' THR . 0.0 OUTLIER -144.37 150.24 37.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.847 0.356 . . . . 73.45 110.895 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.759 HG22 ' CG ' ' D' ' 280' ' ' GLU . 80.0 t -133.42 122.73 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 75.32 111.131 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 79.6 t -124.15 112.83 34.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 72.41 111.095 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . 0.474 HG23 ' O ' ' E' ' 281' ' ' TYR . 74.3 p -69.08 175.25 3.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 73.14 111.17 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . 0.523 ' HB2' ' HA2' ' D' ' 283' ' ' GLY . . . -55.09 -46.01 75.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 44.14 111.142 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.78 -52.18 66.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 73.32 111.1 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 63.41 111.118 179.945 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 94.1 m . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.85 0.357 . . . . 60.24 111.114 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.41 142.53 51.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 72.4 110.883 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.88 133.45 39.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 63.35 110.839 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . 0.428 ' O ' HG13 ' E' ' 264' ' ' VAL . 4.9 p -124.11 118.51 54.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.139 -0.482 . . . . 72.21 111.136 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.96 -75.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 73.3 110.926 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.1 138.9 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 53.44 111.09 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . 0.86 HG11 HG21 ' E' ' 275' ' ' VAL . 40.2 t -117.43 128.46 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 64.51 111.092 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 38.9 t -127.12 118.58 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 71.04 111.159 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.63 132.28 10.18 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.77 -0.728 . . . . 73.15 112.481 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -133.7 116.56 15.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 74.24 110.868 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 74.71 86.77 0.26 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.707 -0.759 . . . . 52.52 112.498 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 51.09 81.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 65.51 110.876 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 16.3 m -117.3 145.42 44.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 73.42 110.873 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -134.11 127.29 31.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 63.23 110.79 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.86 HG21 HG11 ' E' ' 267' ' ' VAL . 46.6 t -133.2 130.5 57.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 64.43 111.142 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . 0.629 HD22 ' O ' ' E' ' 275' ' ' VAL . 3.2 mm? -128.34 107.85 10.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 63.54 110.833 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 23.1 mm -114.27 109.19 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 71.11 111.069 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.62 -137.36 6.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.84 -0.695 . . . . 75.05 112.557 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -111.24 133.24 53.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 70.41 110.902 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.34 133.66 55.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.44 110.905 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . 0.474 ' O ' HG23 ' E' ' 246' ' ' THR . 0.1 OUTLIER -131.26 123.88 29.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 73.03 110.937 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.64 -0.791 . . . . 22.14 112.494 179.968 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.615 ' HG3' HG23 ' A' ' 261' ' ' THR . 13.0 ptm180 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.79 0.329 . . . . 73.02 110.861 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.724 ' HB3' HG22 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -123.21 130.08 52.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 62.43 110.823 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.1 m -128.57 144.31 51.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 74.54 110.872 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.7 124.01 19.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 71.21 111.091 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -76.09 -37.2 58.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 73.11 110.916 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -164.68 138.46 5.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 62.23 110.878 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.597 HG22 ' CG2' ' A' ' 267' ' ' VAL . 9.7 pt -137.82 118.01 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 74.14 111.067 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -128.39 126.91 41.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 75.31 110.909 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.602 HG21 ' CG1' ' A' ' 239' ' ' VAL . 1.7 p -135.56 149.49 49.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 72.52 111.142 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -144.97 168.37 20.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 43.51 110.925 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 65.47 74.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 64.01 110.922 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 41.89 59.11 2.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 73.02 110.811 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.435 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -104.11 155.99 18.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 54.14 111.099 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -135.05 145.92 48.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 72.33 110.905 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.602 ' CG1' HG21 ' A' ' 233' ' ' THR . 16.1 m -139.97 137.39 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 74.21 111.113 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -137.2 129.42 29.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.13 110.917 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.9 mp -122.94 130.34 52.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 75.35 110.846 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.72 -121.42 1.56 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 63.33 112.446 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -144.86 132.7 21.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.87 0.367 . . . . 74.33 110.903 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.517 HG23 ' HA ' ' A' ' 280' ' ' GLU . 18.0 m -120.02 120.9 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.138 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 94.5 t -122.07 129.02 75.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 64.45 111.189 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 74.05 111.196 -179.937 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.851 0.358 . . . . 73.0 111.123 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.615 HG23 ' HG3' ' A' ' 225' ' ' ARG . 98.0 m -127.62 111.04 13.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 61.51 111.117 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.581 HD21 HG23 ' A' ' 277' ' ' ILE . 0.4 OUTLIER -100.52 135.48 41.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 63.3 110.899 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 9.4 t -140.73 123.18 15.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 71.54 110.797 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.678 HG21 ' CD1' ' B' ' 231' ' ' ILE . 4.2 p -113.63 150.17 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 73.11 111.156 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -88.19 -73.31 0.49 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.483 . . . . 73.41 110.956 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 18.5 m -124.06 133.67 53.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 62.51 111.169 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.794 HG22 HD11 ' B' ' 231' ' ' ILE . 9.8 t -118.01 128.87 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 45.22 111.139 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 48.8 t -127.4 117.17 46.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 44.35 111.108 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.74 133.62 10.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.687 -0.768 . . . . 75.31 112.456 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -132.33 148.12 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 75.41 110.96 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.39 88.05 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.817 -0.706 . . . . 63.43 112.429 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 44.45 65.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 63.11 110.913 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 43.4 t -93.82 145.21 24.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.47 . . . . 73.14 110.86 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -123.02 128.45 50.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 74.35 110.835 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.543 ' HB ' HG12 ' A' ' 239' ' ' VAL . 21.2 t -119.3 123.62 71.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 73.21 111.144 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.603 HD23 ' CZ2' ' A' ' 287' ' ' TRP . 0.2 OUTLIER -121.0 111.48 17.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 72.23 110.976 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.724 HG22 ' HB3' ' A' ' 226' ' ' ASN . 20.4 mm -111.79 104.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.188 -0.46 . . . . 72.32 111.174 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.7 -160.22 26.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 72.43 112.468 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -107.01 151.51 25.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 70.23 110.878 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.711 ' HG3' HG12 ' B' ' 244' ' ' VAL . 0.5 OUTLIER -130.26 131.93 45.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 71.31 110.893 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -113.17 125.86 54.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 64.13 110.933 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 131.37 166.55 11.71 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.735 -0.745 . . . . 63.44 112.519 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -82.42 -108.93 0.44 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 33.33 112.524 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.31 51.01 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 75.23 110.907 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.15 30.87 32.48 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.787 -0.721 . . . . 51.32 112.464 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 58.47 83.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.882 0.372 . . . . 74.14 110.882 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.603 ' CZ2' HD23 ' A' ' 276' ' ' LEU . 23.0 t90 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 61.54 110.909 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.57 ' HB3' HG23 ' B' ' 261' ' ' THR . 5.7 mtp180 . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.833 0.349 . . . . 72.1 110.862 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.788 ' HB3' HG22 ' B' ' 277' ' ' ILE . 0.5 OUTLIER -128.22 131.13 48.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.911 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.1 145.32 49.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 75.14 110.876 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.559 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -139.5 124.68 18.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.478 . . . . 72.42 111.075 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.39 -36.05 53.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.483 . . . . 60.25 110.969 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.36 137.6 4.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 72.45 110.856 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.794 HD11 HG22 ' A' ' 267' ' ' VAL . 5.9 pt -138.69 117.64 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 65.43 111.179 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.35 123.72 32.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 74.54 110.875 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.589 HG21 ' CG1' ' B' ' 239' ' ' VAL . 1.7 p -135.61 142.71 45.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 73.13 111.18 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -143.37 167.56 21.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 70.22 110.879 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 68.63 73.6 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 74.15 110.881 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 45.83 54.8 7.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 64.13 110.844 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.27 156.17 18.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 63.3 111.138 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.31 146.54 42.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.829 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.589 ' CG1' HG21 ' B' ' 233' ' ' THR . 18.6 m -136.46 140.85 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 74.14 111.208 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.561 ' HB3' HD22 ' B' ' 276' ' ' LEU . 1.9 tt0 -138.14 122.55 18.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 60.1 110.964 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.6 118.94 33.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.209 -0.45 . . . . 72.1 110.93 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.92 -170.84 24.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.798 -0.715 . . . . 54.41 112.523 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.99 129.05 34.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 74.33 110.909 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.711 HG12 ' HG3' ' A' ' 280' ' ' GLU . 17.5 m -118.99 121.12 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 71.04 111.175 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.471 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 26.6 t -122.15 129.02 75.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 73.31 111.105 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -85.34 175.08 9.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 75.12 111.157 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.05 -42.35 90.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 61.34 111.145 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.96 67.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 73.53 111.08 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.471 ' HB3' ' CG1' ' B' ' 245' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 61.22 111.074 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.905 0.383 . . . . 75.11 110.857 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . 0.562 HG21 ' HB2' ' C' ' 243' ' ' ASN . 27.8 p -100.69 122.05 42.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 73.22 111.17 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.57 HG23 ' HB3' ' B' ' 225' ' ' ARG . 96.7 m -133.91 124.92 27.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 73.24 111.152 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -115.97 134.6 54.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 71.11 110.866 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.89 123.54 19.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 53.34 110.828 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.68 HG21 ' CD1' ' C' ' 231' ' ' ILE . 4.9 p -110.22 150.04 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.501 . . . . 64.53 111.123 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -86.61 -77.1 0.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 62.41 110.835 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 13.8 m -120.16 132.71 55.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 75.54 111.169 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.78 HG22 HD11 ' C' ' 231' ' ' ILE . 5.0 t -118.13 121.0 66.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.304 -0.407 . . . . 63.25 111.107 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.51 117.24 51.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.487 . . . . 64.04 111.138 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.79 133.79 11.09 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 72.02 112.516 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.99 148.12 52.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 63.43 110.933 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.35 82.95 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.75 -0.738 . . . . 43.53 112.545 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 46.8 69.04 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 63.4 110.893 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.92 145.7 26.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 73.23 110.884 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.46 128.38 52.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 72.31 110.891 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.548 ' HB ' HG12 ' B' ' 239' ' ' VAL . 21.7 t -118.98 123.91 72.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 63.13 111.139 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.561 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.2 OUTLIER -124.36 111.66 16.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 75.2 110.951 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.788 HG22 ' HB3' ' B' ' 226' ' ' ASN . 24.0 mm -112.09 104.1 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 72.44 111.165 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.24 -164.62 27.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 45.54 112.443 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -101.25 151.91 21.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 74.52 110.872 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.687 ' HG3' HG12 ' C' ' 244' ' ' VAL . 1.6 pp20? -130.91 142.51 50.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.842 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -127.53 125.92 41.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 73.14 110.914 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 157.7 146.24 4.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.72 -0.752 . . . . 63.02 112.509 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -102.98 -170.23 26.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 45.12 112.462 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? 56.27 25.18 9.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 72.24 110.893 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 141.77 117.86 1.36 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.724 -0.751 . . . . 51.33 112.541 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.51 ' CE2' HG21 ' C' ' 244' ' ' VAL . 3.0 m-85 -55.71 -26.1 43.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 71.23 110.886 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 3.6 t90 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 74.25 110.882 -179.918 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.615 ' HA ' HG23 ' C' ' 261' ' ' THR . 23.9 mmt85 . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.82 0.343 . . . . 75.33 110.87 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.563 ' HB3' HG22 ' C' ' 277' ' ' ILE . 1.2 m120 -84.43 118.44 24.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 73.25 110.877 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 14.9 t -136.68 147.74 46.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.816 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.599 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -135.83 129.0 31.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 62.42 111.145 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.22 -35.24 36.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 62.0 110.91 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.8 136.81 3.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 61.21 110.89 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.78 HD11 HG22 ' B' ' 267' ' ' VAL . 4.6 pt -139.17 117.72 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 73.43 111.156 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.1 124.3 32.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 72.54 110.939 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.579 HG21 ' CG1' ' C' ' 239' ' ' VAL . 1.4 p -135.39 144.21 46.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 62.3 111.105 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 13.1 pm0 -143.53 167.82 21.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 62.03 110.927 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 68.68 70.72 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 73.25 110.926 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? 47.0 57.39 5.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 73.35 110.835 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.418 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -104.57 156.18 18.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 73.0 111.106 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -136.58 141.63 43.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 72.24 110.871 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.579 ' CG1' HG21 ' C' ' 233' ' ' THR . 19.3 m -131.07 140.81 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 74.22 111.105 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.536 ' HB3' HD22 ' C' ' 276' ' ' LEU . 2.0 tp60 -138.02 129.54 27.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 75.23 110.906 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.578 HD13 ' CD1' ' B' ' 277' ' ' ILE . 5.2 mp -123.98 118.65 27.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 72.44 110.957 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.8 -176.74 21.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.767 -0.73 . . . . 74.2 112.506 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.562 ' HB2' HG21 ' B' ' 260' ' ' THR . 25.7 t-20 -85.92 128.91 34.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 70.45 110.851 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.687 HG12 ' HG3' ' B' ' 280' ' ' GLU . 32.2 m -111.67 127.4 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 64.41 111.166 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 22.4 t -122.29 129.07 75.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 70.51 111.132 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 18.3 p -84.18 175.08 9.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 62.54 111.102 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.81 -34.85 70.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.476 . . . . 74.21 111.046 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -70.87 -51.73 24.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 41.23 111.07 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.284 -0.416 . . . . 63.12 111.07 179.907 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.877 0.37 . . . . 74.04 110.914 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 51.3 p -67.13 128.88 38.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 53.41 111.142 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.615 HG23 ' HA ' ' C' ' 225' ' ' ARG . 22.6 m -125.46 109.01 12.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 70.44 111.111 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . 0.642 HD21 HG23 ' C' ' 277' ' ' ILE . 0.4 OUTLIER -107.26 135.87 48.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.44 110.856 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.05 123.61 14.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 43.42 110.883 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.63 HG21 HD11 ' D' ' 231' ' ' ILE . 3.5 p -110.27 145.11 17.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.151 -0.477 . . . . 73.45 111.139 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.43 -75.82 0.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 64.41 110.798 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 25.2 m -126.12 134.28 51.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.179 -0.464 . . . . 72.44 111.061 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.877 HG22 HD11 ' D' ' 231' ' ' ILE . 8.7 t -118.64 127.06 75.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.488 . . . . 72.12 111.134 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.91 116.11 43.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 74.24 111.128 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.69 133.77 10.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.722 . . . . 43.24 112.484 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.29 148.01 52.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 73.22 110.902 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.84 85.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.735 -0.745 . . . . 63.43 112.52 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 47.82 73.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 72.34 110.87 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 38.6 t -103.12 145.48 29.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 63.21 110.817 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -119.65 128.49 53.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 61.45 110.899 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.533 ' CG2' HG12 ' C' ' 239' ' ' VAL . 21.8 t -119.55 123.93 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.124 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.621 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -126.18 111.15 14.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 74.01 110.935 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.653 ' CD1' HD13 ' D' ' 241' ' ' LEU . 38.7 mm -112.18 104.05 16.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 51.45 111.165 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.04 -157.53 27.36 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 72.11 112.477 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -114.52 156.12 25.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 65.31 110.855 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.517 ' HG2' HG13 ' D' ' 244' ' ' VAL . 0.0 OUTLIER -126.6 139.29 53.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.08 -0.509 . . . . 72.53 110.877 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -129.19 125.99 38.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.941 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 148.1 153.9 6.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.768 -0.73 . . . . 73.04 112.502 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . 0.45 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . -99.01 103.81 2.8 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.717 -0.754 . . . . 74.14 112.526 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -179.41 41.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.877 0.37 . . . . 74.55 110.944 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.66 -135.05 11.98 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.75 -0.738 . . . . 73.35 112.488 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -124.32 -1.85 8.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 63.14 110.866 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.621 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 3.7 t90 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 73.3 110.909 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.06 0 CA-C-O 120.788 0.327 . . . . 72.21 110.814 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . 0.579 ' HB3' HG22 ' D' ' 277' ' ' ILE . 1.9 m120 -86.53 110.07 19.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 74.5 110.916 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 2.3 t -124.09 138.15 54.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 72.53 110.847 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . 0.407 ' HB3' HG23 ' C' ' 264' ' ' VAL . . . -121.41 129.02 52.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 74.04 111.139 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.03 -33.12 51.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 73.54 110.899 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -167.77 136.59 2.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 75.13 110.85 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . 0.877 HD11 HG22 ' C' ' 267' ' ' VAL . 4.2 pt -140.41 116.98 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 72.32 111.157 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . 0.463 ' HD2' HG22 ' D' ' 268' ' ' VAL . 11.5 ptp180 -131.41 124.65 30.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 74.24 110.823 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . 0.493 HG21 ' CG1' ' D' ' 239' ' ' VAL . 2.7 p -136.06 143.48 44.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 72.33 111.14 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 17.9 pm0 -142.83 167.7 21.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.25 110.867 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 67.7 78.21 0.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.492 . . . . 71.02 110.893 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 43.92 50.64 7.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 70.41 110.93 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.02 156.1 18.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 63.42 111.137 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.95 155.65 49.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 54.32 110.888 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.564 HG12 ' HB ' ' D' ' 275' ' ' VAL . 17.5 m -141.16 140.06 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 55.32 111.088 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . 0.533 ' HB3' HD22 ' D' ' 276' ' ' LEU . 2.0 tt0 -138.1 119.2 14.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 71.14 110.854 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.653 HD13 ' CD1' ' C' ' 277' ' ' ILE . 3.4 mp -118.78 135.19 54.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 51.14 110.913 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.17 -116.9 1.53 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 73.31 112.499 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -143.62 128.79 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.865 0.365 . . . . 70.13 110.882 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . 0.517 HG13 ' HG2' ' C' ' 280' ' ' GLU . 0.4 OUTLIER -104.55 115.54 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 65.22 111.109 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 80.5 t -122.03 125.95 73.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 61.44 111.087 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . 0.511 HG23 ' O ' ' D' ' 281' ' ' TYR . 18.2 p -86.25 174.99 8.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 64.15 111.11 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . 0.45 ' HB2' ' N ' ' C' ' 283' ' ' GLY . . . -53.92 -42.62 68.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 64.23 111.123 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.97 -44.94 96.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.433 . . . . 63.44 111.072 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 74.22 111.063 179.87 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.859 0.361 . . . . 73.51 111.152 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 90.0 m -99.0 109.33 22.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 73.42 111.122 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -108.9 144.6 36.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 61.22 110.923 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.36 136.06 35.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 64.32 110.846 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.836 HG22 HD11 ' E' ' 231' ' ' ILE . 0.9 OUTLIER -120.17 133.83 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 61.43 111.112 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -70.16 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 75.41 110.888 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 87.1 m -150.85 133.64 15.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 73.32 111.14 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.846 HG22 HD12 ' E' ' 231' ' ' ILE . 13.5 t -117.17 129.19 74.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 64.13 111.178 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . 0.463 HG22 ' HD2' ' D' ' 232' ' ' ARG . 61.2 t -127.2 115.8 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 63.13 111.107 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.0 133.06 11.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 54.12 112.49 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.31 116.62 18.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 72.32 110.936 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.57 87.66 0.17 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.69 -0.767 . . . . 73.33 112.477 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 52.25 88.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 73.31 110.869 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.37 145.68 50.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 61.21 110.914 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -121.35 128.83 52.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.161 -0.472 . . . . 72.32 110.826 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.564 ' HB ' HG12 ' D' ' 239' ' ' VAL . 21.8 t -116.24 126.6 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 71.35 111.079 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.642 HD23 ' CZ2' ' D' ' 287' ' ' TRP . 0.2 OUTLIER -128.24 111.3 13.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.22 110.98 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.579 HG22 ' HB3' ' D' ' 226' ' ' ASN . 45.8 mm -112.6 104.8 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.158 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 138.02 -176.9 20.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.776 -0.726 . . . . 41.31 112.495 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -91.33 156.17 17.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 75.45 110.849 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -131.66 139.02 48.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 61.11 110.887 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . 0.511 ' O ' HG23 ' D' ' 246' ' ' THR . 12.3 m-85 -125.61 125.89 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 72.52 110.836 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' E' ' 247' ' ' ALA . . . -170.66 -87.69 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 74.44 112.476 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 136.84 -50.68 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.669 -0.777 . . . . 34.35 112.487 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 103.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.325 . . . . 51.2 110.917 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 56.07 -101.51 0.14 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.793 -0.718 . . . . 73.13 112.411 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -175.13 122.44 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.814 0.34 . . . . 72.14 110.925 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . 0.642 ' CZ2' HD23 ' D' ' 276' ' ' LEU . 7.7 t90 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 75.22 110.906 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.888 0.375 . . . . 72.43 110.842 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . 0.598 ' HB3' HG22 ' E' ' 277' ' ' ILE . 1.6 m120 -83.52 109.74 17.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 61.21 110.876 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 3.3 m -131.86 137.62 48.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 53.11 110.845 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -108.25 155.01 20.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 70.32 111.09 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -109.56 -26.03 10.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 74.4 110.902 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . 0.688 ' HB2' HG22 ' E' ' 266' ' ' THR . 0.4 OUTLIER -167.88 137.24 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 73.34 110.898 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . 0.846 HD12 HG22 ' D' ' 267' ' ' VAL . 0.4 OUTLIER -139.43 115.9 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.31 111.115 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -132.29 118.46 19.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 73.52 110.862 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . 0.593 HG21 ' CG1' ' E' ' 239' ' ' VAL . 1.3 p -136.21 152.83 51.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 74.35 111.104 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.5 167.29 30.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 75.23 110.896 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 63.75 80.47 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 72.04 110.929 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 45.54 51.81 9.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 74.11 110.825 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . 0.405 ' HB1' ' HB ' ' E' ' 233' ' ' THR . . . -104.54 156.66 17.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 65.45 111.196 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -139.16 154.34 48.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 71.42 110.845 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.63 HG12 ' CG2' ' E' ' 275' ' ' VAL . 19.0 m -142.63 135.68 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 74.53 111.119 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -138.52 129.8 27.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 74.12 110.934 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.831 HD22 HG23 ' D' ' 264' ' ' VAL . 5.4 mp -127.51 135.19 50.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 74.3 110.915 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.16 -124.37 2.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.739 -0.743 . . . . 35.43 112.49 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -144.1 128.95 18.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.367 . . . . 75.53 110.93 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 11.0 t -99.91 119.4 47.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 64.2 111.121 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 57.6 t -122.28 112.91 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 74.21 111.131 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . 0.466 HG23 ' O ' ' E' ' 281' ' ' TYR . 43.9 p -71.92 175.05 6.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 63.04 111.145 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' D' ' 282' ' ' GLY . . . -63.0 -40.5 97.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 21.13 111.155 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.01 -51.97 67.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 74.52 111.112 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 72.14 111.125 179.943 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 98.6 m . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.795 0.331 . . . . 74.2 111.132 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -126.19 125.54 42.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 73.11 110.881 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.24 119.71 35.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 74.42 110.856 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . 1.075 HG21 HD12 ' E' ' 277' ' ' ILE . 75.4 t -107.8 115.46 48.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 64.15 111.172 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . 0.572 ' CD ' ' N ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -64.6 -133.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 71.12 110.906 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . 0.688 HG22 ' HB2' ' E' ' 230' ' ' ASP . 7.1 p -94.71 130.03 41.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 71.25 111.139 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 26.4 t -116.47 123.33 71.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 52.03 111.118 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 38.6 t -110.6 118.36 57.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.082 -0.508 . . . . 70.43 111.107 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.81 133.58 11.7 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.715 -0.755 . . . . 71.24 112.563 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.69 116.55 19.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.881 0.372 . . . . 62.32 110.969 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.88 97.74 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.771 -0.728 . . . . 64.34 112.578 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 51.71 89.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 62.44 110.887 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 31.3 t -124.87 146.54 49.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 70.12 110.868 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -127.19 128.69 46.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 74.04 110.895 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.63 ' CG2' HG12 ' E' ' 239' ' ' VAL . 21.9 t -114.89 122.88 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 61.52 111.159 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.16 110.75 12.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.261 -0.427 . . . . 55.43 110.948 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 1.075 HD12 HG21 ' E' ' 264' ' ' VAL . 26.7 mm -113.76 104.87 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.45 111.088 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.92 -161.8 27.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 73.25 112.513 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.22 156.28 26.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 54.44 110.851 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.77 147.26 44.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 73.22 110.882 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . 0.466 ' O ' HG23 ' E' ' 246' ' ' THR . 17.8 m-85 -130.09 125.81 36.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 75.2 110.905 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 C-N-CA 120.739 -0.743 . . . . 63.14 112.478 179.98 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.447 ' N ' HG23 ' A' ' 261' ' ' THR . 21.3 ptt180 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.804 0.335 . . . . 53.4 110.869 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -83.93 119.51 24.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.903 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.97 137.98 53.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 72.2 110.808 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.53 141.11 46.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 55.11 111.104 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -97.36 -35.64 10.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 63.2 110.87 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.461 ' HB3' HG23 ' A' ' 266' ' ' THR . 7.2 t0 -164.33 138.96 5.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.299 -0.41 . . . . 73.23 110.864 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.456 HD13 HD21 ' A' ' 241' ' ' LEU . 11.0 mt -137.61 117.79 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.11 111.069 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.68 120.28 24.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 71.43 110.819 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.32 146.9 48.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 71.51 111.111 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -148.89 167.09 26.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 71.12 110.939 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 66.82 56.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 65.11 110.954 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 14.9 mtm-85 50.41 64.65 1.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.856 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 156.25 18.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 45.1 111.132 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -129.33 135.68 49.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 74.51 110.884 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.462 HG12 ' HB ' ' A' ' 275' ' ' VAL . 20.4 m -139.73 130.13 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 63.21 111.146 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -122.24 132.73 54.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 72.02 110.905 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.456 HD21 HD13 ' A' ' 231' ' ' ILE . 0.7 OUTLIER -130.43 135.1 47.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 53.41 110.862 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.54 -130.92 6.32 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.805 -0.712 . . . . 50.53 112.539 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -144.56 128.89 17.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.866 0.365 . . . . 64.42 110.899 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' A' ' 280' ' ' GLU . 27.0 m -110.26 126.15 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 71.5 111.129 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.2 m -122.47 129.11 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 64.12 111.063 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 281' ' ' TYR . 34.9 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 71.34 111.154 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 21.7 p . . . . . 0 C--O 1.233 0.184 0 CA-C-O 120.882 0.372 . . . . 73.14 111.125 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.447 HG23 ' N ' ' A' ' 225' ' ' ARG . 0.9 OUTLIER -129.78 108.87 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 71.24 111.136 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -101.86 129.05 48.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 74.24 110.92 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 34.7 m -140.44 123.81 16.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 65.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.578 HG21 HG22 ' A' ' 267' ' ' VAL . 8.6 p -120.28 136.7 56.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 73.3 111.109 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -78.65 -76.13 0.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 70.14 110.809 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 230' ' ' ASP . 3.1 m -127.04 130.6 50.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 70.14 111.131 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.578 HG22 HG21 ' A' ' 264' ' ' VAL . 21.6 t -118.2 125.01 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 64.13 111.116 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.25 122.2 63.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 74.45 111.073 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.17 133.76 9.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 43.54 112.478 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.97 147.89 52.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.372 . . . . 73.2 110.889 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.13 78.61 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.688 -0.768 . . . . 71.22 112.449 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 47.28 63.71 1.86 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.855 0.36 . . . . 72.3 110.887 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 46.3 t -90.25 145.66 24.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 54.35 110.815 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.18 128.04 44.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 71.44 110.841 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.738 HG13 HG23 ' B' ' 239' ' ' VAL . 17.4 t -134.54 123.74 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 64.42 111.114 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.69 111.56 18.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 64.32 110.809 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.404 HD13 HD23 ' A' ' 241' ' ' LEU . 2.1 mp -111.61 104.82 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 65.55 111.155 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.06 -161.17 29.86 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 74.35 112.469 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -120.15 150.24 40.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.783 0.325 . . . . 71.02 110.881 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.5 ' HG2' HG12 ' B' ' 244' ' ' VAL . 7.3 pt-20 -124.21 128.6 49.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.894 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.452 ' O ' HG23 ' A' ' 246' ' ' THR . 0.1 OUTLIER -110.05 125.8 53.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.105 -0.498 . . . . 73.21 110.926 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 125.06 159.8 10.49 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.721 -0.752 . . . . 40.23 112.561 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.613 ' H ' ' HB2' ' B' ' 247' ' ' ALA . . . -108.82 -8.3 28.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.711 -0.757 . . . . 74.22 112.514 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -77.32 60.58 2.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.874 0.369 . . . . 71.43 110.892 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.33 97.39 2.46 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.722 -0.751 . . . . 32.13 112.533 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' B' ' 244' ' ' VAL . 0.1 OUTLIER -51.85 -68.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 74.53 110.819 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 15.6 t90 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 71.23 110.956 -179.955 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.432 ' N ' HG23 ' B' ' 261' ' ' THR . 1.6 ptp180 . . . . . 0 C--O 1.23 0.038 0 CA-C-O 120.892 0.377 . . . . 72.15 110.876 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -90.65 121.44 32.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 74.1 110.86 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 47.6 t -130.14 138.04 50.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 43.42 110.875 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.27 161.91 30.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 73.32 111.099 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.7 -31.91 5.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 52.23 110.904 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -164.39 138.79 5.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 24.35 110.911 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 12.9 mt -137.66 119.1 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 65.3 111.152 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 -131.71 119.15 20.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 74.4 110.899 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.1 OUTLIER -134.59 140.71 46.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 52.11 111.189 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -144.67 167.57 22.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 64.44 110.855 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 61.86 63.37 1.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.086 -0.506 . . . . 72.15 110.959 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 47.99 61.05 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 72.21 110.878 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.419 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -104.57 153.29 21.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 64.14 111.113 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 8.3 mtt-85 -129.19 135.6 49.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 75.11 110.863 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.738 HG23 HG13 ' A' ' 275' ' ' VAL . 24.2 m -140.69 123.91 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 73.31 111.137 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.614 ' HB3' HD22 ' B' ' 276' ' ' LEU . 0.1 OUTLIER -118.52 137.2 53.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 64.21 110.974 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.827 HD23 HD13 ' B' ' 277' ' ' ILE . 0.6 OUTLIER -130.06 118.89 22.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 71.45 110.851 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.27 173.7 13.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.704 -0.76 . . . . 71.11 112.477 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -87.8 137.99 31.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 43.13 110.908 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.5 HG12 ' HG2' ' A' ' 280' ' ' GLU . 30.6 m -120.68 125.68 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 64.11 111.132 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.48 129.2 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.31 111.142 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.7 t -71.55 175.1 5.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 72.44 111.149 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.613 ' HB2' ' H ' ' A' ' 283' ' ' GLY . . . -60.41 -40.57 91.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 71.42 111.165 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.02 -36.37 70.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 51.34 111.11 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.623 ' HB2' ' CD1' ' B' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.199 -0.455 . . . . 65.41 111.129 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.837 0.351 . . . . 71.41 110.828 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 30.5 p -100.53 121.99 42.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 72.13 111.196 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.432 HG23 ' N ' ' B' ' 225' ' ' ARG . 0.7 OUTLIER -129.33 133.73 47.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 64.03 111.171 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -125.85 130.01 50.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 62.43 110.905 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.27 123.8 20.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 70.13 110.846 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.502 HG21 ' CG2' ' B' ' 267' ' ' VAL . 13.5 p -119.26 133.18 66.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 60.53 111.109 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.12 -74.97 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.837 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 97.3 m -135.44 133.71 38.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 43.33 111.13 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.502 ' CG2' HG21 ' B' ' 264' ' ' VAL . 21.7 t -118.25 125.88 74.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 63.43 111.099 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 63.4 t -127.31 125.43 65.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 55.04 111.097 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.5 133.82 8.05 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.725 -0.75 . . . . 65.34 112.48 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -130.98 147.62 52.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.816 0.341 . . . . 62.54 110.906 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.43 64.64 3.25 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.83 -0.7 . . . . 62.42 112.439 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.03 96.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.872 0.367 . . . . 71.41 110.874 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 65.1 m -125.36 145.82 49.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 74.24 110.859 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -127.22 127.51 44.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 61.01 110.799 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.674 HG13 HG23 ' C' ' 239' ' ' VAL . 19.3 t -134.6 123.41 41.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 63.34 111.148 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.614 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.2 OUTLIER -118.64 113.39 21.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.252 -0.431 . . . . 61.14 110.922 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.827 HD13 HD23 ' B' ' 241' ' ' LEU . 2.6 mp -110.07 127.11 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 64.12 111.036 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 127.33 -164.46 20.81 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.691 -0.766 . . . . 74.24 112.468 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -115.05 148.46 38.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 73.33 110.871 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.552 ' CG ' HG12 ' C' ' 244' ' ' VAL . 0.9 OUTLIER -119.72 131.38 55.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 62.01 110.904 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.623 ' CD1' ' HB2' ' B' ' 249' ' ' ALA . 26.1 t80 -116.87 125.99 52.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.959 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 129.58 -175.3 19.07 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.727 . . . . 73.11 112.514 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -136.39 51.44 0.81 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.785 -0.722 . . . . 72.15 112.494 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -98.5 25.98 5.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.342 . . . . 72.35 110.914 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 109.9 18.09 9.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.794 -0.717 . . . . 73.41 112.516 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' C' ' 244' ' ' VAL . 0.2 OUTLIER 69.35 -75.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.938 0.399 . . . . 62.23 110.868 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 15.9 t90 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.5 . . . . 74.3 110.868 -179.955 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.781 0.324 . . . . 72.44 110.883 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -92.15 110.03 21.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 60.23 110.855 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 72.7 m -136.75 139.52 41.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 63.5 110.898 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.84 159.67 31.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 63.45 111.119 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -112.82 -29.28 7.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 74.21 110.921 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.7 138.09 4.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 72.34 110.867 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 9.6 mt -137.88 117.77 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 75.2 111.107 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -133.48 118.98 18.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.475 . . . . 74.43 110.926 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.1 OUTLIER -133.21 146.4 51.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 74.45 111.118 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -150.18 167.15 27.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 75.44 110.911 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.38 64.56 1.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 74.35 110.853 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 47.87 60.26 3.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 65.12 110.846 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.445 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -104.21 150.58 24.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 64.43 111.077 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 35.1 mtt85 -126.07 135.38 51.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 72.15 110.875 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.674 HG23 HG13 ' B' ' 275' ' ' VAL . 17.0 m -139.52 121.57 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 72.4 111.175 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.87 137.13 52.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.51 110.952 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 mp -127.49 118.69 24.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 64.42 110.982 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 134.83 -179.99 17.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.777 -0.725 . . . . 32.51 112.496 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -92.11 135.81 33.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 73.03 110.946 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.552 HG12 ' CG ' ' B' ' 280' ' ' GLU . 14.6 m -116.37 126.11 73.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 71.12 111.128 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.425 HG23 ' HA ' ' B' ' 281' ' ' TYR . 32.8 m -117.83 129.55 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 70.11 111.163 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . 0.73 HG22 ' CD2' ' C' ' 281' ' ' TYR . 11.7 t -69.05 171.13 8.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 72.54 111.178 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.7 -33.79 49.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 41.42 111.123 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' C' ' 249' ' ' ALA . . . -56.59 -35.82 68.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 75.04 111.143 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' C' ' 248' ' ' ALA . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 70.2 111.109 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.891 0.377 . . . . 53.04 110.919 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 30.8 p -97.83 129.29 44.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 74.4 111.118 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.637 HG23 ' HB3' ' D' ' 225' ' ' ARG . 0.3 OUTLIER -133.27 124.99 28.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 74.35 111.179 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -126.23 127.11 45.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 60.33 110.853 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.51 123.23 33.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 62.14 110.83 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' D' ' 231' ' ' ILE . 10.5 p -109.48 144.34 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 75.42 111.096 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.68 -65.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 71.53 110.893 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 30.5 p -147.01 138.36 24.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 64.4 111.216 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.502 ' CG1' HG21 ' C' ' 275' ' ' VAL . 23.3 t -117.61 124.93 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 63.54 111.144 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.66 116.02 41.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 72.42 111.117 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.41 133.01 9.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 64.32 112.475 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -132.44 141.27 48.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 75.14 110.866 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.99 68.67 1.39 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 74.22 112.478 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.83 93.72 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.789 0.328 . . . . 72.53 110.964 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 34.3 t -126.06 145.63 50.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 75.05 110.903 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 13.2 mtm-85 -129.55 127.87 41.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 71.43 110.825 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.646 HG22 ' CG2' ' D' ' 239' ' ' VAL . 17.7 t -137.63 131.54 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 74.32 111.16 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.671 HD12 ' CD1' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -128.36 111.66 13.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 64.22 110.947 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 2.6 mp -106.55 104.73 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 74.21 111.124 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.93 -179.88 23.53 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.763 -0.732 . . . . 64.4 112.471 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -89.74 156.11 18.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 75.11 110.887 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.538 ' HG3' HG12 ' D' ' 244' ' ' VAL . 2.6 pp20? -136.36 143.3 43.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 74.5 110.926 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.73 ' CD2' HG22 ' C' ' 246' ' ' THR . 63.3 t80 -130.02 125.46 35.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.42 110.916 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 149.41 116.87 0.84 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 72.21 112.456 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . 0.527 ' H ' ' HB2' ' D' ' 247' ' ' ALA . . . -62.82 -32.78 84.94 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.686 -0.768 . . . . 62.25 112.508 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -73.44 78.19 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.86 0.362 . . . . 64.34 110.912 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 73.77 104.78 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 72.24 112.458 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -58.23 -29.3 65.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 71.43 110.907 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.671 ' CD1' HD12 ' C' ' 276' ' ' LEU . 17.4 t90 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.142 -0.481 . . . . 74.21 110.983 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . 0.637 ' HB3' HG23 ' C' ' 261' ' ' THR . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.814 0.34 . . . . 73.42 110.861 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -82.91 110.57 18.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 73.31 110.865 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 27.0 m -139.74 147.59 41.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 74.12 110.843 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.17 162.36 24.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 64.0 111.099 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.72 -30.79 5.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 65.3 110.918 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.37 139.15 3.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 70.12 110.874 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . 0.423 ' CD1' HG23 ' C' ' 264' ' ' VAL . 14.3 mt -137.76 116.37 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 62.04 111.112 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.0 117.86 15.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 65.3 110.931 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.7 152.27 51.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 74.2 111.165 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -156.62 167.12 31.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 64.25 110.899 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 64.93 66.27 0.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 75.14 110.828 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? 50.24 45.21 26.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 71.02 110.921 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.6 151.53 20.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 72.42 111.084 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 35.0 mtt85 -132.39 135.59 46.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 74.35 110.845 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.646 ' CG2' HG22 ' C' ' 275' ' ' VAL . 0.4 OUTLIER -133.51 121.49 41.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 75.33 111.165 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . 0.523 ' O ' HD22 ' D' ' 241' ' ' LEU . 0.1 OUTLIER -108.44 135.47 49.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 53.33 110.958 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.55 HD21 HD12 ' D' ' 277' ' ' ILE . 3.5 mm? -126.46 118.59 25.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 72.11 110.872 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 123.05 175.0 14.42 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.792 -0.718 . . . . 33.24 112.468 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.66 144.79 25.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 73.21 110.904 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . 0.538 HG12 ' HG3' ' C' ' 280' ' ' GLU . 34.9 m -118.14 134.82 60.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 64.42 111.139 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 2.5 m -117.44 130.33 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 72.45 111.169 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . 0.418 HG21 ' HA2' ' D' ' 282' ' ' GLY . 14.2 t -68.52 174.68 3.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 74.12 111.103 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . 0.527 ' HB2' ' H ' ' C' ' 283' ' ' GLY . . . -52.86 -36.63 59.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 75.11 111.019 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . 0.403 ' H ' HG23 ' D' ' 246' ' ' THR . . . -56.07 -35.46 67.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.21 111.14 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . 0.591 ' HB2' ' HE1' ' C' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 75.43 111.108 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 77.4 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.883 0.373 . . . . 72.44 111.121 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . 0.558 HG23 ' N ' ' D' ' 225' ' ' ARG . 68.8 m -132.63 118.13 18.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 72.14 111.105 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . 0.51 HD21 HG23 ' D' ' 277' ' ' ILE . 1.8 t-20 -124.6 126.6 46.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 44.42 110.881 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.66 122.91 29.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 61.32 110.808 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.545 HG23 HD13 ' E' ' 231' ' ' ILE . 9.3 p -114.36 144.15 22.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 60.14 111.128 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . 0.445 ' HG3' ' HA ' ' E' ' 229' ' ' LYS . 12.8 mt-10 -86.61 -83.13 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 73.23 110.85 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.59 137.89 47.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 72.53 111.108 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.494 HG21 HD11 ' D' ' 277' ' ' ILE . 99.0 t -117.38 119.74 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 65.51 111.124 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.07 121.65 67.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 65.01 111.086 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.94 133.3 9.31 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.731 -0.747 . . . . 75.22 112.495 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.27 143.72 50.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 74.21 110.828 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 45.41 85.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 71.02 112.434 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 49.93 78.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.371 . . . . 61.02 110.863 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.88 144.67 36.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 52.12 110.879 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -132.78 126.24 31.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 74.14 110.897 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.823 HG13 HG23 ' E' ' 239' ' ' VAL . 44.9 t -139.12 123.24 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 72.42 111.094 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.735 HD12 ' CD1' ' D' ' 287' ' ' TRP . 0.5 OUTLIER -114.53 110.55 19.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 54.31 110.938 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.55 HD12 HD21 ' D' ' 241' ' ' LEU . 10.0 mt -104.83 107.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 72.44 111.133 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.21 173.63 15.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 71.31 112.516 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -93.46 137.09 33.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 75.54 110.897 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.86 141.56 45.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.896 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . 0.413 ' CE2' HG22 ' D' ' 246' ' ' THR . 3.0 t80 -130.28 124.73 33.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.943 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . 0.418 ' HA2' HG21 ' D' ' 246' ' ' THR . . . 166.9 37.61 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.747 . . . . 75.54 112.452 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 50.31 -132.06 29.73 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.74 -0.743 . . . . 63.2 112.515 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -29.35 22.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.802 0.334 . . . . 71.21 110.873 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -58.96 97.12 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.75 -0.738 . . . . 71.23 112.52 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' E' ' 244' ' ' VAL . 0.2 OUTLIER -100.0 -176.43 3.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.938 0.399 . . . . 60.21 110.829 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . 0.735 ' CD1' HD12 ' D' ' 276' ' ' LEU . 15.6 t90 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 62.32 110.902 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . 0.406 ' O ' ' HB3' ' E' ' 262' ' ' ASN . 2.4 ttp180 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.777 0.322 . . . . 75.43 110.873 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -145.19 104.16 3.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 72.11 110.858 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.25 143.59 44.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 25.44 110.871 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.99 164.55 19.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 40.35 111.103 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . 0.445 ' HA ' ' HG3' ' D' ' 265' ' ' GLU . 0.9 OUTLIER -119.2 -36.39 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 74.53 110.914 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.26 138.62 3.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 62.12 110.856 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . 0.545 HD13 HG23 ' D' ' 264' ' ' VAL . 3.1 mp -137.81 113.54 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 72.41 111.139 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . 0.4 ' HG3' ' HA ' ' E' ' 268' ' ' VAL . 8.4 ptm180 -137.85 114.69 10.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 72.12 110.889 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.67 150.78 45.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 74.31 111.135 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -156.16 160.28 39.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.816 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 65.44 68.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 62.23 110.906 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 48.83 54.14 11.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.925 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.89 149.08 26.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 70.41 111.083 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -130.47 135.57 48.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 74.24 110.86 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.823 HG23 HG13 ' D' ' 275' ' ' VAL . 31.9 m -139.86 129.11 28.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 75.32 111.192 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . 0.65 ' O ' HD13 ' E' ' 241' ' ' LEU . 0.0 OUTLIER -119.95 137.59 53.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 70.12 110.952 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.961 HD12 HD12 ' E' ' 277' ' ' ILE . 0.9 OUTLIER -122.66 118.91 29.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 71.31 110.869 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 125.85 174.17 13.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.726 -0.749 . . . . 74.43 112.509 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -100.7 163.03 12.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.902 0.382 . . . . 72.03 110.89 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' D' ' 286' ' ' PHE . 2.6 m -121.88 140.47 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 61.32 111.084 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.81 127.99 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 64.12 111.124 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . 0.487 HG21 ' HA2' ' E' ' 282' ' ' GLY . 10.7 t -69.17 168.78 13.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 75.32 111.152 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.01 -33.9 53.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 71.51 111.088 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.2 -50.12 73.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 73.2 111.133 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 61.05 111.131 179.952 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.854 0.359 . . . . 74.23 111.083 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' E' ' 225' ' ' ARG . 3.7 t-20 -129.15 116.42 19.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 61.0 110.891 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 3.1 p -119.7 123.87 44.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 70.41 110.79 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . 0.966 HG21 HD13 ' E' ' 277' ' ' ILE . 1.0 OUTLIER -104.75 137.17 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 64.13 111.163 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . 0.417 ' N ' ' CD ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -74.1 -146.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 34.54 110.912 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 4.1 t -96.56 137.61 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 65.2 111.171 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . 0.751 ' CG1' HG21 ' E' ' 275' ' ' VAL . 95.9 t -115.01 121.64 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 64.14 111.159 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . 0.422 ' O ' HG13 ' E' ' 268' ' ' VAL . 5.7 p -120.96 120.16 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 72.32 111.108 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.36 133.36 11.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.792 -0.718 . . . . 63.11 112.47 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -131.38 116.45 17.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.338 . . . . 72.41 110.907 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 65.67 80.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 71.42 112.517 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 58.66 88.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 73.2 110.92 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 8.9 t -121.29 145.61 47.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 62.22 110.842 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.5 128.05 34.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 73.45 110.858 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.751 HG21 ' CG1' ' E' ' 267' ' ' VAL . 41.7 t -136.97 123.5 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 50.21 111.142 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . 0.592 HD22 ' HB3' ' E' ' 240' ' ' GLN . 0.8 OUTLIER -121.25 110.93 16.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 72.31 110.994 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.966 HD13 HG21 ' E' ' 264' ' ' VAL . 54.1 mt -107.89 137.53 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 75.45 111.096 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 121.31 -161.57 15.34 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.731 -0.747 . . . . 64.24 112.467 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -128.47 156.96 42.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 71.31 110.857 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.03 118.24 31.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 63.42 110.871 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -103.72 124.77 49.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 65.3 110.917 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . 0.487 ' HA2' HG21 ' E' ' 246' ' ' THR . . . . . . . . 0 N--CA 1.45 -0.401 0 C-N-CA 120.785 -0.722 . . . . 50.02 112.529 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.413 ' N ' HG23 ' A' ' 261' ' ' THR . 15.2 ptt180 . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.789 0.328 . . . . 53.32 110.921 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -107.01 122.81 47.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 64.45 110.884 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 68.7 m -121.85 138.03 54.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 71.32 110.833 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.65 121.01 13.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 74.3 111.068 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.04 -35.95 23.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.235 -0.439 . . . . 63.45 110.913 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -164.17 139.19 5.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 75.44 110.926 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 10.1 mt -137.46 117.72 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.4 111.078 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -127.39 119.97 27.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 63.24 110.87 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.58 148.66 52.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 63.15 111.179 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -148.73 167.55 25.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 73.43 110.863 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 66.5 55.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 73.41 110.854 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.96 64.38 1.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 64.43 110.913 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.19 156.34 17.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 62.15 111.061 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -129.4 135.83 49.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.33 110.878 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.485 HG12 ' HB ' ' A' ' 275' ' ' VAL . 34.4 m -143.16 130.17 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 64.41 111.11 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.581 ' OE1' HD21 ' A' ' 276' ' ' LEU . 1.8 tt0 -131.06 137.19 49.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 75.54 110.9 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.702 ' CD2' HD13 ' A' ' 277' ' ' ILE . 0.7 OUTLIER -126.93 118.8 25.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 75.2 110.925 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 154.02 175.16 24.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.72 . . . . 71.43 112.599 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -85.88 131.15 34.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.936 0.398 . . . . 65.21 110.874 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 29.5 t -110.34 124.24 66.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 62.44 111.152 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 49.2 t -118.84 113.01 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 74.41 111.068 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.098 -0.501 . . . . 64.15 111.193 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . 0.435 HG22 ' N ' ' B' ' 225' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.809 0.338 . . . . 74.31 111.228 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 225' ' ' ARG . 0.2 OUTLIER -92.78 110.72 22.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 73.35 111.21 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.441 ' HB2' HG22 ' A' ' 277' ' ' ILE . 1.0 OUTLIER -94.29 120.28 34.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 63.04 110.929 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 41.3 t -131.58 123.8 28.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 73.31 110.81 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.636 HG21 HG22 ' A' ' 267' ' ' VAL . 7.8 p -122.26 137.03 57.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 72.33 111.144 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -83.03 -71.71 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 61.2 110.951 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 38.8 m -125.88 130.26 50.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.13 111.13 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.636 HG22 HG21 ' A' ' 264' ' ' VAL . 27.6 t -118.2 126.11 74.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 74.15 111.14 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 22.1 t -127.29 117.09 46.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 65.41 111.162 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.04 134.04 9.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.778 -0.725 . . . . 52.55 112.491 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -132.14 147.21 52.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.845 0.355 . . . . 74.34 110.904 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 57.94 73.9 0.4 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 31.34 112.479 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 48.42 59.54 4.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.867 0.365 . . . . 64.1 110.914 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 38.4 t -83.86 145.81 28.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 74.35 110.894 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -123.33 127.69 48.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 75.05 110.883 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.485 ' HB ' HG12 ' A' ' 239' ' ' VAL . 13.8 t -130.79 125.7 58.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 65.42 111.114 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.581 HD21 ' OE1' ' A' ' 240' ' ' GLN . 0.5 OUTLIER -124.71 111.84 16.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 75.41 110.914 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.702 HD13 ' CD2' ' A' ' 241' ' ' LEU . 4.7 mp -108.08 104.74 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 61.44 111.133 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.15 168.36 15.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 55.23 112.397 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -94.27 152.78 18.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.737 0.304 . . . . 72.13 110.835 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -123.2 118.87 28.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.906 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.406 ' CE1' HG11 ' B' ' 245' ' ' VAL . 29.1 t80 -117.6 148.37 41.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 63.11 110.942 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.11 -107.63 0.63 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.794 -0.717 . . . . 64.24 112.507 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' B' ' 247' ' ' ALA . . . -172.33 94.49 0.1 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 75.54 112.472 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -179.49 -34.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 74.14 110.844 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.09 -110.32 3.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 70.01 112.52 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.36 -172.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.371 . . . . 53.03 110.809 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 75.0 110.938 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.757 ' HB3' HG23 ' B' ' 261' ' ' THR . 16.7 ttt-85 . . . . . 0 CA--C 1.526 0.058 0 CA-C-O 120.881 0.372 . . . . 73.42 110.81 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -110.26 123.66 50.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 74.33 110.907 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.83 138.31 54.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 64.33 110.903 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -142.35 120.28 12.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 74.24 111.099 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -31.6 21.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 64.31 110.921 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.46 139.18 5.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 60.21 110.818 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 9.4 mt -137.22 117.85 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 74.43 111.165 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -130.89 119.63 22.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.861 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.1 OUTLIER -132.41 146.84 52.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 74.3 111.153 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -147.1 167.28 24.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 62.34 110.878 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 65.6 54.63 1.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 74.42 110.89 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 19.1 mtt85 51.68 62.62 2.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 62.51 110.807 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.443 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -103.57 156.42 17.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 63.21 111.061 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.89 136.02 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 74.54 110.865 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.648 HG12 ' HB ' ' B' ' 275' ' ' VAL . 19.2 m -141.22 121.74 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 73.42 111.161 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.494 ' O ' HD22 ' B' ' 276' ' ' LEU . 1.7 tt0 -123.03 137.19 55.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 71.01 110.955 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.601 HD23 HD13 ' B' ' 277' ' ' ILE . 0.8 OUTLIER -123.74 118.83 28.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.236 -0.438 . . . . 73.23 110.939 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 150.51 171.15 18.49 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 41.31 112.504 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -86.03 139.06 31.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.893 0.377 . . . . 70.42 110.891 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -117.72 124.32 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 54.41 111.107 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.406 HG11 ' CE1' ' A' ' 281' ' ' TYR . 39.5 t -122.02 128.88 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 53.31 111.105 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 15.5 p -86.81 170.64 11.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 73.1 111.173 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.449 ' HB2' ' HA3' ' A' ' 283' ' ' GLY . . . -63.2 -39.08 93.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 72.04 111.123 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.88 69.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 42.52 111.101 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 72.54 111.079 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.885 0.374 . . . . 71.44 110.922 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.92 123.9 45.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 61.41 111.134 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.757 HG23 ' HB3' ' B' ' 225' ' ' ARG . 6.1 m -95.29 108.89 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 73.44 111.098 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.497 ' HB2' HG22 ' B' ' 277' ' ' ILE . 0.7 OUTLIER -95.86 125.04 40.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 70.5 110.827 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 2.9 p -135.59 123.69 22.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 65.34 110.864 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.637 HG21 HG22 ' B' ' 267' ' ' VAL . 9.9 p -119.78 135.78 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 73.35 111.082 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -74.66 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 75.33 110.913 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 76.8 m -122.29 130.05 52.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 62.51 111.152 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.637 HG22 HG21 ' B' ' 264' ' ' VAL . 39.3 t -118.34 123.46 71.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 71.33 111.094 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.33 118.84 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 64.12 111.087 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.1 134.93 9.73 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.681 -0.771 . . . . 53.02 112.457 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -131.58 147.3 52.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 70.5 110.896 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 59.66 72.39 0.62 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.748 -0.739 . . . . 64.44 112.471 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 49.13 59.16 4.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.951 0.405 . . . . 73.14 110.867 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 33.2 t -83.81 145.52 28.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 63.04 110.836 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.95 127.36 47.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 62.45 110.783 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.648 ' HB ' HG12 ' B' ' 239' ' ' VAL . 10.5 t -131.8 128.22 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 75.32 111.115 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.494 HD22 ' O ' ' B' ' 240' ' ' GLN . 2.7 tm? -128.02 111.93 14.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.504 . . . . 52.22 110.959 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.601 HD13 HD23 ' B' ' 241' ' ' LEU . 4.7 mp -106.15 104.6 17.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 61.13 111.14 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.64 179.03 29.56 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.765 -0.731 . . . . 72.23 112.527 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.33 146.17 24.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.774 0.321 . . . . 73.3 110.949 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.86 119.01 34.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 64.03 110.892 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -118.19 125.85 51.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 72.24 110.904 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 137.37 -43.51 1.21 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 73.25 112.494 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 92.91 135.99 7.51 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 65.55 112.515 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -179.33 -34.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.866 0.365 . . . . 63.52 110.924 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 146.51 -90.98 0.15 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.693 -0.765 . . . . 54.21 112.454 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.03 -49.46 3.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 73.23 110.927 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 74.33 110.913 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.813 0.339 . . . . 74.4 110.896 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -122.75 131.25 53.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 65.43 110.886 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.88 137.87 54.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 55.2 110.862 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' B' ' 264' ' ' VAL . . . -137.39 141.02 41.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 65.13 111.065 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.94 -32.82 8.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 64.24 110.898 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.61 138.32 5.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 72.14 110.847 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 7.3 mt -137.53 117.62 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 63.42 111.1 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -128.37 120.47 27.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.88 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.0 OUTLIER -130.63 149.34 52.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 63.4 111.127 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -147.83 168.03 23.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 73.5 110.858 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 61.39 54.4 3.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 70.43 110.844 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 51.1 66.65 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 72.4 110.858 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.596 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -103.58 156.95 17.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 63.31 111.099 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -125.29 135.18 52.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 72.14 110.807 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.612 HG12 ' HB ' ' C' ' 275' ' ' VAL . 6.4 m -137.9 121.92 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 73.13 111.171 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -122.12 137.34 54.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 63.42 110.861 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.548 HD13 HG13 ' B' ' 277' ' ' ILE . 2.7 mp -126.24 118.87 26.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 70.04 110.953 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.53 176.07 15.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 63.53 112.517 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -91.34 128.97 37.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.889 0.376 . . . . 64.33 110.893 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.93 116.53 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 62.51 111.119 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.502 ' CG1' ' HB3' ' C' ' 249' ' ' ALA . 25.8 t -119.93 118.9 58.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 72.44 111.098 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -70.22 174.24 5.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.172 -0.467 . . . . 74.04 111.157 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.76 -37.99 88.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 51.35 111.088 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.84 -52.04 66.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 74.53 111.101 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . 0.502 ' HB3' ' CG1' ' C' ' 245' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 75.42 111.107 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.903 0.382 . . . . 70.35 110.913 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . 0.418 HG22 ' CG ' ' D' ' 225' ' ' ARG . 0.2 OUTLIER -94.33 131.06 40.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.485 . . . . 75.04 111.108 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 64.0 m -91.95 124.94 36.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 54.03 111.168 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.18 129.33 48.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.426 . . . . 51.25 110.856 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 28.9 t -140.86 123.39 16.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 43.54 110.83 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.665 HG21 HG22 ' C' ' 267' ' ' VAL . 7.5 p -116.53 136.52 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 70.14 111.18 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.01 -74.91 0.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 53.05 110.883 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 31.6 m -116.57 127.66 54.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 63.52 111.105 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.665 HG22 HG21 ' C' ' 264' ' ' VAL . 46.8 t -118.68 123.07 70.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 75.32 111.118 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 24.5 t -126.93 127.64 70.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 65.0 111.109 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -131.18 135.3 8.15 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.748 . . . . 61.32 112.528 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -132.45 148.37 52.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.873 0.368 . . . . 73.45 110.866 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.62 76.17 0.21 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.727 -0.749 . . . . 71.33 112.452 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 47.31 58.82 4.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.875 0.369 . . . . 73.41 110.88 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 37.7 t -83.4 145.4 29.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 63.31 110.835 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -124.53 127.92 48.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 71.5 110.899 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.612 ' HB ' HG12 ' C' ' 239' ' ' VAL . 17.0 t -134.13 123.68 44.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 74.04 111.156 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.661 HD12 ' CE3' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -123.97 119.3 29.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 72.32 110.93 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 4.2 mt -112.08 104.52 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 75.11 111.103 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.35 -159.32 28.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 71.4 112.42 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -110.11 155.99 21.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 63.34 110.907 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -131.24 124.39 30.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.139 -0.482 . . . . 70.24 110.913 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -120.92 125.92 48.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 73.44 110.893 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 135.71 161.66 9.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.789 -0.719 . . . . 30.42 112.483 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . 0.589 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . -96.99 110.11 3.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.772 -0.728 . . . . 63.34 112.488 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -179.24 37.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 72.22 110.972 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 53.49 -110.64 1.46 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 44.22 112.514 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.03 -175.96 5.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 71.51 110.888 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.661 ' CE3' HD12 ' C' ' 276' ' ' LEU . 1.7 p90 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 72.34 110.898 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . 0.418 ' CG ' HG22 ' C' ' 260' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.88 0.371 . . . . 75.4 110.874 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -128.13 112.42 14.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 61.03 110.828 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.53 142.66 49.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 62.02 110.856 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' C' ' 264' ' ' VAL . . . -139.73 133.24 30.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 35.11 111.048 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -97.49 -37.11 10.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 64.01 110.881 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -164.3 137.36 5.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 74.31 110.914 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . 0.449 HG23 ' HB ' ' D' ' 267' ' ' VAL . 6.6 mt -137.92 117.66 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 53.2 111.116 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -123.6 115.46 21.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.876 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . 0.576 ' OG1' ' HB3' ' D' ' 237' ' ' ALA . 0.1 OUTLIER -125.4 148.21 48.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 71.33 111.13 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.59 166.22 30.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 60.13 110.88 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 65.54 52.3 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 73.4 110.917 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 54.46 59.62 4.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 75.22 110.834 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . 0.576 ' HB3' ' OG1' ' D' ' 233' ' ' THR . . . -98.27 155.75 17.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.55 111.059 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 38.2 mtt180 -125.95 135.34 51.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 53.11 110.86 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.617 HG12 ' HB ' ' D' ' 275' ' ' VAL . 6.1 m -137.89 121.81 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 73.24 111.122 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.42 137.12 52.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.897 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.633 HD21 HD12 ' D' ' 277' ' ' ILE . 1.1 mm? -120.96 118.24 29.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 72.43 110.923 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.44 -173.32 19.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.795 -0.717 . . . . 51.32 112.483 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.38 149.9 21.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 53.22 110.898 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.23 116.37 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 72.15 111.14 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . 0.666 HG13 ' HB3' ' D' ' 281' ' ' TYR . 50.3 t -115.02 128.98 71.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 72.23 111.137 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 11.8 t -70.65 174.47 5.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 53.33 111.126 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . 0.589 ' HB2' ' N ' ' C' ' 283' ' ' GLY . . . -63.14 -41.83 99.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 71.14 111.04 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.0 -43.42 81.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 73.43 111.13 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.32 111.063 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . 0.628 HG21 HD22 ' E' ' 243' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.816 0.341 . . . . 64.23 111.252 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . 0.4 HG23 ' N ' ' D' ' 225' ' ' ARG . 0.7 OUTLIER -133.9 109.03 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 61.41 111.148 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . 0.563 ' HB2' HG22 ' D' ' 277' ' ' ILE . 0.3 OUTLIER -107.35 120.55 42.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 74.24 110.844 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 57.9 m -132.11 124.06 28.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 72.33 110.819 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.88 ' HA ' ' HB3' ' E' ' 228' ' ' ALA . 7.9 p -106.55 138.87 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.116 -0.493 . . . . 73.42 111.08 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . 0.457 ' HB2' ' HA ' ' E' ' 229' ' ' LYS . 3.0 tt0 -94.52 -29.53 14.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 72.22 110.863 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . 0.492 ' HB ' ' HA ' ' E' ' 230' ' ' ASP . 1.1 m -152.69 129.22 10.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 52.42 111.147 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.658 HG22 HG21 ' D' ' 264' ' ' VAL . 94.1 t -127.18 120.5 55.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 72.33 111.143 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 40.6 t -127.74 128.0 68.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 54.1 111.097 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -135.23 133.31 6.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.738 . . . . 63.04 112.517 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.47 149.36 51.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 70.14 110.908 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.22 81.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.744 -0.741 . . . . 74.24 112.439 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 45.59 57.66 4.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 72.04 110.892 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 29.7 t -83.84 145.14 28.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 63.23 110.816 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -125.94 127.4 45.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 64.35 110.842 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.619 HG13 HG23 ' E' ' 239' ' ' VAL . 17.1 t -137.02 123.79 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 75.33 111.114 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 1.1 tt -128.17 111.72 13.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 65.33 110.907 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.633 HD12 HD21 ' D' ' 241' ' ' LEU . 16.5 mt -102.42 104.54 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 44.51 111.141 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.02 -168.18 32.91 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.746 -0.74 . . . . 72.42 112.491 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -103.39 140.0 38.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 64.32 110.914 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -111.95 134.85 53.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 55.4 110.928 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . 0.666 ' HB3' HG13 ' D' ' 245' ' ' VAL . 1.2 t80 -120.04 125.8 49.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 61.14 110.879 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.52 -160.73 40.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.686 -0.768 . . . . 70.03 112.474 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 52.2 39.24 50.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 62.13 112.455 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 5.6 mptt 68.77 -76.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.351 . . . . 45.01 110.914 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -173.99 29.32 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.624 -0.798 . . . . 63.31 112.435 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.51 -168.75 2.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.907 0.384 . . . . 72.24 110.831 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 75.41 110.934 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.765 0.317 . . . . 72.32 110.874 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -82.2 114.81 20.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 51.35 110.894 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.03 133.59 55.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 65.13 110.875 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . 0.88 ' HB3' ' HA ' ' D' ' 264' ' ' VAL . . . -122.41 170.04 10.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 72.43 111.135 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . 0.644 ' HE3' ' N ' ' E' ' 229' ' ' LYS . 0.0 OUTLIER -140.45 -34.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 62.24 110.893 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . 0.58 ' N ' ' HD2' ' E' ' 229' ' ' LYS . 8.8 t0 -175.62 131.71 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 70.51 110.821 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . 0.643 HG23 HG11 ' E' ' 267' ' ' VAL . 15.5 mt -132.58 115.78 26.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 71.24 111.128 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -110.99 115.26 29.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 74.55 110.937 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' E' ' 237' ' ' ALA . 0.1 OUTLIER -127.99 128.59 45.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 72.24 111.148 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -136.9 166.55 23.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 74.13 110.878 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 61.68 61.11 1.5 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 73.25 110.884 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 40.2 mtt85 49.35 63.93 1.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.45 110.844 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . 0.459 ' HB3' ' OG1' ' E' ' 233' ' ' THR . . . -104.74 156.48 17.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 75.05 111.057 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -128.06 135.85 50.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 64.03 110.92 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.64 HG12 ' HB ' ' E' ' 275' ' ' VAL . 4.5 m -139.25 121.7 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 74.54 111.181 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.83 137.47 54.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.41 110.913 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.502 HD11 ' CD1' ' E' ' 231' ' ' ILE . 4.8 mp -122.61 117.92 26.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.932 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.8 168.18 11.76 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 72.43 112.551 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . 0.628 HD22 HG21 ' D' ' 260' ' ' THR . 1.0 OUTLIER -85.84 133.77 33.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.898 0.38 . . . . 60.03 110.92 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 97.3 t -109.71 135.51 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 71.32 111.13 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . 0.43 HG13 ' HB3' ' E' ' 281' ' ' TYR . 73.4 t -122.17 129.1 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 73.41 111.163 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.7 t -69.77 171.6 8.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 75.22 111.115 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.26 -33.91 75.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 51.41 111.082 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.22 66.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.274 -0.421 . . . . 75.15 111.063 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 42.34 111.118 179.964 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 93.1 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.814 0.34 . . . . 54.52 111.146 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -108.68 119.34 39.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 65.11 110.933 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.04 132.77 40.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 72.52 110.82 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . 0.724 HG22 ' H ' ' E' ' 266' ' ' THR . 9.4 p -116.8 153.82 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 54.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . 0.599 ' O ' ' HD3' ' E' ' 229' ' ' LYS . 0.2 OUTLIER -112.02 -11.0 13.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 75.44 110.866 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . 0.724 ' H ' HG22 ' E' ' 264' ' ' VAL . 0.2 OUTLIER -167.46 126.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.24 111.122 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . 0.643 HG11 HG23 ' E' ' 231' ' ' ILE . 41.0 t -132.16 117.36 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 72.42 111.104 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.21 139.2 52.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 72.22 111.138 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -144.74 133.41 5.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 35.02 112.5 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -134.02 148.06 51.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 52.51 110.838 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 56.29 86.5 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.701 -0.761 . . . . 54.35 112.503 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 44.98 56.76 5.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.898 0.38 . . . . 61.52 110.895 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.42 145.23 29.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 51.24 110.924 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.93 126.96 39.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.893 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.64 ' HB ' HG12 ' E' ' 239' ' ' VAL . 21.2 t -136.05 123.56 34.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 55.32 111.127 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.03 111.44 12.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 75.22 110.905 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 37.3 mt -104.12 104.62 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 72.11 111.05 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 156.85 -174.5 34.51 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.773 -0.727 . . . . 73.02 112.485 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -103.53 153.05 20.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 75.3 110.867 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -116.27 136.35 53.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 71.23 110.825 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . 0.43 ' HB3' HG13 ' E' ' 245' ' ' VAL . 2.7 t80 -117.46 125.78 51.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 65.53 110.886 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 54.54 112.509 179.968 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 . . . . . 0 N--CA 1.458 -0.039 0 CA-C-O 120.859 0.361 . . . . 71.44 110.861 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.409 ' HB3' HG22 ' A' ' 277' ' ' ILE . 3.7 m120 -87.78 112.28 22.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 71.11 110.93 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.65 148.4 49.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 75.11 110.871 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.17 119.3 10.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 62.24 111.057 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.43 -43.99 88.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 74.5 110.921 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -165.48 136.68 3.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 71.24 110.886 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 9.1 pt -139.07 131.78 37.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 72.43 111.144 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -135.05 139.8 45.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 74.12 110.873 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.738 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.5 OUTLIER -136.31 153.82 51.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 74.43 111.154 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -142.72 168.71 19.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 43.32 110.881 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 74.2 -70.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 64.24 110.886 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.73 53.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 73.05 110.818 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.738 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -91.5 156.82 17.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.03 111.076 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -130.98 138.21 49.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 72.44 110.894 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.771 HG12 ' HB ' ' A' ' 275' ' ' VAL . 27.5 m -122.43 125.47 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 75.31 111.146 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -123.24 118.9 28.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 65.12 110.862 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.64 119.34 36.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 65.13 110.952 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 150.86 169.71 17.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 53.3 112.448 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -85.95 133.36 33.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 75.32 110.886 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.7 t -103.96 133.37 48.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 73.33 111.201 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 97.4 t -119.73 121.97 67.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 73.53 111.093 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.469 HG21 ' HG3' ' A' ' 284' ' ' LYS . 3.0 m . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 74.14 111.158 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.844 0.354 . . . . 50.3 111.115 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.428 HG23 ' HB2' ' B' ' 225' ' ' ARG . 3.3 t -125.18 121.8 35.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 72.32 111.189 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -91.24 127.21 36.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 34.15 110.877 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.4 p -142.41 123.07 14.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 72.43 110.896 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.639 HG21 HG22 ' A' ' 267' ' ' VAL . 8.7 p -118.99 134.47 62.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.45 111.125 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -78.33 -75.78 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.5 . . . . 75.31 110.879 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.91 127.13 53.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 60.42 111.199 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.639 HG22 HG21 ' A' ' 264' ' ' VAL . 47.0 t -118.96 120.85 65.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 72.45 111.142 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 74.5 t -123.47 115.29 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 71.51 111.106 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.72 133.6 11.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 75.13 112.5 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 139.92 48.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 74.34 110.854 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.19 81.1 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.733 -0.746 . . . . 63.44 112.545 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 44.7 62.51 2.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.836 0.35 . . . . 72.24 110.96 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.47 145.06 29.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 74.11 110.857 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -113.27 128.05 56.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 61.2 110.883 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.771 ' HB ' HG12 ' A' ' 239' ' ' VAL . 19.9 t -129.53 123.29 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 74.25 111.129 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.43 111.6 13.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 45.11 110.968 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.409 HG22 ' HB3' ' A' ' 226' ' ' ASN . 2.5 mp -110.33 103.89 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 74.22 111.047 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.54 168.69 15.69 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.736 -0.745 . . . . 74.23 112.503 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -89.72 154.22 20.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 61.51 110.908 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.655 ' CD ' HG13 ' B' ' 244' ' ' VAL . 0.0 OUTLIER -127.65 123.78 36.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 60.41 110.877 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -103.51 128.55 50.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 55.35 110.872 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.97 134.74 6.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 65.11 112.456 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.554 ' H ' ' N ' ' B' ' 247' ' ' ALA . . . -83.33 -112.0 0.53 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.811 -0.709 . . . . 63.45 112.525 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.469 ' HG3' HG21 ' A' ' 246' ' ' THR . 0.1 OUTLIER 63.45 25.45 14.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.728 0.299 . . . . 54.4 110.815 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 145.12 -12.97 1.88 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.748 -0.739 . . . . 52.43 112.486 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.74 ' CZ ' HG11 ' B' ' 244' ' ' VAL . 7.7 t80 72.39 -68.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 75.21 110.867 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 14.5 t90 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 73.11 110.939 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.747 ' HG2' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.787 0.327 . . . . 63.24 110.889 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -93.75 112.7 24.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 62.3 110.908 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 32.4 t -127.61 152.32 47.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.851 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.03 124.27 17.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 35.14 111.064 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.07 -40.24 62.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 73.53 110.936 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -166.26 135.87 3.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 72.33 110.824 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 267' ' ' VAL . 8.1 pt -139.15 130.01 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.481 . . . . 73.24 111.16 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.09 137.28 40.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 61.34 110.894 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.758 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.5 OUTLIER -137.1 150.44 48.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 75.34 111.071 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -142.01 168.63 19.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 55.44 110.869 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 73.19 -71.84 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.883 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -177.93 59.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 64.3 110.898 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.758 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -97.88 156.61 16.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 60.44 111.112 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -130.7 135.87 48.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 73.23 110.843 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.729 HG12 ' HB ' ' B' ' 275' ' ' VAL . 27.7 m -122.22 132.15 71.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 70.21 111.166 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -130.22 119.28 22.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.881 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.401 ' HG ' HD13 ' B' ' 277' ' ' ILE . 4.4 mp -111.69 118.4 35.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 70.15 110.892 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 145.23 175.48 18.4 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.777 -0.725 . . . . 71.33 112.491 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.83 129.37 34.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.394 . . . . 70.1 110.879 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.74 HG11 ' CZ ' ' A' ' 286' ' ' PHE . 92.1 t -102.19 114.74 42.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 72.55 111.195 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.519 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 85.0 t -106.76 129.26 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 71.11 111.169 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.425 HG23 ' H ' ' B' ' 249' ' ' ALA . 6.3 t -74.96 169.58 17.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 75.24 111.166 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.554 ' N ' ' H ' ' A' ' 283' ' ' GLY . . . -63.34 -41.8 98.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 72.12 111.084 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.61 -35.85 68.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 73.45 111.101 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.519 ' HB3' ' CG1' ' B' ' 245' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 51.21 111.072 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.851 0.358 . . . . 61.51 110.862 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . 0.596 HG22 ' NH1' ' C' ' 225' ' ' ARG . 18.0 p -79.89 121.85 25.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 73.15 111.238 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.747 HG23 ' HG2' ' B' ' 225' ' ' ARG . 91.2 m -97.28 108.84 21.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 73.03 111.163 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.794 ' HB3' HD23 ' C' ' 241' ' ' LEU . 0.1 OUTLIER -96.26 126.22 41.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 60.34 110.914 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 5.5 t -141.99 123.46 14.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 73.31 110.802 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.711 HG21 HD11 ' C' ' 231' ' ' ILE . 9.8 p -108.19 136.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.041 -0.527 . . . . 73.21 111.18 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -81.83 -77.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 72.43 110.894 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.5 m -121.08 127.94 52.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 75.43 111.104 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.716 HG22 HD11 ' C' ' 231' ' ' ILE . 15.7 t -118.18 120.32 64.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 74.34 111.106 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 41.3 t -123.38 115.04 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 71.23 111.13 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.52 133.09 10.52 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 55.42 112.496 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -132.48 146.97 52.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.751 0.31 . . . . 64.32 110.967 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.04 75.12 0.22 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.761 -0.733 . . . . 43.0 112.468 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 52.82 78.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.88 0.371 . . . . 72.03 110.893 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 1.4 t -103.66 144.7 31.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 70.1 110.906 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.418 ' O ' HG22 ' C' ' 239' ' ' VAL . 0.9 OUTLIER -112.43 127.58 56.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 60.43 110.818 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.729 ' HB ' HG12 ' B' ' 239' ' ' VAL . 97.0 t -130.5 123.62 55.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 70.2 111.16 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.598 HD23 ' CZ2' ' B' ' 287' ' ' TRP . 0.9 OUTLIER -128.88 111.85 13.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 62.22 110.846 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.401 HD13 ' HG ' ' B' ' 241' ' ' LEU . 3.4 mp -107.7 104.34 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 73.5 111.09 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.29 -171.75 29.44 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.745 -0.74 . . . . 75.11 112.519 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.77 147.95 26.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 74.33 110.975 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.527 ' OE1' HG13 ' C' ' 244' ' ' VAL . 1.8 pt-20 -116.8 121.68 42.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 63.34 110.822 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -112.41 125.72 54.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 75.15 110.967 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 140.08 164.58 9.95 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.743 . . . . 74.41 112.485 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . 0.524 ' HA3' ' HB2' ' C' ' 247' ' ' ALA . . . -103.83 -143.5 12.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 53.31 112.503 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 9.9 mttp 56.87 25.3 10.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 72.33 110.866 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 128.75 -117.49 2.5 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.725 -0.75 . . . . 72.22 112.497 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -173.9 -44.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.882 0.372 . . . . 74.25 110.911 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.598 ' CZ2' HD23 ' B' ' 276' ' ' LEU . 3.7 t90 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 55.41 110.844 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.596 ' NH1' HG22 ' B' ' 260' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.815 0.34 . . . . 74.12 110.842 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -94.08 109.86 21.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 73.44 110.903 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 60.7 p -137.02 148.17 46.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 62.01 110.854 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.22 137.56 47.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.501 . . . . 55.13 111.112 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -86.45 -40.49 15.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 72.5 110.911 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -165.47 136.5 3.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 73.55 110.895 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.716 HD11 HG22 ' B' ' 267' ' ' VAL . 8.3 pt -140.13 117.1 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.54 111.12 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -124.48 116.24 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 71.23 110.885 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.626 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.6 OUTLIER -124.46 136.86 54.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 75.53 111.171 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . 0.401 ' HG3' ' HG3' ' C' ' 235' ' ' GLU . 3.8 pt-20 -121.44 166.95 13.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 71.15 110.872 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.401 ' HG3' ' HG3' ' C' ' 234' ' ' GLU . 2.6 mt-10 60.84 -162.91 0.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.496 . . . . 74.25 110.954 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 -72.65 63.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 75.1 110.877 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.626 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -105.62 156.37 18.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 53.34 111.047 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -135.9 135.95 40.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 65.32 110.839 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.449 HG12 ' CG2' ' C' ' 275' ' ' VAL . 17.4 m -134.35 134.41 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 72.44 111.11 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.428 ' HB3' HD22 ' C' ' 276' ' ' LEU . 1.2 tt0 -130.13 137.37 50.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.501 . . . . 73.32 110.888 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.794 HD23 ' HB3' ' B' ' 262' ' ' ASN . 0.3 OUTLIER -119.12 118.35 31.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 73.22 110.857 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 140.47 -177.77 20.48 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.7 -0.762 . . . . 70.4 112.47 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.494 ' HB3' HG21 ' B' ' 260' ' ' THR . 1.4 p-10 -85.84 153.06 22.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.797 0.332 . . . . 74.24 110.906 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.527 HG13 ' OE1' ' B' ' 280' ' ' GLU . 63.8 t -122.08 114.92 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 73.53 111.106 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.571 HG22 ' HB2' ' C' ' 281' ' ' TYR . 3.8 t -108.0 127.7 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 72.41 111.104 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 6.5 t -69.84 175.07 4.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 64.33 111.045 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.524 ' HB2' ' HA3' ' B' ' 283' ' ' GLY . . . -63.15 -45.05 93.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 70.03 111.116 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.92 -35.89 69.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 54.31 111.072 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 51.45 111.065 179.91 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.847 0.356 . . . . 74.4 110.924 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -100.93 135.07 42.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 52.32 111.152 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 4.3 t -115.66 140.89 48.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 72.41 111.142 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.39 124.42 46.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 54.42 110.881 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.6 131.91 36.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 70.55 110.867 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.799 HG23 HD11 ' D' ' 231' ' ' ILE . 13.6 p -115.46 139.98 39.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.505 . . . . 73.42 111.122 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -83.03 -76.0 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 71.4 110.945 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 25.7 m -137.48 130.64 30.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 74.45 111.119 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.53 ' CG2' HG21 ' C' ' 264' ' ' VAL . 21.4 t -118.41 130.64 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.4 111.187 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 25.9 t -127.49 125.92 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 55.35 111.159 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.03 134.13 10.3 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.788 -0.72 . . . . 74.34 112.474 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.95 117.05 20.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 71.32 110.941 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 61.05 81.88 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.766 -0.73 . . . . 64.12 112.447 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 61.98 110.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.876 0.37 . . . . 72.54 110.888 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 5.1 m -148.43 145.12 27.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 74.43 110.873 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -117.61 126.36 52.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 70.52 110.895 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.449 ' CG2' HG12 ' C' ' 239' ' ' VAL . 16.4 t -127.06 123.05 61.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 70.44 111.095 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.446 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.1 OUTLIER -128.14 117.9 22.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.01 110.896 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.76 HD13 HD12 ' C' ' 241' ' ' LEU . 5.1 mp -111.68 103.35 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 71.1 111.153 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.06 -173.87 28.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 74.53 112.509 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -106.36 156.22 18.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 73.4 110.9 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.661 ' CG ' HG22 ' D' ' 244' ' ' VAL . 1.1 pt-20 -115.71 128.45 55.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 65.55 110.897 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.571 ' HB2' HG22 ' C' ' 245' ' ' VAL . 5.0 m-85 -110.8 129.72 55.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 60.32 110.895 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 120.78 167.25 13.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 72.21 112.471 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . 0.548 ' H ' ' HB2' ' D' ' 247' ' ' ALA . . . -110.9 -161.48 17.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.805 -0.712 . . . . 51.53 112.524 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt 50.9 79.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.794 0.331 . . . . 70.35 110.883 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 86.29 86.9 1.03 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 44.44 112.508 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -50.05 -42.13 49.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 74.33 110.83 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.446 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 15.7 t90 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 65.34 110.882 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.846 0.355 . . . . 71.23 110.9 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -88.12 112.36 22.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 75.35 110.901 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.34 137.48 37.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 73.4 110.892 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . 0.73 ' HB2' HD11 ' D' ' 241' ' ' LEU . . . -117.85 119.48 35.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 52.4 111.081 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -75.25 -29.46 60.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 64.23 110.911 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . 0.421 ' HB2' HG22 ' D' ' 266' ' ' THR . 1.6 t0 -166.19 136.15 3.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 73.22 110.876 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . 0.799 HD11 HG23 ' C' ' 264' ' ' VAL . 0.3 OUTLIER -138.66 117.98 14.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 72.52 111.113 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -126.96 125.25 41.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 73.12 110.881 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . 0.535 ' CB ' ' HB3' ' D' ' 237' ' ' ALA . 0.4 OUTLIER -136.33 155.4 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 63.14 111.119 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -152.99 168.68 25.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 72.13 110.888 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 68.71 -80.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 71.22 110.863 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -159.56 55.58 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 75.44 110.822 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . 0.535 ' HB3' ' CB ' ' D' ' 233' ' ' THR . . . -104.8 146.5 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 74.52 111.147 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -125.78 135.37 51.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 64.43 110.836 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.745 HG11 HG22 ' D' ' 231' ' ' ILE . 18.3 m -122.94 121.69 63.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 34.41 111.147 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -116.55 125.83 52.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 73.24 110.885 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.836 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.9 mm? -111.78 117.72 33.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 74.41 110.86 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.71 179.55 17.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 71.44 112.46 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -86.78 163.09 17.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 75.12 110.899 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . 0.661 HG22 ' CG ' ' C' ' 280' ' ' GLU . 78.2 t -133.16 123.67 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 52.54 111.166 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.57 129.26 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.14 111.119 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.4 t -69.59 175.07 4.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 73.13 111.117 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . 0.548 ' HB2' ' H ' ' C' ' 283' ' ' GLY . . . -59.26 -41.57 89.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 62.54 111.144 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.71 -48.85 76.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 73.11 111.189 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 64.42 111.179 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.872 0.368 . . . . 73.53 111.187 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 98.7 m -91.76 140.98 29.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 61.4 111.191 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.64 119.6 29.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.317 -0.401 . . . . 73.54 110.94 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 15.1 m -132.02 122.62 25.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 72.14 110.88 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.547 HG21 ' CG2' ' D' ' 267' ' ' VAL . 7.7 p -108.32 128.33 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 74.13 111.118 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.96 -74.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 75.13 110.824 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . 0.421 HG22 ' HB2' ' D' ' 230' ' ' ASP . 19.3 p -147.37 133.35 19.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 75.11 111.087 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.659 HG11 HG21 ' D' ' 275' ' ' VAL . 14.3 t -117.05 133.17 64.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 71.01 111.171 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 45.7 t -127.01 117.79 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 74.32 111.138 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.04 133.01 10.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.803 -0.713 . . . . 54.01 112.56 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -132.39 115.37 15.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 63.24 110.911 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.75 72.58 0.95 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.799 -0.715 . . . . 71.04 112.487 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 65.52 100.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.805 0.336 . . . . 74.54 110.923 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 2.6 m -135.98 145.0 45.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 64.55 110.861 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.88 127.15 51.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.51 . . . . 70.22 110.859 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.659 HG21 HG11 ' D' ' 267' ' ' VAL . 15.5 t -133.67 123.08 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 74.21 111.165 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.63 121.88 29.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 75.04 110.857 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.836 ' HB ' HD13 ' D' ' 241' ' ' LEU . 5.2 mp -112.36 104.56 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 75.21 111.073 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.86 169.5 13.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 65.11 112.568 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -89.94 153.87 20.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 75.44 110.906 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . 0.602 ' HG3' HG13 ' E' ' 244' ' ' VAL . 2.1 pt-20 -115.01 135.77 53.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 75.54 110.831 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -112.51 125.54 54.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 74.44 110.929 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 92.13 -142.04 15.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 43.4 112.547 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 65.8 111.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 74.4 112.537 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -51.81 -36.93 49.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 74.32 110.882 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -107.48 -83.24 1.55 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.757 -0.735 . . . . 65.32 112.494 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -177.52 171.96 1.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.371 . . . . 75.2 110.863 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 28.3 t90 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 72.42 110.813 -179.95 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . 0.486 ' CB ' HG22 ' E' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.752 0.311 . . . . 72.25 110.848 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -95.42 111.04 23.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 63.02 110.854 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.37 151.01 44.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.091 -0.504 . . . . 74.33 110.813 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -127.13 119.03 25.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 74.1 111.112 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.48 -36.83 83.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.41 110.895 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.85 141.2 3.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.14 110.874 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . 0.689 ' CG2' HG11 ' E' ' 239' ' ' VAL . 6.8 mt -136.56 116.83 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 75.24 111.152 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -123.76 125.35 44.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 74.4 110.836 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . 0.546 ' CB ' ' HB3' ' E' ' 237' ' ' ALA . 0.5 OUTLIER -136.18 153.39 51.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 44.43 111.128 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -156.27 166.5 33.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 74.45 110.858 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 70.22 -73.67 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 74.42 110.844 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 8.1 mtt85 -167.62 57.85 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 73.34 110.884 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . 0.546 ' HB3' ' CB ' ' E' ' 233' ' ' THR . . . -104.81 150.48 24.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 64.43 111.14 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.76 135.65 47.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.296 -0.411 . . . . 74.12 110.805 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.689 HG11 ' CG2' ' E' ' 231' ' ' ILE . 26.8 m -127.22 128.65 70.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 64.44 111.075 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.49 131.64 53.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 73.34 110.898 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.775 HD13 ' HB ' ' E' ' 277' ' ' ILE . 3.7 mm? -115.5 118.61 33.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 43.4 110.922 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.49 176.48 14.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.64 -0.791 . . . . 53.25 112.422 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -85.73 162.67 18.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.858 0.361 . . . . 75.23 110.893 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.602 HG13 ' HG3' ' D' ' 280' ' ' GLU . 86.2 t -132.58 128.93 58.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 65.45 111.129 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . 0.404 ' O ' HG13 ' E' ' 245' ' ' VAL . 14.8 p -122.31 129.17 75.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 73.25 111.093 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . 0.415 HG21 ' HA2' ' E' ' 282' ' ' GLY . 14.9 t -69.51 170.98 9.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 63.53 111.182 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.49 -33.78 68.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 75.1 111.097 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.62 -35.87 68.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 73.43 111.135 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 33.01 111.083 179.891 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . 0.486 HG22 ' CB ' ' E' ' 225' ' ' ARG . 24.9 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.882 0.373 . . . . 74.53 111.13 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -118.42 118.27 31.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 74.45 110.874 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.31 116.9 24.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.02 110.859 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . 0.551 ' O ' HG13 ' E' ' 264' ' ' VAL . 13.8 p -105.16 117.83 51.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 45.43 111.072 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . 0.551 ' CD ' ' N ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -62.04 -134.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 74.05 110.869 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.99 126.19 40.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 65.22 111.126 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 19.3 t -116.28 135.14 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 64.53 111.146 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.82 115.27 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 41.32 111.131 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.01 132.64 10.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 73.12 112.457 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -132.21 114.23 14.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.358 . . . . 73.05 110.833 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.46 73.42 1.1 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.753 -0.736 . . . . 70.12 112.46 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.42 103.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.804 0.335 . . . . 62.42 110.94 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 3.9 t -138.31 145.37 41.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 72.54 110.874 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.0 128.59 43.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 74.32 110.867 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.502 ' HB ' HG12 ' E' ' 239' ' ' VAL . 19.3 t -136.27 123.3 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 74.04 111.172 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . 0.413 HD22 ' O ' ' E' ' 275' ' ' VAL . 1.2 mm? -128.14 122.26 31.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.269 -0.423 . . . . 71.22 110.89 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.775 ' HB ' HD13 ' E' ' 241' ' ' LEU . 5.0 mp -113.74 125.1 70.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 73.32 111.143 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 128.27 -172.17 19.28 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.653 -0.784 . . . . 71.14 112.43 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.53 156.04 16.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 71.22 110.933 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -124.84 139.22 54.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 74.22 110.94 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -130.54 125.16 33.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 73.13 110.984 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . 0.415 ' HA2' HG21 ' E' ' 246' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.69 -0.767 . . . . 73.14 112.453 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.052 0 CA-C-O 120.828 0.347 . . . . 63.24 110.846 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.541 ' OD1' HG22 ' A' ' 277' ' ' ILE . 9.0 t30 -142.21 137.56 30.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 52.01 110.92 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.31 148.67 50.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 54.34 110.888 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.26 119.31 10.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.4 111.058 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.59 -49.29 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 71.14 110.898 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -165.22 136.9 4.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 75.11 110.875 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.677 HG22 ' CG2' ' A' ' 267' ' ' VAL . 5.9 pt -135.49 130.77 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 71.24 111.127 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.7 125.41 27.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 74.42 110.882 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.557 HG21 HG13 ' A' ' 239' ' ' VAL . 1.6 p -136.86 149.59 47.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 73.25 111.126 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.27 168.51 19.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 62.33 110.869 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 64.63 74.73 0.39 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 73.14 110.893 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 40.85 59.29 2.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 72.12 110.905 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.499 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -103.36 157.19 17.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 72.44 111.04 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.97 143.94 47.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 75.5 110.926 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.707 HG12 ' HB ' ' A' ' 275' ' ' VAL . 14.8 m -134.73 120.6 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 70.54 111.033 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -116.34 129.68 56.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 72.25 110.936 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.5 mp -111.86 117.91 34.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 71.22 110.947 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.25 -166.51 24.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.786 -0.721 . . . . 54.12 112.516 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -108.25 141.7 39.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.971 0.415 . . . . 61.12 110.838 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 244' ' ' VAL . 32.0 m -115.52 118.0 57.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.138 -0.483 . . . . 51.5 111.13 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.708 HG12 ' HB2' ' A' ' 281' ' ' TYR . 6.5 m -123.43 123.03 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 74.33 111.129 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 281' ' ' TYR . 3.2 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 75.02 111.173 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 56.6 m . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.742 0.306 . . . . 64.25 111.198 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 261' ' ' THR . 6.0 t -106.07 122.35 46.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 60.42 111.15 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.02 136.34 52.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 73.45 110.917 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 8.2 t -142.55 123.6 14.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 65.21 110.822 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.58 134.98 54.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 61.24 111.136 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.74 -77.76 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 71.0 110.851 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.22 127.68 53.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 60.43 111.115 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.909 HG13 HD11 ' B' ' 231' ' ' ILE . 0.4 OUTLIER -117.89 131.46 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 71.25 111.111 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.46 116.06 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 62.25 111.115 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.12 133.29 10.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.802 -0.713 . . . . 72.21 112.517 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -133.35 148.51 51.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 63.45 110.872 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.55 79.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.785 -0.721 . . . . 61.21 112.493 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 46.83 66.37 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 75.01 110.907 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 29.6 t -92.78 145.14 24.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 65.34 110.82 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.56 128.19 54.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 70.31 110.856 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.707 ' HB ' HG12 ' A' ' 239' ' ' VAL . 19.3 t -119.25 123.15 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 72.3 111.139 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -129.45 111.49 12.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 73.12 110.937 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.634 ' CD1' HD13 ' B' ' 241' ' ' LEU . 7.2 mm -106.97 110.39 31.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 64.12 111.088 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.15 -178.34 18.84 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 73.33 112.482 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -88.96 156.59 18.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 70.31 110.916 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.769 ' CG ' HG12 ' B' ' 244' ' ' VAL . 0.9 OUTLIER -135.23 146.7 48.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 64.14 110.902 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.767 ' O ' HG22 ' A' ' 246' ' ' THR . 9.2 m-85 -123.06 122.45 38.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 63.32 110.901 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -127.83 -155.99 8.92 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.726 -0.749 . . . . 71.44 112.497 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -144.32 18.5 2.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 72.31 112.478 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.67 -51.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 71.13 110.942 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -102.28 -169.11 26.92 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.729 . . . . 71.34 112.5 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -136.54 31.74 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.911 0.386 . . . . 75.54 110.895 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 75.34 110.975 -179.914 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.726 ' HB3' HG23 ' B' ' 261' ' ' THR . 2.8 mtp180 . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.838 0.351 . . . . 54.0 110.854 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -134.28 110.58 9.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 74.12 110.925 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.95 138.74 54.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 73.43 110.895 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.99 120.01 20.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 72.0 111.175 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -74.88 -35.69 62.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 63.13 110.844 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -166.05 135.8 3.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 71.21 110.864 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.909 HD11 HG13 ' A' ' 267' ' ' VAL . 7.4 pt -141.07 131.58 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 74.13 111.155 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.72 126.8 27.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.837 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.733 HG21 HG13 ' B' ' 239' ' ' VAL . 2.3 p -135.05 140.38 45.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 55.52 111.095 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.19 167.56 21.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 62.11 110.852 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 68.09 69.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 73.41 110.861 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 46.88 35.2 3.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 73.31 110.935 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.42 156.14 20.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 75.23 111.057 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.65 144.6 47.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.25 110.823 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.739 HG12 ' HB ' ' B' ' 275' ' ' VAL . 0.0 OUTLIER -123.71 121.31 62.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 75.25 111.162 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.413 ' HB3' HD22 ' B' ' 276' ' ' LEU . 0.9 OUTLIER -118.24 117.45 29.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.04 110.911 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.634 HD13 ' CD1' ' A' ' 277' ' ' ILE . 4.2 mp -111.48 117.71 33.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 74.15 110.898 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.37 -165.69 26.65 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 54.42 112.505 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -109.07 135.5 50.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 55.21 110.907 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.769 HG12 ' CG ' ' A' ' 280' ' ' GLU . 33.6 m -106.62 123.04 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 54.43 111.142 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' B' ' 281' ' ' TYR . 0.1 OUTLIER -124.54 121.52 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 62.33 111.136 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.3 t -87.76 161.68 17.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 65.31 111.139 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.16 90.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 51.33 111.172 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.11 -34.9 64.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 73.51 111.131 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 74.42 111.136 179.894 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.88 0.372 . . . . 61.02 110.936 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 1.3 m -99.17 136.52 39.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 70.55 111.113 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.726 HG23 ' HB3' ' B' ' 225' ' ' ARG . 97.2 m -134.14 108.82 8.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.426 . . . . 73.15 111.133 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -111.36 132.73 54.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.862 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.9 p -140.0 123.6 17.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 63.23 110.89 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.736 HG21 ' CG1' ' B' ' 267' ' ' VAL . 3.7 p -115.07 144.71 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 64.12 111.095 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.14 -52.09 5.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 74.43 110.875 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 25.1 m -150.33 126.98 10.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 53.55 111.185 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.736 ' CG1' HG21 ' B' ' 264' ' ' VAL . 32.6 m -123.14 136.85 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 62.31 111.11 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 37.8 t -127.22 129.62 70.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 62.32 111.128 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.24 133.4 8.42 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.8 -0.714 . . . . 74.4 112.517 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -133.18 148.92 52.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 74.21 110.89 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.4 87.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.697 -0.763 . . . . 64.21 112.477 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 41.39 50.73 3.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 62.0 110.873 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 47.9 t -83.21 144.87 29.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 73.42 110.833 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 129.85 48.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.098 -0.501 . . . . 73.32 110.871 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.739 ' HB ' HG12 ' B' ' 239' ' ' VAL . 11.9 t -114.14 130.67 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 73.11 111.147 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.413 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.8 OUTLIER -128.73 111.24 12.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 64.34 110.886 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.704 ' CD1' HD13 ' C' ' 241' ' ' LEU . 21.9 mm -110.15 103.43 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 71.12 111.126 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 142.01 -172.45 24.11 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.725 -0.75 . . . . 75.11 112.507 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -91.42 156.35 17.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.708 0.29 . . . . 65.23 110.954 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.648 ' CG ' HG12 ' C' ' 244' ' ' VAL . 0.0 OUTLIER -131.16 142.27 50.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 71.31 110.864 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.498 ' HB2' HG13 ' B' ' 245' ' ' VAL . 8.7 m-85 -127.19 122.83 35.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 64.44 110.936 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -129.97 -158.64 9.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 50.44 112.486 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -111.77 -20.72 6.72 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 33.33 112.465 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.59 34.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 64.41 110.944 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -142.8 176.51 22.41 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.708 -0.758 . . . . 72.24 112.472 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -116.68 -22.88 8.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.837 0.351 . . . . 71.22 110.894 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 72.3 110.913 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.579 ' O ' HG23 ' C' ' 261' ' ' THR . 58.6 ttp180 . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.834 0.349 . . . . 74.3 110.835 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.527 ' OD1' HG22 ' C' ' 277' ' ' ILE . 3.2 t30 -88.06 124.28 33.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.457 . . . . 52.13 110.871 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.5 142.9 50.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 55.31 110.87 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.67 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -137.88 119.17 14.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 52.31 111.097 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.53 -45.83 35.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 73.41 110.905 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -165.97 135.6 3.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 74.03 110.836 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.592 HG22 ' CG2' ' C' ' 267' ' ' VAL . 5.5 pt -138.14 132.1 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 70.15 111.12 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.61 121.44 19.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.827 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.584 HG21 HG13 ' C' ' 239' ' ' VAL . 1.8 p -135.87 138.17 42.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 73.34 111.104 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -138.8 167.71 21.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 61.02 110.877 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 68.95 73.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 71.23 110.838 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 45.07 54.21 7.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 72.14 110.881 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 156.25 18.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 74.44 111.097 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.94 143.7 38.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 61.24 110.804 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.66 HG12 ' HB ' ' C' ' 275' ' ' VAL . 14.8 m -129.5 133.83 64.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 75.23 111.107 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.496 ' OE1' HD21 ' C' ' 276' ' ' LEU . 3.7 tm0? -130.35 120.7 24.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 65.22 110.96 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.704 HD13 ' CD1' ' B' ' 277' ' ' ILE . 5.9 mp -111.64 118.36 35.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 70.03 110.907 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.65 -178.4 19.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.726 -0.75 . . . . 30.32 112.457 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -97.47 128.81 44.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.853 0.359 . . . . 63.24 110.905 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.648 HG12 ' CG ' ' B' ' 280' ' ' GLU . 32.5 m -96.18 127.79 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 71.52 111.154 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.49 129.23 74.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 60.03 111.112 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.4 t -83.83 165.07 19.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 54.41 111.109 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.14 -34.09 76.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 70.01 111.111 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' C' ' 249' ' ' ALA . . . -56.72 -36.21 69.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 73.02 111.102 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' C' ' 248' ' ' ALA . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 74.42 111.054 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 11.0 mp0 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.85 0.357 . . . . 63.35 110.937 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . 0.406 HG22 HD21 ' C' ' 262' ' ' ASN . 1.7 m -100.78 136.06 41.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 53.3 111.145 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.579 HG23 ' O ' ' C' ' 225' ' ' ARG . 96.1 m -125.15 116.83 22.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 72.15 111.121 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . 0.406 HD21 HG22 ' C' ' 260' ' ' THR . 3.0 m120 -126.05 149.8 48.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 62.33 110.916 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 1.8 m -141.72 123.71 15.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 72.42 110.886 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.784 HG21 HD11 ' D' ' 231' ' ' ILE . 5.9 p -109.99 138.93 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 62.42 111.071 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.6 -74.19 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 72.55 110.935 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 7.4 m -126.26 127.79 46.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 52.02 111.156 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.592 ' CG2' HG22 ' C' ' 231' ' ' ILE . 0.3 OUTLIER -117.74 129.69 73.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.21 111.145 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 19.4 t -127.98 115.97 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 74.04 111.132 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.75 133.56 10.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.692 -0.766 . . . . 72.2 112.485 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.06 147.6 52.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.342 . . . . 65.15 110.867 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.43 84.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.785 -0.721 . . . . 64.45 112.43 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 48.06 75.74 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 74.04 110.958 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.69 145.06 32.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 73.43 110.865 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.47 128.42 48.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 73.03 110.822 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.66 ' HB ' HG12 ' C' ' 239' ' ' VAL . 21.3 t -121.32 123.41 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 75.35 111.124 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.788 HD12 ' CE2' ' C' ' 287' ' ' TRP . 0.1 OUTLIER -128.75 113.42 15.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 71.15 110.964 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.723 HD12 HD22 ' D' ' 241' ' ' LEU . 19.0 mm -112.17 104.08 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 52.21 111.093 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.74 -177.07 27.22 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.711 -0.757 . . . . 71.04 112.439 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -95.04 156.19 16.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 74.12 110.971 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.402 ' HG2' HG12 ' D' ' 244' ' ' VAL . 0.0 OUTLIER -126.12 130.93 52.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 75.31 110.847 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -119.23 125.65 49.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 72.52 110.958 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.93 171.91 13.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.692 -0.766 . . . . 63.34 112.466 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . 0.506 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . -70.92 -139.73 0.19 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.782 -0.723 . . . . 40.25 112.487 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 63.15 24.81 14.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.34 . . . . 72.23 110.908 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 61.9 -95.21 0.1 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.685 -0.769 . . . . 62.22 112.441 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -112.58 -175.3 2.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 71.14 110.95 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.788 ' CE2' HD12 ' C' ' 276' ' ' LEU . 21.0 t90 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.236 -0.438 . . . . 74.43 110.93 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . 0.537 ' N ' HG23 ' D' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.83 0.347 . . . . 75.11 110.843 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . 0.507 ' OD1' HG22 ' D' ' 277' ' ' ILE . 2.2 t30 -83.28 111.23 18.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 54.14 110.87 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 4.3 m -126.31 138.13 53.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 60.35 110.852 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.58 123.49 39.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 71.15 111.095 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -40.29 58.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 72.42 110.946 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -165.96 135.95 3.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 73.04 110.895 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . 0.784 HD11 HG21 ' C' ' 264' ' ' VAL . 9.0 pt -141.36 117.66 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 73.03 111.111 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . 0.634 HH11 HG22 ' D' ' 268' ' ' VAL . 0.0 OUTLIER -130.78 122.86 27.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.473 . . . . 62.51 110.928 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . 0.457 HG21 ' CG1' ' D' ' 239' ' ' VAL . 3.0 p -135.94 149.17 48.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 54.21 111.154 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -145.66 167.19 23.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 70.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 67.22 79.86 0.22 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 73.04 110.92 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 42.62 52.28 4.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 75.43 110.857 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.22 156.31 18.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 63.42 111.08 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.16 142.03 25.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.829 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.537 HG12 ' HB ' ' D' ' 275' ' ' VAL . 19.7 m -128.89 139.75 51.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 74.43 111.134 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -128.75 126.03 39.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 52.23 110.915 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.723 HD22 HD12 ' C' ' 277' ' ' ILE . 10.8 mp -111.73 135.21 52.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 74.14 110.875 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 114.74 -176.16 16.6 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.713 -0.756 . . . . 62.32 112.433 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -100.36 135.21 42.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.876 0.37 . . . . 71.21 110.88 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . 0.402 HG12 ' HG2' ' C' ' 280' ' ' GLU . 22.7 m -104.07 133.48 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 52.03 111.137 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 39.9 t -122.22 129.47 75.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 54.3 111.05 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . 0.403 HG23 ' H ' ' D' ' 249' ' ' ALA . 10.9 t -69.55 175.1 4.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 73.21 111.213 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . 0.506 ' HB2' ' N ' ' C' ' 283' ' ' GLY . . . -62.79 -42.92 99.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 52.33 111.078 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.85 74.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 64.33 111.106 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . 0.403 ' H ' HG23 ' D' ' 246' ' ' THR . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 73.31 111.023 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.815 0.341 . . . . 53.41 111.143 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . 0.537 HG23 ' N ' ' D' ' 225' ' ' ARG . 90.2 m -93.24 113.45 25.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 71.41 111.206 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -126.25 145.55 50.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 75.23 110.924 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 21.9 t -135.53 123.8 23.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 73.21 110.8 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.724 HG23 HD11 ' E' ' 231' ' ' ILE . 14.2 p -112.35 133.2 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 75.43 111.167 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.91 -75.18 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 72.41 110.872 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 26.5 m -133.73 132.65 40.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 65.34 111.161 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.645 ' CG2' HG22 ' D' ' 231' ' ' ILE . 13.6 t -117.78 127.36 75.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 44.31 111.076 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . 0.634 HG22 HH11 ' D' ' 232' ' ' ARG . 21.2 t -125.12 116.04 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 34.23 111.129 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.29 132.94 10.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.788 -0.72 . . . . 60.2 112.547 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.4 143.93 50.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 53.05 110.891 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 47.15 85.31 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.716 -0.754 . . . . 74.33 112.483 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 52.74 89.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.847 0.356 . . . . 63.53 110.927 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 47.8 t -126.12 145.01 50.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 73.4 110.829 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 11.8 mtt85 -127.7 128.23 45.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 74.4 110.862 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.537 ' HB ' HG12 ' D' ' 239' ' ' VAL . 23.2 t -119.36 123.68 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 65.33 111.129 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.617 HD12 ' CE2' ' D' ' 287' ' ' TRP . 0.4 OUTLIER -124.47 113.05 17.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 74.34 110.863 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.507 HG22 ' OD1' ' D' ' 226' ' ' ASN . 17.8 mm -112.33 104.21 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 65.35 111.144 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.61 -146.59 16.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.758 -0.734 . . . . 72.24 112.525 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -128.19 150.04 50.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 75.13 110.853 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -111.76 127.16 55.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.965 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . 0.44 ' CZ ' HG21 ' E' ' 245' ' ' VAL . 10.8 m-85 -120.21 125.4 48.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.22 110.898 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 122.99 160.16 10.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 60.32 112.41 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . 0.63 ' N ' ' HB2' ' E' ' 247' ' ' ALA . . . 62.26 163.55 0.32 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 32.23 112.479 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -110.34 48.42 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 71.34 110.927 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -137.04 -92.62 0.31 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.738 -0.744 . . . . 44.32 112.518 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . 0.741 ' CE1' HG11 ' E' ' 244' ' ' VAL . 40.4 t80 -179.6 -64.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 61.22 110.849 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . 0.617 ' CE2' HD12 ' D' ' 276' ' ' LEU . 10.4 t90 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 75.4 110.919 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . 0.658 ' N ' ' HG1' ' E' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.822 0.344 . . . . 71.15 110.904 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.9 112.31 19.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 70.35 110.878 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 19.3 m -131.23 138.7 49.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.31 110.838 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . 0.416 ' HA ' HG13 ' E' ' 264' ' ' VAL . . . -120.52 132.74 55.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 61.54 111.092 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.6 -32.39 41.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 73.1 110.867 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . 0.526 ' CB ' HG22 ' E' ' 266' ' ' THR . 0.7 OUTLIER -165.79 139.03 4.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.415 . . . . 64.31 110.91 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . 0.724 HD11 HG23 ' D' ' 264' ' ' VAL . 0.4 OUTLIER -138.71 116.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 72.15 111.151 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . 0.407 ' CD ' HG22 ' E' ' 268' ' ' VAL . 8.6 ptm180 -129.89 117.77 20.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.861 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . 0.582 HG21 HG13 ' E' ' 239' ' ' VAL . 7.8 p -135.43 151.91 50.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 73.42 111.105 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -157.47 167.27 30.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.907 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 67.54 75.13 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 63.41 110.848 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 45.78 42.9 9.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 63.44 110.864 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' E' ' 233' ' ' THR . . . -104.09 150.61 24.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 73.24 111.045 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . 0.497 HH12 ' N ' ' E' ' 240' ' ' GLN . 0.0 OUTLIER -133.7 148.11 51.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 71.04 110.902 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.674 HG12 ' CG2' ' E' ' 275' ' ' VAL . 6.8 m -130.47 124.13 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 74.5 111.134 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . 0.497 ' N ' HH12 ' E' ' 238' ' ' ARG . 8.6 tm0? -114.65 126.12 54.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 53.33 110.933 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.87 121.4 43.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 72.04 110.941 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 122.03 175.61 14.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 53.4 112.513 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -85.63 139.53 31.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 70.4 110.824 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.741 HG11 ' CE1' ' D' ' 286' ' ' PHE . 30.1 m -104.84 139.17 26.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 53.44 111.135 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . 0.44 HG21 ' CZ ' ' D' ' 281' ' ' TYR . 87.1 t -122.41 129.43 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 64.45 111.095 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.7 t -69.0 174.28 4.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 62.14 111.143 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . 0.63 ' HB2' ' N ' ' D' ' 283' ' ' GLY . . . -59.0 -43.54 91.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 73.42 111.09 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.98 -48.63 77.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 55.3 111.05 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 72.43 111.042 179.971 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . 0.658 ' HG1' ' N ' ' E' ' 225' ' ' ARG . 2.8 t . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.773 0.321 . . . . 63.22 111.09 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.42 150.88 48.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 63.41 110.845 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 68.3 m -139.33 131.98 28.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 73.44 110.887 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . 0.519 HG21 ' CG2' ' E' ' 267' ' ' VAL . 3.6 p -129.28 122.07 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 71.31 111.157 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.25 -78.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 71.33 110.862 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . 0.526 HG22 ' CB ' ' E' ' 230' ' ' ASP . 72.5 p -143.48 135.83 27.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 64.42 111.212 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . 0.519 ' CG2' HG21 ' E' ' 264' ' ' VAL . 18.0 t -117.44 134.6 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 75.13 111.141 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . 0.407 HG22 ' CD ' ' E' ' 232' ' ' ARG . 47.4 t -126.74 119.97 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.3 111.126 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.89 133.27 10.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 73.44 112.548 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.79 126.4 32.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.815 0.34 . . . . 64.54 110.893 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.7 94.44 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 52.34 112.477 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 50.05 75.14 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.92 0.391 . . . . 75.44 110.86 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 7.6 t -114.79 145.6 41.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.474 . . . . 63.22 110.802 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 24.2 mtm-85 -130.85 127.3 38.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 75.14 110.913 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.674 ' CG2' HG12 ' E' ' 239' ' ' VAL . 21.3 t -116.53 125.3 73.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 62.34 111.165 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . 0.514 HD21 ' HE1' ' D' ' 286' ' ' PHE . 0.3 OUTLIER -125.72 111.73 15.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 73.41 110.953 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 31.6 mm -112.9 103.69 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 51.23 111.155 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 137.66 -178.66 18.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.8 -0.714 . . . . 55.55 112.52 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -89.92 156.19 18.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 63.24 110.859 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -121.37 134.31 55.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 64.5 110.879 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -114.35 124.74 52.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 55.23 110.92 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 C-N-CA 120.795 -0.717 . . . . 44.15 112.512 -179.996 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.639 ' O ' HG23 ' A' ' 261' ' ' THR . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.794 0.331 . . . . 72.13 110.917 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -85.15 135.18 34.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 73.53 110.87 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 1.7 m -118.91 136.94 53.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 51.11 110.854 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.35 139.72 39.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.482 . . . . 72.54 111.063 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.95 -73.11 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 64.4 110.931 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -130.43 138.53 50.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 63.4 110.845 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.41 116.71 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 71.32 111.1 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -118.74 115.85 25.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 44.45 110.861 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.75 146.45 52.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.194 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.05 154.96 31.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 74.31 110.883 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 64.23 82.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 55.22 110.934 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 41.85 43.57 2.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.848 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.25 137.93 31.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.092 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 141.9 51.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 73.12 110.809 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.539 HG23 ' HB ' ' A' ' 275' ' ' VAL . 6.0 p -143.58 121.68 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 74.02 111.134 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -122.0 136.61 54.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 61.44 110.888 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.75 118.87 21.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 73.34 110.94 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.72 -120.39 1.05 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.739 . . . . 52.31 112.503 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -144.77 130.28 18.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 72.1 110.86 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -101.95 136.29 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 72.45 111.136 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 38.5 t -122.15 129.12 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 74.42 111.122 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.591 HG21 ' HB2' ' A' ' 284' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 73.42 111.136 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . 0.606 HG21 ' HB3' ' A' ' 279' ' ' ASN . 7.0 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.882 0.373 . . . . 73.54 111.084 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 225' ' ' ARG . 91.9 m -112.79 108.85 18.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 75.23 111.186 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -104.96 138.91 40.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 73.12 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 92.4 p -140.48 123.87 16.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.53 110.833 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.65 HG21 ' CG2' ' A' ' 267' ' ' VAL . 9.6 p -108.26 149.77 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 74.23 111.137 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -102.44 -39.79 6.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 65.11 110.866 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.4 m -150.41 127.31 11.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.453 . . . . 62.1 111.099 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.65 ' CG2' HG21 ' A' ' 264' ' ' VAL . 80.9 t -121.28 120.19 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 61.13 111.08 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.02 129.48 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 73.13 111.206 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -139.73 133.26 5.98 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.764 -0.732 . . . . 71.22 112.49 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.89 147.39 51.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.877 0.37 . . . . 53.33 110.896 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 53.94 89.91 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.665 -0.779 . . . . 61.35 112.533 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 45.23 60.18 3.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 70.15 110.817 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 6.4 t -91.25 145.54 24.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 75.42 110.862 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -132.32 127.8 36.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 74.21 110.884 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.539 ' HB ' HG23 ' A' ' 239' ' ' VAL . 20.3 t -131.85 123.66 51.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 50.41 111.119 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.71 111.59 17.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 73.33 110.931 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 2.3 mp -107.17 104.29 16.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 75.11 111.117 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.04 -152.29 24.42 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.749 -0.738 . . . . 73.22 112.496 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.606 ' HB3' HG21 ' A' ' 260' ' ' THR . 1.6 p30 -127.81 151.52 48.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 75.31 110.878 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.03 124.69 48.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 72.4 110.886 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -106.91 125.86 51.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 74.54 110.923 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 112.65 -68.97 0.23 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.724 . . . . 74.35 112.522 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 101.33 -101.71 2.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.768 -0.729 . . . . 72.24 112.499 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.591 ' HB2' HG21 ' A' ' 246' ' ' THR . 0.0 OUTLIER 63.83 45.93 4.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 73.12 110.828 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.79 17.57 11.8 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.782 -0.723 . . . . 35.31 112.511 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.69 170.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.817 0.341 . . . . 71.32 110.828 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.488 . . . . 75.22 110.915 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.599 ' O ' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.812 0.339 . . . . 64.21 110.861 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -123.15 138.52 54.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 64.42 110.911 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.98 137.7 54.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 70.02 110.804 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 264' ' ' VAL . . . -132.87 140.39 47.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 65.01 111.064 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.07 -31.5 9.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 74.1 110.89 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -164.74 138.77 5.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 73.41 110.826 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 5.7 mt -137.25 121.5 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 71.41 111.099 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -134.06 118.23 17.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 70.01 110.828 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 128.89 32.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.055 -0.521 . . . . 75.4 111.169 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.03 166.86 22.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 74.44 110.888 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.71 71.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.43 110.899 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 46.16 48.19 12.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 72.21 110.804 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -98.48 149.46 22.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 71.22 111.104 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.44 142.88 47.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 75.44 110.843 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.58 HG23 ' HB ' ' B' ' 275' ' ' VAL . 7.3 p -139.58 132.08 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 53.43 111.164 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.546 ' C ' HD23 ' B' ' 241' ' ' LEU . 2.9 tt0 -127.01 137.23 53.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 63.3 110.827 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.546 HD23 ' C ' ' B' ' 240' ' ' GLN . 0.3 OUTLIER -122.19 118.56 28.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 73.11 110.915 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.68 -168.62 18.77 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 62.32 112.475 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -85.76 135.21 33.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.908 0.385 . . . . 73.12 110.881 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 3.3 m -117.72 118.83 59.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 71.35 111.115 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.445 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 21.6 t -104.82 120.17 54.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 74.02 111.124 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.615 HG22 ' HA3' ' B' ' 282' ' ' GLY . 6.0 t -90.76 172.17 8.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 74.0 111.115 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.444 ' HB2' ' H ' ' A' ' 284' ' ' LYS . . . -52.74 -41.81 64.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 72.43 111.055 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . 0.467 ' H ' HG23 ' B' ' 246' ' ' THR . . . -56.79 -36.05 69.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 74.2 111.08 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.464 ' HB2' ' CA ' ' B' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 45.44 111.114 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.903 0.382 . . . . 74.13 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 7.0 t -99.3 137.44 37.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 71.14 111.142 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.599 HG23 ' O ' ' B' ' 225' ' ' ARG . 26.2 m -129.2 132.66 47.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 73.54 111.129 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -120.43 121.87 39.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.943 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 2.0 t -118.91 123.69 45.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 54.31 110.826 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.512 HG21 ' CG2' ' B' ' 267' ' ' VAL . 8.1 p -116.07 139.0 44.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 74.4 111.095 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.39 -75.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 74.12 110.86 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 24.3 m -124.09 130.47 52.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 72.22 111.127 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.512 ' CG2' HG21 ' B' ' 264' ' ' VAL . 94.0 t -118.06 122.8 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 74.2 111.121 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.39 129.14 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 62.21 111.199 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.74 132.76 6.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.699 -0.762 . . . . 53.11 112.412 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.7 147.52 51.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.873 0.368 . . . . 64.41 110.898 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.25 86.39 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.767 -0.73 . . . . 61.43 112.539 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 46.37 66.23 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 65.43 110.863 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 17.4 t -99.2 145.37 27.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 63.42 110.819 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 4.4 ttm-85 -129.76 127.88 41.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 74.5 110.805 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.58 ' HB ' HG23 ' B' ' 239' ' ' VAL . 18.7 t -129.49 123.58 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 65.45 111.134 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -126.88 111.93 14.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 72.45 110.919 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.501 ' CG1' HD13 ' C' ' 241' ' ' LEU . 2.2 mp -108.05 104.32 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 74.52 111.145 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.79 -141.49 8.88 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 71.42 112.472 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -127.99 156.1 43.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.776 0.322 . . . . 63.43 110.908 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -122.57 126.31 47.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 73.32 110.961 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -109.82 127.93 54.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 60.23 110.952 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.615 ' HA3' HG22 ' B' ' 246' ' ' THR . . . 104.84 155.36 22.88 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.752 -0.737 . . . . 72.22 112.519 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . 0.691 ' H ' ' HB2' ' C' ' 247' ' ' ALA . . . -114.03 132.88 10.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.709 -0.758 . . . . 60.12 112.501 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -175.02 44.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.359 . . . . 73.51 110.875 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.04 26.87 27.62 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.72 -0.752 . . . . 62.32 112.523 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 62.34 165.26 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 73.44 110.855 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 38.6 p-90 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 75.43 110.924 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 . . . . . 0 CA--C 1.527 0.058 0 CA-C-O 120.83 0.347 . . . . 64.03 110.841 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.47 131.88 39.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 71.21 110.878 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.1 m -140.09 137.86 34.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 64.1 110.88 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.63 144.58 49.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 72.31 111.121 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -101.41 -25.78 13.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 70.24 110.935 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -164.86 138.58 4.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 74.33 110.811 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.562 ' CD1' HD21 ' C' ' 241' ' ' LEU . 10.8 mt -137.74 117.57 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 54.53 111.102 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -133.27 116.13 15.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 65.33 110.946 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.09 136.19 41.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.55 111.141 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -143.15 167.05 23.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.855 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 60.91 75.49 0.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 70.35 110.894 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 44.48 53.82 6.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 64.14 110.909 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.5 145.86 29.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 30.41 111.127 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.0 137.06 52.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 75.31 110.823 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.443 HG13 HG13 ' B' ' 275' ' ' VAL . 7.6 p -132.12 136.51 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 70.42 111.117 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.453 ' HB3' HD13 ' C' ' 276' ' ' LEU . 3.3 tp60 -132.42 135.49 46.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 73.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.562 HD21 ' CD1' ' C' ' 231' ' ' ILE . 1.3 mp -126.8 118.79 25.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.42 110.933 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.8 -169.58 18.71 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 53.3 112.545 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -99.0 143.06 29.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 74.42 110.876 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 19.0 m -120.81 139.27 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 62.23 111.156 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.511 ' CG1' ' HB3' ' C' ' 249' ' ' ALA . 38.6 t -121.93 120.67 62.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 55.13 111.146 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . 0.609 HG23 ' O ' ' C' ' 281' ' ' TYR . 24.9 p -73.68 173.79 9.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 73.42 111.121 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.691 ' HB2' ' H ' ' B' ' 283' ' ' GLY . . . -63.16 -37.63 87.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 72.02 111.107 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.07 66.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 71.02 111.163 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . 0.511 ' HB3' ' CG1' ' C' ' 245' ' ' VAL . . . . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 61.13 111.164 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.884 0.373 . . . . 65.02 110.881 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 14.7 t -80.64 136.94 36.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 74.1 111.166 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.16 117.56 28.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 73.21 111.109 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.55 134.22 50.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.54 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 2.8 t -135.66 123.49 22.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 73.34 110.931 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.606 HG21 ' CG2' ' C' ' 267' ' ' VAL . 11.8 p -115.49 130.12 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 73.2 111.098 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -64.9 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 75.22 110.945 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 89.3 m -149.9 135.33 18.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 22.44 111.16 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.719 ' CG1' HG21 ' C' ' 275' ' ' VAL . 98.7 t -117.96 124.85 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 53.12 111.171 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.34 128.2 69.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 62.22 111.127 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.14 132.95 7.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.768 -0.729 . . . . 72.24 112.509 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -132.95 139.67 47.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.827 0.346 . . . . 70.43 110.873 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.08 73.52 0.37 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 74.12 112.495 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 63.35 100.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.852 0.358 . . . . 73.53 110.937 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 14.4 m -138.62 145.35 40.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 50.5 110.895 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -129.91 127.68 40.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 64.31 110.917 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.719 HG21 ' CG1' ' C' ' 267' ' ' VAL . 31.5 t -131.38 124.89 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 61.21 111.109 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.453 HD13 ' HB3' ' C' ' 240' ' ' GLN . 0.8 OUTLIER -124.59 111.47 15.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.23 -0.441 . . . . 70.22 110.969 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.713 HG13 HD23 ' D' ' 241' ' ' LEU . 2.6 mp -104.94 133.64 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 74.01 111.161 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.11 -146.67 18.85 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.761 -0.733 . . . . 72.51 112.452 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -128.11 146.27 50.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.338 . . . . 74.43 110.878 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -113.42 123.66 50.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 71.15 110.903 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.609 ' O ' HG23 ' C' ' 246' ' ' THR . 0.3 OUTLIER -103.95 125.65 50.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 65.53 110.913 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 111.62 -54.73 0.53 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.715 -0.755 . . . . 70.3 112.51 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 63.88 -116.66 9.46 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.711 -0.757 . . . . 60.23 112.493 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? 63.41 105.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.343 . . . . 64.51 110.896 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 62.39 60.39 7.95 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.745 -0.74 . . . . 70.23 112.477 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 51.74 -168.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.783 0.325 . . . . 74.53 110.909 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 31.8 m0 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.185 -0.461 . . . . 73.04 110.915 -179.984 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . 0.71 ' O ' HG23 ' D' ' 261' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.229 0.025 0 CA-C-O 120.874 0.369 . . . . 74.12 110.839 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -83.53 140.63 32.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 64.32 110.893 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 1.4 p -139.95 139.0 36.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 62.13 110.871 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.63 159.77 29.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 62.4 111.087 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . 0.419 ' HB2' ' HA ' ' D' ' 265' ' ' GLU . 0.3 OUTLIER -112.32 -29.61 7.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 64.35 110.9 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . 0.498 ' HB3' HG23 ' D' ' 266' ' ' THR . 5.1 t0 -166.48 137.99 3.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 64.05 110.875 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . 0.415 ' CD1' HG23 ' C' ' 264' ' ' VAL . 13.8 mt -137.42 117.53 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 74.12 111.204 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -134.69 120.39 19.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.947 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.18 150.45 50.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 64.31 111.175 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' D' ' 237' ' ' ALA . 9.7 pm0 -157.15 167.29 30.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 64.41 110.917 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 61.22 72.21 0.53 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 75.23 110.885 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 45.28 40.86 5.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 74.3 110.881 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' D' ' 234' ' ' GLU . . . -88.52 144.16 26.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 73.41 111.146 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -125.63 135.83 52.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 72.1 110.89 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.42 139.59 35.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 73.4 111.14 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . 0.634 ' HB3' HD13 ' D' ' 276' ' ' LEU . 2.7 tt0 -131.0 137.28 49.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 64.03 110.942 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 1.029 HD12 HD12 ' D' ' 277' ' ' ILE . 0.6 OUTLIER -118.3 118.72 32.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 64.32 110.874 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.79 175.45 15.78 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.759 -0.734 . . . . 74.42 112.549 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -86.02 150.06 24.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.937 0.399 . . . . 74.14 110.822 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . 0.467 HG23 ' HA ' ' D' ' 280' ' ' GLU . 16.9 m -123.87 138.32 53.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 63.32 111.193 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.14 128.94 75.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 62.13 111.094 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 12.3 t -74.0 175.25 7.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 63.51 111.081 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.84 -44.4 77.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 73.32 111.071 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.45 -52.03 67.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.422 . . . . 73.32 111.122 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 74.02 111.095 179.932 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.802 0.334 . . . . 63.02 111.181 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . 0.71 HG23 ' O ' ' D' ' 225' ' ' ARG . 94.0 m -132.57 134.74 45.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 60.34 111.127 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . 0.479 ' HB3' HG22 ' D' ' 277' ' ' ILE . 0.4 OUTLIER -119.04 121.48 39.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 70.22 110.873 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.57 123.99 42.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 75.05 110.795 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.645 HG23 ' CD1' ' E' ' 231' ' ' ILE . 8.6 p -120.05 146.49 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 71.12 111.163 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . 0.419 ' HA ' ' HB2' ' D' ' 229' ' ' LYS . 15.1 mt-10 -88.76 -73.79 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 72.14 110.876 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . 0.498 HG23 ' HB3' ' D' ' 230' ' ' ASP . 73.2 m -139.85 129.88 24.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 52.31 111.142 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.713 ' CG1' HG21 ' D' ' 275' ' ' VAL . 16.9 t -117.31 120.59 65.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 72.43 111.134 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.59 124.13 72.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 53.51 111.176 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.51 132.21 9.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 71.31 112.512 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -134.04 140.24 46.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 75.54 110.911 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 46.7 87.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 73.24 112.494 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 50.04 75.74 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.914 0.388 . . . . 71.41 110.93 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 35.9 t -107.1 145.45 32.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.07 -0.514 . . . . 60.34 110.844 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -132.67 127.64 35.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 74.42 110.903 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.713 HG21 ' CG1' ' D' ' 267' ' ' VAL . 61.6 t -136.81 124.1 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 63.14 111.119 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.634 HD13 ' HB3' ' D' ' 240' ' ' GLN . 3.6 mm? -121.45 111.61 17.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 70.5 110.917 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 1.029 HD12 HD12 ' D' ' 241' ' ' LEU . 22.4 mt -103.99 114.38 43.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 65.13 111.145 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.6 -162.12 24.07 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.663 -0.78 . . . . 42.45 112.469 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -116.47 145.58 43.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.786 0.327 . . . . 72.02 110.932 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . 0.467 ' HA ' HG23 ' D' ' 244' ' ' VAL . 35.8 tt0 -111.89 132.37 54.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 70.42 110.907 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -110.02 125.38 52.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 75.31 110.918 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 132.06 177.99 15.24 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.725 . . . . 63.21 112.516 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -138.21 111.3 0.8 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.722 -0.751 . . . . 33.24 112.459 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -156.78 22.74 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.339 . . . . 73.13 110.874 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 67.49 121.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.824 -0.703 . . . . 72.52 112.488 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 51.77 -169.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.873 0.368 . . . . 74.41 110.841 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 4.9 m0 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.108 -0.496 . . . . 62.54 110.916 -179.949 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.834 0.35 . . . . 63.43 110.914 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -83.93 112.51 20.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 72.24 110.8 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 6.3 p -129.34 158.96 37.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 70.43 110.878 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . 0.48 ' HB2' HD22 ' E' ' 241' ' ' LEU . . . -131.69 164.73 25.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 75.31 111.113 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.42 -39.32 4.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 70.01 110.921 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . 0.649 ' HB2' HG22 ' E' ' 266' ' ' THR . 0.3 OUTLIER -166.79 141.43 4.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 44.43 110.901 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . 0.645 ' CD1' HG23 ' D' ' 264' ' ' VAL . 3.4 mp -137.22 116.26 15.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 71.43 111.135 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -131.24 118.83 20.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 72.23 110.889 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . 0.411 ' HB ' ' HB1' ' E' ' 237' ' ' ALA . 0.0 OUTLIER -135.99 128.96 31.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 71.34 111.125 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -140.49 158.32 44.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 74.43 110.944 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 63.08 79.31 0.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 75.31 110.918 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.2 50.04 9.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 75.22 110.899 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . 0.411 ' HB1' ' HB ' ' E' ' 233' ' ' THR . . . -104.71 141.55 36.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 74.13 111.094 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -126.39 139.6 53.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 75.41 110.868 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.712 HG23 ' HB ' ' E' ' 275' ' ' VAL . 8.9 p -143.71 141.48 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 71.42 111.124 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . 0.579 ' HB3' HD13 ' E' ' 276' ' ' LEU . 2.5 tt0 -138.33 137.16 37.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 74.02 110.892 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.632 HD23 HG11 ' E' ' 264' ' ' VAL . 1.8 mp -120.43 118.61 30.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.226 -0.443 . . . . 62.53 110.89 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 124.43 168.28 12.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 33.0 112.472 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -86.84 163.14 17.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.907 0.385 . . . . 75.22 110.881 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.16 139.39 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 71.41 111.117 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.63 127.95 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 52.1 111.08 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t -70.03 171.18 9.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 53.22 111.179 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.12 -38.72 92.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 53.44 111.168 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.94 -36.05 69.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 72.53 111.093 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 53.54 111.019 179.885 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 60.6 m . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.747 0.308 . . . . 73.25 111.088 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -125.98 131.22 52.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 70.44 110.922 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 23.1 t -128.51 121.02 27.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 72.23 110.906 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . 0.632 HG11 HD23 ' E' ' 241' ' ' LEU . 8.8 p -104.37 123.09 58.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 72.23 111.127 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -65.59 -143.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 70.34 110.828 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . 0.649 HG22 ' HB2' ' E' ' 230' ' ' ASP . 14.8 p -92.46 130.02 38.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 74.43 111.126 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . 1.028 HG11 HG21 ' E' ' 275' ' ' VAL . 19.5 t -114.84 131.15 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 70.43 111.075 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 52.4 t -122.73 116.76 49.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.135 -0.484 . . . . 73.34 111.112 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -108.06 132.68 11.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.808 -0.71 . . . . 73.11 112.512 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -132.3 115.46 15.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.84 0.352 . . . . 62.34 110.903 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.08 94.12 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.734 -0.746 . . . . 61.41 112.452 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 52.02 87.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.895 0.378 . . . . 61.02 110.909 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 33.3 t -125.66 145.85 49.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 64.31 110.877 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -136.63 128.16 28.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 60.33 110.906 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 1.028 HG21 HG11 ' E' ' 267' ' ' VAL . 96.8 t -136.62 125.34 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 74.0 111.099 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' E' ' 240' ' ' GLN . 3.7 mm? -123.36 116.11 22.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.98 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.497 HD12 ' O ' ' E' ' 240' ' ' GLN . 2.0 mp -109.01 140.8 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.43 111.168 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 112.58 -158.06 14.54 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.792 -0.718 . . . . 71.13 112.495 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -128.19 156.54 42.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.352 . . . . 73.41 110.904 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -111.69 121.81 46.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 73.21 110.882 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -106.23 125.94 51.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.116 -0.493 . . . . 73.5 110.946 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.67 -0.776 . . . . 74.3 112.501 -179.958 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.846 0.355 . . . . 55.43 110.863 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.498 ' HB3' HG22 ' A' ' 277' ' ' ILE . 0.0 OUTLIER -142.24 136.44 29.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 65.01 110.924 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.46 137.09 54.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 72.0 110.901 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.28 131.07 41.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 52.44 111.099 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.81 -28.35 13.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.21 110.867 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.552 ' HB3' HG23 ' A' ' 266' ' ' THR . 1.8 m-20 -166.01 137.3 3.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 74.45 110.899 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 11.1 mt -137.97 117.81 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 62.43 111.139 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -127.67 123.14 34.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.499 . . . . 70.44 110.846 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.632 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.5 OUTLIER -135.56 162.28 33.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 72.13 111.091 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -153.66 167.96 27.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 75.53 110.873 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.66 -69.83 0.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 75.45 110.858 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -178.68 37.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 62.42 110.873 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.632 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -70.52 152.17 44.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 74.14 111.087 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.38 135.64 51.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 45.01 110.868 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.634 HG12 ' HB ' ' A' ' 275' ' ' VAL . 18.7 m -129.45 121.52 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 75.45 111.144 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -119.56 134.15 55.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 75.42 110.884 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 241' ' ' LEU . 6.0 mp -125.65 118.83 26.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 74.44 110.9 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.35 -170.88 22.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.73 . . . . 64.3 112.474 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.88 128.82 34.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 63.22 110.859 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.538 HG11 HD11 ' A' ' 276' ' ' LEU . 1.6 p -123.61 121.98 63.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 73.45 111.134 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.8 p -119.23 129.04 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 70.2 111.107 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 72.12 111.205 179.986 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.883 0.373 . . . . 53.12 111.121 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 95.4 m -107.13 132.59 52.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 72.1 111.151 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.11 119.93 36.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 64.4 110.902 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.1 p -130.09 123.43 30.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 72.34 110.853 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.617 ' HA ' ' HB3' ' B' ' 228' ' ' ALA . 11.5 p -109.3 134.43 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 74.23 111.19 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -74.28 -78.17 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 62.31 110.886 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.552 HG23 ' HB3' ' A' ' 230' ' ' ASP . 36.8 m -136.7 132.18 34.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.33 111.128 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 1.061 HG11 HG21 ' A' ' 275' ' ' VAL . 33.3 t -118.42 120.9 65.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.23 -0.441 . . . . 63.21 111.143 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.22 119.46 60.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 74.21 111.153 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.8 133.52 10.91 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.752 -0.737 . . . . 64.41 112.514 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -116.06 116.28 27.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 73.41 110.989 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.83 83.25 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.757 -0.735 . . . . 65.32 112.537 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 67.08 120.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 74.44 110.898 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.5 t -156.32 145.27 20.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 64.22 110.831 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.73 126.65 46.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 62.31 110.876 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 1.061 HG21 HG11 ' A' ' 267' ' ' VAL . 98.5 t -137.54 123.75 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 64.35 111.079 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.538 HD11 HG11 ' A' ' 244' ' ' VAL . 1.0 OUTLIER -122.8 120.15 32.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 75.23 110.901 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.739 ' CD1' HD13 ' B' ' 241' ' ' LEU . 24.9 mm -112.32 103.74 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 72.35 111.144 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.9 -154.95 25.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.772 -0.728 . . . . 41.12 112.512 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -111.06 151.88 27.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.732 0.301 . . . . 73.13 110.901 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.744 ' HG2' HG22 ' B' ' 244' ' ' VAL . 0.0 OUTLIER -128.1 134.86 49.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 72.34 110.831 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.471 ' HA ' HG13 ' B' ' 245' ' ' VAL . 0.4 OUTLIER -122.22 134.61 54.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 73.33 110.941 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.21 164.03 33.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 40.34 112.441 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 141.26 136.54 3.3 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.788 -0.72 . . . . 61.22 112.522 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -51.79 -45.87 63.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.861 0.362 . . . . 61.22 110.889 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -132.48 -43.24 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.777 -0.725 . . . . 64.51 112.517 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -174.3 -165.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 73.53 110.837 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.47 ' NE1' HD12 ' A' ' 276' ' ' LEU . 15.8 t90 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.503 . . . . 74.32 110.915 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.908 0.385 . . . . 74.23 110.852 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.07 109.95 18.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 74.2 110.808 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.31 137.77 54.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 74.32 110.892 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 264' ' ' VAL . . . -124.71 150.05 46.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 73.14 111.026 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -113.94 -32.78 5.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 62.11 110.977 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . 0.575 ' HB3' HG23 ' B' ' 266' ' ' THR . 0.4 OUTLIER -165.43 137.82 4.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 63.23 110.873 179.834 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 7.7 mt -138.15 117.38 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 65.14 111.167 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -129.52 124.45 33.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 64.34 110.849 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.624 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 0.1 OUTLIER -135.32 163.58 29.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 74.3 111.157 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -148.94 167.99 24.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 75.44 110.948 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.58 -72.19 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 72.55 110.9 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.99 40.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 75.01 110.84 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -69.9 156.71 38.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.446 . . . . 62.25 111.058 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.41 135.12 52.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 74.3 110.871 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.652 ' CG2' HG22 ' A' ' 275' ' ' VAL . 30.0 m -131.81 133.09 61.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 70.15 111.146 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.442 ' C ' HD12 ' B' ' 241' ' ' LEU . 1.9 tt0 -127.95 137.03 52.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 70.43 110.883 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.739 HD13 ' CD1' ' A' ' 277' ' ' ILE . 6.5 mp -125.85 118.28 25.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 74.1 110.905 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.62 -168.14 23.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.802 -0.713 . . . . 73.41 112.512 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -85.86 142.48 28.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.357 . . . . 73.04 110.926 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.744 HG22 ' HG2' ' A' ' 280' ' ' GLU . 2.9 t -125.68 120.58 57.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 52.52 111.171 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.471 HG13 ' HA ' ' A' ' 281' ' ' TYR . 5.5 p -122.08 120.19 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 63.24 111.147 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 11.0 t -74.1 165.67 24.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 71.24 111.142 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.92 76.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 42.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.33 74.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 43.44 111.064 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 63.23 111.075 179.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.868 0.366 . . . . 60.4 110.958 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . 0.715 HG23 ' HB3' ' C' ' 225' ' ' ARG . 27.6 m -100.96 126.86 47.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 73.23 111.176 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 4.4 t -92.65 133.48 35.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.51 111.151 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.547 HD22 HG22 ' B' ' 277' ' ' ILE . 0.4 OUTLIER -126.56 129.77 49.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 64.32 110.887 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 12.9 t -132.98 123.58 26.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 64.02 110.77 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.772 ' HA ' ' HB3' ' C' ' 228' ' ' ALA . 10.3 p -105.86 135.21 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 74.53 111.211 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -77.71 -77.41 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 71.24 110.863 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.575 HG23 ' HB3' ' B' ' 230' ' ' ASP . 18.5 m -134.7 132.26 38.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.44 111.207 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.902 HG11 HG21 ' B' ' 275' ' ' VAL . 23.9 t -118.0 120.84 65.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 54.4 111.169 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.54 120.37 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 75.32 111.117 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.63 133.2 11.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.692 -0.766 . . . . 70.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -116.92 116.5 27.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.809 0.338 . . . . 74.43 110.94 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.96 83.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 55.53 112.505 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 66.5 119.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.826 0.346 . . . . 75.24 110.883 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 22.9 t -156.27 146.77 21.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 73.01 110.847 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -124.24 127.03 47.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 73.22 110.803 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.902 HG21 HG11 ' B' ' 267' ' ' VAL . 87.8 t -137.6 123.15 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 75.21 111.059 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.55 HD12 ' CZ2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -120.97 122.41 40.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 75.14 110.887 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.547 HG22 HD22 ' B' ' 262' ' ' ASN . 27.4 mm -112.55 103.68 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 62.13 111.137 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 152.05 -139.96 7.42 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.758 -0.734 . . . . 74.33 112.53 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . 0.467 ' ND2' ' H ' ' C' ' 243' ' ' ASN . 9.8 m120 -128.31 145.56 51.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 71.43 110.876 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.737 ' CG ' HG13 ' C' ' 244' ' ' VAL . 0.4 OUTLIER -117.03 135.91 53.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 70.15 110.837 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.412 ' HA ' HG13 ' C' ' 245' ' ' VAL . 0.3 OUTLIER -120.64 125.7 48.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 75.22 110.933 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 65.57 174.14 4.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 74.11 112.497 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 137.59 -6.94 3.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 71.01 112.521 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.37 70.93 0.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.367 . . . . 74.13 110.883 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 127.27 -109.33 1.06 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 53.44 112.507 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -121.58 -75.1 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.792 0.33 . . . . 52.41 110.883 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.55 ' CZ2' HD12 ' B' ' 276' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 62.31 110.896 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.715 ' HB3' HG23 ' B' ' 260' ' ' THR . 4.3 mmt85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.764 0.316 . . . . 72.1 110.878 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.465 HD21 HD12 ' C' ' 241' ' ' LEU . 3.3 t-20 -140.08 119.58 13.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 74.43 110.898 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 58.8 m -129.87 141.79 50.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 54.45 110.911 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.772 ' HB3' ' HA ' ' B' ' 264' ' ' VAL . . . -124.95 146.54 49.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 64.24 111.108 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' C' ' 265' ' ' GLU . 0.1 OUTLIER -110.26 -37.86 5.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 75.45 110.899 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . 0.674 ' HB3' HG22 ' C' ' 266' ' ' THR . 4.5 t0 -165.24 137.29 4.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 71.23 110.845 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.97 117.45 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.455 . . . . 73.04 111.189 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -130.73 126.1 35.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 63.23 110.855 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.671 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 0.1 OUTLIER -135.22 164.02 28.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 70.34 111.156 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -144.61 168.6 19.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 73.4 110.828 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.54 -74.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 75.51 110.871 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.27 38.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 74.35 110.824 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.671 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -69.64 157.09 37.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.301 -0.409 . . . . 72.44 111.116 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.76 134.55 52.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 72.3 110.852 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.659 ' CG2' HG22 ' B' ' 275' ' ' VAL . 18.2 m -127.25 122.09 59.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 55.31 111.091 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.94 123.61 49.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 75.5 110.921 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.465 HD12 HD21 ' C' ' 226' ' ' ASN . 4.2 mm? -111.66 119.14 37.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 40.22 110.919 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 122.2 -168.14 14.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.773 -0.727 . . . . 24.43 112.522 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.467 ' H ' ' ND2' ' B' ' 279' ' ' ASN . 2.7 t30 -86.14 149.71 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 60.21 110.94 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.737 HG13 ' CG ' ' B' ' 280' ' ' GLU . 78.9 t -126.35 122.19 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 72.3 111.126 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.412 HG13 ' HA ' ' B' ' 281' ' ' TYR . 7.2 p -116.63 129.27 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 74.43 111.099 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 12.8 p -78.68 165.07 24.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.491 . . . . 72.3 111.103 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.21 -34.0 76.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 73.53 111.071 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.81 -40.4 75.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 63.12 111.062 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 53.11 111.166 179.901 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.823 0.344 . . . . 61.11 110.908 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.26 137.55 32.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 73.23 111.148 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 96.1 m -105.41 131.38 52.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 75.52 111.178 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.05 136.99 53.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 64.33 110.831 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 46.5 t -142.11 123.8 15.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 70.42 110.911 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.492 ' HA ' ' HB3' ' D' ' 228' ' ' ALA . 9.0 p -106.15 138.28 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 74.32 111.139 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' C' ' 229' ' ' LYS . 2.9 tt0 -78.49 -76.63 0.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 74.54 110.927 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . 0.674 HG22 ' HB3' ' C' ' 230' ' ' ASP . 40.9 p -134.95 132.25 38.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.093 -0.503 . . . . 73.15 111.111 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.731 HG11 HG21 ' C' ' 275' ' ' VAL . 97.6 t -117.44 120.68 65.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 70.14 111.171 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.95 119.65 61.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 74.01 111.141 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.52 133.27 11.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.682 -0.77 . . . . 61.52 112.513 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -115.66 116.39 28.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.791 0.329 . . . . 73.43 110.919 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.49 86.52 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.731 -0.747 . . . . 35.42 112.493 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.68 118.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 74.32 110.91 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 37.4 t -157.22 149.1 22.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 70.25 110.818 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 -126.58 127.02 44.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 74.5 110.897 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.731 HG21 HG11 ' C' ' 267' ' ' VAL . 98.7 t -138.2 123.85 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 44.41 111.146 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.636 HD12 ' HE1' ' C' ' 287' ' ' TRP . 0.9 OUTLIER -125.98 122.51 36.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 73.43 110.942 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.468 ' N ' HD23 ' C' ' 276' ' ' LEU . 13.7 mm -112.4 104.18 16.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.262 -0.426 . . . . 72.02 111.077 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.02 -178.38 26.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.682 -0.77 . . . . 65.23 112.483 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -89.63 145.02 25.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.783 0.325 . . . . 73.34 110.889 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.637 ' CG ' HG22 ' D' ' 244' ' ' VAL . 5.5 pt-20 -120.43 125.79 48.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 51.5 110.896 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.471 ' HA ' HG13 ' D' ' 245' ' ' VAL . 26.2 t80 -115.55 140.13 49.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 74.3 110.939 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.55 59.12 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.71 -0.757 . . . . 53.11 112.473 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -68.29 87.29 0.19 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.75 -0.738 . . . . 61.42 112.441 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -58.66 98.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 71.24 110.967 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 62.95 104.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 44.53 112.457 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.83 -166.45 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.799 0.333 . . . . 74.52 110.872 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.636 ' HE1' HD12 ' C' ' 276' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 74.25 110.945 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . 0.555 ' HA ' HG23 ' D' ' 261' ' ' THR . 3.5 mmt85 . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.785 0.326 . . . . 61.54 110.887 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.59 121.94 27.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 70.41 110.844 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.68 137.85 45.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 62.33 110.82 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' C' ' 264' ' ' VAL . . . -131.13 133.31 45.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.052 -0.522 . . . . 52.33 111.072 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -96.9 -30.97 12.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 75.15 110.872 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . 0.729 ' HB3' HG23 ' D' ' 266' ' ' THR . 3.6 t0 -166.35 137.08 3.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 73.13 110.865 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 10.4 mt -139.48 117.07 11.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 63.5 111.081 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.4 126.38 38.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 70.53 110.885 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . 0.738 ' HB ' ' HB3' ' D' ' 237' ' ' ALA . 2.1 p -135.81 164.36 28.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 75.44 111.147 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -145.57 168.76 19.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 72.23 110.921 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 73.35 -75.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 71.33 110.912 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.73 47.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 71.54 110.881 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . 0.738 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -77.32 156.82 31.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 70.43 111.105 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.05 134.46 52.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.883 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.773 HG12 ' HB ' ' D' ' 275' ' ' VAL . 6.2 m -126.87 121.45 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 72.23 111.194 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.92 127.88 55.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 62.22 110.898 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.8 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.1 mm? -116.0 117.89 31.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 55.32 110.932 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.98 -166.89 21.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 44.54 112.479 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -98.85 128.95 45.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 52.34 110.934 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . 0.637 HG22 ' CG ' ' C' ' 280' ' ' GLU . 95.5 t -102.8 124.97 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.14 111.152 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . 0.471 HG13 ' HA ' ' C' ' 281' ' ' TYR . 7.1 p -122.08 128.0 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 64.25 111.199 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -69.63 175.03 4.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 65.23 111.235 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.43 97.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 62.11 111.056 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.17 -40.09 76.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 61.33 111.088 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 42.24 111.142 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . 0.552 HG21 ' OD1' ' E' ' 243' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.853 0.359 . . . . 71.24 111.138 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . 0.555 HG23 ' HA ' ' D' ' 225' ' ' ARG . 29.2 m -96.39 120.81 37.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 62.31 111.099 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . 0.739 ' OD1' HG22 ' D' ' 277' ' ' ILE . 0.5 OUTLIER -121.66 135.93 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 53.44 110.897 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 3.8 m -142.16 124.92 15.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 64.03 110.798 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.612 ' HA ' ' HB3' ' E' ' 228' ' ' ALA . 7.2 p -104.95 122.04 57.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 75.15 111.125 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -56.38 -82.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.924 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . 0.729 HG23 ' HB3' ' D' ' 230' ' ' ASP . 10.7 m -128.4 137.45 51.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.163 -0.471 . . . . 31.44 111.157 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.757 HG11 HG21 ' D' ' 275' ' ' VAL . 64.4 t -118.21 120.68 65.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 72.35 111.154 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 15.0 t -117.45 116.89 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 62.45 111.121 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.24 133.03 11.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.716 -0.754 . . . . 42.32 112.456 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.36 119.28 35.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.828 0.347 . . . . 65.42 110.866 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.09 78.52 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 73.22 112.459 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 68.76 125.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 64.24 110.904 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 12.8 t -156.52 160.59 39.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 73.55 110.891 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.21 127.04 32.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 75.12 110.879 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.773 ' HB ' HG12 ' D' ' 239' ' ' VAL . 89.8 t -137.76 123.64 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 64.22 111.188 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.694 HD12 ' HE1' ' D' ' 287' ' ' TRP . 0.9 OUTLIER -127.73 124.12 37.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 74.21 110.934 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.8 ' HB ' HD13 ' D' ' 241' ' ' LEU . 20.0 mm -112.27 104.88 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.44 111.101 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.21 -144.21 11.83 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.753 -0.737 . . . . 73.11 112.507 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -123.51 139.99 53.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 75.52 110.893 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . 0.758 ' CG ' HG13 ' E' ' 244' ' ' VAL . 11.0 pt-20 -111.89 134.27 53.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 73.54 110.962 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' E' ' 249' ' ' ALA . 17.0 t80 -125.42 125.11 42.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 73.12 110.897 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.3 -150.18 16.96 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.76 -0.734 . . . . 34.22 112.479 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 59.74 18.2 44.92 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.737 -0.744 . . . . 70.32 112.52 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 7.2 mttp 52.46 29.44 7.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.901 0.381 . . . . 73.14 110.93 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.77 127.59 6.14 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.735 -0.745 . . . . 64.34 112.423 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 t80 59.09 175.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.828 0.347 . . . . 71.32 110.88 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . 0.694 ' HE1' HD12 ' D' ' 276' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 74.43 110.951 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 45.5 mmt-85 . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.859 0.361 . . . . 72.54 110.913 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . 0.592 ' HB3' HD12 ' E' ' 241' ' ' LEU . 10.3 m120 -83.76 116.39 22.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 62.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.22 143.07 50.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 72.52 110.895 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . 0.612 ' HB3' ' HA ' ' D' ' 264' ' ' VAL . . . -130.82 136.22 48.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 64.35 111.146 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -88.08 -41.72 12.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 75.5 110.879 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -173.44 138.52 0.7 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 71.5 110.873 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . 0.538 HG23 ' HB ' ' E' ' 267' ' ' VAL . 5.8 mt -132.61 117.8 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 53.43 111.105 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . 0.679 ' HD2' HG13 ' E' ' 268' ' ' VAL . 0.1 OUTLIER -126.96 124.27 39.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 73.4 110.824 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' E' ' 237' ' ' ALA . 5.0 p -135.86 164.73 27.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 65.24 111.086 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -142.13 167.97 20.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.134 -0.484 . . . . 75.34 110.874 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 72.96 -75.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.804 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -179.76 71.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 63.32 110.857 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . 0.591 ' HB3' ' HB ' ' E' ' 233' ' ' THR . . . -101.64 157.02 17.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 62.42 111.095 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.15 134.29 53.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.964 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.753 HG12 ' HB ' ' E' ' 275' ' ' VAL . 4.9 m -128.96 121.81 55.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 71.23 111.075 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . 0.509 HE21 HD21 ' E' ' 276' ' ' LEU . 0.1 OUTLIER -113.96 129.7 56.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.914 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.654 HD13 ' HB ' ' E' ' 277' ' ' ILE . 1.3 mm? -115.25 118.24 32.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 75.12 110.988 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.55 -149.78 18.42 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.749 -0.739 . . . . 73.02 112.478 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . 0.552 ' OD1' HG21 ' D' ' 260' ' ' THR . 4.9 m120 -106.68 130.45 54.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.869 0.366 . . . . 74.21 110.877 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.758 HG13 ' CG ' ' D' ' 280' ' ' GLU . 84.4 t -105.89 127.4 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.168 -0.469 . . . . 54.22 111.134 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' D' ' 281' ' ' TYR . 5.0 p -122.68 124.34 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 72.21 111.169 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . 0.544 HG21 ' C ' ' E' ' 282' ' ' GLY . 8.8 t -70.03 169.64 12.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 72.42 111.129 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.83 -33.9 51.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 44.44 111.159 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.73 -52.1 66.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.42 111.108 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . 0.51 ' HB2' ' CE2' ' D' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 55.54 111.082 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.796 0.332 . . . . 75.02 111.155 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.65 123.14 49.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 74.32 110.931 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 13.6 t -132.59 136.93 46.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 75.13 110.859 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.5 136.59 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.102 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -65.49 -105.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 74.03 110.937 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 85.5 m -117.11 138.05 51.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 73.44 111.152 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . 0.724 HG11 HG21 ' E' ' 275' ' ' VAL . 73.8 t -117.78 118.23 57.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 71.42 111.149 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . 0.679 HG13 ' HD2' ' E' ' 232' ' ' ARG . 0.6 OUTLIER -118.22 114.56 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 71.4 111.091 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.58 131.59 10.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.704 -0.76 . . . . 74.01 112.467 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -114.43 124.29 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 73.42 110.841 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 57.47 68.15 1.85 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 63.1 112.457 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 67.46 129.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.846 0.355 . . . . 62.43 110.849 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 10.5 t -156.92 161.22 39.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 74.13 110.877 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -129.9 127.82 40.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.23 110.846 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.753 ' HB ' HG12 ' E' ' 239' ' ' VAL . 90.5 t -138.88 128.83 32.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 42.33 111.163 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . 0.509 HD21 HE21 ' E' ' 240' ' ' GLN . 0.4 OUTLIER -128.71 127.68 42.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 63.44 110.933 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.654 ' HB ' HD13 ' E' ' 241' ' ' LEU . 43.7 mm -112.23 118.19 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 71.03 111.128 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 121.63 -157.7 16.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 44.24 112.487 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -91.76 156.02 17.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 64.03 110.865 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -134.18 135.71 43.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 73.45 110.947 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . 0.536 ' CD1' HG22 ' E' ' 246' ' ' THR . 50.2 t80 -125.64 124.62 41.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 75.01 110.97 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . 0.544 ' C ' HG21 ' E' ' 246' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.782 -0.723 . . . . 50.3 112.505 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.815 0.34 . . . . 70.4 110.893 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.733 ' OD1' HG22 ' A' ' 277' ' ' ILE . 44.3 m-80 -127.78 122.59 33.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.52 110.906 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.54 138.58 54.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 62.15 110.836 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.32 119.92 11.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.066 -0.515 . . . . 62.24 111.1 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.83 -34.42 45.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.441 . . . . 64.24 110.879 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -165.55 138.81 4.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 62.11 110.928 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.692 HG22 ' CG1' ' A' ' 267' ' ' VAL . 36.5 pt -136.32 132.99 49.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 70.21 111.068 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -134.19 123.52 24.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 75.3 110.921 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -135.52 128.52 31.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 61.31 111.143 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -138.2 166.43 24.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 72.34 110.903 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 66.4 68.75 0.43 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 72.54 110.859 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 49.81 32.9 5.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 64.34 110.921 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.45 156.01 20.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 51.33 111.09 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -139.28 148.04 42.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 70.5 110.821 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.585 HG23 ' HB ' ' A' ' 275' ' ' VAL . 3.1 p -134.86 121.72 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 75.14 111.058 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.77 135.75 53.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.54 110.938 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 mp -130.09 118.87 22.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 70.11 110.914 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 140.81 177.42 16.15 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.741 . . . . 62.2 112.511 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -88.2 128.85 35.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 72.22 110.821 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.09 133.37 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 63.44 111.111 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.04 129.08 75.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 33.35 111.071 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 73.13 111.182 179.934 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . 0.441 HG21 ' C ' ' B' ' 242' ' ' GLY . 96.2 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.913 0.387 . . . . 51.04 111.139 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.3 t -132.56 132.09 42.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 71.22 111.134 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.76 ' OD1' HG23 ' A' ' 277' ' ' ILE . 4.2 t-20 -126.1 149.17 49.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 73.12 110.903 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.3 t -142.36 123.1 14.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 64.13 110.835 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.661 HG21 ' CD1' ' B' ' 231' ' ' ILE . 9.2 p -122.08 124.1 70.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 72.44 111.08 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.45 -70.65 0.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 74.14 110.85 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 95.1 m -131.63 128.29 38.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 63.1 111.166 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.692 ' CG1' HG22 ' A' ' 231' ' ' ILE . 7.2 p -123.23 125.19 71.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 64.44 111.208 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.58 135.64 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 74.01 111.103 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.43 133.81 7.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 51.12 112.427 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.08 148.34 52.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 71.24 110.902 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.7 88.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.75 -0.738 . . . . 72.3 112.468 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 43.26 57.42 3.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.879 0.371 . . . . 73.24 110.852 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.74 145.3 28.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 52.03 110.829 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.12 127.33 47.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 52.02 110.896 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.585 ' HB ' HG23 ' A' ' 239' ' ' VAL . 10.0 t -120.61 123.66 70.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 74.33 111.159 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.13 111.23 14.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 75.3 110.898 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.76 HG23 ' OD1' ' A' ' 262' ' ' ASN . 4.5 mp -113.17 104.79 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 62.32 111.134 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.42 -161.65 26.93 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 74.02 112.493 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.62 156.18 21.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.301 . . . . 72.25 110.961 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.642 ' CG ' HG12 ' B' ' 244' ' ' VAL . 2.2 pp20? -130.37 147.32 52.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.854 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -126.73 125.83 42.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 55.21 110.912 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 144.19 147.94 4.78 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.745 -0.741 . . . . 72.15 112.477 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.438 ' N ' ' H ' ' B' ' 247' ' ' ALA . . . -121.75 25.59 6.8 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 73.52 112.502 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 43.01 1.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 45.41 110.917 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 146.88 -19.85 1.61 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.836 -0.697 . . . . 75.52 112.549 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.441 ' CZ ' HG21 ' B' ' 244' ' ' VAL . 11.3 t80 72.26 -68.93 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 70.12 110.84 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 11.5 t90 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 72.22 110.905 -179.965 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.767 0.318 . . . . 71.31 110.791 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.712 ' OD1' HG22 ' B' ' 277' ' ' ILE . 14.7 m-80 -142.21 128.5 19.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.879 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.95 137.62 54.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 71.14 110.843 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.35 119.99 12.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 73.45 111.091 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -34.8 52.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 62.44 110.849 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -165.67 136.56 3.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 71.03 110.868 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.715 HG22 HG12 ' B' ' 267' ' ' VAL . 27.6 pt -138.57 129.87 36.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 60.14 111.163 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.97 125.69 32.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 74.21 110.906 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 2.7 p -135.67 128.65 31.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 72.04 111.114 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -136.93 166.77 22.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 75.12 110.9 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 64.51 75.06 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 65.44 110.906 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 45.43 36.17 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.55 110.849 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.2 155.63 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.21 111.083 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -140.95 153.74 45.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 74.21 110.901 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.516 HG23 ' HB ' ' B' ' 275' ' ' VAL . 6.0 p -139.55 121.78 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 62.24 111.174 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -117.08 134.9 54.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 72.13 110.837 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.549 HD22 HD21 ' A' ' 262' ' ' ASN . 2.5 mp -130.44 135.33 47.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 75.23 110.92 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.441 ' C ' HG21 ' A' ' 260' ' ' THR . . . 133.55 -124.86 3.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 65.43 112.514 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.44 ' N ' HG21 ' A' ' 260' ' ' THR . 26.8 t30 -145.49 131.38 19.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.915 0.388 . . . . 60.25 110.909 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.642 HG12 ' CG ' ' A' ' 280' ' ' GLU . 18.1 m -114.07 122.8 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 73.43 111.12 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 98.4 t -122.37 129.51 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 51.14 111.086 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.493 HG23 ' H ' ' B' ' 249' ' ' ALA . 13.9 t -69.6 162.59 27.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 71.44 111.12 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.438 ' H ' ' N ' ' A' ' 283' ' ' GLY . . . -63.34 -33.88 76.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 63.51 111.101 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.12 81.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 72.33 111.068 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.493 ' H ' HG23 ' B' ' 246' ' ' THR . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 71.43 111.11 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.835 0.35 . . . . 72.12 110.925 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . 0.689 HG21 ' H ' ' C' ' 243' ' ' ASN . 58.3 m -100.61 133.51 44.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 72.35 111.135 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 87.3 m -134.27 133.19 40.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 62.41 111.12 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.724 ' OD1' HG23 ' B' ' 277' ' ' ILE . 12.5 t-20 -126.48 134.26 50.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 73.23 110.906 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 15.1 m -128.75 123.55 33.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 74.53 110.906 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.488 ' HA ' ' HB3' ' C' ' 228' ' ' ALA . 7.6 p -119.47 141.49 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 73.32 111.155 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.75 -57.63 3.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.86 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 72.3 p -150.2 126.83 10.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 65.02 111.171 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.784 HG23 ' HB ' ' C' ' 231' ' ' ILE . 12.2 p -123.81 135.11 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 73.14 111.11 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 60.5 t -127.14 132.91 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.11 111.161 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.79 134.58 8.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.781 -0.723 . . . . 72.12 112.541 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -132.96 148.59 52.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.744 0.306 . . . . 72.55 110.925 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.58 88.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.746 . . . . 43.41 112.451 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 45.18 62.72 2.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.387 . . . . 64.24 110.867 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 17.0 t -94.67 145.52 24.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 64.4 110.817 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.12 127.48 41.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 64.31 110.925 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.626 HG12 ' CD1' ' B' ' 277' ' ' ILE . 6.2 t -122.67 122.75 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.15 111.141 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.35 114.26 20.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 64.13 110.955 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.724 HG23 ' OD1' ' B' ' 262' ' ' ASN . 3.8 mp -112.41 104.29 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.4 111.12 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.93 -163.48 26.97 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.691 -0.766 . . . . 61.34 112.519 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -110.64 156.18 21.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 53.44 110.841 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.614 ' HG3' HG12 ' C' ' 244' ' ' VAL . 0.4 OUTLIER -127.38 145.72 50.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 62.12 110.891 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -123.06 125.84 45.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 71.22 110.916 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.63 147.11 4.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.666 -0.778 . . . . 74.43 112.449 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' C' ' 247' ' ' ALA . . . -106.74 -22.75 7.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 62.25 112.541 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -52.07 -29.71 22.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.729 0.299 . . . . 75.44 110.862 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -161.85 112.78 0.53 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.68 -0.772 . . . . 43.01 112.456 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -51.79 -29.82 20.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.842 0.353 . . . . 75.32 110.837 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 4.5 t90 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.47 . . . . 71.23 110.935 -179.964 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 69.2 mmt-85 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.845 0.355 . . . . 72.33 110.859 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -82.74 121.03 26.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 73.34 110.949 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.4 m -121.23 144.47 48.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 75.24 110.893 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.488 ' HB3' ' HA ' ' B' ' 264' ' ' VAL . . . -140.78 153.93 46.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 73.2 111.153 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.19 -34.75 4.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 71.41 110.948 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . 0.615 ' HB3' HG23 ' C' ' 266' ' ' THR . 4.9 t0 -165.09 139.3 4.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 64.33 110.877 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.784 ' HB ' HG23 ' B' ' 267' ' ' VAL . 0.5 OUTLIER -136.02 117.2 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 70.14 111.052 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.91 115.86 21.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 74.33 110.903 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.78 128.8 39.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 70.34 111.087 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -137.65 166.42 23.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 62.42 110.944 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 61.48 74.43 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 71.33 110.909 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 45.38 49.94 10.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 64.33 110.817 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.24 147.11 27.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 54.42 111.114 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -134.54 141.16 46.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 71.33 110.885 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.661 HG23 ' HB ' ' C' ' 275' ' ' VAL . 5.7 p -135.01 121.55 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 75.33 111.138 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.606 ' HB3' HD22 ' C' ' 276' ' ' LEU . 4.3 tm0? -116.27 124.68 50.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 74.54 110.896 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.665 HD12 HD13 ' C' ' 277' ' ' ILE . 0.2 OUTLIER -112.38 118.98 36.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.21 -0.45 . . . . 65.51 110.852 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.41 179.94 17.73 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.745 -0.741 . . . . 73.13 112.455 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.689 ' H ' HG21 ' B' ' 260' ' ' THR . 4.6 t30 -89.66 150.06 22.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 61.31 110.886 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.614 HG12 ' HG3' ' B' ' 280' ' ' GLU . 33.2 m -127.97 129.33 69.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 71.15 111.133 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 89.2 t -122.2 129.45 75.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 74.54 111.129 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 13.2 t -69.92 175.17 4.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 55.34 111.172 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.413 ' HB2' ' H ' ' B' ' 283' ' ' GLY . . . -62.37 -41.38 98.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 55.5 111.077 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.9 -52.54 64.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 64.35 111.12 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 54.24 111.072 179.867 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.879 0.371 . . . . 75.33 110.922 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . 0.457 HG21 ' HB3' ' C' ' 279' ' ' ASN . 7.6 p -100.98 122.4 43.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 74.21 111.16 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 88.8 m -100.55 114.78 28.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 74.13 111.151 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . 0.746 ' OD1' HG23 ' C' ' 277' ' ' ILE . 6.4 t-20 -126.29 144.35 50.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.43 110.933 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 47.3 t -139.03 123.02 17.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 61.32 110.818 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.739 ' HA ' ' HB3' ' D' ' 228' ' ' ALA . 7.6 p -111.11 126.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 72.23 111.097 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.83 -77.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 71.15 110.898 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . 0.615 HG23 ' HB3' ' C' ' 230' ' ' ASP . 16.3 m -131.39 130.27 42.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 72.54 111.094 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.617 HG22 ' HB ' ' D' ' 231' ' ' ILE . 0.9 OUTLIER -118.27 130.92 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 72.25 111.108 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.51 133.08 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 42.43 111.106 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -133.25 132.78 6.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.689 -0.767 . . . . 64.4 112.516 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -132.17 142.38 49.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 72.34 110.926 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.76 78.78 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.768 -0.73 . . . . 73.11 112.483 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 58.66 96.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.858 0.361 . . . . 74.41 110.883 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 14.1 m -134.42 145.39 48.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.867 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.01 128.13 35.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 75.35 110.897 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.661 ' HB ' HG23 ' C' ' 239' ' ' VAL . 7.2 t -125.84 123.6 64.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 62.22 111.082 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.2 OUTLIER -123.06 117.29 25.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 72.11 110.908 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.746 HG23 ' OD1' ' C' ' 262' ' ' ASN . 3.1 mp -112.84 131.01 65.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 74.13 111.158 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 123.44 -152.02 17.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.798 -0.715 . . . . 72.21 112.445 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . 0.457 ' HB3' HG21 ' C' ' 260' ' ' THR . 9.5 p-10 -124.58 156.37 37.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.795 0.331 . . . . 73.31 110.877 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -121.03 139.04 53.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 64.25 110.852 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -123.41 126.43 46.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 71.02 110.934 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' D' ' 247' ' ' ALA . . . 136.84 -34.28 2.23 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 74.33 112.488 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 52.32 47.76 55.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.756 -0.735 . . . . 71.53 112.45 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 57.89 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 74.33 110.864 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.81 -79.21 0.8 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.719 -0.753 . . . . 61.34 112.454 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -179.4 108.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.805 0.336 . . . . 75.42 110.859 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 74.33 110.976 -179.975 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.856 0.36 . . . . 64.21 110.867 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . 0.454 HD22 HG22 ' D' ' 277' ' ' ILE . 6.0 m120 -142.13 128.46 19.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 73.52 110.884 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 3.8 m -121.68 139.61 53.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 74.01 110.822 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . 0.739 ' HB3' ' HA ' ' C' ' 264' ' ' VAL . . . -133.63 129.84 37.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 71.34 111.084 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' D' ' 265' ' ' GLU . 9.5 mtmm -97.5 -33.63 11.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 73.05 110.897 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . 0.658 ' HB3' HG23 ' D' ' 266' ' ' THR . 0.2 OUTLIER -165.01 138.16 4.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 72.45 110.881 179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . 0.617 ' HB ' HG22 ' C' ' 267' ' ' VAL . 6.1 mt -137.33 128.72 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 74.22 111.155 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -134.26 115.89 14.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.472 . . . . 71.44 110.908 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 3.5 p -129.82 149.59 51.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 73.13 111.147 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' D' ' 237' ' ' ALA . 5.2 pm0 -156.98 166.71 32.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 72.13 110.883 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 63.26 67.56 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 71.14 110.87 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 36.6 mtt85 49.45 31.76 4.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 74.31 110.932 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' D' ' 234' ' ' GLU . . . -82.55 145.77 29.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 63.43 111.071 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -129.76 135.77 48.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 73.1 110.852 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.429 HG23 ' HB ' ' D' ' 275' ' ' VAL . 6.3 p -130.84 121.7 50.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 73.25 111.075 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . 0.681 ' HB3' HD22 ' D' ' 276' ' ' LEU . 2.5 tm0? -109.12 137.25 47.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.472 . . . . 62.02 110.928 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.529 HD22 ' C ' ' D' ' 240' ' ' GLN . 3.5 mm? -122.72 118.61 28.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.12 110.913 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.41 177.85 15.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.769 -0.729 . . . . 70.1 112.509 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.82 149.36 23.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 64.43 110.927 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' D' ' 280' ' ' GLU . 17.3 m -124.94 132.49 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 40.1 111.14 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.83 129.41 75.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 74.42 111.075 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.3 t -70.09 174.89 4.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 70.45 111.105 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' C' ' 282' ' ' GLY . . . -59.34 -39.5 83.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 71.15 111.074 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.93 -52.05 66.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 75.35 111.046 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 73.02 111.18 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.889 0.376 . . . . 73.43 111.18 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.56 116.65 29.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 55.35 111.121 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . 0.532 ' OD1' HD12 ' E' ' 241' ' ' LEU . 0.5 OUTLIER -126.89 137.09 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 72.5 110.821 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.06 123.41 18.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 65.4 110.821 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.819 HG21 HG23 ' D' ' 267' ' ' VAL . 7.3 p -113.89 138.5 43.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 72.52 111.109 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' D' ' 229' ' ' LYS . 0.7 OUTLIER -81.48 -52.47 7.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 74.1 110.916 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . 0.658 HG23 ' HB3' ' D' ' 230' ' ' ASP . 0.2 OUTLIER -150.96 129.35 12.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 73.32 111.099 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.819 HG23 HG21 ' D' ' 264' ' ' VAL . 1.2 t -118.35 130.62 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 74.22 111.183 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.49 127.75 69.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 63.52 111.146 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -131.06 133.94 7.5 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.763 -0.732 . . . . 65.25 112.473 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.1 148.89 52.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 70.24 110.916 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.34 89.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 71.43 112.468 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 43.75 59.69 2.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.887 0.375 . . . . 51.1 110.849 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 11.0 t -85.85 145.5 27.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 32.13 110.846 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.48 127.75 35.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 75.1 110.887 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . 0.448 HG22 ' CG1' ' E' ' 239' ' ' VAL . 57.9 t -131.87 123.18 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 75.42 111.096 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.4 OUTLIER -121.21 111.74 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 62.31 110.926 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.454 HG22 HD22 ' D' ' 226' ' ' ASN . 1.1 mt -107.88 110.96 33.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 71.44 111.136 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.08 174.7 13.47 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.777 -0.725 . . . . 71.05 112.49 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -89.87 144.91 25.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.358 . . . . 74.31 110.887 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . 0.475 ' HA ' HG23 ' D' ' 244' ' ' VAL . 15.8 pt-20 -113.87 131.73 56.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 74.43 110.874 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -116.83 125.85 52.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 75.43 110.933 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 127.14 150.32 7.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.767 -0.73 . . . . 72.13 112.453 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 58.33 173.56 0.42 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.769 -0.729 . . . . 73.04 112.456 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.04 31.66 5.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.349 . . . . 72.2 110.885 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -112.54 -119.46 3.68 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.805 -0.712 . . . . 72.14 112.5 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -163.4 119.51 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 75.1 110.893 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.137 -0.483 . . . . 73.4 110.938 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . 0.423 ' O ' HG23 ' E' ' 261' ' ' THR . 16.8 ptt-85 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.797 0.332 . . . . 75.12 110.918 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -83.52 123.97 30.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 71.43 110.833 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.58 144.52 48.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 70.23 110.872 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . 0.501 ' HB3' ' HA ' ' D' ' 264' ' ' VAL . . . -140.12 118.9 12.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 73.14 111.078 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' E' ' 265' ' ' GLU . 0.1 OUTLIER -79.09 -42.02 27.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 61.1 110.905 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -168.18 138.19 2.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 62.2 110.883 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . 0.768 HG21 HG21 ' E' ' 239' ' ' VAL . 10.8 mt -129.11 117.07 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 55.23 111.089 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -119.12 115.1 23.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 75.24 110.858 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.61 128.27 32.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 72.44 111.192 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.35 162.26 33.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.878 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.54 76.55 0.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 62.41 110.885 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 43.66 42.09 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.877 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.98 142.61 27.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 63.03 111.171 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -125.42 137.67 54.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 51.32 110.902 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.768 HG21 HG21 ' E' ' 231' ' ' ILE . 7.6 p -136.5 121.92 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 63.2 111.1 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -112.88 137.48 51.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.92 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.658 HD13 ' HB ' ' E' ' 277' ' ' ILE . 1.5 mm? -120.34 118.27 29.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 71.34 110.912 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 123.5 169.14 13.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.727 -0.749 . . . . 71.51 112.472 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.65 146.0 27.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.929 0.395 . . . . 75.24 110.849 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' E' ' 280' ' ' GLU . 24.3 m -111.83 139.72 34.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 65.04 111.153 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 45.3 t -120.98 129.58 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 73.34 111.115 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.2 t -69.04 175.07 3.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.114 -0.494 . . . . 63.11 111.172 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.1 -44.83 79.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 52.34 111.163 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.06 -52.17 66.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.5 111.068 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 74.13 111.118 179.942 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . 0.423 HG23 ' O ' ' E' ' 225' ' ' ARG . 99.1 m . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.789 0.328 . . . . 54.33 111.173 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -124.63 119.6 29.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 42.24 110.956 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.76 120.1 30.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 74.42 110.852 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.4 p -111.52 137.4 44.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 53.25 111.09 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 3.4 tt0 -71.06 -95.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 73.43 110.852 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 93.8 m -119.8 126.2 50.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 72.42 111.167 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . 0.686 ' CG1' HG23 ' E' ' 231' ' ' ILE . 3.5 p -116.07 120.1 63.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 74.24 111.136 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 39.9 t -117.94 119.21 60.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 71.41 111.089 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.51 133.52 9.55 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 74.44 112.502 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.57 147.91 45.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 72.2 110.897 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.6 89.63 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 64.11 112.489 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 41.59 77.58 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 54.12 110.886 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 6.2 t -105.48 145.18 31.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 71.22 110.838 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.06 128.23 49.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 62.31 110.935 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.623 HG21 HG21 ' E' ' 267' ' ' VAL . 85.1 t -132.98 123.96 49.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.44 111.129 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.51 125.82 41.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 72.35 110.942 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.658 ' HB ' HD13 ' E' ' 241' ' ' LEU . 20.9 mm -112.18 124.85 69.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 75.33 111.138 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 113.82 -170.97 13.55 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.682 -0.771 . . . . 50.04 112.458 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -102.68 155.98 17.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 74.4 110.914 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . 0.408 ' HA ' HG22 ' E' ' 244' ' ' VAL . 5.4 pt-20 -121.81 132.67 54.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 74.33 110.856 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -115.35 125.16 52.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 64.51 110.868 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.718 -0.753 . . . . 73.1 112.455 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.594 ' CB ' HG22 ' A' ' 261' ' ' THR . 13.7 ttp85 . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.837 0.351 . . . . 72.54 110.863 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.429 HD22 ' N ' ' A' ' 242' ' ' GLY . 12.4 m-20 -83.95 111.64 19.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 73.32 110.872 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.77 150.72 41.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 45.54 110.826 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -144.0 119.1 10.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 72.23 111.122 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -76.05 -48.53 20.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 70.12 110.887 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -164.92 135.8 4.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 72.33 110.908 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.579 HG22 ' CG2' ' A' ' 267' ' ' VAL . 8.8 pt -139.3 134.36 40.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 41.54 111.154 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -130.93 138.54 49.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 75.34 110.853 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.708 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.5 OUTLIER -136.07 147.14 47.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 71.13 111.133 -179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -134.04 167.02 21.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 71.41 110.869 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.43 -70.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 74.52 110.927 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.38 66.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 75.15 110.879 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.708 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -102.7 157.5 16.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 64.14 111.145 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.25 139.02 50.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 63.51 110.856 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.463 HG21 HD12 ' A' ' 231' ' ' ILE . 4.2 p -122.28 121.65 64.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 72.33 111.09 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.04 116.01 29.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 61.12 110.919 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.1 mp -111.99 118.61 35.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 43.51 110.903 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.429 ' N ' HD22 ' A' ' 226' ' ' ASN . . . 141.32 160.79 8.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 52.31 112.476 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -85.77 134.75 33.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 62.24 110.835 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 17.8 m -106.69 133.63 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.476 . . . . 61.33 111.125 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 39.1 t -122.74 113.06 36.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 62.14 111.038 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 281' ' ' TYR . 5.3 t . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 70.44 111.177 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' THR . . . . . 0.516 HG21 ' HB3' ' B' ' 243' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.858 0.361 . . . . 75.01 111.15 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.594 HG22 ' CB ' ' A' ' 225' ' ' ARG . 0.9 OUTLIER -123.19 108.97 13.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 62.13 111.157 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -92.65 127.61 38.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 52.01 110.84 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.2 t -142.18 123.32 14.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 34.02 110.896 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.633 HG21 HG22 ' A' ' 267' ' ' VAL . 4.8 p -105.93 137.33 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.5 . . . . 52.21 111.175 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -88.74 -66.57 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 75.34 110.865 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 26.3 m -125.45 126.6 45.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 74.44 111.069 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 264' ' ' VAL . 41.3 t -117.69 131.3 70.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 72.23 111.139 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 30.2 t -127.15 115.31 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.134 -0.484 . . . . 62.3 111.167 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.76 132.82 11.25 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 72.1 112.465 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 134.41 45.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 65.43 110.921 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.44 85.36 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.76 -0.733 . . . . 55.31 112.523 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 47.74 79.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.892 0.377 . . . . 34.33 110.958 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.47 145.05 30.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 75.33 110.887 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -113.4 128.44 56.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.877 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.18 123.67 53.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 71.31 111.11 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.411 HD22 ' CE2' ' A' ' 287' ' ' TRP . 25.5 tp -128.15 111.54 13.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 72.2 110.942 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 73.6 mt -109.23 103.92 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 62.04 111.123 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.53 -159.02 28.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.796 -0.716 . . . . 63.31 112.498 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -128.21 156.28 43.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 65.32 110.894 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -115.26 134.71 54.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 70.01 110.883 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.465 ' O ' HG22 ' A' ' 246' ' ' THR . 17.2 m-85 -118.81 126.84 52.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 74.43 110.91 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.82 159.3 26.62 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.799 -0.715 . . . . 63.53 112.516 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.743 ' H ' ' HB2' ' B' ' 247' ' ' ALA . . . -68.07 -130.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.811 -0.709 . . . . 63.24 112.475 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.62 28.19 16.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.77 0.319 . . . . 74.22 110.904 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 92.5 152.38 28.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.783 -0.723 . . . . 73.04 112.504 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -67.47 -35.05 78.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 73.02 110.899 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.411 ' CE2' HD22 ' A' ' 276' ' ' LEU . 15.6 t90 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 75.22 110.96 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.665 ' HB3' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.845 0.355 . . . . 74.52 110.804 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.645 ' OD1' HG22 ' B' ' 277' ' ' ILE . 17.1 m-80 -109.24 119.25 38.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 73.24 110.962 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.63 148.87 51.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.866 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.612 ' HB2' HD21 ' B' ' 241' ' ' LEU . . . -139.26 119.92 14.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 62.54 111.16 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.07 -44.58 30.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 73.53 110.812 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -165.75 134.89 3.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 64.24 110.799 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.633 HD12 HG21 ' B' ' 239' ' ' VAL . 7.6 pt -140.17 133.67 34.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 75.22 111.153 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.92 136.72 42.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 75.12 110.819 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.729 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.5 OUTLIER -136.29 147.97 47.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 72.43 111.098 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -136.1 167.9 20.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 72.51 110.904 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.83 -71.47 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 71.14 110.861 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -179.3 62.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 75.15 110.937 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.729 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -102.3 157.19 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 71.33 111.115 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -129.85 135.26 48.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.829 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.633 HG21 HD12 ' B' ' 231' ' ' ILE . 6.4 p -122.93 129.57 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 75.02 111.151 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.564 ' HB3' HD12 ' B' ' 276' ' ' LEU . 8.8 tm0? -120.11 124.73 46.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 65.25 110.901 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.612 HD21 ' HB2' ' B' ' 228' ' ' ALA . 4.5 mt -111.74 118.88 36.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 74.32 110.929 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.88 176.44 14.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.704 -0.76 . . . . 51.2 112.46 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.516 ' HB3' HG21 ' A' ' 260' ' ' THR . 2.0 p30 -85.92 134.06 33.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.373 . . . . 64.42 110.876 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 1.7 t -104.69 115.25 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 74.34 111.111 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 44.7 t -106.91 122.76 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 55.43 111.13 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.469 HG22 ' O ' ' B' ' 281' ' ' TYR . 14.5 t -96.14 163.26 13.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 71.11 111.19 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.743 ' HB2' ' H ' ' A' ' 283' ' ' GLY . . . -58.73 -33.88 70.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 75.1 111.107 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -35.99 69.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 62.41 111.088 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.5 ' HB2' ' CA ' ' B' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 64.31 111.134 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.881 0.372 . . . . 73.24 110.882 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.85 137.57 32.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 64.03 111.161 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.665 HG23 ' HB3' ' B' ' 225' ' ' ARG . 96.4 m -131.82 122.33 25.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.286 -0.415 . . . . 74.24 111.162 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.79 124.98 50.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 74.3 110.947 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.2 t -141.95 123.68 15.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 72.22 110.841 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.574 HG21 HG22 ' B' ' 267' ' ' VAL . 4.4 p -106.41 137.72 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.477 . . . . 72.53 111.207 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -85.52 -72.67 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 61.1 110.882 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 19.0 p -122.24 126.48 48.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 72.51 111.111 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.574 HG22 HG21 ' B' ' 264' ' ' VAL . 46.1 t -118.28 127.77 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 71.35 111.157 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 58.5 t -127.17 115.23 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 43.41 111.113 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.3 133.19 11.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.74 . . . . 41.41 112.478 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -130.54 139.54 50.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.831 0.348 . . . . 72.15 110.892 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.67 85.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 64.44 112.482 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 45.76 74.34 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 71.44 110.908 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.69 145.68 26.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 63.52 110.872 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 11.0 mtm-85 -113.68 128.17 56.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 74.43 110.912 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 36.1 t -130.17 123.31 55.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 71.51 111.085 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.589 HD23 ' CG ' ' C' ' 240' ' ' GLN . 14.5 tp -128.12 111.32 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 55.11 110.914 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.645 HG22 ' OD1' ' B' ' 226' ' ' ASN . 4.5 mp -107.91 104.55 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 71.24 111.074 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.76 -173.55 27.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.694 -0.765 . . . . 74.22 112.445 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -110.33 154.52 23.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.732 0.301 . . . . 74.12 110.96 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.423 ' HB3' HG13 ' C' ' 244' ' ' VAL . 13.8 tm-20 -111.94 137.22 50.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 74.13 110.881 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.469 ' O ' HG22 ' B' ' 246' ' ' THR . 0.2 OUTLIER -119.95 129.96 54.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 74.51 110.947 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.5 ' CA ' ' HB2' ' B' ' 249' ' ' ALA . . . 107.95 148.13 13.7 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.835 -0.698 . . . . 71.4 112.496 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . 0.59 ' H ' ' HB2' ' C' ' 247' ' ' ALA . . . -68.53 -132.4 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.743 -0.741 . . . . 54.4 112.5 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.7 tptp 62.11 35.54 15.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 75.41 110.865 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 74.89 141.71 0.79 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 75.14 112.464 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -75.44 111.26 10.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.85 0.357 . . . . 64.4 110.924 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.54 ' CE2' HD22 ' B' ' 276' ' ' LEU . 7.0 t90 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 73.31 110.877 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.64 ' HA ' HG23 ' C' ' 261' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.795 0.331 . . . . 73.25 110.822 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -83.89 110.83 18.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 72.52 110.885 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.99 148.13 52.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 65.32 110.892 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' B' ' 264' ' ' VAL . . . -135.21 124.48 24.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 64.22 111.089 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -42.61 16.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.443 . . . . 62.01 110.892 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -166.32 133.89 2.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 72.44 110.839 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.612 HD12 HG11 ' C' ' 239' ' ' VAL . 6.4 pt -140.65 132.07 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 70.23 111.216 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -136.1 135.64 39.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 60.45 110.888 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.733 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.5 OUTLIER -136.67 150.82 48.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 70.11 111.146 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -139.9 168.7 19.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.33 110.931 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.68 -70.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.905 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -179.32 57.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 55.3 110.9 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.733 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -98.46 156.97 16.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 74.24 111.068 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -130.18 135.69 48.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.12 110.86 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.612 HG11 HD12 ' C' ' 231' ' ' ILE . 7.3 p -122.64 128.51 75.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.23 111.079 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.589 ' CG ' HD23 ' B' ' 276' ' ' LEU . 1.2 tm0? -121.14 125.55 47.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 60.23 110.926 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.634 HD13 ' HB ' ' C' ' 277' ' ' ILE . 3.8 mm? -111.59 118.76 36.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 73.54 110.897 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.07 175.38 13.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.633 -0.794 . . . . 61.13 112.448 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -90.45 153.82 20.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.34 . . . . 63.42 110.948 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' B' ' 280' ' ' GLU . 20.1 t -119.83 116.83 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 75.31 111.155 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 48.7 t -108.96 115.33 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 75.23 111.109 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 12.1 t -69.86 175.11 4.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 75.43 111.145 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.59 ' HB2' ' H ' ' B' ' 283' ' ' GLY . . . -55.31 -45.16 76.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 62.45 111.09 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.34 80.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 63.15 111.121 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 44.34 111.148 179.952 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.948 0.404 . . . . 71.02 110.911 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 260' ' ' THR . . . . . 0.506 HG23 ' CB ' ' D' ' 225' ' ' ARG . 5.1 m -65.56 125.03 23.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 62.41 111.117 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.64 HG23 ' HA ' ' C' ' 225' ' ' ARG . 29.0 m -96.15 108.81 21.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 73.33 111.071 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.8 124.23 38.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.478 . . . . 73.33 110.844 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.06 123.21 14.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 71.11 110.828 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.593 HG21 HG22 ' C' ' 267' ' ' VAL . 4.1 p -107.38 139.21 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.081 -0.509 . . . . 73.21 111.15 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -89.56 -65.21 1.04 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 72.03 110.913 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 1.7 p -129.8 126.93 39.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.479 . . . . 55.34 111.132 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.593 HG22 HG21 ' C' ' 264' ' ' VAL . 47.0 t -118.04 126.57 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 64.5 111.155 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 83.4 t -123.07 115.31 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 52.41 111.166 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.37 131.96 10.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.701 -0.761 . . . . 55.44 112.58 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.24 136.29 45.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.786 0.327 . . . . 62.42 110.944 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.56 83.51 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.749 -0.738 . . . . 62.32 112.452 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 46.59 69.99 0.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 74.14 110.929 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.24 145.38 24.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 71.51 110.894 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -113.31 128.4 56.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 73.11 110.84 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.48 HG21 HG11 ' C' ' 267' ' ' VAL . 77.1 t -129.14 121.98 55.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 73.24 111.129 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.465 ' O ' HD12 ' D' ' 241' ' ' LEU . 2.2 tp -128.86 111.17 12.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 43.25 110.906 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.634 ' HB ' HD13 ' C' ' 241' ' ' LEU . 2.7 mp -112.59 104.3 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 61.12 111.096 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.35 -179.46 27.07 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.653 -0.784 . . . . 70.1 112.451 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.34 156.08 18.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.316 . . . . 64.2 110.873 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.84 119.14 27.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 74.21 110.852 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -112.55 125.46 54.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 70.04 110.905 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.15 158.62 7.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 74.3 112.454 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -103.95 -161.85 24.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 71.05 112.503 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt 53.33 34.39 17.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 74.21 110.93 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 131.63 135.4 3.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.649 -0.786 . . . . 54.52 112.463 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -83.7 -26.18 30.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.348 . . . . 70.14 110.91 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.444 ' CE2' HD22 ' C' ' 276' ' ' LEU . 17.0 t90 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 73.13 110.919 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 225' ' ' ARG . . . . . 0.506 ' CB ' HG23 ' C' ' 260' ' ' THR . 11.4 mpt_? . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.841 0.353 . . . . 51.55 110.864 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 226' ' ' ASN . . . . . 0.679 ' ND2' HG22 ' D' ' 277' ' ' ILE . 1.7 m120 -99.88 117.75 34.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 75.53 110.84 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.72 151.97 49.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 54.33 110.837 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -142.36 129.85 21.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 74.13 111.087 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.47 -42.22 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 75.23 110.92 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -166.73 134.92 2.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.11 110.814 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 231' ' ' ILE . . . . . 0.664 HD12 HG11 ' D' ' 239' ' ' VAL . 7.2 pt -141.02 133.01 29.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 73.11 111.117 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -135.7 136.45 40.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 64.21 110.894 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 233' ' ' THR . . . . . 0.665 ' CB ' ' HB3' ' D' ' 237' ' ' ALA . 0.4 OUTLIER -136.86 146.35 45.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 72.05 111.099 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -135.19 168.79 18.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 63.25 110.89 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.12 -72.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 64.31 110.859 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.91 59.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 74.31 110.837 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 237' ' ' ALA . . . . . 0.665 ' HB3' ' CB ' ' D' ' 233' ' ' THR . . . -99.89 157.17 16.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 55.34 111.06 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.61 135.72 46.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 70.44 110.85 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 239' ' ' VAL . . . . . 0.664 HG11 HD12 ' D' ' 231' ' ' ILE . 5.7 p -122.21 121.93 65.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 71.51 111.179 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -118.17 120.92 39.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.899 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 241' ' ' LEU . . . . . 0.465 HD12 ' O ' ' C' ' 276' ' ' LEU . 1.2 mp -112.59 118.8 36.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.947 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.92 165.74 10.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.726 -0.749 . . . . 72.25 112.516 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -85.77 131.0 34.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 62.22 110.908 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 26.5 t -99.09 130.01 48.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 71.22 111.164 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.09 122.48 66.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 61.34 111.137 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.0 t -69.71 165.9 20.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.21 111.119 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.86 -36.38 62.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 53.33 111.16 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.96 -51.94 67.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 52.42 111.113 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 71.24 111.114 179.932 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.912 0.387 . . . . 74.3 111.128 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 94.3 m -108.47 129.17 55.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.218 -0.446 . . . . 71.24 111.208 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.11 127.28 53.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.43 110.873 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 25.7 p -142.53 123.66 14.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 64.21 110.833 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 264' ' ' VAL . . . . . 0.508 HG21 HG22 ' D' ' 267' ' ' VAL . 5.2 p -106.48 134.27 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 73.44 111.131 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -82.22 -77.14 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 72.45 110.849 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.61 126.88 53.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 75.23 111.19 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 267' ' ' VAL . . . . . 0.508 HG22 HG21 ' D' ' 264' ' ' VAL . 94.9 t -117.62 124.76 73.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 73.42 111.168 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.5 114.22 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 62.32 111.163 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.71 133.04 10.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.749 . . . . 75.0 112.456 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.04 143.05 49.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 72.21 110.874 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.96 84.82 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 73.22 112.458 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 45.75 69.65 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.36 . . . . 72.31 110.932 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.4 144.53 25.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 73.4 110.873 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.01 128.42 56.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 72.33 110.866 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 76.6 t -127.41 122.17 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 75.23 111.132 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 276' ' ' LEU . . . . . 0.513 HD13 ' CZ2' ' D' ' 287' ' ' TRP . 2.5 tp -128.56 111.46 13.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 61.52 110.89 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 277' ' ' ILE . . . . . 0.679 HG22 ' ND2' ' D' ' 226' ' ' ASN . 5.8 mt -112.42 104.13 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 63.53 111.098 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.78 -165.51 28.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.763 -0.732 . . . . 71.11 112.485 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -110.05 155.98 21.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.806 0.336 . . . . 71.3 110.899 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.02 131.5 53.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 72.24 110.842 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 281' ' ' TYR . . . . . 0.496 ' HE1' ' HB2' ' E' ' 249' ' ' ALA . 12.7 t80 -124.84 125.73 44.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.129 -0.487 . . . . 74.21 110.929 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 145.27 179.46 21.58 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 51.1 112.487 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -100.62 -149.05 23.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 65.11 112.49 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.51 26.12 13.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 74.3 110.906 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.46 -156.99 15.23 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.721 -0.752 . . . . 52.5 112.503 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 286' ' ' PHE . . . . . 0.606 ' HB3' HG11 ' E' ' 244' ' ' VAL . 27.5 m-85 -116.54 -28.07 6.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.873 0.368 . . . . 71.41 110.892 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 287' ' ' TRP . . . . . 0.513 ' CZ2' HD13 ' D' ' 276' ' ' LEU . 14.8 t90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 65.41 110.928 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.815 0.341 . . . . 74.44 110.886 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -86.55 113.26 22.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.879 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.87 139.35 53.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 55.15 110.831 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 228' ' ' ALA . . . . . 0.471 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -124.21 118.71 27.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 74.03 111.055 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 229' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' E' ' 265' ' ' GLU . 12.5 mttm -75.63 -45.62 36.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 71.21 110.911 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -168.35 135.97 2.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 65.14 110.841 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 231' ' ' ILE . . . . . 0.922 HD12 HG11 ' E' ' 239' ' ' VAL . 8.9 pt -138.16 134.42 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 73.43 111.113 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -135.86 132.7 36.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.908 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 233' ' ' THR . . . . . 0.679 ' OG1' ' HB3' ' E' ' 237' ' ' ALA . 0.5 OUTLIER -136.94 151.51 49.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.21 111.12 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.25 167.56 22.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.904 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 72.78 -69.95 0.18 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 73.41 110.9 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -178.5 63.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 72.41 110.869 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 237' ' ' ALA . . . . . 0.679 ' HB3' ' OG1' ' E' ' 233' ' ' THR . . . -105.86 156.3 18.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 63.33 111.074 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.15 135.61 47.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 72.32 110.889 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 239' ' ' VAL . . . . . 0.922 HG11 HD12 ' E' ' 231' ' ' ILE . 7.2 p -125.0 126.47 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 75.11 111.195 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 240' ' ' GLN . . . . . 0.575 ' C ' HD13 ' E' ' 241' ' ' LEU . 4.7 tm0? -122.71 123.05 40.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 71.2 110.834 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 241' ' ' LEU . . . . . 0.928 HD12 HD12 ' E' ' 277' ' ' ILE . 0.3 OUTLIER -111.85 118.7 36.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 74.42 110.914 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 134.56 169.32 11.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 73.3 112.52 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -85.87 145.41 27.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.849 0.357 . . . . 64.22 110.903 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 244' ' ' VAL . . . . . 0.606 HG11 ' HB3' ' D' ' 286' ' ' PHE . 21.6 t -110.99 135.33 50.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.11 111.118 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 23.4 t -122.12 128.54 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 73.03 111.136 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -69.95 174.96 4.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 74.05 111.141 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.32 94.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 73.45 111.138 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.12 76.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 72.45 111.132 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 249' ' ' ALA . . . . . 0.496 ' HB2' ' HE1' ' D' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 65.11 111.134 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 92.4 m . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.848 0.356 . . . . 44.12 111.09 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.24 119.01 33.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 74.51 110.877 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 98.7 p -133.19 133.24 42.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 74.45 110.871 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 1.2 p -104.46 153.44 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 74.5 111.112 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 265' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 1.6 tt0 -92.22 -51.0 5.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.42 110.902 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 1.4 m -154.43 145.16 22.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 60.24 111.122 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 267' ' ' VAL . . . . . 0.463 HG11 HG21 ' E' ' 275' ' ' VAL . 86.6 t -136.17 120.54 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 63.35 111.172 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 268' ' ' VAL . . . . . 0.451 ' O ' HG13 ' E' ' 268' ' ' VAL . 5.3 p -127.3 115.55 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 72.41 111.11 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.65 133.62 10.82 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.733 . . . . 52.15 112.456 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.57 144.5 44.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 62.52 110.913 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 42.27 76.14 0.12 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.722 -0.752 . . . . 54.04 112.522 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 64.04 116.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 64.03 110.877 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 12.1 m -146.41 145.25 30.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 71.51 110.802 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -114.62 127.69 55.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 71.01 110.86 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 275' ' ' VAL . . . . . 0.516 ' HB ' HG23 ' E' ' 239' ' ' VAL . 24.2 t -127.1 121.9 58.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 70.33 111.09 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.24 112.53 13.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.204 -0.453 . . . . 74.01 110.934 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 277' ' ' ILE . . . . . 0.928 HD12 HD12 ' E' ' 241' ' ' LEU . 55.9 mt -112.26 104.56 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 74.12 111.141 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.46 -154.1 25.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.678 -0.772 . . . . 22.43 112.472 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -122.61 156.1 34.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 65.35 110.88 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -116.4 128.97 55.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 72.22 110.896 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -121.85 126.01 47.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 74.43 110.905 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.705 -0.759 . . . . 51.52 112.448 179.966 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 9.3 ptt? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.848 0.356 . . . . 75.03 110.85 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 16.6 mttt 62.04 98.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 72.51 110.901 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.5 mm -123.65 130.54 74.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.434 . . . . 52.45 111.168 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -166.99 157.44 11.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 75.35 110.892 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.578 ' HB1' HD12 ' A' ' 222' ' ' ILE . . . -136.44 122.34 20.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 63.04 111.111 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.67 HG12 HG22 ' B' ' 223' ' ' VAL . 3.9 mp 57.14 67.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 73.22 111.117 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 93.5 t -149.88 125.37 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 70.33 111.127 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -53.15 147.46 16.52 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 33.03 112.491 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.503 ' HB3' HG23 ' A' ' 261' ' ' THR . 1.6 tmm_? -166.44 99.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.354 . . . . 64.53 110.899 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -83.94 114.16 21.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 62.22 110.858 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 2.6 m -133.97 144.42 48.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 64.34 110.853 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.86 ' HB1' HD11 ' A' ' 231' ' ' ILE . . . -129.05 127.27 41.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 73.24 111.076 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -42.96 37.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 73.43 110.952 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -164.99 138.34 4.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 63.23 110.906 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.86 HD11 ' HB1' ' A' ' 228' ' ' ALA . 3.1 mp -138.43 117.14 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 75.35 111.113 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.724 ' HD2' HG22 ' A' ' 268' ' ' VAL . 7.6 ptp85 -113.59 123.31 49.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 72.44 110.874 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.8 p -135.4 141.74 45.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 72.32 111.175 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.6 pm0 -149.2 167.69 25.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.4 110.886 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 68.56 68.85 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 75.21 110.89 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 47.43 55.68 7.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 65.24 110.844 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.4 156.78 17.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 44.43 111.064 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -125.79 142.77 51.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 73.15 110.896 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.482 HG23 ' CG1' ' A' ' 275' ' ' VAL . 5.4 p -142.99 131.28 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 61.0 111.127 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -138.02 137.26 37.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 73.13 110.89 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.604 HD12 HG13 ' A' ' 277' ' ' ILE . 0.3 OUTLIER -114.69 118.23 33.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.454 . . . . 62.43 110.876 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 146.67 -176.74 25.41 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.701 -0.761 . . . . 61.23 112.481 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -85.92 140.38 30.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.903 0.382 . . . . 64.0 110.882 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.49 ' CG2' HD11 ' A' ' 276' ' ' LEU . 30.1 t -111.82 115.33 49.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 75.33 111.146 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 64.7 t -103.96 128.84 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.41 111.136 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.6 m -98.0 162.97 12.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 72.24 111.121 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.91 -40.88 98.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 73.32 111.077 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' A' ' 284' ' ' LYS . . . -59.01 -36.21 74.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 74.45 111.075 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.508 ' HB2' ' HA2' ' A' ' 282' ' ' GLY . . . -87.54 51.1 2.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 62.31 111.124 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.25 -177.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 64.23 110.921 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.65 -170.09 2.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 62.03 110.859 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -68.79 86.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 74.2 112.468 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -88.82 -40.0 6.4 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.75 -0.738 . . . . 51.3 112.446 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 24.7 mt 65.33 151.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.799 0.333 . . . . 74.31 111.178 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.35 101.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 75.51 110.904 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.596 HG21 ' HE2' ' A' ' 281' ' ' TYR . 5.3 mp -130.75 -40.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 62.04 111.168 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.24 -73.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 75.53 110.879 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 57.61 93.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 71.03 110.885 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -130.86 -40.41 1.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 62.25 110.938 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 15.4 t -82.16 135.25 35.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 72.31 111.115 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.503 HG23 ' HB3' ' A' ' 225' ' ' ARG . 84.7 m -92.03 120.36 32.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 64.53 111.157 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -101.75 119.52 38.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 74.34 110.931 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 17.6 t -142.06 123.98 15.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.43 110.806 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.548 HG21 HG22 ' A' ' 267' ' ' VAL . 8.9 p -110.75 137.77 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 73.34 111.107 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.44 -76.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 73.04 110.857 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 17.5 p -129.41 129.5 44.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 63.14 111.136 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.716 ' HB ' HG23 ' A' ' 231' ' ' ILE . 19.3 t -118.39 120.75 65.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 74.13 111.11 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.724 HG22 ' HD2' ' A' ' 232' ' ' ARG . 26.0 t -111.32 126.49 68.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 60.41 111.1 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.75 132.94 8.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.743 -0.741 . . . . 71.54 112.466 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.73 147.41 52.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.832 0.348 . . . . 73.25 110.87 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 59.66 71.76 0.72 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.713 -0.756 . . . . 63.43 112.451 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 50.06 61.05 3.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.886 0.374 . . . . 72.31 110.868 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 15.9 t -85.99 147.99 25.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 73.15 110.841 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -110.57 128.67 55.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 72.42 110.854 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.687 HG11 HG21 ' A' ' 231' ' ' ILE . 92.2 t -115.59 123.03 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 52.24 111.125 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.49 HD11 ' CG2' ' A' ' 244' ' ' VAL . 0.2 OUTLIER -128.53 111.74 13.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 64.42 110.888 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.604 HG13 HD12 ' A' ' 241' ' ' LEU . 18.1 mm -106.35 104.35 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 62.21 111.115 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.3 179.76 17.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.731 . . . . 75.32 112.48 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -89.84 156.04 18.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 73.41 110.879 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -130.31 140.29 50.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 71.12 110.868 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.596 ' HE2' HG21 ' A' ' 256' ' ' ILE . 7.1 m-85 -119.24 126.01 50.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 73.42 110.9 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.508 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 161.08 142.55 3.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.731 . . . . 23.1 112.494 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -106.27 -18.83 10.62 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.733 -0.746 . . . . 64.34 112.491 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 248' ' ' ALA . 0.5 OUTLIER -72.4 79.33 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 70.34 110.888 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 67.22 112.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.768 -0.73 . . . . 64.52 112.483 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -52.32 111.52 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 72.11 110.877 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 3.1 t90 72.16 -69.19 0.19 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.486 . . . . 70.23 110.931 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -172.95 83.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.288 -0.414 . . . . 74.24 110.895 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.84 163.1 17.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 63.34 110.893 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -167.08 30.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 74.11 110.834 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -58.57 176.3 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 72.45 110.848 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -163.82 -41.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 71.44 110.898 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -52.41 141.79 18.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 64.32 110.868 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -121.34 130.88 53.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 72.12 110.847 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 5.0 p80 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 62.53 110.849 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.839 0.352 . . . . 52.33 110.86 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.78 -58.41 1.9 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 74.23 110.892 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . 0.435 HD13 ' HB2' ' C' ' 220' ' ' ASP . 13.1 tt -150.72 148.78 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 72.3 111.124 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -133.18 -175.75 3.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 71.24 110.876 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.13 130.63 46.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 70.43 111.111 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 2.2 pp -139.09 148.65 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 74.13 111.13 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.67 HG22 HG12 ' A' ' 222' ' ' ILE . 36.0 m -123.58 132.97 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 62.15 111.098 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 67.44 119.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.786 -0.721 . . . . 64.24 112.477 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.499 ' HB3' HG23 ' B' ' 261' ' ' THR . 4.5 ttm-85 -158.7 110.39 2.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.341 . . . . 74.34 110.919 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.696 ' HB3' HG22 ' B' ' 277' ' ' ILE . 1.2 m-20 -105.09 114.23 28.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 72.21 110.927 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.68 143.68 48.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 73.04 110.86 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.09 136.73 53.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 54.15 111.116 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.13 -36.28 16.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 64.21 110.927 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . 0.497 ' HB3' HG23 ' B' ' 266' ' ' THR . 26.6 t70 -165.12 137.74 4.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 72.14 110.848 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.593 HG21 HG11 ' B' ' 275' ' ' VAL . 7.7 mt -138.43 117.88 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 55.0 111.134 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -111.53 125.14 53.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 63.15 110.891 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 4.8 p -135.26 134.83 40.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.476 . . . . 72.05 111.148 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -150.94 167.4 27.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 74.3 110.92 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 66.98 64.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.864 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 77.9 mtm-85 50.46 55.34 9.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 71.31 110.869 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.04 156.57 17.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 64.4 111.126 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.27 140.79 52.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.87 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.556 HG23 ' HB ' ' B' ' 275' ' ' VAL . 3.0 p -132.62 130.43 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 72.02 111.139 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.714 ' C ' HD13 ' B' ' 241' ' ' LEU . 1.8 tm0? -136.6 130.85 32.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 72.05 110.956 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.714 HD13 ' C ' ' B' ' 240' ' ' GLN . 0.1 OUTLIER -118.54 117.9 30.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 72.44 110.973 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.56 175.85 23.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 34.55 112.508 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.88 128.87 34.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.836 0.35 . . . . 73.12 110.925 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -97.15 126.17 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 71.05 111.154 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.453 HG21 ' CZ ' ' A' ' 281' ' ' TYR . 93.4 t -122.11 112.89 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 61.04 111.111 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.457 HG23 ' O ' ' B' ' 281' ' ' TYR . 78.1 p -76.84 170.28 16.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 74.42 111.115 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.75 81.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 64.34 111.13 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.67 77.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 62.44 111.131 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.96 -30.22 23.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 60.42 111.101 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.0 133.02 51.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 74.14 110.933 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 59.2 t60 61.19 86.37 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 73.12 110.854 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 177.12 -117.86 0.61 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 60.5 112.537 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -154.77 126.27 1.85 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.785 -0.722 . . . . 60.24 112.491 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 2.3 mp -99.95 -60.17 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 72.14 111.108 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -56.23 102.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 73.42 110.884 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.84 39.22 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 71.3 111.15 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 23.3 t 58.95 66.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 52.24 110.841 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.92 152.83 34.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 74.55 110.854 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . 0.644 ' HG3' HG12 ' B' ' 223' ' ' VAL . 2.0 tm0? -170.82 48.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 73.15 110.908 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 15.1 t -100.77 137.27 39.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 71.13 111.119 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.931 HG21 HD12 ' C' ' 219' ' ' ILE . 23.7 m -98.45 110.76 23.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 71.11 111.172 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -93.21 119.56 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 71.23 110.886 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 24.8 p -142.17 123.68 14.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 61.01 110.857 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.506 HG21 ' CG2' ' B' ' 267' ' ' VAL . 7.4 p -112.35 137.45 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 60.24 111.128 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.05 -76.78 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 60.53 110.849 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.497 HG23 ' HB3' ' B' ' 230' ' ' ASP . 1.2 m -133.71 130.69 38.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 74.04 111.127 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.506 ' CG2' HG21 ' B' ' 264' ' ' VAL . 21.7 t -118.52 120.53 64.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 73.3 111.148 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 30.4 t -105.04 121.41 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 63.25 111.11 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.47 132.94 10.61 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 52.54 112.449 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.95 147.3 52.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.351 . . . . 74.21 110.895 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.02 78.66 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 73.51 112.461 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 49.68 73.48 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.845 0.355 . . . . 73.35 110.907 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 14.8 t -96.66 147.84 23.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 74.34 110.881 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 24.2 mtm-85 -113.8 128.27 56.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 65.14 110.893 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.593 HG11 HG21 ' B' ' 231' ' ' ILE . 84.6 t -115.75 122.96 70.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 74.4 111.171 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.489 HD23 ' HZ2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -129.59 112.61 13.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 74.23 110.917 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 1.091 HD13 HD23 ' C' ' 241' ' ' LEU . 27.1 mm -109.44 103.98 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 70.01 111.145 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.16 -178.39 19.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 71.14 112.479 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -89.85 156.09 18.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.78 0.324 . . . . 71.2 110.858 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -126.8 139.1 53.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 72.34 110.862 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.457 ' O ' HG23 ' B' ' 246' ' ' THR . 2.0 t80 -120.9 125.87 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 74.24 110.913 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 161.76 149.91 5.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.734 -0.746 . . . . 61.04 112.517 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -105.25 -29.84 4.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 75.12 112.505 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -69.68 86.22 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 73.31 110.902 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 69.65 133.13 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.764 -0.731 . . . . 60.03 112.494 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -77.37 89.54 3.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.895 0.379 . . . . 64.32 110.858 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.489 ' HZ2' HD23 ' B' ' 276' ' ' LEU . 4.9 t90 71.51 -69.66 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 73.52 110.956 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.81 -175.49 2.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 75.04 110.834 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -88.43 153.61 21.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 75.33 110.888 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -173.65 125.48 0.38 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 72.54 110.859 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.74 158.3 37.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 65.14 110.869 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.16 176.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 73.01 110.851 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.62 154.87 20.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 73.44 110.855 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -119.94 -176.14 3.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 74.24 110.877 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 74.31 110.892 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . 0.417 ' CG ' HG22 ' D' ' 219' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.824 0.345 . . . . 72.12 110.923 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 4.1 tptt 59.37 34.45 22.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 72.24 110.886 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.931 HD12 HG21 ' B' ' 261' ' ' THR . 20.6 tt -152.86 144.34 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 75.13 111.096 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . 0.435 ' HB2' HD13 ' B' ' 219' ' ' ILE . 26.2 t0 -103.79 -30.65 10.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 72.23 110.894 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.43 151.18 7.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 25.13 111.096 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 20.2 pt -136.04 28.1 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 60.14 111.109 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 7.7 p -158.85 125.0 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 54.33 111.131 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.43 102.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.694 -0.765 . . . . 72.42 112.474 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.568 ' N ' HG23 ' C' ' 261' ' ' THR . 0.4 OUTLIER -178.56 123.62 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.351 . . . . 74.24 110.88 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.678 ' HB3' HG22 ' C' ' 277' ' ' ILE . 0.7 OUTLIER -83.85 116.78 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 75.12 110.872 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.93 146.36 51.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 41.0 110.866 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.22 134.87 48.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 74.01 111.093 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.73 -34.66 21.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 64.4 110.887 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . 0.618 ' HB3' HG23 ' C' ' 266' ' ' THR . 4.4 t70 -165.52 137.57 4.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 64.02 110.885 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.537 HG21 HG11 ' C' ' 275' ' ' VAL . 8.7 mt -138.36 121.19 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 71.44 111.14 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 21.9 ttm-85 -111.57 125.5 54.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.814 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 3.8 p -135.1 131.74 37.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 74.34 111.157 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -147.82 167.77 23.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 74.11 110.836 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 63.36 72.71 0.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 75.43 110.898 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? 47.29 40.32 10.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 75.44 110.882 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.28 156.1 18.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 50.42 111.091 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -134.57 144.09 47.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 63.43 110.87 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.508 HG23 ' CG1' ' C' ' 275' ' ' VAL . 3.5 p -130.66 121.88 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 74.52 111.15 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.719 ' C ' HD13 ' C' ' 241' ' ' LEU . 2.5 tm0? -124.81 126.68 45.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 71.53 110.938 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 1.091 HD23 HD13 ' B' ' 277' ' ' ILE . 0.1 OUTLIER -117.35 117.43 29.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 74.53 110.911 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 153.35 176.23 25.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.771 -0.728 . . . . 61.32 112.519 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -85.89 128.75 34.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 62.03 110.911 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.91 128.18 46.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 75.22 111.088 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.44 113.43 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 52.52 111.129 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 23.3 p -69.67 169.03 13.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 75.31 111.115 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.17 93.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 71.33 111.043 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.06 82.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 63.05 111.075 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.82 107.16 0.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 63.12 111.08 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 8.3 mt -138.29 -50.26 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 64.21 110.905 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . 0.512 ' ND1' HD11 ' D' ' 250' ' ' LEU . 0.1 OUTLIER -54.14 129.07 33.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 73.12 110.894 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 149.74 93.9 0.11 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.734 . . . . 61.03 112.497 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -67.67 -144.59 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 65.24 112.499 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 13.6 tt -122.34 133.5 68.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.795 0.331 . . . . 72.41 111.164 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.55 -178.35 4.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 64.44 110.871 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 1.2 tt -152.59 132.66 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 74.31 111.18 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.49 -175.01 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 75.11 110.883 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -59.13 178.99 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.151 -0.477 . . . . 74.23 110.88 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -176.45 160.89 2.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 53.31 110.922 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . 0.675 HG21 ' HB3' ' D' ' 243' ' ' ASN . 8.6 t -70.87 131.45 43.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 61.02 111.15 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.568 HG23 ' N ' ' C' ' 225' ' ' ARG . 0.2 OUTLIER -101.41 139.66 36.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 73.32 111.166 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -124.5 128.65 49.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 64.54 110.836 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 5.5 p -141.56 123.77 15.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 75.24 110.887 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.494 HG21 ' CG2' ' C' ' 267' ' ' VAL . 7.5 p -111.27 137.65 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 74.25 111.132 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.58 -76.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.167 -0.469 . . . . 73.45 110.908 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . 0.618 HG23 ' HB3' ' C' ' 230' ' ' ASP . 0.2 OUTLIER -130.72 130.53 43.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 44.43 111.144 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.494 ' CG2' HG21 ' C' ' 264' ' ' VAL . 19.5 t -118.64 129.6 74.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 75.15 111.146 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.68 119.06 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 52.33 111.149 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.39 132.47 10.34 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.767 -0.73 . . . . 52.33 112.488 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -134.05 147.58 50.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.361 . . . . 71.21 110.871 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.39 87.2 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.717 -0.754 . . . . 45.02 112.482 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 45.66 64.4 1.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.849 0.357 . . . . 74.51 110.915 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 4.1 t -88.27 145.78 25.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 60.44 110.871 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 4.0 mtm-85 -117.45 127.8 54.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.505 . . . . 71.22 110.851 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.537 HG11 HG21 ' C' ' 231' ' ' ILE . 83.9 t -116.13 123.5 71.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.42 111.108 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.532 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.3 OUTLIER -128.5 113.65 15.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 73.01 110.861 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 1.026 HD13 HD23 ' D' ' 241' ' ' LEU . 24.7 mm -112.14 104.41 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 73.04 111.132 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.36 -175.08 22.19 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.753 . . . . 72.53 112.512 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.47 156.22 16.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.846 0.355 . . . . 72.14 110.861 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.407 ' CG ' HG13 ' D' ' 244' ' ' VAL . 6.7 pt-20 -126.8 138.04 53.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 72.24 110.887 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -120.63 125.11 46.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.472 . . . . 75.12 110.923 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 164.84 147.7 5.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.752 -0.737 . . . . 73.23 112.503 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -80.77 -48.99 5.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.749 -0.739 . . . . 73.41 112.509 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -51.67 103.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.357 . . . . 65.44 110.868 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 53.69 -147.36 19.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 53.43 112.473 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -122.35 -35.31 3.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 64.14 110.859 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.532 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 13.2 t90 -163.78 -47.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 72.51 110.891 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.88 116.02 18.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 64.4 110.882 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . 0.409 ' ND2' ' H ' ' C' ' 289' ' ' ASN . 2.5 p30 -69.29 88.14 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 70.34 110.882 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -125.96 -66.96 0.9 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 65.44 110.845 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.46 177.6 4.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 74.45 110.878 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 62.79 163.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 71.14 110.823 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -168.59 -171.9 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 70.54 110.85 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -70.69 170.29 12.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 71.42 110.867 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 73.12 110.866 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.826 0.346 . . . . 63.0 110.853 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.77 120.69 23.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 73.14 110.88 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . 0.417 HG22 ' CG ' ' C' ' 217' ' ' MET . 3.1 pt -118.1 41.82 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 52.11 111.137 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -128.12 105.47 8.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 65.31 110.833 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -166.35 176.39 7.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 72.44 111.069 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 23.4 pt -72.47 172.5 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 72.33 111.155 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 61.3 t -85.27 -59.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.474 . . . . 75.44 111.142 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 132.27 -168.75 22.47 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.701 -0.761 . . . . 74.14 112.477 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.569 ' HA ' HG23 ' D' ' 261' ' ' THR . 0.0 OUTLIER -79.84 -74.56 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.808 0.337 . . . . 74.25 110.856 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . 0.749 ' HB3' HG22 ' D' ' 277' ' ' ILE . 2.0 m120 -84.31 114.52 21.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 63.44 110.911 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 3.8 t -134.5 142.71 47.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.41 110.809 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . 0.583 ' CB ' HD11 ' D' ' 231' ' ' ILE . . . -129.29 119.99 24.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.505 . . . . 50.24 111.1 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -34.42 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 63.14 110.892 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -166.12 137.51 3.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 61.52 110.865 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . 0.583 HD11 ' CB ' ' D' ' 228' ' ' ALA . 6.3 mt -138.58 121.69 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 71.43 111.151 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -111.45 126.15 54.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 74.12 110.843 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . 0.439 HG21 ' HB ' ' D' ' 239' ' ' VAL . 5.8 p -135.16 130.57 35.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 61.21 111.141 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -146.44 166.84 25.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 71.34 110.9 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 64.99 71.05 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 74.23 110.925 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.33 34.88 4.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 75.34 110.893 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.89 154.21 23.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 71.44 111.13 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.49 144.43 51.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 74.32 110.899 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.522 HG23 ' CG1' ' D' ' 275' ' ' VAL . 6.0 p -131.51 121.91 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 62.31 111.11 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . 0.694 ' C ' HD13 ' D' ' 241' ' ' LEU . 2.4 tm0? -125.58 125.78 43.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 74.11 110.915 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 1.026 HD23 HD13 ' C' ' 277' ' ' ILE . 0.1 OUTLIER -117.51 118.01 31.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 61.15 110.872 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.01 179.48 26.78 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.752 . . . . 25.21 112.454 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . 0.675 ' HB3' HG21 ' C' ' 260' ' ' THR . 6.6 p30 -86.02 133.54 33.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.902 0.382 . . . . 64.15 110.88 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . 0.407 HG13 ' CG ' ' C' ' 280' ' ' GLU . 19.9 t -103.67 114.95 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 72.11 111.137 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . 0.448 HG11 HD11 ' D' ' 254' ' ' ILE . 21.8 t -110.76 120.7 62.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 71.41 111.168 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 9.6 p -76.56 167.17 22.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.14 111.125 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.26 79.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 72.43 111.109 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.38 -38.25 73.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 55.41 111.046 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.64 103.88 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 54.44 111.101 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . 0.512 HD11 ' ND1' ' C' ' 251' ' ' HIS . 1.4 tp -114.26 -169.96 1.63 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 65.52 110.887 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -64.18 104.24 0.72 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 64.31 110.889 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 176.17 38.14 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.796 -0.716 . . . . 51.41 112.521 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 102.78 24.16 8.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 24.42 112.473 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . 0.448 HD11 HG11 ' D' ' 245' ' ' VAL . 16.9 tt -52.95 -31.73 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 61.54 111.112 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -77.05 80.73 3.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 72.23 110.893 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 1.3 tt -56.73 -26.23 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 64.2 111.137 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 1.4 m 62.03 -174.32 0.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.839 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -78.97 133.2 36.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 73.42 110.855 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . 0.522 ' HB2' HD12 ' E' ' 256' ' ' ILE . 1.2 tm0? -146.97 -73.54 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 63.32 110.935 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 14.3 t -100.04 138.08 37.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 64.12 111.121 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . 0.569 HG23 ' HA ' ' D' ' 225' ' ' ARG . 26.8 m -106.68 108.85 20.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 63.3 111.166 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . 0.409 HD22 ' N ' ' D' ' 263' ' ' SER . 0.1 OUTLIER -100.02 130.53 46.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 72.35 110.885 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . 0.409 ' N ' HD22 ' D' ' 262' ' ' ASN . 5.5 t -140.95 123.76 16.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 42.43 110.867 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.616 HG21 HG22 ' D' ' 267' ' ' VAL . 7.9 p -108.26 141.34 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 65.42 111.126 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -81.07 -76.65 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 75.23 110.9 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.49 128.26 46.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 61.41 111.192 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.616 HG22 HG21 ' D' ' 264' ' ' VAL . 17.8 t -118.5 135.05 60.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 73.2 111.126 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 50.7 t -126.41 126.32 68.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.145 -0.479 . . . . 40.51 111.109 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.07 132.42 8.08 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.729 -0.748 . . . . 70.03 112.504 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -133.51 147.3 51.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.828 0.346 . . . . 64.44 110.931 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.19 89.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 75.15 112.469 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 44.06 59.73 3.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 75.35 110.895 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 17.1 t -83.84 145.41 28.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 40.04 110.861 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -118.1 128.09 54.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 75.55 110.883 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.542 HG11 HG21 ' D' ' 231' ' ' ILE . 92.0 t -119.44 122.02 67.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 71.24 111.135 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.451 HD21 ' OE1' ' D' ' 240' ' ' GLN . 0.2 OUTLIER -129.77 112.11 13.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 71.02 110.949 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.749 HG22 ' HB3' ' D' ' 226' ' ' ASN . 28.3 mm -112.68 104.34 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 71.23 111.106 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.6 -174.24 26.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.678 -0.772 . . . . 75.05 112.509 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -100.37 156.11 17.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.798 0.332 . . . . 61.34 110.889 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . 0.543 ' CD ' HG13 ' E' ' 244' ' ' VAL . 2.1 pt-20 -121.72 118.9 30.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 64.44 110.905 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . 0.492 ' OH ' ' HB2' ' E' ' 249' ' ' ALA . 17.9 t80 -112.42 136.66 51.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 60.01 110.918 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 135.67 175.71 13.98 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 51.32 112.475 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . 0.617 ' CA ' ' HB2' ' E' ' 247' ' ' ALA . . . -107.89 107.69 2.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 62.33 112.463 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -166.07 28.05 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.842 0.353 . . . . 64.04 110.889 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 76.39 -66.48 2.63 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.76 -0.733 . . . . 42.52 112.479 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . 0.734 ' CE1' HG21 ' E' ' 244' ' ' VAL . 59.8 t80 -174.98 156.74 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 62.32 110.866 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -48.96 -74.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 72.45 110.903 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -144.9 124.25 13.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 70.54 110.894 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -155.52 161.96 40.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 74.14 110.857 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -62.62 -64.84 0.8 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.481 . . . . 70.33 110.854 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -179.17 -176.6 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 73.31 110.856 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -64.19 -169.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 75.53 110.873 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -74.91 144.47 43.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 73.2 110.844 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -108.75 -170.7 1.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 75.32 110.836 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 72.3 110.855 -179.987 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 7.5 ptt? . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.857 0.361 . . . . 73.31 110.869 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.16 88.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 44.24 110.903 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 51.4 mt -147.02 145.0 19.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 74.22 111.17 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -161.25 107.43 1.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 73.41 110.855 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.78 123.97 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 73.03 111.153 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -58.69 123.9 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 64.45 111.115 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 6.3 m -152.82 121.8 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 71.24 111.123 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -71.05 -130.39 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 72.02 112.481 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 63.27 -169.07 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.844 0.354 . . . . 54.12 110.884 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . 0.642 ' HB3' HG22 ' E' ' 277' ' ' ILE . 5.2 m120 -83.78 113.72 21.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 71.43 110.9 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 73.3 m -131.05 144.74 51.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 72.15 110.864 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . 0.489 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -125.78 134.63 51.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 74.34 111.086 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.13 -37.1 16.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 64.12 110.881 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -164.98 136.98 4.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 71.21 110.876 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . 0.494 HG21 HG11 ' E' ' 275' ' ' VAL . 9.8 mt -138.78 119.65 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 63.02 111.171 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -111.23 124.88 53.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 62.43 110.884 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 8.4 p -135.07 132.9 38.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 73.31 111.127 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -152.8 166.6 31.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.21 110.927 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 65.14 69.42 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 74.4 110.907 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.47 53.67 12.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 75.03 110.888 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.66 155.91 18.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 41.44 111.119 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 -131.3 135.94 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 50.3 110.847 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.549 HG23 ' HB ' ' E' ' 275' ' ' VAL . 4.0 p -125.99 129.71 72.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 73.31 111.175 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -137.62 135.66 36.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 53.31 110.912 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' D' ' 277' ' ' ILE . 2.0 mp -129.99 118.54 21.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.35 110.918 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 155.25 176.64 27.68 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 54.4 112.505 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -88.95 128.66 35.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 62.54 110.914 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.734 HG21 ' CE1' ' D' ' 286' ' ' PHE . 93.1 t -98.75 123.1 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 60.04 111.14 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . 0.493 HG13 ' HD2' ' E' ' 281' ' ' TYR . 21.8 t -122.17 117.14 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 65.2 111.134 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.9 t -68.11 174.98 3.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 62.42 111.117 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . 0.617 ' HB2' ' CA ' ' D' ' 283' ' ' GLY . . . -61.05 -32.3 71.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.453 . . . . 74.41 111.081 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.12 -35.25 61.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 54.32 111.137 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . 0.492 ' HB2' ' OH ' ' D' ' 281' ' ' TYR . . . 64.84 153.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 60.42 111.088 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.09 109.34 2.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.444 . . . . 71.23 110.927 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -65.02 124.53 22.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 64.42 110.862 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 62.57 -147.74 49.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 44.12 112.472 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 60.23 69.83 1.18 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 75.23 112.514 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 69.0 mt -54.54 -26.76 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.342 . . . . 55.14 111.145 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.37 115.09 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.21 110.877 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . 0.522 HD12 ' HB2' ' D' ' 259' ' ' GLN . 1.2 pt -119.79 71.73 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 73.24 111.107 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 1.5 m -105.56 143.16 34.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 72.44 110.874 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.01 158.23 13.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.095 -0.502 . . . . 70.43 110.853 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -142.95 -65.03 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.928 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 5.8 t -70.71 137.85 50.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 52.42 111.103 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 90.6 m -111.86 130.84 55.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 73.54 111.151 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -126.16 134.41 51.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 74.22 110.866 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.86 123.93 15.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 45.33 110.871 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . 0.538 HG21 ' CG2' ' E' ' 267' ' ' VAL . 11.4 p -108.2 140.72 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 62.35 111.129 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -81.16 -76.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 72.13 110.903 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.6 m -138.03 129.49 27.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 64.34 111.139 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . 0.538 ' CG2' HG21 ' E' ' 264' ' ' VAL . 23.7 t -118.14 120.5 64.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 74.41 111.108 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 52.0 t -104.64 115.82 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 54.13 111.157 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.93 132.58 11.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.743 . . . . 23.24 112.462 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.25 144.25 49.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 74.15 110.943 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.42 87.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.73 . . . . 75.41 112.481 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 48.86 74.84 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 50.33 110.865 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 36.7 t -100.79 145.8 28.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 60.45 110.826 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.66 128.66 54.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 73.2 110.847 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.549 ' HB ' HG23 ' E' ' 239' ' ' VAL . 87.5 t -117.7 122.68 70.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 75.2 111.144 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.442 HD21 ' HZ ' ' D' ' 286' ' ' PHE . 0.4 OUTLIER -129.05 111.72 13.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.942 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.642 HG22 ' HB3' ' E' ' 226' ' ' ASN . 37.2 mm -113.39 104.31 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 61.51 111.091 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 138.89 -172.72 22.98 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.713 -0.756 . . . . 73.43 112.484 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . 0.452 ' H ' ' ND2' ' E' ' 279' ' ' ASN . 1.8 p30 -89.02 154.12 20.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.802 0.334 . . . . 65.11 110.843 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -128.29 130.14 47.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 65.33 110.93 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . 0.493 ' HD2' HG13 ' E' ' 245' ' ' VAL . 1.3 t80 -132.41 121.76 23.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 64.24 110.946 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 164.87 -179.96 39.22 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.68 -0.771 . . . . 72.11 112.447 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -71.3 -151.06 0.86 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.763 -0.732 . . . . 73.34 112.516 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.92 -179.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.844 0.354 . . . . 65.21 110.877 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -110.84 -57.56 0.49 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.778 -0.725 . . . . 62.05 112.508 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -84.01 139.66 32.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 74.24 110.933 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 70.52 7.81 6.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 72.54 110.951 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 1.1 p30 173.81 135.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.53 110.84 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -124.12 154.94 39.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 75.4 110.928 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -147.54 162.53 38.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 71.43 110.849 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.76 -69.64 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 65.1 110.906 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 63.85 -169.92 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 74.24 110.897 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -128.26 174.6 9.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 73.04 110.889 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -143.85 168.75 19.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.258 -0.428 . . . . 72.1 110.852 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 64.2 110.863 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 16.3 mtt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.834 0.35 . . . . 52.41 110.89 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -174.65 174.48 2.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 72.21 110.92 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 9.5 tp -106.9 145.69 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 63.44 111.098 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.01 -170.07 1.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 74.01 110.841 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . 63.86 104.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 44.34 111.065 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.949 HD11 HG21 ' A' ' 261' ' ' THR . 33.7 pt -98.24 -176.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 74.42 111.16 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 19.4 m -51.74 -36.58 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 71.44 111.056 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 108.82 136.35 7.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.702 -0.761 . . . . 62.52 112.461 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.12 159.12 1.27 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.836 0.35 . . . . 75.5 110.863 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -98.31 124.31 42.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 74.31 110.888 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.23 137.85 54.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 72.53 110.82 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.29 123.32 15.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 65.24 111.066 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -84.92 -36.79 21.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.446 . . . . 73.05 110.865 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -164.18 139.29 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 64.43 110.871 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 13.0 mt -137.01 117.68 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 70.22 111.182 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -120.19 115.76 24.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 64.24 110.86 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.23 132.93 47.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 73.24 111.206 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -138.27 157.08 46.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 72.24 110.883 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.468 ' O ' ' C ' ' A' ' 236' ' ' ARG . 6.3 tt0 65.13 88.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 71.44 110.883 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.468 ' C ' ' O ' ' A' ' 235' ' ' GLU . 0.0 OUTLIER 31.68 52.55 0.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 74.52 110.903 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.79 145.59 24.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 72.31 111.113 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -125.76 136.71 53.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 75.13 110.908 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.602 HG12 ' HB ' ' A' ' 275' ' ' VAL . 6.9 m -142.5 121.75 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 71.12 111.089 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.26 137.25 54.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 64.25 110.849 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.68 122.05 26.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.196 -0.456 . . . . 71.23 110.968 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.85 -115.83 0.88 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 52.42 112.523 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -145.44 128.96 17.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 74.5 110.879 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.416 HG23 ' HA ' ' A' ' 280' ' ' GLU . 20.9 m -111.79 127.68 68.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 64.42 111.083 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.1 t -122.24 129.08 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 71.12 111.124 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 2.5 m -91.45 162.34 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 64.2 111.125 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.33 -43.1 99.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 63.12 111.063 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -61.1 -36.18 79.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 71.55 111.117 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.52 ' HB2' ' HA2' ' A' ' 282' ' ' GLY . . . -63.36 -25.26 68.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 65.32 111.037 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.3 tt -51.95 103.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 62.13 110.942 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.97 -63.32 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 54.21 110.826 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 136.11 138.93 3.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.771 -0.728 . . . . 74.43 112.534 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 168.39 164.69 24.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.752 -0.737 . . . . 61.35 112.495 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 8.9 tp -134.1 141.73 43.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 52.45 111.112 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.46 133.88 35.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 63.04 110.868 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.3 tt -116.6 -26.47 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 64.35 111.203 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 58.8 m -98.87 -178.43 3.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 73.3 110.9 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -63.64 -170.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.472 . . . . 63.22 110.875 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.554 HE22 ' HB1' ' B' ' 221' ' ' ALA . 1.4 tp60 -143.2 179.75 6.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 63.53 110.956 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 30.8 p -87.58 137.49 32.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 61.24 111.145 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.949 HG21 HD11 ' A' ' 222' ' ' ILE . 1.3 m -107.75 108.98 20.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.14 111.126 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -94.18 124.97 38.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 55.21 110.907 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.99 123.82 15.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 34.34 110.904 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.631 HG21 HG22 ' A' ' 267' ' ' VAL . 10.4 p -118.66 135.78 57.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 72.42 111.103 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 -75.29 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.469 . . . . 71.21 110.847 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.4 m -123.46 130.29 52.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 71.31 111.108 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.631 HG22 HG21 ' A' ' 264' ' ' VAL . 33.7 t -118.12 129.83 73.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 63.21 111.112 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 36.7 t -127.68 124.83 64.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 71.32 111.114 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.01 134.02 8.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 73.5 112.47 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -132.8 141.68 48.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.78 0.324 . . . . 72.22 110.92 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 57.29 85.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 41.43 112.485 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 44.0 60.56 2.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.827 0.346 . . . . 75.3 110.902 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 11.0 t -83.92 145.36 28.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 61.44 110.93 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 3.3 mpp_? -129.49 127.25 40.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.887 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.602 ' HB ' HG12 ' A' ' 239' ' ' VAL . 17.6 t -137.06 124.01 30.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 63.31 111.13 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.0 111.16 17.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 72.21 110.901 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.674 ' CD1' HD13 ' B' ' 241' ' ' LEU . 30.5 mm -103.3 104.63 16.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 73.53 111.11 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.24 -163.61 28.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 53.21 112.467 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -103.43 155.92 18.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 72.13 110.844 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.6 ' HG3' HG12 ' B' ' 244' ' ' VAL . 2.0 pp20? -129.93 147.32 51.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.12 -0.491 . . . . 72.34 110.922 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -129.69 125.84 36.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 73.23 110.927 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.52 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 165.69 -86.14 0.1 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.705 -0.76 . . . . 70.13 112.506 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 127.75 -97.79 0.47 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.76 -0.733 . . . . 52.21 112.51 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -51.73 127.85 21.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.794 0.33 . . . . 73.24 110.895 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 93.72 -33.22 5.31 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.753 -0.737 . . . . 52.42 112.474 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.39 -174.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.373 . . . . 74.02 110.865 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -51.86 107.58 0.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 75.33 110.91 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.67 -172.17 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 55.13 110.852 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -102.61 150.09 23.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.971 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -121.84 -178.76 3.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 72.45 110.856 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.37 96.05 5.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 73.45 110.818 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.8 143.4 26.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 70.34 110.85 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -178.28 123.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 75.43 110.86 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.07 124.67 20.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 75.21 110.884 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 73.43 110.837 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.868 0.366 . . . . 63.5 110.884 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -99.72 155.64 17.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 71.53 110.865 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 13.3 tt -52.06 146.25 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 75.1 111.096 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -131.71 164.85 25.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 63.23 110.851 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.554 ' HB1' HE22 ' A' ' 259' ' ' GLN . . . -116.04 146.75 41.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 54.4 111.105 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.63 178.76 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 44.53 111.144 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.609 HG23 ' HA ' ' B' ' 259' ' ' GLN . 13.8 m -148.43 -179.9 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 75.44 111.162 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 149.19 -162.92 29.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 61.02 112.521 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.728 ' CB ' HG23 ' B' ' 261' ' ' THR . 1.7 mtt-85 -162.91 120.47 1.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.714 0.292 . . . . 72.13 110.913 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -106.61 115.63 30.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.42 110.897 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.91 137.93 54.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 63.44 110.779 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.16 129.38 29.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 55.04 111.118 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 4.8 tttm -88.88 -36.32 16.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 62.32 110.869 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . 0.456 ' HB3' HG23 ' B' ' 266' ' ' THR . 0.6 OUTLIER -164.4 139.16 5.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 51.11 110.869 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.513 HD13 HD11 ' B' ' 241' ' ' LEU . 13.6 mt -137.31 117.84 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 75.41 111.075 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -127.03 119.65 27.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 63.32 110.84 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.52 140.36 48.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 65.42 111.149 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -140.35 164.38 30.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 72.52 110.874 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' B' ' 236' ' ' ARG . 2.2 tt0 64.07 72.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 74.53 110.809 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' B' ' 235' ' ' GLU . 19.5 ptt-85 37.19 63.43 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 64.12 110.854 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.56 155.06 19.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 34.51 111.107 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.96 135.32 48.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 64.03 110.854 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.56 HG23 HG13 ' A' ' 275' ' ' VAL . 21.0 m -143.11 121.9 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 64.53 111.147 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -118.37 137.26 53.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.33 110.845 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.674 HD13 ' CD1' ' A' ' 277' ' ' ILE . 5.2 mp -125.02 118.54 26.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 72.35 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 143.02 -177.64 21.81 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.739 -0.743 . . . . 60.03 112.473 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.93 139.0 31.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 73.42 110.905 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.6 HG12 ' HG3' ' A' ' 280' ' ' GLU . 27.3 m -116.82 127.49 74.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 64.32 111.139 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 54.2 t -117.5 129.28 74.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 70.42 111.088 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.533 HG21 ' HB2' ' B' ' 284' ' ' LYS . 0.7 OUTLIER -80.18 162.81 24.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 63.35 111.191 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.14 79.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 73.51 111.075 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -62.55 -41.71 99.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.306 -0.407 . . . . 75.05 111.104 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -59.9 117.59 5.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 70.11 111.128 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -175.55 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 74.25 110.967 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -54.35 -28.52 43.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 63.1 110.864 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -52.39 144.8 19.39 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.746 -0.74 . . . . 73.42 112.488 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -138.67 -151.6 5.8 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.717 . . . . 55.42 112.508 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 49.4 mm -52.4 131.35 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 74.34 111.166 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -176.13 -36.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 74.14 110.913 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.5 mp 63.71 84.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 64.25 111.14 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.82 -170.4 3.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 70.54 110.865 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.6 t0 62.77 36.61 13.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.464 . . . . 70.24 110.897 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . 0.609 ' HA ' HG23 ' B' ' 223' ' ' VAL . 7.1 tt0 -92.23 55.52 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 74.31 110.881 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 86.3 m -95.4 122.92 38.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 61.02 111.131 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.728 HG23 ' CB ' ' B' ' 225' ' ' ARG . 5.4 m -94.6 108.84 20.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 65.23 111.149 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -96.59 127.72 42.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 62.31 110.927 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 63.9 p -142.03 123.99 15.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 73.14 110.898 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.556 HG21 HG22 ' B' ' 267' ' ' VAL . 8.8 p -115.18 136.83 50.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 55.35 111.062 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.26 -75.71 0.22 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.117 -0.492 . . . . 74.54 110.862 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.456 HG23 ' HB3' ' B' ' 230' ' ' ASP . 1.7 m -127.4 130.8 50.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 61.2 111.147 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.556 HG22 HG21 ' B' ' 264' ' ' VAL . 28.6 t -118.32 128.29 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 72.03 111.129 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.56 120.43 54.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 70.02 111.1 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.88 133.69 8.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 74.4 112.46 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -133.09 148.02 52.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 74.42 110.893 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.63 76.58 0.19 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.708 -0.758 . . . . 42.43 112.476 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 48.35 62.19 2.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.342 . . . . 73.24 110.924 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 32.6 t -87.43 145.67 26.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 75.55 110.879 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.74 127.38 43.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 73.34 110.937 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.65 HG13 HG23 ' C' ' 239' ' ' VAL . 10.0 t -135.59 124.07 38.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 74.43 111.148 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.46 116.53 26.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.471 . . . . 61.34 110.872 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 29.0 mm -107.72 135.09 47.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 61.23 111.089 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 118.39 -168.75 13.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 64.32 112.392 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -112.38 155.38 24.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.791 0.329 . . . . 65.4 110.908 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.456 ' HG2' HG12 ' C' ' 244' ' ' VAL . 15.7 pt-20 -120.13 137.45 54.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 71.11 110.935 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.94 125.96 50.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 74.35 110.874 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' C' ' 247' ' ' ALA . . . 127.12 159.84 10.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 51.03 112.452 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -101.53 -19.03 16.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.82 -0.705 . . . . 44.15 112.477 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . 0.533 ' HB2' HG21 ' B' ' 246' ' ' THR . 1.4 mmtt -66.97 89.31 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 65.14 110.948 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 66.86 113.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.741 . . . . 71.14 112.506 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -52.85 -66.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.812 0.339 . . . . 61.42 110.865 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -138.13 -49.45 0.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 73.24 110.916 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.27 -171.02 2.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 73.45 110.861 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -133.06 134.93 44.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 70.2 110.909 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 59.52 176.01 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 64.43 110.91 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -171.23 -67.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 71.52 110.892 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -161.15 -68.43 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 71.13 110.868 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -179.2 -179.19 0.55 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 74.12 110.812 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -140.41 26.32 2.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 75.22 110.816 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 72.32 110.871 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.4 mtt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.852 0.358 . . . . 71.13 110.865 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -128.78 165.15 21.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 73.13 110.898 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.52 HD13 ' H ' ' C' ' 219' ' ' ILE . 0.1 OUTLIER -143.53 175.8 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 73.24 111.116 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -166.96 29.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 64.15 110.84 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -151.6 -170.3 3.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 74.13 111.107 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.37 75.91 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 64.32 111.154 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 23.3 m -87.4 145.13 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 55.13 111.122 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -87.91 136.12 13.59 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.769 -0.729 . . . . 31.24 112.437 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -179.45 136.24 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.777 0.322 . . . . 62.42 110.839 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.416 ' ND2' HG22 ' C' ' 277' ' ' ILE . 4.3 m120 -94.64 134.93 36.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 73.11 110.882 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 8.1 t -132.46 137.84 47.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 64.55 110.894 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.95 138.83 44.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 74.21 111.12 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.86 -33.47 11.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.41 . . . . 63.3 110.897 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.71 138.54 5.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 73.51 110.822 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 11.0 mt -137.59 117.89 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 75.22 111.135 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -127.74 121.9 31.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 73.41 110.918 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 141.67 45.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 43.12 111.167 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.18 166.31 25.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 73.51 110.863 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 65.0 57.68 0.96 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.156 -0.475 . . . . 62.31 110.874 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 50.87 61.2 3.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 73.42 110.887 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 151.97 22.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 64.15 111.168 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -125.92 135.38 51.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 64.14 110.886 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.774 HG12 ' HB ' ' C' ' 275' ' ' VAL . 4.4 m -140.66 121.9 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 75.24 111.155 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -115.68 129.71 56.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 71.31 110.986 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.808 HD13 ' HB ' ' C' ' 277' ' ' ILE . 3.3 mm? -114.91 118.72 34.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 54.55 110.938 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.1 174.28 13.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.759 -0.734 . . . . 71.32 112.471 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.54 147.92 22.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.869 0.366 . . . . 63.22 110.856 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.456 HG12 ' HG2' ' B' ' 280' ' ' GLU . 34.9 m -119.09 130.42 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 73.02 111.122 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.407 HG12 ' HB3' ' C' ' 249' ' ' ALA . 21.7 t -122.07 128.97 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 34.53 111.096 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 7.8 p -74.41 162.97 28.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 64.14 111.158 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.503 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -63.08 -33.97 76.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 73.42 111.06 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.81 -41.85 78.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 45.23 111.064 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . 0.697 ' HB2' ' CD1' ' C' ' 281' ' ' TYR . . . -51.73 103.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 64.21 111.097 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 12.4 mt -139.14 -174.39 3.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 73.33 110.875 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -76.34 -170.97 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 64.14 110.894 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 131.69 -21.09 4.52 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.677 -0.773 . . . . 73.11 112.476 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -166.5 -102.43 0.16 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.738 -0.744 . . . . 63.22 112.48 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . 0.617 HD12 ' O ' ' D' ' 252' ' ' GLY . 15.8 pt -142.99 41.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.853 0.359 . . . . 63.25 111.191 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . 0.477 ' HD3' ' HB3' ' D' ' 249' ' ' ALA . 6.0 mtt-85 -80.91 117.24 21.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 71.11 110.94 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 50.5 mt -145.48 145.62 20.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 73.42 111.089 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.92 -37.08 3.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 74.42 110.894 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -59.32 106.26 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 70.22 110.846 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -173.86 -37.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 74.2 110.93 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 26.4 m -76.3 121.98 23.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.163 -0.471 . . . . 63.22 111.175 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.7 m -92.33 125.5 37.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 73.23 111.123 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -113.83 119.99 39.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 75.52 110.878 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 8.3 t -129.9 123.66 31.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 45.53 110.843 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.591 HG21 HG22 ' C' ' 267' ' ' VAL . 9.3 p -117.06 135.97 55.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 71.15 111.128 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -79.12 -76.09 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 72.34 110.884 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 2.1 m -124.53 130.71 52.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 65.53 111.197 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.591 HG22 HG21 ' C' ' 264' ' ' VAL . 21.9 t -118.09 125.27 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.11 111.209 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 57.8 t -127.24 118.73 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 61.34 111.119 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.1 133.78 8.9 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 42.2 112.522 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -132.53 147.66 52.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.807 0.337 . . . . 74.13 110.885 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.14 75.46 0.26 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.686 -0.769 . . . . 52.01 112.499 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 48.64 60.43 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 61.3 110.846 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 21.3 t -85.55 145.85 27.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.34 110.846 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -128.32 127.86 43.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 65.33 110.823 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.774 ' HB ' HG12 ' C' ' 239' ' ' VAL . 17.3 t -135.18 123.89 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 72.42 111.126 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.48 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -121.89 112.29 18.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 72.24 110.865 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.808 ' HB ' HD13 ' C' ' 241' ' ' LEU . 24.7 mm -106.17 123.51 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 65.33 111.105 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 129.17 167.11 12.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 63.34 112.55 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -89.97 145.3 25.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.774 0.321 . . . . 71.21 110.91 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -116.05 134.62 54.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 72.23 110.913 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.697 ' CD1' ' HB2' ' C' ' 249' ' ' ALA . 27.2 t80 -119.68 125.95 49.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 73.52 110.986 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 153.55 168.78 17.77 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 34.25 112.523 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . 0.597 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . -111.68 -18.32 8.03 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.715 -0.755 . . . . 65.4 112.499 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -76.37 67.11 2.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 63.24 110.929 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 78.31 159.63 13.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.714 -0.755 . . . . 62.32 112.518 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -81.27 -74.67 0.32 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.865 0.364 . . . . 65.21 110.859 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.48 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 3.7 t90 -89.56 -65.82 0.98 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 72.04 110.927 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -156.09 -41.59 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 71.0 110.874 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 1.4 m120 63.17 161.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 74.44 110.911 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -179.1 -169.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 73.45 110.914 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -51.99 146.79 8.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.433 . . . . 64.5 110.827 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -136.87 -175.25 3.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 52.43 110.841 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.2 104.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 75.31 110.882 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -165.56 73.37 0.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 73.24 110.865 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 24.1 m170 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 72.31 110.828 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.777 0.322 . . . . 74.31 110.863 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -168.75 43.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 53.23 110.897 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 6.1 tp -118.04 -29.81 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 71.01 111.12 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -70.62 164.79 24.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 72.32 110.859 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . 0.666 ' HB1' HD11 ' E' ' 219' ' ' ILE . . . -97.0 -174.91 3.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 74.24 111.119 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . 0.64 HG13 ' HB3' ' E' ' 221' ' ' ALA . 21.7 pt -129.23 25.36 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 74.02 111.11 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 20.9 m -85.07 142.36 13.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 75.03 111.121 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 58.85 173.89 0.52 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 42.43 112.462 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.19 -169.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.81 0.338 . . . . 71.42 110.891 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.75 113.1 20.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 73.32 110.861 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 2.6 m -128.3 139.76 52.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 71.53 110.84 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.33 157.63 42.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 72.21 111.158 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -112.6 -34.41 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 72.43 110.895 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . 0.491 ' HB3' HG23 ' D' ' 266' ' ' THR . 8.1 t0 -164.53 138.86 5.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 73.53 110.869 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 8.9 mt -137.64 117.74 16.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 72.35 111.196 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -130.54 123.53 29.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 70.13 110.932 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' D' ' 237' ' ' ALA . 0.1 OUTLIER -135.2 146.64 48.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 73.24 111.118 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -146.51 166.61 25.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 74.51 110.901 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 64.93 55.88 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 75.51 110.877 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.85 62.79 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.477 . . . . 73.13 110.862 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . 0.44 ' HB3' ' OG1' ' D' ' 233' ' ' THR . . . -104.49 156.06 18.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 43.42 111.123 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -128.05 135.71 50.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.416 . . . . 73.11 110.817 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.713 HG23 HG13 ' C' ' 275' ' ' VAL . 20.5 m -138.27 122.85 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.11 111.148 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . 0.495 ' C ' HD22 ' D' ' 241' ' ' LEU . 0.0 OUTLIER -116.37 136.43 53.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 72.35 110.938 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.563 HD23 ' CD1' ' C' ' 277' ' ' ILE . 3.8 mm? -119.96 118.98 32.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 50.51 110.89 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.14 171.61 13.0 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.75 . . . . 63.51 112.495 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -93.28 153.95 18.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 74.42 110.888 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 18.5 m -120.67 136.85 56.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 75.34 111.093 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 97.9 t -122.24 130.09 74.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 72.32 111.098 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 1.7 p -68.35 168.54 12.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 75.31 111.097 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . 0.597 ' HB2' ' N ' ' C' ' 283' ' ' GLY . . . -59.57 -34.49 72.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 72.22 111.136 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.44 -37.53 72.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 64.43 111.162 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . 0.622 ' HB2' ' OH ' ' C' ' 281' ' ' TYR . . . 63.71 163.46 0.12 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 35.14 111.146 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . 0.462 HD13 ' CB ' ' E' ' 249' ' ' ALA . 16.0 tp -121.75 112.8 18.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 64.3 110.916 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -59.49 120.69 9.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 63.34 110.865 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . 0.617 ' O ' HD12 ' C' ' 254' ' ' ILE . . . -167.07 -144.77 4.23 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 41.31 112.479 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -57.71 -178.7 0.72 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.746 -0.74 . . . . 74.11 112.515 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . 0.417 HD12 ' HB2' ' D' ' 255' ' ' ARG . 1.5 pp -148.23 155.47 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.838 0.351 . . . . 72.33 111.178 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . 0.417 ' HB2' HD12 ' D' ' 254' ' ' ILE . 2.0 mtt180 69.19 -75.43 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 73.44 110.882 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 35.6 pt -107.47 154.14 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 74.01 111.066 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 13.0 t -178.79 106.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.076 -0.511 . . . . 55.01 110.814 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -66.56 0.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 73.44 110.861 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.3 -170.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 73.21 110.924 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 1.4 m -66.58 135.27 53.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 33.41 111.141 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 98.0 m -102.61 139.17 38.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 75.24 111.148 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.14 130.98 52.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 74.04 110.807 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 5.8 t -142.07 123.9 15.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 62.33 110.81 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.506 HG21 HG22 ' D' ' 267' ' ' VAL . 7.6 p -123.76 138.34 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 63.11 111.131 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.73 -76.4 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 74.05 110.847 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . 0.491 HG23 ' HB3' ' D' ' 230' ' ' ASP . 6.2 m -128.3 130.46 47.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 71.24 111.081 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.506 HG22 HG21 ' D' ' 264' ' ' VAL . 21.3 t -118.4 120.93 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.144 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 18.1 t -121.68 118.45 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 72.51 111.169 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.52 136.49 12.23 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.715 -0.755 . . . . 62.22 112.456 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.44 147.51 52.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.879 0.371 . . . . 75.11 110.894 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.43 76.22 0.2 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.723 -0.751 . . . . 42.43 112.468 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 47.93 61.95 2.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 71.53 110.866 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 30.5 t -87.15 145.99 26.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 52.34 110.871 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -127.49 127.67 44.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 60.44 110.903 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.632 HG13 HG23 ' E' ' 239' ' ' VAL . 14.2 t -132.66 124.15 50.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 71.33 111.071 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.2 OUTLIER -123.44 112.38 17.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.22 110.889 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.466 ' HB ' HD13 ' D' ' 241' ' ' LEU . 28.0 mm -105.0 129.06 58.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 72.13 111.111 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 120.03 170.46 14.36 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 63.43 112.561 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -89.68 154.01 20.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.327 . . . . 71.35 110.867 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . 0.69 ' CG ' HG12 ' E' ' 244' ' ' VAL . 6.5 pt-20 -127.95 133.17 49.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 64.4 110.858 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . 0.476 ' HE1' ' HB2' ' E' ' 249' ' ' ALA . 34.3 t80 -116.22 124.18 49.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 73.14 110.925 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 174.42 -58.32 0.13 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 61.23 112.443 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 91.47 -66.83 2.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.795 -0.717 . . . . 24.25 112.476 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -51.43 -30.32 19.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 75.54 110.917 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -140.34 97.57 0.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.677 -0.773 . . . . 71.4 112.478 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -51.3 -75.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.866 0.365 . . . . 72.44 110.883 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -140.84 -58.28 0.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 64.5 110.932 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -175.12 -178.23 1.17 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 70.45 110.846 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 58.62 177.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 62.22 110.893 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -114.69 -49.28 2.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 72.04 110.873 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 56.85 -177.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.423 . . . . 72.42 110.876 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 63.25 104.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 64.21 110.838 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -142.07 62.1 1.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 64.22 110.778 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 63.05 162.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 74.3 110.82 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 3.7 p80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 71.53 110.879 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.829 0.347 . . . . 71.53 110.877 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.14 177.76 4.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 44.23 110.87 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . 0.666 HD11 ' HB1' ' D' ' 221' ' ' ALA . 26.4 pt -137.88 -174.49 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 72.11 111.137 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.58 145.2 48.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.218 -0.446 . . . . 72.34 110.852 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . 0.64 ' HB3' HG13 ' D' ' 222' ' ' ILE . . . -176.13 117.7 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 74.35 111.076 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.65 45.5 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 74.33 111.06 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.83 144.69 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 73.23 111.198 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 153.29 -172.43 32.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.633 -0.794 . . . . 54.13 112.419 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -54.3 -69.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.78 0.324 . . . . 43.2 110.869 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -97.29 111.66 23.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 72.13 110.868 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 14.8 m -121.94 138.96 54.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 72.41 110.839 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.79 132.82 35.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 73.31 111.073 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.06 -29.24 15.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.878 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -164.52 139.33 5.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 60.42 110.896 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 10.5 mt -136.87 117.57 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 70.12 111.162 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.61 121.11 23.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 72.13 110.869 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' E' ' 237' ' ' ALA . 0.7 OUTLIER -134.51 145.36 48.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 65.34 111.096 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -148.17 167.09 25.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 60.11 110.881 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 65.74 54.41 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 64.43 110.916 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 51.2 62.07 2.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.477 . . . . 74.03 110.852 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' E' ' 233' ' ' THR . . . -104.76 156.15 18.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 73.31 111.12 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -128.32 135.83 50.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.33 110.855 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.632 HG23 HG13 ' D' ' 275' ' ' VAL . 4.2 m -131.99 121.98 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 43.14 111.109 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . 0.653 ' HB3' HD22 ' E' ' 276' ' ' LEU . 0.0 OUTLIER -115.48 137.07 52.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 60.0 110.9 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.826 HD13 ' HB ' ' E' ' 277' ' ' ILE . 4.1 mm? -126.74 121.17 31.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 64.44 110.958 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.19 163.3 11.5 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 64.03 112.456 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -85.7 156.98 20.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.906 0.384 . . . . 74.1 110.854 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.69 HG12 ' CG ' ' D' ' 280' ' ' GLU . 31.6 m -119.42 134.08 64.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 71.13 111.121 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.53 129.54 75.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 51.33 111.085 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . 0.426 HG21 ' HA2' ' E' ' 282' ' ' GLY . 13.6 t -69.49 175.54 4.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 74.01 111.112 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.34 86.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 24.2 111.104 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.4 -53.03 62.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 55.03 111.1 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . 0.476 ' HB2' ' HE1' ' D' ' 281' ' ' TYR . . . 50.32 29.66 3.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 62.33 111.085 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.39 98.05 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 62.45 110.935 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 19.6 m80 63.35 26.75 15.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 74.41 110.899 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -70.79 -34.86 66.16 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.717 . . . . 64.21 112.458 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.1 -143.63 9.49 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.733 . . . . 72.33 112.484 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 2.0 mp 65.3 151.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 71.14 111.179 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . 0.405 ' C ' HD12 ' E' ' 256' ' ' ILE . 7.9 mtt180 -66.65 -170.78 0.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.434 . . . . 74.35 110.818 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . 0.405 HD12 ' C ' ' E' ' 255' ' ' ARG . 2.7 mp 62.81 63.63 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 62.25 111.118 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.48 -170.31 2.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 73.42 110.823 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.56 -170.13 1.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 62.11 110.792 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.82 103.66 2.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 74.52 110.914 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 31.1 p -100.96 137.9 38.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 62.14 111.194 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 5.3 t -128.93 122.53 30.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.451 . . . . 73.14 111.107 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -105.09 119.93 40.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 63.23 110.932 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 29.2 t -127.27 123.83 37.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 62.34 110.822 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . 0.516 HG21 HG22 ' E' ' 267' ' ' VAL . 10.0 p -122.62 137.82 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 71.45 111.152 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.86 -75.07 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 71.44 110.904 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 60.5 m -125.23 133.58 52.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 62.32 111.123 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . 0.516 HG22 HG21 ' E' ' 264' ' ' VAL . 21.9 t -118.23 126.5 75.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 75.24 111.142 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.2 122.89 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 45.24 111.125 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.65 134.43 9.96 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 73.4 112.5 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -133.01 147.75 52.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 70.02 110.884 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.48 78.9 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.843 -0.694 . . . . 71.44 112.444 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 47.18 64.16 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 71.04 110.936 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 41.2 t -86.76 145.88 26.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 73.32 110.852 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -130.73 127.87 39.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 55.51 110.853 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.405 ' HB ' HG12 ' E' ' 239' ' ' VAL . 18.7 t -130.4 123.72 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 65.42 111.189 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.653 HD22 ' HB3' ' E' ' 240' ' ' GLN . 0.2 OUTLIER -121.79 111.94 17.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 72.12 110.914 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.826 ' HB ' HD13 ' E' ' 241' ' ' LEU . 50.5 mm -108.55 132.64 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 63.24 111.18 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 124.42 -177.68 16.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.744 . . . . 73.23 112.483 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -103.18 153.67 20.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.787 0.327 . . . . 64.11 110.839 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.91 132.07 55.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 62.33 110.83 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -130.09 123.74 31.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 73.25 110.908 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . 0.426 ' HA2' HG21 ' E' ' 246' ' ' THR . . . 163.77 73.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 61.1 112.485 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . 48.23 82.45 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.734 -0.746 . . . . 35.11 112.46 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.43 30.82 2.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.836 0.351 . . . . 73.41 110.946 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -63.53 173.28 12.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.751 -0.737 . . . . 32.32 112.435 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.04 -70.14 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.76 0.314 . . . . 72.05 110.848 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . 0.586 ' CZ2' HD23 ' E' ' 276' ' ' LEU . 5.7 t90 -168.24 31.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.962 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.18 -169.66 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 73.0 110.918 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 3.7 t30 63.49 104.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 64.41 110.943 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -110.61 -176.16 2.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 73.45 110.868 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -99.85 51.0 0.91 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 73.22 110.938 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -178.06 69.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 71.42 110.871 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -111.5 166.83 10.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.219 -0.446 . . . . 72.12 110.843 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.12 -178.3 3.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.832 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 7.1 m80 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 74.21 110.852 -179.985 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 4.0 ptp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.828 0.347 . . . . 72.33 110.903 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -179.21 139.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 64.34 110.892 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.9 tt -175.37 149.41 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 71.1 111.115 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -109.7 124.21 50.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 74.52 110.794 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.428 ' O ' HG13 ' A' ' 223' ' ' VAL . . . -178.34 -34.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 74.41 111.079 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.544 HG23 HH12 ' A' ' 225' ' ' ARG . 48.5 mm -51.75 118.71 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 44.43 111.118 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 221' ' ' ALA . 15.9 m -124.36 170.26 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.471 . . . . 73.2 111.143 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -52.02 105.9 0.28 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.686 -0.769 . . . . 64.21 112.467 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.6 ' HG3' HG23 ' A' ' 261' ' ' THR . 9.2 ptp85 -142.21 -173.54 3.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 74.3 110.843 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.99 129.65 30.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.885 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 2.1 p -134.5 140.25 46.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 63.43 110.897 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.82 149.53 51.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 65.45 111.059 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -106.25 -35.63 7.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 71.15 110.874 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -164.86 137.86 4.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 75.43 110.907 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 17.4 mt -138.91 118.72 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 63.54 111.131 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -134.12 117.74 16.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 72.13 110.847 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.7 p -135.55 142.09 45.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 73.41 111.127 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.0 pm0 -147.01 167.9 22.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 72.31 110.93 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 68.94 57.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 75.55 110.909 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 50.37 57.43 6.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.804 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.2 151.75 22.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 44.31 111.101 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -126.11 135.92 52.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 73.54 110.797 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.477 HG23 ' HB ' ' A' ' 275' ' ' VAL . 6.1 p -138.38 121.88 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 63.33 111.096 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.511 ' OE1' HD11 ' A' ' 276' ' ' LEU . 0.5 OUTLIER -114.01 136.0 53.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 72.31 110.948 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.535 HD12 ' HB ' ' A' ' 277' ' ' ILE . 1.6 tp -130.16 118.88 22.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.199 -0.455 . . . . 54.31 110.888 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 139.57 173.22 13.04 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.699 -0.762 . . . . 74.52 112.478 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . 0.446 ' ND2' HD21 ' A' ' 279' ' ' ASN . 8.8 m-20 -85.67 160.45 19.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 74.54 110.903 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 97.9 t -133.07 121.02 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.475 . . . . 72.44 111.16 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 249' ' ' ALA . 59.5 t -122.19 129.04 75.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 70.35 111.131 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 249' ' ' ALA . 6.1 t -75.41 169.29 18.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 72.11 111.108 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.38 -41.52 98.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 54.45 111.064 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.32 -35.88 68.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 60.33 111.118 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.505 ' HB3' ' CG1' ' A' ' 245' ' ' VAL . . . -74.04 -23.6 59.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 62.35 111.16 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.36 85.62 7.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 65.44 110.925 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -178.99 -172.85 0.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 75.32 110.824 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.75 143.25 1.18 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 44.51 112.466 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -100.38 73.76 0.43 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.783 -0.723 . . . . 53.04 112.522 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.45 -176.84 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.863 0.363 . . . . 75.42 111.109 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 12.5 mtt-85 -73.39 108.45 6.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 74.1 110.88 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 44.7 mm -103.38 132.55 49.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 74.34 111.124 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.4 p -171.63 131.33 0.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 64.15 110.807 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -58.13 141.35 50.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.508 . . . . 52.51 110.869 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.468 ' HG3' HG13 ' B' ' 223' ' ' VAL . 0.7 OUTLIER -125.53 -37.54 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 72.22 110.923 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 95.1 m -72.61 122.09 20.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 72.42 111.108 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.6 HG23 ' HG3' ' A' ' 225' ' ' ARG . 26.0 m -116.48 122.41 44.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 73.15 111.147 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.476 ' HB2' HG22 ' A' ' 277' ' ' ILE . 17.5 p30 -107.41 139.34 42.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 63.42 110.875 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.91 123.25 15.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.509 . . . . 64.22 110.812 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.485 HG21 HG22 ' A' ' 267' ' ' VAL . 7.0 p -119.87 137.59 53.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 64.33 111.127 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.91 -77.39 0.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 72.11 110.857 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 35.3 p -127.21 130.18 49.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 55.0 111.146 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.485 HG22 HG21 ' A' ' 264' ' ' VAL . 20.5 t -118.04 120.69 65.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 70.14 111.125 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.77 118.12 53.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 41.24 111.109 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.17 134.37 10.09 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 71.44 112.49 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.63 147.76 52.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.347 . . . . 72.34 110.895 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.78 78.97 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.79 -0.719 . . . . 54.13 112.45 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 47.9 66.3 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.842 0.353 . . . . 73.41 110.825 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 32.7 t -92.76 145.9 24.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 65.12 110.756 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -125.42 128.29 47.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 74.24 110.9 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.477 ' HB ' HG23 ' A' ' 239' ' ' VAL . 20.6 t -134.1 123.76 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 60.03 111.139 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.511 HD11 ' OE1' ' A' ' 240' ' ' GLN . 0.2 OUTLIER -122.42 111.86 17.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.14 110.858 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.535 ' HB ' HD12 ' A' ' 241' ' ' LEU . 3.4 mp -109.78 106.25 20.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.251 -0.431 . . . . 75.45 111.146 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.5 175.56 19.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 63.12 112.488 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.446 HD21 ' ND2' ' A' ' 243' ' ' ASN . 2.9 p30 -107.14 147.72 29.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.817 0.342 . . . . 75.41 110.879 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.435 ' HG2' HG22 ' B' ' 244' ' ' VAL . 12.7 pt-20 -118.97 126.37 51.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.197 -0.456 . . . . 65.05 110.905 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.409 ' CE2' HG11 ' B' ' 245' ' ' VAL . 1.8 t80 -118.55 125.76 50.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 64.21 110.921 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' B' ' 247' ' ' ALA . . . 151.33 -39.66 0.8 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.684 -0.769 . . . . 75.23 112.5 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 123.99 -119.8 3.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 52.24 112.442 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 63.34 25.92 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.794 0.331 . . . . 44.34 110.857 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 77.3 -63.63 3.28 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.705 -0.76 . . . . 72.43 112.49 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -174.49 -167.96 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 73.34 110.893 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.419 ' CZ2' HD23 ' A' ' 276' ' ' LEU . 15.6 t90 -49.44 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 74.11 110.947 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -176.03 143.22 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 74.2 110.882 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -80.28 -170.03 2.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 65.33 110.828 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -157.88 26.15 0.27 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 71.43 110.903 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -144.65 -47.31 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 63.04 110.876 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 72.3 -69.25 0.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 71.32 110.848 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -57.25 179.43 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 74.15 110.908 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.2 161.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 70.11 110.86 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 63.13 110.818 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.801 0.334 . . . . 71.55 110.875 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.57 107.46 1.75 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 75.34 110.937 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.29 165.55 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 73.43 111.109 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -169.88 -170.46 1.02 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.887 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -124.9 150.41 46.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 55.33 111.063 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 8.7 tp -150.43 131.3 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 53.2 111.141 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.468 HG13 ' HG3' ' A' ' 259' ' ' GLN . 7.0 p -114.11 130.35 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 74.13 111.103 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 82.76 126.85 1.07 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 71.53 112.515 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.44 ' O ' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER -179.32 135.9 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.771 0.32 . . . . 60.44 110.93 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.8 137.51 45.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 75.15 110.852 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.59 137.9 38.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 71.03 110.897 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.17 147.85 52.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 74.32 111.104 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.87 -31.46 9.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 73.11 110.917 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.51 137.79 4.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 54.04 110.89 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 15.6 mt -138.19 117.18 14.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 64.14 111.139 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -134.57 115.26 13.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 64.02 110.883 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.3 p -135.86 137.19 41.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 52.32 111.096 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -141.93 167.28 22.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 62.55 110.912 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 66.95 69.51 0.4 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 73.14 110.792 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 46.06 40.52 7.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 62.21 110.82 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.81 148.79 23.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 45.23 111.096 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.8 140.82 50.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 73.43 110.829 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.404 HG13 ' O ' ' B' ' 239' ' ' VAL . 6.1 p -138.96 121.99 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.113 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.61 131.76 56.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 74.03 110.865 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.652 HD12 ' HB ' ' B' ' 277' ' ' ILE . 1.2 tp -130.23 118.94 22.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 71.31 110.921 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 154.92 -138.27 6.05 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 52.32 112.42 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.448 ' OD1' HG23 ' B' ' 245' ' ' VAL . 4.0 t-20 -144.54 143.69 30.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.852 0.358 . . . . 65.34 110.863 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.435 HG22 ' HG2' ' A' ' 280' ' ' GLU . 58.2 t -119.11 115.63 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 73.4 111.134 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.448 HG23 ' OD1' ' B' ' 243' ' ' ASN . 63.9 t -122.21 122.73 67.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 54.1 111.117 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 81.2 p -69.85 163.02 26.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.183 -0.462 . . . . 53.13 111.147 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 282' ' ' GLY . . . -62.76 -34.07 76.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 75.14 111.093 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.06 -41.48 78.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 72.01 111.04 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -53.79 -27.65 30.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 75.02 111.107 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.65 101.0 0.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.963 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.39 -55.1 2.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 55.41 110.927 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -130.39 98.59 0.41 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.692 -0.766 . . . . 61.24 112.479 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 73.28 -100.93 1.09 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.788 -0.72 . . . . 74.45 112.49 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.59 -32.85 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 71.15 111.086 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -170.79 -179.1 2.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 70.53 110.846 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 39.1 mm -108.91 -65.46 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 61.52 111.183 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 54.3 p -160.0 70.04 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.01 110.829 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.59 169.99 8.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 74.43 110.915 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -174.51 70.16 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 72.23 110.884 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.541 HG23 ' CG ' ' C' ' 225' ' ' ARG . 76.3 m -100.95 121.95 42.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 73.21 111.119 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.44 HG23 ' O ' ' B' ' 225' ' ' ARG . 91.3 m -124.06 131.86 53.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.28 -0.418 . . . . 75.33 111.138 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.543 ' HB2' HG22 ' B' ' 277' ' ' ILE . 13.7 p30 -115.57 132.51 56.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 75.23 110.885 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 36.7 m -132.74 123.32 26.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 60.34 110.867 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.49 HG21 ' CG2' ' B' ' 267' ' ' VAL . 7.6 p -119.89 137.09 54.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.126 -0.488 . . . . 63.3 111.132 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -78.99 -77.5 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 75.21 110.857 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 39.1 m -129.9 130.48 45.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.166 -0.47 . . . . 63.41 111.141 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.511 ' CG1' HG21 ' B' ' 275' ' ' VAL . 21.3 t -117.9 120.68 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 63.42 111.168 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.04 121.61 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 73.3 111.17 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.27 133.8 8.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.751 . . . . 55.1 112.543 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -132.55 147.52 52.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.824 0.345 . . . . 65.14 110.893 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.92 84.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.688 -0.768 . . . . 72.1 112.525 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 45.15 63.52 1.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 74.24 110.888 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 26.5 t -93.06 145.68 24.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 63.31 110.884 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -128.57 127.7 42.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 73.53 110.919 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.511 HG21 ' CG1' ' B' ' 267' ' ' VAL . 21.4 t -131.6 123.91 53.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.414 . . . . 72.51 111.144 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.458 HD23 ' CZ2' ' B' ' 287' ' ' TRP . 0.1 OUTLIER -124.76 111.44 15.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.086 -0.506 . . . . 40.33 110.921 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.652 ' HB ' HD12 ' B' ' 241' ' ' LEU . 2.1 mp -111.66 104.83 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 64.24 111.142 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.28 -168.53 32.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 72.22 112.514 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -123.44 153.59 40.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 74.42 110.939 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.574 ' CD ' HG13 ' C' ' 244' ' ' VAL . 0.5 OUTLIER -126.07 121.19 32.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 73.22 110.845 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -109.45 125.71 52.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 72.03 110.928 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 106.21 171.32 23.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.799 -0.715 . . . . 71.51 112.516 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . 0.693 ' H ' ' HB2' ' C' ' 247' ' ' ALA . . . 51.96 -171.68 0.34 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.779 -0.724 . . . . 44.31 112.476 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 131.09 47.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.806 0.336 . . . . 73.43 110.879 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -72.54 78.95 0.7 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.718 . . . . 65.34 112.455 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -178.44 131.22 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 64.34 110.856 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.458 ' CZ2' HD23 ' B' ' 276' ' ' LEU . 15.1 t90 -60.94 124.72 21.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 74.12 110.921 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 62.45 -178.14 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.279 -0.419 . . . . 61.3 110.865 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -139.22 176.79 8.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.22 110.905 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 14.6 m170 63.33 104.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 73.14 110.849 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -161.19 109.32 1.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 61.25 110.881 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.05 173.29 14.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 71.44 110.886 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 51.98 43.26 30.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 74.34 110.885 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -163.95 89.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 74.12 110.896 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 45.4 m80 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 71.35 110.9 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 3.6 ptp . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.88 0.371 . . . . 72.42 110.929 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -123.94 25.87 7.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 65.01 110.876 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.804 HG23 HG12 ' D' ' 219' ' ' ILE . 15.4 mt 70.64 -70.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 74.31 111.172 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' C' ' 221' ' ' ALA . 11.6 m-20 52.71 29.37 7.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.54 110.861 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' C' ' 220' ' ' ASP . . . 68.95 -77.26 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 75.41 111.126 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 71.3 mt 51.78 88.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 63.24 111.085 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 47.6 t -72.67 -40.86 62.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 73.21 111.132 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 68.83 174.56 9.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.701 -0.762 . . . . 71.23 112.487 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.565 ' O ' HG23 ' C' ' 261' ' ' THR . 0.0 OUTLIER -91.77 -65.32 1.02 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 71.25 110.813 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.464 HD22 HD23 ' C' ' 241' ' ' LEU . 21.9 p-10 -122.78 136.43 54.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 75.51 110.95 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 75.6 m -137.7 145.16 42.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 55.52 110.878 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.05 154.35 49.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 50.03 111.061 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.87 -28.48 10.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 72.23 110.922 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.45 137.59 4.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 74.33 110.867 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 18.1 mt -138.43 116.93 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 73.02 111.142 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.12 115.61 13.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 70.54 110.949 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.8 p -135.81 139.27 43.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 64.3 111.15 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -145.62 166.99 24.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 71.21 110.922 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 66.56 66.97 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 71.02 110.9 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 46.84 51.99 11.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.499 . . . . 61.22 110.897 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.08 151.45 23.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 72.12 111.179 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.24 137.17 47.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 75.25 110.836 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.459 HG13 HG13 ' B' ' 275' ' ' VAL . 6.2 p -133.59 121.95 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 72.24 111.126 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -114.15 135.66 53.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 63.45 110.837 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 1.037 HD12 HD13 ' C' ' 277' ' ' ILE . 0.6 OUTLIER -130.16 118.86 22.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 72.23 110.91 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.9 -173.47 22.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.752 -0.737 . . . . 51.42 112.51 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.02 150.4 23.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 50.23 110.931 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.574 HG13 ' CD ' ' B' ' 280' ' ' GLU . 92.7 t -128.87 121.48 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 55.11 111.125 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.06 129.04 75.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 73.03 111.133 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.9 t -77.03 163.66 26.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 62.41 111.248 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.693 ' HB2' ' H ' ' B' ' 283' ' ' GLY . . . -63.16 -33.65 75.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 74.31 111.106 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.53 -35.98 68.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 74.53 111.056 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . 0.418 ' HB2' ' CD2' ' C' ' 281' ' ' TYR . . . -56.71 100.17 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 72.12 111.118 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 33.8 tp -158.38 124.67 4.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 72.35 110.842 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 69.15 -76.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 73.21 110.861 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 52.28 31.86 35.61 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.746 . . . . 52.53 112.476 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 87.24 53.24 2.85 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.719 -0.753 . . . . 63.43 112.504 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 28.8 mm 63.97 75.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 63.41 111.145 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -153.04 114.93 4.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 70.33 110.933 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 39.5 mm -129.97 140.4 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 63.25 111.17 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 6.1 t 58.99 -172.64 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 63.3 110.877 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.27 171.07 14.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 71.45 110.789 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -122.91 57.14 1.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 74.32 110.918 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 20.2 p -99.4 130.51 45.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.199 -0.455 . . . . 75.14 111.097 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.565 HG23 ' O ' ' C' ' 225' ' ' ARG . 30.2 m -134.06 132.15 39.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 54.21 111.178 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . 0.619 ' HB2' HG22 ' C' ' 277' ' ' ILE . 9.9 p-10 -125.38 135.47 52.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 72.23 110.844 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.06 123.78 26.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 71.51 110.829 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.491 HG21 ' CG2' ' C' ' 267' ' ' VAL . 7.4 p -117.67 136.84 53.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 74.35 111.192 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -79.21 -77.0 0.18 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 74.45 110.907 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 5.0 m -129.82 130.52 45.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 75.33 111.145 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.491 ' CG2' HG21 ' C' ' 264' ' ' VAL . 21.0 t -117.87 120.64 65.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 55.25 111.114 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 26.2 t -123.84 120.77 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 50.24 111.111 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.02 133.3 8.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.741 . . . . 43.0 112.436 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -133.27 147.47 51.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.82 0.343 . . . . 61.14 110.89 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.2 87.86 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.793 -0.717 . . . . 65.2 112.474 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 44.38 61.04 2.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.889 0.376 . . . . 74.51 110.863 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 35.2 t -92.15 145.33 24.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 74.01 110.909 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.7 127.69 39.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 74.3 110.93 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.497 HG12 HD11 ' C' ' 277' ' ' ILE . 19.5 t -132.03 123.76 51.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 22.21 111.135 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.478 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.1 OUTLIER -128.05 111.8 13.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 64.43 110.9 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 1.037 HD13 HD12 ' C' ' 241' ' ' LEU . 3.4 mp -111.77 119.9 61.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 73.41 111.109 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.31 -158.34 25.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.735 -0.745 . . . . 35.4 112.467 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -127.98 132.95 49.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.823 0.344 . . . . 74.24 110.851 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.776 ' HG3' HG13 ' D' ' 244' ' ' VAL . 0.0 OUTLIER -111.92 137.78 49.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 74.23 110.88 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.444 ' HE1' ' HB2' ' D' ' 249' ' ' ALA . 14.1 t80 -129.52 125.46 36.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 74.34 110.899 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 126.56 165.68 12.03 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.768 -0.73 . . . . 63.23 112.497 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . 0.746 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . 64.7 155.1 0.15 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.717 -0.754 . . . . 60.51 112.432 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -93.26 65.14 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 61.25 110.961 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -160.28 -113.44 0.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.726 -0.75 . . . . 75.24 112.516 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.454 ' HA ' HG11 ' D' ' 244' ' ' VAL . 5.5 p90 -174.58 -35.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 72.11 110.833 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.478 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 7.2 t90 -154.23 26.81 0.47 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 72.0 110.93 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.23 -49.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 54.14 110.916 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 10.4 t30 57.98 88.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 63.14 110.871 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.23 -170.27 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 72.41 110.897 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.96 169.36 18.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 74.21 110.863 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -146.48 -172.6 3.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 64.15 110.874 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 21.1 t60 63.34 161.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.18 -0.464 . . . . 75.24 110.871 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.18 -170.01 2.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 72.43 110.932 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 1.5 m80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 71.1 110.862 -179.987 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.822 0.344 . . . . 71.42 110.901 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.38 -175.02 0.52 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 73.21 110.964 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . 0.804 HG12 HG23 ' C' ' 219' ' ' ILE . 2.4 mp -85.78 137.35 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 73.11 111.108 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -147.79 -67.41 0.25 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.159 -0.473 . . . . 75.0 110.825 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -173.03 170.53 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 75.34 111.111 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . 0.521 HG23 HG22 ' D' ' 223' ' ' VAL . 9.7 tt -126.03 -37.28 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.23 111.111 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . 0.521 HG22 HG23 ' D' ' 222' ' ' ILE . 34.8 m -146.15 -176.91 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 53.1 111.065 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 160.39 -164.39 34.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.737 . . . . 22.11 112.515 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.441 ' O ' HG23 ' D' ' 261' ' ' THR . 0.0 OUTLIER -52.29 -75.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.35 . . . . 73.24 110.851 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -110.77 127.44 55.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 61.41 110.937 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.3 137.96 49.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 71.12 110.885 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.2 155.25 42.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 60.42 111.126 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.46 -24.69 10.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 54.33 110.91 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . 0.484 ' HB3' HG23 ' D' ' 266' ' ' THR . 0.3 OUTLIER -165.29 137.09 4.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.858 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 16.6 mt -138.66 117.16 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 63.32 111.136 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 -134.6 115.9 14.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 74.53 110.844 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.7 p -135.75 136.63 40.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 62.3 111.094 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -144.44 167.19 23.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 64.31 110.895 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 64.93 68.07 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 71.33 110.831 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 46.35 52.09 10.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 71.23 110.87 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.08 149.98 24.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 73.04 111.126 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -131.47 139.27 49.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 74.14 110.883 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.465 HG13 HG13 ' C' ' 275' ' ' VAL . 7.2 p -133.94 124.24 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 74.05 111.098 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . 0.432 ' HB2' HD22 ' D' ' 276' ' ' LEU . 1.2 tm0? -113.06 132.89 55.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 74.2 110.911 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.761 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.2 mm? -122.34 134.69 54.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 72.31 110.941 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 109.0 -174.66 18.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 70.33 112.431 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -99.36 145.57 27.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.897 0.379 . . . . 74.44 110.911 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . 0.776 HG13 ' HG3' ' C' ' 280' ' ' GLU . 88.1 t -122.19 131.54 72.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.495 . . . . 74.23 111.132 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 66.7 t -122.16 129.15 75.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 64.35 111.101 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t -69.85 167.68 16.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 74.34 111.147 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . 0.746 ' HB2' ' N ' ' C' ' 283' ' ' GLY . . . -62.95 -33.91 76.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 73.4 111.129 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.97 -52.06 66.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 73.4 111.044 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . 0.444 ' HB2' ' HE1' ' C' ' 281' ' ' TYR . . . 51.91 30.49 7.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 74.13 111.073 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.87 -30.4 23.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 71.42 110.987 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -126.65 132.47 51.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.809 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 106.85 -137.58 14.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.658 -0.782 . . . . 44.43 112.447 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 59.87 97.37 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.788 -0.72 . . . . 51.3 112.499 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . 0.525 HD12 ' HB2' ' E' ' 255' ' ' ARG . 1.2 tt -158.26 142.15 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 72.35 111.123 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.56 29.78 7.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 71.3 110.875 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . 0.419 ' CG1' HD11 ' D' ' 254' ' ' ILE . 7.3 pt -148.84 27.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 63.5 111.128 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . 0.415 ' HB3' HG21 ' D' ' 254' ' ' ILE . 1.4 p -131.37 -171.0 2.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 64.44 110.839 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -120.41 106.84 12.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 71.32 110.908 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.93 169.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 64.24 110.876 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 96.1 m -65.0 138.11 58.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.13 111.144 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . 0.441 HG23 ' O ' ' D' ' 225' ' ' ARG . 7.7 m -114.14 123.1 48.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 73.55 111.111 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -126.37 146.7 49.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.894 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 12.8 m -136.99 123.44 20.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 72.32 110.817 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.558 HG21 ' CG2' ' D' ' 267' ' ' VAL . 11.9 p -116.47 133.9 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 72.34 111.127 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.64 -69.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 51.35 110.831 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . 0.484 HG23 ' HB3' ' D' ' 230' ' ' ASP . 92.9 m -143.85 133.39 23.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.13 111.169 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.6 ' CG1' HG21 ' D' ' 275' ' ' VAL . 53.8 t -118.16 125.88 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 73.53 111.181 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 59.9 t -127.11 125.67 66.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 43.13 111.124 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.63 133.74 8.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.769 -0.729 . . . . 71.24 112.532 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.63 138.34 48.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.831 0.348 . . . . 75.04 110.925 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.5 86.28 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.72 -0.752 . . . . 71.04 112.499 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 51.08 81.66 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 73.12 110.871 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 44.8 t -113.54 145.23 41.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 73.54 110.909 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.61 127.5 39.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 64.42 110.833 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.6 HG21 ' CG1' ' D' ' 267' ' ' VAL . 21.7 t -133.05 123.72 48.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 55.42 111.104 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.444 HD23 ' CZ2' ' D' ' 287' ' ' TRP . 0.1 OUTLIER -128.37 111.5 13.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 65.4 110.94 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.773 HG13 HD23 ' E' ' 241' ' ' LEU . 5.0 mp -109.74 130.17 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 64.53 111.124 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.05 172.47 16.2 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.791 -0.719 . . . . 75.42 112.549 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -89.94 141.97 28.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.329 . . . . 74.52 110.888 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . 0.654 ' HG3' HG13 ' E' ' 244' ' ' VAL . 0.0 OUTLIER -121.17 136.74 54.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 64.44 110.884 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -117.26 125.75 51.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 74.25 110.953 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.38 -118.53 6.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 45.35 112.528 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 72.74 157.62 3.9 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.776 -0.726 . . . . 61.31 112.443 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -56.02 -25.33 44.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.803 0.335 . . . . 74.44 110.873 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -171.58 -35.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 63.53 112.513 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -152.93 -72.13 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.314 . . . . 73.1 110.917 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . 0.444 ' CZ2' HD23 ' D' ' 276' ' ' LEU . 14.7 t90 -142.08 -73.28 0.31 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 72.44 110.831 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -173.02 55.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 51.44 110.837 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -59.12 178.75 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 73.03 110.87 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 -177.66 4.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 73.32 110.859 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -85.22 -170.0 2.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 70.43 110.882 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -54.56 172.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 75.41 110.89 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -88.95 -64.5 1.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 73.5 110.844 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -137.2 -47.74 0.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 74.22 110.861 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 71.25 110.857 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.795 0.331 . . . . 63.14 110.872 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -116.4 -27.09 6.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 74.34 110.915 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 2.7 mt -104.75 127.67 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.32 111.136 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -178.65 52.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 71.03 110.908 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . 0.604 ' O ' HD13 ' E' ' 222' ' ' ILE . . . -168.58 135.41 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 43.35 111.069 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . 0.604 HD13 ' O ' ' E' ' 221' ' ' ALA . 30.2 mm -135.39 123.62 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 63.5 111.109 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 16.6 m -147.63 170.51 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 64.43 111.09 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 141.61 -168.07 25.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.829 -0.701 . . . . 51.22 112.501 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . 0.762 ' O ' HG23 ' E' ' 261' ' ' THR . 0.7 OUTLIER -78.91 -75.55 0.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.899 0.38 . . . . 73.33 110.939 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -89.19 137.31 32.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.911 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.9 147.21 44.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 71.35 110.839 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.83 162.08 29.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 32.31 111.095 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . 0.436 ' HB2' ' HA ' ' E' ' 265' ' ' GLU . 3.5 mttm -116.34 -27.32 6.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 72.54 110.884 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . 0.559 ' CB ' HG22 ' E' ' 266' ' ' THR . 1.2 t70 -165.85 137.26 3.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 65.35 110.807 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 15.2 mt -138.07 117.54 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 65.24 111.083 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 15.5 ttt-85 -134.46 118.08 16.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 72.23 110.825 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 2.3 p -135.52 147.4 48.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 72.44 111.133 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' E' ' 237' ' ' ALA . 10.7 pt-20 -156.32 166.87 32.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 74.03 110.886 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 64.08 68.91 0.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 71.43 110.901 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 50.42 31.43 5.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 74.24 110.873 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' E' ' 234' ' ' GLU . . . -85.64 140.65 30.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 71.4 111.064 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.49 137.67 50.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 72.22 110.89 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.46 HG23 ' HB ' ' E' ' 275' ' ' VAL . 6.2 p -130.38 121.95 52.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 62.05 111.084 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . 0.572 ' O ' HD13 ' E' ' 241' ' ' LEU . 0.0 OUTLIER -112.94 136.85 52.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 74.41 110.877 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.773 HD23 HG13 ' D' ' 277' ' ' ILE . 2.0 mm? -124.21 134.16 53.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 62.11 110.869 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 109.18 177.56 21.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.693 -0.765 . . . . 74.3 112.441 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -90.05 148.95 22.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.833 0.349 . . . . 71.31 110.895 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.654 HG13 ' HG3' ' D' ' 280' ' ' GLU . 95.8 t -122.08 131.09 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 42.22 111.145 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 95.4 t -120.8 127.56 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 71.33 111.116 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.6 t -76.84 171.29 14.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 61.25 111.211 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.56 -33.98 76.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 61.21 111.066 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -51.56 68.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 73.55 111.071 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 62.52 -171.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 72.22 111.076 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.61 171.39 1.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 64.24 110.956 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -55.25 -29.61 58.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 75.34 110.83 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -162.34 151.21 21.06 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.757 -0.735 . . . . 44.4 112.485 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -175.14 154.41 18.07 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.761 . . . . 70.41 112.481 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.21 -43.48 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.814 0.34 . . . . 74.35 111.148 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . 0.525 ' HB2' HD12 ' D' ' 254' ' ' ILE . 7.4 ptp85 -159.22 69.03 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 74.01 110.857 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.06 173.33 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 54.45 111.069 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -178.68 147.23 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 62.01 110.896 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -109.85 163.16 13.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.115 -0.493 . . . . 75.21 110.879 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -153.04 121.21 6.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 73.14 110.831 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 96.2 m -96.78 134.47 40.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 73.53 111.13 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . 0.762 HG23 ' O ' ' E' ' 225' ' ' ARG . 85.9 m -91.89 116.06 28.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.137 -0.483 . . . . 60.54 111.153 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -126.12 138.19 53.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.484 . . . . 64.13 110.903 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.42 128.81 53.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 70.24 110.847 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . 0.462 HG21 ' CG2' ' E' ' 267' ' ' VAL . 7.9 p -125.55 137.73 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 73.2 111.188 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' E' ' 229' ' ' LYS . 17.5 mt-10 -82.97 -74.72 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 63.41 110.928 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . 0.559 HG22 ' CB ' ' E' ' 230' ' ' ASP . 38.9 p -142.54 128.06 19.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 72.25 111.132 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . 0.746 HG11 HG21 ' E' ' 275' ' ' VAL . 58.7 t -117.76 120.84 65.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 73.01 111.162 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 81.9 t -115.72 121.57 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 45.01 111.176 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.45 132.54 10.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.758 -0.734 . . . . 54.31 112.521 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.84 139.45 46.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 54.52 110.85 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.84 88.47 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 12.22 112.512 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 49.59 75.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.872 0.368 . . . . 73.41 110.917 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.23 145.38 30.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 43.14 110.863 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -132.83 127.63 34.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 62.22 110.839 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.746 HG21 HG11 ' E' ' 267' ' ' VAL . 74.9 t -133.69 122.97 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 63.22 111.135 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.19 111.34 12.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 61.1 110.88 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.54 HD12 HD12 ' E' ' 241' ' ' LEU . 9.7 mt -112.59 105.84 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 51.45 111.106 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.9 -158.57 28.19 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.787 -0.721 . . . . 63.23 112.448 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -127.96 145.73 50.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.758 0.314 . . . . 75.52 110.871 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -111.89 122.27 47.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 73.11 110.86 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.25 125.94 51.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 65.43 110.985 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 67.72 150.1 0.2 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.725 -0.75 . . . . 72.32 112.418 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.46 -23.77 1.21 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.683 -0.77 . . . . 70.33 112.434 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 2.2 mttp 52.51 55.28 9.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.363 . . . . 62.41 110.917 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 179.32 -109.47 0.27 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.739 -0.743 . . . . 64.41 112.516 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -175.02 167.82 3.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.847 0.356 . . . . 72.43 110.82 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -51.8 -74.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 73.54 110.917 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -68.53 167.86 14.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 62.22 110.882 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -171.04 157.45 5.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 73.33 110.916 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -172.82 138.43 0.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 73.54 110.945 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.32 -170.0 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 74.02 110.833 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -127.59 165.15 20.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 65.01 110.885 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.58 174.22 5.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 70.14 110.85 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -155.11 -42.82 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 73.21 110.854 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 74.51 110.899 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 9.4 tpt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.8 0.333 . . . . 74.35 110.877 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -178.18 76.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 62.12 110.962 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 14.4 tt -113.5 -25.52 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 71.24 111.108 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -54.17 145.09 18.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 71.12 110.846 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.657 ' HB3' ' HD2' ' A' ' 225' ' ' ARG . . . -89.97 -175.38 4.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 72.34 111.11 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 3.3 pt -151.25 172.76 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 74.33 111.123 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 24.2 t 53.7 87.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 75.24 111.076 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 69.26 109.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.798 -0.715 . . . . 43.11 112.468 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.691 ' CB ' HG23 ' A' ' 261' ' ' THR . 0.0 OUTLIER -151.54 144.5 24.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 72.42 110.845 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.701 ' HB3' HG22 ' A' ' 277' ' ' ILE . 0.1 OUTLIER -130.57 109.83 10.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 73.41 110.879 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 1.5 t -125.43 141.81 51.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 52.53 110.896 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.83 119.68 12.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 73.34 111.053 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -74.65 -33.39 62.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 70.43 110.92 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -164.92 138.93 4.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 71.22 110.872 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 10.3 pt -137.35 119.01 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 51.54 111.116 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.85 120.64 37.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 64.11 110.931 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.1 p -129.44 139.18 51.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.216 -0.447 . . . . 74.25 111.108 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -146.53 167.5 23.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 73.35 110.899 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 66.61 65.87 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 75.21 110.944 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 48.85 36.5 8.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.886 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.24 155.83 21.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 73.01 111.121 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -131.71 145.6 51.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 72.51 110.897 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.536 HG23 ' HB ' ' A' ' 275' ' ' VAL . 5.5 p -140.05 121.83 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 71.33 111.2 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -114.54 129.74 56.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 74.12 110.927 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.462 HD22 ' HB ' ' A' ' 277' ' ' ILE . 0.2 OUTLIER -114.83 118.53 33.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 53.55 110.891 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.72 174.87 13.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 50.14 112.54 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -90.92 154.79 19.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 63.34 110.897 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.473 HG13 ' HA ' ' A' ' 280' ' ' GLU . 4.2 p -130.02 123.99 57.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 74.23 111.11 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' A' ' 249' ' ' ALA . 22.0 t -122.07 125.73 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 61.51 111.104 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t -69.98 175.06 4.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 73.11 111.189 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.94 99.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 32.34 111.125 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.21 -47.82 80.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 74.14 111.057 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.409 ' HB3' ' CG1' ' A' ' 245' ' ' VAL . . . -80.23 136.71 36.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 70.5 111.085 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.8 tp -118.07 -171.6 2.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 62.45 110.899 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.82 -40.27 72.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 73.12 110.925 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 91.84 -159.37 25.65 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.661 -0.78 . . . . 74.54 112.54 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.581 ' H ' HD12 ' A' ' 254' ' ' ILE . . . 156.47 62.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 64.3 112.493 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.757 HG22 HG22 ' A' ' 256' ' ' ILE . 3.9 mp -127.77 143.59 40.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.896 0.379 . . . . 75.54 111.119 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 -81.15 57.52 3.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 70.51 110.935 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.757 HG22 HG22 ' A' ' 254' ' ' ILE . 13.5 tt -174.73 138.66 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.25 111.099 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.56 -179.8 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 75.02 110.87 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -104.82 -179.25 3.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 74.45 110.844 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -120.81 38.99 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 72.2 110.939 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 24.4 p -65.21 124.79 23.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 73.2 111.127 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.691 HG23 ' CB ' ' A' ' 225' ' ' ARG . 98.0 m -134.02 124.71 26.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.212 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.632 ' CB ' HD12 ' B' ' 241' ' ' LEU . 0.7 OUTLIER -103.53 121.04 42.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 74.0 110.857 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.629 ' HG ' ' N ' ' C' ' 217' ' ' MET . 0.1 OUTLIER -141.11 123.81 16.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 72.41 110.842 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.616 HG21 ' CD1' ' B' ' 231' ' ' ILE . 8.9 p -119.21 139.58 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 50.32 111.177 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.09 -71.28 0.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 72.11 110.875 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.6 m -124.19 136.09 53.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 74.23 111.081 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.801 HG22 HD11 ' B' ' 231' ' ' ILE . 19.4 t -120.27 133.5 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 74.42 111.175 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.49 127.13 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 74.33 111.165 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.38 133.39 8.38 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.747 . . . . 41.44 112.42 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.61 147.94 51.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 63.33 110.886 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.18 81.6 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.773 -0.727 . . . . 42.21 112.503 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 46.45 65.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 61.52 110.907 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 42.2 t -89.63 145.68 25.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 54.15 110.783 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -119.53 127.9 53.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.088 -0.506 . . . . 71.45 110.88 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.536 ' HB ' HG23 ' A' ' 239' ' ' VAL . 98.8 t -124.38 123.03 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 73.55 111.111 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 27.6 tp -128.71 111.7 13.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.964 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.701 HG22 ' HB3' ' A' ' 226' ' ' ASN . 26.3 mm -110.86 104.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.24 111.131 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.73 170.92 18.4 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 75.51 112.455 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -90.45 137.81 32.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.774 0.321 . . . . 63.24 110.927 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.73 ' HG3' HG23 ' B' ' 244' ' ' VAL . 4.9 pt-20 -111.95 120.27 41.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 74.14 110.923 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.6 125.91 51.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 74.21 110.967 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 118.5 169.95 14.71 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.661 -0.781 . . . . 45.2 112.427 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -67.42 -119.81 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.737 -0.744 . . . . 40.34 112.488 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.53 27.07 7.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.336 . . . . 74.41 110.913 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.02 -103.04 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.762 -0.732 . . . . 74.11 112.458 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -132.08 146.02 51.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.361 . . . . 64.12 110.869 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER 67.28 -78.44 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 71.41 110.904 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -138.04 172.61 12.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 74.13 110.935 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -57.42 149.75 20.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 75.32 110.856 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -157.5 40.77 0.3 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 72.33 110.864 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 59.91 98.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 70.1 110.896 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -109.03 150.54 27.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 75.5 110.87 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.87 175.69 3.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.849 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 61.48 99.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 73.35 110.869 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 23.6 p80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 73.14 110.917 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 2.2 ptm . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.83 0.348 . . . . 74.33 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -109.28 100.87 9.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.424 . . . . 73.43 110.904 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 3.8 mt -99.01 -29.38 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 70.03 111.052 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 59.5 175.63 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 72.13 110.801 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -172.27 45.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 74.25 111.081 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 1.4 pt -105.48 65.07 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 75.34 111.181 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.12 155.23 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 72.14 111.116 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -116.17 -178.67 18.2 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.727 -0.749 . . . . 64.11 112.454 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -171.72 132.26 0.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.752 0.31 . . . . 74.45 110.865 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.524 ' HB3' HG22 ' B' ' 277' ' ' ILE . 0.8 OUTLIER -138.06 109.43 6.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 63.51 110.915 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 22.1 t -126.83 145.96 50.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 61.33 110.87 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.468 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -139.89 119.76 13.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 73.34 111.076 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -35.76 77.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 54.55 110.968 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -165.4 138.28 4.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 73.33 110.899 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.801 HD11 HG22 ' A' ' 267' ' ' VAL . 31.5 pt -132.86 131.25 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 73.44 111.071 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 14.5 ttt180 -134.5 125.16 26.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 71.43 110.856 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.75 128.73 37.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 60.24 111.136 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -134.97 167.4 20.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 73.53 110.883 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 63.06 68.99 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.12 110.918 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 2.6 mtm-85 47.65 40.76 12.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 71.52 110.905 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.74 156.14 17.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 73.13 111.086 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.64 148.41 50.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 73.34 110.905 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' B' ' 275' ' ' VAL . 4.1 p -138.28 121.53 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 70.12 111.172 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -111.2 129.2 56.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 71.42 110.859 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.632 HD12 ' CB ' ' A' ' 262' ' ' ASN . 0.2 OUTLIER -113.79 118.55 34.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.483 . . . . 64.05 110.973 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.24 179.75 16.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.721 . . . . 34.44 112.514 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -87.42 144.51 26.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 72.23 110.918 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.73 HG23 ' HG3' ' A' ' 280' ' ' GLU . 4.7 p -118.88 119.86 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 65.24 111.141 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.35 128.32 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 72.45 111.237 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 48.9 p -80.19 173.92 12.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 61.22 111.172 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.04 96.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 73.23 111.087 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.54 -51.58 68.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 53.14 111.125 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.92 129.2 26.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 73.34 111.151 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 2.0 mt -143.16 -50.5 0.34 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.175 -0.466 . . . . 71.5 110.858 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . 0.443 ' NE2' HG21 ' A' ' 256' ' ' ILE . 40.5 t-80 -157.9 132.48 8.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.881 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -162.19 161.18 33.28 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.747 -0.739 . . . . 74.55 112.518 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 137.64 -72.62 0.44 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.72 -0.752 . . . . 73.13 112.522 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 37.1 mt 63.01 69.87 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.756 0.313 . . . . 63.14 111.101 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 56.9 93.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 75.15 110.89 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.5 pt -143.59 176.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 74.41 111.112 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.79 98.42 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 73.44 110.843 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.593 ' O ' HG23 ' B' ' 260' ' ' THR . 10.8 m-20 -150.44 76.83 1.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 75.0 110.857 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.05 98.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 71.44 110.901 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.593 HG23 ' O ' ' B' ' 258' ' ' ASP . 35.5 p -100.86 121.99 42.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 64.21 111.104 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 2.1 t -126.69 127.27 44.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.429 . . . . 65.11 111.192 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.59 129.03 56.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 75.42 110.887 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.9 t -140.95 122.9 15.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 73.11 110.879 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.628 HG21 ' CD1' ' C' ' 231' ' ' ILE . 4.8 p -112.93 141.97 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.484 . . . . 64.13 111.092 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -80.7 -77.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 74.32 110.886 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 18.9 m -120.87 133.71 55.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.119 -0.491 . . . . 63.35 111.099 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.762 HG22 HD11 ' C' ' 231' ' ' ILE . 3.2 t -117.69 124.5 73.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.14 -0.482 . . . . 75.01 111.088 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 59.7 t -123.66 116.02 46.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.495 . . . . 65.01 111.12 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.58 133.33 10.83 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.723 -0.751 . . . . 61.54 112.511 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.35 147.58 51.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.323 . . . . 65.03 110.965 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.94 84.1 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.713 -0.756 . . . . 72.21 112.496 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 46.1 64.98 1.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.808 0.337 . . . . 75.32 110.865 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 27.9 t -93.94 145.61 24.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 74.24 110.838 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.46 128.02 50.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 72.42 110.833 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' B' ' 239' ' ' VAL . 78.5 t -122.95 123.7 68.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 75.41 111.133 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.723 HD22 ' CE3' ' B' ' 287' ' ' TRP . 0.4 OUTLIER -126.55 111.64 14.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 73.45 110.924 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.524 HG22 ' HB3' ' B' ' 226' ' ' ASN . 27.0 mm -109.59 104.64 17.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 72.13 111.104 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.76 175.87 18.28 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.691 -0.766 . . . . 45.34 112.453 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -89.9 154.99 19.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 71.31 110.834 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.691 ' HG3' HG23 ' C' ' 244' ' ' VAL . 12.6 pt-20 -128.72 146.87 50.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 73.12 110.868 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.41 ' CZ ' HG11 ' C' ' 245' ' ' VAL . 0.6 OUTLIER -126.44 125.85 42.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.932 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 128.97 -147.88 17.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.669 -0.777 . . . . 54.54 112.474 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -128.62 -145.09 5.92 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.837 -0.697 . . . . 61.12 112.508 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 63.27 78.82 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.874 0.368 . . . . 53.54 110.867 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.12 -108.61 0.68 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.761 -0.733 . . . . 64.1 112.458 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.06 -60.06 1.79 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 75.33 110.922 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.723 ' CE3' HD22 ' B' ' 276' ' ' LEU . 5.9 p90 -143.18 14.56 1.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.02 110.872 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.21 -171.72 1.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.411 . . . . 74.1 110.909 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -123.59 92.1 3.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 55.11 110.904 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 72.9 t60 61.62 100.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 73.11 110.872 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -159.58 146.22 16.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 73.41 110.847 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 61.94 100.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 72.04 110.818 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -147.21 97.19 2.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 74.31 110.823 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -176.07 172.2 2.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 70.12 110.833 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 62.21 110.864 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . 0.629 ' N ' ' HG ' ' A' ' 263' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.787 0.327 . . . . 74.4 110.884 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -141.79 138.98 32.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 75.13 110.866 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 33.2 mm 59.36 92.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 72.13 111.124 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.96 116.67 6.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 63.54 110.827 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -92.16 139.54 30.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 53.54 111.13 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 39.1 pt -81.87 156.77 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 74.01 111.152 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 27.7 t 53.33 85.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 62.22 111.13 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -65.59 -162.89 1.0 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.705 -0.76 . . . . 61.2 112.524 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.87 -44.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.868 0.366 . . . . 53.12 110.883 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.58 110.49 6.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.43 110.953 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.543 ' HB2' HD13 ' D' ' 219' ' ' ILE . 1.4 t -130.86 141.09 50.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 72.32 110.863 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.16 135.16 46.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 74.33 111.127 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.49 -29.92 21.01 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.218 -0.447 . . . . 72.42 110.909 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.81 136.61 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 62.45 110.883 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.762 HD11 HG22 ' B' ' 267' ' ' VAL . 3.7 pt -138.4 117.52 14.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 73.41 111.113 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -122.12 116.46 24.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 74.11 110.866 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.415 HG21 ' HB ' ' C' ' 239' ' ' VAL . 2.6 p -124.11 128.76 49.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 62.11 111.143 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.48 167.5 21.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 74.44 110.904 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 64.33 74.72 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 74.53 110.906 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 44.38 38.65 2.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 73.31 110.829 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -93.16 156.17 17.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 72.12 111.1 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.24 156.17 49.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 71.54 110.901 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.415 ' HB ' HG21 ' C' ' 233' ' ' THR . 7.8 p -138.19 146.92 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 72.54 111.117 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -134.75 137.49 43.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 72.52 110.901 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.589 HD22 ' HB ' ' C' ' 277' ' ' ILE . 0.3 OUTLIER -126.88 124.89 40.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 45.42 110.92 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.52 178.09 16.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.676 -0.773 . . . . 72.41 112.489 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -86.47 157.02 19.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 54.34 110.864 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.691 HG23 ' HG3' ' B' ' 280' ' ' GLU . 5.4 p -128.69 135.4 62.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 64.42 111.176 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' B' ' 281' ' ' TYR . 39.3 t -122.09 127.96 75.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 73.03 111.132 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 27.9 p -83.8 162.89 20.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 63.44 111.136 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.23 -34.27 76.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 42.34 111.161 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.95 -51.16 70.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.141 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 63.69 169.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 53.15 111.118 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.41 111.03 4.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.436 . . . . 60.04 110.907 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . 0.498 ' HD2' ' HB1' ' D' ' 247' ' ' ALA . 10.6 p80 -107.27 28.24 8.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 70.43 110.798 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -177.46 116.68 0.55 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.735 -0.745 . . . . 52.13 112.499 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 111.72 -21.06 21.67 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 73.53 112.503 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 15.3 mt 70.72 -70.51 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.866 0.365 . . . . 75.5 111.086 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.83 131.96 8.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 70.05 110.913 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.36 26.38 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 72.23 111.099 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 4.2 m 62.96 162.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 13.25 110.867 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -173.3 136.29 0.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 60.24 110.856 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -160.89 50.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 75.54 110.913 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . 0.499 HG21 ' HB3' ' D' ' 243' ' ' ASN . 27.1 p -90.1 126.08 35.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 61.14 111.124 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.8 m -107.46 108.68 20.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 74.5 111.155 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . 0.733 ' HB2' HD12 ' D' ' 241' ' ' LEU . 0.0 OUTLIER -100.15 130.6 46.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 64.45 110.886 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 29.3 t -142.05 123.26 14.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 75.44 110.798 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.633 HG21 HD11 ' D' ' 231' ' ' ILE . 5.9 p -115.04 148.06 18.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 54.15 111.154 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.94 -72.77 0.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 64.45 110.858 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 27.7 m -129.08 137.54 51.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 73.14 111.066 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.824 HG22 HD11 ' D' ' 231' ' ' ILE . 4.2 t -118.79 129.54 74.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 71.25 111.108 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 73.1 t -127.13 115.96 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 74.34 111.183 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.8 133.04 9.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.727 . . . . 34.05 112.475 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -133.74 147.68 51.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.351 . . . . 73.45 110.941 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.56 89.13 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.769 -0.729 . . . . 64.44 112.499 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 44.8 60.59 2.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.804 0.335 . . . . 65.22 110.873 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.28 144.98 25.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 73.33 110.874 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.59 128.07 48.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.487 . . . . 73.52 110.951 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 94.2 t -123.44 123.56 67.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 64.12 111.159 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.682 HD13 ' CE3' ' C' ' 287' ' ' TRP . 0.5 OUTLIER -126.58 111.69 14.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 74.3 110.925 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.589 ' HB ' HD22 ' C' ' 241' ' ' LEU . 27.4 mm -108.32 104.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 73.45 111.134 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.42 -164.65 29.04 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.814 -0.708 . . . . 53.23 112.606 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -122.01 156.01 34.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.314 . . . . 70.12 110.91 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.75 ' CG ' HG23 ' D' ' 244' ' ' VAL . 9.5 pt-20 -119.51 146.7 45.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 74.53 110.903 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -129.94 134.89 47.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 72.24 110.902 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.49 148.4 20.46 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 62.51 112.549 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . 0.504 ' H ' ' HB2' ' D' ' 247' ' ' ALA . . . 51.77 -161.55 1.89 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 74.43 112.462 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -131.99 -169.47 2.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 61.21 110.934 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 81.2 139.02 2.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.784 -0.722 . . . . 52.3 112.427 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -45.74 -39.64 8.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.782 0.325 . . . . 62.25 110.91 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.682 ' CE3' HD13 ' C' ' 276' ' ' LEU . 4.0 p90 179.67 -29.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.156 -0.475 . . . . 72.41 110.899 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.38 -169.37 1.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 70.31 110.807 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 63.75 106.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 72.52 110.93 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -115.77 -172.09 2.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 74.24 110.9 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -75.07 132.58 41.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.454 . . . . 74.0 110.845 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -119.25 -176.49 3.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 75.51 110.844 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -139.74 -177.76 5.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 71.51 110.877 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.04 -169.88 1.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 53.14 110.883 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 64.35 110.897 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.885 0.374 . . . . 60.1 110.821 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 161.13 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 63.54 110.811 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . 0.543 HD13 ' HB2' ' C' ' 227' ' ' SER . 73.6 mt -137.31 -71.45 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 72.33 111.084 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -173.7 -170.12 0.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 75.44 110.856 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.15 -169.81 2.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.431 . . . . 75.34 111.144 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 3.7 mp -128.62 118.01 46.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 62.41 111.108 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 22.3 t -145.06 65.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 72.04 111.138 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 79.77 -125.89 7.18 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.737 -0.745 . . . . 71.53 112.458 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.35 -167.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 63.04 110.863 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.3 115.63 22.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 64.32 110.859 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.16 138.43 48.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 72.4 110.823 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . 0.402 ' HB3' HG23 ' C' ' 264' ' ' VAL . . . -138.19 119.81 15.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.074 -0.512 . . . . 63.23 111.09 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.41 -27.46 56.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 63.14 110.933 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.24 136.76 2.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 62.33 110.867 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . 0.824 HD11 HG22 ' C' ' 267' ' ' VAL . 4.3 pt -139.35 117.17 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 72.21 111.067 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -126.54 128.98 47.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 73.14 110.882 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.14 128.83 32.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 75.42 111.164 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -133.16 167.34 20.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 73.11 110.943 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 63.88 72.79 0.46 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.469 . . . . 71.24 110.886 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 44.63 47.25 8.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.483 . . . . 64.1 110.867 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -97.98 155.62 17.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 73.02 111.102 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.37 144.4 46.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 70.25 110.866 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 5.6 p -129.11 140.21 49.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 71.33 111.114 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -133.39 121.72 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 74.21 110.927 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' C' ' 262' ' ' ASN . 0.1 OUTLIER -111.78 118.88 36.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 75.53 110.904 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.77 172.35 13.11 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.754 -0.736 . . . . 74.04 112.451 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . 0.499 ' HB3' HG21 ' C' ' 260' ' ' THR . 2.9 p-10 -86.0 143.23 28.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.373 . . . . 73.1 110.938 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . 0.75 HG23 ' CG ' ' C' ' 280' ' ' GLU . 4.4 p -110.23 128.76 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 62.55 111.158 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 23.1 t -122.02 128.94 75.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 61.51 111.198 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 30.5 p -86.14 174.17 9.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 72.22 111.154 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . 0.504 ' HB2' ' H ' ' C' ' 283' ' ' GLY . . . -59.37 -44.58 92.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 51.42 111.069 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.3 -51.23 70.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 55.3 111.121 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 52.07 -169.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 72.42 111.089 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . 0.841 HD11 ' HB2' ' E' ' 249' ' ' ALA . 3.2 tp -90.92 -169.94 2.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 63.33 110.925 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -146.5 103.95 3.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.447 . . . . 72.45 110.834 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 111.65 160.96 16.37 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.724 -0.75 . . . . 64.02 112.496 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 101.93 110.82 3.4 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.626 -0.797 . . . . 62.44 112.465 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 16.2 tt -121.72 -34.31 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 71.32 111.195 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.91 170.67 16.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 63.43 110.873 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 18.9 tt -61.28 140.72 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.32 111.136 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.66 -170.33 2.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 50.43 110.831 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 63.26 104.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 61.45 110.838 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . 0.483 ' NE2' ' H ' ' E' ' 257' ' ' SER . 10.1 pm0 -105.15 27.4 8.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 53.3 110.942 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . 0.723 HG21 ' CG ' ' E' ' 243' ' ' ASN . 35.4 p -85.18 129.94 34.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 63.34 111.098 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 76.9 m -134.13 125.54 28.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 72.44 111.165 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . 0.457 ' OD1' HG22 ' D' ' 277' ' ' ILE . 0.4 OUTLIER -116.71 122.16 43.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 74.11 110.925 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.1 123.54 14.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 73.11 110.786 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.75 HG21 ' CD1' ' E' ' 231' ' ' ILE . 8.0 p -122.76 138.56 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 72.01 111.149 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -72.09 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 74.41 110.898 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 72.9 p -124.48 135.65 53.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 70.32 111.108 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.676 HG22 HD11 ' E' ' 231' ' ' ILE . 7.7 t -119.08 130.51 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 71.23 111.1 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . 0.437 HG11 ' NE ' ' E' ' 232' ' ' ARG . 2.1 t -127.38 120.79 55.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 55.44 111.108 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.46 132.64 9.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.766 -0.73 . . . . 74.42 112.542 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -134.35 149.15 50.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.79 0.329 . . . . 73.15 110.976 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.45 87.53 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 72.01 112.467 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 43.29 56.87 4.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 63.41 110.814 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 30.5 t -86.71 145.08 26.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 74.41 110.88 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.72 128.28 49.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 75.35 110.861 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 98.6 t -119.97 123.21 70.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.469 . . . . 73.14 111.116 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.63 HD23 ' HG2' ' E' ' 240' ' ' GLN . 0.8 OUTLIER -128.46 113.33 15.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 74.24 110.955 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.553 ' HB ' HD22 ' D' ' 241' ' ' LEU . 29.9 mm -112.41 104.73 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 71.45 111.118 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.99 175.89 17.52 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.764 -0.732 . . . . 44.34 112.473 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -89.92 156.12 18.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 74.44 110.909 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . 0.771 ' HG3' HG23 ' E' ' 244' ' ' VAL . 19.8 pt-20 -124.7 134.06 52.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 54.42 110.88 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -124.76 125.78 44.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.91 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 168.81 -152.2 19.67 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 72.41 112.51 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -78.83 57.95 4.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.687 -0.768 . . . . 75.11 112.516 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . 0.519 ' N ' HG23 ' E' ' 246' ' ' THR . 0.0 OUTLIER 54.13 -174.12 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.757 0.313 . . . . 73.53 110.901 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 66.87 144.46 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 34.13 112.534 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -59.73 -172.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 63.12 110.833 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . 0.591 ' CE3' HD13 ' D' ' 276' ' ' LEU . 8.8 p90 -50.57 160.61 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.079 -0.51 . . . . 74.55 110.945 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 12.7 t0 51.75 87.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 65.05 110.929 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -55.5 111.93 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 63.53 110.89 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -95.05 -43.44 8.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 74.52 110.828 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -56.12 124.04 16.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.21 110.848 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -130.25 158.52 39.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 53.51 110.829 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -129.57 169.74 14.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 72.11 110.853 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 62.91 166.32 0.12 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.222 -0.445 . . . . 71.54 110.885 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 73.42 110.836 -179.963 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.843 0.354 . . . . 74.13 110.836 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . 0.475 ' O ' HD13 ' E' ' 219' ' ' ILE . 5.4 mttp -147.29 115.72 6.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 72.5 110.901 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . 0.475 HD13 ' O ' ' E' ' 218' ' ' LYS . 33.2 mm -131.12 118.18 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.34 111.095 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.58 -74.5 0.44 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 74.05 110.884 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.98 170.46 1.86 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 73.3 111.075 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . 0.649 HG22 HG13 ' E' ' 223' ' ' VAL . 46.6 mm -127.58 -71.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 74.32 111.11 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . 0.649 HG13 HG22 ' E' ' 222' ' ' ILE . 34.0 m -150.29 155.77 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 71.42 111.127 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 174.87 -130.08 1.7 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.754 -0.736 . . . . 74.32 112.455 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . 0.648 ' HA ' HG23 ' E' ' 261' ' ' THR . 0.1 OUTLIER -131.28 -59.6 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 72.54 110.872 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.83 109.94 22.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 73.01 110.859 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 1.8 m -134.28 137.51 44.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 75.24 110.892 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . 0.518 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -139.32 124.88 19.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 74.14 111.091 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.41 -25.88 60.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 63.4 110.922 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . 0.685 ' HB3' HG23 ' E' ' 266' ' ' THR . 27.9 t0 -167.15 137.26 2.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 55.54 110.91 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . 0.75 ' CD1' HG21 ' D' ' 264' ' ' VAL . 23.5 pt -138.18 128.94 36.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 61.32 111.182 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . 0.437 ' NE ' HG11 ' D' ' 268' ' ' VAL . 26.2 ttm180 -133.87 131.41 39.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 60.4 110.906 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.43 128.57 31.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 64.54 111.146 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -132.29 166.47 21.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.419 . . . . 63.32 110.896 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 64.53 69.71 0.5 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.474 . . . . 70.35 110.943 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 47.15 35.18 3.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 63.53 110.941 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.38 156.35 18.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.138 -0.483 . . . . 52.1 111.119 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -140.94 158.89 43.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 72.14 110.856 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.525 HG23 ' HB ' ' E' ' 275' ' ' VAL . 4.8 p -138.08 143.12 33.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 63.11 111.114 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . 0.63 ' HG2' HD23 ' D' ' 276' ' ' LEU . 5.7 tm0? -132.39 125.99 32.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.085 -0.507 . . . . 71.12 110.852 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.812 HD13 ' HB ' ' E' ' 277' ' ' ILE . 3.9 mm? -111.9 118.74 36.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 75.32 110.943 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.22 -173.83 20.21 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.758 -0.734 . . . . 73.1 112.524 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . 0.723 ' CG ' HG21 ' D' ' 260' ' ' THR . 5.6 p-10 -104.97 154.76 19.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.925 0.393 . . . . 74.52 110.803 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.771 HG23 ' HG3' ' D' ' 280' ' ' GLU . 4.6 p -115.86 125.02 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 73.01 111.092 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 91.0 t -112.84 129.14 68.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 55.4 111.168 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . 0.519 HG23 ' N ' ' D' ' 284' ' ' LYS . 1.4 m -85.58 163.47 18.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 65.25 111.165 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.83 -34.85 68.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 71.43 111.132 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' E' ' 249' ' ' ALA . . . -57.07 -52.0 67.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 74.31 111.085 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . 0.841 ' HB2' HD11 ' D' ' 250' ' ' LEU . . . 68.88 -77.31 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 73.4 111.113 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . 0.418 HD12 ' HB1' ' E' ' 248' ' ' ALA . 0.2 OUTLIER 51.91 82.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 53.14 110.885 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 56.0 64.51 1.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 73.11 110.928 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -70.95 -46.83 42.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.699 -0.762 . . . . 52.4 112.47 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 163.32 178.11 36.79 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.732 -0.747 . . . . 60.21 112.48 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 5.3 mp -139.98 -42.35 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 72.55 111.121 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 12.2 ttt-85 -175.48 103.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 72.42 110.847 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 51.5 mt 55.88 93.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 64.23 111.134 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . 0.483 ' H ' ' NE2' ' D' ' 259' ' ' GLN . 11.7 t -98.81 -70.32 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 73.1 110.914 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.81 154.78 19.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 71.03 110.876 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.68 25.59 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 73.22 110.955 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 49.7 m -65.51 121.95 16.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 74.24 111.045 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . 0.648 HG23 ' HA ' ' E' ' 225' ' ' ARG . 30.0 m -134.11 127.71 32.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 62.25 111.11 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.69 119.91 39.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 64.54 110.944 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 48.0 t -133.3 125.15 28.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 63.05 110.882 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . 0.465 HG11 ' CG2' ' E' ' 267' ' ' VAL . 5.1 p -128.22 146.68 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 42.44 111.101 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.64 -64.94 1.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 73.45 110.873 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . 0.685 HG23 ' HB3' ' E' ' 230' ' ' ASP . 2.5 m -135.85 138.13 42.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 64.05 111.17 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . 0.465 ' CG2' HG11 ' E' ' 264' ' ' VAL . 7.9 t -126.48 130.84 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 64.23 111.136 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 5.7 p -128.37 124.01 61.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 64.34 111.101 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.77 138.99 15.04 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.718 -0.753 . . . . 60.31 112.475 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -132.93 148.84 52.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.779 0.323 . . . . 62.44 110.963 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.08 88.91 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.726 -0.75 . . . . 54.33 112.494 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 41.84 56.96 3.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.855 0.36 . . . . 52.12 110.925 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 30.2 t -83.92 145.01 28.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 54.14 110.815 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -126.29 127.88 46.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 74.02 110.898 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.525 ' HB ' HG23 ' E' ' 239' ' ' VAL . 99.6 t -116.93 123.52 71.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 73.11 111.155 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.665 HD13 ' CD2' ' E' ' 287' ' ' TRP . 0.3 OUTLIER -128.77 111.83 13.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 73.04 110.885 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.812 ' HB ' HD13 ' E' ' 241' ' ' LEU . 29.4 mm -112.14 104.95 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 72.35 111.09 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.73 -165.06 28.82 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.791 -0.719 . . . . 40.44 112.505 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -116.48 156.01 27.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.819 0.343 . . . . 73.44 110.893 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -118.01 118.92 33.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 72.04 110.973 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -106.86 126.08 51.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 75.02 110.915 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 105.13 -35.23 5.2 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.724 -0.75 . . . . 61.31 112.466 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -66.59 -152.15 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 73.21 112.501 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.59 -58.34 1.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 54.41 110.812 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -152.84 -40.21 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.706 -0.759 . . . . 63.2 112.515 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -113.18 170.21 8.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.884 0.373 . . . . 62.03 110.901 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . 0.665 ' CD2' HD13 ' E' ' 276' ' ' LEU . 13.8 p90 -95.31 25.19 4.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 75.42 110.88 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -174.5 49.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 64.24 110.81 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -140.77 125.82 18.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 72.43 110.879 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.71 -174.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 64.05 110.805 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -171.13 -38.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 75.34 110.843 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 61.83 83.01 0.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 74.33 110.865 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.83 152.77 24.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 73.03 110.803 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -56.25 118.49 4.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 73.35 110.846 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 72.45 110.841 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 6.7 mtp . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.856 0.36 . . . . 62.44 110.892 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.23 -169.8 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 64.23 110.831 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.0 mt -120.54 132.99 68.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 75.11 111.074 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -164.26 27.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 70.12 110.826 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.73 167.95 2.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 74.14 111.047 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.789 HG22 HG23 ' A' ' 223' ' ' VAL . 62.8 mt -63.7 -57.93 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 62.54 111.135 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.875 HG21 HG21 ' A' ' 256' ' ' ILE . 97.4 t -149.87 -72.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 63.34 111.202 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 67.76 122.95 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.759 -0.734 . . . . 34.24 112.516 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.668 ' O ' HG23 ' A' ' 261' ' ' THR . 0.5 OUTLIER -142.85 60.95 1.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 74.32 110.895 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.585 ' OD1' HG22 ' A' ' 277' ' ' ILE . 5.8 m-80 -142.42 135.72 28.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 75.25 110.821 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.99 137.48 54.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 71.1 110.818 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.772 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -127.65 119.64 26.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 64.42 111.096 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.19 -34.04 37.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 64.52 110.915 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.77 132.21 1.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.469 . . . . 70.14 110.907 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.809 HD12 HG21 ' A' ' 239' ' ' VAL . 9.9 pt -141.05 134.35 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 63.44 111.149 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -134.08 128.2 33.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 73.14 110.834 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.479 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.2 OUTLIER -135.21 141.34 45.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 72.25 111.192 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -148.87 151.14 34.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 72.54 110.894 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 64.16 91.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 62.32 110.886 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 39.27 41.12 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 75.53 110.817 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.479 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -102.49 139.69 37.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 72.43 111.097 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.31 158.62 44.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 65.41 110.874 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.809 HG21 HD12 ' A' ' 231' ' ' ILE . 16.3 m -142.72 134.94 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 71.0 111.058 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.458 ' HB3' HD23 ' A' ' 276' ' ' LEU . 0.0 OUTLIER -110.45 134.16 52.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 55.23 110.863 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.772 HD21 ' HB2' ' A' ' 228' ' ' ALA . 0.5 OUTLIER -130.79 118.78 21.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 72.22 110.948 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.34 -121.16 3.07 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.692 -0.766 . . . . 60.33 112.465 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -144.39 129.15 18.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.931 0.396 . . . . 75.03 110.834 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.482 HG13 ' HA ' ' A' ' 280' ' ' GLU . 7.1 p -116.44 123.01 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.483 . . . . 71.33 111.169 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.0 m -121.97 129.05 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 73.15 111.154 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 14.6 t -70.0 162.88 27.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 64.43 111.108 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.11 -33.96 76.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 64.44 111.1 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.97 -35.91 69.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 73.11 111.125 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.47 105.55 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 61.51 111.126 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.955 HD13 HD13 ' A' ' 254' ' ' ILE . 4.9 mp 56.98 -179.26 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 71.24 110.871 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.97 -59.59 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 71.41 110.868 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.02 112.93 1.29 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 70.54 112.536 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 102.32 58.63 0.77 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.717 -0.754 . . . . 73.25 112.527 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.955 HD13 HD13 ' A' ' 250' ' ' LEU . 6.2 tp -89.98 142.03 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.837 0.351 . . . . 65.54 111.149 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.438 ' H ' HD12 ' A' ' 254' ' ' ILE . 14.1 ttm180 -136.24 117.83 14.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 73.24 110.819 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.875 HG21 HG21 ' A' ' 223' ' ' VAL . 1.9 tt -52.1 146.06 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 62.44 111.1 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 17.7 p -114.01 67.02 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.53 110.791 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -54.92 126.94 26.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 64.21 110.888 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -179.12 -36.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 74.04 110.917 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.5 HG21 HD22 ' B' ' 243' ' ' ASN . 0.2 OUTLIER -100.0 128.17 46.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 41.3 111.137 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 225' ' ' ARG . 86.2 m -132.01 125.47 31.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 74.15 111.111 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.71 ' OD1' HG23 ' A' ' 277' ' ' ILE . 7.6 t-20 -105.84 143.51 33.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 74.22 110.933 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.6 p -135.72 123.82 22.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 71.32 110.882 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.626 HG23 HD11 ' B' ' 231' ' ' ILE . 8.1 p -111.19 146.46 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 43.14 111.197 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.63 -64.73 1.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 63.13 110.852 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.3 m -138.8 127.94 24.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 74.01 111.207 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.596 HG11 HG21 ' A' ' 275' ' ' VAL . 13.8 t -118.4 132.12 69.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 74.14 111.133 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.424 HG12 ' HD2' ' A' ' 270' ' ' LYS . 61.5 t -128.31 115.16 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 71.13 111.13 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.07 133.37 10.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 45.12 112.482 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.424 ' HD2' HG12 ' A' ' 268' ' ' VAL . 0.0 OUTLIER -132.72 141.99 48.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.818 0.342 . . . . 63.51 110.896 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.28 86.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 63.15 112.546 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 51.57 81.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 71.23 110.859 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 13.2 t -113.88 144.66 42.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 74.31 110.857 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 49.6 mtt85 -127.79 127.63 43.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 72.35 110.933 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.596 HG21 HG11 ' A' ' 267' ' ' VAL . 13.3 t -124.06 123.97 67.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 73.13 111.11 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 240' ' ' GLN . 1.5 mt -115.15 111.75 21.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 74.33 110.927 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.71 HG23 ' OD1' ' A' ' 262' ' ' ASN . 47.2 mm -112.1 104.92 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 74.45 111.123 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.39 -146.58 18.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.683 -0.77 . . . . 71.32 112.479 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -117.45 150.59 38.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 72.21 110.908 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.788 ' HG3' HG23 ' B' ' 244' ' ' VAL . 14.8 pt-20 -129.54 133.76 47.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 71.42 110.821 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.432 ' HA ' HG23 ' B' ' 245' ' ' VAL . 0.5 OUTLIER -114.42 126.06 54.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.864 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 132.57 150.95 6.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.69 -0.767 . . . . 72.35 112.454 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.423 ' H ' ' HB2' ' B' ' 247' ' ' ALA . . . -116.37 -144.36 8.01 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 32.03 112.499 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.02 -75.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 74.22 110.899 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -117.8 92.63 0.55 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.762 -0.732 . . . . 71.11 112.494 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.404 ' HE1' HG21 ' B' ' 244' ' ' VAL . 71.1 t80 -52.36 114.05 1.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.35 . . . . 74.01 110.896 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 3.0 t90 72.36 -69.2 0.2 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.197 -0.456 . . . . 72.31 110.88 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -122.24 -169.97 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 72.41 110.808 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -52.21 137.23 28.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 72.2 110.928 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.19 141.22 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 73.43 110.876 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -171.3 142.41 1.72 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 74.53 110.884 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.89 170.29 1.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.784 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -174.32 155.66 2.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 73.51 110.853 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -127.6 -73.79 0.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 73.21 110.808 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 75.53 110.834 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 2.5 tpp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.849 0.357 . . . . 73.31 110.888 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.523 ' C ' HD12 ' B' ' 219' ' ' ILE . 0.0 OUTLIER -98.75 61.01 1.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.923 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . 0.573 HG23 ' CE ' ' D' ' 217' ' ' MET . 1.9 mp 70.99 -70.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 73.1 111.126 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 53.38 45.42 28.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 63.01 110.888 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.574 ' O ' HD13 ' B' ' 222' ' ' ILE . . . -143.12 114.14 7.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 71.4 111.079 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . 0.574 HD13 ' O ' ' B' ' 221' ' ' ALA . 34.4 mm -136.47 73.09 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 75.24 111.137 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 6.1 m -152.42 179.18 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 65.2 111.075 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -66.03 156.78 49.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.755 -0.736 . . . . 73.14 112.507 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 5.2 mtt85 -179.19 120.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 74.4 110.825 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.628 ' ND2' HG22 ' B' ' 277' ' ' ILE . 4.0 m-20 -103.51 137.01 42.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 73.32 110.911 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.83 137.65 54.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 73.52 110.91 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.35 139.51 49.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 60.04 111.107 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.32 -36.37 9.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 75.44 110.854 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -164.52 138.77 5.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 73.44 110.785 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.626 HD11 HG23 ' A' ' 264' ' ' VAL . 0.5 OUTLIER -137.43 117.77 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 74.04 111.16 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.36 119.51 30.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 65.43 110.919 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.62 135.39 42.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 50.53 111.136 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -144.94 161.88 38.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 71.2 110.865 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 62.37 74.14 0.44 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.148 -0.478 . . . . 64.31 110.844 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 46.96 51.75 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 74.23 110.905 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.25 148.43 26.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 62.41 111.039 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.28 136.31 43.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 75.42 110.872 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.527 HG11 HG22 ' B' ' 231' ' ' ILE . 2.8 m -124.34 123.53 66.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 70.25 111.071 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.684 ' HB3' HD22 ' B' ' 276' ' ' LEU . 6.5 tm0? -105.74 129.21 53.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 73.52 110.906 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.596 HD13 ' CD1' ' A' ' 277' ' ' ILE . 4.5 mp -125.62 118.65 26.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 61.23 110.892 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.9 -168.93 13.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.716 -0.754 . . . . 74.21 112.488 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.5 HD22 HG21 ' A' ' 260' ' ' THR . 4.8 p30 -87.73 135.06 33.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.875 0.369 . . . . 74.15 110.842 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.788 HG23 ' HG3' ' A' ' 280' ' ' GLU . 6.8 p -119.0 123.95 72.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 63.3 111.147 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.432 HG23 ' HA ' ' A' ' 281' ' ' TYR . 15.7 m -122.1 129.14 75.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 65.43 111.126 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.1 t -76.74 168.89 19.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 64.02 111.159 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.423 ' HB2' ' H ' ' A' ' 283' ' ' GLY . . . -63.07 -33.9 76.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 74.11 111.064 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.91 -35.89 69.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 70.33 111.066 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.64 ' HB2' ' CD1' ' B' ' 281' ' ' TYR . . . -57.43 99.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 32.3 111.113 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 24.8 tp -179.32 -48.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 75.44 110.911 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -52.14 151.69 3.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 73.13 110.863 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 91.72 -19.42 48.35 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.752 -0.737 . . . . 64.15 112.481 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 108.4 144.92 11.26 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.77 -0.729 . . . . 55.23 112.562 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 17.6 pt -51.75 131.6 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.864 0.364 . . . . 75.33 111.154 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.25 -74.33 0.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 75.44 110.83 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.1 mp 51.83 69.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 64.51 111.141 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.25 -170.14 2.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 52.43 110.846 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 63.4 161.21 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 74.42 110.844 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.6 82.45 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.909 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.612 HG21 ' ND2' ' C' ' 243' ' ' ASN . 27.8 p -98.64 124.86 43.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 62.44 111.122 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 3.9 t -119.99 139.95 51.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 64.01 111.136 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.3 145.51 48.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.2 110.918 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.3 t -142.11 123.51 14.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 42.13 110.853 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.632 HG21 HG22 ' B' ' 267' ' ' VAL . 9.0 p -118.16 139.15 46.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 72.34 111.08 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -83.24 -77.37 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.93 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 23.0 m -122.25 127.9 50.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 64.02 111.133 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.689 HG11 HG11 ' B' ' 275' ' ' VAL . 11.9 t -118.53 124.19 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 75.54 111.095 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.7 128.14 69.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 65.42 111.144 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -136.4 133.23 6.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.761 -0.733 . . . . 41.42 112.546 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -133.43 147.93 51.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.843 0.354 . . . . 74.43 110.891 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.24 90.55 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.714 -0.755 . . . . 71.0 112.498 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 43.73 56.3 4.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 75.15 110.888 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 2.3 t -86.85 145.05 26.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 71.4 110.872 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -132.47 127.5 35.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 74.14 110.861 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.689 HG11 HG11 ' B' ' 267' ' ' VAL . 5.9 t -125.66 130.15 72.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 75.14 111.149 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.684 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.7 OUTLIER -122.17 112.07 17.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 75.12 110.991 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.628 HG22 ' ND2' ' B' ' 226' ' ' ASN . 45.8 mm -111.81 115.18 49.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 61.44 111.181 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 122.87 -174.31 16.33 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.698 -0.763 . . . . 72.3 112.46 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -89.87 141.55 28.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 64.54 110.825 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.642 ' HG3' HG23 ' C' ' 244' ' ' VAL . 10.5 pt-20 -117.49 142.18 47.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 74.43 110.842 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.64 ' CD1' ' HB2' ' B' ' 249' ' ' ALA . 12.8 t80 -126.6 126.05 42.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 73.33 110.871 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 158.75 -55.74 0.36 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.782 -0.723 . . . . 71.41 112.504 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 83.93 -60.44 4.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.751 -0.738 . . . . 74.44 112.495 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -51.81 108.7 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.851 0.358 . . . . 72.44 110.903 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.08 95.38 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 31.12 112.503 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -51.72 132.6 31.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.808 0.337 . . . . 61.4 110.918 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 72.36 -69.03 0.2 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.876 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -138.25 -46.06 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 72.34 110.917 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.24 -173.03 4.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.888 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -110.75 140.07 45.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.463 . . . . 70.22 110.881 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -122.33 151.01 41.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 75.44 110.867 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -102.12 152.77 20.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 61.15 110.892 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.1 169.4 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 75.51 110.85 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.21 151.17 36.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 73.22 110.821 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 13.9 m170 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 73.53 110.825 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.878 0.37 . . . . 50.05 110.893 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.16 142.21 21.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 64.33 110.932 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 44.2 mm -117.38 -47.68 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 44.22 111.11 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 61.48 169.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.04 110.85 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 52.68 82.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 71.0 111.089 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 41.0 pt -144.17 148.64 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 65.52 111.109 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . 0.661 HG13 ' HB2' ' C' ' 227' ' ' SER . 65.8 t 52.98 80.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 62.32 111.112 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -141.57 -41.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.729 -0.748 . . . . 40.42 112.437 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -106.32 -44.79 4.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 64.22 110.871 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.91 124.99 21.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 41.41 110.879 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.661 ' HB2' HG13 ' C' ' 223' ' ' VAL . 3.6 t -131.71 137.88 48.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 71.34 110.861 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.7 150.8 51.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 73.44 111.114 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.84 -30.41 9.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 51.23 110.849 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -165.89 137.95 3.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 65.23 110.848 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 5.4 mt -138.8 117.44 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 73.4 111.162 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.669 ' HD2' HG22 ' C' ' 268' ' ' VAL . 13.0 ptp180 -132.19 121.5 23.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.13 110.888 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.407 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.1 OUTLIER -134.6 144.1 47.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.106 -0.497 . . . . 73.02 111.046 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -146.75 166.74 25.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 71.34 110.89 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.49 67.58 0.77 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 72.2 110.881 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 46.73 56.96 5.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 73.43 110.863 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.407 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -104.66 149.72 25.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 75.44 111.05 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -130.54 135.82 48.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 73.15 110.871 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.464 HG12 ' HB ' ' C' ' 275' ' ' VAL . 2.9 m -127.02 123.19 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 63.14 111.156 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.74 ' HB3' HD22 ' C' ' 276' ' ' LEU . 9.3 tm0? -105.58 129.73 53.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.923 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.709 HD13 ' HB ' ' C' ' 277' ' ' ILE . 3.9 mm? -125.78 118.86 26.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.902 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 121.31 -178.5 16.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.665 -0.778 . . . . 75.34 112.474 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.612 ' ND2' HG21 ' B' ' 260' ' ' THR . 7.7 p30 -85.61 147.08 26.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.909 0.385 . . . . 71.54 110.857 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.642 HG23 ' HG3' ' B' ' 280' ' ' GLU . 2.4 p -126.39 123.98 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 62.14 111.116 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.526 HG12 ' HB3' ' C' ' 281' ' ' TYR . 5.4 m -122.11 129.22 75.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 72.43 111.152 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 44.0 p -69.83 172.08 8.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 72.12 111.123 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.03 -33.82 76.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 74.53 111.093 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.84 -35.84 69.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.418 . . . . 64.34 111.107 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.42 142.09 14.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 70.54 111.126 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.23 -59.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.248 -0.433 . . . . 73.05 110.942 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -168.87 89.48 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 75.54 110.883 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -54.06 -30.26 46.0 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.755 -0.736 . . . . 55.34 112.434 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 172.17 -94.29 0.1 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.738 -0.744 . . . . 72.13 112.45 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . 0.405 HG22 HG22 ' C' ' 256' ' ' ILE . 32.1 mt -77.11 148.97 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.837 0.351 . . . . 71.24 111.07 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -88.35 76.99 8.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 55.41 110.835 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . 0.405 HG22 HG22 ' C' ' 254' ' ' ILE . 4.4 tt -173.44 131.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 72.24 111.081 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 8.4 t -166.95 -169.97 1.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 65.41 110.868 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -117.31 164.97 14.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.896 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -108.12 138.84 43.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 70.41 110.925 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . 0.696 HG21 ' OD1' ' D' ' 243' ' ' ASN . 45.9 p -101.09 138.04 38.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 70.13 111.111 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 75.9 m -120.45 139.27 53.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 70.34 111.106 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.18 132.13 51.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 72.54 110.901 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.56 123.56 28.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 61.1 110.883 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.516 HG21 HG22 ' C' ' 267' ' ' VAL . 7.3 p -125.09 142.82 40.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 70.32 111.197 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -87.21 -74.62 0.43 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.2 -0.455 . . . . 70.52 110.914 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 87.0 m -128.57 129.17 45.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 74.31 111.171 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.516 HG22 HG21 ' C' ' 264' ' ' VAL . 21.4 t -118.67 120.68 64.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 61.21 111.054 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . 0.669 HG22 ' HD2' ' C' ' 232' ' ' ARG . 21.3 t -121.89 126.32 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 73.21 111.076 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.63 133.4 7.85 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.744 -0.741 . . . . 73.12 112.496 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -133.02 148.27 52.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.784 0.326 . . . . 70.24 110.925 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.74 84.73 0.02 OUTLIER Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.68 -0.771 . . . . 64.52 112.499 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 45.39 63.19 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 62.14 110.855 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 27.5 t -91.91 145.23 24.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 74.52 110.853 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -131.66 127.61 37.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 74.41 110.882 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.478 HG13 HG23 ' D' ' 239' ' ' VAL . 15.1 t -126.74 131.11 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 62.41 111.151 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.74 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.7 OUTLIER -122.47 111.62 17.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 55.24 110.841 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.709 ' HB ' HD13 ' C' ' 241' ' ' LEU . 51.7 mm -112.22 107.72 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 75.53 111.169 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.05 172.73 12.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 71.3 112.459 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -89.9 147.42 23.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.352 . . . . 64.15 110.869 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.736 ' CG ' HG22 ' D' ' 244' ' ' VAL . 0.5 OUTLIER -118.13 131.58 56.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 73.21 110.887 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.71 ' CE1' ' HB2' ' D' ' 249' ' ' ALA . 12.5 t80 -121.85 133.8 54.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 72.44 110.935 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 134.94 155.76 7.5 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.763 -0.732 . . . . 54.0 112.436 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . 0.496 ' H ' ' HB2' ' D' ' 247' ' ' ALA . . . -93.75 -15.61 48.78 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.818 -0.706 . . . . 54.22 112.445 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 14.5 mttp -72.42 79.17 1.03 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 74.31 110.898 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 65.52 151.85 0.11 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 64.12 112.488 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -78.91 -32.38 45.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 64.12 110.869 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.455 ' CE2' HD23 ' C' ' 276' ' ' LEU . 6.5 t90 -150.0 35.7 0.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 62.13 110.913 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -179.36 -176.29 0.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 63.21 110.903 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -66.82 -169.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 73.24 110.904 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.17 -74.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.833 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 13.0 t60 53.75 90.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 71.34 110.944 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.81 114.04 0.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 71.2 110.847 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -178.86 41.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.863 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.16 163.78 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 74.34 110.801 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 13.1 m170 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 71.43 110.88 -179.967 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . 0.573 ' CE ' HG23 ' B' ' 219' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.834 0.349 . . . . 71.13 110.882 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -75.09 138.92 42.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 71.12 110.918 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . 0.426 HG22 ' O ' ' C' ' 223' ' ' VAL . 2.5 pp -120.16 -33.65 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 74.35 111.178 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 55.16 90.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 71.45 110.901 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . 0.625 ' O ' HD13 ' D' ' 222' ' ' ILE . . . -59.74 154.41 18.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 44.31 111.137 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . 0.625 HD13 ' O ' ' D' ' 221' ' ' ALA . 29.1 mm -132.4 118.41 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 72.25 111.116 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . 0.414 ' O ' HG23 ' D' ' 223' ' ' VAL . 6.4 m -56.77 109.16 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 62.2 111.091 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 68.26 131.77 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.841 -0.695 . . . . 32.21 112.475 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.534 ' H ' HG23 ' D' ' 261' ' ' THR . 0.1 OUTLIER -173.2 -172.06 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.807 0.337 . . . . 73.24 110.86 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.66 110.66 18.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 55.12 110.907 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 12.7 p -126.06 143.12 51.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 72.45 110.832 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.09 156.89 48.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 63.23 111.17 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.47 -31.21 6.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 74.2 110.895 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.43 138.58 5.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 74.44 110.898 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 9.9 mt -137.66 117.81 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 72.53 111.143 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -132.9 120.49 21.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 74.22 110.826 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.97 139.27 44.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 60.23 111.137 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -144.8 166.45 25.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 74.24 110.895 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 61.17 68.15 0.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 65.0 110.848 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 47.44 55.61 8.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 64.2 110.916 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.07 149.01 25.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 34.43 111.054 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.77 135.98 47.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 74.53 110.898 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.478 HG23 HG13 ' C' ' 275' ' ' VAL . 5.3 m -127.07 121.99 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 65.22 111.129 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . 0.76 ' HB3' HD22 ' D' ' 276' ' ' LEU . 6.7 tm0? -105.94 132.83 51.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 70.21 110.844 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.701 HD13 ' HB ' ' D' ' 277' ' ' ILE . 4.1 mm? -129.94 118.64 21.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 65.4 110.964 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.27 176.59 14.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.737 -0.744 . . . . 53.05 112.508 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . 0.696 ' OD1' HG21 ' C' ' 260' ' ' THR . 1.7 p-10 -85.99 149.56 25.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 71.03 110.894 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . 0.736 HG22 ' CG ' ' C' ' 280' ' ' GLU . 3.4 t -120.54 115.05 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 75.31 111.159 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' C' ' 281' ' ' TYR . 6.1 m -122.16 129.39 75.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 64.53 111.108 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . 0.654 HG23 ' H ' ' D' ' 248' ' ' ALA . 11.5 t -69.16 175.2 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 75.35 111.133 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . 0.496 ' HB2' ' H ' ' C' ' 283' ' ' GLY . . . -52.76 -33.72 49.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 53.33 111.097 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . 0.654 ' H ' HG23 ' D' ' 246' ' ' THR . . . -56.67 -51.94 66.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 42.35 111.062 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . 0.71 ' HB2' ' CE1' ' C' ' 281' ' ' TYR . . . 54.93 -175.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.43 . . . . 72.43 111.123 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.51 -39.01 2.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 62.21 110.936 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.26 163.55 37.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 71.32 110.912 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -154.84 116.75 0.74 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.685 -0.769 . . . . 41.45 112.482 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -171.78 -147.49 5.74 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.779 -0.724 . . . . 52.4 112.51 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.92 114.1 16.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.758 0.313 . . . . 63.31 111.183 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -179.4 -169.73 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 71.34 110.803 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . 0.494 ' HB ' HD12 ' D' ' 222' ' ' ILE . 2.0 pp -136.1 136.73 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 73.22 111.133 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.53 -50.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 72.41 110.876 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.0 107.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 64.13 110.837 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -76.44 -74.5 0.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 71.4 110.913 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . 0.649 HG23 ' HG2' ' E' ' 225' ' ' ARG . 27.8 m -90.13 125.38 35.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 73.15 111.134 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . 0.534 HG23 ' H ' ' D' ' 225' ' ' ARG . 81.2 m -105.49 133.18 50.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.448 . . . . 63.34 111.109 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . 0.42 ' ND2' HG23 ' D' ' 277' ' ' ILE . 0.1 OUTLIER -126.11 137.17 53.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 43.2 110.868 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 10.0 t -142.05 123.74 15.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 70.24 110.889 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.505 HG21 ' CG2' ' D' ' 267' ' ' VAL . 8.1 p -126.06 145.07 34.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 74.42 111.138 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -88.83 -76.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 74.01 110.927 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 48.0 m -127.05 128.1 45.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 72.51 111.117 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.512 ' CG1' HG21 ' D' ' 275' ' ' VAL . 21.7 t -118.02 120.86 65.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 73.45 111.195 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.42 125.88 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.251 -0.431 . . . . 73.2 111.125 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -126.62 133.67 8.18 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.75 -0.738 . . . . 52.35 112.524 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.38 147.82 51.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 71.44 110.878 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.79 86.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 73.02 112.507 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 47.62 69.39 0.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.374 . . . . 51.11 110.899 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 19.3 t -100.19 145.35 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 73.32 110.82 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -135.35 128.02 30.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 74.51 110.855 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.512 HG21 ' CG1' ' D' ' 267' ' ' VAL . 14.2 t -128.87 124.22 60.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 71.33 111.101 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.76 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.8 OUTLIER -114.54 114.37 25.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 73.54 110.917 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.701 ' HB ' HD13 ' D' ' 241' ' ' LEU . 38.1 mm -112.03 104.95 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 72.44 111.095 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.55 -174.54 22.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.738 . . . . 65.13 112.521 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -106.78 148.35 28.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 55.34 110.833 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . 0.463 ' CG ' HG13 ' E' ' 244' ' ' VAL . 0.0 OUTLIER -112.75 133.86 54.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 75.44 110.893 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . 0.444 ' HD1' HG23 ' E' ' 245' ' ' VAL . 21.1 t80 -129.37 125.27 36.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.524 . . . . 74.2 110.95 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.23 -139.92 11.1 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.65 -0.786 . . . . 64.24 112.448 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -118.57 -120.52 2.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.76 -0.733 . . . . 75.13 112.444 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt 56.95 24.25 9.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 70.12 110.931 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 76.07 -68.26 2.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.753 . . . . 73.53 112.478 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -161.26 -75.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 71.35 110.886 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . 0.636 ' CZ2' HD23 ' D' ' 276' ' ' LEU . 6.4 t90 -118.7 34.63 5.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.502 . . . . 73.11 110.848 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 51.98 83.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 72.43 110.838 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.9 -171.86 0.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 71.44 110.815 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -99.61 -170.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 73.32 110.82 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -77.95 -74.59 0.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 73.02 110.816 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.13 -169.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 71.11 110.895 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -144.65 50.95 1.26 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 72.33 110.825 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -149.74 172.94 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 61.54 110.839 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 73.0 110.809 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . 0.461 ' HB3' HG21 ' C' ' 223' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.809 0.337 . . . . 72.12 110.874 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -115.57 177.95 4.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 72.41 110.858 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . 0.563 HD11 ' CG1' ' C' ' 223' ' ' VAL . 3.7 mp -136.18 -66.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 73.23 111.118 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.67 -172.3 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 71.55 110.84 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -134.92 154.43 51.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 63.11 111.064 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 2.2 mp -129.59 146.41 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 64.05 111.159 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 23.3 t -117.32 143.12 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 64.33 111.204 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 152.91 155.36 7.08 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.695 -0.764 . . . . 43.22 112.445 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . 0.649 ' HG2' HG23 ' D' ' 260' ' ' THR . 0.0 OUTLIER 68.95 -75.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.361 . . . . 73.24 110.873 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.45 118.5 13.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 45.42 110.867 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.44 146.31 48.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 43.54 110.801 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -137.57 155.54 49.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 64.22 111.129 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.05 -27.82 10.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 63.14 110.962 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.36 139.03 5.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 65.45 110.911 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . . . . . . . . . 10.5 mt -137.32 117.49 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 45.44 111.13 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -131.92 116.75 17.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 75.2 110.93 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.13 134.29 42.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 74.34 111.172 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.96 160.66 40.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 71.22 110.867 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 65.13 74.9 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 73.14 110.919 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 45.52 52.99 8.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 72.11 110.892 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.48 141.22 36.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.274 -0.421 . . . . 72.24 111.106 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -132.37 137.84 47.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 75.52 110.875 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . . . . . . . . . 18.4 m -134.16 137.78 51.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 64.34 111.156 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . 0.477 ' HB3' HD22 ' E' ' 276' ' ' LEU . 1.8 tm0? -124.14 134.26 53.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 64.12 110.921 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.28 126.68 44.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 62.25 110.896 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 127.43 179.97 16.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 54.43 112.478 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -88.05 161.56 17.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 53.0 110.882 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.463 HG13 ' CG ' ' D' ' 280' ' ' GLU . 98.9 t -132.68 121.98 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 43.35 111.175 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . 0.444 HG23 ' HD1' ' D' ' 281' ' ' TYR . 5.4 m -122.24 128.91 75.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 71.23 111.144 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . 0.416 HG21 ' HA2' ' E' ' 282' ' ' GLY . 14.8 t -69.77 174.02 5.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 74.43 111.167 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.03 78.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 43.34 111.066 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.83 -35.82 69.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 63.01 111.142 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.36 105.43 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 61.42 111.049 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -175.61 110.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 74.44 110.925 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 63.32 103.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 73.45 110.832 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -93.35 -144.03 14.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.732 . . . . 42.34 112.489 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -150.82 -89.52 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.705 -0.759 . . . . 61.44 112.534 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . 0.601 HG23 HD11 ' E' ' 256' ' ' ILE . 2.1 tt -51.81 145.78 2.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.862 0.363 . . . . 74.43 111.08 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.61 120.76 42.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 61.44 110.907 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . 0.601 HD11 HG23 ' E' ' 254' ' ' ILE . 5.3 mp -117.19 -27.06 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 71.21 111.084 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 21.4 m 61.18 -171.44 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 70.44 110.892 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 63.49 105.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 54.21 110.869 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -84.44 171.49 12.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 75.42 110.912 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 30.7 m -101.08 138.07 38.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 60.13 111.127 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . 0.431 HG23 ' H ' ' E' ' 225' ' ' ARG . 0.1 OUTLIER -123.23 132.09 53.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 72.3 111.163 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -126.14 122.9 37.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 65.1 110.851 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 3.4 m -127.48 124.06 37.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 53.41 110.866 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . 0.522 HG21 ' CG2' ' E' ' 267' ' ' VAL . 7.1 p -115.8 125.34 72.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 74.44 111.116 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -61.07 -77.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 72.34 110.888 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.81 135.76 28.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 60.02 111.179 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . 1.001 HG11 HG21 ' E' ' 275' ' ' VAL . 39.8 t -118.35 129.35 74.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 73.4 111.053 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 79.4 t -127.32 124.69 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 73.52 111.109 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.02 132.66 8.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 64.14 112.518 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -133.42 116.96 16.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 74.22 110.944 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 71.8 84.46 0.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.739 . . . . 64.21 112.487 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 56.22 86.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 74.14 110.913 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 11.7 t -119.96 145.56 46.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 74.44 110.844 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -137.03 128.22 27.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 71.21 110.878 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 1.001 HG21 HG11 ' E' ' 267' ' ' VAL . 57.4 t -128.93 132.22 67.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 72.44 111.099 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.477 HD22 ' HB3' ' E' ' 240' ' ' GLN . 2.2 tm? -128.39 111.71 13.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.886 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 24.9 mm -108.74 138.58 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 71.22 111.183 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 110.85 -155.84 15.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 31.03 112.52 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -128.12 149.65 50.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 73.52 110.908 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.91 133.28 54.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 74.04 110.887 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -126.38 125.56 42.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.884 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . 0.416 ' HA2' HG21 ' E' ' 246' ' ' THR . . . 153.88 -151.13 22.89 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 63.03 112.528 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -56.69 -178.34 0.43 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.816 -0.707 . . . . 74.45 112.491 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.26 -19.5 61.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.877 0.37 . . . . 73.22 110.918 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -51.8 103.25 0.1 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.707 -0.759 . . . . 71.42 112.535 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -60.0 -75.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.841 0.353 . . . . 71.23 110.919 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . 0.404 ' NE1' HD23 ' E' ' 276' ' ' LEU . 5.6 t90 -130.32 25.24 5.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 75.42 110.899 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.19 -169.96 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.241 -0.436 . . . . 74.0 110.893 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -58.53 172.97 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 62.21 110.922 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -65.28 -25.98 67.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 73.34 110.844 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.32 175.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 74.54 110.874 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 57.2 t60 62.88 97.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 73.15 110.812 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 -103.55 174.85 5.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 63.12 110.871 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -170.18 176.85 4.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 71.22 110.829 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 4.4 m80 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 74.11 110.873 179.975 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.888 0.375 . . . . 72.52 110.859 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.99 149.43 27.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 75.31 110.958 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 10.7 tp -112.53 -30.79 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 74.34 111.179 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -174.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 74.23 110.87 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.572 ' HB1' HG22 ' A' ' 256' ' ' ILE . . . -130.05 24.94 5.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 65.12 111.096 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 1.2 pt -130.59 107.12 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 65.43 111.131 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.797 HG11 ' HA ' ' A' ' 259' ' ' GLN . 11.1 p -123.96 147.7 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 64.21 111.089 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -124.9 -87.81 0.74 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.736 -0.745 . . . . 33.15 112.431 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 63.28 93.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.318 . . . . 70.12 110.888 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.755 ' OD1' HG22 ' A' ' 277' ' ' ILE . 70.2 m-80 -112.71 130.98 55.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.269 -0.423 . . . . 61.33 110.9 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 2.3 t -121.8 137.66 54.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 51.34 110.841 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.93 129.63 21.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 75.44 111.027 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.3 -36.1 21.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 62.13 110.904 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -165.6 138.59 4.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 64.14 110.914 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.573 HG22 HG22 ' A' ' 267' ' ' VAL . 10.3 pt -138.33 134.49 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.21 111.101 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.635 ' HD3' HG22 ' A' ' 268' ' ' VAL . 9.2 ptm180 -134.34 129.26 35.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 65.41 110.923 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.523 HG21 HG13 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -133.68 148.14 51.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 63.21 111.14 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -150.47 167.45 27.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.453 . . . . 73.43 110.884 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.59 65.48 0.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 74.24 110.906 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 50.3 42.21 25.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 72.15 110.948 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.36 156.82 17.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.13 111.104 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.27 143.71 40.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 50.0 110.896 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.733 HG12 ' HB ' ' A' ' 275' ' ' VAL . 0.3 OUTLIER -124.12 121.16 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.23 111.165 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.629 ' HB3' HD22 ' A' ' 276' ' ' LEU . 4.0 tm0? -117.12 128.34 55.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.462 . . . . 75.32 110.923 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 5.8 mp -124.69 118.2 25.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.907 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.05 165.33 10.4 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 64.14 112.45 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -85.95 135.7 33.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.933 0.397 . . . . 71.54 110.812 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 244' ' ' VAL . 6.4 p -116.12 122.21 69.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 75.34 111.115 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.72 HG12 ' CB ' ' A' ' 281' ' ' TYR . 36.0 m -122.08 128.93 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 52.13 111.21 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.487 HG22 ' HA3' ' A' ' 282' ' ' GLY . 13.6 t -73.13 173.03 9.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 70.23 111.13 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.05 99.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.424 . . . . 34.01 111.149 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.16 -36.0 72.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 61.52 111.045 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.476 ' H ' HG23 ' A' ' 246' ' ' THR . . . -51.71 -42.77 62.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 70.53 111.086 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 58.17 178.34 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.269 -0.423 . . . . 64.22 110.875 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.62 128.26 46.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 71.23 110.851 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 81.65 160.25 25.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 55.23 112.446 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 112.13 40.0 1.21 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.77 -0.728 . . . . 74.15 112.445 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 221' ' ' ALA . 4.6 mp -140.62 -65.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.77 0.319 . . . . 62.14 111.077 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.18 104.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 72.45 110.847 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.572 HG22 ' HB1' ' A' ' 221' ' ' ALA . 16.4 tt -170.18 149.19 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 74.43 111.14 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 9.2 t -104.44 101.31 10.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 62.21 110.891 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -173.01 141.52 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 73.24 110.871 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.797 ' HA ' HG11 ' A' ' 223' ' ' VAL . 0.8 OUTLIER -120.42 83.69 2.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 50.34 110.85 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.5 HG21 ' ND2' ' B' ' 243' ' ' ASN . 5.5 t -75.16 121.98 22.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 73.21 111.093 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.429 HG23 ' HB2' ' B' ' 225' ' ' ARG . 2.6 t -134.11 120.71 20.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 71.05 111.169 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.51 ' HB3' HD23 ' B' ' 241' ' ' LEU . 1.2 m120 -99.3 132.65 44.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 75.21 110.915 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.9 p -142.25 123.39 14.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 65.33 110.828 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.55 HG21 HG12 ' A' ' 267' ' ' VAL . 8.8 p -119.68 133.85 65.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 63.33 111.118 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -65.29 -69.84 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.12 110.823 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.2 m -131.64 135.78 47.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 72.45 111.186 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.573 HG22 HG22 ' A' ' 231' ' ' ILE . 15.5 m -127.33 136.04 61.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 72.33 111.17 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.635 HG22 ' HD3' ' A' ' 232' ' ' ARG . 36.6 t -127.19 137.32 58.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 73.13 111.156 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.43 133.61 7.18 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.676 -0.773 . . . . 74.54 112.489 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.63 148.54 52.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.748 0.308 . . . . 73.33 110.906 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.77 84.33 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 55.31 112.445 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 43.52 55.81 4.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 72.35 110.954 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 45.5 t -83.62 144.83 29.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.095 -0.502 . . . . 71.14 110.821 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.02 128.41 49.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 72.12 110.838 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.733 ' HB ' HG12 ' A' ' 239' ' ' VAL . 25.0 t -115.03 126.69 72.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 73.05 111.173 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' A' ' 240' ' ' GLN . 0.2 OUTLIER -128.41 109.85 11.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.457 . . . . 75.41 111.008 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.755 HG22 ' OD1' ' A' ' 226' ' ' ASN . 19.6 mm -112.97 104.49 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 74.21 111.107 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.8 -147.01 17.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.815 -0.707 . . . . 60.52 112.518 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -128.07 155.66 44.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 72.4 110.929 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.772 ' HB3' HG23 ' B' ' 244' ' ' VAL . 1.3 tt0 -122.31 118.94 29.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 63.51 110.926 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.72 ' CB ' HG12 ' A' ' 245' ' ' VAL . 0.5 OUTLIER -109.45 125.89 52.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 74.12 110.866 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.487 ' HA3' HG22 ' A' ' 246' ' ' THR . . . 62.3 176.07 2.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 75.23 112.509 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 120.7 16.12 4.66 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.772 -0.728 . . . . 73.55 112.492 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.1 mttm 59.9 69.41 0.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 74.31 110.891 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.51 174.26 23.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.795 -0.717 . . . . 24.43 112.55 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -60.4 -167.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.823 0.344 . . . . 75.42 110.851 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -40.07 -77.98 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 53.44 110.887 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -176.68 147.32 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 73.31 110.84 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -113.69 -71.54 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 64.34 110.936 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -179.18 -34.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 71.22 110.819 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 63.55 105.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.34 110.85 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.9 -169.83 1.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 71.31 110.785 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -51.87 -30.1 22.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 74.34 110.918 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -168.43 177.76 5.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 74.31 110.886 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 22.0 m80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 74.14 110.843 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 7.7 ttp . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.874 0.369 . . . . 75.14 110.945 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -159.11 146.75 17.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 75.45 110.904 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 12.4 tt -143.95 142.31 24.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.102 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -148.97 138.68 21.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 64.03 110.893 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.43 -173.58 3.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 71.1 111.097 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 1.6 pt -139.42 131.48 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 72.35 111.11 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.482 HG21 ' CG ' ' A' ' 259' ' ' GLN . 10.7 p -160.31 152.12 5.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.189 -0.46 . . . . 64.43 111.069 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -54.4 129.9 44.29 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.731 . . . . 55.24 112.465 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.429 ' HB2' HG23 ' A' ' 261' ' ' THR . 17.4 ptt180 -176.94 174.55 1.72 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.76 0.314 . . . . 64.3 110.907 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -125.68 128.06 47.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 72.34 110.857 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.86 141.57 51.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 65.2 110.858 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.503 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -138.17 128.12 25.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 61.21 111.149 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -40.11 39.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 72.15 110.871 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -166.51 138.1 3.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 71.15 110.854 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.565 HG12 HG12 ' A' ' 267' ' ' VAL . 5.3 pt -138.71 133.13 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 72.02 111.144 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -135.35 128.55 31.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 75.35 110.944 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.513 HG21 HG13 ' B' ' 239' ' ' VAL . 0.3 OUTLIER -135.55 137.31 41.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 71.54 111.155 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 13.1 pm0 -141.59 166.65 24.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 62.43 110.903 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 65.96 67.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 75.23 110.79 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 18.9 mtt180 48.65 49.93 17.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 63.12 110.886 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.49 156.72 17.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 73.52 111.114 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 9.5 mtt-85 -134.29 142.9 47.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 73.01 110.872 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.59 HG12 ' HB ' ' B' ' 275' ' ' VAL . 0.0 OUTLIER -124.21 124.76 69.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.485 . . . . 71.52 111.092 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.595 ' HB3' HD22 ' B' ' 276' ' ' LEU . 0.0 OUTLIER -117.49 128.32 54.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 71.55 110.902 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 262' ' ' ASN . 0.2 OUTLIER -119.87 118.62 31.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 75.45 110.933 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.13 -177.91 16.48 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.748 . . . . 64.32 112.482 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.5 ' ND2' HG21 ' A' ' 260' ' ' THR . 9.2 p30 -85.98 148.95 25.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 53.55 110.937 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.772 HG23 ' HB3' ' A' ' 280' ' ' GLU . 6.7 p -131.08 127.87 61.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 70.33 111.1 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.72 HG12 ' CB ' ' B' ' 281' ' ' TYR . 30.8 m -121.93 129.05 75.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 70.13 111.11 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 20.9 p -80.28 175.0 11.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 54.21 111.129 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.01 -45.29 93.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 71.02 111.082 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.55 -36.02 77.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 44.32 111.126 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.641 ' HB2' ' HA3' ' B' ' 282' ' ' GLY . . . -68.05 102.74 1.36 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 73.25 111.127 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 3.5 tt -164.19 -45.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 75.32 110.935 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -61.2 153.5 25.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.192 -0.458 . . . . 45.14 110.843 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . 0.453 ' HA2' HD11 ' C' ' 250' ' ' LEU . . . 161.33 -107.17 0.3 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.774 -0.727 . . . . 74.4 112.524 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 175.13 -123.71 0.95 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.788 -0.72 . . . . 51.41 112.509 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.81 -35.26 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.857 0.36 . . . . 73.1 111.092 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 54.74 90.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 73.42 110.829 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 5.5 tt -153.61 141.27 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 44.2 111.128 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 27.1 t -151.32 161.23 43.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 71.22 110.896 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -56.23 175.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 72.32 110.823 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -90.18 75.09 7.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 75.42 110.875 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 7.3 t -74.17 130.89 40.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 75.32 111.167 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 90.6 m -133.04 108.89 9.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 70.12 111.115 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.542 ' OD1' HD12 ' C' ' 241' ' ' LEU . 0.9 OUTLIER -88.82 136.12 33.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 73.24 110.878 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 19.5 t -142.51 123.15 14.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 73.34 110.859 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.764 HG23 ' HB3' ' C' ' 228' ' ' ALA . 4.0 p -119.34 140.09 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 62.33 111.116 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -78.1 -73.87 0.29 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 65.42 110.869 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.9 m -131.5 127.68 37.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 53.45 111.138 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.583 ' CG1' HG21 ' B' ' 264' ' ' VAL . 19.4 m -122.61 135.33 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 72.04 111.181 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 57.8 t -127.85 133.33 67.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 44.13 111.147 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.82 133.25 7.54 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.757 . . . . 75.01 112.464 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -132.4 148.56 52.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.796 0.332 . . . . 44.25 110.937 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.42 91.65 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.749 . . . . 71.01 112.484 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 40.44 51.14 2.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 64.11 110.866 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.05 144.55 29.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 63.31 110.88 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.47 128.19 45.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 63.23 110.907 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.59 ' HB ' HG12 ' B' ' 239' ' ' VAL . 26.2 t -118.79 124.61 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 74.42 111.105 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.595 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.4 OUTLIER -126.52 111.49 14.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 71.24 110.917 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.529 HG23 ' ND2' ' B' ' 262' ' ' ASN . 35.6 mm -110.98 104.85 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 74.43 111.095 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.91 -142.81 10.68 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.711 -0.757 . . . . 21.24 112.431 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -123.26 147.37 47.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 65.04 110.809 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.742 ' HB2' HG23 ' C' ' 244' ' ' VAL . 3.9 mm-40 -111.99 129.77 56.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 70.41 110.895 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.72 ' CB ' HG12 ' B' ' 245' ' ' VAL . 0.1 OUTLIER -123.11 130.36 52.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 70.4 110.92 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.641 ' HA3' ' HB2' ' B' ' 249' ' ' ALA . . . 81.95 159.25 24.32 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.765 -0.731 . . . . 64.41 112.499 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 126.1 -87.89 0.35 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.818 -0.706 . . . . 72.54 112.539 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.47 -51.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 62.4 110.858 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -130.2 -89.23 0.52 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.744 -0.741 . . . . 62.34 112.488 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.59 ' HA ' HG21 ' C' ' 244' ' ' VAL . 10.9 p90 -122.19 -34.03 3.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 55.45 110.864 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.68 -169.47 3.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.113 -0.494 . . . . 73.44 110.939 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.38 114.11 9.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.296 -0.411 . . . . 75.42 110.906 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -156.03 -49.37 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.208 -0.451 . . . . 65.42 110.87 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.34 -170.26 2.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 73.45 110.838 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.08 131.04 40.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 75.32 110.888 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -177.81 162.77 1.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 65.21 110.906 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -174.99 -178.22 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.52 110.837 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.77 -170.61 2.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 73.11 110.892 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.0 110.834 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 11.5 ttt . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.877 0.37 . . . . 73.13 110.856 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 6.2 ptpt -178.79 79.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 55.41 110.829 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 1.2 pp -146.76 133.61 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 63.2 111.128 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -176.15 44.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 63.45 110.895 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -173.04 127.39 0.46 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 30.33 111.094 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 30.9 mm -118.04 69.82 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 72.43 111.043 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 20.3 m -141.43 174.12 7.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 73.04 111.166 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 142.55 -142.63 11.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.736 -0.745 . . . . 70.03 112.466 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 14.4 mmt-85 -103.38 -17.65 15.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.811 0.339 . . . . 72.21 110.848 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -141.98 112.75 7.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 75.11 110.892 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 4.5 t -123.17 137.73 54.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 62.43 110.826 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.764 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -133.06 119.65 20.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 33.32 111.094 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -43.51 74.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 60.53 110.873 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -167.24 136.71 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.247 -0.433 . . . . 72.34 110.887 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.599 HG22 ' CG2' ' C' ' 267' ' ' VAL . 3.8 pt -138.13 131.79 41.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 61.51 111.129 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.09 128.37 30.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 74.12 110.891 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.681 HG21 HG13 ' C' ' 239' ' ' VAL . 1.4 p -135.46 144.97 46.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 50.53 111.138 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.88 166.73 25.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 74.21 110.907 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 66.96 68.27 0.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 74.22 110.864 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 46.66 53.92 9.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 72.21 110.871 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.23 156.89 17.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.051 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -132.23 141.3 48.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.34 110.885 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.69 HG12 ' HB ' ' C' ' 275' ' ' VAL . 0.0 OUTLIER -126.06 121.01 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.41 111.132 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.78 117.27 30.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 74.3 110.905 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.542 HD12 ' OD1' ' B' ' 262' ' ' ASN . 0.2 OUTLIER -111.82 118.94 36.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 62.53 110.943 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 122.75 -177.43 16.52 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.76 . . . . 63.31 112.481 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -85.95 131.94 34.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 42.43 110.834 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.742 HG23 ' HB2' ' B' ' 280' ' ' GLU . 3.1 p -116.34 122.52 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 62.32 111.068 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.763 HG12 ' HB2' ' C' ' 281' ' ' TYR . 28.7 m -122.88 129.27 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 65.53 111.148 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . 0.433 HG23 ' O ' ' C' ' 281' ' ' TYR . 59.3 p -69.8 175.2 4.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 75.4 111.093 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.542 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -58.12 -46.1 86.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 73.45 111.078 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -67.96 -36.74 80.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 72.21 111.114 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -53.34 150.68 6.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 73.45 111.162 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . 0.453 HD11 ' HA2' ' B' ' 252' ' ' GLY . 0.0 OUTLIER -158.66 118.75 3.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 65.34 110.849 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -52.2 -58.16 7.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 65.52 110.855 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 100.4 -87.71 0.72 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.678 -0.773 . . . . 70.13 112.493 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . 0.421 ' C ' HD12 ' C' ' 254' ' ' ILE . . . -148.7 111.37 0.53 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 71.34 112.552 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . 0.421 HD12 ' C ' ' C' ' 253' ' ' GLY . 5.4 mp -142.7 138.24 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.848 0.356 . . . . 74.0 111.095 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -170.43 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 74.25 110.785 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 2.6 mp -121.67 106.63 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 61.44 111.129 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 4.8 p -179.26 79.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 52.12 110.836 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 61.15 98.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 75.45 110.883 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.98 -171.49 2.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 74.31 110.951 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 7.6 t -64.97 124.56 22.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 75.13 111.128 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.546 HG22 ' HG2' ' D' ' 225' ' ' ARG . 6.5 t -134.16 141.4 47.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 64.11 111.118 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . 0.5 ' OD1' HG23 ' C' ' 277' ' ' ILE . 2.9 t-20 -113.88 143.04 45.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 73.43 110.86 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 8.5 t -140.16 123.94 17.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 75.31 110.903 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.591 HG23 HD11 ' D' ' 231' ' ' ILE . 8.7 p -120.81 135.78 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 73.32 111.102 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.72 -75.58 0.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 75.14 110.894 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 2.2 m -127.19 127.76 45.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 73.4 111.162 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.854 HG11 HG11 ' C' ' 275' ' ' VAL . 0.0 OUTLIER -118.78 128.28 75.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 63.11 111.151 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 41.7 t -127.92 115.93 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 75.51 111.144 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.67 133.98 11.04 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.794 -0.717 . . . . 64.22 112.472 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -132.08 148.2 52.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.897 0.38 . . . . 73.54 110.888 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 53.55 90.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.683 -0.77 . . . . 60.04 112.513 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 40.87 51.41 3.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.878 0.37 . . . . 74.54 110.859 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 39.1 t -84.87 144.98 28.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.04 110.843 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -127.74 127.85 44.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 71.5 110.884 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.854 HG11 HG11 ' C' ' 267' ' ' VAL . 23.4 t -122.89 123.63 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 64.24 111.129 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.93 114.35 19.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 60.11 110.949 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.5 HG23 ' OD1' ' C' ' 262' ' ' ASN . 31.5 mm -112.57 104.56 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 74.5 111.133 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.04 -164.05 27.61 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.676 -0.774 . . . . 41.35 112.483 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -89.84 155.99 18.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 50.53 110.87 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.466 ' HB3' HG23 ' D' ' 244' ' ' VAL . 5.2 tp10 -129.84 134.87 47.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 63.44 110.911 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.763 ' HB2' HG12 ' C' ' 245' ' ' VAL . 0.1 OUTLIER -130.15 125.38 34.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 73.33 110.967 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' D' ' 247' ' ' ALA . . . -122.54 -166.86 12.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.727 -0.749 . . . . 74.3 112.487 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' D' ' 247' ' ' ALA . . . -101.27 -23.37 9.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 73.12 112.525 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -172.34 32.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 70.15 110.866 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -173.82 -174.01 40.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.796 -0.716 . . . . 74.03 112.531 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -100.84 -173.54 2.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.804 0.335 . . . . 74.14 110.948 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -56.54 100.22 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.253 -0.431 . . . . 73.15 110.906 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -169.4 142.01 2.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 74.0 110.847 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -172.04 32.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 55.21 110.926 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -175.07 124.56 0.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 72.45 110.776 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.22 168.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 74.12 110.837 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -169.67 177.47 4.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 72.11 110.863 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.33 -173.91 4.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 73.41 110.849 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -171.89 63.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 72.33 110.849 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 53.12 110.839 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 1.5 ptp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.854 0.359 . . . . 74.43 110.934 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.1 48.53 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 74.05 110.871 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 31.6 mm -118.86 144.79 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 75.53 111.113 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -174.51 63.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 75.11 110.927 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.61 144.07 0.37 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 64.04 111.115 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . 0.661 HD13 ' H ' ' E' ' 220' ' ' ASP . 10.3 tt -166.99 146.1 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 73.23 111.119 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 19.7 m -145.69 -173.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 51.42 111.151 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -66.1 -110.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.785 -0.722 . . . . 63.22 112.433 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.546 ' HG2' HG22 ' C' ' 261' ' ' THR . 0.0 OUTLIER 51.55 -166.46 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 64.21 110.928 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -81.43 109.43 15.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 74.55 110.902 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.01 149.62 51.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.816 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . 0.511 ' HB2' HD11 ' D' ' 241' ' ' LEU . . . -133.02 160.93 35.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 73.23 111.08 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.42 -37.05 5.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.907 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . 0.407 ' O ' HG23 ' D' ' 267' ' ' VAL . 39.9 t0 -164.6 139.08 5.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.211 -0.45 . . . . 71.23 110.949 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . 0.591 HD11 HG23 ' C' ' 264' ' ' VAL . 0.8 OUTLIER -136.66 117.51 17.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.435 . . . . 73.41 111.155 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -130.38 115.59 17.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 70.14 110.865 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . 0.586 HG21 ' CG1' ' D' ' 239' ' ' VAL . 2.7 p -135.65 147.42 48.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 74.34 111.151 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.74 167.52 24.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 72.2 110.866 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 68.34 67.57 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 73.41 110.855 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 46.46 60.35 3.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 72.33 110.824 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.18 155.78 18.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 62.31 111.12 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -133.35 135.94 45.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.884 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.586 ' CG1' HG21 ' D' ' 233' ' ' THR . 10.2 m -131.48 121.85 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 64.32 111.153 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . 0.448 ' HB3' HD22 ' D' ' 276' ' ' LEU . 7.3 tm0? -118.06 120.37 37.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.33 110.949 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' D' ' 228' ' ' ALA . 0.7 OUTLIER -111.37 119.8 40.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 74.21 110.948 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.99 -175.5 19.11 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.723 -0.751 . . . . 71.35 112.498 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -96.29 128.45 43.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 75.42 110.867 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . 0.466 HG23 ' HB3' ' C' ' 280' ' ' GLU . 3.7 p -111.28 115.81 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 73.33 111.121 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . 0.802 HG12 ' HB2' ' D' ' 281' ' ' TYR . 19.0 m -122.75 124.78 71.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 63.42 111.118 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 6.4 t -70.58 175.23 5.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.181 -0.463 . . . . 53.31 111.197 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . 0.431 ' HB2' ' HA2' ' C' ' 283' ' ' GLY . . . -61.56 -46.38 90.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 63.23 111.14 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.71 -35.96 69.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 61.34 111.109 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.62 163.65 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 74.31 111.103 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . 0.647 HD13 HD21 ' E' ' 250' ' ' LEU . 0.1 OUTLIER -136.73 -47.86 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 63.13 110.921 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 62.81 171.06 0.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 73.52 110.88 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -73.69 -158.31 5.18 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.741 -0.742 . . . . 53.21 112.438 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -108.44 19.07 32.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.731 -0.747 . . . . 54.54 112.462 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 72.9 mt 57.92 95.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 61.03 111.069 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -104.94 176.71 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 75.15 110.864 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . 0.407 HG23 ' O ' ' D' ' 256' ' ' ILE . 6.5 tt -107.77 122.93 62.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 64.4 111.104 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.42 -50.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 51.22 110.86 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -179.01 -50.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 75.44 110.881 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 63.41 160.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 72.05 110.934 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . 0.475 HG21 ' ND2' ' D' ' 279' ' ' ASN . 8.4 t -66.53 133.48 50.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 75.12 111.151 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.05 141.4 47.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 73.53 111.22 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -122.27 144.54 48.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 72.23 110.889 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.22 123.68 14.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 55.32 110.902 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.413 HG21 HG22 ' D' ' 267' ' ' VAL . 14.4 p -120.54 131.53 72.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 75.54 111.101 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.2 -76.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 42.23 110.925 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 3.8 m -128.09 132.05 49.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 74.52 111.165 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 1.069 HG11 HG11 ' D' ' 275' ' ' VAL . 0.2 OUTLIER -117.59 123.63 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 75.3 111.12 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 23.6 t -122.15 115.88 47.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 55.05 111.187 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.05 133.63 10.75 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.767 -0.73 . . . . 61.44 112.529 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -132.11 148.01 52.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.813 0.34 . . . . 62.02 110.878 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.29 76.38 0.17 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.748 . . . . 73.0 112.478 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 48.44 71.68 0.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.362 . . . . 72.23 110.93 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 20.5 t -102.27 145.41 29.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 63.11 110.893 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -123.03 128.33 50.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 73.52 110.814 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 1.069 HG11 HG11 ' D' ' 267' ' ' VAL . 18.8 t -129.47 123.43 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 74.13 111.103 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.732 HD23 ' O ' ' D' ' 275' ' ' VAL . 15.5 mt -127.85 116.8 20.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 55.03 110.871 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.649 ' CD1' HD13 ' E' ' 241' ' ' LEU . 34.2 mm -112.18 104.68 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 73.21 111.188 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.84 -159.25 28.2 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.783 -0.722 . . . . 52.33 112.48 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . 0.475 ' ND2' HG21 ' D' ' 260' ' ' THR . 15.5 m120 -96.61 156.1 16.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 72.41 110.892 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . 0.587 ' HB3' HG23 ' E' ' 244' ' ' VAL . 12.0 tp10 -129.18 118.99 23.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 74.2 110.806 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . 0.802 ' HB2' HG12 ' D' ' 245' ' ' VAL . 0.2 OUTLIER -120.75 124.17 44.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 64.22 110.905 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.81 -76.55 2.22 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 44.42 112.421 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 51.98 -156.11 4.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.749 -0.739 . . . . 32.5 112.516 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -179.42 -34.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.848 0.356 . . . . 63.53 110.964 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -84.27 -126.0 1.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.762 -0.732 . . . . 64.32 112.459 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -22.4 50.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 74.22 110.91 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . 0.414 ' CD2' HD12 ' D' ' 276' ' ' LEU . 0.1 OUTLIER -105.34 103.31 12.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 74.45 110.933 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 3.8 t0 64.18 157.52 0.08 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.284 -0.417 . . . . 75.14 110.871 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -150.18 -171.55 3.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.442 . . . . 74.31 110.886 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.48 -172.66 3.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 74.21 110.872 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -52.41 -59.11 4.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 70.22 110.854 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -161.89 150.11 15.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 74.42 110.88 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -177.42 108.39 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 64.34 110.877 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -162.41 -178.9 6.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 73.31 110.842 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 62.2 110.81 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.861 0.362 . . . . 63.31 110.88 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.03 137.54 39.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 71.34 110.887 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 11.7 tt -176.23 143.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 74.42 111.131 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . 0.661 ' H ' HD13 ' D' ' 222' ' ' ILE . 1.7 p-10 -178.19 81.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 70.12 110.856 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -175.58 118.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 63.42 111.121 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 51.2 mt -145.05 82.99 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 72.11 111.134 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 12.1 p -173.97 148.02 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 70.11 111.114 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 157.28 179.56 32.29 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.714 -0.755 . . . . 43.13 112.481 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 29.5 mtt-85 -52.02 -74.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.833 0.349 . . . . 64.4 110.908 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.03 109.92 22.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 64.44 110.942 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.89 137.84 54.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.482 . . . . 44.4 110.886 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . 0.753 ' HB2' HD21 ' E' ' 241' ' ' LEU . . . -132.13 128.14 37.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.32 111.133 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.52 -30.43 25.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 70.43 110.918 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . 0.533 ' CB ' HG22 ' E' ' 266' ' ' THR . 0.6 OUTLIER -165.0 138.16 4.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 75.52 110.813 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . 0.705 HG23 ' CG2' ' E' ' 267' ' ' VAL . 8.4 mt -137.98 116.71 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 71.23 111.116 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -134.76 115.68 14.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 74.32 110.836 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . 0.483 ' OG1' ' HB3' ' E' ' 237' ' ' ALA . 1.3 p -135.88 145.11 46.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 52.11 111.124 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -143.99 167.72 21.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.147 -0.479 . . . . 74.32 110.886 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 68.07 68.2 0.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 74.2 110.821 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 46.86 61.69 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 71.52 110.937 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . 0.483 ' HB3' ' OG1' ' E' ' 233' ' ' THR . . . -104.88 156.05 18.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 74.1 111.025 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -136.35 136.25 39.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 72.42 110.868 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.506 HG12 ' HB ' ' E' ' 275' ' ' VAL . 13.4 m -135.72 138.65 47.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 42.02 111.149 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -136.98 129.52 30.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 65.23 110.904 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.753 HD21 ' HB2' ' E' ' 228' ' ' ALA . 5.6 mp -114.48 118.71 34.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 74.24 110.839 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.92 179.71 16.21 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.733 -0.746 . . . . 74.25 112.473 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -93.07 143.2 26.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 72.11 110.85 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' D' ' 280' ' ' GLU . 5.5 p -118.59 122.36 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 74.44 111.099 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 5.7 m -122.35 122.09 65.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 75.22 111.138 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.0 t -70.09 173.78 6.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.106 -0.497 . . . . 71.15 111.139 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.0 92.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 52.45 111.174 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.19 72.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 74.44 111.078 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . -77.87 59.65 2.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 55.24 111.025 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . 0.647 HD21 HD13 ' D' ' 250' ' ' LEU . 0.1 OUTLIER -76.64 154.44 34.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 74.32 110.921 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -65.6 118.95 10.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 73.14 110.841 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -79.91 59.76 4.46 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 72.33 112.541 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 148.88 -104.74 0.29 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.793 -0.718 . . . . 72.2 112.533 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 53.1 mt -145.32 -42.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 73.25 111.155 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.15 147.57 51.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 64.32 110.904 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 65.2 mt -147.21 -68.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 62.01 111.118 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 2.0 m 61.71 -179.61 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 74.2 110.853 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -143.93 -175.63 4.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.151 -0.477 . . . . 71.11 110.851 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.4 27.38 2.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 64.31 110.898 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . 0.542 HG21 ' OD1' ' E' ' 279' ' ' ASN . 9.3 t -101.06 137.41 39.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 74.51 111.18 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 94.3 m -130.79 121.62 25.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 31.43 111.12 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . 0.42 ' CB ' HG22 ' E' ' 277' ' ' ILE . 3.7 m120 -108.63 124.4 50.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 72.11 110.907 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 3.8 m -125.83 123.72 39.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 43.34 110.909 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . 0.624 HG21 HG13 ' E' ' 267' ' ' VAL . 12.9 p -123.21 131.73 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 73.13 111.142 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.67 -77.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 72.24 110.913 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . 0.533 HG22 ' CB ' ' E' ' 230' ' ' ASP . 75.4 p -133.52 131.19 39.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 64.44 111.131 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . 0.705 ' CG2' HG23 ' E' ' 231' ' ' ILE . 4.9 m -118.34 120.95 65.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 71.02 111.135 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.63 120.04 63.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 71.13 111.13 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.51 133.76 11.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.776 -0.726 . . . . 75.44 112.477 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -131.87 148.13 52.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 52.44 110.895 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.48 78.74 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.735 -0.745 . . . . 55.0 112.457 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 47.51 68.38 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.372 . . . . 54.33 110.848 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 40.4 t -99.69 145.41 27.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 71.22 110.872 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.96 128.54 43.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 74.14 110.836 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.506 ' HB ' HG12 ' E' ' 239' ' ' VAL . 30.1 t -129.96 123.43 56.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 65.53 111.115 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.553 HD12 ' CD2' ' E' ' 287' ' ' TRP . 54.8 mt -126.01 111.87 15.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 64.21 110.904 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.42 HG22 ' CB ' ' E' ' 262' ' ' ASN . 27.1 mm -104.21 106.35 20.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 65.52 111.131 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.85 -171.8 29.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.753 -0.737 . . . . 71.43 112.463 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . 0.542 ' OD1' HG21 ' E' ' 260' ' ' THR . 4.1 m120 -89.87 154.94 19.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 74.31 110.907 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -127.15 120.58 29.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 64.01 110.902 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.27 125.77 45.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 70.4 110.876 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 126.21 -132.91 7.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.74 -0.743 . . . . 44.51 112.501 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -145.17 157.3 27.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.798 -0.715 . . . . 75.03 112.499 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -175.96 -45.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 70.14 110.874 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 126.52 -74.17 0.43 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.725 -0.75 . . . . 42.23 112.448 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -25.13 50.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 74.2 110.921 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . 0.553 ' CD2' HD12 ' E' ' 276' ' ' LEU . 44.3 m95 -113.46 26.48 10.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.086 -0.506 . . . . 71.21 110.936 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -176.96 -169.82 0.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 74.03 110.917 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -51.88 150.26 4.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 72.45 110.887 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -62.22 -169.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 75.42 110.856 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 63.37 87.25 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 73.33 110.878 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -177.84 151.51 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 73.4 110.861 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -57.77 125.56 23.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 70.25 110.852 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -165.46 -74.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 73.43 110.868 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 79.2 t60 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 74.44 110.847 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 3.6 ppp? . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.83 0.348 . . . . 72.13 110.915 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -175.24 -65.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 72.35 110.913 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 51.4 mt -137.65 147.41 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 64.51 111.122 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -134.64 -169.88 2.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.21 -0.45 . . . . 75.34 110.936 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . 63.75 96.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 62.53 111.035 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 1.3 tt -96.34 -25.14 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 65.45 111.155 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 21.7 t 63.71 101.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 73.13 111.103 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 98.66 55.47 1.08 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.71 -0.757 . . . . 60.32 112.505 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -126.07 170.27 11.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.354 . . . . 71.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.451 ' HB3' HG22 ' A' ' 277' ' ' ILE . 69.4 m-80 -107.28 132.79 52.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.884 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 46.8 m -140.51 148.06 40.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 75.45 110.932 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.11 119.35 10.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 31.1 111.06 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -36.68 78.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 70.44 110.89 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -165.29 137.76 4.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 70.45 110.909 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.597 HG22 ' CG2' ' A' ' 267' ' ' VAL . 6.3 pt -138.5 116.9 13.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 61.23 111.14 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -126.33 129.75 49.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 75.34 110.838 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.632 HG21 ' CG1' ' A' ' 239' ' ' VAL . 5.4 p -136.05 148.97 48.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 73.0 111.169 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.99 168.41 21.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.272 -0.422 . . . . 55.52 110.894 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 69.69 60.41 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.87 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 48.31 58.93 4.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 65.13 110.883 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.09 156.53 17.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 70.01 111.078 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.55 147.67 49.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 75.32 110.865 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.665 HG12 ' HB ' ' A' ' 275' ' ' VAL . 18.7 m -140.68 121.69 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 61.01 111.099 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -125.1 125.1 43.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 74.33 110.914 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.822 HD23 HD13 ' A' ' 277' ' ' ILE . 0.1 OUTLIER -119.77 117.98 29.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 62.44 110.906 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 161.58 162.7 13.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 52.21 112.485 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -85.74 140.66 30.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.875 0.369 . . . . 72.55 110.883 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 97.9 t -114.25 118.56 58.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.48 . . . . 63.42 111.161 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.538 ' CG1' ' HB3' ' A' ' 249' ' ' ALA . 62.0 t -119.61 129.07 75.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 72.4 111.121 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.454 HG23 ' H ' ' A' ' 249' ' ' ALA . 12.9 t -69.85 166.7 18.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 74.2 111.162 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.96 83.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 73.32 111.132 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.0 -44.98 83.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 62.25 111.085 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.564 ' HA ' HD21 ' B' ' 250' ' ' LEU . . . -72.31 111.77 7.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 71.33 111.108 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 24.2 tp -177.23 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.11 110.889 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -26.21 47.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 71.14 110.819 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -52.92 -81.7 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.77 -0.729 . . . . 72.53 112.496 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 165.52 -153.89 24.23 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.661 -0.78 . . . . 72.44 112.425 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.45 -34.84 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.864 0.364 . . . . 73.2 111.173 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.76 114.18 2.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 65.33 110.841 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 4.9 mt -130.86 144.03 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 72.52 111.153 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.02 148.82 20.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 71.12 110.913 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 18.5 t0 61.61 61.95 1.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 62.31 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.01 -176.0 2.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 64.35 110.889 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.7 m -92.02 124.51 36.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 62.25 111.125 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 4.5 t -108.49 120.72 43.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 63.5 111.101 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -102.68 119.79 39.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 71.03 110.903 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.6 t -132.05 123.79 27.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 70.33 110.891 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.86 HG23 ' HB3' ' B' ' 228' ' ' ALA . 4.2 p -116.9 141.38 35.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.143 -0.481 . . . . 75.42 111.082 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.51 -74.8 0.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 64.34 110.869 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.5 m -124.11 136.53 54.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 62.44 111.143 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.597 ' CG2' HG22 ' A' ' 231' ' ' ILE . 3.5 t -120.84 132.57 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 74.11 111.195 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.23 119.87 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 70.23 111.111 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.11 133.66 11.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.717 -0.754 . . . . 73.43 112.52 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -132.36 148.22 52.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 71.51 110.843 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 53.22 74.24 0.32 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.742 . . . . 63.51 112.489 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 47.57 59.52 4.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.898 0.38 . . . . 73.5 110.945 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.61 145.81 28.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 63.55 110.782 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 57.9 mtt85 -118.03 128.31 54.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 72.55 110.902 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.665 ' HB ' HG12 ' A' ' 239' ' ' VAL . 13.6 t -117.4 123.61 71.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 75.25 111.215 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.605 ' O ' HD12 ' B' ' 241' ' ' LEU . 0.8 OUTLIER -124.87 112.63 16.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 74.42 110.991 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.822 HD13 HD23 ' A' ' 241' ' ' LEU . 3.6 mp -112.11 104.4 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 63.54 111.068 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.23 166.18 14.68 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.718 -0.753 . . . . 63.02 112.489 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -100.1 156.21 17.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.817 0.341 . . . . 75.24 110.889 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -115.71 119.75 37.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.898 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.52 125.97 51.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 62.11 110.933 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 69.37 142.56 0.14 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.775 -0.726 . . . . 44.3 112.471 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 129.36 -28.94 3.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.735 -0.745 . . . . 71.31 112.465 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 62.91 56.95 1.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 73.33 110.954 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.525 ' O ' HG11 ' B' ' 244' ' ' VAL . . . -154.07 -119.58 0.73 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.765 -0.731 . . . . 41.31 112.499 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -176.24 -38.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 74.11 110.844 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.426 ' CE2' HD12 ' A' ' 276' ' ' LEU . 2.9 t-105 -127.49 -39.72 1.83 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 72.44 110.954 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 22.4 t0 62.52 94.32 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 73.32 110.924 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -158.64 60.36 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 44.45 110.888 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 63.18 67.79 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 74.23 110.851 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -123.02 162.55 22.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 54.33 110.823 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -173.25 -170.37 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 71.43 110.798 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.21 179.73 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 73.4 110.81 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -141.17 98.23 3.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 75.42 110.824 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 74.31 110.861 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.754 0.311 . . . . 74.05 110.852 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.46 -177.15 3.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 74.42 110.9 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 2.9 mp -124.56 134.03 67.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 72.34 111.155 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -110.37 -173.71 2.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 60.24 110.89 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 62.3 95.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 50.12 111.09 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 10.7 tp -107.95 143.22 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 60.23 111.141 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.27 144.32 8.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 64.52 111.087 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 59.5 96.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.768 -0.73 . . . . 64.32 112.481 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -159.04 127.81 5.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.798 0.332 . . . . 74.23 110.941 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.446 ' HB3' HG22 ' B' ' 277' ' ' ILE . 22.9 m120 -83.99 130.88 34.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 73.44 110.909 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.0 m -140.39 146.02 37.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 73.13 110.853 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.86 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -141.45 119.93 12.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 35.43 111.074 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -32.2 69.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 72.13 110.918 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -166.69 137.41 3.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.275 -0.42 . . . . 62.31 110.912 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.76 ' CD1' HG21 ' A' ' 264' ' ' VAL . 12.8 pt -138.54 117.61 13.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 64.13 111.149 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -131.07 129.18 41.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.846 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.615 HG21 ' CG1' ' B' ' 239' ' ' VAL . 2.3 p -135.59 148.77 49.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 63.14 111.116 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 15.6 pm0 -144.46 168.29 20.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 72.35 110.898 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 69.6 64.85 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 54.35 110.856 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.33 48.38 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 74.11 110.888 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.69 156.63 16.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 73.41 111.126 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.9 154.91 51.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 71.54 110.897 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.615 ' CG1' HG21 ' B' ' 233' ' ' THR . 17.8 m -140.92 138.55 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.22 111.175 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.476 ' HG3' HD13 ' A' ' 276' ' ' LEU . 1.5 tt0 -138.42 123.18 18.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.87 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.605 HD12 ' O ' ' A' ' 276' ' ' LEU . 0.3 OUTLIER -115.65 118.67 33.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 71.32 110.952 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 159.18 161.88 11.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.7 -0.762 . . . . 51.53 112.422 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -86.06 131.12 34.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 64.44 110.935 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.525 HG11 ' O ' ' A' ' 285' ' ' GLY . 85.9 t -96.97 115.05 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 32.34 111.146 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.579 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 91.2 t -109.78 128.99 65.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 50.12 111.099 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.419 HG23 ' H ' ' B' ' 249' ' ' ALA . 13.9 t -70.25 167.52 17.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 64.01 111.134 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.09 76.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 75.25 111.063 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.51 -50.44 73.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 71.53 111.159 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.579 ' HB3' ' CG1' ' B' ' 245' ' ' VAL . . . -62.77 -69.93 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 72.24 111.05 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.564 HD21 ' HA ' ' A' ' 249' ' ' ALA . 0.3 OUTLIER 63.23 164.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.909 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -83.34 138.13 33.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 75.34 110.904 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 144.8 78.59 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.755 -0.736 . . . . 53.51 112.459 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 174.32 157.65 16.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 60.21 112.523 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 14.6 tt -153.5 138.36 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 75.05 111.098 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -174.18 156.73 2.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 74.11 110.883 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.5 mp -95.7 95.61 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 73.23 111.089 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.42 -170.17 2.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 64.23 110.869 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -99.55 -175.32 2.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 71.11 110.891 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -166.81 168.78 13.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 74.41 110.891 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 2.5 m -100.62 129.32 46.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 72.13 111.182 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 4.8 t -110.53 134.58 52.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 64.12 111.076 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.49 133.38 56.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 71.35 110.854 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.3 m -142.81 123.13 13.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 74.23 110.894 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.799 HG21 HD11 ' C' ' 231' ' ' ILE . 8.0 p -119.0 134.43 62.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 54.3 111.161 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -66.51 -75.2 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 73.32 110.885 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 68.8 m -133.32 133.33 42.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 63.33 111.142 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' B' ' 231' ' ' ILE . 0.7 OUTLIER -120.55 138.0 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 74.42 111.148 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.06 124.45 66.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 74.53 111.082 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.31 133.62 11.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.638 -0.792 . . . . 40.24 112.477 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -132.02 148.04 52.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 74.11 110.892 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.3 80.78 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 61.41 112.421 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 44.19 57.79 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.958 0.409 . . . . 64.34 110.923 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.71 145.55 28.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 75.55 110.844 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -119.3 128.77 54.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 73.31 110.901 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.65 HG12 HD11 ' B' ' 277' ' ' ILE . 18.0 t -115.16 125.05 72.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 75.21 111.107 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.431 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.2 OUTLIER -128.11 110.9 12.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.145 -0.48 . . . . 73.33 110.96 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.65 HD11 HG12 ' B' ' 275' ' ' VAL . 4.7 mp -112.61 104.44 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 64.24 111.14 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.31 170.97 21.44 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.754 -0.736 . . . . 60.25 112.486 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -103.89 156.0 18.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.813 0.34 . . . . 73.54 110.909 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -115.92 119.41 35.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 52.22 110.885 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.94 127.74 51.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 71.4 110.951 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 63.19 160.31 0.24 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.696 -0.764 . . . . 20.0 112.539 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 98.4 104.62 2.44 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.806 -0.711 . . . . 23.51 112.473 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.76 103.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.777 0.322 . . . . 75.12 110.98 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 157.99 -127.87 1.98 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.71 -0.757 . . . . 75.13 112.457 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -178.11 -38.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.801 0.334 . . . . 75.11 110.87 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -175.49 -74.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.916 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.83 153.78 27.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 45.02 110.887 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -68.69 124.15 22.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 73.24 110.912 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -165.56 146.57 7.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.22 110.91 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -163.29 103.06 0.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 71.34 110.833 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -171.29 120.22 0.5 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 73.01 110.802 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -173.47 141.71 0.91 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 74.24 110.814 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -172.78 117.41 0.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 74.21 110.925 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 64.13 110.811 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.871 0.367 . . . . 71.14 110.817 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 2.5 tmmt? -159.27 54.41 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 74.2 110.904 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 3.5 mp -118.43 -65.95 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 73.4 111.133 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -178.18 179.39 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 63.41 110.85 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.51 -172.51 2.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 62.24 111.111 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 8.1 tp -136.85 133.88 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 70.12 111.121 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 10.2 p -172.46 132.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 72.33 111.061 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 173.2 -84.27 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.719 -0.753 . . . . 73.12 112.518 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -150.06 -74.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 72.44 110.837 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -100.49 119.6 38.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 72.05 110.897 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.3 m -140.22 142.73 35.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 72.1 110.857 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.691 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -142.29 130.13 21.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 73.02 111.132 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.01 -31.62 39.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 73.12 110.905 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -167.46 135.16 2.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.408 . . . . 65.44 110.851 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.802 HG22 HG22 ' C' ' 267' ' ' VAL . 6.3 pt -142.02 117.23 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 74.44 111.13 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.16 133.51 46.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 73.45 110.807 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.562 HG21 HG13 ' C' ' 239' ' ' VAL . 5.0 p -136.22 152.43 50.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 75.1 111.169 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -145.88 168.25 21.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 74.54 110.816 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 69.67 63.81 0.26 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 74.24 110.892 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.32 58.47 4.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.872 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.62 156.22 18.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 74.04 111.148 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -131.28 137.33 48.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 62.42 110.848 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.673 HG12 ' CG2' ' C' ' 275' ' ' VAL . 6.5 m -123.68 121.77 63.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 61.14 111.161 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.574 ' C ' HD13 ' C' ' 241' ' ' LEU . 0.5 OUTLIER -119.83 115.82 24.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 75.41 110.929 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.858 HD12 HD12 ' C' ' 277' ' ' ILE . 0.2 OUTLIER -111.51 118.69 36.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 62.11 110.934 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 151.1 166.05 13.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.673 -0.775 . . . . 72.11 112.471 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.535 ' ND2' HG23 ' C' ' 245' ' ' VAL . 1.2 p-10 -85.8 146.63 26.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.924 0.392 . . . . 65.11 110.874 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 46.2 t -116.37 122.88 70.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 65.54 111.145 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.595 HG13 ' HB3' ' C' ' 249' ' ' ALA . 74.6 t -122.05 128.53 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 51.03 111.117 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.8 t -69.83 173.23 6.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 73.44 111.164 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.54 76.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 54.44 111.059 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.93 -51.87 67.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 73.31 111.107 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . 0.595 ' HB3' HG13 ' C' ' 245' ' ' VAL . . . -82.22 134.13 35.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 42.14 111.047 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.29 -42.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 62.12 110.952 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -159.1 149.35 19.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 75.41 110.834 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 148.22 160.91 9.26 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.825 -0.702 . . . . 70.33 112.533 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 71.78 119.06 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.698 -0.763 . . . . 53.53 112.506 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -69.97 -26.89 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.338 . . . . 71.44 111.156 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.52 162.46 12.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 73.43 110.916 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 3.2 mp -64.53 141.21 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 73.42 111.142 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 13.9 m -102.25 128.3 48.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 62.34 110.866 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 59.02 -173.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 72.33 110.85 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.54 60.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 70.01 110.857 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.37 137.69 35.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 71.51 111.146 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 87.2 m -128.8 119.83 25.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 65.34 111.094 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -104.86 119.96 40.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 63.04 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 29.2 t -134.32 123.64 24.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 72.2 110.827 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.715 HG21 HG12 ' C' ' 267' ' ' VAL . 8.3 p -119.49 153.32 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 74.45 111.144 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.02 -60.45 1.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 52.34 110.905 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 31.6 p -145.63 127.68 15.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 74.44 111.136 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.802 HG22 HG22 ' C' ' 231' ' ' ILE . 1.0 OUTLIER -122.82 137.38 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 73.11 111.14 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 49.1 t -124.9 125.56 69.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 52.51 111.124 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.77 134.06 11.74 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 41.4 112.52 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -132.36 148.52 52.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.841 0.353 . . . . 74.22 110.864 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.72 85.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.682 -0.77 . . . . 53.54 112.548 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 42.72 59.26 2.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 72.45 110.871 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.8 145.13 28.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 63.21 110.825 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -121.32 128.2 52.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 71.42 110.874 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.673 ' CG2' HG12 ' C' ' 239' ' ' VAL . 31.0 t -116.04 125.19 73.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 72.22 111.14 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.552 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.1 OUTLIER -128.2 111.59 13.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 75.01 110.918 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.858 HD12 HD12 ' C' ' 241' ' ' LEU . 57.2 mt -111.14 104.2 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 71.44 111.14 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.39 178.22 24.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.725 -0.75 . . . . 42.42 112.465 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -108.69 150.96 26.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.779 0.323 . . . . 74.42 110.905 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -112.0 127.9 56.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.44 110.894 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.513 ' CZ ' HG11 ' D' ' 245' ' ' VAL . 1.9 t80 -113.63 125.87 54.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 61.24 110.919 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 51.56 -170.45 0.36 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.767 -0.73 . . . . 63.55 112.489 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 84.94 -133.01 11.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.818 -0.705 . . . . 51.13 112.457 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -45.38 66.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.83 0.348 . . . . 60.31 110.876 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 128.02 -9.17 6.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.713 -0.756 . . . . 71.52 112.443 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.786 ' CE1' HD11 ' D' ' 276' ' ' LEU . 7.8 t80 -171.51 -75.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 73.21 110.87 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.552 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 14.6 t90 -178.95 -57.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 71.35 110.908 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -168.89 -178.57 3.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 71.03 110.894 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -154.18 -74.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 74.2 110.859 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.46 -171.88 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 71.31 110.819 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -134.06 42.88 2.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 65.13 110.892 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -155.88 -71.88 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 72.22 110.909 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -84.52 123.18 30.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 74.22 110.857 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.29 29.29 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 70.42 110.872 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.211 -0.449 . . . . 74.43 110.854 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 20.5 mtp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.79 0.329 . . . . 73.33 110.845 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -136.37 -175.88 4.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 63.54 110.869 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 66.1 mt -79.99 145.28 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 62.2 111.088 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.64 162.6 15.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 72.31 110.872 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -174.98 -170.27 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 72.11 111.088 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . 0.466 HD13 ' H ' ' D' ' 222' ' ' ILE . 0.2 OUTLIER -118.15 149.45 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.423 . . . . 71.52 111.122 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . 0.525 HG13 ' NH1' ' D' ' 225' ' ' ARG . 86.1 t -149.81 120.08 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 44.01 111.16 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -93.96 -122.06 3.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 72.33 112.486 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.525 ' NH1' HG13 ' D' ' 223' ' ' VAL . 0.0 OUTLIER 63.11 -168.93 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 63.45 110.837 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -83.66 115.31 22.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 70.4 110.85 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.35 147.33 49.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 75.23 110.912 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.06 119.91 11.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 63.23 111.092 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.49 -39.33 70.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 71.34 110.913 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -165.81 138.89 4.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 74.25 110.844 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . 0.475 HG23 ' CG2' ' D' ' 267' ' ' VAL . 0.1 OUTLIER -135.38 116.25 19.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 64.45 111.149 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -125.59 125.6 43.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 61.45 110.826 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . 0.593 HG21 ' CG1' ' D' ' 239' ' ' VAL . 1.5 p -135.51 149.0 49.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 64.02 111.096 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 14.9 pm0 -145.65 167.95 21.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 65.1 110.861 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 64.79 76.03 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 54.3 110.899 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 10.5 mtm-85 41.42 56.74 3.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.857 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.54 156.29 18.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 74.11 111.049 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -136.83 151.96 49.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 64.11 110.915 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.646 HG12 ' CG2' ' D' ' 275' ' ' VAL . 18.6 m -137.23 139.53 43.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 71.05 111.078 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . 0.62 ' C ' HD13 ' D' ' 241' ' ' LEU . 19.8 tm0? -137.66 121.28 17.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 74.55 110.912 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.645 HD12 HD12 ' D' ' 277' ' ' ILE . 0.2 OUTLIER -112.21 118.37 35.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 72.14 110.899 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 146.23 169.48 14.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.741 . . . . 52.13 112.534 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . 0.447 ' ND2' HG23 ' D' ' 245' ' ' VAL . 5.8 p-10 -85.95 152.1 23.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.869 0.366 . . . . 45.44 110.909 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 18.2 t -117.57 114.81 46.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 72.04 111.139 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . 0.513 HG11 ' CZ ' ' C' ' 281' ' ' TYR . 67.8 t -107.47 124.06 63.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 60.0 111.181 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t -69.73 168.21 15.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 65.42 111.178 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.19 -34.1 73.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 75.34 111.078 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.74 -36.45 72.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 54.41 111.115 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 60.99 170.41 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 73.11 111.126 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.47 114.31 28.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 63.13 110.897 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -77.64 73.02 4.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 64.42 110.863 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 100.35 167.57 28.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.749 -0.739 . . . . 65.34 112.55 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 71.41 24.34 77.0 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.765 -0.731 . . . . 53.03 112.472 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 15.5 pt -115.11 -25.14 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.848 0.356 . . . . 71.23 111.182 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -101.49 136.66 40.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 74.45 110.942 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 45.7 mm 60.82 83.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 63.12 111.17 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.03 172.74 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 44.11 110.894 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.44 -170.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 74.01 110.834 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -170.92 130.33 0.79 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 64.34 110.913 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . 0.66 HG23 ' HD2' ' E' ' 225' ' ' ARG . 85.8 m -66.51 130.66 43.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 70.24 111.162 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 99.8 m -105.33 125.08 50.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.424 . . . . 53.41 111.127 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . 0.524 ' OD1' HG22 ' D' ' 260' ' ' THR . 0.1 OUTLIER -125.98 129.47 49.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 63.3 110.857 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.23 123.56 14.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 53.21 110.882 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.496 HG23 HD11 ' E' ' 231' ' ' ILE . 14.2 p -109.89 128.77 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 73.33 111.122 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.55 -79.55 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 72.25 110.793 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -121.68 129.93 53.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 75.11 111.085 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.475 ' CG2' HG23 ' D' ' 231' ' ' ILE . 0.5 OUTLIER -117.75 120.33 64.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 65.42 111.103 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 22.4 t -118.74 115.97 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 73.4 111.154 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.14 133.76 10.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.707 -0.759 . . . . 34.31 112.527 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -131.53 147.81 52.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.766 0.317 . . . . 74.25 110.888 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.16 90.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.761 . . . . 73.22 112.521 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 44.28 61.27 2.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 75.33 110.914 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.56 145.81 24.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 75.14 110.937 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 10.7 mtm-85 -124.04 131.23 53.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 65.44 110.865 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.646 ' CG2' HG12 ' D' ' 239' ' ' VAL . 21.8 t -115.27 124.9 72.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 64.04 111.106 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.786 HD11 ' CE1' ' C' ' 286' ' ' PHE . 2.8 mm? -128.4 111.46 13.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 63.31 110.911 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.645 HD12 HD12 ' D' ' 241' ' ' LEU . 18.2 mt -114.16 103.99 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 62.51 111.165 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 151.6 -164.68 30.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 53.23 112.42 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -128.26 150.07 50.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.786 0.327 . . . . 74.44 110.904 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -113.39 145.36 41.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 61.44 110.889 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -129.86 125.93 36.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 73.41 110.927 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 62.28 168.46 0.76 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.76 -0.733 . . . . 75.21 112.449 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 107.63 -124.52 7.6 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 72.23 112.477 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -137.84 91.53 2.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 55.54 110.881 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 71.19 167.29 7.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.748 -0.739 . . . . 32.53 112.518 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . 0.405 ' HB3' HG21 ' E' ' 244' ' ' VAL . 2.6 p90 -51.92 -31.95 30.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.834 0.349 . . . . 74.12 110.874 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 3.0 t90 176.59 105.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 75.0 110.873 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.46 176.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 41.03 110.794 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -115.58 -179.94 3.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.483 . . . . 72.21 110.92 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -137.92 -71.44 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 73.5 110.849 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -178.08 -171.47 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 74.51 110.869 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -106.62 -33.43 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 74.42 110.836 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 62.97 103.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 72.23 110.85 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -119.27 144.36 46.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 72.04 110.8 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 32.1 p80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 71.24 110.838 -179.963 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.839 0.352 . . . . 70.45 110.896 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -163.78 98.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 75.31 110.881 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 1.1 pp -147.84 157.71 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 75.35 111.115 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.8 140.28 1.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 54.54 110.816 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -178.19 -178.03 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 62.22 111.118 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 47.6 mm -53.22 142.19 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 60.4 111.163 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 17.8 m -98.01 169.29 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 64.54 111.175 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -95.89 -169.46 35.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.792 -0.718 . . . . 34.35 112.474 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . 0.66 ' HD2' HG23 ' D' ' 260' ' ' THR . 5.6 ptp180 -63.71 -46.98 82.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.349 . . . . 74.04 110.86 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . 0.465 ' HB3' HG22 ' E' ' 277' ' ' ILE . 3.3 m120 -96.75 109.75 22.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 73.44 110.881 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 31.9 t -134.06 137.85 44.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 54.13 110.802 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.45 136.61 54.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 74.22 111.158 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.44 -35.14 13.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 74.03 110.861 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.39 137.32 3.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 72.23 110.824 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . 0.496 HD11 HG23 ' D' ' 264' ' ' VAL . 1.3 mt -138.06 116.55 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 64.31 111.166 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -123.16 121.68 36.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.02 110.861 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 9.6 p -136.74 149.14 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.14 111.227 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.98 166.44 24.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 73.44 110.862 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . 0.466 ' O ' ' C ' ' E' ' 236' ' ' ARG . 2.4 mt-10 62.23 90.46 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 64.44 110.904 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' E' ' 235' ' ' GLU . 0.9 OUTLIER 31.94 63.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 72.34 110.935 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.03 156.28 18.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 60.03 111.087 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -137.4 137.2 38.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 73.03 110.903 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.561 HG12 ' CG2' ' E' ' 275' ' ' VAL . 16.6 m -126.08 137.76 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 70.43 111.092 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -134.78 126.51 29.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 62.33 110.931 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.471 HD22 ' HB ' ' D' ' 264' ' ' VAL . 1.3 mp -116.98 118.64 32.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.859 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.61 172.38 12.55 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.786 -0.721 . . . . 74.24 112.535 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . 0.488 ' HB3' HG21 ' D' ' 260' ' ' THR . 0.5 OUTLIER -85.57 163.39 18.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 71.04 110.914 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' D' ' 286' ' ' PHE . 21.4 t -129.64 135.54 61.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 73.35 111.132 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 70.3 t -122.86 124.11 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 75.53 111.226 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.7 t -68.47 167.03 15.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 53.02 111.172 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.24 -34.17 75.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 62.22 111.127 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . 0.675 ' HB1' HD12 ' E' ' 250' ' ' LEU . . . -56.89 -36.94 70.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 52.32 111.087 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' E' ' 248' ' ' ALA . . . 68.99 -77.22 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 55.41 111.053 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . 0.675 HD12 ' HB1' ' E' ' 248' ' ' ALA . 0.4 OUTLIER 52.02 63.32 2.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 72.14 110.876 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 36.1 m80 59.0 46.33 13.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 74.04 110.834 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -55.65 -89.8 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.809 -0.71 . . . . 75.1 112.48 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -75.88 113.05 3.77 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.727 -0.749 . . . . 62.04 112.538 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 33.0 pt -98.19 173.01 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.858 0.361 . . . . 74.14 111.091 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . 0.483 ' O ' HD13 ' E' ' 256' ' ' ILE . 0.0 OUTLIER -52.0 -39.75 59.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.43 110.833 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . 0.483 HD13 ' O ' ' E' ' 255' ' ' ARG . 25.7 mm -130.09 100.41 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 35.35 111.149 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 30.7 t -106.88 28.74 7.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 52.5 110.823 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.25 117.57 30.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 74.11 110.855 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -177.59 -55.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 70.41 110.849 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.4 128.31 34.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.26 -0.427 . . . . 70.41 111.148 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . 0.615 HG22 ' HA ' ' E' ' 225' ' ' ARG . 0.5 OUTLIER -126.95 126.82 43.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 72.44 111.125 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -123.0 119.75 31.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 44.44 110.903 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 4.2 p -133.12 123.29 25.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.883 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . 0.617 HG21 HG22 ' E' ' 267' ' ' VAL . 7.4 p -112.3 136.64 47.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 72.14 111.168 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -81.36 -75.53 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 71.42 110.904 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 3.2 m -125.21 129.62 50.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 64.33 111.142 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . 0.617 HG22 HG21 ' E' ' 264' ' ' VAL . 17.6 t -117.32 123.9 72.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 75.43 111.142 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 87.4 t -127.07 115.82 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 54.34 111.133 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.58 133.87 8.81 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 73.4 112.516 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.84 147.54 46.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.359 . . . . 74.54 110.897 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.27 84.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.777 -0.725 . . . . 44.43 112.46 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 49.1 88.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.853 0.359 . . . . 71.31 110.905 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 67.2 m -116.25 145.19 43.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.13 110.85 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.82 128.78 55.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 74.42 110.925 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.561 ' CG2' HG12 ' E' ' 239' ' ' VAL . 16.4 t -115.12 122.86 70.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 72.01 111.11 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.25 111.56 13.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 72.21 110.874 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.465 HG22 ' HB3' ' E' ' 226' ' ' ASN . 61.5 mt -113.71 104.09 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 73.02 111.087 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.3 176.88 15.43 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 73.33 112.445 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -89.35 156.43 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.826 0.345 . . . . 64.33 110.899 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -128.53 137.52 51.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 61.23 110.94 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -120.2 123.75 44.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 72.45 110.923 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 56.42 178.35 0.39 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.686 -0.769 . . . . 75.14 112.536 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . 127.47 165.05 11.8 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.733 -0.746 . . . . 63.1 112.54 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -118.19 -23.22 7.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.823 0.344 . . . . 65.25 110.834 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -62.74 -160.88 0.21 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.734 -0.746 . . . . 42.24 112.525 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -74.82 -28.86 60.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 70.34 110.867 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -98.2 79.28 2.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.156 -0.475 . . . . 73.52 110.881 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 178.47 -177.5 0.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.294 -0.412 . . . . 63.14 110.875 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -156.24 141.9 17.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.84 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -167.99 -169.9 1.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 63.43 110.9 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -88.02 69.37 9.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.839 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.63 -169.98 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 65.13 110.865 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -143.58 -44.76 0.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 74.21 110.866 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -69.31 161.81 28.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 65.43 110.868 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 71.51 110.919 179.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 5.1 mtm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.78 0.324 . . . . 73.02 110.831 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.13 84.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 54.04 110.901 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.5 tt -63.58 -24.94 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 65.44 111.192 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -52.04 156.78 1.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 72.44 110.869 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -146.72 -175.95 5.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 34.34 111.065 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.481 HD11 HD11 ' A' ' 256' ' ' ILE . 15.3 tt -175.2 150.75 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 72.33 111.135 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.713 HG22 HD13 ' A' ' 256' ' ' ILE . 28.3 m -60.55 -177.25 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 60.01 111.069 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 61.67 101.53 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 73.52 112.52 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 261' ' ' THR . 0.0 OUTLIER -176.7 106.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.363 . . . . 55.11 110.831 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -83.19 145.15 29.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 71.21 110.899 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.57 150.26 47.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 75.02 110.85 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.8 119.13 17.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.497 . . . . 61.12 111.092 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -70.76 -49.98 40.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 72.22 110.927 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -165.25 136.37 3.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 45.13 110.862 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.424 HG22 ' CG2' ' A' ' 267' ' ' VAL . 8.0 pt -138.84 134.39 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 74.44 111.1 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -134.49 128.2 32.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 73.25 110.837 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 11.8 p -136.41 149.79 48.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 71.23 111.107 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -120.54 166.24 13.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 75.43 110.869 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 65.39 -159.27 0.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 72.32 110.914 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -74.33 61.41 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 73.33 110.835 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.23 156.43 16.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 70.13 111.108 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.64 143.49 47.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 75.41 110.869 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.672 HG12 ' HB ' ' A' ' 275' ' ' VAL . 16.0 m -135.83 120.83 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 73.3 111.161 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.44 137.7 52.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.889 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.41 118.37 21.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 72.13 110.92 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 149.78 -126.73 2.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 74.21 112.516 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -145.51 143.11 29.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.808 0.337 . . . . 75.0 110.944 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.65 119.9 60.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 75.35 111.121 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 36.7 t -109.19 116.15 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 54.2 111.12 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 247' ' ' ALA . 0.2 OUTLIER -69.85 171.82 8.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 65.33 111.166 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.458 ' H ' HG22 ' A' ' 246' ' ' THR . . . -59.1 -42.73 91.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.266 -0.424 . . . . 73.42 111.1 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . 0.641 ' HB3' ' H ' ' A' ' 283' ' ' GLY . . . -57.03 -35.89 69.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 55.11 111.092 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.656 ' HB2' ' HA2' ' A' ' 282' ' ' GLY . . . -88.03 140.14 29.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.27 -0.423 . . . . 64.02 111.058 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -178.76 119.56 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 41.33 110.937 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 63.02 104.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 71.34 110.886 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -71.64 -58.1 5.57 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 32.13 112.432 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 108.4 -95.68 0.96 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.725 -0.75 . . . . 75.32 112.521 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 25.7 pt -59.49 -173.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.826 0.346 . . . . 72.11 111.118 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.02 169.54 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.908 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.713 HD13 HG22 ' A' ' 223' ' ' VAL . 3.3 mt -51.7 119.42 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 74.11 111.208 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.8 t -96.24 26.58 4.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 70.33 110.868 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.705 ' H ' HG22 ' A' ' 256' ' ' ILE . 15.0 t0 -152.71 85.76 1.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 73.44 110.866 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -96.45 28.7 3.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.454 . . . . 73.01 110.873 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.8 m -98.97 138.08 36.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 63.44 111.077 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 225' ' ' ARG . 54.0 m -132.5 133.64 44.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 53.25 111.167 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.611 HD22 HD23 ' B' ' 241' ' ' LEU . 0.6 OUTLIER -115.88 144.45 44.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 70.11 110.862 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.7 m -141.69 127.97 19.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 71.42 110.824 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.743 HG23 HD11 ' B' ' 231' ' ' ILE . 8.7 p -113.57 137.41 46.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.081 -0.508 . . . . 74.3 111.088 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -85.61 -78.82 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 52.54 110.829 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 4.0 m -115.71 127.04 54.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 75.33 111.101 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.562 HG22 HG21 ' A' ' 264' ' ' VAL . 40.9 t -118.42 124.12 72.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 62.01 111.076 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 78.9 t -124.76 115.21 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.116 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.42 133.08 9.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 53.2 112.499 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -109.03 129.3 55.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.35 . . . . 72.02 110.884 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.92 178.74 10.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.743 . . . . 21.12 112.465 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -47.53 101.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.835 0.35 . . . . 74.32 110.923 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 44.9 t -129.63 154.14 47.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.096 -0.502 . . . . 65.1 110.837 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -112.16 128.05 56.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 65.11 110.827 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.672 ' HB ' HG12 ' A' ' 239' ' ' VAL . 59.2 t -121.0 123.58 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 73.03 111.137 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.726 HD12 ' CE2' ' A' ' 287' ' ' TRP . 0.4 OUTLIER -125.16 111.01 14.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 53.04 110.913 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.615 ' CD1' HD13 ' B' ' 241' ' ' LEU . 31.0 mm -109.96 104.3 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 62.52 111.119 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.74 -163.48 29.67 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.765 -0.731 . . . . 74.14 112.508 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -114.36 156.36 24.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 72.04 110.843 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.725 ' HG2' HG12 ' B' ' 244' ' ' VAL . 8.9 pt-20 -129.23 129.24 44.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.114 -0.494 . . . . 63.34 110.88 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.566 ' CZ ' HG11 ' B' ' 245' ' ' VAL . 0.3 OUTLIER -123.8 128.97 50.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 72.01 110.907 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.656 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 151.34 -169.19 30.94 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.808 -0.71 . . . . 74.14 112.494 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.641 ' H ' ' HB3' ' A' ' 248' ' ' ALA . . . -78.72 -173.84 43.66 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.681 -0.771 . . . . 75.12 112.513 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.3 -75.55 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 61.44 110.927 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 286' ' ' PHE . . . 100.58 175.81 29.77 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.689 -0.767 . . . . 74.42 112.489 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.41 ' HB3' ' O ' ' A' ' 285' ' ' GLY . 9.9 t80 64.01 -81.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 75.42 110.883 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.726 ' CE2' HD12 ' A' ' 276' ' ' LEU . 0.7 OUTLIER -140.69 -41.67 0.4 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.084 -0.507 . . . . 75.12 110.976 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 51.1 t0 63.61 105.5 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 73.32 110.865 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -95.55 -169.82 2.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 73.15 110.922 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -55.55 -26.13 41.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 74.14 110.901 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -169.95 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 75.15 110.942 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -140.48 -169.78 2.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 62.03 110.843 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.33 -170.32 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.845 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.38 103.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.837 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 61.34 110.818 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.813 0.34 . . . . 74.14 110.809 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.7 179.2 7.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 74.14 110.908 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 5.4 pt -152.0 -178.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 62.1 111.106 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.22 -170.24 2.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 74.12 110.915 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -107.44 -75.68 0.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 53.14 111.131 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 1.2 pt -152.86 105.53 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 20.3 111.091 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 14.4 p -175.81 149.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 62.33 111.167 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -52.33 128.7 35.52 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.694 -0.765 . . . . 64.15 112.497 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.731 ' O ' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER -162.54 121.88 2.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 61.21 110.849 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.807 ' HB3' HG22 ' B' ' 277' ' ' ILE . 0.9 OUTLIER -86.57 140.17 30.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 73.11 110.942 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . 0.59 ' HG ' ' N ' ' D' ' 217' ' ' MET . 41.4 m -134.05 140.49 46.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 70.42 110.911 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 264' ' ' VAL . . . -122.71 119.33 30.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 64.11 111.07 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 0.5 OUTLIER -67.93 -44.99 75.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 75.42 110.872 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -156.7 137.53 13.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.53 110.806 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.743 HD11 HG23 ' A' ' 264' ' ' VAL . 0.1 OUTLIER -138.34 117.34 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 71.14 111.16 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -120.1 123.82 44.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 74.01 110.921 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 17.1 p -136.17 140.8 43.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 75.1 111.135 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -121.7 166.93 13.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.167 -0.469 . . . . 63.33 110.809 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.58 -165.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 54.03 110.894 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -73.5 69.84 1.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 72.2 110.892 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 156.4 17.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 41.12 111.077 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.83 135.48 50.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 62.41 110.844 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.645 HG12 ' HB ' ' B' ' 275' ' ' VAL . 19.0 m -126.45 136.08 61.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.41 111.099 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -134.78 126.4 28.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 71.12 110.867 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.615 HD13 ' CD1' ' A' ' 277' ' ' ILE . 3.4 mp -118.46 119.01 33.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 63.04 110.863 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.83 -174.95 21.82 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.727 -0.749 . . . . 75.14 112.471 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -93.53 141.13 28.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 74.31 110.87 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.725 HG12 ' HG2' ' A' ' 280' ' ' GLU . 18.0 m -118.33 122.44 69.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 72.01 111.125 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.566 HG11 ' CZ ' ' A' ' 281' ' ' TYR . 21.3 t -116.54 127.59 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 64.21 111.142 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 57.6 p -87.2 172.79 9.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 74.34 111.131 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.46 ' HB2' ' HA2' ' A' ' 283' ' ' GLY . . . -63.07 -43.1 99.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 63.34 111.129 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -42.68 80.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 63.1 111.16 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.632 ' HB2' ' HA3' ' B' ' 282' ' ' GLY . . . -51.95 -30.36 24.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 65.43 111.091 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.508 HD23 ' OH ' ' A' ' 281' ' ' TYR . 0.5 OUTLIER -116.75 87.22 2.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.208 -0.451 . . . . 73.53 110.983 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -145.62 54.6 1.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.894 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.15 73.84 0.93 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.809 -0.71 . . . . 44.02 112.536 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 176.58 113.07 0.33 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.786 -0.721 . . . . 62.23 112.502 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 3.3 mt -80.81 108.46 14.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.853 0.359 . . . . 65.34 111.132 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -159.05 125.78 4.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 73.43 110.901 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . 0.497 ' O ' HD13 ' B' ' 256' ' ' ILE . 0.0 OUTLIER -115.87 -22.55 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 71.44 111.156 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.5 m 66.49 -168.21 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 73.45 110.902 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -75.94 178.85 5.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 64.44 110.885 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -120.83 111.45 17.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 74.13 110.947 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.484 HG21 ' HB2' ' C' ' 243' ' ' ASN . 6.0 m -99.88 121.78 41.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 62.33 111.128 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.731 HG23 ' O ' ' B' ' 225' ' ' ARG . 96.9 m -105.02 130.4 53.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 63.33 111.213 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.43 147.29 48.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 61.3 110.847 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 28.2 t -142.08 123.45 14.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.44 110.909 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.655 HG21 HG22 ' B' ' 267' ' ' VAL . 11.8 p -109.36 143.53 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 72.23 111.128 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.418 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 4.0 mt-10 -84.58 -75.32 0.35 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 75.14 110.865 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 18.5 p -125.12 127.87 47.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 73.1 111.166 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.655 HG22 HG21 ' B' ' 264' ' ' VAL . 21.2 t -118.27 120.99 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 74.22 111.088 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.8 123.68 70.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 55.33 111.14 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -131.38 133.47 7.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.699 -0.762 . . . . 73.01 112.454 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.28 147.21 31.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 72.11 110.809 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.26 -162.43 32.52 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.751 -0.737 . . . . 65.03 112.565 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -69.56 83.17 0.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 74.55 110.899 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 32.1 t -104.63 164.58 11.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 72.21 110.836 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -124.14 128.72 49.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 75.12 110.839 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.645 ' HB ' HG12 ' B' ' 239' ' ' VAL . 56.6 t -117.94 123.86 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 75.42 111.127 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.661 HD12 ' CE2' ' B' ' 287' ' ' TRP . 0.4 OUTLIER -128.0 111.32 13.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 74.42 110.952 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.807 HG22 ' HB3' ' B' ' 226' ' ' ASN . 12.7 mm -112.76 103.8 16.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.291 -0.413 . . . . 52.55 111.087 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.26 -154.03 25.24 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.777 -0.725 . . . . 63.34 112.514 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -125.31 149.63 47.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.734 0.302 . . . . 63.3 110.899 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -113.95 136.32 53.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 44.04 110.824 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -130.04 127.31 39.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 74.44 110.955 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.632 ' HA3' ' HB2' ' B' ' 249' ' ' ALA . . . 91.36 172.55 43.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 61.51 112.484 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . 0.528 ' N ' ' HB2' ' C' ' 247' ' ' ALA . . . 80.11 125.99 0.6 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.808 -0.71 . . . . 45.31 112.521 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -75.88 68.2 2.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.861 0.363 . . . . 73.23 110.954 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -174.96 -153.12 9.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.705 -0.76 . . . . 53.51 112.49 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -122.0 -33.8 3.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.834 0.35 . . . . 63.41 110.86 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.661 ' CE2' HD12 ' B' ' 276' ' ' LEU . 1.4 t90 -133.66 -53.73 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 65.5 110.906 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -177.94 -50.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 70.14 110.891 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -131.74 164.75 25.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 54.1 110.899 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -139.2 -173.34 3.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 72.54 110.862 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -144.29 -179.98 6.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 65.22 110.873 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -147.58 150.19 33.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 63.02 110.816 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.24 -66.72 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.468 . . . . 73.03 110.849 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -175.24 33.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.323 -0.399 . . . . 72.22 110.83 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 74.13 110.891 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.815 0.34 . . . . 52.51 110.821 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -141.89 178.6 7.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 74.04 110.912 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -172.07 125.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 72.23 111.071 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -179.13 84.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 72.13 110.876 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . 0.562 ' C ' HD12 ' C' ' 222' ' ' ILE . . . -135.87 -58.32 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 75.41 111.169 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . 0.562 HD12 ' C ' ' C' ' 221' ' ' ALA . 3.7 mp 63.76 94.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 72.23 111.068 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 33.0 m -149.2 -177.19 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 54.11 111.155 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -52.55 137.33 34.97 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.746 -0.74 . . . . 73.44 112.466 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.77 129.59 0.99 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.718 0.295 . . . . 64.42 110.906 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.454 ' HB3' HG22 ' C' ' 277' ' ' ILE . 0.1 OUTLIER -101.43 144.15 30.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 62.34 110.889 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.14 137.99 44.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 65.22 110.832 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.681 ' CB ' HD11 ' C' ' 231' ' ' ILE . . . -116.86 119.91 36.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.055 -0.521 . . . . 54.43 111.124 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -72.72 -42.92 63.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 70.1 110.926 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -158.23 136.58 10.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 72.3 110.805 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.681 HD11 ' CB ' ' C' ' 228' ' ' ALA . 1.7 mt -140.01 116.39 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 75.04 111.077 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 16.0 ttp85 -125.63 125.63 43.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 70.32 110.879 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 21.2 p -136.32 146.3 46.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 51.3 111.099 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -121.21 166.1 14.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 60.23 110.88 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.46 -162.5 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 73.02 110.858 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -72.85 70.83 1.01 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.838 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.25 157.22 17.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 72.32 111.058 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -125.59 149.16 48.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 63.44 110.901 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.591 HG12 ' HB ' ' C' ' 275' ' ' VAL . 12.9 m -141.58 137.84 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 71.22 111.138 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -136.65 132.16 34.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 75.35 110.922 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.645 HD13 ' HB ' ' C' ' 277' ' ' ILE . 1.6 mm? -117.89 117.91 30.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.439 . . . . 72.51 110.957 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.44 -177.5 17.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.727 -0.749 . . . . 71.12 112.473 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.484 ' HB2' HG21 ' B' ' 260' ' ' THR . 11.5 t30 -85.76 140.89 30.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 74.24 110.817 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.29 115.85 50.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 55.03 111.139 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.412 HG22 ' HB2' ' C' ' 281' ' ' TYR . 21.4 t -113.66 123.07 68.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 72.41 111.137 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 13.2 t -79.95 175.1 10.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 74.11 111.202 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.528 ' HB2' ' N ' ' B' ' 283' ' ' GLY . . . -62.15 -40.91 97.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 74.52 111.12 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.68 -52.03 66.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 35.54 111.094 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.91 -170.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 75.31 111.072 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . 0.483 HD22 ' O ' ' D' ' 249' ' ' ALA . 20.1 mt -96.33 136.96 36.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 72.43 110.89 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -53.63 102.35 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 62.0 110.861 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 52.96 -173.11 0.37 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.717 -0.754 . . . . 71.52 112.45 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 131.66 -62.21 0.65 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.727 -0.749 . . . . 74.41 112.454 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 28.4 mm 64.24 69.51 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.882 0.372 . . . . 64.32 111.157 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 56.84 78.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 75.1 110.921 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 7.5 pt -150.67 45.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 64.32 111.131 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 2.8 p -124.46 -178.71 4.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 71.34 110.84 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -73.58 162.16 29.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 55.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -107.95 98.2 7.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.945 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . 0.513 HG21 ' CB ' ' D' ' 243' ' ' ASN . 38.1 p -99.09 137.88 36.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 74.44 111.205 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 1.7 t -134.13 133.75 41.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 75.24 111.135 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.13 147.7 49.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 61.25 110.898 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.17 123.21 13.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 74.3 110.878 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.645 HG21 HG22 ' C' ' 267' ' ' VAL . 9.0 p -105.52 153.56 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 71.23 111.156 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -97.45 -49.34 4.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 74.42 110.857 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.74 127.96 14.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 73.44 111.157 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.645 HG22 HG21 ' C' ' 264' ' ' VAL . 29.1 t -125.0 120.95 59.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 73.43 111.184 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 52.1 t -126.51 134.86 65.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 73.34 111.156 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.65 133.41 6.39 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.789 -0.719 . . . . 71.23 112.489 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.17 147.38 28.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 73.2 110.863 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 61.93 -152.64 42.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.728 -0.749 . . . . 54.0 112.507 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -73.64 73.78 1.5 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.359 . . . . 73.23 110.865 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 58.8 m -97.68 157.8 15.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 42.45 110.847 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -119.56 132.72 55.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 64.34 110.82 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.591 ' HB ' HG12 ' C' ' 239' ' ' VAL . 78.7 t -115.32 122.26 68.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 62.25 111.172 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.57 HD23 ' HZ2' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -125.14 111.66 15.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 71.34 110.899 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.645 ' HB ' HD13 ' C' ' 241' ' ' LEU . 20.1 mm -112.63 104.15 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 71.2 111.12 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.58 -159.16 26.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.741 . . . . 70.13 112.459 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.48 156.22 24.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 72.13 110.901 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -113.94 144.61 42.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 74.01 110.848 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.412 ' HB2' HG22 ' C' ' 245' ' ' VAL . 2.6 m-85 -130.14 125.61 35.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 75.12 110.907 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 67.06 150.69 0.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 62.01 112.499 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 138.33 150.67 5.67 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.792 -0.718 . . . . 70.32 112.486 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -64.74 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 74.32 110.896 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -100.81 174.9 25.98 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.748 . . . . 51.02 112.515 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -52.02 -30.37 25.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.868 0.366 . . . . 74.11 110.852 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.57 ' HZ2' HD23 ' C' ' 276' ' ' LEU . 2.0 t90 -126.46 -65.09 0.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 74.33 110.836 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.51 -169.83 2.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.316 -0.402 . . . . 64.41 110.869 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.28 -170.0 2.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.9 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -142.36 -74.82 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 71.42 110.879 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.26 -169.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 74.3 110.886 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 -170.18 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 74.41 110.914 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.05 151.89 28.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.298 -0.41 . . . . 53.33 110.862 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -172.46 154.94 3.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 71.32 110.889 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 1.6 t60 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 63.24 110.868 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . 0.59 ' N ' ' HG ' ' B' ' 227' ' ' SER . 3.4 tpt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.798 0.332 . . . . 51.0 110.905 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.77 29.08 5.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 74.33 110.883 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.06 126.11 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 72.44 111.163 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -173.17 130.59 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 74.44 110.775 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -87.87 162.85 16.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 34.32 111.029 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.2 28.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 75.33 111.201 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 38.9 t -53.65 -65.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 73.24 111.14 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -142.47 -113.26 0.95 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.739 . . . . 75.12 112.536 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.53 ' N ' HG23 ' D' ' 261' ' ' THR . 0.0 OUTLIER 59.98 -168.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.849 0.356 . . . . 73.21 110.843 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -83.03 110.01 17.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 71.43 110.907 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 60.5 p -133.22 156.9 46.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 63.41 110.844 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' D' ' 264' ' ' VAL . . . -129.72 146.79 51.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 75.03 111.029 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.56 -39.91 12.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 61.25 110.847 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -165.3 137.26 4.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 74.03 110.854 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . 0.614 HG21 HG11 ' D' ' 275' ' ' VAL . 5.2 mt -139.35 117.19 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 72.42 111.135 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . 0.449 ' CD ' HG22 ' D' ' 268' ' ' VAL . 8.1 ptp180 -119.8 130.26 54.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 74.24 110.859 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . 0.476 HG21 ' CG1' ' D' ' 239' ' ' VAL . 18.6 p -135.9 142.63 44.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 70.22 111.152 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -121.52 163.68 18.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 74.4 110.948 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 63.86 -164.34 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 71.11 110.891 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 38.6 mtt85 -73.77 69.41 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 70.35 110.84 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.15 156.98 17.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 62.21 111.088 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.57 135.69 52.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 63.42 110.851 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.516 HG12 ' HB ' ' D' ' 275' ' ' VAL . 18.0 m -128.53 136.0 61.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 65.33 111.063 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . 0.452 ' HB3' HD22 ' D' ' 276' ' ' LEU . 2.3 tm0? -136.8 127.53 27.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 75.21 110.862 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 1.2 mt -111.86 118.2 34.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 61.25 110.959 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.74 174.35 13.65 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.786 -0.721 . . . . 61.5 112.479 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . 0.513 ' CB ' HG21 ' C' ' 260' ' ' THR . 0.7 OUTLIER -85.54 149.45 25.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 74.42 110.867 -179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.49 134.42 62.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 64.31 111.166 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . 0.46 HG12 ' HB3' ' D' ' 249' ' ' ALA . 19.5 t -122.55 123.19 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 71.1 111.117 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . 0.689 HG22 ' HA3' ' D' ' 282' ' ' GLY . 5.0 t -73.37 165.0 25.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.447 . . . . 55.25 111.159 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . 0.41 ' HA ' HD23 ' C' ' 250' ' ' LEU . . . -63.15 -38.81 92.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 74.25 111.043 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.63 -35.72 68.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 54.05 111.043 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . 0.518 ' HB1' ' CE2' ' D' ' 281' ' ' TYR . . . -55.67 100.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 64.3 111.054 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 2.2 mp -68.88 -69.35 0.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 71.55 110.894 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -177.39 -36.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 61.52 110.823 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 95.94 -49.02 1.78 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.76 -0.733 . . . . 61.4 112.5 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 170.71 -92.91 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.763 -0.732 . . . . 74.14 112.528 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 9.3 tt -108.36 150.99 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.847 0.356 . . . . 55.32 111.137 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -52.38 169.82 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 75.21 110.9 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . 0.546 HG22 HD12 ' E' ' 254' ' ' ILE . 36.4 mt 59.04 97.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 71.01 111.118 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 60.1 p -162.13 130.96 4.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 61.5 110.89 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 1.9 t70 63.67 105.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.158 -0.474 . . . . 74.12 110.851 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -141.38 93.52 2.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 75.03 110.901 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . 0.546 HG21 ' HB3' ' E' ' 243' ' ' ASN . 6.9 p -95.91 121.93 38.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 74.03 111.181 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . 0.53 HG23 ' N ' ' D' ' 225' ' ' ARG . 23.9 m -92.0 113.77 26.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 71.01 111.18 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -122.08 151.12 41.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 62.14 110.88 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.72 121.98 13.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 72.4 110.848 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.567 ' HB ' HD22 ' E' ' 241' ' ' LEU . 10.6 p -106.48 142.47 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.072 -0.513 . . . . 75.24 111.132 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -84.06 -79.78 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 72.33 110.831 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 48.9 m -127.44 131.97 50.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 74.32 111.099 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.612 ' HB ' HG23 ' D' ' 231' ' ' ILE . 20.1 t -124.06 120.12 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 60.14 111.16 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . 0.449 HG22 ' CD ' ' D' ' 232' ' ' ARG . 26.6 t -118.25 122.99 70.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 63.52 111.116 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.62 133.19 8.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.655 -0.784 . . . . 42.22 112.476 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.0 147.29 31.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 74.42 110.836 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 60.51 -142.62 48.01 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 73.21 112.468 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.38 60.28 2.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.827 0.346 . . . . 72.21 110.88 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 12.7 m -83.83 152.83 24.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.901 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.78 132.41 54.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 74.44 110.866 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.614 HG11 HG21 ' D' ' 231' ' ' ILE . 92.5 t -115.71 122.75 70.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 65.21 111.129 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.1 OUTLIER -129.05 115.91 18.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 65.2 110.913 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 30.7 mm -113.15 103.52 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 62.34 111.109 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.96 -163.15 26.68 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 64.52 112.483 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.97 156.83 25.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.72 0.295 . . . . 63.01 110.876 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.9 118.85 34.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 64.41 110.884 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . 0.518 ' CE2' ' HB1' ' D' ' 249' ' ' ALA . 11.0 t80 -103.83 128.64 51.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 65.53 110.93 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . 0.689 ' HA3' HG22 ' D' ' 246' ' ' THR . . . 88.94 145.65 11.88 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 71.42 112.515 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 95.16 84.19 1.65 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 63.2 112.478 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -58.02 98.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.798 0.332 . . . . 52.0 110.873 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -174.73 -102.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.723 -0.751 . . . . 63.52 112.491 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -173.71 -37.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.863 0.363 . . . . 74.22 110.854 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -144.53 -61.98 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 73.55 110.906 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -164.22 -170.02 1.98 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 60.51 110.874 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -64.85 98.59 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 74.42 110.919 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.28 -170.04 3.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 74.2 110.852 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -154.51 175.52 13.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.197 -0.456 . . . . 75.13 110.836 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -175.43 170.18 3.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 72.3 110.829 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -118.77 -175.62 2.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 64.33 110.851 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -129.99 -174.29 3.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.866 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 73.33 110.896 179.972 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.906 0.384 . . . . 60.32 110.876 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -140.57 -176.23 4.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 73.11 110.907 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 3.3 tt -148.95 144.78 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 64.31 111.11 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.98 178.5 9.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 75.14 110.908 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.79 150.79 48.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 62.53 111.144 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.96 110.27 31.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 70.5 111.13 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 7.2 p -177.17 142.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 72.23 111.159 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 151.84 -174.68 30.85 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 53.02 112.515 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . 0.593 ' O ' HG22 ' E' ' 261' ' ' THR . 5.1 mmp_? -71.7 -74.96 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.806 0.336 . . . . 72.52 110.854 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.45 138.01 52.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 75.12 110.897 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 73.9 p -140.65 160.88 39.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 71.02 110.843 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . 0.601 ' CB ' HD11 ' E' ' 231' ' ' ILE . . . -126.52 127.95 46.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.501 . . . . 62.54 111.116 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -73.44 -35.44 65.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 61.35 110.922 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.53 137.18 3.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 62.51 110.888 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . 0.601 HD11 ' CB ' ' E' ' 228' ' ' ALA . 9.8 mt -139.67 116.4 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 62.02 111.04 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.6 126.29 48.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 70.14 110.904 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . 0.577 HG21 ' CG1' ' E' ' 239' ' ' VAL . 32.6 p -135.82 139.57 43.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 73.41 111.205 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -120.96 167.08 12.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 73.24 110.851 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 65.17 -162.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 75.21 110.877 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -75.23 61.16 1.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.52 110.85 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.32 156.76 17.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 63.44 111.151 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -129.88 135.65 48.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 71.34 110.884 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.577 ' CG1' HG21 ' E' ' 233' ' ' THR . 20.2 m -122.92 134.89 64.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 74.41 111.189 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -135.81 128.99 31.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 52.13 110.868 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.802 HD12 ' HB ' ' E' ' 277' ' ' ILE . 9.9 tp -111.38 118.0 34.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 73.3 110.949 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.31 171.91 12.82 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 43.34 112.446 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . 0.546 ' HB3' HG21 ' D' ' 260' ' ' THR . 0.0 OUTLIER -85.91 163.05 18.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 74.02 110.881 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.99 134.06 60.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 70.21 111.142 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 7.2 t -122.08 121.18 63.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 64.41 111.105 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 12.9 t -69.47 173.45 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 62.44 111.171 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.91 89.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 60.31 111.087 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.72 -36.38 69.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 65.34 111.063 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . 0.453 ' HB2' ' HE1' ' D' ' 281' ' ' TYR . . . 51.71 -169.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 51.42 111.098 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 1.7 tp -95.93 27.45 3.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 64.14 110.99 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 60.79 173.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 73.43 110.88 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -63.04 99.2 0.25 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 53.41 112.543 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 162.89 97.19 0.12 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.719 -0.753 . . . . 65.21 112.477 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . 0.546 HD12 HG22 ' D' ' 256' ' ' ILE . 10.3 tt -51.8 132.22 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.841 0.353 . . . . 75.02 111.184 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.06 -171.23 1.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 75.4 110.844 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 1.1 pt -108.12 67.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 54.03 111.13 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 1.7 t -56.5 -26.36 54.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 53.45 110.852 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -76.47 122.68 24.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.123 -0.489 . . . . 63.01 110.86 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -179.33 -37.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.955 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 7.5 p -100.04 138.03 37.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 63.04 111.173 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . 0.593 HG22 ' O ' ' E' ' 225' ' ' ARG . 1.3 p -124.8 127.04 46.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.257 -0.428 . . . . 73.4 111.165 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.01 119.93 28.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 63.11 110.908 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.73 122.86 40.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 73.34 110.807 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' E' ' 228' ' ' ALA . 0.3 OUTLIER -105.19 145.5 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.21 111.099 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' E' ' 229' ' ' LYS . 2.5 mt-10 -80.59 -76.61 0.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.885 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.38 126.67 17.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 75.21 111.165 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.32 120.59 64.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 72.13 111.132 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 23.4 t -119.69 115.07 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 74.33 111.155 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.02 133.97 11.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.782 -0.723 . . . . 52.44 112.442 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.73 131.45 52.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 65.31 110.871 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.44 -149.65 30.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.711 -0.757 . . . . 73.33 112.484 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -74.97 68.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 72.55 110.894 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 10.3 t -94.01 162.39 13.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 72.24 110.918 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.53 136.0 47.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 71.31 110.852 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.574 ' CG2' HG12 ' E' ' 239' ' ' VAL . 90.8 t -115.57 124.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 45.32 111.135 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.66 117.99 21.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 52.15 110.96 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.802 ' HB ' HD12 ' E' ' 241' ' ' LEU . 24.7 mm -113.47 102.19 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 73.33 111.15 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 131.85 178.89 15.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.789 -0.719 . . . . 51.42 112.509 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -95.69 156.9 16.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.881 0.372 . . . . 63.51 110.872 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.57 138.68 54.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 74.34 110.869 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -124.8 124.52 42.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.492 . . . . 72.13 110.88 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 170.74 -152.26 18.19 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.796 -0.716 . . . . 55.12 112.563 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -57.75 -175.61 0.45 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.751 -0.737 . . . . 53.42 112.448 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -61.39 -169.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 63.21 110.851 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 83.47 138.58 3.49 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.711 -0.757 . . . . 60.31 112.556 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -73.64 -7.32 51.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 73.53 110.895 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -151.75 -42.35 0.11 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.935 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -164.22 166.4 21.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.42 . . . . 72.43 110.814 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.98 -169.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 74.31 110.869 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -79.92 -170.2 2.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 74.31 110.859 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -95.62 153.84 17.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 73.35 110.849 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -121.75 -172.9 2.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 70.35 110.918 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.59 -171.67 2.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 75.23 110.872 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.07 179.61 2.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 70.52 110.881 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.854 179.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.821 0.343 . . . . 62.44 110.875 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.84 154.3 25.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 61.12 110.912 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 43.8 mm -132.24 143.98 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 52.12 111.112 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.0 173.09 17.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 74.42 110.827 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -111.18 -75.54 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 74.15 111.138 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.3 pt -125.37 124.14 66.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 63.31 111.104 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 6.5 p -177.75 122.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 65.4 111.171 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -61.78 169.99 11.24 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.807 -0.711 . . . . 53.34 112.515 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.439 ' HB3' HG23 ' A' ' 261' ' ' THR . 0.0 OUTLIER -168.43 107.56 0.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.816 0.341 . . . . 74.33 110.911 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.433 ' HB2' HG22 ' A' ' 277' ' ' ILE . 3.3 p30 -142.07 120.94 12.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 72.43 110.911 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 76.7 p -121.96 151.65 40.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 73.21 110.876 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.63 119.38 16.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 74.35 111.116 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -67.51 -51.64 48.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 71.44 110.875 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.78 135.47 4.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.276 -0.42 . . . . 73.22 110.834 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 6.4 pt -140.12 134.05 35.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 31.03 111.145 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.19 141.64 48.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 72.54 110.926 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.732 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.3 OUTLIER -137.41 152.84 50.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 74.4 111.133 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -138.35 168.62 19.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 52.12 110.887 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.5 -70.7 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 61.05 110.886 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.8 ptt-85 177.88 63.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 72.13 110.857 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.732 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -99.0 157.21 16.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 75.21 111.145 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -126.41 135.32 51.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 64.44 110.913 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.739 HG12 ' HB ' ' A' ' 275' ' ' VAL . 31.2 m -124.43 124.74 69.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 72.21 111.13 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -114.12 137.49 51.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.877 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 6.0 mp -127.88 118.88 24.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 61.31 110.878 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.07 178.38 15.39 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.794 -0.717 . . . . 61.31 112.557 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -87.97 142.95 27.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.361 . . . . 75.42 110.882 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 244' ' ' VAL . 22.3 m -122.2 123.63 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 73.15 111.118 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 281' ' ' TYR . 21.6 t -119.91 129.19 75.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 74.45 111.156 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 3.3 t -100.86 162.3 13.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 73.42 111.16 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.07 -33.93 54.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 73.14 111.115 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.03 69.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 72.1 111.034 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -52.78 -76.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 72.23 111.097 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -179.36 34.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 52.43 110.878 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 71.29 -70.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.855 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -109.16 -102.5 2.76 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 63.23 112.466 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -173.59 138.63 4.67 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.625 -0.798 . . . . 65.32 112.445 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 61.9 mt -148.06 -41.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.835 0.35 . . . . 74.24 111.185 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -52.07 156.51 1.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 71.33 110.895 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 1.3 pt -132.21 155.11 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 74.32 111.114 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.33 -170.01 0.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 53.41 110.814 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.651 ' OD2' ' HB1' ' B' ' 221' ' ' ALA . 1.1 t70 -63.02 -169.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 74.01 110.885 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.26 112.24 14.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 70.11 110.876 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.558 HG21 ' HB3' ' A' ' 279' ' ' ASN . 9.9 t -69.09 134.78 49.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 60.41 111.143 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.439 HG23 ' HB3' ' A' ' 225' ' ' ARG . 0.2 OUTLIER -119.59 109.75 16.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 75.34 111.154 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -106.21 137.89 43.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 75.03 110.874 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 14.7 m -135.71 123.26 22.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 63.04 110.871 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.672 HG21 HD12 ' A' ' 277' ' ' ILE . 50.8 t -115.54 115.87 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 54.25 111.118 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -75.17 -75.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.021 0.439 . . . . 73.53 110.903 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.41 126.78 45.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 73.42 111.166 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.599 HG22 HD11 ' B' ' 231' ' ' ILE . 1.6 t -117.47 132.56 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 45.12 111.154 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 72.1 t -127.08 114.97 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 65.24 111.126 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.04 131.71 10.69 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.81 -0.71 . . . . 32.52 112.448 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.81 139.94 47.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.866 0.365 . . . . 63.54 110.924 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 47.71 79.5 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.669 -0.777 . . . . 75.34 112.554 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 49.3 77.66 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 73.34 110.86 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.421 ' H ' ' HB2' ' A' ' 237' ' ' ALA . 0.6 OUTLIER -98.08 145.26 26.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 72.33 110.853 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -111.06 127.41 55.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 75.12 110.906 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.739 ' HB ' HG12 ' A' ' 239' ' ' VAL . 73.0 t -131.06 122.58 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 74.43 111.133 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.685 HD12 ' CD2' ' A' ' 287' ' ' TRP . 0.5 OUTLIER -121.92 111.84 17.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 64.04 110.853 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.672 HD12 HG21 ' A' ' 264' ' ' VAL . 25.9 mm -110.24 103.94 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 72.44 111.144 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 142.61 -169.53 25.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.725 -0.75 . . . . 45.32 112.481 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.558 ' HB3' HG21 ' A' ' 260' ' ' THR . 2.5 p30 -112.59 155.95 23.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.78 0.324 . . . . 71.53 110.851 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.553 ' HG2' HG12 ' B' ' 244' ' ' VAL . 0.3 OUTLIER -121.04 141.3 50.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.43 110.842 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.447 ' HB2' HG22 ' A' ' 245' ' ' VAL . 2.3 m-85 -125.61 133.35 52.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 63.42 110.92 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 109.3 149.89 13.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.69 -0.767 . . . . 32.45 112.475 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.599 ' H ' ' HB2' ' B' ' 247' ' ' ALA . . . -68.15 -127.83 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 61.31 112.468 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.28 25.67 14.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.801 0.334 . . . . 53.42 110.875 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.4 133.41 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.685 -0.769 . . . . 41.55 112.523 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -52.44 131.48 33.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.783 0.325 . . . . 55.35 110.853 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.685 ' CD2' HD12 ' A' ' 276' ' ' LEU . 2.0 t90 60.44 59.66 2.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.88 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -51.56 103.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.296 -0.411 . . . . 70.04 110.849 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -172.37 31.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 63.4 110.872 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -155.27 -176.81 6.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 71.01 110.841 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -51.91 -74.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 64.22 110.774 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.3 -170.06 0.27 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 62.3 110.829 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -141.39 -169.85 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 75.02 110.889 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.44 -170.08 2.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 72.31 110.88 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 2.0 t60 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 72.24 110.848 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.839 0.352 . . . . 73.14 110.875 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.35 141.7 46.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 70.44 110.866 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 4.0 mp -139.59 68.83 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 61.44 111.087 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -95.21 116.62 28.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 70.43 110.826 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.651 ' HB1' ' OD2' ' A' ' 258' ' ' ASP . . . -178.32 151.04 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 71.4 111.114 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 16.4 pt -121.79 66.01 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 64.14 111.035 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.59 137.32 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 65.54 111.208 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . 0.503 ' HA2' HG23 ' B' ' 260' ' ' THR . . . -128.78 90.71 0.32 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.782 -0.723 . . . . 75.04 112.463 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 16.3 ttt-85 -101.88 124.51 47.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.856 0.36 . . . . 71.33 110.842 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.585 ' HB2' HG22 ' B' ' 277' ' ' ILE . 2.6 p-10 -121.68 129.67 52.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.24 110.886 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.2 p -124.04 145.19 49.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 63.45 110.868 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.19 119.71 23.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 74.22 111.073 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.73 -46.11 76.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 60.45 110.867 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -166.1 137.1 3.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 75.04 110.849 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.599 HD11 HG22 ' A' ' 267' ' ' VAL . 6.4 pt -140.08 132.88 34.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 73.43 111.16 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -135.33 138.43 43.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 55.11 110.883 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.755 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.5 OUTLIER -136.47 151.92 50.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.236 -0.438 . . . . 71.32 111.153 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -141.96 167.59 21.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.423 . . . . 71.33 110.908 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 72.81 -71.2 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.882 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -178.68 67.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 75.3 110.867 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.755 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -105.45 156.42 18.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 65.3 111.084 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -130.38 135.19 47.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 63.54 110.885 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.759 HG12 ' HB ' ' B' ' 275' ' ' VAL . 25.3 m -126.68 130.2 71.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 73.53 111.112 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.449 ' HB3' HD22 ' B' ' 276' ' ' LEU . 2.1 tt0 -119.07 119.89 35.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 75.52 110.942 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.82 118.57 35.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 71.12 110.945 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.07 175.09 13.81 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 61.44 112.462 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -85.99 136.2 33.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.894 0.378 . . . . 63.12 110.847 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.553 HG12 ' HG2' ' A' ' 280' ' ' GLU . 18.2 m -118.51 121.63 67.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 42.41 111.11 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.463 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 41.0 t -119.52 129.06 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 42.52 111.124 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.423 HG23 ' H ' ' B' ' 249' ' ' ALA . 12.3 t -83.32 175.19 10.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 63.42 111.164 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.599 ' HB2' ' H ' ' A' ' 283' ' ' GLY . . . -63.0 -42.09 99.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 70.44 111.047 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.85 77.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 71.12 111.126 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.463 ' HB3' ' CG1' ' B' ' 245' ' ' VAL . . . -74.3 90.94 2.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 44.1 111.052 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 6.9 mt -118.64 -47.34 2.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 62.53 110.911 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -83.45 142.07 31.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 75.55 110.853 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -100.01 -69.69 0.9 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 63.42 112.513 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 178.97 -165.82 35.04 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.724 -0.75 . . . . 71.52 112.496 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.56 -48.63 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.871 0.367 . . . . 64.11 111.152 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . 0.432 HH12 ' NE ' ' C' ' 255' ' ' ARG . 14.8 ptt85 -147.14 85.62 1.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 73.15 110.918 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . 0.61 HG22 ' O ' ' C' ' 255' ' ' ARG . 26.0 pt -135.69 140.86 43.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 52.12 111.105 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.5 t -133.83 98.05 4.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 64.13 110.851 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -129.07 163.27 25.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 65.4 110.928 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -149.38 80.32 1.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 74.52 110.851 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.503 HG23 ' HA2' ' B' ' 224' ' ' GLY . 8.7 t -66.17 126.18 27.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 73.2 111.13 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 94.2 m -131.84 108.98 9.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 71.23 111.144 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -108.96 136.56 48.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.85 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.84 123.76 21.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.483 . . . . 62.41 110.87 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.964 HG21 HD12 ' B' ' 277' ' ' ILE . 70.5 t -110.34 118.53 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 70.23 111.108 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -67.8 -75.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 73.41 110.884 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 24.7 p -129.56 133.69 47.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 73.3 111.229 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.755 HG23 HG11 ' B' ' 264' ' ' VAL . 2.9 t -118.37 129.37 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 70.23 111.164 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . 0.43 ' O ' HG12 ' B' ' 268' ' ' VAL . 2.2 t -127.36 114.79 37.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 61.41 111.099 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.78 132.42 10.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.678 -0.772 . . . . 51.54 112.45 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -132.09 143.25 49.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 72.54 110.934 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 42.98 69.11 0.67 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 33.32 112.429 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 63.57 101.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.836 0.35 . . . . 71.31 110.911 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 3.6 t -130.33 145.77 51.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 54.45 110.898 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -117.28 127.85 54.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 74.42 110.858 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.759 ' HB ' HG12 ' B' ' 239' ' ' VAL . 85.8 t -130.48 123.65 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 75.24 111.165 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.606 HD23 ' CZ2' ' B' ' 287' ' ' TRP . 0.3 OUTLIER -114.49 112.13 22.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 73.3 110.936 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.964 HD12 HG21 ' B' ' 264' ' ' VAL . 14.4 mm -108.47 104.94 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 74.34 111.108 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 135.7 -157.89 23.51 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.774 -0.727 . . . . 35.41 112.527 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.5 156.04 27.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 74.43 110.878 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.551 ' HG2' HG12 ' C' ' 244' ' ' VAL . 15.2 pt-20 -129.39 141.8 50.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 74.11 110.881 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -129.98 125.73 36.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 74.34 110.888 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 152.35 156.14 7.37 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.685 -0.769 . . . . 64.4 112.474 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . 0.469 ' N ' ' HB2' ' C' ' 247' ' ' ALA . . . -96.11 -53.19 1.52 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 72.43 112.521 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -52.08 103.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.845 0.355 . . . . 73.53 110.833 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 68.52 116.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.751 -0.737 . . . . 22.52 112.457 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' C' ' 244' ' ' VAL . 5.0 t80 -52.1 -33.44 39.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.828 0.347 . . . . 75.21 110.903 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.606 ' CZ2' HD23 ' B' ' 276' ' ' LEU . 15.9 t90 -172.26 -47.58 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 75.01 110.962 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.54 102.44 0.25 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 64.12 110.844 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.72 149.7 49.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 74.33 110.785 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -134.62 155.28 50.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 45.34 110.868 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -153.82 100.1 2.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 63.43 110.875 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.83 152.25 0.94 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.215 -0.448 . . . . 73.14 110.877 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 62.61 165.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 75.23 110.839 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -152.17 26.2 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 75.23 110.919 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 50.43 110.856 -179.928 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.849 0.357 . . . . 71.31 110.832 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . 0.571 ' C ' HD12 ' C' ' 219' ' ' ILE . 0.0 OUTLIER -108.09 -39.68 5.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 74.23 110.896 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.571 HD12 ' C ' ' C' ' 218' ' ' LYS . 4.0 mp 63.05 70.67 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 71.22 111.079 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 63.4 161.02 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 61.32 110.881 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -173.32 52.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 55.13 111.102 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 2.1 pt -106.72 31.43 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 73.44 111.124 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 33.7 m -149.6 151.77 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 74.12 111.107 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 155.09 150.73 5.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.74 . . . . 51.1 112.494 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.26 -65.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 73.53 110.85 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.05 120.63 41.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 75.14 110.864 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 3.3 t -129.67 138.69 51.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 71.02 110.894 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -119.04 131.98 56.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 73.21 111.133 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -33.05 34.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 70.12 110.901 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -166.01 138.0 3.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 72.33 110.864 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -138.69 117.31 13.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 73.54 111.143 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -131.82 130.23 41.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 63.35 110.898 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 0.2 OUTLIER -136.25 155.44 50.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.208 -0.451 . . . . 72.43 111.144 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -144.35 168.06 20.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 72.22 110.885 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.78 -72.23 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 73.31 110.856 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -177.99 64.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 75.55 110.85 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.607 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -105.69 156.46 18.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 35.3 111.087 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -128.79 135.25 48.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 71.23 110.892 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.828 HG12 ' HB ' ' C' ' 275' ' ' VAL . 20.9 m -126.14 121.6 59.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.469 . . . . 62.33 111.117 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.611 ' HB3' HD22 ' C' ' 276' ' ' LEU . 1.8 tt0 -115.63 120.65 40.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 54.11 110.913 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.74 HD22 HG22 ' B' ' 264' ' ' VAL . 3.3 mp -114.96 118.72 34.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 72.44 110.935 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.48 178.23 15.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 74.34 112.503 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -85.65 128.52 34.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.857 0.36 . . . . 71.02 110.891 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.551 HG12 ' HG2' ' B' ' 280' ' ' GLU . 28.5 m -114.07 128.4 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 75.21 111.136 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 46.8 t -122.17 129.02 75.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 73.21 111.086 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -77.5 174.27 11.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 74.41 111.126 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.469 ' HB2' ' N ' ' B' ' 283' ' ' GLY . . . -57.04 -41.03 77.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 73.53 111.045 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' C' ' 249' ' ' ALA . . . -57.1 -51.91 67.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 44.04 111.044 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' C' ' 248' ' ' ALA . . . 71.88 -70.58 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 62.22 111.088 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . 0.639 ' HB3' HD11 ' C' ' 256' ' ' ILE . 0.6 OUTLIER -137.58 178.13 7.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 73.1 110.911 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -106.63 -64.23 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 71.44 110.873 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 167.07 37.22 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.77 -0.729 . . . . 71.11 112.534 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -176.44 31.47 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 34.21 112.572 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . 0.795 HD13 ' HB1' ' D' ' 249' ' ' ALA . 2.2 tt -138.11 145.69 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.76 0.314 . . . . 74.23 111.18 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . 0.61 ' O ' HG22 ' B' ' 256' ' ' ILE . 0.0 OUTLIER -94.16 -26.12 16.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 54.3 110.852 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . 0.639 HD11 ' HB3' ' C' ' 250' ' ' LEU . 65.5 mt 61.31 101.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 52.42 111.147 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.29 136.97 52.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.815 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -92.93 81.88 4.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 64.44 110.914 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.73 26.13 9.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 75.04 110.925 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . 0.794 HG21 ' HB3' ' C' ' 279' ' ' ASN . 4.9 t -100.94 130.01 46.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 71.22 111.125 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 18.7 m -126.58 118.96 25.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.261 -0.427 . . . . 74.42 111.121 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . 0.602 ' OD1' HG23 ' C' ' 277' ' ' ILE . 6.7 t-20 -120.63 144.63 48.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 62.11 110.866 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 9.4 t -141.62 123.85 15.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 71.53 110.905 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.796 HG21 HD12 ' C' ' 277' ' ' ILE . 46.2 t -108.07 145.86 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 64.12 111.205 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.92 -55.69 3.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 74.32 110.84 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.46 128.51 11.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 73.35 111.165 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.761 HG23 HG11 ' C' ' 264' ' ' VAL . 54.4 t -118.75 120.42 64.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 72.02 111.106 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.14 118.06 47.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 74.33 111.16 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.9 133.23 10.1 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.715 -0.755 . . . . 35.45 112.502 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -125.44 147.75 49.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 74.23 110.869 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 47.2 67.85 1.35 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.812 -0.709 . . . . 43.24 112.474 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 64.14 107.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.883 0.373 . . . . 72.24 110.899 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 3.3 m -139.8 150.16 44.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 73.2 110.865 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -124.72 128.24 48.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.831 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.828 ' HB ' HG12 ' C' ' 239' ' ' VAL . 89.8 t -132.28 123.34 50.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 75.25 111.134 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.2 OUTLIER -116.98 117.14 28.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 70.34 110.921 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.796 HD12 HG21 ' C' ' 264' ' ' VAL . 24.9 mm -110.63 104.24 16.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 74.01 111.134 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.03 -162.74 25.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.743 . . . . 55.43 112.491 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . 0.794 ' HB3' HG21 ' C' ' 260' ' ' THR . 8.1 p-10 -106.66 155.97 19.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.787 0.327 . . . . 72.33 110.897 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.642 ' HG3' HG12 ' D' ' 244' ' ' VAL . 2.7 pp20? -131.22 150.15 52.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 71.32 110.852 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.562 ' CE2' HG23 ' C' ' 256' ' ' ILE . 10.8 m-85 -130.05 126.03 36.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 52.11 110.905 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 145.75 141.97 3.73 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.745 -0.741 . . . . 73.21 112.499 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -112.2 -169.5 18.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.732 . . . . 44.23 112.463 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 7.8 tttt 53.89 29.44 9.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 73.25 110.879 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -179.11 -35.26 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.683 -0.77 . . . . 72.34 112.415 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.448 ' CE1' HG21 ' D' ' 244' ' ' VAL . 5.4 t80 71.9 -69.25 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.898 0.38 . . . . 75.22 110.912 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -156.3 -63.46 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 74.53 110.87 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.01 178.06 8.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 72.31 110.85 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -141.0 177.04 8.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 75.15 110.863 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -174.12 -171.21 0.6 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 75.45 110.899 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -175.95 158.3 2.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.12 110.81 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -168.34 -44.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 72.14 110.874 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.41 -175.58 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 75.11 110.901 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -115.13 -69.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 71.15 110.877 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 54.33 110.877 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 4.3 ptp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.855 0.36 . . . . 70.03 110.916 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 15.7 pttt -132.82 134.5 44.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 71.31 110.91 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 45.0 pt -127.17 160.62 35.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 74.12 111.164 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -166.01 147.07 6.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 74.54 110.883 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -139.7 81.87 1.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 61.51 111.076 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 22.5 pt -105.99 166.44 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 65.4 111.106 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 24.9 t 57.62 93.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 73.32 111.178 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -145.52 135.53 6.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.672 -0.775 . . . . 62.23 112.446 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.78 -73.35 0.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.882 0.372 . . . . 72.15 110.879 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . 0.637 ' HB3' HG22 ' D' ' 277' ' ' ILE . 0.1 OUTLIER -89.44 111.98 23.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 73.32 110.887 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.77 137.58 54.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 62.23 110.786 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.09 155.94 37.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.114 -0.493 . . . . 75.21 111.094 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.88 -29.8 8.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 75.01 110.895 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . 0.46 ' HB3' HG23 ' D' ' 266' ' ' THR . 0.3 OUTLIER -165.49 138.31 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 63.32 110.884 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 2.4 mt -138.91 117.28 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.144 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . 0.457 ' HD2' HG23 ' D' ' 268' ' ' VAL . 0.8 OUTLIER -131.64 131.23 43.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.14 110.936 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' D' ' 237' ' ' ALA . 0.2 OUTLIER -136.28 155.9 49.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 70.41 111.086 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -148.28 166.91 26.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 72.44 110.876 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.9 -71.99 0.12 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.104 -0.498 . . . . 73.02 110.861 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -177.0 63.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 74.05 110.845 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -104.76 154.51 19.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 62.45 111.158 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -130.01 134.98 47.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 71.53 110.93 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.782 HG12 ' HB ' ' D' ' 275' ' ' VAL . 21.6 m -127.89 121.19 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 70.31 111.154 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -121.31 128.58 52.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 74.32 110.964 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 mp -120.66 118.79 31.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 65.53 110.917 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 143.14 179.0 19.48 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.752 -0.737 . . . . 73.52 112.474 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -85.83 129.11 34.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.919 0.39 . . . . 71.33 110.864 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . 0.642 HG12 ' HG3' ' C' ' 280' ' ' GLU . 35.1 m -111.39 129.52 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 64.15 111.138 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.31 129.03 75.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 61.02 111.138 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 21.5 p -77.6 174.84 10.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 63.34 111.138 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.1 85.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 74.33 111.144 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' D' ' 249' ' ' ALA . . . -57.03 -52.01 66.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 70.13 111.136 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . 0.795 ' HB1' HD13 ' C' ' 254' ' ' ILE . . . 68.83 -77.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 74.11 111.105 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . 0.622 HD13 ' HB1' ' E' ' 247' ' ' ALA . 0.2 OUTLIER 56.78 94.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 72.44 110.907 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . 0.57 ' O ' HD12 ' C' ' 254' ' ' ILE . 9.3 m-70 63.41 173.32 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 74.53 110.887 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 112.15 119.34 3.73 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.704 -0.76 . . . . 70.43 112.49 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -167.14 -159.81 13.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.813 -0.708 . . . . 63.0 112.528 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . 0.651 HG22 HG12 ' D' ' 256' ' ' ILE . 29.9 mm 63.68 106.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.825 0.345 . . . . 70.45 111.128 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 57.1 ttp85 -81.87 98.74 8.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 75.33 110.893 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . 0.651 HG12 HG22 ' D' ' 254' ' ' ILE . 2.1 pt -153.14 90.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 64.13 111.108 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.71 100.58 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 70.11 110.88 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . 0.639 ' OD2' HD12 ' D' ' 256' ' ' ILE . 2.7 p30 -174.3 -168.99 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 73.24 110.864 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.7 -74.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 74.14 110.949 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 5.4 t -86.31 121.56 29.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 72.21 111.151 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 3.1 m -134.53 126.77 30.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 72.31 111.192 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . 0.525 ' ND2' HG23 ' D' ' 277' ' ' ILE . 3.1 t30 -126.08 139.61 53.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.295 -0.411 . . . . 74.01 110.955 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 7.9 t -142.09 123.81 15.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 74.43 110.844 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.721 HG21 HD12 ' D' ' 277' ' ' ILE . 21.7 t -114.34 149.61 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 70.3 111.172 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.84 -77.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 72.44 110.939 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . 0.46 HG23 ' HB3' ' D' ' 230' ' ' ASP . 1.5 m -127.71 127.83 44.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 63.14 111.108 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.568 ' CG2' HG11 ' D' ' 264' ' ' VAL . 98.2 t -118.69 120.41 64.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 75.02 111.122 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . 0.457 HG23 ' HD2' ' D' ' 232' ' ' ARG . 4.7 p -126.53 117.81 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 74.44 111.102 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.72 132.65 10.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 44.24 112.427 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -126.02 147.13 49.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.341 . . . . 73.12 110.84 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 44.86 76.75 0.11 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.769 -0.729 . . . . 65.55 112.475 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.74 98.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.802 0.334 . . . . 70.23 110.899 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 4.1 t -130.18 145.33 51.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 53.52 110.908 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -123.97 127.97 48.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 60.24 110.849 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.782 ' HB ' HG12 ' D' ' 239' ' ' VAL . 94.3 t -135.56 123.38 37.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 73.32 111.106 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.438 HD13 ' N ' ' D' ' 277' ' ' ILE . 1.1 tm? -121.72 119.57 32.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 73.51 110.893 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.721 HD12 HG21 ' D' ' 264' ' ' VAL . 27.5 mm -112.29 104.24 16.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 71.34 111.165 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.3 -159.07 27.44 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.75 -0.738 . . . . 52.01 112.52 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -115.92 156.12 26.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.77 0.319 . . . . 64.4 110.917 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . 0.506 ' HG2' HG13 ' E' ' 244' ' ' VAL . 10.4 pt-20 -126.03 134.92 51.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 74.13 110.803 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . 0.468 ' CZ ' HG21 ' E' ' 245' ' ' VAL . 7.5 m-85 -120.32 125.94 49.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 72.21 110.958 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.01 158.36 7.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.79 -0.719 . . . . 60.13 112.544 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . 0.575 ' N ' ' HB2' ' E' ' 247' ' ' ALA . . . -104.57 63.93 0.34 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 62.1 112.416 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.94 32.91 1.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.8 0.333 . . . . 73.11 110.876 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 78.98 -67.82 3.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 35.44 112.459 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -178.81 108.75 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 71.05 110.852 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 72.0 -69.44 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 74.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -163.37 160.57 23.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.1 110.859 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.08 111.61 21.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 70.14 110.88 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.54 -61.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 73.43 110.869 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -52.19 159.26 0.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 62.34 110.836 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -165.87 -74.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 72.43 110.908 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -74.3 159.34 32.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 64.24 110.896 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -178.96 -175.9 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 70.54 110.883 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.807 179.939 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.857 0.36 . . . . 54.22 110.883 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 172.7 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 64.05 110.918 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 9.7 tp -160.46 142.77 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 70.02 111.165 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -128.68 133.91 48.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.52 110.895 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -111.38 -179.13 3.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 73.44 111.142 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 2.1 pt -152.18 149.41 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 64.05 111.171 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 12.5 p -96.13 131.34 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 75.02 111.174 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.21 -153.29 51.99 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.728 -0.749 . . . . 71.54 112.535 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . 0.501 ' N ' HG23 ' E' ' 261' ' ' THR . 0.9 OUTLIER 62.1 -169.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.824 0.345 . . . . 51.11 110.874 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -83.8 109.92 17.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 72.51 110.857 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.43 139.85 45.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.2 110.824 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.38 162.06 26.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 75.44 111.151 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.05 -26.87 7.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 61.13 110.887 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . 0.439 ' HB3' HG23 ' E' ' 266' ' ' THR . 0.4 OUTLIER -164.82 138.62 4.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.43 . . . . 75.12 110.841 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . 0.409 HD11 HG13 ' D' ' 264' ' ' VAL . 5.0 mt -138.55 117.35 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 73.43 111.127 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.32 131.23 39.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 72.13 110.791 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.29 157.81 45.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 50.41 111.128 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -150.29 167.55 26.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 62.51 110.933 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 72.09 -73.35 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 74.51 110.846 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -178.29 62.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 70.03 110.85 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.34 156.45 17.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 61.32 111.196 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.19 135.15 47.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 73.11 110.856 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.795 HG12 ' HB ' ' E' ' 275' ' ' VAL . 18.0 m -122.74 121.84 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 72.32 111.143 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . 0.625 ' O ' HD23 ' E' ' 276' ' ' LEU . 2.0 tt0 -119.59 114.41 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.23 110.921 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.481 HD13 ' CD1' ' D' ' 277' ' ' ILE . 3.3 mp -114.84 135.09 54.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 61.51 110.976 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.06 -120.18 2.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.718 -0.754 . . . . 62.21 112.508 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -144.0 128.85 18.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.884 0.373 . . . . 71.43 110.851 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.506 HG13 ' HG2' ' D' ' 280' ' ' GLU . 0.4 OUTLIER -102.86 119.6 51.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 74.35 111.16 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . 0.468 HG21 ' CZ ' ' D' ' 281' ' ' TYR . 41.2 t -122.05 123.52 69.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 72.2 111.138 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.1 t -74.43 174.88 8.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 61.34 111.133 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . 0.622 ' HB1' HD13 ' D' ' 250' ' ' LEU . . . -53.22 -45.64 68.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 75.44 111.099 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.92 -49.8 74.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 71.53 111.132 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 52.69 -169.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 44.4 111.073 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' E' ' 250' ' ' LEU . 0.4 OUTLIER -122.46 89.57 3.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 64.51 110.958 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -52.31 122.82 9.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 74.54 110.819 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -167.58 -117.45 0.4 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 62.11 112.529 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 152.64 120.19 0.83 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.776 -0.726 . . . . 75.42 112.559 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.56 -177.04 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.862 0.363 . . . . 51.42 111.095 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.96 -47.34 1.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 64.24 110.878 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 3.9 tt -177.07 126.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 75.14 111.131 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.21 -171.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 75.14 110.891 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -159.57 155.06 25.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 73.43 110.922 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -146.49 -74.32 0.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 50.5 110.9 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . 0.688 HG21 ' OD1' ' E' ' 279' ' ' ASN . 4.1 t -67.17 135.78 54.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 75.13 111.168 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . 0.501 HG23 ' N ' ' E' ' 225' ' ' ARG . 34.9 m -133.4 123.56 25.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 63.34 111.129 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . 0.638 ' ND2' HG23 ' E' ' 277' ' ' ILE . 0.8 OUTLIER -126.12 123.45 38.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 71.32 110.858 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 43.2 t -127.18 123.81 37.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 60.14 110.878 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . 0.566 HG21 HD12 ' E' ' 277' ' ' ILE . 21.2 t -124.32 150.34 28.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 55.05 111.102 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.01 -77.5 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 72.04 110.865 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . 0.439 HG23 ' HB3' ' E' ' 230' ' ' ASP . 9.4 m -126.37 127.83 46.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 64.22 111.162 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . 0.544 ' CG2' HG11 ' E' ' 264' ' ' VAL . 22.0 t -119.08 120.16 63.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 63.4 111.156 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . 0.417 ' O ' HG13 ' E' ' 268' ' ' VAL . 4.1 p -123.78 118.18 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 73.34 111.154 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.28 136.18 13.39 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.756 -0.735 . . . . 74.23 112.399 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -132.58 133.54 43.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.756 0.313 . . . . 74.24 110.897 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.81 93.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 53.25 112.522 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 44.1 69.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 70.22 110.826 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.34 145.25 26.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 62.13 110.817 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 4.7 mtm180 -127.24 128.19 45.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 73.32 110.872 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.795 ' HB ' HG12 ' E' ' 239' ' ' VAL . 84.2 t -136.85 123.92 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 74.32 111.134 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.625 HD23 ' O ' ' E' ' 240' ' ' GLN . 0.5 OUTLIER -125.64 122.55 36.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 70.52 110.899 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.638 HG23 ' ND2' ' E' ' 262' ' ' ASN . 30.4 mm -112.0 104.53 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 74.4 111.169 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 135.07 -169.84 23.14 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.755 . . . . 74.53 112.518 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . 0.688 ' OD1' HG21 ' E' ' 260' ' ' THR . 2.3 p-10 -99.82 155.96 17.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 71.43 110.897 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -130.6 132.03 45.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.491 . . . . 50.22 110.856 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -113.8 125.9 54.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 73.42 110.874 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 133.48 104.29 0.86 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.742 -0.742 . . . . 73.32 112.485 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -67.63 -121.05 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.797 -0.716 . . . . 73.24 112.465 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp 62.71 25.79 15.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.815 0.34 . . . . 63.31 110.921 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 126.64 -162.5 20.78 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.757 . . . . 54.25 112.471 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -110.99 118.11 35.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.857 0.36 . . . . 74.22 110.868 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . 0.556 ' NE1' HD12 ' E' ' 276' ' ' LEU . 1.6 t90 72.32 -69.0 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 74.11 110.92 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -113.87 151.61 31.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 54.22 110.846 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -100.06 81.63 2.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 75.41 110.95 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -67.44 174.99 3.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 73.22 110.875 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.07 -171.14 2.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 44.43 110.915 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -121.35 159.24 26.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 73.44 110.835 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -125.43 -37.51 2.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 74.14 110.851 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -153.17 -71.34 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 72.44 110.826 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 60.5 t60 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 75.33 110.887 179.98 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 17.8 ptm . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.734 0.302 . . . . 63.02 110.876 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.483 ' O ' HG23 ' A' ' 219' ' ' ILE . 21.0 mmtt -120.04 -74.14 0.62 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.445 . . . . 73.14 110.906 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.529 HD12 ' CG2' ' B' ' 219' ' ' ILE . 0.2 OUTLIER -166.43 -75.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 71.33 111.167 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.03 -171.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 74.0 110.932 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -166.94 139.64 3.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 74.33 111.117 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 1.9 tt -55.12 124.15 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 74.0 111.18 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 17.1 m -151.46 -177.88 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 60.31 111.112 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 152.35 113.67 0.56 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.764 -0.732 . . . . 42.44 112.515 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.651 ' HG3' HG23 ' A' ' 261' ' ' THR . 0.8 OUTLIER -179.29 -175.85 0.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.867 0.365 . . . . 74.42 110.879 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.27 130.35 26.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 62.35 110.876 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 48.4 t -121.81 137.69 54.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.478 . . . . 74.1 110.843 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.62 128.18 34.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 64.23 111.111 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.67 -37.14 13.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.938 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.535 ' HB3' HG23 ' A' ' 266' ' ' THR . 0.7 OUTLIER -164.38 138.9 5.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 63.51 110.878 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.485 HG21 HG21 ' A' ' 239' ' ' VAL . 7.7 mt -137.25 117.53 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 63.5 111.116 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -124.98 117.04 23.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 75.42 110.839 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.31 131.2 36.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 45.13 111.123 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -132.95 164.9 25.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 51.14 110.906 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 236' ' ' ARG . 2.7 tt0 65.0 79.53 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 72.43 110.897 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 235' ' ' GLU . 16.9 ptt180 35.29 60.46 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 74.52 110.918 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.29 152.75 21.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 44.42 111.136 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -129.28 142.52 50.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 74.35 110.831 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.485 HG21 HG21 ' A' ' 231' ' ' ILE . 6.1 p -143.02 121.65 7.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 63.43 111.124 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -108.84 137.46 46.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 72.5 110.98 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.58 118.65 22.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 64.33 110.891 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 131.37 -172.61 20.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.708 -0.758 . . . . 75.12 112.504 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -92.24 139.19 30.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.909 0.385 . . . . 74.54 110.909 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.02 129.7 65.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 75.54 111.21 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 89.5 t -122.07 127.28 75.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 72.11 111.127 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 281' ' ' TYR . 53.6 p -82.9 163.21 21.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 71.11 111.155 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.48 -41.47 98.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 53.31 111.127 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.85 80.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 71.23 111.061 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -55.64 -75.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 43.51 111.113 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.32 126.92 33.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.895 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -167.87 29.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 53.03 110.867 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 136.3 -20.29 3.56 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 54.01 112.534 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -60.42 -178.51 1.97 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.739 . . . . 23.13 112.492 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.1 pp -149.63 -174.96 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.851 0.358 . . . . 74.21 111.121 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 63.25 104.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 71.23 110.875 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 2.9 mp -99.57 -39.65 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 75.1 111.126 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.7 t 62.29 -174.65 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 65.02 110.901 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -60.63 -172.28 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.103 -0.499 . . . . 64.01 110.81 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.76 175.61 9.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.132 -0.486 . . . . 50.51 110.902 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.681 HG23 ' C ' ' B' ' 224' ' ' GLY . 99.6 m -101.01 137.96 38.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.262 -0.426 . . . . 52.21 111.132 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.651 HG23 ' HG3' ' A' ' 225' ' ' ARG . 98.4 m -112.91 111.74 22.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 73.5 111.159 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -111.48 150.3 30.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 44.41 110.805 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 4.4 t -138.31 123.97 19.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 53.24 110.951 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.513 HG21 ' CG2' ' A' ' 267' ' ' VAL . 9.7 p -108.81 135.77 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.45 111.135 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.32 -75.96 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 53.15 110.952 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.535 HG23 ' HB3' ' A' ' 230' ' ' ASP . 1.6 m -130.14 131.98 45.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 73.42 111.153 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.513 ' CG2' HG21 ' A' ' 264' ' ' VAL . 96.7 t -117.89 131.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 55.24 111.147 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 58.6 t -127.55 128.03 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 71.33 111.117 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.98 133.62 7.87 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.735 -0.745 . . . . 42.13 112.515 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -132.8 147.77 52.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.793 0.33 . . . . 65.44 110.877 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.28 78.17 0.11 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.761 -0.733 . . . . 63.0 112.459 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 47.59 64.58 1.55 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.882 0.372 . . . . 71.23 110.941 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 26.3 t -92.93 145.65 24.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 62.43 110.873 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -126.39 128.31 46.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 70.54 110.929 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.693 HG13 HG13 ' B' ' 239' ' ' VAL . 20.6 t -128.92 123.59 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 62.44 111.137 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.425 HD23 ' CZ2' ' A' ' 287' ' ' TRP . 0.2 OUTLIER -111.07 117.24 32.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 64.34 110.917 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.15 112.41 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 71.05 111.152 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 133.01 -164.91 24.11 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 52.2 112.443 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -103.8 152.61 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.877 0.37 . . . . 62.42 110.84 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.537 ' HG3' HG12 ' B' ' 244' ' ' VAL . 1.4 pp20? -131.49 134.51 46.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 73.24 110.968 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.457 ' O ' HG23 ' A' ' 246' ' ' THR . 0.2 OUTLIER -112.4 125.94 54.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 73.45 110.915 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.84 135.8 3.17 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.717 -0.754 . . . . 71.42 112.521 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -111.22 177.11 18.94 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.691 -0.766 . . . . 73.53 112.441 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt 52.0 53.4 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 55.11 110.871 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 177.56 -69.02 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.822 -0.704 . . . . 40.25 112.521 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 2.1 t80 64.34 109.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 75.32 110.823 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.425 ' CZ2' HD23 ' A' ' 276' ' ' LEU . 0.8 OUTLIER 72.93 -67.77 0.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 62.41 110.875 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -156.23 179.22 9.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 64.15 110.828 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.24 149.72 5.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 53.44 110.88 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.91 176.05 8.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 75.41 110.846 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -151.41 -66.99 0.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 72.5 110.903 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.02 150.13 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 64.35 110.842 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -177.0 49.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 72.05 110.846 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -171.95 149.58 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 75.14 110.877 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 74.5 110.843 179.998 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 9.0 mtt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.832 0.348 . . . . 72.52 110.912 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.56 141.06 37.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 73.34 110.922 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . 0.529 ' CG2' HD12 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -71.43 178.67 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 62.2 111.124 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -95.52 63.13 2.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 73.24 110.841 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.425 ' C ' HD12 ' B' ' 222' ' ' ILE . . . -171.77 104.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 75.54 111.15 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . 0.934 HG22 HG23 ' B' ' 223' ' ' VAL . 5.2 mp -142.18 144.05 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.426 . . . . 65.03 111.143 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.934 HG23 HG22 ' B' ' 222' ' ' ILE . 22.7 t 62.55 100.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 72.52 111.08 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . 0.681 ' C ' HG23 ' A' ' 260' ' ' THR . . . 164.61 88.02 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.741 . . . . 64.05 112.51 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.567 ' N ' HG23 ' A' ' 260' ' ' THR . 0.4 OUTLIER -179.49 118.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.806 0.336 . . . . 74.14 110.922 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.34 123.44 14.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 75.21 110.93 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 1.4 t -121.51 137.71 54.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 64.3 110.86 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.549 ' HB2' HD11 ' B' ' 241' ' ' LEU . . . -127.7 129.16 46.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 72.15 111.082 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.26 -35.28 23.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 72.02 110.953 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . 0.611 ' HB3' HG23 ' B' ' 266' ' ' THR . 0.3 OUTLIER -164.56 138.42 5.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.869 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.736 HG21 HG21 ' B' ' 239' ' ' VAL . 11.2 mt -137.64 117.6 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 63.41 111.059 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -130.64 119.3 22.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 73.03 110.846 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.02 131.41 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 70.51 111.148 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -132.04 167.3 19.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 73.55 110.837 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' B' ' 236' ' ' ARG . 0.1 OUTLIER 64.24 78.43 0.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 71.24 110.868 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' B' ' 235' ' ' GLU . 11.0 ptt180 36.34 54.84 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 73.34 110.931 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -100.61 156.15 17.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 52.03 111.137 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -132.59 136.3 46.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 53.13 110.877 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.736 HG21 HG21 ' B' ' 231' ' ' ILE . 6.2 p -137.24 121.71 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 70.42 111.177 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.495 ' OE1' HD11 ' B' ' 276' ' ' LEU . 0.5 OUTLIER -114.22 137.48 51.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 72.15 110.891 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' B' ' 228' ' ' ALA . 0.3 OUTLIER -128.71 118.6 23.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 74.12 110.897 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.7 176.45 14.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.718 -0.753 . . . . 65.44 112.536 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -85.95 133.48 33.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.882 0.372 . . . . 75.02 110.841 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.537 HG12 ' HG3' ' A' ' 280' ' ' GLU . 33.7 m -116.51 132.18 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 74.33 111.105 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 60.1 t -122.04 120.26 60.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 65.31 111.123 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.505 HG23 ' O ' ' B' ' 281' ' ' TYR . 33.6 p -84.68 163.21 19.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 73.14 111.126 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.47 -36.95 84.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 64.23 111.13 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -62.06 -36.51 81.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 65.53 111.138 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -52.31 -75.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 51.41 111.017 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -178.3 174.8 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 61.51 110.969 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -103.07 -26.14 13.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 73.04 110.844 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 172.17 85.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.781 -0.723 . . . . 63.24 112.526 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 174.32 147.43 6.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.735 -0.745 . . . . 75.44 112.53 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 46.1 pt -137.68 -178.02 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.348 . . . . 71.12 111.111 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.23 -64.25 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 73.3 110.869 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 11.0 tt -125.14 124.61 67.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 75.24 111.176 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 14.9 p -179.04 164.81 1.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 65.21 110.824 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.642 ' O ' HG23 ' B' ' 260' ' ' THR . 0.3 OUTLIER -139.51 163.85 31.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 75.43 110.841 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.33 101.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.24 110.933 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.642 HG23 ' O ' ' B' ' 258' ' ' ASP . 49.2 p -101.09 122.55 43.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.438 . . . . 75.14 111.147 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 1.1 t -134.14 108.95 8.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 75.54 111.172 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.544 ' ND2' HG22 ' B' ' 277' ' ' ILE . 11.4 p-10 -95.94 149.52 21.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 60.43 110.897 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 44.6 m -140.22 124.08 17.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 61.12 110.852 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.486 HG21 ' CG2' ' B' ' 267' ' ' VAL . 13.4 p -109.58 131.62 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.48 . . . . 71.41 111.125 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -73.63 -76.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 73.14 110.835 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.611 HG23 ' HB3' ' B' ' 230' ' ' ASP . 1.3 m -131.52 135.38 47.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 71.11 111.118 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.659 ' CG1' HG21 ' B' ' 275' ' ' VAL . 85.5 t -117.67 128.4 74.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 74.22 111.151 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 68.8 t -127.23 119.47 52.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 53.22 111.104 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.3 132.98 9.05 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.743 -0.742 . . . . 64.42 112.461 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.65 147.93 51.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 72.34 110.902 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.44 82.66 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.753 . . . . 55.23 112.478 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 46.3 63.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 75.14 110.849 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 25.7 t -96.78 145.66 25.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 72.42 110.867 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.12 127.99 46.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 65.11 110.859 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.659 HG21 ' CG1' ' B' ' 267' ' ' VAL . 21.6 t -130.85 123.77 55.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 71.24 111.135 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.495 HD11 ' OE1' ' B' ' 240' ' ' GLN . 0.4 OUTLIER -114.86 116.76 29.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 63.12 110.887 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.544 HG22 ' ND2' ' B' ' 262' ' ' ASN . 25.4 mm -110.79 104.18 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 74.24 111.146 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.49 -176.91 21.54 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.781 -0.723 . . . . 72.43 112.463 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -92.17 147.12 23.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.727 0.299 . . . . 71.41 110.91 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.597 ' HG3' HG12 ' C' ' 244' ' ' VAL . 0.0 OUTLIER -128.45 141.7 51.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 65.51 110.858 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.505 ' O ' HG23 ' B' ' 246' ' ' THR . 0.8 OUTLIER -127.1 125.99 42.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.181 -0.463 . . . . 75.11 110.952 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 168.26 151.22 6.98 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.769 -0.729 . . . . 72.13 112.496 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -53.82 176.23 0.31 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.781 -0.723 . . . . 62.32 112.497 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.88 104.76 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 75.41 110.883 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -159.05 -38.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.805 -0.712 . . . . 61.31 112.541 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.66 ' CE1' HD21 ' C' ' 276' ' ' LEU . 10.6 t80 64.43 111.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.858 0.361 . . . . 61.44 110.881 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.441 ' HE1' HD23 ' B' ' 276' ' ' LEU . 0.0 OUTLIER 71.61 -72.14 0.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 75.3 110.885 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -135.09 126.05 27.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 61.52 110.939 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.61 100.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 65.43 110.849 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -175.49 139.45 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 72.22 110.905 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -178.49 157.01 0.97 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 73.24 110.871 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.58 130.93 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 71.35 110.885 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -154.61 169.09 24.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 71.33 110.869 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.54 -177.83 3.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 62.45 110.829 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 64.33 110.933 179.944 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . 0.412 ' N ' HD11 ' C' ' 219' ' ' ILE . 1.4 mtp . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.919 0.39 . . . . 72.0 110.867 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 21.2 mttt 58.62 69.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 71.54 110.897 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.412 HD11 ' N ' ' C' ' 217' ' ' MET . 2.1 mp -127.43 147.07 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 73.12 111.187 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -148.14 171.17 16.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 61.41 110.864 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -76.42 74.33 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 65.43 111.088 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 1.5 pt -84.67 -177.33 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 63.14 111.189 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . 0.706 HG21 ' HA ' ' D' ' 257' ' ' SER . 21.6 t -82.71 150.57 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 72.15 111.078 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 70.6 62.43 3.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 70.51 112.485 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.52 111.38 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 73.23 110.844 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -83.91 139.69 32.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 70.22 110.917 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.88 144.64 50.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.35 110.82 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.94 143.09 51.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 73.35 111.134 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.35 -32.61 12.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 75.32 110.898 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . 0.622 ' HB3' HG22 ' C' ' 266' ' ' THR . 0.2 OUTLIER -165.04 137.85 4.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 72.13 110.924 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.462 HG21 HG21 ' C' ' 239' ' ' VAL . 16.7 mt -137.34 117.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 74.22 111.078 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -132.71 115.87 15.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 74.25 110.861 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -135.41 135.48 40.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.461 . . . . 74.31 111.123 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.48 166.99 23.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 72.2 110.88 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 66.87 72.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 74.43 110.93 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 44.32 53.26 6.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 72.15 110.84 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.2 147.9 26.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 72.41 111.047 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.0 135.75 52.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.868 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.56 HG13 HG13 ' B' ' 275' ' ' VAL . 6.0 p -133.78 121.86 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.54 111.098 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -108.77 136.55 48.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 73.21 110.946 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.17 119.21 22.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 65.05 110.888 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.15 173.66 13.46 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.758 -0.734 . . . . 73.01 112.439 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -85.81 134.22 33.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 73.34 110.865 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.597 HG12 ' HG3' ' B' ' 280' ' ' GLU . 30.9 m -113.45 131.95 63.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.082 -0.508 . . . . 60.33 111.156 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.18 129.24 75.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 74.35 111.145 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 12.9 p -86.71 169.33 12.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 61.44 111.185 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.03 76.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 73.21 111.174 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.37 76.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 71.41 111.106 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.96 103.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 63.53 111.126 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 19.1 mt -140.47 -45.12 0.41 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 61.22 110.867 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.76 167.89 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 61.21 110.87 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -65.95 -77.02 0.29 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.734 -0.746 . . . . 61.24 112.471 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -170.37 71.84 0.12 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 74.44 112.467 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 5.0 pt -137.31 146.86 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 63.43 111.114 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -135.75 76.96 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 74.11 110.884 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.44 178.0 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.162 -0.472 . . . . 62.33 111.103 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 76.5 p -124.44 73.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 71.45 110.899 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.55 178.38 8.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 75.0 110.847 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -178.77 174.33 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 74.52 110.951 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . 0.533 HG21 ' CG ' ' D' ' 243' ' ' ASN . 29.3 m -100.85 137.89 38.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 75.5 111.127 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.612 HG23 ' CB ' ' D' ' 225' ' ' ARG . 1.5 t -125.01 133.17 53.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 31.22 111.149 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . 0.479 ' ND2' HG22 ' C' ' 277' ' ' ILE . 0.8 OUTLIER -126.8 145.73 50.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 71.14 110.893 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.69 123.39 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 63.21 110.885 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.462 HG21 ' CG2' ' C' ' 267' ' ' VAL . 7.9 p -110.48 127.77 67.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 60.35 111.081 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.91 -71.83 0.26 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.107 -0.497 . . . . 71.14 110.847 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . 0.622 HG22 ' HB3' ' C' ' 230' ' ' ASP . 5.7 p -140.48 137.18 33.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 52.3 111.081 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.694 ' CG1' HG21 ' C' ' 275' ' ' VAL . 19.2 t -116.8 128.36 74.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 60.21 111.18 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . 0.405 ' O ' HG12 ' C' ' 268' ' ' VAL . 2.0 t -127.24 117.91 48.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 73.43 111.137 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.1 132.74 9.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.736 -0.745 . . . . 62.45 112.452 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.81 140.94 48.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 71.52 110.931 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 46.58 84.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.701 -0.761 . . . . 64.34 112.49 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 51.1 82.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.885 0.374 . . . . 53.24 110.87 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 29.2 t -116.44 145.61 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 63.42 110.881 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -128.97 127.62 42.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.488 . . . . 72.44 110.825 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.694 HG21 ' CG1' ' C' ' 267' ' ' VAL . 48.2 t -132.07 123.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 64.43 111.125 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.66 HD21 ' CE1' ' B' ' 286' ' ' PHE . 0.1 OUTLIER -112.54 111.58 22.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.221 -0.445 . . . . 64.24 110.952 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.479 HG22 ' ND2' ' C' ' 262' ' ' ASN . 23.4 mm -111.0 104.71 17.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 74.3 111.134 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 153.5 -154.58 25.6 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 51.31 112.48 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -128.14 145.25 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.347 . . . . 74.44 110.92 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -113.06 129.72 56.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 72.02 110.946 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -119.8 126.02 49.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 64.33 110.846 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 103.28 101.68 2.66 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.692 -0.765 . . . . 33.5 112.415 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 95.16 -167.45 26.44 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.712 -0.756 . . . . 55.23 112.478 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -172.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 74.12 110.893 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -86.01 -18.62 59.16 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.754 -0.736 . . . . 71.22 112.45 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.96 124.0 22.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 65.23 110.925 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 16.1 p90 -74.73 -27.38 60.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.926 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -101.29 77.33 1.78 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 65.54 110.886 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -52.1 155.15 1.99 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 72.11 110.914 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -143.09 36.15 1.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 54.41 110.841 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -123.75 -171.34 2.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 64.32 110.895 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -138.21 92.5 2.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 65.21 110.893 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -93.71 164.84 12.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 70.04 110.836 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -80.94 95.62 6.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 61.04 110.883 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 64.01 110.865 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.878 0.37 . . . . 74.45 110.909 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -113.59 51.36 0.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 65.13 110.818 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.94 141.77 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 64.54 111.092 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -173.36 86.32 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 51.41 110.865 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.25 151.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 62.33 111.028 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 7.4 tt -175.66 130.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.23 111.055 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 84.1 t -117.98 -72.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 55.33 111.139 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -141.98 113.5 0.82 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.747 -0.74 . . . . 74.44 112.498 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.612 ' CB ' HG23 ' C' ' 261' ' ' THR . 3.7 ptt180 179.07 -175.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.792 0.33 . . . . 72.14 110.908 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.78 132.17 38.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 62.43 110.847 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.09 150.76 44.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 63.14 110.842 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.1 158.86 36.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 73.05 111.154 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -109.15 -32.94 7.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.29 -0.414 . . . . 72.1 110.938 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -164.63 138.18 5.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 64.44 110.834 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . 0.403 HD12 HG23 ' C' ' 264' ' ' VAL . 13.8 mt -138.85 117.82 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 65.44 111.141 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -133.22 121.39 22.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 65.22 110.859 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 1.7 p -136.39 148.41 47.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.177 -0.465 . . . . 73.22 111.135 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.79 166.52 33.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 74.31 110.915 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 64.09 72.76 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 71.25 110.959 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 47.8 33.86 3.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 74.11 110.853 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.8 142.57 27.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 74.35 111.155 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -126.88 135.87 51.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 60.32 110.902 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.54 HG13 HG13 ' C' ' 275' ' ' VAL . 5.3 p -128.54 137.51 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 64.3 111.114 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . 0.732 ' HB3' HD13 ' D' ' 276' ' ' LEU . 3.7 tm0? -117.32 135.91 53.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 63.03 110.935 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.19 129.75 43.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 71.14 110.898 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 121.74 -131.3 8.44 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.699 -0.762 . . . . 72.32 112.464 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . 0.533 ' CG ' HG21 ' C' ' 260' ' ' THR . 1.8 p-10 -144.99 150.8 37.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 72.5 110.815 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' D' ' 280' ' ' GLU . 13.7 m -122.73 124.36 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 63.5 111.133 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' D' ' 281' ' ' TYR . 28.4 t -121.23 129.05 76.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 62.31 111.194 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . 0.434 HG21 ' HA2' ' D' ' 283' ' ' GLY . 68.4 p -72.26 174.57 7.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 65.34 111.17 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.48 -45.9 73.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.277 -0.419 . . . . 71.53 111.103 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.27 -50.38 73.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 35.23 111.071 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 58.39 -169.99 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 42.41 111.091 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 28.2 tp -71.86 129.03 37.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 55.14 110.978 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -75.06 80.29 2.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 70.44 110.881 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 149.88 -71.34 0.3 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.713 -0.756 . . . . 72.21 112.474 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 142.5 127.75 2.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.751 -0.738 . . . . 63.45 112.528 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 50.5 pt -72.44 167.33 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 70.43 111.116 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -54.35 161.35 1.39 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 62.21 110.914 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 1.1 tt -51.96 -29.7 11.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 55.33 111.119 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . 0.706 ' HA ' HG21 ' C' ' 223' ' ' VAL . 20.0 m -102.9 -170.16 1.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 72.21 110.833 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -169.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.111 -0.495 . . . . 74.34 110.874 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -133.97 -66.67 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 64.32 110.922 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . 0.664 HG23 ' HD2' ' E' ' 225' ' ' ARG . 75.8 m -101.32 121.96 42.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 72.35 111.142 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . 0.628 ' H ' ' NE ' ' E' ' 225' ' ' ARG . 95.1 m -100.33 108.95 21.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 64.2 111.17 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -116.31 150.32 37.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 73.41 110.892 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.37 123.79 16.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 54.21 110.859 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . . . . . . . . . 11.4 p -107.55 134.23 49.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 65.22 111.094 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.45 -75.44 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 75.31 110.855 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 44.8 p -148.74 135.38 19.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 73.11 111.153 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.686 ' CG1' HG21 ' D' ' 275' ' ' VAL . 14.5 t -117.67 128.24 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 62.53 111.07 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . 0.4 HG11 ' HD3' ' E' ' 232' ' ' ARG . 5.9 p -127.19 122.87 60.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 65.33 111.204 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.57 133.84 10.54 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.698 -0.763 . . . . 63.42 112.473 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -132.48 136.48 46.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.808 0.337 . . . . 71.5 110.849 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.68 87.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 64.42 112.506 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 51.95 80.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 74.14 110.883 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 40.7 t -114.61 145.29 42.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 75.25 110.828 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -130.62 127.12 38.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 71.02 110.873 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.686 HG21 ' CG1' ' D' ' 267' ' ' VAL . 85.1 t -136.17 126.74 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 75.04 111.163 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.732 HD13 ' HB3' ' D' ' 240' ' ' GLN . 0.5 OUTLIER -124.2 111.22 15.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 72.15 110.917 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . . . . . . . . . 31.1 mm -109.68 104.85 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 63.53 111.167 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 159.25 -165.36 34.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.795 -0.717 . . . . 52.12 112.522 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -123.66 156.19 36.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.774 0.321 . . . . 70.55 110.92 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . 0.4 ' HA ' HG23 ' D' ' 244' ' ' VAL . 19.3 tt0 -111.77 119.24 37.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 70.31 110.959 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . 0.598 ' HB3' HG13 ' D' ' 245' ' ' VAL . 2.0 m-85 -103.68 125.82 50.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 55.3 110.89 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 62.88 31.63 81.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.718 -0.753 . . . . 52.04 112.471 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' D' ' 246' ' ' THR . . . -95.75 -116.46 3.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 71.01 112.546 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -179.41 34.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 62.31 110.868 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.25 -113.18 3.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.746 -0.74 . . . . 73.23 112.455 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.85 -179.35 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.853 0.358 . . . . 71.23 110.844 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 12.0 p90 -94.44 -25.01 17.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 74.15 110.911 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -101.92 141.12 35.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 71.02 110.901 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.44 -177.85 6.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 53.11 110.926 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -147.43 161.47 40.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 74.35 110.925 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -111.47 -45.29 3.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 72.33 110.851 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.49 69.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 61.11 110.862 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 61.46 173.36 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 74.23 110.808 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 54.9 87.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 75.2 110.836 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 61.03 110.899 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . 0.467 ' HG2' HG21 ' C' ' 266' ' ' THR . 2.2 mtt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.792 0.329 . . . . 62.43 110.858 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . 0.559 ' HG2' HD12 ' E' ' 219' ' ' ILE . 0.0 OUTLIER -163.4 173.72 12.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 73.24 110.953 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . 0.559 HD12 ' HG2' ' E' ' 218' ' ' LYS . 2.9 mt 61.07 99.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 64.12 111.097 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -126.15 158.84 34.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 64.12 110.841 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -131.89 148.23 52.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.02 111.107 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.24 85.41 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 52.42 111.12 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 13.2 p -168.72 139.64 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 42.23 111.139 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 145.69 144.73 4.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 71.21 112.501 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . 0.664 ' HD2' HG23 ' D' ' 260' ' ' THR . 1.5 ptp180 -54.19 -51.3 64.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 65.41 110.934 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -105.42 108.83 20.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 53.31 110.895 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.59 152.41 45.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 61.41 110.873 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.8 163.01 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 63.13 111.123 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.49 -33.31 6.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 74.21 110.942 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . 0.616 ' HB2' HG22 ' E' ' 266' ' ' THR . 0.2 OUTLIER -167.27 140.44 3.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 74.45 110.804 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . 0.525 HG23 HG21 ' E' ' 239' ' ' VAL . 17.3 mt -136.98 114.9 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 55.03 111.118 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . 0.4 ' HD3' HG11 ' D' ' 268' ' ' VAL . 2.9 ttp180 -132.27 119.93 21.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 63.34 110.917 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.69 144.35 45.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 72.44 111.129 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -156.4 166.13 34.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 73.23 110.883 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 59.42 72.3 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 70.33 110.88 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 50.0 43.57 25.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 63.41 110.923 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.09 144.93 29.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 63.44 111.071 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -128.92 141.66 51.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.53 110.881 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.679 ' CG1' HG22 ' D' ' 275' ' ' VAL . 7.8 p -134.77 134.48 53.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 64.22 111.158 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . 0.473 ' HB3' HD13 ' E' ' 276' ' ' LEU . 7.2 tm0? -119.42 137.22 53.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.428 . . . . 71.3 110.864 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.746 HD22 ' HB ' ' E' ' 277' ' ' ILE . 0.1 OUTLIER -130.31 118.72 21.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 73.22 110.935 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 123.73 177.88 15.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.696 -0.764 . . . . 62.43 112.481 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . 0.415 HD22 HG21 ' D' ' 260' ' ' THR . 2.4 p30 -89.65 145.38 25.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.787 0.327 . . . . 71.3 110.941 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 9.6 m -120.16 139.16 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 71.44 111.114 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.5 128.32 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 74.14 111.177 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.5 t -69.77 175.2 4.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 71.32 111.17 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.43 76.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 62.04 111.124 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.13 -51.72 68.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 35.13 111.116 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 54.63 -171.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 70.13 111.088 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 1.7 tt -154.61 121.2 5.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.448 . . . . 74.55 110.992 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -102.42 165.48 11.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.278 -0.419 . . . . 64.22 110.861 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 145.28 160.07 8.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.681 -0.771 . . . . 70.33 112.449 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -130.38 -123.37 2.51 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.731 -0.747 . . . . 71.41 112.522 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 2.0 mp 63.38 105.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 74.52 111.115 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.5 140.99 32.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.86 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 16.8 tt -168.22 148.99 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 74.11 111.147 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.12 105.99 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 72.12 110.84 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -163.14 132.64 4.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 72.01 110.878 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -165.55 109.68 0.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 73.41 110.888 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 67.4 p -101.08 121.86 42.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 75.33 111.123 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . 0.498 HG23 ' HA ' ' E' ' 225' ' ' ARG . 0.8 OUTLIER -134.36 116.51 15.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 65.51 111.177 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.3 136.18 52.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 65.54 110.936 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 1.3 t -126.8 121.88 33.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.841 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . 0.454 HG11 HD21 ' E' ' 241' ' ' LEU . 8.0 p -102.41 123.0 55.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 41.31 111.134 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . 0.432 ' CD ' ' N ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -65.23 -142.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 73.52 110.907 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . 0.616 HG22 ' HB2' ' E' ' 230' ' ' ASP . 3.2 p -92.14 128.79 38.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 71.22 111.122 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . 0.973 HG11 HG21 ' E' ' 275' ' ' VAL . 8.9 t -115.35 133.34 61.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 54.11 111.119 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . 0.407 ' O ' HG13 ' E' ' 268' ' ' VAL . 6.1 p -125.45 121.53 60.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 75.44 111.188 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.44 132.87 11.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.785 -0.721 . . . . 75.04 112.493 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -132.82 116.05 16.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 74.43 110.897 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 64.49 88.14 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 75.44 112.455 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 56.99 86.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 61.51 110.857 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 16.9 t -124.35 145.49 49.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 54.0 110.851 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -136.7 127.13 26.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 64.02 110.892 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.973 HG21 HG11 ' E' ' 267' ' ' VAL . 57.9 t -132.73 134.67 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 33.41 111.094 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' E' ' 240' ' ' GLN . 0.2 OUTLIER -128.39 114.85 17.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 24.21 110.926 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.746 ' HB ' HD22 ' E' ' 241' ' ' LEU . 28.4 mm -111.13 141.16 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 75.3 111.1 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 113.1 -171.86 14.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.694 -0.765 . . . . 72.32 112.442 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -106.82 153.52 22.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.797 0.332 . . . . 71.51 110.868 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -111.85 144.47 41.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 72.33 110.826 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.12 125.35 43.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 75.42 110.902 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 51.83 29.17 25.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.756 -0.735 . . . . 54.21 112.484 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -99.25 18.72 56.14 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.763 -0.732 . . . . 51.51 112.499 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? 53.63 35.17 20.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.884 0.373 . . . . 73.24 110.91 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.27 -103.85 2.98 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.759 -0.734 . . . . 72.34 112.474 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -52.03 157.81 1.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.837 0.351 . . . . 71.51 110.843 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -71.96 148.3 46.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.123 -0.489 . . . . 63.11 110.955 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 6.2 t0 60.93 -179.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 75.25 110.875 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 63.18 104.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 52.31 110.917 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -103.43 -175.06 2.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 73.22 110.884 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.71 134.67 47.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 75.22 110.833 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -133.21 -59.45 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 71.45 110.844 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 56.87 85.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.12 110.867 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.22 137.67 47.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 70.45 110.89 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 71.05 110.846 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.844 0.354 . . . . 65.05 110.843 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -176.74 174.81 1.76 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 71.33 110.891 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.42 173.9 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 54.43 111.07 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.47 177.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 74.34 110.892 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -156.12 148.59 23.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 64.42 111.034 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.501 HG22 HG12 ' A' ' 223' ' ' VAL . 65.8 mt -147.27 -72.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 71.22 111.157 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.501 HG12 HG22 ' A' ' 222' ' ' ILE . 10.3 p -175.54 152.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 74.15 111.116 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 168.25 159.79 14.63 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.744 -0.741 . . . . 55.55 112.466 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -179.12 33.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.808 0.337 . . . . 74.41 110.885 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.516 HD22 HG22 ' A' ' 277' ' ' ILE . 2.3 m120 -142.41 143.63 32.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 32.01 110.852 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 34.5 p -121.72 137.5 54.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 52.52 110.859 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.94 139.92 48.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.486 . . . . 74.23 111.088 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.15 -28.18 13.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 72.34 110.879 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.413 ' HB3' HG23 ' A' ' 266' ' ' THR . 1.1 m-20 -166.17 137.93 3.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 72.21 110.879 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.39 117.29 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 73.45 111.157 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -129.55 122.48 29.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 72.34 110.861 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.8 152.12 50.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 73.44 111.163 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.98 158.94 37.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 70.11 110.948 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 236' ' ' ARG . 1.6 tt0 64.11 83.35 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 71.25 110.892 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 235' ' ' GLU . 0.0 OUTLIER 36.15 59.89 0.89 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 75.01 110.883 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.21 144.02 32.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 73.23 111.087 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -125.79 135.81 52.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 71.3 110.923 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.53 HG12 ' HB ' ' A' ' 275' ' ' VAL . 19.7 m -143.01 121.29 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 64.42 111.137 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -124.88 137.64 54.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 73.12 110.895 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 mp -129.4 118.26 21.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 75.34 110.909 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 148.23 -161.87 28.69 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 60.14 112.51 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -91.11 137.86 32.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 74.35 110.992 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -120.54 131.77 71.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 72.4 111.092 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 61.7 t -122.17 128.97 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 65.32 111.133 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.78 175.15 6.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 72.22 111.189 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.15 -34.56 77.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 72.43 111.117 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . 0.672 ' HB3' ' N ' ' A' ' 283' ' ' GLY . . . -56.97 -37.54 71.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 75.31 111.087 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.614 ' HB2' ' CA ' ' A' ' 282' ' ' GLY . . . -67.67 -75.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 73.2 111.087 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.3 tp 62.53 -169.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 73.54 110.907 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -52.31 109.32 0.37 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.916 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 151.09 177.93 25.41 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.77 -0.729 . . . . 64.31 112.485 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 112.19 116.48 3.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 64.31 112.561 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 33.6 pt -150.22 -175.8 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.829 0.347 . . . . 72.15 111.103 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.19 104.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 73.55 110.852 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 1.5 pp -150.5 171.07 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 72.52 111.101 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.04 -170.05 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 71.22 110.895 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.4 167.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 63.32 110.867 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -120.4 84.0 2.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 74.42 110.911 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 52.0 p -99.77 122.49 42.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 74.43 111.151 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.7 t -131.07 140.59 50.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 71.4 111.144 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -99.31 126.2 45.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.87 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 87.4 p -134.56 123.65 24.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 62.24 110.849 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.437 HG21 HG22 ' A' ' 267' ' ' VAL . 7.1 p -118.67 125.68 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.084 -0.507 . . . . 74.41 111.136 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -74.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.839 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 230' ' ' ASP . 25.8 m -136.45 135.06 38.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 71.52 111.193 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.779 HG11 HG11 ' A' ' 275' ' ' VAL . 0.1 OUTLIER -118.48 126.52 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 73.13 111.124 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 23.2 t -127.48 118.14 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 63.45 111.162 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.68 133.06 8.17 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.747 . . . . 62.04 112.489 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 147.6 52.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.906 0.384 . . . . 53.23 110.892 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.52 84.21 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 70.13 112.444 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 51.35 80.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 75.03 110.865 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 31.6 t -113.34 145.69 40.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 63.54 110.842 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -132.77 127.59 34.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 73.24 110.88 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.779 HG11 HG11 ' A' ' 267' ' ' VAL . 19.0 t -137.7 123.62 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 72.51 111.156 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.671 HD23 ' CZ2' ' A' ' 287' ' ' TRP . 0.6 OUTLIER -121.4 112.36 18.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 73.13 110.906 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.516 HG22 HD22 ' A' ' 226' ' ' ASN . 35.6 mm -103.93 104.51 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 74.41 111.158 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.2 -169.43 28.88 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.67 -0.776 . . . . 63.41 112.486 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -111.12 149.89 30.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.784 0.326 . . . . 71.24 110.88 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.456 ' OE2' HG13 ' B' ' 244' ' ' VAL . 0.1 OUTLIER -121.6 119.1 30.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 75.4 110.923 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -108.14 154.01 22.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 62.12 110.903 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.614 ' CA ' ' HB2' ' A' ' 249' ' ' ALA . . . 122.88 -120.16 4.16 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.72 -0.752 . . . . 50.12 112.496 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.672 ' N ' ' HB3' ' A' ' 248' ' ' ALA . . . -171.3 -143.8 4.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 22.03 112.565 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 69.03 -75.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 71.33 110.888 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -144.48 143.53 12.18 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.728 . . . . 63.21 112.481 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.503 ' HB2' HG11 ' B' ' 244' ' ' VAL . 14.4 p90 -61.1 -20.71 62.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.887 0.375 . . . . 64.41 110.881 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.671 ' CZ2' HD23 ' A' ' 276' ' ' LEU . 5.0 t90 -164.82 -69.43 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.129 -0.487 . . . . 73.22 110.982 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.94 -6.82 12.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 70.41 110.906 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.62 -75.18 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 74.45 110.847 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -97.41 136.04 38.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 71.43 110.839 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -133.04 -69.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.468 . . . . 74.25 110.83 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -174.75 167.15 3.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 64.41 110.839 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -94.55 171.82 8.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 73.52 110.844 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -166.86 173.92 9.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 70.22 110.89 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 3.8 m80 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 72.42 110.791 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.83 0.348 . . . . 75.45 110.87 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.47 104.33 5.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 62.31 110.933 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 7.9 pt -135.07 179.5 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 50.22 111.145 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -140.21 139.32 35.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 70.44 110.858 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -150.2 169.98 20.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 72.14 111.197 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 2.6 pt -143.25 -178.37 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.294 -0.412 . . . . 70.14 111.034 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 34.4 m -147.95 172.53 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 74.2 111.183 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 176.8 -100.15 0.14 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.765 -0.731 . . . . 72.13 112.502 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.483 ' HG2' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER 52.18 87.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.783 0.325 . . . . 75.23 110.818 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -115.25 120.66 40.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 64.34 110.938 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.33 137.93 51.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 74.31 110.825 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.95 152.34 45.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 70.42 111.108 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -28.02 10.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 74.32 110.879 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . 0.541 ' HB3' HG23 ' B' ' 266' ' ' THR . 1.0 OUTLIER -164.65 138.41 5.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.415 . . . . 75.32 110.851 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 11.6 mt -135.44 122.42 34.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 75.22 111.081 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -134.17 117.25 16.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.04 110.911 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.2 145.67 52.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 74.11 111.151 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -154.24 161.53 41.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 73.21 110.85 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 63.61 69.68 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 61.41 110.804 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 47.53 56.7 6.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 70.24 110.936 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.0 144.42 31.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 61.31 111.14 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.03 135.87 52.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 75.45 110.848 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.801 HG12 ' HB ' ' B' ' 275' ' ' VAL . 4.1 m -136.24 121.56 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 73.02 111.138 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.67 134.06 54.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 75.31 110.979 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.578 HD12 ' HB ' ' B' ' 277' ' ' ILE . 0.3 OUTLIER -130.42 119.07 22.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 62.44 110.867 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.81 -116.07 0.72 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.74 . . . . 62.11 112.498 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.98 139.7 29.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.899 0.38 . . . . 73.24 110.902 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 286' ' ' PHE . 46.1 t -118.2 116.27 50.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 74.41 111.138 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 46.0 t -116.27 129.05 73.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 74.44 111.151 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.1 p -92.26 175.23 6.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 71.01 111.186 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.487 ' HB2' ' HA3' ' A' ' 283' ' ' GLY . . . -63.06 -42.65 99.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 25.2 111.07 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.73 -38.37 84.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 64.03 111.126 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' B' ' 281' ' ' TYR . . . -51.66 116.84 2.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 70.34 111.098 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.81 -58.78 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 74.41 110.885 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -117.48 120.88 39.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 75.52 110.808 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -100.26 -137.68 9.91 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 74.42 112.534 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -74.28 177.95 45.13 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.694 -0.765 . . . . 52.2 112.515 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 3.3 mp -111.29 116.73 53.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.781 0.324 . . . . 63.24 111.164 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . 0.645 ' HD3' HG23 ' C' ' 254' ' ' ILE . 0.1 OUTLIER 62.69 97.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 73.43 110.859 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.3 tt -151.52 145.43 16.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 71.12 111.089 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.5 t -145.59 103.64 3.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 75.12 110.81 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -127.94 178.79 5.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 43.32 110.846 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -157.54 71.02 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 70.23 110.821 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.83 137.77 33.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 74.1 111.134 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.483 HG23 ' HG2' ' B' ' 225' ' ' ARG . 96.5 m -130.85 111.92 12.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 75.22 111.133 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -89.43 127.28 35.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 54.42 110.959 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 3.6 m -130.31 123.59 30.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 75.22 110.86 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.476 HG21 HG22 ' B' ' 267' ' ' VAL . 7.3 p -115.48 125.28 72.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 72.12 111.116 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.97 -76.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 61.5 110.905 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.541 HG23 ' HB3' ' B' ' 230' ' ' ASP . 94.6 m -137.01 137.65 39.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 73.34 111.093 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.684 ' CG1' HG21 ' B' ' 275' ' ' VAL . 4.4 t -117.8 128.35 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 74.33 111.177 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 25.6 t -127.64 117.16 45.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 44.45 111.101 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.39 132.53 9.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.723 -0.751 . . . . 71.34 112.498 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -133.27 125.08 28.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.863 0.363 . . . . 74.04 110.889 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.76 83.91 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 55.42 112.508 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 54.35 84.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 70.42 110.843 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 22.8 t -119.25 145.63 45.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 54.43 110.831 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -135.34 127.32 29.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 75.53 110.903 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.801 ' HB ' HG12 ' B' ' 239' ' ' VAL . 61.9 t -135.35 124.55 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 64.33 111.122 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.07 111.69 17.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 65.44 110.875 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' B' ' 241' ' ' LEU . 27.3 mm -103.86 104.53 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.455 . . . . 73.22 111.149 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.83 -160.21 28.51 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 74.21 112.486 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -115.91 147.87 40.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.324 . . . . 74.12 110.909 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.633 ' HG3' HG13 ' C' ' 244' ' ' VAL . 1.0 OUTLIER -120.82 118.88 31.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.9 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.476 ' CD2' ' HB1' ' B' ' 249' ' ' ALA . 11.4 t80 -112.27 127.46 55.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 71.43 110.954 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.555 ' O ' ' HB2' ' C' ' 247' ' ' ALA . . . 145.9 -48.59 0.68 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.808 -0.71 . . . . 61.45 112.47 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 74.06 11.32 81.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.725 -0.75 . . . . 73.12 112.48 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.96 60.86 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 53.32 110.868 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 96.26 120.26 3.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.763 -0.732 . . . . 62.45 112.487 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -50.95 108.45 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.324 . . . . 74.13 110.912 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 71.79 -69.57 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.155 -0.475 . . . . 74.34 110.889 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -121.27 -170.01 1.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 71.03 110.886 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -54.47 -42.94 71.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 72.43 110.888 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.35 105.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 75.31 110.748 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -128.54 84.88 2.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.492 . . . . 75.03 110.852 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -117.88 179.65 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 72.24 110.871 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -152.44 31.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 73.24 110.846 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -134.77 172.33 13.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 64.15 110.873 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 8.1 p80 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 74.24 110.874 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 4.2 mtp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.776 0.322 . . . . 64.41 110.805 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.51 114.83 20.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 74.32 110.882 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 6.2 tt -173.32 135.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 55.4 111.158 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.94 -73.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 74.12 110.859 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -169.6 83.09 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 71.44 111.065 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 2.7 mp -77.67 70.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 55.53 111.109 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.33 174.3 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 51.24 111.151 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 139.69 -155.31 24.17 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.722 -0.751 . . . . 33.13 112.466 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -127.78 -72.32 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.798 0.332 . . . . 64.3 110.831 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -83.98 110.07 18.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 62.22 110.834 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.34 137.91 50.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 63.33 110.849 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -123.35 150.55 43.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 54.11 111.117 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -102.37 -26.2 13.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 72.5 110.875 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . 0.502 ' HB3' HG23 ' C' ' 266' ' ' THR . 0.5 OUTLIER -165.04 138.79 4.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 52.44 110.809 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.467 ' CD1' HG23 ' B' ' 264' ' ' VAL . 11.5 mt -136.61 117.68 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 72.53 111.183 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.94 119.32 21.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 74.42 110.882 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.52 150.4 52.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 55.41 111.142 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -156.71 166.68 32.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 63.03 110.854 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.59 67.51 0.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 74.31 110.946 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 48.31 58.23 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 71.21 110.908 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.33 148.37 26.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 74.25 111.102 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -129.36 135.86 49.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 73.23 110.903 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.644 ' CG2' HG22 ' B' ' 275' ' ' VAL . 28.3 m -135.27 121.56 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 72.14 111.141 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.09 137.54 52.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 73.12 110.954 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.05 118.4 21.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 71.22 110.927 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 139.36 -168.91 24.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.777 -0.725 . . . . 61.45 112.461 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -91.93 145.03 24.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 64.52 110.921 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.633 HG13 ' HG3' ' B' ' 280' ' ' GLU . 56.1 t -125.98 124.89 67.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 75.34 111.129 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 48.4 t -122.83 118.28 54.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 44.05 111.063 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 6.4 t -77.84 174.96 10.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 62.35 111.163 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' B' ' 282' ' ' GLY . . . -63.83 -45.56 89.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 63.25 111.097 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . 0.586 ' O ' HD23 ' C' ' 250' ' ' LEU . . . -56.05 -35.77 67.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 74.24 111.082 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . 0.553 ' HB1' ' CD2' ' C' ' 281' ' ' TYR . . . -58.67 98.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.312 -0.404 . . . . 45.24 111.069 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . 0.586 HD23 ' O ' ' C' ' 248' ' ' ALA . 0.6 OUTLIER -131.71 25.46 4.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 64.3 110.943 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -125.38 177.18 6.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 71.2 110.88 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -144.45 -108.27 0.6 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.637 -0.792 . . . . 74.03 112.422 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -160.31 -60.81 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.672 -0.775 . . . . 64.01 112.437 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . 0.645 HG23 ' HD3' ' B' ' 255' ' ' ARG . 2.0 mp 62.95 74.52 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.79 0.328 . . . . 72.24 111.083 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.65 -70.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 71.2 110.895 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 30.9 mm -119.59 149.82 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 55.11 111.134 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 2.5 p -110.48 55.16 0.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 65.55 110.862 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.57 -179.62 7.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 73.43 110.838 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.13 135.63 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 61.33 110.854 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . 0.464 HG22 ' HG3' ' D' ' 225' ' ' ARG . 70.0 p -100.86 137.58 39.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 74.25 111.154 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.704 HG23 ' HA3' ' D' ' 224' ' ' GLY . 2.1 t -108.45 137.05 47.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 72.33 111.141 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -119.99 139.01 53.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 73.14 110.931 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 22.8 m -130.68 123.74 30.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 72.31 110.925 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.542 HG21 ' CG2' ' C' ' 267' ' ' VAL . 7.1 p -112.01 126.86 69.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 72.31 111.083 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.8 -74.0 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.49 . . . . 73.34 110.88 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . 0.502 HG23 ' HB3' ' C' ' 230' ' ' ASP . 92.5 m -140.8 136.65 32.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 64.42 111.189 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.656 ' CG1' HG21 ' C' ' 275' ' ' VAL . 94.4 t -117.96 127.02 75.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 70.43 111.111 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 40.1 t -127.5 126.79 67.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 72.1 111.039 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.25 133.0 8.24 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.767 -0.73 . . . . 73.11 112.502 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -132.62 140.96 48.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.832 0.349 . . . . 61.14 110.924 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.11 70.15 0.94 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.781 -0.723 . . . . 64.51 112.434 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 64.85 97.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 70.55 110.881 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 70.2 m -131.7 145.94 51.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 55.14 110.879 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 36.2 mtt85 -131.48 127.09 36.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 73.13 110.837 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.656 HG21 ' CG1' ' C' ' 267' ' ' VAL . 21.7 t -133.43 123.89 47.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 61.22 111.134 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.23 111.59 17.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 62.22 110.972 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 30.8 mm -105.65 104.34 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 74.44 111.181 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 152.97 -152.49 24.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.735 -0.745 . . . . 72.41 112.482 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -116.75 138.17 51.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.758 0.313 . . . . 50.43 110.941 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.661 ' CG ' HG22 ' D' ' 244' ' ' VAL . 4.4 pt-20 -111.79 118.83 36.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.457 . . . . 74.22 110.832 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.553 ' CD2' ' HB1' ' C' ' 249' ' ' ALA . 9.1 t80 -114.45 124.63 52.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 71.01 111.008 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' D' ' 247' ' ' ALA . . . 161.5 -58.53 0.3 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 23.1 112.463 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 91.31 -42.0 2.85 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.717 -0.754 . . . . 74.24 112.426 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -30.21 14.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 74.24 110.859 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -147.05 106.45 0.36 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.694 -0.765 . . . . 62.43 112.455 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -55.34 -23.35 23.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 74.2 110.898 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -153.81 -52.16 0.1 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.456 . . . . 75.24 110.934 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -132.59 149.25 52.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.412 . . . . 72.11 110.849 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -78.75 86.56 4.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 62.22 110.916 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -167.55 -174.86 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 75.22 110.927 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -93.03 154.84 17.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 75.52 110.862 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -176.26 118.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.877 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.74 174.68 1.78 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.233 -0.44 . . . . 61.54 110.888 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -130.02 176.9 7.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 71.33 110.847 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 12.0 p80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 74.52 110.778 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.88 0.371 . . . . 74.3 110.859 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -161.96 112.78 1.62 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 73.04 110.896 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 3.6 tt -53.65 -27.98 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 75.42 111.14 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.42 143.12 55.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 74.14 110.909 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -125.08 165.57 17.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 33.3 111.141 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 5.3 mp -137.86 108.45 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 61.54 111.141 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 35.9 m -94.13 162.74 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 72.32 111.123 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . 0.704 ' HA3' HG23 ' C' ' 261' ' ' THR . . . -169.09 -172.86 36.26 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.752 -0.737 . . . . 43.0 112.507 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.464 ' HG3' HG22 ' C' ' 260' ' ' THR . 1.6 mmt85 -52.25 -59.88 3.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.85 0.357 . . . . 75.35 110.827 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -109.56 115.52 30.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 55.43 110.891 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.83 140.9 52.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 72.02 110.869 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.45 147.88 49.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 72.3 111.115 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -100.72 -26.16 13.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 70.11 110.929 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.98 138.26 4.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 73.5 110.922 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . 0.451 ' CD1' HG23 ' C' ' 264' ' ' VAL . 12.3 mt -137.03 117.89 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 73.21 111.178 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -133.06 118.41 18.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 70.52 110.878 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.49 150.76 52.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 74.03 111.144 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -157.0 167.29 30.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 73.04 110.898 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.54 66.45 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 74.35 110.851 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 50.08 43.97 25.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 73.44 110.874 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.1 152.38 21.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.34 111.079 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -135.34 135.25 40.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 63.32 110.869 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.602 HG23 HG13 ' C' ' 275' ' ' VAL . 18.1 m -133.58 121.19 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 61.23 111.126 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -108.07 134.63 50.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 74.02 110.914 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.28 118.03 20.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 74.04 110.924 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.16 -118.3 1.35 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.778 -0.725 . . . . 53.24 112.497 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -145.97 133.26 20.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.891 0.377 . . . . 73.43 110.866 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . 0.661 HG22 ' CG ' ' C' ' 280' ' ' GLU . 74.4 t -110.2 121.18 62.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 65.52 111.165 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.47 119.96 58.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 74.23 111.134 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -69.99 175.36 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 64.52 111.103 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' C' ' 282' ' ' GLY . . . -53.47 -46.1 69.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 75.24 111.114 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.2 -49.52 77.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 71.54 111.076 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 63.21 -174.89 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 63.14 111.112 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . 0.602 HD23 HG22 ' D' ' 256' ' ' ILE . 0.2 OUTLIER -52.02 107.86 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 64.22 110.879 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -52.91 164.97 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 74.22 110.88 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 90.8 -44.4 2.87 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 60.43 112.515 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 134.12 -55.19 0.75 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 70.34 112.512 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 14.7 tt -58.32 144.11 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.36 . . . . 74.51 111.164 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -57.23 178.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 75.55 110.913 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . 0.602 HG22 HD23 ' D' ' 250' ' ' LEU . 6.1 pt -58.71 177.98 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 75.33 111.145 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 36.6 p -150.99 92.55 1.83 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 63.33 110.883 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -173.42 139.42 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 72.5 110.868 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.88 30.51 6.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 65.34 110.813 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . 0.419 HG21 HD21 ' E' ' 243' ' ' ASN . 0.2 OUTLIER -65.19 138.23 58.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 73.35 111.08 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . 0.426 HG23 ' O ' ' D' ' 225' ' ' ARG . 49.9 m -112.71 108.88 18.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.34 111.149 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . 0.556 ' OD1' HG23 ' D' ' 277' ' ' ILE . 1.3 t-20 -90.77 131.98 36.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 75.44 110.861 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.97 123.87 38.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 53.13 110.924 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.523 HG21 ' CG2' ' D' ' 267' ' ' VAL . 9.7 p -118.39 129.1 75.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.143 -0.48 . . . . 42.21 111.064 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.52 -75.23 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 62.12 110.929 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 48.9 m -136.52 135.6 38.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 63.21 111.138 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.533 ' CG1' HG21 ' D' ' 275' ' ' VAL . 97.5 t -117.89 127.06 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 72.11 111.184 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 28.1 t -127.22 122.93 61.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 72.33 111.101 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.29 132.44 8.55 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.771 -0.728 . . . . 73.15 112.507 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.13 144.89 50.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.808 0.337 . . . . 65.03 110.934 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.79 70.38 0.79 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.726 . . . . 73.04 112.478 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.47 94.3 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 34.23 110.924 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 30.9 t -126.27 145.02 50.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 60.34 110.892 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -131.68 126.35 34.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 74.24 110.909 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.683 HG13 HG23 ' E' ' 239' ' ' VAL . 16.6 t -132.1 132.42 61.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 60.15 111.08 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.55 111.11 12.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.104 -0.498 . . . . 72.02 110.903 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.556 HG23 ' OD1' ' D' ' 262' ' ' ASN . 24.5 mm -108.03 106.59 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 74.2 111.107 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.27 -146.15 17.42 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.788 -0.72 . . . . 72.02 112.523 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.98 156.11 17.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 73.33 110.88 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . 0.759 ' CG ' HG22 ' E' ' 244' ' ' VAL . 0.0 OUTLIER -145.25 122.56 11.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 63.44 110.803 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -119.93 124.45 46.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 73.42 110.937 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . -149.59 -140.09 3.2 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.783 -0.722 . . . . 75.34 112.531 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' E' ' 247' ' ' ALA . . . -139.16 -98.36 0.41 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 35.42 112.494 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.52 101.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.818 0.342 . . . . 71.24 110.937 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 71.49 -116.06 5.95 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 74.32 112.462 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.63 152.31 21.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.815 0.341 . . . . 63.51 110.898 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 72.95 -69.76 0.18 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.138 -0.483 . . . . 72.51 110.881 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -100.35 170.41 8.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 72.23 110.891 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -143.1 64.45 1.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 75.53 110.886 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -125.24 -171.44 2.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 72.22 110.796 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -110.53 110.07 20.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 73.13 110.855 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -179.06 119.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 74.34 110.893 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -124.84 -68.39 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 72.31 110.863 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 53.42 -171.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 63.15 110.872 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.158 -0.474 . . . . 72.24 110.904 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.787 0.327 . . . . 70.22 110.919 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -135.26 -67.1 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.436 . . . . 63.42 110.88 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 40.3 mm 61.05 100.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 65.53 111.086 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.55 98.25 1.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 63.13 110.87 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.91 103.37 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 63.13 111.122 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -151.61 171.74 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 75.24 111.133 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 65.5 t -127.07 -71.32 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 75.12 111.092 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -129.03 -130.36 3.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.795 -0.717 . . . . 65.12 112.505 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.18 -169.92 0.18 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.803 0.335 . . . . 73.44 110.895 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 -84.32 117.57 23.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 71.12 110.9 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 93.0 p -131.8 140.16 49.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 75.43 110.893 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -120.43 146.21 46.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 51.2 111.116 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -95.89 -26.73 15.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 71.53 110.924 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.31 138.88 5.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 70.25 110.944 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . 0.471 ' CD1' HG23 ' D' ' 264' ' ' VAL . 10.8 mt -137.15 117.71 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 71.33 111.122 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -131.77 121.47 24.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 73.0 110.884 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.4 147.61 49.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 70.21 111.151 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -157.05 161.11 39.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 64.4 110.936 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 64.89 72.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 75.55 110.883 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.25 37.9 12.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 64.21 110.849 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.83 141.48 29.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 61.42 111.148 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.73 135.46 52.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 74.34 110.931 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.683 HG23 HG13 ' D' ' 275' ' ' VAL . 25.2 m -138.12 122.01 21.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 72.21 111.146 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . 0.503 ' C ' HD12 ' E' ' 241' ' ' LEU . 2.5 tp60 -119.48 134.06 55.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 71.34 110.882 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.503 HD12 ' C ' ' E' ' 240' ' ' GLN . 6.5 mp -130.74 118.06 20.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 61.34 110.946 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 145.52 -108.99 0.49 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.79 -0.719 . . . . 73.43 112.483 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . 0.419 HD21 HG21 ' D' ' 260' ' ' THR . 0.0 OUTLIER -144.37 150.24 37.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.847 0.356 . . . . 73.45 110.895 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.759 HG22 ' CG ' ' D' ' 280' ' ' GLU . 80.0 t -133.42 122.73 45.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 75.32 111.131 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 79.6 t -124.15 112.83 34.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 72.41 111.095 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . 0.474 HG23 ' O ' ' E' ' 281' ' ' TYR . 74.3 p -69.08 175.25 3.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 73.14 111.17 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . 0.523 ' HB2' ' HA2' ' D' ' 283' ' ' GLY . . . -55.09 -46.01 75.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 44.14 111.142 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.78 -52.18 66.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 73.32 111.1 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.24 -169.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 63.41 111.118 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . 0.645 HD23 ' OH ' ' E' ' 281' ' ' TYR . 59.7 tp -147.58 149.63 32.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 65.33 110.917 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -53.44 140.35 28.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 74.12 110.907 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -55.34 176.46 0.61 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.694 -0.765 . . . . 71.14 112.549 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -128.57 -120.69 2.31 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.696 -0.764 . . . . 74.23 112.465 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 3.2 tt -145.3 149.44 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.816 0.341 . . . . 74.03 111.192 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.18 99.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.428 . . . . 71.43 110.881 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 mp -91.59 -27.79 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 75.22 111.093 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 2.3 m -79.08 60.95 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 74.32 110.815 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -177.73 142.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 75.23 110.86 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . 0.413 ' HG3' HG23 ' D' ' 260' ' ' THR . 0.4 OUTLIER -174.56 165.79 3.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 71.24 110.919 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 17.0 p -72.6 136.66 45.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 63.23 111.166 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 94.1 m -92.25 128.74 38.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 60.24 111.114 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.41 142.53 51.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 72.4 110.883 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.88 133.45 39.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 63.35 110.839 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . 0.428 ' O ' HG13 ' E' ' 264' ' ' VAL . 4.9 p -124.11 118.51 54.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.139 -0.482 . . . . 72.21 111.136 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.96 -75.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 73.3 110.926 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.1 138.9 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 53.44 111.09 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . 0.86 HG11 HG21 ' E' ' 275' ' ' VAL . 40.2 t -117.43 128.46 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 64.51 111.092 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 38.9 t -127.12 118.58 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 71.04 111.159 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.63 132.28 10.18 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.77 -0.728 . . . . 73.15 112.481 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -133.7 116.56 15.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 74.24 110.868 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 74.71 86.77 0.26 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.707 -0.759 . . . . 52.52 112.498 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 51.09 81.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 65.51 110.876 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 16.3 m -117.3 145.42 44.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 73.42 110.873 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -134.11 127.29 31.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 63.23 110.79 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.86 HG21 HG11 ' E' ' 267' ' ' VAL . 46.6 t -133.2 130.5 57.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 64.43 111.142 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.629 HD22 ' O ' ' E' ' 275' ' ' VAL . 3.2 mm? -128.34 107.85 10.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 63.54 110.833 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 23.1 mm -114.27 109.19 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 71.11 111.069 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.62 -137.36 6.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.84 -0.695 . . . . 75.05 112.557 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -111.24 133.24 53.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.76 0.314 . . . . 70.41 110.902 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.34 133.66 55.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.44 110.905 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . 0.645 ' OH ' HD23 ' E' ' 250' ' ' LEU . 0.1 OUTLIER -131.26 123.88 29.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 73.03 110.937 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 110.44 -77.65 0.23 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.64 -0.791 . . . . 22.14 112.494 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -50.79 125.66 23.71 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.71 -0.757 . . . . 75.03 112.453 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -84.97 -68.88 0.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.346 . . . . 64.3 110.953 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -50.27 -79.35 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.744 -0.741 . . . . 73.34 112.462 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -62.99 1.34 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.845 0.355 . . . . 73.35 110.847 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 4.1 p90 178.34 -31.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 70.53 110.91 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -87.84 60.12 5.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.301 -0.409 . . . . 74.31 110.942 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -51.64 136.34 27.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 70.11 110.871 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -107.29 -171.18 1.83 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 74.31 110.879 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -87.61 145.73 26.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 72.33 110.841 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -56.02 142.73 35.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 72.42 110.807 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -161.51 -172.24 3.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 75.53 110.875 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -97.35 -170.49 2.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 72.22 110.925 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 75.55 110.816 -179.992 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 4.3 mmt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.813 0.34 . . . . 75.03 110.867 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.74 -179.33 4.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 73.32 110.92 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 18.4 pt -124.31 26.59 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 64.45 111.144 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -176.76 111.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.52 110.899 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -129.34 29.61 5.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 72.25 111.006 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.3 118.05 7.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 74.43 111.143 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.725 HG13 ' HA ' ' A' ' 259' ' ' GLN . 7.4 p -139.96 146.11 25.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 75.54 111.159 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 174.37 174.95 41.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.762 -0.732 . . . . 74.4 112.437 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.615 ' HG3' HG23 ' A' ' 261' ' ' THR . 13.0 ptm180 -156.32 153.95 29.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.79 0.329 . . . . 73.02 110.861 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.724 ' HB3' HG22 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -123.21 130.08 52.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 62.43 110.823 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.1 m -128.57 144.31 51.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 74.54 110.872 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.7 124.01 19.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 71.21 111.091 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -76.09 -37.2 58.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 73.11 110.916 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -164.68 138.46 5.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 62.23 110.878 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.597 HG22 ' CG2' ' A' ' 267' ' ' VAL . 9.7 pt -137.82 118.01 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 74.14 111.067 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -128.39 126.91 41.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 75.31 110.909 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.602 HG21 ' CG1' ' A' ' 239' ' ' VAL . 1.7 p -135.56 149.49 49.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 72.52 111.142 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -144.97 168.37 20.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 43.51 110.925 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 65.47 74.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 64.01 110.922 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 41.89 59.11 2.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 73.02 110.811 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.435 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -104.11 155.99 18.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.168 -0.469 . . . . 54.14 111.099 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -135.05 145.92 48.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 72.33 110.905 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.602 ' CG1' HG21 ' A' ' 233' ' ' THR . 16.1 m -139.97 137.39 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 74.21 111.113 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -137.2 129.42 29.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.13 110.917 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.9 mp -122.94 130.34 52.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 75.35 110.846 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 144.72 -121.42 1.56 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.735 -0.745 . . . . 63.33 112.446 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -144.86 132.7 21.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.87 0.367 . . . . 74.33 110.903 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.517 HG23 ' HA ' ' A' ' 280' ' ' GLU . 18.0 m -120.02 120.9 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.138 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.502 ' CG1' ' HB3' ' A' ' 249' ' ' ALA . 94.5 t -122.07 129.02 75.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 64.45 111.189 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t -78.19 166.67 22.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 74.05 111.196 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.07 -33.89 76.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 60.14 111.133 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.82 -37.97 71.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 73.34 111.129 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.502 ' HB3' ' CG1' ' A' ' 245' ' ' VAL . . . -66.05 -23.44 66.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 42.45 111.061 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 6.9 tp -76.73 64.91 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 72.42 110.965 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -179.16 34.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.445 . . . . 64.44 110.77 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 152.15 -159.7 28.49 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.716 -0.754 . . . . 54.34 112.479 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 175.6 172.23 40.25 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 62.54 112.507 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.496 HG23 ' O ' ' B' ' 250' ' ' LEU . 3.4 pt -120.5 175.04 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 64.13 111.124 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.514 ' O ' HD13 ' A' ' 256' ' ' ILE . 23.6 ttp180 -126.75 84.41 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 52.22 110.867 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.514 HD13 ' O ' ' A' ' 255' ' ' ARG . 44.9 mm -140.09 135.69 37.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 64.23 111.108 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.06 -49.4 71.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 64.05 110.848 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.98 -76.21 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 74.53 110.897 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.725 ' HA ' HG13 ' A' ' 223' ' ' VAL . 0.8 OUTLIER 51.61 42.35 29.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 61.23 110.97 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.52 121.79 30.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 73.0 111.123 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.615 HG23 ' HG3' ' A' ' 225' ' ' ARG . 98.0 m -127.62 111.04 13.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 61.51 111.117 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.581 HD21 HG23 ' A' ' 277' ' ' ILE . 0.4 OUTLIER -100.52 135.48 41.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 63.3 110.899 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 9.4 t -140.73 123.18 15.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 71.54 110.797 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.678 HG21 ' CD1' ' B' ' 231' ' ' ILE . 4.2 p -113.63 150.17 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 73.11 111.156 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -88.19 -73.31 0.49 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.483 . . . . 73.41 110.956 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 18.5 m -124.06 133.67 53.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 62.51 111.169 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.794 HG22 HD11 ' B' ' 231' ' ' ILE . 9.8 t -118.01 128.87 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 45.22 111.139 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 48.8 t -127.4 117.17 46.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 44.35 111.108 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.74 133.62 10.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.687 -0.768 . . . . 75.31 112.456 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -132.33 148.12 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 75.41 110.96 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.39 88.05 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.817 -0.706 . . . . 63.43 112.429 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 44.45 65.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 63.11 110.913 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 43.4 t -93.82 145.21 24.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.47 . . . . 73.14 110.86 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -123.02 128.45 50.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 74.35 110.835 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.543 ' HB ' HG12 ' A' ' 239' ' ' VAL . 21.2 t -119.3 123.62 71.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 73.21 111.144 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.603 HD23 ' CZ2' ' A' ' 287' ' ' TRP . 0.2 OUTLIER -121.0 111.48 17.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 72.23 110.976 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.724 HG22 ' HB3' ' A' ' 226' ' ' ASN . 20.4 mm -111.79 104.44 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.188 -0.46 . . . . 72.32 111.174 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 140.7 -160.22 26.54 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 72.43 112.468 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -107.01 151.51 25.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 70.23 110.878 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.711 ' HG3' HG12 ' B' ' 244' ' ' VAL . 0.5 OUTLIER -130.26 131.93 45.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 71.31 110.893 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -113.17 125.86 54.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 64.13 110.933 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 131.37 166.55 11.71 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.735 -0.745 . . . . 63.44 112.519 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -82.42 -108.93 0.44 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 33.33 112.524 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.31 51.01 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 75.23 110.907 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.15 30.87 32.48 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.787 -0.721 . . . . 51.32 112.464 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 58.47 83.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.882 0.372 . . . . 74.14 110.882 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.603 ' CZ2' HD23 ' A' ' 276' ' ' LEU . 23.0 t90 55.45 63.14 2.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 61.54 110.909 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.16 -169.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.258 -0.428 . . . . 73.52 110.938 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -119.75 161.71 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 72.34 110.974 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -51.93 116.53 2.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 75.52 110.934 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -152.57 -73.1 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 73.5 110.889 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 8.4 m170 63.09 168.2 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 71.41 110.806 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -154.85 178.01 10.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 73.13 110.844 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -84.41 137.14 33.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 62.32 110.889 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 8.5 m170 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 75.44 110.863 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.828 0.347 . . . . 63.33 110.941 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.04 -170.56 2.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 62.11 110.887 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 2.5 tt -71.02 150.31 9.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 71.52 111.151 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . 0.448 ' HB2' HG22 ' B' ' 222' ' ' ILE . 7.0 m-20 -55.73 175.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.89 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.525 ' HB3' ' OG ' ' B' ' 257' ' ' SER . . . -95.44 24.56 5.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 71.44 111.07 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . 0.448 HG22 ' HB2' ' B' ' 220' ' ' ASP . 12.5 tt -111.06 136.18 47.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 61.13 111.122 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 92.7 t -149.86 105.51 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 75.41 111.13 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -80.46 164.75 47.62 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 70.11 112.467 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.57 ' HB3' HG23 ' B' ' 261' ' ' THR . 5.7 mtp180 -170.76 127.42 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.833 0.349 . . . . 72.1 110.862 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.788 ' HB3' HG22 ' B' ' 277' ' ' ILE . 0.5 OUTLIER -128.22 131.13 48.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.911 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.1 145.32 49.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 75.14 110.876 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.559 ' HB3' HG23 ' A' ' 264' ' ' VAL . . . -139.5 124.68 18.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.478 . . . . 72.42 111.075 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.39 -36.05 53.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.483 . . . . 60.25 110.969 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.36 137.6 4.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 72.45 110.856 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.794 HD11 HG22 ' A' ' 267' ' ' VAL . 5.9 pt -138.69 117.64 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 65.43 111.179 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.35 123.72 32.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 74.54 110.875 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.589 HG21 ' CG1' ' B' ' 239' ' ' VAL . 1.7 p -135.61 142.71 45.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 73.13 111.18 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -143.37 167.56 21.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 70.22 110.879 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 68.63 73.6 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 74.15 110.881 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 45.83 54.8 7.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 64.13 110.844 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.27 156.17 18.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 63.3 111.138 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.31 146.54 42.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.829 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.589 ' CG1' HG21 ' B' ' 233' ' ' THR . 18.6 m -136.46 140.85 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 74.14 111.208 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.561 ' HB3' HD22 ' B' ' 276' ' ' LEU . 1.9 tt0 -138.14 122.55 18.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 60.1 110.964 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.6 118.94 33.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.209 -0.45 . . . . 72.1 110.93 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.92 -170.84 24.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.798 -0.715 . . . . 54.41 112.523 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.99 129.05 34.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 74.33 110.909 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.711 HG12 ' HG3' ' A' ' 280' ' ' GLU . 17.5 m -118.99 121.12 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 71.04 111.175 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.471 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 26.6 t -122.15 129.02 75.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 73.31 111.105 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -85.34 175.08 9.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 75.12 111.157 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.05 -42.35 90.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 61.34 111.145 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.96 67.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 73.53 111.08 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.471 ' HB3' ' CG1' ' B' ' 245' ' ' VAL . . . -60.2 -25.36 65.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 61.22 111.074 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.496 ' O ' HG23 ' A' ' 254' ' ' ILE . 1.2 tp -55.64 -25.85 41.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 74.14 110.947 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -115.14 58.36 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.33 110.889 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -168.59 -161.37 18.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.652 -0.785 . . . . 74.34 112.414 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 112.84 136.59 6.67 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.76 -0.733 . . . . 71.14 112.464 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.92 50.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.857 0.361 . . . . 65.02 111.219 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . 0.506 ' HE ' HG21 ' C' ' 254' ' ' ILE . 0.0 OUTLIER 69.64 -74.83 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 72.41 110.886 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 44.4 mm 60.83 81.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.179 -0.464 . . . . 65.41 111.126 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . 0.525 ' OG ' ' HB3' ' B' ' 221' ' ' ALA . 2.0 t -83.16 115.24 21.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 74.42 110.816 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.402 ' O ' HG23 ' B' ' 260' ' ' THR . 12.3 t0 -178.77 105.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 74.01 110.863 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -68.71 93.76 0.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 75.11 110.857 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.562 HG21 ' HB2' ' C' ' 243' ' ' ASN . 27.8 p -100.69 122.05 42.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 73.22 111.17 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.57 HG23 ' HB3' ' B' ' 225' ' ' ARG . 96.7 m -133.91 124.92 27.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 73.24 111.152 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -115.97 134.6 54.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 71.11 110.866 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.89 123.54 19.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 53.34 110.828 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.68 HG21 ' CD1' ' C' ' 231' ' ' ILE . 4.9 p -110.22 150.04 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.099 -0.501 . . . . 64.53 111.123 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -86.61 -77.1 0.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 62.41 110.835 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 13.8 m -120.16 132.71 55.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 75.54 111.169 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.78 HG22 HD11 ' C' ' 231' ' ' ILE . 5.0 t -118.13 121.0 66.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.304 -0.407 . . . . 63.25 111.107 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.51 117.24 51.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.487 . . . . 64.04 111.138 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.79 133.79 11.09 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 72.02 112.516 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.99 148.12 52.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 63.43 110.933 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.35 82.95 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.75 -0.738 . . . . 43.53 112.545 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 46.8 69.04 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 63.4 110.893 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.92 145.7 26.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 73.23 110.884 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.46 128.38 52.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 72.31 110.891 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.548 ' HB ' HG12 ' B' ' 239' ' ' VAL . 21.7 t -118.98 123.91 72.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 63.13 111.139 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.561 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.2 OUTLIER -124.36 111.66 16.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 75.2 110.951 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.788 HG22 ' HB3' ' B' ' 226' ' ' ASN . 24.0 mm -112.09 104.1 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 72.44 111.165 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.24 -164.62 27.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 45.54 112.443 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -101.25 151.91 21.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 74.52 110.872 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.687 ' HG3' HG12 ' C' ' 244' ' ' VAL . 1.6 pp20? -130.91 142.51 50.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.842 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -127.53 125.92 41.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 73.14 110.914 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 157.7 146.24 4.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.72 -0.752 . . . . 63.02 112.509 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -102.98 -170.23 26.22 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 45.12 112.462 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? 56.27 25.18 9.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 72.24 110.893 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 141.77 117.86 1.36 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.724 -0.751 . . . . 51.33 112.541 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.51 ' CE2' HG21 ' C' ' 244' ' ' VAL . 3.0 m-85 -55.71 -26.1 43.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.338 . . . . 71.23 110.886 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -139.43 -65.0 0.48 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 74.25 110.882 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.45 124.26 35.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 61.41 110.844 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -51.93 141.75 17.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 64.22 110.884 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -158.65 165.61 34.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 74.2 110.898 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -89.97 -172.21 3.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 74.15 110.834 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -130.51 -169.89 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 73.32 110.896 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.87 -171.32 3.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 61.41 110.816 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -77.65 -170.24 1.76 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.216 -0.447 . . . . 61.12 110.915 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 63.24 110.833 179.951 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.816 0.341 . . . . 74.54 110.86 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.51 172.43 8.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 73.11 110.942 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.464 HD13 ' N ' ' C' ' 220' ' ' ASP . 0.0 OUTLIER -157.55 145.28 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.291 -0.413 . . . . 73.01 111.11 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . 0.464 ' N ' HD13 ' C' ' 219' ' ' ILE . 0.3 OUTLIER -179.0 132.92 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 61.42 110.86 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . 0.636 ' H ' HD12 ' C' ' 222' ' ' ILE . . . -177.6 73.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 75.34 111.122 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . 0.636 HD12 ' H ' ' C' ' 221' ' ' ALA . 4.6 mp -139.9 145.07 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 40.12 111.088 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . 0.459 HG12 HG12 ' D' ' 222' ' ' ILE . 32.7 m -62.59 -176.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 75.51 111.131 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -175.69 176.47 47.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.805 -0.712 . . . . 53.44 112.534 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.615 ' HA ' HG23 ' C' ' 261' ' ' THR . 23.9 mmt85 -71.0 -67.05 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 75.33 110.87 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.563 ' HB3' HG22 ' C' ' 277' ' ' ILE . 1.2 m120 -84.43 118.44 24.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 73.25 110.877 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 14.9 t -136.68 147.74 46.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.816 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.599 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -135.83 129.0 31.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 62.42 111.145 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.22 -35.24 36.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 62.0 110.91 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.8 136.81 3.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 61.21 110.89 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.78 HD11 HG22 ' B' ' 267' ' ' VAL . 4.6 pt -139.17 117.72 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 73.43 111.156 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.1 124.3 32.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 72.54 110.939 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.579 HG21 ' CG1' ' C' ' 239' ' ' VAL . 1.4 p -135.39 144.21 46.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 62.3 111.105 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 13.1 pm0 -143.53 167.82 21.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 62.03 110.927 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 68.68 70.72 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 73.25 110.926 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? 47.0 57.39 5.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 73.35 110.835 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.418 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -104.57 156.18 18.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 73.0 111.106 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -136.58 141.63 43.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 72.24 110.871 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.579 ' CG1' HG21 ' C' ' 233' ' ' THR . 19.3 m -131.07 140.81 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 74.22 111.105 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.536 ' HB3' HD22 ' C' ' 276' ' ' LEU . 2.0 tp60 -138.02 129.54 27.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 75.23 110.906 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.578 HD13 ' CD1' ' B' ' 277' ' ' ILE . 5.2 mp -123.98 118.65 27.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 72.44 110.957 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.8 -176.74 21.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.767 -0.73 . . . . 74.2 112.506 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.562 ' HB2' HG21 ' B' ' 260' ' ' THR . 25.7 t-20 -85.92 128.91 34.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 70.45 110.851 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.687 HG12 ' HG3' ' B' ' 280' ' ' GLU . 32.2 m -111.67 127.4 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 64.41 111.166 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 22.4 t -122.29 129.07 75.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 70.51 111.132 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 18.3 p -84.18 175.08 9.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 62.54 111.102 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.81 -34.85 70.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.476 . . . . 74.21 111.046 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -70.87 -51.73 24.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 41.23 111.07 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 52.36 -170.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.284 -0.416 . . . . 63.12 111.07 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.03 -177.34 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 70.22 110.913 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -168.89 67.01 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.448 . . . . 75.2 110.888 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 178.47 88.09 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.767 -0.73 . . . . 63.4 112.473 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 52.68 -144.85 20.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 60.4 112.446 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . 0.506 HG21 ' HE ' ' B' ' 255' ' ' ARG . 13.4 pt -117.82 -36.29 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 75.44 111.155 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 55.96 -176.47 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 72.14 110.867 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 42.3 mt -139.31 69.26 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 70.34 111.113 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 2.6 p -52.09 157.62 1.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 64.31 110.947 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -59.96 178.54 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 72.4 110.886 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -105.95 79.55 1.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 74.04 110.914 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 51.3 p -67.13 128.88 38.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 53.41 111.142 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.615 HG23 ' HA ' ' C' ' 225' ' ' ARG . 22.6 m -125.46 109.01 12.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 70.44 111.111 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . 0.642 HD21 HG23 ' C' ' 277' ' ' ILE . 0.4 OUTLIER -107.26 135.87 48.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.44 110.856 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.05 123.61 14.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 43.42 110.883 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.63 HG21 HD11 ' D' ' 231' ' ' ILE . 3.5 p -110.27 145.11 17.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.151 -0.477 . . . . 73.45 111.139 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.43 -75.82 0.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 64.41 110.798 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 25.2 m -126.12 134.28 51.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.179 -0.464 . . . . 72.44 111.061 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.877 HG22 HD11 ' D' ' 231' ' ' ILE . 8.7 t -118.64 127.06 75.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.488 . . . . 72.12 111.134 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.91 116.11 43.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 74.24 111.128 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.69 133.77 10.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.785 -0.722 . . . . 43.24 112.484 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.29 148.01 52.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 73.22 110.902 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.84 85.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.735 -0.745 . . . . 63.43 112.52 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 47.82 73.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 72.34 110.87 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 38.6 t -103.12 145.48 29.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 63.21 110.817 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -119.65 128.49 53.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 61.45 110.899 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.533 ' CG2' HG12 ' C' ' 239' ' ' VAL . 21.8 t -119.55 123.93 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.124 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.621 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -126.18 111.15 14.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 74.01 110.935 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.653 ' CD1' HD13 ' D' ' 241' ' ' LEU . 38.7 mm -112.18 104.05 16.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 51.45 111.165 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.04 -157.53 27.36 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 72.11 112.477 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -114.52 156.12 25.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 65.31 110.855 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.517 ' HG2' HG13 ' D' ' 244' ' ' VAL . 0.0 OUTLIER -126.6 139.29 53.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.08 -0.509 . . . . 72.53 110.877 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -129.19 125.99 38.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.941 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 148.1 153.9 6.11 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.768 -0.73 . . . . 73.04 112.502 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . 0.45 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . -99.01 103.81 2.8 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.717 -0.754 . . . . 74.14 112.526 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -179.41 41.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.877 0.37 . . . . 74.55 110.944 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.66 -135.05 11.98 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.75 -0.738 . . . . 73.35 112.488 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -124.32 -1.85 8.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 63.14 110.866 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.621 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 3.7 t90 -174.29 -65.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 73.3 110.909 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -122.12 -171.34 2.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 75.32 110.932 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -52.56 127.84 24.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 73.2 110.906 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -52.08 139.21 23.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 74.2 110.879 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -163.67 49.5 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 74.41 110.892 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -129.04 -73.67 0.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 70.15 110.869 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.56 126.81 31.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 72.23 110.888 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 71.28 -70.02 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 64.12 110.911 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 64.33 110.813 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.881 0.372 . . . . 65.04 110.909 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -162.2 -177.32 5.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 73.23 110.884 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 6.2 pt -141.9 168.12 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 73.3 111.15 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -172.5 139.07 0.94 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 74.42 110.835 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . 0.539 ' HB1' ' HE2' ' E' ' 218' ' ' LYS . . . -174.38 112.52 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 42.2 111.106 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . 0.459 HG12 HG12 ' C' ' 223' ' ' VAL . 4.0 mp -139.65 146.99 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 75.03 111.123 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 12.3 p -124.22 147.39 28.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.187 -0.461 . . . . 71.44 111.097 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -144.3 -152.77 5.71 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.753 -0.736 . . . . 54.52 112.436 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -72.5 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.327 . . . . 72.21 110.814 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . 0.579 ' HB3' HG22 ' D' ' 277' ' ' ILE . 1.9 m120 -86.53 110.07 19.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 74.5 110.916 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 2.3 t -124.09 138.15 54.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 72.53 110.847 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . 0.407 ' HB3' HG23 ' C' ' 264' ' ' VAL . . . -121.41 129.02 52.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 74.04 111.139 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.03 -33.12 51.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 73.54 110.899 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -167.77 136.59 2.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 75.13 110.85 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . 0.877 HD11 HG22 ' C' ' 267' ' ' VAL . 4.2 pt -140.41 116.98 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 72.32 111.157 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . 0.463 ' HD2' HG22 ' D' ' 268' ' ' VAL . 11.5 ptp180 -131.41 124.65 30.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 74.24 110.823 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . 0.493 HG21 ' CG1' ' D' ' 239' ' ' VAL . 2.7 p -136.06 143.48 44.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 72.33 111.14 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 17.9 pm0 -142.83 167.7 21.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.25 110.867 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 67.7 78.21 0.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.492 . . . . 71.02 110.893 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 43.92 50.64 7.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 70.41 110.93 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.02 156.1 18.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 63.42 111.137 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.95 155.65 49.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 54.32 110.888 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.564 HG12 ' HB ' ' D' ' 275' ' ' VAL . 17.5 m -141.16 140.06 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 55.32 111.088 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . 0.533 ' HB3' HD22 ' D' ' 276' ' ' LEU . 2.0 tt0 -138.1 119.2 14.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 71.14 110.854 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.653 HD13 ' CD1' ' C' ' 277' ' ' ILE . 3.4 mp -118.78 135.19 54.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 51.14 110.913 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.17 -116.9 1.53 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 73.31 112.499 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -143.62 128.79 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.865 0.365 . . . . 70.13 110.882 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . 0.517 HG13 ' HG2' ' C' ' 280' ' ' GLU . 0.4 OUTLIER -104.55 115.54 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 65.22 111.109 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 80.5 t -122.03 125.95 73.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 61.44 111.087 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . 0.511 HG23 ' O ' ' D' ' 281' ' ' TYR . 18.2 p -86.25 174.99 8.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 64.15 111.11 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . 0.45 ' HB2' ' N ' ' C' ' 283' ' ' GLY . . . -53.92 -42.62 68.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 64.23 111.123 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.97 -44.94 96.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.433 . . . . 63.44 111.072 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.81 -169.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 74.22 111.063 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' E' ' 249' ' ' ALA . 0.3 OUTLIER -141.77 -170.67 3.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 51.35 110.896 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -72.61 -175.16 1.57 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.21 -0.45 . . . . 70.41 110.804 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -135.26 -145.96 5.24 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.749 -0.739 . . . . 54.41 112.538 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 169.6 166.62 28.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.787 -0.721 . . . . 62.12 112.492 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . 0.726 HG23 HG12 ' D' ' 256' ' ' ILE . 2.2 tt -51.93 146.01 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.847 0.356 . . . . 62.02 111.147 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -77.84 98.74 5.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 41.21 110.857 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . 0.726 HG12 HG23 ' D' ' 254' ' ' ILE . 3.1 pt -151.11 168.27 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 64.22 111.13 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.63 99.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 64.33 110.931 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -173.65 102.74 0.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 60.53 110.892 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -176.62 159.88 1.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 64.11 110.952 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 25.8 p -77.34 125.72 29.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.303 -0.408 . . . . 73.51 111.152 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 90.0 m -99.0 109.33 22.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 73.42 111.122 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -108.9 144.6 36.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 61.22 110.923 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.36 136.06 35.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 64.32 110.846 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.836 HG22 HD11 ' E' ' 231' ' ' ILE . 0.9 OUTLIER -120.17 133.83 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 61.43 111.112 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -70.16 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 75.41 110.888 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 87.1 m -150.85 133.64 15.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 73.32 111.14 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.846 HG22 HD12 ' E' ' 231' ' ' ILE . 13.5 t -117.17 129.19 74.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.247 -0.433 . . . . 64.13 111.178 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . 0.463 HG22 ' HD2' ' D' ' 232' ' ' ARG . 61.2 t -127.2 115.8 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 63.13 111.107 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.0 133.06 11.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 54.12 112.49 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.31 116.62 18.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 72.32 110.936 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.57 87.66 0.17 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.69 -0.767 . . . . 73.33 112.477 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 52.25 88.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 73.31 110.869 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.37 145.68 50.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 61.21 110.914 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -121.35 128.83 52.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.161 -0.472 . . . . 72.32 110.826 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.564 ' HB ' HG12 ' D' ' 239' ' ' VAL . 21.8 t -116.24 126.6 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 71.35 111.079 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.642 HD23 ' CZ2' ' D' ' 287' ' ' TRP . 0.2 OUTLIER -128.24 111.3 13.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.22 110.98 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.579 HG22 ' HB3' ' D' ' 226' ' ' ASN . 45.8 mm -112.6 104.8 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.158 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 138.02 -176.9 20.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.776 -0.726 . . . . 41.31 112.495 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -91.33 156.17 17.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 75.45 110.849 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -131.66 139.02 48.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 61.11 110.887 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . 0.511 ' O ' HG23 ' D' ' 246' ' ' THR . 12.3 m-85 -125.61 125.89 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 72.52 110.836 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' E' ' 247' ' ' ALA . . . -170.66 -87.69 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 74.44 112.476 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 136.84 -50.68 0.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.669 -0.777 . . . . 34.35 112.487 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 103.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.325 . . . . 51.2 110.917 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 56.07 -101.51 0.14 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.793 -0.718 . . . . 73.13 112.411 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -175.13 122.44 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.814 0.34 . . . . 72.14 110.925 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . 0.642 ' CZ2' HD23 ' D' ' 276' ' ' LEU . 7.7 t90 51.17 32.83 8.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 75.22 110.906 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.19 -171.42 0.2 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 54.54 110.86 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -110.87 176.75 4.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.13 110.916 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -127.95 99.87 5.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 70.24 110.823 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.45 161.29 1.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 75.25 110.792 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -162.42 -74.11 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 75.4 110.828 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.08 111.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 74.41 110.815 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -177.69 -174.8 0.48 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 72.45 110.907 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 5.2 t60 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 61.24 110.919 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.829 0.347 . . . . 73.43 110.912 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . 0.539 ' HE2' ' HB1' ' D' ' 221' ' ' ALA . 0.2 OUTLIER -177.22 142.12 0.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 71.31 110.929 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 8.7 tp -172.85 139.15 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.262 -0.427 . . . . 62.43 111.129 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.0 140.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 72.53 110.851 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -105.35 -68.54 0.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 44.41 111.078 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.65 121.86 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 73.4 111.127 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . 0.51 HG12 HH12 ' E' ' 225' ' ' ARG . 6.2 m -140.76 111.04 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 61.22 111.209 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -71.87 -128.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.824 -0.703 . . . . 64.34 112.504 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . 0.51 HH12 HG12 ' E' ' 223' ' ' VAL . 0.0 OUTLIER 62.46 -168.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 72.43 110.842 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . 0.598 ' HB3' HG22 ' E' ' 277' ' ' ILE . 1.6 m120 -83.52 109.74 17.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 61.21 110.876 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 3.3 m -131.86 137.62 48.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 53.11 110.845 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -108.25 155.01 20.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 70.32 111.09 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -109.56 -26.03 10.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 74.4 110.902 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . 0.688 ' HB2' HG22 ' E' ' 266' ' ' THR . 0.4 OUTLIER -167.88 137.24 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 73.34 110.898 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . 0.846 HD12 HG22 ' D' ' 267' ' ' VAL . 0.4 OUTLIER -139.43 115.9 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.31 111.115 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -132.29 118.46 19.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 73.52 110.862 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . 0.593 HG21 ' CG1' ' E' ' 239' ' ' VAL . 1.3 p -136.21 152.83 51.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 74.35 111.104 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.5 167.29 30.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 75.23 110.896 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 63.75 80.47 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 72.04 110.929 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 45.54 51.81 9.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 74.11 110.825 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . 0.405 ' HB1' ' HB ' ' E' ' 233' ' ' THR . . . -104.54 156.66 17.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 65.45 111.196 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -139.16 154.34 48.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 71.42 110.845 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.63 HG12 ' CG2' ' E' ' 275' ' ' VAL . 19.0 m -142.63 135.68 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 74.53 111.119 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -138.52 129.8 27.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 74.12 110.934 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.831 HD22 HG23 ' D' ' 264' ' ' VAL . 5.4 mp -127.51 135.19 50.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 74.3 110.915 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.16 -124.37 2.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.739 -0.743 . . . . 35.43 112.49 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -144.1 128.95 18.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.367 . . . . 75.53 110.93 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 11.0 t -99.91 119.4 47.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 64.2 111.121 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 57.6 t -122.28 112.91 36.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.451 . . . . 74.21 111.131 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . 0.466 HG23 ' O ' ' E' ' 281' ' ' TYR . 43.9 p -71.92 175.05 6.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 63.04 111.145 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' D' ' 282' ' ' GLY . . . -63.0 -40.5 97.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 21.13 111.155 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.01 -51.97 67.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 74.52 111.112 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . 0.65 ' HB2' HD11 ' D' ' 250' ' ' LEU . . . 51.83 -169.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 72.14 111.125 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 12.6 tp -71.84 -66.7 0.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 65.22 110.876 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -177.2 169.4 2.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 71.54 110.845 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -52.77 111.44 1.65 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.74 -0.743 . . . . 62.01 112.485 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 69.76 138.83 0.12 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.734 -0.746 . . . . 64.32 112.469 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . 0.457 HD12 ' H ' ' E' ' 255' ' ' ARG . 6.2 tp -160.89 143.51 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.776 0.322 . . . . 73.11 111.141 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . 0.457 ' H ' HD12 ' E' ' 254' ' ' ILE . 4.8 mtm180 -61.7 -170.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.181 -0.463 . . . . 72.54 110.839 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.26 178.6 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 74.44 111.154 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.62 111.35 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 71.31 110.852 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -173.41 127.25 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 62.12 110.849 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -178.19 -36.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.932 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 11.0 p -72.04 137.1 46.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 71.53 111.128 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 98.6 m -121.1 125.68 47.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.2 111.132 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -126.19 125.54 42.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 73.11 110.881 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.24 119.71 35.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 74.42 110.856 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . 1.075 HG21 HD12 ' E' ' 277' ' ' ILE . 75.4 t -107.8 115.46 48.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 64.15 111.172 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . 0.572 ' CD ' ' N ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -64.6 -133.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 71.12 110.906 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . 0.688 HG22 ' HB2' ' E' ' 230' ' ' ASP . 7.1 p -94.71 130.03 41.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 71.25 111.139 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 26.4 t -116.47 123.33 71.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 52.03 111.118 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 38.6 t -110.6 118.36 57.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.082 -0.508 . . . . 70.43 111.107 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.81 133.58 11.7 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.715 -0.755 . . . . 71.24 112.563 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.69 116.55 19.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.881 0.372 . . . . 62.32 110.969 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.88 97.74 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.771 -0.728 . . . . 64.34 112.578 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 51.71 89.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 62.44 110.887 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 31.3 t -124.87 146.54 49.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 70.12 110.868 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -127.19 128.69 46.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 74.04 110.895 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.63 ' CG2' HG12 ' E' ' 239' ' ' VAL . 21.9 t -114.89 122.88 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 61.52 111.159 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.647 HD23 ' CZ2' ' E' ' 287' ' ' TRP . 0.1 OUTLIER -129.16 110.75 12.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.261 -0.427 . . . . 55.43 110.948 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 1.075 HD12 HG21 ' E' ' 264' ' ' VAL . 26.7 mm -113.76 104.87 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.45 111.088 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 143.92 -161.8 27.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 73.25 112.513 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.22 156.28 26.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 54.44 110.851 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.77 147.26 44.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 73.22 110.882 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . 0.466 ' O ' HG23 ' E' ' 246' ' ' THR . 17.8 m-85 -130.09 125.81 36.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 75.2 110.905 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 163.5 167.03 23.34 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.739 -0.743 . . . . 63.14 112.478 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -67.79 -138.01 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.698 -0.763 . . . . 64.23 112.506 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -51.71 140.48 18.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 74.45 110.934 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 108.49 86.22 1.78 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 72.22 112.53 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -51.82 -35.08 43.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.349 . . . . 72.33 110.883 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . 0.647 ' CZ2' HD23 ' E' ' 276' ' ' LEU . 14.8 t90 -176.14 -44.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 74.24 110.886 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -127.15 160.57 30.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 73.31 110.845 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -127.17 -170.19 2.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 71.32 110.942 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -152.46 113.48 4.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 65.32 110.826 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -178.15 129.66 0.13 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 74.13 110.823 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -150.97 25.92 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 74.32 110.794 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 52.51 88.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.866 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.24 -169.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 64.23 110.874 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 72.12 110.846 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 29.0 ttm . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.861 0.363 . . . . 75.32 110.954 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -179.23 -35.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 71.44 110.899 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.1 tt -51.78 150.94 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 62.43 111.137 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -95.89 26.32 4.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.487 . . . . 74.41 110.862 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -151.75 98.81 2.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 55.51 111.05 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 9.2 tt -159.22 150.95 6.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 53.11 111.162 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.91 153.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 53.54 111.14 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 106.62 106.01 3.08 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 54.32 112.44 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.508 ' H ' HG23 ' A' ' 261' ' ' THR . 21.3 ptt180 -179.55 146.04 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.804 0.335 . . . . 53.4 110.869 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -83.93 119.51 24.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.903 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.97 137.98 53.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 72.2 110.808 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.53 141.11 46.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 55.11 111.104 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -97.36 -35.64 10.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 63.2 110.87 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.461 ' HB3' HG23 ' A' ' 266' ' ' THR . 7.2 t0 -164.33 138.96 5.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.299 -0.41 . . . . 73.23 110.864 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.456 HD13 HD21 ' A' ' 241' ' ' LEU . 11.0 mt -137.61 117.79 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.11 111.069 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.68 120.28 24.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 71.43 110.819 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.32 146.9 48.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 71.51 111.111 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -148.89 167.09 26.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 71.12 110.939 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 66.82 56.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 65.11 110.954 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 14.9 mtm-85 50.41 64.65 1.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.856 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 156.25 18.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 45.1 111.132 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -129.33 135.68 49.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 74.51 110.884 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.462 HG12 ' HB ' ' A' ' 275' ' ' VAL . 20.4 m -139.73 130.13 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 63.21 111.146 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -122.24 132.73 54.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 72.02 110.905 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.456 HD21 HD13 ' A' ' 231' ' ' ILE . 0.7 OUTLIER -130.43 135.1 47.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 53.41 110.862 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.54 -130.92 6.32 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.805 -0.712 . . . . 50.53 112.539 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -144.56 128.89 17.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.866 0.365 . . . . 64.42 110.899 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' A' ' 280' ' ' GLU . 27.0 m -110.26 126.15 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 71.5 111.129 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.2 m -122.47 129.11 75.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 64.12 111.063 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 281' ' ' TYR . 34.9 p -71.74 174.65 6.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 71.34 111.154 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.61 80.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 62.42 111.09 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.99 -35.92 69.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 73.12 111.168 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.71 -29.95 20.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 33.44 111.102 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.18 85.38 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 73.05 110.945 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -178.2 34.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 73.1 110.888 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 65.65 -167.42 33.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.759 -0.734 . . . . 75.13 112.451 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -168.67 -75.97 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.683 -0.77 . . . . 74.14 112.426 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 29.2 mm 63.25 72.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.343 . . . . 55.13 111.193 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.51 140.74 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 72.03 110.869 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 11.5 tt -66.78 131.05 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 74.24 111.133 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.5 p -179.33 -35.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 62.51 110.84 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.19 107.58 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 73.11 110.88 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -178.04 34.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.231 -0.441 . . . . 60.14 110.927 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 21.7 p -100.32 121.97 42.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 73.14 111.125 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.508 HG23 ' H ' ' A' ' 225' ' ' ARG . 0.9 OUTLIER -129.78 108.87 10.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 71.24 111.136 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -101.86 129.05 48.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 74.24 110.92 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 34.7 m -140.44 123.81 16.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 65.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.578 HG21 HG22 ' A' ' 267' ' ' VAL . 8.6 p -120.28 136.7 56.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 73.3 111.109 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -78.65 -76.13 0.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 70.14 110.809 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 230' ' ' ASP . 3.1 m -127.04 130.6 50.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 70.14 111.131 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.578 HG22 HG21 ' A' ' 264' ' ' VAL . 21.6 t -118.2 125.01 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 64.13 111.116 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.25 122.2 63.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 74.45 111.073 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.17 133.76 9.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 43.54 112.478 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.97 147.89 52.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.372 . . . . 73.2 110.889 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.13 78.61 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.688 -0.768 . . . . 71.22 112.449 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 47.28 63.71 1.86 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.855 0.36 . . . . 72.3 110.887 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 46.3 t -90.25 145.66 24.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 54.35 110.815 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.18 128.04 44.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 71.44 110.841 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.738 HG13 HG23 ' B' ' 239' ' ' VAL . 17.4 t -134.54 123.74 43.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 64.42 111.114 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.69 111.56 18.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 64.32 110.809 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.404 HD13 HD23 ' A' ' 241' ' ' LEU . 2.1 mp -111.61 104.82 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 65.55 111.155 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.06 -161.17 29.86 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 74.35 112.469 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -120.15 150.24 40.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.783 0.325 . . . . 71.02 110.881 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.5 ' HG2' HG12 ' B' ' 244' ' ' VAL . 7.3 pt-20 -124.21 128.6 49.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.894 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.452 ' O ' HG23 ' A' ' 246' ' ' THR . 0.1 OUTLIER -110.05 125.8 53.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.105 -0.498 . . . . 73.21 110.926 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 125.06 159.8 10.49 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.721 -0.752 . . . . 40.23 112.561 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.613 ' H ' ' HB2' ' B' ' 247' ' ' ALA . . . -108.82 -8.3 28.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.711 -0.757 . . . . 74.22 112.514 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -77.32 60.58 2.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.874 0.369 . . . . 71.43 110.892 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 104.33 97.39 2.46 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.722 -0.751 . . . . 32.13 112.533 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.426 ' CE2' HG21 ' B' ' 244' ' ' VAL . 0.1 OUTLIER -51.85 -68.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 74.53 110.819 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -142.25 -69.66 0.35 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 71.23 110.956 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -104.38 -169.83 1.68 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 73.1 110.91 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -55.09 174.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 74.51 110.87 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.09 179.36 6.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 63.52 110.805 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 7.2 m80 59.97 174.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 72.0 110.822 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 63.19 101.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 70.15 110.866 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -112.49 -170.22 1.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 62.24 110.886 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.96 -72.69 0.57 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 52.42 110.859 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 74.12 110.928 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.807 0.337 . . . . 62.34 110.908 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.17 -40.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 52.35 110.903 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.89 124.58 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.291 -0.413 . . . . 61.12 111.082 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.18 117.35 0.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 53.1 110.881 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -155.82 173.72 16.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 75.32 111.16 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 64.6 mt -70.1 138.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 72.51 111.127 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.437 HG11 ' O ' ' C' ' 223' ' ' VAL . 21.9 t -128.9 135.31 62.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 74.33 111.187 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 172.76 113.29 0.3 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.697 -0.763 . . . . 62.2 112.419 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.535 ' H ' HG23 ' B' ' 261' ' ' THR . 1.6 ptp180 -179.49 148.83 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.892 0.377 . . . . 72.15 110.876 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -90.65 121.44 32.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 74.1 110.86 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 47.6 t -130.14 138.04 50.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 43.42 110.875 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.27 161.91 30.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 73.32 111.099 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.7 -31.91 5.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 52.23 110.904 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -164.39 138.79 5.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 24.35 110.911 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 12.9 mt -137.66 119.1 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 65.3 111.152 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 -131.71 119.15 20.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 74.4 110.899 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.1 OUTLIER -134.59 140.71 46.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 52.11 111.189 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -144.67 167.57 22.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 64.44 110.855 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 61.86 63.37 1.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.086 -0.506 . . . . 72.15 110.959 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 47.99 61.05 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 72.21 110.878 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.419 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -104.57 153.29 21.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 64.14 111.113 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 8.3 mtt-85 -129.19 135.6 49.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 75.11 110.863 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.738 HG23 HG13 ' A' ' 275' ' ' VAL . 24.2 m -140.69 123.91 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 73.31 111.137 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.614 ' HB3' HD22 ' B' ' 276' ' ' LEU . 0.1 OUTLIER -118.52 137.2 53.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 64.21 110.974 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.827 HD23 HD13 ' B' ' 277' ' ' ILE . 0.6 OUTLIER -130.06 118.89 22.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 71.45 110.851 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.27 173.7 13.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.704 -0.76 . . . . 71.11 112.477 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -87.8 137.99 31.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 43.13 110.908 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.5 HG12 ' HG2' ' A' ' 280' ' ' GLU . 30.6 m -120.68 125.68 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 64.11 111.132 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.48 129.2 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.31 111.142 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.7 t -71.55 175.1 5.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 72.44 111.149 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.613 ' HB2' ' H ' ' A' ' 283' ' ' GLY . . . -60.41 -40.57 91.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 71.42 111.165 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.02 -36.37 70.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 51.34 111.11 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.623 ' HB2' ' CD1' ' B' ' 281' ' ' TYR . . . -52.33 -29.83 25.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.199 -0.455 . . . . 65.41 111.129 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.92 57.55 3.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 62.34 110.963 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -117.22 -67.24 1.01 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 71.11 110.86 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -144.08 -145.01 4.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.736 -0.745 . . . . 74.21 112.468 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -173.93 104.53 0.2 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.778 -0.725 . . . . 52.23 112.503 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 28.2 mm -83.06 148.9 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 62.24 111.161 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . 0.618 ' O ' HD13 ' B' ' 256' ' ' ILE . 11.1 ttp85 -71.52 82.67 0.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 71.12 110.865 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . 0.618 HD13 ' O ' ' B' ' 255' ' ' ARG . 27.0 mm -134.21 149.41 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 63.14 111.1 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 62.2 p -66.07 106.41 1.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.838 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -114.58 77.29 1.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 74.53 110.911 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -114.19 79.69 1.29 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 71.41 110.828 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 30.5 p -100.53 121.99 42.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 72.13 111.196 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.535 HG23 ' H ' ' B' ' 225' ' ' ARG . 0.7 OUTLIER -129.33 133.73 47.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 64.03 111.171 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -125.85 130.01 50.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 62.43 110.905 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.27 123.8 20.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 70.13 110.846 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.502 HG21 ' CG2' ' B' ' 267' ' ' VAL . 13.5 p -119.26 133.18 66.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 60.53 111.109 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.12 -74.97 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.837 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 97.3 m -135.44 133.71 38.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 43.33 111.13 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.502 ' CG2' HG21 ' B' ' 264' ' ' VAL . 21.7 t -118.25 125.88 74.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 63.43 111.099 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 63.4 t -127.31 125.43 65.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 55.04 111.097 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.5 133.82 8.05 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.725 -0.75 . . . . 65.34 112.48 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -130.98 147.62 52.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.816 0.341 . . . . 62.54 110.906 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.43 64.64 3.25 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.83 -0.7 . . . . 62.42 112.439 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.03 96.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.872 0.367 . . . . 71.41 110.874 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 65.1 m -125.36 145.82 49.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 74.24 110.859 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 3.2 ttm-85 -127.22 127.51 44.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 61.01 110.799 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.674 HG13 HG23 ' C' ' 239' ' ' VAL . 19.3 t -134.6 123.41 41.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 63.34 111.148 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.614 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.2 OUTLIER -118.64 113.39 21.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.252 -0.431 . . . . 61.14 110.922 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.827 HD13 HD23 ' B' ' 241' ' ' LEU . 2.6 mp -110.07 127.11 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 64.12 111.036 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 127.33 -164.46 20.81 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.691 -0.766 . . . . 74.24 112.468 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -115.05 148.46 38.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 73.33 110.871 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.552 ' CG ' HG12 ' C' ' 244' ' ' VAL . 0.9 OUTLIER -119.72 131.38 55.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 62.01 110.904 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.623 ' CD1' ' HB2' ' B' ' 249' ' ' ALA . 26.1 t80 -116.87 125.99 52.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.959 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 129.58 -175.3 19.07 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.727 . . . . 73.11 112.514 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -136.39 51.44 0.81 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.785 -0.722 . . . . 72.15 112.494 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -98.5 25.98 5.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.817 0.342 . . . . 72.35 110.914 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 109.9 18.09 9.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.794 -0.717 . . . . 73.41 112.516 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' C' ' 244' ' ' VAL . 0.2 OUTLIER 69.35 -75.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.938 0.399 . . . . 62.23 110.868 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -141.95 -73.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.5 . . . . 74.3 110.868 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.66 -172.08 3.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 74.45 110.846 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -83.75 -64.59 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 71.5 110.88 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -121.84 -175.66 3.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 72.55 110.886 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -178.87 -176.86 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 64.13 110.874 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 19.7 t60 63.02 163.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 71.03 110.838 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -166.92 159.05 13.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 74.01 110.857 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -53.26 167.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 74.22 110.872 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 72.23 110.914 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 4.1 mtm . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.837 0.351 . . . . 75.34 110.89 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -105.74 86.19 2.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.903 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 3.2 mt -124.56 139.65 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 70.31 111.101 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -95.0 44.33 1.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 64.21 110.899 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -168.67 76.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 73.14 111.066 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 31.9 mm -104.58 83.79 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 61.42 111.186 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . 0.437 ' O ' HG11 ' B' ' 223' ' ' VAL . 6.6 p -51.68 122.63 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 64.15 111.169 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -146.2 -107.97 0.54 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.728 -0.748 . . . . 65.32 112.471 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.24 -57.57 0.9 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.781 0.324 . . . . 72.44 110.883 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -92.15 110.03 21.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 60.23 110.855 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 72.7 m -136.75 139.52 41.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 63.5 110.898 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.84 159.67 31.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 63.45 111.119 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -112.82 -29.28 7.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 74.21 110.921 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.7 138.09 4.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 72.34 110.867 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 9.6 mt -137.88 117.77 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 75.2 111.107 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -133.48 118.98 18.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.475 . . . . 74.43 110.926 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.1 OUTLIER -133.21 146.4 51.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 74.45 111.118 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -150.18 167.15 27.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 75.44 110.911 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 61.38 64.56 1.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 74.35 110.853 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 47.87 60.26 3.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 65.12 110.846 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.445 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -104.21 150.58 24.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 64.43 111.077 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 35.1 mtt85 -126.07 135.38 51.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 72.15 110.875 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.674 HG23 HG13 ' B' ' 275' ' ' VAL . 17.0 m -139.52 121.57 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 72.4 111.175 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.87 137.13 52.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.51 110.952 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.5 mp -127.49 118.69 24.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 64.42 110.982 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 134.83 -179.99 17.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.777 -0.725 . . . . 32.51 112.496 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -92.11 135.81 33.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 73.03 110.946 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.552 HG12 ' CG ' ' B' ' 280' ' ' GLU . 14.6 m -116.37 126.11 73.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 71.12 111.128 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.425 HG23 ' HA ' ' B' ' 281' ' ' TYR . 32.8 m -117.83 129.55 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 70.11 111.163 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . 0.73 HG22 ' CD2' ' C' ' 281' ' ' TYR . 11.7 t -69.05 171.13 8.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 72.54 111.178 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.7 -33.79 49.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 41.42 111.123 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' C' ' 251' ' ' HIS . . . -56.59 -35.82 68.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 75.04 111.143 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' C' ' 248' ' ' ALA . . . 69.21 -76.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 70.2 111.109 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.8 mt -119.94 -34.72 3.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 75.11 110.939 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . 0.606 ' HB2' ' HB1' ' C' ' 248' ' ' ALA . 9.9 t-80 52.04 78.08 0.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 72.45 110.904 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 129.79 174.82 13.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.67 -0.776 . . . . 71.03 112.49 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -102.79 19.35 47.45 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.818 -0.706 . . . . 74.34 112.537 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.42 178.63 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.869 0.366 . . . . 74.34 111.111 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -132.73 141.9 48.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 71.42 110.89 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 12.6 pt -127.08 151.25 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 53.32 111.144 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -157.18 50.54 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.33 110.903 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.88 148.52 30.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 71.52 110.889 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.27 109.95 20.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 53.04 110.919 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 30.8 p -97.83 129.29 44.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 74.4 111.118 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.637 HG23 ' HB3' ' D' ' 225' ' ' ARG . 0.3 OUTLIER -133.27 124.99 28.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 74.35 111.179 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -126.23 127.11 45.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 60.33 110.853 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.51 123.23 33.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 62.14 110.83 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' D' ' 231' ' ' ILE . 10.5 p -109.48 144.34 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 75.42 111.096 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.68 -65.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 71.53 110.893 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 30.5 p -147.01 138.36 24.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 64.4 111.216 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.502 ' CG1' HG21 ' C' ' 275' ' ' VAL . 23.3 t -117.61 124.93 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 63.54 111.144 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.66 116.02 41.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 72.42 111.117 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.41 133.01 9.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 64.32 112.475 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -132.44 141.27 48.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.352 . . . . 75.14 110.866 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.99 68.67 1.39 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 74.22 112.478 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.83 93.72 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.789 0.328 . . . . 72.53 110.964 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 34.3 t -126.06 145.63 50.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 75.05 110.903 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 13.2 mtm-85 -129.55 127.87 41.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 71.43 110.825 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.646 HG22 ' CG2' ' D' ' 239' ' ' VAL . 17.7 t -137.63 131.54 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 74.32 111.16 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.671 HD12 ' CD1' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -128.36 111.66 13.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 64.22 110.947 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 2.6 mp -106.55 104.73 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 74.21 111.124 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.93 -179.88 23.53 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.763 -0.732 . . . . 64.4 112.471 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -89.74 156.11 18.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.889 0.376 . . . . 75.11 110.887 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.538 ' HG3' HG12 ' D' ' 244' ' ' VAL . 2.6 pp20? -136.36 143.3 43.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 74.5 110.926 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.73 ' CD2' HG22 ' C' ' 246' ' ' THR . 63.3 t80 -130.02 125.46 35.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.42 110.916 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 149.41 116.87 0.84 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 72.21 112.456 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . 0.527 ' H ' ' HB2' ' D' ' 247' ' ' ALA . . . -62.82 -32.78 84.94 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.686 -0.768 . . . . 62.25 112.508 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -73.44 78.19 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.86 0.362 . . . . 64.34 110.912 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 73.77 104.78 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 72.24 112.458 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -58.23 -29.3 65.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 71.43 110.907 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.671 ' CD1' HD12 ' C' ' 276' ' ' LEU . 17.4 t90 -164.13 -41.77 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.142 -0.481 . . . . 74.21 110.983 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -129.48 -66.71 0.79 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 74.35 110.897 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 1.6 t30 62.91 163.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 60.32 110.889 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -174.42 37.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.42 110.876 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -80.75 100.36 8.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 71.23 110.891 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -174.4 114.1 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 73.31 110.862 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.8 -175.35 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 72.23 110.909 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -93.1 106.9 18.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 71.22 110.87 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.195 -0.457 . . . . 72.43 110.9 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.844 0.354 . . . . 75.44 110.854 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -59.59 160.14 7.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 72.04 110.824 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . 0.461 HD13 ' N ' ' D' ' 220' ' ' ASP . 0.0 OUTLIER -173.47 145.48 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 70.43 111.168 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . 0.461 ' N ' HD13 ' D' ' 219' ' ' ILE . 0.2 OUTLIER -171.26 174.25 4.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.945 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . 0.509 ' CB ' HD12 ' D' ' 222' ' ' ILE . . . -151.8 168.01 26.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.286 -0.415 . . . . 75.44 111.066 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . 0.509 HD12 ' CB ' ' D' ' 221' ' ' ALA . 4.8 mp 61.26 90.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 72.01 111.166 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 13.8 p -65.8 145.71 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 63.13 111.167 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 130.99 -144.79 16.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.681 -0.771 . . . . 70.43 112.502 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.637 ' HB3' HG23 ' C' ' 261' ' ' THR . 0.4 OUTLIER 62.67 -168.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.814 0.34 . . . . 73.42 110.861 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -82.91 110.57 18.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 73.31 110.865 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 27.0 m -139.74 147.59 41.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 74.12 110.843 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.17 162.36 24.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 64.0 111.099 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.72 -30.79 5.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 65.3 110.918 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.37 139.15 3.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 70.12 110.874 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . 0.423 ' CD1' HG23 ' C' ' 264' ' ' VAL . 14.3 mt -137.76 116.37 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 62.04 111.112 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.0 117.86 15.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 65.3 110.931 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.7 152.27 51.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 74.2 111.165 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -156.62 167.12 31.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 64.25 110.899 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 64.93 66.27 0.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 75.14 110.828 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? 50.24 45.21 26.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 71.02 110.921 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.6 151.53 20.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 72.42 111.084 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 35.0 mtt85 -132.39 135.59 46.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 74.35 110.845 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.646 ' CG2' HG22 ' C' ' 275' ' ' VAL . 0.4 OUTLIER -133.51 121.49 41.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 75.33 111.165 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . 0.523 ' O ' HD22 ' D' ' 241' ' ' LEU . 0.1 OUTLIER -108.44 135.47 49.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 53.33 110.958 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.55 HD21 HD12 ' D' ' 277' ' ' ILE . 3.5 mm? -126.46 118.59 25.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 72.11 110.872 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 123.05 175.0 14.42 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.792 -0.718 . . . . 33.24 112.468 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.66 144.79 25.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 73.21 110.904 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . 0.538 HG12 ' HG3' ' C' ' 280' ' ' GLU . 34.9 m -118.14 134.82 60.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 64.42 111.139 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 2.5 m -117.44 130.33 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 72.45 111.169 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . 0.418 HG21 ' HA2' ' D' ' 282' ' ' GLY . 14.2 t -68.52 174.68 3.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 74.12 111.103 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . 0.527 ' HB2' ' H ' ' C' ' 283' ' ' GLY . . . -52.86 -36.63 59.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 75.11 111.019 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . 0.403 ' H ' HG23 ' D' ' 246' ' ' THR . . . -56.07 -35.46 67.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 73.21 111.14 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . 0.591 ' HB2' ' HE1' ' C' ' 281' ' ' TYR . . . 64.39 158.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 75.43 111.108 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.73 166.03 18.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 61.2 110.865 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -179.27 120.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 71.32 110.887 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 153.13 176.41 25.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.779 -0.724 . . . . 74.34 112.484 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 145.94 120.03 1.26 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.714 -0.755 . . . . 54.34 112.497 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . 0.528 HD12 ' CD2' ' E' ' 251' ' ' HIS . 62.5 mt -147.68 -72.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 73.55 111.115 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -133.35 -74.34 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 75.41 110.911 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 10.3 tp -52.09 145.9 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 74.5 111.148 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.33 -178.09 1.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 71.52 110.873 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.77 110.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 75.1 110.871 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.36 135.19 55.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.981 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 77.4 p -95.03 124.84 39.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 72.44 111.121 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . 0.558 HG23 ' N ' ' D' ' 225' ' ' ARG . 68.8 m -132.63 118.13 18.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 72.14 111.105 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . 0.51 HD21 HG23 ' D' ' 277' ' ' ILE . 1.8 t-20 -124.6 126.6 46.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 44.42 110.881 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.66 122.91 29.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 61.32 110.808 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.545 HG23 HD13 ' E' ' 231' ' ' ILE . 9.3 p -114.36 144.15 22.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 60.14 111.128 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . 0.445 ' HG3' ' HA ' ' E' ' 229' ' ' LYS . 12.8 mt-10 -86.61 -83.13 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 73.23 110.85 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.59 137.89 47.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 72.53 111.108 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.494 HG21 HD11 ' D' ' 277' ' ' ILE . 99.0 t -117.38 119.74 62.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 65.51 111.124 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.07 121.65 67.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 65.01 111.086 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.94 133.3 9.31 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.731 -0.747 . . . . 75.22 112.495 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.27 143.72 50.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 74.21 110.828 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 45.41 85.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 71.02 112.434 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 49.93 78.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.371 . . . . 61.02 110.863 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.88 144.67 36.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 52.12 110.879 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -132.78 126.24 31.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 74.14 110.897 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.823 HG13 HG23 ' E' ' 239' ' ' VAL . 44.9 t -139.12 123.24 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 72.42 111.094 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.735 HD12 ' CD1' ' D' ' 287' ' ' TRP . 0.5 OUTLIER -114.53 110.55 19.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 54.31 110.938 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.55 HD12 HD21 ' D' ' 241' ' ' LEU . 10.0 mt -104.83 107.43 22.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 72.44 111.133 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.21 173.63 15.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 71.31 112.516 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -93.46 137.09 33.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 75.54 110.897 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.86 141.56 45.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.896 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . 0.413 ' CE2' HG22 ' D' ' 246' ' ' THR . 3.0 t80 -130.28 124.73 33.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.943 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . 0.418 ' HA2' HG21 ' D' ' 246' ' ' THR . . . 166.9 37.61 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.747 . . . . 75.54 112.452 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 50.31 -132.06 29.73 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.74 -0.743 . . . . 63.2 112.515 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -29.35 22.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.802 0.334 . . . . 71.21 110.873 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -58.96 97.12 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.75 -0.738 . . . . 71.23 112.52 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' E' ' 244' ' ' VAL . 0.2 OUTLIER -100.0 -176.43 3.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.938 0.399 . . . . 60.21 110.829 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . 0.735 ' CD1' HD12 ' D' ' 276' ' ' LEU . 15.6 t90 -61.92 -59.21 5.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 62.32 110.902 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.14 170.07 23.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 63.52 110.905 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -140.87 146.46 37.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 70.5 110.89 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.49 155.86 26.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 64.01 110.868 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -157.41 70.84 0.62 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.255 -0.429 . . . . 75.44 110.774 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.78 166.96 21.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 54.14 110.812 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -159.29 138.65 11.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 74.02 110.841 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -113.69 161.39 17.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.84 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 72.52 110.821 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 2.1 ptp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.86 0.362 . . . . 72.13 110.894 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -148.47 -173.34 4.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 72.55 110.924 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 2.1 mp 63.73 93.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 64.24 111.179 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.65 -174.75 0.39 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 73.33 110.893 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . 0.651 ' O ' HD13 ' E' ' 222' ' ' ILE . . . -167.94 80.5 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 73.13 111.066 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . 0.671 HG22 ' CG2' ' E' ' 223' ' ' VAL . 21.1 mm -136.55 144.57 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 51.25 111.127 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . 0.671 ' CG2' HG22 ' E' ' 222' ' ' ILE . 0.2 OUTLIER 49.62 -168.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 75.43 111.13 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . 0.444 ' H ' HG12 ' E' ' 223' ' ' VAL . . . -148.59 120.04 1.14 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 63.02 112.546 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . 0.406 ' O ' ' HB3' ' E' ' 262' ' ' ASN . 2.4 ttp180 -63.21 -160.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.777 0.322 . . . . 75.43 110.873 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -145.19 104.16 3.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 72.11 110.858 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.25 143.59 44.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 25.44 110.871 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.99 164.55 19.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 40.35 111.103 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . 0.445 ' HA ' ' HG3' ' D' ' 265' ' ' GLU . 0.9 OUTLIER -119.2 -36.39 3.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 74.53 110.914 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.26 138.62 3.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 62.12 110.856 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . 0.545 HD13 HG23 ' D' ' 264' ' ' VAL . 3.1 mp -137.81 113.54 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 72.41 111.139 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . 0.4 ' HG3' ' HA ' ' E' ' 268' ' ' VAL . 8.4 ptm180 -137.85 114.69 10.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 72.12 110.889 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.67 150.78 45.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 74.31 111.135 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -156.16 160.28 39.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.816 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 65.44 68.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 62.23 110.906 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 48.83 54.14 11.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.925 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.89 149.08 26.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 70.41 111.083 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -130.47 135.57 48.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 74.24 110.86 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.823 HG23 HG13 ' D' ' 275' ' ' VAL . 31.9 m -139.86 129.11 28.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 75.32 111.192 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . 0.65 ' O ' HD13 ' E' ' 241' ' ' LEU . 0.0 OUTLIER -119.95 137.59 53.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 70.12 110.952 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.961 HD12 HD12 ' E' ' 277' ' ' ILE . 0.9 OUTLIER -122.66 118.91 29.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 71.31 110.869 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 125.85 174.17 13.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.726 -0.749 . . . . 74.43 112.509 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -100.7 163.03 12.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.902 0.382 . . . . 72.03 110.89 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' D' ' 286' ' ' PHE . 2.6 m -121.88 140.47 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 61.32 111.084 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.81 127.99 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 64.12 111.124 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . 0.487 HG21 ' HA2' ' E' ' 282' ' ' GLY . 10.7 t -69.17 168.78 13.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 75.32 111.152 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.01 -33.9 53.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 71.51 111.088 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.2 -50.12 73.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 73.2 111.133 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 53.48 -173.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 61.05 111.131 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . 0.488 HD13 ' H ' ' E' ' 251' ' ' HIS . 0.2 OUTLIER -152.58 153.08 32.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 64.2 110.886 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . 0.528 ' CD2' HD12 ' D' ' 254' ' ' ILE . 43.6 m-70 -51.54 133.13 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 73.31 110.906 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -115.5 -161.61 13.09 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.757 -0.735 . . . . 61.01 112.553 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 111.52 90.49 1.97 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 62.43 112.519 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 19.5 tt -157.04 150.65 9.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 72.43 111.123 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.99 -74.71 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 73.24 110.811 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 14.5 pt -150.33 -177.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 73.23 111.117 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.9 145.62 1.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 72.25 110.773 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -120.63 43.88 2.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 70.43 110.875 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.21 -19.66 10.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 62.31 110.903 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.55 120.14 39.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.24 111.199 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.46 107.54 5.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 74.23 111.083 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' E' ' 225' ' ' ARG . 3.7 t-20 -129.15 116.42 19.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 61.0 110.891 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 3.1 p -119.7 123.87 44.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 70.41 110.79 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . 0.966 HG21 HD13 ' E' ' 277' ' ' ILE . 1.0 OUTLIER -104.75 137.17 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 64.13 111.163 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . 0.417 ' N ' ' CD ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -74.1 -146.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 34.54 110.912 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 4.1 t -96.56 137.61 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 65.2 111.171 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . 0.751 ' CG1' HG21 ' E' ' 275' ' ' VAL . 95.9 t -115.01 121.64 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 64.14 111.159 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . 0.422 ' O ' HG13 ' E' ' 268' ' ' VAL . 5.7 p -120.96 120.16 61.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 72.32 111.108 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.36 133.36 11.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.792 -0.718 . . . . 63.11 112.47 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -131.38 116.45 17.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.338 . . . . 72.41 110.907 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 65.67 80.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 71.42 112.517 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 58.66 88.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 73.2 110.92 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 8.9 t -121.29 145.61 47.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 62.22 110.842 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.5 128.05 34.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 73.45 110.858 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.751 HG21 ' CG1' ' E' ' 267' ' ' VAL . 41.7 t -136.97 123.5 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 50.21 111.142 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.592 HD22 ' HB3' ' E' ' 240' ' ' GLN . 0.8 OUTLIER -121.25 110.93 16.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 72.31 110.994 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.966 HD13 HG21 ' E' ' 264' ' ' VAL . 54.1 mt -107.89 137.53 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 75.45 111.096 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 121.31 -161.57 15.34 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.731 -0.747 . . . . 64.24 112.467 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -128.47 156.96 42.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 71.31 110.857 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.03 118.24 31.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 63.42 110.871 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -103.72 124.77 49.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 65.3 110.917 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . 0.487 ' HA2' HG21 ' E' ' 246' ' ' THR . . . 149.19 178.43 24.21 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.785 -0.722 . . . . 50.02 112.529 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -105.8 129.47 9.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.739 -0.743 . . . . 71.11 112.447 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 11.5 mtmm 50.8 67.9 0.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.801 0.334 . . . . 73.45 110.918 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -151.87 40.09 0.76 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.706 -0.759 . . . . 51.11 112.507 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -51.47 146.23 7.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.89 0.376 . . . . 55.33 110.849 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -50.48 -57.14 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 74.21 110.912 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -65.13 99.32 0.36 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 54.44 110.889 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -131.08 91.1 2.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 73.21 110.927 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -164.47 162.92 22.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 70.44 110.81 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -52.15 129.8 28.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 71.02 110.881 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -101.78 -27.38 13.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 74.21 110.829 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 59.54 -170.09 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 63.5 110.892 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -52.57 110.51 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 72.42 110.906 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.469 . . . . 70.54 110.825 -179.932 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.828 0.347 . . . . 74.4 110.901 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.16 -170.07 0.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 54.1 110.91 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.74 179.59 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 63.52 111.149 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.77 179.19 9.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 62.14 110.896 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -79.82 114.95 19.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 65.15 111.077 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.9 mp -113.39 -26.6 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 72.52 111.129 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 6.8 m -55.57 159.58 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 53.35 111.083 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 87.24 73.6 1.28 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.724 -0.751 . . . . 31.13 112.532 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.428 ' H ' HG23 ' A' ' 261' ' ' THR . 15.2 ptt180 -163.25 160.69 24.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 53.32 110.921 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -107.01 122.81 47.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 64.45 110.884 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 68.7 m -121.85 138.03 54.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 71.32 110.833 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.65 121.01 13.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 74.3 111.068 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.04 -35.95 23.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.235 -0.439 . . . . 63.45 110.913 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -164.17 139.19 5.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 75.44 110.926 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 10.1 mt -137.46 117.72 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.4 111.078 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -127.39 119.97 27.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 63.24 110.87 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.58 148.66 52.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 63.15 111.179 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -148.73 167.55 25.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 73.43 110.863 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 66.5 55.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 73.41 110.854 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.96 64.38 1.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 64.43 110.913 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.19 156.34 17.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 62.15 111.061 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -129.4 135.83 49.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.33 110.878 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.485 HG12 ' HB ' ' A' ' 275' ' ' VAL . 34.4 m -143.16 130.17 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 64.41 111.11 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.581 ' OE1' HD21 ' A' ' 276' ' ' LEU . 1.8 tt0 -131.06 137.19 49.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 75.54 110.9 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.702 ' CD2' HD13 ' A' ' 277' ' ' ILE . 0.7 OUTLIER -126.93 118.8 25.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 75.2 110.925 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 154.02 175.16 24.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.787 -0.72 . . . . 71.43 112.599 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -85.88 131.15 34.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.936 0.398 . . . . 65.21 110.874 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 29.5 t -110.34 124.24 66.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 62.44 111.152 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 49.2 t -118.84 113.01 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 74.41 111.068 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.94 168.29 15.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.098 -0.501 . . . . 64.15 111.193 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.06 -36.69 84.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 74.12 111.083 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.1 -39.8 75.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 74.14 111.133 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.76 -30.82 24.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 65.43 111.07 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.72 -38.06 71.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 64.12 110.873 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.4 ' C ' HD21 ' B' ' 250' ' ' LEU . 3.3 t60 -77.15 176.06 9.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 74.24 110.898 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 94.23 154.03 30.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.78 -0.724 . . . . 42.23 112.476 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -78.03 -71.58 1.21 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 70.11 112.506 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.49 HD12 ' HE1' ' B' ' 251' ' ' HIS . 4.4 mt -96.51 110.31 24.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.853 0.358 . . . . 75.53 111.132 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.65 144.21 28.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 63.03 110.874 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.99 131.4 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 61.12 111.132 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.5 p -177.31 -175.54 0.57 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 73.5 110.812 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 18.2 t0 61.94 55.14 2.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 15.45 110.883 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -124.66 -37.31 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 64.22 110.956 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.435 HG22 ' N ' ' B' ' 225' ' ' ARG . 0.0 OUTLIER -69.6 123.11 20.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.173 -0.467 . . . . 74.31 111.228 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.428 HG23 ' H ' ' A' ' 225' ' ' ARG . 0.2 OUTLIER -92.78 110.72 22.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 73.35 111.21 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.441 ' HB2' HG22 ' A' ' 277' ' ' ILE . 1.0 OUTLIER -94.29 120.28 34.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 63.04 110.929 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 41.3 t -131.58 123.8 28.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 73.31 110.81 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.636 HG21 HG22 ' A' ' 267' ' ' VAL . 7.8 p -122.26 137.03 57.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 72.33 111.144 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -83.03 -71.71 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 61.2 110.951 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 38.8 m -125.88 130.26 50.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.13 111.13 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.636 HG22 HG21 ' A' ' 264' ' ' VAL . 27.6 t -118.2 126.11 74.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 74.15 111.14 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 22.1 t -127.29 117.09 46.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 65.41 111.162 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.04 134.04 9.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.778 -0.725 . . . . 52.55 112.491 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -132.14 147.21 52.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.845 0.355 . . . . 74.34 110.904 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 57.94 73.9 0.4 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 31.34 112.479 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 48.42 59.54 4.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.867 0.365 . . . . 64.1 110.914 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 38.4 t -83.86 145.81 28.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 74.35 110.894 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -123.33 127.69 48.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 75.05 110.883 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.485 ' HB ' HG12 ' A' ' 239' ' ' VAL . 13.8 t -130.79 125.7 58.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 65.42 111.114 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.581 HD21 ' OE1' ' A' ' 240' ' ' GLN . 0.5 OUTLIER -124.71 111.84 16.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 75.41 110.914 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.702 HD13 ' CD2' ' A' ' 241' ' ' LEU . 4.7 mp -108.08 104.74 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 61.44 111.133 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.15 168.36 15.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 55.23 112.397 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -94.27 152.78 18.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.737 0.304 . . . . 72.13 110.835 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -123.2 118.87 28.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.906 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.406 ' CE1' HG11 ' B' ' 245' ' ' VAL . 29.1 t80 -117.6 148.37 41.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 63.11 110.942 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.11 -107.63 0.63 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.794 -0.717 . . . . 64.24 112.507 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' B' ' 247' ' ' ALA . . . -172.33 94.49 0.1 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 75.54 112.472 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -179.49 -34.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 74.14 110.844 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.09 -110.32 3.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 70.01 112.52 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.36 -172.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.371 . . . . 53.03 110.809 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -72.54 -9.01 58.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 75.0 110.938 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.75 -179.78 5.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 74.41 110.862 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -55.89 -69.32 0.15 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 74.55 110.876 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -165.74 176.67 7.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 74.24 110.829 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -148.44 177.75 9.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 63.3 110.867 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.52 117.52 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 72.4 110.865 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -172.6 114.33 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 72.31 110.854 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.514 ' N ' HH22 ' C' ' 238' ' ' ARG . 31.2 p80 -157.54 130.08 7.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 61.24 110.872 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 8.5 t60 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 63.01 110.873 179.954 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 6.2 mtp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.841 0.353 . . . . 73.41 110.86 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -115.73 139.66 49.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 74.52 110.893 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 13.4 tt -176.03 144.18 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 74.11 111.108 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.08 174.06 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 72.41 110.877 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -170.77 97.62 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 61.43 111.108 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.65 124.2 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 75.13 111.118 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 96.4 t -149.94 -72.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 71.04 111.093 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 58.51 174.97 0.54 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.769 -0.729 . . . . 62.43 112.475 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.757 ' HB3' HG23 ' B' ' 261' ' ' THR . 16.7 ttt-85 -173.56 139.07 0.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 73.42 110.81 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -110.26 123.66 50.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 74.33 110.907 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.83 138.31 54.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 64.33 110.903 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -142.35 120.28 12.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.494 . . . . 74.24 111.099 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -31.6 21.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 64.31 110.921 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.46 139.18 5.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 60.21 110.818 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 9.4 mt -137.22 117.85 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 74.43 111.165 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -130.89 119.63 22.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.861 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.1 OUTLIER -132.41 146.84 52.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 74.3 111.153 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -147.1 167.28 24.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 62.34 110.878 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 65.6 54.63 1.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 74.42 110.89 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 19.1 mtt85 51.68 62.62 2.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 62.51 110.807 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.443 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -103.57 156.42 17.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 63.21 111.061 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.89 136.02 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 74.54 110.865 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.648 HG12 ' HB ' ' B' ' 275' ' ' VAL . 19.2 m -141.22 121.74 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 73.42 111.161 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.494 ' O ' HD22 ' B' ' 276' ' ' LEU . 1.7 tt0 -123.03 137.19 55.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 71.01 110.955 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.601 HD23 HD13 ' B' ' 277' ' ' ILE . 0.8 OUTLIER -123.74 118.83 28.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.236 -0.438 . . . . 73.23 110.939 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 150.51 171.15 18.49 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 41.31 112.504 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -86.03 139.06 31.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.893 0.377 . . . . 70.42 110.891 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -117.72 124.32 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 54.41 111.107 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.406 HG11 ' CE1' ' A' ' 281' ' ' TYR . 39.5 t -122.02 128.88 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 53.31 111.105 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 15.5 p -86.81 170.64 11.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 73.1 111.173 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.449 ' HB2' ' HA3' ' A' ' 283' ' ' GLY . . . -63.2 -39.08 93.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 72.04 111.123 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.88 69.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 42.52 111.101 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.645 ' HB2' HD13 ' C' ' 250' ' ' LEU . . . -88.58 49.88 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 72.54 111.079 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.4 HD21 ' C ' ' A' ' 251' ' ' HIS . 65.6 tp -112.22 -63.6 1.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 62.05 110.934 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . 0.49 ' HE1' HD12 ' A' ' 254' ' ' ILE . 1.9 t60 -138.31 172.78 12.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 70.1 110.884 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 96.98 71.76 1.07 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.731 . . . . 54.4 112.482 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 58.32 49.67 73.91 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.752 . . . . 52.03 112.516 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . 0.594 HG22 ' H ' ' B' ' 256' ' ' ILE . 48.7 mm -73.35 -70.91 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.866 0.365 . . . . 62.12 111.143 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 57.07 33.16 22.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.082 -0.508 . . . . 71.52 110.88 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . 0.594 ' H ' HG22 ' B' ' 254' ' ' ILE . 13.8 tt -61.03 147.5 10.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 72.03 111.107 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.6 p -168.32 77.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 75.35 110.825 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -146.23 120.21 9.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.479 . . . . 64.31 110.841 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -120.83 91.72 3.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 71.44 110.922 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.92 123.9 45.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 61.41 111.134 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.757 HG23 ' HB3' ' B' ' 225' ' ' ARG . 6.1 m -95.29 108.89 21.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 73.44 111.098 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.497 ' HB2' HG22 ' B' ' 277' ' ' ILE . 0.7 OUTLIER -95.86 125.04 40.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 70.5 110.827 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 2.9 p -135.59 123.69 22.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 65.34 110.864 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.637 HG21 HG22 ' B' ' 267' ' ' VAL . 9.9 p -119.78 135.78 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 73.35 111.082 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -74.66 0.27 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 75.33 110.913 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 76.8 m -122.29 130.05 52.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 62.51 111.152 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.637 HG22 HG21 ' B' ' 264' ' ' VAL . 39.3 t -118.34 123.46 71.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 71.33 111.094 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.33 118.84 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 64.12 111.087 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.1 134.93 9.73 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.681 -0.771 . . . . 53.02 112.457 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -131.58 147.3 52.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 70.5 110.896 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 59.66 72.39 0.62 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.748 -0.739 . . . . 64.44 112.471 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 49.13 59.16 4.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.951 0.405 . . . . 73.14 110.867 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 33.2 t -83.81 145.52 28.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 63.04 110.836 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -123.95 127.36 47.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 62.45 110.783 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.648 ' HB ' HG12 ' B' ' 239' ' ' VAL . 10.5 t -131.8 128.22 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 75.32 111.115 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.494 HD22 ' O ' ' B' ' 240' ' ' GLN . 2.7 tm? -128.02 111.93 14.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.504 . . . . 52.22 110.959 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.601 HD13 HD23 ' B' ' 241' ' ' LEU . 4.7 mp -106.15 104.6 17.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 61.13 111.14 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.64 179.03 29.56 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.765 -0.731 . . . . 72.23 112.527 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.33 146.17 24.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.774 0.321 . . . . 73.3 110.949 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.86 119.01 34.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 64.03 110.892 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -118.19 125.85 51.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 72.24 110.904 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 137.37 -43.51 1.21 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 73.25 112.494 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 92.91 135.99 7.51 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.698 -0.763 . . . . 65.55 112.515 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -179.33 -34.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.866 0.365 . . . . 63.52 110.924 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 146.51 -90.98 0.15 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.693 -0.765 . . . . 54.21 112.454 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.03 -49.46 3.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 73.23 110.927 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -179.24 35.32 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 74.33 110.913 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.1 176.11 0.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 74.31 110.824 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -104.31 91.59 3.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 72.04 110.918 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -131.46 -175.74 3.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 72.55 110.909 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 61.8 168.95 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.305 -0.407 . . . . 71.22 110.886 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -175.03 94.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 71.44 110.808 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.83 -172.19 2.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 71.23 110.888 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -165.84 -170.36 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 65.15 110.899 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.432 . . . . 72.22 110.847 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.754 0.311 . . . . 65.34 110.874 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.19 -75.31 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 71.44 110.869 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 2.2 tt -61.55 132.57 27.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 54.44 111.083 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -93.43 44.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 64.51 110.911 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -90.54 142.7 27.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 50.42 111.076 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 4.8 tp -169.63 135.68 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 65.14 111.121 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 22.3 t -144.26 148.15 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 71.34 111.142 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . 0.414 ' O ' HG23 ' C' ' 261' ' ' THR . . . 91.61 -107.17 3.47 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 63.04 112.439 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 63.45 160.34 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.813 0.339 . . . . 74.4 110.896 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -122.75 131.25 53.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 65.43 110.886 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.88 137.87 54.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 55.2 110.862 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' B' ' 264' ' ' VAL . . . -137.39 141.02 41.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 65.13 111.065 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.94 -32.82 8.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 64.24 110.898 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.61 138.32 5.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 72.14 110.847 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 7.3 mt -137.53 117.62 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 63.42 111.1 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -128.37 120.47 27.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.88 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.0 OUTLIER -130.63 149.34 52.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 63.4 111.127 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -147.83 168.03 23.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 73.5 110.858 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 61.39 54.4 3.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 70.43 110.844 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 51.1 66.65 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 72.4 110.858 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.596 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -103.58 156.95 17.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 63.31 111.099 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.514 HH22 ' N ' ' A' ' 294' ' ' HIS . 1.0 OUTLIER -125.29 135.18 52.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 72.14 110.807 -179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.612 HG12 ' HB ' ' C' ' 275' ' ' VAL . 6.4 m -137.9 121.92 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 73.13 111.171 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -122.12 137.34 54.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 63.42 110.861 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.548 HD13 HG13 ' B' ' 277' ' ' ILE . 2.7 mp -126.24 118.87 26.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 70.04 110.953 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 141.53 176.07 15.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 63.53 112.517 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -91.34 128.97 37.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.889 0.376 . . . . 64.33 110.893 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.93 116.53 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 62.51 111.119 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.502 ' CG1' ' HB3' ' C' ' 249' ' ' ALA . 25.8 t -119.93 118.9 58.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 72.44 111.098 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -70.22 174.24 5.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.172 -0.467 . . . . 74.04 111.157 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.76 -37.99 88.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 51.35 111.088 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.84 -52.04 66.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 74.53 111.101 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . 0.502 ' HB3' ' CG1' ' C' ' 245' ' ' VAL . . . -64.19 -25.32 68.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 75.42 111.107 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . 0.645 HD13 ' HB2' ' B' ' 249' ' ' ALA . 9.3 mt -81.9 -27.1 33.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 72.33 110.94 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.97 -178.87 4.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 72.41 110.841 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 61.02 -117.61 12.25 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.714 -0.755 . . . . 73.52 112.497 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 161.94 70.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 52.3 112.521 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . 0.437 HD13 ' CB ' ' D' ' 249' ' ' ALA . 1.0 OUTLIER -95.9 24.43 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 55.12 111.114 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 51.9 82.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 74.23 110.936 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 3.6 pt -63.47 178.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 64.2 111.107 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 2.5 t -158.84 39.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 64.04 110.874 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -75.06 76.12 2.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.078 -0.51 . . . . 70.04 110.883 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -139.15 37.26 2.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 70.35 110.913 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . 0.418 HG22 ' CG ' ' D' ' 225' ' ' ARG . 0.2 OUTLIER -94.33 131.06 40.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.485 . . . . 75.04 111.108 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.414 HG23 ' O ' ' C' ' 224' ' ' GLY . 64.0 m -91.95 124.94 36.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 54.03 111.168 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.18 129.33 48.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.426 . . . . 51.25 110.856 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 28.9 t -140.86 123.39 16.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 43.54 110.83 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.665 HG21 HG22 ' C' ' 267' ' ' VAL . 7.5 p -116.53 136.52 53.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 70.14 111.18 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.01 -74.91 0.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 53.05 110.883 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 31.6 m -116.57 127.66 54.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 63.52 111.105 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.665 HG22 HG21 ' C' ' 264' ' ' VAL . 46.8 t -118.68 123.07 70.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 75.32 111.118 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 24.5 t -126.93 127.64 70.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 65.0 111.109 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -131.18 135.3 8.15 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.748 . . . . 61.32 112.528 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -132.45 148.37 52.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.873 0.368 . . . . 73.45 110.866 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 55.62 76.17 0.21 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.727 -0.749 . . . . 71.33 112.452 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 47.31 58.82 4.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.875 0.369 . . . . 73.41 110.88 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 37.7 t -83.4 145.4 29.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 63.31 110.835 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -124.53 127.92 48.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 71.5 110.899 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.612 ' HB ' HG12 ' C' ' 239' ' ' VAL . 17.0 t -134.13 123.68 44.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 74.04 111.156 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.661 HD12 ' CE3' ' C' ' 287' ' ' TRP . 0.4 OUTLIER -123.97 119.3 29.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 72.32 110.93 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 4.2 mt -112.08 104.52 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 75.11 111.103 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.35 -159.32 28.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 71.4 112.42 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -110.11 155.99 21.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 63.34 110.907 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -131.24 124.39 30.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.139 -0.482 . . . . 70.24 110.913 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -120.92 125.92 48.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 73.44 110.893 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 135.71 161.66 9.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.789 -0.719 . . . . 30.42 112.483 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . 0.589 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . -96.99 110.11 3.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.772 -0.728 . . . . 63.34 112.488 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -179.24 37.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 72.22 110.972 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 53.49 -110.64 1.46 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 44.22 112.514 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.03 -175.96 5.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 71.51 110.888 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.661 ' CE3' HD12 ' C' ' 276' ' ' LEU . 1.7 p90 -59.14 -21.76 59.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 72.34 110.898 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -175.25 158.05 2.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 70.03 110.884 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 53.62 90.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 74.44 110.966 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -76.16 120.78 21.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 61.05 110.829 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -52.84 147.56 8.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.13 110.912 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.12 -169.91 1.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 72.31 110.901 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -96.31 165.54 12.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 73.21 110.879 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.32 161.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 64.32 110.802 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 4.3 t60 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 75.21 110.907 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 5.9 mtm . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.821 0.343 . . . . 73.54 110.872 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -132.77 96.59 3.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 71.1 110.884 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 10.5 tt -115.83 -36.55 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.243 -0.435 . . . . 75.11 111.187 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 52.04 50.37 18.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 74.43 110.878 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.39 131.78 42.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 71.02 111.114 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 2.6 mp -125.18 136.79 59.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 62.12 111.165 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 27.6 m -98.13 172.97 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 70.22 111.133 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 129.07 166.29 11.9 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.7 -0.762 . . . . 74.21 112.505 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.675 ' H ' HG23 ' D' ' 261' ' ' THR . 0.7 OUTLIER 69.31 -75.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.371 . . . . 75.4 110.874 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -128.13 112.42 14.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 61.03 110.828 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.53 142.66 49.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 62.02 110.856 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' C' ' 264' ' ' VAL . . . -139.73 133.24 30.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 35.11 111.048 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -97.49 -37.11 10.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 64.01 110.881 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -164.3 137.36 5.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 74.31 110.914 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . 0.449 HG23 ' HB ' ' D' ' 267' ' ' VAL . 6.6 mt -137.92 117.66 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 53.2 111.116 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -123.6 115.46 21.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.876 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . 0.576 ' OG1' ' HB3' ' D' ' 237' ' ' ALA . 0.1 OUTLIER -125.4 148.21 48.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 71.33 111.13 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.59 166.22 30.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 60.13 110.88 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 65.54 52.3 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 73.4 110.917 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 54.46 59.62 4.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 75.22 110.834 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . 0.576 ' HB3' ' OG1' ' D' ' 233' ' ' THR . . . -98.27 155.75 17.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.55 111.059 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 38.2 mtt180 -125.95 135.34 51.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 53.11 110.86 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.617 HG12 ' HB ' ' D' ' 275' ' ' VAL . 6.1 m -137.89 121.81 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 73.24 111.122 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.42 137.12 52.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.897 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.633 HD21 HD12 ' D' ' 277' ' ' ILE . 1.1 mm? -120.96 118.24 29.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 72.43 110.923 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.44 -173.32 19.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.795 -0.717 . . . . 51.32 112.483 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.38 149.9 21.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 53.22 110.898 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.23 116.37 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 72.15 111.14 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . 0.666 HG13 ' HB3' ' D' ' 281' ' ' TYR . 50.3 t -115.02 128.98 71.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 72.23 111.137 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 11.8 t -70.65 174.47 5.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 53.33 111.126 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . 0.589 ' HB2' ' N ' ' C' ' 283' ' ' GLY . . . -63.14 -41.83 99.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 71.14 111.04 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.0 -43.42 81.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 73.43 111.13 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . 0.437 ' CB ' HD13 ' C' ' 254' ' ' ILE . . . 51.81 -169.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.32 111.063 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . 0.677 HD13 ' HB3' ' E' ' 249' ' ' ALA . 12.0 tp -61.1 132.68 54.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 60.31 110.908 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . 0.576 ' N ' HD12 ' D' ' 250' ' ' LEU . 6.7 m-70 -77.77 92.47 4.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 72.24 110.826 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 139.59 -54.18 0.67 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.828 -0.701 . . . . 63.21 112.494 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 112.69 -179.05 19.16 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.829 -0.7 . . . . 70.41 112.474 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 29.8 mt 64.42 108.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.309 . . . . 74.42 111.152 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . 0.446 ' HG3' HD23 ' D' ' 250' ' ' LEU . 0.0 OUTLIER -143.85 172.63 12.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 72.02 110.851 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 20.0 tt -128.58 142.44 43.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 70.43 111.135 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 54.9 p -109.16 -173.95 2.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 74.31 110.868 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 21.4 t0 60.43 99.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 75.31 110.866 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.7 -46.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.0 110.9 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . 0.628 HG21 HD22 ' E' ' 243' ' ' ASN . 0.1 OUTLIER -100.83 137.78 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 64.23 111.252 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . 0.675 HG23 ' H ' ' D' ' 225' ' ' ARG . 0.7 OUTLIER -133.9 109.03 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 61.41 111.148 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . 0.563 ' HB2' HG22 ' D' ' 277' ' ' ILE . 0.3 OUTLIER -107.35 120.55 42.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 74.24 110.844 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 57.9 m -132.11 124.06 28.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 72.33 110.819 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.88 ' HA ' ' HB3' ' E' ' 228' ' ' ALA . 7.9 p -106.55 138.87 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.116 -0.493 . . . . 73.42 111.08 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . 0.457 ' HB2' ' HA ' ' E' ' 229' ' ' LYS . 3.0 tt0 -94.52 -29.53 14.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 72.22 110.863 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . 0.492 ' HB ' ' HA ' ' E' ' 230' ' ' ASP . 1.1 m -152.69 129.22 10.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 52.42 111.147 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.658 HG22 HG21 ' D' ' 264' ' ' VAL . 94.1 t -127.18 120.5 55.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 72.33 111.143 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 40.6 t -127.74 128.0 68.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 54.1 111.097 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -135.23 133.31 6.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.738 . . . . 63.04 112.517 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.47 149.36 51.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 70.14 110.908 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.22 81.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.744 -0.741 . . . . 74.24 112.439 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 45.59 57.66 4.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 72.04 110.892 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 29.7 t -83.84 145.14 28.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 63.23 110.816 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -125.94 127.4 45.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 64.35 110.842 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.619 HG13 HG23 ' E' ' 239' ' ' VAL . 17.1 t -137.02 123.79 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 75.33 111.114 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 1.1 tt -128.17 111.72 13.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 65.33 110.907 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.633 HD12 HD21 ' D' ' 241' ' ' LEU . 16.5 mt -102.42 104.54 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 44.51 111.141 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.02 -168.18 32.91 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.746 -0.74 . . . . 72.42 112.491 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -103.39 140.0 38.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 64.32 110.914 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -111.95 134.85 53.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 55.4 110.928 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . 0.666 ' HB3' HG13 ' D' ' 245' ' ' VAL . 1.2 t80 -120.04 125.8 49.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 61.14 110.879 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 82.52 -160.73 40.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.686 -0.768 . . . . 70.03 112.474 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 52.2 39.24 50.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 62.13 112.455 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 5.6 mptt 68.77 -76.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.351 . . . . 45.01 110.914 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -173.99 29.32 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.624 -0.798 . . . . 63.31 112.435 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.51 -168.75 2.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.907 0.384 . . . . 72.24 110.831 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -111.97 23.72 13.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 75.41 110.934 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.48 -171.77 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 54.11 110.864 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -112.97 29.82 7.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 75.41 110.881 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.97 -170.06 0.54 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.814 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -132.02 -171.39 2.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 74.44 110.856 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.66 165.65 25.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 60.33 110.877 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -171.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 73.13 110.813 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -100.97 26.17 7.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 74.24 110.862 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 75.15 110.872 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.839 0.352 . . . . 72.24 110.867 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -57.01 -26.12 59.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 73.22 110.882 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . 0.471 HG22 ' H ' ' E' ' 221' ' ' ALA . 51.2 mm -82.89 142.75 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 63.2 111.119 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -131.5 45.44 2.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 61.02 110.866 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . 0.471 ' H ' HG22 ' E' ' 219' ' ' ILE . . . 62.32 91.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 62.04 111.088 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 3.4 pt -151.11 49.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 74.51 111.109 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . 0.431 HG11 HH11 ' E' ' 225' ' ' ARG . 8.1 p -174.77 159.75 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 74.55 111.12 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . 0.409 ' N ' HG22 ' E' ' 223' ' ' VAL . . . -68.11 -134.9 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.709 -0.758 . . . . 73.31 112.49 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . 0.431 HH11 HG11 ' E' ' 223' ' ' VAL . 0.6 OUTLIER 63.42 -167.13 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 72.32 110.874 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -82.2 114.81 20.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 51.35 110.894 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.03 133.59 55.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 65.13 110.875 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . 0.88 ' HB3' ' HA ' ' D' ' 264' ' ' VAL . . . -122.41 170.04 10.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 72.43 111.135 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . 0.644 ' HE3' ' N ' ' E' ' 229' ' ' LYS . 0.0 OUTLIER -140.45 -34.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 62.24 110.893 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . 0.58 ' N ' ' HD2' ' E' ' 229' ' ' LYS . 8.8 t0 -175.62 131.71 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 70.51 110.821 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . 0.643 HG23 HG11 ' E' ' 267' ' ' VAL . 15.5 mt -132.58 115.78 26.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 71.24 111.128 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -110.99 115.26 29.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 74.55 110.937 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' E' ' 237' ' ' ALA . 0.1 OUTLIER -127.99 128.59 45.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 72.24 111.148 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -136.9 166.55 23.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 74.13 110.878 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 61.68 61.11 1.5 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 73.25 110.884 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 40.2 mtt85 49.35 63.93 1.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.45 110.844 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . 0.459 ' HB3' ' OG1' ' E' ' 233' ' ' THR . . . -104.74 156.48 17.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 75.05 111.057 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -128.06 135.85 50.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 64.03 110.92 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.64 HG12 ' HB ' ' E' ' 275' ' ' VAL . 4.5 m -139.25 121.7 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 74.54 111.181 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.83 137.47 54.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.41 110.913 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.502 HD11 ' CD1' ' E' ' 231' ' ' ILE . 4.8 mp -122.61 117.92 26.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.932 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.8 168.18 11.76 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 72.43 112.551 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . 0.628 HD22 HG21 ' D' ' 260' ' ' THR . 1.0 OUTLIER -85.84 133.77 33.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.898 0.38 . . . . 60.03 110.92 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 97.3 t -109.71 135.51 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 71.32 111.13 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . 0.43 HG13 ' HB3' ' E' ' 281' ' ' TYR . 73.4 t -122.17 129.1 75.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 73.41 111.163 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 14.7 t -69.77 171.6 8.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 75.22 111.115 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.26 -33.91 75.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 51.41 111.082 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.22 66.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.274 -0.421 . . . . 75.15 111.063 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . 0.677 ' HB3' HD13 ' D' ' 250' ' ' LEU . . . 51.54 -169.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 42.34 111.118 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 7.1 tp -173.52 81.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 74.03 110.964 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -129.7 100.72 5.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.884 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -103.9 -30.11 5.28 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 53.11 112.449 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 138.29 42.41 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.783 -0.722 . . . . 73.41 112.473 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 4.0 pt -144.35 -178.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.816 0.341 . . . . 60.05 111.154 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -164.81 151.15 10.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 74.32 110.892 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 8.2 tt -156.06 144.94 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 52.22 111.108 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 3.4 m 60.16 177.77 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 73.5 110.814 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -107.26 168.15 9.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 65.42 110.843 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -68.09 165.71 17.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.891 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.46 121.83 42.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 74.21 111.141 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 93.1 m -92.13 111.07 22.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 54.52 111.146 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -108.68 119.34 39.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 65.11 110.933 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.04 132.77 40.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 72.52 110.82 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . 0.724 HG22 ' H ' ' E' ' 266' ' ' THR . 9.4 p -116.8 153.82 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 54.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . 0.599 ' O ' ' HD3' ' E' ' 229' ' ' LYS . 0.2 OUTLIER -112.02 -11.0 13.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 75.44 110.866 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . 0.724 ' H ' HG22 ' E' ' 264' ' ' VAL . 0.2 OUTLIER -167.46 126.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.24 111.122 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . 0.643 HG11 HG23 ' E' ' 231' ' ' ILE . 41.0 t -132.16 117.36 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 72.42 111.104 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.21 139.2 52.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 72.22 111.138 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -144.74 133.41 5.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 35.02 112.5 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -134.02 148.06 51.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 52.51 110.838 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 56.29 86.5 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.701 -0.761 . . . . 54.35 112.503 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 44.98 56.76 5.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.898 0.38 . . . . 61.52 110.895 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.42 145.23 29.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 51.24 110.924 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.93 126.96 39.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.893 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.64 ' HB ' HG12 ' E' ' 239' ' ' VAL . 21.2 t -136.05 123.56 34.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 55.32 111.127 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.653 HD13 ' CD2' ' E' ' 287' ' ' TRP . 1.2 mp -129.03 111.44 12.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 75.22 110.905 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 37.3 mt -104.12 104.62 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 72.11 111.05 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 156.85 -174.5 34.51 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.773 -0.727 . . . . 73.02 112.485 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -103.53 153.05 20.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.854 0.359 . . . . 75.3 110.867 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -116.27 136.35 53.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 71.23 110.825 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . 0.43 ' HB3' HG13 ' E' ' 245' ' ' VAL . 2.7 t80 -117.46 125.78 51.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 65.53 110.886 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 52.97 26.71 27.79 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 54.54 112.509 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -83.98 -16.49 67.41 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.794 -0.717 . . . . 43.44 112.468 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 7.3 mttt 63.35 41.65 7.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 72.02 110.944 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 67.93 137.97 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 54.23 112.483 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.05 119.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.777 0.323 . . . . 73.33 110.939 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . 0.653 ' CD2' HD13 ' E' ' 276' ' ' LEU . 11.0 p90 -50.5 118.47 3.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.137 -0.483 . . . . 70.23 110.839 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 9.2 t70 63.96 91.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 65.12 110.914 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -113.08 -176.52 2.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.45 110.89 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.54 -176.29 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 72.44 110.927 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -62.29 -177.82 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 72.32 110.901 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -60.08 152.84 23.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 64.2 110.879 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -173.73 107.92 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 74.32 110.851 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -154.88 -169.89 3.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 72.34 110.887 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 65.31 110.866 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.813 0.339 . . . . 71.33 110.914 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 9.1 pttt -161.01 -47.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 64.45 110.93 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 45.4 mm 52.39 84.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 73.22 111.089 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.86 85.4 2.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 75.53 110.857 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -178.21 140.89 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 75.23 111.107 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 222' ' ' ILE . 1.1 tt -142.23 90.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 74.41 111.104 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.0 p -177.5 143.26 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.5 . . . . 53.1 111.158 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -55.52 171.32 1.66 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.767 -0.73 . . . . 73.43 112.478 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -172.66 100.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 71.44 110.861 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.409 ' HB3' HG22 ' A' ' 277' ' ' ILE . 3.7 m120 -87.78 112.28 22.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 71.11 110.93 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.65 148.4 49.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 75.11 110.871 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.17 119.3 10.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 62.24 111.057 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.45 ' NZ ' HD13 ' C' ' 219' ' ' ILE . 0.7 OUTLIER -65.43 -43.99 88.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 74.5 110.921 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -165.48 136.68 3.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 71.24 110.886 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 9.1 pt -139.07 131.78 37.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 72.43 111.144 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -135.05 139.8 45.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 74.12 110.873 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.738 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.5 OUTLIER -136.31 153.82 51.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 74.43 111.154 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -142.72 168.71 19.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 43.32 110.881 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 74.2 -70.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 64.24 110.886 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.73 53.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 73.05 110.818 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.738 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -91.5 156.82 17.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.03 111.076 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -130.98 138.21 49.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 72.44 110.894 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.771 HG12 ' HB ' ' A' ' 275' ' ' VAL . 27.5 m -122.43 125.47 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 75.31 111.146 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -123.24 118.9 28.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 65.12 110.862 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.64 119.34 36.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 65.13 110.952 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 150.86 169.71 17.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.739 . . . . 53.3 112.448 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -85.95 133.36 33.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 75.32 110.886 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.7 t -103.96 133.37 48.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 73.33 111.201 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 97.4 t -119.73 121.97 67.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 73.53 111.093 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.469 HG21 ' HG3' ' A' ' 284' ' ' LYS . 3.0 m -69.88 161.71 29.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 74.14 111.158 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.04 -41.74 99.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 71.2 111.09 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . 0.482 ' HB2' ' HD2' ' A' ' 284' ' ' LYS . . . -56.99 -36.01 69.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 65.31 111.135 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.64 ' HA ' HD12 ' B' ' 250' ' ' LEU . . . -54.38 -27.11 34.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 44.34 111.122 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 37.7 tp -66.5 89.76 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 73.03 110.904 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -177.57 -66.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 71.45 110.863 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -104.0 -100.77 2.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.772 -0.728 . . . . 70.45 112.482 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 129.46 -153.79 20.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.764 -0.731 . . . . 75.55 112.492 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 15.2 mt 70.64 -70.44 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 55.43 111.206 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.49 -170.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 75.25 110.921 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' B' ' 257' ' ' SER . 8.4 tp -71.24 139.59 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 71.02 111.095 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -74.37 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 51.34 110.903 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.24 -170.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 62.2 110.898 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.627 ' CG ' HG11 ' B' ' 223' ' ' VAL . 0.1 OUTLIER -173.93 42.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 71.1 110.975 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.03 133.84 52.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 50.3 111.115 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.428 HG23 ' HB2' ' B' ' 225' ' ' ARG . 3.3 t -125.18 121.8 35.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 72.32 111.189 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -91.24 127.21 36.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 34.15 110.877 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 2.4 p -142.41 123.07 14.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 72.43 110.896 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.639 HG21 HG22 ' A' ' 267' ' ' VAL . 8.7 p -118.99 134.47 62.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.45 111.125 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -78.33 -75.78 0.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.099 -0.5 . . . . 75.31 110.879 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.91 127.13 53.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 60.42 111.199 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.639 HG22 HG21 ' A' ' 264' ' ' VAL . 47.0 t -118.96 120.85 65.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 72.45 111.142 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 74.5 t -123.47 115.29 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 71.51 111.106 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.72 133.6 11.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.727 -0.749 . . . . 75.13 112.5 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 139.92 48.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 74.34 110.854 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.19 81.1 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.733 -0.746 . . . . 63.44 112.545 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 44.7 62.51 2.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.836 0.35 . . . . 72.24 110.96 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.47 145.06 29.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 74.11 110.857 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -113.27 128.05 56.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 61.2 110.883 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.771 ' HB ' HG12 ' A' ' 239' ' ' VAL . 19.9 t -129.53 123.29 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 74.25 111.129 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.43 111.6 13.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 45.11 110.968 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.409 HG22 ' HB3' ' A' ' 226' ' ' ASN . 2.5 mp -110.33 103.89 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 74.22 111.047 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.54 168.69 15.69 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.736 -0.745 . . . . 74.23 112.503 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -89.72 154.22 20.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 61.51 110.908 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.655 ' CD ' HG13 ' B' ' 244' ' ' VAL . 0.0 OUTLIER -127.65 123.78 36.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 60.41 110.877 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.576 ' HB3' HD21 ' B' ' 250' ' ' LEU . 43.6 m-85 -103.51 128.55 50.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 55.35 110.872 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.97 134.74 6.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 65.11 112.456 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.554 ' H ' ' N ' ' B' ' 247' ' ' ALA . . . -83.33 -112.0 0.53 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.811 -0.709 . . . . 63.45 112.525 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.482 ' HD2' ' HB2' ' A' ' 248' ' ' ALA . 0.1 OUTLIER 63.45 25.45 14.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.728 0.299 . . . . 54.4 110.815 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 145.12 -12.97 1.88 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.748 -0.739 . . . . 52.43 112.486 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.74 ' CZ ' HG11 ' B' ' 244' ' ' VAL . 7.7 t80 72.39 -68.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 75.21 110.867 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -147.39 -48.09 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 73.11 110.939 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -134.27 -175.84 4.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.236 -0.438 . . . . 74.44 110.898 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -78.75 146.86 33.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 63.01 110.955 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.02 170.79 15.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 73.23 110.879 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -119.02 -74.36 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 71.42 110.889 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -176.37 -177.96 0.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.442 . . . . 74.03 110.859 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -176.48 107.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 62.43 110.942 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -97.16 143.1 28.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 72.32 110.842 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 75.41 110.856 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 75.8 mmm . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.805 0.336 . . . . 75.32 110.908 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -156.3 -170.02 3.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 75.25 110.911 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 28.1 mm 64.19 90.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 54.2 111.136 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.29 152.81 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 51.51 110.876 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -51.78 138.92 22.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 71.01 111.117 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 2.1 mp -130.32 149.04 33.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 73.11 111.142 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.627 HG11 ' CG ' ' A' ' 259' ' ' GLN . 19.2 t -64.54 151.32 9.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 75.14 111.148 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -51.58 115.5 3.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.696 -0.764 . . . . 30.43 112.516 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.747 ' HG2' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER -132.48 143.44 49.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.787 0.327 . . . . 63.24 110.889 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -93.75 112.7 24.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 62.3 110.908 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 32.4 t -127.61 152.32 47.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.851 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.03 124.27 17.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 35.14 111.064 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.07 -40.24 62.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 73.53 110.936 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -166.26 135.87 3.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 72.33 110.824 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 267' ' ' VAL . 8.1 pt -139.15 130.01 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.481 . . . . 73.24 111.16 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.09 137.28 40.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 61.34 110.894 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.758 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.5 OUTLIER -137.1 150.44 48.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 75.34 111.071 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -142.01 168.63 19.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 55.44 110.869 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 73.19 -71.84 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.883 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -177.93 59.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 64.3 110.898 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.758 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -97.88 156.61 16.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 60.44 111.112 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -130.7 135.87 48.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 73.23 110.843 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.729 HG12 ' HB ' ' B' ' 275' ' ' VAL . 27.7 m -122.22 132.15 71.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 70.21 111.166 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -130.22 119.28 22.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.881 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.401 ' HG ' HD13 ' B' ' 277' ' ' ILE . 4.4 mp -111.69 118.4 35.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 70.15 110.892 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 145.23 175.48 18.4 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.777 -0.725 . . . . 71.33 112.491 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.83 129.37 34.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.394 . . . . 70.1 110.879 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.74 HG11 ' CZ ' ' A' ' 286' ' ' PHE . 92.1 t -102.19 114.74 42.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 72.55 111.195 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.519 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 85.0 t -106.76 129.26 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 71.11 111.169 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.425 HG23 ' H ' ' B' ' 249' ' ' ALA . 6.3 t -74.96 169.58 17.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 75.24 111.166 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.554 ' N ' ' H ' ' A' ' 283' ' ' GLY . . . -63.34 -41.8 98.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 72.12 111.084 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.61 -35.85 68.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 73.45 111.101 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.519 ' HB3' ' CG1' ' B' ' 245' ' ' VAL . . . -74.65 -24.18 58.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 51.21 111.072 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.64 HD12 ' HA ' ' A' ' 249' ' ' ALA . 0.2 OUTLIER -88.98 -24.89 22.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 61.45 110.857 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -132.89 50.11 2.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 55.41 110.878 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 168.61 -97.48 0.13 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.775 -0.726 . . . . 54.44 112.462 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -56.51 144.69 36.82 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.694 -0.765 . . . . 61.45 112.523 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 3.2 pt -147.2 -177.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 73.51 111.172 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 58.8 86.54 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 72.24 110.807 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.25 43.08 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 71.12 111.066 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . 0.409 ' HB2' HD11 ' A' ' 256' ' ' ILE . 0.3 OUTLIER -58.87 159.64 6.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 74.33 110.881 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.81 159.74 16.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.32 110.819 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.4 29.0 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 61.51 110.862 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.596 HG22 ' NH1' ' C' ' 225' ' ' ARG . 18.0 p -79.89 121.85 25.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 73.15 111.238 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.747 HG23 ' HG2' ' B' ' 225' ' ' ARG . 91.2 m -97.28 108.84 21.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 73.03 111.163 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.794 ' HB3' HD23 ' C' ' 241' ' ' LEU . 0.1 OUTLIER -96.26 126.22 41.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 60.34 110.914 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 5.5 t -141.99 123.46 14.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 73.31 110.802 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.711 HG21 HD11 ' C' ' 231' ' ' ILE . 9.8 p -108.19 136.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.041 -0.527 . . . . 73.21 111.18 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -81.83 -77.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 72.43 110.894 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.5 m -121.08 127.94 52.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 75.43 111.104 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.716 HG22 HD11 ' C' ' 231' ' ' ILE . 15.7 t -118.18 120.32 64.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 74.34 111.106 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 41.3 t -123.38 115.04 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 71.23 111.13 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.52 133.09 10.52 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 55.42 112.496 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -132.48 146.97 52.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.751 0.31 . . . . 64.32 110.967 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.04 75.12 0.22 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.761 -0.733 . . . . 43.0 112.468 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 52.82 78.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.88 0.371 . . . . 72.03 110.893 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 1.4 t -103.66 144.7 31.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 70.1 110.906 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.418 ' O ' HG22 ' C' ' 239' ' ' VAL . 0.9 OUTLIER -112.43 127.58 56.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 60.43 110.818 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.729 ' HB ' HG12 ' B' ' 239' ' ' VAL . 97.0 t -130.5 123.62 55.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 70.2 111.16 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.598 HD23 ' CZ2' ' B' ' 287' ' ' TRP . 0.9 OUTLIER -128.88 111.85 13.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 62.22 110.846 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.401 HD13 ' HG ' ' B' ' 241' ' ' LEU . 3.4 mp -107.7 104.34 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 73.5 111.09 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.29 -171.75 29.44 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.745 -0.74 . . . . 75.11 112.519 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.77 147.95 26.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 74.33 110.975 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.527 ' OE1' HG13 ' C' ' 244' ' ' VAL . 1.8 pt-20 -116.8 121.68 42.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 63.34 110.822 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -112.41 125.72 54.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 75.15 110.967 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 140.08 164.58 9.95 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.743 . . . . 74.41 112.485 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . 0.524 ' HA3' ' HB2' ' C' ' 247' ' ' ALA . . . -103.83 -143.5 12.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 53.31 112.503 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 9.9 mttp 56.87 25.3 10.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 72.33 110.866 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 128.75 -117.49 2.5 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.725 -0.75 . . . . 72.22 112.497 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -173.9 -44.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.882 0.372 . . . . 74.25 110.911 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.598 ' CZ2' HD23 ' B' ' 276' ' ' LEU . 3.7 t90 -125.51 -68.45 0.83 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 55.41 110.844 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -142.31 -169.93 3.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 73.2 110.916 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -56.31 144.53 30.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 64.2 110.874 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -170.47 157.54 6.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 73.4 110.879 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -151.33 146.86 26.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 74.14 110.897 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.95 158.77 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 74.4 110.816 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -164.01 134.57 4.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 73.03 110.88 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -150.38 179.52 8.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 72.24 110.864 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 75.45 110.912 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.5 mtp . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.776 0.322 . . . . 62.51 110.955 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt 61.06 179.17 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 75.55 110.938 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.45 HD13 ' NZ ' ' A' ' 229' ' ' LYS . 3.1 mp 62.3 70.46 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.242 -0.436 . . . . 71.42 111.125 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -177.58 133.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 72.3 110.873 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' E' ' 217' ' ' MET . . . -173.95 70.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 73.41 111.094 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 1.9 pt -150.75 136.09 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 72.41 111.124 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 91.2 t -103.19 -69.85 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 75.13 111.14 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 74.11 -112.92 3.94 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.744 -0.741 . . . . 75.13 112.479 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.596 ' NH1' HG22 ' B' ' 260' ' ' THR . 0.1 OUTLIER -121.21 -69.77 0.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.815 0.34 . . . . 74.12 110.842 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -94.08 109.86 21.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 73.44 110.903 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 60.7 p -137.02 148.17 46.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 62.01 110.854 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.22 137.56 47.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.501 . . . . 55.13 111.112 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -86.45 -40.49 15.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 72.5 110.911 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -165.47 136.5 3.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 73.55 110.895 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.716 HD11 HG22 ' B' ' 267' ' ' VAL . 8.3 pt -140.13 117.1 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.54 111.12 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -124.48 116.24 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 71.23 110.885 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.626 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.6 OUTLIER -124.46 136.86 54.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 75.53 111.171 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . 0.401 ' HG3' ' HG3' ' C' ' 235' ' ' GLU . 3.8 pt-20 -121.44 166.95 13.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 71.15 110.872 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.401 ' HG3' ' HG3' ' C' ' 234' ' ' GLU . 2.6 mt-10 60.84 -162.91 0.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.108 -0.496 . . . . 74.25 110.954 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 -72.65 63.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 75.1 110.877 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.626 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -105.62 156.37 18.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 53.34 111.047 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -135.9 135.95 40.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 65.32 110.839 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.449 HG12 ' CG2' ' C' ' 275' ' ' VAL . 17.4 m -134.35 134.41 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 72.44 111.11 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.428 ' HB3' HD22 ' C' ' 276' ' ' LEU . 1.2 tt0 -130.13 137.37 50.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.501 . . . . 73.32 110.888 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.794 HD23 ' HB3' ' B' ' 262' ' ' ASN . 0.3 OUTLIER -119.12 118.35 31.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 73.22 110.857 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 140.47 -177.77 20.48 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.7 -0.762 . . . . 70.4 112.47 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.494 ' HB3' HG21 ' B' ' 260' ' ' THR . 1.4 p-10 -85.84 153.06 22.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.797 0.332 . . . . 74.24 110.906 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.527 HG13 ' OE1' ' B' ' 280' ' ' GLU . 63.8 t -122.08 114.92 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 73.53 111.106 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.571 HG22 ' HB2' ' C' ' 281' ' ' TYR . 3.8 t -108.0 127.7 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 72.41 111.104 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 6.5 t -69.84 175.07 4.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 64.33 111.045 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.524 ' HB2' ' HA3' ' B' ' 283' ' ' GLY . . . -63.15 -45.05 93.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 70.03 111.116 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.92 -35.89 69.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 54.31 111.072 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.25 -174.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 51.45 111.065 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.61 -176.09 3.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 71.21 110.915 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -54.23 -50.61 66.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 73.03 110.864 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 135.16 -165.43 24.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.835 -0.697 . . . . 51.34 112.508 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 65.91 -141.56 41.97 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.695 -0.764 . . . . 72.24 112.485 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 28.0 mm 61.65 99.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.934 0.397 . . . . 51.13 111.135 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -88.02 -74.35 0.45 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.138 -0.483 . . . . 72.52 110.949 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . 0.432 HG22 ' OD1' ' C' ' 258' ' ' ASP . 5.2 mp -78.15 129.78 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 64.42 111.065 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.47 120.67 24.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 63.5 110.846 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . 0.432 ' OD1' HG22 ' C' ' 256' ' ' ILE . 5.5 p-10 -168.3 64.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 73.4 110.862 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -104.44 -68.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 74.4 110.924 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -100.93 135.07 42.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 52.32 111.152 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 4.3 t -115.66 140.89 48.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 72.41 111.142 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.39 124.42 46.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 54.42 110.881 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.6 131.91 36.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 70.55 110.867 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.799 HG23 HD11 ' D' ' 231' ' ' ILE . 13.6 p -115.46 139.98 39.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.505 . . . . 73.42 111.122 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -83.03 -76.0 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 71.4 110.945 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 25.7 m -137.48 130.64 30.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 74.45 111.119 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.53 ' CG2' HG21 ' C' ' 264' ' ' VAL . 21.4 t -118.41 130.64 72.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.4 111.187 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 25.9 t -127.49 125.92 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 55.35 111.159 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.03 134.13 10.3 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.788 -0.72 . . . . 74.34 112.474 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.95 117.05 20.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 71.32 110.941 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 61.05 81.88 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.766 -0.73 . . . . 64.12 112.447 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 61.98 110.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.876 0.37 . . . . 72.54 110.888 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 5.1 m -148.43 145.12 27.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 74.43 110.873 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -117.61 126.36 52.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 70.52 110.895 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.449 ' CG2' HG12 ' C' ' 239' ' ' VAL . 16.4 t -127.06 123.05 61.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 70.44 111.095 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.446 HD23 ' CZ2' ' C' ' 287' ' ' TRP . 0.1 OUTLIER -128.14 117.9 22.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.01 110.896 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.76 HD13 HD12 ' C' ' 241' ' ' LEU . 5.1 mp -111.68 103.35 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 71.1 111.153 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.06 -173.87 28.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 74.53 112.509 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -106.36 156.22 18.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 73.4 110.9 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.661 ' CG ' HG22 ' D' ' 244' ' ' VAL . 1.1 pt-20 -115.71 128.45 55.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 65.55 110.897 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.571 ' HB2' HG22 ' C' ' 245' ' ' VAL . 5.0 m-85 -110.8 129.72 55.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 60.32 110.895 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 120.78 167.25 13.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 72.21 112.471 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . 0.548 ' H ' ' HB2' ' D' ' 247' ' ' ALA . . . -110.9 -161.48 17.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.805 -0.712 . . . . 51.53 112.524 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt 50.9 79.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.794 0.331 . . . . 70.35 110.883 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 86.29 86.9 1.03 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.726 -0.75 . . . . 44.44 112.508 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -50.05 -42.13 49.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 74.33 110.83 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.446 ' CZ2' HD23 ' C' ' 276' ' ' LEU . 15.7 t90 -158.04 68.42 0.5 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 65.34 110.882 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -168.02 -170.93 1.43 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.28 -0.418 . . . . 74.45 110.845 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -112.57 111.99 23.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 72.43 110.873 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -55.49 101.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 72.02 110.811 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.09 -170.11 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 73.04 110.863 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 164.03 3.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 73.35 110.878 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.07 -42.39 2.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 70.45 110.928 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -52.12 -31.94 33.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 60.34 110.88 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 73.45 110.802 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 32.0 mtt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.896 0.379 . . . . 71.33 110.846 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.36 91.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 71.22 110.852 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 1.1 pp -112.14 169.23 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 73.32 111.139 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -170.4 125.57 0.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 72.32 110.853 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -170.57 131.34 0.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 74.45 111.121 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . 0.804 HG12 HG23 ' D' ' 223' ' ' VAL . 17.6 tt -174.17 138.32 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.234 -0.439 . . . . 73.15 111.145 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . 0.804 HG23 HG12 ' D' ' 222' ' ' ILE . 58.2 t 58.32 91.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.229 -0.442 . . . . 73.03 111.133 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -152.07 -167.53 15.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.712 -0.756 . . . . 72.12 112.459 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -120.07 -76.73 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 71.23 110.9 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -88.12 112.36 22.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 75.35 110.901 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.34 137.48 37.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 73.4 110.892 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . 0.73 ' HB2' HD11 ' D' ' 241' ' ' LEU . . . -117.85 119.48 35.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 52.4 111.081 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -75.25 -29.46 60.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 64.23 110.911 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . 0.421 ' HB2' HG22 ' D' ' 266' ' ' THR . 1.6 t0 -166.19 136.15 3.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 73.22 110.876 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . 0.799 HD11 HG23 ' C' ' 264' ' ' VAL . 0.3 OUTLIER -138.66 117.98 14.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 72.52 111.113 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -126.96 125.25 41.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 73.12 110.881 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . 0.535 ' CB ' ' HB3' ' D' ' 237' ' ' ALA . 0.4 OUTLIER -136.33 155.4 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 63.14 111.119 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -152.99 168.68 25.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 72.13 110.888 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 68.71 -80.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 71.22 110.863 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -159.56 55.58 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 75.44 110.822 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . 0.535 ' HB3' ' CB ' ' D' ' 233' ' ' THR . . . -104.8 146.5 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 74.52 111.147 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -125.78 135.37 51.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 64.43 110.836 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.745 HG11 HG22 ' D' ' 231' ' ' ILE . 18.3 m -122.94 121.69 63.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 34.41 111.147 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -116.55 125.83 52.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 73.24 110.885 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.836 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.9 mm? -111.78 117.72 33.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 74.41 110.86 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.71 179.55 17.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 71.44 112.46 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -86.78 163.09 17.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 75.12 110.899 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . 0.661 HG22 ' CG ' ' C' ' 280' ' ' GLU . 78.2 t -133.16 123.67 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 52.54 111.166 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.57 129.26 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.14 111.119 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.4 t -69.59 175.07 4.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 73.13 111.117 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . 0.548 ' HB2' ' H ' ' C' ' 283' ' ' GLY . . . -59.26 -41.57 89.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 62.54 111.144 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.71 -48.85 76.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 73.11 111.189 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.57 -179.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 64.42 111.179 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.8 167.78 20.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 71.34 110.857 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -86.61 52.65 2.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 65.42 110.819 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.72 -28.21 56.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 63.42 112.517 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 90.42 147.8 18.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.708 -0.758 . . . . 35.24 112.457 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.68 -172.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.799 0.333 . . . . 73.01 111.112 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.39 -169.57 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 63.01 110.795 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . 0.629 HG23 ' OD2' ' D' ' 258' ' ' ASP . 50.4 mm -51.23 119.26 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 72.45 111.142 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 35.3 m -119.65 -9.21 9.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 71.32 110.806 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . 0.629 ' OD2' HG23 ' D' ' 256' ' ' ILE . 0.7 OUTLIER -50.99 165.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 73.5 110.915 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -148.66 -75.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 71.42 110.929 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 2.8 t -101.43 138.27 38.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 73.53 111.187 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 98.7 m -91.76 140.98 29.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 61.4 111.191 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.64 119.6 29.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.317 -0.401 . . . . 73.54 110.94 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 15.1 m -132.02 122.62 25.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 72.14 110.88 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.547 HG21 ' CG2' ' D' ' 267' ' ' VAL . 7.7 p -108.32 128.33 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 74.13 111.118 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.96 -74.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 75.13 110.824 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . 0.421 HG22 ' HB2' ' D' ' 230' ' ' ASP . 19.3 p -147.37 133.35 19.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 75.11 111.087 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.659 HG11 HG21 ' D' ' 275' ' ' VAL . 14.3 t -117.05 133.17 64.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 71.01 111.171 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 45.7 t -127.01 117.79 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 74.32 111.138 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.04 133.01 10.73 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.803 -0.713 . . . . 54.01 112.56 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -132.39 115.37 15.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 63.24 110.911 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.75 72.58 0.95 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.799 -0.715 . . . . 71.04 112.487 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 65.52 100.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.805 0.336 . . . . 74.54 110.923 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 2.6 m -135.98 145.0 45.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 64.55 110.861 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.88 127.15 51.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.51 . . . . 70.22 110.859 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.659 HG21 HG11 ' D' ' 267' ' ' VAL . 15.5 t -133.67 123.08 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 74.21 111.165 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.63 121.88 29.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 75.04 110.857 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.836 ' HB ' HD13 ' D' ' 241' ' ' LEU . 5.2 mp -112.36 104.56 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 75.21 111.073 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 144.86 169.5 13.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 65.11 112.568 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -89.94 153.87 20.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 75.44 110.906 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . 0.602 ' HG3' HG13 ' E' ' 244' ' ' VAL . 2.1 pt-20 -115.01 135.77 53.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 75.54 110.831 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -112.51 125.54 54.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 74.44 110.929 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 92.13 -142.04 15.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 43.4 112.547 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 65.8 111.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.746 -0.74 . . . . 74.4 112.537 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -51.81 -36.93 49.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 74.32 110.882 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -107.48 -83.24 1.55 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.757 -0.735 . . . . 65.32 112.494 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -177.52 171.96 1.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.371 . . . . 75.2 110.863 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -56.6 99.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 72.42 110.813 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.56 -54.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.421 . . . . 71.04 110.871 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -179.47 34.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 70.5 110.862 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 8.2 m80 52.55 69.01 0.74 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 72.42 110.817 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -53.7 141.67 25.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 74.21 110.89 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.83 -169.99 2.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 73.44 110.847 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -62.53 155.02 26.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.453 . . . . 74.21 110.845 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.33 -171.83 1.0 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 74.43 110.884 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 74.55 110.848 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . 0.446 ' HB2' ' HB1' ' C' ' 221' ' ' ALA . 2.6 ttt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.901 0.382 . . . . 63.34 110.93 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.25 -175.39 5.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 61.23 110.882 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 2.0 tt -130.47 143.11 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 64.42 111.156 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.31 -173.64 4.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 71.42 110.85 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . 0.56 ' O ' HD13 ' E' ' 222' ' ' ILE . . . -114.07 174.4 5.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 55.13 111.121 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . 0.56 HD13 ' O ' ' E' ' 221' ' ' ALA . 46.3 mm -137.73 134.95 46.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 72.42 111.19 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.96 158.19 38.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 70.13 111.084 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -174.59 151.96 13.43 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.778 -0.725 . . . . 70.13 112.492 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . 0.486 ' CB ' HG22 ' E' ' 261' ' ' THR . 0.0 OUTLIER -53.44 -46.09 69.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.752 0.311 . . . . 72.25 110.848 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -95.42 111.04 23.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 63.02 110.854 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.37 151.01 44.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.091 -0.504 . . . . 74.33 110.813 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . . . . . . . . . . . -127.13 119.03 25.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 74.1 111.112 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.48 -36.83 83.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 75.41 110.895 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.85 141.2 3.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.14 110.874 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . 0.689 ' CG2' HG11 ' E' ' 239' ' ' VAL . 6.8 mt -136.56 116.83 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 75.24 111.152 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -123.76 125.35 44.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 74.4 110.836 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . 0.546 ' CB ' ' HB3' ' E' ' 237' ' ' ALA . 0.5 OUTLIER -136.18 153.39 51.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 44.43 111.128 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -156.27 166.5 33.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 74.45 110.858 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 70.22 -73.67 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 74.42 110.844 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 8.1 mtt85 -167.62 57.85 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 73.34 110.884 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . 0.546 ' HB3' ' CB ' ' E' ' 233' ' ' THR . . . -104.81 150.48 24.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 64.43 111.14 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.76 135.65 47.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.296 -0.411 . . . . 74.12 110.805 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.689 HG11 ' CG2' ' E' ' 231' ' ' ILE . 26.8 m -127.22 128.65 70.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 64.44 111.075 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.49 131.64 53.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 73.34 110.898 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.775 HD13 ' HB ' ' E' ' 277' ' ' ILE . 3.7 mm? -115.5 118.61 33.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 43.4 110.922 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.49 176.48 14.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.64 -0.791 . . . . 53.25 112.422 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -85.73 162.67 18.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.858 0.361 . . . . 75.23 110.893 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.602 HG13 ' HG3' ' D' ' 280' ' ' GLU . 86.2 t -132.58 128.93 58.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 65.45 111.129 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . 0.404 ' O ' HG13 ' E' ' 245' ' ' VAL . 14.8 p -122.31 129.17 75.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 73.25 111.093 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . 0.415 HG21 ' HA2' ' E' ' 282' ' ' GLY . 14.9 t -69.51 170.98 9.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 63.53 111.182 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.49 -33.78 68.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 75.1 111.097 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.62 -35.87 68.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 73.43 111.135 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 57.39 -169.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 33.01 111.083 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.18 140.13 44.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 71.41 110.986 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -172.04 31.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 74.12 110.838 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -162.62 23.88 0.2 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.715 -0.755 . . . . 73.1 112.467 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -143.79 -160.15 8.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.729 -0.748 . . . . 74.44 112.527 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 1.4 tt -117.99 -38.99 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.339 . . . . 63.52 111.149 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 59.73 98.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.865 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 tt -118.39 -41.83 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 75.31 111.177 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.38 163.81 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 75.22 110.829 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -104.41 -169.02 1.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 65.12 110.835 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.49 -36.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 70.22 110.993 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 2.9 t -64.74 127.92 33.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.192 -0.458 . . . . 72.44 111.179 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . 0.486 HG22 ' CB ' ' E' ' 225' ' ' ARG . 24.9 p -115.61 141.41 48.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 74.53 111.13 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -118.42 118.27 31.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 74.45 110.874 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.31 116.9 24.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.02 110.859 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . 0.551 ' O ' HG13 ' E' ' 264' ' ' VAL . 13.8 p -105.16 117.83 51.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 45.43 111.072 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . 0.551 ' CD ' ' N ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -62.04 -134.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 74.05 110.869 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.99 126.19 40.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 65.22 111.126 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 19.3 t -116.28 135.14 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 64.53 111.146 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.82 115.27 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 41.32 111.131 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.01 132.64 10.81 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 73.12 112.457 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -132.21 114.23 14.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.358 . . . . 73.05 110.833 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.46 73.42 1.1 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.753 -0.736 . . . . 70.12 112.46 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.42 103.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.804 0.335 . . . . 62.42 110.94 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 3.9 t -138.31 145.37 41.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 72.54 110.874 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.0 128.59 43.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 74.32 110.867 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.502 ' HB ' HG12 ' E' ' 239' ' ' VAL . 19.3 t -136.27 123.3 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 74.04 111.172 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.413 HD22 ' O ' ' E' ' 275' ' ' VAL . 1.2 mm? -128.14 122.26 31.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.269 -0.423 . . . . 71.22 110.89 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.775 ' HB ' HD13 ' E' ' 241' ' ' LEU . 5.0 mp -113.74 125.1 70.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 73.32 111.143 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 128.27 -172.17 19.28 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.653 -0.784 . . . . 71.14 112.43 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.53 156.04 16.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 71.22 110.933 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -124.84 139.22 54.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 74.22 110.94 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -130.54 125.16 33.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 73.13 110.984 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . 0.415 ' HA2' HG21 ' E' ' 246' ' ' THR . . . 153.43 -151.89 23.59 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.69 -0.767 . . . . 73.14 112.453 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -168.29 121.81 0.98 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.72 -0.752 . . . . 63.21 112.479 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 180.0 -34.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 63.2 110.906 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 145.64 -132.23 4.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.712 -0.756 . . . . 30.32 112.477 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.2 145.2 32.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.784 0.326 . . . . 63.34 110.881 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 65.6 13.55 8.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.156 -0.475 . . . . 73.32 110.904 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -178.72 47.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 75.22 110.856 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -51.17 166.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 73.05 110.885 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.19 -169.49 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 71.21 110.837 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -127.58 -38.6 1.9 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 72.33 110.899 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -72.57 79.13 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 61.13 110.878 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -68.26 178.95 1.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 75.41 110.774 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -152.57 -42.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 71.02 110.91 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 75.21 110.826 179.968 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 1.9 mtt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.823 0.344 . . . . 73.31 110.88 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.463 ' O ' HD13 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -71.04 85.78 0.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 73.24 110.879 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.463 HD13 ' O ' ' A' ' 218' ' ' LYS . 25.0 mm -129.24 149.94 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.259 -0.428 . . . . 63.11 111.162 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -80.08 59.02 3.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 73.33 110.822 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.652 ' HB2' ' HB3' ' A' ' 255' ' ' ARG . . . -172.68 -178.86 2.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 74.53 111.065 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.433 HG22 HG12 ' A' ' 223' ' ' VAL . 79.3 mt -138.79 -72.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 60.11 111.099 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.433 HG12 HG22 ' A' ' 222' ' ' ILE . 8.8 p -175.16 152.91 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 74.45 111.182 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -64.77 -155.3 0.16 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.675 -0.774 . . . . 64.3 112.51 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.38 100.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.828 0.347 . . . . 63.24 110.846 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.541 ' OD1' HG22 ' A' ' 277' ' ' ILE . 9.0 t30 -142.21 137.56 30.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 52.01 110.92 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.31 148.67 50.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 54.34 110.888 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.26 119.31 10.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.4 111.058 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.59 -49.29 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 71.14 110.898 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -165.22 136.9 4.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 75.11 110.875 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.677 HG22 ' CG2' ' A' ' 267' ' ' VAL . 5.9 pt -135.49 130.77 50.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 71.24 111.127 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.7 125.41 27.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 74.42 110.882 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.557 HG21 HG13 ' A' ' 239' ' ' VAL . 1.6 p -136.86 149.59 47.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 73.25 111.126 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.27 168.51 19.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 62.33 110.869 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 64.63 74.73 0.39 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.47 . . . . 73.14 110.893 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 40.85 59.29 2.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 72.12 110.905 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.499 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -103.36 157.19 17.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 72.44 111.04 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.97 143.94 47.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 75.5 110.926 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.707 HG12 ' HB ' ' A' ' 275' ' ' VAL . 14.8 m -134.73 120.6 32.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 70.54 111.033 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -116.34 129.68 56.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 72.25 110.936 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.5 mp -111.86 117.91 34.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 71.22 110.947 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.25 -166.51 24.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.786 -0.721 . . . . 54.12 112.516 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -108.25 141.7 39.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.971 0.415 . . . . 61.12 110.838 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 244' ' ' VAL . 32.0 m -115.52 118.0 57.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.138 -0.483 . . . . 51.5 111.13 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.708 HG12 ' HB2' ' A' ' 281' ' ' TYR . 6.5 m -123.43 123.03 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 74.33 111.129 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.767 HG22 ' O ' ' A' ' 281' ' ' TYR . 3.2 t -91.78 161.06 15.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 75.02 111.173 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.15 -43.9 93.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 63.43 111.079 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.11 -35.02 66.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 53.52 111.084 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.814 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -64.99 -14.83 61.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 74.55 111.101 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 62.76 -176.36 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 72.41 110.867 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -145.87 -46.64 0.21 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.148 -0.478 . . . . 71.32 110.817 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 66.54 68.27 1.72 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 63.43 112.507 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 129.21 -137.42 9.57 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.802 -0.713 . . . . 50.04 112.502 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.5 tt -126.22 -37.62 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.833 0.349 . . . . 73.43 111.182 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.652 ' HB3' ' HB2' ' A' ' 221' ' ' ALA . 1.2 ttm180 -179.3 -170.01 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 64.42 110.859 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.22 165.38 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 74.22 111.131 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.53 148.95 36.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 72.51 110.841 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.68 ' OD1' HG21 ' B' ' 219' ' ' ILE . 0.7 OUTLIER 52.65 -170.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 71.31 110.894 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -173.84 176.16 2.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.979 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 56.6 m -76.99 135.56 38.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 64.25 111.198 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 261' ' ' THR . 6.0 t -106.07 122.35 46.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 60.42 111.15 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.02 136.34 52.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 73.45 110.917 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 8.2 t -142.55 123.6 14.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 65.21 110.822 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.58 134.98 54.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 61.24 111.136 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.74 -77.76 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 71.0 110.851 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.22 127.68 53.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 60.43 111.115 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.909 HG13 HD11 ' B' ' 231' ' ' ILE . 0.4 OUTLIER -117.89 131.46 70.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 71.25 111.111 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.46 116.06 42.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 62.25 111.115 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.12 133.29 10.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.802 -0.713 . . . . 72.21 112.517 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -133.35 148.51 51.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 63.45 110.872 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.55 79.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.785 -0.721 . . . . 61.21 112.493 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 46.83 66.37 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 75.01 110.907 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 29.6 t -92.78 145.14 24.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 65.34 110.82 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.56 128.19 54.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 70.31 110.856 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.707 ' HB ' HG12 ' A' ' 239' ' ' VAL . 19.3 t -119.25 123.15 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 72.3 111.139 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -129.45 111.49 12.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 73.12 110.937 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.634 ' CD1' HD13 ' B' ' 241' ' ' LEU . 7.2 mm -106.97 110.39 31.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 64.12 111.088 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.15 -178.34 18.84 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 73.33 112.482 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -88.96 156.59 18.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 70.31 110.916 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.769 ' CG ' HG12 ' B' ' 244' ' ' VAL . 0.9 OUTLIER -135.23 146.7 48.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 64.14 110.902 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.767 ' O ' HG22 ' A' ' 246' ' ' THR . 9.2 m-85 -123.06 122.45 38.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 63.32 110.901 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -127.83 -155.99 8.92 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.726 -0.749 . . . . 71.44 112.497 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -144.32 18.5 2.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 72.31 112.478 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.67 -51.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 71.13 110.942 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -102.28 -169.11 26.92 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.729 . . . . 71.34 112.5 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -136.54 31.74 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.911 0.386 . . . . 75.54 110.895 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 -179.31 -37.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 75.34 110.975 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.52 -170.37 2.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 75.33 110.856 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -88.14 79.29 7.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 62.13 110.864 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -93.68 136.07 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 50.42 110.845 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -175.47 152.65 1.38 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 62.01 110.818 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 60.84 56.16 2.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 72.54 110.913 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -172.43 123.77 0.47 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 55.01 110.913 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -105.49 138.54 41.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 64.11 110.882 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 1.1 t60 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 70.45 110.898 -179.989 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.774 0.321 . . . . 75.22 110.902 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.39 133.21 48.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 65.13 110.876 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . 0.68 HG21 ' OD1' ' A' ' 258' ' ' ASP . 4.0 mp -138.7 147.81 24.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 71.41 111.09 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -161.57 86.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 73.41 110.861 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -171.62 -170.56 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 64.31 111.124 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . 0.551 HD13 ' HB3' ' B' ' 257' ' ' SER . 6.4 tp -52.28 139.28 9.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.279 -0.419 . . . . 74.31 111.054 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.532 HG12 HE21 ' B' ' 259' ' ' GLN . 14.9 p -147.14 139.28 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 74.31 111.139 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -92.79 -175.93 41.26 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.774 -0.727 . . . . 61.21 112.477 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.726 ' HB3' HG23 ' B' ' 261' ' ' THR . 2.8 mtp180 -169.11 105.76 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.838 0.351 . . . . 54.0 110.854 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -134.28 110.58 9.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 74.12 110.925 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.95 138.74 54.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 73.43 110.895 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.99 120.01 20.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 72.0 111.175 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -74.88 -35.69 62.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 63.13 110.844 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -166.05 135.8 3.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 71.21 110.864 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.909 HD11 HG13 ' A' ' 267' ' ' VAL . 7.4 pt -141.07 131.58 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 74.13 111.155 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.72 126.8 27.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.837 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.733 HG21 HG13 ' B' ' 239' ' ' VAL . 2.3 p -135.05 140.38 45.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 55.52 111.095 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.19 167.56 21.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 62.11 110.852 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 68.09 69.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.067 -0.515 . . . . 73.41 110.861 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 46.88 35.2 3.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 73.31 110.935 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.42 156.14 20.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 75.23 111.057 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.65 144.6 47.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.25 110.823 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.739 HG12 ' HB ' ' B' ' 275' ' ' VAL . 0.0 OUTLIER -123.71 121.31 62.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 75.25 111.162 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.413 ' HB3' HD22 ' B' ' 276' ' ' LEU . 0.9 OUTLIER -118.24 117.45 29.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.04 110.911 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.634 HD13 ' CD1' ' A' ' 277' ' ' ILE . 4.2 mp -111.48 117.71 33.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 74.15 110.898 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.37 -165.69 26.65 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 54.42 112.505 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -109.07 135.5 50.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 55.21 110.907 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.769 HG12 ' CG ' ' A' ' 280' ' ' GLU . 33.6 m -106.62 123.04 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 54.43 111.142 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' B' ' 281' ' ' TYR . 0.1 OUTLIER -124.54 121.52 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 62.33 111.136 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.3 t -87.76 161.68 17.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 65.31 111.139 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.814 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.93 -38.16 90.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 51.33 111.172 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.11 -34.9 64.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 73.51 111.131 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -91.8 115.46 28.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 74.42 111.136 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 24.0 tp -166.06 -66.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.901 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . 0.486 ' CE1' HD11 ' C' ' 254' ' ' ILE . 0.2 OUTLIER 52.27 30.89 8.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 73.21 110.842 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 66.4 174.45 5.87 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.733 -0.746 . . . . 30.55 112.429 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -57.87 161.03 10.71 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.781 -0.723 . . . . 32.33 112.523 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . 0.54 HD13 ' H ' ' B' ' 254' ' ' ILE . 0.1 OUTLIER -143.48 179.59 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 71.33 111.145 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.41 160.72 31.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.01 110.914 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 mt 60.5 99.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 63.43 111.111 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . 0.551 ' HB3' HD13 ' B' ' 222' ' ' ILE . 0.3 OUTLIER -95.23 -178.47 4.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 73.42 110.876 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -113.36 -28.79 7.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 65.15 110.838 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . 0.532 HE21 HG12 ' B' ' 223' ' ' VAL . 0.0 OUTLIER 62.96 98.78 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 61.02 110.936 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 1.3 m -99.17 136.52 39.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 70.55 111.113 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.726 HG23 ' HB3' ' B' ' 225' ' ' ARG . 97.2 m -134.14 108.82 8.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.426 . . . . 73.15 111.133 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -111.36 132.73 54.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.862 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.9 p -140.0 123.6 17.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 63.23 110.89 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.736 HG21 ' CG1' ' B' ' 267' ' ' VAL . 3.7 p -115.07 144.71 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 64.12 111.095 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.14 -52.09 5.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 74.43 110.875 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 25.1 m -150.33 126.98 10.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 53.55 111.185 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.736 ' CG1' HG21 ' B' ' 264' ' ' VAL . 32.6 m -123.14 136.85 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 62.31 111.11 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 37.8 t -127.22 129.62 70.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 62.32 111.128 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.24 133.4 8.42 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.8 -0.714 . . . . 74.4 112.517 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -133.18 148.92 52.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 74.21 110.89 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.4 87.59 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.697 -0.763 . . . . 64.21 112.477 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 41.39 50.73 3.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 62.0 110.873 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 47.9 t -83.21 144.87 29.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 73.42 110.833 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 129.85 48.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.098 -0.501 . . . . 73.32 110.871 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.739 ' HB ' HG12 ' B' ' 239' ' ' VAL . 11.9 t -114.14 130.67 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 73.11 111.147 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.413 HD22 ' HB3' ' B' ' 240' ' ' GLN . 0.8 OUTLIER -128.73 111.24 12.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 64.34 110.886 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.704 ' CD1' HD13 ' C' ' 241' ' ' LEU . 21.9 mm -110.15 103.43 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 71.12 111.126 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 142.01 -172.45 24.11 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.725 -0.75 . . . . 75.11 112.507 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -91.42 156.35 17.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.708 0.29 . . . . 65.23 110.954 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.648 ' CG ' HG12 ' C' ' 244' ' ' VAL . 0.0 OUTLIER -131.16 142.27 50.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 71.31 110.864 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.498 ' HB2' HG13 ' B' ' 245' ' ' VAL . 8.7 m-85 -127.19 122.83 35.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 64.44 110.936 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . -129.97 -158.64 9.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 50.44 112.486 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -111.77 -20.72 6.72 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 33.33 112.465 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.59 34.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 64.41 110.944 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -142.8 176.51 22.41 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.708 -0.758 . . . . 72.24 112.472 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -116.68 -22.88 8.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.837 0.351 . . . . 71.22 110.894 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -156.13 -41.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 72.3 110.913 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -174.07 85.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 65.44 110.832 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -110.47 -170.38 1.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 75.52 110.921 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -167.47 -70.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 75.3 110.883 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.02 -171.64 1.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.814 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -96.65 32.82 1.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 73.32 110.816 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.12 173.24 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 61.4 110.892 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -76.43 -169.87 1.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 74.15 110.926 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 37.6 t60 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 72.21 110.827 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 16.5 mtt . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.81 0.338 . . . . 72.55 110.894 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -106.09 125.92 51.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 74.41 110.903 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 3.5 mp -117.0 -28.88 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 73.15 111.142 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 56.34 -173.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.101 -0.499 . . . . 71.41 110.851 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -135.61 -73.04 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 70.4 111.121 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 2.2 pt -150.85 67.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 73.21 111.068 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 25.6 m -106.78 -31.49 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 61.24 111.097 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -145.93 100.62 0.23 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.705 -0.76 . . . . 34.13 112.458 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.579 ' O ' HG23 ' C' ' 261' ' ' THR . 58.6 ttp180 -153.37 118.36 5.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.834 0.349 . . . . 74.3 110.835 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.527 ' OD1' HG22 ' C' ' 277' ' ' ILE . 3.2 t30 -88.06 124.28 33.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.457 . . . . 52.13 110.871 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.53 ' OG ' HG21 ' D' ' 219' ' ' ILE . 0.1 OUTLIER -123.5 142.9 50.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 55.31 110.87 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.67 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -137.88 119.17 14.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 52.31 111.097 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.53 -45.83 35.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 73.41 110.905 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -165.97 135.6 3.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.258 -0.428 . . . . 74.03 110.836 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.592 HG22 ' CG2' ' C' ' 267' ' ' VAL . 5.5 pt -138.14 132.1 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 70.15 111.12 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -135.61 121.44 19.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.827 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.584 HG21 HG13 ' C' ' 239' ' ' VAL . 1.8 p -135.87 138.17 42.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 73.34 111.104 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -138.8 167.71 21.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 61.02 110.877 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 68.95 73.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 71.23 110.838 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 45.07 54.21 7.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 72.14 110.881 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.42 156.25 18.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 74.44 111.097 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.94 143.7 38.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 61.24 110.804 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.66 HG12 ' HB ' ' C' ' 275' ' ' VAL . 14.8 m -129.5 133.83 64.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 75.23 111.107 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.496 ' OE1' HD21 ' C' ' 276' ' ' LEU . 3.7 tm0? -130.35 120.7 24.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 65.22 110.96 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.704 HD13 ' CD1' ' B' ' 277' ' ' ILE . 5.9 mp -111.64 118.36 35.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 70.03 110.907 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.65 -178.4 19.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.726 -0.75 . . . . 30.32 112.457 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -97.47 128.81 44.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.853 0.359 . . . . 63.24 110.905 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.648 HG12 ' CG ' ' B' ' 280' ' ' GLU . 32.5 m -96.18 127.79 47.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 71.52 111.154 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.49 129.23 74.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 60.03 111.112 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.4 t -83.83 165.07 19.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 54.41 111.109 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.14 -34.09 76.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 70.01 111.111 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' C' ' 249' ' ' ALA . . . -56.72 -36.21 69.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 73.02 111.102 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' C' ' 248' ' ' ALA . . . 69.09 -77.23 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 74.42 111.054 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.48 51.91 1.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 74.45 110.906 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . 0.601 ' HA ' ' HB1' ' D' ' 247' ' ' ALA . 9.7 t-80 72.15 -69.33 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 53.55 110.903 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -137.58 34.36 2.18 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.778 -0.725 . . . . 75.45 112.457 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -163.03 -168.88 25.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.793 -0.718 . . . . 75.42 112.576 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . 0.486 HD11 ' CE1' ' B' ' 251' ' ' HIS . 4.1 mp -135.63 109.67 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 74.51 111.057 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -132.73 -174.86 3.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 71.33 110.848 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 36.1 pt -77.68 176.55 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 65.33 111.111 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.72 -172.04 2.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 73.32 110.818 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.5 169.74 8.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 64.52 110.89 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 11.0 mp0 -111.11 104.01 12.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 63.35 110.937 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . 0.406 HG22 HD21 ' C' ' 262' ' ' ASN . 1.7 m -100.78 136.06 41.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 53.3 111.145 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.579 HG23 ' O ' ' C' ' 225' ' ' ARG . 96.1 m -125.15 116.83 22.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 72.15 111.121 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . 0.406 HD21 HG22 ' C' ' 260' ' ' THR . 3.0 m120 -126.05 149.8 48.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 62.33 110.916 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 1.8 m -141.72 123.71 15.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 72.42 110.886 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.784 HG21 HD11 ' D' ' 231' ' ' ILE . 5.9 p -109.99 138.93 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 62.42 111.071 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.669 ' CD ' HD12 ' E' ' 219' ' ' ILE . 0.4 OUTLIER -84.6 -74.19 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 72.55 110.935 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 7.4 m -126.26 127.79 46.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 52.02 111.156 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.592 ' CG2' HG22 ' C' ' 231' ' ' ILE . 0.3 OUTLIER -117.74 129.69 73.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.21 111.145 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 19.4 t -127.98 115.97 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 74.04 111.132 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.75 133.56 10.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.692 -0.766 . . . . 72.2 112.485 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.06 147.6 52.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.342 . . . . 65.15 110.867 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.43 84.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.785 -0.721 . . . . 64.45 112.43 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 48.06 75.74 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 74.04 110.958 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.69 145.06 32.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 73.43 110.865 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.47 128.42 48.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 73.03 110.822 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.66 ' HB ' HG12 ' C' ' 239' ' ' VAL . 21.3 t -121.32 123.41 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 75.35 111.124 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.788 HD12 ' CE2' ' C' ' 287' ' ' TRP . 0.1 OUTLIER -128.75 113.42 15.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 71.15 110.964 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.723 HD12 HD22 ' D' ' 241' ' ' LEU . 19.0 mm -112.17 104.08 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 52.21 111.093 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.74 -177.07 27.22 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.711 -0.757 . . . . 71.04 112.439 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -95.04 156.19 16.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 74.12 110.971 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.402 ' HG2' HG12 ' D' ' 244' ' ' VAL . 0.0 OUTLIER -126.12 130.93 52.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 75.31 110.847 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -119.23 125.65 49.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 72.52 110.958 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.93 171.91 13.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.692 -0.766 . . . . 63.34 112.466 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . 0.506 ' N ' ' HB2' ' D' ' 247' ' ' ALA . . . -70.92 -139.73 0.19 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.782 -0.723 . . . . 40.25 112.487 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 63.15 24.81 14.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.34 . . . . 72.23 110.908 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 61.9 -95.21 0.1 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.685 -0.769 . . . . 62.22 112.441 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -112.58 -175.3 2.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.786 0.327 . . . . 71.14 110.95 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.788 ' CE2' HD12 ' C' ' 276' ' ' LEU . 21.0 t90 -50.13 -74.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.236 -0.438 . . . . 74.43 110.93 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -71.21 -175.73 1.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.432 . . . . 72.03 110.848 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -109.78 179.66 4.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 73.51 110.932 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.85 -169.98 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 63.44 110.894 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -138.24 -171.65 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 64.11 110.874 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -68.51 144.22 54.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 64.35 110.889 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.36 -174.41 4.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 73.4 110.851 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -137.5 -170.06 2.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 74.15 110.839 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 72.13 110.877 -179.946 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 18.6 ptp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.82 0.343 . . . . 65.11 110.933 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.12 102.03 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 63.22 110.894 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . 0.53 HG21 ' OG ' ' C' ' 227' ' ' SER . 5.9 pt -88.66 -177.59 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 50.45 111.113 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -133.24 -74.31 0.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 63.32 110.822 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -155.19 -170.02 3.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 52.11 111.115 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 10.5 tt -169.44 146.18 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 65.11 111.12 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 63.4 t -129.52 -72.0 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 63.14 111.156 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -91.59 -138.5 8.04 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 53.51 112.503 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.537 ' N ' HG23 ' D' ' 261' ' ' THR . 0.0 OUTLIER 63.43 -168.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.83 0.347 . . . . 75.11 110.843 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . 0.507 ' OD1' HG22 ' D' ' 277' ' ' ILE . 2.2 t30 -83.28 111.23 18.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 54.14 110.87 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 4.3 m -126.31 138.13 53.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 60.35 110.852 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.58 123.49 39.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 71.15 111.095 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -40.29 58.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 72.42 110.946 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -165.96 135.95 3.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 73.04 110.895 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . 0.784 HD11 HG21 ' C' ' 264' ' ' VAL . 9.0 pt -141.36 117.66 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 73.03 111.111 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . 0.634 HH11 HG22 ' D' ' 268' ' ' VAL . 0.0 OUTLIER -130.78 122.86 27.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.473 . . . . 62.51 110.928 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . 0.457 HG21 ' CG1' ' D' ' 239' ' ' VAL . 3.0 p -135.94 149.17 48.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 54.21 111.154 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -145.66 167.19 23.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 70.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 67.22 79.86 0.22 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 73.04 110.92 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 42.62 52.28 4.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 75.43 110.857 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.22 156.31 18.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 63.42 111.08 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.16 142.03 25.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 73.23 110.829 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.537 HG12 ' HB ' ' D' ' 275' ' ' VAL . 19.7 m -128.89 139.75 51.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 74.43 111.134 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -128.75 126.03 39.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 52.23 110.915 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.723 HD22 HD12 ' C' ' 277' ' ' ILE . 10.8 mp -111.73 135.21 52.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 74.14 110.875 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 114.74 -176.16 16.6 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.713 -0.756 . . . . 62.32 112.433 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -100.36 135.21 42.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.876 0.37 . . . . 71.21 110.88 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . 0.402 HG12 ' HG2' ' C' ' 280' ' ' GLU . 22.7 m -104.07 133.48 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 52.03 111.137 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 39.9 t -122.22 129.47 75.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 54.3 111.05 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . 0.403 HG23 ' H ' ' D' ' 249' ' ' ALA . 10.9 t -69.55 175.1 4.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 73.21 111.213 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . 0.601 ' HB1' ' HA ' ' C' ' 251' ' ' HIS . . . -62.79 -42.92 99.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 52.33 111.078 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.85 74.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 64.33 111.106 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . 0.403 ' H ' HG23 ' D' ' 246' ' ' THR . . . 53.88 -171.34 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 73.31 111.023 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.11 91.52 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.476 . . . . 72.31 110.925 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -76.89 -174.88 3.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 73.22 110.882 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 109.43 -20.23 28.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.697 -0.764 . . . . 64.44 112.458 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . 167.95 -104.74 0.22 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.788 -0.72 . . . . 74.25 112.494 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 13.6 pt -144.64 44.19 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.76 0.314 . . . . 71.32 111.132 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -93.72 174.84 6.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 65.03 110.946 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 4.1 pt -110.87 -179.05 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 62.04 111.172 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.91 -172.35 2.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 73.41 110.918 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -119.63 173.63 6.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 70.11 110.824 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.62 119.99 19.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 73.41 110.989 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 29.3 m -95.98 137.92 34.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 53.41 111.143 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . 0.537 HG23 ' N ' ' D' ' 225' ' ' ARG . 90.2 m -93.24 113.45 25.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 71.41 111.206 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -126.25 145.55 50.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 75.23 110.924 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 21.9 t -135.53 123.8 23.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 73.21 110.8 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.724 HG23 HD11 ' E' ' 231' ' ' ILE . 14.2 p -112.35 133.2 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 75.43 111.167 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.91 -75.18 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 72.41 110.872 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 26.5 m -133.73 132.65 40.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 65.34 111.161 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.645 ' CG2' HG22 ' D' ' 231' ' ' ILE . 13.6 t -117.78 127.36 75.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 44.31 111.076 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . 0.634 HG22 HH11 ' D' ' 232' ' ' ARG . 21.2 t -125.12 116.04 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 34.23 111.129 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.29 132.94 10.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.788 -0.72 . . . . 60.2 112.547 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.4 143.93 50.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 53.05 110.891 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 47.15 85.31 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.716 -0.754 . . . . 74.33 112.483 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 52.74 89.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.847 0.356 . . . . 63.53 110.927 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 47.8 t -126.12 145.01 50.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 73.4 110.829 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 11.8 mtt85 -127.7 128.23 45.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 74.4 110.862 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.537 ' HB ' HG12 ' D' ' 239' ' ' VAL . 23.2 t -119.36 123.68 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 65.33 111.129 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.617 HD12 ' CE2' ' D' ' 287' ' ' TRP . 0.4 OUTLIER -124.47 113.05 17.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 74.34 110.863 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.507 HG22 ' OD1' ' D' ' 226' ' ' ASN . 17.8 mm -112.33 104.21 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 65.35 111.144 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.61 -146.59 16.01 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.758 -0.734 . . . . 72.24 112.525 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -128.19 150.04 50.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 75.13 110.853 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -111.76 127.16 55.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.965 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . 0.44 ' CZ ' HG21 ' E' ' 245' ' ' VAL . 10.8 m-85 -120.21 125.4 48.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.22 110.898 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 122.99 160.16 10.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 60.32 112.41 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . 0.63 ' N ' ' HB2' ' E' ' 247' ' ' ALA . . . 62.26 163.55 0.32 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 32.23 112.479 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -110.34 48.42 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 71.34 110.927 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -137.04 -92.62 0.31 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.738 -0.744 . . . . 44.32 112.518 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . 0.741 ' CE1' HG11 ' E' ' 244' ' ' VAL . 40.4 t80 -179.6 -64.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 61.22 110.849 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . 0.617 ' CE2' HD12 ' D' ' 276' ' ' LEU . 10.4 t90 -168.9 39.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 75.4 110.919 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -179.63 -38.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.837 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.14 157.32 1.38 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.456 . . . . 54.42 110.937 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -140.17 -174.28 3.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 75.52 110.875 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -51.88 -72.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 65.33 110.882 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.34 105.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 52.14 110.861 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -91.43 -26.05 19.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 70.2 110.89 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.16 -179.93 4.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 63.3 110.84 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 6.9 p80 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 64.2 110.893 -179.968 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.883 0.373 . . . . 74.42 110.864 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -178.85 122.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.54 110.887 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . 0.669 HD12 ' CD ' ' C' ' 265' ' ' GLU . 4.8 mt -126.75 135.13 64.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 54.34 111.156 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -71.11 144.48 50.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 54.31 110.87 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -125.67 -75.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 55.0 111.153 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 3.6 mp 52.23 75.2 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 62.13 111.162 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 21.2 m -149.26 -173.92 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 73.11 111.098 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -83.89 -131.47 2.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.765 -0.731 . . . . 73.11 112.468 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.92 -167.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 71.15 110.904 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.9 112.31 19.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 70.35 110.878 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 19.3 m -131.23 138.7 49.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.31 110.838 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . 0.416 ' HA ' HG13 ' E' ' 264' ' ' VAL . . . -120.52 132.74 55.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 61.54 111.092 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.6 -32.39 41.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 73.1 110.867 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . 0.526 ' CB ' HG22 ' E' ' 266' ' ' THR . 0.7 OUTLIER -165.79 139.03 4.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.415 . . . . 64.31 110.91 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . 0.724 HD11 HG23 ' D' ' 264' ' ' VAL . 0.4 OUTLIER -138.71 116.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 72.15 111.151 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . 0.407 ' CD ' HG22 ' E' ' 268' ' ' VAL . 8.6 ptm180 -129.89 117.77 20.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.861 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . 0.582 HG21 HG13 ' E' ' 239' ' ' VAL . 7.8 p -135.43 151.91 50.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 73.42 111.105 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -157.47 167.27 30.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.907 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 67.54 75.13 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 63.41 110.848 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 45.78 42.9 9.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 63.44 110.864 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' E' ' 233' ' ' THR . . . -104.09 150.61 24.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 73.24 111.045 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . 0.497 HH12 ' N ' ' E' ' 240' ' ' GLN . 0.0 OUTLIER -133.7 148.11 51.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 71.04 110.902 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.674 HG12 ' CG2' ' E' ' 275' ' ' VAL . 6.8 m -130.47 124.13 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 74.5 111.134 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . 0.497 ' N ' HH12 ' E' ' 238' ' ' ARG . 8.6 tm0? -114.65 126.12 54.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 53.33 110.933 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.87 121.4 43.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 72.04 110.941 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 122.03 175.61 14.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 53.4 112.513 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -85.63 139.53 31.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 70.4 110.824 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.741 HG11 ' CE1' ' D' ' 286' ' ' PHE . 30.1 m -104.84 139.17 26.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 53.44 111.135 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . 0.44 HG21 ' CZ ' ' D' ' 281' ' ' TYR . 87.1 t -122.41 129.43 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 64.45 111.095 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.7 t -69.0 174.28 4.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 62.14 111.143 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . 0.63 ' HB2' ' N ' ' D' ' 283' ' ' GLY . . . -59.0 -43.54 91.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 73.42 111.09 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.98 -48.63 77.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 55.3 111.05 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 52.5 -170.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 72.43 111.042 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 4.6 tp -177.1 154.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 64.1 110.919 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -159.48 156.65 28.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 65.04 110.829 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.74 137.54 4.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 64.43 112.517 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -166.68 -179.16 39.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.751 . . . . 42.11 112.483 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.6 25.64 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.903 0.383 . . . . 74.42 111.14 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -160.14 143.32 13.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 71.11 110.872 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.87 177.74 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 65.01 111.141 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 1.1 t -179.46 -37.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 71.41 110.858 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 29.7 t0 63.5 161.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.106 -0.497 . . . . 61.32 110.806 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -74.47 131.09 40.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 73.21 110.903 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 20.5 m -66.85 138.26 57.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 54.54 111.111 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 2.8 t -103.55 134.31 47.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 63.22 111.09 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.42 150.88 48.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 63.41 110.845 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 68.3 m -139.33 131.98 28.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 73.44 110.887 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . 0.519 HG21 ' CG2' ' E' ' 267' ' ' VAL . 3.6 p -129.28 122.07 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 71.31 111.157 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.25 -78.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 71.33 110.862 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . 0.526 HG22 ' CB ' ' E' ' 230' ' ' ASP . 72.5 p -143.48 135.83 27.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 64.42 111.212 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . 0.519 ' CG2' HG21 ' E' ' 264' ' ' VAL . 18.0 t -117.44 134.6 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 75.13 111.141 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . 0.407 HG22 ' CD ' ' E' ' 232' ' ' ARG . 47.4 t -126.74 119.97 54.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.3 111.126 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.89 133.27 10.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 73.44 112.548 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.79 126.4 32.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.815 0.34 . . . . 64.54 110.893 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.7 94.44 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 52.34 112.477 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 50.05 75.14 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.92 0.391 . . . . 75.44 110.86 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 7.6 t -114.79 145.6 41.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.156 -0.474 . . . . 63.22 110.802 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 24.2 mtm-85 -130.85 127.3 38.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 75.14 110.913 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.674 ' CG2' HG12 ' E' ' 239' ' ' VAL . 21.3 t -116.53 125.3 73.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 62.34 111.165 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.514 HD21 ' HE1' ' D' ' 286' ' ' PHE . 0.3 OUTLIER -125.72 111.73 15.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 73.41 110.953 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . . . . . . . . . 31.6 mm -112.9 103.69 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 51.23 111.155 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 137.66 -178.66 18.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.8 -0.714 . . . . 55.55 112.52 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -89.92 156.19 18.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 63.24 110.859 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -121.37 134.31 55.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 64.5 110.879 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -114.35 124.74 52.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 55.23 110.92 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 96.45 -20.79 48.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.795 -0.717 . . . . 44.15 112.512 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -72.96 -22.59 79.0 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 54.31 112.472 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 51.85 83.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 64.31 110.909 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 65.2 109.76 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 53.53 112.522 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 57.73 -168.02 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.351 . . . . 74.01 110.857 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . 0.476 ' CZ3' HD12 ' E' ' 276' ' ' LEU . 1.1 m-90 -47.78 -57.85 5.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 72.15 110.951 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -147.35 171.94 14.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 71.43 110.911 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -123.73 96.62 5.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 61.15 110.883 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -170.0 49.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 64.2 110.916 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -145.9 -178.93 6.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 71.42 110.885 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -156.73 142.14 17.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 73.12 110.868 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.67 -174.92 3.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 50.34 110.876 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.18 -175.0 1.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 73.14 110.874 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 70.44 110.921 -179.942 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.873 0.368 . . . . 74.13 110.92 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.626 ' O ' HD13 ' A' ' 219' ' ' ILE . 0.1 OUTLIER -117.89 107.06 13.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 73.01 110.873 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.626 HD13 ' O ' ' A' ' 218' ' ' LYS . 25.3 mm -135.43 150.0 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 74.15 111.053 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.49 -170.61 1.93 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 75.44 110.873 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -172.27 168.56 5.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 62.34 111.137 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.5 pt -152.18 179.37 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 72.03 111.142 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 38.6 t -58.05 141.11 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 75.21 111.083 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 52.99 76.84 0.16 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.742 . . . . 44.4 112.47 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.639 ' O ' HG23 ' A' ' 261' ' ' THR . 1.0 OUTLIER -175.76 121.11 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.794 0.331 . . . . 72.13 110.917 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -85.15 135.18 34.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 73.53 110.87 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 1.7 m -118.91 136.94 53.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 51.11 110.854 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.35 139.72 39.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.482 . . . . 72.54 111.063 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.95 -73.11 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 64.4 110.931 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -130.43 138.53 50.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 63.4 110.845 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.41 116.71 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 71.32 111.1 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -118.74 115.85 25.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 44.45 110.861 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.75 146.45 52.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.194 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -156.05 154.96 31.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 74.31 110.883 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 64.23 82.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 55.22 110.934 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 41.85 43.57 2.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.848 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.25 137.93 31.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.092 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 141.9 51.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 73.12 110.809 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.539 HG23 ' HB ' ' A' ' 275' ' ' VAL . 6.0 p -143.58 121.68 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 74.02 111.134 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -122.0 136.61 54.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 61.44 110.888 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.75 118.87 21.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 73.34 110.94 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 152.72 -120.39 1.05 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.747 -0.739 . . . . 52.31 112.503 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -144.77 130.28 18.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 72.1 110.86 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -101.95 136.29 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 72.45 111.136 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 38.5 t -122.15 129.12 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 74.42 111.122 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.591 HG21 ' HB2' ' A' ' 284' ' ' LYS . 0.2 OUTLIER -99.92 163.1 12.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 73.42 111.136 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.03 -42.09 99.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 74.23 111.132 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.06 -36.01 70.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 74.25 111.083 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -52.45 -75.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 72.23 111.18 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.598 HD13 HD11 ' A' ' 254' ' ' ILE . 0.1 OUTLIER -179.2 -170.16 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 70.04 110.961 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.408 ' H ' HD23 ' A' ' 250' ' ' LEU . 29.6 m170 -68.82 -38.15 79.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 73.23 110.818 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -169.34 -43.36 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.75 -0.738 . . . . 71.33 112.464 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 164.93 171.81 31.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.693 -0.765 . . . . 74.23 112.501 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.598 HD11 HD13 ' A' ' 250' ' ' LEU . 3.8 mp -139.35 -62.39 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.875 0.369 . . . . 72.12 111.211 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -169.6 140.94 2.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 75.01 110.875 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 15.8 tt -163.05 143.77 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 74.23 111.132 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.6 148.97 21.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 71.12 110.929 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 55.46 -173.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 62.24 110.825 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.33 137.96 1.53 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 73.44 110.86 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.606 HG21 ' HB3' ' A' ' 279' ' ' ASN . 7.0 t -65.65 125.48 25.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 73.54 111.084 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 225' ' ' ARG . 91.9 m -112.79 108.85 18.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 75.23 111.186 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -104.96 138.91 40.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 73.12 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 92.4 p -140.48 123.87 16.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.53 110.833 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.65 HG21 ' CG2' ' A' ' 267' ' ' VAL . 9.6 p -108.26 149.77 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 74.23 111.137 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -102.44 -39.79 6.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 65.11 110.866 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.4 m -150.41 127.31 11.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.453 . . . . 62.1 111.099 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.65 ' CG2' HG21 ' A' ' 264' ' ' VAL . 80.9 t -121.28 120.19 61.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 61.13 111.08 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.02 129.48 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 73.13 111.206 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -139.73 133.26 5.98 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.764 -0.732 . . . . 71.22 112.49 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.89 147.39 51.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.877 0.37 . . . . 53.33 110.896 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 53.94 89.91 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.665 -0.779 . . . . 61.35 112.533 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 45.23 60.18 3.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 70.15 110.817 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 6.4 t -91.25 145.54 24.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 75.42 110.862 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -132.32 127.8 36.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 74.21 110.884 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.539 ' HB ' HG23 ' A' ' 239' ' ' VAL . 20.3 t -131.85 123.66 51.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 50.41 111.119 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.71 111.59 17.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 73.33 110.931 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 2.3 mp -107.17 104.29 16.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 75.11 111.117 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.04 -152.29 24.42 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.749 -0.738 . . . . 73.22 112.496 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.606 ' HB3' HG21 ' A' ' 260' ' ' THR . 1.6 p30 -127.81 151.52 48.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 75.31 110.878 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.03 124.69 48.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 72.4 110.886 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -106.91 125.86 51.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 74.54 110.923 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 112.65 -68.97 0.23 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.724 . . . . 74.35 112.522 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 101.33 -101.71 2.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.768 -0.729 . . . . 72.24 112.499 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.591 ' HB2' HG21 ' A' ' 246' ' ' THR . 0.0 OUTLIER 63.83 45.93 4.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 73.12 110.828 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.79 17.57 11.8 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.782 -0.723 . . . . 35.31 112.511 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.69 170.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.817 0.341 . . . . 71.32 110.828 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -61.38 -172.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.488 . . . . 75.22 110.915 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -58.69 98.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 72.33 110.857 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -147.74 -73.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 54.42 110.911 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -178.98 -170.54 0.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.131 -0.486 . . . . 73.43 110.923 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -73.19 -170.29 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 71.03 110.808 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -73.06 -68.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 64.34 110.839 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 55.07 -175.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 64.33 110.84 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -145.7 -70.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 74.03 110.858 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 64.43 110.831 -179.953 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . 0.713 ' N ' ' HH ' ' C' ' 281' ' ' TYR . 7.0 ttp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.784 0.326 . . . . 64.01 110.866 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.442 ' N ' HG22 ' C' ' 256' ' ' ILE . 0.7 OUTLIER -65.67 143.21 57.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 74.1 110.836 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . 0.654 HG13 HD12 ' B' ' 256' ' ' ILE . 1.0 OUTLIER -137.21 68.4 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 73.3 111.11 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.48 91.51 3.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 73.33 110.886 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.61 ' HB1' HD12 ' B' ' 222' ' ' ILE . . . -109.39 131.79 54.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 71.25 111.115 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . 0.61 HD12 ' HB1' ' B' ' 221' ' ' ALA . 4.5 mp 51.82 69.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 63.12 111.151 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.405 ' O ' HG13 ' B' ' 223' ' ' VAL . 6.7 p -176.81 122.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 74.13 111.151 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 152.46 -138.24 6.32 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.685 -0.769 . . . . 52.35 112.468 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.599 ' O ' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER -174.64 133.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 64.21 110.861 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -123.15 138.52 54.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 64.42 110.911 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.98 137.7 54.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 70.02 110.804 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 264' ' ' VAL . . . -132.87 140.39 47.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 65.01 111.064 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.07 -31.5 9.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 74.1 110.89 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -164.74 138.77 5.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 73.41 110.826 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 5.7 mt -137.25 121.5 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 71.41 111.099 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -134.06 118.23 17.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 70.01 110.828 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 128.89 32.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.055 -0.521 . . . . 75.4 111.169 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.03 166.86 22.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 74.44 110.888 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.71 71.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.43 110.899 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 46.16 48.19 12.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 72.21 110.804 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -98.48 149.46 22.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 71.22 111.104 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.44 142.88 47.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 75.44 110.843 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.58 HG23 ' HB ' ' B' ' 275' ' ' VAL . 7.3 p -139.58 132.08 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 53.43 111.164 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.546 ' C ' HD23 ' B' ' 241' ' ' LEU . 2.9 tt0 -127.01 137.23 53.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 63.3 110.827 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.546 HD23 ' C ' ' B' ' 240' ' ' GLN . 0.3 OUTLIER -122.19 118.56 28.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 73.11 110.915 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.68 -168.62 18.77 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 62.32 112.475 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -85.76 135.21 33.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.908 0.385 . . . . 73.12 110.881 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 3.3 m -117.72 118.83 59.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 71.35 111.115 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.488 HG21 HD11 ' B' ' 222' ' ' ILE . 21.6 t -104.82 120.17 54.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 74.02 111.124 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.615 HG22 ' HA3' ' B' ' 282' ' ' GLY . 6.0 t -90.76 172.17 8.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 74.0 111.115 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.444 ' HB2' ' H ' ' A' ' 284' ' ' LYS . . . -52.74 -41.81 64.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 72.43 111.055 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . 0.467 ' H ' HG23 ' B' ' 246' ' ' THR . . . -56.79 -36.05 69.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 74.2 111.08 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.464 ' HB2' ' CA ' ' B' ' 282' ' ' GLY . . . -82.08 93.21 6.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 45.44 111.114 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 1.4 tp -76.97 -169.96 1.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 75.51 110.924 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -52.13 119.61 4.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 70.03 110.897 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -169.1 -176.08 38.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.747 . . . . 71.04 112.469 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 86.9 104.95 0.82 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 71.22 112.507 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . 0.473 ' H ' HD12 ' B' ' 219' ' ' ILE . 18.4 tt -175.02 150.77 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.804 0.335 . . . . 62.21 111.101 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 63.06 -170.08 0.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 71.31 110.924 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . 0.654 HD12 HG13 ' B' ' 219' ' ' ILE . 26.8 mt 64.27 107.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 62.51 111.055 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.93 -170.27 0.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 72.13 110.84 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 63.31 103.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 74.4 110.91 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -101.89 164.8 11.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.13 110.911 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 7.0 t -99.3 137.44 37.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 71.14 111.142 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.599 HG23 ' O ' ' B' ' 225' ' ' ARG . 26.2 m -129.2 132.66 47.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 73.54 111.129 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -120.43 121.87 39.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.943 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 2.0 t -118.91 123.69 45.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 54.31 110.826 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.512 HG21 ' CG2' ' B' ' 267' ' ' VAL . 8.1 p -116.07 139.0 44.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 74.4 111.095 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.39 -75.53 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 74.12 110.86 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 24.3 m -124.09 130.47 52.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 72.22 111.127 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.512 ' CG2' HG21 ' B' ' 264' ' ' VAL . 94.0 t -118.06 122.8 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 74.2 111.121 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.39 129.14 70.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 62.21 111.199 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.74 132.76 6.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.699 -0.762 . . . . 53.11 112.412 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.7 147.52 51.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.873 0.368 . . . . 64.41 110.898 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.25 86.39 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.767 -0.73 . . . . 61.43 112.539 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 46.37 66.23 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 65.43 110.863 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 17.4 t -99.2 145.37 27.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 63.42 110.819 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 4.4 ttm-85 -129.76 127.88 41.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 74.5 110.805 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.58 ' HB ' HG23 ' B' ' 239' ' ' VAL . 18.7 t -129.49 123.58 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 65.45 111.134 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -126.88 111.93 14.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 72.45 110.919 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.501 ' CG1' HD13 ' C' ' 241' ' ' LEU . 2.2 mp -108.05 104.32 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 74.52 111.145 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.79 -141.49 8.88 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.748 -0.739 . . . . 71.42 112.472 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -127.99 156.1 43.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.776 0.322 . . . . 63.43 110.908 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -122.57 126.31 47.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 73.32 110.961 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.559 ' OH ' HG22 ' B' ' 219' ' ' ILE . 0.4 OUTLIER -109.82 127.93 54.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 60.23 110.952 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.615 ' HA3' HG22 ' B' ' 246' ' ' THR . . . 104.84 155.36 22.88 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.752 -0.737 . . . . 72.22 112.519 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . 0.691 ' H ' ' HB2' ' C' ' 247' ' ' ALA . . . -114.03 132.88 10.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.709 -0.758 . . . . 60.12 112.501 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -175.02 44.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.359 . . . . 73.51 110.875 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.04 26.87 27.62 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.72 -0.752 . . . . 62.32 112.523 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 62.34 165.26 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.872 0.368 . . . . 73.44 110.855 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 38.6 p-90 -52.0 -32.56 34.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 75.43 110.924 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -75.95 149.01 37.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.844 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -89.89 -73.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 64.32 110.847 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -94.59 140.3 30.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.857 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -99.99 -68.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 54.03 110.872 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 51.84 87.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 75.35 110.789 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -102.3 -74.77 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 64.14 110.908 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -179.25 -169.93 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 53.2 110.879 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 75.51 110.879 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 2.5 tmm? . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.917 0.389 . . . . 74.33 110.849 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt 63.03 28.61 16.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 71.24 110.906 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 59.5 mt 61.35 80.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 75.22 111.137 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -159.76 89.33 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 74.34 110.843 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -172.56 -170.0 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 70.24 111.141 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 2.1 tt -100.42 -33.11 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 65.51 111.134 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 22.1 t 52.28 69.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 71.23 111.133 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 172.18 123.41 0.71 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.725 -0.75 . . . . 64.32 112.51 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -150.5 -74.61 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.347 . . . . 64.03 110.841 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.47 131.88 39.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 71.21 110.878 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.1 m -140.09 137.86 34.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 64.1 110.88 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.63 144.58 49.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 72.31 111.121 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -101.41 -25.78 13.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 70.24 110.935 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -164.86 138.58 4.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 74.33 110.811 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.562 ' CD1' HD21 ' C' ' 241' ' ' LEU . 10.8 mt -137.74 117.57 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 54.53 111.102 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -133.27 116.13 15.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 65.33 110.946 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.09 136.19 41.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.55 111.141 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -143.15 167.05 23.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.855 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 60.91 75.49 0.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 70.35 110.894 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 44.48 53.82 6.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 64.14 110.909 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.5 145.86 29.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 30.41 111.127 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.0 137.06 52.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 75.31 110.823 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.443 HG13 HG13 ' B' ' 275' ' ' VAL . 7.6 p -132.12 136.51 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 70.42 111.117 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.453 ' HB3' HD13 ' C' ' 276' ' ' LEU . 3.3 tp60 -132.42 135.49 46.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 73.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.562 HD21 ' CD1' ' C' ' 231' ' ' ILE . 1.3 mp -126.8 118.79 25.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.42 110.933 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.8 -169.58 18.71 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 53.3 112.545 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -99.0 143.06 29.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 74.42 110.876 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 19.0 m -120.81 139.27 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 62.23 111.156 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.511 ' CG1' ' HB3' ' C' ' 249' ' ' ALA . 38.6 t -121.93 120.67 62.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 55.13 111.146 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . 0.609 HG23 ' O ' ' C' ' 281' ' ' TYR . 24.9 p -73.68 173.79 9.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 73.42 111.121 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.691 ' HB2' ' H ' ' B' ' 283' ' ' GLY . . . -63.16 -37.63 87.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 72.02 111.107 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.07 66.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 71.02 111.163 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . 0.511 ' HB3' ' CG1' ' C' ' 245' ' ' VAL . . . -56.62 -24.95 51.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 61.13 111.164 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . 0.484 HD11 ' CD2' ' B' ' 281' ' ' TYR . 0.1 OUTLIER -62.21 -42.14 99.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 73.32 110.929 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.19 138.99 33.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 65.11 110.793 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 129.04 -158.7 22.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.744 -0.741 . . . . 72.22 112.528 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -129.71 -119.49 2.15 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 63.34 112.52 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 15.2 mt 70.68 -70.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 72.33 111.148 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . 0.57 ' CG ' HD11 ' B' ' 256' ' ' ILE . 11.2 ttm180 63.17 104.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.835 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . 0.7 HD11 ' HB3' ' D' ' 255' ' ' ARG . 18.5 tt -124.17 150.84 28.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 60.33 111.069 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.07 -39.44 11.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 71.44 110.825 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.86 170.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 75.13 110.87 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -176.46 36.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 65.02 110.881 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 14.7 t -80.64 136.94 36.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 74.1 111.166 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.16 117.56 28.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 73.21 111.109 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.55 134.22 50.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.54 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 2.8 t -135.66 123.49 22.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 73.34 110.931 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.606 HG21 ' CG2' ' C' ' 267' ' ' VAL . 11.8 p -115.49 130.12 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 73.2 111.098 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -64.9 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 75.22 110.945 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 89.3 m -149.9 135.33 18.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 22.44 111.16 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.719 ' CG1' HG21 ' C' ' 275' ' ' VAL . 98.7 t -117.96 124.85 73.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 53.12 111.171 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.34 128.2 69.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 62.22 111.127 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -129.14 132.95 7.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.768 -0.729 . . . . 72.24 112.509 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -132.95 139.67 47.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.827 0.346 . . . . 70.43 110.873 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.08 73.52 0.37 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.75 -0.738 . . . . 74.12 112.495 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 63.35 100.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.852 0.358 . . . . 73.53 110.937 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 14.4 m -138.62 145.35 40.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 50.5 110.895 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -129.91 127.68 40.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 64.31 110.917 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.719 HG21 ' CG1' ' C' ' 267' ' ' VAL . 31.5 t -131.38 124.89 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 61.21 111.109 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.453 HD13 ' HB3' ' C' ' 240' ' ' GLN . 0.8 OUTLIER -124.59 111.47 15.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.23 -0.441 . . . . 70.22 110.969 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.713 HG13 HD23 ' D' ' 241' ' ' LEU . 2.6 mp -104.94 133.64 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 74.01 111.161 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 117.11 -146.67 18.85 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.761 -0.733 . . . . 72.51 112.452 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -128.11 146.27 50.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.811 0.338 . . . . 74.43 110.878 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -113.42 123.66 50.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 71.15 110.903 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.713 ' HH ' ' N ' ' B' ' 217' ' ' MET . 0.3 OUTLIER -103.95 125.65 50.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 65.53 110.913 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 111.62 -54.73 0.53 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.715 -0.755 . . . . 70.3 112.51 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 63.88 -116.66 9.46 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.711 -0.757 . . . . 60.23 112.493 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? 63.41 105.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.343 . . . . 64.51 110.896 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 62.39 60.39 7.95 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.745 -0.74 . . . . 70.23 112.477 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 51.74 -168.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.783 0.325 . . . . 74.53 110.909 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 31.8 m0 -50.69 -55.37 16.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.185 -0.461 . . . . 73.04 110.915 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -116.56 131.49 56.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 53.22 110.828 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -51.82 120.47 5.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 65.11 110.9 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -173.26 171.27 4.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 63.1 110.858 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -128.93 135.11 48.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 55.23 110.836 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -169.6 129.55 1.02 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 74.13 110.891 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -177.82 149.18 0.58 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 72.42 110.885 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -178.93 -170.76 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 74.11 110.894 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 64.04 110.879 179.93 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.857 0.36 . . . . 63.11 110.894 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . 0.411 ' O ' ' CG1' ' D' ' 219' ' ' ILE . 0.5 OUTLIER -179.23 -45.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 63.2 110.903 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . 0.411 ' CG1' ' O ' ' D' ' 218' ' ' LYS . 22.3 pt 43.38 -164.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 73.34 111.085 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.0 -72.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 75.4 110.869 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -153.73 122.32 6.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 71.51 111.068 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . 0.537 HD13 ' H ' ' D' ' 222' ' ' ILE . 0.1 OUTLIER -143.39 179.12 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 75.53 111.16 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 62.2 t -115.67 -71.25 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 73.42 111.13 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -91.14 153.51 22.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 64.21 112.512 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.71 ' O ' HG23 ' D' ' 261' ' ' THR . 0.1 OUTLIER -179.41 133.48 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 74.12 110.839 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -83.53 140.63 32.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 64.32 110.893 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 1.4 p -139.95 139.0 36.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 62.13 110.871 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.63 159.77 29.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 62.4 111.087 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . 0.419 ' HB2' ' HA ' ' D' ' 265' ' ' GLU . 0.3 OUTLIER -112.32 -29.61 7.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 64.35 110.9 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . 0.498 ' HB3' HG23 ' D' ' 266' ' ' THR . 5.1 t0 -166.48 137.99 3.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 64.05 110.875 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . 0.415 ' CD1' HG23 ' C' ' 264' ' ' VAL . 13.8 mt -137.42 117.53 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 74.12 111.204 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -134.69 120.39 19.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.947 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.18 150.45 50.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 64.31 111.175 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' D' ' 237' ' ' ALA . 9.7 pm0 -157.15 167.29 30.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 64.41 110.917 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 61.22 72.21 0.53 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 75.23 110.885 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 45.28 40.86 5.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 74.3 110.881 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' D' ' 234' ' ' GLU . . . -88.52 144.16 26.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 73.41 111.146 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -125.63 135.83 52.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 72.1 110.89 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.42 139.59 35.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 73.4 111.14 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . 0.634 ' HB3' HD13 ' D' ' 276' ' ' LEU . 2.7 tt0 -131.0 137.28 49.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 64.03 110.942 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 1.029 HD12 HD12 ' D' ' 277' ' ' ILE . 0.6 OUTLIER -118.3 118.72 32.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 64.32 110.874 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 119.79 175.45 15.78 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.759 -0.734 . . . . 74.42 112.549 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -86.02 150.06 24.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.937 0.399 . . . . 74.14 110.822 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . 0.467 HG23 ' HA ' ' D' ' 280' ' ' GLU . 16.9 m -123.87 138.32 53.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 63.32 111.193 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.14 128.94 75.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 62.13 111.094 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 12.3 t -74.0 175.25 7.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 63.51 111.081 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.84 -44.4 77.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 73.32 111.071 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . 0.876 ' HB1' HD12 ' D' ' 250' ' ' LEU . . . -57.45 -52.03 67.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.422 . . . . 73.32 111.122 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.72 30.04 6.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 74.02 111.095 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . 0.876 HD12 ' HB1' ' D' ' 248' ' ' ALA . 0.2 OUTLIER -62.67 148.25 47.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 63.15 110.93 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -179.09 155.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 71.13 110.866 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . 0.708 ' HA3' HD11 ' E' ' 250' ' ' LEU . . . -52.53 -27.66 26.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 32.01 112.492 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -170.63 175.12 44.55 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.696 -0.764 . . . . 53.52 112.486 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 4.6 pt -51.73 167.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 72.23 111.16 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . 0.7 ' HB3' HD11 ' C' ' 256' ' ' ILE . 0.0 OUTLIER -52.3 153.65 2.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 63.24 110.843 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . 0.677 HD12 HD11 ' E' ' 256' ' ' ILE . 23.8 mm -114.41 61.41 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 61.41 111.095 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 14.4 m 51.65 40.18 26.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 55.03 110.827 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 72.44 -69.33 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 73.35 110.809 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 72.21 -68.68 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 70.24 110.958 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 3.3 t -64.83 137.49 57.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 63.02 111.181 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . 0.71 HG23 ' O ' ' D' ' 225' ' ' ARG . 94.0 m -132.57 134.74 45.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 60.34 111.127 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . 0.479 ' HB3' HG22 ' D' ' 277' ' ' ILE . 0.4 OUTLIER -119.04 121.48 39.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 70.22 110.873 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.57 123.99 42.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 75.05 110.795 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.645 HG23 ' CD1' ' E' ' 231' ' ' ILE . 8.6 p -120.05 146.49 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 71.12 111.163 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . 0.419 ' HA ' ' HB2' ' D' ' 229' ' ' LYS . 15.1 mt-10 -88.76 -73.79 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 72.14 110.876 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . 0.498 HG23 ' HB3' ' D' ' 230' ' ' ASP . 73.2 m -139.85 129.88 24.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 52.31 111.142 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.713 ' CG1' HG21 ' D' ' 275' ' ' VAL . 16.9 t -117.31 120.59 65.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 72.43 111.134 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.59 124.13 72.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 53.51 111.176 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.51 132.21 9.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 71.31 112.512 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -134.04 140.24 46.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 75.54 110.911 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 46.7 87.17 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 73.24 112.494 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 50.04 75.74 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.914 0.388 . . . . 71.41 110.93 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 35.9 t -107.1 145.45 32.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.07 -0.514 . . . . 60.34 110.844 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -132.67 127.64 35.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 74.42 110.903 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.713 HG21 ' CG1' ' D' ' 267' ' ' VAL . 61.6 t -136.81 124.1 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 63.14 111.119 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.634 HD13 ' HB3' ' D' ' 240' ' ' GLN . 3.6 mm? -121.45 111.61 17.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 70.5 110.917 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 1.029 HD12 HD12 ' D' ' 241' ' ' LEU . 22.4 mt -103.99 114.38 43.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 65.13 111.145 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 132.6 -162.12 24.07 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.663 -0.78 . . . . 42.45 112.469 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -116.47 145.58 43.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.786 0.327 . . . . 72.02 110.932 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . 0.467 ' HA ' HG23 ' D' ' 244' ' ' VAL . 35.8 tt0 -111.89 132.37 54.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 70.42 110.907 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -110.02 125.38 52.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 75.31 110.918 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 132.06 177.99 15.24 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.725 . . . . 63.21 112.516 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -138.21 111.3 0.8 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.722 -0.751 . . . . 33.24 112.459 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -156.78 22.74 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.339 . . . . 73.13 110.874 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 67.49 121.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.824 -0.703 . . . . 72.52 112.488 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 51.77 -169.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.873 0.368 . . . . 74.41 110.841 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -76.34 -25.56 54.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.108 -0.496 . . . . 62.54 110.916 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -119.06 155.3 31.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 63.02 110.85 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -52.08 -32.25 34.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 73.42 110.835 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.92 132.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 75.43 110.836 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -167.12 138.44 3.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 54.4 110.806 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 56.51 -177.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 51.11 110.788 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -131.81 -169.99 2.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.821 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 10.3 m170 62.82 171.79 0.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.811 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 71.12 110.793 -179.98 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 1.3 ptp . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.878 0.37 . . . . 74.22 110.842 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.58 143.29 45.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 60.44 110.948 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 1.1 pp -149.83 151.32 12.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 70.32 111.137 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.44 -171.84 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 73.42 110.831 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . 0.468 ' O ' HD13 ' E' ' 222' ' ' ILE . . . -143.64 156.72 44.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.41 111.104 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . 0.468 HD13 ' O ' ' E' ' 221' ' ' ALA . 45.9 mm -138.02 143.37 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 74.43 111.081 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 91.6 t -146.4 99.98 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 75.22 111.099 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . 71.78 -128.48 14.87 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.818 -0.706 . . . . 73.44 112.518 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 58.85 -170.15 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.35 . . . . 63.43 110.914 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -83.93 112.51 20.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 72.24 110.8 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 6.3 p -129.34 158.96 37.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 70.43 110.878 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . 0.48 ' HB2' HD22 ' E' ' 241' ' ' LEU . . . -131.69 164.73 25.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 75.31 111.113 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.42 -39.32 4.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 70.01 110.921 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . 0.649 ' HB2' HG22 ' E' ' 266' ' ' THR . 0.3 OUTLIER -166.79 141.43 4.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 44.43 110.901 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . 0.645 ' CD1' HG23 ' D' ' 264' ' ' VAL . 3.4 mp -137.22 116.26 15.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 71.43 111.135 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -131.24 118.83 20.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 72.23 110.889 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . 0.411 ' HB ' ' HB1' ' E' ' 237' ' ' ALA . 0.0 OUTLIER -135.99 128.96 31.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 71.34 111.125 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -140.49 158.32 44.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 74.43 110.944 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 63.08 79.31 0.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 75.31 110.918 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.2 50.04 9.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 75.22 110.899 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . 0.411 ' HB1' ' HB ' ' E' ' 233' ' ' THR . . . -104.71 141.55 36.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 74.13 111.094 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -126.39 139.6 53.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 75.41 110.868 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.712 HG23 ' HB ' ' E' ' 275' ' ' VAL . 8.9 p -143.71 141.48 25.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 71.42 111.124 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . 0.579 ' HB3' HD13 ' E' ' 276' ' ' LEU . 2.5 tt0 -138.33 137.16 37.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 74.02 110.892 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.632 HD23 HG11 ' E' ' 264' ' ' VAL . 1.8 mp -120.43 118.61 30.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.226 -0.443 . . . . 62.53 110.89 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 124.43 168.28 12.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 33.0 112.472 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -86.84 163.14 17.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.907 0.385 . . . . 75.22 110.881 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.16 139.39 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 71.41 111.117 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 60.2 t -115.63 127.95 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 52.1 111.08 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.6 t -70.03 171.18 9.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 53.22 111.179 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.12 -38.72 92.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 53.44 111.168 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.94 -36.05 69.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 72.53 111.093 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 60.55 -179.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 53.54 111.019 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . 0.708 HD11 ' HA3' ' D' ' 252' ' ' GLY . 0.4 OUTLIER -52.87 170.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 73.04 110.922 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -51.91 -68.89 0.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 64.4 110.896 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . -172.98 162.89 34.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.796 -0.716 . . . . 75.45 112.489 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . 75.46 157.61 6.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.769 -0.729 . . . . 75.34 112.455 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . 0.573 HG22 HG13 ' E' ' 256' ' ' ILE . 66.2 mt -64.8 125.25 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.796 0.331 . . . . 72.44 111.123 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.88 112.46 25.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 70.24 110.858 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . 0.677 HD11 HD12 ' D' ' 256' ' ' ILE . 44.5 mt -146.59 97.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 75.34 111.107 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -178.57 139.5 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 71.42 110.83 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 64.11 157.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 73.54 110.881 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -149.86 128.26 12.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 74.35 110.884 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 8.8 t -101.39 129.15 47.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.435 . . . . 65.52 111.2 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 60.6 m -105.39 128.44 53.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 73.25 111.088 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -125.98 131.22 52.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 70.44 110.922 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 23.1 t -128.51 121.02 27.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 72.23 110.906 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . 0.632 HG11 HD23 ' E' ' 241' ' ' LEU . 8.8 p -104.37 123.09 58.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 72.23 111.127 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' E' ' 265' ' ' GLU . 0.0 OUTLIER -65.59 -143.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 70.34 110.828 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . 0.649 HG22 ' HB2' ' E' ' 230' ' ' ASP . 14.8 p -92.46 130.02 38.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 74.43 111.126 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . 1.028 HG11 HG21 ' E' ' 275' ' ' VAL . 19.5 t -114.84 131.15 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 70.43 111.075 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 52.4 t -122.73 116.76 49.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.135 -0.484 . . . . 73.34 111.112 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -108.06 132.68 11.25 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.808 -0.71 . . . . 73.11 112.512 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 10.6 tptt -132.3 115.46 15.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.84 0.352 . . . . 62.34 110.903 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.08 94.12 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.734 -0.746 . . . . 61.41 112.452 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 52.02 87.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.895 0.378 . . . . 61.02 110.909 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 33.3 t -125.66 145.85 49.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 64.31 110.877 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -136.63 128.16 28.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 60.33 110.906 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 1.028 HG21 HG11 ' E' ' 267' ' ' VAL . 96.8 t -136.62 125.34 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 74.0 111.099 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' E' ' 240' ' ' GLN . 3.7 mm? -123.36 116.11 22.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.98 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.497 HD12 ' O ' ' E' ' 240' ' ' GLN . 2.0 mp -109.01 140.8 26.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.43 111.168 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 112.58 -158.06 14.54 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.792 -0.718 . . . . 71.13 112.495 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -128.19 156.54 42.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.352 . . . . 73.41 110.904 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -111.69 121.81 46.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 73.21 110.882 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -106.23 125.94 51.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.116 -0.493 . . . . 73.5 110.946 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 134.57 172.21 12.74 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.67 -0.776 . . . . 74.3 112.501 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -74.4 -164.37 11.07 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.771 -0.728 . . . . 65.05 112.519 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.07 -75.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 62.21 110.862 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 100.6 174.78 29.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.707 -0.759 . . . . 74.42 112.539 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 1.5 t80 63.95 158.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 73.33 110.816 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -81.54 57.06 3.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 74.31 110.894 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -179.11 -171.86 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 71.11 110.858 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -109.7 -170.14 1.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 75.54 110.847 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -51.96 112.97 0.87 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 64.15 110.917 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.48 -170.59 3.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 63.32 110.864 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -60.54 -175.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 72.24 110.854 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -55.34 128.49 34.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 54.23 110.803 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -176.36 123.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 74.41 110.898 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 73.0 110.863 179.984 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.853 0.359 . . . . 54.23 110.903 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -178.5 -35.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 71.13 110.923 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.7 tt -152.17 150.37 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 65.33 111.144 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 1.3 t0 63.29 161.81 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 75.03 110.857 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.432 ' O ' HD13 ' A' ' 222' ' ' ILE . . . -79.52 133.52 36.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 63.34 111.129 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.432 HD13 ' O ' ' A' ' 221' ' ' ALA . 24.8 mm -120.96 151.1 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 60.55 111.144 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 4.9 m -149.74 173.88 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 73.11 111.161 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 133.47 89.73 0.39 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.781 -0.723 . . . . 62.4 112.489 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -69.17 85.33 0.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.846 0.355 . . . . 55.43 110.863 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.498 ' HB3' HG22 ' A' ' 277' ' ' ILE . 0.0 OUTLIER -142.24 136.44 29.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 65.01 110.924 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.46 137.09 54.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 72.0 110.901 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.28 131.07 41.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 52.44 111.099 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.81 -28.35 13.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.21 110.867 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.552 ' HB3' HG23 ' A' ' 266' ' ' THR . 1.8 m-20 -166.01 137.3 3.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 74.45 110.899 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 11.1 mt -137.97 117.81 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 62.43 111.139 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -127.67 123.14 34.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.499 . . . . 70.44 110.846 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.632 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.5 OUTLIER -135.56 162.28 33.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 72.13 111.091 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -153.66 167.96 27.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 75.53 110.873 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.66 -69.83 0.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 75.45 110.858 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -178.68 37.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 62.42 110.873 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.632 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -70.52 152.17 44.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 74.14 111.087 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.38 135.64 51.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 45.01 110.868 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.634 HG12 ' HB ' ' A' ' 275' ' ' VAL . 18.7 m -129.45 121.52 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 75.45 111.144 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -119.56 134.15 55.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 75.42 110.884 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 241' ' ' LEU . 6.0 mp -125.65 118.83 26.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 74.44 110.9 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 135.35 -170.88 22.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.73 . . . . 64.3 112.474 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.88 128.82 34.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 63.22 110.859 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.538 HG11 HD11 ' A' ' 276' ' ' LEU . 1.6 p -123.61 121.98 63.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 73.45 111.134 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.423 ' CG2' ' HB3' ' A' ' 249' ' ' ALA . 6.8 p -119.23 129.04 75.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 70.2 111.107 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 14.2 t -87.03 162.89 17.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 72.12 111.205 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.14 -34.0 67.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 74.2 111.08 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.94 -36.27 70.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.3 -0.409 . . . . 65.23 111.089 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.739 ' HB2' ' HA3' ' A' ' 282' ' ' GLY . . . -61.8 96.62 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 64.14 111.101 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.79 97.24 0.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 72.43 110.915 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 59.76 73.35 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 74.23 110.787 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -77.02 88.15 0.98 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.799 -0.715 . . . . 74.34 112.463 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.51 37.68 3.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.731 -0.747 . . . . 61.31 112.443 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.1 mp 52.06 68.83 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.846 0.355 . . . . 65.23 111.166 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -91.34 66.06 5.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 73.23 110.843 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 12.4 tt -172.47 -37.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 74.34 111.131 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.07 89.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 75.41 110.855 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.46 -32.13 7.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 72.41 110.86 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 56.76 57.54 4.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 72.42 110.923 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 20.7 p -99.14 138.07 36.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 53.12 111.121 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 95.4 m -107.13 132.59 52.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 72.1 111.151 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.11 119.93 36.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 64.4 110.902 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.1 p -130.09 123.43 30.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 72.34 110.853 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.617 ' HA ' ' HB3' ' B' ' 228' ' ' ALA . 11.5 p -109.3 134.43 51.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 74.23 111.19 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -74.28 -78.17 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 62.31 110.886 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.552 HG23 ' HB3' ' A' ' 230' ' ' ASP . 36.8 m -136.7 132.18 34.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.33 111.128 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 1.061 HG11 HG21 ' A' ' 275' ' ' VAL . 33.3 t -118.42 120.9 65.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.23 -0.441 . . . . 63.21 111.143 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.22 119.46 60.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 74.21 111.153 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.8 133.52 10.91 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.752 -0.737 . . . . 64.41 112.514 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -116.06 116.28 27.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 73.41 110.989 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 58.83 83.25 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.757 -0.735 . . . . 65.32 112.537 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 67.08 120.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 74.44 110.898 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 3.5 t -156.32 145.27 20.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 64.22 110.831 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.73 126.65 46.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 62.31 110.876 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 1.061 HG21 HG11 ' A' ' 267' ' ' VAL . 98.5 t -137.54 123.75 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 64.35 111.079 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.538 HD11 HG11 ' A' ' 244' ' ' VAL . 1.0 OUTLIER -122.8 120.15 32.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 75.23 110.901 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.739 ' CD1' HD13 ' B' ' 241' ' ' LEU . 24.9 mm -112.32 103.74 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 72.35 111.144 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.9 -154.95 25.89 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.772 -0.728 . . . . 41.12 112.512 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -111.06 151.88 27.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.732 0.301 . . . . 73.13 110.901 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.744 ' HG2' HG22 ' B' ' 244' ' ' VAL . 0.0 OUTLIER -128.1 134.86 49.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 72.34 110.831 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.471 ' HA ' HG13 ' B' ' 245' ' ' VAL . 0.4 OUTLIER -122.22 134.61 54.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 73.33 110.941 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.739 ' HA3' ' HB2' ' A' ' 249' ' ' ALA . . . 82.21 164.03 33.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 40.34 112.441 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 141.26 136.54 3.3 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.788 -0.72 . . . . 61.22 112.522 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -51.79 -45.87 63.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.861 0.362 . . . . 61.22 110.889 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -132.48 -43.24 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.777 -0.725 . . . . 64.51 112.517 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -174.3 -165.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 73.53 110.837 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.47 ' NE1' HD12 ' A' ' 276' ' ' LEU . 15.8 t90 -46.29 -74.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.503 . . . . 74.32 110.915 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.42 66.05 2.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 71.22 110.898 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -51.62 110.01 0.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 74.25 110.941 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -142.07 -48.94 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 74.32 110.859 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 62.93 104.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.834 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.99 149.48 32.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 52.44 110.847 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -165.01 173.71 11.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 62.34 110.832 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.16 -173.92 0.3 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.254 -0.43 . . . . 74.23 110.784 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 71.55 110.843 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . 0.584 ' CE ' HG22 ' C' ' 254' ' ' ILE . 1.5 ptt? . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.877 0.37 . . . . 74.22 110.851 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.634 ' O ' HD13 ' B' ' 219' ' ' ILE . 3.1 mttt -175.82 153.14 1.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 75.3 110.911 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . 0.634 HD13 ' O ' ' B' ' 218' ' ' LYS . 24.9 mm -135.43 150.14 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 72.12 111.162 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.37 -58.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.04 110.861 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.34 -176.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 32.51 111.121 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 10.0 pt -51.8 168.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 73.32 111.075 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.812 HG12 ' HB3' ' B' ' 259' ' ' GLN . 5.4 m -138.57 106.34 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 64.31 111.088 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 68.13 128.0 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.694 -0.765 . . . . 65.55 112.572 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -155.93 87.6 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.908 0.385 . . . . 74.23 110.852 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.07 109.95 18.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 74.2 110.808 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.31 137.77 54.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 74.32 110.892 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 264' ' ' VAL . . . -124.71 150.05 46.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 73.14 111.026 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -113.94 -32.78 5.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 62.11 110.977 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . 0.575 ' HB3' HG23 ' B' ' 266' ' ' THR . 0.4 OUTLIER -165.43 137.82 4.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 63.23 110.873 179.834 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 7.7 mt -138.15 117.38 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 65.14 111.167 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -129.52 124.45 33.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 64.34 110.849 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.624 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 0.1 OUTLIER -135.32 163.58 29.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 74.3 111.157 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -148.94 167.99 24.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 75.44 110.948 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.58 -72.19 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 72.55 110.9 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.99 40.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 75.01 110.84 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -69.9 156.71 38.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.446 . . . . 62.25 111.058 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.41 135.12 52.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 74.3 110.871 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.652 ' CG2' HG22 ' A' ' 275' ' ' VAL . 30.0 m -131.81 133.09 61.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 70.15 111.146 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.442 ' C ' HD12 ' B' ' 241' ' ' LEU . 1.9 tt0 -127.95 137.03 52.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 70.43 110.883 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.739 HD13 ' CD1' ' A' ' 277' ' ' ILE . 6.5 mp -125.85 118.28 25.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 74.1 110.905 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.62 -168.14 23.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.802 -0.713 . . . . 73.41 112.512 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -85.86 142.48 28.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.357 . . . . 73.04 110.926 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.744 HG22 ' HG2' ' A' ' 280' ' ' GLU . 2.9 t -125.68 120.58 57.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 52.52 111.171 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.471 HG13 ' HA ' ' A' ' 281' ' ' TYR . 5.5 p -122.08 120.19 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 63.24 111.147 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 11.0 t -74.1 165.67 24.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 71.24 111.142 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.92 76.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 42.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.33 74.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 43.44 111.064 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -54.06 -28.28 37.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 63.23 111.075 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 1.4 tt -88.16 132.13 34.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 72.41 110.927 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -176.77 -35.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 75.33 110.898 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 113.0 131.68 5.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.762 -0.732 . . . . 62.43 112.483 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 167.06 -26.56 0.15 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.744 -0.741 . . . . 52.33 112.51 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 37.4 mt 63.49 86.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 72.0 111.123 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -178.38 110.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 73.45 110.918 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 pp -150.18 174.11 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 64.25 111.097 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -178.92 131.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 62.03 110.908 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -178.88 142.42 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 72.04 110.85 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . 0.812 ' HB3' HG12 ' B' ' 223' ' ' VAL . 1.9 pt20 -174.11 40.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 60.4 110.958 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.715 HG23 ' HB3' ' C' ' 225' ' ' ARG . 27.6 m -100.96 126.86 47.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 73.23 111.176 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 4.4 t -92.65 133.48 35.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 72.51 111.151 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.547 HD22 HG22 ' B' ' 277' ' ' ILE . 0.4 OUTLIER -126.56 129.77 49.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 64.32 110.887 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 12.9 t -132.98 123.58 26.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 64.02 110.77 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.772 ' HA ' ' HB3' ' C' ' 228' ' ' ALA . 10.3 p -105.86 135.21 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 74.53 111.211 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -77.71 -77.41 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 71.24 110.863 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.575 HG23 ' HB3' ' B' ' 230' ' ' ASP . 18.5 m -134.7 132.26 38.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.44 111.207 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.902 HG11 HG21 ' B' ' 275' ' ' VAL . 23.9 t -118.0 120.84 65.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 54.4 111.169 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.54 120.37 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 75.32 111.117 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.63 133.2 11.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.692 -0.766 . . . . 70.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -116.92 116.5 27.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.809 0.338 . . . . 74.43 110.94 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.96 83.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 55.53 112.505 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 66.5 119.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.826 0.346 . . . . 75.24 110.883 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 22.9 t -156.27 146.77 21.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 73.01 110.847 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -124.24 127.03 47.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 73.22 110.803 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.902 HG21 HG11 ' B' ' 267' ' ' VAL . 87.8 t -137.6 123.15 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 75.21 111.059 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.55 HD12 ' CZ2' ' B' ' 287' ' ' TRP . 0.2 OUTLIER -120.97 122.41 40.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 75.14 110.887 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.547 HG22 HD22 ' B' ' 262' ' ' ASN . 27.4 mm -112.55 103.68 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 62.13 111.137 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 152.05 -139.96 7.42 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.758 -0.734 . . . . 74.33 112.53 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . 0.467 ' ND2' ' H ' ' C' ' 243' ' ' ASN . 9.8 m120 -128.31 145.56 51.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 71.43 110.876 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.737 ' CG ' HG13 ' C' ' 244' ' ' VAL . 0.4 OUTLIER -117.03 135.91 53.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 70.15 110.837 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.412 ' HA ' HG13 ' C' ' 245' ' ' VAL . 0.3 OUTLIER -120.64 125.7 48.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 75.22 110.933 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 65.57 174.14 4.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 74.11 112.497 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 137.59 -6.94 3.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 71.01 112.521 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.37 70.93 0.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.367 . . . . 74.13 110.883 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 127.27 -109.33 1.06 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 53.44 112.507 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -121.58 -75.1 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.792 0.33 . . . . 52.41 110.883 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.55 ' CZ2' HD12 ' B' ' 276' ' ' LEU . 0.1 OUTLIER -96.06 -64.85 1.01 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 62.31 110.896 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -122.53 -41.95 2.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 73.1 110.871 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -177.82 -67.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 75.02 110.886 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 16.0 t60 61.78 85.19 0.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 64.21 110.848 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.82 -178.07 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 75.34 110.89 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -164.38 -178.79 5.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 52.54 110.803 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -155.03 160.78 41.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 63.24 110.817 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.83 -175.2 2.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 64.33 110.809 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 5.3 t60 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 74.21 110.857 -179.975 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 12.5 ttt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.781 0.324 . . . . 70.31 110.826 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -90.54 109.18 20.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 71.51 110.875 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 2.2 mp -105.66 118.65 53.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 54.42 111.054 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.67 -173.81 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 71.4 110.859 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -83.2 136.09 34.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 74.01 111.067 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 62.3 mt -82.57 121.53 35.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 72.22 111.091 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 33.4 m -74.18 -32.26 31.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 53.35 111.152 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 94.36 116.02 2.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.734 . . . . 65.44 112.442 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.715 ' HB3' HG23 ' B' ' 260' ' ' THR . 4.3 mmt85 -137.19 -42.07 0.57 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.764 0.316 . . . . 72.1 110.878 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.465 HD21 HD12 ' C' ' 241' ' ' LEU . 3.3 t-20 -140.08 119.58 13.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 74.43 110.898 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 58.8 m -129.87 141.79 50.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 54.45 110.911 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.772 ' HB3' ' HA ' ' B' ' 264' ' ' VAL . . . -124.95 146.54 49.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 64.24 111.108 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.72 ' HE3' HG21 ' D' ' 222' ' ' ILE . 0.1 OUTLIER -110.26 -37.86 5.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 75.45 110.899 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . 0.674 ' HB3' HG22 ' C' ' 266' ' ' THR . 4.5 t0 -165.24 137.29 4.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 71.23 110.845 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.97 117.45 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.455 . . . . 73.04 111.189 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -130.73 126.1 35.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 63.23 110.855 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.671 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 0.1 OUTLIER -135.22 164.02 28.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 70.34 111.156 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -144.61 168.6 19.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 73.4 110.828 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.54 -74.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 75.51 110.871 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.27 38.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 74.35 110.824 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.671 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -69.64 157.09 37.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.301 -0.409 . . . . 72.44 111.116 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.76 134.55 52.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 72.3 110.852 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.659 ' CG2' HG22 ' B' ' 275' ' ' VAL . 18.2 m -127.25 122.09 59.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 55.31 111.091 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.94 123.61 49.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 75.5 110.921 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.465 HD12 HD21 ' C' ' 226' ' ' ASN . 4.2 mm? -111.66 119.14 37.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 40.22 110.919 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 122.2 -168.14 14.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.773 -0.727 . . . . 24.43 112.522 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.467 ' H ' ' ND2' ' B' ' 279' ' ' ASN . 2.7 t30 -86.14 149.71 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 60.21 110.94 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.737 HG13 ' CG ' ' B' ' 280' ' ' GLU . 78.9 t -126.35 122.19 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 72.3 111.126 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.412 HG13 ' HA ' ' B' ' 281' ' ' TYR . 7.2 p -116.63 129.27 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 74.43 111.099 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 12.8 p -78.68 165.07 24.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.491 . . . . 72.3 111.103 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.21 -34.0 76.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 73.53 111.071 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.81 -40.4 75.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 63.12 111.062 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -51.74 104.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 53.11 111.166 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -178.75 -69.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 43.22 110.883 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.03 -175.52 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 53.34 110.836 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 70.16 53.68 13.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.783 -0.722 . . . . 71.24 112.462 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 142.9 -52.4 0.64 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.685 -0.769 . . . . 64.11 112.466 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . 0.584 HG22 ' CE ' ' B' ' 217' ' ' MET . 32.8 mt 55.55 75.73 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.369 . . . . 75.31 111.146 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -167.5 98.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 73.41 110.936 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.59 135.53 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 73.22 111.159 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 1.6 t -177.66 158.67 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 74.44 110.838 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.4 145.06 1.6 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 75.51 110.846 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -146.91 29.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 61.11 110.908 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.26 137.55 32.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 73.23 111.148 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 96.1 m -105.41 131.38 52.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 75.52 111.178 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.05 136.99 53.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 64.33 110.831 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 46.5 t -142.11 123.8 15.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 70.42 110.911 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.492 ' HA ' ' HB3' ' D' ' 228' ' ' ALA . 9.0 p -106.15 138.28 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 74.32 111.139 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' C' ' 229' ' ' LYS . 2.9 tt0 -78.49 -76.63 0.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 74.54 110.927 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . 0.674 HG22 ' HB3' ' C' ' 230' ' ' ASP . 40.9 p -134.95 132.25 38.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.093 -0.503 . . . . 73.15 111.111 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.731 HG11 HG21 ' C' ' 275' ' ' VAL . 97.6 t -117.44 120.68 65.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 70.14 111.171 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.95 119.65 61.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 74.01 111.141 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.52 133.27 11.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.682 -0.77 . . . . 61.52 112.513 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -115.66 116.39 28.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.791 0.329 . . . . 73.43 110.919 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.49 86.52 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.731 -0.747 . . . . 35.42 112.493 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.68 118.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 74.32 110.91 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 37.4 t -157.22 149.1 22.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 70.25 110.818 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 -126.58 127.02 44.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 74.5 110.897 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.731 HG21 HG11 ' C' ' 267' ' ' VAL . 98.7 t -138.2 123.85 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 44.41 111.146 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.636 HD12 ' HE1' ' C' ' 287' ' ' TRP . 0.9 OUTLIER -125.98 122.51 36.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 73.43 110.942 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.468 ' N ' HD23 ' C' ' 276' ' ' LEU . 13.7 mm -112.4 104.18 16.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.262 -0.426 . . . . 72.02 111.077 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.02 -178.38 26.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.682 -0.77 . . . . 65.23 112.483 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -89.63 145.02 25.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.783 0.325 . . . . 73.34 110.889 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.637 ' CG ' HG22 ' D' ' 244' ' ' VAL . 5.5 pt-20 -120.43 125.79 48.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 51.5 110.896 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.471 ' HA ' HG13 ' D' ' 245' ' ' VAL . 26.2 t80 -115.55 140.13 49.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 74.3 110.939 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.55 59.12 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.71 -0.757 . . . . 53.11 112.473 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -68.29 87.29 0.19 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.75 -0.738 . . . . 61.42 112.441 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -58.66 98.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 71.24 110.967 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 62.95 104.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 44.53 112.457 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.83 -166.45 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.799 0.333 . . . . 74.52 110.872 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.636 ' HE1' HD12 ' C' ' 276' ' ' LEU . 0.1 OUTLIER -50.62 -43.68 56.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 74.25 110.945 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -173.79 -170.03 0.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 43.52 110.824 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -144.73 -74.34 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 70.2 110.918 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.07 -171.51 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 71.25 110.899 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -98.29 -32.71 11.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 74.22 110.894 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.58 -177.36 4.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 70.24 110.808 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -157.53 132.7 8.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 74.14 110.848 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -166.76 113.07 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 75.44 110.865 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 72.54 110.838 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.808 0.337 . . . . 75.32 110.883 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.03 99.85 2.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.405 . . . . 64.53 110.921 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . . . . . . . . . 2.2 mp -115.4 142.91 26.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.296 -0.411 . . . . 74.43 111.161 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -173.44 142.75 1.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 63.2 110.811 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . 62.12 102.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 74.21 111.094 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . 0.72 HG21 ' HE3' ' C' ' 229' ' ' LYS . 4.2 mp -139.08 67.35 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 74.31 111.174 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 12.3 m -152.16 163.21 2.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.149 -0.478 . . . . 61.31 111.087 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 162.13 -179.34 37.52 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.7 -0.762 . . . . 62.34 112.507 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.555 ' HA ' HG23 ' D' ' 261' ' ' THR . 3.5 mmt85 -54.66 -64.31 0.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.785 0.326 . . . . 61.54 110.887 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.59 121.94 27.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 70.41 110.844 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.68 137.85 45.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 62.33 110.82 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' C' ' 264' ' ' VAL . . . -131.13 133.31 45.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.052 -0.522 . . . . 52.33 111.072 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -96.9 -30.97 12.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 75.15 110.872 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . 0.729 ' HB3' HG23 ' D' ' 266' ' ' THR . 3.6 t0 -166.35 137.08 3.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 73.13 110.865 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . . . . . . . . . 10.4 mt -139.48 117.07 11.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 63.5 111.081 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.4 126.38 38.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 70.53 110.885 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . 0.738 ' HB ' ' HB3' ' D' ' 237' ' ' ALA . 2.1 p -135.81 164.36 28.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 75.44 111.147 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -145.57 168.76 19.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 72.23 110.921 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 73.35 -75.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 71.33 110.912 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.73 47.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 71.54 110.881 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . 0.738 ' HB3' ' HB ' ' D' ' 233' ' ' THR . . . -77.32 156.82 31.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 70.43 111.105 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.05 134.46 52.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.883 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.773 HG12 ' HB ' ' D' ' 275' ' ' VAL . 6.2 m -126.87 121.45 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 72.23 111.194 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.92 127.88 55.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 62.22 110.898 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.8 HD13 ' HB ' ' D' ' 277' ' ' ILE . 3.1 mm? -116.0 117.89 31.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 55.32 110.932 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 129.98 -166.89 21.9 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 44.54 112.479 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -98.85 128.95 45.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 52.34 110.934 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . 0.637 HG22 ' CG ' ' C' ' 280' ' ' GLU . 95.5 t -102.8 124.97 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.14 111.152 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . 0.471 HG13 ' HA ' ' C' ' 281' ' ' TYR . 7.1 p -122.08 128.0 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 64.25 111.199 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -69.63 175.03 4.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.138 -0.483 . . . . 65.23 111.235 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.43 97.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 62.11 111.056 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.17 -40.09 76.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 61.33 111.088 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 56.64 -175.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 42.24 111.142 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.91 115.13 10.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 74.35 110.94 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -101.67 27.0 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.786 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . -112.4 -46.97 0.72 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.809 -0.71 . . . . 64.25 112.496 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -147.85 158.31 27.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 73.44 112.487 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 1.1 pt -92.24 148.42 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.84 0.352 . . . . 61.22 111.157 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.46 -170.3 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 73.41 110.836 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 29.7 mm 64.0 106.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 62.12 111.135 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.37 -170.54 1.66 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.103 -0.499 . . . . 54.21 110.878 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.85 178.96 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 75.44 110.791 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.92 25.36 0.49 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.138 -0.483 . . . . 74.12 110.834 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . 0.552 HG21 ' OD1' ' E' ' 243' ' ' ASN . 0.2 OUTLIER -100.18 129.52 46.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 71.24 111.138 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . 0.555 HG23 ' HA ' ' D' ' 225' ' ' ARG . 29.2 m -96.39 120.81 37.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 62.31 111.099 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . 0.739 ' OD1' HG22 ' D' ' 277' ' ' ILE . 0.5 OUTLIER -121.66 135.93 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 53.44 110.897 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . 0.526 ' OG ' HD11 ' E' ' 222' ' ' ILE . 3.8 m -142.16 124.92 15.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 64.03 110.798 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.612 ' HA ' ' HB3' ' E' ' 228' ' ' ALA . 7.2 p -104.95 122.04 57.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 75.15 111.125 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -56.38 -82.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.924 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . 0.729 HG23 ' HB3' ' D' ' 230' ' ' ASP . 10.7 m -128.4 137.45 51.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.163 -0.471 . . . . 31.44 111.157 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.757 HG11 HG21 ' D' ' 275' ' ' VAL . 64.4 t -118.21 120.68 65.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 72.35 111.154 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 15.0 t -117.45 116.89 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 62.45 111.121 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.24 133.03 11.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.716 -0.754 . . . . 42.32 112.456 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.36 119.28 35.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.828 0.347 . . . . 65.42 110.866 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.09 78.52 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 73.22 112.459 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 68.76 125.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 64.24 110.904 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 12.8 t -156.52 160.59 39.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 73.55 110.891 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.21 127.04 32.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 75.12 110.879 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.773 ' HB ' HG12 ' D' ' 239' ' ' VAL . 89.8 t -137.76 123.64 26.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 64.22 111.188 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.694 HD12 ' HE1' ' D' ' 287' ' ' TRP . 0.9 OUTLIER -127.73 124.12 37.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 74.21 110.934 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.8 ' HB ' HD13 ' D' ' 241' ' ' LEU . 20.0 mm -112.27 104.88 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.44 111.101 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.21 -144.21 11.83 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.753 -0.737 . . . . 73.11 112.507 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -123.51 139.99 53.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 75.52 110.893 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . 0.758 ' CG ' HG13 ' E' ' 244' ' ' VAL . 11.0 pt-20 -111.89 134.27 53.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 73.54 110.962 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' E' ' 249' ' ' ALA . 17.0 t80 -125.42 125.11 42.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 73.12 110.897 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.3 -150.18 16.96 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.76 -0.734 . . . . 34.22 112.479 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 59.74 18.2 44.92 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.737 -0.744 . . . . 70.32 112.52 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 7.2 mttp 52.46 29.44 7.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.901 0.381 . . . . 73.14 110.93 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.77 127.59 6.14 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.735 -0.745 . . . . 64.34 112.423 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 t80 59.09 175.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.828 0.347 . . . . 71.32 110.88 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . 0.694 ' HE1' HD12 ' D' ' 276' ' ' LEU . 0.9 OUTLIER -51.47 -34.94 37.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 74.43 110.951 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -142.12 165.56 27.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 61.14 110.893 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -106.66 157.89 17.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 62.33 110.925 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -171.99 152.75 3.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 74.23 110.868 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -131.6 166.97 20.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 73.1 110.865 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -147.77 -65.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 60.14 110.82 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.62 134.21 34.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 74.01 110.857 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.36 130.31 40.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 75.12 110.906 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 74.34 110.82 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 1.3 tpt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.844 0.354 . . . . 55.23 110.864 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.58 116.87 29.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 74.02 110.877 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . 0.611 HG22 HD13 ' D' ' 222' ' ' ILE . 1.0 OUTLIER -137.64 175.41 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 72.52 111.148 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -177.57 79.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 60.33 110.828 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -178.19 130.48 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 70.21 111.081 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . 0.526 HD11 ' OG ' ' D' ' 263' ' ' SER . 6.7 tp -174.99 131.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 64.54 111.103 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 7.4 p -177.39 138.78 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 55.13 111.163 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -175.52 -176.97 44.21 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.776 -0.726 . . . . 72.12 112.535 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 45.5 mmt-85 -73.4 -57.26 4.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 72.54 110.913 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . 0.592 ' HB3' HD12 ' E' ' 241' ' ' LEU . 10.3 m120 -83.76 116.39 22.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 62.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.22 143.07 50.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 72.52 110.895 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . 0.612 ' HB3' ' HA ' ' D' ' 264' ' ' VAL . . . -130.82 136.22 48.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 64.35 111.146 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -88.08 -41.72 12.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 75.5 110.879 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -173.44 138.52 0.7 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 71.5 110.873 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . 0.538 HG23 ' HB ' ' E' ' 267' ' ' VAL . 5.8 mt -132.61 117.8 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 53.43 111.105 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . 0.679 ' HD2' HG13 ' E' ' 268' ' ' VAL . 0.1 OUTLIER -126.96 124.27 39.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 73.4 110.824 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' E' ' 237' ' ' ALA . 5.0 p -135.86 164.73 27.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 65.24 111.086 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -142.13 167.97 20.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.134 -0.484 . . . . 75.34 110.874 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 72.96 -75.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.804 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -179.76 71.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 63.32 110.857 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . 0.591 ' HB3' ' HB ' ' E' ' 233' ' ' THR . . . -101.64 157.02 17.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 62.42 111.095 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.15 134.29 53.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.964 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.753 HG12 ' HB ' ' E' ' 275' ' ' VAL . 4.9 m -128.96 121.81 55.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 71.23 111.075 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . 0.509 HE21 HD21 ' E' ' 276' ' ' LEU . 0.1 OUTLIER -113.96 129.7 56.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.914 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.654 HD13 ' HB ' ' E' ' 277' ' ' ILE . 1.3 mm? -115.25 118.24 32.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 75.12 110.988 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 128.55 -149.78 18.42 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.749 -0.739 . . . . 73.02 112.478 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . 0.552 ' OD1' HG21 ' D' ' 260' ' ' THR . 4.9 m120 -106.68 130.45 54.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.869 0.366 . . . . 74.21 110.877 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.758 HG13 ' CG ' ' D' ' 280' ' ' GLU . 84.4 t -105.89 127.4 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.168 -0.469 . . . . 54.22 111.134 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' D' ' 281' ' ' TYR . 5.0 p -122.68 124.34 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 72.21 111.169 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . 0.544 HG21 ' C ' ' E' ' 282' ' ' GLY . 8.8 t -70.03 169.64 12.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 72.42 111.129 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -52.83 -33.9 51.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 44.44 111.159 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.73 -52.1 66.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.42 111.108 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . 0.51 ' HB2' ' CE2' ' D' ' 281' ' ' TYR . . . 61.76 -178.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 55.54 111.082 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.85 120.15 28.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.939 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -55.09 154.48 5.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 73.14 110.877 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 165.34 166.97 25.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 73.23 112.451 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -102.94 -72.77 0.94 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.702 -0.761 . . . . 54.43 112.475 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 16.9 tt -143.83 130.5 16.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.841 0.353 . . . . 71.43 111.107 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . 0.552 ' O ' HD13 ' E' ' 256' ' ' ILE . 0.0 OUTLIER -178.14 166.76 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 61.21 110.87 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . 0.552 HD13 ' O ' ' E' ' 255' ' ' ARG . 30.6 mm -126.27 134.48 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 63.23 111.16 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 3.7 m -59.38 -178.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 61.04 110.83 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.61 179.95 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 71.53 110.888 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -126.9 25.38 6.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 72.41 110.945 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 27.8 p -72.13 137.84 47.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 75.42 111.121 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.18 108.79 21.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.02 111.155 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.65 123.14 49.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 74.32 110.931 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 13.6 t -132.59 136.93 46.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 75.13 110.859 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.5 136.59 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.102 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -65.49 -105.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 74.03 110.937 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 85.5 m -117.11 138.05 51.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 73.44 111.152 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . 0.724 HG11 HG21 ' E' ' 275' ' ' VAL . 73.8 t -117.78 118.23 57.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.247 -0.433 . . . . 71.42 111.149 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . 0.679 HG13 ' HD2' ' E' ' 232' ' ' ARG . 0.6 OUTLIER -118.22 114.56 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 71.4 111.091 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.58 131.59 10.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.704 -0.76 . . . . 74.01 112.467 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -114.43 124.29 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 73.42 110.841 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 57.47 68.15 1.85 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 63.1 112.457 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 67.46 129.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.846 0.355 . . . . 62.43 110.849 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 10.5 t -156.92 161.22 39.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 74.13 110.877 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -129.9 127.82 40.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.23 110.846 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.753 ' HB ' HG12 ' E' ' 239' ' ' VAL . 90.5 t -138.88 128.83 32.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 42.33 111.163 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.715 HD12 ' HE1' ' E' ' 287' ' ' TRP . 0.4 OUTLIER -128.71 127.68 42.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 63.44 110.933 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.654 ' HB ' HD13 ' E' ' 241' ' ' LEU . 43.7 mm -112.23 118.19 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 71.03 111.128 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 121.63 -157.7 16.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 44.24 112.487 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -91.76 156.02 17.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 64.03 110.865 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -134.18 135.71 43.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 73.45 110.947 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . 0.536 ' CD1' HG22 ' E' ' 246' ' ' THR . 50.2 t80 -125.64 124.62 41.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 75.01 110.97 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . 0.544 ' C ' HG21 ' E' ' 246' ' ' THR . . . -121.76 175.26 16.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.782 -0.723 . . . . 50.3 112.505 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . 0.526 ' N ' HG21 ' E' ' 246' ' ' THR . . . -94.98 7.65 70.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.73 . . . . 43.5 112.507 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.53 -44.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.833 0.349 . . . . 52.45 110.929 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 147.66 148.47 4.76 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.697 -0.763 . . . . 71.15 112.431 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 1.2 t80 56.45 -175.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 73.22 110.853 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . 0.715 ' HE1' HD12 ' E' ' 276' ' ' LEU . 0.4 OUTLIER -51.85 -30.71 24.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.136 -0.484 . . . . 75.33 110.892 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -153.55 -74.54 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 65.13 110.868 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 6.2 t30 56.69 -170.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 62.42 110.952 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -135.69 -169.99 2.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 71.4 110.846 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 2.0 t60 63.3 161.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 61.12 110.832 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.73 63.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.21 110.882 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -92.65 44.02 1.14 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 73.1 110.853 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -158.61 26.34 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 72.32 110.818 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 19.1 m170 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 63.04 110.839 -179.988 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.859 0.361 . . . . 74.02 110.89 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -147.38 119.97 8.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 74.25 110.884 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.7 tt -157.18 23.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 51.41 111.113 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.16 -170.09 0.16 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.21 -0.45 . . . . 75.23 110.883 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.551 ' C ' HD12 ' A' ' 222' ' ' ILE . . . -170.39 -174.9 1.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 75.34 111.103 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.551 HD12 ' C ' ' A' ' 221' ' ' ALA . 1.9 mp 62.11 46.65 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 71.3 111.142 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.2 t -150.23 142.63 17.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.15 111.134 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -52.74 135.27 38.61 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.751 . . . . 54.04 112.491 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -174.51 154.79 2.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.34 . . . . 70.4 110.893 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.733 ' OD1' HG22 ' A' ' 277' ' ' ILE . 44.3 m-80 -127.78 122.59 33.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.52 110.906 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.54 138.58 54.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 62.15 110.836 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -143.32 119.92 11.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.066 -0.515 . . . . 62.24 111.1 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.83 -34.42 45.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.441 . . . . 64.24 110.879 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -165.55 138.81 4.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 62.11 110.928 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.692 HG22 ' CG1' ' A' ' 267' ' ' VAL . 36.5 pt -136.32 132.99 49.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 70.21 111.068 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -134.19 123.52 24.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 75.3 110.921 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -135.52 128.52 31.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 61.31 111.143 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -138.2 166.43 24.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 72.34 110.903 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 66.4 68.75 0.43 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 72.54 110.859 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 49.81 32.9 5.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 64.34 110.921 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.45 156.01 20.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 51.33 111.09 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -139.28 148.04 42.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 70.5 110.821 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.585 HG23 ' HB ' ' A' ' 275' ' ' VAL . 3.1 p -134.86 121.72 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 75.14 111.058 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.77 135.75 53.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.54 110.938 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 mp -130.09 118.87 22.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 70.11 110.914 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 140.81 177.42 16.15 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.741 . . . . 62.2 112.511 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -88.2 128.85 35.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 72.22 110.821 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.09 133.37 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 63.44 111.111 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.524 ' CG1' ' HB3' ' A' ' 249' ' ' ALA . 97.8 t -122.04 129.08 75.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 33.35 111.071 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 13.8 t -72.93 164.02 27.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 73.13 111.182 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.93 -33.84 76.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 75.23 111.095 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . 0.451 ' HB2' ' NZ ' ' A' ' 284' ' ' LYS . . . -56.74 -35.89 69.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 65.42 111.097 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.524 ' HB3' ' CG1' ' A' ' 245' ' ' VAL . . . -72.02 -24.67 61.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 64.2 111.147 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 22.2 tp -51.94 103.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 71.43 110.975 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -162.95 -63.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 72.2 110.865 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -96.33 162.23 22.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.678 -0.772 . . . . 61.12 112.452 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.65 34.4 5.15 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.706 -0.759 . . . . 73.23 112.438 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 7.9 tp -56.95 -25.41 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 62.21 111.09 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.486 ' C ' HD12 ' A' ' 256' ' ' ILE . 13.3 mtm180 63.17 104.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 71.13 110.865 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.486 HD12 ' C ' ' A' ' 255' ' ' ARG . 5.2 mp 61.24 93.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 74.33 111.183 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 77.8 p -102.32 26.5 7.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 64.24 110.88 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -137.19 -178.02 5.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 64.1 110.822 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.13 25.29 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 71.24 110.952 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.441 HG21 ' C ' ' B' ' 242' ' ' GLY . 96.2 m -81.54 135.45 35.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 51.04 111.139 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 3.3 t -132.56 132.09 42.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 71.22 111.134 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.76 ' OD1' HG23 ' A' ' 277' ' ' ILE . 4.2 t-20 -126.1 149.17 49.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 73.12 110.903 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.3 t -142.36 123.1 14.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 64.13 110.835 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.661 HG21 ' CD1' ' B' ' 231' ' ' ILE . 9.2 p -122.08 124.1 70.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 72.44 111.08 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.45 -70.65 0.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 74.14 110.85 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 95.1 m -131.63 128.29 38.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 63.1 111.166 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.692 ' CG1' HG22 ' A' ' 231' ' ' ILE . 7.2 p -123.23 125.19 71.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 64.44 111.208 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.58 135.64 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 74.01 111.103 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.43 133.81 7.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 51.12 112.427 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.08 148.34 52.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 71.24 110.902 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.7 88.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.75 -0.738 . . . . 72.3 112.468 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 43.26 57.42 3.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.879 0.371 . . . . 73.24 110.852 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.74 145.3 28.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 52.03 110.829 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.12 127.33 47.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 52.02 110.896 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.585 ' HB ' HG23 ' A' ' 239' ' ' VAL . 10.0 t -120.61 123.66 70.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 74.33 111.159 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.13 111.23 14.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 75.3 110.898 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.76 HG23 ' OD1' ' A' ' 262' ' ' ASN . 4.5 mp -113.17 104.79 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 62.32 111.134 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.42 -161.65 26.93 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.749 -0.738 . . . . 74.02 112.493 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.62 156.18 21.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.301 . . . . 72.25 110.961 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.642 ' CG ' HG12 ' B' ' 244' ' ' VAL . 2.2 pp20? -130.37 147.32 52.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.854 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.502 ' CD1' HD21 ' B' ' 250' ' ' LEU . 8.2 m-85 -126.73 125.83 42.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 55.21 110.912 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 144.19 147.94 4.78 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.745 -0.741 . . . . 72.15 112.477 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.438 ' N ' ' H ' ' B' ' 247' ' ' ALA . . . -121.75 25.59 6.8 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 73.52 112.502 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.451 ' NZ ' ' HB2' ' A' ' 248' ' ' ALA . 0.0 OUTLIER -110.03 43.01 1.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 45.41 110.917 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 146.88 -19.85 1.61 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.836 -0.697 . . . . 75.52 112.549 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.441 ' CZ ' HG21 ' B' ' 244' ' ' VAL . 11.3 t80 72.26 -68.93 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 70.12 110.84 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -141.91 -44.09 0.35 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 72.22 110.905 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.44 174.35 3.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 75.11 110.867 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -52.39 152.37 3.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 64.04 110.815 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.43 -170.89 3.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 74.42 110.905 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -83.24 -169.98 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 70.42 110.865 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -168.03 66.39 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.891 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -175.96 131.43 0.25 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 61.45 110.863 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.1 176.18 0.9 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 73.12 110.791 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.152 -0.476 . . . . 75.11 110.94 179.937 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.804 0.335 . . . . 60.04 110.921 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 -169.92 2.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 51.24 110.872 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . 0.438 HD11 ' N ' ' B' ' 254' ' ' ILE . 7.7 tt -51.67 123.84 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 72.4 111.103 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.17 -169.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 51.43 110.892 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.56 -169.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 64.02 111.114 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . 0.568 HG21 ' HA ' ' B' ' 257' ' ' SER . 0.2 OUTLIER -124.52 -75.27 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 61.33 111.149 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.498 HG21 HG23 ' A' ' 222' ' ' ILE . 6.8 p -177.51 144.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.31 111.164 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -131.43 147.71 18.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 74.23 112.512 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.77 134.96 25.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.767 0.318 . . . . 71.31 110.791 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.712 ' OD1' HG22 ' B' ' 277' ' ' ILE . 14.7 m-80 -142.21 128.5 19.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.879 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.95 137.62 54.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 71.14 110.843 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -141.35 119.99 12.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 73.45 111.091 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -34.8 52.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 62.44 110.849 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -165.67 136.56 3.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 71.03 110.868 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.715 HG22 HG12 ' B' ' 267' ' ' VAL . 27.6 pt -138.57 129.87 36.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 60.14 111.163 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.97 125.69 32.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 74.21 110.906 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 2.7 p -135.67 128.65 31.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 72.04 111.114 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -136.93 166.77 22.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 75.12 110.9 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 64.51 75.06 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 65.44 110.906 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 45.43 36.17 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 75.55 110.849 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.2 155.63 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.21 111.083 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -140.95 153.74 45.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 74.21 110.901 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.516 HG23 ' HB ' ' B' ' 275' ' ' VAL . 6.0 p -139.55 121.78 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 62.24 111.174 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -117.08 134.9 54.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 72.13 110.837 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.549 HD22 HD21 ' A' ' 262' ' ' ASN . 2.5 mp -130.44 135.33 47.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 75.23 110.92 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.441 ' C ' HG21 ' A' ' 260' ' ' THR . . . 133.55 -124.86 3.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 65.43 112.514 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.44 ' N ' HG21 ' A' ' 260' ' ' THR . 26.8 t30 -145.49 131.38 19.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.915 0.388 . . . . 60.25 110.909 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.642 HG12 ' CG ' ' A' ' 280' ' ' GLU . 18.1 m -114.07 122.8 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 73.43 111.12 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' B' ' 249' ' ' ALA . 98.4 t -122.37 129.51 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 51.14 111.086 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.493 HG23 ' H ' ' B' ' 249' ' ' ALA . 13.9 t -69.6 162.59 27.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 71.44 111.12 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.438 ' H ' ' N ' ' A' ' 283' ' ' GLY . . . -63.34 -33.88 76.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 63.51 111.101 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.12 81.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 72.33 111.068 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.493 ' H ' HG23 ' B' ' 246' ' ' THR . . . -51.55 -32.88 29.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 71.43 111.11 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.502 HD21 ' CD1' ' A' ' 281' ' ' TYR . 47.3 mt -51.82 -45.06 63.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 75.22 110.918 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -104.93 141.24 36.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.447 . . . . 72.51 110.853 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 153.26 -125.76 1.84 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.703 -0.761 . . . . 71.15 112.434 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 164.8 73.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.68 -0.771 . . . . 33.32 112.468 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . 0.438 ' N ' HD11 ' B' ' 219' ' ' ILE . 26.4 pt -146.12 136.95 18.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 74.31 111.157 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -78.24 136.2 37.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 72.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 32.4 mm -109.1 149.47 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 24.41 111.121 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . 0.568 ' HA ' HG21 ' B' ' 222' ' ' ILE . 0.3 OUTLIER -157.35 -175.18 5.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 63.53 110.868 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 13.6 t70 58.15 86.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 72.44 110.877 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . 0.454 ' CB ' HG13 ' B' ' 223' ' ' VAL . 3.8 pt20 -70.04 135.54 49.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 72.12 110.925 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.689 HG21 ' H ' ' C' ' 243' ' ' ASN . 58.3 m -100.61 133.51 44.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 72.35 111.135 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 87.3 m -134.27 133.19 40.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 62.41 111.12 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.724 ' OD1' HG23 ' B' ' 277' ' ' ILE . 12.5 t-20 -126.48 134.26 50.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 73.23 110.906 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 15.1 m -128.75 123.55 33.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 74.53 110.906 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.488 ' HA ' ' HB3' ' C' ' 228' ' ' ALA . 7.6 p -119.47 141.49 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 73.32 111.155 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.75 -57.63 3.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.86 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 72.3 p -150.2 126.83 10.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 65.02 111.171 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.784 HG23 ' HB ' ' C' ' 231' ' ' ILE . 12.2 p -123.81 135.11 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 73.14 111.11 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 60.5 t -127.14 132.91 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.11 111.161 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.79 134.58 8.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.781 -0.723 . . . . 72.12 112.541 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -132.96 148.59 52.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.744 0.306 . . . . 72.55 110.925 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.58 88.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.746 . . . . 43.41 112.451 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 45.18 62.72 2.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.387 . . . . 64.24 110.867 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 17.0 t -94.67 145.52 24.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 64.4 110.817 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.12 127.48 41.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 64.31 110.925 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.626 HG12 ' CD1' ' B' ' 277' ' ' ILE . 6.2 t -122.67 122.75 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.15 111.141 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.35 114.26 20.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 64.13 110.955 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.724 HG23 ' OD1' ' B' ' 262' ' ' ASN . 3.8 mp -112.41 104.29 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.4 111.12 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 141.93 -163.48 26.97 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.691 -0.766 . . . . 61.34 112.519 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -110.64 156.18 21.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 53.44 110.841 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.614 ' HG3' HG12 ' C' ' 244' ' ' VAL . 0.4 OUTLIER -127.38 145.72 50.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 62.12 110.891 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -123.06 125.84 45.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 71.22 110.916 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.63 147.11 4.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.666 -0.778 . . . . 74.43 112.449 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' C' ' 247' ' ' ALA . . . -106.74 -22.75 7.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 62.25 112.541 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -52.07 -29.71 22.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.729 0.299 . . . . 75.44 110.862 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -161.85 112.78 0.53 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.68 -0.772 . . . . 43.01 112.456 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -51.79 -29.82 20.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.842 0.353 . . . . 75.32 110.837 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -157.5 84.28 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.47 . . . . 71.23 110.935 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 1.2 t0 62.88 -169.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 62.32 110.842 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -64.24 123.1 18.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 61.21 110.897 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -156.29 26.98 0.35 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.888 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 52.47 -170.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 72.12 110.841 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -127.18 123.59 37.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 63.04 110.887 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -60.13 -175.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 71.5 110.857 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -170.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 62.24 110.834 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 22.3 m170 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.892 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.872 0.368 . . . . 63.04 110.927 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . 0.477 ' C ' HD12 ' C' ' 219' ' ' ILE . 33.6 mmtt -120.78 -51.35 2.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 62.01 110.907 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.477 HD12 ' C ' ' C' ' 218' ' ' LYS . 4.3 mp 62.22 82.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 72.12 111.122 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -117.35 71.28 0.8 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 73.12 110.853 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -167.76 39.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 61.31 111.095 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . 1.121 HD13 HD13 ' D' ' 219' ' ' ILE . 1.2 pt -138.52 -179.32 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 71.14 111.082 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . 0.831 HG23 HD12 ' C' ' 222' ' ' ILE . 86.8 t 60.53 92.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 75.53 111.148 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 103.57 44.77 1.63 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 73.34 112.512 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 69.2 mmt-85 -140.58 -167.85 2.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.845 0.355 . . . . 72.33 110.859 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -82.74 121.03 26.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 73.34 110.949 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 1.4 m -121.23 144.47 48.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 75.24 110.893 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.488 ' HB3' ' HA ' ' B' ' 264' ' ' VAL . . . -140.78 153.93 46.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 73.2 111.153 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.19 -34.75 4.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 71.41 110.948 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . 0.615 ' HB3' HG23 ' C' ' 266' ' ' THR . 4.9 t0 -165.09 139.3 4.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.46 . . . . 64.33 110.877 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.784 ' HB ' HG23 ' B' ' 267' ' ' VAL . 0.5 OUTLIER -136.02 117.2 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 70.14 111.052 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.91 115.86 21.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 74.33 110.903 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.78 128.8 39.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 70.34 111.087 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -137.65 166.42 23.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 62.42 110.944 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 61.48 74.43 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 71.33 110.909 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 45.38 49.94 10.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 64.33 110.817 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.24 147.11 27.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 54.42 111.114 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -134.54 141.16 46.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 71.33 110.885 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.661 HG23 ' HB ' ' C' ' 275' ' ' VAL . 5.7 p -135.01 121.55 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 75.33 111.138 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.606 ' HB3' HD22 ' C' ' 276' ' ' LEU . 4.3 tm0? -116.27 124.68 50.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 74.54 110.896 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.665 HD12 HD13 ' C' ' 277' ' ' ILE . 0.2 OUTLIER -112.38 118.98 36.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.21 -0.45 . . . . 65.51 110.852 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.41 179.94 17.73 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.745 -0.741 . . . . 73.13 112.455 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.689 ' H ' HG21 ' B' ' 260' ' ' THR . 4.6 t30 -89.66 150.06 22.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 61.31 110.886 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.614 HG12 ' HG3' ' B' ' 280' ' ' GLU . 33.2 m -127.97 129.33 69.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 71.15 111.133 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 89.2 t -122.2 129.45 75.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 74.54 111.129 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 13.2 t -69.92 175.17 4.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 55.34 111.172 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.413 ' HB2' ' H ' ' B' ' 283' ' ' GLY . . . -62.37 -41.38 98.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 55.5 111.077 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.9 -52.54 64.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 64.35 111.12 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . 0.441 ' O ' HD12 ' C' ' 250' ' ' LEU . . . 52.2 26.94 4.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 54.24 111.072 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . 0.441 HD12 ' O ' ' C' ' 249' ' ' ALA . 0.2 OUTLIER 179.9 -169.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 70.43 110.862 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -175.72 -53.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 55.34 110.879 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.57 -36.71 0.28 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 64.24 112.502 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -68.27 -151.8 0.35 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 64.01 112.47 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 3.8 mp -134.71 -41.14 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.339 . . . . 75.44 111.138 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 2.4 ptt-85 -125.63 163.65 22.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 70.32 110.896 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 45.4 pt -139.9 175.53 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 73.23 111.154 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 20.0 m -156.08 -74.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 71.24 110.898 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 59.73 97.62 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 64.11 110.86 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -117.99 81.23 1.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 75.33 110.922 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . 0.457 HG21 ' HB3' ' C' ' 279' ' ' ASN . 7.6 p -100.98 122.4 43.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 74.21 111.16 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 88.8 m -100.55 114.78 28.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 74.13 111.151 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . 0.746 ' OD1' HG23 ' C' ' 277' ' ' ILE . 6.4 t-20 -126.29 144.35 50.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.43 110.933 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 47.3 t -139.03 123.02 17.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 61.32 110.818 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.739 ' HA ' ' HB3' ' D' ' 228' ' ' ALA . 7.6 p -111.11 126.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 72.23 111.097 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.83 -77.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 71.15 110.898 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . 0.615 HG23 ' HB3' ' C' ' 230' ' ' ASP . 16.3 m -131.39 130.27 42.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 72.54 111.094 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.617 HG22 ' HB ' ' D' ' 231' ' ' ILE . 0.9 OUTLIER -118.27 130.92 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 72.25 111.108 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.51 133.08 68.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 42.43 111.106 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -133.25 132.78 6.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.689 -0.767 . . . . 64.4 112.516 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -132.17 142.38 49.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 72.34 110.926 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 51.76 78.78 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.768 -0.73 . . . . 73.11 112.483 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 58.66 96.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.858 0.361 . . . . 74.41 110.883 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 14.1 m -134.42 145.39 48.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.867 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.01 128.13 35.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 75.35 110.897 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.661 ' HB ' HG23 ' C' ' 239' ' ' VAL . 7.2 t -125.84 123.6 64.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 62.22 111.082 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' C' ' 240' ' ' GLN . 0.2 OUTLIER -123.06 117.29 25.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 72.11 110.908 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.746 HG23 ' OD1' ' C' ' 262' ' ' ASN . 3.1 mp -112.84 131.01 65.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 74.13 111.158 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 123.44 -152.02 17.01 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.798 -0.715 . . . . 72.21 112.445 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . 0.457 ' HB3' HG21 ' C' ' 260' ' ' THR . 9.5 p-10 -124.58 156.37 37.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.795 0.331 . . . . 73.31 110.877 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -121.03 139.04 53.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 64.25 110.852 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -123.41 126.43 46.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 71.02 110.934 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' D' ' 247' ' ' ALA . . . 136.84 -34.28 2.23 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 74.33 112.488 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 52.32 47.76 55.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.756 -0.735 . . . . 71.53 112.45 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 57.89 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 74.33 110.864 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.81 -79.21 0.8 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.719 -0.753 . . . . 61.34 112.454 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -179.4 108.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.805 0.336 . . . . 75.42 110.859 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 72.31 -68.92 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 74.33 110.976 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -111.74 147.95 34.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 72.13 110.904 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -52.22 151.57 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 65.34 110.891 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.68 -74.51 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 73.24 110.863 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.51 -169.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 74.23 110.849 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.08 -170.21 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.887 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -62.8 116.17 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 71.05 110.824 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -173.62 114.89 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 74.32 110.896 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.782 -179.953 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.875 0.369 . . . . 70.1 110.896 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . 0.492 ' C ' HD12 ' D' ' 219' ' ' ILE . 0.8 OUTLIER -138.68 153.71 48.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 63.24 110.892 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . 1.121 HD13 HD13 ' C' ' 222' ' ' ILE . 5.4 mp -143.03 144.11 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 74.31 111.179 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -145.59 87.98 1.82 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 74.25 110.852 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . 0.605 ' O ' HD13 ' D' ' 222' ' ' ILE . . . -170.88 44.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 63.33 111.063 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . 0.605 HD13 ' O ' ' D' ' 221' ' ' ALA . 26.4 mm -135.25 149.53 28.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 64.12 111.155 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 10.5 p -52.34 150.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 63.31 111.162 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -142.38 148.37 20.07 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.723 -0.751 . . . . 75.51 112.431 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.465 HH12 HD11 ' E' ' 219' ' ' ILE . 37.3 mmt180 -55.59 -30.08 60.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 64.21 110.867 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . 0.454 HD22 HG22 ' D' ' 277' ' ' ILE . 6.0 m120 -142.13 128.46 19.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 73.52 110.884 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 3.8 m -121.68 139.61 53.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 74.01 110.822 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . 0.739 ' HB3' ' HA ' ' C' ' 264' ' ' VAL . . . -133.63 129.84 37.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 71.34 111.084 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' D' ' 265' ' ' GLU . 9.5 mtmm -97.5 -33.63 11.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 73.05 110.897 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . 0.658 ' HB3' HG23 ' D' ' 266' ' ' THR . 0.2 OUTLIER -165.01 138.16 4.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 72.45 110.881 179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . 0.617 ' HB ' HG22 ' C' ' 267' ' ' VAL . 6.1 mt -137.33 128.72 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 74.22 111.155 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -134.26 115.89 14.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.472 . . . . 71.44 110.908 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . . . . . . . . . 3.5 p -129.82 149.59 51.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 73.13 111.147 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' D' ' 237' ' ' ALA . 5.2 pm0 -156.98 166.71 32.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 72.13 110.883 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 63.26 67.56 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 71.14 110.87 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 36.6 mtt85 49.45 31.76 4.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 74.31 110.932 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' D' ' 234' ' ' GLU . . . -82.55 145.77 29.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 63.43 111.071 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -129.76 135.77 48.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 73.1 110.852 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.429 HG23 ' HB ' ' D' ' 275' ' ' VAL . 6.3 p -130.84 121.7 50.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 73.25 111.075 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . 0.681 ' HB3' HD22 ' D' ' 276' ' ' LEU . 2.5 tm0? -109.12 137.25 47.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.472 . . . . 62.02 110.928 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.529 HD22 ' C ' ' D' ' 240' ' ' GLN . 3.5 mm? -122.72 118.61 28.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 74.12 110.913 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 126.41 177.85 15.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.769 -0.729 . . . . 70.1 112.509 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.82 149.36 23.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 64.43 110.927 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' D' ' 280' ' ' GLU . 17.3 m -124.94 132.49 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 40.1 111.14 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.83 129.41 75.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 74.42 111.075 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.3 t -70.09 174.89 4.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 70.45 111.105 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' C' ' 282' ' ' GLY . . . -59.34 -39.5 83.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 71.15 111.074 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.93 -52.05 66.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 75.35 111.046 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 59.1 -169.79 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 73.02 111.18 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . 0.75 ' HB3' HG23 ' D' ' 254' ' ' ILE . 0.3 OUTLIER -54.66 108.53 0.4 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 73.25 110.913 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -52.31 157.49 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 72.41 110.837 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 71.04 -177.03 36.07 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.725 -0.75 . . . . 32.43 112.492 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -73.79 78.44 0.89 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.747 -0.74 . . . . 51.12 112.515 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . 0.75 HG23 ' HB3' ' D' ' 250' ' ' LEU . 2.6 tt -170.07 144.63 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 51.24 111.125 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.45 -173.88 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 53.3 110.827 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . . . . . . . . . 29.5 mt 63.94 106.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 73.31 111.152 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . 0.427 ' HA ' HD23 ' D' ' 250' ' ' LEU . 4.8 p -85.34 -170.86 3.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 73.44 110.88 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.44 167.2 1.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 54.52 110.818 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -140.09 100.03 3.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 75.45 110.918 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 13.0 t -96.47 138.4 34.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 73.43 111.18 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.56 116.65 29.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 55.35 111.121 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . 0.532 ' OD1' HD12 ' E' ' 241' ' ' LEU . 0.5 OUTLIER -126.89 137.09 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 72.5 110.821 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.06 123.41 18.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 65.4 110.821 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.819 HG21 HG23 ' D' ' 267' ' ' VAL . 7.3 p -113.89 138.5 43.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 72.52 111.109 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' D' ' 229' ' ' LYS . 0.7 OUTLIER -81.48 -52.47 7.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 74.1 110.916 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . 0.658 HG23 ' HB3' ' D' ' 230' ' ' ASP . 0.2 OUTLIER -150.96 129.35 12.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 73.32 111.099 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.819 HG23 HG21 ' D' ' 264' ' ' VAL . 1.2 t -118.35 130.62 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 74.22 111.183 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.49 127.75 69.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 63.52 111.146 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -131.06 133.94 7.5 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.763 -0.732 . . . . 65.25 112.473 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.1 148.89 52.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 70.24 110.916 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 52.34 89.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 71.43 112.468 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 43.75 59.69 2.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.887 0.375 . . . . 51.1 110.849 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 11.0 t -85.85 145.5 27.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 32.13 110.846 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.48 127.75 35.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 75.1 110.887 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . 0.448 HG22 ' CG1' ' E' ' 239' ' ' VAL . 57.9 t -131.87 123.18 50.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 75.42 111.096 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' D' ' 240' ' ' GLN . 0.4 OUTLIER -121.21 111.74 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 62.31 110.926 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.454 HG22 HD22 ' D' ' 226' ' ' ASN . 1.1 mt -107.88 110.96 33.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 71.44 111.136 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 136.08 174.7 13.47 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.777 -0.725 . . . . 71.05 112.49 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -89.87 144.91 25.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.358 . . . . 74.31 110.887 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . 0.475 ' HA ' HG23 ' D' ' 244' ' ' VAL . 15.8 pt-20 -113.87 131.73 56.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 74.43 110.874 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -116.83 125.85 52.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 75.43 110.933 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 127.14 150.32 7.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.767 -0.73 . . . . 72.13 112.453 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . 58.33 173.56 0.42 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.769 -0.729 . . . . 73.04 112.456 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.04 31.66 5.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.349 . . . . 72.2 110.885 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . -112.54 -119.46 3.68 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.805 -0.712 . . . . 72.14 112.5 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -163.4 119.51 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 75.1 110.893 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 63.13 21.87 13.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.137 -0.483 . . . . 73.4 110.938 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.48 -169.7 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 63.42 110.813 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -105.3 -172.82 2.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 64.23 110.923 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -54.33 137.55 41.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 75.14 110.858 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -171.24 -174.97 1.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.875 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.03 -170.43 2.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 63.52 110.87 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -170.48 -175.74 1.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 61.12 110.854 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -149.3 -175.34 4.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 72.12 110.88 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 74.3 110.832 -179.913 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.853 0.358 . . . . 73.23 110.893 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . 0.694 ' HB2' HD12 ' E' ' 256' ' ' ILE . 5.0 mptt -156.56 122.46 4.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 74.54 110.91 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . 0.465 HD11 HH12 ' D' ' 225' ' ' ARG . 36.1 mt -143.48 148.38 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 72.21 111.11 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -154.77 176.55 12.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 75.4 110.905 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . 61.16 179.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 72.34 111.02 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . . . . . . . . . 1.1 pt -113.46 107.34 22.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.436 . . . . 54.15 111.139 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.9 148.0 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 74.44 111.104 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -76.35 -131.67 0.41 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.665 -0.778 . . . . 62.13 112.539 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . 0.518 ' H ' HG23 ' E' ' 261' ' ' THR . 16.8 ptt-85 179.93 178.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 75.12 110.918 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -83.52 123.97 30.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 71.43 110.833 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.58 144.52 48.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 70.23 110.872 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . 0.501 ' HB3' ' HA ' ' D' ' 264' ' ' VAL . . . -140.12 118.9 12.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 73.14 111.078 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' E' ' 265' ' ' GLU . 0.1 OUTLIER -79.09 -42.02 27.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 61.1 110.905 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -168.18 138.19 2.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 62.2 110.883 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . 0.768 HG21 HG21 ' E' ' 239' ' ' VAL . 10.8 mt -129.11 117.07 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 55.23 111.089 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -119.12 115.1 23.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 75.24 110.858 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.61 128.27 32.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 72.44 111.192 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.35 162.26 33.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.878 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.54 76.55 0.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 62.41 110.885 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 43.66 42.09 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.877 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.98 142.61 27.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 63.03 111.171 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -125.42 137.67 54.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 51.32 110.902 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.768 HG21 HG21 ' E' ' 231' ' ' ILE . 7.6 p -136.5 121.92 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 63.2 111.1 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -112.88 137.48 51.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.92 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.658 HD13 ' HB ' ' E' ' 277' ' ' ILE . 1.5 mm? -120.34 118.27 29.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 71.34 110.912 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 123.5 169.14 13.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.727 -0.749 . . . . 71.51 112.472 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.65 146.0 27.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.929 0.395 . . . . 75.24 110.849 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' E' ' 280' ' ' GLU . 24.3 m -111.83 139.72 34.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 65.04 111.153 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 45.3 t -120.98 129.58 75.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 73.34 111.115 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 11.2 t -69.04 175.07 3.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.114 -0.494 . . . . 63.11 111.172 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.1 -44.83 79.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 52.34 111.163 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.06 -52.17 66.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.5 111.068 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . . . . . . . . . . . 59.38 -177.7 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 74.13 111.118 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 10.2 tp -51.96 107.59 0.21 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 74.21 110.943 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -79.59 149.43 31.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 75.02 110.824 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.55 -58.57 4.45 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.732 -0.747 . . . . 33.14 112.485 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.48 -143.48 12.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.743 -0.741 . . . . 74.23 112.478 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 10.2 tt -175.33 130.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 72.22 111.135 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.62 152.53 18.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.889 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . 0.694 HD12 ' HB2' ' E' ' 218' ' ' LYS . 13.8 pt -150.23 51.31 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 73.53 111.126 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.09 167.54 1.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 74.33 110.878 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -55.89 174.19 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 65.25 110.876 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -138.0 -75.07 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 72.35 110.955 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 14.0 t -101.11 137.34 39.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 74.15 111.134 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . 0.518 HG23 ' H ' ' E' ' 225' ' ' ARG . 99.1 m -92.5 111.59 23.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 54.33 111.173 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -124.63 119.6 29.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 42.24 110.956 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.76 120.1 30.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 74.42 110.852 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 8.4 p -111.52 137.4 44.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 53.25 111.09 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 3.4 tt0 -71.06 -95.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 73.43 110.852 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 93.8 m -119.8 126.2 50.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 72.42 111.167 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . 0.686 ' CG1' HG23 ' E' ' 231' ' ' ILE . 3.5 p -116.07 120.1 63.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 74.24 111.136 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . . . . . . . . . 39.9 t -117.94 119.21 60.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 71.41 111.089 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.51 133.52 9.55 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 74.44 112.502 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.57 147.91 45.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 72.2 110.897 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 54.6 89.63 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 64.11 112.489 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 41.59 77.58 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 54.12 110.886 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 6.2 t -105.48 145.18 31.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 71.22 110.838 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.06 128.23 49.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 62.31 110.935 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.623 HG21 HG21 ' E' ' 267' ' ' VAL . 85.1 t -132.98 123.96 49.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.44 111.129 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.705 HD12 ' NE1' ' E' ' 287' ' ' TRP . 0.3 OUTLIER -127.51 125.82 41.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 72.35 110.942 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.658 ' HB ' HD13 ' E' ' 241' ' ' LEU . 20.9 mm -112.18 124.85 69.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 75.33 111.138 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 113.82 -170.97 13.55 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.682 -0.771 . . . . 50.04 112.458 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -102.68 155.98 17.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 74.4 110.914 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . 0.408 ' HA ' HG22 ' E' ' 244' ' ' VAL . 5.4 pt-20 -121.81 132.67 54.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 74.33 110.856 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -115.35 125.16 52.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 64.51 110.868 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 162.39 -178.22 38.25 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.718 -0.753 . . . . 73.1 112.455 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -51.99 168.91 0.61 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.73 -0.748 . . . . 72.23 112.444 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -51.8 109.74 0.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.858 0.361 . . . . 72.14 110.897 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . -164.71 118.98 0.84 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.704 -0.76 . . . . 75.4 112.491 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -59.72 -20.91 59.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 73.24 110.881 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . 0.705 ' NE1' HD12 ' E' ' 276' ' ' LEU . 0.1 OUTLIER -155.94 -49.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 72.22 110.951 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -112.66 -74.67 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 73.21 110.874 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -148.55 176.93 9.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 70.15 110.89 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -52.04 123.54 10.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 72.41 110.869 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -171.82 168.15 6.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.856 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -164.93 112.54 1.02 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 75.24 110.785 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -177.75 127.17 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 74.42 110.884 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -126.89 -68.58 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 71.43 110.861 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 28.6 p80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.878 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 2.8 mpp? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.88 0.372 . . . . 74.23 110.855 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.28 173.74 6.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.856 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.7 pt -147.93 -178.24 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 50.41 111.177 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -133.8 -170.68 2.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 73.13 110.867 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.61 ' O ' HD13 ' A' ' 222' ' ' ILE . . . -104.72 168.23 9.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 55.22 111.074 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.61 HD13 ' O ' ' A' ' 221' ' ' ALA . 34.8 mm -135.7 141.47 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 74.11 111.117 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.716 HG12 ' HG3' ' A' ' 259' ' ' GLN . 33.6 m -80.38 151.88 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 75.43 111.158 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.68 111.32 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.709 -0.758 . . . . 53.21 112.481 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.594 ' CB ' HG22 ' A' ' 261' ' ' THR . 13.7 ttp85 -142.67 95.89 2.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 72.54 110.863 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.429 HD22 ' N ' ' A' ' 242' ' ' GLY . 12.4 m-20 -83.95 111.64 19.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 73.32 110.872 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.77 150.72 41.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 45.54 110.826 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -144.0 119.1 10.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 72.23 111.122 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -76.05 -48.53 20.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 70.12 110.887 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -164.92 135.8 4.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 72.33 110.908 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.579 HG22 ' CG2' ' A' ' 267' ' ' VAL . 8.8 pt -139.3 134.36 40.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 41.54 111.154 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -130.93 138.54 49.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 75.34 110.853 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.708 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 0.5 OUTLIER -136.07 147.14 47.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 71.13 111.133 -179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -134.04 167.02 21.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 71.41 110.869 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.43 -70.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 74.52 110.927 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.38 66.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 75.15 110.879 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.708 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -102.7 157.5 16.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 64.14 111.145 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.25 139.02 50.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 63.51 110.856 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.463 HG21 HD12 ' A' ' 231' ' ' ILE . 4.2 p -122.28 121.65 64.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 72.33 111.09 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.04 116.01 29.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 61.12 110.919 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.1 mp -111.99 118.61 35.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 43.51 110.903 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.429 ' N ' HD22 ' A' ' 226' ' ' ASN . . . 141.32 160.79 8.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 52.31 112.476 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -85.77 134.75 33.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.842 0.353 . . . . 62.24 110.835 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 17.8 m -106.69 133.63 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.476 . . . . 61.33 111.125 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 39.1 t -122.74 113.06 36.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 62.14 111.038 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 281' ' ' TYR . 5.3 t -93.46 162.66 13.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 70.44 111.177 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.61 -33.88 64.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.186 -0.461 . . . . 72.4 111.069 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -35.91 69.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 61.31 111.122 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.49 ' HB2' ' CA ' ' A' ' 282' ' ' GLY . . . -58.75 102.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 52.1 111.137 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -177.45 -176.81 0.64 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 72.22 110.917 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -165.67 -68.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 70.43 110.845 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 151.07 -44.97 0.65 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.778 -0.725 . . . . 55.5 112.501 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -90.04 -147.26 16.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.727 -0.749 . . . . 63.34 112.445 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.452 HD11 ' HA2' ' B' ' 253' ' ' GLY . 42.6 pt -61.06 161.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.778 0.323 . . . . 73.34 111.16 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.8 ttm-85 -109.3 140.08 43.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.196 -0.456 . . . . 73.33 110.905 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 14.5 pt -132.39 178.7 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.1 111.162 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 19.2 p -177.93 164.33 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 54.12 110.836 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -96.89 -176.16 3.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 75.12 110.884 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.716 ' HG3' HG12 ' A' ' 223' ' ' VAL . 11.3 tt0 -120.74 44.42 2.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 72.34 110.977 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.516 HG21 ' HB3' ' B' ' 243' ' ' ASN . 0.2 OUTLIER -75.8 134.78 40.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 75.01 111.15 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.594 HG22 ' CB ' ' A' ' 225' ' ' ARG . 0.9 OUTLIER -123.19 108.97 13.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 62.13 111.157 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -92.65 127.61 38.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 52.01 110.84 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.2 t -142.18 123.32 14.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 34.02 110.896 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.633 HG21 HG22 ' A' ' 267' ' ' VAL . 4.8 p -105.93 137.33 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.5 . . . . 52.21 111.175 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -88.74 -66.57 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 75.34 110.865 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 26.3 m -125.45 126.6 45.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 74.44 111.069 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 264' ' ' VAL . 41.3 t -117.69 131.3 70.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 72.23 111.139 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 30.2 t -127.15 115.31 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.134 -0.484 . . . . 62.3 111.167 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.76 132.82 11.25 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 72.1 112.465 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.92 134.41 45.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 65.43 110.921 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.44 85.36 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.76 -0.733 . . . . 55.31 112.523 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 47.74 79.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.892 0.377 . . . . 34.33 110.958 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.47 145.05 30.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 75.33 110.887 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -113.4 128.44 56.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.877 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 95.0 t -131.18 123.67 53.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 71.31 111.11 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.411 HD22 ' CE2' ' A' ' 287' ' ' TRP . 25.5 tp -128.15 111.54 13.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 72.2 110.942 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 73.6 mt -109.23 103.92 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 62.04 111.123 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 154.53 -159.02 28.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.796 -0.716 . . . . 63.31 112.498 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -128.21 156.28 43.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 65.32 110.894 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -115.26 134.71 54.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 70.01 110.883 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.465 ' O ' HG22 ' A' ' 246' ' ' THR . 17.2 m-85 -118.81 126.84 52.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 74.43 110.91 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.49 ' CA ' ' HB2' ' A' ' 249' ' ' ALA . . . 101.82 159.3 26.62 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.799 -0.715 . . . . 63.53 112.516 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.743 ' H ' ' HB2' ' B' ' 247' ' ' ALA . . . -68.07 -130.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.811 -0.709 . . . . 63.24 112.475 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.62 28.19 16.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.77 0.319 . . . . 74.22 110.904 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 92.5 152.38 28.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.783 -0.723 . . . . 73.04 112.504 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -67.47 -35.05 78.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 73.02 110.899 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.411 ' CE2' HD22 ' A' ' 276' ' ' LEU . 15.6 t90 -174.96 -68.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 75.22 110.96 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -175.47 65.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 65.44 110.841 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -119.16 -43.67 2.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.425 . . . . 63.54 110.904 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 2.2 t60 63.41 105.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.493 . . . . 74.01 110.84 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -74.04 -169.83 0.83 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 72.33 110.891 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.54 -175.07 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 71.44 110.828 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 31.2 m80 63.14 103.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 74.52 110.877 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 59.09 76.61 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.05 110.855 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 22.0 m170 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 72.53 110.811 -179.982 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.852 0.358 . . . . 43.2 110.922 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.97 169.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 70.23 110.902 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 40.9 mm -71.16 -40.72 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 70.44 111.111 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.15 -171.55 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 53.35 110.886 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 62.26 179.06 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 73.34 111.128 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 5.2 tt -156.26 135.71 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.26 -0.427 . . . . 72.41 111.076 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 258' ' ' ASP . 7.0 p -113.65 135.51 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 71.21 111.145 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.44 108.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.675 -0.774 . . . . 73.32 112.604 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.665 ' HB3' HG23 ' B' ' 261' ' ' THR . 0.0 OUTLIER -146.48 119.04 8.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 74.52 110.804 -179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.645 ' OD1' HG22 ' B' ' 277' ' ' ILE . 17.1 m-80 -109.24 119.25 38.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 73.24 110.962 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.63 148.87 51.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.866 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.612 ' HB2' HD21 ' B' ' 241' ' ' LEU . . . -139.26 119.92 14.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 62.54 111.16 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.07 -44.58 30.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 73.53 110.812 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -165.75 134.89 3.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 64.24 110.799 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.633 HD12 HG21 ' B' ' 239' ' ' VAL . 7.6 pt -140.17 133.67 34.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 75.22 111.153 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.92 136.72 42.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 75.12 110.819 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.729 ' OG1' ' HB3' ' B' ' 237' ' ' ALA . 0.5 OUTLIER -136.29 147.97 47.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 72.43 111.098 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -136.1 167.9 20.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 72.51 110.904 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.83 -71.47 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 71.14 110.861 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -179.3 62.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 75.15 110.937 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.729 ' HB3' ' OG1' ' B' ' 233' ' ' THR . . . -102.3 157.19 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 71.33 111.115 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -129.85 135.26 48.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.829 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.633 HG21 HD12 ' B' ' 231' ' ' ILE . 6.4 p -122.93 129.57 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.471 . . . . 75.02 111.151 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.564 ' HB3' HD12 ' B' ' 276' ' ' LEU . 8.8 tm0? -120.11 124.73 46.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 65.25 110.901 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.612 HD21 ' HB2' ' B' ' 228' ' ' ALA . 4.5 mt -111.74 118.88 36.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 74.32 110.929 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.88 176.44 14.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.704 -0.76 . . . . 51.2 112.46 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.516 ' HB3' HG21 ' A' ' 260' ' ' THR . 2.0 p30 -85.92 134.06 33.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.373 . . . . 64.42 110.876 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 1.7 t -104.69 115.25 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 74.34 111.111 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 44.7 t -106.91 122.76 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 55.43 111.13 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.469 HG22 ' O ' ' B' ' 281' ' ' TYR . 14.5 t -96.14 163.26 13.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 71.11 111.19 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.743 ' HB2' ' H ' ' A' ' 283' ' ' GLY . . . -58.73 -33.88 70.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 75.1 111.107 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.88 -35.99 69.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 62.41 111.088 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.5 ' HB2' ' CA ' ' B' ' 282' ' ' GLY . . . -59.12 -41.44 88.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 64.31 111.134 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 6.9 mt 56.36 -177.91 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.42 110.928 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -125.39 70.81 1.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 74.32 110.816 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -61.69 -59.7 9.33 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 50.22 112.443 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . 0.452 ' HA2' HD11 ' A' ' 254' ' ' ILE . . . 177.46 154.86 12.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.706 -0.759 . . . . 73.33 112.477 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 2.3 tt -52.47 133.18 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.824 0.345 . . . . 75.23 111.112 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -147.99 144.01 27.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 73.43 110.888 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . 0.645 HD13 ' H ' ' C' ' 255' ' ' ARG . 2.4 pp -55.18 155.57 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 72.31 111.094 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 14.8 p -161.34 144.11 12.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 73.22 110.833 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.442 ' O ' HG23 ' B' ' 223' ' ' VAL . 5.0 m-20 -58.14 175.61 0.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 64.31 110.86 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -110.58 81.74 1.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 73.24 110.882 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.85 137.57 32.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 64.03 111.161 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.665 HG23 ' HB3' ' B' ' 225' ' ' ARG . 96.4 m -131.82 122.33 25.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.286 -0.415 . . . . 74.24 111.162 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.79 124.98 50.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 74.3 110.947 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 1.2 t -141.95 123.68 15.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 72.22 110.841 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.574 HG21 HG22 ' B' ' 267' ' ' VAL . 4.4 p -106.41 137.72 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.477 . . . . 72.53 111.207 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -85.52 -72.67 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 61.1 110.882 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 19.0 p -122.24 126.48 48.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 72.51 111.111 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.574 HG22 HG21 ' B' ' 264' ' ' VAL . 46.1 t -118.28 127.77 75.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 71.35 111.157 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 58.5 t -127.17 115.23 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 43.41 111.113 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.3 133.19 11.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.74 . . . . 41.41 112.478 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -130.54 139.54 50.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.831 0.348 . . . . 72.15 110.892 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 49.67 85.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 64.44 112.482 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 45.76 74.34 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 71.44 110.908 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.69 145.68 26.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 63.52 110.872 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 11.0 mtm-85 -113.68 128.17 56.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 74.43 110.912 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . . . . . . . . . 36.1 t -130.17 123.31 55.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 71.51 111.085 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.589 HD23 ' CG ' ' C' ' 240' ' ' GLN . 14.5 tp -128.12 111.32 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 55.11 110.914 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.645 HG22 ' OD1' ' B' ' 226' ' ' ASN . 4.5 mp -107.91 104.55 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 71.24 111.074 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.76 -173.55 27.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.694 -0.765 . . . . 74.22 112.445 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -110.33 154.52 23.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.732 0.301 . . . . 74.12 110.96 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.423 ' HB3' HG13 ' C' ' 244' ' ' VAL . 13.8 tm-20 -111.94 137.22 50.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 74.13 110.881 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.469 ' O ' HG22 ' B' ' 246' ' ' THR . 0.2 OUTLIER -119.95 129.96 54.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 74.51 110.947 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.5 ' CA ' ' HB2' ' B' ' 249' ' ' ALA . . . 107.95 148.13 13.7 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.835 -0.698 . . . . 71.4 112.496 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . 0.59 ' H ' ' HB2' ' C' ' 247' ' ' ALA . . . -68.53 -132.4 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.743 -0.741 . . . . 54.4 112.5 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.7 tptp 62.11 35.54 15.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 75.41 110.865 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 74.89 141.71 0.79 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 75.14 112.464 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -75.44 111.26 10.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.85 0.357 . . . . 64.4 110.924 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.54 ' CE2' HD22 ' B' ' 276' ' ' LEU . 7.0 t90 52.12 29.91 7.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 73.31 110.877 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.53 94.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 74.2 110.923 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.88 -177.16 3.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 74.45 110.934 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -118.89 -176.64 3.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 75.34 110.833 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -84.51 -59.12 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 74.42 110.849 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 59.68 -170.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 74.42 110.911 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -123.38 151.83 42.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 64.44 110.886 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.33 157.1 23.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 75.15 110.862 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 60.43 110.879 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.8 0.333 . . . . 71.15 110.818 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.43 100.81 4.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 62.42 110.892 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 17.4 tt -174.74 144.03 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 73.12 111.141 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -178.18 130.38 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 62.32 110.874 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -173.42 124.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 71.33 111.15 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 2.0 pt -149.34 136.49 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 72.4 111.043 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 22.9 t 63.45 101.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 72.42 111.115 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -147.66 158.15 27.61 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.709 -0.758 . . . . 75.35 112.458 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.64 ' HA ' HG23 ' C' ' 261' ' ' THR . 0.0 OUTLIER -53.24 -74.6 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.795 0.331 . . . . 73.25 110.822 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -83.89 110.83 18.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 72.52 110.885 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.99 148.13 52.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 65.32 110.892 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' B' ' 264' ' ' VAL . . . -135.21 124.48 24.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 64.22 111.089 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -42.61 16.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.443 . . . . 62.01 110.892 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -166.32 133.89 2.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 72.44 110.839 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.612 HD12 HG11 ' C' ' 239' ' ' VAL . 6.4 pt -140.65 132.07 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 70.23 111.216 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -136.1 135.64 39.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 60.45 110.888 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.733 ' OG1' ' HB3' ' C' ' 237' ' ' ALA . 0.5 OUTLIER -136.67 150.82 48.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 70.11 111.146 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -139.9 168.7 19.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.33 110.931 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.68 -70.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.905 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -179.32 57.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 55.3 110.9 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.733 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -98.46 156.97 16.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 74.24 111.068 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -130.18 135.69 48.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.12 110.86 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.612 HG11 HD12 ' C' ' 231' ' ' ILE . 7.3 p -122.64 128.51 75.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.23 111.079 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.589 ' CG ' HD23 ' B' ' 276' ' ' LEU . 1.2 tm0? -121.14 125.55 47.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 60.23 110.926 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.634 HD13 ' HB ' ' C' ' 277' ' ' ILE . 3.8 mm? -111.59 118.76 36.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 73.54 110.897 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 132.07 175.38 13.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.633 -0.794 . . . . 61.13 112.448 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -90.45 153.82 20.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.813 0.34 . . . . 63.42 110.948 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' B' ' 280' ' ' GLU . 20.1 t -119.83 116.83 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 75.31 111.155 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 48.7 t -108.96 115.33 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 75.23 111.109 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 12.1 t -69.86 175.11 4.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 75.43 111.145 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.59 ' HB2' ' H ' ' B' ' 283' ' ' GLY . . . -55.31 -45.16 76.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 62.45 111.09 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.34 80.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 63.15 111.121 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . 51.98 -169.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 44.34 111.148 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . 0.487 HD12 ' CZ ' ' C' ' 281' ' ' TYR . 0.3 OUTLIER -55.96 176.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 75.21 110.873 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.09 -58.97 2.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 73.3 110.872 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -151.48 120.6 1.11 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.723 -0.751 . . . . 52.44 112.437 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -151.8 -173.73 21.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 54.12 112.529 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 13.2 pt -148.84 25.27 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.857 0.361 . . . . 73.43 111.166 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . 0.645 ' H ' HD13 ' B' ' 256' ' ' ILE . 0.0 OUTLIER 53.46 -170.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 71.34 110.846 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 29.3 mt 64.16 82.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 71.2 111.073 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.21 157.63 1.38 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 73.24 110.876 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . 0.478 ' N ' HG22 ' D' ' 256' ' ' ILE . 0.6 OUTLIER -67.67 -169.92 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.881 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -175.01 155.63 2.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 71.02 110.911 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . 0.506 HG23 ' CB ' ' D' ' 225' ' ' ARG . 5.1 m -65.56 125.03 23.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 62.41 111.117 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.64 HG23 ' HA ' ' C' ' 225' ' ' ARG . 29.0 m -96.15 108.81 21.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 73.33 111.071 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.8 124.23 38.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.147 -0.478 . . . . 73.33 110.844 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.06 123.21 14.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 71.11 110.828 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.593 HG21 HG22 ' C' ' 267' ' ' VAL . 4.1 p -107.38 139.21 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.081 -0.509 . . . . 73.21 111.15 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -89.56 -65.21 1.04 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 72.03 110.913 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . 0.473 HG21 ' HG2' ' E' ' 217' ' ' MET . 1.7 p -129.8 126.93 39.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.479 . . . . 55.34 111.132 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.593 HG22 HG21 ' C' ' 264' ' ' VAL . 47.0 t -118.04 126.57 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 64.5 111.155 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 83.4 t -123.07 115.31 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 52.41 111.166 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.37 131.96 10.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.701 -0.761 . . . . 55.44 112.58 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.24 136.29 45.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.786 0.327 . . . . 62.42 110.944 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 50.56 83.51 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.749 -0.738 . . . . 62.32 112.452 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 46.59 69.99 0.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 74.14 110.929 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.24 145.38 24.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 71.51 110.894 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -113.31 128.4 56.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 73.11 110.84 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.48 HG21 HG11 ' C' ' 267' ' ' VAL . 77.1 t -129.14 121.98 55.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 73.24 111.129 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.465 ' O ' HD12 ' D' ' 241' ' ' LEU . 2.2 tp -128.86 111.17 12.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 43.25 110.906 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.634 ' HB ' HD13 ' C' ' 241' ' ' LEU . 2.7 mp -112.59 104.3 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 61.12 111.096 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.35 -179.46 27.07 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.653 -0.784 . . . . 70.1 112.451 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.34 156.08 18.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.316 . . . . 64.2 110.873 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.84 119.14 27.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 74.21 110.852 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.487 ' CZ ' HD12 ' C' ' 250' ' ' LEU . 0.4 OUTLIER -112.55 125.46 54.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 70.04 110.905 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.15 158.62 7.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 74.3 112.454 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -103.95 -161.85 24.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 71.05 112.503 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt 53.33 34.39 17.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.359 . . . . 74.21 110.93 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 131.63 135.4 3.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.649 -0.786 . . . . 54.52 112.463 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -83.7 -26.18 30.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.348 . . . . 70.14 110.91 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.444 ' CE2' HD22 ' C' ' 276' ' ' LEU . 17.0 t90 -171.57 -42.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 73.13 110.919 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -114.43 97.55 6.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 65.24 110.841 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -55.44 171.7 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 74.25 110.904 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.41 -57.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 74.34 110.832 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.02 156.86 1.43 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 64.34 110.876 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -160.36 -179.94 8.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 71.34 110.821 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -98.3 177.4 5.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.459 . . . . 72.32 110.861 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 57.51 -170.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 72.12 110.91 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.272 -0.422 . . . . 74.33 110.797 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 217' ' ' MET . . . . . . . . . . . . . 1.2 mtm . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.863 0.363 . . . . 75.54 110.898 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 218' ' ' LYS . . . . . . . . . . . . . 5.6 mttt 59.04 93.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 71.32 110.863 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 219' ' ' ILE . . . . . 0.449 HD12 ' N ' ' D' ' 220' ' ' ASP . 2.1 pp -142.28 -177.68 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 63.52 111.13 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 220' ' ' ASP . . . . . 0.449 ' N ' HD12 ' D' ' 219' ' ' ILE . 3.2 m-20 -150.11 -74.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 75.12 110.845 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 221' ' ' ALA . . . . . . . . . . . . . . . -177.82 165.51 2.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 74.45 111.045 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 222' ' ' ILE . . . . . . . . . . . . . 3.9 tt -175.68 140.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 73.32 111.094 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 19.1 m -105.02 -175.66 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 62.02 111.151 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . 146.83 -175.43 26.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.783 -0.722 . . . . 74.13 112.477 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 225' ' ' ARG . . . . . 0.506 ' CB ' HG23 ' C' ' 260' ' ' THR . 11.4 mpt_? -88.09 -55.0 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 51.55 110.864 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 226' ' ' ASN . . . . . 0.679 ' ND2' HG22 ' D' ' 277' ' ' ILE . 1.7 m120 -99.88 117.75 34.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 75.53 110.84 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.72 151.97 49.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 54.33 110.837 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 228' ' ' ALA . . . . . . . . . . . . . . . -142.36 129.85 21.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.494 . . . . 74.13 111.087 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.47 -42.22 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 75.23 110.92 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 230' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -166.73 134.92 2.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.11 110.814 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 231' ' ' ILE . . . . . 0.664 HD12 HG11 ' D' ' 239' ' ' VAL . 7.2 pt -141.02 133.01 29.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 73.11 111.117 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 232' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -135.7 136.45 40.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 64.21 110.894 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 233' ' ' THR . . . . . 0.665 ' CB ' ' HB3' ' D' ' 237' ' ' ALA . 0.4 OUTLIER -136.86 146.35 45.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 72.05 111.099 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 234' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -135.19 168.79 18.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 63.25 110.89 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 73.12 -72.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 64.31 110.859 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.91 59.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 74.31 110.837 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 237' ' ' ALA . . . . . 0.665 ' HB3' ' CB ' ' D' ' 233' ' ' THR . . . -99.89 157.17 16.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 55.34 111.06 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.61 135.72 46.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 70.44 110.85 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 239' ' ' VAL . . . . . 0.664 HG11 HD12 ' D' ' 231' ' ' ILE . 5.7 p -122.21 121.93 65.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 71.51 111.179 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 240' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -118.17 120.92 39.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.899 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 241' ' ' LEU . . . . . 0.465 HD12 ' O ' ' C' ' 276' ' ' LEU . 1.2 mp -112.59 118.8 36.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.947 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 242' ' ' GLY . . . . . . . . . . . . . . . 142.92 165.74 10.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.726 -0.749 . . . . 72.25 112.516 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 243' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -85.77 131.0 34.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 62.22 110.908 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 244' ' ' VAL . . . . . . . . . . . . . 26.5 t -99.09 130.01 48.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 71.22 111.164 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 245' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.09 122.48 66.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 61.34 111.137 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 246' ' ' THR . . . . . . . . . . . . . 14.0 t -69.71 165.9 20.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.21 111.119 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.86 -36.38 62.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 53.33 111.16 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.96 -51.94 67.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 52.42 111.113 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 249' ' ' ALA . . . . . . . . . . . . . . . 52.08 -170.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 71.24 111.114 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 250' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.18 121.58 14.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 61.31 110.906 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 251' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -72.11 145.28 48.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.31 110.839 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 252' ' ' GLY . . . . . . . . . . . . . . . 111.6 142.36 8.83 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.708 -0.758 . . . . 61.3 112.503 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 253' ' ' GLY . . . . . . . . . . . . . . . -141.66 -60.98 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.749 -0.738 . . . . 64.3 112.538 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 254' ' ' ILE . . . . . . . . . . . . . 25.8 mm 63.55 76.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.358 . . . . 71.45 111.202 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 255' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 53.81 -170.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 70.2 110.878 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 256' ' ' ILE . . . . . 0.478 HG22 ' N ' ' C' ' 258' ' ' ASP . 1.2 pt -82.2 175.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 74.51 111.118 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 257' ' ' SER . . . . . . . . . . . . . 2.7 p -176.9 155.88 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 74.31 110.879 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 258' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -84.39 -177.85 6.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 61.02 110.849 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 259' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -172.33 -170.5 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 73.12 110.932 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.59 135.08 54.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 74.3 111.128 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 94.3 m -108.47 129.17 55.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.218 -0.446 . . . . 71.24 111.208 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 262' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.11 127.28 53.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.43 110.873 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 263' ' ' SER . . . . . 0.423 ' HB3' HD11 ' E' ' 222' ' ' ILE . 25.7 p -142.53 123.66 14.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 64.21 110.833 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 264' ' ' VAL . . . . . 0.508 HG21 HG22 ' D' ' 267' ' ' VAL . 5.2 p -106.48 134.27 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 73.44 111.131 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 265' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -82.22 -77.14 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 72.45 110.849 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 266' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.61 126.88 53.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 75.23 111.19 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . 0.508 HG22 HG21 ' D' ' 264' ' ' VAL . 94.9 t -117.62 124.76 73.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 73.42 111.168 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 268' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.5 114.22 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 62.32 111.163 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.71 133.04 10.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.749 . . . . 75.0 112.456 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.04 143.05 49.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 72.21 110.874 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 271' ' ' GLY . . . . . . . . . . . . . . . 48.96 84.82 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 73.22 112.458 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 272' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 45.75 69.65 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.36 . . . . 72.31 110.932 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 273' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.4 144.53 25.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 73.4 110.873 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 274' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.01 128.42 56.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 72.33 110.866 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 275' ' ' VAL . . . . . . . . . . . . . 76.6 t -127.41 122.17 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 75.23 111.132 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 276' ' ' LEU . . . . . 0.513 HD13 ' CZ2' ' D' ' 287' ' ' TRP . 2.5 tp -128.56 111.46 13.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 61.52 110.89 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 277' ' ' ILE . . . . . 0.679 HG22 ' ND2' ' D' ' 226' ' ' ASN . 5.8 mt -112.42 104.13 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 63.53 111.098 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.78 -165.51 28.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.763 -0.732 . . . . 71.11 112.485 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -110.05 155.98 21.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.806 0.336 . . . . 71.3 110.899 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 280' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.02 131.5 53.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 72.24 110.842 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 281' ' ' TYR . . . . . 0.496 ' HE1' ' HB2' ' E' ' 249' ' ' ALA . 12.7 t80 -124.84 125.73 44.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.129 -0.487 . . . . 74.21 110.929 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 282' ' ' GLY . . . . . . . . . . . . . . . 145.27 179.46 21.58 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 51.1 112.487 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 283' ' ' GLY . . . . . . . . . . . . . . . -100.62 -149.05 23.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 65.11 112.49 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 284' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.51 26.12 13.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 74.3 110.906 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.46 -156.99 15.23 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.721 -0.752 . . . . 52.5 112.503 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 286' ' ' PHE . . . . . 0.606 ' HB3' HG11 ' E' ' 244' ' ' VAL . 27.5 m-85 -116.54 -28.07 6.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.873 0.368 . . . . 71.41 110.892 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 287' ' ' TRP . . . . . 0.513 ' CZ2' HD13 ' D' ' 276' ' ' LEU . 14.8 t90 -164.01 59.44 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 65.41 110.928 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 288' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -137.7 -169.81 2.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 64.33 110.833 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 289' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -104.58 171.85 7.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 70.42 110.84 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 290' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -179.03 -169.86 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.493 . . . . 75.21 110.863 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 291' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -145.54 -50.22 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.449 . . . . 65.55 110.824 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 292' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 63.31 -171.14 0.17 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.425 . . . . 75.41 110.837 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 293' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -69.36 122.71 19.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 73.43 110.882 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 294' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -179.09 -179.17 0.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 73.52 110.889 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 295' ' ' HIS . . . . . . . . . . . . . 28.2 p80 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 73.51 110.804 -179.988 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' E' E ' 217' ' ' MET . . . . . 0.473 ' HG2' HG21 ' C' ' 266' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.81 0.338 . . . . 63.32 110.901 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 218' ' ' LYS . . . . . 0.435 ' HD3' HD11 ' D' ' 219' ' ' ILE . 4.6 mttt -130.53 176.98 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 63.32 110.913 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 219' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.95 151.47 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 53.14 111.117 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 220' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -152.15 132.37 13.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 72.41 110.85 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 221' ' ' ALA . . . . . . . . . . . . . . . -107.72 141.79 38.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 72.45 111.15 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 222' ' ' ILE . . . . . 0.423 HD11 ' HB3' ' D' ' 263' ' ' SER . 1.0 OUTLIER -114.53 -24.88 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 71.2 111.06 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 223' ' ' VAL . . . . . . . . . . . . . 21.6 t 63.79 106.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 72.21 111.133 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 224' ' ' GLY . . . . . . . . . . . . . . . -149.14 -176.74 22.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.804 -0.712 . . . . 64.14 112.531 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 225' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -55.86 -71.07 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.341 . . . . 74.44 110.886 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 226' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -86.55 113.26 22.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.879 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 227' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.87 139.35 53.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 55.15 110.831 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 228' ' ' ALA . . . . . 0.471 ' HB3' HG23 ' D' ' 264' ' ' VAL . . . -124.21 118.71 27.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 74.03 111.055 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 229' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' E' ' 265' ' ' GLU . 12.5 mttm -75.63 -45.62 36.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 71.21 110.911 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 230' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -168.35 135.97 2.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 65.14 110.841 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 231' ' ' ILE . . . . . 0.922 HD12 HG11 ' E' ' 239' ' ' VAL . 8.9 pt -138.16 134.42 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 73.43 111.113 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 232' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -135.86 132.7 36.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.908 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 233' ' ' THR . . . . . 0.679 ' OG1' ' HB3' ' E' ' 237' ' ' ALA . 0.5 OUTLIER -136.94 151.51 49.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.21 111.12 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 234' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.25 167.56 22.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 72.21 110.904 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 235' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 72.78 -69.95 0.18 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 73.41 110.9 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 236' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -178.5 63.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 72.41 110.869 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 237' ' ' ALA . . . . . 0.679 ' HB3' ' OG1' ' E' ' 233' ' ' THR . . . -105.86 156.3 18.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 63.33 111.074 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 238' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.15 135.61 47.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 72.32 110.889 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 239' ' ' VAL . . . . . 0.922 HG11 HD12 ' E' ' 231' ' ' ILE . 7.2 p -125.0 126.47 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 75.11 111.195 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 240' ' ' GLN . . . . . 0.575 ' C ' HD13 ' E' ' 241' ' ' LEU . 4.7 tm0? -122.71 123.05 40.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 71.2 110.834 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 241' ' ' LEU . . . . . 0.928 HD12 HD12 ' E' ' 277' ' ' ILE . 0.3 OUTLIER -111.85 118.7 36.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 74.42 110.914 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 242' ' ' GLY . . . . . . . . . . . . . . . 134.56 169.32 11.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 73.3 112.52 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 243' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -85.87 145.41 27.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.849 0.357 . . . . 64.22 110.903 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 244' ' ' VAL . . . . . 0.606 HG11 ' HB3' ' D' ' 286' ' ' PHE . 21.6 t -110.99 135.33 50.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.11 111.118 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 245' ' ' VAL . . . . . . . . . . . . . 23.4 t -122.12 128.54 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 73.03 111.136 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 246' ' ' THR . . . . . . . . . . . . . 13.9 t -69.95 174.96 4.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 74.05 111.141 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 247' ' ' ALA . . . . . 0.595 ' HB3' ' CG ' ' E' ' 291' ' ' HIS . . . -59.72 -43.32 94.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 73.45 111.138 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.07 -49.12 76.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 72.45 111.132 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 249' ' ' ALA . . . . . 0.496 ' HB2' ' HE1' ' D' ' 281' ' ' TYR . . . 60.76 -175.44 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 65.11 111.134 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 250' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.82 -171.54 1.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 74.43 110.891 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 251' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -108.44 34.67 3.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 64.43 110.84 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 252' ' ' GLY . . . . . . . . . . . . . . . 129.75 -172.33 20.05 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.688 -0.768 . . . . 71.42 112.501 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 253' ' ' GLY . . . . . . . . . . . . . . . -174.54 140.31 5.32 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.665 -0.778 . . . . 61.24 112.479 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 254' ' ' ILE . . . . . . . . . . . . . 2.8 mp -98.36 -61.83 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.763 0.316 . . . . 73.05 111.13 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 255' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -166.3 -40.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 64.32 110.84 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 256' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.57 135.63 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 63.55 111.158 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 257' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.67 -42.27 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 75.52 110.811 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.72 -173.97 4.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 75.32 110.798 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 259' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -156.8 25.8 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 71.21 110.869 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 260' ' ' THR . . . . . . . . . . . . . 1.5 p -92.29 129.95 38.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 74.02 111.151 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 261' ' ' THR . . . . . . . . . . . . . 92.4 m -109.63 121.5 45.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 44.12 111.09 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 262' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.24 119.01 33.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 74.51 110.877 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 263' ' ' SER . . . . . . . . . . . . . 98.7 p -133.19 133.24 42.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 74.45 110.871 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 264' ' ' VAL . . . . . . . . . . . . . 1.2 p -104.46 153.44 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 74.5 111.112 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 265' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' E' ' 229' ' ' LYS . 1.6 tt0 -92.22 -51.0 5.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.42 110.902 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 266' ' ' THR . . . . . . . . . . . . . 1.4 m -154.43 145.16 22.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 60.24 111.122 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . 0.463 HG11 HG21 ' E' ' 275' ' ' VAL . 86.6 t -136.17 120.54 25.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 63.35 111.172 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 268' ' ' VAL . . . . . 0.451 ' O ' HG13 ' E' ' 268' ' ' VAL . 5.3 p -127.3 115.55 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 72.41 111.11 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.65 133.62 10.82 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.733 . . . . 52.15 112.456 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.57 144.5 44.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 62.52 110.913 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 271' ' ' GLY . . . . . . . . . . . . . . . 42.27 76.14 0.12 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.722 -0.752 . . . . 54.04 112.522 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 64.04 116.3 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 64.03 110.877 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 273' ' ' SER . . . . . . . . . . . . . 12.1 m -146.41 145.25 30.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 71.51 110.802 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 274' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -114.62 127.69 55.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 71.01 110.86 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 275' ' ' VAL . . . . . 0.516 ' HB ' HG23 ' E' ' 239' ' ' VAL . 24.2 t -127.1 121.9 58.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 70.33 111.09 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 276' ' ' LEU . . . . . 0.663 HD13 ' CE2' ' E' ' 287' ' ' TRP . 0.2 OUTLIER -130.24 112.53 13.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.204 -0.453 . . . . 74.01 110.934 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' E' E ' 277' ' ' ILE . . . . . 0.928 HD12 HD12 ' E' ' 241' ' ' LEU . 55.9 mt -112.26 104.56 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 74.12 111.141 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 278' ' ' GLY . . . . . . . . . . . . . . . 148.46 -154.1 25.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.678 -0.772 . . . . 22.43 112.472 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 279' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -122.61 156.1 34.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 65.35 110.88 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 280' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -116.4 128.97 55.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 72.22 110.896 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 281' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -121.85 126.01 47.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 74.43 110.905 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 282' ' ' GLY . . . . . . . . . . . . . . . 152.54 -176.51 30.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.705 -0.759 . . . . 51.52 112.448 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 283' ' ' GLY . . . . . . . . . . . . . . . -51.99 148.75 10.02 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.761 . . . . 72.41 112.536 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 284' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? 72.28 -68.79 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 73.22 110.885 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.68 67.44 0.98 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 64.24 112.497 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 286' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -176.1 172.6 2.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.744 0.307 . . . . 61.14 110.93 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 287' ' ' TRP . . . . . 0.663 ' CE2' HD13 ' E' ' 276' ' ' LEU . 1.3 t90 -51.47 -37.63 49.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.185 -0.462 . . . . 73.33 110.978 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 288' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -91.55 -173.57 3.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 72.1 110.861 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 289' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 63.1 163.77 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 62.44 110.909 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 290' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -169.4 -170.25 1.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 63.42 110.875 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 291' ' ' HIS . . . . . 0.595 ' CG ' ' HB3' ' E' ' 247' ' ' ALA . 13.7 t-80 -52.07 160.26 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 62.13 110.854 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 292' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.31 -174.72 3.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 71.24 110.876 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 293' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -148.65 156.44 42.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 71.44 110.815 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 294' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -62.55 -35.07 78.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 70.44 110.9 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 75.44 110.878 179.993 . . . . . . . . 1 1 . 1 stop_ save_